#Chr	Start	End	Ref	Alt	Ref.Gene	Func.refGene	ExonicFunc.refGene	Gene.ensGene	avsnp150	AAChange.ensGene	AAChange.refGene	clinvar: Clinvar 	 CancerVar: CancerVar and Evidence 	Freq_ExAC_ALL	Freq_esp6500siv2_all	Freq_1000g2015aug_all	Freq_gnomAD_genome_ALL	CADD_raw	CADD_phred	SIFT_score	GERP++_RS	phastCons20way_mammalian	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Interpro_domain	AAChange.knownGene	MetaSVM_score	Freq_gnomAD_genome_POPs	OMIM	Phenotype_MIM	OrphaNumber	Orpha	Pathway	Therap_list	Diag_list	Prog_list	Polyphen2_HDIV_score	FATHMM_score	MetaLR_score	MutationAssessor_score	cosmic91	icgc28	Otherinfo
1	2117558	2117558	C	T	FAAP20	exonic	synonymous SNV	ENSG00000162585	rs3123595	ENSG00000162585:ENST00000400919:exon7:c.G93A:p.A31A	FAAP20:NM_001282672:exon6:c.G93A:p.A31A,FAAP20:NM_001282671:exon7:c.G93A:p.A31A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1169	.	0.144569	0.1358	.	.	.	.	.	.	.	.	.	.	AFR:0.2648,AMR:0.0704,EAS:0.0897,FIN:0.0559,NFE:0.0932,OTH:0.0908,ASJ:0.0232	615183	.	.	.	.	.	.	.	.	.	.	.	1	MU9473577	het
1	2125172	2125172	G	A	FAAP20	exonic	nonsynonymous SNV	ENSG00000162585	rs1058411	ENSG00000162585:ENST00000378546:exon3:c.C376T:p.P126S,ENSG00000162585:ENST00000400918:exon3:c.C376T:p.P126S,ENSG00000162585:ENST00000414253:exon3:c.C376T:p.P126S,ENSG00000162585:ENST00000378545:exon4:c.C685T:p.P229S	FAAP20:NM_001256946:exon3:c.C376T:p.P126S,FAAP20:NM_001282673:exon3:c.C376T:p.P126S,FAAP20:NM_182533:exon3:c.C376T:p.P126S,FAAP20:NM_001282670:exon7:c.C685T:p.P229S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1225	0.2005	0.207867	MU72161	-0.943	0.021	0.737	1.1	0.001	.	.	FAAP20, FANCA interaction domain	C1orf86:uc001aiy.3:exon3:c.C376T:p.P126S,C1orf86:uc031pkv.1:exon3:c.C376T:p.P126S	-0.913	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|1|321|0.00311526,AMR:0.1922,EAS:0.0859,FIN:0.0265,NFE:0.0920,OTH:0.0561,ASJ:0.4615	615183	.	.	.	.	.	.	.	0.229	1.19	0.000	0.9	1	1(thyroid)	0.0937
1	2488153	2488153	A	G	TNFRSF14	exonic	nonsynonymous SNV	ENSG00000157873	rs4870	ENSG00000157873:ENST00000355716:exon1:c.A50G:p.K17R,ENSG00000157873:ENST00000409119:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000426449:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000434817:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000435221:exon2:c.A50G:p.K17R,ENSG00000157873:ENST00000451778:exon2:c.A50G:p.K17R	TNFRSF14:NM_001297605:exon1:c.A50G:p.K17R,TNFRSF14:NM_003820:exon1:c.A50G:p.K17R	clinvar: not_provided 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5443	0.5580	0.614816	MU4560918	-0.182	1.198	0.471	-1.09	0.000	.	.	.	TNFRSF14:uc001ajr.3:exon1:c.A50G:p.K17R,TNFRSF14:uc009vlf.1:exon1:c.A50G:p.K17R,TNFRSF14:uc010nzc.1:exon1:c.A50G:p.K17R	-0.931	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.5446,EAS:0.5143,FIN:0.4467,NFE:0.4609,OTH:0.4842,ASJ:0.7156	602746	.	.	.	.	.	.	.	0.61	-2.37	0.000	1.175	1	1(pancreas)	0.4735
1	2490898	2490898	C	A	TNFRSF14	intronic	.	ENSG00000157873	rs2257763	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5899	.	0.640775	0.5671	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C450A:p.C150X	.	AFR:0.7517,AMR:0.5358,EAS:0.5143,FIN:0.5020,NFE:0.4867,OTH:0.5307,ASJ:0.4603	602746	.	.	.	.	.	.	.	.	.	.	.	1	MU15519966	hom
1	2490942	2490942	C	A	TNFRSF14	intronic	.	ENSG00000157873	rs2281852	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5713	.	0.597843	ESAD-UK|2|409|0.00488998,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C494A:p.A165E	.	AFR:0.5331,AMR:0.6520,EAS:0.4570,FIN:0.4611,NFE:0.4991,OTH:0.4821,ASJ:0.5251	602746	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.5256
1	2491205	2491205	C	T	TNFRSF14	intronic	.	ENSG00000157873	rs2234161	.	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6596	.	0.64397	12(central_nervous_system)	.	.	.	.	.	.	.	.	TNFRSF14:uc001ajt.1:exon3:c.C757T:p.R253C	.	AFR:MU15520040,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.7639,FIN:0.5358,NFE:0.4603,OTH:0.5130,ASJ:0.5704	602746	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.5006
1	3328358	3328358	T	C	PRDM16	exonic	nonsynonymous SNV	ENSG00000142611	rs870124	ENSG00000142611:ENST00000509860:exon5:c.T1024C:p.S342P,ENSG00000142611:ENST00000270722:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000378391:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000441472:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000442529:exon9:c.T1597C:p.S533P,ENSG00000142611:ENST00000511072:exon9:c.T1600C:p.S534P,ENSG00000142611:ENST00000514189:exon9:c.T1600C:p.S534P,ENSG00000142611:ENST00000378398:exon10:c.T1600C:p.S534P	PRDM16:NM_022114:exon9:c.T1597C:p.S533P,PRDM16:NM_199454:exon9:c.T1597C:p.S533P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8897	0.8777	0.945088	0.9008	-0.543	0.172	0.651	5.33	0.826	.	.	.	PRDM16:uc001akc.3:exon9:c.T1597C:p.S533P,PRDM16:uc001ake.3:exon9:c.T1597C:p.S533P,PRDM16:uc001akf.3:exon9:c.T1597C:p.S533P,PRDM16:uc009vlh.3:exon9:c.T700C:p.S234P	-0.955	AFR:0.9696,AMR:0.9332,EAS:0.9994,FIN:0.9196,NFE:0.8459,OTH:0.8794,ASJ:0.86	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	0.0	3.38	0.000	-1.7	1	MU113190	hom
1	3329021	3329021	G	A	PRDM16	exonic	nonsynonymous SNV	ENSG00000142611	rs369599647	ENSG00000142611:ENST00000509860:exon5:c.G1687A:p.E563K,ENSG00000142611:ENST00000270722:exon9:c.G2260A:p.E754K,ENSG00000142611:ENST00000378391:exon9:c.G2260A:p.E754K,ENSG00000142611:ENST00000441472:exon9:c.G2260A:p.E754K,ENSG00000142611:ENST00000442529:exon9:c.G2260A:p.E754K,ENSG00000142611:ENST00000511072:exon9:c.G2263A:p.E755K,ENSG00000142611:ENST00000514189:exon9:c.G2263A:p.E755K,ENSG00000142611:ENST00000378398:exon10:c.G2263A:p.E755K	PRDM16:NM_022114:exon9:c.G2260A:p.E754K,PRDM16:NM_199454:exon9:c.G2260A:p.E754K	clinvar: Uncertain_significance 	 CancerVar: 6#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, 1, 1, 0] 	4.172e-05	0.0002	.	.	5.261	25.7	0.001	4.41	0.887	.	.	.	PRDM16:uc001akc.3:exon9:c.G2260A:p.E754K,PRDM16:uc001ake.3:exon9:c.G2260A:p.E754K,PRDM16:uc001akf.3:exon9:c.G2260A:p.E754K,PRDM16:uc009vlh.3:exon9:c.G1363A:p.E455K	-1.043	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	0.997	2.89	0.064	2.455	1	MU130982667	het
1	3342804	3342804	G	T	PRDM16	intronic	.	ENSG00000142611	rs870171	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2980	0.3151	0.379393	0.3182	.	.	.	.	.	.	.	.	.	.	AFR:0.4240,AMR:0.3126,EAS:0.5156,FIN:0.2263,NFE:0.2621,OTH:0.2577,ASJ:0.2748	605557	615373;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	MU82061590	het
1	6529526	6529526	C	T	PLEKHG5	intronic	.	ENSG00000171680	rs201675267	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0002	.	0.000199681	0.0002	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0037,FIN:0,NFE:0,OTH:0,ASJ:0	611101	611067;615376;	369867;206580;	369867|RI-CMT type C|<1 / 1 000 000|Autosomal recessive|All ages<br>Childhood<br>Adult|615376 ~206580|Autosomal recessive distal spinal muscular atrophy type 4<br>Distal spinal muscular atrophy type 4<br>dSMA4|<1 / 1 000 000|Autosomal recessive|Childhood|611067 ~	~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	1	.	het
1	6700131	6700131	-	A	DNAJC11	intronic	.	ENSG00000007923	rs56145914	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0586	.	.	0.5015	.	.	.	.	.	.	.	.	.	.	AFR:0.4670,AMR:0.3532,EAS:0.5996,FIN:0.124,NFE:0.5262,OTH:0.4655,ASJ:0.5448	614827	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	6704635	6704635	A	G	DNAJC11	exonic	synonymous SNV	ENSG00000007923	rs200458	ENSG00000007923:ENST00000377573:exon9:c.T810C:p.G270G,ENSG00000007923:ENST00000294401:exon10:c.T1080C:p.G360G,ENSG00000007923:ENST00000377577:exon10:c.T1080C:p.G360G,ENSG00000007923:ENST00000542246:exon10:c.T966C:p.G322G	DNAJC11:NM_018198:exon10:c.T1080C:p.G360G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8836	0.9000	0.833067	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	DNAJC11:uc010nzu.1:exon9:c.T810C:p.G270G,DNAJC11:uc001aof.2:exon10:c.T1080C:p.G360G,DNAJC11:uc001aog.2:exon10:c.T1080C:p.G360G	.	AFR:0.8748,AMR:0.8724,EAS:0.8841,FIN:0.5730,NFE:0.8712,OTH:0.9033,ASJ:0.9499	614827	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.9041
1	6947717	6947717	C	T	CAMTA1	exonic	nonsynonymous SNV	ENSG00000171735	rs3810982	ENSG00000171735:ENST00000557126:exon4:c.C238T:p.L80F	CAMTA1:NM_001242701:exon4:c.C238T:p.L80F	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1909	.	0.208267	0.1898	2.631	20.4	0.005	3.21	1.000	.	.	CG-1 DNA-binding domain	CAMTA1:uc021ofq.1:exon4:c.C238T:p.L80F	-0.952	AFR:0.1976,AMR:0.1029,EAS:0.2621,FIN:0.2021,NFE:0.1813,OTH:0.1527,ASJ:0.2185	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	0.000	.	1	MU4566693	hom
1	7430266	7430266	C	T	CAMTA1	intronic	.	ENSG00000237402	rs3752542	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.29393	0.1749	.	.	.	.	.	.	.	.	.	.	AFR:0.1209,AMR:0.3186,EAS:0.5284,FIN:0.1766,NFE:0.1603,OTH:0.1772,ASJ:0.1424	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	MU15700596	het
1	7700627	7700627	G	T	CAMTA1	intronic	.	ENSG00000171735	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	9.905e-05	.	.	3.23e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.665e-05,OTH:0,ASJ:0	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	.	het
1	7723957	7723957	G	A	CAMTA1	exonic	synonymous SNV	ENSG00000171735	rs12128526	ENSG00000171735:ENST00000303635:exon9:c.G1350A:p.S450S,ENSG00000171735:ENST00000439411:exon9:c.G1350A:p.S450S	CAMTA1:NM_001349608:exon8:c.G1260A:p.S420S,CAMTA1:NM_001349612:exon8:c.G1260A:p.S420S,CAMTA1:NM_001349609:exon9:c.G1350A:p.S450S,CAMTA1:NM_001349610:exon9:c.G1350A:p.S450S,CAMTA1:NM_015215:exon9:c.G1350A:p.S450S	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4450	0.4300	0.40016	1(large_intestine)	.	.	.	.	.	.	.	.	CAMTA1:uc001aoi.3:exon9:c.G1350A:p.S450S	.	AFR:MU110401,AMR:LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.3886,FIN:0.4964,NFE:0.4333,OTH:0.3456,ASJ:0.4396	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	2(lung)	0.4891
1	7737799	7737799	A	G	CAMTA1	intronic	.	ENSG00000171735	rs3011926	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5498	0.5563	0.591653	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.5458,AMR:0.5805,EAS:0.6093,FIN:0.6447,NFE:0.4857,OTH:0.5329,ASJ:0.4773	611501	614756;	314647;	314647|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614756 ~	.	.	.	.	.	.	.	.	1	1(biliary_tract)	0.5236
1	8073461	8073461	G	A	ERRFI1	exonic	stopgain	ENSG00000116285	rs201650762	ENSG00000116285:ENST00000377482:exon4:c.C1198T:p.R400X	ERRFI1:NM_018948:exon4:c.C1198T:p.R400X	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	8.237e-05	7.7e-05	.	6.457e-05	9.041	35	.	0.737	0.985	.	.	.	ERRFI1:uc001aoz.3:exon4:c.C1198T:p.R400X	.	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	608069	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	9781643	9781643	C	T	PIK3CD	exonic	synonymous SNV	ENSG00000171608	rs140468930	ENSG00000171608:ENST00000543390:exon8:c.C954T:p.L318L,ENSG00000171608:ENST00000361110:exon14:c.C2025T:p.L675L,ENSG00000171608:ENST00000377346:exon15:c.C1953T:p.L651L,ENSG00000171608:ENST00000536656:exon15:c.C2025T:p.L675L	PIK3CD:NM_001350235:exon14:c.C1866T:p.L622L,PIK3CD:NM_001350234:exon15:c.C1950T:p.L650L,PIK3CD:NM_005026:exon15:c.C1953T:p.L651L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0249	0.0006	0.0289537	0.0062	.	.	.	.	.	0.0069	0.422	.	PIK3CD:uc001aqe.4:exon14:c.C2025T:p.L675L,PIK3CD:uc010oaf.2:exon14:c.C1950T:p.L650L,PIK3CD:uc021ogb.1:exon14:c.C1305T:p.L435L,PIK3CD:uc001aqb.4:exon15:c.C1953T:p.L651L	.	AFR:0.0017,AMR:0.1196,EAS:0.0049,FIN:0.0072,NFE:0.0021,OTH:0.0122,ASJ:0	602839	615513;	397596;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	1	.	het
1	9784423	9784423	C	T	PIK3CD	exonic	synonymous SNV	ENSG00000171608	rs11121484	ENSG00000171608:ENST00000361110:exon21:c.C2880T:p.Y960Y,ENSG00000171608:ENST00000377346:exon22:c.C2808T:p.Y936Y,ENSG00000171608:ENST00000536656:exon22:c.C2880T:p.Y960Y	PIK3CD:NM_001350235:exon21:c.C2721T:p.Y907Y,PIK3CD:NM_001350234:exon22:c.C2805T:p.Y935Y,PIK3CD:NM_005026:exon22:c.C2808T:p.Y936Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1730	0.2305	0.305911	2(large_intestine)	.	.	.	.	.	.	.	.	PIK3CD:uc001aqe.4:exon21:c.C2880T:p.Y960Y,PIK3CD:uc010oaf.2:exon21:c.C2805T:p.Y935Y,PIK3CD:uc021ogb.1:exon21:c.C2160T:p.Y720Y,PIK3CD:uc001aqb.4:exon22:c.C2808T:p.Y936Y	.	AFR:MU130633,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.5410,FIN:0.1993,NFE:0.0861,OTH:0.1187,ASJ:0.2123	602839	615513;	397596;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	1	1(lung)	0.0613
1	11181327	11181327	C	T	MTOR	exonic	synonymous SNV	ENSG00000198793	rs11121691	ENSG00000198793:ENST00000376838:exon11:c.G1524A:p.L508L,ENSG00000198793:ENST00000361445:exon49:c.G6909A:p.L2303L	MTOR:NM_004958:exon49:c.G6909A:p.L2303L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2184	0.3021	0.220647	23(meninges)	.	.	.	.	.	.	.	.	MTOR:uc001asc.3:exon11:c.G1524A:p.L508L,MTOR:uc001asd.3:exon49:c.G6909A:p.L2303L	.	AFR:.,AMR:.,EAS:0.4310,FIN:0.1337,NFE:0.3633,OTH:0.0593,ASJ:0.2797	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7629,7625	.	,7626	.	.	.	.	1	1(stomach)	0.2270
1	11190646	11190646	G	A	MTOR	exonic	synonymous SNV	ENSG00000198793	rs2275527	ENSG00000198793:ENST00000376838:exon1:c.C168T:p.S56S,ENSG00000198793:ENST00000361445:exon39:c.C5553T:p.S1851S	MTOR:NM_004958:exon39:c.C5553T:p.S1851S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2215	0.3059	0.228634	3(lung)	.	.	.	.	.	.	.	.	MTOR:uc001asc.3:exon1:c.C168T:p.S56S,MTOR:uc001asd.3:exon39:c.C5553T:p.S1851S	.	AFR:24(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,FIN:0.2823,NFE:0.4400,OTH:0.1360,ASJ:MU668989	601231	616638;	457485;	457485|MINDS syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616638 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04136 Autophagy - other~ko04138 Autophagy - yeast~ko04139 Mitophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7629,7625	.	,7626	.	.	.	.	1	1(thyroid)	0.3642
1	11854457	11854457	G	A	MTHFR	exonic	synonymous SNV	ENSG00000177000	rs4846051	ENSG00000177000:ENST00000376592:exon7:c.C1305T:p.F435F,ENSG00000177000:ENST00000376583:exon8:c.C1428T:p.F476F,ENSG00000177000:ENST00000376590:exon8:c.C1305T:p.F435F,ENSG00000177000:ENST00000376585:exon9:c.C1428T:p.F476F	MTHFR:NM_001330358:exon8:c.C1428T:p.F476F,MTHFR:NM_005957:exon8:c.C1305T:p.F435F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9697	0.8905	0.902955	0.9091	.	.	.	.	.	.	.	.	MTHFR:uc031plg.1:exon4:c.C570T:p.F190F,MTHFR:uc001atb.1:exon7:c.C1374T:p.F458F,MTHFR:uc001atc.2:exon8:c.C1305T:p.F435F	.	AFR:0.6825,AMR:0.9809,EAS:0.9988,FIN:1,NFE:0.9992,OTH:0.9867,ASJ:0.9768	607093	181500;188050;236250;601634;	268357;823;395;	268357|-|Unknown|-|-|182940 301410 601634 ~823|-|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|182940 301410 601634 ~395|MTHFR deficiency<br>Methylene tetrahydrofolate reductase deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|236250 ~	.	.	.	.	.	.	.	.	1	MU81691184	hom
1	14105139	14105139	T	A	PRDM2	exonic	nonsynonymous SNV	ENSG00000116731	rs2076324	ENSG00000116731:ENST00000413440:exon3:c.T246A:p.D82E,ENSG00000116731:ENST00000343137:exon4:c.T246A:p.D82E,ENSG00000116731:ENST00000235372:exon8:c.T849A:p.D283E,ENSG00000116731:ENST00000311066:exon8:c.T849A:p.D283E	PRDM2:NM_001007257:exon3:c.T246A:p.D82E,PRDM2:NM_012231:exon8:c.T849A:p.D283E,PRDM2:NM_015866:exon8:c.T849A:p.D283E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3563	0.3206	0.371206	0.3255	-1.966	0.001	1.0	-3.62	0.313	.	.	SET domain	PRDM2:uc001avk.3:exon4:c.T246A:p.D82E,PRDM2:uc021ogk.1:exon4:c.T138A:p.D46E,PRDM2:uc001avh.3:exon8:c.T849A:p.D283E,PRDM2:uc001avi.3:exon8:c.T849A:p.D283E	-1.058	AFR:0.2430,AMR:0.5269,EAS:0.3429,FIN:0.3495,NFE:0.3530,OTH:0.3623,ASJ:0.3067	601196	.	.	.	.	.	.	.	0.003	4.98	0.000	0	1	MU19318037	het
1	14143003	14143003	A	G	PRDM2	exonic	nonsynonymous SNV	ENSG00000116731	rs1046331	ENSG00000116731:ENST00000505823:exon3:c.A101G:p.Q34R,ENSG00000116731:ENST00000503842:exon4:c.A101G:p.Q34R,ENSG00000116731:ENST00000376048:exon7:c.A593G:p.Q198R	PRDM2:NM_001135610:exon7:c.A593G:p.Q198R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8256	0.8744	0.821286	0.8594	0.129	3.917	0.0	-4.33	0.332	.	.	.	PRDM2:uc001avg.3:exon7:c.A593G:p.Q198R	-1.038	AFR:0.9377,AMR:0.8067,EAS:0.6968,FIN:0.8144,NFE:0.8477,OTH:0.8388,ASJ:0.7748	601196	.	.	.	.	.	.	.	0.0	0.56	0.000	.	1	MU20384874	het
1	16256007	16256007	T	C	SPEN	exonic	nonsynonymous SNV	ENSG00000065526	rs848209	ENSG00000065526:ENST00000375759:exon11:c.T3272C:p.L1091P	SPEN:NM_015001:exon11:c.T3272C:p.L1091P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6154	0.6878	0.648962	1(lung)	-0.797	0.043	0.846	3.51	0.197	.	.	.	SPEN:uc010obp.1:exon10:c.T3149C:p.L1050P,SPEN:uc001axk.1:exon11:c.T3272C:p.L1091P	-1.030	AFR:1(urinary_tract),AMR:MU4550099,EAS:0.6713,FIN:0.9243,NFE:0.7584,OTH:0.61,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,COCA-CN|3|321|0.00934579	613484	.	.	.	.	.	.	.	0.0	3.2	0.000	-0.895	1	1(thyroid)	0.2983
1	16259813	16259813	A	G	SPEN	exonic	nonsynonymous SNV	ENSG00000065526	rs848210	ENSG00000065526:ENST00000375759:exon11:c.A7078G:p.N2360D	SPEN:NM_015001:exon11:c.A7078G:p.N2360D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6146	0.6896	0.648962	MU4549778	-1.105	0.010	0.853	3.1	0.006	.	.	.	SPEN:uc010obp.1:exon10:c.A6955G:p.N2319D,SPEN:uc001axk.1:exon11:c.A7078G:p.N2360D	-1.042	AFR:LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.6706,EAS:0.7590,FIN:0.6033,NFE:0.2976,OTH:0.6101,ASJ:0.9239	613484	.	.	.	.	.	.	.	0.0	3.13	0.000	-0.625	1	3(haematopoietic_and_lymphoid_tissue)	0.5793
1	16261372	16261372	C	T	SPEN	exonic	synonymous SNV	ENSG00000065526	rs41269149	ENSG00000065526:ENST00000375759:exon11:c.C8637T:p.N2879N	SPEN:NM_015001:exon11:c.C8637T:p.N2879N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0003	0.0002	0.000199681	0.0003	.	.	.	.	.	.	.	.	SPEN:uc010obp.1:exon10:c.C8514T:p.N2838N,SPEN:uc001axk.1:exon11:c.C8637T:p.N2879N	.	AFR:0.0001,AMR:0,EAS:0,FIN:0.0003,NFE:0.0004,OTH:0,ASJ:0	613484	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	16464673	16464673	G	A	EPHA2	exonic	synonymous SNV	ENSG00000142627	rs2230597	ENSG00000142627:ENST00000358432:exon5:c.C987T:p.P329P	EPHA2:NM_001329090:exon4:c.C825T:p.P275P,EPHA2:NM_004431:exon5:c.C987T:p.P329P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3787	0.3888	0.349441	0.3666	.	.	.	.	.	.	.	.	EPHA2:uc001aya.2:exon5:c.C987T:p.P329P,EPHA2:uc010oca.2:exon5:c.C987T:p.P329P	.	AFR:0.3567,AMR:0.3753,EAS:0.1239,FIN:0.3430,NFE:0.3990,OTH:0.4059,ASJ:0.4669	176946	116600;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	1	MU65392	het
1	16464936	16464936	C	T	EPHA2	intronic	.	ENSG00000142627	rs2291804	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0266	0.0158	0.0265575	0.0212	.	.	.	.	.	0.0060	0.098	.	.	.	AFR:0.0030,AMR:0.0167,EAS:0.0216,FIN:0.0458,NFE:0.0261,OTH:0.0266,ASJ:0.0099	176946	116600;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	1	MU21675673	het
1	17380497	17380497	G	T	SDHB	exonic	synonymous SNV	ENSG00000117118	rs2746462	ENSG00000117118:ENST00000375499:exon1:c.C18A:p.A6A	SDHB:NM_003000:exon1:c.C18A:p.A6A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9721	0.9515	0.957069	0.9577	.	.	.	.	.	.	.	.	SDHB:uc001bae.3:exon1:c.C18A:p.A6A	.	AFR:0.9069,AMR:0.9690,EAS:0.9994,FIN:0.9823,NFE:0.9755,OTH:0.9785,ASJ:0.9371	185470	115310;171300;606764;606864;612359;	201;97286;44890;29072;29072;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	1	MU81693539	hom
1	19018405	19018405	G	A	PAX7	exonic	synonymous SNV	ENSG00000009709	rs2076020	ENSG00000009709:ENST00000375375:exon5:c.G744A:p.E248E,ENSG00000009709:ENST00000400661:exon5:c.G738A:p.E246E,ENSG00000009709:ENST00000420770:exon5:c.G744A:p.E248E	PAX7:NM_001135254:exon5:c.G744A:p.E248E,PAX7:NM_002584:exon5:c.G744A:p.E248E,PAX7:NM_013945:exon5:c.G738A:p.E246E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0862	0.0405	0.101038	MU141754	.	.	.	.	.	.	.	.	PAX7:uc001bay.3:exon5:c.G744A:p.E248E,PAX7:uc001baz.3:exon5:c.G738A:p.E246E,PAX7:uc010oct.2:exon5:c.G744A:p.E248E	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.0595,EAS:0.1169,FIN:0.1358,NFE:0.2256,OTH:0.0805,ASJ:0.0137	167410	268220;	780;99756;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~	 ~	.	.	.	.	.	.	.	1	1(large_intestine)	0.0588
1	19018432	19018432	A	C	PAX7	exonic	synonymous SNV	ENSG00000009709	rs2076019	ENSG00000009709:ENST00000375375:exon5:c.A771C:p.T257T,ENSG00000009709:ENST00000400661:exon5:c.A765C:p.T255T,ENSG00000009709:ENST00000420770:exon5:c.A771C:p.T257T	PAX7:NM_001135254:exon5:c.A771C:p.T257T,PAX7:NM_002584:exon5:c.A771C:p.T257T,PAX7:NM_013945:exon5:c.A765C:p.T255T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0990	0.0548	0.1248	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	PAX7:uc001bay.3:exon5:c.A771C:p.T257T,PAX7:uc001baz.3:exon5:c.A765C:p.T255T,PAX7:uc010oct.2:exon5:c.A771C:p.T257T	.	AFR:0.0709,AMR:0.0524,EAS:0.1391,FIN:0.2299,NFE:0.0804,OTH:0.0591,ASJ:0.1193	167410	268220;	780;99756;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~	 ~	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.0591
1	19027239	19027239	A	G	PAX7	exonic	synonymous SNV	ENSG00000009709	rs2743201	ENSG00000009709:ENST00000375375:exon6:c.A879G:p.P293P,ENSG00000009709:ENST00000400661:exon6:c.A873G:p.P291P,ENSG00000009709:ENST00000420770:exon6:c.A879G:p.P293P	PAX7:NM_001135254:exon6:c.A879G:p.P293P,PAX7:NM_002584:exon6:c.A879G:p.P293P,PAX7:NM_013945:exon6:c.A873G:p.P291P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3747	0.3721	0.488618	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PAX7:uc001bay.3:exon6:c.A879G:p.P293P,PAX7:uc001baz.3:exon6:c.A873G:p.P291P,PAX7:uc010oct.2:exon6:c.A879G:p.P293P	.	AFR:MU760649,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.5991,FIN:0.4414,NFE:0.3767,OTH:0.5857,ASJ:0.3923	167410	268220;	780;99756;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~	 ~	.	.	.	.	.	.	.	1	2(liver)	0.3289
1	20980880	20980880	G	A	DDOST	intronic	.	ENSG00000244038	rs607254	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3878	0.3863	0.357228	ESAD-UK|2|409|0.00488998,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.3787,AMR:0.3687,EAS:0.4338,FIN:0.2736,NFE:0.3759,OTH:0.3940,ASJ:0.4007	602202	614507;	300536;	300536|CDG syndrome type Ir<br>CDG-Ir<br>CDG1R<br>Carbohydrate deficient glycoprotein syndrome type Ir<br>Congenital disorder of glycosylation type 1r<br>Congenital disorder of glycosylation type Ir|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614507 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.3814
1	20982631	20982631	G	A	DDOST	exonic	synonymous SNV	ENSG00000244038	rs4704	ENSG00000244038:ENST00000415136:exon2:c.C255T:p.G85G,ENSG00000244038:ENST00000375048:exon3:c.C366T:p.G122G,ENSG00000244038:ENST00000602624:exon3:c.C315T:p.G105G	DDOST:NM_005216:exon3:c.C366T:p.G122G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5844	0.6502	0.58726	1(oesophagus)	.	.	.	.	.	.	.	.	DDOST:uc010ode.1:exon2:c.C255T:p.G85G,DDOST:uc001bdo.1:exon3:c.C366T:p.G122G	.	AFR:MU4553462,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,EAS:0.7344,FIN:0.5573,NFE:0.59,OTH:0.3861,ASJ:0.6286	602202	614507;	300536;	300536|CDG syndrome type Ir<br>CDG-Ir<br>CDG1R<br>Carbohydrate deficient glycoprotein syndrome type Ir<br>Congenital disorder of glycosylation type 1r<br>Congenital disorder of glycosylation type Ir|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614507 ~	.	.	.	.	.	.	.	.	1	1(lung)	0.6179
1	23885498	23885498	T	C	ID3	exonic	nonsynonymous SNV	ENSG00000117318	rs11574	ENSG00000117318:ENST00000374561:exon2:c.A313G:p.T105A	ID3:NM_002167:exon2:c.A313G:p.T105A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8037	0.8219	0.890375	0.8086	-2.559	0.001	0.865	-2.76	0.145	.	.	.	ID3:uc001bhh.4:exon2:c.A313G:p.T105A	-0.986	AFR:0.9543,AMR:0.7303,EAS:0.9746,FIN:0.6847,NFE:0.7405,OTH:0.7541,ASJ:0.9040	600277	.	.	.	.	.	.	.	0.0	-0.56	0.000	-0.205	1	MU81695702	hom
1	23885599	23885599	T	C	ID3	intronic	.	ENSG00000117318	rs2067053	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3787	0.4114	0.463658	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:4(large_intestine),AMR:MU762893,EAS:0.4032,FIN:0.5970,NFE:0.3161,OTH:0.3633,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	600277	.	.	.	.	.	.	.	.	.	.	.	1	2(lung)	0.3548
1	27087549	27087549	A	C	ARID1A	exonic	nonsynonymous SNV	ENSG00000117713	rs367889013	ENSG00000117713:ENST00000374152:exon4:c.A974C:p.Q325P,ENSG00000117713:ENST00000324856:exon5:c.A2123C:p.Q708P,ENSG00000117713:ENST00000457599:exon5:c.A2123C:p.Q708P	ARID1A:NM_006015:exon5:c.A2123C:p.Q708P,ARID1A:NM_139135:exon5:c.A2123C:p.Q708P	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.0032	.	0.00459265	2(large_intestine)	1.949	15.89	0.091	5.77	1.000	.	.	.	ARID1A:uc001bmw.1:exon4:c.A974C:p.Q325P,ARID1A:uc001bmt.1:exon5:c.A2123C:p.Q708P,ARID1A:uc001bmu.1:exon5:c.A2123C:p.Q708P,ARID1A:uc001bmv.1:exon5:c.A2123C:p.Q708P	-1.083	AFR:.,AMR:.,EAS:0.0001,FIN:0,NFE:0,OTH:0,ASJ:9.698e-05	603024	614607;	1465;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~	.	,808,807,811,812,806,809,810,804,805	.	.	0.003	1.73	0.036	0.925	1	2(soft_tissue)	0
1	29399108	29399108	A	C	EPB41	intronic	.	ENSG00000159023	rs78656686	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.0139776	0.0352	.	.	.	.	.	.	.	.	.	.	AFR:0.0064,AMR:0.0084,EAS:0,FIN:0.0637,NFE:0.0490,OTH:0.0631,ASJ:0.0265	130500	611804;	288;	288|HE|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|130600 235370 611804 ~	.	.	.	.	.	.	.	.	1	MU115591195	het
1	36937059	36937059	A	G	CSF3R	exonic	synonymous SNV	ENSG00000119535	rs3917981	ENSG00000119535:ENST00000331941:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000338937:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000418048:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000440588:exon8:c.T1260C:p.T420T,ENSG00000119535:ENST00000361632:exon9:c.T1260C:p.T420T,ENSG00000119535:ENST00000373103:exon10:c.T1260C:p.T420T,ENSG00000119535:ENST00000373104:exon10:c.T1260C:p.T420T,ENSG00000119535:ENST00000373106:exon10:c.T1260C:p.T420T	CSF3R:NM_000760:exon10:c.T1260C:p.T420T,CSF3R:NM_156039:exon10:c.T1260C:p.T420T,CSF3R:NM_172313:exon10:c.T1260C:p.T420T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5648	0.6086	0.592452	2(lung)	.	.	.	.	.	.	.	.	CSF3R:uc001cav.2:exon10:c.T1260C:p.T420T,CSF3R:uc001caw.2:exon10:c.T1260C:p.T420T,CSF3R:uc001cax.2:exon10:c.T1260C:p.T420T	.	AFR:MU767632,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,EAS:0.7304,FIN:0.4165,NFE:0.5397,OTH:0.4061,ASJ:0.5927	138971	617014;	420702;	420702|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|617014 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer ~	.	,2078,2077	.	.	.	.	.	1	1(urinary_tract)	0.6111
1	36937065	36937065	A	G	CSF3R	exonic	synonymous SNV	ENSG00000119535	rs3917980	ENSG00000119535:ENST00000331941:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000338937:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000418048:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000440588:exon8:c.T1254C:p.R418R,ENSG00000119535:ENST00000361632:exon9:c.T1254C:p.R418R,ENSG00000119535:ENST00000373103:exon10:c.T1254C:p.R418R,ENSG00000119535:ENST00000373104:exon10:c.T1254C:p.R418R,ENSG00000119535:ENST00000373106:exon10:c.T1254C:p.R418R	CSF3R:NM_000760:exon10:c.T1254C:p.R418R,CSF3R:NM_156039:exon10:c.T1254C:p.R418R,CSF3R:NM_172313:exon10:c.T1254C:p.R418R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3156	0.2997	0.246406	0.2815	.	.	.	.	.	.	.	.	CSF3R:uc001cav.2:exon10:c.T1254C:p.R418R,CSF3R:uc001caw.2:exon10:c.T1254C:p.R418R,CSF3R:uc001cax.2:exon10:c.T1254C:p.R418R	.	AFR:0.2036,AMR:0.2404,EAS:0.1168,FIN:0.3480,NFE:0.3277,OTH:0.3190,ASJ:0.3543	138971	617014;	420702;	420702|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|617014 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer ~	.	,2078,2077	.	.	.	.	.	1	MU4568824	unknown
1	40363054	40363054	G	C	MYCL	exonic	nonsynonymous SNV	ENSG00000116990	rs3134614	ENSG00000116990:ENST00000372816:exon2:c.C1085G:p.T362S,ENSG00000116990:ENST00000397332:exon3:c.C1175G:p.T392S	MYCL:NM_001033081:exon2:c.C1085G:p.T362S,MYCL:NM_001033082:exon3:c.C1175G:p.T392S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8865	0.9037	0.935703	0.9116	0.145	4.091	1.0	4.53	0.999	.	.	.	MYCL1:uc001ces.2:exon2:c.C1085G:p.T362S,MYCL1:uc001cer.2:exon3:c.C1175G:p.T392S	-0.955	AFR:0.9750,AMR:0.8568,EAS:0.9975,FIN:0.8808,NFE:0.8796,OTH:0.8707,ASJ:0.8477	164850	.	.	.	.	.	.	.	0.0	-0.9	0.000	-0.77	1	MU3888723	hom
1	40980731	40980731	G	T	EXO5	exonic	nonsynonymous SNV	ENSG00000164002	rs11208299	ENSG00000164002:ENST00000372703:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000418186:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000419161:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000420209:exon2:c.G515T:p.G172V,ENSG00000164002:ENST00000296380:exon3:c.G515T:p.G172V,ENSG00000164002:ENST00000443729:exon3:c.G515T:p.G172V,ENSG00000164002:ENST00000358527:exon4:c.G515T:p.G172V	EXO5:NM_001346948:exon2:c.G515T:p.G172V,EXO5:NM_001346954:exon2:c.G515T:p.G172V,EXO5:NM_001346956:exon2:c.G515T:p.G172V,EXO5:NM_001346946:exon3:c.G515T:p.G172V,EXO5:NM_001346951:exon3:c.G515T:p.G172V,EXO5:NM_001346952:exon3:c.G515T:p.G172V,EXO5:NM_001346955:exon3:c.G515T:p.G172V,EXO5:NM_022774:exon3:c.G515T:p.G172V,EXO5:NM_001346947:exon4:c.G515T:p.G172V,EXO5:NM_001346949:exon4:c.G515T:p.G172V,EXO5:NM_001346950:exon4:c.G515T:p.G172V,EXO5:NM_001346953:exon4:c.G515T:p.G172V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4444	0.4619	0.542133	LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	1.360	12.58	1.0	3.96	0.998	.	.	.	EXO5:uc021omb.1:exon1:c.G515T:p.G172V,EXO5:uc001cfr.3:exon2:c.G515T:p.G172V,EXO5:uc001cfp.3:exon3:c.G515T:p.G172V,EXO5:uc001cfq.3:exon4:c.G515T:p.G172V	-0.951	AFR:0.4570,AMR:0.6495,EAS:0.4967,FIN:0.4858,NFE:0.3426,OTH:0.3644,ASJ:0.5550	.	.	.	.	.	.	.	.	0.0	1.83	0.000	-3.005	1	1(large_intestine)	0.4286
1	45796899	45796899	C	G	MUTYH	exonic	synonymous SNV	ENSG00000132781	rs74318065	ENSG00000132781:ENST00000488731:exon5:c.G432C:p.T144T,ENSG00000132781:ENST00000528332:exon5:c.G474C:p.T158T,ENSG00000132781:ENST00000529984:exon5:c.G432C:p.T144T,ENSG00000132781:ENST00000354383:exon14:c.G1350C:p.T450T,ENSG00000132781:ENST00000355498:exon14:c.G1347C:p.T449T,ENSG00000132781:ENST00000372098:exon14:c.G1422C:p.T474T,ENSG00000132781:ENST00000372100:exon14:c.G1380C:p.T460T,ENSG00000132781:ENST00000372110:exon14:c.G1392C:p.T464T,ENSG00000132781:ENST00000372115:exon14:c.G1389C:p.T463T,ENSG00000132781:ENST00000448481:exon14:c.G1380C:p.T460T,ENSG00000132781:ENST00000450313:exon14:c.G1431C:p.T477T,ENSG00000132781:ENST00000456914:exon14:c.G1347C:p.T449T,ENSG00000132781:ENST00000528013:exon14:c.G1389C:p.T463T,ENSG00000132781:ENST00000372104:exon15:c.G1347C:p.T449T	MUTYH:NM_001350650:exon13:c.G1002C:p.T334T,MUTYH:NM_001350651:exon13:c.G1002C:p.T334T,MUTYH:NM_001048171:exon14:c.G1389C:p.T463T,MUTYH:NM_001048172:exon14:c.G1350C:p.T450T,MUTYH:NM_001048173:exon14:c.G1347C:p.T449T,MUTYH:NM_001048174:exon14:c.G1347C:p.T449T,MUTYH:NM_001128425:exon14:c.G1431C:p.T477T,MUTYH:NM_001293190:exon14:c.G1392C:p.T464T,MUTYH:NM_001293191:exon14:c.G1380C:p.T460T,MUTYH:NM_001293192:exon14:c.G1071C:p.T357T,MUTYH:NM_001293196:exon14:c.G1071C:p.T357T,MUTYH:NM_012222:exon14:c.G1422C:p.T474T,MUTYH:NM_001293195:exon15:c.G1347C:p.T449T	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 0] 	0.0049	0.0042	0.0103834	LICA-CN|1|402|0.00248756	.	.	.	.	.	.	.	.	MUTYH:uc010oll.2:exon5:c.G474C:p.T158T,MUTYH:uc001cnf.3:exon14:c.G1347C:p.T449T,MUTYH:uc001cng.3:exon14:c.G1380C:p.T460T,MUTYH:uc001cnh.3:exon14:c.G1350C:p.T450T,MUTYH:uc001cni.3:exon14:c.G1347C:p.T449T,MUTYH:uc001cnj.3:exon14:c.G1071C:p.T357T,MUTYH:uc001cnl.3:exon14:c.G1389C:p.T463T,MUTYH:uc001cnm.3:exon14:c.G1422C:p.T474T,MUTYH:uc001cnn.3:exon14:c.G1392C:p.T464T,MUTYH:uc001cno.3:exon14:c.G1071C:p.T357T,MUTYH:uc009vxp.3:exon14:c.G1431C:p.T477T,MUTYH:uc009vxo.3:exon15:c.G1347C:p.T449T	.	AFR:0.0062,AMR:0.0103,EAS:0.0033,FIN:0.0265,NFE:0.0063,OTH:0.0021,ASJ:0.0012	604933	132600;608456;613659;	220460;247798;91414;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247798|MUTYH-related AFAP<br>MUTYH-related attenuated FAP<br>MUTYH-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|608456 ~91414|Epithelioma calcificans of Malherbe<br>Pilomatricoma|Unknown|Not applicable|Childhood<br>Adolescent<br>Adult|132600 ~	.	.	.	.	.	.	.	.	1	1(soft_tissue)	0.0020
1	45797505	45797505	C	G	MUTYH	exonic	nonsynonymous SNV	ENSG00000132781	rs3219489	ENSG00000132781:ENST00000467459:exon4:c.G347C:p.S116T,ENSG00000132781:ENST00000412971:exon7:c.G546C:p.Q182H,ENSG00000132781:ENST00000354383:exon12:c.G933C:p.Q311H,ENSG00000132781:ENST00000355498:exon12:c.G930C:p.Q310H,ENSG00000132781:ENST00000372098:exon12:c.G1005C:p.Q335H,ENSG00000132781:ENST00000372100:exon12:c.G963C:p.Q321H,ENSG00000132781:ENST00000372110:exon12:c.G975C:p.Q325H,ENSG00000132781:ENST00000372115:exon12:c.G972C:p.Q324H,ENSG00000132781:ENST00000448481:exon12:c.G963C:p.Q321H,ENSG00000132781:ENST00000450313:exon12:c.G1014C:p.Q338H,ENSG00000132781:ENST00000456914:exon12:c.G930C:p.Q310H,ENSG00000132781:ENST00000528013:exon12:c.G972C:p.Q324H,ENSG00000132781:ENST00000372104:exon13:c.G930C:p.Q310H	MUTYH:NM_001350650:exon11:c.G585C:p.Q195H,MUTYH:NM_001350651:exon11:c.G585C:p.Q195H,MUTYH:NM_001048171:exon12:c.G972C:p.Q324H,MUTYH:NM_001048172:exon12:c.G933C:p.Q311H,MUTYH:NM_001048173:exon12:c.G930C:p.Q310H,MUTYH:NM_001048174:exon12:c.G930C:p.Q310H,MUTYH:NM_001128425:exon12:c.G1014C:p.Q338H,MUTYH:NM_001293190:exon12:c.G975C:p.Q325H,MUTYH:NM_001293191:exon12:c.G963C:p.Q321H,MUTYH:NM_001293192:exon12:c.G654C:p.Q218H,MUTYH:NM_001293196:exon12:c.G654C:p.Q218H,MUTYH:NM_012222:exon12:c.G1005C:p.Q335H,MUTYH:NM_001293195:exon13:c.G930C:p.Q310H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2967	0.2541	0.313498	1(large_intestine)	0.336	6.039	0.168	1.26	0.732	.	.	DNA glycosylase|Helix-turn-helix, base-excision DNA repair, C-terminal	MUTYH:uc001cnf.3:exon12:c.G930C:p.Q310H,MUTYH:uc001cng.3:exon12:c.G963C:p.Q321H,MUTYH:uc001cnh.3:exon12:c.G933C:p.Q311H,MUTYH:uc001cni.3:exon12:c.G930C:p.Q310H,MUTYH:uc001cnj.3:exon12:c.G654C:p.Q218H,MUTYH:uc001cnl.3:exon12:c.G972C:p.Q324H,MUTYH:uc001cnm.3:exon12:c.G1005C:p.Q335H,MUTYH:uc001cnn.3:exon12:c.G975C:p.Q325H,MUTYH:uc001cno.3:exon12:c.G654C:p.Q218H,MUTYH:uc009vxp.3:exon12:c.G1014C:p.Q338H,MUTYH:uc009vxo.3:exon13:c.G930C:p.Q310H	-0.933	AFR:MU120737,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.2696,FIN:0.4353,NFE:0.3013,OTH:0.4143,ASJ:0.2584	604933	132600;608456;613659;	220460;247798;91414;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247798|MUTYH-related AFAP<br>MUTYH-related attenuated FAP<br>MUTYH-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|608456 ~91414|Epithelioma calcificans of Malherbe<br>Pilomatricoma|Unknown|Not applicable|Childhood<br>Adolescent<br>Adult|132600 ~	.	.	.	.	0.343	3.23	0.000	2.665	1	19(soft_tissue)	0.2278
1	45805880	45805880	G	A	TOE1	UTR5	.	ENSG00000132781	rs2275602	ENSG00000132781:ENST00000467940:exon1:c.C47T:p.T16I	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.0037	0.0004	0.00678914	0.0032	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0.0012,EAS:0.0259,FIN:0.0063,NFE:0.002,OTH:0.0031,ASJ:0	613931	.	.	.	.	.	.	.	.	.	.	.	1	MU85250637	het
1	46521517	46521517	G	A	LOC110117498-PIK3R3;PIK3R3	exonic	synonymous SNV	ENSG00000117461	rs785468	ENSG00000117461:ENST00000262741:exon7:c.C891T:p.S297S,ENSG00000117461:ENST00000540385:exon7:c.C1029T:p.S343S,ENSG00000117461:ENST00000372006:exon8:c.C891T:p.S297S,ENSG00000117461:ENST00000420542:exon8:c.C891T:p.S297S	PIK3R3:NM_001328654:exon5:c.C423T:p.S141S,PIK3R3:NM_001328653:exon6:c.C648T:p.S216S,LOC110117498-PIK3R3:NM_001303427:exon7:c.C1029T:p.S343S,PIK3R3:NM_001328648:exon7:c.C759T:p.S253S,PIK3R3:NM_001328649:exon7:c.C759T:p.S253S,PIK3R3:NM_001328650:exon7:c.C759T:p.S253S,PIK3R3:NM_001328651:exon7:c.C759T:p.S253S,PIK3R3:NM_001328652:exon7:c.C891T:p.S297S,PIK3R3:NM_003629:exon7:c.C891T:p.S297S,PIK3R3:NM_001114172:exon8:c.C891T:p.S297S,PIK3R3:NM_001303428:exon8:c.C942T:p.S314S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6810	0.6715	0.637979	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PIK3R3:uc010olv.2:exon2:c.C261T:p.S87S,PIK3R3:uc001cpb.4:exon7:c.C891T:p.S297S,PIK3R3:uc010olw.2:exon7:c.C1029T:p.S343S,PIK3R3:uc001cpc.4:exon8:c.C891T:p.S297S,PIK3R3:uc009vyc.3:exon8:c.C942T:p.S314S	.	AFR:0.6766,AMR:0.5981,EAS:0.7086,FIN:0.645,NFE:0.7415,OTH:0.7094,ASJ:0.6487	.	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.7047
1	46521559	46521559	A	T	LOC110117498-PIK3R3;PIK3R3	exonic	nonsynonymous SNV	ENSG00000117461	rs785467	ENSG00000117461:ENST00000262741:exon7:c.T849A:p.N283K,ENSG00000117461:ENST00000540385:exon7:c.T987A:p.N329K,ENSG00000117461:ENST00000372006:exon8:c.T849A:p.N283K,ENSG00000117461:ENST00000420542:exon8:c.T849A:p.N283K	PIK3R3:NM_001328654:exon5:c.T381A:p.N127K,PIK3R3:NM_001328653:exon6:c.T606A:p.N202K,LOC110117498-PIK3R3:NM_001303427:exon7:c.T987A:p.N329K,PIK3R3:NM_001328648:exon7:c.T717A:p.N239K,PIK3R3:NM_001328649:exon7:c.T717A:p.N239K,PIK3R3:NM_001328650:exon7:c.T717A:p.N239K,PIK3R3:NM_001328651:exon7:c.T717A:p.N239K,PIK3R3:NM_001328652:exon7:c.T849A:p.N283K,PIK3R3:NM_003629:exon7:c.T849A:p.N283K,PIK3R3:NM_001114172:exon8:c.T849A:p.N283K,PIK3R3:NM_001303428:exon8:c.T900A:p.N300K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6940	0.7183	0.682109	MU81700272	0.729	9.016	1.0	3.95	0.999	.	.	PI3K p85 subunit, inter-SH2 domain	PIK3R3:uc010olv.2:exon2:c.T219A:p.N73K,PIK3R3:uc001cpb.4:exon7:c.T849A:p.N283K,PIK3R3:uc010olw.2:exon7:c.T987A:p.N329K,PIK3R3:uc001cpc.4:exon8:c.T849A:p.N283K,PIK3R3:uc009vyc.3:exon8:c.T900A:p.N300K	-0.960	AFR:COCA-CN|5|321|0.0155763,AMR:0.7188,EAS:0.6599,FIN:0.7086,NFE:0.6461,OTH:0.7414,ASJ:0.7464	.	.	.	.	.	.	.	.	0.0	1.75	0.000	-1.725	1	1(skin)	0.7095
1	47685455	47685455	T	C	TAL1	exonic	synonymous SNV	ENSG00000162367	rs927462	ENSG00000162367:ENST00000294339:exon4:c.A933G:p.K311K,ENSG00000162367:ENST00000371883:exon4:c.A939G:p.K313K,ENSG00000162367:ENST00000371884:exon5:c.A933G:p.K311K	TAL1:NM_001290406:exon3:c.A456G:p.K152K,TAL1:NM_001287347:exon5:c.A933G:p.K311K,TAL1:NM_001290403:exon5:c.A933G:p.K311K,TAL1:NM_001290405:exon5:c.A933G:p.K311K,TAL1:NM_001290404:exon6:c.A933G:p.K311K,TAL1:NM_003189:exon6:c.A933G:p.K311K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	1.0000	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TAL1:uc009vyq.2:exon3:c.A203G:p.N68S	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	187040	613065;	513;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~	.	.	.	.	.	.	.	.	1	2(large_intestine)	1
1	47746678	47746678	G	C	STIL	exonic	synonymous SNV	ENSG00000123473	rs10789505	ENSG00000123473:ENST00000243182:exon12:c.C1452G:p.S484S,ENSG00000123473:ENST00000337817:exon12:c.C1452G:p.S484S,ENSG00000123473:ENST00000371877:exon12:c.C1452G:p.S484S,ENSG00000123473:ENST00000396221:exon12:c.C1452G:p.S484S,ENSG00000123473:ENST00000360380:exon13:c.C1452G:p.S484S,ENSG00000123473:ENST00000447475:exon14:c.C1311G:p.S437S	STIL:NM_001048166:exon12:c.C1452G:p.S484S,STIL:NM_003035:exon12:c.C1452G:p.S484S,STIL:NM_001282936:exon13:c.C1452G:p.S484S,STIL:NM_001282937:exon13:c.C1452G:p.S484S,STIL:NM_001282938:exon14:c.C1311G:p.S437S,STIL:NM_001282939:exon14:c.C1311G:p.S437S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1269	0.1650	0.232029	4(soft_tissue)	.	.	.	.	.	.	.	.	STIL:uc001crf.1:exon2:c.C291G:p.S97S,STIL:uc001crc.1:exon12:c.C1452G:p.S484S,STIL:uc001crd.1:exon12:c.C1452G:p.S484S,STIL:uc010omo.1:exon12:c.C1452G:p.S484S,STIL:uc001cre.1:exon13:c.C1452G:p.S484S,STIL:uc010omn.1:exon13:c.C1311G:p.S437S,STIL:uc001crg.1:exon14:c.C1311G:p.S437S	.	AFR:1(large_intestine),AMR:MU29706754,EAS:0.1618,FIN:0.3569,NFE:0.0585,OTH:0.0861,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(stomach)	0.2993
1	47767914	47767914	G	A	STIL	exonic	nonsynonymous SNV	ENSG00000123473	rs3125630	ENSG00000123473:ENST00000413565:exon2:c.C269T:p.A90V,ENSG00000123473:ENST00000243182:exon4:c.C257T:p.A86V,ENSG00000123473:ENST00000337817:exon4:c.C257T:p.A86V,ENSG00000123473:ENST00000371877:exon4:c.C257T:p.A86V,ENSG00000123473:ENST00000396221:exon4:c.C257T:p.A86V,ENSG00000123473:ENST00000360380:exon5:c.C257T:p.A86V,ENSG00000123473:ENST00000447475:exon5:c.C257T:p.A86V	STIL:NM_001048166:exon4:c.C257T:p.A86V,STIL:NM_003035:exon4:c.C257T:p.A86V,STIL:NM_001282936:exon5:c.C257T:p.A86V,STIL:NM_001282937:exon5:c.C257T:p.A86V,STIL:NM_001282938:exon5:c.C257T:p.A86V,STIL:NM_001282939:exon5:c.C257T:p.A86V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5034	0.5931	0.60643	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	0.778	9.328	1.0	5.42	0.994	.	.	.	STIL:uc001crc.1:exon4:c.C257T:p.A86V,STIL:uc001crd.1:exon4:c.C257T:p.A86V,STIL:uc010omn.1:exon4:c.C257T:p.A86V,STIL:uc010omo.1:exon4:c.C257T:p.A86V,STIL:uc001cre.1:exon5:c.C257T:p.A86V,STIL:uc001crg.1:exon5:c.C257T:p.A86V	-0.967	AFR:0.5630,AMR:0.8405,EAS:0.3609,FIN:0.5386,NFE:0.3710,OTH:0.4608,ASJ:0.5561	181590	612703;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	1.87	0.000	-2.85	1	1(breast)	0.4497
1	51873951	51873951	G	A	EPS15	exonic	synonymous SNV	ENSG00000085832	rs1065754	ENSG00000085832:ENST00000396122:exon4:c.C360T:p.Y120Y,ENSG00000085832:ENST00000371733:exon15:c.C1329T:p.Y443Y	EPS15:NM_001159969:exon3:c.C387T:p.Y129Y,EPS15:NM_001981:exon15:c.C1329T:p.Y443Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7347	0.7293	0.822684	0.7522	.	.	.	.	.	.	.	.	EPS15:uc001csp.3:exon3:c.C387T:p.Y129Y,EPS15:uc001csq.1:exon15:c.C1329T:p.Y443Y	.	AFR:0.8763,AMR:0.7840,EAS:0.9975,FIN:0.7030,NFE:0.6682,OTH:0.7290,ASJ:0.5728	600051	.	.	.	.	.	.	.	.	.	.	.	1	MU81700903	hom
1	55505732	55505732	A	G	PCSK9	intronic	.	ENSG00000169174	rs2495482	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9370	0.9116	0.908546	0.9128	.	.	.	.	.	.	.	.	.	.	AFR:0.8318,AMR:0.8389,EAS:0.9353,FIN:0.9691,NFE:0.9459,OTH:0.9440,ASJ:0.9437	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU81701675	hom
1	55523033	55523033	A	G	PCSK9	exonic	synonymous SNV	ENSG00000169174	rs509504	ENSG00000169174:ENST00000543384:exon5:c.A426G:p.Q142Q,ENSG00000169174:ENST00000302118:exon7:c.A1026G:p.Q342Q	PCSK9:NM_174936:exon7:c.A1026G:p.Q342Q	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.9945	0.9797	0.981829	0.9829	.	.	.	.	.	.	.	.	PCSK9:uc001cyf.2:exon7:c.A1026G:p.Q342Q	.	AFR:0.9397,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU81701677	hom
1	55524197	55524197	A	G	PCSK9	exonic	synonymous SNV	ENSG00000169174	rs540796	ENSG00000169174:ENST00000543384:exon7:c.A728G:p.Y243C	PCSK9:NM_174936:exon9:c.A1380G:p.V460V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8544	0.8178	0.869209	0.8316	.	.	.	.	.	.	.	.	PCSK9:uc001cyf.2:exon9:c.A1380G:p.V460V	.	AFR:0.7927,AMR:0.9069,EAS:0.9988,FIN:0.8171,NFE:0.8337,OTH:0.8582,ASJ:0.8245	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU9830779	hom
1	55524237	55524237	G	A	PCSK9	exonic	nonsynonymous SNV	ENSG00000169174	rs562556	ENSG00000169174:ENST00000302118:exon9:c.G1420A:p.V474I	PCSK9:NM_174936:exon9:c.G1420A:p.V474I	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8544	0.8178	0.86901	COCA-CN|5|321|0.0155763	-1.303	0.004	0.412	-8.95	0.000	.	.	.	PCSK9:uc001cyf.2:exon9:c.G1420A:p.V474I	-0.970	AFR:0.8315,AMR:0.7928,EAS:0.8245,FIN:0.9988,NFE:0.8170,OTH:0.8334,ASJ:0.9069	607786	603776;	.	.	.	.	.	.	0.013	-0.52	0.000	1.555	1	1(thyroid)	0.8571
1	55524340	55524353	GTGTGTGTGTGTGT	-	PCSK9	intronic	.	ENSG00000169174	rs368103912	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1478	.	0.911542	0.6520	.	.	.	.	.	.	.	.	.	.	AFR:0.5516,AMR:0.6592,EAS:0.8207,FIN:0.5988,NFE:0.6917,OTH:0.7062,ASJ:0.7344	607786	603776;	.	.	.	.	.	.	.	.	.	.	1	MU113565531	hom
1	55529187	55529187	G	A	PCSK9	exonic	nonsynonymous SNV	ENSG00000169174	rs505151	ENSG00000169174:ENST00000302118:exon12:c.G2009A:p.G670E	PCSK9:NM_174936:exon12:c.G2009A:p.G670E	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9433	0.8894	0.898962	0.8930	-1.402	0.003	1.0	0.348	0.001	.	.	.	PCSK9:uc001cyf.2:exon12:c.G2009A:p.G670E	-0.976	AFR:0.7349,AMR:0.9761,EAS:0.9427,FIN:0.9485,NFE:0.9569,OTH:0.9532,ASJ:0.9437	607786	603776;	.	.	.	.	.	.	0.0	-0.35	0.000	-2.34	1	MU26731505	hom
1	65310489	65310489	T	C	JAK1	exonic	synonymous SNV	ENSG00000162434	rs2230588	ENSG00000162434:ENST00000342505:exon16:c.A2199G:p.P733P	JAK1:NM_001321852:exon16:c.A2199G:p.P733P,JAK1:NM_001321856:exon16:c.A2199G:p.P733P,JAK1:NM_001321857:exon16:c.A2196G:p.P732P,JAK1:NM_002227:exon16:c.A2199G:p.P733P,JAK1:NM_001320923:exon17:c.A2199G:p.P733P,JAK1:NM_001321854:exon17:c.A2199G:p.P733P,JAK1:NM_001321855:exon17:c.A2199G:p.P733P,JAK1:NM_001321853:exon18:c.A2199G:p.P733P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2935	0.3492	0.372604	0.3717	.	.	.	.	.	.	.	.	JAK1:uc001dbu.1:exon16:c.A2199G:p.P733P,JAK1:uc009wam.1:exon17:c.A2199G:p.P733P	.	AFR:0.6204,AMR:0.3349,EAS:0.3046,FIN:0.2774,NFE:0.2630,OTH:0.2969,ASJ:0.3675	147795	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6191,6193,6192	.	.	.	.	.	.	1	MU110244	het
1	65321388	65321388	G	A	JAK1	intronic	.	ENSG00000162434	rs310229	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3574	0.3801	0.402556	MU17839990	.	.	.	.	.	0	0	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.4079,EAS:0.4665,FIN:0.3974,NFE:0.3180,OTH:0.3254,ASJ:0.5930	147795	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	1	1(lung)	0.3296
1	66036501	66036501	G	T	LEPR	intronic	.	ENSG00000116678	rs2186248	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9999	0.9995	1	0.9996	.	.	.	.	.	.	.	.	.	.	AFR:0.9987,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	.	.	.	.	1	MU81702628	hom
1	66058513	66058513	A	G	LEPR	exonic	nonsynonymous SNV	ENSG00000116678	rs1137101	ENSG00000116678:ENST00000371058:exon4:c.A668G:p.Q223R,ENSG00000116678:ENST00000344610:exon6:c.A668G:p.Q223R,ENSG00000116678:ENST00000349533:exon6:c.A668G:p.Q223R,ENSG00000116678:ENST00000371059:exon6:c.A668G:p.Q223R,ENSG00000116678:ENST00000371060:exon6:c.A668G:p.Q223R	LEPR:NM_001198687:exon5:c.A668G:p.Q223R,LEPR:NM_001198688:exon5:c.A668G:p.Q223R,LEPR:NM_001198689:exon5:c.A668G:p.Q223R,LEPR:NM_001003679:exon6:c.A668G:p.Q223R,LEPR:NM_001003680:exon6:c.A668G:p.Q223R,LEPR:NM_002303:exon6:c.A668G:p.Q223R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5103	0.4903	0.584265	MU114597	1.483	13.22	0.22	3.66	0.966	.	.	Immunoglobulin-like fold	LEPR:uc001dcj.3:exon5:c.A668G:p.Q223R,LEPR:uc001dck.3:exon5:c.A668G:p.Q223R,LEPR:uc021ool.1:exon5:c.A668G:p.Q223R,LEPR:uc001dcg.3:exon6:c.A668G:p.Q223R,LEPR:uc001dch.3:exon6:c.A668G:p.Q223R,LEPR:uc001dci.3:exon6:c.A668G:p.Q223R	-1.102	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AMR:0.5338,EAS:0.4494,FIN:0.3775,NFE:0.875,OTH:0.6017,ASJ:0.5530	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	0.282	0.56	0.050	1.935	1	1(large_intestine)	0.4783
1	66067109	66067109	T	C	LEPR	exonic	synonymous SNV	ENSG00000116678	rs1805134	ENSG00000116678:ENST00000371058:exon7:c.T1029C:p.S343S,ENSG00000116678:ENST00000344610:exon9:c.T1029C:p.S343S,ENSG00000116678:ENST00000349533:exon9:c.T1029C:p.S343S,ENSG00000116678:ENST00000371059:exon9:c.T1029C:p.S343S,ENSG00000116678:ENST00000371060:exon9:c.T1029C:p.S343S	LEPR:NM_001198687:exon8:c.T1029C:p.S343S,LEPR:NM_001198688:exon8:c.T1029C:p.S343S,LEPR:NM_001198689:exon8:c.T1029C:p.S343S,LEPR:NM_001003679:exon9:c.T1029C:p.S343S,LEPR:NM_001003680:exon9:c.T1029C:p.S343S,LEPR:NM_002303:exon9:c.T1029C:p.S343S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2287	0.2437	0.253994	0.2404	.	.	.	.	.	.	.	.	LEPR:uc001dcj.3:exon8:c.T1029C:p.S343S,LEPR:uc001dck.3:exon8:c.T1029C:p.S343S,LEPR:uc021ool.1:exon8:c.T1029C:p.S343S,LEPR:uc001dcg.3:exon9:c.T1029C:p.S343S,LEPR:uc001dch.3:exon9:c.T1029C:p.S343S,LEPR:uc001dci.3:exon9:c.T1029C:p.S343S	.	AFR:0.3252,AMR:0.1447,EAS:0.0563,FIN:0.2427,NFE:0.2141,OTH:0.2347,ASJ:0.34	601007	614963;	179494;	179494|-|-|Autosomal recessive|-|614963 ~	.	.	.	.	.	.	.	.	1	MU114613	het
1	76313874	76313874	C	T	MSH4	intronic	.	ENSG00000057468	rs2047435	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1866	0.1860	0.233027	0.2166	.	.	.	.	.	.	.	.	.	.	AFR:0.3034,AMR:0.3669,EAS:0.2475,FIN:0.1856,NFE:0.1651,OTH:0.1980,ASJ:0.1093	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU17758367	het
1	76344011	76344011	C	A	MSH4	intronic	.	ENSG00000057468	rs1493367	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7967	0.7411	0.792732	0.7763	.	.	.	.	.	0	0.006	.	.	.	AFR:0.7152,AMR:0.8218,EAS:0.9845,FIN:0.8051,NFE:0.7779,OTH:0.7912,ASJ:0.8377	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU81703300	het
1	76344711	76344711	A	T	MSH4	exonic	synonymous SNV	ENSG00000057468	rs5745449	ENSG00000057468:ENST00000263187:exon12:c.A1575T:p.L525L	MSH4:NM_002440:exon12:c.A1575T:p.L525L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7963	0.7415	0.792732	0.7759	.	.	.	.	.	.	.	.	MSH4:uc001dhd.2:exon12:c.A1575T:p.L525L	.	AFR:0.7147,AMR:0.8234,EAS:0.9833,FIN:0.8055,NFE:0.7774,OTH:0.7898,ASJ:0.8377	602105	.	.	.	.	.	.	.	.	.	.	.	1	MU81703331	het
1	76346920	76346920	-	AT	MSH4	intronic	.	ENSG00000057468	rs5745466	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9880	0.9555	0.956669	0.9644	.	.	.	.	.	.	.	.	.	.	AFR:0.8755,AMR:0.9952,EAS:1,FIN:1,NFE:0.9995,OTH:0.9959,ASJ:1	602105	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	76378361	76378362	TT	-	MSH4	intronic	.	ENSG00000057468	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602105	.	.	.	.	.	.	.	.	.	.	.	1	.	unknown
1	85733374	85733374	C	T	BCL10	exonic	nonsynonymous SNV	ENSG00000142867	rs3768235	ENSG00000142867:ENST00000370580:exon3:c.G638A:p.G213E	BCL10:NM_001320715:exon3:c.G605A:p.G202E,BCL10:NM_003921:exon3:c.G638A:p.G213E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0640	0.0419	0.0720847	0.0467	1.357	12.56	0.372	-0.914	0.994	.	.	.	BCL10:uc021opd.1:exon3:c.G638A:p.G213E	-0.973	AFR:0.0142,AMR:0.0979,EAS:0.1467,FIN:0.0450,NFE:0.0527,OTH:0.05,ASJ:0.0166	603517	137245;156240;605027;616098;	547;50251;52417;	547|NHL|1-5 / 10 000|-|Adult|605027 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~52417|Extranodal marginal zone B-cell lymphoma<br>MALToma<br>Mucosa-associated lymphatic tissue lymphoma<br>Mucosa-associated lymphoid tissue lymphoma|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|137245 ~	.	.	.	.	0.0	.	0.011	-1.01	1	MU580721	het
1	85741620	85741620	G	A	BCL10	intronic	.	ENSG00000142867	rs78420282	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.00399361	0.0014	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0247,FIN:0,NFE:0,OTH:0.0020,ASJ:0	603517	137245;156240;605027;616098;	547;50251;52417;	547|NHL|1-5 / 10 000|-|Adult|605027 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~52417|Extranodal marginal zone B-cell lymphoma<br>MALToma<br>Mucosa-associated lymphatic tissue lymphoma<br>Mucosa-associated lymphoid tissue lymphoma|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|137245 ~	.	.	.	.	.	.	.	.	1	.	het
1	85741968	85741968	G	C	BCL10	intronic	.	ENSG00000142867	rs12562182	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0928	0.0610	0.0834665	0.0628	.	.	.	.	.	.	.	.	.	.	AFR:0.0172,AMR:0.0933,EAS:0.1388,FIN:0.0725,NFE:0.0771,OTH:0.0663,ASJ:0.0563	603517	137245;156240;605027;616098;	547;50251;52417;	547|NHL|1-5 / 10 000|-|Adult|605027 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~52417|Extranodal marginal zone B-cell lymphoma<br>MALToma<br>Mucosa-associated lymphatic tissue lymphoma<br>Mucosa-associated lymphoid tissue lymphoma|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|137245 ~	.	.	.	.	.	.	.	.	1	MU10026866	het
1	91727781	91727781	C	G	HFM1	intronic	.	ENSG00000162669	rs580070	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2034	0.2018	0.121406	0.1908	.	.	.	.	.	.	.	.	.	.	AFR:0.1457,AMR:0.1527,EAS:0.0031,FIN:0.1934,NFE:0.2400,OTH:0.1990,ASJ:0.1159	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	.	het
1	91728053	91728053	G	A	HFM1	exonic	synonymous SNV	ENSG00000162669	rs585898	ENSG00000162669:ENST00000370424:exon33:c.C3108T:p.A1036A,ENSG00000162669:ENST00000370425:exon37:c.C4071T:p.A1357A	HFM1:NM_001017975:exon37:c.C4071T:p.A1357A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9990	0.999201	0.9987	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon18:c.C1635T:p.A545A,HFM1:uc010osu.2:exon33:c.C3108T:p.A1036A,HFM1:uc001doa.4:exon37:c.C4071T:p.A1357A	.	AFR:0.9954,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704389	hom
1	91781413	91781413	T	G	HFM1	exonic	synonymous SNV	ENSG00000162669	rs281992	ENSG00000162669:ENST00000370424:exon24:c.A2136C:p.I712I,ENSG00000162669:ENST00000294696:exon28:c.A795C:p.I265I,ENSG00000162669:ENST00000370425:exon28:c.A3099C:p.I1033I	HFM1:NM_001017975:exon28:c.A3099C:p.I1033I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7059	0.6881	0.762979	0.6920	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon9:c.A663C:p.I221I,HFM1:uc010osv.1:exon22:c.A2151C:p.I717I,HFM1:uc010osu.2:exon24:c.A2136C:p.I712I,HFM1:uc001doa.4:exon28:c.A3099C:p.I1033I	.	AFR:0.7378,AMR:0.7105,EAS:0.8246,FIN:0.6821,NFE:0.6500,OTH:0.6875,ASJ:0.8212	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU19378877	het
1	91781644	91781644	C	G	HFM1	intronic	.	ENSG00000162669	rs11589490	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2034	0.2137	0.125	0.2037	.	.	.	.	.	.	.	.	.	.	AFR:0.1350,AMR:0.1647,EAS:0.0031,FIN:0.2188,NFE:0.2645,OTH:0.2212,ASJ:0.1258	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	.	het
1	91782031	91782031	T	C	HFM1	exonic	nonsynonymous SNV	ENSG00000162669	rs11584478	ENSG00000162669:ENST00000370424:exon22:c.A1852G:p.I618V,ENSG00000162669:ENST00000294696:exon26:c.A511G:p.I171V,ENSG00000162669:ENST00000370425:exon26:c.A2815G:p.I939V	HFM1:NM_001017975:exon26:c.A2815G:p.I939V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1998	0.2167	0.125	.	0.386	6.488	0.812	1.31	1.000	.	.	Sec63 domain	HFM1:uc001dob.4:exon7:c.A379G:p.I127V,HFM1:uc010osv.1:exon20:c.A1867G:p.I623V,HFM1:uc010osu.2:exon22:c.A1852G:p.I618V,HFM1:uc001doa.4:exon26:c.A2815G:p.I939V	-1.046	AFR:0.2027,AMR:0.1345,EAS:0.1258,FIN:0.0031,NFE:0.2173,OTH:0.2633,ASJ:0.1638	615684	615724;	.	.	.	.	.	.	0.001	0.22	0.029	-0.845	1	1(urinary_tract)	0.2174
1	91784887	91784887	G	A	HFM1	exonic	synonymous SNV	ENSG00000162669	rs10493845	ENSG00000162669:ENST00000370424:exon20:c.C1680T:p.T560T,ENSG00000162669:ENST00000294696:exon24:c.C339T:p.T113T,ENSG00000162669:ENST00000370425:exon24:c.C2643T:p.T881T	HFM1:NM_001017975:exon24:c.C2643T:p.T881T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2951	0.3117	0.236422	MU580750	.	.	.	.	.	.	.	.	HFM1:uc001dob.4:exon6:c.C339T:p.T113T,HFM1:uc010osv.1:exon18:c.C1695T:p.T565T,HFM1:uc010osu.2:exon20:c.C1680T:p.T560T,HFM1:uc001doa.4:exon24:c.C2643T:p.T881T	.	AFR:COCA-CN|2|321|0.00623053,AMR:0.3070,EAS:0.2895,FIN:0.1921,NFE:0.1743,OTH:0.3188,ASJ:0.2576	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	1(liver)	0.3504
1	91841301	91841301	T	C	HFM1	intronic	.	ENSG00000162669	rs282036	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9991	0.999201	0.9987	.	.	.	.	.	.	.	.	.	.	AFR:0.9953,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704472	hom
1	91851253	91851253	T	C	HFM1	exonic	synonymous SNV	ENSG00000162669	rs282026	ENSG00000162669:ENST00000448819:exon3:c.A210G:p.Q70Q,ENSG00000162669:ENST00000427444:exon4:c.A507G:p.Q169Q,ENSG00000162669:ENST00000370425:exon5:c.A633G:p.Q211Q	HFM1:NM_001017975:exon5:c.A633G:p.Q211Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9997	0.9990	0.999201	0.9987	.	.	.	.	.	.	.	.	HFM1:uc001doc.1:exon4:c.A633G:p.Q211Q,HFM1:uc001doa.4:exon5:c.A633G:p.Q211Q	.	AFR:0.9955,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	.	.	.	.	1	MU81704499	hom
1	91859795	91859795	T	C	HFM1	exonic	nonsynonymous SNV	ENSG00000162669	rs282009	ENSG00000162669:ENST00000427444:exon3:c.A223G:p.I75V,ENSG00000162669:ENST00000370425:exon4:c.A349G:p.I117V,ENSG00000162669:ENST00000455133:exon4:c.A349G:p.I117V	HFM1:NM_001017975:exon4:c.A349G:p.I117V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9997	0.9991	0.999201	0.9987	-2.189	0.001	1.0	1.52	0.304	.	.	.	HFM1:uc001doc.1:exon3:c.A349G:p.I117V,HFM1:uc001doa.4:exon4:c.A349G:p.I117V	-0.972	AFR:0.9954,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	615684	615724;	.	.	.	.	.	.	0.0	0.49	0.015	-2.24	1	MU81704512	unknown
1	91859801	91859801	A	G	HFM1	exonic	nonsynonymous SNV	ENSG00000162669	rs11165778	ENSG00000162669:ENST00000427444:exon3:c.T217C:p.S73P,ENSG00000162669:ENST00000370425:exon4:c.T343C:p.S115P,ENSG00000162669:ENST00000455133:exon4:c.T343C:p.S115P	HFM1:NM_001017975:exon4:c.T343C:p.S115P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2034	0.2303	0.136781	.	-0.473	0.256	0.29	-2.82	0.237	.	.	.	HFM1:uc001doc.1:exon3:c.T343C:p.S115P,HFM1:uc001doa.4:exon4:c.T343C:p.S115P	-1.053	AFR:0.2155,AMR:0.1737,EAS:0.1258,FIN:0.0031,NFE:0.2203,OTH:0.2659,ASJ:0.1663	615684	615724;	.	.	.	.	.	.	0.0	0.26	0.038	1.04	1	1(pancreas)	0.2223
1	92174260	92174260	A	G	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs284878	ENSG00000069702:ENST00000525962:exon13:c.T2247C:p.T749T,ENSG00000069702:ENST00000212355:exon14:c.T2247C:p.T749T,ENSG00000069702:ENST00000465892:exon14:c.T2244C:p.T748T,ENSG00000069702:ENST00000370399:exon15:c.T2244C:p.T748T	TGFBR3:NM_001195683:exon14:c.T2244C:p.T748T,TGFBR3:NM_003243:exon14:c.T2247C:p.T749T,TGFBR3:NM_001195684:exon15:c.T2244C:p.T748T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9337	0.9394	0.906749	0.9356	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon14:c.T2247C:p.T749T,TGFBR3:uc001doi.3:exon14:c.T2244C:p.T748T,TGFBR3:uc001doj.3:exon15:c.T2244C:p.T748T,TGFBR3:uc010osy.2:exon15:c.T2121C:p.T707T,TGFBR3:uc009wde.3:exon17:c.T1332C:p.T444T	.	AFR:0.9334,AMR:0.9582,EAS:0.7531,FIN:0.9699,NFE:0.9472,OTH:0.9491,ASJ:0.9007	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU81704562	hom
1	92185657	92185657	C	T	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs1805112	ENSG00000069702:ENST00000525962:exon8:c.G1206A:p.P402P,ENSG00000069702:ENST00000212355:exon9:c.G1206A:p.P402P,ENSG00000069702:ENST00000465892:exon9:c.G1203A:p.P401P,ENSG00000069702:ENST00000370399:exon10:c.G1203A:p.P401P	TGFBR3:NM_001195683:exon9:c.G1203A:p.P401P,TGFBR3:NM_003243:exon9:c.G1206A:p.P402P,TGFBR3:NM_001195684:exon10:c.G1203A:p.P401P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4177	0.3817	0.40615	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon9:c.G1206A:p.P402P,TGFBR3:uc001doi.3:exon9:c.G1203A:p.P401P,TGFBR3:uc001doj.3:exon10:c.G1203A:p.P401P,TGFBR3:uc010osy.2:exon10:c.G1080A:p.P360P,TGFBR3:uc009wde.3:exon12:c.G537A:p.P179P	.	AFR:0.4029,AMR:0.3062,EAS:0.4272,FIN:0.5458,NFE:0.4860,OTH:0.4281,ASJ:0.3062	600742	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.4192
1	92200382	92200382	T	C	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs2306888	ENSG00000069702:ENST00000525962:exon4:c.A519G:p.S173S,ENSG00000069702:ENST00000212355:exon5:c.A519G:p.S173S,ENSG00000069702:ENST00000465892:exon5:c.A519G:p.S173S,ENSG00000069702:ENST00000370399:exon6:c.A519G:p.S173S	TGFBR3:NM_001195683:exon5:c.A519G:p.S173S,TGFBR3:NM_003243:exon5:c.A519G:p.S173S,TGFBR3:NM_001195684:exon6:c.A519G:p.S173S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0177	0.0005	0.0323482	0.0083	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon5:c.A519G:p.S173S,TGFBR3:uc001doi.3:exon5:c.A519G:p.S173S,TGFBR3:uc001doj.3:exon6:c.A519G:p.S173S,TGFBR3:uc010osy.2:exon6:c.A393G:p.S131S	.	AFR:0.0006,AMR:0.0979,EAS:0.0870,FIN:0.0029,NFE:0.0007,OTH:0.0071,ASJ:0	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU81704572	het
1	92262874	92262874	T	C	TGFBR3	exonic	synonymous SNV	ENSG00000069702	rs2810904	ENSG00000069702:ENST00000525962:exon2:c.A216G:p.A72A,ENSG00000069702:ENST00000533089:exon2:c.A216G:p.A72A,ENSG00000069702:ENST00000212355:exon3:c.A216G:p.A72A,ENSG00000069702:ENST00000465892:exon3:c.A216G:p.A72A,ENSG00000069702:ENST00000370399:exon4:c.A216G:p.A72A	TGFBR3:NM_001195683:exon3:c.A216G:p.A72A,TGFBR3:NM_003243:exon3:c.A216G:p.A72A,TGFBR3:NM_001195684:exon4:c.A216G:p.A72A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6631	0.6786	0.715256	0.6616	.	.	.	.	.	.	.	.	TGFBR3:uc001doh.3:exon3:c.A216G:p.A72A,TGFBR3:uc001doi.3:exon3:c.A216G:p.A72A,TGFBR3:uc001doj.3:exon4:c.A216G:p.A72A,TGFBR3:uc010osy.2:exon4:c.A90G:p.A30A	.	AFR:0.7388,AMR:0.6730,EAS:0.7667,FIN:0.5975,NFE:0.6226,OTH:0.6375,ASJ:0.5867	600742	.	.	.	.	.	.	.	.	.	.	.	1	MU143026	hom
1	92944314	92944314	-	AG	GFI1	intronic	.	ENSG00000162676	rs371078453	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0790	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600871	607847;613107;	486;2688;	486|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|202700 257100 613107 ~2688|-|-|-|-|607847 ~	.	.	.	.	.	.	.	.	1	.	unknown
1	92946479	92946479	G	A	GFI1	exonic	synonymous SNV	ENSG00000162676	rs11164605	ENSG00000162676:ENST00000294702:exon4:c.C465T:p.C155C,ENSG00000162676:ENST00000370332:exon4:c.C465T:p.C155C,ENSG00000162676:ENST00000427103:exon4:c.C465T:p.C155C	GFI1:NM_001127215:exon4:c.C465T:p.C155C,GFI1:NM_001127216:exon4:c.C465T:p.C155C,GFI1:NM_005263:exon4:c.C465T:p.C155C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8883	0.8519	0.91893	0.8503	.	.	.	.	.	.	.	.	GFI1:uc001dou.4:exon4:c.C465T:p.C155C,GFI1:uc001dov.4:exon4:c.C465T:p.C155C,GFI1:uc001dow.4:exon4:c.C465T:p.C155C	.	AFR:0.9214,AMR:0.9076,EAS:0.9667,FIN:0.7807,NFE:0.8087,OTH:0.8330,ASJ:0.9139	600871	607847;613107;	486;2688;	486|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|202700 257100 613107 ~2688|-|-|-|-|607847 ~	.	.	.	.	.	.	.	.	1	MU81704682	hom
1	97770920	97770920	C	T	DPYD	exonic	nonsynonymous SNV	ENSG00000188641	rs1801160	ENSG00000188641:ENST00000370192:exon18:c.G2194A:p.V732I	DPYD:NM_000110:exon18:c.G2194A:p.V732I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0465	0.0414	0.0439297	ESAD-UK|1|409|0.00244499	5.369	25.9	0.057	5.55	0.806	.	.	Aldolase-type TIM barrel|Dihydroorotate dehydrogenase domain	DPYD:uc001drv.3:exon18:c.G2194A:p.V732I	-0.076	AFR:0.0324,AMR:0.0213,EAS:0.1060,FIN:0.0128,NFE:0.0200,OTH:0.0412,ASJ:0.0359	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	0.998	-0.75	0.473	1.71	1	1(large_intestine)	0.0468
1	98039541	98039541	A	G	DPYD	intronic	.	ENSG00000188641	rs56293913	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1046	0.0948	0.0636981	0.1070	.	.	.	.	.	.	.	.	.	.	AFR:0.0585,AMR:0.0622,EAS:0.0087,FIN:0.1890,NFE:0.1273,OTH:0.1354,ASJ:0.1060	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	.	.	.	.	1	MU580780	het
1	98348885	98348885	G	A	DPYD	exonic	nonsynonymous SNV	ENSG00000188641	rs1801265	ENSG00000188641:ENST00000306031:exon2:c.C85T:p.R29C,ENSG00000188641:ENST00000370192:exon2:c.C85T:p.R29C	DPYD:NM_000110:exon2:c.C85T:p.R29C,DPYD:NM_001160301:exon2:c.C85T:p.R29C	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7652	0.7159	0.739816	0.7199	.	.	.	.	.	.	.	.	DPYD:uc001drv.3:exon2:c.C85T:p.R29C,DPYD:uc001drw.3:exon2:c.C85T:p.R29C	.	AFR:0.5991,AMR:0.7769,EAS:0.9284,FIN:0.7140,NFE:0.7626,OTH:0.7352,ASJ:0.8642	612779	274270;	1675;	1675|Familial pyrimidinemia|Unknown|-|All ages|274270 ~	.	.	.	.	.	.	.	.	1	MU4134499	hom
1	104076462	104076462	C	T	RNPC3	exonic	synonymous SNV	ENSG00000185946	rs6697444	ENSG00000185946:ENST00000423855:exon3:c.C342T:p.G114G,ENSG00000185946:ENST00000524631:exon3:c.C342T:p.G114G,ENSG00000185946:ENST00000531883:exon4:c.C342T:p.G114G,ENSG00000185946:ENST00000533099:exon4:c.C342T:p.G114G	RNPC3:NM_017619:exon3:c.C342T:p.G114G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6387	0.6468	0.602037	0.6343	.	.	.	.	.	.	.	.	RNPC3:uc010oul.1:exon3:c.C342T:p.G114G,RNPC3:uc010oum.1:exon3:c.C342T:p.G114G,RNPC3:uc010oun.2:exon3:c.C342T:p.G114G	.	AFR:0.7232,AMR:0.5846,EAS:0.3890,FIN:0.5876,NFE:0.6228,OTH:0.6074,ASJ:0.6443	.	.	.	.	.	.	.	.	.	.	.	.	1	MU26035144	het
1	104076495	104076495	A	G	RNPC3	intronic	.	ENSG00000185946	rs6702220	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6556	.	0.644169	0.6617	.	.	.	.	.	.	.	.	.	.	AFR:0.8362,AMR:0.5978,EAS:0.3862,FIN:0.5725,NFE:0.6176,OTH:0.6072,ASJ:0.6358	.	.	.	.	.	.	.	.	.	.	.	.	1	MU26035183	het
1	110882444	110882444	A	G	RBM15	exonic	synonymous SNV	ENSG00000162775	rs814771	ENSG00000162775:ENST00000369784:exon1:c.A417G:p.E139E,ENSG00000162775:ENST00000487146:exon1:c.A417G:p.E139E,ENSG00000162775:ENST00000602849:exon1:c.A417G:p.E139E	RBM15:NM_001201545:exon1:c.A417G:p.E139E,RBM15:NM_022768:exon1:c.A417G:p.E139E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7613	0.7918	0.822883	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RBM15:uc001dzl.1:exon1:c.A417G:p.E139E,RBM15:uc001dzm.1:exon1:c.A417G:p.E139E,RBM15:uc021orn.1:exon1:c.A417G:p.E139E	.	AFR:0.7926,AMR:0.9240,EAS:0.6954,FIN:0.7301,NFE:0.6873,OTH:0.7495,ASJ:0.8385	606077	.	.	.	.	.	.	.	.	.	.	.	1	1(biliary_tract)	0.7510
1	110883569	110883569	A	T	RBM15	exonic	synonymous SNV	ENSG00000162775	rs3738752	ENSG00000162775:ENST00000369784:exon1:c.A1542T:p.P514P,ENSG00000162775:ENST00000487146:exon1:c.A1542T:p.P514P,ENSG00000162775:ENST00000602849:exon1:c.A1542T:p.P514P	RBM15:NM_001201545:exon1:c.A1542T:p.P514P,RBM15:NM_022768:exon1:c.A1542T:p.P514P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1960	0.1416	0.176118	1(lung)	.	.	.	.	.	.	.	.	RBM15:uc001dzl.1:exon1:c.A1542T:p.P514P,RBM15:uc001dzm.1:exon1:c.A1542T:p.P514P,RBM15:uc021orn.1:exon1:c.A1542T:p.P514P	.	AFR:1(breast),AMR:1(large_intestine),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,FIN:0.1518,NFE:0.0524,OTH:0.1882,ASJ:MU580808	606077	.	.	.	.	.	.	.	.	.	.	.	1	1(stomach)	0.2583
1	113456546	113456546	A	T	SLC16A1	exonic	nonsynonymous SNV	ENSG00000155380	rs1049434	ENSG00000155380:ENST00000369626:exon5:c.T1470A:p.D490E,ENSG00000155380:ENST00000538576:exon5:c.T1470A:p.D490E	SLC16A1:NM_001166496:exon5:c.T1470A:p.D490E,SLC16A1:NM_003051:exon5:c.T1470A:p.D490E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5972	0.6662	0.676717	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	-0.947	0.020	1.0	2.74	0.095	.	.	.	SLC16A1:uc001ecx.3:exon5:c.T1470A:p.D490E,SLC16A1:uc001ecy.3:exon5:c.T1470A:p.D490E	-0.939	AFR:0.6639,AMR:0.8573,EAS:0.6358,FIN:0.6710,NFE:0.5837,OTH:0.5817,ASJ:0.5431	600682	245340;610021;616095;	438075;165991;171690;	438075|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Childhood|616095 ~165991|EIHI<br>Exercise-induced hyperinsulinemic hypoglycemia<br>Hyperinsulinism due to SLC16A1 deficiency<br>Hyperinsulinism due to monocarboxylate transporter 1 deficiency|-|Autosomal dominant|-|610021 ~171690|Erythrocyte lactate transporter defect|-|-|-|245340 ~	.	.	.	.	0.0	2.08	0.005	-0.345	1	1(pancreas)	0.5825
1	113460683	113460683	T	G	SLC16A1	intronic	.	ENSG00000155380	rs1344429	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5386	0.2844	0.356829	0.0838	.	.	.	.	.	.	.	.	.	.	AFR:0.1086,AMR:0.0925,EAS:0.2941,FIN:0.0435,NFE:0.0539,OTH:0.0579,ASJ:0	600682	245340;610021;616095;	438075;165991;171690;	438075|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Childhood|616095 ~165991|EIHI<br>Exercise-induced hyperinsulinemic hypoglycemia<br>Hyperinsulinism due to SLC16A1 deficiency<br>Hyperinsulinism due to monocarboxylate transporter 1 deficiency|-|Autosomal dominant|-|610021 ~171690|Erythrocyte lactate transporter defect|-|-|-|245340 ~	.	.	.	.	.	.	.	.	1	.	hom
1	114448389	114448389	C	T	DCLRE1B	exonic	nonsynonymous SNV	ENSG00000118655	rs11552449	ENSG00000118655:ENST00000369563:exon1:c.C181T:p.H61Y	DCLRE1B:NM_001363690:exon1:c.C181T:p.H61Y,DCLRE1B:NM_022836:exon1:c.C181T:p.H61Y	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2118	0.1292	0.242212	MU135663	1.186	11.67	0.489	3.57	0.233	.	.	Metallo-beta-lactamase	DCLRE1B:uc001eeg.3:exon1:c.C181T:p.H61Y	-1.067	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.1658,EAS:0.3628,FIN:0.0927,NFE:0.6346,OTH:0.1838,ASJ:0.0399	609683	.	.	.	.	.	.	.	0.136	-1.0	0.089	0	1	1(lung)	0.1740
1	114449662	114449662	T	C	DCLRE1B	exonic	synonymous SNV	ENSG00000118655	rs3761936	ENSG00000118655:ENST00000369563:exon2:c.T234C:p.H78H	DCLRE1B:NM_001363690:exon2:c.T234C:p.H78H,DCLRE1B:NM_022836:exon2:c.T234C:p.H78H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2117	0.1296	0.243411	0.1661	.	.	.	.	.	.	.	.	DCLRE1B:uc001eeg.3:exon2:c.T234C:p.H78H	.	AFR:0.0398,AMR:0.3621,EAS:0.6344,FIN:0.1835,NFE:0.1747,OTH:0.1830,ASJ:0.0933	609683	.	.	.	.	.	.	.	.	.	.	.	1	MU135678	het
1	114680310	114680310	G	A	SYT6	exonic	nonsynonymous SNV	ENSG00000134207	rs41274114	ENSG00000134207:ENST00000369547:exon3:c.C623T:p.T208I,ENSG00000134207:ENST00000393296:exon3:c.C878T:p.T293I,ENSG00000134207:ENST00000607941:exon3:c.C623T:p.T208I,ENSG00000134207:ENST00000608203:exon3:c.C623T:p.T208I,ENSG00000134207:ENST00000609117:exon3:c.C623T:p.T208I,ENSG00000134207:ENST00000610222:exon3:c.C878T:p.T293I	SYT6:NM_001253772:exon3:c.C878T:p.T293I,SYT6:NM_001270805:exon3:c.C623T:p.T208I,SYT6:NM_001366223:exon3:c.C623T:p.T208I,SYT6:NM_001366224:exon3:c.C878T:p.T293I,SYT6:NM_001366225:exon3:c.C878T:p.T293I,SYT6:NM_001366226:exon3:c.C623T:p.T208I,SYT6:NM_205848:exon3:c.C623T:p.T208I	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.1644	0.1848	0.164736	0.1717	4.446	24.2	0.221	5.45	0.998	.	.	C2 domain	SYT6:uc001eev.3:exon3:c.C623T:p.T208I,SYT6:uc021orz.1:exon3:c.C623T:p.T208I	-0.973	AFR:0.1971,AMR:0.1468,EAS:0.0815,FIN:0.1378,NFE:0.1752,OTH:0.1670,ASJ:0.2219	607718	.	.	.	.	.	.	.	0.022	-0.31	0.128	0.26	1	.	het
1	114682632	114682632	G	T	SYT6	intronic	.	ENSG00000134207	rs72690087	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1112	.	0.0690895	0.0961	.	.	.	.	.	.	.	.	.	.	AFR:0.0813,AMR:0.0766,EAS:0.0006,FIN:0.0816,NFE:0.1204,OTH:0.0900,ASJ:0.0662	607718	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	114940633	114940633	A	-	TRIM33	intronic	.	ENSG00000197323	rs397981357	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5981	.	0.696685	0.8236	.	.	.	.	.	.	.	.	.	.	AFR:0.8736,AMR:0.8254,EAS:0.9741,FIN:0.7737,NFE:0.7888,OTH:0.7803,ASJ:0.7243	605769	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	114948281	114948281	A	G	TRIM33	exonic	nonsynonymous SNV	ENSG00000197323	rs6537825	ENSG00000197323:ENST00000450349:exon14:c.T1415C:p.I472T,ENSG00000197323:ENST00000358465:exon15:c.T2519C:p.I840T,ENSG00000197323:ENST00000369543:exon15:c.T2519C:p.I840T	TRIM33:NM_015906:exon15:c.T2519C:p.I840T,TRIM33:NM_033020:exon15:c.T2519C:p.I840T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8921	0.9423	0.85643	MU807108	0.726	8.995	1.0	4.35	0.993	.	.	.	TRIM33:uc001eey.1:exon2:c.T104C:p.I35T,TRIM33:uc010owr.2:exon10:c.T1361C:p.I454T,TRIM33:uc010ows.2:exon14:c.T1415C:p.I472T,TRIM33:uc001eew.3:exon15:c.T2519C:p.I840T,TRIM33:uc001eex.3:exon15:c.T2519C:p.I840T	-1.066	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.9250,EAS:0.8266,FIN:0.87,NFE:0.5813,OTH:0.9674,ASJ:0.9707	605769	.	.	.	.	.	.	.	0.0	-0.55	0.039	-1.955	1	86(lung)	0.9320
1	120054208	120054208	C	T	HSD3B1	exonic	synonymous SNV	ENSG00000203857	rs6200	ENSG00000203857:ENST00000528909:exon2:c.C228T:p.V76V,ENSG00000203857:ENST00000235547:exon3:c.C234T:p.V78V,ENSG00000203857:ENST00000369413:exon3:c.C228T:p.V76V,ENSG00000203857:ENST00000531340:exon3:c.C228T:p.V76V	HSD3B1:NM_000862:exon3:c.C228T:p.V76V,HSD3B1:NM_001328615:exon3:c.C228T:p.V76V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0456	0.1009	0.128794	0.0897	.	.	.	.	.	.	.	.	HSD3B1:uc031pnt.1:exon2:c.C228T:p.V76V,HSD3B1:uc001ehv.1:exon3:c.C228T:p.V76V	.	AFR:0.2994,AMR:0.0573,EAS:0.0446,FIN:0,NFE:0.0018,OTH:0.0234,ASJ:0.0033	109715	.	.	.	.	.	.	.	.	.	.	.	1	MU85093349	unknown
1	120054215	120054215	A	G	HSD3B1	exonic	nonsynonymous SNV	ENSG00000203857	rs6201	ENSG00000203857:ENST00000528909:exon2:c.A235G:p.I79V,ENSG00000203857:ENST00000235547:exon3:c.A241G:p.I81V,ENSG00000203857:ENST00000369413:exon3:c.A235G:p.I79V,ENSG00000203857:ENST00000531340:exon3:c.A235G:p.I79V	HSD3B1:NM_000862:exon3:c.A235G:p.I79V,HSD3B1:NM_001328615:exon3:c.A235G:p.I79V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0482	0.1092	0.136581	0.0974	-2.148	0.001	1.0	0.153	0.047	.	.	3-beta hydroxysteroid dehydrogenase/isomerase|NAD(P)-binding domain	HSD3B1:uc031pnt.1:exon2:c.A235G:p.I79V,HSD3B1:uc001ehv.1:exon3:c.A235G:p.I79V	-0.998	AFR:0.3269,AMR:0.0585,EAS:0.0446,FIN:0,NFE:0.0019,OTH:0.0244,ASJ:0.0033	109715	.	.	.	.	.	.	.	0.0	-1.46	0.045	-1.625	1	MU85093350	unknown
1	120054250	120054250	T	A	HSD3B1	exonic	synonymous SNV	ENSG00000203857	rs6202	ENSG00000203857:ENST00000528909:exon2:c.T270A:p.G90G,ENSG00000203857:ENST00000235547:exon3:c.T276A:p.G92G,ENSG00000203857:ENST00000369413:exon3:c.T270A:p.G90G	HSD3B1:NM_000862:exon3:c.T270A:p.G90G,HSD3B1:NM_001328615:exon3:c.T270A:p.G90G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0460	0.1023	0.128794	0.0899	.	.	.	.	.	.	.	.	HSD3B1:uc031pnt.1:exon2:c.T270A:p.G90G,HSD3B1:uc001ehv.1:exon3:c.T270A:p.G90G	.	AFR:0.3018,AMR:0.0591,EAS:0.0456,FIN:0,NFE:0.0018,OTH:0.0239,ASJ:0.0034	109715	.	.	.	.	.	.	.	.	.	.	.	1	MU85093361	het
1	120057002	120057002	T	C	HSD3B1	exonic	nonsynonymous SNV	ENSG00000203857	rs6205	ENSG00000203857:ENST00000528909:exon3:c.T856C:p.F286L,ENSG00000203857:ENST00000235547:exon4:c.T862C:p.F288L,ENSG00000203857:ENST00000369413:exon4:c.T856C:p.F286L	HSD3B1:NM_000862:exon4:c.T856C:p.F286L,HSD3B1:NM_001328615:exon4:c.T856C:p.F286L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0543	0.1318	0.157748	0.1136	-1.838	0.002	1.0	-0.227	0.105	.	.	3-beta hydroxysteroid dehydrogenase/isomerase|NAD(P)-binding domain	HSD3B1:uc031pnt.1:exon3:c.T856C:p.F286L,HSD3B1:uc001ehv.1:exon4:c.T856C:p.F286L	-0.986	AFR:0.3826,AMR:0.0644,EAS:0.0465,FIN:0.0003,NFE:0.0020,OTH:0.0265,ASJ:0.0033	109715	.	.	.	.	.	.	.	0.0	0.31	0.007	-2.765	1	MU85093362	het
1	120057158	120057158	C	T	HSD3B1	exonic	synonymous SNV	ENSG00000203857	rs6203	ENSG00000203857:ENST00000528909:exon3:c.C1012T:p.L338L,ENSG00000203857:ENST00000235547:exon4:c.C1018T:p.L340L,ENSG00000203857:ENST00000369413:exon4:c.C1012T:p.L338L	HSD3B1:NM_000862:exon4:c.C1012T:p.L338L,HSD3B1:NM_001328615:exon4:c.C1012T:p.L338L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4388	0.3219	0.366813	1(liver)	.	.	.	.	.	.	.	.	HSD3B1:uc031pnt.1:exon3:c.C1012T:p.L338L,HSD3B1:uc001ehv.1:exon4:c.C1012T:p.L338L	.	AFR:MU89685,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.0963,FIN:0.5431,NFE:0.3841,OTH:0.6566,ASJ:0.3701	109715	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.5444
1	120057246	120057246	C	A	HSD3B1	exonic	nonsynonymous SNV	ENSG00000203857	rs1047303	ENSG00000203857:ENST00000528909:exon3:c.C1100A:p.T367N,ENSG00000203857:ENST00000235547:exon4:c.C1106A:p.T369N,ENSG00000203857:ENST00000369413:exon4:c.C1100A:p.T367N	HSD3B1:NM_000862:exon4:c.C1100A:p.T367N,HSD3B1:NM_001328615:exon4:c.C1100A:p.T367N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7554	0.7492	0.833466	COCA-CN|5|321|0.0155763	-1.422	0.003	0.303	-0.043	0.000	.	.	.	HSD3B1:uc031pnt.1:exon3:c.C1100A:p.T367N,HSD3B1:uc001ehv.1:exon4:c.C1100A:p.T367N	-1.061	AFR:0.7697,AMR:0.8843,EAS:0.6887,FIN:0.9312,NFE:0.7460,OTH:0.6915,ASJ:0.8141	109715	.	.	.	.	.	.	.	0.01	-0.58	0.151	2.52	1	1(large_intestine)	0.7485
1	120458924	120458924	G	A	NOTCH2	exonic	synonymous SNV	ENSG00000134250	rs3795666	ENSG00000134250:ENST00000256646:exon34:c.C6421T:p.L2141L	NOTCH2:NM_024408:exon34:c.C6421T:p.L2141L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0415	0.0179	0.0483227	0.0251	.	.	.	.	.	.	.	.	NOTCH2:uc001eik.3:exon34:c.C6421T:p.L2141L	.	AFR:0.0140,AMR:0.0716,EAS:0.0728,FIN:0.0355,NFE:0.0207,OTH:0.0387,ASJ:0.0199	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7845,	.	.	.	.	.	.	1	MU11268904	het
1	120496329	120496330	TT	-	NOTCH2	intronic	.	ENSG00000134250	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	1	.	het
1	120572547	120572547	T	C	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs61788900	ENSG00000134250:ENST00000256646:exon2:c.A137G:p.N46S,ENSG00000134250:ENST00000602566:exon3:c.A20G:p.N7S	NOTCH2:NM_001200001:exon2:c.A137G:p.N46S,NOTCH2:NM_024408:exon2:c.A137G:p.N46S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4736	.	.	4(penis)	2.196	17.48	0.129	5.05	1.000	.	.	EGF-like domain	NOTCH2:uc001eik.3:exon2:c.A137G:p.N46S,NOTCH2:uc001eil.3:exon2:c.A137G:p.N46S,NOTCH2:uc021osy.1:exon2:c.A20G:p.N7S	-0.943	AFR:4(thyroid),AMR:2(large_intestine),EAS:1(biliary_tract),FIN:MU617194,NFE:LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,THCA-CN|1|50|0.02,OTH:0.3958,ASJ:1(kidney)	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7845,	.	.	0.01	-0.03	0.124	0.885	1	4(haematopoietic_and_lymphoid_tissue)	0.2468
1	120572572	120572572	C	T	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs61788901	ENSG00000134250:ENST00000256646:exon2:c.G112A:p.E38K	NOTCH2:NM_001200001:exon2:c.G112A:p.E38K,NOTCH2:NM_024408:exon2:c.G112A:p.E38K	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4699	.	.	2(haematopoietic_and_lymphoid_tissue)	2.535	19.69	0.058	2.14	0.988	.	.	EGF-like domain	NOTCH2:uc001eik.3:exon2:c.G112A:p.E38K,NOTCH2:uc001eil.3:exon2:c.G112A:p.E38K	-1.097	AFR:1(central_nervous_system),AMR:18(upper_aerodigestive_tract),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,FIN:0.3980,NFE:0.2513,OTH:0.4313,ASJ:MU4547029	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7845,	.	.	0.044	0.13	0.049	0.02	1	1(thyroid)	0.4424
1	120611960	120611960	C	T	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs2603926	ENSG00000134250:ENST00000256646:exon1:c.G61A:p.A21T	NOTCH2:NM_001200001:exon1:c.G61A:p.A21T,NOTCH2:NM_024408:exon1:c.G61A:p.A21T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.3634	.	.	0.0644	3.041	22.4	0.642	2.14	0.912	.	.	.	NOTCH2:uc001eik.3:exon1:c.G61A:p.A21T,NOTCH2:uc001eil.3:exon1:c.G61A:p.A21T	-0.954	AFR:0.1695,AMR:0.0369,EAS:0.0059,FIN:0.0054,NFE:0.0408,OTH:0.0340,ASJ:0.0505	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7845,	.	.	0.0	0.38	0.018	0.625	1	MU869951	het
1	120611964	120611964	G	C	NOTCH2	exonic	nonsynonymous SNV	ENSG00000134250	rs11810554	ENSG00000134250:ENST00000256646:exon1:c.C57G:p.C19W	NOTCH2:NM_001200001:exon1:c.C57G:p.C19W,NOTCH2:NM_024408:exon1:c.C57G:p.C19W	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4493	.	.	0.3877	2.208	17.56	0.185	2.04	0.868	.	.	.	NOTCH2:uc001eik.3:exon1:c.C57G:p.C19W,NOTCH2:uc001eil.3:exon1:c.C57G:p.C19W	-1.048	AFR:0.2278,AMR:0.4293,EAS:0.4526,FIN:0.4558,NFE:0.4469,OTH:0.4300,ASJ:0.4312	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7845,	.	.	0.001	0.4	0.036	1.04	1	MU815514	het
1	120612006	120612006	G	A	NOTCH2	exonic	synonymous SNV	ENSG00000134250	rs4021006	ENSG00000134250:ENST00000256646:exon1:c.C15T:p.R5R	NOTCH2:NM_001200001:exon1:c.C15T:p.R5R,NOTCH2:NM_024408:exon1:c.C15T:p.R5R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4638	.	0.39397	0.3802	.	.	.	.	.	.	.	.	NOTCH2:uc001eik.3:exon1:c.C15T:p.R5R,NOTCH2:uc001eil.3:exon1:c.C15T:p.R5R	.	AFR:0.2426,AMR:0.4346,EAS:0.4369,FIN:0.4496,NFE:0.4286,OTH:0.4243,ASJ:0.4070	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	7845,	.	.	.	.	.	.	1	MU657255	het
1	120612040	120612040	-	CCGCCGCCGCCGCCG	NOTCH2NLR	ncRNA_exonic	.	ENSG00000134250	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600275	102500;610205;	261629;52;955;	261629|Alagille-Watson syndrome due to a NOTCH2 point mutation<br>Arteriohepatic dysplasia due to a NOTCH2 point mutation<br>Syndromic bile duct paucity due to a NOTCH2 point mutation|-|-|-|610205 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~955|Acrodentoosteodysplasia<br>Acroosteolysis with osteoporosis and changes in skull and mandible<br>Arthrodentoosteodysplasia<br>Cheney syndrome<br>Hajdu-Cheney syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|102400 102500 ~	.	.	.	.	.	.	.	.	1	.	het
1	147087721	147087721	T	A	BCL9;NBPF19	intronic	.	ENSG00000116128	rs3737843	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4461	0.3704	0.316693	0.4042	.	.	.	.	.	.	.	.	.	.	AFR:0.0906,AMR:0.3397,EAS:0.4359,FIN:0.6025,NFE:0.5327,OTH:0.5133,ASJ:0.4503	602597	.	.	.	.	.	.	.	.	.	.	.	1	MU790640	het
1	147091972	147091972	C	T	BCL9	exonic	nonsynonymous SNV	ENSG00000116128	rs3820129	ENSG00000116128:ENST00000234739:exon8:c.C2011T:p.P671S	BCL9:NM_004326:exon8:c.C2011T:p.P671S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3143	0.2961	0.181909	0.3084	3.160	22.6	0.02	3.92	1.000	.	.	.	BCL9:uc010ozr.1:exon5:c.C1789T:p.P597S,BCL9:uc001epq.3:exon8:c.C2011T:p.P671S	-1.031	AFR:0.0747,AMR:0.2231,EAS:0.0812,FIN:0.4587,NFE:0.4336,OTH:0.3814,ASJ:0.3411	602597	.	.	.	.	.	.	.	0.079	0.53	0.065	1.555	1	MU21284346	het
1	150240527	150240527	C	T	APH1A	exonic	synonymous SNV	ENSG00000117362	.	ENSG00000117362:ENST00000360244:exon2:c.G114A:p.G38G,ENSG00000117362:ENST00000369109:exon2:c.G114A:p.G38G	APH1A:NM_001077628:exon2:c.G114A:p.G38G,APH1A:NM_016022:exon2:c.G114A:p.G38G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0065	0.186	.	APH1A:uc001ety.2:exon2:c.G114A:p.G38G,APH1A:uc001etz.2:exon2:c.G114A:p.G38G	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607629	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	150241230	150241230	G	T	APH1A	UTR5	.	ENSG00000117362	rs2275780	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1662	0.0888	0.150559	0.0980	.	.	.	.	.	.	.	.	.	.	AFR:0.0304,AMR:0.0955,EAS:0.3539,FIN:0.1156,NFE:0.1036,OTH:0.1265,ASJ:0.1225	607629	.	.	.	.	.	.	.	.	.	.	.	1	MU67334414	het
1	154561925	154561925	C	T	ADAR	exonic	synonymous SNV	ENSG00000160710	rs1127309	ENSG00000160710:ENST00000529168:exon8:c.G2589A:p.V863V,ENSG00000160710:ENST00000292205:exon9:c.G2811A:p.V937V,ENSG00000160710:ENST00000368471:exon9:c.G1797A:p.V599V,ENSG00000160710:ENST00000368474:exon9:c.G2682A:p.V894V	ADAR:NM_001025107:exon9:c.G1797A:p.V599V,ADAR:NM_001111:exon9:c.G2682A:p.V894V,ADAR:NM_001193495:exon9:c.G1797A:p.V599V,ADAR:NM_001365045:exon9:c.G2709A:p.V903V,ADAR:NM_001365048:exon9:c.G1797A:p.V599V,ADAR:NM_015840:exon9:c.G2604A:p.V868V,ADAR:NM_015841:exon9:c.G2547A:p.V849V,ADAR:NM_001365046:exon10:c.G1797A:p.V599V,ADAR:NM_001365047:exon10:c.G1797A:p.V599V,ADAR:NM_001365049:exon10:c.G1719A:p.V573V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2745	0.2980	0.28095	1(stomach)	.	.	.	.	.	.	.	.	ADAR:uc001ffh.3:exon9:c.G2682A:p.V894V,ADAR:uc001ffi.3:exon9:c.G2604A:p.V868V,ADAR:uc001ffj.3:exon9:c.G2547A:p.V849V,ADAR:uc001ffk.3:exon9:c.G1797A:p.V599V,ADAR:uc021pag.1:exon9:c.G1797A:p.V599V	.	AFR:MU11284454,AMR:COCA-CN|3|321|0.00934579,EAS:0.2978,FIN:0.2124,NFE:0.3113,OTH:0.2776,ASJ:0.2894	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.3124
1	154574820	154574820	T	C	ADAR	exonic	nonsynonymous SNV	ENSG00000160710	rs1466731	ENSG00000160710:ENST00000529168:exon1:c.A283G:p.R95G,ENSG00000160710:ENST00000292205:exon2:c.A427G:p.R143G,ENSG00000160710:ENST00000368474:exon2:c.A298G:p.R100G	ADAR:NM_001111:exon2:c.A298G:p.R100G,ADAR:NM_001365045:exon2:c.A325G:p.R109G,ADAR:NM_015840:exon2:c.A298G:p.R100G,ADAR:NM_015841:exon2:c.A298G:p.R100G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9988	0.9957	0.996206	0.9969	-1.562	0.002	0.807	-2.82	0.000	.	.	.	ADAR:uc001ffh.3:exon2:c.A298G:p.R100G,ADAR:uc001ffi.3:exon2:c.A298G:p.R100G,ADAR:uc001ffj.3:exon2:c.A298G:p.R100G	-1.015	AFR:0.9892,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	0.0	2.45	0.009	-0.205	1	MU81711582	hom
1	154575040	154575040	C	T	ADAR	exonic	synonymous SNV	ENSG00000160710	rs1802645	ENSG00000160710:ENST00000529168:exon1:c.G63A:p.R21R,ENSG00000160710:ENST00000292205:exon2:c.G207A:p.R69R,ENSG00000160710:ENST00000368474:exon2:c.G78A:p.R26R	ADAR:NM_001111:exon2:c.G78A:p.R26R,ADAR:NM_001365045:exon2:c.G105A:p.R35R,ADAR:NM_015840:exon2:c.G78A:p.R26R,ADAR:NM_015841:exon2:c.G78A:p.R26R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9992	0.9972	0.997005	0.9978	.	.	.	.	.	.	.	.	ADAR:uc001ffh.3:exon2:c.G78A:p.R26R,ADAR:uc001ffi.3:exon2:c.G78A:p.R26R,ADAR:uc001ffj.3:exon2:c.G78A:p.R26R,ADAR:uc001ffn.2:exon2:c.G78A:p.R26R	.	AFR:0.9924,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	146920	127400;615010;	51;41;	51|Encephalopathy with basal ganglia calcification<br>Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|114100 225750 610181 610329 610333 612952 615010 615846 ~41|Acropigmentation of Dohi|Unknown|Autosomal dominant|Childhood|127400 ~	.	.	.	.	.	.	.	.	1	MU81711590	hom
1	155870416	155870416	G	A	RIT1	intronic	.	ENSG00000143622	rs1749409	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8772	0.7934	0.779752	0.8171	.	.	.	.	.	0	0	.	.	.	AFR:0.5463,AMR:0.9356,EAS:0.9377,FIN:0.9035,NFE:0.9284,OTH:0.8921,ASJ:0.8676	609591	615355;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	.	.	.	.	.	.	.	.	1	MU26075081	het
1	155880573	155880573	C	G	RIT1	exonic	nonsynonymous SNV	ENSG00000143622	rs493446	ENSG00000143622:ENST00000368322:exon2:c.G31C:p.E11Q	RIT1:NM_001256821:exon2:c.G31C:p.E11Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.8775	0.7952	0.779952	0.8174	-0.532	0.183	0.43	-0.379	0.012	.	.	.	RIT1:uc031pqc.1:exon2:c.G31C:p.E11Q	-1.065	AFR:0.5470,AMR:0.9356,EAS:0.9382,FIN:0.9038,NFE:0.9286,OTH:0.8918,ASJ:0.8676	609591	615355;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	.	,9550,9551	.	.	.	-0.21	0.078	.	1	MU26075246	het
1	156107534	156107534	C	T	LMNA	exonic	synonymous SNV	ENSG00000160789	rs4641	ENSG00000160789:ENST00000361308:exon10:c.C1698T:p.H566H,ENSG00000160789:ENST00000368299:exon10:c.C1698T:p.H566H,ENSG00000160789:ENST00000368300:exon10:c.C1698T:p.H566H,ENSG00000160789:ENST00000392353:exon10:c.C1455T:p.H485H,ENSG00000160789:ENST00000448611:exon10:c.C1362T:p.H454H,ENSG00000160789:ENST00000368297:exon11:c.C1455T:p.H485H,ENSG00000160789:ENST00000473598:exon11:c.C1401T:p.H467H,ENSG00000160789:ENST00000368301:exon13:c.C1698T:p.H566H	LMNA:NM_001257374:exon10:c.C1362T:p.H454H,LMNA:NM_001282626:exon10:c.C1698T:p.H566H,LMNA:NM_005572:exon10:c.C1698T:p.H566H,LMNA:NM_170707:exon10:c.C1698T:p.H566H,LMNA:NM_001282624:exon11:c.C1455T:p.H485H,LMNA:NM_001282625:exon13:c.C1698T:p.H566H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2655	0.1970	0.220248	1(stomach)	.	.	.	.	.	.	.	.	LMNA:uc010pha.1:exon5:c.C666T:p.H222H,LMNA:uc001fng.2:exon10:c.C1698T:p.H566H,LMNA:uc001fni.3:exon10:c.C1698T:p.H566H,LMNA:uc009wro.2:exon10:c.C1698T:p.H566H,LMNA:uc010pgz.2:exon10:c.C1362T:p.H454H,LMNA:uc001fnj.3:exon11:c.C1455T:p.H485H,LMNA:uc001fnk.3:exon11:c.C1401T:p.H467H,LMNA:uc001fnf.1:exon13:c.C1698T:p.H566H	.	AFR:2(breast),AMR:MU107165,EAS:0.1960,FIN:0.0919,NFE:0.2912,OTH:0.23,ASJ:LUSC-KR|6|170|0.0352941,COCA-CN|4|321|0.0124611	150330	115200;151660;159001;176670;181350;212112;248370;275210;605588;610140;613205;616516;	261;98855;157973;168796;98856;1662;2457;90153;2229;261;98853;740;264;2348;300751;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98855|EDMD3|-|Autosomal recessive|-|616516 ~157973|L-CMD<br>LMNA-related congenital muscular dystrophy|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|613205 ~168796|Atriodigital dysplasia, Slovenian type<br>Cardiac conduction disease-dilated cardiomyopathy-brachydactyly syndrome|<1 / 1 000 000|Autosomal dominant|Adult|610140 ~98856|AR-CMT2B1<br>Autosomal recessive Charcot-Marie-Tooth disease type 2B1<br>Autosomal recessive axonal CMT4C1|Unknown|Autosomal recessive|Childhood|605588 ~1662|Hyperkeratosis-contracture syndrome<br>Lethal restrictive dermopathy<br>Tight skin contracture syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal|275210 ~2457|MAD|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|248370 608612 ~90153|-|-|Autosomal recessive|-|248370 ~2229|Cardiogenital syndrome<br>Malouf syndrome<br>Najjar syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|212112 ~261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~740|HGPS<br>Progeria|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|176670 ~264|LGMD1B<br>Limb-girdle muscular dystrophy due to lamin A/C deficiency|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|159001 ~2348|Dunnigan syndrome<br>FPLD2<br>Familial partial lipodystrophy type 2|Unknown|Autosomal dominant|Adolescent<br>Adult|151660 ~300751|-|Unknown|Autosomal dominant|-|115200 ~	.	.	.	.	.	.	.	.	1	1(thyroid)	0.2466
1	156785617	156785617	G	A	NTRK1	UTR5	.	ENSG00000198400	rs1800601	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6674	0.6177	0.636981	0.6243	.	.	.	.	.	.	.	.	.	.	AFR:0.5074,AMR:0.6926,EAS:0.8288,FIN:0.6437,NFE:0.6591,OTH:0.6449,ASJ:0.6887	191315	155240;256800;	642;653;99361;	642|HSAN4<br>Insensitivity to pain-anhidrosis syndrome|-|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|256800 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	MU718802	hom
1	156848910	156848910	A	-	NTRK1	intronic	.	ENSG00000198400	rs1799770	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0625	0.0667	0.0892572	.	.	.	.	.	.	.	.	.	.	.	AFR:0.0594,AMR:0.1041,EAS:0.0695,FIN:0.0698,NFE:0.0295,OTH:0.0403,ASJ:0.0370	191315	155240;256800;	642;653;99361;	642|HSAN4<br>Insensitivity to pain-anhidrosis syndrome|-|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|256800 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	1	1(soft_tissue)	0.0602
1	161284224	161284224	-	GT	SDHC	intronic	.	ENSG00000143252	rs35215598	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1053	0.1122	0.169728	0.1217	.	.	.	.	.	.	.	.	.	.	AFR:0.2141,AMR:0.0668,EAS:0.1867,FIN:0.1002,NFE:0.0724,OTH:0.0998,ASJ:0.03	602413	605373;606764;606864;	97286;44890;29072;	97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	1	.	hom
1	161332346	161332346	C	G	SDHC	UTR3	.	ENSG00000143252	rs3813632	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1029	0.0694	0.128794	0.0873	.	.	.	.	.	.	.	.	.	.	AFR:0.0978,AMR:0.0656,EAS:0.1768,FIN:0.0986,NFE:0.0710,OTH:0.0937,ASJ:0.0298	602413	605373;606764;606864;	97286;44890;29072;	97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~	.	.	.	.	.	.	.	.	1	MU652984	hom
1	161643269	161643269	C	T	FCGR2B	intronic	.	ENSG00000072694	rs2045571	ENSG00000072694:ENST00000428605:exon5:c.C662T:p.T221M	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1957	0.1544	.	0.1745	.	.	.	.	.	.	.	.	FCGR2B:uc009wum.2:exon5:c.C662T:p.T221M	.	AFR:0.2593,AMR:0.1072,EAS:0.2654,FIN:0.1746,NFE:0.1221,OTH:0.1486,ASJ:0.125	604590	152700;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	1	MU11293000	hom
1	161643798	161643798	T	C	FCGR2B	exonic	nonsynonymous SNV	ENSG00000072694	rs1050501	ENSG00000072694:ENST00000367960:exon4:c.T674C:p.I225T,ENSG00000072694:ENST00000367961:exon4:c.T674C:p.I225T,ENSG00000072694:ENST00000236937:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000358671:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000367962:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000403078:exon5:c.T695C:p.I232T	FCGR2B:NM_001190828:exon4:c.T674C:p.I225T,FCGR2B:NM_001002273:exon5:c.T692C:p.I231T,FCGR2B:NM_001002274:exon5:c.T695C:p.I232T,FCGR2B:NM_001002275:exon5:c.T692C:p.I231T,FCGR2B:NM_004001:exon5:c.T695C:p.I232T	clinvar: protective,_risk_factor 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, -1, 1, 1] 	0.2369	.	0.185903	MU4552844	0.457	7.094	0.256	2.85	0.298	.	.	.	FCGR2B:uc009wun.2:exon4:c.T674C:p.I225T,FCGR2B:uc001gay.2:exon5:c.T692C:p.I231T,FCGR2B:uc001gaz.2:exon5:c.T695C:p.I232T,FCGR2B:uc001gba.2:exon5:c.T692C:p.I231T,FCGR2B:uc001gbb.2:exon5:c.T695C:p.I232T	-1.039	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,AMR:0.2360,EAS:0.2101,FIN:0.1761,NFE:0.3179,OTH:0.2774,ASJ:0.3094	604590	152700;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	,4953	0.256	1.47	0.026	1.04	1	7(upper_aerodigestive_tract)	0.1645
1	161645259	161645259	T	G	FCGR2B	intronic	.	ENSG00000072694	rs1674759	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.792532	0.8326	.	.	.	.	.	.	.	.	.	.	AFR:0.7640,AMR:0.8604,EAS:0.8306,FIN:0.8873,NFE:0.8578,OTH:0.8535,ASJ:0.7919	604590	152700;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	1	MU113392205	hom
1	162737116	162737116	C	G	DDR2	exonic	synonymous SNV	ENSG00000162733	rs2298258	ENSG00000162733:ENST00000458105:exon1:c.C90G:p.L30L,ENSG00000162733:ENST00000367921:exon11:c.C1260G:p.L420L,ENSG00000162733:ENST00000367922:exon12:c.C1260G:p.L420L	DDR2:NM_001354982:exon11:c.C1260G:p.L420L,DDR2:NM_001354983:exon11:c.C1260G:p.L420L,DDR2:NM_006182:exon11:c.C1260G:p.L420L,DDR2:NM_001014796:exon12:c.C1260G:p.L420L	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2242	0.2573	0.348442	0.2473	.	.	.	.	.	.	.	.	DDR2:uc001gcg.3:exon11:c.C1260G:p.L420L,DDR2:uc001gcf.3:exon12:c.C1260G:p.L420L	.	AFR:0.4814,AMR:0.3890,EAS:0.3938,FIN:0.0808,NFE:0.1358,OTH:0.1386,ASJ:0.1391	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	.	,2212	.	.	.	.	.	.	1	MU647178	hom
1	162740327	162740327	T	C	DDR2	intronic	.	ENSG00000162733	rs1780003	ENSG00000162733:ENST00000458105:exon2:c.T359C:p.V120A	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9855	0.9476	0.945487	0.9541	-0.266	0.793	0.0	-10.1	0.000	.	.	.	.	-1.062	AFR:0.8402,AMR:0.9928,EAS:1,FIN:1,NFE:0.9993,OTH:0.9867,ASJ:1	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	.	.	.	.	.	1.39	0.010	.	1	MU81714571	hom
1	162746113	162746113	C	T	DDR2	exonic	nonsynonymous SNV	ENSG00000162733	.	ENSG00000162733:ENST00000367921:exon16:c.C2236T:p.R746W,ENSG00000162733:ENST00000367922:exon17:c.C2236T:p.R746W	DDR2:NM_001354982:exon16:c.C2236T:p.R746W,DDR2:NM_001354983:exon16:c.C2236T:p.R746W,DDR2:NM_006182:exon16:c.C2236T:p.R746W,DDR2:NM_001014796:exon17:c.C2236T:p.R746W	clinvar: UNK 	 CancerVar: 9#Tier_II_potential EVS=[1, 0, 0, 1, 0, 0, 1, 0, 2, 2, 1, 1] 	.	.	.	3.23e-05	7.545	34	0.001	4.24	1.000	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain	DDR2:uc001gcg.3:exon16:c.C2236T:p.R746W,DDR2:uc001gcf.3:exon17:c.C2236T:p.R746W	0.596	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	191311	271665;	93358;	93358|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|271665 ~	.	,2212	.	.	1.0	-1.68	0.696	2.795	1	MU113383906	het
1	170501385	170501385	A	C	GORAB	exonic	synonymous SNV	ENSG00000120370	rs7531125	ENSG00000120370:ENST00000367762:exon1:c.A96C:p.G32G,ENSG00000120370:ENST00000367763:exon1:c.A96C:p.G32G	GORAB:NM_001146039:exon1:c.A96C:p.G32G,GORAB:NM_152281:exon1:c.A96C:p.G32G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9797	0.9355	0.927516	0.9418	.	.	.	.	.	.	.	.	GORAB:uc001ggz.4:exon1:c.A96C:p.G32G,GORAB:uc001gha.2:exon1:c.A96C:p.G32G,GORAB:uc009wvw.2:exon1:c.A96C:p.G32G	.	AFR:0.7985,AMR:0.9821,EAS:0.9994,FIN:1,NFE:0.9987,OTH:0.9919,ASJ:0.9834	607983	231070;	2078;	2078|-|<1 / 1 000 000|Autosomal recessive|Neonatal|231070 ~	.	.	.	.	.	.	.	.	1	MU4568428	hom
1	170521376	170521376	G	A	GORAB	exonic	nonsynonymous SNV	ENSG00000120370	rs913257	ENSG00000120370:ENST00000367763:exon5:c.G958A:p.E320K	GORAB:NM_152281:exon5:c.G958A:p.E320K,GORAB:NM_001320252:exon7:c.G418A:p.E140K	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5394	0.4859	0.592652	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	5.381	25.9	0.059	2.65	0.171	.	.	.	GORAB:uc001ghd.2:exon2:c.G337A:p.E113K,GORAB:uc001ghc.2:exon4:c.G418A:p.E140K,GORAB:uc001gha.2:exon5:c.G958A:p.E320K,GORAB:uc009wvx.2:exon5:c.G418A:p.E140K,GORAB:uc001ghb.2:exon7:c.G418A:p.E140K	-1.034	AFR:0.5294,AMR:0.5227,EAS:0.4139,FIN:0.9022,NFE:0.5713,OTH:0.4809,ASJ:0.6193	607983	231070;	2078;	2078|-|<1 / 1 000 000|Autosomal recessive|Neonatal|231070 ~	.	.	.	.	0.777	-0.01	0.085	2.16	1	1(large_intestine)	0.5245
1	173878832	173878832	T	C	SERPINC1	exonic	synonymous SNV	ENSG00000117601	rs5878	ENSG00000117601:ENST00000367698:exon5:c.A1011G:p.Q337Q	SERPINC1:NM_000488:exon5:c.A1011G:p.Q337Q,SERPINC1:NM_001365052:exon6:c.A867G:p.Q289Q	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4029	0.4882	0.535743	0.4717	.	.	.	.	.	.	.	.	SERPINC1:uc001gjt.3:exon5:c.A1011G:p.Q337Q	.	AFR:0.7680,AMR:0.2632,EAS:0.6539,FIN:0.2885,NFE:0.3395,OTH:0.3706,ASJ:0.53	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU158486	het
1	173878862	173878862	T	C	SERPINC1	exonic	synonymous SNV	ENSG00000117601	rs5877	ENSG00000117601:ENST00000367698:exon5:c.A981G:p.V327V	SERPINC1:NM_000488:exon5:c.A981G:p.V327V,SERPINC1:NM_001365052:exon6:c.A837G:p.V279V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4079	0.4836	0.545327	0.4688	.	.	.	.	.	.	.	.	SERPINC1:uc001gjt.3:exon5:c.A981G:p.V327V	.	AFR:0.7612,AMR:0.3353,EAS:0.6751,FIN:0.2736,NFE:0.3346,OTH:0.3673,ASJ:0.5265	107300	613118;	82;	82|Hereditary thrombophilia due to congenital antithrombin 3 deficiency|-|-|-|613118 ~	.	.	.	.	.	.	.	.	1	MU158492	het
1	179112145	179112145	C	G	ABL2	exonic	nonsynonymous SNV	ENSG00000143322	rs1318056	ENSG00000143322:ENST00000344730:exon1:c.G35C:p.S12T,ENSG00000143322:ENST00000408940:exon1:c.G35C:p.S12T,ENSG00000143322:ENST00000504405:exon1:c.G35C:p.S12T,ENSG00000143322:ENST00000512653:exon1:c.G35C:p.S12T	ABL2:NM_001136000:exon1:c.G35C:p.S12T,ABL2:NM_001168239:exon1:c.G35C:p.S12T,ABL2:NM_005158:exon1:c.G35C:p.S12T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0749	0.0931	0.0742812	.	0.511	7.517	0.194	2.49	0.007	.	.	.	ABL2:uc001gmg.4:exon1:c.G35C:p.S12T,ABL2:uc001gmi.4:exon1:c.G35C:p.S12T,ABL2:uc001gmk.3:exon1:c.G35C:p.S12T,ABL2:uc009wxf.2:exon1:c.G35C:p.S12T,ABL2:uc010pne.2:exon1:c.G35C:p.S12T	-1.064	AFR:.,AMR:0.0835,EAS:0.0513,FIN:0.0960,NFE:0.0006,OTH:0.0676,ASJ:0.1067	164690	.	.	.	.	.	.	.	0.007	-0.87	0.006	.	1	3(soft_tissue)	0.0855
1	179176303	179176303	-	T	ABL2	intronic	.	ENSG00000143322	rs573654560	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.0980431	0.1280	.	.	.	.	.	.	.	.	.	.	AFR:0.1239,AMR:0.0714,EAS:0.0927,FIN:0.1697,NFE:0.1338,OTH:0.1142,ASJ:0.0935	164690	.	.	.	.	.	.	.	.	.	.	.	1	MU111667227	het
1	179176398	179176398	G	A	ABL2	intronic	.	ENSG00000143322	rs2171958	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.4998	0.5052	.	.	.	.	.	.	.	.	.	.	AFR:0.5225,AMR:0.5744,EAS:0.4956,FIN:0.4744,NFE:0.5020,OTH:0.5032,ASJ:0.3833	164690	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	180243524	180243524	A	G	LHX4	exonic	nonsynonymous SNV	ENSG00000121454	rs7536561	ENSG00000121454:ENST00000263726:exon6:c.A983G:p.N328S	LHX4:NM_033343:exon6:c.A983G:p.N328S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4850	0.4107	0.426318	0.4295	-0.369	0.458	1.0	3.27	1.000	.	.	.	LHX4:uc001goe.2:exon6:c.A983G:p.N328S	-0.956	AFR:0.1917,AMR:0.2840,EAS:0.6141,FIN:0.5750,NFE:0.5128,OTH:0.5297,ASJ:0.5878	602146	262700;	85442;	85442|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|262700 ~	.	.	.	.	0.0	-2.24	0.000	-0.03	1	MU114774	hom
1	183177218	183177218	A	G	LAMC2	intronic	.	ENSG00000058085	rs647347	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4739	0.4475	0.496206	0.4515	.	.	.	.	.	.	.	.	.	.	AFR:0.4648,AMR:0.5120,EAS:0.5694,FIN:0.4966,NFE:0.4171,OTH:0.4662,ASJ:0.4073	150292	226650;226700;	79404;251393;79402;79405;89840;	79404|Epidermolysis bullosa letalis<br>JEB-H<br>Junctional epidermolysis bullosa generalisata gravis<br>Junctional epidermolysis bullosa, Herlitz-Pearson type|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226700 ~251393|JEB-nH loc|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~79402|GABEB<br>Generalized atrophic benign epidermolysis bullosa<br>JEB-nH gen<br>Junctional epidermolysis bullosa generalisata mitis<br>Junctional epidermolysis bullosa, Disentis type|Unknown|Autosomal recessive|Infancy<br>Neonatal|226650 ~79405|EBJ-I<br>Inverse JEB<br>JEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~89840|JEN-nH|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226650 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	1	MU11323905	het
1	186292803	186292803	C	T	TPR	intronic	.	ENSG00000047410	rs3818293	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1242	0.0733	0.121805	LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.0934,AMR:0.0248,EAS:0.0733,FIN:0.2668,NFE:0.1009,OTH:0.1073,ASJ:0.1643	189940	.	.	.	~ko03013 RNA transport~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.1245
1	196642233	196642233	G	A	CFH	exonic	nonsynonymous SNV	ENSG00000000971	rs800292	ENSG00000000971:ENST00000359637:exon2:c.G184A:p.V62I,ENSG00000000971:ENST00000367429:exon2:c.G184A:p.V62I,ENSG00000000971:ENST00000439155:exon2:c.G184A:p.V62I	CFH:NM_000186:exon2:c.G184A:p.V62I,CFH:NM_001014975:exon2:c.G184A:p.V62I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3210	0.3866	0.468051	MU581298	-0.812	0.040	1.0	5.12	0.028	.	.	Sushi/SCR/CCP domain	CFH:uc001gti.4:exon2:c.G184A:p.V62I,CFH:uc001gtj.4:exon2:c.G184A:p.V62I,CFH:uc009wyw.3:exon2:c.G184A:p.V62I,CFH:uc009wyx.3:exon2:c.G184A:p.V62I	-0.942	AFR:LAML-KR|4|205|0.0195122,COCA-CN|1|321|0.00311526,AMR:0.3934,EAS:0.3640,FIN:0.2318,NFE:0.4191,OTH:0.2930,ASJ:0.7150	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	0.0	-0.09	0.000	-2.885	1	2(stomach)	0.2372
1	196642969	196642969	-	TT	CFH	intronic	.	ENSG00000000971	rs35507625	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2568	.	0.305711	0.2361	.	.	.	.	.	.	.	.	.	.	AFR:0.1806,AMR:0.2958,EAS:0.5019,FIN:0.2693,NFE:0.2270,OTH:0.2716,ASJ:0.2252	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	.	het
1	196654324	196654324	A	C	CFH	exonic	synonymous SNV	ENSG00000000971	rs1061147	ENSG00000000971:ENST00000359637:exon6:c.A729C:p.A243A,ENSG00000000971:ENST00000367429:exon7:c.A921C:p.A307A,ENSG00000000971:ENST00000439155:exon7:c.A921C:p.A307A	CFH:NM_000186:exon7:c.A921C:p.A307A,CFH:NM_001014975:exon7:c.A921C:p.A307A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6666	0.6081	0.713059	0.6188	.	.	.	.	.	.	.	.	CFH:uc009wyx.3:exon6:c.A729C:p.A243A,CFH:uc001gti.4:exon7:c.A921C:p.A307A,CFH:uc001gtj.4:exon7:c.A921C:p.A307A,CFH:uc009wyw.3:exon7:c.A921C:p.A307A	.	AFR:0.5773,AMR:0.7830,EAS:0.9559,FIN:0.5500,NFE:0.6138,OTH:0.6071,ASJ:0.6689	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	MU155913	hom
1	196659237	196659237	C	T	CFH	exonic	nonsynonymous SNV	ENSG00000000971	rs1061170	ENSG00000000971:ENST00000359637:exon8:c.C1012T:p.H338Y,ENSG00000000971:ENST00000367429:exon9:c.C1204T:p.H402Y,ENSG00000000971:ENST00000439155:exon9:c.C1204T:p.H402Y	CFH:NM_000186:exon9:c.C1204T:p.H402Y,CFH:NM_001014975:exon9:c.C1204T:p.H402Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6721	0.6243	0.733427	ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	-3.918	0.001	1.0	-9.09	0.000	.	.	Sushi/SCR/CCP domain	CFH:uc009wyx.3:exon8:c.C1012T:p.H338Y,CFH:uc001gti.4:exon9:c.C1204T:p.H402Y,CFH:uc001gtj.4:exon9:c.C1204T:p.H402Y,CFH:uc009wyw.3:exon9:c.C1129T:p.H377Y	-1.007	AFR:0.6336,AMR:0.6282,EAS:0.6689,FIN:0.9557,NFE:0.55,OTH:0.6144,ASJ:0.7885	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	0.0	-0.03	0.000	.	1	1(large_intestine)	0.6104
1	196661505	196661505	G	C	CFH	intronic	.	ENSG00000000971	rs10922094	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.733227	0.6325	.	.	.	.	.	.	.	.	.	.	AFR:0.6290,AMR:0.7862,EAS:0.9554,FIN:0.5514,NFE:0.6109,OTH:0.6076,ASJ:0.6689	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	MU115452194	hom
1	196682947	196682947	G	A	CFH	exonic	synonymous SNV	ENSG00000000971	rs2274700	ENSG00000000971:ENST00000367429:exon10:c.G1419A:p.A473A	CFH:NM_000186:exon10:c.G1419A:p.A473A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4431	0.4262	0.479034	LAML-KR|4|205|0.0195122,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	CFH:uc001gtj.4:exon10:c.G1419A:p.A473A	.	AFR:0.4239,AMR:0.4696,EAS:0.51,FIN:0.4261,NFE:0.3805,OTH:0.4042,ASJ:0.4412	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	5(haematopoietic_and_lymphoid_tissue)	0.4274
1	196695742	196695742	A	G	CFH	exonic	synonymous SNV	ENSG00000000971	rs3753396	ENSG00000000971:ENST00000367429:exon13:c.A2016G:p.Q672Q	CFH:NM_000186:exon13:c.A2016G:p.Q672Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1947	0.1369	0.202875	1(stomach)	.	.	.	.	.	.	.	.	CFH:uc001gtj.4:exon13:c.A2016G:p.Q672Q	.	AFR:MU155931,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,EAS:0.0606,FIN:0.3126,NFE:0.1258,OTH:0.5119,ASJ:0.1567	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	2(haematopoietic_and_lymphoid_tissue)	0.1479
1	196709774	196709774	G	T	CFH	exonic	nonsynonymous SNV	ENSG00000000971	rs1065489	ENSG00000000971:ENST00000367429:exon18:c.G2808T:p.E936D	CFH:NM_000186:exon18:c.G2808T:p.E936D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1955	0.1380	0.203275	3(haematopoietic_and_lymphoid_tissue)	-0.535	0.180	0.593	-2.39	0.002	.	.	Sushi/SCR/CCP domain	CFH:uc001gtj.4:exon18:c.G2808T:p.E936D	-0.954	AFR:MU155940,AMR:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LICA-CN|3|402|0.00746269,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,EAS:0.0603,FIN:0.3149,NFE:0.1258,OTH:0.5142,ASJ:0.1585	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	0.75	-0.02	0.000	0.945	1	2(large_intestine)	0.1496
1	196712577	196712577	T	C	CFH	intronic	.	ENSG00000000971	rs513699	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2585	.	.	1(pancreas)	.	.	.	.	.	0	0.028	.	.	.	AFR:MU11352223,AMR:SKCA-BR|1|100|0.01,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|7|205|0.0341463,COCA-CN|4|321|0.0124611,NKTL-SG|1|50|0.02,ESCA-CN|1|332|0.00301205,EAS:0.0245,FIN:0.0230,NFE:0.0144,OTH:0.0716,ASJ:0.0246	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	8(haematopoietic_and_lymphoid_tissue)	0.0147
1	196712586	196712586	C	T	CFH	exonic	synonymous SNV	ENSG00000000971	rs61822181	ENSG00000000971:ENST00000367429:exon20:c.C3138T:p.T1046T	CFH:NM_000186:exon20:c.C3138T:p.T1046T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2657	.	.	2(thyroid)	.	.	.	.	.	.	.	.	CFH:uc001gtj.4:exon20:c.C3138T:p.T1046T	.	AFR:1(pancreas),AMR:MU4550049,EAS:0.0505,FIN:0.0457,NFE:0.0428,OTH:0.0510,ASJ:SKCA-BR|1|100|0.01,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|6|205|0.0292683,COCA-CN|3|321|0.00934579,NKTL-SG|1|50|0.02	134370	126700;235400;609814;610698;	200421;2134;329918;54370;93571;93579;2134;90038;93579;93581;75376;	200421|-|-|-|-|609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~329918|C3 glomerulopathy<br>Non-Ig-mediated MPGN<br>Non-Ig-mediated membranoproliferative glomerulonephritis<br>Non-immunoglobulin-mediated MPGN|-|-|-|609814 614809 ~54370|MPGN<br>Mesangiocapillary glomerulonephritis|1-5 / 10 000|-|-|305800 609814 614809 615008 ~93571|Membranoproliferative glomerulonephritis type 2|1-9 / 1 000 000|Autosomal recessive|Childhood|609814 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~2134|Atypical HUS<br>D-HUS<br>Hemolytic-uremic syndrome without diarrhea<br>aHUS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|235400 609814 612922 612923 612924 612925 612926 615008 ~90038|D+HUS<br>Hemolytic-uremic syndrome with diarrhea<br>Shiga-like toxin-associated HUS<br>Sxt-HUS<br>Typical HUS|Unknown|Not applicable|All ages|235400 ~93579|Atypical HUS with H factor anomaly<br>D-HUS with H factor anomaly<br>Hemolytic-uremic syndrome without diarrhea with H factor anomaly<br>aHUS with H factor anomaly|-|-|-|235400 609814 ~93581|Atypical HUS with anti-factor H antibodies<br>D-HUS with anti-factor H antibodies<br>Hemolytic-uremic syndrome without diarrhea with anti-factor H antibodies<br>aHUS with anti-factor H antibodies|-|-|-|235400 ~75376|DHRD<br>Dominant drusen<br>Dominant radial drusen<br>Doyne honeycomb retinal dystrophy<br>Malattia leventinese|Unknown|Autosomal dominant|Adult|126600 126700 ~	.	.	.	.	.	.	.	.	1	6(lung)	0.1337
1	197053561	197053561	-	A	ASPM	intronic	.	ENSG00000066279	rs200839523	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2816	.	.	0.3436	.	.	.	.	.	.	.	.	.	.	AFR:0.1751,AMR:0.2805,EAS:0.1960,FIN:0.4242,NFE:0.4495,OTH:0.4074,ASJ:0.4405	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU9408466	het
1	197055925	197055925	T	C	ASPM	intronic	.	ENSG00000066279	rs10754213	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8786	0.7551	0.782748	0.7908	.	.	.	.	.	0	0	.	.	.	AFR:0.4511,AMR:0.9079,EAS:1,FIN:0.9407,NFE:0.9131,OTH:0.9192,ASJ:0.9238	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717435	hom
1	197069932	197069932	C	A	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs117963393	ENSG00000066279:ENST00000367409:exon18:c.G8449T:p.A2817S	ASPM:NM_018136:exon18:c.G8449T:p.A2817S	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0020	.	0.00678914	0.0015	3.080	22.5	0.039	1.71	0.005	.	.	IQ motif, EF-hand binding site	ASPM:uc001gtw.4:exon4:c.G1993T:p.A665S,ASPM:uc001gtu.3:exon18:c.G8449T:p.A2817S	-0.503	AFR:0,AMR:0,EAS:0.0283,FIN:0,NFE:6.682e-05,OTH:0,ASJ:0	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.974	-0.78	0.234	1.795	1	MU80656264	het
1	197070442	197070442	G	T	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs3762271	ENSG00000066279:ENST00000367409:exon18:c.C7939A:p.L2647I	ASPM:NM_018136:exon18:c.C7939A:p.L2647I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3399	0.3229	0.214257	2(large_intestine)	0.354	6.204	0.203	-1.27	0.115	.	.	IQ motif, EF-hand binding site;IQ motif, EF-hand binding site|P-loop containing nucleoside triphosphate hydrolase	ASPM:uc001gtw.4:exon4:c.C1483A:p.L495I,ASPM:uc001gtu.3:exon18:c.C7939A:p.L2647I	-0.998	AFR:MU152290,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.0920,FIN:0.2236,NFE:0.4106,OTH:0.1720,ASJ:0.3159	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.989	-0.83	0.000	2.215	1	1(lung)	0.3893
1	197070697	197070697	T	C	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs41310927	ENSG00000066279:ENST00000367409:exon18:c.A7684G:p.S2562G	ASPM:NM_018136:exon18:c.A7684G:p.S2562G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.3409	0.3211	0.214257	3(haematopoietic_and_lymphoid_tissue)	5.206	25.5	0.021	5.15	1.000	.	.	IQ motif, EF-hand binding site|P-loop containing nucleoside triphosphate hydrolase	ASPM:uc001gtw.4:exon4:c.A1228G:p.S410G,ASPM:uc001gtu.3:exon18:c.A7684G:p.S2562G	-1.045	AFR:MU152297,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0912,FIN:0.2224,NFE:0.4106,OTH:0.1714,ASJ:0.3140	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.978	-0.75	0.000	3.175	1	1(liver)	0.3896
1	197070707	197070707	G	A	ASPM	exonic	synonymous SNV	ENSG00000066279	rs41308365	ENSG00000066279:ENST00000367409:exon18:c.C7674T:p.I2558I	ASPM:NM_018136:exon18:c.C7674T:p.I2558I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3403	0.3217	0.214257	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ASPM:uc001gtw.4:exon4:c.C1218T:p.I406I,ASPM:uc001gtu.3:exon18:c.C7674T:p.I2558I	.	AFR:MU152305,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0908,FIN:0.2212,NFE:0.4106,OTH:0.1712,ASJ:0.3133	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(breast)	0.3894
1	197070815	197070815	T	C	ASPM	exonic	synonymous SNV	ENSG00000066279	rs1412640	ENSG00000066279:ENST00000367409:exon18:c.A7566G:p.L2522L	ASPM:NM_018136:exon18:c.A7566G:p.L2522L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8876	0.7869	0.815895	0.8174	.	.	.	.	.	.	.	.	ASPM:uc001gtw.4:exon4:c.A1110G:p.L370L,ASPM:uc001gtu.3:exon18:c.A7566G:p.L2522L	.	AFR:0.5454,AMR:0.9163,EAS:1,FIN:0.9410,NFE:0.9131,OTH:0.9254,ASJ:0.9272	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717480	hom
1	197070901	197070901	A	G	ASPM	exonic	nonsynonymous SNV	ENSG00000066279	rs964201	ENSG00000066279:ENST00000367409:exon18:c.T7480C:p.Y2494H	ASPM:NM_018136:exon18:c.T7480C:p.Y2494H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9956	0.9957	0.997404	0.9962	0.626	8.336	1.0	4.83	0.900	.	.	IQ motif, EF-hand binding site|P-loop containing nucleoside triphosphate hydrolase	ASPM:uc001gtw.4:exon4:c.T1024C:p.Y342H,ASPM:uc001gtu.3:exon18:c.T7480C:p.Y2494H	-0.934	AFR:0.9994,AMR:0.9988,EAS:1,FIN:1,NFE:0.9927,OTH:0.9980,ASJ:1	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.001	-0.74	0.000	-2.065	1	MU81717489	hom
1	197072420	197072420	T	C	ASPM	exonic	synonymous SNV	ENSG00000066279	rs41310925	ENSG00000066279:ENST00000367409:exon18:c.A5961G:p.Q1987Q	ASPM:NM_018136:exon18:c.A5961G:p.Q1987Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3408	0.3213	0.213059	1(large_intestine)	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon18:c.A5961G:p.Q1987Q	.	AFR:4(lung),AMR:2(urinary_tract),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|5|170|0.0294118,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.3144,NFE:0.0855,OTH:0.2248,ASJ:MU152312	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	5(haematopoietic_and_lymphoid_tissue)	0.4106
1	197073932	197073932	T	C	ASPM	exonic	synonymous SNV	ENSG00000066279	rs2878749	ENSG00000066279:ENST00000367409:exon18:c.A4449G:p.K1483K	ASPM:NM_018136:exon18:c.A4449G:p.K1483K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3439	0.3224	0.214457	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon18:c.A4449G:p.K1483K	.	AFR:MU9408519,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.0921,FIN:0.2242,NFE:0.4106,OTH:0.1715,ASJ:0.3162	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(breast)	0.3895
1	197091537	197091537	A	T	ASPM	exonic	synonymous SNV	ENSG00000066279	rs4915337	ENSG00000066279:ENST00000367408:exon10:c.T1329A:p.S443S,ENSG00000066279:ENST00000294732:exon14:c.T3579A:p.S1193S,ENSG00000066279:ENST00000367409:exon14:c.T3579A:p.S1193S	ASPM:NM_001206846:exon14:c.T3579A:p.S1193S,ASPM:NM_018136:exon14:c.T3579A:p.S1193S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8779	0.7547	0.782548	0.7906	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon14:c.T3579A:p.S1193S,ASPM:uc001gtv.3:exon14:c.T3579A:p.S1193S	.	AFR:0.4511,AMR:0.9079,EAS:0.9988,FIN:0.9408,NFE:0.9126,OTH:0.9194,ASJ:0.92	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU81717511	hom
1	197094030	197094030	C	T	ASPM	exonic	synonymous SNV	ENSG00000066279	rs6676084	ENSG00000066279:ENST00000367408:exon8:c.G888A:p.R296R,ENSG00000066279:ENST00000294732:exon12:c.G3138A:p.R1046R,ENSG00000066279:ENST00000367409:exon12:c.G3138A:p.R1046R	ASPM:NM_001206846:exon12:c.G3138A:p.R1046R,ASPM:NM_018136:exon12:c.G3138A:p.R1046R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2801	0.2635	0.216653	2(urinary_tract)	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon12:c.G3138A:p.R1046R,ASPM:uc001gtv.3:exon12:c.G3138A:p.R1046R	.	AFR:MU155414,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.1620,FIN:0.2644,NFE:0.3278,OTH:0.1009,ASJ:0.2524	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.3053
1	197112533	197112533	G	A	ASPM	exonic	synonymous SNV	ENSG00000066279	rs6677082	ENSG00000066279:ENST00000294732:exon3:c.C849T:p.S283S,ENSG00000066279:ENST00000367409:exon3:c.C849T:p.S283S	ASPM:NM_001206846:exon3:c.C849T:p.S283S,ASPM:NM_018136:exon3:c.C849T:p.S283S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8698	0.7308	0.755591	0.7690	.	.	.	.	.	.	.	.	ASPM:uc001gtu.3:exon3:c.C849T:p.S283S,ASPM:uc001gtv.3:exon3:c.C849T:p.S283S	.	AFR:0.3794,AMR:0.9043,EAS:0.9808,FIN:0.9408,NFE:0.9125,OTH:0.9129,ASJ:0.9205	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU17987338	hom
1	197113073	197113073	G	A	ASPM	intronic	.	ENSG00000066279	rs1571964	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8704	0.7302	0.755591	0.7694	.	.	.	.	.	.	.	.	.	.	AFR:0.3798,AMR:0.9043,EAS:0.9802,FIN:0.9408,NFE:0.9125,OTH:0.9131,ASJ:0.9205	605481	608716;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	1	MU17987498	hom
1	198703306	198703306	C	T	PTPRC	intronic	.	ENSG00000081237	rs6683595	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1938	0.2212	0.278754	0.2181	.	.	.	.	.	.	.	.	.	.	AFR:0.3838,AMR:0.3165,EAS:0.2680,FIN:0.1180,NFE:0.1410,OTH:0.1373,ASJ:0.1325	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	MU11357414	het
1	198704294	198704294	C	T	PTPRC	exonic	synonymous SNV	ENSG00000081237	rs7540378	ENSG00000081237:ENST00000348564:exon20:c.C1833T:p.G611G,ENSG00000081237:ENST00000594404:exon20:c.C1827T:p.G609G,ENSG00000081237:ENST00000352140:exon22:c.C2166T:p.G722G,ENSG00000081237:ENST00000367367:exon22:c.C2118T:p.G706G,ENSG00000081237:ENST00000529828:exon22:c.C2172T:p.G724G,ENSG00000081237:ENST00000367376:exon23:c.C2310T:p.G770G,ENSG00000081237:ENST00000442510:exon23:c.C2316T:p.G772G	PTPRC:NM_080921:exon20:c.C1833T:p.G611G,PTPRC:NM_002838:exon23:c.C2316T:p.G772G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1683	0.1639	0.226238	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PTPRC:uc001gut.2:exon20:c.C1833T:p.G611G,PTPRC:uc010ppg.2:exon22:c.C2118T:p.G706G,PTPRC:uc021pgy.2:exon22:c.C2172T:p.G724G,PTPRC:uc001gur.2:exon23:c.C2316T:p.G772G	.	AFR:0.1624,AMR:0.2423,EAS:0.1291,FIN:0.2645,NFE:0.0688,OTH:0.1234,ASJ:0.2940	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	2(large_intestine)	0.1150
1	198711171	198711171	A	-	PTPRC	intronic	.	ENSG00000081237	rs370217220	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1991	.	.	0.0325	.	.	.	.	.	.	.	.	.	.	AFR:0.0168,AMR:0.1568,EAS:0.0377,FIN:0.1098,NFE:0.0292,OTH:0.0508,ASJ:0.0238	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	MU111658114	het
1	198717219	198717220	TT	-	PTPRC	intronic	.	ENSG00000081237	rs546749152	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2059	.	0.279553	0.1991	.	.	.	.	.	.	.	.	.	.	AFR:0.3068,AMR:0.3094,EAS:0.2757,FIN:0.0693,NFE:0.1311,OTH:0.1295,ASJ:0.1445	151460	608971;609532;	284102;169154;169157;169160;	284102|Response to PEG/IFN-ribavirin in HCV|-|-|-|609532 ~169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	.	.	.	.	.	.	.	.	1	.	het
1	200534248	200534248	C	T	KIF14	exonic	synonymous SNV	ENSG00000118193	rs7543730	ENSG00000118193:ENST00000367350:exon25:c.G4020A:p.E1340E	KIF14:NM_001305792:exon23:c.G2547A:p.E849E,KIF14:NM_014875:exon25:c.G4020A:p.E1340E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5717	0.5359	0.563498	0.5250	.	.	.	.	.	.	.	.	KIF14:uc010ppj.1:exon23:c.G2547A:p.E849E,KIF14:uc010ppk.1:exon25:c.G4020A:p.E1340E	.	AFR:0.4177,AMR:0.4868,EAS:0.6865,FIN:0.5287,NFE:0.5686,OTH:0.5400,ASJ:0.6093	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	.	.	.	.	1	MU708297	hom
1	200558363	200558363	T	C	KIF14	exonic	synonymous SNV	ENSG00000118193	rs6665951	ENSG00000118193:ENST00000367350:exon18:c.A3096G:p.E1032E	KIF14:NM_001305792:exon16:c.A1623G:p.E541E,KIF14:NM_014875:exon18:c.A3096G:p.E1032E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7515	0.8067	0.766573	0.7926	.	.	.	.	.	.	.	.	KIF14:uc010ppj.1:exon16:c.A1623G:p.E541E,KIF14:uc010ppk.1:exon18:c.A3096G:p.E1032E	.	AFR:0.8873,AMR:0.6100,EAS:0.6856,FIN:0.7478,NFE:0.7711,OTH:0.7556,ASJ:0.8411	611279	616258;	439897;	439897|-|<1 / 1 000 000|Autosomal recessive|Antenatal|616258 ~	.	.	.	.	.	.	.	.	1	MU9422538	hom
1	201020105	201020105	A	G	CACNA1S	intronic	.	ENSG00000081248	rs6702590	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7705	0.7548	0.880391	0.7864	.	.	.	.	.	0	0	.	.	.	AFR:0.9291,AMR:0.8532,EAS:0.9975,FIN:0.7546,NFE:0.6883,OTH:0.7332,ASJ:0.7450	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	MU32834473	hom
1	201044748	201044748	A	G	CACNA1S	intronic	.	ENSG00000081248	rs1998721	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7814	0.7033	0.759585	0.7224	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.5560,AMR:0.7148,EAS:0.9470,FIN:0.7916,NFE:0.7745,OTH:0.7827,ASJ:0.7583	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	MU81717919	hom
1	201060865	201060865	G	A	CACNA1S	exonic	synonymous SNV	ENSG00000081248	rs2296383	ENSG00000081248:ENST00000362061:exon5:c.C597T:p.I199I,ENSG00000081248:ENST00000367338:exon5:c.C597T:p.I199I	CACNA1S:NM_000069:exon5:c.C597T:p.I199I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3887	0.3298	0.305112	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	CACNA1S:uc001gvv.3:exon5:c.C597T:p.I199I	.	AFR:0.3251,AMR:0.1063,EAS:0.4503,FIN:0.3453,NFE:0.3780,OTH:0.4281,ASJ:0.3421	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	.	.	.	.	1	1(bone)	0.4236
1	201063072	201063072	G	C	CACNA1S	exonic	nonsynonymous SNV	ENSG00000081248	rs374324813	ENSG00000081248:ENST00000362061:exon3:c.C336G:p.F112L,ENSG00000081248:ENST00000367338:exon3:c.C336G:p.F112L	CACNA1S:NM_000069:exon3:c.C336G:p.F112L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	8.237e-06	7.7e-05	.	3.23e-05	1.769	14.80	1.0	3.5	0.998	.	.	Ion transport domain	CACNA1S:uc001gvv.3:exon3:c.C336G:p.F112L	-0.163	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	114208	170400;188580;601887;	423;79102;681;	423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~79102|Thyrotoxic hypokalemic periodic paralysis|<1 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|188580 613239 614834 ~681|Westphall disease|1-9 / 100 000|Autosomal dominant|Childhood|170400 613345 ~	.	.	.	.	0.022	-3.68	0.626	0.205	1	.	het
1	201334382	201334382	G	A	TNNT2	exonic	synonymous SNV	ENSG00000118194	rs3729547	ENSG00000118194:ENST00000360372:exon7:c.C303T:p.I101I,ENSG00000118194:ENST00000236918:exon8:c.C333T:p.I111I,ENSG00000118194:ENST00000367315:exon8:c.C318T:p.I106I,ENSG00000118194:ENST00000367317:exon8:c.C318T:p.I106I,ENSG00000118194:ENST00000438742:exon8:c.C303T:p.I101I,ENSG00000118194:ENST00000367318:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000367322:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000421663:exon9:c.C324T:p.I108I,ENSG00000118194:ENST00000422165:exon9:c.C333T:p.I111I,ENSG00000118194:ENST00000509001:exon9:c.C318T:p.I106I,ENSG00000118194:ENST00000455702:exon10:c.C348T:p.I116I,ENSG00000118194:ENST00000458432:exon10:c.C354T:p.I118I	TNNT2:NM_001001432:exon8:c.C303T:p.I101I,TNNT2:NM_001001430:exon9:c.C318T:p.I106I,TNNT2:NM_001001431:exon9:c.C318T:p.I106I,TNNT2:NM_001276347:exon9:c.C318T:p.I106I,TNNT2:NM_000364:exon10:c.C348T:p.I116I,TNNT2:NM_001276345:exon10:c.C348T:p.I116I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7194	0.6828	0.695088	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	TNNT2:uc009wzs.1:exon3:c.C243T:p.I81I,TNNT2:uc001gwk.1:exon7:c.C141T:p.I47I,TNNT2:uc009wzr.4:exon7:c.C141T:p.I47I,TNNT2:uc001gwh.4:exon8:c.C291T:p.I97I,TNNT2:uc021phc.2:exon8:c.C318T:p.I106I,TNNT2:uc001gwg.4:exon9:c.C318T:p.I106I,TNNT2:uc009wzt.2:exon9:c.C318T:p.I106I,TNNT2:uc001gwf.4:exon10:c.C348T:p.I116I	.	AFR:MU109570,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6157,FIN:0.7685,NFE:0.7682,OTH:0.5336,ASJ:0.6921	191045	115195;601494;612422;	75249;154;54260;	75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	1(thyroid)	0.7944
1	201341176	201341180	AGAAG	-	TNNT2	intronic	.	ENSG00000118194	rs45533739	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5919	.	0.520367	0.5292	.	.	.	.	.	.	.	.	.	.	AFR:0.3040,AMR:0.6776,EAS:0.4630,FIN:0.6784,NFE:0.6170,OTH:0.6173,ASJ:0.6333	191045	115195;601494;612422;	75249;154;54260;	75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	1	.	het
1	201981862	201981862	T	C	ELF3	exonic	synonymous SNV	ENSG00000163435	rs2819362	ENSG00000163435:ENST00000359651:exon4:c.T573C:p.P191P,ENSG00000163435:ENST00000367283:exon5:c.T573C:p.P191P,ENSG00000163435:ENST00000367284:exon5:c.T573C:p.P191P,ENSG00000163435:ENST00000446188:exon5:c.T567C:p.P189P	ELF3:NM_001114309:exon5:c.T573C:p.P191P,ELF3:NM_004433:exon5:c.T573C:p.P191P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6047	0.6059	0.704273	0.6257	.	.	.	.	.	.	.	.	ELF3:uc001gxg.4:exon4:c.T573C:p.P191P,ELF3:uc001gxh.4:exon5:c.T573C:p.P191P,ELF3:uc001gxi.4:exon5:c.T573C:p.P191P	.	AFR:0.7838,AMR:0.6002,EAS:0.7574,FIN:0.5828,NFE:0.5337,OTH:0.5939,ASJ:0.5933	602191	.	.	.	.	.	.	.	.	.	.	.	1	MU4555319	hom
1	204403659	204403659	A	G	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs3747636	ENSG00000133056:ENST00000367187:exon25:c.T3594C:p.N1198N,ENSG00000133056:ENST00000424712:exon26:c.T3510C:p.N1170N	PIK3C2B:NM_002646:exon25:c.T3594C:p.N1198N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3009	0.3060	0.404952	1(breast)	.	.	.	.	.	.	.	.	PIK3C2B:uc001haw.3:exon25:c.T3594C:p.N1198N,PIK3C2B:uc010pqv.2:exon26:c.T3510C:p.N1170N	.	AFR:MU145541,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.4997,FIN:0.2685,NFE:0.1854,OTH:0.5248,ASJ:0.3431	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(large_intestine)	0.3210
1	204413297	204413297	C	T	PIK3C2B	intronic	.	ENSG00000133056	rs2292459	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7286	0.7105	0.610823	MU813473	.	.	.	.	.	0.0004	0.054	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6782,EAS:0.7578,FIN:0.8433,NFE:0.4751,OTH:0.7230,ASJ:0.4977	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.7839
1	204413299	204413299	G	A	PIK3C2B	intronic	.	ENSG00000133056	rs2292460	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7081	0.6927	0.561502	MU731753	.	.	.	.	.	0	0.006	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.6541,EAS:0.7458,FIN:0.8267,NFE:0.3269,OTH:0.7226,ASJ:0.4457	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.7821
1	204416111	204416111	A	G	PIK3C2B	intronic	.	ENSG00000133056	rs3106365	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.865815	0.9020	.	.	.	.	.	.	.	.	.	.	AFR:0.6910,AMR:0.9618,EAS:0.8517,FIN:0.9997,NFE:0.9969,OTH:0.9816,ASJ:0.9801	602838	.	.	.	.	.	.	.	.	.	.	.	1	.	hom
1	204423811	204423811	G	A	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs61762608	ENSG00000133056:ENST00000367187:exon13:c.C2052T:p.I684I,ENSG00000133056:ENST00000424712:exon13:c.C2052T:p.I684I	PIK3C2B:NM_002646:exon13:c.C2052T:p.I684I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0308	0.0249	0.0221645	0.0286	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon12:c.C2052T:p.I684I,PIK3C2B:uc001haw.3:exon13:c.C2052T:p.I684I,PIK3C2B:uc010pqv.2:exon13:c.C2052T:p.I684I	.	AFR:0.0063,AMR:0.0227,EAS:0.0012,FIN:0.0545,NFE:0.0380,OTH:0.0428,ASJ:0.0232	602838	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	204425028	204425028	G	A	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs3765156	ENSG00000133056:ENST00000367187:exon12:c.C1899T:p.F633F,ENSG00000133056:ENST00000424712:exon12:c.C1899T:p.F633F	PIK3C2B:NM_002646:exon12:c.C1899T:p.F633F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1914	0.1389	0.203275	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon11:c.C1899T:p.F633F,PIK3C2B:uc001haw.3:exon12:c.C1899T:p.F633F,PIK3C2B:uc010pqv.2:exon12:c.C1899T:p.F633F	.	AFR:1(large_intestine),AMR:1(breast),EAS:MU145551,FIN:ESAD-UK|2|409|0.00488998,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,NFE:0.1695,OTH:0.0746,ASJ:1(liver)	602838	.	.	.	.	.	.	.	.	.	.	.	1	1(lung)	0.0668
1	204429679	204429679	G	A	PIK3C2B	exonic	nonsynonymous SNV	ENSG00000133056	rs142843233	ENSG00000133056:ENST00000367187:exon7:c.C1421T:p.T474M,ENSG00000133056:ENST00000424712:exon7:c.C1421T:p.T474M	PIK3C2B:NM_002646:exon7:c.C1421T:p.T474M	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, 1, 0, 0] 	0.0014	0.0002	0.00299521	3.233e-05	6.452	29.9	0.0	5.81	0.987	0.9925	0.826	Ubiquitin-related domain	PIK3C2B:uc001hax.1:exon6:c.C1421T:p.T474M,PIK3C2B:uc001haw.3:exon7:c.C1421T:p.T474M,PIK3C2B:uc010pqv.2:exon7:c.C1421T:p.T474M	-0.184	AFR:0,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	602838	.	.	.	.	.	.	.	0.936	-0.07	0.423	2.365	1	MU129123552	het
1	204438334	204438334	C	T	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs1124777	ENSG00000133056:ENST00000367187:exon3:c.G597A:p.P199P,ENSG00000133056:ENST00000424712:exon3:c.G597A:p.P199P	PIK3C2B:NM_002646:exon3:c.G597A:p.P199P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8916	0.7767	0.728035	0.7878	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon2:c.G597A:p.P199P,PIK3C2B:uc001haw.3:exon3:c.G597A:p.P199P,PIK3C2B:uc010pqv.2:exon3:c.G597A:p.P199P	.	AFR:0.3585,AMR:0.8413,EAS:0.7540,FIN:0.9648,NFE:0.9841,OTH:0.9265,ASJ:0.9636	602838	.	.	.	.	.	.	.	.	.	.	.	1	MU17996773	hom
1	204438643	204438643	G	T	PIK3C2B	exonic	synonymous SNV	ENSG00000133056	rs1553921	ENSG00000133056:ENST00000415899:exon2:c.C288A:p.L96L,ENSG00000133056:ENST00000367187:exon3:c.C288A:p.L96L,ENSG00000133056:ENST00000424712:exon3:c.C288A:p.L96L	PIK3C2B:NM_002646:exon3:c.C288A:p.L96L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8903	0.7763	0.727236	0.7869	.	.	.	.	.	.	.	.	PIK3C2B:uc001hax.1:exon2:c.C288A:p.L96L,PIK3C2B:uc001haw.3:exon3:c.C288A:p.L96L,PIK3C2B:uc010pqv.2:exon3:c.C288A:p.L96L	.	AFR:0.3551,AMR:0.8405,EAS:0.7531,FIN:0.9645,NFE:0.9840,OTH:0.9264,ASJ:0.9636	602838	.	.	.	.	.	.	.	.	.	.	.	1	MU17996820	hom
1	204494436	204494436	C	T	MDM4	intronic	.	ENSG00000198625	rs3789051	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.307708	0.3891	.	.	.	.	.	.	.	.	.	.	AFR:0.1278,AMR:0.4988,EAS:0.2761,FIN:0.5705,NFE:0.4991,OTH:0.4673,ASJ:0.4267	602704	.	.	.	.	.	.	.	.	.	.	.	1	.	het
1	204501383	204501383	C	T	MDM4	intronic	.	ENSG00000198625	rs4252697	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1897	0.1557	0.198083	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:MU11368138,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0792,FIN:0.0859,NFE:0.1987,OTH:0.3660,ASJ:0.1771	602704	.	.	.	.	.	.	.	.	.	.	.	1	8(meninges)	0.2064
1	204516025	204516025	A	G	MDM4	intronic	.	ENSG00000198625	rs2290854	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6451	0.5536	0.539337	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6003,AMR:0.2930,EAS:0.6324,FIN:0.6473,NFE:0.7944,OTH:0.7221,ASJ:0.5993	602704	.	.	.	.	.	.	.	.	.	.	.	1	4(soft_tissue)	0.6908
1	206647742	206647742	A	G	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs1539242	ENSG00000143466:ENST00000367120:exon4:c.A156G:p.Q52Q	IKBKE:NM_001193322:exon4:c.A156G:p.Q52Q,IKBKE:NM_014002:exon4:c.A156G:p.Q52Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9986	0.9984	0.999401	0.9985	.	.	.	.	.	.	.	.	IKBKE:uc001hdz.2:exon4:c.A156G:p.Q52Q,IKBKE:uc009xbu.2:exon4:c.A156G:p.Q52Q,IKBKE:uc009xbv.2:exon4:c.A156G:p.Q52Q	.	AFR:0.9998,AMR:0.9988,EAS:1,FIN:0.9991,NFE:0.9974,OTH:0.9980,ASJ:1	605048	.	.	.	.	.	.	.	.	.	.	.	1	MU4564045	hom
1	206647787	206647787	T	C	IKBKE	exonic	synonymous SNV	ENSG00000143466	rs1539243	ENSG00000143466:ENST00000367120:exon4:c.T201C:p.I67I	IKBKE:NM_001193322:exon4:c.T201C:p.I67I,IKBKE:NM_014002:exon4:c.T201C:p.I67I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8591	0.8459	0.899161	0.8525	.	.	.	.	.	.	.	.	IKBKE:uc001hdz.2:exon4:c.T201C:p.I67I,IKBKE:uc009xbu.2:exon4:c.T201C:p.I67I,IKBKE:uc009xbv.2:exon4:c.T201C:p.I67I	.	AFR:0.8711,AMR:0.9129,EAS:0.9846,FIN:0.8333,NFE:0.8311,OTH:0.8299,ASJ:0.7947	605048	.	.	.	.	.	.	.	.	.	.	.	1	MU81719582	hom
1	226019646	226019646	A	G	EPHX1	exonic	nonsynonymous SNV	ENSG00000143819	rs67892231	ENSG00000143819:ENST00000272167:exon3:c.A350G:p.K117R,ENSG00000143819:ENST00000366837:exon3:c.A350G:p.K117R,ENSG00000143819:ENST00000445856:exon3:c.A350G:p.K117R,ENSG00000143819:ENST00000448202:exon3:c.A350G:p.K117R	EPHX1:NM_000120:exon3:c.A350G:p.K117R,EPHX1:NM_001136018:exon3:c.A350G:p.K117R,EPHX1:NM_001291163:exon3:c.A350G:p.K117R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 1, 0] 	0.0037	7.7e-05	0.00738818	0.0002	3.443	23.0	0.05	5.58	0.996	.	.	Alpha/Beta hydrolase fold|Epoxide hydrolase, N-terminal	EPHX1:uc001hpk.3:exon3:c.A350G:p.K117R,EPHX1:uc001hpl.3:exon3:c.A350G:p.K117R,EPHX1:uc031psj.1:exon3:c.A350G:p.K117R	-0.968	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0002,OTH:0.0031,ASJ:0	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	0.258	3.84	0.021	0.95	1	.	unknown
1	226019653	226019653	G	A	EPHX1	exonic	synonymous SNV	ENSG00000143819	rs1131873	ENSG00000143819:ENST00000272167:exon3:c.G357A:p.K119K,ENSG00000143819:ENST00000366837:exon3:c.G357A:p.K119K,ENSG00000143819:ENST00000445856:exon3:c.G357A:p.K119K,ENSG00000143819:ENST00000448202:exon3:c.G357A:p.K119K	EPHX1:NM_000120:exon3:c.G357A:p.K119K,EPHX1:NM_001136018:exon3:c.G357A:p.K119K,EPHX1:NM_001291163:exon3:c.G357A:p.K119K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1601	0.1445	0.191094	MU150991	.	.	.	.	.	.	.	.	EPHX1:uc001hpk.3:exon3:c.G357A:p.K119K,EPHX1:uc001hpl.3:exon3:c.G357A:p.K119K,EPHX1:uc031psj.1:exon3:c.G357A:p.K119K	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.1388,EAS:0.1253,FIN:0.1954,NFE:0.3069,OTH:0.1085,ASJ:0.1312	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	1	1(large_intestine)	0.1332
1	226027068	226027069	GT	-	EPHX1	intronic	.	ENSG00000143819	rs878921666	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	132810	189800;607748;	238475;275555;	238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~275555|-|1-5 / 10 000|-|Adult|189800 609402 609403 609404 614595 ~	~ko00980 Metabolism of xenobiotics by cytochrome P450~ko04976 Bile secretion~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	1	.	unknown
1	226570840	226570840	T	C	PARP1	exonic	synonymous SNV	ENSG00000143799	rs1805415	ENSG00000143799:ENST00000366794:exon8:c.A1056G:p.K352K	PARP1:NM_001618:exon8:c.A1056G:p.K352K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7939	0.8601	0.789337	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PARP1:uc001hqd.4:exon8:c.A1056G:p.K352K	.	AFR:MU4559844,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.8962,FIN:0.6388,NFE:0.8411,OTH:0.5603,ASJ:0.8228	173870	.	.	.	.	.	.	.	.	.	.	.	1	1(liver)	0.7643
1	226573364	226573364	A	G	PARP1	exonic	synonymous SNV	ENSG00000143799	rs1805414	ENSG00000143799:ENST00000366794:exon7:c.T852C:p.A284A	PARP1:NM_001618:exon7:c.T852C:p.A284A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4228	0.4077	0.516573	MU4559841	.	.	.	.	.	.	.	.	PARP1:uc001hqd.4:exon7:c.T852C:p.A284A	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AMR:0.4306,EAS:0.5060,FIN:0.33,NFE:0.8154,OTH:0.3971,ASJ:0.5477	173870	.	.	.	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.3312
1	226578099	226578099	T	C	PARP1	intronic	.	ENSG00000143799	rs1805403	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8059	0.8233	0.857628	0.8477	.	.	.	.	.	.	.	.	.	.	AFR:0.9384,AMR:0.8246,EAS:0.9481,FIN:0.8815,NFE:0.7819,OTH:0.8255,ASJ:0.6933	173870	.	.	.	.	.	.	.	.	.	.	.	1	MU18520760	het
1	226580021	226580021	G	T	PARP1	intronic	.	ENSG00000143799	rs1805405	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1944	0.2417	0.255791	0.2283	.	.	.	.	.	0.0304	0.08	.	.	.	AFR:0.3709,AMR:0.1352,EAS:0.3451,FIN:0.1585,NFE:0.1620,OTH:0.1342,ASJ:0.1457	173870	.	.	.	.	.	.	.	.	.	.	.	1	MU737447	het
1	231488524	231488524	C	T	SPRTN	exonic	nonsynonymous SNV	ENSG00000010072	rs2437150	ENSG00000010072:ENST00000295050:exon5:c.C887T:p.P296L	SPRTN:NM_032018:exon5:c.C887T:p.P296L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5988	0.5793	0.532947	0.5920	0.053	3.111	0.293	1.26	0.001	.	.	.	SPRTN:uc001hur.4:exon5:c.C887T:p.P296L	-0.903	AFR:0.4543,AMR:0.5227,EAS:0.5725,FIN:0.6947,NFE:0.6493,OTH:0.6478,ASJ:0.6490	616086	616200;	435953;	435953|Ruijs-Aalfs syndrome|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent|616200 ~	.	.	.	.	0.0	0.99	0.000	0.73	1	MU21239736	het
1	231557623	231557623	G	C	EGLN1	exonic	nonsynonymous SNV	ENSG00000135766	rs186996510	ENSG00000135766:ENST00000366641:exon1:c.C12G:p.D4E	EGLN1:NM_022051:exon1:c.C12G:p.D4E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0033	.	0.00658946	0.0015	3.298	22.9	0.312	3.51	0.998	.	.	.	EGLN1:uc001huv.2:exon1:c.C12G:p.D4E	-0.569	AFR:0,AMR:0.005,EAS:0.0236,FIN:0,NFE:0.0002,OTH:0.0010,ASJ:0	606425	609070;609820;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko04066 HIF-1 signaling pathway~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	0.01	-2.08	0.220	0	1	MU82173364	het
1	237551376	237551376	T	A	RYR2	intronic	.	ENSG00000198626	rs10754602	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5751	0.5273	0.55651	0.5325	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.4675,AMR:0.7446,EAS:0.6148,FIN:0.5416,NFE:0.5458,OTH:0.5662,ASJ:0.5033	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU24513954	het
1	237617757	237617757	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs3765097	ENSG00000198626:ENST00000542537:exon14:c.C1311T:p.S437S,ENSG00000198626:ENST00000366574:exon15:c.C1359T:p.S453S,ENSG00000198626:ENST00000360064:exon16:c.C1353T:p.S451S	RYR2:NM_001035:exon15:c.C1359T:p.S453S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5755	0.5119	0.535743	0.5238	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon15:c.C1359T:p.S453S	.	AFR:0.3184,AMR:0.5897,EAS:0.7073,FIN:0.5894,NFE:0.5988,OTH:0.5867,ASJ:0.6033	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU18032197	het
1	237620049	237620049	T	C	RYR2	intronic	.	ENSG00000198626	rs2045955	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5514	0.4634	0.53115	0.4984	.	.	.	.	.	.	.	.	.	.	AFR:0.3107,AMR:0.5624,EAS:0.7823,FIN:0.5657,NFE:0.5521,OTH:0.5643,ASJ:0.57	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU786721	het
1	237711797	237711797	A	G	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2253273	ENSG00000198626:ENST00000542537:exon25:c.A2925G:p.S975S,ENSG00000198626:ENST00000366574:exon26:c.A2973G:p.S991S,ENSG00000198626:ENST00000360064:exon27:c.A2967G:p.S989S	RYR2:NM_001035:exon26:c.A2973G:p.S991S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9262	0.8511	0.830272	0.8540	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon26:c.A2973G:p.S991S	.	AFR:0.6002,AMR:0.9414,EAS:0.8838,FIN:0.9762,NFE:0.9567,OTH:0.9450,ASJ:0.9603	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU4558519	hom
1	237753075	237753075	T	-	RYR2	intronic	.	ENSG00000198626	rs11331089	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4622	0.3469	0.285144	0.3537	.	.	.	.	.	.	.	.	.	.	AFR:0.1250,AMR:0.5570,EAS:0.2506,FIN:0.4796,NFE:0.4511,OTH:0.4165,ASJ:0.4467	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	.	het
1	237801770	237801770	T	C	RYR2	exonic	synonymous SNV	ENSG00000198626	rs707189	ENSG00000198626:ENST00000542537:exon44:c.T6858C:p.L2286L,ENSG00000198626:ENST00000366574:exon45:c.T6906C:p.L2302L,ENSG00000198626:ENST00000360064:exon46:c.T6900C:p.L2300L	RYR2:NM_001035:exon45:c.T6906C:p.L2302L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9884	0.9592	0.954872	0.9641	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon45:c.T6906C:p.L2302L	.	AFR:0.8753,AMR:0.9881,EAS:1,FIN:0.9994,NFE:0.9999,OTH:0.9898,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724737	hom
1	237814783	237814783	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs684923	ENSG00000198626:ENST00000542537:exon50:c.C7758T:p.H2586H,ENSG00000198626:ENST00000366574:exon51:c.C7806T:p.H2602H,ENSG00000198626:ENST00000360064:exon52:c.C7800T:p.H2600H	RYR2:NM_001035:exon51:c.C7806T:p.H2602H	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5198	0.4507	0.554912	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon51:c.C7806T:p.H2602H	.	AFR:0.4881,AMR:0.5021,EAS:0.2947,FIN:0.8125,NFE:0.4991,OTH:0.4477,ASJ:0.4940	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.4603
1	237863718	237863718	T	G	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2797436	ENSG00000198626:ENST00000542537:exon64:c.T9270G:p.S3090S,ENSG00000198626:ENST00000366574:exon65:c.T9318G:p.S3106S,ENSG00000198626:ENST00000360064:exon66:c.T9312G:p.S3104S	RYR2:NM_001035:exon65:c.T9318G:p.S3106S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9917	0.9718	0.969249	0.9715	.	.	.	.	.	.	.	.	RYR2:uc010pxz.1:exon4:c.T183G:p.S61S,RYR2:uc001hyl.1:exon65:c.T9318G:p.S3106S	.	AFR:0.9005,AMR:0.9964,EAS:1,FIN:1,NFE:0.9993,OTH:0.9969,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724751	hom
1	237881770	237881770	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2797441	ENSG00000198626:ENST00000542537:exon72:c.C10455T:p.T3485T,ENSG00000198626:ENST00000366574:exon73:c.C10503T:p.T3501T,ENSG00000198626:ENST00000360064:exon74:c.C10497T:p.T3499T	RYR2:NM_001035:exon73:c.C10503T:p.T3501T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9886	0.9616	0.960463	0.9623	.	.	.	.	.	.	.	.	RYR2:uc010pxz.1:exon12:c.C1368T:p.T456T,RYR2:uc001hyl.1:exon73:c.C10503T:p.T3501T	.	AFR:0.8678,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9949,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724767	hom
1	237890437	237890437	C	T	RYR2	exonic	synonymous SNV	ENSG00000198626	rs2685301	ENSG00000198626:ENST00000542537:exon75:c.C10728T:p.S3576S,ENSG00000198626:ENST00000366574:exon76:c.C10776T:p.S3592S,ENSG00000198626:ENST00000360064:exon77:c.C10770T:p.S3590S	RYR2:NM_001035:exon76:c.C10776T:p.S3592S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9885	0.9608	0.960264	0.9625	.	.	.	.	.	.	.	.	RYR2:uc001hyl.1:exon76:c.C10776T:p.S3592S	.	AFR:0.8687,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9949,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724775	hom
1	237893674	237893674	C	T	RYR2	intronic	.	ENSG00000198626	rs2797445	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9954	0.9854	0.985224	0.9853	.	.	.	.	.	.	.	.	.	.	AFR:0.9485,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU81724780	hom
1	237946964	237946964	T	C	RYR2	intronic	.	ENSG00000198626	rs790889	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4859	0.3267	0.414736	COCA-CN|6|321|0.0186916	.	.	.	.	.	0.0017	0.088	.	.	.	AFR:0.3555,AMR:0.3130,EAS:0.4371,FIN:0.6710,NFE:0.3587,OTH:0.3411,ASJ:0.3866	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	1(liver)	0.3712
1	237951451	237951451	A	G	RYR2	intronic	.	ENSG00000198626	rs2256242	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5750	0.6176	0.636581	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.6090,AMR:0.7662,EAS:0.6258,FIN:0.6894,NFE:0.5272,OTH:0.5375,ASJ:0.4749	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	1(haematopoietic_and_lymphoid_tissue)	0.5723
1	237957161	237957161	A	G	RYR2	intronic	.	ENSG00000198626	rs790901	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7399	0.6514	0.757588	0.6830	.	.	.	.	.	0	0	.	.	.	AFR:0.5929,AMR:0.8091,EAS:0.9580,FIN:0.6922,NFE:0.6941,OTH:0.7182,ASJ:0.6821	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU13920819	hom
1	237957309	237957309	A	C	RYR2	intronic	.	ENSG00000198626	rs790900	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7273	0.6478	0.750799	0.6803	.	.	.	.	.	.	.	.	.	.	AFR:0.6020,AMR:0.7995,EAS:0.9579,FIN:0.6896,NFE:0.6851,OTH:0.7122,ASJ:0.6755	180902	600996;604772;	3286;217656;	3286|Bidirectional tachycardia induced by catecholamine<br>CPVT<br>Double tachycardia induced by catecholamines<br>Malignant paroxysmal ventricular tachycardia<br>Multifocal ventricular premature beats|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604772 611938 614021 614916 615441 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	.	.	.	.	1	MU13920863	hom
1	241663902	241663902	-	GA	FH	intronic	.	ENSG00000091483	rs144131869	.	.	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.1185	.	.	.	.	.	.	.	.	.	.	AFR:0.0699,AMR:0.0911,EAS:0.1058,FIN:0.1649,NFE:0.1361,OTH:0.1257,ASJ:0.1176	136850	150800;606812;	24;523;	24|Fumarase deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|606812 ~523|Familial leiomyomatosis and renal cell cancer<br>Familial leiomyomatosis cutis et uteri<br>Familial leiomyomatosis with renal carcinoma<br>Familial multiple cutaneous leiomyomas<br>HLRCC<br>Hereditary leiomyomatosis<br>Hereditary leiomyomatosis with renal carcinoma<br>Hereditary multiple cutaneous leiomyomas<br>MCUL<br>Multiple cutaneous and uterine leiomyomas<br>Reed syndrome|Unknown|Autosomal dominant|Adolescent<br>Adult<br>Elderly|150800 ~	~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko00720 Carbon fixation pathways in prokaryotes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04934 Cushing syndrome~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma~~M00009 Citrate cycle (TCA cycle, Krebs cycle)~M00011 Citrate cycle, second carbon oxidation, 2-oxoglutarate =>~~M00173 Reductive citrate cycle (Arnon-Buchanan cycle)~M00376 3-Hydroxypropionate bi-cycle ~	.	.	.	.	.	.	.	1	.	het
1	242030151	242030151	A	G	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs735943	ENSG00000174371:ENST00000348581:exon9:c.A1061G:p.H354R,ENSG00000174371:ENST00000518483:exon9:c.A1061G:p.H354R,ENSG00000174371:ENST00000366548:exon11:c.A1061G:p.H354R	EXO1:NM_003686:exon9:c.A1061G:p.H354R,EXO1:NM_006027:exon9:c.A1061G:p.H354R,EXO1:NM_001319224:exon10:c.A1061G:p.H354R,EXO1:NM_130398:exon11:c.A1061G:p.H354R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5930	0.5674	0.636981	0.6067	-0.879	0.029	0.997	-0.821	0.933	.	.	.	EXO1:uc021plj.1:exon9:c.A1061G:p.H354R,EXO1:uc021plk.1:exon9:c.A1061G:p.H354R,EXO1:uc009xgq.3:exon10:c.A1061G:p.H354R,EXO1:uc001hzh.3:exon11:c.A1061G:p.H354R	-0.990	AFR:0.6181,AMR:0.6770,EAS:0.7866,FIN:0.6154,NFE:0.5774,OTH:0.5922,ASJ:0.5232	606063	.	.	.	.	.	.	.	0.0	1.41	0.000	1.025	1	MU16150612	hom
1	242042545	242042545	A	G	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1776148	ENSG00000174371:ENST00000348581:exon11:c.A2009G:p.E670G,ENSG00000174371:ENST00000518483:exon11:c.A2009G:p.E670G,ENSG00000174371:ENST00000366548:exon13:c.A2009G:p.E670G	EXO1:NM_003686:exon11:c.A2009G:p.E670G,EXO1:NM_006027:exon11:c.A2009G:p.E670G,EXO1:NM_001319224:exon12:c.A2006G:p.E669G,EXO1:NM_130398:exon13:c.A2009G:p.E670G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6573	0.6550	0.681909	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-0.519	0.197	0.382	-5.51	0.000	.	.	.	EXO1:uc021plj.1:exon11:c.A2009G:p.E670G,EXO1:uc021plk.1:exon11:c.A2009G:p.E670G,EXO1:uc009xgq.3:exon12:c.A2006G:p.E669G,EXO1:uc001hzh.3:exon13:c.A2009G:p.E670G	-1.000	AFR:0.6669,AMR:0.6913,EAS:0.6722,FIN:0.8226,NFE:0.6128,OTH:0.6491,ASJ:0.6885	606063	.	.	.	.	.	.	.	0.0	1.44	0.000	0.41	1	1(thyroid)	0.6373
1	242045275	242045275	C	T	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs1635498	ENSG00000174371:ENST00000348581:exon12:c.C2167T:p.R723C,ENSG00000174371:ENST00000518483:exon12:c.C2167T:p.R723C,ENSG00000174371:ENST00000366548:exon14:c.C2167T:p.R723C	EXO1:NM_003686:exon12:c.C2167T:p.R723C,EXO1:NM_006027:exon12:c.C2167T:p.R723C,EXO1:NM_001319224:exon13:c.C2164T:p.R722C,EXO1:NM_130398:exon14:c.C2167T:p.R723C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9564	0.9452	0.915335	0.9462	3.117	22.6	0.188	1.84	0.565	.	.	.	EXO1:uc021plj.1:exon12:c.C2167T:p.R723C,EXO1:uc021plk.1:exon12:c.C2167T:p.R723C,EXO1:uc009xgq.3:exon13:c.C2164T:p.R722C,EXO1:uc001hzh.3:exon14:c.C2167T:p.R723C	-0.976	AFR:0.8801,AMR:0.9712,EAS:0.8691,FIN:0.9954,NFE:0.9780,OTH:0.9744,ASJ:0.9669	606063	.	.	.	.	.	.	.	0.85	1.35	0.000	0.345	1	MU18036633	hom
1	242048674	242048674	C	T	EXO1	exonic	nonsynonymous SNV	ENSG00000174371	rs9350	ENSG00000174371:ENST00000348581:exon13:c.C2270T:p.P757L,ENSG00000174371:ENST00000518483:exon13:c.C2270T:p.P757L,ENSG00000174371:ENST00000366548:exon15:c.C2270T:p.P757L	EXO1:NM_003686:exon13:c.C2270T:p.P757L,EXO1:NM_006027:exon13:c.C2270T:p.P757L,EXO1:NM_001319224:exon14:c.C2267T:p.P756L,EXO1:NM_130398:exon15:c.C2270T:p.P757L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2036	0.1674	0.251597	0.1896	6.327	29.3	0.021	6.0	0.611	.	.	.	EXO1:uc021plj.1:exon13:c.C2270T:p.P757L,EXO1:uc021plk.1:exon13:c.C2270T:p.P757L,EXO1:uc009xgq.3:exon14:c.C2267T:p.P756L,EXO1:uc001hzh.3:exon15:c.C2270T:p.P757L	-0.995	AFR:0.1853,AMR:0.3185,EAS:0.4456,FIN:0.1565,NFE:0.1668,OTH:0.1865,ASJ:0.1060	606063	.	.	.	.	.	.	.	0.827	-0.12	0.000	2.43	1	MU151457	het
1	247587531	247587531	A	G	NLRP3	exonic	synonymous SNV	ENSG00000162711	rs4925543	ENSG00000162711:ENST00000336119:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000348069:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000366496:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000391827:exon3:c.A786G:p.R262R,ENSG00000162711:ENST00000366497:exon4:c.A786G:p.R262R,ENSG00000162711:ENST00000391828:exon5:c.A786G:p.R262R	NLRP3:NM_001127462:exon3:c.A786G:p.R262R,NLRP3:NM_001243133:exon3:c.A780G:p.R260R,NLRP3:NM_004895:exon3:c.A786G:p.R262R,NLRP3:NM_183395:exon3:c.A786G:p.R262R,NLRP3:NM_001127461:exon4:c.A786G:p.R262R,NLRP3:NM_001079821:exon5:c.A786G:p.R262R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9426	0.9188	0.919928	0.9332	.	.	.	.	.	.	.	.	NLRP3:uc001ict.1:exon3:c.A780G:p.R260R,NLRP3:uc001icu.3:exon3:c.A786G:p.R262R,NLRP3:uc001icv.3:exon3:c.A786G:p.R262R,NLRP3:uc001icw.3:exon3:c.A786G:p.R262R,NLRP3:uc010pyw.2:exon3:c.A780G:p.R260R,NLRP3:uc001ics.3:exon4:c.A786G:p.R262R,NLRP3:uc001icr.3:exon5:c.A786G:p.R262R	.	AFR:0.8519,AMR:0.9737,EAS:0.9975,FIN:0.9522,NFE:0.9645,OTH:0.9562,ASJ:0.9735	606416	120100;191900;607115;	1451;575;47045;	1451|Chronic infantile neurological cutaneous articular syndrome<br>IOMID syndrome<br>Infantile-onset multisystem inflammatory disease<br>NOMID syndrome<br>Neonatal-onset multisystem inflammatory disease<br>Prieur-Griscelli syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|607115 ~575|Neutrophilic urticaria|Unknown|Autosomal dominant|Childhood<br>Neonatal<br>Infancy|191900 ~47045|FCAS<br>FCU<br>Familial cold autoinflammatory syndrome|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|120100 616115 ~	.	.	.	.	.	.	.	.	1	MU81725544	hom
2	17912335	17912335	C	T	SMC6	intronic	.	ENSG00000163029	rs147083003	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0225	0.0013	0.0279553	0.0067	.	.	.	.	.	.	.	.	.	.	AFR:0.0029,AMR:0.1507,EAS:0.0241,FIN:0.0009,NFE:0.0005,OTH:0.0082,ASJ:0	609387	.	.	.	.	.	.	.	.	.	.	.	2	MU113991528	het
2	17942775	17942775	T	A	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs1812152	ENSG00000178295:ENST00000317402:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000381254:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000524465:exon3:c.T274A:p.S92T,ENSG00000178295:ENST00000532257:exon3:c.T274A:p.S92T	GEN1:NM_001130009:exon3:c.T274A:p.S92T,GEN1:NM_182625:exon3:c.T274A:p.S92T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7138	0.6712	0.813698	0.6849	0.082	3.418	1.0	0.326	0.953	.	.	PIN domain-like|XPG N-terminal	GEN1:uc002rct.2:exon3:c.T274A:p.S92T,GEN1:uc002rcu.2:exon3:c.T274A:p.S92T,GEN1:uc010yjs.1:exon3:c.T274A:p.S92T	-1.005	AFR:0.7717,AMR:0.7912,EAS:0.9790,FIN:0.5835,NFE:0.6234,OTH:0.6493,ASJ:0.6376	612449	.	.	.	.	.	.	.	0.0	-0.01	0.000	-0.86	2	MU31230816	hom
2	17954027	17954027	G	A	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs300175	ENSG00000178295:ENST00000528873:exon3:c.G242A:p.S81N,ENSG00000178295:ENST00000317402:exon8:c.G929A:p.S310N,ENSG00000178295:ENST00000381254:exon8:c.G929A:p.S310N	GEN1:NM_001130009:exon8:c.G929A:p.S310N,GEN1:NM_182625:exon8:c.G929A:p.S310N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9932	0.9835	0.977037	0.9882	-3.164	0.001	0.706	-11.3	0.001	.	.	.	GEN1:uc002rct.2:exon8:c.G929A:p.S310N,GEN1:uc002rcu.2:exon8:c.G929A:p.S310N,GEN1:uc010yjs.1:exon8:c.G929A:p.S310N	-0.973	AFR:0.9588,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9949,ASJ:1	612449	.	.	.	.	.	.	.	0.001	0.81	0.000	-0.66	2	MU81728351	hom
2	17962450	17962450	A	G	GEN1	exonic	synonymous SNV	ENSG00000178295	rs300168	ENSG00000178295:ENST00000317402:exon14:c.A1971G:p.E657E,ENSG00000178295:ENST00000381254:exon14:c.A1971G:p.E657E	GEN1:NM_001130009:exon14:c.A1971G:p.E657E,GEN1:NM_182625:exon14:c.A1971G:p.E657E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5758	0.4261	0.573882	0.4552	.	.	.	.	.	.	.	.	GEN1:uc002rct.2:exon14:c.A1971G:p.E657E,GEN1:uc002rcu.2:exon14:c.A1971G:p.E657E,GEN1:uc010yjs.1:exon14:c.A1971G:p.E657E	.	AFR:0.2301,AMR:0.6746,EAS:0.9261,FIN:0.5026,NFE:0.5059,OTH:0.5378,ASJ:0.5033	612449	.	.	.	.	.	.	.	.	.	.	.	2	MU17872203	hom
2	17962518	17962518	C	T	GEN1	exonic	nonsynonymous SNV	ENSG00000178295	rs300169	ENSG00000178295:ENST00000317402:exon14:c.C2039T:p.T680I,ENSG00000178295:ENST00000381254:exon14:c.C2039T:p.T680I	GEN1:NM_001130009:exon14:c.C2039T:p.T680I,GEN1:NM_182625:exon14:c.C2039T:p.T680I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6981	0.6187	0.757987	0.6392	-0.073	1.943	1.0	1.16	0.862	.	.	.	GEN1:uc002rct.2:exon14:c.C2039T:p.T680I,GEN1:uc002rcu.2:exon14:c.C2039T:p.T680I,GEN1:uc010yjs.1:exon14:c.C2039T:p.T680I	-0.997	AFR:0.6127,AMR:0.7721,EAS:0.9783,FIN:0.5833,NFE:0.6234,OTH:0.6442,ASJ:0.63	612449	.	.	.	.	.	.	.	0.0	2.01	0.000	-1.845	2	MU31230939	hom
2	21228730	21228730	C	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs148127628	ENSG00000084674:ENST00000233242:exon26:c.G11010T:p.R3670S	APOB:NM_000384:exon26:c.G11010T:p.R3670S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	9.077e-05	7.7e-05	.	6.46e-05	-0.484	0.240	0.848	-11.1	0.084	.	.	.	APOB:uc002red.3:exon26:c.G11010T:p.R3670S	-0.997	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0,ASJ:0	107730	144010;615558;	.	.	.	.	.	.	0.013	-0.3	0.092	-0.605	2	.	het
2	21231387	21231387	T	G	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs2163204	ENSG00000084674:ENST00000233242:exon26:c.A8353C:p.N2785H	APOB:NM_000384:exon26:c.A8353C:p.N2785H	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 1, 2, -1, 0, 0] 	0.0081	0.0009	0.0117812	0.0049	-1.995	0.001	0.2	1.46	0.298	.	.	.	APOB:uc002red.3:exon26:c.A8353C:p.N2785H	-0.940	AFR:0.0001,AMR:0.0227,EAS:0.0657,FIN:0.0006,NFE:0.0012,OTH:0.0041,ASJ:0.0033	107730	144010;615558;	.	.	.	.	.	.	0.006	5.77	0.001	0.86	2	MU13421510	het
2	21231524	21231524	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs676210	ENSG00000084674:ENST00000233242:exon26:c.C8216T:p.P2739L	APOB:NM_000384:exon26:c.C8216T:p.P2739L	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.2928	0.1965	0.366214	MU156045	5.787	27.1	0.0	5.22	1.000	.	.	.	APOB:uc002red.3:exon26:c.C8216T:p.P2739L	-1.071	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.2347,EAS:0.2153,FIN:0.1424,NFE:0.7298,OTH:0.2563,ASJ:0.1459	107730	144010;615558;	.	.	.	.	.	.	1.0	5.21	0.000	2.785	2	1(large_intestine)	0.2276
2	21232803	21232803	T	C	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs584542	ENSG00000084674:ENST00000233242:exon26:c.A6937G:p.I2313V	APOB:NM_000384:exon26:c.A6937G:p.I2313V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9950	0.9816	0.986222	0.9842	-4.107	0.001	0.626	-3.8	0.005	.	.	.	APOB:uc002red.3:exon26:c.A6937G:p.I2313V	-0.985	AFR:0.9457,AMR:0.9976,EAS:0.9981,FIN:1,NFE:0.9996,OTH:0.9969,ASJ:1	107730	144010;615558;	.	.	.	.	.	.	0.002	5.78	0.000	1.465	2	MU81728574	hom
2	21235475	21235475	T	C	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs568413	ENSG00000084674:ENST00000233242:exon26:c.A4265G:p.Y1422C	APOB:NM_000384:exon26:c.A4265G:p.Y1422C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9999	0.9997	1	0.9997	.	.	.	.	.	.	.	.	APOB:uc002red.3:exon26:c.A4265G:p.Y1422C	.	AFR:0.9997,AMR:1,EAS:1,FIN:1,NFE:0.9997,OTH:0.9990,ASJ:1	107730	144010;615558;	.	.	.	.	.	.	.	.	.	.	2	MU81728579	hom
2	21250914	21250914	G	A	APOB	exonic	nonsynonymous SNV	ENSG00000084674	rs679899	ENSG00000084674:ENST00000233242:exon14:c.C1853T:p.A618V,ENSG00000084674:ENST00000399256:exon14:c.C1853T:p.A618V	APOB:NM_000384:exon14:c.C1853T:p.A618V	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.4857	0.3655	0.485024	0.4190	5.620	26.6	0.005	5.73	0.712	.	.	Lipid transport protein, N-terminal|Vitellinogen, superhelical	APOB:uc002red.3:exon14:c.C1853T:p.A618V	-0.928	AFR:0.1710,AMR:0.3926,EAS:0.8424,FIN:0.5479,NFE:0.4846,OTH:0.5061,ASJ:0.3576	107730	144010;615558;	.	.	.	.	.	.	1.0	-0.62	0.000	2.695	2	MU4129271	hom
2	24905927	24905927	G	C	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs11125744	ENSG00000084676:ENST00000288599:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000348332:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000395856:exon6:c.G462C:p.T154T,ENSG00000084676:ENST00000407230:exon6:c.G9C:p.T3T,ENSG00000084676:ENST00000538539:exon7:c.G462C:p.T154T,ENSG00000084676:ENST00000406961:exon8:c.G462C:p.T154T,ENSG00000084676:ENST00000405141:exon9:c.G462C:p.T154T	NCOA1:NM_147233:exon6:c.G462C:p.T154T,NCOA1:NM_147223:exon7:c.G462C:p.T154T,NCOA1:NM_001362950:exon8:c.G462C:p.T154T,NCOA1:NM_001362952:exon8:c.G462C:p.T154T,NCOA1:NM_001362954:exon8:c.G462C:p.T154T,NCOA1:NM_001362955:exon8:c.G462C:p.T154T,NCOA1:NM_003743:exon8:c.G462C:p.T154T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8689	0.7864	0.80651	0.8160	.	.	.	.	.	.	.	.	NCOA1:uc002rfi.3:exon6:c.G9C:p.T3T,NCOA1:uc002rfj.3:exon6:c.G462C:p.T154T,NCOA1:uc002rfk.3:exon6:c.G462C:p.T154T,NCOA1:uc002rfl.3:exon6:c.G462C:p.T154T,NCOA1:uc010eye.3:exon7:c.G462C:p.T154T	.	AFR:0.5729,AMR:0.9306,EAS:0.9957,FIN:0.9123,NFE:0.9034,OTH:0.8724,ASJ:0.9040	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	MU4558267	hom
2	24974945	24974945	T	G	NCOA1	exonic	synonymous SNV	ENSG00000084676	rs11125763	ENSG00000084676:ENST00000288599:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000348332:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000395856:exon18:c.T3801G:p.L1267L,ENSG00000084676:ENST00000407230:exon18:c.T3348G:p.L1116L,ENSG00000084676:ENST00000538539:exon19:c.T3801G:p.L1267L,ENSG00000084676:ENST00000406961:exon20:c.T3801G:p.L1267L,ENSG00000084676:ENST00000405141:exon21:c.T3801G:p.L1267L	NCOA1:NM_147233:exon18:c.T3801G:p.L1267L,NCOA1:NM_147223:exon19:c.T3801G:p.L1267L,NCOA1:NM_001362950:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362952:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362954:exon20:c.T3801G:p.L1267L,NCOA1:NM_001362955:exon20:c.T3801G:p.L1267L,NCOA1:NM_003743:exon20:c.T3801G:p.L1267L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8784	0.8189	0.836062	0.8444	.	.	.	.	.	.	.	.	NCOA1:uc010eyf.3:exon2:c.T480G:p.L160L,NCOA1:uc002rfi.3:exon18:c.T3348G:p.L1116L,NCOA1:uc002rfj.3:exon18:c.T3801G:p.L1267L,NCOA1:uc002rfk.3:exon18:c.T3801G:p.L1267L,NCOA1:uc002rfl.3:exon18:c.T3801G:p.L1267L,NCOA1:uc010eye.3:exon19:c.T3801G:p.L1267L	.	AFR:0.6732,AMR:0.9368,EAS:0.9957,FIN:0.9118,NFE:0.9033,OTH:0.8763,ASJ:0.9040	602691	.	.	.	~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	2	MU81728834	hom
2	25469913	25469913	C	T	DNMT3A	intronic	.	ENSG00000119772	rs2276599	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7167	0.6863	0.614018	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	.	.	.	.	.	0	0	.	.	.	AFR:0.7006,AMR:0.5654,EAS:0.6656,FIN:0.6001,NFE:0.8238,OTH:0.7565,ASJ:0.7363	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.7525
2	25536827	25536827	G	A	DNMT3A	exonic	synonymous SNV	ENSG00000119772	rs41284843	ENSG00000119772:ENST00000264709:exon2:c.C27T:p.P9P,ENSG00000119772:ENST00000321117:exon2:c.C27T:p.P9P,ENSG00000119772:ENST00000380756:exon2:c.C27T:p.P9P,ENSG00000119772:ENST00000406659:exon2:c.C27T:p.P9P	DNMT3A:NM_001320892:exon2:c.C27T:p.P9P,DNMT3A:NM_022552:exon2:c.C27T:p.P9P,DNMT3A:NM_175629:exon2:c.C27T:p.P9P,DNMT3A:NM_175630:exon2:c.C27T:p.P9P	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1550	0.0766	0.0948482	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,LIAD-FR|1|32|0.03125	.	.	.	.	.	.	.	.	DNMT3A:uc002rgc.4:exon2:c.C27T:p.P9P,DNMT3A:uc002rgd.4:exon2:c.C27T:p.P9P,DNMT3A:uc002rgf.3:exon2:c.C27T:p.P9P	.	AFR:0.0809,AMR:0.0589,EAS:0.0894,FIN:0.0871,NFE:0.0619,OTH:0.0972,ASJ:0.0610	602769	615879;	404443;	404443|DNMT3A-related overgrowth syndrome|<1 / 1 000 000|Unknown|Neonatal|615879 ~	.	,2229,2225,2226,2233,2228,2236	.	,2227,2235,2231,2230,2232,2234	.	.	.	.	2	1(liver)	0.0990
2	27440785	27440785	C	T	CAD	exonic	synonymous SNV	ENSG00000084774	rs1275536	ENSG00000084774:ENST00000264705:exon2:c.C123T:p.T41T,ENSG00000084774:ENST00000403525:exon2:c.C123T:p.T41T	CAD:NM_001306079:exon2:c.C123T:p.T41T,CAD:NM_004341:exon2:c.C123T:p.T41T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9986	0.9958	0.995807	0.9947	.	.	.	.	.	.	.	.	CAD:uc002rji.3:exon2:c.C123T:p.T41T,CAD:uc010eyw.3:exon2:c.C123T:p.T41T	.	AFR:0.9815,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	114010	616457;	448010;	448010|CDG syndrome type IZ<br>CDG-IZ<br>CDG1Z<br>Carbohydrate deficient glycoprotein syndrome type IZ<br>Congenital disorder of glycosylation type 1Z|<1 / 1 000 000|Autosomal recessive|Infancy|616457 ~	.	.	.	.	.	.	.	.	2	MU81729819	hom
2	29416366	29416366	G	C	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs1881421	ENSG00000171094:ENST00000431873:exon4:c.C1077G:p.D359E,ENSG00000171094:ENST00000389048:exon29:c.C4587G:p.D1529E	ALK:NM_001353765:exon10:c.C1383G:p.D461E,ALK:NM_004304:exon29:c.C4587G:p.D1529E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4600	0.4335	0.572883	1(haematopoietic_and_lymphoid_tissue)	-1.393	0.003	1.0	-3.42	0.000	.	.	.	ALK:uc010ymo.3:exon10:c.C1383G:p.D461E,ALK:uc031rnw.1:exon11:c.C1383G:p.D461E,ALK:uc002rmy.3:exon29:c.C4587G:p.D1529E	-0.993	AFR:8(meninges),AMR:MU151094,EAS:0.4808,FIN:0.6142,NFE:0.6055,OTH:0.3377,ASJ:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,619,622,616,620,623,621,624,618	.	.	0.0	1.7	0.000	-0.695	2	1(breast)	0.7553
2	29416481	29416481	T	C	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs1881420	ENSG00000171094:ENST00000431873:exon4:c.A962G:p.K321R,ENSG00000171094:ENST00000389048:exon29:c.A4472G:p.K1491R	ALK:NM_001353765:exon10:c.A1268G:p.K423R,ALK:NM_004304:exon29:c.A4472G:p.K1491R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3318	0.2234	0.415136	6(meninges)	1.619	13.96	0.408	1.9	0.987	.	.	.	ALK:uc010ymo.3:exon10:c.A1268G:p.K423R,ALK:uc031rnw.1:exon11:c.A1268G:p.K423R,ALK:uc002rmy.3:exon29:c.A4472G:p.K1491R	-0.933	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:2(breast),EAS:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,FIN:0.2737,NFE:0.2434,OTH:0.5334,ASJ:MU3888415	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,619,622,616,620,623,621,624,618	.	.	0.0	-1.1	0.000	1.475	2	8(soft_tissue)	0.2067
2	29416572	29416572	T	C	ALK	exonic	nonsynonymous SNV	ENSG00000171094	rs1670283	ENSG00000171094:ENST00000431873:exon4:c.A871G:p.I291V,ENSG00000171094:ENST00000389048:exon29:c.A4381G:p.I1461V	ALK:NM_001353765:exon10:c.A1177G:p.I393V,ALK:NM_004304:exon29:c.A4381G:p.I1461V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.9972	0.9903	0.992212	COCA-CN|5|321|0.0155763	-2.014	0.001	1.0	-0.134	0.001	.	.	.	ALK:uc010ymo.3:exon10:c.A1177G:p.I393V,ALK:uc031rnw.1:exon11:c.A1177G:p.I393V,ALK:uc002rmy.3:exon29:c.A4381G:p.I1461V	-0.987	AFR:0.9907,AMR:0.9680,EAS:0.9934,FIN:1,NFE:1,OTH:0.9999,ASJ:0.9940	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,619,622,616,620,623,621,624,618	.	.	0.0	-0.89	0.000	-1.1	2	30(lung)	0.9990
2	29444076	29444076	G	T	ALK	intronic	.	ENSG00000171094	rs1534545	ENSG00000171094:ENST00000453137:exon4:c.C237A:p.F79L	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3087	.	0.374601	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	-0.053	2.104	0.0	2.44	0.034	.	.	.	.	-0.916	AFR:0.2385,AMR:0.1525,EAS:0.2119,FIN:0.7398,NFE:0.2981,OTH:0.2032,ASJ:0.5274	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	-0.83	0.000	.	2	5(meninges)	0.2643
2	29444095	29444095	C	T	ALK	intronic	.	ENSG00000171094	rs1569156	ENSG00000171094:ENST00000453137:exon4:c.G218A:p.W73X	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9757	.	0.914736	0.9329	0.034	2.916	.	-1.17	0.003	.	.	.	.	.	AFR:0.7762,AMR:0.9833,EAS:0.9414,FIN:1,NFE:0.9995,OTH:0.9898,ASJ:0.9934	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU23036355	hom
2	29445458	29445458	G	T	ALK	exonic	synonymous SNV	ENSG00000171094	rs3795850	ENSG00000171094:ENST00000453137:exon2:c.C69A:p.G23G,ENSG00000171094:ENST00000389048:exon21:c.C3375A:p.G1125G	ALK:NM_001353765:exon2:c.C171A:p.G57G,ALK:NM_004304:exon21:c.C3375A:p.G1125G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3271	0.2214	0.415935	MU18066530	.	.	.	.	.	.	.	.	ALK:uc010ymo.3:exon2:c.C171A:p.G57G,ALK:uc031rnw.1:exon3:c.C171A:p.G57G,ALK:uc002rmy.3:exon21:c.C3375A:p.G1125G	.	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611,AMR:0.2742,EAS:0.5383,FIN:0.2119,NFE:0.7426,OTH:0.3158,ASJ:0.2537	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,619,622,616,620,623,621,624,618	.	.	.	.	.	.	2	6(meninges)	0.2119
2	29445798	29445798	T	C	ALK	intronic	.	ENSG00000171094	rs4666182	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.922923	0.9371	.	.	.	.	.	.	.	.	.	.	AFR:0.7909,AMR:0.9868,EAS:0.9426,FIN:1,NFE:0.9995,OTH:0.9898,ASJ:0.9934	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	29445809	29445809	T	C	ALK	intronic	.	ENSG00000171094	rs11685441	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.130591	0.2166	.	.	.	.	.	.	.	.	.	.	AFR:0.0494,AMR:0.1519,EAS:0.0068,FIN:0.3335,NFE:0.3075,OTH:0.2689,ASJ:0.3233	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	29445982	29445982	G	C	ALK	intronic	.	ENSG00000171094	rs11689436	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.25599	0.3873	.	.	.	.	.	.	.	.	.	.	AFR:0.2100,AMR:0.2410,EAS:0.0327,FIN:0.5147,NFE:0.5011,OTH:0.4600,ASJ:0.4834	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29446184	29446184	C	G	ALK	intronic	.	ENSG00000171094	rs2276550	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3312	0.2234	0.420727	0.2763	.	.	.	.	.	.	.	.	.	.	AFR:0.2548,AMR:0.5418,EAS:0.7584,FIN:0.3162,NFE:0.2133,OTH:0.2844,ASJ:0.2185	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU21150305	het
2	29446202	29446202	G	A	ALK	intronic	.	ENSG00000171094	rs4622670	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2896	0.2663	0.176518	MU742525	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.2520,EAS:0.1818,FIN:0.3543,NFE:0.0327,OTH:0.3506,ASJ:0.0629	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	1(lung)	0.3609
2	29446721	29446721	A	G	ALK	UTR5	.	ENSG00000171094	rs4665447	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.854633	0.8794	.	.	.	.	.	.	.	.	.	.	AFR:0.6369,AMR:0.9617,EAS:0.9340,FIN:0.9759,NFE:0.9801,OTH:0.9622,ASJ:0.9669	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	hom
2	29447108	29447108	G	A	ALK	intronic	.	ENSG00000171094	rs4387740	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.727436	0.7086	.	.	.	.	.	.	.	.	.	.	AFR:0.6098,AMR:0.7947,EAS:0.7670,FIN:0.8268,NFE:0.7242,OTH:0.7495,ASJ:0.7152	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	MU114075717	hom
2	29447253	29447253	A	G	ALK	intronic	.	ENSG00000171094	rs6723311	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.629393	0.5322	.	.	.	.	.	.	.	.	.	.	AFR:0.4892,AMR:0.7375,EAS:0.8872,FIN:0.5295,NFE:0.5070,OTH:0.5439,ASJ:0.5364	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29448846	29448846	C	G	ALK	intronic	.	ENSG00000171094	rs11683248	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.256789	0.3521	.	.	.	.	.	.	.	.	.	.	AFR:0.3117,AMR:0.1814,EAS:0.0358,FIN:0.4512,NFE:0.3948,OTH:0.3650,ASJ:0.3907	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29449345	29449348	AAAA	-	ALK	intronic	.	ENSG00000171094	rs147512176	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.4651	.	.	.	.	.	.	.	.	.	.	AFR:0.3345,AMR:0.4043,EAS:0.2934,FIN:0.3602,NFE:0.5546,OTH:0.4664,ASJ:0.4805	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29449423	29449423	G	A	ALK	intronic	.	ENSG00000171094	rs6744522	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.305112	0.4403	.	.	.	.	.	.	.	.	.	.	AFR:0.2829,AMR:0.3270,EAS:0.0315,FIN:0.5762,NFE:0.5481,OTH:0.4856,ASJ:0.4597	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29449526	29449526	C	T	ALK	intronic	.	ENSG00000171094	rs1881419	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.388778	0.3004	.	.	.	.	.	.	.	.	.	.	AFR:0.1990,AMR:0.5,EAS:0.6807,FIN:0.3245,NFE:0.2992,OTH:0.3480,ASJ:0.2649	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	2	.	het
2	29455267	29455267	A	G	ALK	exonic	synonymous SNV	ENSG00000171094	rs2256740	ENSG00000171094:ENST00000389048:exon15:c.T2535C:p.G845G	ALK:NM_004304:exon15:c.T2535C:p.G845G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6121	0.6614	0.5	1(stomach)	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon15:c.T2535C:p.G845G	.	AFR:19(soft_tissue),AMR:16(meninges),EAS:MU584960,FIN:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,NFE:0.6208,OTH:0.5538,ASJ:1(haematopoietic_and_lymphoid_tissue)	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,619,622,616,620,623,621,624,618	.	.	.	.	.	.	2	1(liver)	0.4880
2	29543663	29543663	T	C	ALK	exonic	synonymous SNV	ENSG00000171094	rs2293564	ENSG00000171094:ENST00000389048:exon7:c.A1500G:p.Q500Q	ALK:NM_004304:exon7:c.A1500G:p.Q500Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8716	0.7909	0.776558	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon7:c.A1500G:p.Q500Q	.	AFR:0.8023,AMR:0.5071,EAS:0.8808,FIN:0.9086,NFE:0.9241,OTH:0.9216,ASJ:0.8771	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,619,622,616,620,623,621,624,618	.	.	.	.	.	.	2	18(meninges)	0.8939
2	29940529	29940529	A	T	ALK	exonic	synonymous SNV	ENSG00000171094	rs2246745	ENSG00000171094:ENST00000389048:exon2:c.T702A:p.P234P,ENSG00000171094:ENST00000431873:exon2:c.T702A:p.P234P	ALK:NM_004304:exon2:c.T702A:p.P234P	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7335	0.6270	0.589257	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon2:c.T702A:p.P234P	.	AFR:0.6361,AMR:0.2397,EAS:0.7881,FIN:0.7342,NFE:0.7362,OTH:0.8163,ASJ:0.7224	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,619,622,616,620,623,621,624,618	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.7633
2	30143499	30143499	G	C	ALK	exonic	synonymous SNV	ENSG00000171094	rs4358080	ENSG00000171094:ENST00000389048:exon1:c.C27G:p.L9L,ENSG00000171094:ENST00000431873:exon1:c.C27G:p.L9L	ALK:NM_004304:exon1:c.C27G:p.L9L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8949	0.9093	0.89377	0.8892	.	.	.	.	.	.	.	.	ALK:uc002rmy.3:exon1:c.C27G:p.L9L	.	AFR:0.8349,AMR:0.9459,EAS:1,FIN:0.8627,NFE:0.9123,OTH:0.9002,ASJ:0.8245	105590	613014;	635;	635|-|1-5 / 10 000|Not applicable|Childhood|256700 613013 613014 613015 613016 613017 616792 ~	~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	617,,619,622,616,620,623,621,624,618	.	.	.	.	.	.	2	MU84195	het
2	31178818	31178818	C	T	GALNT14	exonic	synonymous SNV	ENSG00000158089	rs2288100	ENSG00000158089:ENST00000356174:exon4:c.G393A:p.K131K,ENSG00000158089:ENST00000430167:exon4:c.G393A:p.K131K,ENSG00000158089:ENST00000349752:exon5:c.G492A:p.K164K,ENSG00000158089:ENST00000324589:exon6:c.G507A:p.K169K,ENSG00000158089:ENST00000420311:exon6:c.G387A:p.K129K,ENSG00000158089:ENST00000406653:exon7:c.G432A:p.K144K	GALNT14:NM_001329097:exon5:c.G492A:p.K164K,GALNT14:NM_024572:exon5:c.G492A:p.K164K,GALNT14:NM_001253826:exon6:c.G507A:p.K169K,GALNT14:NM_001329095:exon6:c.G387A:p.K129K,GALNT14:NM_001253827:exon7:c.G432A:p.K144K,GALNT14:NM_001329096:exon7:c.G432A:p.K144K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1541	0.1322	0.127995	MU82738	.	.	.	.	.	.	.	.	GALNT14:uc010ezo.2:exon4:c.G393A:p.K131K,GALNT14:uc002rnr.3:exon5:c.G492A:p.K164K,GALNT14:uc002rns.3:exon6:c.G507A:p.K169K,GALNT14:uc010ymr.2:exon6:c.G387A:p.K129K,GALNT14:uc002rnq.3:exon7:c.G432A:p.K144K,GALNT14:uc010ezp.1:exon7:c.G405A:p.K135K	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.1358,EAS:0.0800,FIN:0.3013,NFE:0.1837,OTH:0.1787,ASJ:0.0640	608225	.	.	.	.	.	.	.	.	.	.	.	2	1(lung)	0.1599
2	44123758	44123758	G	A	LRPPRC	intronic	.	ENSG00000138095	rs76850904	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0985	0.1032	0.0858626	0.0967	.	.	.	.	.	.	.	.	.	.	AFR:0.1141,AMR:0.0550,EAS:0.0074,FIN:0.0693,NFE:0.1039,OTH:0.1033,ASJ:0.1291	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	.	het
2	44123759	44123759	G	A	LRPPRC	intronic	.	ENSG00000138095	rs3795859	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1599	0.0823	0.205072	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1099,AMR:0.0266,EAS:0.1325,FIN:0.4553,NFE:0.1376,OTH:0.1069,ASJ:0.2029	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	3(haematopoietic_and_lymphoid_tissue)	0.1469
2	44201376	44201376	T	C	LRPPRC	exonic	synonymous SNV	ENSG00000138095	rs4953042	ENSG00000138095:ENST00000260665:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000409659:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000409946:exon9:c.A1068G:p.Q356Q,ENSG00000138095:ENST00000447246:exon9:c.A990G:p.Q330Q	LRPPRC:NM_133259:exon9:c.A1068G:p.Q356Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2099	0.1152	0.255791	MU733051	.	.	.	.	.	.	.	.	LRPPRC:uc010yob.1:exon8:c.A768G:p.Q256Q,LRPPRC:uc002rtr.2:exon9:c.A1068G:p.Q356Q,LRPPRC:uc010faw.1:exon9:c.A990G:p.Q330Q	.	AFR:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.1504,EAS:0.2847,FIN:0.1689,NFE:0.5044,OTH:0.1844,ASJ:0.0500	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.1521
2	44209477	44209477	C	T	LRPPRC	exonic	synonymous SNV	ENSG00000138095	rs6741066	ENSG00000138095:ENST00000260665:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000409659:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000409946:exon2:c.G246A:p.Q82Q,ENSG00000138095:ENST00000447246:exon2:c.G168A:p.Q56Q	LRPPRC:NM_133259:exon2:c.G246A:p.Q82Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6240	0.7243	0.503994	2(large_intestine)	.	.	.	.	.	.	.	.	LRPPRC:uc002rtr.2:exon2:c.G246A:p.Q82Q,LRPPRC:uc010faw.1:exon2:c.G168A:p.Q56Q	.	AFR:MU108002,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,EAS:0.7029,FIN:0.5347,NFE:0.7550,OTH:0.0222,ASJ:0.6781	607544	220111;	70472;	70472|COX deficiency, French-Canadian type<br>Cytochrome C oxidase deficiency, French-Canadian type<br>Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type<br>Leigh syndrome, French-Canadian type<br>Leigh syndrome, Saguenay-Lac-Saint-Jean type<br>SLSJ-COX deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|220111 ~	.	.	.	.	.	.	.	.	2	1(stomach)	0.7353
2	46583281	46583281	-	T	EPAS1	intronic	.	ENSG00000116016	rs35508970	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2007	.	0.707468	0.1773	.	.	.	.	.	.	.	.	.	.	AFR:0.2228,AMR:0.2924,EAS:0.0907,FIN:0.1698,NFE:0.1551,OTH:0.1682,ASJ:0.2008	603349	611783;	247511;	247511|Autosomal dominant secondary erythrocytosis|Unknown|Autosomal dominant|Infancy<br>Neonatal|609820 611783 ~	~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	2	.	het
2	47641561	47641562	AA	-	MSH2	intronic	.	ENSG00000095002	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	609309	120435;158320;276300;	252202;587;144;	252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~587|Multiple keratoacanthoma, Muir-Torre type|Unknown|Autosomal dominant|Adult|158320 ~144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	48030838	48030838	A	T	MSH6	intronic	.	ENSG00000116062;ENSG00000138081	rs2020911	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4043	0.3146	0.400958	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3215,AMR:0.1746,EAS:0.37,FIN:0.6412,NFE:0.3298,OTH:0.3606,ASJ:0.4761	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	22(large_intestine)	0.3313
2	48033551	48033551	C	G	MSH6	intronic	.	ENSG00000116062;ENSG00000138081	rs3136367	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7426	0.7872	0.809105	MU18078954	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,AMR:0.7725,EAS:0.6214,FIN:0.7351,NFE:0.8835,OTH:0.6606,ASJ:0.9177	600678	276300;608089;614350;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	2	1(liver)	0.7160
2	55873385	55873385	C	G	PNPT1	intronic	.	ENSG00000138035	rs7584120	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1298	0.2032	0.198482	0.1801	.	.	.	.	.	.	.	.	.	.	AFR:0.4087,AMR:0.0668,EAS:0.1059,FIN:0.0536,NFE:0.0965,OTH:0.0927,ASJ:0.1921	610316	614932;614934;	90636;319514;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~319514|COXPD13|<1 / 1 000 000|-|Infancy|614932 ~	.	.	.	.	.	.	.	.	2	MU773618	het
2	55900231	55900231	-	A	PNPT1	intronic	.	ENSG00000138035	rs146633902	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1243	0.0933	0.0654952	0.0884	.	.	.	.	.	.	.	.	.	.	AFR:0.0313,AMR:0.1138,EAS:0.0025,FIN:0.1201,NFE:0.1257,OTH:0.1073,ASJ:0.0839	610316	614932;614934;	90636;319514;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~319514|COXPD13|<1 / 1 000 000|-|Infancy|614932 ~	.	.	.	.	.	.	.	.	2	.	het
2	58388696	58388696	A	G	FANCL	exonic	synonymous SNV	ENSG00000115392	rs848291	ENSG00000115392:ENST00000403676:exon8:c.T630C:p.S210S,ENSG00000115392:ENST00000449070:exon9:c.T804C:p.S268S,ENSG00000115392:ENST00000403295:exon11:c.T897C:p.S299S,ENSG00000115392:ENST00000233741:exon12:c.T981C:p.S327S,ENSG00000115392:ENST00000402135:exon12:c.T996C:p.S332S	FANCL:NM_001114636:exon12:c.T996C:p.S332S,FANCL:NM_018062:exon12:c.T981C:p.S327S	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.6487	0.7041	0.70647	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FANCL:uc010fcf.1:exon9:c.T804C:p.S268S,FANCL:uc010fce.3:exon11:c.T897C:p.S299S,FANCL:uc002rzw.4:exon12:c.T981C:p.S327S,FANCL:uc002rzx.4:exon12:c.T996C:p.S332S	.	AFR:0.6976,AMR:0.8947,EAS:0.5430,FIN:0.5789,NFE:0.6272,OTH:0.6195,ASJ:0.6751	608111	614083;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	,4922	.	.	.	.	.	.	2	2(haematopoietic_and_lymphoid_tissue)	0.6442
2	58453843	58453843	-	A	FANCL	intronic	.	ENSG00000115392	rs372101290	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3679	0.2509	0.259585	0.2920	.	.	.	.	.	.	.	.	.	.	AFR:0.0835,AMR:0.4194,EAS:0.3209,FIN:0.4288,NFE:0.3730,OTH:0.3878,ASJ:0.3333	608111	614083;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	2	MU112120040	het
2	61108996	61108996	A	T	REL	intronic	.	ENSG00000162924	rs842650	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1532	0.0689	0.10643	0.0863	.	.	.	.	.	.	.	.	.	.	AFR:0.1195,AMR:0.1038,EAS:0.0993,FIN:0.0610,NFE:0.0685,OTH:0.0888,ASJ:0.1788	164910	.	.	.	~ko04014 Ras signaling pathway~ko04624 Toll and Imd signaling pathway~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	2	MU81733188	het
2	68729931	68729931	A	G	APLF	exonic	synonymous SNV	ENSG00000169621	rs112136813	ENSG00000169621:ENST00000529851:exon2:c.A165G:p.L55L,ENSG00000169621:ENST00000303795:exon3:c.A237G:p.L79L,ENSG00000169621:ENST00000445692:exon3:c.A237G:p.L79L	APLF:NM_173545:exon3:c.A237G:p.L79L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0311	0.0280	0.0273562	0.0251	.	.	.	.	.	.	.	.	APLF:uc010fdf.2:exon2:c.A165G:p.L55L,APLF:uc002sep.3:exon3:c.A237G:p.L79L	.	AFR:0.0076,AMR:0.0311,EAS:0.0383,FIN:0.0275,NFE:0.0321,OTH:0.0337,ASJ:0.0397	611035	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	68729992	68729992	A	G	APLF	exonic	nonsynonymous SNV	ENSG00000169621	rs11902811	ENSG00000169621:ENST00000529851:exon2:c.A226G:p.I76V,ENSG00000169621:ENST00000303795:exon3:c.A298G:p.I100V,ENSG00000169621:ENST00000445692:exon3:c.A298G:p.I100V	APLF:NM_173545:exon3:c.A298G:p.I100V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0776	0.1794	0.160543	0.1535	-0.206	1.066	1.0	5.09	0.012	.	.	SMAD/FHA domain	APLF:uc010fdf.2:exon2:c.A226G:p.I76V,APLF:uc002sep.3:exon3:c.A298G:p.I100V	-0.935	AFR:0.4313,AMR:0.0609,EAS:0.0377,FIN:0.0315,NFE:0.0458,OTH:0.0673,ASJ:0.0497	611035	.	.	.	.	.	.	.	0.0	2.21	0.000	-2.175	2	MU151773	het
2	68753240	68753240	T	A	APLF	exonic	nonsynonymous SNV	ENSG00000169621	rs35002937	ENSG00000169621:ENST00000303795:exon6:c.T670A:p.S224T,ENSG00000169621:ENST00000445692:exon6:c.T670A:p.S224T	APLF:NM_173545:exon6:c.T670A:p.S224T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1543	0.2716	0.229633	0.2344	-0.570	0.147	1.0	3.6	0.043	.	.	.	APLF:uc010fdf.2:exon5:c.T598A:p.S200T,APLF:uc002sep.3:exon6:c.T670A:p.S224T	-0.924	AFR:0.5444,AMR:0.1172,EAS:0.0476,FIN:0.0866,NFE:0.1222,OTH:0.1380,ASJ:0.2119	611035	.	.	.	.	.	.	.	0.001	1.96	0.000	-1.63	2	MU151781	het
2	68794483	68794483	C	A	APLF	exonic	nonsynonymous SNV	ENSG00000169621	rs36021078	ENSG00000169621:ENST00000303795:exon9:c.C1297A:p.Q433K	APLF:NM_173545:exon9:c.C1297A:p.Q433K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.0307	0.0265	0.0267572	.	5.058	25.2	0.011	4.99	0.998	.	.	Zinc finger, C2H2, APLF-like	APLF:uc002ser.1:exon4:c.C490A:p.Q164K,APLF:uc002sep.3:exon9:c.C1297A:p.Q433K	-1.032	AFR:0.0249,AMR:0.0073,EAS:0.0397,FIN:0.0343,NFE:0.0272,OTH:0.0325,ASJ:0.0311	611035	.	.	.	.	.	.	.	0.997	1.72	0.041	.	2	1(large_intestine)	0.0327
2	68794528	68794528	G	T	APLF	intronic	.	ENSG00000169621	rs6751531	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1560	0.2654	0.229832	0.2343	.	.	.	.	.	.	.	.	.	.	AFR:0.5453,AMR:0.1175,EAS:0.0480,FIN:0.0845,NFE:0.1217,OTH:0.1366,ASJ:0.2119	611035	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	74080159	74080159	T	C	STAMBP	intronic	.	ENSG00000124356	rs6722659	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.466254	0.4312	.	.	.	.	.	.	.	.	.	.	AFR:0.7235,AMR:0.3409,EAS:0.3953,FIN:0.2668,NFE:0.3157,OTH:0.3327,ASJ:0.4007	606247	614261;	294016;	294016|MIC-CAP syndrome<br>MIC-CM syndrome<br>Microcephaly-cutaneous capillary malformation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614261 ~	.	.	.	.	.	.	.	.	2	MU116790481	het
2	74128433	74128433	C	T	ACTG2	UTR5	.	ENSG00000163017	rs1050146	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7697	0.7628	0.707867	0.7708	.	.	.	.	.	.	.	.	.	.	AFR:0.7010,AMR:0.8795,EAS:0.5767,FIN:0.8539,NFE:0.8053,OTH:0.8014,ASJ:0.7517	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	MU753936	hom
2	74129474	74129474	T	C	ACTG2	intronic	.	ENSG00000163017	rs1726025	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5897	0.5568	0.562899	MU753938	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.5948,EAS:0.7440,FIN:0.4733,NFE:0.4856,OTH:0.6981,ASJ:0.5271	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.6150
2	74135797	74135797	T	C	ACTG2	intronic	.	ENSG00000163017	rs702461	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6476	0.5947	0.575879	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0001	0.048	.	.	.	AFR:0.6214,AMR:0.4490,EAS:0.5662,FIN:0.4907,NFE:0.7430,OTH:0.6957,ASJ:0.7883	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.6728
2	74135898	74135898	A	G	ACTG2	exonic	synonymous SNV	ENSG00000163017	rs756128	ENSG00000163017:ENST00000409731:exon3:c.A225G:p.E75E,ENSG00000163017:ENST00000345517:exon4:c.A354G:p.E118E,ENSG00000163017:ENST00000442912:exon4:c.A354G:p.E118E,ENSG00000163017:ENST00000409624:exon5:c.A354G:p.E118E	ACTG2:NM_001199893:exon3:c.A225G:p.E75E,ACTG2:NM_001615:exon4:c.A354G:p.E118E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6403	0.5900	0.571885	0.6143	.	.	.	.	.	.	.	.	ACTG2:uc010yrn.2:exon3:c.A225G:p.E75E,ACTG2:uc002sjw.3:exon4:c.A354G:p.E118E,ACTG2:uc010fey.3:exon5:c.A354G:p.E118E	.	AFR:0.4483,AMR:0.7892,EAS:0.4901,FIN:0.7384,NFE:0.6839,OTH:0.6578,ASJ:0.5497	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	MU753952	hom
2	74140789	74140789	T	C	ACTG2	intronic	.	ENSG00000163017	rs891698	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6494	0.6196	0.60004	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.6377,AMR:0.5326,EAS:0.5533,FIN:0.4914,NFE:0.7378,OTH:0.6827,ASJ:0.7950	102545	155310;	2604;	2604|Familial hollow visceral myopathy<br>Hereditary hollow visceral myopathy<br>Megaduodenum and/or megacystis|Unknown|Autosomal dominant|All ages|155310 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.6619
2	75185856	75185856	G	T	POLE4	exonic	nonsynonymous SNV	ENSG00000115350	rs12366	ENSG00000115350:ENST00000483063:exon1:c.G50T:p.G17V	POLE4:NM_019896:exon1:c.G50T:p.G17V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4146	0.3250	0.341653	1(upper_aerodigestive_tract)	3.708	23.3	0.226	3.58	0.046	.	.	.	POLE4:uc002snf.3:exon1:c.G50T:p.G17V	-0.919	AFR:MU93397,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.3261,FIN:0.3173,NFE:0.5232,OTH:0.4248,ASJ:0.3517	607269	.	.	.	.	.	.	.	0.468	1.51	0.000	0.895	2	1(liver)	0.2697
2	85360829	85360831	GGC	-	TCF7L1	exonic	nonframeshift deletion	ENSG00000152284	rs566806913	ENSG00000152284:ENST00000282111:exon1:c.22_24del:p.8_8del	TCF7L1:NM_031283:exon1:c.22_24del:p.8_8del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.75	.	0.382588	0.4514	.	.	.	.	.	.	.	.	TCF7L1:uc002soy.3:exon1:c.22_24del:p.8_8del	.	AFR:0.5374,AMR:0.3534,EAS:0.1810,FIN:0.5503,NFE:0.4306,OTH:0.4443,ASJ:0.3649	604652	.	.	.	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04916 Melanogenesis~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05221 Acute myeloid leukemia~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	2	.	het
2	85622059	85622059	T	C	CAPG	exonic	nonsynonymous SNV	ENSG00000042493	rs6886	ENSG00000042493:ENST00000453973:exon4:c.A269G:p.H90R,ENSG00000042493:ENST00000263867:exon10:c.A1004G:p.H335R,ENSG00000042493:ENST00000409670:exon10:c.A1004G:p.H335R,ENSG00000042493:ENST00000409724:exon10:c.A1004G:p.H335R,ENSG00000042493:ENST00000409921:exon10:c.A959G:p.H320R	CAPG:NM_001320734:exon9:c.A911G:p.H304R,CAPG:NM_001256139:exon10:c.A1004G:p.H335R,CAPG:NM_001256140:exon10:c.A959G:p.H320R,CAPG:NM_001320732:exon10:c.A1004G:p.H335R,CAPG:NM_001320733:exon10:c.A1004G:p.H335R,CAPG:NM_001747:exon10:c.A1004G:p.H335R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5882	0.6744	0.585064	0.6479	1.450	13.05	0.477	3.9	0.995	.	.	ADF-H/Gelsolin-like domain|Gelsolin-like domain	CAPG:uc002spl.2:exon10:c.A1004G:p.H335R,CAPG:uc002spm.2:exon10:c.A959G:p.H320R,CAPG:uc010fgi.2:exon10:c.A1004G:p.H335R	-1.007	AFR:0.7341,AMR:0.4057,EAS:0.4653,FIN:0.6216,NFE:0.6419,OTH:0.6076,ASJ:0.5397	153615	.	.	.	.	.	.	.	0.0	0.64	0.000	-0.045	2	MU805017	het
2	85625222	85625222	T	G	CAPG	exonic	synonymous SNV	ENSG00000042493	rs6885	ENSG00000042493:ENST00000453973:exon2:c.A78C:p.P26P,ENSG00000042493:ENST00000263867:exon8:c.A813C:p.P271P,ENSG00000042493:ENST00000409670:exon8:c.A813C:p.P271P,ENSG00000042493:ENST00000409724:exon8:c.A813C:p.P271P,ENSG00000042493:ENST00000409921:exon8:c.A768C:p.P256P	CAPG:NM_001320734:exon7:c.A720C:p.P240P,CAPG:NM_001256139:exon8:c.A813C:p.P271P,CAPG:NM_001256140:exon8:c.A768C:p.P256P,CAPG:NM_001320732:exon8:c.A813C:p.P271P,CAPG:NM_001320733:exon8:c.A813C:p.P271P,CAPG:NM_001747:exon8:c.A813C:p.P271P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2239	0.2880	0.251597	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	CAPG:uc010fgj.1:exon5:c.A495C:p.P165P,CAPG:uc002spl.2:exon8:c.A813C:p.P271P,CAPG:uc002spm.2:exon8:c.A768C:p.P256P,CAPG:uc010fgi.2:exon8:c.A813C:p.P271P	.	AFR:0.2682,AMR:0.3776,EAS:0.1788,FIN:0.0797,NFE:0.2134,OTH:0.2507,ASJ:0.1169	153615	.	.	.	.	.	.	.	.	.	.	.	2	1(breast)	0.2251
2	88874891	88874891	C	A	EIF2AK3	exonic	nonsynonymous SNV	ENSG00000172071	rs1805165	ENSG00000172071:ENST00000415570:exon12:c.G1747T:p.A583S,ENSG00000172071:ENST00000303236:exon13:c.G2110T:p.A704S,ENSG00000172071:ENST00000419748:exon13:c.G1657T:p.A553S	EIF2AK3:NM_001313915:exon13:c.G1657T:p.A553S,EIF2AK3:NM_004836:exon13:c.G2110T:p.A704S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7021	0.8017	0.720647	0.7688	1.963	15.98	1.0	4.91	0.998	.	.	Protein kinase domain	EIF2AK3:uc002stc.4:exon13:c.G2110T:p.A704S	-0.930	AFR:0.9445,AMR:0.7088,EAS:0.5186,FIN:0.6582,NFE:0.7264,OTH:0.7051,ASJ:0.7815	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	0.003	-0.43	0.000	-0.09	2	MU815303	het
2	88882942	88882942	T	A	EIF2AK3	intronic	.	ENSG00000172071	rs6750998	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2542	0.2394	0.204273	0.2174	.	.	.	.	.	0	0.006	.	.	.	AFR:0.1306,AMR:0.1675,EAS:0.1606,FIN:0.2018,NFE:0.2756,OTH:0.2423,ASJ:0.3767	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	.	.	.	.	2	MU585094	het
2	88890432	88890432	T	G	EIF2AK3	exonic	nonsynonymous SNV	ENSG00000172071	rs549674310	ENSG00000172071:ENST00000415570:exon4:c.A543C:p.E181D,ENSG00000172071:ENST00000303236:exon5:c.A906C:p.E302D,ENSG00000172071:ENST00000419748:exon5:c.A453C:p.E151D	EIF2AK3:NM_001313915:exon5:c.A453C:p.E151D,EIF2AK3:NM_004836:exon5:c.A906C:p.E302D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0005	.	0.000599042	.	1.711	14.47	0.233	3.43	0.998	.	.	.	EIF2AK3:uc002stc.4:exon5:c.A906C:p.E302D	-0.605	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	0.008	-0.73	0.260	1.82	2	MU129607718	het
2	88895123	88895123	T	C	EIF2AK3	exonic	nonsynonymous SNV	ENSG00000172071	rs13045	ENSG00000172071:ENST00000415570:exon2:c.A134G:p.Q45R,ENSG00000172071:ENST00000303236:exon3:c.A497G:p.Q166R,ENSG00000172071:ENST00000419748:exon3:c.A44G:p.Q15R	EIF2AK3:NM_001313915:exon3:c.A44G:p.Q15R,EIF2AK3:NM_004836:exon3:c.A497G:p.Q166R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6379	0.7347	0.648962	0.7040	1.089	11.15	0.924	6.16	0.989	.	.	Quinoprotein alcohol dehydrogenase-like superfamily	EIF2AK3:uc002stc.4:exon3:c.A497G:p.Q166R	-0.950	AFR:0.8633,AMR:0.6091,EAS:0.4832,FIN:0.6032,NFE:0.6675,OTH:0.6391,ASJ:0.7285	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	0.0	1.63	0.000	-2.045	2	MU13566225	het
2	88913273	88913273	G	C	EIF2AK3	exonic	nonsynonymous SNV	ENSG00000172071	rs867529	ENSG00000172071:ENST00000303236:exon2:c.C407G:p.S136C	EIF2AK3:NM_004836:exon2:c.C407G:p.S136C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2983	0.1984	0.280551	LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	2.316	18.27	0.134	5.38	0.950	.	.	Quinoprotein alcohol dehydrogenase-like superfamily	EIF2AK3:uc002stc.4:exon2:c.C407G:p.S136C	-0.898	AFR:0.2313,AMR:0.0559,EAS:0.2167,FIN:0.4832,NFE:0.3419,OTH:0.2732,ASJ:0.2950	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	0.002	1.51	0.000	1.295	2	4(lung)	0.2949
2	88926730	88926732	CAG	-	EIF2AK3	exonic	nonframeshift deletion	ENSG00000172071	rs72416210	ENSG00000172071:ENST00000303236:exon1:c.61_63del:p.21_21del	EIF2AK3:NM_004836:exon1:c.61_63del:p.21_21del	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6612	.	0.796526	0.7771	.	.	.	.	.	.	.	.	EIF2AK3:uc002stc.4:exon1:c.61_63del:p.21_21del	.	AFR:0.8697,AMR:0.8137,EAS:0.8371,FIN:0.7781,NFE:0.7198,OTH:0.7446,ASJ:0.6162	604032	226980;	1667;	1667|Early-onset diabetes mellitus with multiple epiphyseal dysplasia<br>WRS|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226980 ~	.	.	.	.	.	.	.	.	2	.	het
2	100019496	100019496	A	G	REV1	exonic	synonymous SNV	ENSG00000135945	rs2305354	ENSG00000135945:ENST00000258428:exon20:c.T3240C:p.I1080I,ENSG00000135945:ENST00000393445:exon20:c.T3237C:p.I1079I	REV1:NM_001037872:exon20:c.T3237C:p.I1079I,REV1:NM_016316:exon20:c.T3240C:p.I1080I,REV1:NM_001321454:exon21:c.T3348C:p.I1116I,REV1:NM_001321455:exon21:c.T3027C:p.I1009I,REV1:NM_001321458:exon21:c.T1770C:p.I590I,REV1:NM_001321459:exon21:c.T1671C:p.I557I,REV1:NM_001321460:exon21:c.T1671C:p.I557I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5797	0.6132	0.588658	1(breast)	.	.	.	.	.	.	.	.	REV1:uc002tac.3:exon20:c.T3237C:p.I1079I,REV1:uc002tad.3:exon20:c.T3240C:p.I1080I	.	AFR:MU13237564,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.7456,FIN:0.6885,NFE:0.5066,OTH:0.3393,ASJ:0.6129	606134	.	.	.	.	.	.	.	.	.	.	.	2	1(stomach)	0.6567
2	100022772	100022772	T	C	REV1	intronic	.	ENSG00000135945	rs717454	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4276	0.4140	0.396366	MU13237569	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4061,EAS:0.6196,FIN:0.4437,NFE:0.3045,OTH:0.4470,ASJ:0.4033	606134	.	.	.	.	.	.	.	.	.	.	.	2	1(lung)	0.3961
2	100027151	100027151	G	C	REV1	intronic	.	ENSG00000135945	rs3087385	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0198	0.0168	0.00898562	0.0136	.	.	.	.	.	0.0002	0.042	.	.	.	AFR:0.0030,AMR:0.0107,EAS:0,FIN:0.0200,NFE:0.0191,OTH:0.0214,ASJ:0.0265	606134	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	100055506	100055506	A	G	REV1	exonic	nonsynonymous SNV	ENSG00000135945	rs3087386	ENSG00000135945:ENST00000258428:exon6:c.T770C:p.F257S,ENSG00000135945:ENST00000393445:exon6:c.T770C:p.F257S	REV1:NM_001037872:exon6:c.T770C:p.F257S,REV1:NM_001321454:exon6:c.T770C:p.F257S,REV1:NM_016316:exon6:c.T770C:p.F257S,REV1:NM_001321455:exon7:c.T560C:p.F187S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5755	0.6015	0.580272	1(stomach)	-1.561	0.002	0.465	-0.027	0.333	.	.	.	REV1:uc002tae.1:exon4:c.T707C:p.F236S,REV1:uc002tac.3:exon6:c.T770C:p.F257S,REV1:uc002tad.3:exon6:c.T770C:p.F257S	-0.979	AFR:1(breast),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:MU754754,FIN:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,NFE:0.6019,OTH:0.7121,ASJ:1(oesophagus)	606134	.	.	.	.	.	.	.	0.0	1.8	0.000	-2.045	2	1(thyroid)	0.6874
2	100058870	100058870	C	T	REV1	exonic	nonsynonymous SNV	ENSG00000135945	rs3087403	ENSG00000135945:ENST00000258428:exon5:c.G412A:p.V138M,ENSG00000135945:ENST00000393445:exon5:c.G412A:p.V138M	REV1:NM_001037872:exon5:c.G412A:p.V138M,REV1:NM_001321454:exon5:c.G412A:p.V138M,REV1:NM_016316:exon5:c.G412A:p.V138M,REV1:NM_001321455:exon6:c.G202A:p.V68M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2675	0.2800	0.225839	MU152412	1.780	14.87	0.113	1.76	0.567	.	.	.	REV1:uc002tae.1:exon3:c.G349A:p.V117M,REV1:uc002tac.3:exon5:c.G412A:p.V138M,REV1:uc002tad.3:exon5:c.G412A:p.V138M	-0.996	AFR:COCA-CN|1|321|0.00311526,AMR:0.2590,EAS:0.3708,FIN:0.3543,NFE:0.0573,OTH:0.2510,ASJ:0.2794	606134	.	.	.	.	.	.	.	0.038	1.59	0.000	1.52	2	1(bone)	0.2632
2	100218080	100218080	G	A	AFF3	exonic	synonymous SNV	ENSG00000144218	rs4851214	ENSG00000144218:ENST00000409236:exon12:c.C1188T:p.A396A,ENSG00000144218:ENST00000317233:exon13:c.C1188T:p.A396A,ENSG00000144218:ENST00000356421:exon13:c.C1263T:p.A421A,ENSG00000144218:ENST00000409579:exon14:c.C1263T:p.A421A	AFF3:NM_001025108:exon13:c.C1263T:p.A421A,AFF3:NM_002285:exon13:c.C1188T:p.A396A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3073	0.1981	0.239816	1(urinary_tract)	.	.	.	.	.	.	.	.	AFF3:uc010fiq.1:exon12:c.C1188T:p.A396A,AFF3:uc002taf.3:exon13:c.C1263T:p.A421A,AFF3:uc002tag.3:exon13:c.C1188T:p.A396A,AFF3:uc002tah.1:exon14:c.C1263T:p.A421A,AFF3:uc010yvr.1:exon14:c.C1647T:p.A549A	.	AFR:4(lung),AMR:MU71617,EAS:0.2102,FIN:0.0550,NFE:0.2440,OTH:0.2252,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|3|321|0.00934579	601464	.	.	.	.	.	.	.	.	.	.	.	2	2(large_intestine)	0.3587
2	100288931	100288931	G	A	AFF3	intronic	.	ENSG00000144218	rs4851222	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	0.5469	0.599241	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.5578,AMR:0.6906,EAS:0.4106,FIN:0.6371,NFE:0.5146,OTH:0.4844,ASJ:0.6038	601464	.	.	.	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.5298
2	100343557	100343557	C	T	AFF3	exonic	nonsynonymous SNV	ENSG00000144218	rs4851223	ENSG00000144218:ENST00000409236:exon9:c.G1073A:p.S358N,ENSG00000144218:ENST00000317233:exon10:c.G1073A:p.S358N,ENSG00000144218:ENST00000356421:exon10:c.G1148A:p.S383N,ENSG00000144218:ENST00000409579:exon11:c.G1148A:p.S383N	AFF3:NM_001025108:exon10:c.G1148A:p.S383N,AFF3:NM_002285:exon10:c.G1073A:p.S358N	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	AFF3:uc010fiq.1:exon9:c.G1073A:p.S358N,AFF3:uc002taf.3:exon10:c.G1148A:p.S383N,AFF3:uc002tag.3:exon10:c.G1073A:p.S358N,AFF3:uc002tah.1:exon11:c.G1148A:p.S383N,AFF3:uc010fir.1:exon11:c.G1304A:p.S435N,AFF3:uc010yvr.1:exon11:c.G1535A:p.S512N	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601464	.	.	.	.	.	.	.	.	.	.	.	2	MU81737770	hom
2	109345582	109345582	T	A	RANBP2	intronic	.	ENSG00000153201	rs201485597	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0043	.	0.00219649	0.0037	.	.	.	.	.	0.8400	0.512	.	.	.	AFR:0.0018,AMR:0.0084,EAS:0,FIN:0.0003,NFE:0.0057,OTH:0.0051,ASJ:0	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	.	het
2	109347947	109347947	T	G	RANBP2	intronic	.	ENSG00000153201	rs826526	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2698	0.3914	0.382987	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	.	.	AFR:0.3568,AMR:0.7089,EAS:0.2947,FIN:0.0532,NFE:0.1984,OTH:0.2391,ASJ:0.1683	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	1(lung)	0.2730
2	109352542	109352542	G	A	RANBP2	intronic	.	ENSG00000153201	rs826577	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2665	0.3215	0.382987	MU82298852	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.3564,EAS:0.1651,FIN:0.2947,NFE:0.0530,OTH:0.1982,ASJ:0.7087	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	3(soft_tissue)	0.2391
2	109367977	109367977	A	G	RANBP2	intronic	.	ENSG00000153201	rs144029181	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1587	.	0.146366	LUSC-KR|2|170|0.0117647,GACA-CN|1|123|0.00813008	.	.	.	.	.	0.0001	0.024	.	.	.	AFR:0.1600,AMR:0.1523,EAS:0.2114,FIN:0.0272,NFE:0.1744,OTH:0.1763,ASJ:0.1029	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	1(skin)	0.1825
2	109374952	109374952	A	G	RANBP2	exonic	synonymous SNV	ENSG00000153201	rs826549	ENSG00000153201:ENST00000283195:exon18:c.A2550G:p.S850S	RANBP2:NM_006267:exon18:c.A2550G:p.S850S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2604	0.3083	.	MU585172	.	.	.	.	.	.	.	.	RANBP2:uc002tem.4:exon18:c.A2550G:p.S850S	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,AMR:0.3427,EAS:0.1541,FIN:0.2857,NFE:0.0354,OTH:0.1939,ASJ:0.6873	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	1(lung)	0.2293
2	109381438	109381438	A	G	RANBP2	exonic	synonymous SNV	ENSG00000153201	rs61748149	ENSG00000153201:ENST00000283195:exon20:c.A4443G:p.G1481G	RANBP2:NM_006267:exon20:c.A4443G:p.G1481G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0610	0.0551	0.0688898	0.0468	.	.	.	.	.	.	.	.	RANBP2:uc002tem.4:exon20:c.A4443G:p.G1481G	.	AFR:0.0501,AMR:0.0346,EAS:0.0080,FIN:0.0206,NFE:0.0549,OTH:0.0550,ASJ:0.0695	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	.	het
2	109389463	109389463	G	A	RANBP2	exonic	synonymous SNV	ENSG00000153201	rs826580	ENSG00000153201:ENST00000283195:exon23:c.G8253A:p.E2751E	RANBP2:NM_006267:exon23:c.G8253A:p.E2751E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9959	0.9842	0.98722	0.9884	.	.	.	.	.	.	.	.	RANBP2:uc002tem.4:exon23:c.G8253A:p.E2751E	.	AFR:0.9595,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	601181	608033;	88619;	88619|ADANE<br>Recurrent acute necrotizing encephalopathy|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|608033 ~	.	.	.	.	.	.	.	.	2	MU81738486	hom
2	112686988	112686988	G	A	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs13027171	ENSG00000153208:ENST00000295408:exon2:c.G353A:p.S118N,ENSG00000153208:ENST00000421804:exon2:c.G353A:p.S118N	MERTK:NM_006343:exon2:c.G353A:p.S118N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2313	0.2219	0.168131	MU13261932	-1.221	0.006	0.714	-3.98	0.569	.	.	Immunoglobulin|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	MERTK:uc002thk.1:exon2:c.G353A:p.S118N	-1.025	AFR:COCA-CN|1|321|0.00311526,AMR:0.1977,EAS:0.1791,FIN:0.3212,NFE:0.1420,OTH:0.2009,ASJ:0.0645	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.001	-0.34	0.000	0.495	2	1(urinary_tract)	0.2780
2	112702647	112702647	C	T	MERTK	intronic	.	ENSG00000153208	rs11683694	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2395	0.2487	0.190695	0.2196	.	.	.	.	.	.	.	.	.	.	AFR:0.1381,AMR:0.1885,EAS:0.1418,FIN:0.2022,NFE:0.2795,OTH:0.2133,ASJ:0.3278	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	MU755137	het
2	112705157	112705157	T	C	MERTK	intronic	.	ENSG00000153208	rs3761701	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5845	0.5847	0.514776	1(bone)	.	.	.	.	.	.	.	.	.	.	AFR:MU13261954,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,GACA-CN|1|123|0.00813008,COCA-CN|2|321|0.00623053,EAS:0.5057,FIN:0.6244,NFE:0.6887,OTH:0.2478,ASJ:0.5774	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	1(stomach)	0.6613
2	112751928	112751928	G	A	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs7604639	ENSG00000153208:ENST00000409780:exon8:c.G869A:p.R290K,ENSG00000153208:ENST00000295408:exon9:c.G1397A:p.R466K,ENSG00000153208:ENST00000421804:exon9:c.G1397A:p.R466K	MERTK:NM_006343:exon9:c.G1397A:p.R466K	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5972	0.6340	0.561502	73(lung)	-1.256	0.005	1.0	-3.17	0.328	.	.	Fibronectin type III|Immunoglobulin-like fold	MERTK:uc002thk.1:exon9:c.G1397A:p.R466K,MERTK:uc002thl.1:exon9:c.G869A:p.R290K	-0.967	AFR:MU755143,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.6596,FIN:0.6340,NFE:0.6887,OTH:0.2466,ASJ:0.6217	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.0	0.65	0.000	-1.685	2	5(haematopoietic_and_lymphoid_tissue)	0.6623
2	112754880	112754880	G	A	MERTK	intronic	.	ENSG00000153208	rs3811633	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2384	0.2495	0.190096	MU755152	.	.	.	.	.	.	.	.	.	.	AFR:COCA-CN|2|321|0.00623053,AMR:0.2197,EAS:0.1874,FIN:0.3278,NFE:0.1409,OTH:0.2021,ASJ:0.1392	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2791
2	112754943	112754943	C	T	MERTK	exonic	synonymous SNV	ENSG00000153208	rs3811634	ENSG00000153208:ENST00000409780:exon9:c.C966T:p.N322N,ENSG00000153208:ENST00000295408:exon10:c.C1494T:p.N498N,ENSG00000153208:ENST00000421804:exon10:c.C1494T:p.N498N	MERTK:NM_006343:exon10:c.C1494T:p.N498N	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2385	0.2497	0.190495	0.2198	1.865	15.37	.	1.35	0.913	.	.	.	MERTK:uc002thk.1:exon10:c.C1494T:p.N498N,MERTK:uc002thl.1:exon10:c.C966T:p.N322N	-1.042	AFR:0.1394,AMR:0.1878,EAS:0.1413,FIN:0.2022,NFE:0.2791,OTH:0.2153,ASJ:0.3278	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	0.000	.	2	MU755155	het
2	112755001	112755001	A	G	MERTK	exonic	nonsynonymous SNV	ENSG00000153208	rs2230515	ENSG00000153208:ENST00000409780:exon9:c.A1024G:p.I342V,ENSG00000153208:ENST00000295408:exon10:c.A1552G:p.I518V,ENSG00000153208:ENST00000421804:exon10:c.A1552G:p.I518V	MERTK:NM_006343:exon10:c.A1552G:p.I518V	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5973	0.6339	0.561502	73(lung)	-1.806	0.002	0.795	-2.03	0.431	.	.	.	MERTK:uc002thk.1:exon10:c.A1552G:p.I518V,MERTK:uc002thl.1:exon10:c.A1024G:p.I342V	-0.960	AFR:1(large_intestine),AMR:MU755158,EAS:0.6218,FIN:0.6603,NFE:0.6340,OTH:0.6887,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	0.001	-0.81	0.000	-0.085	2	4(haematopoietic_and_lymphoid_tissue)	0.2469
2	112765973	112765973	A	G	MERTK	exonic	synonymous SNV	ENSG00000153208	rs1131244	ENSG00000153208:ENST00000409780:exon13:c.A1353G:p.S451S,ENSG00000153208:ENST00000295408:exon14:c.A1881G:p.S627S,ENSG00000153208:ENST00000421804:exon14:c.A1881G:p.S627S	MERTK:NM_006343:exon14:c.A1881G:p.S627S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5825	0.5878	0.515176	LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	MERTK:uc002thk.1:exon14:c.A1881G:p.S627S,MERTK:uc002thl.1:exon14:c.A1353G:p.S451S	.	AFR:0.5805,AMR:0.5181,EAS:0.6887,FIN:0.2469,NFE:0.6615,OTH:0.6273,ASJ:0.6223	604705	613862;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	2	2(lung)	0.6090
2	121713022	121713022	C	G	GLI2	intronic	.	ENSG00000074047	rs6718382	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9999	.	1	1.0000	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	MU81739801	unknown
2	121726447	121726447	G	A	GLI2	exonic	synonymous SNV	ENSG00000074047	rs2592595	ENSG00000074047:ENST00000360874:exon3:c.G388A:p.G130S	GLI2:NM_001371271:exon6:c.G801A:p.S267S,GLI2:NM_005270:exon6:c.G801A:p.S267S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9401	0.8092	0.827276	0.8415	0.628	8.346	0.994	-9.82	0.535	.	.	.	GLI2:uc002tmv.1:exon3:c.G412A:p.G138S	-0.987	AFR:0.4716,AMR:0.9582,EAS:0.9988,FIN:0.9954,NFE:0.9864,OTH:0.9633,ASJ:0.9570	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.006	.	0.000	.	2	MU81739854	hom
2	121746956	121746956	G	T	GLI2	exonic	nonsynonymous SNV	ENSG00000074047	rs3738880	ENSG00000074047:ENST00000361492:exon13:c.G3466T:p.A1156S,ENSG00000074047:ENST00000452319:exon14:c.G3466T:p.A1156S	GLI2:NM_001371271:exon14:c.G3466T:p.A1156S,GLI2:NM_005270:exon14:c.G3466T:p.A1156S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6296	0.6234	0.508986	0.6086	-0.059	2.058	0.515	0.039	0.049	.	.	.	GLI2:uc002tmt.4:exon10:c.G2482T:p.A828S,GLI2:uc002tmu.4:exon10:c.G2431T:p.A811S,GLI2:uc010flp.3:exon13:c.G3466T:p.A1156S	-1.041	AFR:0.4041,AMR:0.5730,EAS:0.4901,FIN:0.6738,NFE:0.7230,OTH:0.6582,ASJ:0.6589	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.156	2.53	0.000	1.65	2	MU22958533	het
2	121747406	121747406	G	A	GLI2	exonic	nonsynonymous SNV	ENSG00000074047	rs12711538	ENSG00000074047:ENST00000361492:exon13:c.G3916A:p.D1306N,ENSG00000074047:ENST00000452319:exon14:c.G3916A:p.D1306N	GLI2:NM_001371271:exon14:c.G3916A:p.D1306N,GLI2:NM_005270:exon14:c.G3916A:p.D1306N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6464	0.6769	0.567093	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	-0.401	0.385	1.0	2.13	0.005	.	.	.	GLI2:uc002tmt.4:exon10:c.G2932A:p.D978N,GLI2:uc002tmu.4:exon10:c.G2881A:p.D961N,GLI2:uc010flp.3:exon13:c.G3916A:p.D1306N	-1.028	AFR:0.6592,AMR:0.5805,EAS:0.6623,FIN:0.4870,NFE:0.6745,OTH:0.7234,ASJ:0.5883	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.0	2.6	0.000	-1.545	2	1(large_intestine)	0.6701
2	121747429	121747429	A	G	GLI2	exonic	synonymous SNV	ENSG00000074047	rs10167980	ENSG00000074047:ENST00000361492:exon13:c.A3939G:p.P1313P,ENSG00000074047:ENST00000452319:exon14:c.A3939G:p.P1313P	GLI2:NM_001371271:exon14:c.A3939G:p.P1313P,GLI2:NM_005270:exon14:c.A3939G:p.P1313P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6344	0.6241	0.51238	0.6130	.	.	.	.	.	.	.	.	GLI2:uc002tmt.4:exon10:c.A2955G:p.P985P,GLI2:uc002tmu.4:exon10:c.A2904G:p.P968P,GLI2:uc010flp.3:exon13:c.A3939G:p.P1313P	.	AFR:0.4068,AMR:0.5728,EAS:0.4981,FIN:0.6808,NFE:0.7277,OTH:0.6615,ASJ:0.6623	165230	610829;615849;	420584;2162;	420584|-|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|615849 ~2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	~ko04340 Hedgehog signaling pathway~ko04390 Hippo signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	2	MU634692	unknown
2	127819777	127819777	C	T	BIN1	intronic	.	ENSG00000136717	rs61748157	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1580	0.1055	0.0972444	0.1035	.	.	.	.	.	0	0.004	.	.	.	AFR:0.0617,AMR:0.0823,EAS:0.0210,FIN:0.1219,NFE:0.1306,OTH:0.1306,ASJ:0.1656	601248	255200;	169186;	169186|AR-CNM|Unknown|Autosomal recessive|Childhood|255200 615959 ~	.	.	.	.	.	.	.	.	2	.	het
2	127821499	127821499	T	C	BIN1	intronic	.	ENSG00000136717	rs72481904	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3704	0.2872	0.345248	MU755367	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.3079,EAS:0.4081,FIN:0.4067,NFE:0.4042,OTH:0.3790,ASJ:0.1669	601248	255200;	169186;	169186|AR-CNM|Unknown|Autosomal recessive|Childhood|255200 615959 ~	.	.	.	.	.	.	.	.	2	1(lung)	0.3546
2	141274576	141274576	T	C	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs4954672	ENSG00000168702:ENST00000389484:exon50:c.A8031G:p.Q2677Q	LRP1B:NM_018557:exon50:c.A8031G:p.Q2677Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7150	0.7467	0.642372	0.7137	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon50:c.A8031G:p.Q2677Q	.	AFR:0.6961,AMR:0.7542,EAS:0.3999,FIN:0.6857,NFE:0.7578,OTH:0.7296,ASJ:0.8543	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU800510	hom
2	141474402	141474402	-	A	LRP1B	intronic	.	ENSG00000168702	rs398104769	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5608	0.5631	0.46246	0.5477	.	.	.	.	.	.	.	.	.	.	AFR:0.3869,AMR:0.4498,EAS:0.3916,FIN:0.5835,NFE:0.6495,OTH:0.5813,ASJ:0.7318	608766	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	141528592	141528592	T	C	LRP1B	intronic	.	ENSG00000168702	rs7599219	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8727	0.8384	.	0.8586	.	.	.	.	.	.	.	.	.	.	AFR:0.7653,AMR:0.9111,EAS:1,FIN:0.8989,NFE:0.8841,OTH:0.8755,ASJ:0.8676	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU81741507	hom
2	141533662	141533662	T	C	LRP1B	intronic	.	ENSG00000168702	rs996361	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8732	0.8384	0.855232	0.8591	.	.	.	.	.	0.0002	0.01	.	.	.	AFR:0.7660,AMR:0.9117,EAS:1,FIN:0.8985,NFE:0.8846,OTH:0.8758,ASJ:0.8676	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU81741515	hom
2	141571329	141571329	T	C	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs3749010	ENSG00000168702:ENST00000389484:exon32:c.A5256G:p.S1752S	LRP1B:NM_018557:exon32:c.A5256G:p.S1752S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8708	0.8370	0.845248	0.8491	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon32:c.A5256G:p.S1752S	.	AFR:0.7260,AMR:0.8098,EAS:0.9932,FIN:0.8967,NFE:0.8937,OTH:0.8809,ASJ:0.8642	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU4547566	hom
2	141598473	141598473	-	T	LRP1B	intronic	.	ENSG00000168702	rs35745624	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9923	8e-05	0.977636	0.9811	.	.	.	.	.	.	.	.	.	.	AFR:0.9375,AMR:0.9880,EAS:1,FIN:1,NFE:0.9987,OTH:0.9888,ASJ:1	608766	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	141625835	141625835	A	-	LRP1B	intronic	.	ENSG00000168702	rs34488899	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3108	.	0.416933	0.1958	.	.	.	.	.	.	.	.	.	.	AFR:0.1823,AMR:0.2286,EAS:0.0578,FIN:0.3613,NFE:0.2143,OTH:0.2126,ASJ:0.1290	608766	.	.	.	.	.	.	.	.	.	.	.	2	.	hom
2	141709419	141709419	T	G	LRP1B	intronic	.	ENSG00000168702	rs1429348	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6465	0.5681	0.536542	0.5993	.	.	.	.	.	.	.	.	.	.	AFR:0.3409,AMR:0.6400,EAS:0.6889,FIN:0.7539,NFE:0.6946,OTH:0.6929,ASJ:0.6358	608766	.	.	.	.	.	.	.	.	.	.	.	2	MU755724	het
2	141816621	141816621	A	G	LRP1B	exonic	synonymous SNV	ENSG00000168702	rs1525579	ENSG00000168702:ENST00000389484:exon9:c.T1239C:p.V413V	LRP1B:NM_018557:exon9:c.T1239C:p.V413V	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9843	0.9405	0.945288	0.9499	.	.	.	.	.	.	.	.	LRP1B:uc002tvj.1:exon9:c.T1239C:p.V413V	.	AFR:0.8252,AMR:0.9916,EAS:1,FIN:1,NFE:0.9996,OTH:0.9918,ASJ:1	608766	.	.	.	.	,7092	.	.	.	.	.	.	2	MU81741570	hom
2	142567910	142567910	T	C	LRP1B	exonic	nonsynonymous SNV	ENSG00000168702	rs12990449	ENSG00000168702:ENST00000389484:exon2:c.A143G:p.Q48R,ENSG00000168702:ENST00000434794:exon2:c.A143G:p.Q48R	LRP1B:NM_018557:exon2:c.A143G:p.Q48R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.2338	0.1752	0.217452	0.1856	1.379	12.68	0.329	4.45	1.000	.	.	EGF-like domain;Low-density lipoprotein (LDL) receptor class A, conserved site	LRP1B:uc002tvj.1:exon2:c.A143G:p.Q48R,LRP1B:uc010fnl.1:exon2:c.A254G:p.Q85R	-1.072	AFR:0.0954,AMR:0.1986,EAS:0.4038,FIN:0.1832,NFE:0.2105,OTH:0.2010,ASJ:0.3477	608766	.	.	.	.	,7092	.	.	0.001	-3.68	0.000	-0.31	2	MU760781	hom
2	152432311	152432311	T	C	NEB	exonic	synonymous SNV	ENSG00000183091	rs33988153	ENSG00000183091:ENST00000413693:exon7:c.A1101G:p.P367P,ENSG00000183091:ENST00000172853:exon79:c.A11808G:p.P3936P,ENSG00000183091:ENST00000409198:exon80:c.A11808G:p.P3936P,ENSG00000183091:ENST00000603639:exon105:c.A16911G:p.P5637P,ENSG00000183091:ENST00000604864:exon105:c.A16911G:p.P5637P,ENSG00000183091:ENST00000397345:exon107:c.A16911G:p.P5637P,ENSG00000183091:ENST00000427231:exon107:c.A16911G:p.P5637P	NEB:NM_004543:exon80:c.A11808G:p.P3936P,NEB:NM_001164507:exon107:c.A16911G:p.P5637P,NEB:NM_001164508:exon107:c.A16911G:p.P5637P,NEB:NM_001271208:exon107:c.A16911G:p.P5637P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1984	0.1894	0.110224	.	.	.	.	.	.	.	.	.	NEB:uc002txr.3:exon7:c.A1206G:p.P402P,NEB:uc021vrb.1:exon78:c.A11808G:p.P3936P,NEB:uc010fnx.3:exon79:c.A11772G:p.P3924P,NEB:uc021vrd.1:exon80:c.A11808G:p.P3936P,NEB:uc002txu.3:exon107:c.A16911G:p.P5637P,NEB:uc021vrc.1:exon107:c.A16911G:p.P5637P,NEB:uc031rpp.1:exon107:c.A16911G:p.P5637P	.	AFR:0.1751,AMR:0.0473,EAS:0.2748,FIN:0.0012,NFE:0.2520,OTH:0.2476,ASJ:0.1283	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2290
2	152490458	152490458	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6710212	ENSG00000183091:ENST00000603639:exon63:c.T9124C:p.C3042R,ENSG00000183091:ENST00000604864:exon63:c.T9124C:p.C3042R,ENSG00000183091:ENST00000397345:exon65:c.T9124C:p.C3042R,ENSG00000183091:ENST00000427231:exon65:c.T9124C:p.C3042R	NEB:NM_001164507:exon65:c.T9124C:p.C3042R,NEB:NM_001164508:exon65:c.T9124C:p.C3042R,NEB:NM_001271208:exon65:c.T9124C:p.C3042R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9928	0.9757	0.972045	0.9771	0.806	9.498	0.971	6.02	0.994	.	.	.	NEB:uc002txu.3:exon65:c.T9124C:p.C3042R,NEB:uc021vrc.1:exon65:c.T9124C:p.C3042R,NEB:uc031rpp.1:exon65:c.T9124C:p.C3042R	-0.915	AFR:0.9192,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	3.85	0.000	.	2	MU81742117	hom
2	152496526	152496526	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6713162	ENSG00000183091:ENST00000603639:exon60:c.T8734C:p.S2912P,ENSG00000183091:ENST00000604864:exon60:c.T8734C:p.S2912P,ENSG00000183091:ENST00000172853:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000397345:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000409198:exon62:c.T8734C:p.S2912P,ENSG00000183091:ENST00000427231:exon62:c.T8734C:p.S2912P	NEB:NM_001164507:exon62:c.T8734C:p.S2912P,NEB:NM_001164508:exon62:c.T8734C:p.S2912P,NEB:NM_001271208:exon62:c.T8734C:p.S2912P,NEB:NM_004543:exon62:c.T8734C:p.S2912P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2540	0.3010	0.445288	MU119575	2.013	16.29	1.0	5.46	0.985	.	.	.	NEB:uc021vrb.1:exon60:c.T8734C:p.S2912P,NEB:uc002txu.3:exon62:c.T8734C:p.S2912P,NEB:uc010fnx.3:exon62:c.T8734C:p.S2912P,NEB:uc021vrc.1:exon62:c.T8734C:p.S2912P,NEB:uc021vrd.1:exon62:c.T8734C:p.S2912P,NEB:uc031rpp.1:exon62:c.T8734C:p.S2912P	-0.974	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3143,EAS:0.1376,FIN:0.2417,NFE:0.5910,OTH:0.1398,ASJ:0.6350	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	3.73	0.000	-2.8	2	1(large_intestine)	0.1572
2	152500449	152500449	C	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs13013209	ENSG00000183091:ENST00000603639:exon55:c.G7839C:p.K2613N,ENSG00000183091:ENST00000604864:exon55:c.G7839C:p.K2613N,ENSG00000183091:ENST00000172853:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000397345:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000409198:exon57:c.G7839C:p.K2613N,ENSG00000183091:ENST00000427231:exon57:c.G7839C:p.K2613N	NEB:NM_001164507:exon57:c.G7839C:p.K2613N,NEB:NM_001164508:exon57:c.G7839C:p.K2613N,NEB:NM_001271208:exon57:c.G7839C:p.K2613N,NEB:NM_004543:exon57:c.G7839C:p.K2613N	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.4150	0.3498	0.293331	1(urinary_tract)	6.495	31	0.026	5.77	1.000	.	.	.	NEB:uc021vrb.1:exon55:c.G7839C:p.K2613N,NEB:uc002txu.3:exon57:c.G7839C:p.K2613N,NEB:uc010fnx.3:exon57:c.G7839C:p.K2613N,NEB:uc021vrc.1:exon57:c.G7839C:p.K2613N,NEB:uc021vrd.1:exon57:c.G7839C:p.K2613N,NEB:uc031rpp.1:exon57:c.G7839C:p.K2613N	-0.977	AFR:MU4546905,AMR:COCA-CN|3|321|0.00934579,EAS:0.0874,FIN:0.4448,NFE:0.4007,OTH:0.2562,ASJ:0.3553	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.999	1.13	0.000	3.455	2	1(bone)	0.4464
2	152511778	152511778	A	C	NEB	intronic	.	ENSG00000183091	rs10930723	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3411	0.2905	0.430911	0.3008	.	.	.	.	.	0.0001	0.064	.	.	.	AFR:0.5887,AMR:0.1316,EAS:0.5946,FIN:0.1401,NFE:0.1569,OTH:0.1980,ASJ:0.2483	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU17371938	het
2	152515683	152515683	G	A	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs75807392	ENSG00000183091:ENST00000603639:exon45:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000604864:exon45:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000172853:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000397345:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000409198:exon47:c.C5971T:p.H1991Y,ENSG00000183091:ENST00000427231:exon47:c.C5971T:p.H1991Y	NEB:NM_001164507:exon47:c.C5971T:p.H1991Y,NEB:NM_001164508:exon47:c.C5971T:p.H1991Y,NEB:NM_001271208:exon47:c.C5971T:p.H1991Y,NEB:NM_004543:exon47:c.C5971T:p.H1991Y	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0774	0.0422	0.0920527	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	-0.057	2.073	1.0	4.38	0.474	0.0002	0.046	.	NEB:uc021vrb.1:exon45:c.C5971T:p.H1991Y,NEB:uc002txu.3:exon47:c.C5971T:p.H1991Y,NEB:uc010fnx.3:exon47:c.C5971T:p.H1991Y,NEB:uc021vrc.1:exon47:c.C5971T:p.H1991Y,NEB:uc021vrd.1:exon47:c.C5971T:p.H1991Y,NEB:uc031rpp.1:exon47:c.C5971T:p.H1991Y	-1.006	AFR:0.0621,AMR:0.0224,EAS:0.0298,FIN:0.2491,NFE:0.0930,OTH:0.0587,ASJ:0.0489	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.677	0.92	0.000	1.59	2	1(lung)	0.0723
2	152521096	152521096	C	T	NEB	exonic	synonymous SNV	ENSG00000183091	rs10170273	ENSG00000183091:ENST00000603639:exon42:c.G5370A:p.E1790E,ENSG00000183091:ENST00000604864:exon42:c.G5370A:p.E1790E,ENSG00000183091:ENST00000172853:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000397345:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000409198:exon44:c.G5370A:p.E1790E,ENSG00000183091:ENST00000427231:exon44:c.G5370A:p.E1790E	NEB:NM_001164507:exon44:c.G5370A:p.E1790E,NEB:NM_001164508:exon44:c.G5370A:p.E1790E,NEB:NM_001271208:exon44:c.G5370A:p.E1790E,NEB:NM_004543:exon44:c.G5370A:p.E1790E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3018	0.2951	0.434904	MU119622	.	.	.	.	.	.	.	.	NEB:uc021vrb.1:exon42:c.G5370A:p.E1790E,NEB:uc002txu.3:exon44:c.G5370A:p.E1790E,NEB:uc010fnx.3:exon44:c.G5370A:p.E1790E,NEB:uc021vrc.1:exon44:c.G5370A:p.E1790E,NEB:uc021vrd.1:exon44:c.G5370A:p.E1790E,NEB:uc031rpp.1:exon44:c.G5370A:p.E1790E	.	AFR:MELA-AU|1|183|0.00546448,COCA-CN|5|321|0.0155763,AMR:0.3056,EAS:0.1325,FIN:0.2533,NFE:0.5882,OTH:0.1394,ASJ:0.6058	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(skin)	0.1569
2	152527572	152527572	C	T	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs7426114	ENSG00000183091:ENST00000603639:exon36:c.G4471A:p.V1491M,ENSG00000183091:ENST00000604864:exon36:c.G4471A:p.V1491M,ENSG00000183091:ENST00000172853:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000397345:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000409198:exon38:c.G4471A:p.V1491M,ENSG00000183091:ENST00000427231:exon38:c.G4471A:p.V1491M	NEB:NM_001164507:exon38:c.G4471A:p.V1491M,NEB:NM_001164508:exon38:c.G4471A:p.V1491M,NEB:NM_001271208:exon38:c.G4471A:p.V1491M,NEB:NM_004543:exon38:c.G4471A:p.V1491M	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.7386	0.6615	0.533147	MU761016	5.308	25.8	0.03	5.42	0.996	.	.	.	NEB:uc021vrb.1:exon36:c.G4471A:p.V1491M,NEB:uc002txu.3:exon38:c.G4471A:p.V1491M,NEB:uc010fnx.3:exon38:c.G4471A:p.V1491M,NEB:uc021vrc.1:exon38:c.G4471A:p.V1491M,NEB:uc021vrd.1:exon38:c.G4471A:p.V1491M,NEB:uc031rpp.1:exon38:c.G4471A:p.V1491M	-1.161	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.6642,EAS:0.8609,FIN:0.7450,NFE:0.4091,OTH:0.8606,ASJ:0.2882	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.82	3.22	0.000	2.325	2	1(large_intestine)	0.8429
2	152527608	152527608	C	T	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs34577613	ENSG00000183091:ENST00000603639:exon36:c.G4435A:p.V1479I,ENSG00000183091:ENST00000604864:exon36:c.G4435A:p.V1479I,ENSG00000183091:ENST00000172853:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000397345:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000409198:exon38:c.G4435A:p.V1479I,ENSG00000183091:ENST00000427231:exon38:c.G4435A:p.V1479I	NEB:NM_001164507:exon38:c.G4435A:p.V1479I,NEB:NM_001164508:exon38:c.G4435A:p.V1479I,NEB:NM_001271208:exon38:c.G4435A:p.V1479I,NEB:NM_004543:exon38:c.G4435A:p.V1479I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1899	0.1914	0.335264	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	1.430	12.95	0.597	4.25	0.998	.	.	.	NEB:uc021vrb.1:exon36:c.G4435A:p.V1479I,NEB:uc002txu.3:exon38:c.G4435A:p.V1479I,NEB:uc010fnx.3:exon38:c.G4435A:p.V1479I,NEB:uc021vrc.1:exon38:c.G4435A:p.V1479I,NEB:uc021vrd.1:exon38:c.G4435A:p.V1479I,NEB:uc031rpp.1:exon38:c.G4435A:p.V1479I	-1.009	AFR:0.2132,AMR:0.3921,EAS:0.1490,FIN:0.5405,NFE:0.1216,OTH:0.1069,ASJ:0.1017	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	3.5	0.000	-1.78	2	1(large_intestine)	0.1544
2	152531077	152531077	A	G	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6711382	ENSG00000183091:ENST00000603639:exon34:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000604864:exon34:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000172853:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000397345:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000409198:exon36:c.T3901C:p.Y1301H,ENSG00000183091:ENST00000427231:exon36:c.T3901C:p.Y1301H	NEB:NM_001164507:exon36:c.T3901C:p.Y1301H,NEB:NM_001164508:exon36:c.T3901C:p.Y1301H,NEB:NM_001271208:exon36:c.T3901C:p.Y1301H,NEB:NM_004543:exon36:c.T3901C:p.Y1301H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8265	0.8178	0.716054	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	1.671	14.24	0.456	5.52	0.994	.	.	.	NEB:uc021vrb.1:exon34:c.T3901C:p.Y1301H,NEB:uc002txu.3:exon36:c.T3901C:p.Y1301H,NEB:uc010fnx.3:exon36:c.T3901C:p.Y1301H,NEB:uc021vrc.1:exon36:c.T3901C:p.Y1301H,NEB:uc021vrd.1:exon36:c.T3901C:p.Y1301H,NEB:uc031rpp.1:exon36:c.T3901C:p.Y1301H	-0.984	AFR:0.8055,AMR:0.6410,EAS:0.8510,FIN:0.5892,NFE:0.8883,OTH:0.8950,ASJ:0.9055	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.0	0.91	0.000	-1.385	2	1(haematopoietic_and_lymphoid_tissue)	0.8605
2	152531781	152531781	C	A	NEB	intronic	.	ENSG00000183091	rs12618063	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2548	0.1643	0.28774	0.1840	.	.	.	.	.	.	.	.	.	.	AFR:0.3115,AMR:0.0897,EAS:0.4639,FIN:0.1117,NFE:0.1057,OTH:0.1393,ASJ:0.1490	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	MU761022	het
2	152536498	152536498	T	A	NEB	exonic	nonsynonymous SNV	ENSG00000183091	rs6735208	ENSG00000183091:ENST00000603639:exon29:c.A3081T:p.K1027N,ENSG00000183091:ENST00000604864:exon29:c.A3081T:p.K1027N,ENSG00000183091:ENST00000172853:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000397345:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000409198:exon31:c.A3081T:p.K1027N,ENSG00000183091:ENST00000427231:exon31:c.A3081T:p.K1027N	NEB:NM_001164507:exon31:c.A3081T:p.K1027N,NEB:NM_001164508:exon31:c.A3081T:p.K1027N,NEB:NM_001271208:exon31:c.A3081T:p.K1027N,NEB:NM_004543:exon31:c.A3081T:p.K1027N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7499	0.6986	0.583466	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	3.606	23.2	0.131	-1.62	0.997	.	.	.	NEB:uc021vrb.1:exon29:c.A3081T:p.K1027N,NEB:uc002txu.3:exon31:c.A3081T:p.K1027N,NEB:uc010fnx.3:exon31:c.A3081T:p.K1027N,NEB:uc021vrc.1:exon31:c.A3081T:p.K1027N,NEB:uc021vrd.1:exon31:c.A3081T:p.K1027N,NEB:uc031rpp.1:exon31:c.A3081T:p.K1027N	-1.010	AFR:0.6939,AMR:0.3867,EAS:0.7318,FIN:0.4932,NFE:0.8647,OTH:0.8361,ASJ:0.8711	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	0.982	3.22	0.000	1.65	2	1(breast)	0.8043
2	152573981	152573981	A	G	NEB	exonic	synonymous SNV	ENSG00000183091	rs4611637	ENSG00000183091:ENST00000603639:exon8:c.T771C:p.A257A,ENSG00000183091:ENST00000604864:exon8:c.T771C:p.A257A,ENSG00000183091:ENST00000172853:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000397345:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000409198:exon10:c.T771C:p.A257A,ENSG00000183091:ENST00000427231:exon10:c.T771C:p.A257A	NEB:NM_001164507:exon10:c.T771C:p.A257A,NEB:NM_001164508:exon10:c.T771C:p.A257A,NEB:NM_001271208:exon10:c.T771C:p.A257A,NEB:NM_004543:exon10:c.T771C:p.A257A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7438	0.6861	0.569289	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	NEB:uc021vrb.1:exon8:c.T771C:p.A257A,NEB:uc002txu.3:exon10:c.T771C:p.A257A,NEB:uc010fnx.3:exon10:c.T771C:p.A257A,NEB:uc021vrc.1:exon10:c.T771C:p.A257A,NEB:uc021vrd.1:exon10:c.T771C:p.A257A,NEB:uc031rpp.1:exon10:c.T771C:p.A257A	.	AFR:0.6784,AMR:0.3451,EAS:0.7351,FIN:0.4548,NFE:0.8545,OTH:0.8362,ASJ:0.8604	161650	256030;	171430;171433;171436;171439;	171430|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|161800 256030 615348 615731 616165 ~171433|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609284 615731 ~171436|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|161800 256030 609285 610687 615731 616165 ~171439|Mild nemaline myopathy|<1 / 1 000 000|Autosomal dominant|Childhood|161800 256030 609273 609284 609285 615731 ~	.	.	.	.	.	.	.	.	2	1(breast)	0.7965
2	169789016	169789016	T	C	ABCB11	exonic	synonymous SNV	ENSG00000073734	rs497692	ENSG00000073734:ENST00000263817:exon24:c.A3084G:p.A1028A	ABCB11:NM_003742:exon24:c.A3084G:p.A1028A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5557	0.4546	0.496805	0.4676	.	.	.	.	.	.	.	.	ABCB11:uc010zda.1:exon11:c.A1410G:p.A470A,ABCB11:uc010zdb.1:exon11:c.A1512G:p.A504A,ABCB11:uc002ueo.1:exon24:c.A3084G:p.A1028A	.	AFR:0.2680,AMR:0.5859,EAS:0.6359,FIN:0.5378,NFE:0.5353,OTH:0.5337,ASJ:0.6126	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU585262	hom
2	169801488	169801488	A	G	ABCB11	intronic	.	ENSG00000073734	rs853789	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7663	0.7523	0.855232	0.7491	.	.	.	.	.	.	.	.	.	.	AFR:0.9016,AMR:0.8433,EAS:0.9806,FIN:0.6540,NFE:0.6558,OTH:0.7090,ASJ:0.7517	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU81743974	hom
2	169814655	169814655	G	T	ABCB11	intronic	.	ENSG00000073734	rs853772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5399	0.4506	0.497604	0.4537	.	.	.	.	.	.	.	.	.	.	AFR:0.2681,AMR:0.5815,EAS:0.6344,FIN:0.5161,NFE:0.5150,OTH:0.5163,ASJ:0.5828	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU18167943	hom
2	169842809	169842809	T	C	ABCB11	intronic	.	ENSG00000073734	rs2287618	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7053	0.7396	0.774161	0.7312	.	.	.	.	.	.	.	.	.	.	AFR:0.8273,AMR:0.5203,EAS:0.7994,FIN:0.6964,NFE:0.6929,OTH:0.6701,ASJ:0.6887	603201	601847;605479;	65682;99961;172;79304;	65682|BRIC<br>Summerskill-Walshe-Tygstrup syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|243300 605479 ~99961|BRIC type 2<br>BRIC2|-|-|-|605479 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~	.	.	.	.	.	.	.	.	2	MU23484908	hom
2	173292709	173292709	A	G	ITGA6	intronic	.	ENSG00000226963	rs6744873	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3560	0.3208	0.500599	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EOPC-DE|1|202|0.0049505	.	.	.	.	.	.	.	.	.	.	AFR:0.3607,AMR:0.4865,EAS:0.2416,FIN:0.8855,NFE:0.3204,OTH:0.2360,ASJ:0.4988	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.3509
2	173292713	173292713	C	T	ITGA6	intronic	.	ENSG00000226963	rs6716540	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3463	0.3175	0.489018	0.3521	.	.	.	.	.	.	.	.	.	.	AFR:0.4824,AMR:0.4730,EAS:0.8664,FIN:0.2892,NFE:0.2327,OTH:0.3306,ASJ:0.2384	147556	226730;	79403;	79403|Carmi syndrome<br>JEB-PA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226730 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04640 Hematopoietic cell lineage~ko04810 Regulation of actin cytoskeleton~ko05145 Toxoplasmosis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	2	MU16475346	unknown
2	175436940	175436940	G	A	WIPF1	exonic	nonsynonymous SNV	ENSG00000115935	rs4972450	ENSG00000115935:ENST00000272746:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000359761:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000392547:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000409415:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000409891:exon5:c.C593T:p.P198L,ENSG00000115935:ENST00000392546:exon6:c.C593T:p.P198L	WIPF1:NM_001077269:exon5:c.C593T:p.P198L,WIPF1:NM_003387:exon5:c.C593T:p.P198L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9411	0.923	0.907947	0.9292	0.950	10.37	1.0	5.02	0.942	.	.	.	WIPF1:uc002uiz.3:exon5:c.C593T:p.P198L,WIPF1:uc002uja.3:exon5:c.C593T:p.P198L,WIPF1:uc002ujb.2:exon5:c.C593T:p.P198L,WIPF1:uc002ujc.1:exon5:c.C593T:p.P198L,WIPF1:uc010fqt.1:exon5:c.C593T:p.P198L,WIPF1:uc010zep.1:exon5:c.C593T:p.P198L	-0.966	AFR:0.8450,AMR:0.9558,EAS:0.9926,FIN:0.9774,NFE:0.9571,OTH:0.9612,ASJ:0.8940	602357	614493;	906;	906|Eczema-thrombocytopenia-immunodeficiency syndrome<br>WAS|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|277970 301000 600903 614493 ~	.	.	.	.	0.0	1.68	0.000	-2.28	2	MU26801477	hom
2	175677022	175677022	C	T	CHN1	intronic	.	ENSG00000128656	rs12613075	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4335	0.3596	0.336861	0.3693	.	.	.	.	.	.	.	.	.	.	AFR:0.1096,AMR:0.2967,EAS:0.4411,FIN:0.4768,NFE:0.4856,OTH:0.4550,ASJ:0.3907	118423	604356;	233;	233|DRS<br>DURS<br>Duane syndrome<br>Stilling-Turk-Duane syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|126800 604356 616219 617041 ~	.	.	.	.	.	.	.	.	2	MU82176465	het
2	176952792	176952792	G	A	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs73974635	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.438299	0.3480	.	.	.	.	.	.	.	.	.	.	AFR:0.6538,AMR:0.2986,EAS:0.3222,FIN:0.1477,NFE:0.2311,OTH:0.2684,ASJ:0.2384	.	.	.	.	.	.	.	.	.	.	.	.	2	MU87912363	unknown
2	176952798	176952798	G	T	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs73974637	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.438299	0.3482	.	.	.	.	.	.	.	.	.	.	AFR:0.6539,AMR:0.2990,EAS:0.3214,FIN:0.1477,NFE:0.2314,OTH:0.2695,ASJ:0.2384	.	.	.	.	.	.	.	.	.	.	.	.	2	MU87912364	unknown
2	176952926	176952926	C	T	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs66508389	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.421925	0.3506	.	.	.	.	.	.	.	.	.	.	AFR:0.6577,AMR:0.3026,EAS:0.3241,FIN:0.1474,NFE:0.2328,OTH:0.2648,ASJ:0.2384	.	.	.	.	.	.	.	.	.	.	.	.	2	MU116798863	het
2	176953061	176953061	A	T	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs6732069	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.422524	0.3513	.	.	.	.	.	.	.	.	.	.	AFR:0.6578,AMR:0.3034,EAS:0.3265,FIN:0.1476,NFE:0.2333,OTH:0.2639,ASJ:0.2384	.	.	.	.	.	.	.	.	.	.	.	.	2	MU87912365	het
2	176953287	176953287	-	C	EVX2;HOXD13	intergenic	.	ENSG00000174279;ENSG00000128714	rs397943469	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.420927	0.3503	.	.	.	.	.	.	.	.	.	.	AFR:0.6570,AMR:0.3026,EAS:0.3232,FIN:0.1481,NFE:0.2329,OTH:0.2643,ASJ:0.2367	.	.	.	.	.	.	.	.	.	.	.	.	2	.	het
2	176957822	176957822	G	A	HOXD13	exonic	synonymous SNV	ENSG00000128714	rs2518053	ENSG00000128714:ENST00000392539:exon1:c.G204A:p.A68A	HOXD13:NM_000523:exon1:c.G204A:p.A68A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3683	.	0.447883	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	HOXD13:uc002ukf.1:exon1:c.G204A:p.A68A	.	AFR:0.4274,AMR:0.7508,EAS:0.3192,FIN:0.3236,NFE:0.2284,OTH:0.3080,ASJ:0.2533	142989	113200;113300;186000;186300;610713;	93409;93406;295195;93403;93387;	93409|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610713 ~93406|Postaxial syndactyly with metacarpal synostosis<br>SD5|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|186300 ~295195|SD2, Vordingborg type<br>SD2a<br>SPD, Vordingborg type<br>SPD1<br>Synpolydactyly, Vordingborg type|-|Autosomal dominant|-|186000 ~93403|Synpolydactyly|Unknown|Autosomal dominant|Infancy<br>Neonatal|186000 608180 610234 ~93387|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|113300 613382 ~	.	.	.	.	.	.	.	.	2	8(large_intestine)	0.3191
2	187487160	187487160	G	A	ITGAV	intronic	.	ENSG00000138448	rs9333288	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7458	0.7575	0.76258	0.7530	.	.	.	.	.	0	0.004	.	.	.	AFR:0.7741,AMR:0.7291,EAS:0.8623,FIN:0.7467,NFE:0.7342,OTH:0.7295,ASJ:0.7119	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	2	MU26816650	hom
2	187532417	187532417	G	A	ITGAV	exonic	nonsynonymous SNV	ENSG00000138448	rs2230616	ENSG00000138448:ENST00000374907:exon22:c.G2239A:p.V747I,ENSG00000138448:ENST00000261023:exon24:c.G2347A:p.V783I,ENSG00000138448:ENST00000433736:exon24:c.G2209A:p.V737I	ITGAV:NM_001145000:exon22:c.G2239A:p.V747I,ITGAV:NM_001144999:exon24:c.G2209A:p.V737I,ITGAV:NM_002210:exon24:c.G2347A:p.V783I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9978	0.9909	0.992212	0.9923	2.394	18.78	0.694	3.39	1.000	.	.	Integrin alpha-2|Integrin domain	ITGAV:uc010frs.4:exon22:c.G2239A:p.V747I,ITGAV:uc002upq.4:exon24:c.G2347A:p.V783I,ITGAV:uc010zfv.3:exon24:c.G2209A:p.V737I	-0.948	AFR:0.9732,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	193210	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko04810 Regulation of actin cytoskeleton~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.002	0.62	0.000	0.39	2	MU81747102	hom
2	189863389	189863389	C	T	COL3A1	intronic	.	ENSG00000168542	rs13306272	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2641	0.2436	0.246805	0.2350	.	.	.	.	.	0	0	.	.	.	AFR:0.1949,AMR:0.2434,EAS:0.2144,FIN:0.2589,NFE:0.2504,OTH:0.2587,ASJ:0.3609	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	.	.	.	.	2	MU13400799	het
2	189864080	189864080	G	A	COL3A1	exonic	nonsynonymous SNV	ENSG00000168542	rs1800255	ENSG00000168542:ENST00000304636:exon30:c.G2092A:p.A698T,ENSG00000168542:ENST00000317840:exon30:c.G2092A:p.A698T	COL3A1:NM_000090:exon30:c.G2092A:p.A698T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3204	0.2139	0.21845	0.2118	3.334	22.9	0.231	0.873	0.906	.	.	.	COL3A1:uc002uqj.1:exon30:c.G2092A:p.A698T	-1.057	AFR:0.1219,AMR:0.2368,EAS:0.2178,FIN:0.2579,NFE:0.2463,OTH:0.2485,ASJ:0.3411	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	0.0	-3.23	0.000	0.975	2	MU121280	het
2	189875421	189875421	T	G	COL3A1	exonic	nonsynonymous SNV	ENSG00000168542	rs1516446	ENSG00000168542:ENST00000317840:exon41:c.T3150G:p.H1050Q,ENSG00000168542:ENST00000304636:exon50:c.T4059G:p.H1353Q	COL3A1:NM_000090:exon50:c.T4059G:p.H1353Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9985	0.9949	0.996605	0.9958	0.421	6.799	1.0	1.42	0.979	.	.	Fibrillar collagen, C-terminal|Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1	COL3A1:uc002uqj.1:exon50:c.T4059G:p.H1353Q	-0.950	AFR:0.9852,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:0.9967	120180	130050;	286;	286|EDS IV<br>EDS type 4<br>Ehlers-Danlos syndrome type 4<br>Ehlers-Danlos syndrome type IV<br>Sack-Barabas syndrome|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|130050 ~	.	.	.	.	0.0	0.36	0.000	-3.715	2	MU81747200	hom
2	191874667	191874667	A	G	STAT1	exonic	synonymous SNV	ENSG00000115415	rs2066802	ENSG00000115415:ENST00000409465:exon2:c.T63C:p.L21L,ENSG00000115415:ENST00000424722:exon2:c.T63C:p.L21L,ENSG00000115415:ENST00000454414:exon2:c.T63C:p.L21L,ENSG00000115415:ENST00000540176:exon2:c.T63C:p.L21L,ENSG00000115415:ENST00000361099:exon3:c.T63C:p.L21L,ENSG00000115415:ENST00000392322:exon3:c.T63C:p.L21L,ENSG00000115415:ENST00000432058:exon3:c.T63C:p.L21L,ENSG00000115415:ENST00000452281:exon3:c.T63C:p.L21L,ENSG00000115415:ENST00000392323:exon4:c.T69C:p.L23L	STAT1:NM_007315:exon3:c.T63C:p.L21L,STAT1:NM_139266:exon3:c.T63C:p.L21L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0854	0.0655	0.114617	0.0697	.	.	.	.	.	.	.	.	STAT1:uc010fse.2:exon2:c.T63C:p.L21L,STAT1:uc002usj.2:exon3:c.T63C:p.L21L,STAT1:uc002usk.2:exon3:c.T63C:p.L21L,STAT1:uc002usl.2:exon4:c.T69C:p.L23L	.	AFR:0.0719,AMR:0.0513,EAS:0.2211,FIN:0.0401,NFE:0.0595,OTH:0.0643,ASJ:0.1159	600555	613796;614162;614892;	319595;391487;391311;	319595|MSMD due to partial STAT1 deficiency<br>MSMD due to partial signal transducer and activator of transcription 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to partial signal transducer and activator of transcription 1 deficiency|<1 / 1 000 000|Autosomal dominant|Childhood|614892 ~391487|-|<1 / 1 000 000|Autosomal dominant|Infancy|614162 ~391311|STAT1 deficiency|-|Autosomal recessive|-|613796 ~	~ko04062 Chemokine signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	2	MU22987982	het
2	191922841	191922841	G	A	STAT4	intronic	.	ENSG00000138378	rs3024866	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6415	0.5701	0.496406	0.5778	.	.	.	.	.	0.0006	0.06	.	.	.	AFR:0.2175,AMR:0.5168,EAS:0.5229,FIN:0.7042,NFE:0.7574,OTH:0.6857,ASJ:0.7185	600558	612253;	.	.	~ko04217 Necroptosis~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	2	MU13402894	hom
2	198257795	198257795	T	C	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs4685	ENSG00000115524:ENST00000335508:exon24:c.A3657G:p.V1219V	SF3B1:NM_012433:exon24:c.A3657G:p.V1219V	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6717	0.7360	0.71845	0.6804	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon24:c.A3657G:p.V1219V	.	AFR:0.8292,AMR:0.5299,EAS:0.5310,FIN:0.5539,NFE:0.6499,OTH:0.6245,ASJ:0.7517	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	,9684,9683,9685	.	9677,,9681,9680,9676,9675,9678,9679	.	.	.	.	2	MU137937	het
2	198265173	198265173	T	A	SF3B1	intronic	.	ENSG00000115524	rs788017	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6669	.	0.717851	0.6813	.	.	.	.	.	.	.	.	.	.	AFR:0.8299,AMR:0.5255,EAS:0.5281,FIN:0.5566,NFE:0.6509,OTH:0.6255,ASJ:0.7433	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	.	.	.	.	.	.	.	2	MU13407940	het
2	198265526	198265526	A	G	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs788018	ENSG00000115524:ENST00000335508:exon18:c.T2631C:p.G877G	SF3B1:NM_012433:exon18:c.T2631C:p.G877G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6708	0.7351	0.716653	0.6806	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon18:c.T2631C:p.G877G	.	AFR:0.8284,AMR:0.5310,EAS:0.5255,FIN:0.5545,NFE:0.6510,OTH:0.6301,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	,9684,9683,9685	.	9677,,9681,9680,9676,9675,9678,9679	.	.	.	.	2	MU137951	het
2	198267770	198267770	-	AA	SF3B1	intronic	.	ENSG00000115524	rs3217350	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.6743	0.7355	0.717452	0.6793	.	.	.	.	.	.	.	.	.	.	AFR:0.8259,AMR:0.5323,EAS:0.5323,FIN:0.5537,NFE:0.6492,OTH:0.6268,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	.	.	.	.	.	.	.	2	.	het
2	198283305	198283305	T	C	SF3B1	exonic	synonymous SNV	ENSG00000115524	rs788023	ENSG00000115524:ENST00000335508:exon5:c.A423G:p.K141K	SF3B1:NM_012433:exon5:c.A423G:p.K141K	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6725	0.7394	0.720647	0.6838	.	.	.	.	.	.	.	.	SF3B1:uc002uue.3:exon5:c.A423G:p.K141K	.	AFR:0.8395,AMR:0.5311,EAS:0.5273,FIN:0.5554,NFE:0.6508,OTH:0.6281,ASJ:0.7450	605590	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	,9684,9683,9685	.	9677,,9681,9680,9676,9675,9678,9679	.	.	.	.	2	MU137962	het
2	202122995	202122995	A	G	CASP8	exonic	nonsynonymous SNV	ENSG00000064012	rs3769823	ENSG00000064012:ENST00000358485:exon1:c.A41G:p.K14R,ENSG00000064012:ENST00000437283:exon1:c.A41G:p.K14R	CASP8:NM_001080125:exon1:c.A41G:p.K14R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6673	0.6695	0.646366	LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916	-0.732	0.061	1.0	2.78	0.001	.	.	Death effector domain|Death-like domain	CASP8:uc002uxt.1:exon1:c.A41G:p.K14R	-0.995	AFR:0.6618,AMR:0.5774,EAS:0.6167,FIN:0.7326,NFE:0.6444,OTH:0.7127,ASJ:0.5658	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	0.008	4.26	0.000	.	2	1(thyroid)	0.6714
2	202149589	202149589	G	C	CASP8	exonic	nonsynonymous SNV	ENSG00000064012	rs1045485	ENSG00000064012:ENST00000444430:exon2:c.G190C:p.D64H,ENSG00000064012:ENST00000264274:exon6:c.G601C:p.D201H,ENSG00000064012:ENST00000323492:exon7:c.G808C:p.D270H,ENSG00000064012:ENST00000358485:exon8:c.G1030C:p.D344H,ENSG00000064012:ENST00000392263:exon8:c.G808C:p.D270H,ENSG00000064012:ENST00000264275:exon9:c.G904C:p.D302H,ENSG00000064012:ENST00000432109:exon9:c.G853C:p.D285H	CASP8:NM_033356:exon7:c.G808C:p.D270H,CASP8:NM_001080124:exon8:c.G808C:p.D270H,CASP8:NM_001080125:exon8:c.G1030C:p.D344H,CASP8:NM_001228:exon9:c.G904C:p.D302H,CASP8:NM_033355:exon9:c.G853C:p.D285H	clinvar: Benign/Likely_benign,_protective 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0907	0.1097	0.0527157	MU154954	-0.432	0.323	0.166	-3.42	0.000	.	.	Caspase-like domain|Peptidase C14,  p20 domain|Peptidase C14A, caspase catalytic domain	CASP8:uc010ftf.2:exon4:c.G601C:p.D201H,CASP8:uc002uxw.1:exon7:c.G808C:p.D270H,CASP8:uc002uxq.1:exon8:c.G808C:p.D270H,CASP8:uc002uxt.1:exon8:c.G1030C:p.D344H,CASP8:uc002uxp.1:exon9:c.G904C:p.D302H,CASP8:uc002uxr.1:exon9:c.G853C:p.D285H	-1.006	AFR:LUSC-KR|1|170|0.00588235,AMR:0.0973,EAS:0.0692,FIN:0.07,NFE:0,OTH:0.1017,ASJ:0.0649	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	,1874	0.129	1.68	0.000	1.045	2	1(lung)	0.1261
2	202151163	202151163	A	G	CASP8	intronic	.	ENSG00000064012	rs3769818	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7151	0.7429	0.745208	MU18189875	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.7305,EAS:0.5670,FIN:0.6424,NFE:0.7249,OTH:0.6720,ASJ:0.7850	601763	114480;114550;211980;607271;	275517;449;88673;227535;	275517|ALPS with recurrent viral infections<br>CEDS<br>Caspase 8 deficiency syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|607271 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05130 Pathogenic Escherichia coli infection~ko05134 Legionellosis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	2	2(upper_aerodigestive_tract)	0.7251
2	209101906	209101906	A	-	IDH1	intronic	.	ENSG00000138413	rs57383668	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9898	.	0.982628	0.9861	.	.	.	.	.	.	.	.	.	.	AFR:0.9526,AMR:0.9964,EAS:1,FIN:1,NFE:0.9994,OTH:0.9938,ASJ:1	147700	137800;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko00020 Citrate cycle (TCA cycle)~ko00480 Glutathione metabolism~ko00720 Carbon fixation pathways in prokaryotes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko01210 2-Oxocarboxylic acid metabolism~ko01230 Biosynthesis of amino acids~ko04146 Peroxisome~~M00009 Citrate cycle (TCA cycle, Krebs cycle)~M00010 Citrate cycle, first carbon oxidation, oxaloacetate =>~~M00173 Reductive citrate cycle (Arnon-Buchanan cycle)~M00740 Methylaspartate cycle ~	.	.	.	.	.	.	.	2	.	hom
2	211456637	211456637	A	G	CPS1	exonic	nonsynonymous SNV	ENSG00000021826	rs1047883	ENSG00000021826:ENST00000233072:exon10:c.A1030G:p.T344A,ENSG00000021826:ENST00000430249:exon11:c.A1048G:p.T350A	CPS1:NM_001875:exon10:c.A1030G:p.T344A,CPS1:NM_001122633:exon11:c.A1030G:p.T344A,CPS1:NM_001369256:exon11:c.A1063G:p.T355A,CPS1:NM_001369257:exon12:c.A1030G:p.T344A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5697	0.5917	.	0.5769	0.154	4.189	0.067	-0.92	0.417	.	.	Carbamoyl-phosphate synthase small subunit, GATase1 domain|Class I glutamine amidotransferase-like|Glutamine amidotransferase	CPS1:uc002vee.4:exon10:c.A1030G:p.T344A,CPS1:uc010fur.3:exon11:c.A1048G:p.T350A	-0.903	AFR:0.6195,AMR:0.4952,EAS:0.5581,FIN:0.6195,NFE:0.5478,OTH:0.5938,ASJ:0.5638	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	0.001	-2.59	0.000	1.495	2	MU4566590	unknown
2	211456639	211456639	C	T	CPS1	exonic	synonymous SNV	ENSG00000021826	rs2229589	ENSG00000021826:ENST00000233072:exon10:c.C1032T:p.T344T,ENSG00000021826:ENST00000430249:exon11:c.C1050T:p.T350T	CPS1:NM_001875:exon10:c.C1032T:p.T344T,CPS1:NM_001122633:exon11:c.C1032T:p.T344T,CPS1:NM_001369256:exon11:c.C1065T:p.T355T,CPS1:NM_001369257:exon12:c.C1032T:p.T344T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5736	0.5976	0.591254	0.5896	.	.	.	.	.	.	.	.	CPS1:uc002vee.4:exon10:c.C1032T:p.T344T,CPS1:uc010fur.3:exon11:c.C1050T:p.T350T	.	AFR:0.6634,AMR:0.5024,EAS:0.5581,FIN:0.6195,NFE:0.5481,OTH:0.5938,ASJ:0.5638	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	MU13944213	unknown
2	211481257	211481257	C	G	CPS1	exonic	synonymous SNV	ENSG00000021826	rs2287599	ENSG00000021826:ENST00000451903:exon11:c.C1326G:p.G442G,ENSG00000021826:ENST00000233072:exon21:c.C2679G:p.G893G,ENSG00000021826:ENST00000430249:exon22:c.C2697G:p.G899G	CPS1:NM_001875:exon21:c.C2679G:p.G893G,CPS1:NM_001122633:exon22:c.C2679G:p.G893G,CPS1:NM_001369256:exon22:c.C2712G:p.G904G,CPS1:NM_001369257:exon23:c.C2679G:p.G893G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5861	0.6622	0.649161	0.6316	.	.	.	.	.	.	.	.	CPS1:uc010fus.3:exon11:c.C1326G:p.G442G,CPS1:uc002vee.4:exon21:c.C2679G:p.G893G,CPS1:uc010fur.3:exon22:c.C2697G:p.G899G	.	AFR:0.8648,AMR:0.5155,EAS:0.5,FIN:0.5673,NFE:0.5358,OTH:0.5680,ASJ:0.5767	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	MU13944242	het
2	211527828	211527828	T	-	CPS1	intronic	.	ENSG00000021826	rs397703682	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.7547	.	0.77476	0.8552	.	.	.	.	.	.	.	.	.	.	AFR:0.7533,AMR:0.8290,EAS:0.9375,FIN:0.9002,NFE:0.8987,OTH:0.9048,ASJ:0.9190	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	.	.	.	.	2	.	hom
2	211540507	211540507	C	A	CPS1	exonic	nonsynonymous SNV	ENSG00000021826	rs1047891	ENSG00000021826:ENST00000451903:exon26:c.C2864A:p.T955N,ENSG00000021826:ENST00000233072:exon36:c.C4217A:p.T1406N,ENSG00000021826:ENST00000430249:exon37:c.C4235A:p.T1412N	CPS1:NM_001875:exon36:c.C4217A:p.T1406N,CPS1:NM_001122633:exon37:c.C4217A:p.T1406N,CPS1:NM_001369256:exon37:c.C4250A:p.T1417N,CPS1:NM_001369257:exon38:c.C4217A:p.T1406N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3034	0.3292	0.288538	0.3275	2.953	22.1	0.237	5.2	1.000	.	.	Carbamoyl-phosphate synthetase, large subunit oligomerisation domain;Methylglyoxal synthase-like domain	CPS1:uc010fus.3:exon26:c.C2864A:p.T955N,CPS1:uc002vee.4:exon36:c.C4217A:p.T1406N,CPS1:uc010fur.3:exon37:c.C4235A:p.T1412N	-1.073	AFR:0.3725,AMR:0.3138,EAS:0.1578,FIN:0.3426,NFE:0.3171,OTH:0.3289,ASJ:0.3146	608307	237300;615371;	147;	147|CPS1 deficiency<br>CPS1D<br>Carbamoyl-phosphate synthetase I deficiency<br>Carbamoyl-phosphate synthetase deficiency|1-9 / 1 000 000|Autosomal recessive|Neonatal<br>All ages|237300 ~	.	.	.	.	0.009	-1.67	0.000	1.695	2	MU816614	het
2	215603804	215603804	T	A	BARD1	intronic	.	ENSG00000138376	rs2034250	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.297724	0.2956	.	.	.	.	.	.	.	.	.	.	AFR:0.2751,AMR:0.2721,EAS:0.3973,FIN:0.3766,NFE:0.2762,OTH:0.3258,ASJ:0.3377	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	.	het
2	215632192	215632192	G	A	BARD1	intronic	.	ENSG00000138376	rs5031011	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3614	0.3353	0.352236	0.3655	.	.	.	.	.	.	.	.	.	.	AFR:0.3481,AMR:0.2938,EAS:0.3850,FIN:0.4501,NFE:0.3537,OTH:0.4131,ASJ:0.4073	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU757044	het
2	215632255	215632255	C	T	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs2070094	ENSG00000138376:ENST00000449967:exon5:c.G1087A:p.V363M,ENSG00000138376:ENST00000260947:exon6:c.G1519A:p.V507M	BARD1:NM_001282543:exon5:c.G1462A:p.V488M,BARD1:NM_000465:exon6:c.G1519A:p.V507M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3783	0.2806	0.366214	0.3845	0.209	4.771	0.269	-11.3	0.313	.	.	Ankyrin repeat-containing domain	BARD1:uc021vwf.1:exon4:c.G1228A:p.V410M,BARD1:uc010zjm.1:exon5:c.G1087A:p.V363M,BARD1:uc021vwd.1:exon5:c.G217A:p.V73M,BARD1:uc021vwe.1:exon5:c.G1462A:p.V488M,BARD1:uc002veu.2:exon6:c.G1519A:p.V507M,BARD1:uc021vwj.1:exon6:c.G1111A:p.V371M	-1.097	AFR:0.3705,AMR:0.3103,EAS:0.3806,FIN:0.4676,NFE:0.3741,OTH:0.4286,ASJ:0.4238	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.001	-0.17	0.000	1.23	2	MU152802	het
2	215632256	215632256	A	G	BARD1	exonic	synonymous SNV	ENSG00000138376	rs2070093	ENSG00000138376:ENST00000449967:exon5:c.T1086C:p.H362H,ENSG00000138376:ENST00000260947:exon6:c.T1518C:p.H506H	BARD1:NM_001282543:exon5:c.T1461C:p.H487H,BARD1:NM_000465:exon6:c.T1518C:p.H506H	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8134	0.7138	0.770567	0.7658	.	.	.	.	.	.	.	.	BARD1:uc021vwf.1:exon4:c.T1227C:p.H409H,BARD1:uc010zjm.1:exon5:c.T1086C:p.H362H,BARD1:uc021vwd.1:exon5:c.T216C:p.H72H,BARD1:uc021vwe.1:exon5:c.T1461C:p.H487H,BARD1:uc002veu.2:exon6:c.T1518C:p.H506H,BARD1:uc021vwj.1:exon6:c.T1110C:p.H370H	.	AFR:0.6055,AMR:0.7883,EAS:0.9543,FIN:0.8947,NFE:0.8028,OTH:0.8286,ASJ:0.7848	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU31491380	hom
2	215634055	215634055	C	T	BARD1	intronic	.	ENSG00000138376	rs6704780	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3818	0.3595	0.365216	0.3855	.	.	.	.	.	.	.	.	.	.	AFR:0.3717,AMR:0.3110,EAS:0.3835,FIN:0.4670,NFE:0.3754,OTH:0.4284,ASJ:0.4267	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	2	MU757049	het
2	215645464	215645464	C	G	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs2229571	ENSG00000138376:ENST00000449967:exon3:c.G702C:p.R234S,ENSG00000138376:ENST00000260947:exon4:c.G1134C:p.R378S	BARD1:NM_001282543:exon3:c.G1077C:p.R359S,BARD1:NM_000465:exon4:c.G1134C:p.R378S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5487	0.5318	0.459265	0.5519	0.673	8.652	0.174	-1.03	0.050	.	.	.	BARD1:uc021vwf.1:exon2:c.G843C:p.R281S,BARD1:uc010zjm.1:exon3:c.G702C:p.R234S,BARD1:uc021vwe.1:exon3:c.G1077C:p.R359S,BARD1:uc002veu.2:exon4:c.G1134C:p.R378S	-0.921	AFR:0.4006,AMR:0.4376,EAS:0.3851,FIN:0.6827,NFE:0.6283,OTH:0.6214,ASJ:0.5894	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.024	-0.67	0.000	1.67	2	MU152809	hom
2	215674224	215674224	G	A	BARD1	exonic	nonsynonymous SNV	ENSG00000138376	rs1048108	ENSG00000138376:ENST00000260947:exon1:c.C70T:p.P24S,ENSG00000138376:ENST00000421162:exon1:c.C70T:p.P24S,ENSG00000138376:ENST00000455743:exon1:c.C70T:p.P24S	BARD1:NM_000465:exon1:c.C70T:p.P24S,BARD1:NM_001282543:exon1:c.C70T:p.P24S,BARD1:NM_001282545:exon1:c.C70T:p.P24S,BARD1:NM_001282548:exon1:c.C70T:p.P24S,BARD1:NM_001282549:exon1:c.C70T:p.P24S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4377	0.3031	0.33127	0.3408	1.242	11.97	0.184	3.1	0.116	.	.	.	BARD1:uc002veu.2:exon1:c.C70T:p.P24S,BARD1:uc021vwe.1:exon1:c.C70T:p.P24S,BARD1:uc021vwg.1:exon1:c.C70T:p.P24S,BARD1:uc021vwh.1:exon1:c.C70T:p.P24S,BARD1:uc021vwi.1:exon1:c.C70T:p.P24S,BARD1:uc021vwj.1:exon1:c.C70T:p.P24S	-1.043	AFR:0.2121,AMR:0.4141,EAS:0.3779,FIN:0.4177,NFE:0.3819,OTH:0.4378,ASJ:0.41	601593	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.002	-0.72	0.000	1.195	2	MU152818	het
2	216229692	216229692	A	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs11651	ENSG00000115414:ENST00000456923:exon19:c.T3039C:p.Y1013Y,ENSG00000115414:ENST00000345488:exon41:c.T6282C:p.Y2094Y,ENSG00000115414:ENST00000346544:exon42:c.T6363C:p.Y2121Y,ENSG00000115414:ENST00000356005:exon42:c.T6618C:p.Y2206Y,ENSG00000115414:ENST00000357867:exon42:c.T6258C:p.Y2086Y,ENSG00000115414:ENST00000359671:exon43:c.T6888C:p.Y2296Y,ENSG00000115414:ENST00000421182:exon43:c.T6450C:p.Y2150Y,ENSG00000115414:ENST00000432072:exon43:c.T6531C:p.Y2177Y,ENSG00000115414:ENST00000443816:exon43:c.T6525C:p.Y2175Y,ENSG00000115414:ENST00000336916:exon44:c.T6795C:p.Y2265Y,ENSG00000115414:ENST00000354785:exon44:c.T7161C:p.Y2387Y,ENSG00000115414:ENST00000446046:exon44:c.T6720C:p.Y2240Y,ENSG00000115414:ENST00000323926:exon45:c.T7068C:p.Y2356Y	FN1:NM_001365523:exon42:c.T6543C:p.Y2181Y,FN1:NM_212474:exon42:c.T6258C:p.Y2086Y,FN1:NM_212476:exon42:c.T6618C:p.Y2206Y,FN1:NM_001306130:exon43:c.T6531C:p.Y2177Y,FN1:NM_001306131:exon43:c.T6525C:p.Y2175Y,FN1:NM_001306132:exon43:c.T6450C:p.Y2150Y,FN1:NM_001365517:exon43:c.T6891C:p.Y2297Y,FN1:NM_001365518:exon43:c.T6888C:p.Y2296Y,FN1:NM_001365519:exon43:c.T6816C:p.Y2272Y,FN1:NM_001365520:exon43:c.T6813C:p.Y2271Y,FN1:NM_001365524:exon43:c.T6528C:p.Y2176Y,FN1:NM_001365521:exon44:c.T6798C:p.Y2266Y,FN1:NM_001365522:exon44:c.T6723C:p.Y2241Y,FN1:NM_002026:exon44:c.T6795C:p.Y2265Y,FN1:NM_212478:exon44:c.T6720C:p.Y2240Y,FN1:NM_212482:exon44:c.T7161C:p.Y2387Y,FN1:NM_001306129:exon45:c.T7068C:p.Y2356Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4079	0.2481	0.282748	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	FN1:uc002vez.3:exon17:c.T1650C:p.Y550Y,FN1:uc010zjp.2:exon19:c.T2772C:p.Y924Y,FN1:uc002vfg.3:exon42:c.T6618C:p.Y2206Y,FN1:uc002vfh.3:exon42:c.T6258C:p.Y2086Y,FN1:uc002vfb.3:exon43:c.T6525C:p.Y2175Y,FN1:uc002vfc.3:exon43:c.T6450C:p.Y2150Y,FN1:uc002vfj.3:exon43:c.T6531C:p.Y2177Y,FN1:uc002vfa.3:exon44:c.T7161C:p.Y2387Y,FN1:uc002vfe.3:exon44:c.T6795C:p.Y2265Y,FN1:uc002vff.3:exon44:c.T6720C:p.Y2240Y,FN1:uc002vfi.3:exon45:c.T7068C:p.Y2356Y	.	AFR:0.2534,AMR:0.0982,EAS:0.3940,FIN:0.2816,NFE:0.2758,OTH:0.3266,ASJ:0.3369	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	1(large_intestine)	0.2751
2	216235089	216235089	C	T	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs1250209	ENSG00000115414:ENST00000456923:exon16:c.G2659A:p.V887I,ENSG00000115414:ENST00000356005:exon39:c.G6238A:p.V2080I,ENSG00000115414:ENST00000357867:exon39:c.G5878A:p.V1960I,ENSG00000115414:ENST00000346544:exon40:c.G6148A:p.V2050I,ENSG00000115414:ENST00000359671:exon40:c.G6508A:p.V2170I,ENSG00000115414:ENST00000421182:exon40:c.G6070A:p.V2024I,ENSG00000115414:ENST00000432072:exon40:c.G6151A:p.V2051I,ENSG00000115414:ENST00000443816:exon40:c.G6145A:p.V2049I,ENSG00000115414:ENST00000336916:exon41:c.G6415A:p.V2139I,ENSG00000115414:ENST00000354785:exon41:c.G6781A:p.V2261I,ENSG00000115414:ENST00000446046:exon41:c.G6340A:p.V2114I,ENSG00000115414:ENST00000323926:exon42:c.G6688A:p.V2230I	FN1:NM_001365523:exon39:c.G6163A:p.V2055I,FN1:NM_212474:exon39:c.G5878A:p.V1960I,FN1:NM_212476:exon39:c.G6238A:p.V2080I,FN1:NM_001306130:exon40:c.G6151A:p.V2051I,FN1:NM_001306131:exon40:c.G6145A:p.V2049I,FN1:NM_001306132:exon40:c.G6070A:p.V2024I,FN1:NM_001365517:exon40:c.G6511A:p.V2171I,FN1:NM_001365518:exon40:c.G6508A:p.V2170I,FN1:NM_001365519:exon40:c.G6436A:p.V2146I,FN1:NM_001365520:exon40:c.G6433A:p.V2145I,FN1:NM_001365524:exon40:c.G6148A:p.V2050I,FN1:NM_001365521:exon41:c.G6418A:p.V2140I,FN1:NM_001365522:exon41:c.G6343A:p.V2115I,FN1:NM_002026:exon41:c.G6415A:p.V2139I,FN1:NM_212478:exon41:c.G6340A:p.V2114I,FN1:NM_212482:exon41:c.G6781A:p.V2261I,FN1:NM_001306129:exon42:c.G6688A:p.V2230I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	1.0000	0.9998	0.9998	0.9998	3.072	22.4	1.0	5.6	0.999	.	.	Fibronectin type III|Immunoglobulin-like fold;Fibronectin, type I	FN1:uc010fvd.1:exon7:c.G961A:p.V321I,FN1:uc010fvc.1:exon11:c.G1507A:p.V503I,FN1:uc002vez.3:exon14:c.G1270A:p.V424I,FN1:uc010zjp.2:exon16:c.G2392A:p.V798I,FN1:uc002vfg.3:exon39:c.G6238A:p.V2080I,FN1:uc002vfh.3:exon39:c.G5878A:p.V1960I,FN1:uc002vfb.3:exon40:c.G6145A:p.V2049I,FN1:uc002vfc.3:exon40:c.G6070A:p.V2024I,FN1:uc002vfj.3:exon40:c.G6151A:p.V2051I,FN1:uc002vfa.3:exon41:c.G6781A:p.V2261I,FN1:uc002vfe.3:exon41:c.G6415A:p.V2139I,FN1:uc002vff.3:exon41:c.G6340A:p.V2114I,FN1:uc002vfi.3:exon42:c.G6688A:p.V2230I	-0.928	AFR:0.9994,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	0.29	0.000	-0.455	2	MU81750207	hom
2	216240127	216240128	AC	-	FN1	intronic	.	ENSG00000115414	rs3214672	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3189	0.2450	0.379593	0.2731	.	.	.	.	.	.	.	.	.	.	AFR:0.2521,AMR:0.3873,EAS:0.7909,FIN:0.2484,NFE:0.2268,OTH:0.2771,ASJ:0.39	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU114604750	het
2	216242917	216242917	T	A	FN1	exonic	synonymous SNV	ENSG00000115414	rs1132741	ENSG00000115414:ENST00000456923:exon10:c.A1569T:p.G523G,ENSG00000115414:ENST00000356005:exon33:c.A5148T:p.G1716G,ENSG00000115414:ENST00000357867:exon33:c.A5148T:p.G1716G,ENSG00000115414:ENST00000421182:exon33:c.A5148T:p.G1716G,ENSG00000115414:ENST00000443816:exon33:c.A5148T:p.G1716G,ENSG00000115414:ENST00000336916:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000345488:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000346544:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000357009:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000359671:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000432072:exon34:c.A5421T:p.G1807G,ENSG00000115414:ENST00000446046:exon34:c.A5418T:p.G1806G,ENSG00000115414:ENST00000323926:exon35:c.A5691T:p.G1897G,ENSG00000115414:ENST00000354785:exon35:c.A5691T:p.G1897G	FN1:NM_001306131:exon33:c.A5148T:p.G1716G,FN1:NM_001306132:exon33:c.A5148T:p.G1716G,FN1:NM_001365523:exon33:c.A5148T:p.G1716G,FN1:NM_212474:exon33:c.A5148T:p.G1716G,FN1:NM_212476:exon33:c.A5148T:p.G1716G,FN1:NM_001306130:exon34:c.A5421T:p.G1807G,FN1:NM_001365517:exon34:c.A5421T:p.G1807G,FN1:NM_001365518:exon34:c.A5418T:p.G1806G,FN1:NM_001365519:exon34:c.A5421T:p.G1807G,FN1:NM_001365520:exon34:c.A5418T:p.G1806G,FN1:NM_001365521:exon34:c.A5421T:p.G1807G,FN1:NM_001365522:exon34:c.A5421T:p.G1807G,FN1:NM_001365524:exon34:c.A5418T:p.G1806G,FN1:NM_002026:exon34:c.A5418T:p.G1806G,FN1:NM_212478:exon34:c.A5418T:p.G1806G,FN1:NM_001306129:exon35:c.A5691T:p.G1897G,FN1:NM_212482:exon35:c.A5691T:p.G1897G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2868	0.1899	0.324681	LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	FN1:uc010fvc.1:exon5:c.A777T:p.G259G,FN1:uc002vez.3:exon7:c.A273T:p.G91G,FN1:uc010zjp.2:exon10:c.A1302T:p.G434G,FN1:uc002vfb.3:exon33:c.A5148T:p.G1716G,FN1:uc002vfc.3:exon33:c.A5148T:p.G1716G,FN1:uc002vfg.3:exon33:c.A5148T:p.G1716G,FN1:uc002vfh.3:exon33:c.A5148T:p.G1716G,FN1:uc002vfe.3:exon34:c.A5418T:p.G1806G,FN1:uc002vff.3:exon34:c.A5418T:p.G1806G,FN1:uc002vfj.3:exon34:c.A5421T:p.G1807G,FN1:uc002vfa.3:exon35:c.A5691T:p.G1897G,FN1:uc002vfi.3:exon35:c.A5691T:p.G1897G	.	AFR:0.2265,AMR:0.0876,EAS:0.39,FIN:0.7924,NFE:0.2491,OTH:0.2271,ASJ:0.3726	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	1(haematopoietic_and_lymphoid_tissue)	0.2684
2	216249587	216249587	C	T	FN1	exonic	synonymous SNV	ENSG00000115414	rs13652	ENSG00000115414:ENST00000456923:exon5:c.G873A:p.E291E,ENSG00000115414:ENST00000336916:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000345488:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000346544:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000356005:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000357009:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000357867:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000359671:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000421182:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000443816:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000446046:exon28:c.G4452A:p.E1484E,ENSG00000115414:ENST00000323926:exon29:c.G4725A:p.E1575E,ENSG00000115414:ENST00000354785:exon29:c.G4725A:p.E1575E,ENSG00000115414:ENST00000432072:exon29:c.G4725A:p.E1575E	FN1:NM_001306131:exon28:c.G4452A:p.E1484E,FN1:NM_001306132:exon28:c.G4452A:p.E1484E,FN1:NM_001365518:exon28:c.G4452A:p.E1484E,FN1:NM_001365520:exon28:c.G4452A:p.E1484E,FN1:NM_001365523:exon28:c.G4452A:p.E1484E,FN1:NM_001365524:exon28:c.G4452A:p.E1484E,FN1:NM_002026:exon28:c.G4452A:p.E1484E,FN1:NM_212474:exon28:c.G4452A:p.E1484E,FN1:NM_212476:exon28:c.G4452A:p.E1484E,FN1:NM_212478:exon28:c.G4452A:p.E1484E,FN1:NM_001306129:exon29:c.G4725A:p.E1575E,FN1:NM_001306130:exon29:c.G4725A:p.E1575E,FN1:NM_001365517:exon29:c.G4725A:p.E1575E,FN1:NM_001365519:exon29:c.G4725A:p.E1575E,FN1:NM_001365521:exon29:c.G4725A:p.E1575E,FN1:NM_001365522:exon29:c.G4725A:p.E1575E,FN1:NM_212482:exon29:c.G4725A:p.E1575E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8752	0.8493	0.86861	0.8734	.	.	.	.	.	.	.	.	FN1:uc010zjp.2:exon5:c.G606A:p.E202E,FN1:uc002vfb.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfc.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfe.3:exon28:c.G4452A:p.E1484E,FN1:uc002vff.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfg.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfh.3:exon28:c.G4452A:p.E1484E,FN1:uc002vfa.3:exon29:c.G4725A:p.E1575E,FN1:uc002vfi.3:exon29:c.G4725A:p.E1575E,FN1:uc002vfj.3:exon29:c.G4725A:p.E1575E	.	AFR:0.8131,AMR:0.8890,EAS:1,FIN:0.9270,NFE:0.8818,OTH:0.8890,ASJ:0.8046	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU81750265	hom
2	216251697	216251697	G	A	FN1	intronic	.	ENSG00000115414	rs35343655	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3241	0.2398	0.373602	0.2721	.	.	.	.	.	.	.	.	.	.	AFR:0.2433,AMR:0.3888,EAS:0.7932,FIN:0.2484,NFE:0.2270,OTH:0.2780,ASJ:0.3885	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU21425088	het
2	216253039	216253039	G	C	FN1	intronic	.	ENSG00000115414	rs1250215	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5491	0.5241	0.411741	0.5267	.	.	.	.	.	.	.	.	.	.	AFR:0.3086,AMR:0.4880,EAS:0.2151,FIN:0.6778,NFE:0.6522,OTH:0.5939,ASJ:0.4073	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU25472968	het
2	216269095	216269095	C	T	FN1	intronic	.	ENSG00000115414	rs13306359	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3648	0.3458	0.286941	0.3347	.	.	.	.	.	.	.	.	.	.	AFR:0.2350,AMR:0.3041,EAS:0.0686,FIN:0.3869,NFE:0.4101,OTH:0.3727,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177168	het
2	216269209	216269209	T	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs1053238	ENSG00000115414:ENST00000323926:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000336916:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000345488:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000346544:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000354785:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000356005:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000357009:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000357867:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000359671:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000421182:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000432072:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000443816:exon20:c.A3156C:p.P1052P,ENSG00000115414:ENST00000446046:exon20:c.A3156C:p.P1052P	FN1:NM_001306129:exon20:c.A3156C:p.P1052P,FN1:NM_001306130:exon20:c.A3156C:p.P1052P,FN1:NM_001306131:exon20:c.A3156C:p.P1052P,FN1:NM_001306132:exon20:c.A3156C:p.P1052P,FN1:NM_001365517:exon20:c.A3156C:p.P1052P,FN1:NM_001365518:exon20:c.A3156C:p.P1052P,FN1:NM_001365519:exon20:c.A3156C:p.P1052P,FN1:NM_001365520:exon20:c.A3156C:p.P1052P,FN1:NM_001365521:exon20:c.A3156C:p.P1052P,FN1:NM_001365522:exon20:c.A3156C:p.P1052P,FN1:NM_001365523:exon20:c.A3156C:p.P1052P,FN1:NM_001365524:exon20:c.A3156C:p.P1052P,FN1:NM_002026:exon20:c.A3156C:p.P1052P,FN1:NM_212474:exon20:c.A3156C:p.P1052P,FN1:NM_212476:exon20:c.A3156C:p.P1052P,FN1:NM_212478:exon20:c.A3156C:p.P1052P,FN1:NM_212482:exon20:c.A3156C:p.P1052P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3643	0.3462	0.286741	0.3376	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfb.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfc.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfe.3:exon20:c.A3156C:p.P1052P,FN1:uc002vff.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfg.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfh.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfi.3:exon20:c.A3156C:p.P1052P,FN1:uc002vfj.3:exon20:c.A3156C:p.P1052P	.	AFR:0.2361,AMR:0.3062,EAS:0.0698,FIN:0.3954,NFE:0.4123,OTH:0.3724,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177191	het
2	216269254	216269254	T	G	FN1	exonic	synonymous SNV	ENSG00000115414	rs7589580	ENSG00000115414:ENST00000323926:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000336916:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000345488:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000346544:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000354785:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000356005:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000357009:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000357867:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000359671:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000421182:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000432072:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000443816:exon20:c.A3111C:p.G1037G,ENSG00000115414:ENST00000446046:exon20:c.A3111C:p.G1037G	FN1:NM_001306129:exon20:c.A3111C:p.G1037G,FN1:NM_001306130:exon20:c.A3111C:p.G1037G,FN1:NM_001306131:exon20:c.A3111C:p.G1037G,FN1:NM_001306132:exon20:c.A3111C:p.G1037G,FN1:NM_001365517:exon20:c.A3111C:p.G1037G,FN1:NM_001365518:exon20:c.A3111C:p.G1037G,FN1:NM_001365519:exon20:c.A3111C:p.G1037G,FN1:NM_001365520:exon20:c.A3111C:p.G1037G,FN1:NM_001365521:exon20:c.A3111C:p.G1037G,FN1:NM_001365522:exon20:c.A3111C:p.G1037G,FN1:NM_001365523:exon20:c.A3111C:p.G1037G,FN1:NM_001365524:exon20:c.A3111C:p.G1037G,FN1:NM_002026:exon20:c.A3111C:p.G1037G,FN1:NM_212474:exon20:c.A3111C:p.G1037G,FN1:NM_212476:exon20:c.A3111C:p.G1037G,FN1:NM_212478:exon20:c.A3111C:p.G1037G,FN1:NM_212482:exon20:c.A3111C:p.G1037G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3644	0.3462	0.286941	0.3384	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfb.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfc.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfe.3:exon20:c.A3111C:p.G1037G,FN1:uc002vff.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfg.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfh.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfi.3:exon20:c.A3111C:p.G1037G,FN1:uc002vfj.3:exon20:c.A3111C:p.G1037G	.	AFR:0.237,AMR:0.3079,EAS:0.0699,FIN:0.3945,NFE:0.4131,OTH:0.3760,ASJ:0.3245	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU82177210	het
2	216272819	216272819	C	G	FN1	intronic	.	ENSG00000115414	rs7570208	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6051	0.6068	0.665935	0.6195	.	.	.	.	.	.	.	.	.	.	AFR:0.6739,AMR:0.6504,EAS:0.9277,FIN:0.5985,NFE:0.5594,OTH:0.5930,ASJ:0.6133	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU26084458	het
2	216272900	216272900	T	G	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs2577301	ENSG00000115414:ENST00000323926:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000336916:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000345488:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000346544:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000354785:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000356005:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000357009:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000357867:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000359671:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000421182:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000432072:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000443816:exon17:c.A2449C:p.T817P,ENSG00000115414:ENST00000446046:exon17:c.A2449C:p.T817P	FN1:NM_001306129:exon17:c.A2449C:p.T817P,FN1:NM_001306130:exon17:c.A2449C:p.T817P,FN1:NM_001306131:exon17:c.A2449C:p.T817P,FN1:NM_001306132:exon17:c.A2449C:p.T817P,FN1:NM_001365517:exon17:c.A2449C:p.T817P,FN1:NM_001365518:exon17:c.A2449C:p.T817P,FN1:NM_001365519:exon17:c.A2449C:p.T817P,FN1:NM_001365520:exon17:c.A2449C:p.T817P,FN1:NM_001365521:exon17:c.A2449C:p.T817P,FN1:NM_001365522:exon17:c.A2449C:p.T817P,FN1:NM_001365523:exon17:c.A2449C:p.T817P,FN1:NM_001365524:exon17:c.A2449C:p.T817P,FN1:NM_002026:exon17:c.A2449C:p.T817P,FN1:NM_212474:exon17:c.A2449C:p.T817P,FN1:NM_212476:exon17:c.A2449C:p.T817P,FN1:NM_212478:exon17:c.A2449C:p.T817P,FN1:NM_212482:exon17:c.A2449C:p.T817P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	1.0000	0.9999	0.9998	0.9998	1.626	14.00	0.314	5.93	0.070	.	.	Fibronectin type III|Immunoglobulin-like fold	FN1:uc002vfa.3:exon17:c.A2449C:p.T817P,FN1:uc002vfb.3:exon17:c.A2449C:p.T817P,FN1:uc002vfc.3:exon17:c.A2449C:p.T817P,FN1:uc002vfe.3:exon17:c.A2449C:p.T817P,FN1:uc002vff.3:exon17:c.A2449C:p.T817P,FN1:uc002vfg.3:exon17:c.A2449C:p.T817P,FN1:uc002vfh.3:exon17:c.A2449C:p.T817P,FN1:uc002vfi.3:exon17:c.A2449C:p.T817P,FN1:uc002vfj.3:exon17:c.A2449C:p.T817P	-0.957	AFR:0.9995,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	0.51	0.000	-0.69	2	MU81750388	hom
2	216272907	216272907	A	T	FN1	exonic	synonymous SNV	ENSG00000115414	rs7596677	ENSG00000115414:ENST00000323926:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000336916:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000345488:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000346544:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000354785:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000356005:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000357009:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000357867:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000359671:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000421182:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000432072:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000443816:exon17:c.T2442A:p.P814P,ENSG00000115414:ENST00000446046:exon17:c.T2442A:p.P814P	FN1:NM_001306129:exon17:c.T2442A:p.P814P,FN1:NM_001306130:exon17:c.T2442A:p.P814P,FN1:NM_001306131:exon17:c.T2442A:p.P814P,FN1:NM_001306132:exon17:c.T2442A:p.P814P,FN1:NM_001365517:exon17:c.T2442A:p.P814P,FN1:NM_001365518:exon17:c.T2442A:p.P814P,FN1:NM_001365519:exon17:c.T2442A:p.P814P,FN1:NM_001365520:exon17:c.T2442A:p.P814P,FN1:NM_001365521:exon17:c.T2442A:p.P814P,FN1:NM_001365522:exon17:c.T2442A:p.P814P,FN1:NM_001365523:exon17:c.T2442A:p.P814P,FN1:NM_001365524:exon17:c.T2442A:p.P814P,FN1:NM_002026:exon17:c.T2442A:p.P814P,FN1:NM_212474:exon17:c.T2442A:p.P814P,FN1:NM_212476:exon17:c.T2442A:p.P814P,FN1:NM_212478:exon17:c.T2442A:p.P814P,FN1:NM_212482:exon17:c.T2442A:p.P814P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3394	0.2522	0.421526	0.2924	.	.	.	.	.	.	.	.	FN1:uc002vfa.3:exon17:c.T2442A:p.P814P,FN1:uc002vfb.3:exon17:c.T2442A:p.P814P,FN1:uc002vfc.3:exon17:c.T2442A:p.P814P,FN1:uc002vfe.3:exon17:c.T2442A:p.P814P,FN1:uc002vff.3:exon17:c.T2442A:p.P814P,FN1:uc002vfg.3:exon17:c.T2442A:p.P814P,FN1:uc002vfh.3:exon17:c.T2442A:p.P814P,FN1:uc002vfi.3:exon17:c.T2442A:p.P814P,FN1:uc002vfj.3:exon17:c.T2442A:p.P814P	.	AFR:0.2128,AMR:0.4557,EAS:0.9243,FIN:0.3105,NFE:0.2552,OTH:0.3014,ASJ:0.3675	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU25473493	het
2	216274854	216274855	AC	-	FN1	intronic	.	ENSG00000115414	rs397987770	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3020	.	0.39397	0.2624	.	.	.	.	.	.	.	.	.	.	AFR:0.1430,AMR:0.4381,EAS:0.9171,FIN:0.3021,NFE:0.2392,OTH:0.2831,ASJ:0.3576	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	.	unknown
2	216283958	216283958	T	A	FN1	intronic	.	ENSG00000115414	rs3796123	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3206	0.2354	0.411542	0.2791	.	.	.	.	.	0.0005	0.006	.	.	.	AFR:0.2161,AMR:0.4594,EAS:0.9247,FIN:0.2898,NFE:0.2310,OTH:0.2867,ASJ:0.3742	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU26084546	het
2	216299550	216299550	G	A	FN1	intronic	.	ENSG00000115414	rs2577290	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3196	0.1445	0.422324	0.3007	.	.	.	.	.	0.0132	0.174	.	.	.	AFR:0.2916,AMR:0.4555,EAS:0.9251,FIN:0.2948,NFE:0.2287,OTH:0.2945,ASJ:0.3691	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU26084633	unknown
2	216299551	216299551	C	A	FN1	intronic	.	ENSG00000115414	rs2692234	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3196	0.1314	0.422324	0.3011	.	.	.	.	.	0.0002	0.022	.	.	.	AFR:0.2921,AMR:0.4577,EAS:0.9251,FIN:0.2952,NFE:0.2290,OTH:0.2945,ASJ:0.3667	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU26084672	unknown
2	216300482	216300482	T	A	FN1	exonic	nonsynonymous SNV	ENSG00000115414	rs1250259	ENSG00000115414:ENST00000323926:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000336916:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000345488:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000346544:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000354785:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000356005:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000357009:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000357867:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000359671:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000421182:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000426059:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000432072:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000443816:exon1:c.A44T:p.Q15L,ENSG00000115414:ENST00000446046:exon1:c.A44T:p.Q15L	FN1:NM_001306129:exon1:c.A44T:p.Q15L,FN1:NM_001306130:exon1:c.A44T:p.Q15L,FN1:NM_001306131:exon1:c.A44T:p.Q15L,FN1:NM_001306132:exon1:c.A44T:p.Q15L,FN1:NM_001365517:exon1:c.A44T:p.Q15L,FN1:NM_001365518:exon1:c.A44T:p.Q15L,FN1:NM_001365519:exon1:c.A44T:p.Q15L,FN1:NM_001365520:exon1:c.A44T:p.Q15L,FN1:NM_001365521:exon1:c.A44T:p.Q15L,FN1:NM_001365522:exon1:c.A44T:p.Q15L,FN1:NM_001365523:exon1:c.A44T:p.Q15L,FN1:NM_001365524:exon1:c.A44T:p.Q15L,FN1:NM_002026:exon1:c.A44T:p.Q15L,FN1:NM_054034:exon1:c.A44T:p.Q15L,FN1:NM_212474:exon1:c.A44T:p.Q15L,FN1:NM_212476:exon1:c.A44T:p.Q15L,FN1:NM_212478:exon1:c.A44T:p.Q15L,FN1:NM_212482:exon1:c.A44T:p.Q15L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7691	0.7885	0.795128	COCA-CN|5|321|0.0155763	1.570	13.69	1.0	5.35	0.947	.	.	.	FN1:uc002vfa.3:exon1:c.A44T:p.Q15L,FN1:uc002vfb.3:exon1:c.A44T:p.Q15L,FN1:uc002vfc.3:exon1:c.A44T:p.Q15L,FN1:uc002vfe.3:exon1:c.A44T:p.Q15L,FN1:uc002vff.3:exon1:c.A44T:p.Q15L,FN1:uc002vfg.3:exon1:c.A44T:p.Q15L,FN1:uc002vfh.3:exon1:c.A44T:p.Q15L,FN1:uc002vfi.3:exon1:c.A44T:p.Q15L,FN1:uc002vfj.3:exon1:c.A44T:p.Q15L,FN1:uc002vfl.3:exon1:c.A44T:p.Q15L	-0.961	AFR:0.7912,AMR:0.8614,EAS:0.8013,FIN:0.9302,NFE:0.7946,OTH:0.7365,ASJ:0.7613	135600	601894;614101;	84090;	84090|GFND<br>Glomerulopathy with fibronectin deposits|<1 / 1 000 000|Autosomal dominant|All ages|137950 601894 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.0	1.28	0.000	-0.895	2	1(thyroid)	0.7811
2	217012901	217012901	A	G	XRCC5	exonic	synonymous SNV	ENSG00000079246	rs207906	ENSG00000079246:ENST00000392132:exon14:c.A1572G:p.T524T,ENSG00000079246:ENST00000392133:exon16:c.A1572G:p.T524T	XRCC5:NM_021141:exon14:c.A1572G:p.T524T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8710	0.8732	0.882788	0.8815	.	.	.	.	.	.	.	.	XRCC5:uc002vfz.3:exon11:c.A1230G:p.T410T,XRCC5:uc002vfy.3:exon14:c.A1572G:p.T524T	.	AFR:0.8683,AMR:0.9093,EAS:0.9220,FIN:0.9187,NFE:0.8729,OTH:0.9083,ASJ:0.8742	194364	.	.	.	.	.	.	.	.	.	.	.	2	MU26214825	het
2	220022176	220022176	C	T	NHEJ1	intronic	.	ENSG00000187736;ENSG00000213901	rs6436120	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9646	0.9163	0.902356	0.9324	.	.	.	.	.	.	.	.	.	.	AFR:0.7672,AMR:0.9785,EAS:1,FIN:1,NFE:0.9984,OTH:0.9827,ASJ:0.9868	611290	611291;	169079;	169079|Cernunnos XLFD<br>Cernunnos deficiency<br>Combined immunodeficiency-microcephaly-growth retardation-sensitivity to ionizing radiation syndrome<br>NHEJ1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|611291 ~	.	.	.	.	.	.	.	.	2	MU81751416	hom
2	220466344	220466344	-	T	STK11IP	intronic	.	ENSG00000144589	rs397735129	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5384	.	0.591653	0.8052	.	.	.	.	.	.	.	.	.	.	AFR:0.5218,AMR:0.8675,EAS:0.9961,FIN:0.7952,NFE:0.9438,OTH:0.9109,ASJ:0.8881	607172	.	.	.	.	.	.	.	.	.	.	.	2	.	unknown
2	220473355	220473355	G	A	STK11IP	exonic	nonsynonymous SNV	ENSG00000144589	rs673951	ENSG00000144589:ENST00000295641:exon15:c.G1687A:p.V563I,ENSG00000144589:ENST00000456909:exon15:c.G1654A:p.V552I	STK11IP:NM_052902:exon15:c.G1654A:p.V552I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3671	0.2519	0.350439	0.3047	0.176	4.425	0.253	0.456	0.001	.	.	.	STK11IP:uc002vmm.1:exon14:c.G1654A:p.V552I,STK11IP:uc010zll.2:exon14:c.G1558A:p.V520I,STK11IP:uc002vml.3:exon15:c.G1687A:p.V563I	-1.030	AFR:0.0784,AMR:0.3652,EAS:0.6822,FIN:0.4357,NFE:0.3574,OTH:0.3640,ASJ:0.3344	607172	.	.	.	.	.	.	.	0.035	3.5	0.000	1.32	2	MU738070	het
2	220476443	220476443	C	T	STK11IP	exonic	nonsynonymous SNV	ENSG00000144589	rs627530	ENSG00000144589:ENST00000295641:exon18:c.C2255T:p.S752F,ENSG00000144589:ENST00000456909:exon18:c.C2222T:p.S741F	STK11IP:NM_052902:exon18:c.C2222T:p.S741F	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9376	0.8398	0.839058	0.8456	1.670	14.24	0.054	1.31	0.000	.	.	.	STK11IP:uc002vml.3:exon18:c.C2255T:p.S752F	-1.018	AFR:0.5283,AMR:0.9642,EAS:0.9975,FIN:0.9547,NFE:0.9720,OTH:0.9517,ASJ:0.9570	607172	.	.	.	.	.	.	.	0.004	3.48	0.000	1.6	2	MU81752072	hom
2	223084914	223084914	G	A	PAX3	exonic	nonsynonymous SNV	ENSG00000135903	rs200701839	ENSG00000135903:ENST00000336840:exon7:c.C1118T:p.P373L,ENSG00000135903:ENST00000344493:exon7:c.C1118T:p.P373L,ENSG00000135903:ENST00000350526:exon7:c.C1118T:p.P373L,ENSG00000135903:ENST00000392069:exon7:c.C1118T:p.P373L,ENSG00000135903:ENST00000392070:exon7:c.C1118T:p.P373L,ENSG00000135903:ENST00000409551:exon7:c.C1115T:p.P372L	PAX3:NM_001127366:exon7:c.C1115T:p.P372L,PAX3:NM_181457:exon7:c.C1118T:p.P373L,PAX3:NM_181458:exon7:c.C1118T:p.P373L,PAX3:NM_181459:exon7:c.C1118T:p.P373L,PAX3:NM_181460:exon7:c.C1118T:p.P373L,PAX3:NM_181461:exon7:c.C1118T:p.P373L	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0003	0.0002	0.000199681	0.0003	4.654	24.5	0.077	4.59	0.985	.	.	Paired box protein 7, C-terminal	PAX3:uc002vmt.2:exon7:c.C1118T:p.P373L,PAX3:uc002vmv.2:exon7:c.C1118T:p.P373L,PAX3:uc002vmw.2:exon7:c.C1118T:p.P373L,PAX3:uc002vmx.2:exon7:c.C1118T:p.P373L,PAX3:uc002vmy.2:exon7:c.C1115T:p.P372L,PAX3:uc010fwo.3:exon7:c.C1118T:p.P373L	0.154	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0.0004,OTH:0,ASJ:0	606597	122880;148820;193500;268220;	780;99756;3440;894;3440;896;1529;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~894|WS1<br>Waardenburg syndrome type I|1-9 / 100 000|Autosomal dominant|Neonatal|193500 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~896|Klein-Waardenburg syndrome<br>WS3<br>Waardenburg syndrome type III<br>Waardenburg syndrome with limb anomalies|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|148820 ~1529|CDHS<br>Sommer-Young-Wee-Frye syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|122880 ~	 ~	.	.	.	0.993	-1.31	0.574	1.445	2	.	het
2	223161889	223161889	A	G	PAX3	exonic	synonymous SNV	ENSG00000135903	rs12623857	ENSG00000135903:ENST00000258387:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000336840:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000344493:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000350526:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000392069:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000392070:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000409551:exon2:c.T129C:p.G43G,ENSG00000135903:ENST00000409828:exon2:c.T129C:p.G43G	PAX3:NM_000438:exon2:c.T129C:p.G43G,PAX3:NM_001127366:exon2:c.T129C:p.G43G,PAX3:NM_013942:exon2:c.T129C:p.G43G,PAX3:NM_181457:exon2:c.T129C:p.G43G,PAX3:NM_181458:exon2:c.T129C:p.G43G,PAX3:NM_181459:exon2:c.T129C:p.G43G,PAX3:NM_181460:exon2:c.T129C:p.G43G,PAX3:NM_181461:exon2:c.T129C:p.G43G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8872	0.8465	0.904353	0.8514	.	.	.	.	.	.	.	.	PAX3:uc002vmt.2:exon2:c.T129C:p.G43G,PAX3:uc002vmv.2:exon2:c.T129C:p.G43G,PAX3:uc002vmw.2:exon2:c.T129C:p.G43G,PAX3:uc002vmx.2:exon2:c.T129C:p.G43G,PAX3:uc002vmy.2:exon2:c.T129C:p.G43G,PAX3:uc002vmz.2:exon2:c.T129C:p.G43G,PAX3:uc002vna.2:exon2:c.T129C:p.G43G,PAX3:uc010fwo.3:exon2:c.T129C:p.G43G	.	AFR:0.8433,AMR:0.9165,EAS:1,FIN:0.8283,NFE:0.8402,OTH:0.8523,ASJ:0.9305	606597	122880;148820;193500;268220;	780;99756;3440;894;3440;896;1529;	780|-|Unknown|Multigenic/multifactorial|Childhood|268210 268220 ~99756|-|-|-|-|268220 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~894|WS1<br>Waardenburg syndrome type I|1-9 / 100 000|Autosomal dominant|Neonatal|193500 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~896|Klein-Waardenburg syndrome<br>WS3<br>Waardenburg syndrome type III<br>Waardenburg syndrome with limb anomalies|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|148820 ~1529|CDHS<br>Sommer-Young-Wee-Frye syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|122880 ~	 ~	.	.	.	.	.	.	.	2	MU81752201	het
2	225346646	225346646	T	C	CUL3	exonic	synonymous SNV	ENSG00000036257	rs2070127	ENSG00000036257:ENST00000344951:exon13:c.A1794G:p.Q598Q,ENSG00000036257:ENST00000264414:exon14:c.A1992G:p.Q664Q,ENSG00000036257:ENST00000409096:exon14:c.A1920G:p.Q640Q,ENSG00000036257:ENST00000409777:exon14:c.A1920G:p.Q640Q	CUL3:NM_001257197:exon13:c.A1794G:p.Q598Q,CUL3:NM_001257198:exon14:c.A2010G:p.Q670Q,CUL3:NM_003590:exon14:c.A1992G:p.Q664Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1845	0.1744	0.232628	0.1837	.	.	.	.	.	.	.	.	CUL3:uc010zls.2:exon13:c.A1794G:p.Q598Q,CUL3:uc002vny.3:exon14:c.A1992G:p.Q664Q,CUL3:uc010fwy.2:exon14:c.A2010G:p.Q670Q	.	AFR:0.2716,AMR:0.2285,EAS:0.2708,FIN:0.1473,NFE:0.1309,OTH:0.1721,ASJ:0.1358	603136	614496;	300530;757;	300530|PHA2E|<1 / 1 000 000|Autosomal dominant|-|614496 ~757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~	.	.	.	.	.	.	.	.	2	MU25439382	het
2	225362478	225362478	C	T	CUL3	exonic	nonsynonymous SNV	ENSG00000036257	rs3738952	ENSG00000036257:ENST00000344951:exon11:c.G1501A:p.V501I,ENSG00000036257:ENST00000264414:exon12:c.G1699A:p.V567I,ENSG00000036257:ENST00000409096:exon12:c.G1627A:p.V543I,ENSG00000036257:ENST00000409777:exon12:c.G1627A:p.V543I	CUL3:NM_001257197:exon11:c.G1501A:p.V501I,CUL3:NM_001257198:exon12:c.G1717A:p.V573I,CUL3:NM_003590:exon12:c.G1699A:p.V567I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1280	0.0712	0.139377	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	3.432	23.0	0.192	6.16	1.000	.	.	Cullin homology|Cullin, N-terminal	CUL3:uc010zls.2:exon11:c.G1501A:p.V501I,CUL3:uc002vny.3:exon12:c.G1699A:p.V567I,CUL3:uc010fwy.2:exon12:c.G1717A:p.V573I	-1.111	AFR:0.0855,AMR:0.0310,EAS:0.0861,FIN:0.2714,NFE:0.0921,OTH:0.0872,ASJ:0.1902	603136	614496;	300530;757;	300530|PHA2E|<1 / 1 000 000|Autosomal dominant|-|614496 ~757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~	.	.	.	.	0.0	-0.76	0.000	0.69	2	1(breast)	0.1255
2	225367669	225367669	C	T	CUL3	intronic	.	ENSG00000036257	rs3754629	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1857	0.1752	0.232628	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1857,AMR:0.2727,EAS:0.1358,FIN:0.2711,NFE:0.1564,OTH:0.1322,ASJ:0.2277	603136	614496;	300530;757;	300530|PHA2E|<1 / 1 000 000|Autosomal dominant|-|614496 ~757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~	.	.	.	.	.	.	.	.	2	1(breast)	0.1728
2	225434445	225434445	A	G	CUL3	exonic	synonymous SNV	ENSG00000036257	rs10498163	.	CUL3:NM_001257198:exon1:c.T45C:p.H15H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2999	.	0.28095	0.2821	.	.	.	.	.	.	.	.	CUL3:uc010fwy.2:exon1:c.T45C:p.H15H	.	AFR:0.1706,AMR:0.3594,EAS:0.3046,FIN:0.2849,NFE:0.3338,OTH:0.3476,ASJ:0.3709	603136	614496;	300530;757;	300530|PHA2E|<1 / 1 000 000|Autosomal dominant|-|614496 ~757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~	.	.	.	.	.	.	.	.	2	MU24815200	het
2	228102723	228102723	G	C	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs13424243	ENSG00000169031:ENST00000396578:exon2:c.G127C:p.G43R	COL4A3:NM_000091:exon2:c.G127C:p.G43R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 2, 1, 0] 	0.2884	0.3511	0.230232	0.3127	4.616	24.5	0.013	4.31	0.001	.	.	.	COL4A3:uc002vom.2:exon2:c.G127C:p.G43R	-1.817	AFR:0.3182,AMR:0.2380,EAS:0.0278,FIN:0.3427,NFE:0.3384,OTH:0.2889,ASJ:0.3477	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	1.0	-4.63	0.000	4.08	2	MU121352	hom
2	228111435	228111435	T	C	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs10178458	ENSG00000169031:ENST00000396578:exon7:c.T422C:p.L141P	COL4A3:NM_000091:exon7:c.T422C:p.L141P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8302	0.7704	0.796725	0.7805	-0.830	0.037	1.0	3.62	0.029	.	.	.	COL4A3:uc002vom.2:exon7:c.T422C:p.L141P	-0.919	AFR:0.6284,AMR:0.8720,EAS:0.9280,FIN:0.8270,NFE:0.8347,OTH:0.8180,ASJ:0.7781	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.004	-3.4	0.000	-1.39	2	MU18207837	hom
2	228113175	228113175	A	G	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs6436669	ENSG00000169031:ENST00000396578:exon9:c.A485G:p.E162G	COL4A3:NM_000091:exon9:c.A485G:p.E162G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8304	0.7701	0.796326	0.7808	0.832	9.659	0.828	1.24	0.181	.	.	.	COL4A3:uc002vom.2:exon9:c.A485G:p.E162G	-0.962	AFR:0.6290,AMR:0.8723,EAS:0.9284,FIN:0.8286,NFE:0.8343,OTH:0.8184,ASJ:0.7781	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.001	-3.17	0.000	1.355	2	MU18208095	hom
2	228121101	228121101	G	T	COL4A3	exonic	nonsynonymous SNV	ENSG00000169031	rs55703767	ENSG00000169031:ENST00000396578:exon17:c.G976T:p.D326Y	COL4A3:NM_000091:exon17:c.G976T:p.D326Y	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.1668	0.1658	0.115815	0.1557	3.398	23.0	0.113	3.01	0.980	.	.	.	COL4A3:uc002vom.2:exon17:c.G976T:p.D326Y	-0.969	AFR:0.0383,AMR:0.1253,EAS:0.1114,FIN:0.1933,NFE:0.2184,OTH:0.1969,ASJ:0.1887	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	0.244	-3.3	0.001	1.89	2	MU156674	het
2	228128540	228128540	C	T	COL4A3	exonic	synonymous SNV	ENSG00000169031	rs10205042	ENSG00000169031:ENST00000396578:exon21:c.C1195T:p.L399L	COL4A3:NM_000091:exon21:c.C1195T:p.L399L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7667	0.7180	0.767572	0.7419	.	.	.	.	.	.	.	.	COL4A3:uc002vom.2:exon21:c.C1195T:p.L399L	.	AFR:0.6775,AMR:0.8242,EAS:0.8912,FIN:0.8013,NFE:0.7453,OTH:0.7597,ASJ:0.6589	120070	104200;141200;203780;	63;88919;63;88918;	63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88919|-|-|Autosomal recessive|Childhood|203780 ~63|Alport deafness-nephropathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked dominant|Childhood|104200 203780 301050 ~88918|-|-|Autosomal dominant|Childhood|104200 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	2	MU18208390	het
2	228159661	228159662	TT	-	LOC654841	ncRNA_intronic	.	ENSG00000236432	rs202047534	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2051	.	0.228035	0.1807	.	.	.	.	.	.	.	.	.	.	AFR:0.2001,AMR:0.1219,EAS:0.2827,FIN:0.1517,NFE:0.1620,OTH:0.1718,ASJ:0.1230	.	.	.	.	.	.	.	.	.	.	.	.	2	MU2279050	unknown
2	232952286	232952286	A	G	DIS3L2	exonic	synonymous SNV	ENSG00000144535	rs11887184	ENSG00000144535:ENST00000409307:exon5:c.A456G:p.Q152Q,ENSG00000144535:ENST00000433430:exon5:c.A456G:p.Q152Q,ENSG00000144535:ENST00000273009:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000325385:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000360410:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000390005:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000409401:exon6:c.A456G:p.Q152Q,ENSG00000144535:ENST00000445090:exon6:c.A456G:p.Q152Q	DIS3L2:NM_001257281:exon6:c.A456G:p.Q152Q,DIS3L2:NM_001257282:exon6:c.A456G:p.Q152Q,DIS3L2:NM_152383:exon6:c.A456G:p.Q152Q	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0961	0.1047	0.11242	0.1046	.	.	.	.	.	.	.	.	DIS3L2:uc010fxz.3:exon6:c.A456G:p.Q152Q,DIS3L2:uc031rrt.1:exon6:c.A456G:p.Q152Q	.	AFR:0.1882,AMR:0.1471,EAS:0.0389,FIN:0.0685,NFE:0.0699,OTH:0.0988,ASJ:0.0894	614184	267000;	2849;	2849|Nephroblastomatosis-fetal ascites-macrosomia-Wilms tumor syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267000 ~	.	.	.	.	.	.	.	.	2	.	het
2	234669144	234669144	G	A	UGT1A1	exonic	nonsynonymous SNV	ENSG00000241635;ENSG00000242366	rs4148323	ENSG00000242366:ENST00000305208:exon1:c.G211A:p.G71R,ENSG00000241635:ENST00000360418:exon1:c.G211A:p.G71R,ENSG00000241635:ENST00000608383:exon1:c.G211A:p.G71R	UGT1A1:NM_000463:exon1:c.G211A:p.G71R	clinvar: drug_response 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0207	0.0013	0.034345	3(lung)	4.055	23.7	0.04	5.14	0.951	.	.	.	UGT1A1:uc002vvb.3:exon1:c.G211A:p.G71R,UGT1A1:uc010znc.1:exon1:c.G211A:p.G71R	-1.081	AFR:MU13449765,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.0005,FIN:0.0227,NFE:0,OTH:0.1434,ASJ:0.0149	191740	143500;218800;237900;601816;606785;	205;79235;2312;205;79234;	205|Bilirubin uridinediphosphate glucuronosyltransferase deficiency<br>Bilirubin-UGT deficiency<br>Hereditary unconjugated hyperbilirubinemia<br>UGT deficiency|1-9 / 100 000|Autosomal recessive|Neonatal|218800 606785 ~79235|Arias syndrome<br>Bilirubin uridinediphosphate glucuronosyltransferase deficiency type 2<br>Bilirubin-UGT deficiency type 2<br>Hereditary unconjugated hyperbilirubinemia type 2<br>UGT deficiency type 2|Unknown|Autosomal recessive|Childhood|606785 ~2312|Lucey-Driscoll syndrome|-|-|-|237900 ~205|Bilirubin uridinediphosphate glucuronosyltransferase deficiency<br>Bilirubin-UGT deficiency<br>Hereditary unconjugated hyperbilirubinemia<br>UGT deficiency|1-9 / 100 000|Autosomal recessive|Neonatal|218800 606785 ~79234|Bilirubin uridinediphosphate glucuronosyltransferase deficiency type 1<br>Bilirubin-UGT deficiency type 1<br>Hereditary unconjugated hyperbilirubinemia type 1<br>UGT deficiency type 1|Unknown|Autosomal recessive|Infancy<br>Neonatal|218800 ~	~ko00040 Pentose and glucuronate interconversions~ko00053 Ascorbate and aldarate metabolism~ko00140 Steroid hormone biosynthesis~ko00830 Retinol metabolism~ko00860 Porphyrin and chlorophyll metabolism~ko00980 Metabolism of xenobiotics by cytochrome P450~ko00982 Drug metabolism - cytochrome P450~ko00983 Drug metabolism - other enzymes~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko05204 Chemical carcinogenesis~~M00014 Glucuronate pathway (uronate pathway)~M00129 Ascorbate biosynthesis, animals, glucose-1P => ascorbate ~	.	.	.	0.127	0.09	0.001	1.39	2	1(haematopoietic_and_lymphoid_tissue)	0.0426
2	240003870	240003870	G	A	HDAC4	exonic	synonymous SNV	ENSG00000068024	rs1063639	ENSG00000068024:ENST00000543185:exon15:c.C1317T:p.P439P,ENSG00000068024:ENST00000345617:exon21:c.C2565T:p.P855P	HDAC4:NM_006037:exon21:c.C2565T:p.P855P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5333	0.5061	0.595248	0.5092	.	.	.	.	.	.	.	.	HDAC4:uc010fyy.3:exon18:c.C2436T:p.P812P,HDAC4:uc002vyk.4:exon21:c.C2565T:p.P855P	.	AFR:0.5783,AMR:0.6277,EAS:0.7295,FIN:0.4685,NFE:0.4490,OTH:0.5092,ASJ:0.4667	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	MU792285	hom
2	240078488	240078488	C	G	HDAC4	intronic	.	ENSG00000068024	rs76103770	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0896	0.0855	0.0860623	0.0939	.	.	.	.	.	.	.	.	.	.	AFR:0.0533,AMR:0.0789,EAS:0.1885,FIN:0.0971,NFE:0.1082,OTH:0.0937,ASJ:0.0497	605314	.	.	.	~ko04371 Apelin signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	2	MU737330	het
3	3192636	3192636	A	G	CRBN	exonic	synonymous SNV	ENSG00000113851	rs199720401	ENSG00000113851:ENST00000231948:exon11:c.T1242C:p.F414F,ENSG00000113851:ENST00000432408:exon11:c.T1239C:p.F413F	CRBN:NM_001173482:exon11:c.T1239C:p.F413F,CRBN:NM_016302:exon11:c.T1242C:p.F414F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1] 	0.0098	0.0002	0.0165735	0.0002	.	.	.	.	.	.	.	.	CRBN:uc003bpq.3:exon11:c.T1242C:p.F414F,CRBN:uc003bpr.3:exon11:c.T1239C:p.F413F	.	AFR:0.0002,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0.0031,ASJ:0	609262	607417;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	2056,2057,2055,	.	.	.	.	.	.	3	.	het
3	3197918	3197918	A	G	CRBN	exonic	synonymous SNV	ENSG00000113851	rs17027638	ENSG00000113851:ENST00000231948:exon6:c.T735C:p.Y245Y,ENSG00000113851:ENST00000432408:exon6:c.T732C:p.Y244Y	CRBN:NM_001173482:exon6:c.T732C:p.Y244Y,CRBN:NM_016302:exon6:c.T735C:p.Y245Y	clinvar: Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.1349	0.0154	0.248403	0.0734	.	.	.	.	.	.	.	.	CRBN:uc011aso.2:exon5:c.T546C:p.Y182Y,CRBN:uc003bpq.3:exon6:c.T735C:p.Y245Y,CRBN:uc003bpr.3:exon6:c.T732C:p.Y244Y	.	AFR:0.0103,AMR:0.2422,EAS:0.6993,FIN:0.1083,NFE:0.0252,OTH:0.0908,ASJ:0.0099	609262	607417;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	2056,2057,2055,	.	.	.	.	.	.	3	MU18013455	het
3	3215954	3215954	A	G	CRBN	intronic	.	ENSG00000113851	rs1669321	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9673	0.8820	0.883786	0.9009	.	.	.	.	.	0.0001	0.07	.	.	.	AFR:0.6555,AMR:0.9713,EAS:1,FIN:1,NFE:0.9985,OTH:0.9786,ASJ:0.9934	609262	607417;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	3	MU81756919	hom
3	8955389	8955389	C	T	RAD18	exonic	nonsynonymous SNV	ENSG00000070950	rs373572	ENSG00000070950:ENST00000264926:exon8:c.G905A:p.R302Q	RAD18:NM_020165:exon8:c.G905A:p.R302Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6951	0.7043	0.647564	0.6904	3.782	23.4	0.617	4.47	0.998	.	.	SAP domain	RAD18:uc003brd.3:exon8:c.G905A:p.R302Q	-0.988	AFR:0.6630,AMR:0.6631,EAS:0.3531,FIN:0.7584,NFE:0.7244,OTH:0.7270,ASJ:0.7550	605256	.	.	.	.	.	.	.	0.001	1.85	0.000	-1.61	3	MU17638060	hom
3	9005078	9005078	C	T	RAD18	UTR5	.	ENSG00000070950	rs615967	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7529	0.6622	0.597644	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.6503,AMR:0.3926,EAS:0.8046,FIN:0.3831,NFE:0.7921,OTH:0.7830,ASJ:0.6914	605256	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.7561
3	9517369	9517369	C	T	SETD5	exonic	nonsynonymous SNV	ENSG00000168137	rs11542009	ENSG00000168137:ENST00000407969:exon21:c.C3980T:p.T1327I,ENSG00000168137:ENST00000302463:exon22:c.C3629T:p.T1210I,ENSG00000168137:ENST00000406341:exon22:c.C3923T:p.T1308I,ENSG00000168137:ENST00000402198:exon23:c.C3923T:p.T1308I,ENSG00000168137:ENST00000402466:exon24:c.C3629T:p.T1210I	SETD5:NM_001080517:exon23:c.C3923T:p.T1308I,SETD5:NM_001292043:exon25:c.C3629T:p.T1210I,SETD5:NM_001349451:exon26:c.C3629T:p.T1210I	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 0, 0] 	0.0760	0.0835	0.0393371	ESAD-UK|1|409|0.00244499	3.711	23.3	0.018	5.23	1.000	.	.	.	SETD5:uc003brx.3:exon13:c.C2930T:p.T977I,SETD5:uc010hck.3:exon14:c.C2369T:p.T790I,SETD5:uc003brv.3:exon19:c.C3590T:p.T1197I,SETD5:uc003bru.3:exon22:c.C3629T:p.T1210I,SETD5:uc003brt.3:exon23:c.C3923T:p.T1308I	-0.586	AFR:0.0782,AMR:0.0282,EAS:0.1258,FIN:0.0019,NFE:0.0590,OTH:0.1199,ASJ:0.0538	615743	615761;	404440;	404440|-|<1 / 1 000 000|Unknown|Neonatal<br>Infancy|615761 ~	.	.	.	.	0.908	-2.86	0.043	0.805	3	1(salivary_gland)	0.0878
3	9792690	9792690	A	G	OGG1	exonic	nonsynonymous SNV	ENSG00000114026	.	ENSG00000114026:ENST00000302003:exon2:c.A199G:p.T67A,ENSG00000114026:ENST00000302008:exon2:c.A199G:p.T67A,ENSG00000114026:ENST00000302036:exon2:c.A199G:p.T67A,ENSG00000114026:ENST00000339511:exon2:c.A199G:p.T67A,ENSG00000114026:ENST00000344629:exon2:c.A199G:p.T67A,ENSG00000114026:ENST00000349503:exon2:c.A199G:p.T67A,ENSG00000114026:ENST00000383826:exon2:c.A199G:p.T67A,ENSG00000114026:ENST00000449570:exon2:c.A199G:p.T67A	OGG1:NM_001354648:exon2:c.A199G:p.T67A,OGG1:NM_001354649:exon2:c.A199G:p.T67A,OGG1:NM_001354650:exon2:c.A199G:p.T67A,OGG1:NM_001354651:exon2:c.A199G:p.T67A,OGG1:NM_001354652:exon2:c.A199G:p.T67A,OGG1:NM_002542:exon2:c.A199G:p.T67A,OGG1:NM_016819:exon2:c.A199G:p.T67A,OGG1:NM_016820:exon2:c.A199G:p.T67A,OGG1:NM_016821:exon2:c.A199G:p.T67A,OGG1:NM_016826:exon2:c.A199G:p.T67A,OGG1:NM_016827:exon2:c.A199G:p.T67A,OGG1:NM_016828:exon2:c.A199G:p.T67A,OGG1:NM_016829:exon2:c.A199G:p.T67A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	.	.	.	.	0.258	5.280	0.129	4.37	0.998	.	.	8-oxoguanine DNA glycosylase, N-terminal	OGG1:uc003bsh.3:exon2:c.A199G:p.T67A,OGG1:uc003bsi.3:exon2:c.A199G:p.T67A,OGG1:uc003bsj.3:exon2:c.A199G:p.T67A,OGG1:uc003bsk.3:exon2:c.A199G:p.T67A,OGG1:uc003bsl.3:exon2:c.A199G:p.T67A,OGG1:uc003bsm.3:exon2:c.A199G:p.T67A,OGG1:uc003bsn.3:exon2:c.A199G:p.T67A,OGG1:uc003bso.3:exon2:c.A199G:p.T67A	-0.827	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601982	144700;	422526;	422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.523	0.57	0.187	2.705	3	.	het
3	9798140	9798140	C	G	OGG1	intronic	.	ENSG00000114026	rs2072668	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2810	0.2437	0.335463	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.2496,AMR:0.2605,EAS:0.2219,FIN:0.6127,NFE:0.1855,OTH:0.2167,ASJ:0.3361	601982	144700;	422526;	422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.2261
3	9798773	9798773	C	G	OGG1	exonic	nonsynonymous SNV	ENSG00000114026	rs1052133	ENSG00000114026:ENST00000302003:exon7:c.C994G:p.P332A,ENSG00000114026:ENST00000344629:exon7:c.C977G:p.S326C	OGG1:NM_001354649:exon5:c.C644G:p.S215C,OGG1:NM_002542:exon7:c.C977G:p.S326C,OGG1:NM_016820:exon7:c.C994G:p.P332A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2721	0.2111	0.302117	2(soft_tissue)	0.045	3.028	0.176	-1.32	0.038	.	.	.	OGG1:uc003bsq.2:exon3:c.C121G:p.P41A,OGG1:uc003bsp.2:exon4:c.C289G:p.P97A,OGG1:uc003bsr.2:exon4:c.C272G:p.S91C,OGG1:uc010hcm.2:exon4:c.C355G:p.P119A,OGG1:uc003bsi.3:exon7:c.C977G:p.S326C,OGG1:uc003bsj.3:exon7:c.C994G:p.P332A	-0.903	AFR:2(lung),AMR:MU138292,EAS:0.2224,FIN:0.1674,NFE:0.3305,OTH:0.2185,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	601982	144700;	422526;	422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.121	0.73	0.000	0.69	3	2(haematopoietic_and_lymphoid_tissue)	0.6068
3	9823302	9823302	T	G	TADA3	intronic	.	ENSG00000114026;ENSG00000171148	rs6443264	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2646	.	0.331869	0.2429	.	.	.	.	.	.	.	.	.	.	AFR:0.2447,AMR:0.3385,EAS:0.6002,FIN:0.1853,NFE:0.2131,OTH:0.2245,ASJ:0.2152	602945	.	.	.	.	.	.	.	.	.	.	.	3	MU792546	het
3	9824651	9824651	C	T	TADA3	intronic	.	ENSG00000114026;ENSG00000171148	rs6443265	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.65016	0.6563	.	.	.	.	.	.	.	.	.	.	AFR:0.5406,AMR:0.6340,EAS:0.7360,FIN:0.6966,NFE:0.7027,OTH:0.6708,ASJ:0.8146	602945	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	10128965	10128965	-	T	FANCD2;FANCD2OS	intronic	.	ENSG00000144554;ENSG00000163705	rs371321981	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0390	.	.	0.0298	.	.	.	.	.	.	.	.	.	.	AFR:0.0190,AMR:0.0217,EAS:0.0136,FIN:0.0163,NFE:0.0386,OTH:0.0309,ASJ:0.0354	.	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	10142949	10142949	C	T	FANCD2	UTR3	.	ENSG00000144554	rs3172417	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3281	0.3072	0.214657	.	.	.	.	.	.	.	.	.	.	.	AFR:0.3122,AMR:0.0833,EAS:0.4834,FIN:0.1103,NFE:0.4501,OTH:0.4301,ASJ:0.2512	613984	227646;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	3	17(soft_tissue)	0.3905
3	14174427	14174427	A	T	TMEM43	exonic	nonsynonymous SNV	ENSG00000170876	rs4685076	ENSG00000170876:ENST00000306077:exon6:c.A504T:p.K168N	TMEM43:NM_024334:exon6:c.A504T:p.K168N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3209	0.2876	0.352636	0.2969	2.489	19.40	0.219	1.56	1.000	.	.	.	TMEM43:uc003byl.1:exon4:c.A144T:p.K48N,TMEM43:uc003byk.2:exon6:c.A504T:p.K168N	-0.896	AFR:0.2786,AMR:0.4212,EAS:0.4300,FIN:0.2923,NFE:0.2893,OTH:0.2740,ASJ:0.2682	612048	604400;614302;	261;98853;217656;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.203	1.3	0.000	2.015	3	MU124093	het
3	14175262	14175262	T	C	TMEM43	exonic	nonsynonymous SNV	ENSG00000170876	rs2340917	ENSG00000170876:ENST00000306077:exon7:c.T536C:p.M179T	TMEM43:NM_024334:exon7:c.T536C:p.M179T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3724	0.3328	0.463259	0.3565	0.428	6.855	1.0	5.32	0.297	.	.	.	TMEM43:uc003byl.1:exon5:c.T176C:p.M59T,TMEM43:uc003byk.2:exon7:c.T536C:p.M179T	-0.943	AFR:0.4188,AMR:0.5095,EAS:0.6592,FIN:0.3033,NFE:0.2967,OTH:0.3037,ASJ:0.2682	612048	604400;614302;	261;98853;217656;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.0	1.6	0.000	-2.25	3	MU124112	het
3	14187449	14187449	G	T	XPC	exonic	nonsynonymous SNV	ENSG00000154767	rs2228001	ENSG00000154767:ENST00000285021:exon16:c.C2815A:p.Q939K,ENSG00000154767:ENST00000449060:exon16:c.C2704A:p.Q902K	XPC:NM_001354726:exon15:c.C2236A:p.Q746K,XPC:NM_001354727:exon16:c.C2809A:p.Q937K,XPC:NM_001354729:exon16:c.C2797A:p.Q933K,XPC:NM_001354730:exon16:c.C2569A:p.Q857K,XPC:NM_004628:exon16:c.C2815A:p.Q939K	clinvar: drug_response 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6325	0.6421	0.684704	0.6556	1.250	12.01	1.0	4.24	0.998	.	.	.	XPC:uc011avf.2:exon15:c.C2236A:p.Q746K,XPC:uc011ave.2:exon16:c.C2815A:p.Q939K,XPC:uc011avg.2:exon16:c.C2704A:p.Q902K	-0.955	AFR:0.7228,AMR:0.7057,EAS:0.6382,FIN:0.6985,NFE:0.6087,OTH:0.6337,ASJ:0.5629	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.0	1.93	0.000	-2.455	3	MU11483739	het
3	14190237	14190237	T	G	XPC	intronic	.	ENSG00000154767	rs2279017	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6302	0.6353	0.679712	0.6502	.	.	.	.	.	0	0.046	.	.	.	AFR:0.7024,AMR:0.7041,EAS:0.6413,FIN:0.6985,NFE:0.6094,OTH:0.6319,ASJ:0.5667	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	MU705240	het
3	14197987	14197987	A	T	XPC	exonic	synonymous SNV	ENSG00000154767	rs2958057	ENSG00000154767:ENST00000285021:exon10:c.T1881A:p.A627A,ENSG00000154767:ENST00000449060:exon10:c.T1770A:p.A590A	XPC:NM_001354726:exon9:c.T1302A:p.A434A,XPC:NM_001354729:exon10:c.T1863A:p.A621A,XPC:NM_001354730:exon10:c.T1635A:p.A545A,XPC:NM_004628:exon10:c.T1881A:p.A627A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	1	.	1	1	.	.	.	.	.	.	.	.	XPC:uc021wtl.1:exon2:c.T99A:p.A33A,XPC:uc011avf.2:exon9:c.T1302A:p.A434A,XPC:uc011ave.2:exon10:c.T1881A:p.A627A,XPC:uc011avg.2:exon10:c.T1770A:p.A590A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	3	MU81758228	hom
3	14220023	14220023	G	C	XPC	exonic	nonsynonymous SNV	ENSG00000154767	rs1870134	ENSG00000154767:ENST00000285021:exon1:c.C46G:p.L16V,ENSG00000154767:ENST00000449060:exon1:c.C46G:p.L16V,ENSG00000154767:ENST00000476581:exon1:c.C46G:p.L16V,ENSG00000154767:ENST00000511155:exon1:c.C46G:p.L16V	XPC:NM_001354727:exon1:c.C46G:p.L16V,XPC:NM_001354729:exon1:c.C46G:p.L16V,XPC:NM_001354730:exon1:c.C46G:p.L16V,XPC:NM_004628:exon1:c.C46G:p.L16V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0378	0.0049	0.0650958	3(prostate)	-1.850	0.002	0.244	-4.02	0.000	.	.	.	XPC:uc011ave.2:exon1:c.C46G:p.L16V,XPC:uc011avg.2:exon1:c.C46G:p.L16V	-1.071	AFR:3(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,FIN:0.0194,NFE:0.0046,OTH:0.0800,ASJ:MU758474	613208	278720;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.001	0.94	0.000	0.69	3	2(lung)	0
3	25502851	25502851	G	A	RARB	intronic	.	ENSG00000077092	rs77748152	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0649	0.0284	0.0642971	COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.0424,AMR:0.0121,EAS:0.0133,FIN:0.0519,NFE:0.0975,OTH:0.0384,ASJ:0.1659	180220	615524;	2470;	2470|Anophthalmia-pulmonary hypoplasia syndrome<br>MCOPS9<br>Syndromic microphthalmia type 9|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601186 615524 ~	~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	1(haematopoietic_and_lymphoid_tissue)	0.0656
3	25679806	25679826	AAAAAAAAAAAAAAAAAAAAA	-	TOP2B	intronic	.	ENSG00000077097	rs752264371	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0021	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	126431	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	30656168	30656168	G	A	TGFBR2	intronic	.	ENSG00000163513	rs6791557	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.502995	0.4614	.	.	.	.	.	.	.	.	.	.	AFR:0.3984,AMR:0.4117,EAS:0.7776,FIN:0.5140,NFE:0.4560,OTH:0.4826,ASJ:0.3154	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU86952688	hom
3	30686414	30686414	A	G	TGFBR2	intronic	.	ENSG00000163513	rs1155705	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3725	0.3215	0.412939	0.3733	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3381,AMR:0.3005,EAS:0.6901,FIN:0.3946,NFE:0.3618,OTH:0.3615,ASJ:0.2616	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU15034252	hom
3	30713126	30713126	T	A	TGFBR2	intronic	.	ENSG00000163513	rs11466512	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2928	0.2555	0.271965	0.2595	.	.	.	.	.	0.0003	0.022	.	.	.	AFR:0.1511,AMR:0.4243,EAS:0.2998,FIN:0.2978,NFE:0.3006,OTH:0.2658,ASJ:0.2167	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU585873	het
3	30713842	30713842	C	T	TGFBR2	exonic	synonymous SNV	ENSG00000163513	rs2228048	ENSG00000163513:ENST00000295754:exon4:c.C1167T:p.N389N,ENSG00000163513:ENST00000359013:exon5:c.C1242T:p.N414N	TGFBR2:NM_003242:exon4:c.C1167T:p.N389N,TGFBR2:NM_001024847:exon5:c.C1242T:p.N414N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0551	0.0183	0.103435	0.0426	.	.	.	.	.	.	.	.	TGFBR2:uc003ceo.3:exon4:c.C1167T:p.N389N,TGFBR2:uc021wut.1:exon4:c.C801T:p.N267N,TGFBR2:uc003cen.3:exon5:c.C1242T:p.N414N	.	AFR:0.0320,AMR:0.0215,EAS:0.3201,FIN:0.0470,NFE:0.0189,OTH:0.0399,ASJ:0.0563	190182	133239;610168;614331;	144;284973;558;60030;91387;99977;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~284973|MFS2|-|Autosomal dominant|All ages|610168 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~60030|Aortic aneurysm syndrome due to TGF-beta receptors anomalies|Unknown|Autosomal dominant|Infancy<br>Neonatal|609192 610168 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04659 Th17 cell differentiation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05142 Chagas disease (American trypanosomiasis)~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	3	MU764777	het
3	38592406	38592406	A	G	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs1805126	ENSG00000183873:ENST00000414099:exon26:c.T5403C:p.D1801D,ENSG00000183873:ENST00000449557:exon26:c.T5295C:p.D1765D,ENSG00000183873:ENST00000450102:exon26:c.T5295C:p.D1765D,ENSG00000183873:ENST00000423572:exon27:c.T5454C:p.D1818D,ENSG00000183873:ENST00000425664:exon27:c.T5403C:p.D1801D,ENSG00000183873:ENST00000451551:exon27:c.T5295C:p.D1765D,ENSG00000183873:ENST00000455624:exon27:c.T5358C:p.D1786D,ENSG00000183873:ENST00000333535:exon28:c.T5457C:p.D1819D,ENSG00000183873:ENST00000413689:exon28:c.T5457C:p.D1819D,ENSG00000183873:ENST00000443581:exon28:c.T5454C:p.D1818D	SCN5A:NM_001099405:exon27:c.T5403C:p.D1801D,SCN5A:NM_001160161:exon27:c.T5295C:p.D1765D,SCN5A:NM_001354701:exon27:c.T5400C:p.D1800D,SCN5A:NM_000335:exon28:c.T5454C:p.D1818D,SCN5A:NM_001099404:exon28:c.T5457C:p.D1819D,SCN5A:NM_001160160:exon28:c.T5358C:p.D1786D,SCN5A:NM_198056:exon28:c.T5457C:p.D1819D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3878	0.4314	0.492412	0.4472	.	.	.	.	.	.	.	.	SCN5A:uc021wvj.1:exon24:c.T4893C:p.D1631D,SCN5A:uc021wvi.1:exon25:c.T5055C:p.D1685D,SCN5A:uc021wvl.1:exon26:c.T5295C:p.D1765D,SCN5A:uc021wvm.1:exon26:c.T5403C:p.D1801D,SCN5A:uc021wvk.1:exon27:c.T5358C:p.D1786D,SCN5A:uc021wvn.1:exon27:c.T5454C:p.D1818D,SCN5A:uc021wvo.1:exon27:c.T5457C:p.D1819D,SCN5A:uc021wvp.1:exon27:c.T5457C:p.D1819D	.	AFR:0.6625,AMR:0.3765,EAS:0.5580,FIN:0.4376,NFE:0.3240,OTH:0.3633,ASJ:0.3367	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	MU4554855	het
3	38622467	38622467	T	C	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs7430407	ENSG00000183873:ENST00000414099:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000423572:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000449557:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000450102:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000455624:exon16:c.A3183G:p.E1061E,ENSG00000183873:ENST00000333535:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000413689:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000425664:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000443581:exon17:c.A3183G:p.E1061E,ENSG00000183873:ENST00000451551:exon17:c.A3183G:p.E1061E	SCN5A:NM_000335:exon17:c.A3183G:p.E1061E,SCN5A:NM_001099404:exon17:c.A3183G:p.E1061E,SCN5A:NM_001099405:exon17:c.A3183G:p.E1061E,SCN5A:NM_001160160:exon17:c.A3183G:p.E1061E,SCN5A:NM_001160161:exon17:c.A3183G:p.E1061E,SCN5A:NM_001354701:exon17:c.A3183G:p.E1061E,SCN5A:NM_198056:exon17:c.A3183G:p.E1061E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9128	0.8850	0.923123	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SCN5A:uc021wvw.1:exon8:c.A2016G:p.E672E,SCN5A:uc021wvi.1:exon14:c.A2781G:p.E927E,SCN5A:uc021wvj.1:exon14:c.A2781G:p.E927E,SCN5A:uc021wvk.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvl.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvm.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvn.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvo.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvp.1:exon16:c.A3183G:p.E1061E,SCN5A:uc021wvq.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvr.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvs.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvt.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvu.1:exon17:c.A3183G:p.E1061E,SCN5A:uc021wvv.1:exon17:c.A3183G:p.E1061E	.	AFR:0.9032,AMR:0.8836,EAS:0.8742,FIN:0.9994,NFE:0.9242,OTH:0.8978,ASJ:0.9284	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	1(thyroid)	0.9155
3	38645325	38645325	T	G	SCN5A	exonic	nonsynonymous SNV	ENSG00000183873	rs1060501143	ENSG00000183873:ENST00000414099:exon11:c.A1768C:p.K590Q,ENSG00000183873:ENST00000423572:exon11:c.A1768C:p.K590Q,ENSG00000183873:ENST00000449557:exon11:c.A1768C:p.K590Q,ENSG00000183873:ENST00000450102:exon11:c.A1768C:p.K590Q,ENSG00000183873:ENST00000455624:exon11:c.A1768C:p.K590Q,ENSG00000183873:ENST00000333535:exon12:c.A1768C:p.K590Q,ENSG00000183873:ENST00000413689:exon12:c.A1768C:p.K590Q,ENSG00000183873:ENST00000425664:exon12:c.A1768C:p.K590Q,ENSG00000183873:ENST00000443581:exon12:c.A1768C:p.K590Q,ENSG00000183873:ENST00000451551:exon12:c.A1768C:p.K590Q	SCN5A:NM_000335:exon12:c.A1768C:p.K590Q,SCN5A:NM_001099404:exon12:c.A1768C:p.K590Q,SCN5A:NM_001099405:exon12:c.A1768C:p.K590Q,SCN5A:NM_001160160:exon12:c.A1768C:p.K590Q,SCN5A:NM_001160161:exon12:c.A1768C:p.K590Q,SCN5A:NM_001354701:exon12:c.A1768C:p.K590Q,SCN5A:NM_198056:exon12:c.A1768C:p.K590Q	clinvar: Uncertain_significance 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 2, 0, 0] 	.	.	.	.	4.610	24.4	0.011	4.12	0.999	.	.	Voltage-gated Na+ ion channel, cytoplasmic domain	SCN5A:uc021wvw.1:exon3:c.A601C:p.K201Q,SCN5A:uc021wvi.1:exon9:c.A1366C:p.K456Q,SCN5A:uc021wvj.1:exon9:c.A1366C:p.K456Q,SCN5A:uc021wvk.1:exon11:c.A1768C:p.K590Q,SCN5A:uc021wvl.1:exon11:c.A1768C:p.K590Q,SCN5A:uc021wvm.1:exon11:c.A1768C:p.K590Q,SCN5A:uc021wvn.1:exon11:c.A1768C:p.K590Q,SCN5A:uc021wvo.1:exon11:c.A1768C:p.K590Q,SCN5A:uc021wvp.1:exon11:c.A1768C:p.K590Q,SCN5A:uc021wvq.1:exon12:c.A1768C:p.K590Q,SCN5A:uc021wvr.1:exon12:c.A1768C:p.K590Q,SCN5A:uc021wvs.1:exon12:c.A1768C:p.K590Q,SCN5A:uc021wvt.1:exon12:c.A1768C:p.K590Q,SCN5A:uc021wvu.1:exon12:c.A1768C:p.K590Q,SCN5A:uc021wvv.1:exon12:c.A1768C:p.K590Q	0.938	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	0.999	-2.99	0.869	2.915	3	.	het
3	38674712	38674712	T	C	SCN5A	exonic	synonymous SNV	ENSG00000183873	rs6599230	ENSG00000183873:ENST00000414099:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000423572:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000449557:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000450102:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000455624:exon1:c.A87G:p.A29A,ENSG00000183873:ENST00000327956:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000333535:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000413689:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000425664:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000443581:exon2:c.A87G:p.A29A,ENSG00000183873:ENST00000451551:exon2:c.A87G:p.A29A	SCN5A:NM_000335:exon2:c.A87G:p.A29A,SCN5A:NM_001099404:exon2:c.A87G:p.A29A,SCN5A:NM_001099405:exon2:c.A87G:p.A29A,SCN5A:NM_001160160:exon2:c.A87G:p.A29A,SCN5A:NM_001160161:exon2:c.A87G:p.A29A,SCN5A:NM_001354701:exon2:c.A87G:p.A29A,SCN5A:NM_198056:exon2:c.A87G:p.A29A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7737	0.8360	0.781749	0.7947	.	.	.	.	.	.	.	.	SCN5A:uc021wvx.1:exon2:c.A95G:p.Q32R	.	AFR:0.8943,AMR:0.7255,EAS:0.7012,FIN:0.6997,NFE:0.7774,OTH:0.7398,ASJ:0.7417	600163	113900;272120;601144;601154;603829;603830;608567;614022;	334;166282;101016;768;228140;154;130;871;	334|-|-|Autosomal dominant|-|607554 608583 608988 611493 611494 611819 612201 612240 613055 613120 613980 614022 614049 614050 615377 615378 615770 ~166282|Familial sinus node dysfunction|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|163800 182190 608567 614090 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~228140|Familial paroxysmal ventricular fibrillation, non Brugada type|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|All ages|603829 612956 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~130|Bangungut<br>Dream disease<br>Idiopathic ventricular fibrillation, Brugada type<br>Pokkuri death syndrome<br>SUNDS<br>Sudden unexplained nocturnal death syndrome|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|601144 611777 611875 611876 612838 613119 613120 613123 616399 ~871|Familial Lengre disease<br>Familial Lev disease<br>Familial Lev-Lengre disease<br>Familial PCCD<br>Familial progressive heart block<br>Hereditary bundle branch defect|Unknown|Autosomal dominant|Adult|113900 115080 140400 604559 612838 ~	.	.	.	.	.	.	.	.	3	MU24669512	hom
3	39108503	39108503	G	A	WDR48	exonic	synonymous SNV	ENSG00000114742	rs7624734	.	WDR48:NM_001346225:exon6:c.G537A:p.L179L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.447085	0.4558	.	.	.	.	.	.	.	.	.	.	AFR:0.7795,AMR:0.3055,EAS:0.3959,FIN:0.2959,NFE:0.3285,OTH:0.3391,ASJ:0.3967	612167	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	39111140	39111140	C	A	WDR48	exonic	synonymous SNV	ENSG00000114742	rs2293312	ENSG00000114742:ENST00000396258:exon6:c.C331A:p.R111R,ENSG00000114742:ENST00000302313:exon7:c.C577A:p.R193R,ENSG00000114742:ENST00000441361:exon7:c.C367A:p.R123R	WDR48:NM_001303402:exon6:c.C331A:p.R111R,WDR48:NM_001346227:exon6:c.C52A:p.R18R,WDR48:NM_001303403:exon7:c.C550A:p.R184R,WDR48:NM_001346226:exon7:c.C406A:p.R136R,WDR48:NM_001346228:exon7:c.C367A:p.R123R,WDR48:NM_020839:exon7:c.C577A:p.R193R,WDR48:NM_001346225:exon8:c.C691A:p.R231R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3509	0.4692	0.447085	MU11645448	.	.	.	.	.	.	.	.	WDR48:uc011ayu.1:exon6:c.C331A:p.R111R,WDR48:uc003cit.3:exon7:c.C577A:p.R193R,WDR48:uc011ayt.1:exon7:c.C550A:p.R184R	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.4561,EAS:0.3055,FIN:0.4033,NFE:0.3949,OTH:0.2959,ASJ:0.7793	612167	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.3289
3	39129742	39129742	A	C	WDR48	intronic	.	ENSG00000114742	rs3736573	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3433	0.4588	0.476038	0.4502	.	.	.	.	.	.	.	.	.	.	AFR:0.8189,AMR:0.3337,EAS:0.5508,FIN:0.2609,NFE:0.2854,OTH:0.3231,ASJ:0.3775	612167	.	.	.	.	.	.	.	.	.	.	.	3	MU18051743	hom
3	46904812	46904812	G	A	MYL3	exonic	synonymous SNV	ENSG00000160808	rs2233264	ENSG00000160808:ENST00000292327:exon1:c.C69T:p.P23P,ENSG00000160808:ENST00000395869:exon1:c.C69T:p.P23P,ENSG00000160808:ENST00000431168:exon3:c.C69T:p.P23P	MYL3:NM_000258:exon1:c.C69T:p.P23P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0184	0.0167	0.0371406	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MYL3:uc003cql.1:exon1:c.C69T:p.P23P	.	AFR:0.0228,AMR:0.0353,EAS:0.0099,FIN:0.0801,NFE:0.0329,OTH:0.0075,ASJ:0.0251	160790	608751;	.	.	.	.	.	.	.	.	.	.	3	1(haematopoietic_and_lymphoid_tissue)	0.0183
3	47125385	47125385	G	A	SETD2	exonic	nonsynonymous SNV	ENSG00000181555	rs4082155	ENSG00000181555:ENST00000409792:exon12:c.C5885T:p.P1962L	SETD2:NM_001349370:exon11:c.C5753T:p.P1918L,SETD2:NM_014159:exon12:c.C5885T:p.P1962L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.5342	0.4713	0.469848	0.4931	1.276	12.14	0.311	2.94	0.998	.	.	.	SETD2:uc003cqs.3:exon12:c.C5885T:p.P1962L,SETD2:uc003cqv.3:exon13:c.C6086T:p.P2029L	-0.947	AFR:0.2820,AMR:0.4771,EAS:0.5424,FIN:0.6158,NFE:0.5774,OTH:0.5767,ASJ:0.4933	612778	616831;	.	.	.	,9650,9653,9651	.	.	0.001	1.98	0.000	0.895	3	MU585924	het
3	47162661	47162661	A	G	SETD2	exonic	synonymous SNV	ENSG00000181555	rs6767907	ENSG00000181555:ENST00000409792:exon3:c.T3465C:p.N1155N,ENSG00000181555:ENST00000412450:exon3:c.T3333C:p.N1111N	SETD2:NM_001349370:exon2:c.T3333C:p.N1111N,SETD2:NM_014159:exon3:c.T3465C:p.N1155N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6343	0.6448	0.678315	0.6568	.	.	.	.	.	.	.	.	SETD2:uc003cqs.3:exon3:c.T3465C:p.N1155N,SETD2:uc003cqv.3:exon3:c.T3432C:p.N1144N	.	AFR:0.7570,AMR:0.6945,EAS:0.6937,FIN:0.6316,NFE:0.6017,OTH:0.6337,ASJ:0.5667	612778	616831;	.	.	.	,9653,9651	.	.	.	.	.	.	3	MU18259588	het
3	47447225	47447225	C	T	PTPN23	intronic	.	ENSG00000076201	rs139593091	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0167	0.0038	0.0165735	0.0069	.	.	.	.	.	.	.	.	.	.	AFR:0.0057,AMR:0.0215,EAS:0.0105,FIN:0.0109,NFE:0.0049,OTH:0.0122,ASJ:0.0132	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU113353106	het
3	47449058	47449058	T	C	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs900688	ENSG00000076201:ENST00000431726:exon11:c.T609C:p.T203T,ENSG00000076201:ENST00000265562:exon12:c.T987C:p.T329T	PTPN23:NM_001304482:exon11:c.T609C:p.T203T,PTPN23:NM_015466:exon12:c.T987C:p.T329T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9863	0.9493	0.953874	0.9584	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon11:c.T882C:p.T294T,PTPN23:uc011bay.1:exon11:c.T597C:p.T199T,PTPN23:uc003crf.1:exon12:c.T987C:p.T329T	.	AFR:0.8548,AMR:0.9928,EAS:1,FIN:1,NFE:0.9993,OTH:0.9959,ASJ:0.9901	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU81761996	hom
3	47451411	47451411	C	T	PTPN23	intronic	.	ENSG00000076201	rs3736177	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4389	0.3590	0.400559	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.3680,AMR:0.2721,EAS:0.4967,FIN:0.5317,NFE:0.3682,OTH:0.3949,ASJ:0.5	606584	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.3868
3	47452087	47452087	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs900689	ENSG00000076201:ENST00000431726:exon19:c.G2421A:p.P807P,ENSG00000076201:ENST00000265562:exon20:c.G2799A:p.P933P	PTPN23:NM_001304482:exon19:c.G2421A:p.P807P,PTPN23:NM_015466:exon20:c.G2799A:p.P933P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9867	0.9511	0.954872	0.9600	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon19:c.G2694A:p.P898P,PTPN23:uc011bay.1:exon19:c.G2409A:p.P803P,PTPN23:uc003crf.1:exon20:c.G2799A:p.P933P	.	AFR:0.8595,AMR:0.9928,EAS:1,FIN:1,NFE:0.9994,OTH:0.9959,ASJ:0.99	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU4555978	hom
3	47452118	47452118	G	A	PTPN23	exonic	nonsynonymous SNV	ENSG00000076201	rs6780013	ENSG00000076201:ENST00000431726:exon19:c.G2452A:p.A818T,ENSG00000076201:ENST00000265562:exon20:c.G2830A:p.A944T	PTPN23:NM_001304482:exon19:c.G2452A:p.A818T,PTPN23:NM_015466:exon20:c.G2830A:p.A944T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3708	0.3481	0.345248	1(salivary_gland)	-0.951	0.020	1.0	-5.83	0.018	.	.	.	PTPN23:uc011baw.1:exon19:c.G2725A:p.A909T,PTPN23:uc011bay.1:exon19:c.G2440A:p.A814T,PTPN23:uc003crf.1:exon20:c.G2830A:p.A944T	-0.972	AFR:MU133991,AMR:COCA-CN|2|321|0.00623053,PBCA-DE|1|499|0.00200401,EAS:0.2631,FIN:0.3005,NFE:0.42,OTH:0.3756,ASJ:0.3439	606584	.	.	.	.	.	.	.	0.0	4.31	0.000	-0.77	3	1(thyroid)	0.3590
3	47452786	47452786	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs1531875	ENSG00000076201:ENST00000431726:exon19:c.G3120A:p.E1040E,ENSG00000076201:ENST00000265562:exon20:c.G3498A:p.E1166E	PTPN23:NM_001304482:exon19:c.G3120A:p.E1040E,PTPN23:NM_015466:exon20:c.G3498A:p.E1166E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5413	0.4852	0.458866	LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	PTPN23:uc011baw.1:exon19:c.G3393A:p.E1131E,PTPN23:uc011bay.1:exon19:c.G3108A:p.E1036E,PTPN23:uc003crf.1:exon20:c.G3498A:p.E1166E	.	AFR:0.5033,AMR:0.2811,EAS:0.4934,FIN:0.4622,NFE:0.6315,OTH:0.6030,ASJ:0.4819	606584	.	.	.	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.5888
3	47454399	47454399	G	A	PTPN23	exonic	synonymous SNV	ENSG00000076201	rs6789730	ENSG00000076201:ENST00000431726:exon24:c.G4257A:p.P1419P,ENSG00000076201:ENST00000265562:exon25:c.G4635A:p.P1545P	PTPN23:NM_001304482:exon24:c.G4257A:p.P1419P,PTPN23:NM_015466:exon25:c.G4635A:p.P1545P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9872	0.9547	0.954673	0.9077	.	.	.	.	.	.	.	.	PTPN23:uc011bay.1:exon24:c.G4245A:p.P1415P,PTPN23:uc003crf.1:exon25:c.G4635A:p.P1545P	.	AFR:0.8071,AMR:0.9365,EAS:0.9812,FIN:0.9173,NFE:0.9510,OTH:0.9412,ASJ:0.9458	606584	.	.	.	.	.	.	.	.	.	.	.	3	MU4564936	hom
3	48602523	48602523	-	GGC	COL7A1	intronic	.	ENSG00000114270	rs138595277	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9999	0.9998	0.999401	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	120120	131705;131750;131850;132000;226600;604129;607523;	89843;79408;79409;79410;231568;79411;	89843|DEB, pruriginosa<br>DEB-Pr<br>Pruriginous dystrophic epidermolysis bullosa|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604129 ~79408|Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis<br>Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type<br>RDEB generalisata gravis<br>RDEB, Hallopeau-Siemens type<br>RDEB-sev gen<br>Severe generalized RDEB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79409|Dystrophic epidermolysis bullosa inversa<br>Inverse RDEB<br>Inverse recessive dystrophic epidermolysis bullosa<br>RDEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79410|DEB-Pt<br>Pretibial DEB|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131850 ~231568|Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types<br>DDEB, Pasini and Cockayne-Touraine types<br>DDEB, generalized<br>DDEB-gen|Unknown|Autosomal dominant|Infancy<br>Neonatal|131750 ~79411|DEB, bullous dermolysis of the newborn<br>DEB-BDN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131705 ~	.	.	.	.	.	.	.	.	3	.	hom
3	48625231	48625231	C	T	COL7A1	exonic	nonsynonymous SNV	ENSG00000114270	rs540205999	ENSG00000114270:ENST00000328333:exon21:c.G2852A:p.R951H,ENSG00000114270:ENST00000454817:exon21:c.G2852A:p.R951H	COL7A1:NM_000094:exon21:c.G2852A:p.R951H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, -1, 0, 0] 	4.154e-05	.	0.000199681	.	0.291	5.603	0.59	-4.86	0.030	.	.	Fibronectin type III|Immunoglobulin-like fold	COL7A1:uc003ctz.2:exon21:c.G2852A:p.R951H	-1.006	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	120120	131705;131750;131850;132000;226600;604129;607523;	89843;79408;79409;79410;231568;79411;	89843|DEB, pruriginosa<br>DEB-Pr<br>Pruriginous dystrophic epidermolysis bullosa|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|604129 ~79408|Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis<br>Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type<br>RDEB generalisata gravis<br>RDEB, Hallopeau-Siemens type<br>RDEB-sev gen<br>Severe generalized RDEB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79409|Dystrophic epidermolysis bullosa inversa<br>Inverse RDEB<br>Inverse recessive dystrophic epidermolysis bullosa<br>RDEB-I|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226600 ~79410|DEB-Pt<br>Pretibial DEB|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131850 ~231568|Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types<br>DDEB, Pasini and Cockayne-Touraine types<br>DDEB, generalized<br>DDEB-gen|Unknown|Autosomal dominant|Infancy<br>Neonatal|131750 ~79411|DEB, bullous dermolysis of the newborn<br>DEB-BDN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|131705 ~	.	.	.	.	0.0	0.51	0.100	0.3	3	MU41175408	het
3	49398514	49398514	C	A	RHOA	intronic	.	ENSG00000067560	rs892974	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.8667	.	0.886182	0.8014	.	.	.	.	.	.	.	.	.	.	AFR:0.8630,AMR:0.8333,EAS:0.9944,FIN:0.7823,NFE:0.7436,OTH:0.7887,ASJ:0.7727	165390	.	.	.	~ko04011 MAPK signaling pathway - yeast~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04350 TGF-beta signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04660 T cell receptor signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04972 Pancreatic secretion~ko05100 Bacterial invasion of epithelial cells~ko05130 Pathogenic Escherichia coli infection~ko05133 Pertussis~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	.	unknown
3	49398519	49398519	-	A	RHOA	intronic	.	ENSG00000067560	rs749506733	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0	.	.	0.0138	.	.	.	.	.	.	.	.	.	.	AFR:0.0257,AMR:0.0215,EAS:0.0108,FIN:0.0475,NFE:0.0048,OTH:0.0059,ASJ:0.0153	165390	.	.	.	~ko04011 MAPK signaling pathway - yeast~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04350 TGF-beta signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04660 T cell receptor signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04972 Pancreatic secretion~ko05100 Bacterial invasion of epithelial cells~ko05130 Pathogenic Escherichia coli infection~ko05133 Pertussis~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	.	unknown
3	49723727	49723727	C	-	MST1	intronic	.	ENSG00000173531	rs762013151	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0044	.	.	0.1617	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.1031delG:p.G344fs	.	AFR:0.2859,AMR:0.1439,EAS:0.2840,FIN:0.1129,NFE:0.0759,OTH:0.08,ASJ:0.0417	142408	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	49723735	49723735	C	G	MST1	intronic	.	ENSG00000173531	rs184629099	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3671	.	.	0.0093	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.G1023C:p.G341G	.	AFR:0.0017,AMR:0.0135,EAS:0,FIN:0.0003,NFE:0.0164,OTH:0.0180,ASJ:0.0327	142408	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	49723784	49723784	C	A	MST1	exonic	synonymous SNV	ENSG00000173531	rs9713651	ENSG00000173531:ENST00000383728:exon7:c.G753T:p.P251P,ENSG00000173531:ENST00000449682:exon8:c.G978T:p.P326P	MST1:NM_020998:exon8:c.G978T:p.P326P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4369	0.3782	.	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.G974T:p.R325L	.	AFR:0.4461,AMR:0.3271,EAS:0.3973,FIN:0.9428,NFE:0.4230,OTH:0.4640,ASJ:0.5537	142408	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.4705
3	49723823	49723823	A	G	MST1	exonic	synonymous SNV	ENSG00000173531	rs7431215	ENSG00000173531:ENST00000383728:exon7:c.T714C:p.T238T,ENSG00000173531:ENST00000449682:exon8:c.T939C:p.T313T	MST1:NM_020998:exon8:c.T939C:p.T313T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3743	.	.	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	MST1:uc011bcs.1:exon8:c.T935C:p.L312P	.	AFR:MU4552991,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02,EAS:0.0761,FIN:0.2579,NFE:0.1089,OTH:0.0021,ASJ:0.1358	142408	.	.	.	.	.	.	.	.	.	.	.	3	2(breast)	0.1803
3	49724491	49724492	AC	-	MST1	exonic	frameshift deletion	ENSG00000173531	rs561203180	ENSG00000173531:ENST00000383728:exon5:c.391_392del:p.V131fs,ENSG00000173531:ENST00000545762:exon5:c.459_460del:p.V153fs,ENSG00000173531:ENST00000449682:exon6:c.616_617del:p.V206fs	MST1:NM_020998:exon6:c.616_617del:p.V206fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0010	.	0.00179712	9.688e-05	.	.	.	.	.	.	.	.	MST1:uc003cxg.3:exon6:c.616_617del:p.V206fs,MST1:uc010hkx.2:exon6:c.379_380del:p.V127fs,MST1:uc011bcs.1:exon6:c.616_617del:p.V206fs,MST1:uc011bct.1:exon6:c.616_617del:p.V206fs	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0,ASJ:0	142408	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	49724808	49724808	T	C	MST1	exonic	synonymous SNV	ENSG00000173531	rs3020779	ENSG00000173531:ENST00000383728:exon3:c.A234G:p.P78P,ENSG00000173531:ENST00000449682:exon4:c.A459G:p.P153P	MST1:NM_020998:exon4:c.A459G:p.P153P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8574	0.7876	0.860224	0.8201	.	.	.	.	.	.	.	.	MST1:uc003cxg.3:exon4:c.A459G:p.P153P,MST1:uc010hkx.2:exon4:c.A222G:p.P74P,MST1:uc011bcs.1:exon4:c.A459G:p.P153P,MST1:uc011bct.1:exon4:c.A459G:p.P153P	.	AFR:0.7258,AMR:0.8819,EAS:0.9963,FIN:0.8986,NFE:0.8320,OTH:0.8599,ASJ:0.8079	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU81762505	hom
3	49726028	49726028	T	C	MST1	intronic	.	ENSG00000173531	rs62262685	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4498	.	.	0.2800	.	.	.	.	.	0.0005	0.002	.	.	.	AFR:0.3296,AMR:0.3122,EAS:0.3076,FIN:0.3306,NFE:0.2354,OTH:0.2416,ASJ:0.2722	142408	.	.	.	.	.	.	.	.	.	.	.	3	MU665637	het
3	49726070	49726070	G	A	MST1	exonic	nonsynonymous SNV	ENSG00000173531	rs62262686	ENSG00000173531:ENST00000449682:exon1:c.C55T:p.P19S,ENSG00000173531:ENST00000545762:exon1:c.C13T:p.P5S	MST1:NM_020998:exon1:c.C55T:p.P19S	clinvar: not_provided 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3968	.	.	3(pancreas)	0.054	3.124	0.251	-0.229	0.997	.	.	.	MST1:uc003cxg.3:exon1:c.C55T:p.P19S,MST1:uc011bcs.1:exon1:c.C55T:p.P19S,MST1:uc011bct.1:exon1:c.C55T:p.P19S	-0.390	AFR:1(thyroid),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:18(upper_aerodigestive_tract),FIN:3(central_nervous_system),NFE:MU684592,OTH:SKCA-BR|1|100|0.01,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,ASJ:1(oesophagus)	142408	.	.	.	.	.	.	.	0.982	-2.17	0.542	1.69	3	1(liver)	0.1420
3	49760039	49760039	T	C	GMPPB	exonic	nonsynonymous SNV	ENSG00000173540	rs1466685	ENSG00000173540:ENST00000308375:exon5:c.A551G:p.Q184R,ENSG00000173540:ENST00000308388:exon5:c.A551G:p.Q184R,ENSG00000173540:ENST00000480687:exon6:c.A551G:p.Q184R	GMPPB:NM_013334:exon5:c.A551G:p.Q184R,GMPPB:NM_021971:exon5:c.A551G:p.Q184R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9967	0.9892	0.989018	0.9889	0.422	6.799	0.071	-2.63	0.913	.	.	Nucleotide-diphospho-sugar transferases|Nucleotidyl transferase domain	GMPPB:uc003cxk.1:exon5:c.A551G:p.Q184R,GMPPB:uc003cxl.1:exon5:c.A551G:p.Q184R	-0.902	AFR:0.9620,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:0.9949,ASJ:1	615320	615350;615351;615352;	363623;370959;370968;588;	363623|LGMD2T|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615352 ~370959|CMD with cerebellar involvement<br>CMD-CRB|-|-|-|606612 613151 613155 613156 615351 ~370968|CMD with intellectual disability<br>CMD-MR|-|-|-|606612 608840 613155 613156 615351 ~588|MEB syndrome<br>Muscle-eye-brain syndrome<br>Santavuori congenital muscular dystrophy|Unknown|Autosomal recessive|Infancy<br>Neonatal|236670 253280 253800 613150 613153 613154 615181 615350 ~	.	.	.	.	0.0	-3.29	0.000	-0.49	3	MU81762601	hom
3	49928691	49928691	T	C	MST1R	exonic	nonsynonymous SNV	ENSG00000164078	rs7433231	ENSG00000164078:ENST00000344206:exon16:c.A3436G:p.S1146G,ENSG00000164078:ENST00000296474:exon17:c.A3583G:p.S1195G	MST1R:NM_001318913:exon15:c.A3265G:p.S1089G,MST1R:NM_001244937:exon16:c.A3436G:p.S1146G,MST1R:NM_002447:exon17:c.A3583G:p.S1195G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MST1R:uc031rzv.1:exon6:c.A220G:p.S74G,MST1R:uc031rzw.1:exon15:c.A3265G:p.S1089G,MST1R:uc011bdc.2:exon16:c.A3436G:p.S1146G,MST1R:uc003cxy.4:exon17:c.A3583G:p.S1195G	.	AFR:1.0000,AMR:0.9999,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600168	617075;	150;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~	.	.	.	.	.	.	.	.	3	23(upper_aerodigestive_tract)	1
3	51978220	51978220	A	G	PARP3	exonic	nonsynonymous SNV	ENSG00000041880	rs28547534	ENSG00000041880:ENST00000498510:exon2:c.A299G:p.H100R,ENSG00000041880:ENST00000398755:exon3:c.A320G:p.H107R,ENSG00000041880:ENST00000431474:exon3:c.A299G:p.H100R,ENSG00000041880:ENST00000417220:exon4:c.A299G:p.H100R	PARP3:NM_001003931:exon3:c.A320G:p.H107R,PARP3:NM_001370240:exon3:c.A299G:p.H100R,PARP3:NM_005485:exon3:c.A299G:p.H100R,PARP3:NM_001370239:exon4:c.A299G:p.H100R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9927	0.9920	0.997604	0.9937	.	.	.	.	.	.	.	.	PARP3:uc003dby.3:exon3:c.A299G:p.H100R,PARP3:uc003dbz.3:exon3:c.A320G:p.H107R	.	AFR:0.9977,AMR:0.9928,EAS:1,FIN:0.9946,NFE:0.9907,OTH:0.9908,ASJ:1	607726	.	.	.	.	.	.	.	.	.	.	.	3	MU4565297	hom
3	53222761	53222761	C	T	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs2306574	ENSG00000163932:ENST00000394729:exon15:c.C1441T:p.L481L,ENSG00000163932:ENST00000330452:exon16:c.C1441T:p.L481L	PRKCD:NM_001354676:exon15:c.C1498T:p.L500L,PRKCD:NM_001354678:exon15:c.C1489T:p.L497L,PRKCD:NM_212539:exon15:c.C1441T:p.L481L,PRKCD:NM_001316327:exon16:c.C1441T:p.L481L,PRKCD:NM_001354679:exon16:c.C1441T:p.L481L,PRKCD:NM_006254:exon16:c.C1441T:p.L481L,PRKCD:NM_001354680:exon17:c.C1441T:p.L481L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7480	0.7583	0.713458	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon15:c.C1441T:p.L481L,PRKCD:uc003dgl.3:exon16:c.C1441T:p.L481L	.	AFR:0.7580,AMR:0.7198,EAS:0.7667,FIN:0.7833,NFE:0.7338,OTH:0.7843,ASJ:0.7356	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	1(urinary_tract)	0.7556
3	53223927	53223927	C	G	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs1075865	ENSG00000163932:ENST00000394729:exon17:c.C1782G:p.T594T,ENSG00000163932:ENST00000330452:exon18:c.C1782G:p.T594T	PRKCD:NM_001354676:exon17:c.C1839G:p.T613T,PRKCD:NM_001354678:exon17:c.C1830G:p.T610T,PRKCD:NM_212539:exon17:c.C1782G:p.T594T,PRKCD:NM_001316327:exon18:c.C1782G:p.T594T,PRKCD:NM_001354679:exon18:c.C1782G:p.T594T,PRKCD:NM_006254:exon18:c.C1782G:p.T594T,PRKCD:NM_001354680:exon19:c.C1782G:p.T594T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9655	0.9335	0.901957	0.9428	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon17:c.C1782G:p.T594T,PRKCD:uc003dgl.3:exon18:c.C1782G:p.T594T	.	AFR:0.8065,AMR:0.9905,EAS:0.9728,FIN:1,NFE:0.9993,OTH:0.9806,ASJ:0.9967	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	MU81763707	hom
3	53224002	53224002	T	C	PRKCD	exonic	synonymous SNV	ENSG00000163932	rs900495	ENSG00000163932:ENST00000394729:exon17:c.T1857C:p.P619P,ENSG00000163932:ENST00000330452:exon18:c.T1857C:p.P619P	PRKCD:NM_001354676:exon17:c.T1914C:p.P638P,PRKCD:NM_001354678:exon17:c.T1905C:p.P635P,PRKCD:NM_212539:exon17:c.T1857C:p.P619P,PRKCD:NM_001316327:exon18:c.T1857C:p.P619P,PRKCD:NM_001354679:exon18:c.T1857C:p.P619P,PRKCD:NM_006254:exon18:c.T1857C:p.P619P,PRKCD:NM_001354680:exon19:c.T1857C:p.P619P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9835	0.9393	0.940495	0.9481	.	.	.	.	.	.	.	.	PRKCD:uc003dgm.3:exon17:c.T1857C:p.P619P,PRKCD:uc003dgl.3:exon18:c.T1857C:p.P619P	.	AFR:0.8192,AMR:0.9905,EAS:1,FIN:1,NFE:0.9993,OTH:0.9888,ASJ:0.9967	176977	615559;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	.	.	.	.	.	.	.	.	3	MU81763716	hom
3	53766026	53766026	T	C	CACNA1D	intronic	.	ENSG00000157388	rs2612033	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8887	0.8671	0.910942	0.8868	.	.	.	.	.	.	.	.	.	.	AFR:0.8822,AMR:0.9115,EAS:1,FIN:0.9115,NFE:0.8702,OTH:0.9012,ASJ:0.8344	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU81763800	het
3	53769479	53769479	C	T	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs1045958	ENSG00000157388:ENST00000481478:exon15:c.C1779T:p.S593S,ENSG00000157388:ENST00000350061:exon20:c.C2700T:p.S900S,ENSG00000157388:ENST00000422281:exon20:c.C2700T:p.S900S,ENSG00000157388:ENST00000288139:exon21:c.C2760T:p.S920S	CACNA1D:NM_001128839:exon20:c.C2700T:p.S900S,CACNA1D:NM_001128840:exon20:c.C2700T:p.S900S,CACNA1D:NM_000720:exon21:c.C2760T:p.S920S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2994	0.2545	0.192292	0.2681	.	.	.	.	.	.	.	.	CACNA1D:uc003dgx.1:exon4:c.C144T:p.S48S,CACNA1D:uc003dgw.4:exon15:c.C1701T:p.S567S,CACNA1D:uc003dgv.5:exon20:c.C2700T:p.S900S,CACNA1D:uc003dgy.5:exon20:c.C2700T:p.S900S,CACNA1D:uc003dgu.5:exon21:c.C2760T:p.S920S	.	AFR:0.0693,AMR:0.3313,EAS:0.2042,FIN:0.3673,NFE:0.3585,OTH:0.3374,ASJ:0.3377	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU4565454	het
3	53779776	53779776	A	G	CACNA1D	intronic	.	ENSG00000157388	rs17053453	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0739	0.0705	0.0710863	0.0688	.	.	.	.	.	.	.	.	.	.	AFR:0.0806,AMR:0.0788,EAS:0.1046,FIN:0.0464,NFE:0.0627,OTH:0.0631,ASJ:0.0861	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU113461781	het
3	53837619	53837619	G	T	CACNA1D	intronic	.	ENSG00000157388	rs56382996	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0985	0.1710	0.178115	0.1511	.	.	.	.	.	.	.	.	.	.	AFR:0.3664,AMR:0.1002,EAS:0.0537,FIN:0.0638,NFE:0.0659,OTH:0.0733,ASJ:0.1026	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU113343256	het
3	53845295	53845295	C	T	CACNA1D	exonic	synonymous SNV	ENSG00000157388	rs10154841	ENSG00000157388:ENST00000481478:exon43:c.C5427T:p.N1809N,ENSG00000157388:ENST00000422281:exon46:c.C6276T:p.N2092N,ENSG00000157388:ENST00000350061:exon48:c.C6348T:p.N2116N,ENSG00000157388:ENST00000288139:exon49:c.C6408T:p.N2136N	CACNA1D:NM_001128839:exon46:c.C6276T:p.N2092N,CACNA1D:NM_001128840:exon48:c.C6348T:p.N2116N,CACNA1D:NM_000720:exon49:c.C6408T:p.N2136N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1397	0.2525	0.261182	0.2263	.	.	.	.	.	.	.	.	CACNA1D:uc003dgw.4:exon43:c.C5349T:p.N1783N,CACNA1D:uc003dgy.5:exon46:c.C6276T:p.N2092N,CACNA1D:uc003dgv.5:exon48:c.C6348T:p.N2116N,CACNA1D:uc003dgu.5:exon49:c.C6408T:p.N2136N	.	AFR:0.5779,AMR:0.1301,EAS:0.1354,FIN:0.0841,NFE:0.0810,OTH:0.0930,ASJ:0.1358	114206	614896;615474;	369929;324321;	369929|APA with seizures and neurological abnormalities<br>Aldosterone-secreting adenoma with seizures and neurological abnormalities<br>Conn adenoma with seizures and neurological abnormalities|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|615474 ~324321|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614896 ~	.	.	.	.	.	.	.	.	3	MU11671530	het
3	57131759	57131759	T	C	IL17RD	exonic	nonsynonymous SNV	ENSG00000144730	rs140930246	ENSG00000144730:ENST00000296318:exon12:c.A1972G:p.M658V,ENSG00000144730:ENST00000427856:exon12:c.A1900G:p.M634V,ENSG00000144730:ENST00000463523:exon12:c.A1540G:p.M514V,ENSG00000144730:ENST00000320057:exon13:c.A1540G:p.M514V	IL17RD:NM_017563:exon12:c.A1972G:p.M658V,IL17RD:NM_001318864:exon13:c.A1540G:p.M514V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0014	.	0.00319489	0.0007	2.339	18.42	0.005	5.79	0.969	.	.	.	IL17RD:uc003dik.3:exon12:c.A1900G:p.M634V,IL17RD:uc003dil.3:exon12:c.A1972G:p.M658V,IL17RD:uc011bex.1:exon12:c.A1540G:p.M514V,IL17RD:uc010hna.3:exon13:c.A1540G:p.M514V	-1.145	AFR:0,AMR:0,EAS:0.0142,FIN:0,NFE:0,OTH:0,ASJ:0	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	0.15	2.86	0.019	1.895	3	MU85134476	het
3	57132200	57132200	A	G	IL17RD	exonic	synonymous SNV	ENSG00000144730	rs2291462	ENSG00000144730:ENST00000296318:exon12:c.T1531C:p.L511L,ENSG00000144730:ENST00000427856:exon12:c.T1459C:p.L487L,ENSG00000144730:ENST00000463523:exon12:c.T1099C:p.L367L,ENSG00000144730:ENST00000320057:exon13:c.T1099C:p.L367L	IL17RD:NM_017563:exon12:c.T1531C:p.L511L,IL17RD:NM_001318864:exon13:c.T1099C:p.L367L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8239	0.7910	0.736222	0.7820	.	.	.	.	.	.	.	.	IL17RD:uc003dik.3:exon12:c.T1459C:p.L487L,IL17RD:uc003dil.3:exon12:c.T1531C:p.L511L,IL17RD:uc011bex.1:exon12:c.T1099C:p.L367L,IL17RD:uc010hna.3:exon13:c.T1099C:p.L367L	.	AFR:0.6457,AMR:0.8377,EAS:0.4777,FIN:0.8980,NFE:0.8579,OTH:0.8405,ASJ:0.8841	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	.	.	.	.	3	MU21327509	het
3	57138419	57138419	G	A	IL17RD	exonic	nonsynonymous SNV	ENSG00000144730	rs6780995	ENSG00000144730:ENST00000296318:exon8:c.C764T:p.T255M,ENSG00000144730:ENST00000427856:exon8:c.C692T:p.T231M,ENSG00000144730:ENST00000463523:exon8:c.C332T:p.T111M,ENSG00000144730:ENST00000320057:exon9:c.C332T:p.T111M	IL17RD:NM_017563:exon8:c.C764T:p.T255M,IL17RD:NM_001318864:exon9:c.C332T:p.T111M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6490	0.6661	0.530152	ESAD-UK|1|409|0.00244499,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053	2.678	20.7	0.094	-0.521	0.999	.	.	Interleukin 17 receptor D, N-terminal	IL17RD:uc003dik.3:exon8:c.C692T:p.T231M,IL17RD:uc003dil.3:exon8:c.C764T:p.T255M,IL17RD:uc011bex.1:exon8:c.C332T:p.T111M,IL17RD:uc010hna.3:exon9:c.C332T:p.T111M	-1.079	AFR:0.6306,AMR:0.5815,EAS:0.6921,FIN:0.1156,NFE:0.7376,OTH:0.6926,ASJ:0.5180	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	0.943	2.89	0.000	1.245	3	1(bone)	0.6633
3	57139972	57139972	A	G	IL17RD	exonic	synonymous SNV	ENSG00000144730	rs1545981	ENSG00000144730:ENST00000296318:exon7:c.T660C:p.H220H,ENSG00000144730:ENST00000427856:exon7:c.T588C:p.H196H,ENSG00000144730:ENST00000463523:exon7:c.T228C:p.H76H,ENSG00000144730:ENST00000320057:exon8:c.T228C:p.H76H	IL17RD:NM_017563:exon7:c.T660C:p.H220H,IL17RD:NM_001318864:exon8:c.T228C:p.H76H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8697	0.8589	0.79373	0.8421	.	.	.	.	.	.	.	.	IL17RD:uc003dik.3:exon7:c.T588C:p.H196H,IL17RD:uc003dil.3:exon7:c.T660C:p.H220H,IL17RD:uc011bex.1:exon7:c.T228C:p.H76H,IL17RD:uc010hna.3:exon8:c.T228C:p.H76H	.	AFR:0.7636,AMR:0.8926,EAS:0.4838,FIN:0.9342,NFE:0.8975,OTH:0.8929,ASJ:0.8974	606807	615267;	478;	478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	.	.	.	.	.	.	.	.	3	MU21327553	het
3	59908126	59908126	A	G	FHIT	exonic	synonymous SNV	ENSG00000189283	rs1385816	ENSG00000189283:ENST00000341848:exon4:c.T294C:p.H98H,ENSG00000189283:ENST00000468189:exon8:c.T294C:p.H98H,ENSG00000189283:ENST00000476844:exon8:c.T294C:p.H98H,ENSG00000189283:ENST00000492590:exon8:c.T294C:p.H98H	FHIT:NM_001320901:exon6:c.T126C:p.H42H,FHIT:NM_001166243:exon8:c.T294C:p.H98H,FHIT:NM_001320899:exon8:c.T294C:p.H98H,FHIT:NM_002012:exon8:c.T294C:p.H98H,FHIT:NM_001320900:exon9:c.T294C:p.H98H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2453	0.1671	0.22484	MU585983	.	.	.	.	.	.	.	.	FHIT:uc003dkx.4:exon8:c.T294C:p.H98H,FHIT:uc003dky.3:exon8:c.T294C:p.H98H,FHIT:uc010hnn.1:exon8:c.T294C:p.H98H	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2171,EAS:0.3792,FIN:0.0861,NFE:0.3110,OTH:0.3657,ASJ:0.0926	601153	.	.	.	.	.	.	.	.	.	.	.	3	7(soft_tissue)	0.2349
3	71015021	71015021	G	T	FOXP1	intronic	.	ENSG00000114861	rs7638391	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9452	0.9413	0.974641	0.9489	.	.	.	.	.	.	.	.	.	.	AFR:0.9831,AMR:0.9535,EAS:1,FIN:0.9476,NFE:0.9238,OTH:0.9559,ASJ:0.9139	605515	613670;	391372;	391372|-|<1 / 1 000 000|-|Infancy<br>Neonatal|613670 ~	.	.	.	.	.	.	.	.	3	MU81765255	hom
3	78663956	78663956	G	A	ROBO1	intronic	.	ENSG00000169855	rs1027832	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4516	0.3502	0.353435	0.3768	.	.	.	.	.	0	0.012	.	.	.	AFR:0.2184,AMR:0.5679,EAS:0.3237,FIN:0.5078,NFE:0.4363,OTH:0.4279,ASJ:0.4759	602430	.	.	.	.	.	.	.	.	.	.	.	3	MU759938	hom
3	78666765	78666765	T	C	ROBO1	intronic	.	ENSG00000169855	rs9839790	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6225	0.6195	0.575479	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.5908,AMR:0.4635,EAS:0.7053,FIN:0.5208,NFE:0.6726,OTH:0.6460,ASJ:0.6483	602430	.	.	.	.	.	.	.	.	.	.	.	3	1(haematopoietic_and_lymphoid_tissue)	0.6148
3	78676467	78676467	A	G	ROBO1	intronic	.	ENSG00000169855	rs7636043	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9648	0.9735	0.969848	0.9692	.	.	.	.	.	0	0	.	.	.	AFR:0.9787,AMR:0.9881,EAS:0.9926,FIN:0.9648,NFE:0.9616,OTH:0.9541,ASJ:0.9901	602430	.	.	.	.	.	.	.	.	.	.	.	3	MU18278522	hom
3	89521602	89521602	-	C	EPHA3	intronic	.	ENSG00000044524	rs112297761	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2114	0.2286	0.161542	0.2434	.	.	.	.	.	.	.	.	.	.	AFR:0.2070,AMR:0.2248,EAS:0.0931,FIN:0.3804,NFE:0.2497,OTH:0.2736,ASJ:0.1556	179611	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	89521693	89521693	T	C	EPHA3	exonic	nonsynonymous SNV	ENSG00000044524	rs35124509	ENSG00000044524:ENST00000336596:exon16:c.T2770C:p.W924R	EPHA3:NM_005233:exon16:c.T2770C:p.W924R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3759	0.4683	0.391174	MU11759109	2.291	18.10	0.229	3.84	0.230	.	.	Sterile alpha motif domain|Sterile alpha motif/pointed domain	EPHA3:uc003dqy.3:exon16:c.T2770C:p.W924R	-0.915	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.4612,EAS:0.3681,FIN:0.3477,NFE:0.1942,OTH:0.5043,ASJ:0.6298	179611	.	.	.	.	.	.	.	0.0	-1.73	0.000	-2.3	3	1(skin)	0.3919
3	89521725	89521725	T	C	EPHA3	exonic	synonymous SNV	ENSG00000044524	rs1054750	ENSG00000044524:ENST00000336596:exon16:c.T2802C:p.G934G	EPHA3:NM_005233:exon16:c.T2802C:p.G934G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1998	0.1868	0.129593	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	EPHA3:uc003dqy.3:exon16:c.T2802C:p.G934G	.	AFR:0.2102,AMR:0.0898,EAS:0.1556,FIN:0.0927,NFE:0.3812,OTH:0.2501,ASJ:0.2201	179611	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.2654
3	100467018	100467018	T	C	TFG	exonic	synonymous SNV	ENSG00000114354	rs11353	ENSG00000114354:ENST00000240851:exon8:c.T846C:p.P282P,ENSG00000114354:ENST00000418917:exon8:c.T834C:p.P278P,ENSG00000114354:ENST00000476228:exon8:c.T834C:p.P278P,ENSG00000114354:ENST00000490574:exon8:c.T846C:p.P282P	TFG:NM_001007565:exon8:c.T846C:p.P282P,TFG:NM_001195478:exon8:c.T846C:p.P282P,TFG:NM_001195479:exon8:c.T834C:p.P278P,TFG:NM_006070:exon8:c.T846C:p.P282P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6993	0.6551	0.713059	MU760146	-0.585	0.136	.	4.77	0.997	.	.	.	TFG:uc003due.3:exon8:c.T846C:p.P282P,TFG:uc003duf.3:exon8:c.T846C:p.P282P,TFG:uc003dug.3:exon8:c.T834C:p.P278P,TFG:uc003dui.3:exon8:c.T846C:p.P282P	-1.026	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.6676,EAS:0.7792,FIN:0.6192,NFE:0.5946,OTH:0.6703,ASJ:0.6560	602498	604484;615658;	431329;90117;	431329|SPG57<br>Spastic paraplegia due to partial TFG deficiency|<1 / 1 000 000|Autosomal recessive|Infancy|615658 ~90117|HMSNP<br>Hereditary motor and sensory neuropathy, proximal type|Unknown|Autosomal dominant|-|604484 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	0.000	.	3	2(haematopoietic_and_lymphoid_tissue)	0.6739
3	121154974	121154974	T	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs1381057	ENSG00000051341:ENST00000264233:exon28:c.A7538G:p.Q2513R	POLQ:NM_199420:exon28:c.A7538G:p.Q2513R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7217	0.6696	0.745208	0.6799	-1.556	0.002	1.0	-0.307	0.086	.	.	DNA-directed DNA polymerase, family A, palm domain	POLQ:uc003eed.3:exon13:c.A5054G:p.Q1685R,POLQ:uc003eee.4:exon28:c.A7538G:p.Q2513R	-0.965	AFR:0.6569,AMR:0.6957,EAS:0.9017,FIN:0.7032,NFE:0.6616,OTH:0.7031,ASJ:0.6767	604419	.	.	.	.	.	.	.	0.0	0.85	0.000	-1.14	3	MU13963964	hom
3	121208833	121208833	G	C	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs3218649	ENSG00000051341:ENST00000264233:exon16:c.C2945G:p.T982R	POLQ:NM_199420:exon16:c.C2945G:p.T982R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6741	0.6028	0.696486	0.6272	-1.568	0.002	0.567	-3.86	0.006	.	.	.	POLQ:uc003eed.3:exon1:c.C461G:p.T154R,POLQ:uc003eee.4:exon16:c.C2945G:p.T982R	-1.009	AFR:0.5635,AMR:0.6376,EAS:0.9020,FIN:0.6802,NFE:0.6208,OTH:0.6663,ASJ:0.5430	604419	.	.	.	.	.	.	.	0.0	0.82	0.000	-0.84	3	MU132061	hom
3	121238749	121238749	G	A	POLQ	exonic	synonymous SNV	ENSG00000051341	rs702018	ENSG00000051341:ENST00000264233:exon9:c.C1437T:p.G479G	POLQ:NM_199420:exon9:c.C1437T:p.G479G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9995	0.9985	0.997404	0.9983	.	.	.	.	.	.	.	.	POLQ:uc003eee.4:exon9:c.C1437T:p.G479G	.	AFR:0.9940,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	604419	.	.	.	.	.	.	.	.	.	.	.	3	MU81768041	hom
3	121263720	121263720	C	A	POLQ	exonic	nonsynonymous SNV	ENSG00000051341	rs702017	ENSG00000051341:ENST00000264233:exon2:c.G197T:p.R66I	POLQ:NM_199420:exon2:c.G197T:p.R66I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9964	0.9886	0.988618	0.9896	0.494	7.389	0.525	-2.11	0.374	.	.	.	POLQ:uc003eee.4:exon2:c.G197T:p.R66I	-0.988	AFR:0.9637,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	604419	.	.	.	.	.	.	.	0.0	0.86	0.000	-1.67	3	MU81768070	hom
3	121976253	121976253	G	A	CASR	intronic	.	ENSG00000036828	rs9869985	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9437	0.9123	0.921925	0.9106	.	.	.	.	.	.	.	.	.	.	AFR:0.8122,AMR:0.9773,EAS:0.9808,FIN:0.9189,NFE:0.9519,OTH:0.9257,ASJ:0.9934	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	.	.	.	.	3	MU81768493	hom
3	122003045	122003045	G	C	CASR	exonic	synonymous SNV	ENSG00000036828	rs2036400	ENSG00000036828:ENST00000296154:exon6:c.G2244C:p.P748P,ENSG00000036828:ENST00000490131:exon7:c.G2244C:p.P748P,ENSG00000036828:ENST00000498619:exon7:c.G2274C:p.P758P	CASR:NM_000388:exon7:c.G2244C:p.P748P,CASR:NM_001178065:exon7:c.G2274C:p.P758P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9916	0.9720	0.972843	0.9740	.	.	.	.	.	.	.	.	CASR:uc003eev.4:exon7:c.G2244C:p.P748P,CASR:uc003eew.4:exon7:c.G2274C:p.P758P	.	AFR:0.9092,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:0.9949,ASJ:1	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	.	.	.	.	3	MU81768516	hom
3	122003832	122003832	G	C	CASR	exonic	nonsynonymous SNV	ENSG00000036828	rs1801726	ENSG00000036828:ENST00000296154:exon6:c.G3031C:p.E1011Q,ENSG00000036828:ENST00000490131:exon7:c.G3031C:p.E1011Q,ENSG00000036828:ENST00000498619:exon7:c.G3061C:p.E1021Q	CASR:NM_000388:exon7:c.G3031C:p.E1011Q,CASR:NM_001178065:exon7:c.G3061C:p.E1021Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9446	0.9178	0.924121	0.9148	-0.624	0.109	1.0	5.79	0.342	.	.	.	CASR:uc003eev.4:exon7:c.G3031C:p.E1011Q,CASR:uc003eew.4:exon7:c.G3061C:p.E1021Q	-0.937	AFR:0.8274,AMR:0.9785,EAS:0.9809,FIN:0.9190,NFE:0.9516,OTH:0.9264,ASJ:0.9934	601199	145980;239200;601198;612899;	112;2238;263417;428;417;405;93372;	112|Renal tubular normotensive hypokalemic alkalosis with hypercalciuria<br>Salt-losing tubular disorder, Henle's loop type<br>Salt-wasting tubulopathy, Henle's loop type|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|241200 300971 601198 601678 602522 607364 613090 ~2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~263417|Bartter syndrome type 5<br>Bartter syndrome type V|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|601198 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~417|NSHPT|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|Neonatal|239200 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~93372|FHH type 1|1-9 / 100 000|Autosomal dominant|All ages|145980 ~	.	.	.	.	0.0	-2.35	0.000	.	3	MU81768527	hom
3	124482495	124482503	TTGTTGAAC	-	ITGB5	exonic	nonframeshift deletion	ENSG00000082781	rs150512726	ENSG00000082781:ENST00000296181:exon15:c.2367_2375del:p.789_792del	ITGB5:NM_001354766:exon14:c.1908_1916del:p.636_639del,ITGB5:NM_001354764:exon15:c.2043_2051del:p.681_684del,ITGB5:NM_001354765:exon15:c.2043_2051del:p.681_684del,ITGB5:NM_002213:exon15:c.2367_2375del:p.789_792del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1111	0.1083	0.0872604	0.0837	.	.	.	.	.	.	.	.	ITGB5:uc003eho.3:exon15:c.2367_2375del:p.789_792del	.	AFR:0.0243,AMR:0.0778,EAS:0.0611,FIN:0.0971,NFE:0.1170,OTH:0.0978,ASJ:0.0861	147561	.	.	.	~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04810 Regulation of actin cytoskeleton~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	3	.	het
3	128204951	128204951	C	T	GATA2	exonic	nonsynonymous SNV	ENSG00000179348	rs2335052	ENSG00000179348:ENST00000341105:exon3:c.G490A:p.A164T,ENSG00000179348:ENST00000430265:exon3:c.G490A:p.A164T,ENSG00000179348:ENST00000487848:exon4:c.G490A:p.A164T	GATA2:NM_001145662:exon3:c.G490A:p.A164T,GATA2:NM_032638:exon3:c.G490A:p.A164T,GATA2:NM_001145661:exon4:c.G490A:p.A164T	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2056	0.1638	0.232827	1(breast)	1.482	13.22	0.403	1.83	0.999	.	.	.	GATA2:uc003ekn.3:exon3:c.G490A:p.A164T,GATA2:uc003eko.2:exon3:c.G490A:p.A164T,GATA2:uc003ekm.3:exon4:c.G490A:p.A164T	-1.065	AFR:MU83133,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.1769,FIN:0.2524,NFE:0.2185,OTH:0.3781,ASJ:0.1800	137295	601626;614038;614172;614286;	52688;228423;3226;519;	52688|-|1-9 / 100 000|-|All ages|614286 ~228423|Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections<br>Dendritic cell, monocyte, B and NK lymphoid deficiency<br>MonoMAC<br>Monocyte-B-natural killer-dendritic cell deficiency syndrome<br>Monocytopenia and mycobacterial infection syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|614172 ~3226|Emberger syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614038 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	,5843	.	,5844	0.013	-4.32	0.000	0	3	1(large_intestine)	0.1862
3	128205860	128205860	G	C	GATA2	exonic	synonymous SNV	ENSG00000179348	rs1573858	ENSG00000179348:ENST00000341105:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000430265:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000492608:exon2:c.C15G:p.P5P,ENSG00000179348:ENST00000487848:exon3:c.C15G:p.P5P,ENSG00000179348:ENST00000498200:exon3:c.C15G:p.P5P	GATA2:NM_001145662:exon2:c.C15G:p.P5P,GATA2:NM_032638:exon2:c.C15G:p.P5P,GATA2:NM_001145661:exon3:c.C15G:p.P5P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6943	0.6934	0.709864	1(prostate)	.	.	.	.	.	.	.	.	GATA2:uc003ekn.3:exon2:c.C15G:p.P5P,GATA2:uc003eko.2:exon2:c.C15G:p.P5P,GATA2:uc003ekm.3:exon3:c.C15G:p.P5P	.	AFR:MU77941,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.7816,FIN:0.7236,NFE:0.7318,OTH:0.7293,ASJ:0.6532	137295	601626;614038;614172;614286;	52688;228423;3226;519;	52688|-|1-9 / 100 000|-|All ages|614286 ~228423|Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections<br>Dendritic cell, monocyte, B and NK lymphoid deficiency<br>MonoMAC<br>Monocyte-B-natural killer-dendritic cell deficiency syndrome<br>Monocytopenia and mycobacterial infection syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|614172 ~3226|Emberger syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614038 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	,5843	.	,5844	.	.	.	.	3	4(large_intestine)	0.5255
3	129020778	129020778	A	G	HMCES	intronic	.	ENSG00000183624	rs6765930	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7957	0.8211	0.809704	0.8190	.	.	.	.	.	.	.	.	.	.	AFR:0.9009,AMR:0.7524,EAS:0.7009,FIN:0.8328,NFE:0.7859,OTH:0.7984,ASJ:0.8278	.	.	.	.	.	.	.	.	.	.	.	.	3	MU18309036	hom
3	129023630	129023630	G	A	HMCES	exonic	nonsynonymous SNV	ENSG00000183624	rs60527165	ENSG00000183624:ENST00000417226:exon6:c.G901A:p.E301K,ENSG00000183624:ENST00000383463:exon7:c.G1027A:p.E343K,ENSG00000183624:ENST00000389735:exon7:c.G1027A:p.E343K,ENSG00000183624:ENST00000502878:exon7:c.G1027A:p.E343K	HMCES:NM_001363881:exon6:c.G901A:p.E301K,HMCES:NM_001370345:exon6:c.G883A:p.E295K,HMCES:NM_001006109:exon7:c.G1027A:p.E343K,HMCES:NM_001370343:exon7:c.G1027A:p.E343K,HMCES:NM_001370344:exon7:c.G1027A:p.E343K,HMCES:NM_020187:exon7:c.G1027A:p.E343K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.0256	0.0108	0.0497204	0.0196	2.988	22.2	0.012	1.61	0.994	.	.	.	C3orf37:uc003elu.3:exon6:c.G901A:p.E301K,C3orf37:uc003elt.3:exon7:c.G1027A:p.E343K,C3orf37:uc003elv.3:exon7:c.G1027A:p.E343K,C3orf37:uc003elw.3:exon7:c.G1027A:p.E343K	-1.143	AFR:0.0319,AMR:0.0024,EAS:0.1242,FIN:0.0203,NFE:0.0029,OTH:0.0102,ASJ:0	.	.	.	.	.	.	.	.	0.728	.	0.005	2.35	3	MU14512677	het
3	133329943	133329943	G	A	TOPBP1	exonic	synonymous SNV	ENSG00000163781	rs1444601	ENSG00000163781:ENST00000260810:exon25:c.C4078T:p.L1360L	TOPBP1:NM_001363889:exon25:c.C4063T:p.L1355L,TOPBP1:NM_007027:exon25:c.C4078T:p.L1360L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6905	0.7468	0.682109	0.7131	.	.	.	.	.	.	.	.	TOPBP1:uc003eps.3:exon25:c.C4078T:p.L1360L	.	AFR:0.7736,AMR:0.6842,EAS:0.5854,FIN:0.6523,NFE:0.7102,OTH:0.6811,ASJ:0.6788	607760	.	.	.	.	.	.	.	.	.	.	.	3	MU4134346	hom
3	133335787	133335787	C	T	TOPBP1	intronic	.	ENSG00000163781	rs3732574	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6891	0.6987	0.632188	0.6683	.	.	.	.	.	.	.	.	.	.	AFR:0.6156,AMR:0.6706,EAS:0.5899,FIN:0.6531,NFE:0.7103,OTH:0.6725,ASJ:0.6755	607760	.	.	.	.	.	.	.	.	.	.	.	3	MU23050173	hom
3	133341988	133341988	T	C	TOPBP1	exonic	nonsynonymous SNV	ENSG00000163781	rs10935070	ENSG00000163781:ENST00000260810:exon19:c.A3125G:p.N1042S	TOPBP1:NM_001363889:exon19:c.A3110G:p.N1037S,TOPBP1:NM_007027:exon19:c.A3125G:p.N1042S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.2898	0.2447	0.187899	0.2219	-2.603	0.001	0.313	-9.36	0.001	.	.	BRCT domain	TOPBP1:uc003ept.1:exon4:c.A137G:p.N46S,TOPBP1:uc003eps.3:exon19:c.A3125G:p.N1042S	-0.918	AFR:0.0614,AMR:0.3628,EAS:0.0198,FIN:0.2466,NFE:0.3187,OTH:0.2714,ASJ:0.3079	607760	.	.	.	.	.	.	.	0.0	2.78	0.000	-0.77	3	.	het
3	133368362	133368362	T	G	TOPBP1	exonic	nonsynonymous SNV	ENSG00000163781	rs3192149	ENSG00000163781:ENST00000260810:exon10:c.A1369C:p.K457Q	TOPBP1:NM_001363889:exon10:c.A1354C:p.K452Q,TOPBP1:NM_007027:exon10:c.A1369C:p.K457Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7159	0.7728	0.695887	0.7347	1.150	11.48	1.0	4.84	0.873	.	.	.	TOPBP1:uc003eps.3:exon10:c.A1369C:p.K457Q	-1.029	AFR:0.7850,AMR:0.6957,EAS:0.5878,FIN:0.6737,NFE:0.7405,OTH:0.6976,ASJ:0.7119	607760	.	.	.	.	.	.	.	0.0	2.75	0.000	-1.265	3	MU14391089	hom
3	134670524	134670524	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs7644369	ENSG00000154928:ENST00000398015:exon3:c.C435T:p.S145S,ENSG00000154928:ENST00000474732:exon3:c.C369T:p.S123S,ENSG00000154928:ENST00000482618:exon3:c.C435T:p.S145S	EPHB1:NM_004441:exon3:c.C435T:p.S145S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4628	0.4879	0.48143	2(lung)	.	.	.	.	.	.	.	.	EPHB1:uc003eqt.3:exon3:c.C435T:p.S145S,EPHB1:uc011bly.2:exon3:c.C435T:p.S145S	.	AFR:MU150981,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.6072,FIN:0.5359,NFE:0.5430,OTH:0.1963,ASJ:0.4687	600600	.	.	.	.	.	.	.	.	.	.	.	3	1(large_intestine)	0.3564
3	134884908	134884908	G	A	EPHB1	exonic	nonsynonymous SNV	ENSG00000154928	rs202034365	ENSG00000154928:ENST00000493838:exon6:c.G367A:p.V123I,ENSG00000154928:ENST00000398015:exon8:c.G1684A:p.V562I	EPHB1:NM_004441:exon8:c.G1684A:p.V562I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0026	0.0004	0.00299521	.	2.629	20.4	0.896	6.07	1.000	.	.	Ephrin receptor ligand binding domain|Ephrin type-B receptor 1, ligand binding domain|Galactose-binding domain-like;Ephrin receptor, transmembrane domain	EPHB1:uc003equ.3:exon6:c.G367A:p.V123I,EPHB1:uc003eqt.3:exon8:c.G1684A:p.V562I	-1.044	AFR:0.0018,AMR:0.0002,EAS:0.0033,FIN:0,NFE:0.0003,OTH:0.0034,ASJ:0	600600	.	.	.	.	.	.	.	0.002	2.8	0.025	0.26	3	2(large_intestine)	0.0020
3	134898742	134898742	C	T	EPHB1	exonic	synonymous SNV	ENSG00000154928	rs1042787	ENSG00000154928:ENST00000493838:exon8:c.C483T:p.Y161Y,ENSG00000154928:ENST00000398015:exon10:c.C1800T:p.Y600Y	EPHB1:NM_004441:exon10:c.C1800T:p.Y600Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4494	0.4166	0.537939	0.4358	.	.	.	.	.	.	.	.	EPHB1:uc003equ.3:exon8:c.C483T:p.Y161Y,EPHB1:uc003eqt.3:exon10:c.C1800T:p.Y600Y	.	AFR:0.5083,AMR:0.4653,EAS:0.7172,FIN:0.3184,NFE:0.3933,OTH:0.4206,ASJ:0.2748	600600	.	.	.	.	.	.	.	.	.	.	.	3	MU4133192	hom
3	134967368	134967368	G	A	EPHB1	intronic	.	ENSG00000154928	rs11717042	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3120	0.2276	0.280751	MU28582199	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2490,EAS:0.2386,FIN:0.2914,NFE:0.2867,OTH:0.2944,ASJ:0.2552	600600	.	.	.	.	.	.	.	.	.	.	.	3	1(lung)	0.2304
3	139065748	139065748	A	G	MRPS22	exonic	synonymous SNV	ENSG00000175110	rs11556243	ENSG00000175110:ENST00000310776:exon2:c.A201G:p.K67K,ENSG00000175110:ENST00000465056:exon2:c.A198G:p.K66K,ENSG00000175110:ENST00000465373:exon2:c.A216G:p.K72K,ENSG00000175110:ENST00000478464:exon2:c.A78G:p.K26K,ENSG00000175110:ENST00000498505:exon2:c.A198G:p.K66K,ENSG00000175110:ENST00000495075:exon4:c.A201G:p.K67K,ENSG00000175110:ENST00000495225:exon4:c.A111G:p.K37K	MRPS22:NM_001363857:exon2:c.A78G:p.K26K,MRPS22:NM_001363893:exon2:c.A198G:p.K66K,MRPS22:NM_020191:exon2:c.A201G:p.K67K	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0074	0.0091	0.00599042	0.0058	.	.	.	.	.	.	.	.	MRPS22:uc003etb.3:exon2:c.A201G:p.K67K	.	AFR:0.0022,AMR:0.0084,EAS:0,FIN:0.0023,NFE:0.0091,OTH:0.0061,ASJ:0.0132	605810	611719;	137908;	137908|COXPD5<br>Combined oxidative phosphorylation defect type 5|<1 / 1 000 000|Autosomal recessive|Antenatal<br>Neonatal|611719 ~	.	.	.	.	.	.	.	.	3	.	het
3	142168331	142168331	C	T	ATR	exonic	synonymous SNV	ENSG00000175054	rs1802904	ENSG00000175054:ENST00000383101:exon46:c.G7683A:p.Q2561Q,ENSG00000175054:ENST00000350721:exon47:c.G7875A:p.Q2625Q	ATR:NM_001354579:exon46:c.G7683A:p.Q2561Q,ATR:NM_001184:exon47:c.G7875A:p.Q2625Q	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8646	0.8978	0.916334	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon47:c.G7875A:p.Q2625Q	.	AFR:0.8880,AMR:0.9702,EAS:0.8079,FIN:0.9420,NFE:0.7995,OTH:0.8651,ASJ:0.7775	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	,926,925	.	.	.	.	.	.	3	17(meninges)	0.8510
3	142217537	142217537	A	G	ATR	exonic	synonymous SNV	ENSG00000175054	rs2227932	ENSG00000175054:ENST00000514393:exon2:c.T143C:p.M48T	ATR:NM_001354579:exon31:c.T5268C:p.Y1756Y,ATR:NM_001184:exon32:c.T5460C:p.Y1820Y	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0942	0.0768	0.066893	.	.	.	.	.	.	.	.	.	ATR:uc003eux.4:exon32:c.T5460C:p.Y1820Y	.	AFR:.,AMR:0.0814,EAS:0.0489,FIN:0.0894,NFE:0,OTH:0.1276,ASJ:0.0205	601215	210600;614564;	313846;808;	313846|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614564 ~808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	,926,925	.	.	.	.	.	.	3	16(lung)	0.1158
3	148756825	148756825	G	A	HLTF	intronic	.	ENSG00000071794	rs6764352	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9754	0.9796	0.980232	0.9847	.	.	.	.	.	.	.	.	.	.	AFR:0.9954,AMR:0.9857,EAS:1,FIN:0.9903,NFE:0.9752,OTH:0.9878,ASJ:0.9834	603257	.	.	.	.	.	.	.	.	.	.	.	3	MU81772047	hom
3	148786108	148786108	C	T	HLTF	exonic	synonymous SNV	ENSG00000071794	rs812249	ENSG00000071794:ENST00000310053:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000392912:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000465259:exon8:c.G909A:p.T303T,ENSG00000071794:ENST00000494055:exon8:c.G909A:p.T303T	HLTF:NM_001318934:exon8:c.G909A:p.T303T,HLTF:NM_001318935:exon8:c.G909A:p.T303T,HLTF:NM_003071:exon8:c.G909A:p.T303T,HLTF:NM_139048:exon8:c.G909A:p.T303T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.7527	0.742412	MU16602666	.	.	.	.	.	.	.	.	HLTF:uc003ewq.1:exon8:c.G909A:p.T303T,HLTF:uc003ewr.1:exon8:c.G909A:p.T303T,HLTF:uc003ews.1:exon8:c.G909A:p.T303T,HLTF:uc010hve.1:exon8:c.G909A:p.T303T	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7369,EAS:0.8289,FIN:0.7980,NFE:0.7213,OTH:0.7109,ASJ:0.8307	603257	.	.	.	.	.	.	.	.	.	.	.	3	1(prostate)	0.6853
3	154890381	154890381	G	A	MME	exonic	synonymous SNV	ENSG00000196549	rs61760409	ENSG00000196549:ENST00000360490:exon22:c.G2133A:p.V711V,ENSG00000196549:ENST00000460393:exon22:c.G2133A:p.V711V,ENSG00000196549:ENST00000462745:exon22:c.G2133A:p.V711V,ENSG00000196549:ENST00000492661:exon22:c.G2133A:p.V711V,ENSG00000196549:ENST00000493237:exon22:c.G2133A:p.V711V	MME:NM_000902:exon22:c.G2133A:p.V711V,MME:NM_001354642:exon22:c.G2133A:p.V711V,MME:NM_001354643:exon22:c.G2133A:p.V711V,MME:NM_007287:exon22:c.G2133A:p.V711V,MME:NM_007288:exon22:c.G2133A:p.V711V,MME:NM_007289:exon22:c.G2133A:p.V711V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0100	0.0066	0.00858626	0.0056	.	.	.	.	.	.	.	.	MME:uc003fab.1:exon22:c.G2133A:p.V711V,MME:uc003fac.1:exon22:c.G2133A:p.V711V,MME:uc003fad.1:exon22:c.G2133A:p.V711V,MME:uc003fae.1:exon22:c.G2133A:p.V711V,MME:uc010hvr.1:exon22:c.G2133A:p.V711V	.	AFR:0.0015,AMR:0.0012,EAS:0,FIN:0.0057,NFE:0.0088,OTH:0.0071,ASJ:0	120520	617017;617018;	443950;	443950|AR-CMT2T<br>Autosomal recessive axonal Charcot-Marie-Tooth disease type 2T<br>CMT2T|<1 / 1 000 000|Autosomal recessive|Adult|616233 617017 ~	.	.	.	.	.	.	.	.	3	.	het
3	156864399	156864404	AAAAAA	-	CCNL1	intronic	.	ENSG00000163660	rs370594663	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3974	.	.	0.2697	.	.	.	.	.	.	.	.	.	.	AFR:0.1564,AMR:0.4884,EAS:0.3810,FIN:0.3577,NFE:0.2936,OTH:0.3046,ASJ:0.2364	613384	.	.	.	.	.	.	.	.	.	.	.	3	.	unknown
3	156867776	156867776	-	AA	CCNL1	intronic	.	ENSG00000163660	rs386398342	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4059	0.375	0.471446	0.3984	.	.	.	.	.	.	.	.	.	.	AFR:0.4588,AMR:0.6320,EAS:0.5539,FIN:0.3358,NFE:0.3495,OTH:0.3766,ASJ:0.37	613384	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	156870816	156870816	A	G	CCNL1	intronic	.	ENSG00000163660	rs41272613	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2546	0.1954	0.23722	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.2035,AMR:0.0990,EAS:0.1821,FIN:0.3578,NFE:0.1823,OTH:0.2377,ASJ:0.4580	613384	.	.	.	.	.	.	.	.	.	.	.	3	2(haematopoietic_and_lymphoid_tissue)	0.2219
3	156877277	156877278	AA	-	CCNL1	intronic	.	ENSG00000163660	rs59715654	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2563	0.1984	0.241214	0.2060	.	.	.	.	.	.	.	.	.	.	AFR:0.1101,AMR:0.4547,EAS:0.3579,FIN:0.1817,NFE:0.2366,OTH:0.2220,ASJ:0.1846	613384	.	.	.	.	.	.	.	.	.	.	.	3	MU76841695	het
3	178922274	178922274	C	A	PIK3CA	intronic	.	ENSG00000121879	rs2699896	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5614	0.6697	0.584665	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6189,AMR:0.8533,EAS:0.6689,FIN:0.2710,NFE:0.4851,OTH:0.5604,ASJ:0.5203	171834	114480;114500;114550;162900;167000;182000;211980;602501;612918;613659;615108;	201;140944;60040;79414;449;88673;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~140944|Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome<br>Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|612918 ~60040|MCAP<br>MCM<br>MCMTC<br>Macrocephaly-capillary malformation syndrome<br>Macrocephaly-cutis marmorata telangiectatica congenita syndrome<br>Megalencephaly-capillary malformation syndrome<br>Megalencephaly-cutis marmorata telangiectatica congenita syndrome|<1 / 1 000 000|Not applicable|Infancy<br>Neonatal|602501 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	3	3(soft_tissue)	0.5509
3	182681740	182681740	C	T	DCUN1D1	exonic	synonymous SNV	ENSG00000043093	rs4859146	ENSG00000043093:ENST00000292782:exon3:c.G318A:p.A106A,ENSG00000043093:ENST00000469954:exon3:c.G273A:p.A91A,ENSG00000043093:ENST00000497606:exon3:c.G273A:p.A91A,ENSG00000043093:ENST00000460412:exon4:c.G273A:p.A91A,ENSG00000043093:ENST00000487822:exon4:c.G273A:p.A91A	DCUN1D1:NM_001308101:exon3:c.G273A:p.A91A,DCUN1D1:NM_020640:exon3:c.G318A:p.A106A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6885	0.7567	0.613019	0.7363	.	.	.	.	.	.	.	.	DCUN1D1:uc003fld.1:exon3:c.G318A:p.A106A	.	AFR:0.7379,AMR:0.6966,EAS:0.2701,FIN:0.7646,NFE:0.7835,OTH:0.7352,ASJ:0.6291	605905	.	.	.	.	.	.	.	.	.	.	.	3	MU11206066	het
3	182681853	182681853	T	C	DCUN1D1	intronic	.	ENSG00000043093	rs4859147	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5527	0.4870	0.377796	0.4947	.	.	.	.	.	.	.	.	.	.	AFR:0.1233,AMR:0.5668,EAS:0.2506,FIN:0.6638,NFE:0.6864,OTH:0.6130,ASJ:0.4768	605905	.	.	.	.	.	.	.	.	.	.	.	3	MU26132409	het
3	183211906	183211906	A	G	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs1520101	ENSG00000172578:ENST00000341319:exon5:c.T1311C:p.N437N,ENSG00000172578:ENST00000468734:exon5:c.T1278C:p.N426N	KLHL6:NM_130446:exon5:c.T1311C:p.N437N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5610	0.5813	0.697883	0.5713	.	.	.	.	.	.	.	.	KLHL6:uc003flr.3:exon5:c.T1311C:p.N437N	.	AFR:0.8114,AMR:0.6065,EAS:0.7741,FIN:0.3972,NFE:0.4564,OTH:0.4501,ASJ:0.5667	614214	.	.	.	.	.	.	.	.	.	.	.	3	MU103694	hom
3	183212026	183212026	C	T	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs2256061	ENSG00000172578:ENST00000341319:exon5:c.G1191A:p.S397S,ENSG00000172578:ENST00000468734:exon5:c.G1158A:p.S386S	KLHL6:NM_130446:exon5:c.G1191A:p.S397S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1788	0.2111	0.150759	0.1841	.	.	.	.	.	.	.	.	KLHL6:uc003flt.1:exon4:c.G947A:p.R316Q	.	AFR:0.2286,AMR:0.1468,EAS:0.0166,FIN:0.1391,NFE:0.1910,OTH:0.1605,ASJ:0.1589	614214	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	183226072	183226072	G	A	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs16857707	ENSG00000172578:ENST00000341319:exon3:c.C684T:p.Y228Y,ENSG00000172578:ENST00000468734:exon3:c.C651T:p.Y217Y	KLHL6:NM_130446:exon3:c.C684T:p.Y228Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0486	0.0772	0.122005	0.0767	.	.	.	.	.	.	.	.	KLHL6:uc003flr.3:exon3:c.C684T:p.Y228Y,KLHL6:uc003flt.1:exon3:c.C678T:p.Y226Y	.	AFR:0.2244,AMR:0.0477,EAS:0.1790,FIN:0.0083,NFE:0.0019,OTH:0.0286,ASJ:0.0033	614214	.	.	.	.	.	.	.	.	.	.	.	3	MU794080	het
3	183226186	183226186	C	T	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs61447052	ENSG00000172578:ENST00000341319:exon3:c.G570A:p.K190K,ENSG00000172578:ENST00000468734:exon3:c.G537A:p.K179K	KLHL6:NM_130446:exon3:c.G570A:p.K190K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0346	0.0254	0.0804712	0.0335	.	.	.	.	.	.	.	.	KLHL6:uc003flr.3:exon3:c.G570A:p.K190K,KLHL6:uc003flt.1:exon3:c.G564A:p.K188K	.	AFR:0.0728,AMR:0.0394,EAS:0.1796,FIN:0.0083,NFE:0.0017,OTH:0.0234,ASJ:0.0033	614214	.	.	.	.	.	.	.	.	.	.	.	3	MU586201	het
3	183226213	183226213	A	G	KLHL6	exonic	synonymous SNV	ENSG00000172578	rs16857710	ENSG00000172578:ENST00000341319:exon3:c.T543C:p.A181A,ENSG00000172578:ENST00000468734:exon3:c.T510C:p.A170A	KLHL6:NM_130446:exon3:c.T543C:p.A181A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0565	0.1069	0.146166	0.0994	.	.	.	.	.	.	.	.	KLHL6:uc003flr.3:exon3:c.T543C:p.A181A,KLHL6:uc003flt.1:exon3:c.T537C:p.A179A	.	AFR:0.3031,AMR:0.0513,EAS:0.1794,FIN:0.0083,NFE:0.0025,OTH:0.0346,ASJ:0.0033	614214	.	.	.	.	.	.	.	.	.	.	.	3	MU586202	het
3	184094183	184094183	A	G	THPO	exonic	synonymous SNV	ENSG00000090534	rs956732	.	THPO:NM_001290003:exon3:c.T285C:p.S95S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	.	.	0.506789	0.5124	.	.	.	.	.	.	.	.	.	.	AFR:0.6077,AMR:0.5979,EAS:0.4200,FIN:0.3705,NFE:0.4993,OTH:0.4469,ASJ:0.5298	600044	187950;	3318;71493;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~	.	.	.	.	.	.	.	.	3	.	hom
3	185046766	185046766	T	A	MAP3K13	intronic	.	ENSG00000073803	rs9859234	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.730831	0.7726	.	.	.	.	.	.	.	.	.	.	AFR:0.6109,AMR:0.7998,EAS:0.7895,FIN:0.8489,NFE:0.8412,OTH:0.8202,ASJ:0.8167	604915	.	.	.	.	.	.	.	.	.	.	.	3	.	hom
3	185155430	185155430	-	T	MAP3K13	intronic	.	ENSG00000073803	rs5855064	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5905	.	0.616214	0.7684	.	.	.	.	.	.	.	.	.	.	AFR:0.6852,AMR:0.7870,EAS:0.7418,FIN:0.7263,NFE:0.8259,OTH:0.7861,ASJ:0.8433	604915	.	.	.	.	.	.	.	.	.	.	.	3	.	unknown
3	187447032	187447032	G	A	BCL6	exonic	synonymous SNV	ENSG00000113916	rs1056932	ENSG00000113916:ENST00000450123:exon4:c.C1161T:p.N387N,ENSG00000113916:ENST00000232014:exon5:c.C1161T:p.N387N,ENSG00000113916:ENST00000406870:exon5:c.C1161T:p.N387N	BCL6:NM_001134738:exon4:c.C1161T:p.N387N,BCL6:NM_001130845:exon5:c.C1161T:p.N387N,BCL6:NM_001706:exon5:c.C1161T:p.N387N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6435	0.4974	0.565296	MU794210	.	.	.	.	.	.	.	.	BCL6:uc011bsf.1:exon4:c.C1161T:p.N387N,BCL6:uc003frp.3:exon5:c.C1161T:p.N387N,BCL6:uc003frq.2:exon5:c.C1161T:p.N387N,BCL6:uc010hza.2:exon5:c.C855T:p.N285N	.	AFR:COCA-CN|6|321|0.0186916,AMR:0.5310,EAS:0.7482,FIN:0.7086,NFE:0.7937,OTH:0.6955,ASJ:0.1832	109565	.	.	.	~ko04068 FoxO signaling pathway~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	3	1(breast)	0.6432
3	191888453	191888453	A	-	FGF12	intronic	.	ENSG00000114279	rs34265167	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4192	.	0.437899	0.4049	.	.	.	.	.	.	.	.	.	.	AFR:0.5939,AMR:0.3778,EAS:0.4905,FIN:0.3292,NFE:0.2925,OTH:0.3448,ASJ:0.3723	601513	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	195594152	195594153	CT	-	TNK2	intronic	.	ENSG00000061938	rs10579442	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1597	0.1288	0.121206	0.1293	.	.	.	.	.	.	.	.	.	.	AFR:0.0540,AMR:0.1575,EAS:0.0655,FIN:0.1977,NFE:0.1576,OTH:0.1633,ASJ:0.2616	606994	.	.	.	.	.	.	.	.	.	.	.	3	MU114027310	het
3	195594950	195594950	G	A	TNK2	exonic	nonsynonymous SNV	ENSG00000061938	rs56260729	ENSG00000061938:ENST00000416152:exon4:c.C875T:p.P292L,ENSG00000061938:ENST00000333602:exon12:c.C2174T:p.P725L,ENSG00000061938:ENST00000392400:exon12:c.C2174T:p.P725L,ENSG00000061938:ENST00000428187:exon12:c.C2270T:p.P757L,ENSG00000061938:ENST00000381916:exon13:c.C2408T:p.P803L	TNK2:NM_001308046:exon12:c.C2270T:p.P757L,TNK2:NM_005781:exon12:c.C2174T:p.P725L,TNK2:NM_001010938:exon13:c.C2291T:p.P764L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2286	0.1553	0.123802	0.1623	-0.727	0.063	0.673	1.38	0.001	.	.	Mig-6 domain	TNK2:uc003fvq.1:exon1:c.C395T:p.P132L,TNK2:uc003fvr.1:exon4:c.C749T:p.P250L,TNK2:uc003fvs.1:exon12:c.C2270T:p.P757L,TNK2:uc003fvu.1:exon12:c.C2174T:p.P725L,TNK2:uc003fvt.1:exon13:c.C2408T:p.P803L	-0.937	AFR:0.0405,AMR:0.1921,EAS:0.0457,FIN:0.2428,NFE:0.2194,OTH:0.2243,ASJ:0.26	606994	.	.	.	.	.	.	.	0.0	1.73	0.000	-1.935	3	MU82303383	het
3	195595297	195595297	C	T	TNK2	exonic	synonymous SNV	ENSG00000061938	rs144161756	ENSG00000061938:ENST00000416152:exon4:c.G528A:p.T176T,ENSG00000061938:ENST00000333602:exon12:c.G1827A:p.T609T,ENSG00000061938:ENST00000392400:exon12:c.G1827A:p.T609T,ENSG00000061938:ENST00000428187:exon12:c.G1923A:p.T641T,ENSG00000061938:ENST00000381916:exon13:c.G2061A:p.T687T	TNK2:NM_001308046:exon12:c.G1923A:p.T641T,TNK2:NM_005781:exon12:c.G1827A:p.T609T,TNK2:NM_001010938:exon13:c.G1944A:p.T648T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0069	0.0026	0.00439297	0.0032	.	.	.	.	.	.	.	.	TNK2:uc003fvq.1:exon1:c.G48A:p.T16T,TNK2:uc003fvr.1:exon4:c.G402A:p.T134T,TNK2:uc003fvs.1:exon12:c.G1923A:p.T641T,TNK2:uc003fvu.1:exon12:c.G1827A:p.T609T,TNK2:uc003fvt.1:exon13:c.G2061A:p.T687T	.	AFR:0.0016,AMR:0,EAS:0.0160,FIN:0.0011,NFE:0.0036,OTH:0.0020,ASJ:0	606994	.	.	.	.	.	.	.	.	.	.	.	3	MU82254572	het
3	195615376	195615376	A	G	TNK2	exonic	synonymous SNV	ENSG00000061938	rs3747669	ENSG00000061938:ENST00000316664:exon2:c.T84C:p.D28D,ENSG00000061938:ENST00000333602:exon2:c.T84C:p.D28D,ENSG00000061938:ENST00000381916:exon2:c.T273C:p.D91D,ENSG00000061938:ENST00000392400:exon2:c.T84C:p.D28D,ENSG00000061938:ENST00000428187:exon2:c.T180C:p.D60D,ENSG00000061938:ENST00000439230:exon2:c.T84C:p.D28D,ENSG00000061938:ENST00000447060:exon2:c.T84C:p.D28D,ENSG00000061938:ENST00000427576:exon3:c.T276C:p.D92D,ENSG00000061938:ENST00000433111:exon4:c.T84C:p.D28D	TNK2:NM_001010938:exon2:c.T156C:p.D52D,TNK2:NM_001308046:exon2:c.T180C:p.D60D,TNK2:NM_005781:exon2:c.T84C:p.D28D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3383	0.3904	0.442692	0.3750	.	.	.	.	.	.	.	.	TNK2:uc003fvs.1:exon2:c.T180C:p.D60D,TNK2:uc003fvt.1:exon2:c.T273C:p.D91D,TNK2:uc003fvu.1:exon2:c.T84C:p.D28D,TNK2:uc010hzx.1:exon2:c.T126C:p.D42D	.	AFR:0.6015,AMR:0.3747,EAS:0.4336,FIN:0.2859,NFE:0.2625,OTH:0.3045,ASJ:0.3841	606994	.	.	.	.	.	.	.	.	.	.	.	3	MU686129	het
3	195619549	195619549	-	GAG	TNK2	UTR5	.	ENSG00000061938	rs10626163	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.591653	0.5816	.	.	.	.	.	.	.	.	.	.	AFR:0.8179,AMR:0.5060,EAS:0.4773,FIN:0.4782,NFE:0.4898,OTH:0.5124,ASJ:0.5067	606994	.	.	.	.	.	.	.	.	.	.	.	3	.	het
3	195782176	195782176	C	T	TFRC	intronic	.	ENSG00000072274	rs419068	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3201	0.1909	0.298123	0.3158	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3054,AMR:0.2614,EAS:0.1800,FIN:0.3665,NFE:0.3264,OTH:0.3296,ASJ:0.3467	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU28881240	unknown
3	195782177	195782177	A	G	TFRC	intronic	.	ENSG00000072274	rs366268	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3203	0.1933	0.298323	0.3163	.	.	.	.	.	0.0008	0.026	.	.	.	AFR:0.3066,AMR:0.2614,EAS:0.1807,FIN:0.3666,NFE:0.3265,OTH:0.3296,ASJ:0.3467	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU81776678	unknown
3	195782184	195782184	C	T	TFRC	intronic	.	ENSG00000072274	rs419059	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3204	0.3201	0.298123	0.3160	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.3056,AMR:0.2614,EAS:0.1802,FIN:0.3667,NFE:0.3265,OTH:0.3296,ASJ:0.3467	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU81776694	unknown
3	195798258	195798258	T	C	TFRC	intronic	.	ENSG00000072274	rs480760	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9497	0.8857	0.894169	0.9015	.	.	.	.	.	.	.	.	.	.	AFR:0.7292,AMR:0.9606,EAS:1,FIN:0.9657,NFE:0.9670,OTH:0.9654,ASJ:0.9768	190010	616740;	.	.	.	.	.	.	.	.	.	.	3	MU81776721	hom
3	195798320	195798320	G	C	TFRC	exonic	nonsynonymous SNV	ENSG00000072274	rs41301381	ENSG00000072274:ENST00000420415:exon5:c.C391G:p.L131V,ENSG00000072274:ENST00000360110:exon6:c.C634G:p.L212V,ENSG00000072274:ENST00000392396:exon6:c.C634G:p.L212V	TFRC:NM_001313965:exon5:c.C391G:p.L131V,TFRC:NM_001128148:exon6:c.C634G:p.L212V,TFRC:NM_003234:exon6:c.C634G:p.L212V	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0020	0.0002	0.00379393	0.0013	-0.748	0.056	0.718	1.89	0.023	.	.	.	TFRC:uc010hzy.3:exon5:c.C391G:p.L131V,TFRC:uc003fvz.4:exon6:c.C634G:p.L212V,TFRC:uc003fwa.4:exon6:c.C634G:p.L212V	-0.926	AFR:0,AMR:0.0012,EAS:0.0235,FIN:0,NFE:0,OTH:0,ASJ:0	190010	616740;	.	.	.	.	.	.	0.001	3.14	0.012	2.195	3	.	het
3	196199204	196199204	G	T	RNF168	exonic	nonsynonymous SNV	ENSG00000163961	rs3796129	ENSG00000163961:ENST00000318037:exon6:c.C1202A:p.P401Q	RNF168:NM_152617:exon6:c.C1202A:p.P401Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5405	0.5172	0.402356	0.5038	2.051	16.54	0.058	4.29	0.713	.	.	.	RNF168:uc010iah.3:exon5:c.C701A:p.P234Q,RNF168:uc003fwq.3:exon6:c.C1202A:p.P401Q	-1.041	AFR:0.2989,AMR:0.4306,EAS:0.1776,FIN:0.6676,NFE:0.6172,OTH:0.5706,ASJ:0.6225	612688	611943;	420741;	420741|RNF168 deficiency<br>Radiosensitivity-immunodeficiency-dysmorphic features-learning difficulties syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Adolescent|611943 ~	.	.	.	.	0.8	3.18	0.000	2.38	3	MU27951640	het
4	1374714	1374714	C	T	UVSSA	exonic	nonsynonymous SNV	ENSG00000163945	rs77731309	ENSG00000163945:ENST00000511563:exon5:c.C452T:p.P151L,ENSG00000163945:ENST00000512728:exon5:c.C452T:p.P151L,ENSG00000163945:ENST00000389851:exon12:c.C1799T:p.P600L,ENSG00000163945:ENST00000507531:exon12:c.C1799T:p.P600L,ENSG00000163945:ENST00000511216:exon12:c.C1799T:p.P600L	UVSSA:NM_001317934:exon12:c.C1799T:p.P600L,UVSSA:NM_001317935:exon12:c.C1799T:p.P600L,UVSSA:NM_020894:exon12:c.C1799T:p.P600L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0] 	0.0009	0.0004	0.00279553	0.0011	6.024	27.9	0.003	4.56	0.003	.	.	ENTH/VHS	UVSSA:uc010ibv.3:exon5:c.C452T:p.P151L,UVSSA:uc003gde.4:exon12:c.C1799T:p.P600L	0.003	AFR:0.0007,AMR:0,EAS:0.0080,FIN:0,NFE:0.0007,OTH:0.0031,ASJ:0	614632	614640;	178338;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~	.	.	.	.	1.0	0.68	0.372	2.93	4	.	het
4	1807894	1807894	G	A	FGFR3	exonic	synonymous SNV	ENSG00000068078	rs7688609	ENSG00000068078:ENST00000352904:exon11:c.G1617A:p.T539T,ENSG00000068078:ENST00000412135:exon12:c.G1617A:p.T539T,ENSG00000068078:ENST00000260795:exon13:c.G1953A:p.T651T,ENSG00000068078:ENST00000340107:exon14:c.G1959A:p.T653T,ENSG00000068078:ENST00000440486:exon14:c.G1953A:p.T651T,ENSG00000068078:ENST00000481110:exon14:c.G1956A:p.T652T	FGFR3:NM_022965:exon12:c.G1617A:p.T539T,FGFR3:NM_000142:exon14:c.G1953A:p.T651T,FGFR3:NM_001163213:exon14:c.G1959A:p.T653T,FGFR3:NM_001354809:exon14:c.G1956A:p.T652T,FGFR3:NM_001354810:exon14:c.G1956A:p.T652T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9873	0.9551	0.95607	MU81778057	.	.	.	.	.	.	.	.	FGFR3:uc003gds.3:exon12:c.G1617A:p.T539T,FGFR3:uc003gdq.3:exon14:c.G1956A:p.T652T,FGFR3:uc003gdr.3:exon14:c.G1953A:p.T651T,FGFR3:uc003gdu.2:exon14:c.G1959A:p.T653T	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.9604,EAS:0.9988,FIN:1,NFE:1,OTH:1,ASJ:0.8608	134934	100800;109800;114500;146000;149730;162900;187600;187601;273300;602849;603956;610474;612247;616482;	85165;93262;85164;53271;363483;363494;363504;842;876;99865;2655;93274;1860;2655;79414;2363;429;15;	85165|SADDAN|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|616482 ~93262|Crouzon-dermoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal|612247 ~85164|CATSHL syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|610474 ~53271|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|602849 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~93274|Cloverleaf skull-micromelic bone dysplasia syndrome<br>TD2<br>Thanatophoric dwarfism type 2<br>Thanatophoric dwarfism-cloverleaf skull syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|156830 187601 ~1860|TD1<br>Thanatophoric dwarfism type 1|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|187600 ~2655|TD<br>Thanatophoric dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|156830 187600 187601 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~429|-|1-9 / 100 000|Autosomal dominant|Childhood|146000 ~15|-|1-9 / 100 000|Autosomal dominant|Neonatal|100800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05219 Bladder cancer~ko05230 Central carbon metabolism in cancer ~	,5469,5498,5475,5482,5477,5485,5471,5472,5473,5478,5484,5470,5486,5480,5497,5488,5483,5487,5479,5474,5481,5476	.	.	.	.	.	.	4	18(meninges)	0.9997
4	2160894	2160894	C	T	POLN	exonic	synonymous SNV	ENSG00000130997	rs10488836	ENSG00000130997:ENST00000382865:exon12:c.G1599A:p.L533L,ENSG00000130997:ENST00000511885:exon14:c.G1599A:p.L533L	POLN:NM_181808:exon14:c.G1599A:p.L533L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1132	0.1179	0.201478	0.1202	.	.	.	.	.	.	.	.	POLN:uc003ger.2:exon12:c.G1599A:p.L533L,POLN:uc011bvi.1:exon14:c.G1599A:p.L533L	.	AFR:0.2293,AMR:0.1647,EAS:0.3679,FIN:0.0338,NFE:0.0519,OTH:0.0754,ASJ:0.0695	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU762430	het
4	2175733	2175733	A	G	POLN	exonic	synonymous SNV	ENSG00000130997	rs2022302	ENSG00000130997:ENST00000382865:exon9:c.T1323C:p.H441H,ENSG00000130997:ENST00000511885:exon11:c.T1323C:p.H441H	POLN:NM_181808:exon11:c.T1323C:p.H441H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1898	0.2473	0.321885	0.2399	.	.	.	.	.	.	.	.	POLN:uc010ich.1:exon5:c.T96C:p.H32H,POLN:uc003ger.2:exon9:c.T1323C:p.H441H,POLN:uc011bvi.1:exon11:c.T1323C:p.H441H	.	AFR:0.5182,AMR:0.2470,EAS:0.3956,FIN:0.0859,NFE:0.1042,OTH:0.1589,ASJ:0.1391	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU24274680	het
4	2176454	2176454	G	A	POLN	exonic	nonsynonymous SNV	ENSG00000130997	rs9328764	ENSG00000130997:ENST00000382865:exon8:c.C1273T:p.R425C,ENSG00000130997:ENST00000511885:exon10:c.C1273T:p.R425C	POLN:NM_181808:exon10:c.C1273T:p.R425C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1905	0.2472	0.321885	0.2401	3.482	23.1	0.258	4.48	0.992	.	.	.	POLN:uc010ich.1:exon4:c.C46T:p.R16C,POLN:uc003ger.2:exon8:c.C1273T:p.R425C,POLN:uc011bvi.1:exon10:c.C1273T:p.R425C	-0.974	AFR:0.5190,AMR:0.2476,EAS:0.3965,FIN:0.0860,NFE:0.1043,OTH:0.1571,ASJ:0.1391	610887	.	.	.	.	.	.	.	0.0	3.0	0.000	-2.4	4	MU11968384	het
4	2181016	2181016	T	C	POLN	intronic	.	ENSG00000130997	rs35787308	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1899	0.2460	0.321885	0.2399	.	.	.	.	.	.	.	.	.	.	AFR:0.5187,AMR:0.2482,EAS:0.3974,FIN:0.0857,NFE:0.1041,OTH:0.1589,ASJ:0.1391	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU18358960	het
4	2181080	2181080	T	C	POLN	exonic	synonymous SNV	ENSG00000130997	rs6830513	ENSG00000130997:ENST00000382865:exon6:c.A1134G:p.T378T,ENSG00000130997:ENST00000511885:exon8:c.A1134G:p.T378T	POLN:NM_181808:exon8:c.A1134G:p.T378T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1896	0.2470	0.321885	0.2400	.	.	.	.	.	.	.	.	POLN:uc003ger.2:exon6:c.A1134G:p.T378T,POLN:uc011bvi.1:exon8:c.A1134G:p.T378T	.	AFR:0.5191,AMR:0.2470,EAS:0.3964,FIN:0.0859,NFE:0.1041,OTH:0.1571,ASJ:0.1391	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU11968459	het
4	2194946	2194946	C	T	POLN	exonic	nonsynonymous SNV	ENSG00000130997	rs10011549	ENSG00000130997:ENST00000382865:exon5:c.G1006A:p.G336S,ENSG00000130997:ENST00000511885:exon7:c.G1006A:p.G336S	POLN:NM_181808:exon7:c.G1006A:p.G336S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1906	0.2575	0.330671	0.2457	-0.253	0.844	0.214	0.379	0.225	.	.	.	POLN:uc010ich.1:exon3:c.G6A:p.M2I,POLN:uc003ger.2:exon5:c.G1006A:p.G336S,POLN:uc011bvi.1:exon7:c.G1006A:p.G336S	-0.974	AFR:0.5431,AMR:0.2464,EAS:0.3944,FIN:0.0854,NFE:0.1039,OTH:0.1588,ASJ:0.1333	610887	.	.	.	.	.	.	.	0.014	3.54	0.000	.	4	MU18359031	unknown
4	2194953	2194953	G	A	POLN	exonic	synonymous SNV	ENSG00000130997	rs10002583	ENSG00000130997:ENST00000382865:exon5:c.C999T:p.G333G,ENSG00000130997:ENST00000511885:exon7:c.C999T:p.G333G	POLN:NM_181808:exon7:c.C999T:p.G333G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1905	0.2578	0.330671	0.2460	.	.	.	.	.	.	.	.	POLN:uc003ger.2:exon5:c.C999T:p.G333G,POLN:uc011bvi.1:exon7:c.C999T:p.G333G	.	AFR:0.5437,AMR:0.2464,EAS:0.3949,FIN:0.0855,NFE:0.1039,OTH:0.1588,ASJ:0.1333	610887	.	.	.	.	.	.	.	.	.	.	.	4	MU18359053	unknown
4	2195024	2195024	T	G	POLN	exonic	nonsynonymous SNV	ENSG00000130997	rs10018786	ENSG00000130997:ENST00000382865:exon5:c.A928C:p.M310L,ENSG00000130997:ENST00000511885:exon7:c.A928C:p.M310L	POLN:NM_181808:exon7:c.A928C:p.M310L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1940	0.2574	0.330671	0.2479	-0.932	0.022	1.0	4.64	0.109	.	.	.	POLN:uc003ger.2:exon5:c.A928C:p.M310L,POLN:uc011bvi.1:exon7:c.A928C:p.M310L	-0.944	AFR:0.5470,AMR:0.2452,EAS:0.3980,FIN:0.0859,NFE:0.1037,OTH:0.1619,ASJ:0.1333	610887	.	.	.	.	.	.	.	0.0	2.61	0.000	-2.445	4	MU762445	het
4	25664244	25664244	G	A	SLC34A2	intronic	.	ENSG00000157765	rs4697597	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0708	0.0427	0.121605	MU11973799	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,GACA-JP|1|585|0.0017094,AMR:0.0575,EAS:0.1340,FIN:0.03,NFE:0.2838,OTH:0.0464,ASJ:0.0640	604217	265100;	60025;	60025|-|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|All ages|265100 ~	.	.	.	.	.	.	.	.	4	1(lung)	0.0289
4	25678199	25678199	A	G	SLC34A2	exonic	nonsynonymous SNV	ENSG00000157765	rs6448389	ENSG00000157765:ENST00000382051:exon13:c.A1901G:p.D634G,ENSG00000157765:ENST00000503434:exon13:c.A1898G:p.D633G,ENSG00000157765:ENST00000504570:exon13:c.A1898G:p.D633G	SLC34A2:NM_001177998:exon13:c.A1898G:p.D633G,SLC34A2:NM_001177999:exon13:c.A1898G:p.D633G,SLC34A2:NM_006424:exon13:c.A1901G:p.D634G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8643	0.8760	0.910743	0.8992	0.576	7.988	1.0	4.99	0.264	.	.	.	SLC34A2:uc003grr.3:exon13:c.A1901G:p.D634G,SLC34A2:uc003grs.3:exon13:c.A1898G:p.D633G,SLC34A2:uc010iev.3:exon13:c.A1898G:p.D633G	-0.970	AFR:0.9638,AMR:0.8612,EAS:0.9994,FIN:0.9121,NFE:0.8528,OTH:0.8824,ASJ:0.8113	604217	265100;	60025;	60025|-|Unknown|Autosomal recessive<br>or&nbsp;Not applicable|All ages|265100 ~	.	.	.	.	0.0	2.17	0.000	-2.62	4	MU81781878	hom
4	39302029	39302029	T	C	RFC1	exonic	synonymous SNV	ENSG00000035928	rs2066786	ENSG00000035928:ENST00000349703:exon20:c.A2541G:p.P847P,ENSG00000035928:ENST00000381897:exon20:c.A2544G:p.P848P	RFC1:NM_001363495:exon19:c.A2463G:p.P821P,RFC1:NM_001363496:exon19:c.A2466G:p.P822P,RFC1:NM_001204747:exon20:c.A2544G:p.P848P,RFC1:NM_002913:exon20:c.A2541G:p.P847P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5511	0.4247	0.465256	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RFC1:uc003gtx.2:exon20:c.A2541G:p.P847P,RFC1:uc003gty.2:exon20:c.A2544G:p.P848P	.	AFR:0.4539,AMR:0.1328,EAS:0.56,FIN:0.6638,NFE:0.5629,OTH:0.5747,ASJ:0.6139	102579	.	.	.	.	.	.	.	.	.	.	.	4	1(urinary_tract)	0.5541
4	55130078	55130078	T	C	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs2229307	ENSG00000134853:ENST00000257290:exon4:c.T612C:p.N204N,ENSG00000134853:ENST00000508170:exon4:c.T612C:p.N204N,ENSG00000134853:ENST00000509490:exon4:c.T612C:p.N204N	PDGFRA:NM_001347827:exon4:c.T612C:p.N204N,PDGFRA:NM_001347829:exon4:c.T612C:p.N204N,PDGFRA:NM_001347830:exon4:c.T651C:p.N217N,PDGFRA:NM_006206:exon4:c.T612C:p.N204N,PDGFRA:NM_001347828:exon5:c.T687C:p.N229N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1796	0.1650	0.236222	0.1677	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon3:c.T294C:p.N98N,PDGFRA:uc003hal.3:exon4:c.T612C:p.N204N,PDGFRA:uc003han.4:exon4:c.T612C:p.N204N	.	AFR:0.2562,AMR:0.3759,EAS:0.1780,FIN:0.1216,NFE:0.1175,OTH:0.1487,ASJ:0.07	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8557,8564	,8558	.	.	.	.	.	4	MU12032527	hom
4	55133726	55133726	T	G	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs4358459	ENSG00000134853:ENST00000257290:exon7:c.T939G:p.G313G,ENSG00000134853:ENST00000509490:exon7:c.T939G:p.G313G	PDGFRA:NM_001347827:exon7:c.T939G:p.G313G,PDGFRA:NM_001347829:exon7:c.T939G:p.G313G,PDGFRA:NM_001347830:exon7:c.T978G:p.G326G,PDGFRA:NM_006206:exon7:c.T939G:p.G313G,PDGFRA:NM_001347828:exon8:c.T1014G:p.G338G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1775	0.1632	0.234225	0.1669	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon6:c.T621G:p.G207G,PDGFRA:uc003han.4:exon7:c.T939G:p.G313G	.	AFR:0.2557,AMR:0.3747,EAS:0.1782,FIN:0.1219,NFE:0.1162,OTH:0.1472,ASJ:0.0662	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8557,8564	,8558	.	.	.	.	.	4	MU12032533	hom
4	55139771	55139771	T	C	PDGFRA	exonic	nonsynonymous SNV	ENSG00000134853	rs35597368	ENSG00000134853:ENST00000257290:exon10:c.T1432C:p.S478P,ENSG00000134853:ENST00000509490:exon10:c.T1432C:p.S478P	PDGFRA:NM_001347827:exon10:c.T1432C:p.S478P,PDGFRA:NM_001347829:exon10:c.T1432C:p.S478P,PDGFRA:NM_001347830:exon10:c.T1471C:p.S491P,PDGFRA:NM_006206:exon10:c.T1432C:p.S478P,PDGFRA:NM_001347828:exon11:c.T1507C:p.S503P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1516	0.1443	0.199281	0.1473	-0.578	0.142	0.305	0.811	0.000	.	.	Immunoglobulin-like fold	PDGFRA:uc010igq.1:exon9:c.T1114C:p.S372P,PDGFRA:uc003han.4:exon10:c.T1432C:p.S478P	-1.098	AFR:0.2301,AMR:0.2596,EAS:0.1338,FIN:0.1224,NFE:0.1024,OTH:0.1424,ASJ:0.0497	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8557,8564	,8558	.	0.0	-0.95	0.000	-0.345	4	MU26845387	hom
4	55141055	55141055	A	G	PDGFRA	exonic	synonymous SNV	ENSG00000134853	rs1873778	ENSG00000134853:ENST00000257290:exon12:c.A1701G:p.P567P,ENSG00000134853:ENST00000509490:exon12:c.A1701G:p.P567P	PDGFRA:NM_001347827:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347829:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347830:exon12:c.A1740G:p.P580P,PDGFRA:NM_006206:exon12:c.A1701G:p.P567P,PDGFRA:NM_001347828:exon13:c.A1776G:p.P592P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9880	0.9589	0.957668	0.9677	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon11:c.A1383G:p.P461P,PDGFRA:uc003han.4:exon12:c.A1701G:p.P567P	.	AFR:0.8906,AMR:0.9881,EAS:0.9994,FIN:1,NFE:0.9986,OTH:0.9908,ASJ:0.9834	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8557,8564	,8558	.	.	.	.	.	4	MU81783993	hom
4	55143577	55143577	G	A	PDGFRA	exonic	synonymous SNV	ENSG00000134853;ENSG00000145216	rs10028020	ENSG00000134853:ENST00000257290:exon13:c.G1809A:p.A603A,ENSG00000134853:ENST00000509490:exon13:c.G1809A:p.A603A,ENSG00000145216:ENST00000507166:exon14:c.G1089A:p.A363A	PDGFRA:NM_001347827:exon13:c.G1809A:p.A603A,PDGFRA:NM_001347829:exon13:c.G1809A:p.A603A,PDGFRA:NM_001347830:exon13:c.G1848A:p.A616A,PDGFRA:NM_006206:exon13:c.G1809A:p.A603A,PDGFRA:NM_001347828:exon14:c.G1884A:p.A628A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1583	0.1662	0.228035	0.1664	.	.	.	.	.	.	.	.	PDGFRA:uc010igq.1:exon12:c.G1491A:p.A497A,PDGFRA:uc003han.4:exon13:c.G1809A:p.A603A,PDGFRA:uc003haa.3:exon14:c.G1089A:p.A363A	.	AFR:0.3054,AMR:0.2763,EAS:0.1379,FIN:0.1125,NFE:0.0999,OTH:0.1337,ASJ:0.0497	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8557,8564	,8558	.	.	.	.	.	4	MU12032552	het
4	55152040	55152040	C	T	PDGFRA	exonic	synonymous SNV	ENSG00000134853;ENSG00000145216	rs2228230	ENSG00000134853:ENST00000257290:exon18:c.C2472T:p.V824V,ENSG00000145216:ENST00000507166:exon19:c.C1752T:p.V584V	PDGFRA:NM_001347829:exon18:c.C2472T:p.V824V,PDGFRA:NM_001347830:exon18:c.C2511T:p.V837V,PDGFRA:NM_006206:exon18:c.C2472T:p.V824V,PDGFRA:NM_001347828:exon19:c.C2547T:p.V849V	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1820	0.1983	0.240415	0.1941	.	.	.	.	.	.	.	.	PDGFRA:uc003han.4:exon18:c.C2472T:p.V824V,PDGFRA:uc003haa.3:exon19:c.C1752T:p.V584V	.	AFR:0.3254,AMR:0.3026,EAS:0.1316,FIN:0.1271,NFE:0.1392,OTH:0.1582,ASJ:0.0633	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8557,8564	,8558	.	.	.	.	.	4	MU797701	het
4	55161391	55161391	T	C	PDGFRA	exonic	synonymous SNV	ENSG00000134853;ENSG00000145216	rs7685117	ENSG00000134853:ENST00000257290:exon23:c.T3222C:p.D1074D,ENSG00000145216:ENST00000507166:exon24:c.T2502C:p.D834D	PDGFRA:NM_001347829:exon23:c.T3222C:p.D1074D,PDGFRA:NM_001347830:exon23:c.T3261C:p.D1087D,PDGFRA:NM_006206:exon23:c.T3222C:p.D1074D,PDGFRA:NM_001347828:exon24:c.T3297C:p.D1099D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9990	0.9968	0.997204	0.9980	.	.	.	.	.	.	.	.	PDGFRA:uc003han.4:exon23:c.T3222C:p.D1074D,PDGFRA:uc003haa.3:exon24:c.T2502C:p.D834D	.	AFR:0.9929,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	173490	606764;607685;	3260;44890;	3260|-|Unknown|-|Adult|607685 ~44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer ~	,8557,8564	,8558	.	.	.	.	.	4	MU81784009	hom
4	55948108	55948108	A	G	KDR	intronic	.	ENSG00000250646	rs2412617	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9986	0.9976	0.996805	0.9975	.	.	.	.	.	.	.	.	.	.	AFR:0.9923,AMR:1,EAS:1,FIN:1,NFE:0.9995,OTH:0.9980,ASJ:0.9967	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU81784046	hom
4	55968053	55968053	A	C	KDR	intronic	.	ENSG00000128052	rs7655964	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3475	0.2826	0.292931	MU81784053	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3084,EAS:0.5298,FIN:0.2947,NFE:0.3079,OTH:0.3853,ASJ:0.1496	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	1(lung)	0.3656
4	55976947	55976947	-	A	KDR	intronic	.	ENSG00000128052	rs397762998	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3950	.	.	0.6444	.	.	.	.	.	.	.	.	.	.	AFR:0.6675,AMR:0.6218,EAS:0.7746,FIN:0.5906,NFE:0.6283,OTH:0.6221,ASJ:0.5312	191306	602089;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	.	het
4	66197804	66197804	C	T	EPHA5	exonic	synonymous SNV	ENSG00000145242	rs7349683	ENSG00000145242:ENST00000432638:exon15:c.G2406A:p.G802G,ENSG00000145242:ENST00000354839:exon16:c.G2829A:p.G943G,ENSG00000145242:ENST00000273854:exon17:c.G2895A:p.G965G,ENSG00000145242:ENST00000511294:exon17:c.G2898A:p.G966G	EPHA5:NM_001281766:exon16:c.G2832A:p.G944G,EPHA5:NM_182472:exon16:c.G2829A:p.G943G,EPHA5:NM_001281765:exon17:c.G2898A:p.G966G,EPHA5:NM_001281767:exon17:c.G2898A:p.G966G,EPHA5:NM_001318761:exon17:c.G2691A:p.G897G,EPHA5:NM_004439:exon17:c.G2895A:p.G965G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3465	0.2829	0.326677	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	EPHA5:uc003hcz.3:exon16:c.G2829A:p.G943G,EPHA5:uc011cai.2:exon16:c.G2832A:p.G944G,EPHA5:uc003hcx.3:exon17:c.G2691A:p.G897G,EPHA5:uc003hcy.3:exon17:c.G2895A:p.G965G,EPHA5:uc003hda.2:exon17:c.G2898A:p.G966G,EPHA5:uc011cah.2:exon17:c.G2898A:p.G966G	.	AFR:0.2977,AMR:0.1274,EAS:0.3411,FIN:0.4289,NFE:0.3329,OTH:0.3694,ASJ:0.2888	600004	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.3796
4	66535284	66535284	G	A	EPHA5	exonic	synonymous SNV	ENSG00000145242	rs55860557	ENSG00000145242:ENST00000273854:exon1:c.C177T:p.N59N,ENSG00000145242:ENST00000354839:exon1:c.C177T:p.N59N,ENSG00000145242:ENST00000432638:exon1:c.C177T:p.N59N,ENSG00000145242:ENST00000511294:exon1:c.C177T:p.N59N	EPHA5:NM_001281765:exon1:c.C177T:p.N59N,EPHA5:NM_001281766:exon1:c.C177T:p.N59N,EPHA5:NM_001281767:exon1:c.C177T:p.N59N,EPHA5:NM_004439:exon1:c.C177T:p.N59N,EPHA5:NM_182472:exon1:c.C177T:p.N59N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2093	0.1673	0.115016	0.1888	.	.	.	.	.	.	.	.	EPHA5:uc003hcy.3:exon1:c.C177T:p.N59N,EPHA5:uc003hcz.3:exon1:c.C177T:p.N59N,EPHA5:uc003hda.2:exon1:c.C177T:p.N59N,EPHA5:uc011cah.2:exon1:c.C177T:p.N59N,EPHA5:uc011cai.2:exon1:c.C177T:p.N59N	.	AFR:0.1123,AMR:0.0913,EAS:0.0148,FIN:0.2768,NFE:0.2341,OTH:0.2254,ASJ:0.2152	600004	.	.	.	.	.	.	.	.	.	.	.	4	MU159232	het
4	74285239	74285239	C	T	ALB	exonic	synonymous SNV	ENSG00000163631	rs962004	ENSG00000163631:ENST00000415165:exon9:c.C1092T:p.L364L,ENSG00000163631:ENST00000401494:exon11:c.C1323T:p.L441L,ENSG00000163631:ENST00000503124:exon11:c.C1218T:p.L406L,ENSG00000163631:ENST00000295897:exon13:c.C1668T:p.L556L,ENSG00000163631:ENST00000509063:exon13:c.C1668T:p.L556L	ALB:NM_000477:exon13:c.C1668T:p.L556L	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5354	0.5183	0.483427	MU14553863	.	.	.	.	.	.	.	.	ALB:uc003hgw.4:exon9:c.C1092T:p.L364L,ALB:uc011cbf.2:exon12:c.C1338T:p.L446L,ALB:uc003hgs.4:exon13:c.C1668T:p.L556L,ALB:uc011cbe.2:exon13:c.C705T:p.L235L	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5268,EAS:0.4401,FIN:0.47,NFE:0.5680,OTH:0.5490,ASJ:0.4163	103600	615999;616000;	86816;	86816|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|616000 ~	.	.	.	.	.	.	.	.	4	1(lung)	0.5874
4	75248434	75248434	A	G	EREG	exonic	synonymous SNV	ENSG00000124882	rs2367707	ENSG00000124882:ENST00000244869:exon4:c.A351G:p.E117E	EREG:NM_001432:exon4:c.A351G:p.E117E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7927	0.7781	0.767772	0.7915	.	.	.	.	.	.	.	.	EREG:uc003hie.1:exon4:c.A351G:p.E117E	.	AFR:0.7749,AMR:0.8747,EAS:0.6850,FIN:0.8136,NFE:0.7999,OTH:0.8241,ASJ:0.8377	602061	.	.	.	.	.	.	.	.	.	.	.	4	MU796131	hom
4	83778839	83778839	T	C	SEC31A	intronic	.	ENSG00000138674	rs7658703	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2412	0.2843	0.351637	1(breast)	.	.	.	.	.	0.0303	0.15	.	.	.	AFR:MU586415,AMR:ESAD-UK|2|409|0.00488998,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.4382,FIN:0.1571,NFE:0.2053,OTH:0.5118,ASJ:0.2720	610257	.	.	.	.	.	.	.	.	.	.	.	4	1(stomach)	0.1630
4	83788344	83788344	A	T	SEC31A	exonic	synonymous SNV	ENSG00000138674	rs2045478	ENSG00000138674:ENST00000264405:exon3:c.T324A:p.G108G,ENSG00000138674:ENST00000443462:exon8:c.T993A:p.G331G,ENSG00000138674:ENST00000500777:exon8:c.T1008A:p.G336G,ENSG00000138674:ENST00000505472:exon8:c.T1008A:p.G336G,ENSG00000138674:ENST00000311785:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000326950:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000348405:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000395310:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000432794:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000448323:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000505984:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000508479:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000508502:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000509142:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000513858:exon9:c.T1008A:p.G336G,ENSG00000138674:ENST00000355196:exon11:c.T1008A:p.G336G	SEC31A:NM_001191049:exon8:c.T993A:p.G331G,SEC31A:NM_001077206:exon9:c.T1008A:p.G336G,SEC31A:NM_001077207:exon9:c.T1008A:p.G336G,SEC31A:NM_001077208:exon9:c.T1008A:p.G336G,SEC31A:NM_001300744:exon9:c.T1008A:p.G336G,SEC31A:NM_001300745:exon9:c.T1008A:p.G336G,SEC31A:NM_001318119:exon9:c.T1008A:p.G336G,SEC31A:NM_016211:exon9:c.T1008A:p.G336G,SEC31A:NM_001318120:exon11:c.T1008A:p.G336G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9990	0.9967	0.996805	0.9971	.	.	.	.	.	.	.	.	SEC31A:uc003hne.3:exon3:c.T324A:p.G108G,SEC31A:uc011ccm.2:exon8:c.T993A:p.G331G,SEC31A:uc003hnf.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hng.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnh.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hni.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnk.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnl.3:exon9:c.T1008A:p.G336G,SEC31A:uc003hnn.2:exon9:c.T1008A:p.G336G,SEC31A:uc003hno.3:exon9:c.T1008A:p.G336G,SEC31A:uc011ccl.2:exon9:c.T1008A:p.G336G,SEC31A:uc011ccn.2:exon9:c.T1008A:p.G336G,SEC31A:uc003hnm.3:exon11:c.T1008A:p.G336G	.	AFR:0.9896,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	610257	.	.	.	.	.	.	.	.	.	.	.	4	MU81786544	hom
4	83793243	83793243	A	C	SEC31A	intronic	.	ENSG00000138674	rs4693525	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7608	0.7377	0.712859	0.7453	.	.	.	.	.	0.0004	0.302	.	.	.	AFR:0.6426,AMR:0.8019,EAS:0.7389,FIN:0.8280,NFE:0.7823,OTH:0.7739,ASJ:0.6987	610257	.	.	.	.	.	.	.	.	.	.	.	4	MU16678361	het
4	84362443	84362443	T	G	HELQ	intronic	.	ENSG00000163312	rs4693088	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4691	0.5462	0.514377	0.4615	.	.	.	.	.	.	.	.	.	.	AFR:0.4779,AMR:0.5537,EAS:0.6753,FIN:0.4527,NFE:0.4281,OTH:0.4827,ASJ:0.2715	606769	.	.	.	.	.	.	.	.	.	.	.	4	MU18418811	het
4	84364751	84364751	A	G	HELQ	exonic	synonymous SNV	ENSG00000163312	rs7665103	ENSG00000163312:ENST00000510985:exon5:c.T1281C:p.I427I,ENSG00000163312:ENST00000295488:exon6:c.T1482C:p.I494I	HELQ:NM_001297755:exon5:c.T1281C:p.I427I,HELQ:NM_133636:exon6:c.T1482C:p.I494I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4668	0.4197	0.507788	0.4518	.	.	.	.	.	.	.	.	HELQ:uc010ikb.3:exon5:c.T1281C:p.I427I,HELQ:uc003hom.3:exon6:c.T1482C:p.I494I	.	AFR:0.4436,AMR:0.5513,EAS:0.6749,FIN:0.4522,NFE:0.4286,OTH:0.4817,ASJ:0.2715	606769	.	.	.	.	.	.	.	.	.	.	.	4	MU105612	het
4	84370091	84370091	A	G	HELQ	exonic	synonymous SNV	ENSG00000163312	rs13141136	ENSG00000163312:ENST00000295488:exon3:c.T1036C:p.L346L,ENSG00000163312:ENST00000508591:exon3:c.T1036C:p.L346L,ENSG00000163312:ENST00000510985:exon3:c.T1036C:p.L346L	HELQ:NM_001297755:exon3:c.T1036C:p.L346L,HELQ:NM_133636:exon3:c.T1036C:p.L346L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4336	0.3225	0.414537	MU4568051	.	.	.	.	.	.	.	.	HELQ:uc003hom.3:exon3:c.T1036C:p.L346L,HELQ:uc003hon.1:exon3:c.T718C:p.L240L,HELQ:uc010ikb.3:exon3:c.T1036C:p.L346L	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.3675,EAS:0.5443,FIN:0.2781,NFE:0.6743,OTH:0.4523,ASJ:0.1501	606769	.	.	.	.	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.4274
4	84370125	84370125	A	-	HELQ	intronic	.	ENSG00000163312	rs10718573	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6132	.	0.676518	0.6258	.	.	.	.	.	.	.	.	.	.	AFR:0.7816,AMR:0.6349,EAS:0.6820,FIN:0.5842,NFE:0.5366,OTH:0.6048,ASJ:0.4781	606769	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	84374480	84374480	C	T	HELQ	exonic	nonsynonymous SNV	ENSG00000163312	rs1494961	ENSG00000163312:ENST00000295488:exon2:c.G916A:p.V306I,ENSG00000163312:ENST00000508591:exon2:c.G916A:p.V306I,ENSG00000163312:ENST00000510985:exon2:c.G916A:p.V306I	HELQ:NM_001297755:exon2:c.G916A:p.V306I,HELQ:NM_001297758:exon2:c.G805A:p.V269I,HELQ:NM_001297759:exon2:c.G916A:p.V306I,HELQ:NM_133636:exon2:c.G916A:p.V306I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5623	0.5944	0.664537	1(haematopoietic_and_lymphoid_tissue)	0.595	8.121	1.0	2.29	0.990	.	.	P-loop containing nucleoside triphosphate hydrolase	HELQ:uc003hom.3:exon2:c.G916A:p.V306I,HELQ:uc003hon.1:exon2:c.G598A:p.V200I,HELQ:uc003hoo.1:exon2:c.G805A:p.V269I,HELQ:uc003hop.1:exon2:c.G598A:p.V200I,HELQ:uc003hoq.1:exon2:c.G916A:p.V306I,HELQ:uc010ikb.3:exon2:c.G916A:p.V306I	-1.011	AFR:MU18419015,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,THCA-CN|1|50|0.02,EAS:0.7809,FIN:0.6244,NFE:0.4470,OTH:0.6774,ASJ:0.6032	606769	.	.	.	.	.	.	.	0.0	0.39	0.000	-2.42	4	19(soft_tissue)	0.5052
4	84376743	84376743	A	T	HELQ	exonic	nonsynonymous SNV	ENSG00000163312	rs6831595	ENSG00000163312:ENST00000295488:exon1:c.T104A:p.V35E,ENSG00000163312:ENST00000508591:exon1:c.T104A:p.V35E,ENSG00000163312:ENST00000510985:exon1:c.T104A:p.V35E	HELQ:NM_001297755:exon1:c.T104A:p.V35E,HELQ:NM_001297758:exon1:c.T104A:p.V35E,HELQ:NM_001297759:exon1:c.T104A:p.V35E,HELQ:NM_133636:exon1:c.T104A:p.V35E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	1.0000	0.9999	1	1.0000	-1.530	0.002	1.0	-3.44	0.000	.	.	.	HELQ:uc003hom.3:exon1:c.T104A:p.V35E,HELQ:uc003hoo.1:exon1:c.T104A:p.V35E,HELQ:uc003hoq.1:exon1:c.T104A:p.V35E,HELQ:uc010ikb.3:exon1:c.T104A:p.V35E	-0.964	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	606769	.	.	.	.	.	.	.	0.0	0.53	0.000	-1.24	4	MU81786772	hom
4	84383810	84383810	C	T	ABRAXAS1	exonic	nonsynonymous SNV	ENSG00000163322	rs12642536	ENSG00000163322:ENST00000321945:exon9:c.G1042A:p.A348T,ENSG00000163322:ENST00000506553:exon9:c.G895A:p.A299T	ABRAXAS1:NM_001345962:exon8:c.G715A:p.A239T,ABRAXAS1:NM_139076:exon9:c.G1042A:p.A348T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.4308	0.3272	0.41893	1(stomach)	2.475	19.31	0.011	2.75	0.057	.	.	.	FAM175A:uc003hov.2:exon8:c.G715A:p.A239T,FAM175A:uc003hou.2:exon9:c.G1042A:p.A348T	-0.934	AFR:MU159712,AMR:MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611,EAS:0.1635,FIN:0.5432,NFE:0.2781,OTH:0.6768,ASJ:0.3720	611143	.	.	.	.	.	.	.	0.822	0.81	0.000	1.95	4	1(large_intestine)	0.4516
4	88029482	88029482	C	G	AFF1	intronic	.	ENSG00000172493	rs3733377	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2097	0.1692	0.186302	COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.1941,AMR:0.0992,EAS:0.1133,FIN:0.3865,NFE:0.2714,OTH:0.2069,ASJ:0.2768	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	2(haematopoietic_and_lymphoid_tissue)	0.2051
4	88048163	88048163	-	T	AFF1	intronic	.	ENSG00000172493	rs11448202	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2324	0.1770	0.213059	0.1729	.	.	.	.	.	.	.	.	.	.	AFR:0.1048,AMR:0.3033,EAS:0.2317,FIN:0.1355,NFE:0.2035,OTH:0.1964,ASJ:0.2986	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	.	het
4	88052219	88052219	T	C	AFF1	intronic	.	ENSG00000172493	rs342467	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5937	0.5927	0.567292	0.5752	.	.	.	.	.	.	.	.	.	.	AFR:0.5581,AMR:0.7005,EAS:0.5726,FIN:0.5315,NFE:0.5867,OTH:0.5615,ASJ:0.7086	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	MU23102211	hom
4	88056720	88056720	T	-	AFF1	intronic	.	ENSG00000172493	rs398083273	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.6550	.	0.570288	0.5778	.	.	.	.	.	.	.	.	.	.	AFR:0.5653,AMR:0.7017,EAS:0.5720,FIN:0.5331,NFE:0.5873,OTH:0.5634,ASJ:0.7133	159557	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	4	.	hom
4	99850126	99850126	A	G	EIF4E	UTR5	.	ENSG00000263923	rs11723037	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5189	0.5489	0.614217	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.5561,AMR:0.8307,EAS:0.48,FIN:0.6716,NFE:0.4572,OTH:0.4207,ASJ:0.4748	133440	615091;	.	.	.	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.4370
4	103514658	103514658	T	C	NFKB1	exonic	synonymous SNV	ENSG00000109320	rs1609993	ENSG00000109320:ENST00000600343:exon5:c.T600C:p.A200A,ENSG00000109320:ENST00000508584:exon6:c.T522C:p.A174A,ENSG00000109320:ENST00000226574:exon12:c.T1143C:p.A381A,ENSG00000109320:ENST00000394820:exon12:c.T1140C:p.A380A,ENSG00000109320:ENST00000505458:exon12:c.T1140C:p.A380A	NFKB1:NM_001165412:exon12:c.T1140C:p.A380A,NFKB1:NM_001319226:exon12:c.T1140C:p.A380A,NFKB1:NM_003998:exon12:c.T1143C:p.A381A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9401	0.9420	0.969848	0.9425	.	.	.	.	.	.	.	.	NFKB1:uc011cer.2:exon5:c.T600C:p.A200A,NFKB1:uc011cep.2:exon12:c.T1143C:p.A381A,NFKB1:uc011ceq.2:exon12:c.T1140C:p.A380A	.	AFR:0.9856,AMR:0.9402,EAS:1,FIN:0.9250,NFE:0.9179,OTH:0.9173,ASJ:0.9040	164011	616576;	1572;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~	~ko01523 Antifolate resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05030 Cocaine addiction~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU81788168	hom
4	103514737	103514737	C	T	NFKB1	intronic	.	ENSG00000109320	rs4648049	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0490	0.0651	0.0704872	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.0662,AMR:0.1148,EAS:0.0067,FIN:0.0564,NFE:0.0598,OTH:0.0443,ASJ:0.0310	164011	616576;	1572;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~	~ko01523 Antifolate resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05030 Cocaine addiction~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.0550
4	103514741	103514741	T	C	NFKB1	intronic	.	ENSG00000109320	rs4648050	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3459	0.3092	0.329073	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.3286,AMR:0.2579,EAS:0.24,FIN:0.4453,NFE:0.3731,OTH:0.3410,ASJ:0.4617	164011	616576;	1572;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~	~ko01523 Antifolate resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05030 Cocaine addiction~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.3292
4	103534740	103534740	-	A	NFKB1	splicing	.	ENSG00000109320	rs148268461	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0706	0.0835	0.0842652	0.0790	.	.	.	.	.	.	.	.	.	.	AFR:0.1183,AMR:0.0411,EAS:0.0884,FIN:0.0791,NFE:0.0593,OTH:0.0661,ASJ:0.0102	164011	616576;	1572;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~	~ko01523 Antifolate resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05030 Cocaine addiction~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05133 Pertussis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD)~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	4	MU29134980	het
4	104061993	104061993	C	G	CENPE	exonic	nonsynonymous SNV	ENSG00000138778	rs1381657	ENSG00000138778:ENST00000380026:exon35:c.G5657C:p.S1886T,ENSG00000138778:ENST00000265148:exon36:c.G5732C:p.S1911T	CENPE:NM_001286734:exon35:c.G5657C:p.S1886T,CENPE:NM_001813:exon36:c.G5732C:p.S1911T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1932	0.1815	0.210863	2(haematopoietic_and_lymphoid_tissue)	-1.564	0.002	0.501	-1.34	0.001	.	.	.	CENPE:uc003hxc.1:exon35:c.G5657C:p.S1886T,CENPE:uc003hxb.1:exon36:c.G5732C:p.S1911T	-1.099	AFR:MU77894,AMR:BRCA-KR|1|50|0.02,EAS:0.1713,FIN:0.1874,NFE:0.2185,OTH:0.1307,ASJ:0.1679	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	0.247	-0.65	0.000	0.11	4	1(thyroid)	0.1195
4	104062223	104062223	C	T	CENPE	exonic	synonymous SNV	ENSG00000138778	rs1381658	ENSG00000138778:ENST00000380026:exon35:c.G5427A:p.T1809T,ENSG00000138778:ENST00000265148:exon36:c.G5502A:p.T1834T	CENPE:NM_001286734:exon35:c.G5427A:p.T1809T,CENPE:NM_001813:exon36:c.G5502A:p.T1834T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1909	0.1397	0.169129	MU4566242	.	.	.	.	.	.	.	.	CENPE:uc003hxc.1:exon35:c.G5427A:p.T1809T,CENPE:uc003hxb.1:exon36:c.G5502A:p.T1834T	.	AFR:COCA-CN|1|321|0.00311526,AMR:0.1342,EAS:0.1766,FIN:0.2185,NFE:0.1311,OTH:0.1205,ASJ:0.0570	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	.	.	.	.	4	1(thyroid)	0.1757
4	104063071	104063071	C	T	CENPE	intronic	.	ENSG00000138778	rs2711898	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4066	0.4567	0.449681	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:0.4467,AMR:0.5847,EAS:0.4305,FIN:0.2948,NFE:0.4197,OTH:0.3950,ASJ:0.3807	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.4170
4	104082349	104082349	C	T	CENPE	exonic	synonymous SNV	ENSG00000138778	rs2251634	ENSG00000138778:ENST00000380026:exon19:c.G1950A:p.Q650Q,ENSG00000138778:ENST00000265148:exon20:c.G2025A:p.Q675Q,ENSG00000138778:ENST00000503705:exon20:c.G2025A:p.Q675Q	CENPE:NM_001286734:exon19:c.G1950A:p.Q650Q,CENPE:NM_001813:exon20:c.G2025A:p.Q675Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4063	0.4585	0.45008	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	CENPE:uc003hxc.1:exon19:c.G1950A:p.Q650Q,CENPE:uc003hxb.1:exon20:c.G2025A:p.Q675Q	.	AFR:0.4486,AMR:0.5911,EAS:0.4305,FIN:0.2931,NFE:0.4200,OTH:0.3953,ASJ:0.3807	117143	616051;	808;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~	.	.	.	.	.	.	.	.	4	3(lung)	0.4175
4	106196819	106196819	G	T	TET2	exonic	nonsynonymous SNV	ENSG00000168769	rs142312318	ENSG00000168769:ENST00000380013:exon11:c.G5152T:p.V1718L,ENSG00000168769:ENST00000513237:exon11:c.G5215T:p.V1739L,ENSG00000168769:ENST00000540549:exon11:c.G5152T:p.V1718L	TET2:NM_001127208:exon11:c.G5152T:p.V1718L	clinvar: not_provided 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.0030	0.0048	0.000599042	SARC-US|1|240|0.00416667	-1.281	0.005	0.377	-2.29	0.014	.	.	2OGFeDO, oxygenase domain|WD40/YVTN repeat-like-containing domain	TET2:uc003hxk.3:exon11:c.G5152T:p.V1718L,TET2:uc011cez.2:exon11:c.G5215T:p.V1739L	-0.898	AFR:0.0046,AMR:0.0016,EAS:0,FIN:0,NFE:0.0060,OTH:0.0068,ASJ:0	612839	614286;	52688;	52688|-|1-9 / 100 000|-|All ages|614286 ~	.	9974,,9975	.	9976,9978,,9977,9981,9980,9979	0.007	4.42	0.003	1.575	4	14(haematopoietic_and_lymphoid_tissue)	0.0051
4	106395181	106395181	G	A	PPA2	exonic	synonymous SNV	ENSG00000138777	rs4699179	ENSG00000138777:ENST00000341695:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000348706:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000351450:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000354147:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000357415:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000380004:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000432483:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000504028:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000510015:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000513649:exon1:c.C27T:p.R9R,ENSG00000138777:ENST00000514209:exon1:c.C27T:p.R9R	PPA2:NM_006903:exon1:c.C27T:p.R9R,PPA2:NM_176866:exon1:c.C27T:p.R9R,PPA2:NM_176867:exon1:c.C27T:p.R9R,PPA2:NM_176869:exon1:c.C27T:p.R9R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2100	0.1595	0.0810703	0.1587	.	.	.	.	.	.	.	.	PPA2:uc003hxl.3:exon1:c.C27T:p.R9R,PPA2:uc003hxn.3:exon1:c.C27T:p.R9R,PPA2:uc003hxo.3:exon1:c.C27T:p.R9R,PPA2:uc003hxp.3:exon1:c.C27T:p.R9R	.	AFR:0.0438,AMR:0.1367,EAS:0.0006,FIN:0.2048,NFE:0.2304,OTH:0.2177,ASJ:0.1060	609988	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	119736598	119736598	C	T	SEC24D	intronic	.	ENSG00000150961	rs6843524	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8717	0.8982	0.854832	0.8819	.	.	.	.	.	0	0	.	.	.	AFR:0.9290,AMR:0.8878,EAS:0.7006,FIN:0.8623,NFE:0.8791,OTH:0.8643,ASJ:0.9007	607186	616294;	2050;	2050|Bone fragility-craniosynostosis-proptosis-hydrocephalus syndrome|<1 / 1 000 000|Not applicable<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|112240 616294 ~	.	.	.	.	.	.	.	.	4	MU797145	hom
4	119736796	119736796	A	C	SEC24D	exonic	synonymous SNV	ENSG00000150961	rs2389688	ENSG00000150961:ENST00000509818:exon4:c.T334G:p.F112V,ENSG00000150961:ENST00000506622:exon6:c.T590G:p.L197R	SEC24D:NM_001318066:exon5:c.T483G:p.P161P,SEC24D:NM_014822:exon5:c.T483G:p.P161P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4624	0.3966	0.436901	0.4121	.	.	.	.	.	.	.	.	SEC24D:uc003ici.4:exon5:c.T483G:p.P161P,SEC24D:uc003icj.4:exon5:c.T483G:p.P161P	.	AFR:0.2911,AMR:0.5372,EAS:0.5509,FIN:0.4851,NFE:0.4376,OTH:0.4764,ASJ:0.5033	607186	616294;	2050;	2050|Bone fragility-craniosynostosis-proptosis-hydrocephalus syndrome|<1 / 1 000 000|Not applicable<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|112240 616294 ~	.	.	.	.	.	.	.	.	4	MU158328	hom
4	122739183	122739183	C	G	CCNA2	intronic	.	ENSG00000145386	rs3217772	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3623	0.2780	0.276757	0.2988	.	.	.	.	.	.	.	.	.	.	AFR:0.0769,AMR:0.4545,EAS:0.4112,FIN:0.4229,NFE:0.3729,OTH:0.3765,ASJ:0.32	123835	.	.	.	~ko04110 Cell cycle~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04914 Progesterone-mediated oocyte maturation~ko05161 Hepatitis B~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	4	MU11832855	hom
4	122742217	122742217	T	C	CCNA2	exonic	nonsynonymous SNV	ENSG00000145386	rs769242	ENSG00000145386:ENST00000274026:exon3:c.A487G:p.I163V	CCNA2:NM_001237:exon3:c.A487G:p.I163V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9629	0.9691	0.96865	0.9672	0.665	8.596	1.0	4.14	0.999	.	.	Cyclin-A, N-terminal	CCNA2:uc003iec.4:exon3:c.A487G:p.I163V	-0.995	AFR:0.9913,AMR:0.9760,EAS:0.9382,FIN:0.9453,NFE:0.9605,OTH:0.9664,ASJ:0.9901	123835	.	.	.	~ko04110 Cell cycle~ko04152 AMPK signaling pathway~ko04218 Cellular senescence~ko04914 Progesterone-mediated oocyte maturation~ko05161 Hepatitis B~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	2.65	0.000	-2.175	4	MU27950768	hom
4	126240510	126240510	T	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs2940779	ENSG00000196159:ENST00000394329:exon1:c.T2944C:p.L982L	FAT4:NM_001291285:exon1:c.T2944C:p.L982L,FAT4:NM_001291303:exon1:c.T2944C:p.L982L,FAT4:NM_024582:exon1:c.T2944C:p.L982L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7012	0.7660	0.721046	0.7296	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon1:c.T2944C:p.L982L	.	AFR:0.8901,AMR:0.7243,EAS:0.4728,FIN:0.5910,NFE:0.7007,OTH:0.6646,ASJ:0.7285	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU23614382	hom
4	126241335	126241335	C	G	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs36052762	ENSG00000196159:ENST00000394329:exon1:c.C3769G:p.Q1257E	FAT4:NM_001291285:exon1:c.C3769G:p.Q1257E,FAT4:NM_001291303:exon1:c.C3769G:p.Q1257E,FAT4:NM_024582:exon1:c.C3769G:p.Q1257E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0852	0.0384	0.108626	0.0478	0.853	9.790	0.376	3.89	0.998	.	.	Cadherin|Cadherin-like	FAT4:uc003ifj.4:exon1:c.C3769G:p.Q1257E	-0.679	AFR:0.0306,AMR:0.1663,EAS:0.1989,FIN:0.0407,NFE:0.0357,OTH:0.0601,ASJ:0.0530	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.054	5.33	0.000	0.56	4	MU160106	het
4	126241871	126241871	C	T	FAT4	exonic	synonymous SNV	ENSG00000196159	rs2710555	ENSG00000196159:ENST00000394329:exon1:c.C4305T:p.I1435I	FAT4:NM_001291285:exon1:c.C4305T:p.I1435I,FAT4:NM_001291303:exon1:c.C4305T:p.I1435I,FAT4:NM_024582:exon1:c.C4305T:p.I1435I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6974	0.7544	0.711262	0.7203	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon1:c.C4305T:p.I1435I	.	AFR:0.8596,AMR:0.7196,EAS:0.4617,FIN:0.5917,NFE:0.7007,OTH:0.6612,ASJ:0.7285	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU23614425	hom
4	126329789	126329789	T	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs958415	ENSG00000196159:ENST00000335110:exon4:c.T654C:p.D218D,ENSG00000196159:ENST00000394329:exon4:c.T5760C:p.D1920D	FAT4:NM_001291285:exon4:c.T5760C:p.D1920D,FAT4:NM_001291303:exon4:c.T5760C:p.D1920D,FAT4:NM_024582:exon4:c.T5760C:p.D1920D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9966	0.9905	0.988419	0.9917	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon4:c.T5760C:p.D1920D,FAT4:uc011cgp.2:exon4:c.T654C:p.D218D	.	AFR:0.9728,AMR:0.9952,EAS:1,FIN:1,NFE:0.9991,OTH:0.9959,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU81789789	hom
4	126336703	126336703	T	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs17009618	ENSG00000196159:ENST00000335110:exon5:c.T1479C:p.N493N,ENSG00000196159:ENST00000394329:exon5:c.T6585C:p.N2195N	FAT4:NM_001291285:exon5:c.T6585C:p.N2195N,FAT4:NM_001291303:exon5:c.T6585C:p.N2195N,FAT4:NM_024582:exon5:c.T6585C:p.N2195N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1776	0.1330	0.204673	0.1451	.	.	.	.	.	.	.	.	FAT4:uc003ifj.4:exon5:c.T6585C:p.N2195N,FAT4:uc011cgp.2:exon5:c.T1479C:p.N493N	.	AFR:0.1379,AMR:0.2907,EAS:0.2572,FIN:0.1317,NFE:0.1318,OTH:0.1520,ASJ:0.1490	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU4566437	hom
4	126369872	126369872	G	C	FAT4	exonic	synonymous SNV	ENSG00000196159	rs988863	ENSG00000196159:ENST00000335110:exon9:c.G2595C:p.V865V,ENSG00000196159:ENST00000394329:exon9:c.G7701C:p.V2567V	FAT4:NM_001291285:exon9:c.G7707C:p.V2569V,FAT4:NM_001291303:exon9:c.G7707C:p.V2569V,FAT4:NM_024582:exon9:c.G7701C:p.V2567V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9978	0.9924	0.990815	0.9932	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon1:c.G135C:p.V45V,FAT4:uc003ifj.4:exon9:c.G7701C:p.V2567V,FAT4:uc011cgp.2:exon9:c.G2595C:p.V865V	.	AFR:0.9763,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU81789833	hom
4	126371814	126371814	C	T	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs73849225	ENSG00000196159:ENST00000335110:exon9:c.C4537T:p.H1513Y,ENSG00000196159:ENST00000394329:exon9:c.C9643T:p.H3215Y	FAT4:NM_001291285:exon9:c.C9649T:p.H3217Y,FAT4:NM_001291303:exon9:c.C9649T:p.H3217Y,FAT4:NM_024582:exon9:c.C9643T:p.H3215Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0803	0.1376	0.117812	0.1226	3.301	22.9	0.08	3.77	0.871	.	.	Cadherin|Cadherin-like	FAT4:uc003ifi.1:exon1:c.C2077T:p.H693Y,FAT4:uc003ifj.4:exon9:c.C9643T:p.H3215Y,FAT4:uc011cgp.2:exon9:c.C4537T:p.H1513Y	-1.017	AFR:0.2633,AMR:0.0610,EAS:0.0012,FIN:0.0808,NFE:0.0710,OTH:0.0746,ASJ:0.0861	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.728	0.67	0.000	0.65	4	.	het
4	126372742	126372742	G	A	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs1567047	ENSG00000196159:ENST00000335110:exon9:c.G5465A:p.G1822D,ENSG00000196159:ENST00000394329:exon9:c.G10571A:p.G3524D	FAT4:NM_001291285:exon9:c.G10577A:p.G3526D,FAT4:NM_001291303:exon9:c.G10577A:p.G3526D,FAT4:NM_024582:exon9:c.G10571A:p.G3524D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.2673	0.2207	0.230631	1(breast)	5.933	27.6	0.013	5.77	0.424	.	.	Cadherin|Cadherin-like	FAT4:uc003ifi.1:exon1:c.G3005A:p.G1002D,FAT4:uc003ifj.4:exon9:c.G10571A:p.G3524D,FAT4:uc011cgp.2:exon9:c.G5465A:p.G1822D	-1.086	AFR:MU701527,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.0634,FIN:0.2752,NFE:0.2567,OTH:0.4149,ASJ:0.2253	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	1.0	0.59	0.000	2.8	4	2(stomach)	0.2572
4	126373789	126373789	G	A	FAT4	exonic	nonsynonymous SNV	ENSG00000196159	rs12650153	ENSG00000196159:ENST00000335110:exon9:c.G6512A:p.S2171N,ENSG00000196159:ENST00000394329:exon9:c.G11618A:p.S3873N	FAT4:NM_001291285:exon9:c.G11624A:p.S3875N,FAT4:NM_001291303:exon9:c.G11624A:p.S3875N,FAT4:NM_024582:exon9:c.G11618A:p.S3873N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9978	0.9925	0.991014	0.9931	1.631	14.02	0.671	5.27	0.994	.	.	Cadherin|Cadherin-like;EGF-like calcium-binding domain|EGF-like domain|Growth factor receptor cysteine-rich domain	FAT4:uc003ifi.1:exon1:c.G4052A:p.S1351N,FAT4:uc003ifj.4:exon9:c.G11618A:p.S3873N,FAT4:uc011cgp.2:exon9:c.G6512A:p.S2171N	-0.924	AFR:0.9760,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	0.0	-2.26	0.000	-2.215	4	MU81789855	hom
4	126397321	126397321	C	T	FAT4	intronic	.	ENSG00000196159	rs17009761	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3745	0.3960	0.337859	0.3952	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3859,AMR:0.2751,EAS:0.2744,FIN:0.4394,NFE:0.4083,OTH:0.4252,ASJ:0.3907	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU11839003	het
4	126412575	126412575	A	G	FAT4	exonic	synonymous SNV	ENSG00000196159	rs1014866	ENSG00000196159:ENST00000335110:exon15:c.A9321G:p.R3107R,ENSG00000196159:ENST00000394329:exon17:c.A14598G:p.R4866R	FAT4:NM_001291285:exon17:c.A14601G:p.R4867R,FAT4:NM_001291303:exon17:c.A14604G:p.R4868R,FAT4:NM_024582:exon17:c.A14598G:p.R4866R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7569	0.7442	0.740615	0.7566	.	.	.	.	.	.	.	.	FAT4:uc003ifi.1:exon9:c.A7029G:p.R2343R,FAT4:uc011cgp.2:exon15:c.A9321G:p.R3107R,FAT4:uc003ifj.4:exon17:c.A14598G:p.R4866R	.	AFR:0.7063,AMR:0.7321,EAS:0.8694,FIN:0.7915,NFE:0.7663,OTH:0.7673,ASJ:0.7567	612411	615546;616006;	2136;314679;	2136|Lymphedema-lymphangiectasia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|235510 616006 ~314679|Van Maldergem syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|601390 615546 ~	.	.	.	.	.	.	.	.	4	MU21902856	hom
4	143007419	143007419	A	G	INPP4B	intronic	.	ENSG00000109452	rs336324	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7139	0.5949	0.604832	0.6499	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3903,AMR:0.7464,EAS:0.6491,FIN:0.7729,NFE:0.7603,OTH:0.7290,ASJ:0.7086	607494	.	.	.	.	.	.	.	.	.	.	.	4	MU779897	het
4	143033778	143033778	T	C	INPP4B	exonic	synonymous SNV	ENSG00000109452	rs3822141	ENSG00000109452:ENST00000511838:exon15:c.A1638G:p.L546L,ENSG00000109452:ENST00000514525:exon15:c.A1806G:p.L602L,ENSG00000109452:ENST00000308502:exon19:c.A2193G:p.L731L,ENSG00000109452:ENST00000262992:exon20:c.A2193G:p.L731L,ENSG00000109452:ENST00000508116:exon21:c.A2193G:p.L731L,ENSG00000109452:ENST00000510812:exon21:c.A2193G:p.L731L,ENSG00000109452:ENST00000509777:exon22:c.A2193G:p.L731L,ENSG00000109452:ENST00000513000:exon23:c.A2193G:p.L731L	INPP4B:NM_001101669:exon22:c.A2193G:p.L731L,INPP4B:NM_001331040:exon22:c.A2193G:p.L731L,INPP4B:NM_003866:exon23:c.A2193G:p.L731L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.0816	0.0544	0.0748802	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	INPP4B:uc011chn.1:exon15:c.A1638G:p.L546L,INPP4B:uc003iiw.4:exon22:c.A2193G:p.L731L,INPP4B:uc003iix.4:exon23:c.A2193G:p.L731L	.	AFR:0.0574,AMR:0.0123,EAS:0.0695,FIN:0.0586,NFE:0.0788,OTH:0.0747,ASJ:0.0919	607494	.	.	.	.	,6189	.	.	.	.	.	.	4	1(lung)	0.0815
4	143043404	143043404	C	T	INPP4B	intronic	.	ENSG00000109452	rs13133767	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1276	0.1057	0.100839	0.1061	.	.	.	.	.	0	0.01	.	.	.	AFR:0.0349,AMR:0.1196,EAS:0.0566,FIN:0.1448,NFE:0.1409,OTH:0.1421,ASJ:0.0927	607494	.	.	.	.	.	.	.	.	.	.	.	4	MU81790407	het
4	143067054	143067054	G	A	INPP4B	exonic	synonymous SNV	ENSG00000109452	rs35390852	ENSG00000109452:ENST00000511838:exon11:c.C1104T:p.G368G,ENSG00000109452:ENST00000514525:exon11:c.C1272T:p.G424G,ENSG00000109452:ENST00000308502:exon15:c.C1659T:p.G553G,ENSG00000109452:ENST00000262992:exon16:c.C1659T:p.G553G,ENSG00000109452:ENST00000508116:exon17:c.C1659T:p.G553G,ENSG00000109452:ENST00000510812:exon17:c.C1659T:p.G553G,ENSG00000109452:ENST00000509777:exon18:c.C1659T:p.G553G,ENSG00000109452:ENST00000513000:exon19:c.C1659T:p.G553G	INPP4B:NM_001101669:exon18:c.C1659T:p.G553G,INPP4B:NM_001331040:exon18:c.C1659T:p.G553G,INPP4B:NM_003866:exon19:c.C1659T:p.G553G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.1182	0.0913	0.0958466	MU109175	.	.	.	.	.	.	.	.	INPP4B:uc011chn.1:exon11:c.C1104T:p.G368G,INPP4B:uc011chp.1:exon11:c.C1272T:p.G424G,INPP4B:uc003iiw.4:exon18:c.C1659T:p.G553G,INPP4B:uc003iix.4:exon19:c.C1659T:p.G553G	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.0957,EAS:0.1089,FIN:0.0728,NFE:0.0498,OTH:0.1293,ASJ:0.0277	607494	.	.	.	.	,6189	.	.	.	.	.	.	4	1(breast)	0.1290
4	143118279	143118279	-	AAA	INPP4B	intronic	.	ENSG00000109452	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607494	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	143130034	143130034	A	T	INPP4B	intronic	.	ENSG00000109452	rs1907123	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9301	0.9015	0.903355	0.9142	.	.	.	.	.	.	.	.	.	.	AFR:0.8248,AMR:0.9318,EAS:0.9469,FIN:0.9570,NFE:0.9520,OTH:0.9402,ASJ:0.8212	607494	.	.	.	.	.	.	.	.	.	.	.	4	MU27779519	hom
4	143235865	143235865	C	G	INPP4B	exonic	synonymous SNV	ENSG00000109452	rs3756122	ENSG00000109452:ENST00000308502:exon5:c.G423C:p.G141G,ENSG00000109452:ENST00000262992:exon6:c.G423C:p.G141G,ENSG00000109452:ENST00000508116:exon7:c.G423C:p.G141G,ENSG00000109452:ENST00000510812:exon7:c.G423C:p.G141G,ENSG00000109452:ENST00000512630:exon7:c.G423C:p.G141G,ENSG00000109452:ENST00000509777:exon8:c.G423C:p.G141G,ENSG00000109452:ENST00000513000:exon9:c.G423C:p.G141G	INPP4B:NM_001101669:exon8:c.G423C:p.G141G,INPP4B:NM_001331040:exon8:c.G423C:p.G141G,INPP4B:NM_003866:exon9:c.G423C:p.G141G	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 1] 	0.1844	0.0884	0.199481	MU109191	.	.	.	.	.	0.9836	0.634	.	INPP4B:uc003iiw.4:exon8:c.G423C:p.G141G,INPP4B:uc003iix.4:exon9:c.G423C:p.G141G	.	AFR:COCA-CN|4|321|0.0124611,AMR:0.1385,EAS:0.2464,FIN:0.1026,NFE:0.4863,OTH:0.2483,ASJ:0.0241	607494	.	.	.	.	,6189	.	.	.	.	.	.	4	10(soft_tissue)	0.1339
4	143324094	143324094	G	A	INPP4B	exonic	synonymous SNV	ENSG00000109452	rs1982966	ENSG00000109452:ENST00000506297:exon1:c.C69T:p.D23D,ENSG00000109452:ENST00000308502:exon4:c.C369T:p.D123D,ENSG00000109452:ENST00000506217:exon4:c.C369T:p.D123D,ENSG00000109452:ENST00000262992:exon5:c.C369T:p.D123D,ENSG00000109452:ENST00000508116:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000510812:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000512630:exon6:c.C369T:p.D123D,ENSG00000109452:ENST00000509777:exon7:c.C369T:p.D123D,ENSG00000109452:ENST00000513000:exon8:c.C369T:p.D123D	INPP4B:NM_001101669:exon7:c.C369T:p.D123D,INPP4B:NM_001331040:exon7:c.C369T:p.D123D,INPP4B:NM_003866:exon8:c.C369T:p.D123D	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.3155	0.2579	0.252596	13(soft_tissue)	.	.	.	.	.	.	.	.	INPP4B:uc003iiw.4:exon7:c.C369T:p.D123D,INPP4B:uc003iix.4:exon8:c.C369T:p.D123D	.	AFR:1(large_intestine),AMR:MU586505,EAS:0.2785,FIN:0.0757,NFE:0.2470,OTH:0.3477,ASJ:LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	607494	.	.	.	.	,6189	.	.	.	.	.	.	4	1(thyroid)	0.2472
4	153303509	153303509	C	T	FBXW7	UTR5	.	ENSG00000109670	rs75360200	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0081	0.0075	0.00459265	0.0072	.	.	.	.	.	.	.	.	.	.	AFR:0.0016,AMR:0.0048,EAS:0.0006,FIN:0.0128,NFE:0.0099,OTH:0.0071,ASJ:0.0132	606278	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	169428733	169428733	T	C	PALLD	intronic	.	ENSG00000129116	rs1962362	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.402356	0.4093	.	.	.	.	.	.	.	.	.	.	AFR:0.2371,AMR:0.4260,EAS:0.6077,FIN:0.4851,NFE:0.4693,OTH:0.4376,ASJ:0.3344	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	.	.	.	.	4	MU18750111	het
4	169428772	169428772	G	A	PALLD	intronic	.	ENSG00000129116	rs10517998	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0646965	0.1009	.	.	.	.	.	.	.	.	.	.	AFR:0.0634,AMR:0.0813,EAS:0,FIN:0.1162,NFE:0.1280,OTH:0.1273,ASJ:0.1689	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	.	.	.	.	4	.	het
4	169432673	169432673	C	T	PALLD	exonic	synonymous SNV	ENSG00000129116	rs61051061	ENSG00000129116:ENST00000261509:exon2:c.C18T:p.S6S,ENSG00000129116:ENST00000505667:exon2:c.C18T:p.S6S,ENSG00000129116:ENST00000511948:exon3:c.C18T:p.S6S	PALLD:NM_001166108:exon2:c.C18T:p.S6S,PALLD:NM_016081:exon2:c.C18T:p.S6S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1943	0.2159	0.184904	1(breast)	.	.	.	.	.	.	.	.	PALLD:uc003iru.3:exon2:c.C18T:p.S6S,PALLD:uc011cjx.2:exon2:c.C18T:p.S6S	.	AFR:MU141334,AMR:SKCA-BR|1|100|0.01,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.2269,FIN:0.1687,NFE:0.2550,OTH:0.1640,ASJ:0.2047	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	.	.	.	.	4	1(haematopoietic_and_lymphoid_tissue)	0.1999
4	169432841	169432841	G	A	PALLD	exonic	synonymous SNV	ENSG00000129116	rs1806729	ENSG00000129116:ENST00000508898:exon1:c.G123A:p.K41K,ENSG00000129116:ENST00000261509:exon2:c.G186A:p.K62K,ENSG00000129116:ENST00000505667:exon2:c.G186A:p.K62K	PALLD:NM_001166108:exon2:c.G186A:p.K62K,PALLD:NM_016081:exon2:c.G186A:p.K62K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2841	0.2944	0.236022	MU24941349	.	.	.	.	.	.	.	.	PALLD:uc003iru.3:exon2:c.G186A:p.K62K,PALLD:uc011cjx.2:exon2:c.G186A:p.K62K	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.3009,EAS:0.2076,FIN:0.2815,NFE:0.1681,OTH:0.3892,ASJ:0.2344	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	.	.	.	.	4	1(lung)	0.3378
4	169433326	169433326	T	C	PALLD	exonic	nonsynonymous SNV	ENSG00000129116	rs7655494	ENSG00000129116:ENST00000333488:exon1:c.T302C:p.M101T,ENSG00000129116:ENST00000508898:exon1:c.T608C:p.M203T,ENSG00000129116:ENST00000261509:exon2:c.T671C:p.M224T,ENSG00000129116:ENST00000505667:exon2:c.T671C:p.M224T	PALLD:NM_001166108:exon2:c.T671C:p.M224T,PALLD:NM_016081:exon2:c.T671C:p.M224T	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2852	0.2836	0.239617	0.3014	-2.123	0.001	1.0	3.67	0.059	.	.	Immunoglobulin-like fold	PALLD:uc003iru.3:exon2:c.T671C:p.M224T,PALLD:uc011cjx.2:exon2:c.T671C:p.M224T	-1.015	AFR:0.2472,AMR:0.2069,EAS:0.1710,FIN:0.3876,NFE:0.3317,OTH:0.3163,ASJ:0.2815	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	0.0	0.14	0.000	-2.585	4	MU24941396	unknown
4	169433327	169433327	G	A	PALLD	exonic	nonsynonymous SNV	ENSG00000129116	rs7671781	ENSG00000129116:ENST00000333488:exon1:c.G303A:p.M101I,ENSG00000129116:ENST00000508898:exon1:c.G609A:p.M203I,ENSG00000129116:ENST00000261509:exon2:c.G672A:p.M224I,ENSG00000129116:ENST00000505667:exon2:c.G672A:p.M224I	PALLD:NM_001166108:exon2:c.G672A:p.M224I,PALLD:NM_016081:exon2:c.G672A:p.M224I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2852	0.2836	0.239617	LICA-CN|3|402|0.00746269,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	-1.837	0.002	0.208	-10.8	0.009	.	.	Immunoglobulin-like fold	PALLD:uc003iru.3:exon2:c.G672A:p.M224I,PALLD:uc011cjx.2:exon2:c.G672A:p.M224I	-1.071	AFR:0.3013,AMR:0.2468,EAS:0.2815,FIN:0.1702,NFE:0.3879,OTH:0.3318,ASJ:0.2074	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	0.0	0.18	0.000	0	4	1(breast)	0.3163
4	169433333	169433333	C	T	PALLD	exonic	synonymous SNV	ENSG00000129116	rs7673220	ENSG00000129116:ENST00000333488:exon1:c.C309T:p.D103D,ENSG00000129116:ENST00000508898:exon1:c.C615T:p.D205D,ENSG00000129116:ENST00000261509:exon2:c.C678T:p.D226D,ENSG00000129116:ENST00000505667:exon2:c.C678T:p.D226D	PALLD:NM_001166108:exon2:c.C678T:p.D226D,PALLD:NM_016081:exon2:c.C678T:p.D226D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2851	0.3020	0.239617	0.3010	.	.	.	.	.	.	.	.	PALLD:uc003iru.3:exon2:c.C678T:p.D226D,PALLD:uc011cjx.2:exon2:c.C678T:p.D226D	.	AFR:0.2463,AMR:0.2069,EAS:0.1700,FIN:0.3881,NFE:0.3315,OTH:0.3160,ASJ:0.2815	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	.	.	.	.	4	MU24941497	unknown
4	169433444	169433444	C	T	PALLD	exonic	synonymous SNV	ENSG00000129116	rs72695199	ENSG00000129116:ENST00000333488:exon1:c.C420T:p.S140S,ENSG00000129116:ENST00000508898:exon1:c.C726T:p.S242S,ENSG00000129116:ENST00000261509:exon2:c.C789T:p.S263S,ENSG00000129116:ENST00000505667:exon2:c.C789T:p.S263S	PALLD:NM_001166108:exon2:c.C789T:p.S263S,PALLD:NM_016081:exon2:c.C789T:p.S263S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1049	0.1043	0.0573083	MU141345	.	.	.	.	.	.	.	.	PALLD:uc003iru.3:exon2:c.C789T:p.S263S,PALLD:uc011cjx.2:exon2:c.C789T:p.S263S	.	AFR:MALY-DE|1|241|0.00414938,LUSC-KR|1|170|0.00588235,AMR:0.0931,EAS:0.0800,FIN:0.1689,NFE:0,OTH:0.1165,ASJ:0.0384	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	.	.	.	.	4	1(lung)	0.1266
4	169799408	169799408	G	C	PALLD	exonic	nonsynonymous SNV	ENSG00000129116	rs535155432	ENSG00000129116:ENST00000507735:exon2:c.G366C:p.Q122H,ENSG00000129116:ENST00000335742:exon11:c.G1353C:p.Q451H	PALLD:NM_001166110:exon2:c.G366C:p.Q122H	clinvar: Benign 	 CancerVar: -1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0007	.	0.00159744	0.0014	-0.283	0.724	0.034	0.155	0.000	.	.	.	PALLD:uc003irw.3:exon2:c.G366C:p.Q122H	-1.004	AFR:0.0001,AMR:0.0096,EAS:0,FIN:0.0038,NFE:0.0011,OTH:0.0041,ASJ:0	608092	606856;	1333;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~	.	.	.	.	0.0	0.26	0.125	0	4	.	het
4	178243595	178243595	A	G	NEIL3	intronic	.	ENSG00000109674	rs3792606	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0607	0.0286	0.103634	0.0385	.	.	.	.	.	.	.	.	.	.	AFR:0.0236,AMR:0.0923,EAS:0.2667,FIN:0.0143,NFE:0.0266,OTH:0.0286,ASJ:0.0066	608934	.	.	.	.	.	.	.	.	.	.	.	4	MU16711590	het
4	178256978	178256978	-	A	NEIL3	splicing	.	ENSG00000109674	rs35737622	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0641	0.0312	0.10643	0.0421	.	.	.	.	.	.	.	.	.	.	AFR:0.0343,AMR:0.0962,EAS:0.2664,FIN:0.0142,NFE:0.0268,OTH:0.0329,ASJ:0.0166	608934	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	178274565	178274565	A	G	NEIL3	exonic	synonymous SNV	ENSG00000109674	rs2048074	ENSG00000109674:ENST00000264596:exon8:c.A1143G:p.R381R	NEIL3:NM_018248:exon8:c.A1143G:p.R381R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6907	0.7412	0.609026	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	NEIL3:uc003iut.2:exon8:c.A1143G:p.R381R	.	AFR:MU122629,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6957,FIN:0.7026,NFE:0.7682,OTH:0.3804,ASJ:0.7119	608934	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.7453
4	178274694	178274694	T	G	NEIL3	exonic	synonymous SNV	ENSG00000109674	rs10007075	ENSG00000109674:ENST00000264596:exon8:c.T1272G:p.V424V	NEIL3:NM_018248:exon8:c.T1272G:p.V424V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6661	0.6685	0.542532	MU122640	.	.	.	.	.	.	.	.	NEIL3:uc003iut.2:exon8:c.T1272G:p.V424V	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.6496,EAS:0.6851,FIN:0.77,NFE:0.3833,OTH:0.7401,ASJ:0.4904	608934	.	.	.	.	.	.	.	.	.	.	.	4	1(breast)	0.7430
4	178274750	178274750	C	T	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs13112358	ENSG00000109674:ENST00000264596:exon8:c.C1328T:p.P443L	NEIL3:NM_018248:exon8:c.C1328T:p.P443L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6899	0.7407	0.608826	1(haematopoietic_and_lymphoid_tissue)	-0.693	0.075	0.686	-4.99	0.715	.	.	.	NEIL3:uc003iut.2:exon8:c.C1328T:p.P443L	-1.000	AFR:MU122663,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.6950,FIN:0.7050,NFE:0.7682,OTH:0.3794,ASJ:0.7119	608934	.	.	.	.	.	.	.	0.0	3.84	0.000	0.485	4	1(lung)	0.7447
4	178274835	178274835	A	C	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs13112390	ENSG00000109674:ENST00000264596:exon8:c.A1413C:p.Q471H	NEIL3:NM_018248:exon8:c.A1413C:p.Q471H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7337	0.7711	0.66254	1(liver)	-0.597	0.127	0.642	-1.15	0.022	.	.	.	NEIL3:uc003iut.2:exon8:c.A1413C:p.Q471H	-1.063	AFR:1(large_intestine),AMR:MU122675,EAS:0.7413,FIN:0.7233,NFE:0.7691,OTH:0.8013,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	608934	.	.	.	.	.	.	.	0.0	3.81	0.000	-2.515	4	1(prostate)	0.4387
4	178281754	178281754	G	A	NEIL3	exonic	nonsynonymous SNV	ENSG00000109674	rs1876268	ENSG00000109674:ENST00000264596:exon9:c.G1558A:p.G520R	NEIL3:NM_018248:exon9:c.G1558A:p.G520R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9539	0.9492	0.931909	0.9510	0.752	9.165	1.0	4.74	0.398	.	.	Zinc finger, GRF-type	NEIL3:uc003iut.2:exon9:c.G1558A:p.G520R	-0.977	AFR:0.9044,AMR:0.9605,EAS:0.9833,FIN:0.9791,NFE:0.9657,OTH:0.9664,ASJ:0.9901	608934	.	.	.	.	.	.	.	0.0	2.24	0.000	-2.8	4	MU81792852	hom
4	185310218	185310218	C	T	IRF2	exonic	synonymous SNV	ENSG00000168310	rs1131553	ENSG00000168310:ENST00000502750:exon4:c.G315A:p.G105G,ENSG00000168310:ENST00000393593:exon9:c.G744A:p.G248G	IRF2:NM_002199:exon9:c.G744A:p.G248G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4220	0.3768	0.423123	0.3864	.	.	.	.	.	.	.	.	IRF2:uc003iwf.4:exon9:c.G744A:p.G248G	.	AFR:0.3492,AMR:0.5312,EAS:0.4330,FIN:0.3788,NFE:0.3945,OTH:0.4158,ASJ:0.4007	147576	.	.	.	.	.	.	.	.	.	.	.	4	MU586547	hom
4	185340726	185340726	A	-	IRF2	intronic	.	ENSG00000168310	rs762523551	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1435	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	147576	.	.	.	.	.	.	.	.	.	.	.	4	.	het
4	185587165	185587165	A	G	PRIMPOL	exonic	nonsynonymous SNV	ENSG00000164306	rs2463447	ENSG00000164306:ENST00000515774:exon5:c.A116G:p.Q39R,ENSG00000164306:ENST00000314970:exon6:c.A503G:p.Q168R,ENSG00000164306:ENST00000503752:exon6:c.A503G:p.Q168R,ENSG00000164306:ENST00000512834:exon6:c.A503G:p.Q168R	PRIMPOL:NM_001300767:exon5:c.A116G:p.Q39R,PRIMPOL:NM_001300768:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345891:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345892:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345893:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345895:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345896:exon6:c.A503G:p.Q168R,PRIMPOL:NM_001345899:exon6:c.A503G:p.Q168R,PRIMPOL:NM_152683:exon6:c.A503G:p.Q168R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9873	0.9592	0.966853	0.9642	.	.	.	.	.	.	.	.	CCDC111:uc003iwm.2:exon5:c.A116G:p.Q39R,CCDC111:uc003iwj.2:exon6:c.A503G:p.Q168R,CCDC111:uc003iwk.2:exon6:c.A503G:p.Q168R	.	AFR:0.8792,AMR:0.9893,EAS:1,FIN:0.9977,NFE:0.9981,OTH:0.9919,ASJ:1	615421	615420;	.	.	.	.	.	.	.	.	.	.	4	MU81793151	hom
4	187516880	187516880	A	G	FAT1	exonic	synonymous SNV	ENSG00000083857	rs1298865	ENSG00000083857:ENST00000509927:exon1:c.T75C:p.S25S,ENSG00000083857:ENST00000441802:exon26:c.T13101C:p.S4367S	FAT1:NM_005245:exon26:c.T13101C:p.S4367S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4212	0.4541	0.491813	1(thyroid)	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon26:c.T13101C:p.S4367S	.	AFR:MU4567056,AMR:ESAD-UK|2|409|0.00488998,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.6638,FIN:0.5299,NFE:0.4172,OTH:0.6185,ASJ:0.4742	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(lung)	0.3804
4	187519206	187519206	C	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1280097	ENSG00000083857:ENST00000441802:exon23:c.G12177C:p.K4059N	FAT1:NM_005245:exon23:c.G12177C:p.K4059N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.9953	0.9952	0.997404	0.9958	0.199	4.672	1.0	-0.147	0.797	.	.	EGF-like calcium-binding domain|EGF-like domain	FAT1:uc003izf.3:exon23:c.G12177C:p.K4059N	-0.950	AFR:0.9987,AMR:0.9976,EAS:1,FIN:0.9969,NFE:0.9933,OTH:0.9949,ASJ:1	600976	.	.	.	.	,4923	.	.	0.0	-2.25	0.000	-1.635	4	MU81793643	hom
4	187521037	187521037	C	A	FAT1	intronic	.	ENSG00000083857	rs10009030	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3225	0.2838	0.284744	ESAD-UK|2|409|0.00488998,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2971,AMR:0.2302,EAS:0.3967,FIN:0.4142,NFE:0.2841,OTH:0.3191,ASJ:0.3592	600976	.	.	.	.	.	.	.	.	.	.	.	4	1(upper_aerodigestive_tract)	0.3269
4	187525020	187525020	A	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs2637777	ENSG00000083857:ENST00000441802:exon19:c.T10660G:p.S3554A	FAT1:NM_005245:exon19:c.T10660G:p.S3554A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4276	0.4716	0.51278	1(breast)	-0.348	0.515	0.43	2.19	0.761	.	.	Cadherin-like	FAT1:uc003izf.3:exon19:c.T10660G:p.S3554A	-1.002	AFR:MU14006115,AMR:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,COCA-CN|4|321|0.0124611,EAS:0.7324,FIN:0.5371,NFE:0.4172,OTH:0.6255,ASJ:0.4939	600976	.	.	.	.	,4923	.	.	0.0	1.2	0.000	0.425	4	1(haematopoietic_and_lymphoid_tissue)	0.3789
4	187531022	187531022	A	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs28647489	ENSG00000083857:ENST00000441802:exon15:c.T10001C:p.V3334A	FAT1:NM_005245:exon15:c.T10001C:p.V3334A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.1497	0.1284	0.192492	MU3888713	0.149	4.138	0.732	2.77	0.856	.	.	Cadherin-like	FAT1:uc003izf.3:exon15:c.T10001C:p.V3334A	-0.930	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.1602,EAS:0.1563,FIN:0.1225,NFE:0.4094,OTH:0.1389,ASJ:0.1609	600976	.	.	.	.	,4923	.	.	0.001	4.04	0.000	1.395	4	5(prostate)	0.1387
4	187534363	187534363	G	A	FAT1	exonic	synonymous SNV	ENSG00000083857	rs2249916	ENSG00000083857:ENST00000441802:exon13:c.C9363T:p.N3121N	FAT1:NM_005245:exon13:c.C9363T:p.N3121N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5913	0.6222	0.611422	0.6188	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon13:c.C9363T:p.N3121N	.	AFR:0.6946,AMR:0.6430,EAS:0.6702,FIN:0.5823,NFE:0.5777,OTH:0.6091,ASJ:0.5861	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	MU14006196	het
4	187538942	187538942	T	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1280098	ENSG00000083857:ENST00000441802:exon10:c.A8798C:p.Q2933P	FAT1:NM_005245:exon10:c.A8798C:p.Q2933P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5554	0.6234	0.592053	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874	-1.112	0.009	1.0	4.04	0.044	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon10:c.A8798C:p.Q2933P	-0.940	AFR:0.5898,AMR:0.7045,EAS:0.5298,FIN:0.6355,NFE:0.5183,OTH:0.5375,ASJ:0.5871	600976	.	.	.	.	,4923	.	.	0.0	0.79	0.000	-2.575	4	1(haematopoietic_and_lymphoid_tissue)	0.5682
4	187541601	187541601	A	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs775398395	ENSG00000083857:ENST00000441802:exon10:c.T6139C:p.F2047L	FAT1:NM_005245:exon10:c.T6139C:p.F2047L	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	8.281e-06	.	.	.	3.516	23.1	0.019	4.0	0.003	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon10:c.T6139C:p.F2047L	-0.600	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600976	.	.	.	.	,4923	.	.	0.999	0.64	0.258	2.15	4	.	het
4	187542755	187542755	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs28489116	ENSG00000083857:ENST00000441802:exon10:c.A4985G:p.N1662S	FAT1:NM_005245:exon10:c.A4985G:p.N1662S	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1517	0.1314	0.200479	7(prostate)	2.935	22.0	0.335	5.19	0.675	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon10:c.A4985G:p.N1662S	-1.037	AFR:1(large_intestine),AMR:MU159933,EAS:0.1646,FIN:0.1775,NFE:0.1627,OTH:0.1225,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	600976	.	.	.	.	,4923	.	.	0.998	0.17	0.000	2.195	4	1(haematopoietic_and_lymphoid_tissue)	0.4214
4	187557893	187557893	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs328418	ENSG00000083857:ENST00000441802:exon5:c.A3818G:p.H1273R	FAT1:NM_005245:exon5:c.A3818G:p.H1273R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5876	0.6338	0.645767	1(kidney)	-1.030	0.014	1.0	4.99	0.003	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon5:c.A3818G:p.H1273R	-0.954	AFR:MU14006434,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,RECA-EU|1|422|0.00236967,EAS:0.8076,FIN:0.6471,NFE:0.6060,OTH:0.6689,ASJ:0.6358	600976	.	.	.	.	,4923	.	.	0.0	0.84	0.000	-2.11	4	1(urinary_tract)	0.5607
4	187584587	187584587	A	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs77280820	ENSG00000083857:ENST00000441802:exon3:c.T3446C:p.M1149T	FAT1:NM_005245:exon3:c.T3446C:p.M1149T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.0032	0.0050	0.00279553	.	0.897	10.06	0.115	5.33	0.965	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon3:c.T3446C:p.M1149T	-1.062	AFR:0.0029,AMR:0.0010,EAS:0.0066,FIN:0,NFE:0.0003,OTH:0.0050,ASJ:0.0024	600976	.	.	.	.	,4923	.	.	0.121	0.71	0.069	-0.365	4	1(haematopoietic_and_lymphoid_tissue)	0
4	187584771	187584771	C	G	FAT1	intronic	.	ENSG00000083857	rs172903	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9673	0.9625	0.983427	0.9714	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.9888,AMR:0.9666,EAS:1,FIN:0.9720,NFE:0.9585,OTH:0.9705,ASJ:0.9702	600976	.	.	.	.	.	.	.	.	.	.	.	4	MU81793736	hom
4	187627792	187627792	T	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs11939575	ENSG00000083857:ENST00000441802:exon2:c.A3190G:p.R1064G	FAT1:NM_005245:exon2:c.A3190G:p.R1064G	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7609	0.8272	0.745807	LAML-KR|5|205|0.0243902,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	0.930	10.26	1.0	4.6	0.007	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.A3190G:p.R1064G,FAT1:uc010iso.1:exon2:c.A3190G:p.R1064G	-0.947	AFR:0.7963,AMR:0.8886,EAS:0.7517,FIN:0.5136,NFE:0.7496,OTH:0.7913,ASJ:0.6790	600976	.	.	.	.	,4923	.	.	0.0	0.54	0.000	-3.06	4	1(breast)	0.7959
4	187628398	187628398	C	G	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs1877731	ENSG00000083857:ENST00000441802:exon2:c.G2584C:p.V862L	FAT1:NM_005245:exon2:c.G2584C:p.V862L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7460	0.7755	0.689097	LAML-KR|5|205|0.0243902,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	-1.358	0.004	1.0	3.06	0.035	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.G2584C:p.V862L,FAT1:uc010iso.1:exon2:c.G2584C:p.V862L	-0.935	AFR:0.7483,AMR:0.7208,EAS:0.7533,FIN:0.5149,NFE:0.7503,OTH:0.7906,ASJ:0.6663	600976	.	.	.	.	,4923	.	.	0.0	0.95	0.000	-0.735	4	5(haematopoietic_and_lymphoid_tissue)	0.7908
4	187629140	187629140	G	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs367863	ENSG00000083857:ENST00000441802:exon2:c.C1842G:p.F614L	FAT1:NM_005245:exon2:c.C1842G:p.F614L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.7476	0.7801	0.690495	MU11955600	-0.701	0.071	1.0	3.53	0.206	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.C1842G:p.F614L,FAT1:uc010iso.1:exon2:c.C1842G:p.F614L	-0.980	AFR:LAML-KR|5|205|0.0243902,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.7519,EAS:0.6659,FIN:0.7517,NFE:0.5111,OTH:0.7499,ASJ:0.7350	600976	.	.	.	.	,4923	.	.	0.0	1.35	0.000	-1.85	4	3(lung)	0.7907
4	187629497	187629497	G	A	FAT1	exonic	synonymous SNV	ENSG00000083857	rs458021	ENSG00000083857:ENST00000441802:exon2:c.C1485T:p.N495N	FAT1:NM_005245:exon2:c.C1485T:p.N495N	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5644	0.5618	0.421925	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	FAT1:uc003izf.3:exon2:c.C1485T:p.N495N,FAT1:uc010iso.1:exon2:c.C1485T:p.N495N	.	AFR:0.5399,AMR:0.3539,EAS:0.5927,FIN:0.2295,NFE:0.6330,OTH:0.6530,ASJ:0.5465	600976	.	.	.	.	,4923	.	.	.	.	.	.	4	1(lung)	0.6196
4	187629538	187629538	C	T	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs3733413	ENSG00000083857:ENST00000441802:exon2:c.G1444A:p.V482I,ENSG00000083857:ENST00000509647:exon2:c.G1444A:p.V482I	FAT1:NM_005245:exon2:c.G1444A:p.V482I	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.4865	0.4607	0.338858	MU21520090	0.580	8.014	0.144	2.77	0.069	.	.	Cadherin-like;Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.G1444A:p.V482I,FAT1:uc010iso.1:exon2:c.G1444A:p.V482I	-0.917	AFR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.4354,EAS:0.4594,FIN:0.5596,NFE:0.1415,OTH:0.4957,ASJ:0.2282	600976	.	.	.	.	,4923	.	.	0.059	0.44	0.000	1.075	4	1(urinary_tract)	0.5652
4	187629770	187629770	A	C	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs3733414	ENSG00000083857:ENST00000441802:exon2:c.T1212G:p.S404R,ENSG00000083857:ENST00000509647:exon2:c.T1212G:p.S404R	FAT1:NM_005245:exon2:c.T1212G:p.S404R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5576	0.5432	0.398962	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	0.506	7.479	0.531	1.45	0.626	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.T1212G:p.S404R,FAT1:uc010iso.1:exon2:c.T1212G:p.S404R	-0.899	AFR:0.5191,AMR:0.2812,EAS:0.6,FIN:0.2302,NFE:0.6335,OTH:0.6523,ASJ:0.5453	600976	.	.	.	.	,4923	.	.	0.134	-1.75	0.000	1.32	4	5(haematopoietic_and_lymphoid_tissue)	0.6186
4	187630590	187630590	G	A	FAT1	exonic	nonsynonymous SNV	ENSG00000083857	rs3733415	ENSG00000083857:ENST00000441802:exon2:c.C392T:p.A131V,ENSG00000083857:ENST00000509647:exon2:c.C392T:p.A131V	FAT1:NM_005245:exon2:c.C392T:p.A131V	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1798	0.2047	0.261382	45(meninges)	3.251	22.8	0.002	5.2	0.155	.	.	Cadherin|Cadherin-like	FAT1:uc003izf.3:exon2:c.C392T:p.A131V,FAT1:uc010iso.1:exon2:c.C392T:p.A131V	-1.016	AFR:MU766445,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.3610,FIN:0.1196,NFE:0.1523,OTH:0.2834,ASJ:0.2063	600976	.	.	.	.	,4923	.	.	0.904	0.21	0.000	2.775	4	1(breast)	0.1160
4	187630989	187630989	C	A	FAT1	UTR5	.	ENSG00000083857	rs17077740	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2267	0.2031	0.261382	MU11955634	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.2062,EAS:0.1193,FIN:0.1556,NFE:0.2824,OTH:0.1163,ASJ:0.3611	600976	.	.	.	.	.	.	.	.	.	.	.	4	1(lung)	0.1374
5	230980	230980	A	G	SDHA	intronic	.	ENSG00000073578	rs2288461	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8810	0.9126	0.858427	0.9009	.	.	.	.	.	0	0	.	.	.	AFR:0.9713,AMR:0.8923,EAS:0.6590,FIN:0.9201,NFE:0.8853,OTH:0.8867,ASJ:0.7848	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU16880685	hom
5	231111	231111	T	C	SDHA	exonic	synonymous SNV	ENSG00000073578	rs1126417	ENSG00000073578:ENST00000510361:exon6:c.T747C:p.P249P,ENSG00000073578:ENST00000264932:exon7:c.T891C:p.P297P,ENSG00000073578:ENST00000504309:exon7:c.T891C:p.P297P	SDHA:NM_001294332:exon6:c.T747C:p.P249P,SDHA:NM_001330758:exon7:c.T891C:p.P297P,SDHA:NM_004168:exon7:c.T891C:p.P297P	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7078	0.7687	0.653355	MU4562957	.	.	.	.	.	.	.	.	SDHA:uc003jaq.4:exon2:c.T216C:p.P72P,SDHA:uc021xvu.1:exon2:c.T216C:p.P72P,SDHA:uc011clw.2:exon6:c.T747C:p.P249P,SDHA:uc003jao.4:exon7:c.T891C:p.P297P,SDHA:uc011clv.1:exon7:c.T891C:p.P297P	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.7402,EAS:0.6516,FIN:0.7067,NFE:0.3323,OTH:0.7666,ASJ:0.7825	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	1(thyroid)	0.7589
5	236587	236587	G	T	SDHA	exonic	synonymous SNV	ENSG00000073578	rs35964044	ENSG00000073578:ENST00000510361:exon9:c.G1161T:p.L387L,ENSG00000073578:ENST00000264932:exon10:c.G1305T:p.L435L,ENSG00000073578:ENST00000504309:exon10:c.G1305T:p.L435L	SDHA:NM_001294332:exon9:c.G1161T:p.L387L,SDHA:NM_001330758:exon10:c.G1305T:p.L435L,SDHA:NM_004168:exon10:c.G1305T:p.L435L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0193	0.0146	0.0151757	0.0164	.	.	.	.	.	.	.	.	SDHA:uc003jaq.4:exon5:c.G630T:p.L210L,SDHA:uc021xvu.1:exon5:c.G630T:p.L210L,SDHA:uc011clw.2:exon9:c.G1161T:p.L387L,SDHA:uc003jao.4:exon10:c.G1305T:p.L435L,SDHA:uc011clv.1:exon10:c.G1305T:p.L435L	.	AFR:0.0037,AMR:0.0095,EAS:0.0006,FIN:0.0395,NFE:0.0196,OTH:0.0255,ASJ:0.0298	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	.	het
5	254861	254861	C	G	SDHA	intronic	.	ENSG00000073578	rs2241600	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.652756	0.7383	.	.	.	.	.	.	.	.	.	.	AFR:0.7851,AMR:0.6516,EAS:0.3348,FIN:0.7478,NFE:0.7577,OTH:0.7418,ASJ:0.6987	600857	252011;256000;613642;614165;	29072;154;255210;255241;506;70474;3208;	29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~255210|MILS<br>Maternally-inherited Leigh disease<br>Maternally-inherited infantile subacute necrotizing encephalopathy|-|Mitochondrial inheritance|Childhood<br>Infancy|256000 ~255241|Infantile subacute necrotizing encephalopathy with leukodystrophy<br>Leigh disease with leukodystrophy|-|Autosomal recessive|Infancy<br>Neonatal|256000 616277 ~506|Infantile subacute necrotizing encephalopathy<br>Leigh disease|1-9 / 100 000|Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|256000 ~70474|Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency<br>Cardiomyopathy with myopathy due to COX deficiency<br>Leigh disease with myopathy|-|-|-|256000 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~	.	.	.	.	.	.	.	.	5	MU1256647	hom
5	635709	635709	C	T	CEP72	intronic	.	ENSG00000112877	rs1697985	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2460	0.2467	0.282947	0.2555	.	.	.	.	.	.	.	.	.	.	AFR:0.2751,AMR:0.2763,EAS:0.4412,FIN:0.2476,NFE:0.2262,OTH:0.2363,ASJ:0.2450	616475	.	.	.	.	.	.	.	.	.	.	.	5	MU21708776	het
5	640705	640705	A	G	CEP72	exonic	nonsynonymous SNV	ENSG00000112877	rs868649	ENSG00000112877:ENST00000264935:exon9:c.A1525G:p.T509A	CEP72:NM_018140:exon9:c.A1525G:p.T509A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2456	0.2171	0.26877	0.2466	-1.278	0.005	0.492	-2.31	0.001	.	.	.	CEP72:uc003jbf.3:exon9:c.A1525G:p.T509A	-0.905	AFR:0.2430,AMR:0.2745,EAS:0.4419,FIN:0.2479,NFE:0.2265,OTH:0.2352,ASJ:0.2450	616475	.	.	.	.	.	.	.	0.002	1.39	0.000	0.74	5	MU798460	het
5	1255520	1255520	G	A	TERT	exonic	synonymous SNV	ENSG00000164362	rs33954691	ENSG00000164362:ENST00000334602:exon13:c.C2850T:p.H950H,ENSG00000164362:ENST00000310581:exon14:c.C3039T:p.H1013H	TERT:NM_001193376:exon13:c.C2850T:p.H950H,TERT:NM_198253:exon14:c.C3039T:p.H1013H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1239	0.0738	0.117812	MU26172753	.	.	.	.	.	.	.	.	TERT:uc021xwa.1:exon2:c.C226T:p.R76C	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,AMR:0.0858,EAS:0.2452,FIN:0.1358,NFE:0.1551,OTH:0.0944,ASJ:0.0231	187270	601626;613989;614742;615134;	618;88;1775;3322;519;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	20(meninges)	0.1007
5	1294086	1294086	C	T	TERT	exonic	synonymous SNV	ENSG00000164362	rs2736098	ENSG00000164362:ENST00000296820:exon2:c.G915A:p.A305A,ENSG00000164362:ENST00000310581:exon2:c.G915A:p.A305A,ENSG00000164362:ENST00000334602:exon2:c.G915A:p.A305A,ENSG00000164362:ENST00000460137:exon2:c.G915A:p.A305A,ENSG00000164362:ENST00000508104:exon2:c.G915A:p.A305A	TERT:NM_001193376:exon2:c.G915A:p.A305A,TERT:NM_198253:exon2:c.G915A:p.A305A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4045	0.2075	0.265575	1(stomach)	.	.	.	.	.	.	.	.	TERT:uc003jca.1:exon2:c.G915A:p.A305A,TERT:uc003jcb.1:exon2:c.G915A:p.A305A,TERT:uc003jcc.1:exon2:c.G915A:p.A305A	.	AFR:5(meninges),AMR:MU88724,EAS:0.2150,FIN:0.1015,NFE:0.2243,OTH:0.2450,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	187270	601626;613989;614742;615134;	618;88;1775;3322;519;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	1(breast)	0.3790
5	1295349	1295349	A	G	TERT	upstream	.	ENSG00000164362	rs2853669	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	.	.	0.297923	0.2395	.	.	.	.	.	.	.	.	.	.	AFR:0.1181,AMR:0.2482,EAS:0.3893,FIN:0.2318,NFE:0.2906,OTH:0.2887,ASJ:0.3212	187270	601626;613989;614742;615134;	618;88;1775;3322;519;	618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	.	het
5	6600064	6600064	G	T	NSUN2	exonic	nonsynonymous SNV	ENSG00000037474	rs61744358	ENSG00000037474:ENST00000506139:exon18:c.C2174A:p.P725Q,ENSG00000037474:ENST00000539938:exon18:c.C1571A:p.P524Q,ENSG00000037474:ENST00000264670:exon19:c.C2279A:p.P760Q	NSUN2:NM_001193455:exon18:c.C2174A:p.P725Q,NSUN2:NM_017755:exon19:c.C2279A:p.P760Q	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0588	0.0659	0.0551118	0.0592	0.517	7.556	0.085	1.59	0.000	.	.	.	NSUN2:uc003jdt.3:exon13:c.C1571A:p.P524Q,NSUN2:uc003jdv.3:exon18:c.C1571A:p.P524Q,NSUN2:uc011cmk.2:exon18:c.C2174A:p.P725Q,NSUN2:uc003jdu.3:exon19:c.C2279A:p.P760Q	-1.123	AFR:0.0639,AMR:0.0430,EAS:0.0018,FIN:0.0398,NFE:0.0679,OTH:0.0602,ASJ:0.0629	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	0.003	1.31	0.007	0	5	.	het
5	6605532	6605532	C	A	NSUN2	intronic	.	ENSG00000037474	rs2303707	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6609	.	0.675319	0.6733	.	.	.	.	.	0	0	.	.	.	AFR:0.7452,AMR:0.6205,EAS:0.6636,FIN:0.5731,NFE:0.6623,OTH:0.6120,ASJ:0.6987	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	5	MU16722209	hom
5	6622122	6622122	T	A	NSUN2	intronic	.	ENSG00000037474	rs16877704	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0384	0.0430	0.0159744	0.0371	.	.	.	.	.	0.0001	0.038	.	.	.	AFR:0.0102,AMR:0.0227,EAS:0,FIN:0.0421,NFE:0.0567,OTH:0.0356,ASJ:0.0331	610916	611091;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	5	.	het
5	10250443	10250443	T	C	CCT5	UTR5	.	ENSG00000150753	rs2578618	ENSG00000150753:ENST00000511700:exon1:c.T89C:p.V30A	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7892	0.7181	0.685304	0.7414	.	.	.	.	.	.	.	.	.	.	AFR:0.4588,AMR:0.7983,EAS:0.8346,FIN:0.8600,NFE:0.8573,OTH:0.8173,ASJ:0.8609	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795367	het
5	10254817	10254817	A	G	CCT5	exonic	synonymous SNV	ENSG00000150753	rs2578617	ENSG00000150753:ENST00000280326:exon3:c.A198G:p.G66G,ENSG00000150753:ENST00000503026:exon3:c.A135G:p.G45G,ENSG00000150753:ENST00000515676:exon3:c.A84G:p.G28G	CCT5:NM_001306153:exon3:c.A135G:p.G45G,CCT5:NM_001306156:exon3:c.A84G:p.G28G,CCT5:NM_012073:exon3:c.A198G:p.G66G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7895	0.7187	0.685903	0.7418	.	.	.	.	.	.	.	.	CCT5:uc003jeq.3:exon3:c.A198G:p.G66G,CCT5:uc011cms.2:exon3:c.A84G:p.G28G	.	AFR:0.4596,AMR:0.7962,EAS:0.8331,FIN:0.8603,NFE:0.8578,OTH:0.8166,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795384	het
5	10256161	10256161	T	C	CCT5	exonic	synonymous SNV	ENSG00000150753	rs1042392	ENSG00000150753:ENST00000506600:exon3:c.T147C:p.R49R,ENSG00000150753:ENST00000515390:exon3:c.T261C:p.R87R,ENSG00000150753:ENST00000280326:exon4:c.T426C:p.R142R,ENSG00000150753:ENST00000503026:exon4:c.T363C:p.R121R,ENSG00000150753:ENST00000515676:exon4:c.T312C:p.R104R	CCT5:NM_001306154:exon3:c.T261C:p.R87R,CCT5:NM_001306155:exon3:c.T147C:p.R49R,CCT5:NM_001306153:exon4:c.T363C:p.R121R,CCT5:NM_001306156:exon4:c.T312C:p.R104R,CCT5:NM_012073:exon4:c.T426C:p.R142R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7948	0.7274	0.692492	0.7493	.	.	.	.	.	.	.	.	CCT5:uc011cmr.2:exon3:c.T261C:p.R87R,CCT5:uc011cmt.2:exon3:c.T147C:p.R49R,CCT5:uc003jeq.3:exon4:c.T426C:p.R142R,CCT5:uc011cms.2:exon4:c.T312C:p.R104R	.	AFR:0.4732,AMR:0.7983,EAS:0.8465,FIN:0.8612,NFE:0.8637,OTH:0.8177,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU44187827	het
5	10262740	10262740	C	A	CCT5	intronic	.	ENSG00000150753	rs2578642	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7894	0.7187	0.685903	0.7416	.	.	.	.	.	.	.	.	.	.	AFR:0.4589,AMR:0.7971,EAS:0.8337,FIN:0.8603,NFE:0.8580,OTH:0.8153,ASJ:0.8576	610150	256840;	139578;	139578|HSAN with spastic paraplegia|<1 / 1 000 000|Autosomal recessive|Childhood|256840 ~	.	.	.	.	.	.	.	.	5	MU81795401	het
5	14184079	14184079	G	A	TRIO	intronic	.	ENSG00000038382	rs354300	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8173	.	0.8127	0.8239	.	.	.	.	.	.	.	.	.	.	AFR:0.6845,AMR:0.7278,EAS:0.9926,FIN:0.9139,NFE:0.8693,OTH:0.8517,ASJ:0.8179	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	MU81795659	hom
5	14290805	14290805	G	A	TRIO	intronic	.	ENSG00000038382	rs30629	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5072	0.4419	0.410743	ESAD-UK|2|409|0.00488998,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.4647,AMR:0.2003,EAS:0.6126,FIN:0.5478,NFE:0.6005,OTH:0.5712,ASJ:0.4426	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	1(upper_aerodigestive_tract)	0.5409
5	14420027	14420027	A	C	TRIO	exonic	synonymous SNV	ENSG00000038382	rs30612	ENSG00000038382:ENST00000513206:exon30:c.A4299C:p.T1433T,ENSG00000038382:ENST00000344204:exon34:c.A5100C:p.T1700T,ENSG00000038382:ENST00000512070:exon34:c.A4923C:p.T1641T,ENSG00000038382:ENST00000537187:exon34:c.A5100C:p.T1700T	TRIO:NM_007118:exon34:c.A5100C:p.T1700T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8298	0.8960	0.81869	0.8768	.	.	.	.	.	.	.	.	TRIO:uc003jfh.1:exon29:c.A4047C:p.T1349T,TRIO:uc003jff.3:exon34:c.A5100C:p.T1700T	.	AFR:0.9709,AMR:0.8305,EAS:0.7165,FIN:0.8351,NFE:0.8536,OTH:0.8405,ASJ:0.8974	601893	617061;	.	.	.	.	.	.	.	.	.	.	5	MU4548262	het
5	35857177	35857177	G	C	IL7R	intronic	.	ENSG00000168685	rs1353252	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6395	0.7428	0.647364	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU586611,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.8686,FIN:0.5442,NFE:0.6567,OTH:0.4019,ASJ:0.7189	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	5	2(lung)	0.7384
5	35861068	35861068	T	C	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs1494558	ENSG00000168685:ENST00000303115:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000343305:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000506850:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000511982:exon2:c.T197C:p.I66T,ENSG00000168685:ENST00000514217:exon2:c.T197C:p.I66T	IL7R:NM_002185:exon2:c.T197C:p.I66T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.6279	0.7009	0.59984	3(urinary_tract)	-0.950	0.020	0.881	2.16	0.292	.	.	.	IL7R:uc003jjs.4:exon2:c.T197C:p.I66T,IL7R:uc011coo.3:exon2:c.T197C:p.I66T	-0.953	AFR:2(stomach),AMR:2(large_intestine),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,FIN:0.6843,NFE:0.7474,OTH:0.5358,ASJ:MU586612	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.0	-0.76	0.000	.	5	18(soft_tissue)	0.6556
5	35871190	35871190	G	A	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs1494555	ENSG00000168685:ENST00000303115:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000343305:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000506850:exon4:c.G412A:p.V138I,ENSG00000168685:ENST00000514217:exon4:c.G412A:p.V138I	IL7R:NM_002185:exon4:c.G412A:p.V138I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.6519	0.7458	0.666933	18(soft_tissue)	-0.630	0.106	0.664	-1.61	0.008	.	.	Fibronectin type III|Immunoglobulin-like fold	IL7R:uc003jjs.4:exon4:c.G412A:p.V138I,IL7R:uc011coo.3:exon4:c.G412A:p.V138I	-0.974	AFR:2(stomach),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:MU586614,FIN:MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611,NFE:0.7252,OTH:0.8671,ASJ:1(skin)	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.0	-1.12	0.000	.	5	2(large_intestine)	0.5530
5	35874575	35874575	C	T	IL7R	exonic	nonsynonymous SNV	ENSG00000168685	rs6897932	ENSG00000168685:ENST00000303115:exon6:c.C731T:p.T244I	IL7R:NM_002185:exon6:c.C731T:p.T244I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2327	0.2141	0.172524	2(haematopoietic_and_lymphoid_tissue)	-0.235	0.925	0.522	-2.49	0.543	.	.	.	IL7R:uc003jjs.4:exon6:c.C731T:p.T244I	-0.806	AFR:4(large_intestine),AMR:1(pancreas),EAS:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,FIN:0.2188,NFE:0.0963,OTH:0.1802,ASJ:MU98017	146661	608971;	169154;169157;169160;	169154|T-B+ SCID due to IL-7Ralpha deficiency|-|-|-|608971 ~169157|T-B+ SCID due to CD45 deficiency|-|Autosomal recessive|-|608971 ~169160|T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta|-|-|-|608971 610163 615615 615617 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04630 JAK-STAT signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05340 Primary immunodeficiency ~	,6187	.	.	0.0	-3.91	0.000	0.46	5	1(lung)	0.2781
5	38942449	38942449	G	A	RICTOR	exonic	nonsynonymous SNV	ENSG00000164327	rs61748204	ENSG00000164327:ENST00000357387:exon38:c.C5084T:p.T1695I,ENSG00000164327:ENST00000296782:exon39:c.C5156T:p.T1719I	RICTOR:NM_001285440:exon38:c.C4115T:p.T1372I,RICTOR:NM_152756:exon38:c.C5084T:p.T1695I,RICTOR:NM_001285439:exon39:c.C5156T:p.T1719I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0292	0.0270	0.0351438	0.0224	-0.019	2.411	0.734	-3.13	0.985	.	.	.	RICTOR:uc003jlp.2:exon38:c.C5084T:p.T1695I,RICTOR:uc010ivf.2:exon38:c.C4115T:p.T1372I,RICTOR:uc003jlo.2:exon39:c.C5156T:p.T1719I	-1.065	AFR:0.0345,AMR:0.0299,EAS:0.0074,FIN:0.0086,NFE:0.0198,OTH:0.0235,ASJ:0.0166	609022	.	.	.	.	.	.	.	0.0	0.94	0.015	0.55	5	.	het
5	38950776	38950776	G	A	RICTOR	exonic	synonymous SNV	ENSG00000164327	rs2115949	ENSG00000164327:ENST00000296782:exon31:c.C3174T:p.S1058S,ENSG00000164327:ENST00000357387:exon31:c.C3174T:p.S1058S	RICTOR:NM_001285439:exon31:c.C3174T:p.S1058S,RICTOR:NM_001285440:exon31:c.C2319T:p.S773S,RICTOR:NM_152756:exon31:c.C3174T:p.S1058S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9658	0.9521	0.949481	0.9624	.	.	.	.	.	.	.	.	RICTOR:uc003jlo.2:exon31:c.C3174T:p.S1058S,RICTOR:uc003jlp.2:exon31:c.C3174T:p.S1058S,RICTOR:uc010ivf.2:exon31:c.C2319T:p.S773S	.	AFR:0.9120,AMR:0.9665,EAS:0.9926,FIN:0.9914,NFE:0.9802,OTH:0.9755,ASJ:0.9834	609022	.	.	.	.	.	.	.	.	.	.	.	5	MU81796672	het
5	38953665	38953665	-	A	RICTOR	intronic	.	ENSG00000164327	rs33912683	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9376	0.8929	0.934105	0.9387	.	.	.	.	.	.	.	.	.	.	AFR:0.8858,AMR:0.9494,EAS:0.9913,FIN:0.9582,NFE:0.9581,OTH:0.9537,ASJ:0.9733	609022	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	56111751	56111751	G	C	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs28710284	ENSG00000095015:ENST00000399503:exon1:c.G351C:p.A117A	MAP3K1:NM_005921:exon1:c.G351C:p.A117A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7955	.	0.685703	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon1:c.G351C:p.A117A	.	AFR:0.7508,AMR:0.6573,EAS:0.8404,FIN:0.5916,NFE:0.8094,OTH:0.8129,ASJ:0.6225	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(thyroid)	0.7950
5	56152416	56152416	C	A	MAP3K1	intronic	.	ENSG00000237705	rs832567	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6132	0.6989	0.526158	0.6521	.	.	.	.	.	0.0006	0.018	.	.	.	AFR:0.6500,AMR:0.4618,EAS:0.2040,FIN:0.7156,NFE:0.6929,OTH:0.6793,ASJ:0.7748	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	MU767397	het
5	56161787	56161787	G	A	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs832575	ENSG00000095015:ENST00000399503:exon6:c.G1284A:p.T428T	MAP3K1:NM_005921:exon6:c.G1284A:p.T428T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8479	0.8530	0.804313	0.8481	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon6:c.G1284A:p.T428T	.	AFR:0.7975,AMR:0.7005,EAS:0.7163,FIN:0.9001,NFE:0.8844,OTH:0.8890,ASJ:0.8907	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	MU18483702	hom
5	56177443	56177443	G	A	MAP3K1	exonic	nonsynonymous SNV	ENSG00000095015	rs702689	ENSG00000095015:ENST00000399503:exon14:c.G2416A:p.D806N	MAP3K1:NM_005921:exon14:c.G2416A:p.D806N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.5984	0.6501	0.476438	MU12351955	2.329	18.36	0.195	5.56	1.000	.	.	.	MAP3K1:uc003jqw.4:exon14:c.G2416A:p.D806N	-0.975	AFR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,AMR:0.6061,EAS:0.4555,FIN:0.7748,NFE:0.2011,OTH:0.7146,ASJ:0.4892	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	0.999	0.82	0.000	2.085	5	76(lung)	0.6930
5	56177743	56177743	G	A	MAP3K1	exonic	nonsynonymous SNV	ENSG00000095015	rs832582	ENSG00000095015:ENST00000399503:exon14:c.G2716A:p.V906I	MAP3K1:NM_005921:exon14:c.G2716A:p.V906I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7648	0.7985	0.708267	75(lung)	-2.273	0.001	0.847	3.58	0.036	.	.	.	MAP3K1:uc003jqw.4:exon14:c.G2716A:p.V906I	-1.009	AFR:MU12351967,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02,EAS:0.7459,FIN:0.6089,NFE:0.8477,OTH:0.5902,ASJ:0.7760	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	0.0	1.56	0.000	0.11	5	1(large_intestine)	0.8130
5	56177849	56177851	CAA	-	MAP3K1	exonic	nonframeshift deletion	ENSG00000095015	rs10552703	ENSG00000095015:ENST00000399503:exon14:c.2822_2824del:p.941_942del	MAP3K1:NM_005921:exon14:c.2822_2824del:p.941_942del	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7393	.	.	0.7706	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon14:c.2822_2824del:p.941_942del	.	AFR:0.7403,AMR:0.5958,EAS:0.5813,FIN:0.8033,NFE:0.8077,OTH:0.7961,ASJ:0.8425	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	.	hom
5	56178217	56178217	A	C	MAP3K1	exonic	synonymous SNV	ENSG00000095015	rs832583	ENSG00000095015:ENST00000399503:exon14:c.A3190C:p.R1064R	MAP3K1:NM_005921:exon14:c.A3190C:p.R1064R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7653	0.7995	0.708267	1(thyroid)	.	.	.	.	.	.	.	.	MAP3K1:uc003jqw.4:exon14:c.A3190C:p.R1064R	.	AFR:2(breast),AMR:MU4558542,EAS:0.7764,FIN:0.7465,NFE:0.6089,OTH:0.8477,ASJ:LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	1(haematopoietic_and_lymphoid_tissue)	0.5897
5	56179341	56179341	G	A	MAP3K1	intronic	.	ENSG00000095015	rs16886463	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1462	0.0768	0.163538	2(breast)	.	.	.	.	.	.	.	.	.	.	AFR:MU12351990,AMR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.0213,FIN:0.1451,NFE:0.07,OTH:0.3877,ASJ:0.1027	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	5(soft_tissue)	0.0979
5	56180480	56180480	A	G	MAP3K1	intronic	.	ENSG00000095015	rs3736430	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1552	0.0995	0.182708	1(breast)	.	.	.	.	.	0	0	.	.	.	AFR:1(liver),AMR:1(biliary_tract),EAS:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,FIN:0.1246,NFE:0.0962,OTH:0.1587,ASJ:MU678558	600982	613762;	242;	242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	5	5(soft_tissue)	0.0728
5	57754004	57754004	C	T	PLK2	intronic	.	ENSG00000145632	rs697135	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4229	0.5076	0.422324	0.5019	.	.	.	.	.	0.0001	0.162	.	.	.	AFR:0.6283,AMR:0.4317,EAS:0.2460,FIN:0.4819,NFE:0.4702,OTH:0.4561,ASJ:0.3691	607023	.	.	.	.	.	.	.	.	.	.	.	5	MU27120297	unknown
5	57754005	57754005	G	A	PLK2	intronic	.	ENSG00000145632	rs1848510	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4005	0.3392	0.403155	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	0	0.002	.	.	.	AFR:MU10792843,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.2718,FIN:0.4725,NFE:0.4570,OTH:0.4926,ASJ:0.3326	607023	.	.	.	.	.	.	.	.	.	.	.	5	2(lung)	0.3064
5	57754808	57754808	G	A	PLK2	intronic	.	ENSG00000145632	rs697133	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6662	0.6373	0.740216	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0013	0.062	.	.	.	AFR:0.6426,AMR:0.7164,EAS:0.62,FIN:0.8881,NFE:0.6009,OTH:0.5763,ASJ:0.7780	607023	.	.	.	.	.	.	.	.	.	.	.	5	1(liver)	0.6322
5	57755703	57755703	C	T	PLK2	exonic	synonymous SNV	ENSG00000145632	rs3211270	ENSG00000145632:ENST00000274289:exon1:c.G84A:p.A28A	PLK2:NM_001252226:exon1:c.G84A:p.A28A,PLK2:NM_006622:exon1:c.G84A:p.A28A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3825	0.3143	0.390974	1(lung)	.	.	.	.	.	.	.	.	PLK2:uc003jrn.3:exon1:c.G84A:p.A28A,PLK2:uc021xyx.1:exon1:c.G84A:p.A28A	.	AFR:MU131745,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,EAS:0.2665,FIN:0.4594,NFE:0.4437,OTH:0.4901,ASJ:0.3109	607023	.	.	.	.	.	.	.	.	.	.	.	5	1(thyroid)	0.2623
5	67589188	67589188	C	T	PIK3R1	exonic	synonymous SNV	ENSG00000145675	rs3730090	ENSG00000145675:ENST00000519025:exon3:c.C195T:p.F65F,ENSG00000145675:ENST00000521409:exon3:c.C87T:p.F29F,ENSG00000145675:ENST00000523872:exon3:c.C87T:p.F29F,ENSG00000145675:ENST00000320694:exon4:c.C276T:p.F92F,ENSG00000145675:ENST00000336483:exon4:c.C366T:p.F122F,ENSG00000145675:ENST00000274335:exon9:c.C1176T:p.F392F,ENSG00000145675:ENST00000396611:exon9:c.C1176T:p.F392F,ENSG00000145675:ENST00000521381:exon10:c.C1176T:p.F392F,ENSG00000145675:ENST00000521657:exon10:c.C1176T:p.F392F	PIK3R1:NM_001242466:exon3:c.C87T:p.F29F,PIK3R1:NM_181504:exon4:c.C366T:p.F122F,PIK3R1:NM_181524:exon4:c.C276T:p.F92F,PIK3R1:NM_181523:exon10:c.C1176T:p.F392F	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0695	.	.	1(meninges)	.	.	.	.	.	.	.	.	PIK3R1:uc011crb.2:exon2:c.C186T:p.F62F,PIK3R1:uc003jve.3:exon3:c.C213T:p.F71F,PIK3R1:uc021xzn.1:exon3:c.C87T:p.F29F,PIK3R1:uc003jvc.3:exon4:c.C276T:p.F92F,PIK3R1:uc003jvd.3:exon4:c.C366T:p.F122F,PIK3R1:uc003jva.3:exon10:c.C1176T:p.F392F	.	AFR:1(breast),AMR:MU5385283,EAS:0.0488,FIN:0.1055,NFE:0.0310,OTH:0.0397,ASJ:COCA-CN|2|321|0.00623053,LAML-CN|1|81|0.0123457	171833	269880;615214;616005;	397596;229717;33110;3163;	397596|APDS<br>Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adult|615513 616005 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~3163|Aarskog-Ose-Pande syndrome<br>Lipodystrophy-Rieger anomaly-diabetes syndrome<br>Rieger anomaly-partial lipodystrophy syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|269880 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	9068,,9069,9067	.	.	.	.	.	.	5	1(lung)	0.1729
5	68692375	68692375	-	AA	RAD17	splicing	.	ENSG00000152942	rs377737971	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0859	.	.	0.2677	.	.	.	.	.	.	.	.	.	.	AFR:0.1192,AMR:0.2398,EAS:0.4316,FIN:0.2798,NFE:0.3370,OTH:0.2997,ASJ:0.2311	603139	.	.	.	.	.	.	.	.	.	.	.	5	.	hom
5	70338045	70338045	T	C	GTF2H2	exonic	synonymous SNV	ENSG00000145736	.	ENSG00000145736:ENST00000425596:exon12:c.A717G:p.A239A,ENSG00000145736:ENST00000274400:exon13:c.A888G:p.A296A,ENSG00000145736:ENST00000330280:exon14:c.A888G:p.A296A	GTF2H2:NM_001364572:exon12:c.A717G:p.A239A,GTF2H2:NM_001364568:exon13:c.A888G:p.A296A,GTF2H2:NM_001364569:exon13:c.A888G:p.A296A,GTF2H2:NM_001364570:exon13:c.A888G:p.A296A,GTF2H2:NM_001515:exon13:c.A888G:p.A296A,GTF2H2:NM_001364567:exon14:c.A888G:p.A296A,GTF2H2:NM_001364571:exon14:c.A888G:p.A296A,GTF2H2:NM_001364573:exon14:c.A720G:p.A240A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	GTF2H2:uc011crt.2:exon12:c.A717G:p.A239A,GTF2H2:uc003kav.4:exon13:c.A888G:p.A296A,GTF2H2:uc003kau.4:exon14:c.A888G:p.A296A	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601748	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	.	hom
5	74877266	74877266	C	T	POLK	exonic	synonymous SNV	ENSG00000122008	rs3213801	ENSG00000122008:ENST00000503479:exon6:c.C729T:p.A243A,ENSG00000122008:ENST00000504026:exon6:c.C927T:p.A309A,ENSG00000122008:ENST00000508526:exon6:c.C927T:p.A309A,ENSG00000122008:ENST00000509126:exon6:c.C927T:p.A309A,ENSG00000122008:ENST00000514141:exon6:c.C927T:p.A309A,ENSG00000122008:ENST00000515295:exon6:c.C927T:p.A309A,ENSG00000122008:ENST00000241436:exon7:c.C927T:p.A309A,ENSG00000122008:ENST00000352007:exon7:c.C927T:p.A309A,ENSG00000122008:ENST00000380481:exon7:c.C657T:p.A219A,ENSG00000122008:ENST00000510815:exon7:c.C657T:p.A219A	POLK:NM_001345921:exon6:c.C729T:p.A243A,POLK:NM_016218:exon7:c.C927T:p.A309A,POLK:NM_001345922:exon8:c.C657T:p.A219A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2432	0.2123	0.270966	0.2257	.	.	.	.	.	.	.	.	POLK:uc003kea.3:exon6:c.C927T:p.A309A,POLK:uc003keb.3:exon6:c.C927T:p.A309A,POLK:uc003kee.3:exon6:c.C927T:p.A309A,POLK:uc010izq.3:exon6:c.C927T:p.A309A,POLK:uc003kdw.3:exon7:c.C927T:p.A309A,POLK:uc003kec.3:exon7:c.C657T:p.A219A,POLK:uc003ked.3:exon7:c.C657T:p.A219A	.	AFR:0.2182,AMR:0.1551,EAS:0.3205,FIN:0.2486,NFE:0.2167,OTH:0.2403,ASJ:0.2667	605650	.	.	.	~ko03460 Fanconi anemia pathway~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	MU19724719	het
5	79950700	79950717	GCAGCGGCTGCAGCGGCC	-	MSH3	exonic	nonframeshift deletion	ENSG00000113318	rs201874762	ENSG00000113318:ENST00000265081:exon1:c.154_171del:p.52_57del	MSH3:NM_002439:exon1:c.154_171del:p.52_57del	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2405	0.2791	.	0.2574	.	.	.	.	.	.	.	.	MSH3:uc003kgz.4:exon1:c.154_171del:p.52_57del,DHFR:uc011ctl.2:exon1:c.66_83del:p.22_28del	.	AFR:0.3122,AMR:0.1571,EAS:0.0527,FIN:0.2330,NFE:0.2613,OTH:0.2539,ASJ:0.2972	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	.	.	.	.	5	MU1663839	het
5	79950742	79950750	CCCCCAGCT	-	MSH3	exonic	nonframeshift deletion	ENSG00000113318	rs144629981	ENSG00000113318:ENST00000265081:exon1:c.196_204del:p.66_68del	MSH3:NM_002439:exon1:c.196_204del:p.66_68del	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.4142	0.3096	0.234425	0.2455	.	.	.	.	.	.	.	.	MSH3:uc003kgz.4:exon1:c.196_204del:p.66_68del,DHFR:uc011ctl.2:exon1:c.33_41del:p.11_14del	.	AFR:0.2850,AMR:0.1509,EAS:0.0511,FIN:0.2243,NFE:0.2537,OTH:0.2426,ASJ:0.2891	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	.	.	.	.	5	.	het
5	79950781	79950781	A	G	MSH3	exonic	nonsynonymous SNV	ENSG00000113318	rs1650697	ENSG00000113318:ENST00000265081:exon1:c.A235G:p.I79V	MSH3:NM_002439:exon1:c.A235G:p.I79V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.9029	.	0.76857	MU4555167	-2.211	0.001	1.0	-4.46	0.000	0.0025	0.082	.	MSH3:uc003kgz.4:exon1:c.A235G:p.I79V,DHFR:uc011ctl.2:exon1:c.T2C:p.M1T	-1.021	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.7888,EAS:0.7488,FIN:0.7417,NFE:0.6673,OTH:0.7326,ASJ:0.9090	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	0.0	-2.04	0.000	-1.1	5	1(thyroid)	0.7527
5	79960955	79960955	G	A	MSH3	intronic	.	ENSG00000113318	rs1382543	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2654	0.3045	0.249401	0.2645	.	.	.	.	.	0.0005	0.016	.	.	.	AFR:0.3377,AMR:0.1587,EAS:0.0512,FIN:0.2316,NFE:0.2586,OTH:0.2531,ASJ:0.2980	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	5	.	het
5	80149981	80149981	A	G	MSH3	exonic	nonsynonymous SNV	ENSG00000113318	rs184967	ENSG00000113318:ENST00000265081:exon21:c.A2846G:p.Q949R	MSH3:NM_002439:exon21:c.A2846G:p.Q949R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.8731	0.8552	0.902157	MU4549212	0.224	4.933	1.0	0.287	0.991	.	.	DNA mismatch repair protein MutS, C-terminal|P-loop containing nucleoside triphosphate hydrolase	MSH3:uc003kgz.4:exon21:c.A2846G:p.Q949R	-0.948	AFR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,AMR:0.8711,EAS:0.9189,FIN:0.8067,NFE:1,OTH:0.8713,ASJ:0.8881	600887	608089;617100;	.	.	~ko01524 Platinum drug resistance~ko03430 Mismatch repair~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	,7597	.	.	0.0	-1.93	0.000	-0.32	5	42(large_intestine)	0.8461
5	86649044	86649044	C	T	RASA1	exonic	nonsynonymous SNV	ENSG00000145715	rs532587037	ENSG00000145715:ENST00000274376:exon9:c.C1324T:p.P442S,ENSG00000145715:ENST00000456692:exon9:c.C793T:p.P265S,ENSG00000145715:ENST00000515800:exon9:c.C1324T:p.P442S,ENSG00000145715:ENST00000506290:exon10:c.C826T:p.P276S,ENSG00000145715:ENST00000512763:exon10:c.C823T:p.P275S	RASA1:NM_002890:exon9:c.C1324T:p.P442S,RASA1:NM_022650:exon9:c.C793T:p.P265S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0001	.	0.000199681	.	3.227	22.8	0.116	6.01	1.000	.	.	SH2 domain	RASA1:uc003kiw.3:exon9:c.C1324T:p.P442S,RASA1:uc003kix.3:exon9:c.C793T:p.P265S,RASA1:uc010jaw.3:exon9:c.C790T:p.P264S,RASA1:uc011ctv.2:exon10:c.C823T:p.P275S,RASA1:uc011ctw.2:exon10:c.C826T:p.P276S	-0.588	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	139150	605462;608354;608355;	2346;90307;137667;	2346|Klippel-Trnaunay-Weber syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Childhood<br>Adolescent|149000 608355 ~90307|-|-|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|608355 ~137667|CM-AVM|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|608354 ~	.	.	.	.	0.0	-1.63	0.372	-0.06	5	.	het
5	98192165	98192167	AGG	-	CHD1	exonic	nonframeshift deletion	ENSG00000153922	rs138635992	ENSG00000153922:ENST00000284049:exon35:c.5050_5052del:p.1684_1684del	CHD1:NM_001270:exon35:c.5050_5052del:p.1684_1684del,CHD1:NM_001364113:exon37:c.5314_5316del:p.1772_1772del	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.2221	0.2945	0.21266	0.2448	.	.	.	.	.	.	.	.	CHD1:uc010jbn.3:exon10:c.1228_1230del:p.410_410del,CHD1:uc003knf.3:exon35:c.5050_5052del:p.1684_1684del	.	AFR:0.3372,AMR:0.1607,EAS:0.0389,FIN:0.1507,NFE:0.2403,OTH:0.2045,ASJ:0.3609	602118	.	.	.	.	,2048	.	.	.	.	.	.	5	MU615432	het
5	98199204	98199204	C	T	CHD1	exonic	synonymous SNV	ENSG00000153922	rs161941	ENSG00000153922:ENST00000505657:exon2:c.G222A:p.E74E,ENSG00000153922:ENST00000284049:exon31:c.G4335A:p.E1445E	CHD1:NM_001270:exon31:c.G4335A:p.E1445E,CHD1:NM_001364113:exon33:c.G4599A:p.E1533E	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.2545	0.3719	0.296326	0.3149	.	.	.	.	.	.	.	.	CHD1:uc010jbn.3:exon6:c.G513A:p.E171E,CHD1:uc003knf.3:exon31:c.G4335A:p.E1445E	.	AFR:0.5512,AMR:0.1746,EAS:0.0389,FIN:0.1543,NFE:0.2568,OTH:0.2335,ASJ:0.3675	602118	.	.	.	.	,2048	.	.	.	.	.	.	5	MU12415828	het
5	98229104	98229104	T	C	CHD1	intronic	.	ENSG00000153922	rs17166428	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0809	0.1389	0.115615	0.1244	.	.	.	.	.	.	.	.	.	.	AFR:0.2823,AMR:0.0407,EAS:0.0254,FIN:0.0547,NFE:0.0693,OTH:0.0695,ASJ:0.0464	602118	.	.	.	.	.	.	.	.	.	.	.	5	MU14585752	het
5	112162854	112162854	T	C	APC	exonic	synonymous SNV	ENSG00000134982	rs2229992	ENSG00000134982:ENST00000504915:exon3:c.T147C:p.Y49Y,ENSG00000134982:ENST00000507379:exon10:c.T1404C:p.Y468Y,ENSG00000134982:ENST00000257430:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000457016:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000512211:exon12:c.T1458C:p.Y486Y,ENSG00000134982:ENST00000508376:exon13:c.T1458C:p.Y486Y	APC:NM_001127511:exon10:c.T1404C:p.Y468Y,APC:NM_001354897:exon11:c.T1488C:p.Y496Y,APC:NM_001354899:exon11:c.T1374C:p.Y458Y,APC:NM_001354901:exon11:c.T1281C:p.Y427Y,APC:NM_001354902:exon11:c.T1185C:p.Y395Y,APC:NM_001354905:exon11:c.T978C:p.Y326Y,APC:NM_000038:exon12:c.T1458C:p.Y486Y,APC:NM_001354895:exon12:c.T1458C:p.Y486Y,APC:NM_001354898:exon12:c.T1383C:p.Y461Y,APC:NM_001354900:exon12:c.T1335C:p.Y445Y,APC:NM_001354903:exon12:c.T1155C:p.Y385Y,APC:NM_001354904:exon12:c.T1080C:p.Y360Y,APC:NM_001127510:exon13:c.T1458C:p.Y486Y,APC:NM_001354896:exon13:c.T1512C:p.Y504Y,APC:NM_001354906:exon13:c.T609C:p.Y203Y	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5780	0.4622	0.509984	0.4692	.	.	.	.	.	.	.	.	APC:uc011cvt.2:exon10:c.T1404C:p.Y468Y,APC:uc003kpy.4:exon12:c.T1458C:p.Y486Y,APC:uc003kpz.4:exon13:c.T1458C:p.Y486Y,APC:uc010jbz.3:exon13:c.T609C:p.Y203Y	.	AFR:0.2085,AMR:0.6579,EAS:0.6538,FIN:0.5003,NFE:0.5762,OTH:0.5430,ASJ:0.5894	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	737,743,740,,745,739,738,742	.	,741	.	.	.	.	5	MU151723	hom
5	112164561	112164561	G	A	APC	exonic	synonymous SNV	ENSG00000134982;ENSG00000258864	rs351771	ENSG00000134982:ENST00000504915:exon5:c.G324A:p.A108A,ENSG00000134982:ENST00000507379:exon12:c.G1581A:p.A527A,ENSG00000134982:ENST00000257430:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000457016:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000512211:exon14:c.G1635A:p.A545A,ENSG00000134982:ENST00000508376:exon15:c.G1635A:p.A545A	APC:NM_001127511:exon12:c.G1581A:p.A527A,APC:NM_001354897:exon13:c.G1665A:p.A555A,APC:NM_001354899:exon13:c.G1551A:p.A517A,APC:NM_001354901:exon13:c.G1458A:p.A486A,APC:NM_001354902:exon13:c.G1362A:p.A454A,APC:NM_001354905:exon13:c.G1155A:p.A385A,APC:NM_000038:exon14:c.G1635A:p.A545A,APC:NM_001354895:exon14:c.G1635A:p.A545A,APC:NM_001354898:exon14:c.G1560A:p.A520A,APC:NM_001354900:exon14:c.G1512A:p.A504A,APC:NM_001354903:exon14:c.G1332A:p.A444A,APC:NM_001354904:exon14:c.G1257A:p.A419A,APC:NM_001127510:exon15:c.G1635A:p.A545A,APC:NM_001354896:exon15:c.G1689A:p.A563A,APC:NM_001354906:exon15:c.G786A:p.A262A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6481	0.5864	0.666134	0.5927	.	.	.	.	.	.	.	.	APC:uc011cvt.2:exon12:c.G1581A:p.A527A,APC:uc003kpy.4:exon14:c.G1635A:p.A545A,APC:uc003kpz.4:exon15:c.G1635A:p.A545A,APC:uc010jbz.3:exon15:c.G786A:p.A262A	.	AFR:0.5342,AMR:0.6926,EAS:0.8064,FIN:0.5564,NFE:0.6048,OTH:0.6212,ASJ:0.5894	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	737,743,740,,745,739,738,742	.	,741	.	.	.	.	5	MU151734	hom
5	112175770	112175770	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs41115	ENSG00000134982:ENST00000257430:exon16:c.G4479A:p.T1493T,ENSG00000134982:ENST00000457016:exon16:c.G4479A:p.T1493T,ENSG00000134982:ENST00000508376:exon17:c.G4479A:p.T1493T	APC:NM_001127511:exon14:c.G4425A:p.T1475T,APC:NM_001354897:exon15:c.G4509A:p.T1503T,APC:NM_001354899:exon15:c.G4395A:p.T1465T,APC:NM_001354901:exon15:c.G4302A:p.T1434T,APC:NM_001354902:exon15:c.G4206A:p.T1402T,APC:NM_001354905:exon15:c.G3999A:p.T1333T,APC:NM_000038:exon16:c.G4479A:p.T1493T,APC:NM_001354895:exon16:c.G4479A:p.T1493T,APC:NM_001354898:exon16:c.G4404A:p.T1468T,APC:NM_001354900:exon16:c.G4356A:p.T1452T,APC:NM_001354903:exon16:c.G4176A:p.T1392T,APC:NM_001354904:exon16:c.G4101A:p.T1367T,APC:NM_001127510:exon17:c.G4479A:p.T1493T,APC:NM_001354896:exon17:c.G4533A:p.T1511T,APC:NM_001354906:exon17:c.G3630A:p.T1210T	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6486	0.5862	0.665535	0.5933	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G2379A:p.T793T,APC:uc011cvt.2:exon14:c.G4425A:p.T1475T,APC:uc003kpy.4:exon16:c.G4479A:p.T1493T,APC:uc003kpz.4:exon17:c.G4479A:p.T1493T,APC:uc010jbz.3:exon17:c.G3630A:p.T1210T	.	AFR:0.5356,AMR:0.6918,EAS:0.8082,FIN:0.5563,NFE:0.6050,OTH:0.6209,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	737,743,740,,745,739,738,742	.	,741	.	.	.	.	5	MU62815	hom
5	112176325	112176325	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs42427	ENSG00000134982:ENST00000257430:exon16:c.G5034A:p.G1678G,ENSG00000134982:ENST00000457016:exon16:c.G5034A:p.G1678G,ENSG00000134982:ENST00000508376:exon17:c.G5034A:p.G1678G	APC:NM_001127511:exon14:c.G4980A:p.G1660G,APC:NM_001354897:exon15:c.G5064A:p.G1688G,APC:NM_001354899:exon15:c.G4950A:p.G1650G,APC:NM_001354901:exon15:c.G4857A:p.G1619G,APC:NM_001354902:exon15:c.G4761A:p.G1587G,APC:NM_001354905:exon15:c.G4554A:p.G1518G,APC:NM_000038:exon16:c.G5034A:p.G1678G,APC:NM_001354895:exon16:c.G5034A:p.G1678G,APC:NM_001354898:exon16:c.G4959A:p.G1653G,APC:NM_001354900:exon16:c.G4911A:p.G1637G,APC:NM_001354903:exon16:c.G4731A:p.G1577G,APC:NM_001354904:exon16:c.G4656A:p.G1552G,APC:NM_001127510:exon17:c.G5034A:p.G1678G,APC:NM_001354896:exon17:c.G5088A:p.G1696G,APC:NM_001354906:exon17:c.G4185A:p.G1395G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6514	0.5901	0.666733	0.5956	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G2934A:p.G978G,APC:uc011cvt.2:exon14:c.G4980A:p.G1660G,APC:uc003kpy.4:exon16:c.G5034A:p.G1678G,APC:uc003kpz.4:exon17:c.G5034A:p.G1678G,APC:uc010jbz.3:exon17:c.G4185A:p.G1395G	.	AFR:0.5373,AMR:0.6950,EAS:0.8068,FIN:0.5573,NFE:0.6082,OTH:0.6255,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	737,743,740,,745,739,738,742	.	,741	.	.	.	.	5	MU62789	hom
5	112176559	112176559	T	G	APC	exonic	synonymous SNV	ENSG00000134982	rs866006	ENSG00000134982:ENST00000257430:exon16:c.T5268G:p.S1756S,ENSG00000134982:ENST00000457016:exon16:c.T5268G:p.S1756S,ENSG00000134982:ENST00000508376:exon17:c.T5268G:p.S1756S	APC:NM_001127511:exon14:c.T5214G:p.S1738S,APC:NM_001354897:exon15:c.T5298G:p.S1766S,APC:NM_001354899:exon15:c.T5184G:p.S1728S,APC:NM_001354901:exon15:c.T5091G:p.S1697S,APC:NM_001354902:exon15:c.T4995G:p.S1665S,APC:NM_001354905:exon15:c.T4788G:p.S1596S,APC:NM_000038:exon16:c.T5268G:p.S1756S,APC:NM_001354895:exon16:c.T5268G:p.S1756S,APC:NM_001354898:exon16:c.T5193G:p.S1731S,APC:NM_001354900:exon16:c.T5145G:p.S1715S,APC:NM_001354903:exon16:c.T4965G:p.S1655S,APC:NM_001354904:exon16:c.T4890G:p.S1630S,APC:NM_001127510:exon17:c.T5268G:p.S1756S,APC:NM_001354896:exon17:c.T5322G:p.S1774S,APC:NM_001354906:exon17:c.T4419G:p.S1473S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6508	0.5880	0.666933	0.5942	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.T3168G:p.S1056S,APC:uc011cvt.2:exon14:c.T5214G:p.S1738S,APC:uc003kpy.4:exon16:c.T5268G:p.S1756S,APC:uc003kpz.4:exon17:c.T5268G:p.S1756S,APC:uc010jbz.3:exon17:c.T4419G:p.S1473S	.	AFR:0.5361,AMR:0.6933,EAS:0.8055,FIN:0.5574,NFE:0.6065,OTH:0.6214,ASJ:0.5993	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	737,743,740,,745,739,738,742	.	,741	.	.	.	.	5	MU18515471	hom
5	112176756	112176756	T	A	APC	exonic	nonsynonymous SNV	ENSG00000134982	rs459552	ENSG00000134982:ENST00000257430:exon16:c.T5465A:p.V1822D,ENSG00000134982:ENST00000457016:exon16:c.T5465A:p.V1822D,ENSG00000134982:ENST00000508376:exon17:c.T5465A:p.V1822D	APC:NM_001127511:exon14:c.T5411A:p.V1804D,APC:NM_001354897:exon15:c.T5495A:p.V1832D,APC:NM_001354899:exon15:c.T5381A:p.V1794D,APC:NM_001354901:exon15:c.T5288A:p.V1763D,APC:NM_001354902:exon15:c.T5192A:p.V1731D,APC:NM_001354905:exon15:c.T4985A:p.V1662D,APC:NM_000038:exon16:c.T5465A:p.V1822D,APC:NM_001354895:exon16:c.T5465A:p.V1822D,APC:NM_001354898:exon16:c.T5390A:p.V1797D,APC:NM_001354900:exon16:c.T5342A:p.V1781D,APC:NM_001354903:exon16:c.T5162A:p.V1721D,APC:NM_001354904:exon16:c.T5087A:p.V1696D,APC:NM_001127510:exon17:c.T5465A:p.V1822D,APC:NM_001354896:exon17:c.T5519A:p.V1840D,APC:NM_001354906:exon17:c.T4616A:p.V1539D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.7981	0.8263	0.865415	0.8113	1.486	13.24	0.672	3.59	0.991	.	.	.	APC:uc010jca.3:exon3:c.T3365A:p.V1122D,APC:uc011cvt.2:exon14:c.T5411A:p.V1804D,APC:uc003kpy.4:exon16:c.T5465A:p.V1822D,APC:uc003kpz.4:exon17:c.T5465A:p.V1822D,APC:uc010jbz.3:exon17:c.T4616A:p.V1539D	-0.947	AFR:0.9616,AMR:0.8062,EAS:0.8937,FIN:0.6910,NFE:0.7465,OTH:0.7719,ASJ:0.7767	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	698,737,740,743,,745,739,738,742	.	,741	0.0	-2.3	0.000	-0.895	5	MU151742	hom
5	112177171	112177171	G	A	APC	exonic	synonymous SNV	ENSG00000134982	rs465899	ENSG00000134982:ENST00000257430:exon16:c.G5880A:p.P1960P,ENSG00000134982:ENST00000457016:exon16:c.G5880A:p.P1960P,ENSG00000134982:ENST00000508376:exon17:c.G5880A:p.P1960P	APC:NM_001127511:exon14:c.G5826A:p.P1942P,APC:NM_001354897:exon15:c.G5910A:p.P1970P,APC:NM_001354899:exon15:c.G5796A:p.P1932P,APC:NM_001354901:exon15:c.G5703A:p.P1901P,APC:NM_001354902:exon15:c.G5607A:p.P1869P,APC:NM_001354905:exon15:c.G5400A:p.P1800P,APC:NM_000038:exon16:c.G5880A:p.P1960P,APC:NM_001354895:exon16:c.G5880A:p.P1960P,APC:NM_001354898:exon16:c.G5805A:p.P1935P,APC:NM_001354900:exon16:c.G5757A:p.P1919P,APC:NM_001354903:exon16:c.G5577A:p.P1859P,APC:NM_001354904:exon16:c.G5502A:p.P1834P,APC:NM_001127510:exon17:c.G5880A:p.P1960P,APC:NM_001354896:exon17:c.G5934A:p.P1978P,APC:NM_001354906:exon17:c.G5031A:p.P1677P	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6488	0.5869	0.666534	0.5952	.	.	.	.	.	.	.	.	APC:uc010jca.3:exon3:c.G3780A:p.P1260P,APC:uc011cvt.2:exon14:c.G5826A:p.P1942P,APC:uc003kpy.4:exon16:c.G5880A:p.P1960P,APC:uc003kpz.4:exon17:c.G5880A:p.P1960P,APC:uc010jbz.3:exon17:c.G5031A:p.P1677P	.	AFR:0.5409,AMR:0.6938,EAS:0.8097,FIN:0.5564,NFE:0.6055,OTH:0.6224,ASJ:0.5927	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	737,743,740,,745,739,738,742	.	,741	.	.	.	.	5	MU62778	hom
5	121411217	121411217	C	T	LOX	exonic	nonsynonymous SNV	ENSG00000113083	rs575190694	ENSG00000113083:ENST00000508067:exon2:c.G138A:p.M46I,ENSG00000113083:ENST00000231004:exon3:c.G760A:p.V254I	LOX:NM_001178102:exon2:c.G70A:p.V24I,LOX:NM_002317:exon3:c.G760A:p.V254I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	8.267e-05	.	0.000599042	.	3.663	23.2	0.183	5.48	1.000	.	.	.	LOX:uc011cwk.2:exon2:c.G70A:p.V24I,LOX:uc003ksu.3:exon3:c.G760A:p.V254I	-0.891	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	153455	.	.	.	.	.	.	.	0.099	1.5	0.099	0.845	5	.	het
5	121779390	121779390	G	C	MGC32805	ncRNA_intronic	.	ENSG00000250328	rs3811879	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2689	.	0.198083	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:MU12178320,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.0727,FIN:0.2057,NFE:0.2086,OTH:0.2299,ASJ:0.2121	.	.	.	.	.	.	.	.	.	.	.	.	5	1(oesophagus)	0.3080
5	127597518	127597518	G	A	FBN2	exonic	synonymous SNV	ENSG00000138829	rs10070365	ENSG00000138829:ENST00000262464:exon64:c.C8274T:p.S2758S,ENSG00000138829:ENST00000508053:exon70:c.C8274T:p.S2758S	FBN2:NM_001999:exon64:c.C8274T:p.S2758S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1043	0.1386	0.112819	0.1328	.	.	.	.	.	.	.	.	FBN2:uc003kuu.3:exon64:c.C8274T:p.S2758S	.	AFR:0.1751,AMR:0.0823,EAS:0.0334,FIN:0.1368,NFE:0.1237,OTH:0.1115,ASJ:0.0629	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU10349839	het
5	127614472	127614472	A	G	FBN2	exonic	synonymous SNV	ENSG00000138829	rs190450	ENSG00000138829:ENST00000262464:exon57:c.T7200C:p.S2400S,ENSG00000138829:ENST00000508053:exon63:c.T7200C:p.S2400S	FBN2:NM_001999:exon57:c.T7200C:p.S2400S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7281	0.6779	0.726637	0.7155	.	.	.	.	.	.	.	.	FBN2:uc003kuu.3:exon57:c.T7200C:p.S2400S	.	AFR:0.6347,AMR:0.6766,EAS:0.8793,FIN:0.7811,NFE:0.7281,OTH:0.7694,ASJ:0.7119	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU801110	het
5	127622491	127622491	T	C	FBN2	exonic	nonsynonymous SNV	ENSG00000138829	rs32209	ENSG00000138829:ENST00000262464:exon55:c.A6931G:p.M2311V,ENSG00000138829:ENST00000508053:exon61:c.A6931G:p.M2311V	FBN2:NM_001999:exon55:c.A6931G:p.M2311V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1151	0.0978	0.232827	0.1255	1.914	15.67	0.43	5.34	1.000	.	.	EGF-like calcium-binding domain|EGF-like domain|Growth factor receptor cysteine-rich domain	FBN2:uc003kuu.3:exon55:c.A6931G:p.M2311V	-0.959	AFR:0.2166,AMR:0.0453,EAS:0.6404,FIN:0.0521,NFE:0.0441,OTH:0.0673,ASJ:0.0662	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	0.0	-2.16	0.000	-0.7	5	MU16768154	het
5	127640783	127640783	G	A	FBN2	intronic	.	ENSG00000138829	rs27713	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7258	.	0.734425	0.6851	.	.	.	.	.	0	0.034	.	.	.	AFR:0.5368,AMR:0.6599,EAS:0.8618,FIN:0.7728,NFE:0.7275,OTH:0.7669,ASJ:0.7	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	.	.	.	.	5	MU681300	het
5	127685135	127685135	C	T	FBN2	exonic	nonsynonymous SNV	ENSG00000138829	rs154001	ENSG00000138829:ENST00000508989:exon22:c.G2794A:p.V932I,ENSG00000138829:ENST00000262464:exon23:c.G2893A:p.V965I,ENSG00000138829:ENST00000508053:exon29:c.G2893A:p.V965I	FBN2:NM_001999:exon23:c.G2893A:p.V965I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7234	0.6622	0.73103	COCA-CN|5|321|0.0155763	3.009	22.3	0.331	3.32	1.000	.	.	EGF-like calcium-binding domain|EGF-like calcium-binding, conserved site|EGF-like domain|TB domain	FBN2:uc003kuv.2:exon22:c.G2794A:p.V932I,FBN2:uc003kuu.3:exon23:c.G2893A:p.V965I	-0.947	AFR:0.6947,AMR:0.6250,EAS:0.7682,FIN:0.9442,NFE:0.7234,OTH:0.6936,ASJ:0.7655	612570	121050;616118;	115;	115|Beals syndrome<br>Beals-Hecht syndrome<br>CCA syndrome<br>Distal arthrogryposis type 9|Unknown|Autosomal dominant|Neonatal|121050 ~	.	.	.	.	0.118	-3.01	0.000	-0.39	5	1(haematopoietic_and_lymphoid_tissue)	0.7357
5	131705949	131705949	T	C	SLC22A5	exonic	synonymous SNV	ENSG00000197375	rs2631365	ENSG00000197375:ENST00000245407:exon1:c.T285C:p.L95L,ENSG00000197375:ENST00000435065:exon1:c.T285C:p.L95L,ENSG00000197375:ENST00000437841:exon1:c.T285C:p.L95L	SLC22A5:NM_001308122:exon1:c.T285C:p.L95L,SLC22A5:NM_003060:exon1:c.T285C:p.L95L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4968	0.3497	0.486222	0.4225	.	.	.	.	.	.	.	.	SLC22A5:uc003kww.4:exon1:c.T285C:p.L95L,SLC22A5:uc003kwx.4:exon1:c.T285C:p.L95L	.	AFR:0.3594,AMR:0.3258,EAS:0.6584,FIN:0.5161,NFE:0.4164,OTH:0.4498,ASJ:0.3733	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU4553927	het
5	131719999	131719999	A	G	SLC22A5	intronic	.	ENSG00000197375	rs4551059	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	1	.	1	1	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU81802464	hom
5	131721174	131721174	A	G	SLC22A5	exonic	synonymous SNV	ENSG00000197375	rs274558	ENSG00000197375:ENST00000245407:exon4:c.A807G:p.L269L,ENSG00000197375:ENST00000415928:exon5:c.A576G:p.L192L,ENSG00000197375:ENST00000435065:exon5:c.A879G:p.L293L	SLC22A5:NM_003060:exon4:c.A807G:p.L269L,SLC22A5:NM_001308122:exon5:c.A879G:p.L293L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4393	0.3783	0.486222	0.4229	.	.	.	.	.	.	.	.	SLC22A5:uc003kww.4:exon4:c.A807G:p.L269L,SLC22A5:uc003kwx.4:exon5:c.A879G:p.L293L	.	AFR:0.3601,AMR:0.3225,EAS:0.6601,FIN:0.5161,NFE:0.4168,OTH:0.4509,ASJ:0.3775	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU159204	het
5	131721204	131721204	T	C	SLC22A5	intronic	.	ENSG00000197375	rs274557	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4399	0.3739	0.486022	0.4228	.	.	.	.	.	.	.	.	.	.	AFR:0.3599,AMR:0.3233,EAS:0.6611,FIN:0.5157,NFE:0.4168,OTH:0.4477,ASJ:0.3775	603377	212140;	158;	158|CDSP<br>CUD<br>Carnitine transporter defect<br>Carnitine uptake deficiency<br>Deficiency of plasma-membrane carnitine transporter<br>SPCD|-|Autosomal recessive|Infancy<br>Neonatal|212140 ~	~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	5	MU18216091	het
5	132216801	132216801	T	C	AFF4	exonic	nonsynonymous SNV	ENSG00000072364	.	ENSG00000072364:ENST00000265343:exon21:c.A3442G:p.T1148A	AFF4:NM_014423:exon21:c.A3442G:p.T1148A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 0] 	.	.	.	.	3.431	23.0	0.052	6.03	0.994	.	.	.	AFF4:uc003kyd.3:exon21:c.A3442G:p.T1148A,AFF4:uc011cxk.2:exon22:c.A2476G:p.T826A	-0.218	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	604417	616368;	444077;	444077|CHOPS syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|616368 ~	.	.	.	.	0.992	-0.1	0.437	2.205	5	.	het
5	132232315	132232315	G	A	AFF4	exonic	synonymous SNV	ENSG00000072364	rs739863	ENSG00000072364:ENST00000265343:exon11:c.C2007T:p.P669P,ENSG00000072364:ENST00000378595:exon11:c.C2007T:p.P669P	AFF4:NM_014423:exon11:c.C2007T:p.P669P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1451	0.1177	0.105232	0.1139	.	.	.	.	.	.	.	.	AFF4:uc003kyd.3:exon11:c.C2007T:p.P669P,AFF4:uc003kye.1:exon11:c.C2007T:p.P669P,AFF4:uc011cxk.2:exon12:c.C1041T:p.P347P	.	AFR:0.0362,AMR:0.0718,EAS:0.1154,FIN:0.1268,NFE:0.1556,OTH:0.1489,ASJ:0.1358	604417	616368;	444077;	444077|CHOPS syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|616368 ~	.	.	.	.	.	.	.	.	5	MU12197476	het
5	132267850	132267850	-	T	AFF4	intronic	.	ENSG00000072364	rs397826144	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1731	0.0684	.	0.1125	.	.	.	.	.	.	.	.	.	.	AFR:0.0361,AMR:0.0723,EAS:0.1120,FIN:0.1248,NFE:0.1538,OTH:0.1458,ASJ:0.1358	604417	616368;	444077;	444077|CHOPS syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|616368 ~	.	.	.	.	.	.	.	.	5	.	unknown
5	132267859	132267859	A	T	AFF4	intronic	.	ENSG00000072364	rs56157864	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1643	.	0.105232	0.1132	.	.	.	.	.	.	.	.	.	.	AFR:0.0363,AMR:0.0718,EAS:0.1123,FIN:0.1262,NFE:0.1548,OTH:0.1468,ASJ:0.1358	604417	616368;	444077;	444077|CHOPS syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal|616368 ~	.	.	.	.	.	.	.	.	5	MU12197505	unknown
5	135382989	135382989	G	C	TGFBI	exonic	synonymous SNV	ENSG00000120708	rs1442	ENSG00000120708:ENST00000305126:exon6:c.G651C:p.L217L,ENSG00000120708:ENST00000442011:exon6:c.G651C:p.L217L	TGFBI:NM_000358:exon6:c.G651C:p.L217L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4270	0.3435	0.317692	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TGFBI:uc011cyb.2:exon2:c.G129C:p.L43L,TGFBI:uc003lbf.4:exon6:c.G651C:p.L217L,TGFBI:uc003lbh.4:exon6:c.G129C:p.L43L	.	AFR:0.3583,AMR:0.0891,EAS:0.3709,FIN:0.3807,NFE:0.4891,OTH:0.4709,ASJ:0.4582	601692	121820;121900;122200;602082;607541;608470;608471;	98964;98961;98963;98960;98964;98962;98956;	98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98961|Anterior limiting membrane dystrophy type I<br>Atypical granular corneal dystrophy<br>Corneal dystrophy of Bowman layer type I<br>Geographic corneal dystrophy<br>Granular corneal dystrophy type 3<br>Granular corneal dystrophy type III<br>RBCD<br>Superficial granular corneal dystrophy|<1 / 1 000 000|Autosomal dominant|Childhood|608470 ~98963|Avellino corneal dystrophy<br>GCD2<br>GCDII<br>Granular corneal dystrophy type 2<br>Granular-lattice corneal dystrophy|Unknown|Autosomal dominant|Childhood|607541 ~98960|Anterior limiting membrane dystrophy type II<br>Corneal dystrophy of Bowman layer type II<br>Curly fiber corneal dystrophy<br>Honeycomb corneal dystrophy<br>TBCD<br>Waardenburg-Jonker corneal dystrophy|Unknown|Autosomal dominant|Adolescent<br>Childhood<br>Adult|602082 ~98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98962|Classic GCD<br>Classic granular corneal dystrophy<br>Corneal dystrophy Groenouw type I<br>GCD1<br>GCDI<br>Granular corneal dystrophy type 1|Unknown|Autosomal dominant|Childhood|121900 ~98956|-|-|Autosomal dominant|-|121820 ~	.	.	.	.	.	.	.	.	5	3(lung)	0.4418
5	135388663	135388663	A	G	TGFBI	exonic	synonymous SNV	ENSG00000120708	rs1054124	ENSG00000120708:ENST00000604555:exon3:c.A213G:p.V71V,ENSG00000120708:ENST00000305126:exon8:c.A981G:p.V327V,ENSG00000120708:ENST00000442011:exon8:c.A981G:p.V327V	TGFBI:NM_000358:exon8:c.A981G:p.V327V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3213	0.3455	0.387181	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	TGFBI:uc011cyb.2:exon4:c.A459G:p.V153V,TGFBI:uc003lbf.4:exon8:c.A981G:p.V327V,TGFBI:uc003lbg.4:exon8:c.A180G:p.V60V,TGFBI:uc003lbh.4:exon8:c.A459G:p.V153V	.	AFR:MU666509,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.5159,FIN:0.3508,NFE:0.3146,OTH:0.3163,ASJ:0.3568	601692	121820;121900;122200;602082;607541;608470;608471;	98964;98961;98963;98960;98964;98962;98956;	98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98961|Anterior limiting membrane dystrophy type I<br>Atypical granular corneal dystrophy<br>Corneal dystrophy of Bowman layer type I<br>Geographic corneal dystrophy<br>Granular corneal dystrophy type 3<br>Granular corneal dystrophy type III<br>RBCD<br>Superficial granular corneal dystrophy|<1 / 1 000 000|Autosomal dominant|Childhood|608470 ~98963|Avellino corneal dystrophy<br>GCD2<br>GCDII<br>Granular corneal dystrophy type 2<br>Granular-lattice corneal dystrophy|Unknown|Autosomal dominant|Childhood|607541 ~98960|Anterior limiting membrane dystrophy type II<br>Corneal dystrophy of Bowman layer type II<br>Curly fiber corneal dystrophy<br>Honeycomb corneal dystrophy<br>TBCD<br>Waardenburg-Jonker corneal dystrophy|Unknown|Autosomal dominant|Adolescent<br>Childhood<br>Adult|602082 ~98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98962|Classic GCD<br>Classic granular corneal dystrophy<br>Corneal dystrophy Groenouw type I<br>GCD1<br>GCDI<br>Granular corneal dystrophy type 1|Unknown|Autosomal dominant|Childhood|121900 ~98956|-|-|Autosomal dominant|-|121820 ~	.	.	.	.	.	.	.	.	5	1(thyroid)	0.2851
5	135391374	135391374	C	T	TGFBI	exonic	synonymous SNV	ENSG00000120708	rs1133170	ENSG00000120708:ENST00000305126:exon11:c.C1416T:p.L472L,ENSG00000120708:ENST00000442011:exon11:c.C1416T:p.L472L	TGFBI:NM_000358:exon11:c.C1416T:p.L472L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2787	0.2800	0.280152	LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	TGFBI:uc011cyb.2:exon7:c.C894T:p.L298L,TGFBI:uc003lbf.4:exon11:c.C1416T:p.L472L,TGFBI:uc003lbg.4:exon11:c.C615T:p.L205L,TGFBI:uc003lbh.4:exon11:c.C894T:p.L298L	.	AFR:0.2857,AMR:0.3084,EAS:0.3146,FIN:0.2148,NFE:0.2719,OTH:0.2863,ASJ:0.2122	601692	121820;121900;122200;602082;607541;608470;608471;	98964;98961;98963;98960;98964;98962;98956;	98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98961|Anterior limiting membrane dystrophy type I<br>Atypical granular corneal dystrophy<br>Corneal dystrophy of Bowman layer type I<br>Geographic corneal dystrophy<br>Granular corneal dystrophy type 3<br>Granular corneal dystrophy type III<br>RBCD<br>Superficial granular corneal dystrophy|<1 / 1 000 000|Autosomal dominant|Childhood|608470 ~98963|Avellino corneal dystrophy<br>GCD2<br>GCDII<br>Granular corneal dystrophy type 2<br>Granular-lattice corneal dystrophy|Unknown|Autosomal dominant|Childhood|607541 ~98960|Anterior limiting membrane dystrophy type II<br>Corneal dystrophy of Bowman layer type II<br>Curly fiber corneal dystrophy<br>Honeycomb corneal dystrophy<br>TBCD<br>Waardenburg-Jonker corneal dystrophy|Unknown|Autosomal dominant|Adolescent<br>Childhood<br>Adult|602082 ~98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98962|Classic GCD<br>Classic granular corneal dystrophy<br>Corneal dystrophy Groenouw type I<br>GCD1<br>GCDI<br>Granular corneal dystrophy type 1|Unknown|Autosomal dominant|Childhood|121900 ~98956|-|-|Autosomal dominant|-|121820 ~	.	.	.	.	.	.	.	.	5	1(breast)	0.2929
5	135392426	135392426	T	C	TGFBI	exonic	synonymous SNV	ENSG00000120708	rs4669	ENSG00000120708:ENST00000305126:exon12:c.T1620C:p.F540F,ENSG00000120708:ENST00000442011:exon12:c.T1620C:p.F540F	TGFBI:NM_000358:exon12:c.T1620C:p.F540F	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3312	0.3756	0.420527	LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	TGFBI:uc011cyb.2:exon8:c.T1098C:p.F366F,TGFBI:uc003lbf.4:exon12:c.T1620C:p.F540F,TGFBI:uc003lbg.4:exon12:c.T819C:p.F273F,TGFBI:uc003lbh.4:exon12:c.T1098C:p.F366F	.	AFR:0.3872,AMR:0.6255,EAS:0.3146,FIN:0.3139,NFE:0.2851,OTH:0.2876,ASJ:0.3532	601692	121820;121900;122200;602082;607541;608470;608471;	98964;98961;98963;98960;98964;98962;98956;	98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98961|Anterior limiting membrane dystrophy type I<br>Atypical granular corneal dystrophy<br>Corneal dystrophy of Bowman layer type I<br>Geographic corneal dystrophy<br>Granular corneal dystrophy type 3<br>Granular corneal dystrophy type III<br>RBCD<br>Superficial granular corneal dystrophy|<1 / 1 000 000|Autosomal dominant|Childhood|608470 ~98963|Avellino corneal dystrophy<br>GCD2<br>GCDII<br>Granular corneal dystrophy type 2<br>Granular-lattice corneal dystrophy|Unknown|Autosomal dominant|Childhood|607541 ~98960|Anterior limiting membrane dystrophy type II<br>Corneal dystrophy of Bowman layer type II<br>Curly fiber corneal dystrophy<br>Honeycomb corneal dystrophy<br>TBCD<br>Waardenburg-Jonker corneal dystrophy|Unknown|Autosomal dominant|Adolescent<br>Childhood<br>Adult|602082 ~98964|Biber-Haab-Dimmer dystrophy<br>Classic lattice corneal dystrophy<br>LCD1<br>LCDI<br>Lattice corneal dystrophy type 1|Unknown|Autosomal dominant|All ages|122200 608471 ~98962|Classic GCD<br>Classic granular corneal dystrophy<br>Corneal dystrophy Groenouw type I<br>GCD1<br>GCDI<br>Granular corneal dystrophy type 1|Unknown|Autosomal dominant|Childhood|121900 ~98956|-|-|Autosomal dominant|-|121820 ~	.	.	.	.	.	.	.	.	5	1(lung)	0.3316
5	137708434	137708434	C	T	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs4835678	ENSG00000120733:ENST00000510866:exon1:c.C72T:p.I24I,ENSG00000120733:ENST00000314358:exon2:c.C264T:p.I88I	KDM3B:NM_016604:exon2:c.C264T:p.I88I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6376	0.5804	0.67492	0.5873	.	.	.	.	.	.	.	.	KDM3B:uc003lcy.1:exon2:c.C264T:p.I88I	.	AFR:0.5556,AMR:0.7237,EAS:0.8572,FIN:0.5458,NFE:0.5802,OTH:0.55,ASJ:0.6225	609373	.	.	.	.	.	.	.	.	.	.	.	5	MU16771788	hom
5	137717213	137717213	G	A	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs10073922	ENSG00000120733:ENST00000510866:exon5:c.G522A:p.E174E,ENSG00000120733:ENST00000314358:exon6:c.G714A:p.E238E	KDM3B:NM_016604:exon6:c.G714A:p.E238E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3497	0.2958	0.290735	0.2882	.	.	.	.	.	.	.	.	KDM3B:uc003lcy.1:exon6:c.G714A:p.E238E	.	AFR:0.1523,AMR:0.3962,EAS:0.2704,FIN:0.3093,NFE:0.3568,OTH:0.3088,ASJ:0.2947	609373	.	.	.	.	.	.	.	.	.	.	.	5	MU586785	het
5	137717265	137717265	G	A	KDM3B	exonic	nonsynonymous SNV	ENSG00000120733	rs6865472	ENSG00000120733:ENST00000510866:exon5:c.G574A:p.A192T,ENSG00000120733:ENST00000314358:exon6:c.G766A:p.A256T	KDM3B:NM_016604:exon6:c.G766A:p.A256T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9951	0.9823	0.978435	0.9828	-0.332	0.561	0.773	-2.75	0.029	.	.	.	KDM3B:uc003lcy.1:exon6:c.G766A:p.A256T	-1.016	AFR:0.9396,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	609373	.	.	.	.	.	.	.	0.0	0.15	0.000	0.69	5	MU81803283	hom
5	137727169	137727169	G	T	KDM3B	exonic	nonsynonymous SNV	ENSG00000120733	rs34608821	ENSG00000120733:ENST00000394866:exon3:c.G816T:p.E272D,ENSG00000120733:ENST00000314358:exon8:c.G1848T:p.E616D	KDM3B:NM_016604:exon8:c.G1848T:p.E616D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0036	0.0035	0.00159744	0.0023	-0.536	0.179	0.408	-0.02	0.998	.	.	.	KDM3B:uc003lcy.1:exon8:c.G1848T:p.E616D,KDM3B:uc010jew.1:exon8:c.G816T:p.E272D	-1.113	AFR:0.0006,AMR:0.0012,EAS:0,FIN:0.0006,NFE:0.0036,OTH:0.0041,ASJ:0.0166	609373	.	.	.	.	.	.	.	0.002	-0.05	0.059	0	5	.	het
5	137733891	137733891	A	G	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs17294563	ENSG00000120733:ENST00000394866:exon5:c.A1824G:p.V608V,ENSG00000120733:ENST00000314358:exon10:c.A2856G:p.V952V	KDM3B:NM_016604:exon10:c.A2856G:p.V952V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1563	0.1338	0.111621	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	KDM3B:uc003lcy.1:exon10:c.A2856G:p.V952V,KDM3B:uc010jew.1:exon10:c.A1824G:p.V608V	.	AFR:0.1287,AMR:0.0348,EAS:0.1424,FIN:0.0123,NFE:0.1719,OTH:0.1851,ASJ:0.0931	609373	.	.	.	.	.	.	.	.	.	.	.	5	1(urinary_tract)	0.1673
5	137754695	137754695	T	C	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs7726234	ENSG00000120733:ENST00000542866:exon7:c.T585C:p.G195G,ENSG00000120733:ENST00000394866:exon9:c.T2457C:p.G819G,ENSG00000120733:ENST00000314358:exon14:c.T3489C:p.G1163G	KDM3B:NM_016604:exon14:c.T3489C:p.G1163G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6389	0.5840	0.678115	0.5891	.	.	.	.	.	.	.	.	KDM3B:uc011cys.1:exon7:c.T585C:p.G195G,KDM3B:uc003lcy.1:exon14:c.T3489C:p.G1163G,KDM3B:uc010jew.1:exon14:c.T2457C:p.G819G	.	AFR:0.5631,AMR:0.7237,EAS:0.8617,FIN:0.5458,NFE:0.5795,OTH:0.5482,ASJ:0.6225	609373	.	.	.	.	.	.	.	.	.	.	.	5	MU801381	hom
5	137754808	137754808	G	A	KDM3B	exonic	nonsynonymous SNV	ENSG00000120733	rs7706614	ENSG00000120733:ENST00000542866:exon7:c.G698A:p.S233N,ENSG00000120733:ENST00000394866:exon9:c.G2570A:p.S857N,ENSG00000120733:ENST00000314358:exon14:c.G3602A:p.S1201N	KDM3B:NM_016604:exon14:c.G3602A:p.S1201N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0434	0.0401	0.0597045	0.0363	1.942	15.85	0.144	5.63	1.000	.	.	.	KDM3B:uc011cys.1:exon7:c.G698A:p.S233N,KDM3B:uc003lcy.1:exon14:c.G3602A:p.S1201N,KDM3B:uc010jew.1:exon14:c.G2570A:p.S857N	-1.050	AFR:0.0556,AMR:0.0322,EAS:0.0105,FIN:0.0289,NFE:0.0301,OTH:0.0346,ASJ:0.0331	609373	.	.	.	.	.	.	.	0.001	0.03	0.016	0.6	5	.	het
5	137760048	137760048	G	A	KDM3B	intronic	.	ENSG00000120733	rs41300795	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0440	0.0405	0.0595048	0.0366	.	.	.	.	.	.	.	.	.	.	AFR:0.0565,AMR:0.0322,EAS:0.0111,FIN:0.0289,NFE:0.0299,OTH:0.0348,ASJ:0.0331	609373	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	137766066	137766066	G	A	KDM3B	exonic	synonymous SNV	ENSG00000120733	rs61749634	ENSG00000120733:ENST00000542866:exon15:c.G2118A:p.V706V,ENSG00000120733:ENST00000394866:exon17:c.G3990A:p.V1330V,ENSG00000120733:ENST00000314358:exon22:c.G5022A:p.V1674V	KDM3B:NM_016604:exon22:c.G5022A:p.V1674V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0434	0.0401	.	0.0362	.	.	.	.	.	.	.	.	KDM3B:uc011cys.1:exon15:c.G2118A:p.V706V,KDM3B:uc003lcy.1:exon22:c.G5022A:p.V1674V,KDM3B:uc010jew.1:exon22:c.G3990A:p.V1330V	.	AFR:0.0554,AMR:0.0322,EAS:0.0111,FIN:0.0289,NFE:0.0299,OTH:0.0348,ASJ:0.0331	609373	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	141014494	141014494	T	C	HDAC3	exonic	synonymous SNV	ENSG00000171720	rs2530223	ENSG00000171720:ENST00000305264:exon3:c.A165G:p.Q55Q	HDAC3:NM_001355039:exon3:c.A165G:p.Q55Q,HDAC3:NM_003883:exon3:c.A165G:p.Q55Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6253	0.6832	0.639776	0.6716	.	.	.	.	.	.	.	.	HDAC3:uc003llf.2:exon3:c.A165G:p.Q55Q	.	AFR:0.8538,AMR:0.7303,EAS:0.3067,FIN:0.6067,NFE:0.6193,OTH:0.6582,ASJ:0.5927	605166	.	.	.	~ko04919 Thyroid hormone signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	MU105200	het
5	141016288	141016288	T	G	HDAC3	intronic	.	ENSG00000171720	rs1421896	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6339	0.6985	0.65635	0.6829	.	.	.	.	.	.	.	.	.	.	AFR:0.8823,AMR:0.7506,EAS:0.3059,FIN:0.6066,NFE:0.6247,OTH:0.6609,ASJ:0.6026	605166	.	.	.	~ko04919 Thyroid hormone signaling pathway~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	5	MU19773804	unknown
5	141975067	141975067	A	C	FGF1	intronic	.	ENSG00000231185	rs34003	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4951	0.5364	0.56889	LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	.	.	AFR:0.5453,AMR:0.7159,EAS:0.4669,FIN:0.6409,NFE:0.4739,OTH:0.4661,ASJ:0.3950	131220	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04390 Hippo signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	5	1(lung)	0.4888
5	142254679	142254679	A	G	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs185200	ENSG00000145819:ENST00000274498:exon3:c.A255G:p.R85R,ENSG00000145819:ENST00000378004:exon3:c.A255G:p.R85R,ENSG00000145819:ENST00000378013:exon3:c.A171G:p.R57R	ARHGAP26:NM_001135608:exon3:c.A255G:p.R85R,ARHGAP26:NM_001349547:exon3:c.A147G:p.R49R,ARHGAP26:NM_015071:exon3:c.A255G:p.R85R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4468	0.4620	0.673722	0.4728	.	.	.	.	.	.	.	.	ARHGAP26:uc003lmt.3:exon3:c.A255G:p.R85R,ARHGAP26:uc003lmw.3:exon3:c.A255G:p.R85R,ARHGAP26:uc011dbj.2:exon3:c.A255G:p.R85R	.	AFR:0.8006,AMR:0.5084,EAS:0.8806,FIN:0.2917,NFE:0.2887,OTH:0.3640,ASJ:0.3079	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU24874862	het
5	142416741	142416741	T	C	ARHGAP26	intronic	.	ENSG00000145819	rs192194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7071	0.7795	0.644768	0.7523	.	.	.	.	.	.	.	.	.	.	AFR:0.7955,AMR:0.5621,EAS:0.3362,FIN:0.7196,NFE:0.7903,OTH:0.7474,ASJ:0.7649	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU15244426	het
5	142421415	142421415	T	G	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs2270068	ENSG00000145819:ENST00000274498:exon14:c.T1245G:p.G415G,ENSG00000145819:ENST00000378004:exon14:c.T1245G:p.G415G	ARHGAP26:NM_001135608:exon14:c.T1245G:p.G415G,ARHGAP26:NM_001349547:exon14:c.T1137G:p.G379G,ARHGAP26:NM_015071:exon14:c.T1245G:p.G415G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9619	0.9983	0.888179	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARHGAP26:uc003lmt.3:exon14:c.T1245G:p.G415G,ARHGAP26:uc003lmw.3:exon14:c.T1245G:p.G415G,ARHGAP26:uc011dbj.2:exon14:c.T1245G:p.G415G	.	AFR:0.9698,AMR:0.9969,EAS:1,FIN:0.5162,NFE:0.9885,OTH:0.9983,ASJ:0.9414	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	1(breast)	0.9827
5	142593652	142593652	C	T	ARHGAP26	exonic	synonymous SNV	ENSG00000145819	rs258819	ENSG00000145819:ENST00000425417:exon2:c.C200T:p.T67M	ARHGAP26:NM_001349547:exon21:c.C1971T:p.N657N,ARHGAP26:NM_001135608:exon22:c.C2190T:p.N730N,ARHGAP26:NM_015071:exon22:c.C2355T:p.N785N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9938	0.9962	0.996406	0.9931	.	.	.	.	.	0.0002	0.11	.	ARHGAP26:uc003lmw.3:exon21:c.C2079T:p.N693N,ARHGAP26:uc003lmt.3:exon22:c.C2190T:p.N730N,ARHGAP26:uc011dbj.2:exon22:c.C2355T:p.N785N	.	AFR:0.9993,AMR:0.9964,EAS:1,FIN:0.9675,NFE:0.9949,OTH:0.9876,ASJ:1	605370	607785;	86834;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	.	.	.	.	.	.	.	.	5	MU81804076	hom
5	149447771	149447771	G	A	CSF1R	intronic	.	ENSG00000182578	rs34928010	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1090	0.1139	0.178914	0.1183	.	.	.	.	.	0.0017	0.232	.	.	.	AFR:0.2651,AMR:0.2554,EAS:0.1685,FIN:0.0321,NFE:0.0441,OTH:0.0645,ASJ:0.0927	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	5	MU769524	het
5	149449420	149449420	G	A	CSF1R	intronic	.	ENSG00000182578	rs200626267	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0029	0.0002	0.00499201	0.0005	.	.	.	.	.	.	.	.	.	.	AFR:0.0006,AMR:0.0012,EAS:0.0012,FIN:0,NFE:0.0003,OTH:0.0031,ASJ:0	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	5	.	het
5	149457678	149457678	G	A	CSF1R	exonic	synonymous SNV	ENSG00000182578	rs2228422	ENSG00000182578:ENST00000504875:exon4:c.C726T:p.T242T,ENSG00000182578:ENST00000543093:exon4:c.C726T:p.T242T,ENSG00000182578:ENST00000286301:exon5:c.C726T:p.T242T	CSF1R:NM_001288705:exon4:c.C726T:p.T242T,CSF1R:NM_005211:exon5:c.C726T:p.T242T,CSF1R:NM_001349736:exon6:c.C726T:p.T242T	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5153	0.4807	0.38738	4(lung)	.	.	.	.	.	.	.	.	CSF1R:uc011dcd.2:exon3:c.C282T:p.T94T,CSF1R:uc003lrl.3:exon4:c.C726T:p.T242T,CSF1R:uc011dce.1:exon4:c.C726T:p.T242T,CSF1R:uc011dcf.2:exon4:c.C726T:p.T242T,CSF1R:uc003lrm.3:exon5:c.C726T:p.T242T	.	AFR:1(stomach),AMR:1(breast),EAS:1(thyroid),FIN:MU586881,NFE:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,OTH:0.4998,ASJ:1(liver)	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	,2067,2070,2068	.	,2069	.	.	.	.	5	14(meninges)	0.3213
5	149460343	149460343	G	A	CSF1R	exonic	synonymous SNV	ENSG00000182578	rs17652007	ENSG00000182578:ENST00000504875:exon2:c.C294T:p.H98H,ENSG00000182578:ENST00000543093:exon2:c.C294T:p.H98H,ENSG00000182578:ENST00000286301:exon3:c.C294T:p.H98H	CSF1R:NM_001288705:exon2:c.C294T:p.H98H,CSF1R:NM_005211:exon3:c.C294T:p.H98H,CSF1R:NM_001349736:exon4:c.C294T:p.H98H	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0493	0.0115	0.0776757	MU769533	.	.	.	.	.	.	.	.	CSF1R:uc003lrl.3:exon2:c.C294T:p.H98H,CSF1R:uc011dce.1:exon2:c.C294T:p.H98H,CSF1R:uc011dcf.2:exon2:c.C294T:p.H98H,CSF1R:uc003lrm.3:exon3:c.C294T:p.H98H	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,AMR:0.0317,EAS:0.2053,FIN:0.0066,NFE:0.2506,OTH:0.0261,ASJ:0.0234	164770	221820;	313808;	313808|ALSP<br>Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia<br>Autosomal dominant leukoencephalopathy with neuroaxonal spheroids<br>FPSG<br>Familial dementia, Neumann type<br>Familial progressive subcortical gliosis<br>GPSC<br>HDLS<br>Hereditary diffuse leukoencephalopathy with spheroids<br>POLD<br>Pigmentary orthochromatic leukodystrophy<br>Subcortical gliosis of Neumann|<1 / 1 000 000|Autosomal dominant|Adult|221820 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04061 Viral protein interaction with cytokine and cytokine~~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	,2067,2070,2068	.	,2069	.	.	.	.	5	1(meninges)	0.0057
5	156670823	156670823	G	A	ITK	intronic	.	ENSG00000113263	rs17595865	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0531	0.0540	0.0321486	0.0491	.	.	.	.	.	.	.	.	.	.	AFR:0.0135,AMR:0.0443,EAS:0,FIN:0.0555,NFE:0.0725,OTH:0.0541,ASJ:0.0993	186973	613011;	238505;	238505|CD27 deficiency|<1 / 1 000 000|Autosomal recessive|Childhood|613011 615122 ~	.	.	.	.	.	.	.	.	5	.	het
5	161119071	161119071	G	T	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs12522663	ENSG00000145863:ENST00000274545:exon8:c.G951T:p.A317A,ENSG00000145863:ENST00000523217:exon8:c.G921T:p.A307A	GABRA6:NM_000811:exon8:c.G951T:p.A317A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9902	0.9655	0.968251	0.9699	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon2:c.G264T:p.A88A,GABRA6:uc003lyu.2:exon8:c.G951T:p.A317A	.	AFR:0.8962,AMR:0.9881,EAS:1,FIN:1,NFE:0.9997,OTH:0.9878,ASJ:1	137143	.	.	.	.	.	.	.	.	.	.	.	5	MU81806764	hom
5	161119179	161119179	T	C	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs539296903	ENSG00000145863:ENST00000274545:exon8:c.T1059C:p.T353T,ENSG00000145863:ENST00000523217:exon8:c.T1029C:p.T343T	GABRA6:NM_000811:exon8:c.T1059C:p.T353T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0002	.	0.000399361	.	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon2:c.T372C:p.T124T,GABRA6:uc003lyu.2:exon8:c.T1059C:p.T353T	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	137143	.	.	.	.	.	.	.	.	.	.	.	5	.	het
5	161128627	161128627	C	T	GABRA6	exonic	nonsynonymous SNV	ENSG00000145863	rs34907804	ENSG00000145863:ENST00000274545:exon9:c.C1210T:p.P404S,ENSG00000145863:ENST00000523217:exon9:c.C1180T:p.P394S	GABRA6:NM_000811:exon9:c.C1210T:p.P404S	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0663	0.0928	0.0728834	0.0777	1.417	12.88	0.174	5.16	0.395	.	.	Neurotransmitter-gated ion-channel transmembrane domain	GABRA6:uc003lyv.2:exon3:c.C523T:p.P175S,GABRA6:uc003lyu.2:exon9:c.C1210T:p.P404S	-0.963	AFR:0.1174,AMR:0.0598,EAS:0,FIN:0.0547,NFE:0.0699,OTH:0.0663,ASJ:0.0861	137143	.	.	.	.	.	.	.	0.005	-1.71	0.006	0.805	5	.	het
5	161128761	161128761	C	G	GABRA6	exonic	synonymous SNV	ENSG00000145863	rs4277944	ENSG00000145863:ENST00000274545:exon9:c.C1344G:p.V448V,ENSG00000145863:ENST00000523217:exon9:c.C1314G:p.V438V	GABRA6:NM_000811:exon9:c.C1344G:p.V448V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9893	0.9620	.	0.9680	.	.	.	.	.	.	.	.	GABRA6:uc003lyv.2:exon3:c.C657G:p.V219V,GABRA6:uc003lyu.2:exon9:c.C1344G:p.V448V	.	AFR:0.8895,AMR:0.9869,EAS:1,FIN:1,NFE:0.9996,OTH:0.9888,ASJ:1	137143	.	.	.	.	.	.	.	.	.	.	.	5	MU81806783	hom
5	162890953	162890953	G	A	HMMR	exonic	synonymous SNV	ENSG00000072571	rs380101	ENSG00000072571:ENST00000353866:exon2:c.G138A:p.Q46Q,ENSG00000072571:ENST00000358715:exon2:c.G138A:p.Q46Q,ENSG00000072571:ENST00000393915:exon2:c.G138A:p.Q46Q	HMMR:NM_001142556:exon2:c.G138A:p.Q46Q,HMMR:NM_012484:exon2:c.G138A:p.Q46Q,HMMR:NM_012485:exon2:c.G138A:p.Q46Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1.0000	.	.	.	.	.	.	.	.	HMMR:uc003lzf.3:exon2:c.G138A:p.Q46Q,HMMR:uc003lzg.3:exon2:c.G138A:p.Q46Q,HMMR:uc003lzh.3:exon2:c.G138A:p.Q46Q	.	AFR:0.9999,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	5	MU81806833	hom
5	162896650	162896650	C	T	HMMR	exonic	nonsynonymous SNV	ENSG00000072571	rs299284	ENSG00000072571:ENST00000432118:exon2:c.C16T:p.R6C,ENSG00000072571:ENST00000353866:exon4:c.C229T:p.R77C,ENSG00000072571:ENST00000358715:exon5:c.C274T:p.R92C,ENSG00000072571:ENST00000393915:exon5:c.C277T:p.R93C	HMMR:NM_001142557:exon2:c.C16T:p.R6C,HMMR:NM_012485:exon4:c.C229T:p.R77C,HMMR:NM_001142556:exon5:c.C277T:p.R93C,HMMR:NM_012484:exon5:c.C274T:p.R92C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1037	0.1079	0.0746805	3(skin)	7.507	34	0.009	5.31	0.998	.	.	Hyaluronan mediated motility receptor, N-terminal	HMMR:uc011dem.2:exon2:c.C16T:p.R6C,HMMR:uc003lzg.3:exon4:c.C229T:p.R77C,HMMR:uc003lzf.3:exon5:c.C274T:p.R92C,HMMR:uc003lzh.3:exon5:c.C277T:p.R93C	-0.881	AFR:MU50503669,AMR:MELA-AU|2|183|0.010929,COCA-CN|1|321|0.00311526,EAS:0.0916,FIN:0.0658,NFE:0.1159,OTH:0.0086,ASJ:0.1069	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	1.0	-1.18	0.013	2.72	5	1(pancreas)	0.1188
5	162902516	162902516	T	C	HMMR	exonic	nonsynonymous SNV	ENSG00000072571	rs299290	ENSG00000072571:ENST00000432118:exon8:c.T845C:p.V282A,ENSG00000072571:ENST00000353866:exon10:c.T1058C:p.V353A,ENSG00000072571:ENST00000358715:exon11:c.T1103C:p.V368A,ENSG00000072571:ENST00000393915:exon11:c.T1106C:p.V369A	HMMR:NM_001142557:exon8:c.T845C:p.V282A,HMMR:NM_012485:exon10:c.T1058C:p.V353A,HMMR:NM_001142556:exon11:c.T1106C:p.V369A,HMMR:NM_012484:exon11:c.T1103C:p.V368A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2839	0.2636	0.3127	4(large_intestine)	-1.577	0.002	0.214	-3.29	0.668	.	.	Hyaluronan mediated motility receptor, N-terminal	HMMR:uc011dem.2:exon8:c.T845C:p.V282A,HMMR:uc003lzg.3:exon10:c.T1058C:p.V353A,HMMR:uc003lzf.3:exon11:c.T1103C:p.V368A,HMMR:uc003lzh.3:exon11:c.T1106C:p.V369A	-0.937	AFR:2(stomach),AMR:1(biliary_tract),EAS:MU89203,FIN:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,NFE:0.2882,OTH:0.3116,ASJ:1(haematopoietic_and_lymphoid_tissue)	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.047	3.25	0.000	0	5	10(soft_tissue)	0.2983
5	162909687	162909687	G	A	HMMR	exonic	synonymous SNV	ENSG00000072571	rs17600938	ENSG00000072571:ENST00000432118:exon10:c.G1164A:p.K388K,ENSG00000072571:ENST00000353866:exon12:c.G1377A:p.K459K,ENSG00000072571:ENST00000358715:exon13:c.G1422A:p.K474K,ENSG00000072571:ENST00000393915:exon13:c.G1425A:p.K475K	HMMR:NM_001142557:exon10:c.G1164A:p.K388K,HMMR:NM_012485:exon12:c.G1377A:p.K459K,HMMR:NM_001142556:exon13:c.G1425A:p.K475K,HMMR:NM_012484:exon13:c.G1422A:p.K474K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1138	0.1192	0.11242	0.1187	.	.	.	.	.	.	.	.	HMMR:uc011dem.2:exon10:c.G1164A:p.K388K,HMMR:uc003lzg.3:exon12:c.G1377A:p.K459K,HMMR:uc003lzf.3:exon13:c.G1422A:p.K474K,HMMR:uc003lzh.3:exon13:c.G1425A:p.K475K	.	AFR:0.1331,AMR:0.1014,EAS:0.0507,FIN:0.1368,NFE:0.1145,OTH:0.1227,ASJ:0.1060	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	5	.	het
5	162909716	162909716	C	T	HMMR	exonic	nonsynonymous SNV	ENSG00000072571	rs299295	ENSG00000072571:ENST00000432118:exon10:c.C1193T:p.A398V,ENSG00000072571:ENST00000353866:exon12:c.C1406T:p.A469V,ENSG00000072571:ENST00000358715:exon13:c.C1451T:p.A484V,ENSG00000072571:ENST00000393915:exon13:c.C1454T:p.A485V	HMMR:NM_001142557:exon10:c.C1193T:p.A398V,HMMR:NM_012485:exon12:c.C1406T:p.A469V,HMMR:NM_001142556:exon13:c.C1454T:p.A485V,HMMR:NM_012484:exon13:c.C1451T:p.A484V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2326	0.2556	0.215655	LAML-KR|1|205|0.00487805	0.773	9.295	1.0	4.27	0.039	.	.	.	HMMR:uc011dem.2:exon10:c.C1193T:p.A398V,HMMR:uc003lzg.3:exon12:c.C1406T:p.A469V,HMMR:uc003lzf.3:exon13:c.C1451T:p.A484V,HMMR:uc003lzh.3:exon13:c.C1454T:p.A485V	-0.957	AFR:0.2549,AMR:0.3007,EAS:0.2433,FIN:0.0593,NFE:0.2849,OTH:0.2474,ASJ:0.1671	600936	114480;	227535;	227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.0	3.83	0.000	-2.455	5	1(haematopoietic_and_lymphoid_tissue)	0.2597
5	169129422	169129422	A	G	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs2306559	ENSG00000134516:ENST00000256935:exon14:c.A1374G:p.K458K,ENSG00000134516:ENST00000524185:exon14:c.A1374G:p.K458K	DOCK2:NM_004946:exon14:c.A1374G:p.K458K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4067	0.3758	0.385383	0.3894	.	.	.	.	.	.	.	.	DOCK2:uc010jjl.1:exon2:c.A27G:p.K9K,DOCK2:uc003maf.3:exon14:c.A1374G:p.K458K	.	AFR:0.2327,AMR:0.3017,EAS:0.7142,FIN:0.3755,NFE:0.4528,OTH:0.3916,ASJ:0.4367	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU10617326	het
5	169145648	169145648	A	T	DOCK2	intronic	.	ENSG00000134516	rs80250373	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0614	0.0580	0.0557109	0.0541	.	.	.	.	.	.	.	.	.	.	AFR:0.0492,AMR:0.0335,EAS:0.0006,FIN:0.0710,NFE:0.0591,OTH:0.0580,ASJ:0.0861	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	.	het
5	169435713	169435713	A	C	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs2287727	ENSG00000134516:ENST00000520908:exon18:c.A1671C:p.L557L,ENSG00000134516:ENST00000540750:exon18:c.A378C:p.L126L,ENSG00000134516:ENST00000256935:exon32:c.A3195C:p.L1065L	DOCK2:NM_004946:exon32:c.A3195C:p.L1065L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2919	0.2207	0.243011	0.2467	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon18:c.A1671C:p.L557L,DOCK2:uc003maf.3:exon32:c.A3195C:p.L1065L	.	AFR:0.0696,AMR:0.3517,EAS:0.4252,FIN:0.3768,NFE:0.2895,OTH:0.3129,ASJ:0.2781	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU137499	het
5	169454941	169454941	C	G	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs9791113	ENSG00000134516:ENST00000520908:exon20:c.C1932G:p.L644L,ENSG00000134516:ENST00000540750:exon20:c.C639G:p.L213L,ENSG00000134516:ENST00000256935:exon34:c.C3456G:p.L1152L	DOCK2:NM_004946:exon34:c.C3456G:p.L1152L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3923	0.4059	0.486222	0.4008	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon20:c.C1932G:p.L644L,DOCK2:uc003maf.3:exon34:c.C3456G:p.L1152L	.	AFR:0.5439,AMR:0.3995,EAS:0.5767,FIN:0.3441,NFE:0.3172,OTH:0.3361,ASJ:0.3543	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU21948493	hom
5	169461399	169461399	G	A	DOCK2	intronic	.	ENSG00000134516	rs3763047	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3921	0.4232	0.499201	0.4113	.	.	.	.	.	0	0.002	.	.	.	AFR:0.6033,AMR:0.4031,EAS:0.5722,FIN:0.3246,NFE:0.3099,OTH:0.3282,ASJ:0.3510	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU799485	hom
5	169461547	169461547	C	T	DOCK2	exonic	synonymous SNV	ENSG00000134516	rs3763048	ENSG00000134516:ENST00000520908:exon21:c.C2088T:p.T696T,ENSG00000134516:ENST00000540750:exon21:c.C795T:p.T265T,ENSG00000134516:ENST00000256935:exon35:c.C3612T:p.T1204T	DOCK2:NM_004946:exon35:c.C3612T:p.T1204T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3995	0.4343	0.506789	0.4184	.	.	.	.	.	.	.	.	DOCK2:uc010jjm.3:exon21:c.C2088T:p.T696T,DOCK2:uc003maf.3:exon35:c.C3612T:p.T1204T	.	AFR:0.6093,AMR:0.4069,EAS:0.5732,FIN:0.3263,NFE:0.3194,OTH:0.3306,ASJ:0.37	603122	616433;	447737;	447737|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616433 ~	.	.	.	.	.	.	.	.	5	MU586927	hom
5	176516631	176516631	G	A	FGFR4	exonic	nonsynonymous SNV	ENSG00000160867	rs1966265	ENSG00000160867:ENST00000393637:exon1:c.G28A:p.V10I,ENSG00000160867:ENST00000430285:exon1:c.G28A:p.V10I,ENSG00000160867:ENST00000292408:exon2:c.G28A:p.V10I,ENSG00000160867:ENST00000292410:exon2:c.G28A:p.V10I,ENSG00000160867:ENST00000393648:exon2:c.G28A:p.V10I,ENSG00000160867:ENST00000502906:exon2:c.G28A:p.V10I,ENSG00000160867:ENST00000503708:exon2:c.G28A:p.V10I,ENSG00000160867:ENST00000513166:exon2:c.G28A:p.V10I,ENSG00000160867:ENST00000514472:exon2:c.G28A:p.V10I,ENSG00000160867:ENST00000510911:exon3:c.G28A:p.V10I	FGFR4:NM_022963:exon1:c.G28A:p.V10I,FGFR4:NM_001291980:exon2:c.G28A:p.V10I,FGFR4:NM_001354984:exon2:c.G28A:p.V10I,FGFR4:NM_002011:exon2:c.G28A:p.V10I,FGFR4:NM_213647:exon2:c.G28A:p.V10I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.2408	0.1708	0.228834	MU14815861	-1.656	0.002	0.417	-2.16	0.001	.	.	.	FGFR4:uc003mfn.1:exon1:c.G28A:p.V10I,FGFR4:uc003mfo.3:exon1:c.G28A:p.V10I,FGFR4:uc011dfw.1:exon1:c.G28A:p.V10I,FGFR4:uc003mfl.3:exon2:c.G28A:p.V10I,FGFR4:uc003mfm.3:exon2:c.G28A:p.V10I,FGFR4:uc011dfu.2:exon2:c.G28A:p.V10I	-0.974	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.1956,EAS:0.2787,FIN:0.1556,NFE:0.5037,OTH:0.2179,ASJ:0.0525	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	0.0	-1.17	0.000	0.345	5	1(haematopoietic_and_lymphoid_tissue)	0.2352
5	176517461	176517461	T	G	FGFR4	exonic	synonymous SNV	ENSG00000160867	rs446382	ENSG00000160867:ENST00000393637:exon2:c.T162G:p.R54R,ENSG00000160867:ENST00000292408:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000292410:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000393648:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000502906:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000503708:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000513166:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000514472:exon3:c.T162G:p.R54R,ENSG00000160867:ENST00000510911:exon4:c.T162G:p.R54R	FGFR4:NM_022963:exon2:c.T162G:p.R54R,FGFR4:NM_001291980:exon3:c.T162G:p.R54R,FGFR4:NM_001354984:exon3:c.T162G:p.R54R,FGFR4:NM_002011:exon3:c.T162G:p.R54R,FGFR4:NM_213647:exon3:c.T162G:p.R54R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7647	0.6832	0.775958	MU71026	.	.	.	.	.	.	.	.	FGFR4:uc003mfn.1:exon2:c.T162G:p.R54R,FGFR4:uc003mfo.3:exon2:c.T162G:p.R54R,FGFR4:uc011dfw.1:exon2:c.T162G:p.R54R,FGFR4:uc003mfl.3:exon3:c.T162G:p.R54R,FGFR4:uc003mfm.3:exon3:c.T162G:p.R54R,FGFR4:uc011dfu.2:exon3:c.T162G:p.R54R	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.7118,EAS:0.8103,FIN:0.7119,NFE:0.9729,OTH:0.7490,ASJ:0.5979	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	17(meninges)	0.7323
5	176517797	176517797	C	T	FGFR4	exonic	nonsynonymous SNV	ENSG00000160867	rs376618	ENSG00000160867:ENST00000393637:exon3:c.C407T:p.P136L,ENSG00000160867:ENST00000292408:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000292410:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000393648:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000502906:exon4:c.C407T:p.P136L,ENSG00000160867:ENST00000503708:exon4:c.C407T:p.P136L	FGFR4:NM_022963:exon3:c.C407T:p.P136L,FGFR4:NM_001291980:exon4:c.C407T:p.P136L,FGFR4:NM_001354984:exon4:c.C407T:p.P136L,FGFR4:NM_002011:exon4:c.C407T:p.P136L,FGFR4:NM_213647:exon4:c.C407T:p.P136L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7950	0.7211	0.807308	COCA-CN|5|321|0.0155763	0.399	6.606	0.332	2.85	0.010	.	.	.	FGFR4:uc003mfn.1:exon3:c.C407T:p.P136L,FGFR4:uc003mfo.3:exon3:c.C407T:p.P136L,FGFR4:uc011dfw.1:exon3:c.C407T:p.P136L,FGFR4:uc003mfl.3:exon4:c.C407T:p.P136L,FGFR4:uc003mfm.3:exon4:c.C407T:p.P136L,FGFR4:uc011dfu.2:exon4:c.C407T:p.P136L	-0.960	AFR:0.7468,AMR:0.6533,EAS:0.7550,FIN:1,NFE:0.8038,OTH:0.7525,ASJ:0.8337	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	0.0	-1.26	0.000	0	5	17(meninges)	0.7873
5	176518037	176518037	A	G	FGFR4	exonic	nonsynonymous SNV	ENSG00000160867	rs55675160	ENSG00000160867:ENST00000393637:exon4:c.A535G:p.T179A,ENSG00000160867:ENST00000292408:exon5:c.A535G:p.T179A,ENSG00000160867:ENST00000292410:exon5:c.A535G:p.T179A,ENSG00000160867:ENST00000393648:exon5:c.A535G:p.T179A,ENSG00000160867:ENST00000502906:exon5:c.A535G:p.T179A,ENSG00000160867:ENST00000503708:exon5:c.A535G:p.T179A	FGFR4:NM_022963:exon4:c.A535G:p.T179A,FGFR4:NM_001291980:exon5:c.A535G:p.T179A,FGFR4:NM_001354984:exon5:c.A535G:p.T179A,FGFR4:NM_002011:exon5:c.A535G:p.T179A,FGFR4:NM_213647:exon5:c.A535G:p.T179A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0029	.	0.00798722	MU114405269	-0.875	0.029	0.279	3.56	0.590	.	.	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	FGFR4:uc003mfo.3:exon4:c.A535G:p.T179A,FGFR4:uc011dfw.1:exon4:c.A535G:p.T179A,FGFR4:uc003mfl.3:exon5:c.A535G:p.T179A,FGFR4:uc003mfm.3:exon5:c.A535G:p.T179A,FGFR4:uc011dfu.2:exon5:c.A535G:p.T179A	-1.099	AFR:LAML-KR|2|205|0.0097561,AMR:0.0016,EAS:0,FIN:0,NFE:0.0297,OTH:0,ASJ:0	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	0.017	-0.25	0.032	0.99	5	1(soft_tissue)	0
5	176518784	176518784	C	T	FGFR4	exonic	synonymous SNV	ENSG00000160867	rs452885	ENSG00000160867:ENST00000393637:exon5:c.C702T:p.R234R,ENSG00000160867:ENST00000292408:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000292410:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000393648:exon6:c.C702T:p.R234R,ENSG00000160867:ENST00000502906:exon6:c.C702T:p.R234R	FGFR4:NM_022963:exon5:c.C702T:p.R234R,FGFR4:NM_001291980:exon6:c.C702T:p.R234R,FGFR4:NM_001354984:exon6:c.C702T:p.R234R,FGFR4:NM_002011:exon6:c.C702T:p.R234R,FGFR4:NM_213647:exon6:c.C702T:p.R234R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7949	0.7211	0.807109	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FGFR4:uc003mfo.3:exon5:c.C702T:p.R234R,FGFR4:uc011dfw.1:exon5:c.C702T:p.R234R,FGFR4:uc003mfl.3:exon6:c.C702T:p.R234R,FGFR4:uc003mfm.3:exon6:c.C702T:p.R234R,FGFR4:uc011dfu.2:exon6:c.C702T:p.R234R	.	AFR:0.7460,AMR:0.6523,EAS:0.7550,FIN:1,NFE:0.8033,OTH:0.7520,ASJ:0.8329	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	17(meninges)	0.7883
5	176522728	176522728	C	T	FGFR4	intronic	.	ENSG00000160867	rs42409	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7280	0.5984	0.701877	0.6355	.	.	.	.	.	0.0001	0.018	.	.	.	AFR:0.4138,AMR:0.7770,EAS:0.9715,FIN:0.7158,NFE:0.6962,OTH:0.7080,ASJ:0.6623	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	MU81808028	hom
5	176523597	176523597	A	G	FGFR4	intronic	.	ENSG00000160867	rs31776	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7643	0.6889	0.785343	0.7157	.	.	.	.	.	0	0.004	.	.	.	AFR:0.6139,AMR:0.8079,EAS:0.9727,FIN:0.7489,NFE:0.7318,OTH:0.7592,ASJ:0.6887	134935	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	5	MU10675511	hom
5	176562097	176562097	G	A	NSD1	UTR5	.	ENSG00000165671	rs199639292	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0] 	0.0052	0.0002	0.0103834	0.0003	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0.0001,OTH:0.0061,ASJ:0	606681	117550;130650;601626;	519;116;821;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~821|Cerebral gigantism|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown<br>or&nbsp;Autosomal recessive|Neonatal|117550 617169 ~	.	.	.	.	.	.	.	.	5	.	het
5	176721198	176721198	T	C	NSD1	exonic	synonymous SNV	ENSG00000165671	rs28580074	ENSG00000165671:ENST00000361032:exon20:c.T6520C:p.L2174L,ENSG00000165671:ENST00000439151:exon23:c.T6829C:p.L2277L,ENSG00000165671:ENST00000347982:exon24:c.T6022C:p.L2008L,ENSG00000165671:ENST00000354179:exon24:c.T6022C:p.L2008L	NSD1:NM_022455:exon23:c.T6829C:p.L2277L,NSD1:NM_001365684:exon24:c.T6022C:p.L2008L,NSD1:NM_172349:exon24:c.T6022C:p.L2008L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8242	0.8990	0.771366	1(stomach)	.	.	.	.	.	.	.	.	NSD1:uc021yip.1:exon3:c.T301C:p.L101L,NSD1:uc003mfr.4:exon23:c.T6829C:p.L2277L,NSD1:uc003mft.4:exon24:c.T6022C:p.L2008L,NSD1:uc011dfx.2:exon24:c.T5773C:p.L1925L	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU586936,EAS:0.8480,FIN:0.9257,NFE:0.7888,OTH:0.8907,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	606681	117550;130650;601626;	519;116;821;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~821|Cerebral gigantism|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown<br>or&nbsp;Autosomal recessive|Neonatal|117550 617169 ~	.	.	.	.	.	.	.	.	5	22(soft_tissue)	0.4776
5	176940384	176940384	G	A	DDX41	exonic	synonymous SNV	ENSG00000183258	rs335438	ENSG00000183258:ENST00000330503:exon10:c.C1254T:p.R418R,ENSG00000183258:ENST00000507955:exon11:c.C1200T:p.R400R	DDX41:NM_001321732:exon10:c.C822T:p.R274R,DDX41:NM_001321830:exon11:c.C822T:p.R274R,DDX41:NM_016222:exon11:c.C1200T:p.R400R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4198	0.4609	0.386382	0.4396	.	.	.	.	.	.	.	.	DDX41:uc003mhq.1:exon9:c.C540T:p.R180R,DDX41:uc003mhn.3:exon10:c.C807T:p.R269R,DDX41:uc003mhp.3:exon10:c.C807T:p.R269R,DDX41:uc003mho.3:exon11:c.C1200T:p.R400R	.	AFR:0.4548,AMR:0.3266,EAS:0.1702,FIN:0.4526,NFE:0.4664,OTH:0.4061,ASJ:0.4040	608170	616871;	.	.	.	.	.	.	.	.	.	.	5	MU157920	het
5	180046344	180046344	G	C	FLT4	exonic	nonsynonymous SNV	ENSG00000037280	rs448012	ENSG00000037280:ENST00000261937:exon19:c.C2670G:p.H890Q,ENSG00000037280:ENST00000393347:exon19:c.C2670G:p.H890Q,ENSG00000037280:ENST00000502649:exon19:c.C2670G:p.H890Q	FLT4:NM_001354989:exon19:c.C2670G:p.H890Q,FLT4:NM_002020:exon19:c.C2670G:p.H890Q,FLT4:NM_182925:exon19:c.C2670G:p.H890Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6247	0.5970	0.582668	1(urinary_tract)	5.326	25.8	0.045	1.22	1.000	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain	FLT4:uc003mlz.4:exon19:c.C2670G:p.H890Q,FLT4:uc003mma.4:exon19:c.C2670G:p.H890Q	-0.907	AFR:79(lung),AMR:MU678928,EAS:0.6216,FIN:0.5506,NFE:0.7367,OTH:0.5233,ASJ:SKCA-BR|1|100|0.01,LUSC-KR|3|170|0.0176471,COCA-CN|7|321|0.0218069,BLCA-CN|1|103|0.00970874	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	0.18	-1.54	0.000	0.04	5	1(thyroid)	0.4763
5	180047863	180047863	C	G	FLT4	intronic	.	ENSG00000037280	rs423086	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9876	0.9531	0.960064	0.9627	.	.	.	.	.	.	.	.	.	.	AFR:0.8699,AMR:0.9940,EAS:1,FIN:1,NFE:0.9993,OTH:0.9929,ASJ:1	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU81809230	hom
5	180055862	180055862	T	G	FLT4	intronic	.	ENSG00000037280	rs383985	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6016	0.4137	0.648363	0.5611	.	.	.	.	.	.	.	.	.	.	AFR:0.5503,AMR:0.7266,EAS:0.8290,FIN:0.5185,NFE:0.5400,OTH:0.5491,ASJ:0.5403	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU681706	het
5	180071996	180071996	G	A	FLT4	intronic	.	ENSG00000037280	rs567611756	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.000199681	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	136352	153100;602089;	79452;	79452|Congenital primary lymphedema<br>Hereditary lymphedema type I<br>Nonne-Milroy lymphedema|Unknown|Autosomal dominant|Infancy<br>Neonatal|153100 247440 611944 613480 615907 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	5	MU43236836	het
6	325126	325126	A	G	DUSP22	intronic	.	ENSG00000112679	rs2757553	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.996805	0.9836	.	.	.	.	.	.	.	.	.	.	AFR:0.9701,AMR:0.9817,EAS:0.9950,FIN:0.9786,NFE:0.9909,OTH:0.9896,ASJ:0.9966	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	325403	325403	G	A	DUSP22	intronic	.	ENSG00000112679	rs28517601	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.448882	SKCA-BR|1|100|0.01	.	.	.	.	.	.	.	.	.	.	AFR:0.4451,AMR:0.4021,EAS:0.4362,FIN:0.4699,NFE:0.4720,OTH:0.4602,ASJ:0.4648	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(skin)	0.448
6	325544	325544	A	G	DUSP22	intronic	.	ENSG00000112679	rs28733103	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	SKCA-BR|1|100|0.01,PRAD-CA|1|306|0.00326797	.	.	.	.	.	.	.	.	.	.	AFR:0.4135,AMR:0.4588,EAS:0.2794,FIN:0.4791,NFE:0.3795,OTH:0.3840,ASJ:0.4074	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(prostate)	0.3932
6	325549	325549	G	A	DUSP22	intronic	.	ENSG00000112679	rs2488422	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.1463	.	.	.	.	.	.	.	.	.	.	AFR:0.2011,AMR:0.1741,EAS:0.2748,FIN:0.1402,NFE:0.1075,OTH:0.1175,ASJ:0.0481	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU43698069	het
6	325557	325557	G	T	DUSP22	intronic	.	ENSG00000112679	rs2797328	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.1947	.	.	.	.	.	.	.	.	.	.	AFR:0.2682,AMR:0.2135,EAS:0.3047,FIN:0.2377,NFE:0.1407,OTH:0.1202,ASJ:0.0612	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU43698139	het
6	325711	325711	C	T	DUSP22	intronic	.	ENSG00000112679	rs28546796	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	MU28569467	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|3|402|0.00746269,COCA-CN|1|321|0.00311526,AMR:0.2050,EAS:0.3341,FIN:0.3115,NFE:0.1980,OTH:0.2830,ASJ:0.1067	616778	.	.	.	.	.	.	.	.	.	.	.	6	2(liver)	0.2376
6	325873	325873	T	C	DUSP22	intronic	.	ENSG00000112679	rs2797329	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.997804	0.9956	.	.	.	.	.	.	.	.	.	.	AFR:0.9902,AMR:0.9986,EAS:0.9992,FIN:0.9932,NFE:0.9986,OTH:0.9974,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	325886	325886	T	G	DUSP22	intronic	.	ENSG00000112679	rs59368675	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.0053	.	.	.	.	.	.	.	.	.	.	AFR:0.0049,AMR:0,EAS:0.0030,FIN:0.0038,NFE:0.0065,OTH:0.0025,ASJ:0.0122	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	325961	325961	T	C	DUSP22	intronic	.	ENSG00000112679	rs2797330	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.971046	0.9765	.	.	.	.	.	.	.	.	.	.	AFR:0.9660,AMR:0.9744,EAS:0.9888,FIN:0.9693,NFE:0.9835,OTH:0.9676,ASJ:0.9795	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU80942806	hom
6	326134	326134	G	A	DUSP22	intronic	.	ENSG00000112679	rs2757557	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.996805	0.9956	.	.	.	.	.	.	.	.	.	.	AFR:0.9887,AMR:0.9913,EAS:1,FIN:0.9949,NFE:0.9992,OTH:0.9978,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	326819	326819	C	A	DUSP22	intronic	.	ENSG00000112679	rs2757558	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	.	0.2842	.	.	.	.	.	.	.	.	.	.	AFR:0.3320,AMR:0.2538,EAS:0.3289,FIN:0.2667,NFE:0.2583,OTH:0.2819,ASJ:0.2797	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU25012989	het
6	335175	335175	A	T	DUSP22	intronic	.	ENSG00000112679	rs2671431	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9993	0.9980	0.997804	0.9980	.	.	.	.	.	.	.	.	.	.	AFR:0.9932,AMR:0.9988,EAS:1,FIN:0.9997,NFE:1,OTH:1,ASJ:1	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU81809497	hom
6	348906	348906	G	A	DUSP22	exonic	synonymous SNV	ENSG00000112679	rs11242812	ENSG00000112679:ENST00000604971:exon4:c.G264A:p.P88P,ENSG00000112679:ENST00000605315:exon4:c.G264A:p.P88P,ENSG00000112679:ENST00000603453:exon6:c.G264A:p.P88P,ENSG00000112679:ENST00000419235:exon7:c.G573A:p.P191P	DUSP22:NM_001286555:exon7:c.G573A:p.P191P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4882	.	.	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	DUSP22:uc003msy.1:exon6:c.G444A:p.P148P,DUSP22:uc011dhn.1:exon7:c.G573A:p.P191P	.	AFR:MU4553881,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,EAS:0.4929,FIN:0.4795,NFE:0.4567,OTH:0.4781,ASJ:0.4800	616778	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4698
6	350829	350829	G	A	DUSP22	exonic	synonymous SNV	ENSG00000112679	rs1129085	ENSG00000112679:ENST00000344450:exon8:c.G516A:p.P172P	DUSP22:NM_020185:exon8:c.G516A:p.P172P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3887	0.3573	.	0.3837	.	.	.	.	.	.	.	.	DUSP22:uc003msx.3:exon8:c.G516A:p.P172P	.	AFR:0.4602,AMR:0.3674,EAS:0.4923,FIN:0.3651,NFE:0.3336,OTH:0.3775,ASJ:0.3423	616778	.	.	.	.	.	.	.	.	.	.	.	6	MU34371818	het
6	405146	405146	C	G	IRF4	intronic	.	ENSG00000137265	rs75719951	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0287	0.0020	0.0623003	0.0139	.	.	.	.	.	.	.	.	.	.	AFR:0.0037,AMR:0.0513,EAS:0.1617,FIN:0.0100,NFE:0.0025,OTH:0.0204,ASJ:0	601900	611724;	.	.	.	.	.	.	.	.	.	.	6	MU681324	het
6	1611802	1611802	-	GGC	FOXC1	exonic	nonframeshift insertion	ENSG00000054598	rs545470261	ENSG00000054598:ENST00000380874:exon1:c.1122_1123insGGC:p.S374delinsSG	FOXC1:NM_001453:exon1:c.1122_1123insGGC:p.S374delinsSG	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0614	0.1601	0.152157	0.2124	.	.	.	.	.	.	.	.	FOXC1:uc003mtp.3:exon1:c.1122_1123insGGC:p.S374delinsSG	.	AFR:0.1174,AMR:0.2957,EAS:0.6654,FIN:0.1875,NFE:0.2132,OTH:0.2433,ASJ:0.3243	601090	601631;602482;	782;91483;98978;91483;98978;	782|Axenfeld syndrome<br>Rieger syndrome|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|180500 601499 602482 ~91483|-|-|Autosomal dominant|Neonatal|137600 601631 602482 ~98978|-|-|Autosomal dominant|-|601631 602482 ~91483|-|-|Autosomal dominant|Neonatal|137600 601631 602482 ~98978|-|-|Autosomal dominant|-|601631 602482 ~	.	.	.	.	.	.	.	.	6	MU5018396	hom
6	5431340	5431340	A	G	FARS2	exonic	nonsynonymous SNV	ENSG00000145982	rs11243011	ENSG00000145982:ENST00000445533:exon2:c.A227G:p.N76S,ENSG00000145982:ENST00000274680:exon4:c.A839G:p.N280S,ENSG00000145982:ENST00000324331:exon4:c.A839G:p.N280S	FARS2:NM_001318872:exon4:c.A839G:p.N280S,FARS2:NM_006567:exon4:c.A839G:p.N280S	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2188	0.1522	0.235224	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	1.402	12.80	0.355	3.13	1.000	.	.	Aminoacyl-tRNA synthetase, class II|Phenylalanyl-tRNA synthetase;Phenylalanyl-tRNA synthetase	FARS2:uc003mwr.2:exon4:c.A839G:p.N280S,FARS2:uc010jnv.1:exon4:c.A839G:p.N280S	-1.069	AFR:0.1663,AMR:0.0759,EAS:0.2616,FIN:0.4969,NFE:0.1535,OTH:0.1795,ASJ:0.2303	611592	614946;617046;	319519;	319519|COXPD14|<1 / 1 000 000|-|Neonatal<br>Infancy|614946 ~	.	.	.	.	0.001	0.01	0.034	-1.405	6	1(prostate)	0.1843
6	5619688	5619688	A	G	FARS2	intronic	.	ENSG00000145982	rs7751107	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.148163	0.1622	.	.	.	.	.	.	.	.	.	.	AFR:0.1359,AMR:0.1563,EAS:0.0315,FIN:0.1849,NFE:0.1846,OTH:0.1782,ASJ:0.2086	611592	614946;617046;	319519;	319519|COXPD14|<1 / 1 000 000|-|Neonatal<br>Infancy|614946 ~	.	.	.	.	.	.	.	.	6	.	het
6	7542148	7542148	-	A	DSP	UTR5	.	ENSG00000096696	rs17133512	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.1994	0.1665	0.199681	0.1715	.	.	.	.	.	.	.	.	.	.	AFR:0.2098,AMR:0.2231,EAS:0.2494,FIN:0.1620,NFE:0.1418,OTH:0.1656,ASJ:0.1126	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	.	het
6	7563983	7563983	T	G	DSP	exonic	synonymous SNV	ENSG00000096696	rs2806234	ENSG00000096696:ENST00000379802:exon6:c.T741G:p.A247A,ENSG00000096696:ENST00000418664:exon6:c.T741G:p.A247A	DSP:NM_001008844:exon6:c.T741G:p.A247A,DSP:NM_001319034:exon6:c.T741G:p.A247A,DSP:NM_004415:exon6:c.T741G:p.A247A	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9991	0.9985	1	0.9995	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon6:c.T741G:p.A247A,DSP:uc003mxq.1:exon6:c.T741G:p.A247A,DSP:uc021yle.1:exon6:c.T741G:p.A247A	.	AFR:0.9999,AMR:1,EAS:1,FIN:0.9991,NFE:0.9992,OTH:0.9990,ASJ:1	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU81810273	hom
6	7572262	7572262	A	G	DSP	exonic	synonymous SNV	ENSG00000096696	rs2076304	ENSG00000096696:ENST00000379802:exon15:c.A2091G:p.G697G,ENSG00000096696:ENST00000418664:exon15:c.A2091G:p.G697G	DSP:NM_001008844:exon15:c.A2091G:p.G697G,DSP:NM_001319034:exon15:c.A2091G:p.G697G,DSP:NM_004415:exon15:c.A2091G:p.G697G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7614	0.7859	0.774361	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon15:c.A2091G:p.G697G,DSP:uc003mxq.1:exon15:c.A2091G:p.G697G,DSP:uc021yle.1:exon15:c.A2091G:p.G697G	.	AFR:0.7676,AMR:0.7984,EAS:0.8543,FIN:0.8169,NFE:0.7120,OTH:0.7585,ASJ:0.7506	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.7357
6	7576527	7576527	G	A	DSP	exonic	synonymous SNV	ENSG00000096696	rs1016835	ENSG00000096696:ENST00000379802:exon19:c.G2631A:p.R877R,ENSG00000096696:ENST00000418664:exon19:c.G2631A:p.R877R	DSP:NM_001008844:exon19:c.G2631A:p.R877R,DSP:NM_001319034:exon19:c.G2631A:p.R877R,DSP:NM_004415:exon19:c.G2631A:p.R877R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7718	0.7481	0.735423	0.7345	.	.	.	.	.	0.0001	0.03	.	DSP:uc003mxp.1:exon19:c.G2631A:p.R877R,DSP:uc003mxq.1:exon19:c.G2631A:p.R877R,DSP:uc021yle.1:exon19:c.G2631A:p.R877R	.	AFR:0.6387,AMR:0.7661,EAS:0.7970,FIN:0.7140,NFE:0.7824,OTH:0.7628,ASJ:0.8444	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU14034205	het
6	7576661	7576661	C	T	DSP	exonic	nonsynonymous SNV	ENSG00000096696	rs755099716	ENSG00000096696:ENST00000379802:exon19:c.C2765T:p.T922I,ENSG00000096696:ENST00000418664:exon19:c.C2765T:p.T922I	DSP:NM_001008844:exon19:c.C2765T:p.T922I,DSP:NM_001319034:exon19:c.C2765T:p.T922I,DSP:NM_004415:exon19:c.C2765T:p.T922I	clinvar: Uncertain_significance 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0] 	0.0002	.	.	.	4.443	24.2	0.002	5.16	0.987	.	.	.	DSP:uc003mxp.1:exon19:c.C2765T:p.T922I,DSP:uc003mxq.1:exon19:c.C2765T:p.T922I,DSP:uc021yle.1:exon19:c.C2765T:p.T922I	-1.100	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	0.454	1.25	0.055	1.895	6	.	het
6	7577260	7577260	C	T	DSP	exonic	synonymous SNV	ENSG00000096696	rs2064217	ENSG00000096696:ENST00000379802:exon20:c.C2862T:p.C954C,ENSG00000096696:ENST00000418664:exon20:c.C2862T:p.C954C	DSP:NM_001008844:exon20:c.C2862T:p.C954C,DSP:NM_001319034:exon20:c.C2862T:p.C954C,DSP:NM_004415:exon20:c.C2862T:p.C954C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2438	0.2688	0.27516	MU586982	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon20:c.C2862T:p.C954C,DSP:uc003mxq.1:exon20:c.C2862T:p.C954C,DSP:uc021yle.1:exon20:c.C2862T:p.C954C	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,AMR:0.2733,EAS:0.2440,FIN:0.2119,NFE:0.2015,OTH:0.2560,ASJ:0.3759	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.2309
6	7581636	7581636	G	A	DSP	exonic	nonsynonymous SNV	ENSG00000096696	rs6929069	ENSG00000096696:ENST00000379802:exon23:c.G5213A:p.R1738Q	DSP:NM_004415:exon23:c.G5213A:p.R1738Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1724	0.1941	0.240415	3(haematopoietic_and_lymphoid_tissue)	0.509	7.501	0.076	3.24	0.272	.	.	.	DSP:uc003mxp.1:exon23:c.G5213A:p.R1738Q	-1.093	AFR:MU586983,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,EAS:0.3352,FIN:0.2053,NFE:0.1391,OTH:0.2005,ASJ:0.1975	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	0.003	-0.62	0.076	0.2	6	1(urinary_tract)	0.1804
6	7585967	7585967	G	C	DSP	exonic	synonymous SNV	ENSG00000096696	rs2744380	ENSG00000096696:ENST00000379802:exon24:c.G8472C:p.G2824G,ENSG00000096696:ENST00000418664:exon24:c.G6675C:p.G2225G	DSP:NM_001008844:exon24:c.G6675C:p.G2225G,DSP:NM_001319034:exon24:c.G7143C:p.G2381G,DSP:NM_004415:exon24:c.G8472C:p.G2824G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7117	0.6881	0.709465	0.6718	.	.	.	.	.	.	.	.	DSP:uc003mxp.1:exon24:c.G8472C:p.G2824G,DSP:uc003mxq.1:exon24:c.G6675C:p.G2225G,DSP:uc021yle.1:exon24:c.G7143C:p.G2381G	.	AFR:0.6315,AMR:0.7398,EAS:0.7978,FIN:0.6403,NFE:0.6820,OTH:0.6875,ASJ:0.7781	125647	605676;607450;607655;609638;612908;615821;	65282;50942;158687;293165;217656;65282;	65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~50942|Keratosis palmoplantaris striata et areata<br>Keratosis palmoplantaris varians of Wachters<br>Striate palmoplantar keratoderma|-|Autosomal dominant|-|148700 607654 612908 ~158687|LAEB|<1 / 1 000 000|Autosomal recessive|Neonatal|609638 ~293165|Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|607655 ~217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~65282|Carvajal syndrome<br>KWWH type II<br>Keratoderma with woolly hair type II<br>Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome<br>Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy<br>Childhood|605676 615821 ~	.	.	.	.	.	.	.	.	6	MU14034520	het
6	10398707	10398707	G	A	TFAP2A	exonic	synonymous SNV	ENSG00000137203	rs3734391	ENSG00000137203:ENST00000319516:exon7:c.C1245T:p.N415N,ENSG00000137203:ENST00000379604:exon7:c.C1257T:p.N419N,ENSG00000137203:ENST00000379608:exon7:c.C1239T:p.N413N,ENSG00000137203:ENST00000379613:exon7:c.C1263T:p.N421N,ENSG00000137203:ENST00000482890:exon8:c.C1257T:p.N419N	TFAP2A:NM_001032280:exon7:c.C1239T:p.N413N,TFAP2A:NM_001042425:exon7:c.C1245T:p.N415N,TFAP2A:NM_003220:exon7:c.C1257T:p.N419N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1180	0.1242	0.0888578	LAML-KR|1|205|0.00487805	.	.	.	.	.	.	.	.	TFAP2A:uc003myq.3:exon7:c.C1239T:p.N413N,TFAP2A:uc003myr.3:exon7:c.C1257T:p.N419N,TFAP2A:uc003myt.3:exon7:c.C1245T:p.N415N	.	AFR:0.1100,AMR:0.0792,EAS:0.2384,FIN:0.0210,NFE:0.1025,OTH:0.1383,ASJ:0.0815	107580	113620;	1297;	1297|BOFS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;No data available|Neonatal|113620 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.1092
6	10420098	10420098	C	T	TFAP2A	UTR5	.	ENSG00000137203	rs1621700	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.147364	0.1736	.	.	.	.	.	.	.	.	.	.	AFR:0.0385,AMR:0.3580,EAS:0.0470,FIN:0.2999,NFE:0.2238,OTH:0.2168,ASJ:0.1523	107580	113620;	1297;	1297|BOFS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;No data available|Neonatal|113620 ~	.	.	.	.	.	.	.	.	6	MU118048284	het
6	18139214	18139214	G	A	TPMT	exonic	synonymous SNV	ENSG00000137364	rs2842934	ENSG00000137364:ENST00000309983:exon6:c.C474T:p.I158I	TPMT:NM_000367:exon6:c.C474T:p.I158I,TPMT:NM_001346818:exon6:c.C474T:p.I158I,TPMT:NM_001346817:exon7:c.C474T:p.I158I	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7633	0.7943	0.752995	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	TPMT:uc003ncm.3:exon6:c.C474T:p.I158I,TPMT:uc010jpm.1:exon6:c.C474T:p.I158I	.	AFR:0.7849,AMR:0.8096,EAS:0.7053,FIN:0.7670,NFE:0.7666,OTH:0.7819,ASJ:0.7596	187680	610460;	413687;	413687|-|-|-|-|610460 616903 ~	.	.	.	.	.	.	.	.	6	1(stomach)	0.7515
6	18258516	18258516	G	A	DEK	intronic	.	ENSG00000124795	rs172520	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2847	0.3295	0.36242	0.3129	.	.	.	.	.	.	.	.	.	.	AFR:0.5674,AMR:0.4212,EAS:0.0891,FIN:0.2034,NFE:0.2123,OTH:0.2546,ASJ:0.3245	125264	.	.	.	.	.	.	.	.	.	.	.	6	MU12560614	het
6	24653376	24653376	G	A	TDP2	exonic	synonymous SNV	ENSG00000111802	rs1129644	ENSG00000111802:ENST00000341060:exon5:c.C468T:p.N156N,ENSG00000111802:ENST00000378198:exon6:c.C642T:p.N214N,ENSG00000111802:ENST00000545995:exon6:c.C732T:p.N244N	TDP2:NM_016614:exon6:c.C642T:p.N214N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7393	0.7642	0.805112	1(urinary_tract)	.	.	.	.	.	.	.	.	TDP2:uc003nej.3:exon6:c.C642T:p.N214N,TDP2:uc010jpu.1:exon6:c.C642T:p.N214N	.	AFR:1(oesophagus),AMR:MU4132850,EAS:0.7576,FIN:0.9091,NFE:0.8469,OTH:0.6755,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205	605764	616949;	404493;	404493|SCAR23<br>Spinocerebellar ataxia autosomal recessive type 23|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|616949 ~	.	.	.	.	.	.	.	.	6	1(kidney)	0.8453
6	26045737	26045737	C	G	HIST1H3C	exonic	synonymous SNV	ENSG00000196532	rs3752418	ENSG00000196532:ENST00000540144:exon1:c.C99G:p.T33T	HIST1H3C:NM_003531:exon1:c.C99G:p.T33T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1456	0.0752	0.216853	0.1068	.	.	.	.	.	.	.	.	HIST1H3C:uc003nfv.3:exon1:c.C99G:p.T33T	.	AFR:0.0960,AMR:0.2625,EAS:0.5179,FIN:0.0825,NFE:0.0660,OTH:0.1018,ASJ:0.1126	602812	.	.	.	~ko05034 Alcoholism~ko05202 Transcriptional misregulation in cancer~ko05322 Systemic lupus erythematosus ~	.	.	.	.	.	.	.	6	MU105929	het
6	26045929	26045929	T	C	HIST1H3C	exonic	synonymous SNV	ENSG00000196532	rs3752416	ENSG00000196532:ENST00000540144:exon1:c.T291C:p.C97C	HIST1H3C:NM_003531:exon1:c.T291C:p.C97C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6713	0.6891	0.705272	0.6989	.	.	.	.	.	.	.	.	HIST1H3C:uc003nfv.3:exon1:c.T291C:p.C97C	.	AFR:0.7176,AMR:0.6591,EAS:0.8665,FIN:0.6825,NFE:0.6759,OTH:0.7071,ASJ:0.6733	602812	.	.	.	~ko05034 Alcoholism~ko05202 Transcriptional misregulation in cancer~ko05322 Systemic lupus erythematosus ~	.	.	.	.	.	.	.	6	MU4557974	het
6	26091336	26091336	T	C	HFE	intronic	.	ENSG00000010704	rs2071303	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3686	0.3458	0.426717	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.014	.	.	.	AFR:0.3642,AMR:0.3748,EAS:0.3411,FIN:0.6552,NFE:0.3763,OTH:0.3213,ASJ:0.4120	613609	104300;176100;176200;235200;612635;614193;	465508;79473;101330;443062;95159;1020;	465508|Symptomatic form of HFE-related hereditary hemochromatosis<br>Symptomatic form of classic hemochromatosis|-|Autosomal recessive|-|235200 ~79473|Protoporphyrinogen oxidase deficiency<br>Variegate porphyria|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|176200 ~101330|PCT|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|176090 176100 ~443062|Porphyria cutanea tarda type II|-|Autosomal dominant|-|176100 ~95159|HEP|<1 / 1 000 000|Autosomal recessive|-|176100 ~1020|EOFAD<br>Early-onset familial autosomal dominant Alzheimer disease<br>Familial Alzheimer disease|1-9 / 100 000|Autosomal dominant|Adult|104300 104310 602096 605055 605526 606187 606889 607116 607822 609636 609790 611073 611152 611154 611155 ~	.	.	.	.	.	.	.	.	6	1(stomach)	0.3722
6	28872446	28872446	T	C	TRIM27	intronic	.	ENSG00000204713	rs209126	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5675	0.6261	0.680911	0.6037	.	.	.	.	.	0.0011	0.018	.	.	.	AFR:0.8643,AMR:0.5683,EAS:0.6902,FIN:0.4335,NFE:0.4924,OTH:0.4990,ASJ:0.5464	602165	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	30858732	30858733	CT	-	MIR4640	ncRNA_exonic	.	ENSG00000264594	rs61596908	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0355	0.0468	0.0527157	0.0432	.	.	.	.	.	.	.	.	.	.	AFR:0.1019,AMR:0.0513,EAS:0.0741,FIN:0.0066,NFE:0.0159,OTH:0.0204,ASJ:0.0099	.	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	30862423	30862423	C	T	DDR1	exonic	nonsynonymous SNV	ENSG00000204580	rs1264319	ENSG00000204580:ENST00000361741:exon6:c.C599T:p.P200L,ENSG00000204580:ENST00000417521:exon6:c.C794T:p.P265L	DDR1:NM_001202522:exon10:c.C1406T:p.P469L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1676	0.1966	0.128195	3(soft_tissue)	2.508	19.52	0.308	2.73	0.970	.	.	.	DDR1:uc003nrw.1:exon6:c.C803T:p.P268L,DDR1:uc003nrx.2:exon10:c.C1406T:p.P469L	-1.073	AFR:29(lung),AMR:.,EAS:0.1792,FIN:0.1869,NFE:0.1098,OTH:0.1433,ASJ:.	600408	.	.	.	.	.	.	.	0.0	-1.19	0.064	.	6	3(breast)	0.0900
6	30864829	30864829	T	C	DDR1	exonic	synonymous SNV	ENSG00000204580	rs1049623	ENSG00000204580:ENST00000361741:exon9:c.T909C:p.V303V,ENSG00000204580:ENST00000417521:exon9:c.T1104C:p.V368V,ENSG00000204580:ENST00000376567:exon12:c.T1797C:p.V599V,ENSG00000204580:ENST00000418800:exon13:c.T1797C:p.V599V,ENSG00000204580:ENST00000508312:exon13:c.T1851C:p.V617V,ENSG00000204580:ENST00000513240:exon13:c.T1908C:p.V636V,ENSG00000204580:ENST00000376568:exon14:c.T1908C:p.V636V,ENSG00000204580:ENST00000376569:exon14:c.T1797C:p.V599V,ENSG00000204580:ENST00000376570:exon15:c.T1797C:p.V599V,ENSG00000204580:ENST00000452441:exon15:c.T1908C:p.V636V,ENSG00000204580:ENST00000324771:exon16:c.T1908C:p.V636V,ENSG00000204580:ENST00000376575:exon16:c.T1908C:p.V636V,ENSG00000204580:ENST00000454612:exon17:c.T1797C:p.V599V	DDR1:NM_001202522:exon11:c.T1470C:p.V490V,DDR1:NM_001202523:exon13:c.T1851C:p.V617V,DDR1:NM_001297652:exon13:c.T1797C:p.V599V,DDR1:NM_001297653:exon13:c.T1797C:p.V599V,DDR1:NM_013994:exon13:c.T1908C:p.V636V,DDR1:NM_001297654:exon14:c.T1908C:p.V636V,DDR1:NM_001954:exon15:c.T1797C:p.V599V,DDR1:NM_013993:exon15:c.T1908C:p.V636V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4631	0.4071	0.535743	1(large_intestine)	.	.	.	.	.	.	.	.	DDR1:uc003nrw.1:exon9:c.T1113C:p.V371V,DDR1:uc003nrx.2:exon11:c.T1470C:p.V490V,DDR1:uc003nru.3:exon12:c.T1797C:p.V599V,DDR1:uc003nrt.3:exon13:c.T1797C:p.V599V,DDR1:uc003nrv.3:exon13:c.T1908C:p.V636V,DDR1:uc010jse.3:exon13:c.T1797C:p.V599V,DDR1:uc011dms.2:exon13:c.T1851C:p.V617V,DDR1:uc003nrs.3:exon14:c.T1908C:p.V636V,DDR1:uc003nrq.3:exon15:c.T1797C:p.V599V,DDR1:uc003nrr.3:exon15:c.T1908C:p.V636V	.	AFR:MU157872,AMR:LAML-KR|1|205|0.00487805,EAS:0.4650,FIN:0.5692,NFE:0.3808,OTH:0.6677,ASJ:0.4341	600408	.	.	.	.	.	.	.	.	.	.	.	6	1(prostate)	0.4067
6	30865279	30865279	C	T	DDR1	exonic	synonymous SNV	ENSG00000204580	rs116772905	ENSG00000204580:ENST00000361741:exon10:c.C1122T:p.G374G,ENSG00000204580:ENST00000417521:exon10:c.C1317T:p.G439G,ENSG00000204580:ENST00000376567:exon13:c.C2010T:p.G670G,ENSG00000204580:ENST00000418800:exon14:c.C2010T:p.G670G,ENSG00000204580:ENST00000508312:exon14:c.C2064T:p.G688G,ENSG00000204580:ENST00000513240:exon14:c.C2139T:p.G713G,ENSG00000204580:ENST00000376568:exon15:c.C2121T:p.G707G,ENSG00000204580:ENST00000376569:exon15:c.C2010T:p.G670G,ENSG00000204580:ENST00000376570:exon16:c.C2010T:p.G670G,ENSG00000204580:ENST00000452441:exon16:c.C2121T:p.G707G,ENSG00000204580:ENST00000324771:exon17:c.C2121T:p.G707G,ENSG00000204580:ENST00000376575:exon17:c.C2139T:p.G713G,ENSG00000204580:ENST00000454612:exon18:c.C2010T:p.G670G	DDR1:NM_001202522:exon12:c.C1683T:p.G561G,DDR1:NM_001202523:exon14:c.C2064T:p.G688G,DDR1:NM_001297652:exon14:c.C2010T:p.G670G,DDR1:NM_001297653:exon14:c.C2010T:p.G670G,DDR1:NM_013994:exon14:c.C2139T:p.G713G,DDR1:NM_001297654:exon15:c.C2121T:p.G707G,DDR1:NM_001954:exon16:c.C2010T:p.G670G,DDR1:NM_013993:exon16:c.C2121T:p.G707G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0250	0.0125	0.0247604	0.0146	.	.	.	.	.	.	.	.	DDR1:uc003nrw.1:exon10:c.C1326T:p.G442G,DDR1:uc003nrx.2:exon12:c.C1683T:p.G561G,DDR1:uc003nru.3:exon13:c.C2010T:p.G670G,DDR1:uc003nrt.3:exon14:c.C2010T:p.G670G,DDR1:uc003nrv.3:exon14:c.C2139T:p.G713G,DDR1:uc010jse.3:exon14:c.C2010T:p.G670G,DDR1:uc011dms.2:exon14:c.C2064T:p.G688G,DDR1:uc003nrs.3:exon15:c.C2121T:p.G707G,DDR1:uc003nrq.3:exon16:c.C2010T:p.G670G,DDR1:uc003nrr.3:exon16:c.C2121T:p.G707G	.	AFR:0.0029,AMR:0.0477,EAS:0.0724,FIN:0.0066,NFE:0.0150,OTH:0.0184,ASJ:0.0099	600408	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	30866929	30866929	G	A	DDR1	intronic	.	ENSG00000204580	rs115029731	UNKNOWN	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0078	0.0095	0.00479233	0.0067	.	.	.	.	.	0.0003	0.184	.	.	.	AFR:0.0022,AMR:0.0095,EAS:0.0006,FIN:0.0057,NFE:0.0100,OTH:0.0081,ASJ:0.0033	600408	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	32164869	32164869	G	C	NOTCH4	intronic	.	ENSG00000204301	rs2071280	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3066	0.2523	0.230232	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU649741,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,EAS:0.1956,FIN:0.2871,NFE:0.46,OTH:0.1437,ASJ:0.2679	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	12(soft_tissue)	0.2907
6	32172065	32172065	T	G	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs1044506	ENSG00000204301:ENST00000375023:exon19:c.A2967C:p.G989G	NOTCH4:NM_004557:exon19:c.A2967C:p.G989G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9165	0.9034	0.963259	0.9054	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon19:c.A2967C:p.G989G	.	AFR:0.9704,AMR:0.9427,EAS:0.9957,FIN:0.8716,NFE:0.8629,OTH:0.8988,ASJ:0.9603	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	hom
6	32183175	32183175	G	A	NOTCH4	intronic	.	ENSG00000204301	rs3131290	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4138	0.3276	0.277556	MU113474871	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|2|170|0.0117647,AMR:0.3435,EAS:0.3134,FIN:0.5464,NFE:0.1712,OTH:0.3940,ASJ:0.2134	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	13(soft_tissue)	0.4198
6	32184705	32184705	G	A	NOTCH4	intronic	.	ENSG00000204301	rs3134798	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.7723	0.7697	0.824481	0.7647	.	.	.	.	.	.	.	.	NOTCH4:uc003obc.3:exon11:c.C1878T:p.H626H	.	AFR:0.8603,AMR:0.6782,EAS:0.8995,FIN:0.6301,NFE:0.7298,OTH:0.7311,ASJ:0.9133	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	.	hom
6	32188297	32188297	G	C	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs423023	ENSG00000204301:ENST00000375023:exon6:c.C1044G:p.G348G	NOTCH4:NM_004557:exon6:c.C1044G:p.G348G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3189	.	0.320288	14(soft_tissue)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon6:c.C1044G:p.G348G,NOTCH4:uc003obc.3:exon6:c.C1044G:p.G348G	.	AFR:MU684120,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,EAS:0.2118,FIN:0.2697,NFE:0.47,OTH:0.1875,ASJ:0.2878	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	2(haematopoietic_and_lymphoid_tissue)	0.3153
6	32188383	32188383	T	C	NOTCH4	exonic	nonsynonymous SNV	ENSG00000204301	rs422951	ENSG00000204301:ENST00000375023:exon6:c.A958G:p.T320A	NOTCH4:NM_004557:exon6:c.A958G:p.T320A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4035	0.4002	0.343051	MU113489694	-2.277	0.001	0.546	-4.96	0.273	.	.	EGF-like calcium-binding domain|EGF-like domain	NOTCH4:uc003obb.3:exon6:c.A958G:p.T320A,NOTCH4:uc003obc.3:exon6:c.A958G:p.T320A	-0.758	AFR:LUSC-KR|4|170|0.0235294,AMR:0.4018,EAS:0.3174,FIN:0.5767,NFE:0.1597,OTH:0.4453,ASJ:0.3017	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.0	-2.98	0.351	0.57	6	16(soft_tissue)	0.4739
6	32188603	32188603	C	T	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs520803	ENSG00000204301:ENST00000375023:exon5:c.G852A:p.Q284Q	NOTCH4:NM_004557:exon5:c.G852A:p.Q284Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3060	0.2841	0.267772	MU12600513	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon5:c.G852A:p.Q284Q,NOTCH4:uc003obc.3:exon5:c.G852A:p.Q284Q	.	AFR:LAML-KR|1|205|0.00487805,AMR:0.2860,EAS:0.2715,FIN:0.4765,NFE:0.1332,OTH:0.3149,ASJ:0.2127	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	2(haematopoietic_and_lymphoid_tissue)	0.3328
6	32188640	32188640	T	C	NOTCH4	exonic	nonsynonymous SNV	ENSG00000204301	rs520692	ENSG00000204301:ENST00000375023:exon5:c.A815G:p.D272G	NOTCH4:NM_004557:exon5:c.A815G:p.D272G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3058	0.2829	0.267772	MU12600519	0.672	8.640	0.339	3.6	0.577	.	.	EGF-like domain|EGF-like, conserved site	NOTCH4:uc003obb.3:exon5:c.A815G:p.D272G,NOTCH4:uc003obc.3:exon5:c.A815G:p.D272G	-0.793	AFR:LAML-KR|2|205|0.0097561,AMR:0.2844,EAS:0.2715,FIN:0.4702,NFE:0.1298,OTH:0.3154,ASJ:0.2120	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.001	-2.85	0.356	1.925	6	13(soft_tissue)	0.3304
6	32188642	32188642	T	C	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs520688	ENSG00000204301:ENST00000375023:exon5:c.A813G:p.P271P	NOTCH4:NM_004557:exon5:c.A813G:p.P271P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3109	0.2834	0.280152	1(kidney)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon5:c.A813G:p.P271P,NOTCH4:uc003obc.3:exon5:c.A813G:p.P271P	.	AFR:1(breast),AMR:MU615475,EAS:0.2872,FIN:0.2122,NFE:0.2715,OTH:0.4702,ASJ:LAML-KR|1|205|0.00487805	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.1829
6	32188823	32188823	G	A	NOTCH4	exonic	nonsynonymous SNV	ENSG00000204301	rs8192585	ENSG00000204301:ENST00000375023:exon4:c.C731T:p.S244L	NOTCH4:NM_004557:exon4:c.C731T:p.S244L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0358	0.0307	0.0221645	MU110700	-1.301	0.005	0.681	-6.92	0.002	.	.	EGF-like domain	NOTCH4:uc003obb.3:exon4:c.C731T:p.S244L,NOTCH4:uc003obc.3:exon4:c.C731T:p.S244L	-1.097	AFR:MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,AMR:0.0380,EAS:0.0227,FIN:0.0132,NFE:0.0130,OTH:0.0521,ASJ:0.0210	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.001	-3.08	0.151	-1.82	6	1(breast)	0.0479
6	32189032	32189032	T	C	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs415929	ENSG00000204301:ENST00000375023:exon4:c.A522G:p.T174T	NOTCH4:NM_004557:exon4:c.A522G:p.T174T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3113	0.2835	0.279952	LAML-KR|1|205|0.00487805	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon4:c.A522G:p.T174T,NOTCH4:uc003obc.3:exon4:c.A522G:p.T174T	.	AFR:0.2897,AMR:0.2141,EAS:0.4702,FIN:0.1877,NFE:0.3154,OTH:0.3335,ASJ:0.2709	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(breast)	0.3306
6	32190406	32190406	A	G	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs443198	ENSG00000204301:ENST00000375023:exon3:c.T333C:p.G111G	NOTCH4:NM_004557:exon3:c.T333C:p.G111G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3804	0.4040	0.460663	2(lung)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon3:c.T333C:p.G111G,NOTCH4:uc003obc.3:exon3:c.T333C:p.G111G	.	AFR:2(breast),AMR:MU713734,EAS:0.3795,FIN:0.4611,NFE:0.3225,OTH:0.4338,ASJ:LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(urinary_tract)	0.5261
6	32190484	32190484	G	A	NOTCH4	exonic	synonymous SNV	ENSG00000204301	rs8192569	ENSG00000204301:ENST00000375023:exon3:c.C255T:p.P85P	NOTCH4:NM_004557:exon3:c.C255T:p.P85P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1414	0.1555	0.215056	1(large_intestine)	.	.	.	.	.	.	.	.	NOTCH4:uc003obb.3:exon3:c.C255T:p.P85P,NOTCH4:uc003obc.3:exon3:c.C255T:p.P85P	.	AFR:1(breast),AMR:MU116684,EAS:0.1588,FIN:0.2985,NFE:0.1196,OTH:0.09,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	5(soft_tissue)	0.2807
6	32190871	32190871	T	A	NOTCH4	intronic	.	ENSG00000204301	rs2854049	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0735	0.0803	0.11262	LUSC-KR|1|170|0.00588235	.	.	.	.	.	0	0	.	.	.	AFR:0.0711,AMR:0.1390,EAS:0.0563,FIN:0.1598,NFE:0.0141,OTH:0.0375,ASJ:0.0609	164951	.	.	.	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	1(lung)	0.0504
6	32818774	32818774	T	C	TAP1	exonic	nonsynonymous SNV	ENSG00000168394	rs1057141	ENSG00000168394:ENST00000354258:exon4:c.A1177G:p.I393V,ENSG00000168394:ENST00000425148:exon4:c.A394G:p.I132V	TAP1:NM_000593:exon4:c.A1177G:p.I393V,TAP1:NM_001292022:exon4:c.A394G:p.I132V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2047	0.1961	0.228235	MU12613212	-0.723	0.064	0.683	-2.4	0.777	.	.	ABC transporter type 1, transmembrane domain	TAP1:uc003ocg.3:exon4:c.A1177G:p.I393V,TAP1:uc011dqi.2:exon4:c.A394G:p.I132V	-0.969	AFR:ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.2059,EAS:0.1671,FIN:0.2185,NFE:0.2379,OTH:0.2017,ASJ:0.2690	170260	604571;	34592;	34592|Bare lymphocyte syndrome type 1|-|Autosomal recessive|Childhood|604571 ~	.	.	.	.	0.0	-2.6	0.162	-0.37	6	3(soft_tissue)	0.1692
6	35423662	35423662	A	C	FANCE	exonic	synonymous SNV	ENSG00000112039	rs4713867	ENSG00000112039:ENST00000229769:exon2:c.A387C:p.P129P	FANCE:NM_021922:exon2:c.A387C:p.P129P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7211	0.7357	0.777955	0.7433	.	.	.	.	.	.	.	.	FANCE:uc003oko.1:exon2:c.A387C:p.P129P,FANCE:uc010jvw.1:exon2:c.A387C:p.P129P	.	AFR:0.8741,AMR:0.7995,EAS:0.6605,FIN:0.6994,NFE:0.6843,OTH:0.7255,ASJ:0.7417	613976	600901;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	6	MU18657626	hom
6	36645696	36645696	A	G	CDKN1A	exonic	nonsynonymous SNV	ENSG00000124762	rs2395655	ENSG00000124762:ENST00000448526:exon1:c.A83G:p.D28G	CDKN1A:NM_001291549:exon2:c.A83G:p.D28G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4641	.	0.527556	MU46305489	.	.	.	.	.	.	.	.	CDKN1A:uc011dtq.2:exon1:c.A83G:p.D28G	.	AFR:COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4816,EAS:0.3425,FIN:0.5596,NFE:0.4895,OTH:0.3667,ASJ:0.6871	116899	.	.	.	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04630 JAK-STAT signaling pathway~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,1969	.	.	.	.	.	.	6	1(large_intestine)	0.3996
6	36651971	36651971	C	A	CDKN1A	exonic	nonsynonymous SNV	ENSG00000124762	rs1801270	ENSG00000124762:ENST00000244741:exon2:c.C93A:p.S31R,ENSG00000124762:ENST00000405375:exon2:c.C93A:p.S31R,ENSG00000124762:ENST00000448526:exon2:c.C195A:p.S65R,ENSG00000124762:ENST00000373711:exon3:c.C93A:p.S31R	CDKN1A:NM_000389:exon2:c.C93A:p.S31R,CDKN1A:NM_001220777:exon2:c.C93A:p.S31R,CDKN1A:NM_001220778:exon2:c.C93A:p.S31R,CDKN1A:NM_001291549:exon3:c.C195A:p.S65R,CDKN1A:NM_078467:exon3:c.C93A:p.S31R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1479	0.1276	0.25619	1(large_intestine)	-1.757	0.002	1.0	-3.6	0.149	.	.	.	CDKN1A:uc003omm.4:exon2:c.C93A:p.S31R,CDKN1A:uc003omn.3:exon2:c.C93A:p.S31R,CDKN1A:uc011dtq.2:exon2:c.C195A:p.S65R,CDKN1A:uc021yzc.1:exon2:c.C93A:p.S31R,CDKN1A:uc021yzb.1:exon3:c.C93A:p.S31R	-1.075	AFR:1(thyroid),AMR:1(breast),EAS:MU77405,FIN:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,NFE:0.1458,OTH:0.2477,ASJ:1(liver)	116899	.	.	.	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04630 JAK-STAT signaling pathway~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	,1969	.	.	0.0	-1.61	0.077	-1.02	6	1(lung)	0.2978
6	36652339	36652339	C	G	CDKN1A	intronic	.	ENSG00000124762	rs3176352	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3667	0.3878	0.503594	MU29871221	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3870,EAS:0.4702,FIN:0.3146,NFE:0.5938,OTH:0.2368,ASJ:0.6302	116899	.	.	.	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04630 JAK-STAT signaling pathway~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	6	1(lung)	0.2599
6	36653597	36653597	C	T	CDKN1A	UTR3	.	ENSG00000124762	rs1059234	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1388	0.1045	0.231829	MU18215601	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.1263,EAS:0.2943,FIN:0.0728,NFE:0.4734,OTH:0.0639,ASJ:0.1812	116899	.	.	.	~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04630 JAK-STAT signaling pathway~ko04921 Oxytocin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	6	1(breast)	0.0653
6	37348920	37348920	C	T	RNF8	intronic	.	ENSG00000112130	rs2284923	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5179	0.5006	0.604034	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0	.	.	.	AFR:0.5120,AMR:0.5827,EAS:0.4636,FIN:0.7700,NFE:0.3713,OTH:0.4756,ASJ:0.5835	611685	.	.	.	.	.	.	.	.	.	.	.	6	1(lung)	0.4684
6	37349033	37349033	G	A	RNF8	exonic	synonymous SNV	ENSG00000112130	rs2284922	ENSG00000112130:ENST00000373479:exon7:c.G1344A:p.T448T	RNF8:NM_003958:exon7:c.G1344A:p.T448T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4395	0.4043	0.560304	0.4191	.	.	.	.	.	.	.	.	RNF8:uc003onq.4:exon7:c.G1344A:p.T448T,RNF8:uc011dtx.2:exon7:c.G1140A:p.T380T	.	AFR:0.5315,AMR:0.5322,EAS:0.7497,FIN:0.2789,NFE:0.3482,OTH:0.3615,ASJ:0.4205	611685	.	.	.	.	.	.	.	.	.	.	.	6	MU24947047	het
6	41903782	41903782	A	C	CCND3	exonic	nonsynonymous SNV	ENSG00000112576	rs1051130	ENSG00000112576:ENST00000414200:exon4:c.T559G:p.S187A,ENSG00000112576:ENST00000415497:exon4:c.T187G:p.S63A,ENSG00000112576:ENST00000510503:exon4:c.T395G:p.L132R,ENSG00000112576:ENST00000372987:exon5:c.T625G:p.S209A,ENSG00000112576:ENST00000372988:exon5:c.T532G:p.S178A,ENSG00000112576:ENST00000372991:exon5:c.T775G:p.S259A,ENSG00000112576:ENST00000511642:exon5:c.T532G:p.S178A	CCND3:NM_001136125:exon4:c.T559G:p.S187A,CCND3:NM_001136126:exon4:c.T187G:p.S63A,CCND3:NM_001136017:exon5:c.T532G:p.S178A,CCND3:NM_001287427:exon5:c.T625G:p.S209A,CCND3:NM_001287434:exon5:c.T187G:p.S63A,CCND3:NM_001760:exon5:c.T775G:p.S259A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5443	0.6243	0.592452	1(biliary_tract)	-1.116	0.009	0.561	0.192	0.074	.	.	Cyclin, C-terminal domain;Cyclin, C-terminal domain|Cyclin-like;Cyclin, N-terminal|Cyclin-like	CCND3:uc003oro.3:exon4:c.T559G:p.S187A,CCND3:uc011duk.2:exon4:c.T187G:p.S63A,CCND3:uc003orm.3:exon5:c.T625G:p.S209A,CCND3:uc003orn.3:exon5:c.T775G:p.S259A,CCND3:uc003orp.3:exon5:c.T532G:p.S178A	-0.932	AFR:1(breast),AMR:1(thyroid),EAS:MU4550745,FIN:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,BLCA-CN|1|103|0.00970874,NFE:0.6191,OTH:0.8028,ASJ:1(pancreas)	123834	.	.	.	~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04510 Focal adhesion~ko04630 JAK-STAT signaling pathway~ko05162 Measles~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis ~	.	.	.	0.0	1.93	0.010	0.205	6	62(lung)	0.5263
6	43582180	43582180	C	T	POLH	exonic	synonymous SNV	ENSG00000170734	rs140971385	ENSG00000170734:ENST00000535400:exon10:c.C1842T:p.A614A,ENSG00000170734:ENST00000372236:exon11:c.C2028T:p.A676A	POLH:NM_001291969:exon9:c.C1656T:p.A552A,POLH:NM_006502:exon11:c.C2028T:p.A676A	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0005	0.0008	0.000798722	0.0011	.	.	.	.	.	.	.	.	POLH:uc003ovr.4:exon8:c.C1776T:p.A592A,POLH:uc010jyu.2:exon9:c.C1656T:p.A552A,POLH:uc003ovq.4:exon11:c.C2028T:p.A676A	.	AFR:0.0035,AMR:0,EAS:0.0025,FIN:0,NFE:0,OTH:0,ASJ:0	603968	278750;	90342;	90342|XPV|<1 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|278750 ~	.	.	.	.	.	.	.	.	6	.	het
6	44268371	44268371	T	C	AARS2	exonic	synonymous SNV	ENSG00000124608	rs325008	ENSG00000124608:ENST00000244571:exon22:c.A2871G:p.S957S	AARS2:NM_020745:exon22:c.A2871G:p.S957S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9426	0.8711	0.869409	0.8912	.	.	.	.	.	.	.	.	AARS2:uc010jza.1:exon22:c.A2871G:p.S957S	.	AFR:0.6787,AMR:0.9606,EAS:0.9975,FIN:0.9954,NFE:0.9709,OTH:0.9469,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU4546910	hom
6	44269023	44269023	T	C	AARS2	intronic	.	ENSG00000124608;ENSG00000178233;ENSG00000272442	rs325007	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9421	0.8683	0.867812	0.8895	.	.	.	.	.	.	.	.	.	.	AFR:0.6724,AMR:0.9593,EAS:0.9969,FIN:0.9954,NFE:0.9709,OTH:0.9467,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	.	.	.	.	6	MU81815181	hom
6	44275011	44275011	T	C	AARS2	exonic	nonsynonymous SNV	ENSG00000124608	rs324136	ENSG00000124608:ENST00000244571:exon6:c.A1015G:p.I339V	AARS2:NM_020745:exon6:c.A1015G:p.I339V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9469	0.8866	0.888978	0.9059	-0.555	0.161	0.378	2.88	0.879	.	.	Alanine-tRNA ligase, class IIc, anti-codon-binding domain|Alanyl-tRNA synthetase, class IIc, N-terminal|Alanyl-tRNA synthetase, class IIc, core domain	AARS2:uc010jza.1:exon6:c.A1015G:p.I339V	-1.086	AFR:0.7292,AMR:0.9618,EAS:0.9975,FIN:0.9954,NFE:0.9716,OTH:0.9497,ASJ:0.9139	612035	614096;615889;	135;99853;319504;	135|Childhood ataxia with diffuse central nervous system hypomyelination<br>Leukoencephalopathy with vanishing white matter<br>Myelinosis centralis diffusa|Unknown|Autosomal recessive|Childhood|603896 615889 ~99853|-|<1 / 1 000 000|Autosomal recessive|Childhood<br>Adolescent<br>Adult|603896 615889 ~319504|COXPD8|<1 / 1 000 000|-|Neonatal<br>Infancy|614096 ~	.	.	.	.	0.0	-0.43	0.033	-1.04	6	MU81815212	hom
6	93967851	93967851	C	T	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs345730	ENSG00000135333:ENST00000369303:exon11:c.G2076A:p.P692P	EPHA7:NM_001288629:exon11:c.G2061A:p.P687P,EPHA7:NM_004440:exon11:c.G2076A:p.P692P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7226	0.6783	0.73123	0.6823	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon11:c.G2076A:p.P692P,EPHA7:uc003pof.3:exon11:c.G2061A:p.P687P,EPHA7:uc011eac.2:exon11:c.G2064A:p.P688P	.	AFR:0.6010,AMR:0.6930,EAS:0.7868,FIN:0.7228,NFE:0.7056,OTH:0.7035,ASJ:0.7550	602190	.	.	.	.	.	.	.	.	.	.	.	6	MU20730318	hom
6	93982124	93982124	A	G	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs345713	ENSG00000135333:ENST00000369303:exon6:c.T1341C:p.S447S	EPHA7:NM_001288629:exon6:c.T1341C:p.S447S,EPHA7:NM_004440:exon6:c.T1341C:p.S447S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8735	0.9151	0.900359	0.8912	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon6:c.T1341C:p.S447S,EPHA7:uc003pof.3:exon6:c.T1341C:p.S447S,EPHA7:uc011eac.2:exon6:c.T1341C:p.S447S	.	AFR:0.9733,AMR:0.8070,EAS:0.7869,FIN:0.8502,NFE:0.8689,OTH:0.8686,ASJ:0.9437	602190	.	.	.	.	.	.	.	.	.	.	.	6	MU721640	hom
6	94067981	94067981	C	T	EPHA7	exonic	synonymous SNV	ENSG00000135333	rs164544	ENSG00000135333:ENST00000369303:exon4:c.G981A:p.A327A	EPHA7:NM_001288629:exon4:c.G981A:p.A327A,EPHA7:NM_004440:exon4:c.G981A:p.A327A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6284	0.6362	0.730431	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	EPHA7:uc003poe.3:exon4:c.G981A:p.A327A,EPHA7:uc003pof.3:exon4:c.G981A:p.A327A,EPHA7:uc011eac.2:exon4:c.G981A:p.A327A	.	AFR:0.6591,AMR:0.8392,EAS:0.4899,FIN:0.8439,NFE:0.6164,OTH:0.5493,ASJ:0.6906	602190	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.6063
6	94120192	94120192	G	A	EPHA7	UTR3	.	ENSG00000135333	rs474809	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5384	0.5549	0.632987	ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.5908,AMR:0.7911,EAS:0.26,FIN:0.6793,NFE:0.5762,OTH:0.4763,ASJ:0.6112	602190	.	.	.	.	.	.	.	.	.	.	.	6	4(large_intestine)	0.5469
6	105300262	105300262	-	AG	HACE1	intronic	.	ENSG00000085382	rs10635352	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6682	0.6597	0.620008	0.6452	.	.	.	.	.	.	.	.	.	.	AFR:0.5858,AMR:0.6190,EAS:0.5638,FIN:0.6368,NFE:0.6865,OTH:0.6902,ASJ:0.7633	610876	616756;	464282;	464282|SPPRS syndrome<br>Spastic paraplegia-psychomotor retardation-seizures syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616756 ~	.	.	.	.	.	.	.	.	6	.	hom
6	105307435	105307435	G	A	HACE1	intronic	.	ENSG00000085382	rs2499655	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5276	0.3781	0.438099	0.4390	.	.	.	.	.	0.0013	0.092	.	.	.	AFR:0.2035,AMR:0.4353,EAS:0.5557,FIN:0.5210,NFE:0.5351,OTH:0.5277,ASJ:0.6060	610876	616756;	464282;	464282|SPPRS syndrome<br>Spastic paraplegia-psychomotor retardation-seizures syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616756 ~	.	.	.	.	.	.	.	.	6	MU81819230	hom
6	106547372	106547372	C	G	PRDM1	exonic	nonsynonymous SNV	ENSG00000057657	rs811925	ENSG00000057657:ENST00000369089:exon2:c.C207G:p.D69E,ENSG00000057657:ENST00000450060:exon2:c.C246G:p.D82E,ENSG00000057657:ENST00000369091:exon4:c.C501G:p.D167E,ENSG00000057657:ENST00000369096:exon4:c.C609G:p.D203E	PRDM1:NM_182907:exon2:c.C207G:p.D69E,PRDM1:NM_001198:exon4:c.C609G:p.D203E	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1651	0.1672	0.15016	3(soft_tissue)	0.884	9.973	0.712	5.94	1.000	.	.	SET domain	PRDM1:uc003pre.3:exon2:c.C207G:p.D69E,PRDM1:uc003prd.2:exon4:c.C609G:p.D203E	-0.381	AFR:.,AMR:.,EAS:0.1580,FIN:0.1551,NFE:0.1225,OTH:0.0179,ASJ:0.1657	603423	.	.	.	.	.	.	9097,	0.66	-2.5	0.262	2.42	6	1(pleura)	0.2450
6	111631316	111631316	A	G	REV3L	intronic	.	ENSG00000272356	rs191081586	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0009	0.0002	0.00539137	0.0009	.	.	.	.	.	.	.	.	.	.	AFR:0.0007,AMR:0,EAS:0.0117,FIN:0,NFE:0,OTH:0.0020,ASJ:0	602776	.	.	.	.	.	.	.	.	.	.	.	6	MU82308013	het
6	111695073	111695073	C	T	REV3L	exonic	synonymous SNV	ENSG00000009413	rs455645	ENSG00000009413:ENST00000368802:exon13:c.G4485A:p.S1495S,ENSG00000009413:ENST00000358835:exon14:c.G4485A:p.S1495S,ENSG00000009413:ENST00000368805:exon14:c.G4485A:p.S1495S,ENSG00000009413:ENST00000435970:exon15:c.G4251A:p.S1417S	REV3L:NM_002912:exon14:c.G4485A:p.S1495S,REV3L:NM_001286432:exon15:c.G4251A:p.S1417S,REV3L:NM_001286431:exon16:c.G4251A:p.S1417S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7159	0.6862	0.586462	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.G4485A:p.S1495S,REV3L:uc003pux.4:exon15:c.G4251A:p.S1417S,REV3L:uc003puz.4:exon15:c.G4251A:p.S1417S	.	AFR:0.6670,AMR:0.4393,EAS:0.7682,FIN:0.4651,NFE:0.6989,OTH:0.8072,ASJ:0.6826	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.7169
6	111695268	111695268	C	T	REV3L	exonic	synonymous SNV	ENSG00000009413	rs455732	ENSG00000009413:ENST00000368802:exon13:c.G4290A:p.V1430V,ENSG00000009413:ENST00000358835:exon14:c.G4290A:p.V1430V,ENSG00000009413:ENST00000368805:exon14:c.G4290A:p.V1430V,ENSG00000009413:ENST00000435970:exon15:c.G4056A:p.V1352V	REV3L:NM_002912:exon14:c.G4290A:p.V1430V,REV3L:NM_001286432:exon15:c.G4056A:p.V1352V,REV3L:NM_001286431:exon16:c.G4056A:p.V1352V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4703	0.3946	0.354034	1(liver)	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.G4290A:p.V1430V,REV3L:uc003pux.4:exon15:c.G4056A:p.V1352V,REV3L:uc003puz.4:exon15:c.G4056A:p.V1352V	.	AFR:MU721734,AMR:LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,EAS:0.1064,FIN:0.4246,NFE:0.4702,OTH:0.4310,ASJ:0.3983	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4971
6	111695887	111695887	G	A	REV3L	exonic	nonsynonymous SNV	ENSG00000009413	rs462779	ENSG00000009413:ENST00000368802:exon13:c.C3671T:p.T1224I,ENSG00000009413:ENST00000358835:exon14:c.C3671T:p.T1224I,ENSG00000009413:ENST00000368805:exon14:c.C3671T:p.T1224I,ENSG00000009413:ENST00000435970:exon15:c.C3437T:p.T1146I	REV3L:NM_002912:exon14:c.C3671T:p.T1224I,REV3L:NM_001286432:exon15:c.C3437T:p.T1146I,REV3L:NM_001286431:exon16:c.C3437T:p.T1146I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7165	0.6866	0.586462	0.6672	0.396	6.577	1.0	1.45	0.417	.	.	.	REV3L:uc003puy.4:exon13:c.C3671T:p.T1224I,REV3L:uc003pux.4:exon15:c.C3437T:p.T1146I,REV3L:uc003puz.4:exon15:c.C3437T:p.T1146I	-0.991	AFR:0.4399,AMR:0.6818,EAS:0.4652,FIN:0.6987,NFE:0.8075,OTH:0.7172,ASJ:0.7667	602776	.	.	.	.	.	.	.	0.0	5.02	0.001	-1.355	6	MU4714890	het
6	111696257	111696257	G	A	REV3L	exonic	synonymous SNV	ENSG00000009413	rs461646	ENSG00000009413:ENST00000368802:exon13:c.C3301T:p.L1101L,ENSG00000009413:ENST00000358835:exon14:c.C3301T:p.L1101L,ENSG00000009413:ENST00000368805:exon14:c.C3301T:p.L1101L,ENSG00000009413:ENST00000435970:exon15:c.C3067T:p.L1023L	REV3L:NM_002912:exon14:c.C3301T:p.L1101L,REV3L:NM_001286432:exon15:c.C3067T:p.L1023L,REV3L:NM_001286431:exon16:c.C3067T:p.L1023L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7161	0.6859	0.586661	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.C3301T:p.L1101L,REV3L:uc003pux.4:exon15:c.C3067T:p.L1023L,REV3L:uc003puz.4:exon15:c.C3067T:p.L1023L	.	AFR:MU4714901,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.4403,FIN:0.6859,NFE:0.7682,OTH:0.4633,ASJ:0.6671	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(liver)	0.6988
6	111696852	111696852	T	C	REV3L	exonic	synonymous SNV	ENSG00000009413	rs458486	ENSG00000009413:ENST00000368802:exon13:c.A2706G:p.G902G,ENSG00000009413:ENST00000358835:exon14:c.A2706G:p.G902G,ENSG00000009413:ENST00000368805:exon14:c.A2706G:p.G902G,ENSG00000009413:ENST00000435970:exon15:c.A2472G:p.G824G	REV3L:NM_002912:exon14:c.A2706G:p.G902G,REV3L:NM_001286432:exon15:c.A2472G:p.G824G,REV3L:NM_001286431:exon16:c.A2472G:p.G824G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4710	0.3945	0.354233	MU12436274	.	.	.	.	.	.	.	.	REV3L:uc003puy.4:exon13:c.A2706G:p.G902G,REV3L:uc003pux.4:exon15:c.A2472G:p.G824G,REV3L:uc003puz.4:exon15:c.A2472G:p.G824G	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,AMR:0.3978,EAS:0.4221,FIN:0.4702,NFE:0.4268,OTH:0.4974,ASJ:0.1059	602776	.	.	.	.	.	.	.	.	.	.	.	6	1(breast)	0.5350
6	111696914	111696914	G	A	REV3L	exonic	nonsynonymous SNV	ENSG00000009413	rs748014293	ENSG00000009413:ENST00000368802:exon13:c.C2644T:p.R882C,ENSG00000009413:ENST00000358835:exon14:c.C2644T:p.R882C,ENSG00000009413:ENST00000368805:exon14:c.C2644T:p.R882C,ENSG00000009413:ENST00000435970:exon15:c.C2410T:p.R804C	REV3L:NM_002912:exon14:c.C2644T:p.R882C,REV3L:NM_001286432:exon15:c.C2410T:p.R804C,REV3L:NM_001286431:exon16:c.C2410T:p.R804C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 2, -1, 0, 0] 	3.318e-05	.	.	.	0.672	8.640	0.029	4.6	0.357	.	.	Domain of unknown function DUF4683	REV3L:uc003puy.4:exon13:c.C2644T:p.R882C,REV3L:uc003pux.4:exon15:c.C2410T:p.R804C,REV3L:uc003puz.4:exon15:c.C2410T:p.R804C	-0.908	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	602776	.	.	.	.	.	.	.	0.0	4.9	0.003	1.01	6	1(skin)	.
6	114265587	114265587	T	C	HDAC2	intronic	.	ENSG00000196591	rs13204445	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2389	0.2288	0.217652	MU4786238	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,AMR:0.2192,EAS:0.1659,FIN:0.2450,NFE:0.3017,OTH:0.2013,ASJ:0.1462	605164	.	.	.	~ko04110 Cell cycle~ko04213 Longevity regulating pathway - multiple species~ko04330 Notch signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05016 Huntington disease~ko05034 Alcoholism~ko05165 Human papillomavirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	6	1(liver)	0.2586
6	117642992	117642992	-	T	ROS1	intronic	.	ENSG00000047936	rs11451804	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.438299	0.4604	.	.	.	.	.	.	.	.	.	.	AFR:0.5757,AMR:0.5584,EAS:0.4341,FIN:0.1336,NFE:0.4016,OTH:0.4516,ASJ:0.4433	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	117644258	117644258	G	C	ROS1	intronic	.	ENSG00000047936	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	117647769	117647769	T	G	ROS1	intronic	.	ENSG00000047936	rs185865637	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	0.00159744	3.232e-05	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	117653330	117653330	A	-	ROS1	intronic	.	ENSG00000047936	rs199863437	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.1057	.	.	.	.	.	.	.	.	.	.	AFR:0.1580,AMR:0.1292,EAS:0.0840,FIN:0.1778,NFE:0.0619,OTH:0.1242,ASJ:0.1607	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	117654711	117654711	T	C	ROS1	intronic	.	ENSG00000047936	rs2095283	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	1	0.9990	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:0.9988,FIN:0.9991,NFE:0.9983,OTH:0.9980,ASJ:1	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	117656555	117656555	T	G	ROS1	intronic	.	ENSG00000047936	rs9385006	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.757987	0.7751	.	.	.	.	.	.	.	.	.	.	AFR:0.8458,AMR:0.7422,EAS:0.6043,FIN:0.6943,NFE:0.7745,OTH:0.7525,ASJ:0.7767	165020	.	.	.	.	.	.	.	.	.	.	.	6	MU114372260	het
6	117656948	117656948	T	C	ROS1	intronic	.	ENSG00000047936	rs536308308	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.000798722	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	165020	.	.	.	.	.	.	.	.	.	.	.	6	.	het
6	117678083	117678083	A	G	ROS1	intronic	.	ENSG00000047936	rs2243384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4657	0.4254	0.394569	MU687081	.	.	.	.	.	0	0	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.4054,EAS:0.4093,FIN:0.5033,NFE:0.4882,OTH:0.4413,ASJ:0.2292	165020	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.4875
6	117725578	117725578	T	A	ROS1	exonic	synonymous SNV	ENSG00000047936	rs2243378	ENSG00000047936:ENST00000368508:exon5:c.A303T:p.L101L,ENSG00000047936:ENST00000368507:exon6:c.A330T:p.L110L	ROS1:NM_002944:exon5:c.A303T:p.L101L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5497	0.5992	0.67512	MU136033	.	.	.	.	.	.	.	.	ROS1:uc003pxp.1:exon5:c.A303T:p.L101L	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,AMR:0.6261,EAS:0.4785,FIN:0.3775,NFE:0.5655,OTH:0.6040,ASJ:0.8677	165020	.	.	.	.	,9578,9579,9580	.	.	.	.	.	.	6	2(large_intestine)	0.5096
6	117730819	117730819	G	A	ROS1	intronic	.	ENSG00000047936	rs2273601	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2795	0.3166	0.360224	1(lung)	.	.	.	.	.	.	.	.	.	.	AFR:1(upper_aerodigestive_tract),AMR:MU18067807,EAS:0.3241,FIN:0.4715,NFE:0.1659,OTH:0.2233,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	165020	.	.	.	.	.	.	.	.	.	.	.	6	1(liver)	0.2706
6	128312033	128312033	A	G	PTPRK	intronic	.	ENSG00000152894	rs12055782	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2965	0.2202	0.263179	MU806746	.	.	.	.	.	0.0002	0.024	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.2552,EAS:0.3795,FIN:0.2947,NFE:0.4038,OTH:0.3626,ASJ:0.0855	602545	.	.	.	.	.	.	.	.	.	.	.	6	1(lung)	0.3026
6	128383562	128383562	-	A	LOC101928140	ncRNA_intronic	.	ENSG00000227945	rs11422080	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.957668	0.9075	.	.	.	.	.	.	.	.	.	.	AFR:0.9730,AMR:0.9342,EAS:1,FIN:0.9064,NFE:0.8568,OTH:0.9090,ASJ:0.9536	.	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	128388799	128388799	G	T	PTPRK	exonic	synonymous SNV	ENSG00000152894	rs35030557	ENSG00000152894:ENST00000368207:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368210:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368213:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368215:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368226:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000368227:exon12:c.C2022A:p.L674L,ENSG00000152894:ENST00000532331:exon12:c.C2022A:p.L674L	PTPRK:NM_001291983:exon11:c.C1635A:p.L545L,PTPRK:NM_001135648:exon12:c.C2022A:p.L674L,PTPRK:NM_001291981:exon12:c.C2022A:p.L674L,PTPRK:NM_001291982:exon12:c.C2022A:p.L674L,PTPRK:NM_001291984:exon12:c.C2022A:p.L674L,PTPRK:NM_002844:exon12:c.C2022A:p.L674L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3739	0.3150	0.245208	1(liver)	.	.	.	.	.	.	.	.	PTPRK:uc003qbl.1:exon10:c.C1632A:p.L544L,PTPRK:uc003qbj.3:exon12:c.C2022A:p.L674L,PTPRK:uc003qbk.3:exon12:c.C2022A:p.L674L,PTPRK:uc010kfc.3:exon12:c.C2022A:p.L674L,PTPRK:uc011ebu.2:exon12:c.C2022A:p.L674L,PTPRK:uc011ebv.1:exon12:c.C2022A:p.L674L	.	AFR:MU134141,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.0922,FIN:0.4234,NFE:0.3543,OTH:0.2363,ASJ:0.3367	602545	.	.	.	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.5055
6	128403745	128403745	A	G	PTPRK	exonic	synonymous SNV	ENSG00000152894	rs17828130	ENSG00000152894:ENST00000368207:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368210:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368213:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368215:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368226:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000368227:exon10:c.T1614C:p.V538V,ENSG00000152894:ENST00000532331:exon10:c.T1614C:p.V538V	PTPRK:NM_001291983:exon9:c.T1227C:p.V409V,PTPRK:NM_001135648:exon10:c.T1614C:p.V538V,PTPRK:NM_001291981:exon10:c.T1614C:p.V538V,PTPRK:NM_001291982:exon10:c.T1614C:p.V538V,PTPRK:NM_001291984:exon10:c.T1614C:p.V538V,PTPRK:NM_002844:exon10:c.T1614C:p.V538V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5892	0.4865	0.481829	0.4893	.	.	.	.	.	.	.	.	PTPRK:uc003qbl.1:exon8:c.T1224C:p.V408V,PTPRK:uc003qbj.3:exon10:c.T1614C:p.V538V,PTPRK:uc003qbk.3:exon10:c.T1614C:p.V538V,PTPRK:uc010kfc.3:exon10:c.T1614C:p.V538V,PTPRK:uc011ebu.2:exon10:c.T1614C:p.V538V,PTPRK:uc011ebv.1:exon10:c.T1614C:p.V538V	.	AFR:0.1828,AMR:0.6918,EAS:0.5370,FIN:0.5369,NFE:0.6335,OTH:0.5806,ASJ:0.5232	602545	.	.	.	.	.	.	.	.	.	.	.	6	MU14046683	hom
6	129381026	129381026	C	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs4404787	ENSG00000196569:ENST00000421865:exon3:c.C381A:p.T127T	LAMA2:NM_000426:exon3:c.C381A:p.T127T,LAMA2:NM_001079823:exon3:c.C381A:p.T127T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9578	0.9473	0.936701	0.9540	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon3:c.C381A:p.T127T,LAMA2:uc003qbo.3:exon3:c.C381A:p.T127T,LAMA2:uc021zfb.1:exon3:c.C381A:p.T127T	.	AFR:0.9027,AMR:0.9773,EAS:0.9759,FIN:0.9840,NFE:0.9723,OTH:0.9644,ASJ:0.9636	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU81821229	het
6	129612808	129612808	A	G	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs1027199	ENSG00000196569:ENST00000421865:exon20:c.A2799G:p.Q933Q	LAMA2:NM_000426:exon20:c.A2799G:p.Q933Q,LAMA2:NM_001079823:exon20:c.A2799G:p.Q933Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2683	0.2584	0.313898	0.2719	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon20:c.A2799G:p.Q933Q,LAMA2:uc003qbo.3:exon20:c.A2799G:p.Q933Q,LAMA2:uc021zfb.1:exon20:c.A2799G:p.Q933Q	.	AFR:0.3228,AMR:0.2524,EAS:0.4294,FIN:0.2984,NFE:0.2232,OTH:0.2459,ASJ:0.2067	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU105678	het
6	129634255	129634255	G	A	LAMA2	intronic	.	ENSG00000196569	rs3798663	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2190	0.2277	0.355232	0.2465	.	.	.	.	.	.	.	.	.	.	AFR:0.4602,AMR:0.3146,EAS:0.5412,FIN:0.1478,NFE:0.1187,OTH:0.1561,ASJ:0.1126	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU18714958	het
6	129722389	129722389	A	G	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs3749877	ENSG00000196569:ENST00000421865:exon38:c.A5466G:p.E1822E	LAMA2:NM_000426:exon38:c.A5466G:p.E1822E,LAMA2:NM_001079823:exon38:c.A5466G:p.E1822E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4978	0.5161	0.544529	0.5112	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon38:c.A5466G:p.E1822E,LAMA2:uc003qbo.3:exon38:c.A5466G:p.E1822E,LAMA2:uc021zfb.1:exon38:c.A5466G:p.E1822E	.	AFR:0.6206,AMR:0.4845,EAS:0.5824,FIN:0.4613,NFE:0.4523,OTH:0.5051,ASJ:0.5705	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU12472152	het
6	129722425	129722425	G	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs3749878	ENSG00000196569:ENST00000421865:exon38:c.G5502A:p.E1834E	LAMA2:NM_000426:exon38:c.G5502A:p.E1834E,LAMA2:NM_001079823:exon38:c.G5502A:p.E1834E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4963	0.5150	0.543331	0.5089	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon38:c.G5502A:p.E1834E,LAMA2:uc003qbo.3:exon38:c.G5502A:p.E1834E,LAMA2:uc021zfb.1:exon38:c.G5502A:p.E1834E	.	AFR:0.6208,AMR:0.4784,EAS:0.5815,FIN:0.4559,NFE:0.4496,OTH:0.5020,ASJ:0.5667	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU4554300	het
6	129762112	129762112	G	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs2297738	ENSG00000196569:ENST00000421865:exon43:c.G6237A:p.T2079T	LAMA2:NM_000426:exon43:c.G6237A:p.T2079T,LAMA2:NM_001079823:exon43:c.G6237A:p.T2079T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1683	0.1390	0.182508	0.1654	.	.	.	.	.	.	.	.	LAMA2:uc003qbn.3:exon43:c.G6237A:p.T2079T,LAMA2:uc003qbo.3:exon43:c.G6237A:p.T2079T,LAMA2:uc021zfb.1:exon43:c.G6237A:p.T2079T	.	AFR:0.1297,AMR:0.1993,EAS:0.2135,FIN:0.2033,NFE:0.1698,OTH:0.1864,ASJ:0.1258	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU113879	het
6	129807714	129807714	G	A	LAMA2	exonic	synonymous SNV	ENSG00000196569	rs2229850	ENSG00000196569:ENST00000421865:exon56:c.G7845A:p.P2615P	LAMA2:NM_001079823:exon55:c.G7833A:p.P2611P,LAMA2:NM_000426:exon56:c.G7845A:p.P2615P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3080	0.3422	0.403754	0.3535	.	.	.	.	.	.	.	.	LAMA2:uc003qbo.3:exon54:c.G7827A:p.P2609P,LAMA2:uc003qbn.3:exon55:c.G7839A:p.P2613P,LAMA2:uc021zfb.1:exon56:c.G7845A:p.P2615P	.	AFR:0.5389,AMR:0.3007,EAS:0.3878,FIN:0.3129,NFE:0.2609,OTH:0.2953,ASJ:0.2285	156225	607855;	258;	258|CMD1A<br>Congenital muscular dystrophy due to laminin alpha2 deficiency<br>MDC1A<br>Merosin-negative congenital muscular dystrophy|1-9 / 1 000 000|Autosomal recessive|Neonatal|607855 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC)~ko05414 Dilated cardiomyopathy (DCM)~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	6	MU12472301	het
6	137519238	137519238	A	G	IFNGR1	exonic	nonsynonymous SNV	ENSG00000027697	rs1887415	ENSG00000027697:ENST00000367739:exon7:c.T1400C:p.L467P,ENSG00000027697:ENST00000543628:exon7:c.T1316C:p.L439P	IFNGR1:NM_000416:exon7:c.T1400C:p.L467P,IFNGR1:NM_001363527:exon7:c.T1277C:p.L426P,IFNGR1:NM_001363526:exon8:c.T1370C:p.L457P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0519	0.0053	0.0838658	0.0128	1.122	11.34	0.123	1.96	0.262	.	.	.	IFNGR1:uc003qho.2:exon7:c.T1400C:p.L467P,IFNGR1:uc011edm.1:exon7:c.T1316C:p.L439P	-0.973	AFR:0.0142,AMR:0.0776,EAS:0.0426,FIN:0.0200,NFE:0.0019,OTH:0.0347,ASJ:0.0166	107470	209950;600263;607948;610424;615978;	319581;3389;319569;99898;	319581|Autosomal dominant MSMD due to partial IFNgammaR1 deficiency<br>Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal dominant|Adolescent|615978 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~319569|Autosomal recessive MSMD due to partial IFNgammaR1 deficiency<br>Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal recessive|-|209950 ~99898|MSMD due to complete IFNgammaR1 deficiency<br>MSMD due to complete interferon gamma receptor 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|209950 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04066 HIF-1 signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05132 Salmonella infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	0.233	-1.33	0.150	1.35	6	MU80603211	het
6	137540370	137540370	A	G	IFNGR1	intronic	.	ENSG00000027697	rs7749390	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4834	0.4282	0.502396	0.4295	.	.	.	.	.	.	.	.	.	.	AFR:0.5046,AMR:0.3696,EAS:0.5894,FIN:0.3465,NFE:0.3881,OTH:0.45,ASJ:0.5232	107470	209950;600263;607948;610424;615978;	319581;3389;319569;99898;	319581|Autosomal dominant MSMD due to partial IFNgammaR1 deficiency<br>Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal dominant|Adolescent|615978 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~319569|Autosomal recessive MSMD due to partial IFNgammaR1 deficiency<br>Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency<br>Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency|<1 / 1 000 000|Autosomal recessive|-|209950 ~99898|MSMD due to complete IFNgammaR1 deficiency<br>MSMD due to complete interferon gamma receptor 1 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|209950 ~	~ko04060 Cytokine-cytokine receptor interaction~ko04066 HIF-1 signaling pathway~ko04217 Necroptosis~ko04380 Osteoclast differentiation~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05132 Salmonella infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	6	MU20697206	het
6	138195962	138195964	CTC	-	TNFAIP3	intronic	.	ENSG00000118503	rs2307859	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.6105	0.4825	0.533946	0.5196	.	.	.	.	.	.	.	.	.	.	AFR:0.1745,AMR:0.5396,EAS:0.8602,FIN:0.6460,NFE:0.6471,OTH:0.6118,ASJ:0.5728	191163	616744;	.	.	.	.	.	.	.	.	.	.	6	.	hom
6	146207563	146207563	A	G	LOC100507557	ncRNA_exonic	.	ENSG00000235652	rs1062067	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4445	0.3704	0.349641	0.3706	.	.	.	.	.	.	.	.	.	.	AFR:0.2724,AMR:0.2148,EAS:0.3506,FIN:0.4762,NFE:0.4118,OTH:0.3937,ASJ:0.3974	.	.	.	.	.	.	.	.	.	.	.	.	6	MU12506364	hom
6	146234644	146234644	G	A	SHPRH	exonic	synonymous SNV	ENSG00000146414	rs9497426	ENSG00000146414:ENST00000275233:exon24:c.C4296T:p.C1432C,ENSG00000146414:ENST00000367503:exon24:c.C4308T:p.C1436C,ENSG00000146414:ENST00000367505:exon24:c.C4296T:p.C1432C,ENSG00000146414:ENST00000438092:exon24:c.C4308T:p.C1436C	SHPRH:NM_001042683:exon24:c.C4296T:p.C1432C,SHPRH:NM_001370327:exon24:c.C4296T:p.C1432C,SHPRH:NM_173082:exon24:c.C4308T:p.C1436C,SHPRH:NM_001370328:exon26:c.C2853T:p.C951C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7804	0.8120	0.836262	0.8023	.	.	.	.	.	.	.	.	SHPRH:uc003qlg.1:exon23:c.C2964T:p.C988C,SHPRH:uc003qle.3:exon24:c.C4308T:p.C1436C,SHPRH:uc003qlf.3:exon24:c.C4296T:p.C1432C	.	AFR:0.9376,AMR:0.8950,EAS:0.8269,FIN:0.6485,NFE:0.7536,OTH:0.7688,ASJ:0.7980	608048	.	.	.	.	.	.	.	.	.	.	.	6	MU800391	het
6	149983216	149983216	G	A	LATS1	exonic	synonymous SNV	ENSG00000131023	rs3924871	ENSG00000131023:ENST00000253339:exon7:c.C3042T:p.D1014D,ENSG00000131023:ENST00000543571:exon8:c.C3042T:p.D1014D	LATS1:NM_001350392:exon7:c.C2202T:p.D734D,LATS1:NM_004690:exon8:c.C3042T:p.D1014D,LATS1:NM_001350340:exon9:c.C2727T:p.D909D,LATS1:NM_001350339:exon10:c.C2826T:p.D942D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4492	0.4227	0.550719	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LATS1:uc003qmu.2:exon8:c.C3042T:p.D1014D,LATS1:uc010kif.2:exon9:c.C2727T:p.D909D	.	AFR:0.4418,AMR:0.5405,EAS:0.3742,FIN:0.8296,NFE:0.3674,OTH:0.3535,ASJ:0.6346	603473	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.3998
6	150004779	150004779	A	G	LATS1	exonic	synonymous SNV	ENSG00000131023	rs3798761	ENSG00000131023:ENST00000253339:exon3:c.T1446C:p.S482S,ENSG00000131023:ENST00000392273:exon4:c.T1446C:p.S482S,ENSG00000131023:ENST00000543571:exon4:c.T1446C:p.S482S	LATS1:NM_001350392:exon3:c.T606C:p.S202S,LATS1:NM_001270519:exon4:c.T1446C:p.S482S,LATS1:NM_004690:exon4:c.T1446C:p.S482S,LATS1:NM_001350339:exon5:c.T1131C:p.S377S,LATS1:NM_001350340:exon5:c.T1131C:p.S377S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4493	0.4243	0.552316	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LATS1:uc003qmv.2:exon3:c.T1446C:p.S482S,LATS1:uc003qmu.2:exon4:c.T1446C:p.S482S,LATS1:uc003qmw.3:exon4:c.T1446C:p.S482S,LATS1:uc010kif.2:exon5:c.T1131C:p.S377S,LATS1:uc010kig.1:exon5:c.T1131C:p.S377S	.	AFR:0.4425,AMR:0.5429,EAS:0.3742,FIN:0.8317,NFE:0.3673,OTH:0.3535,ASJ:0.6376	603473	.	.	.	.	.	.	.	.	.	.	.	6	1(urinary_tract)	0.3949
6	152201875	152201875	T	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs4986934	ENSG00000091831:ENST00000415488:exon1:c.T84C:p.R28R,ENSG00000091831:ENST00000206249:exon3:c.T729C:p.R243R,ENSG00000091831:ENST00000427531:exon3:c.T210C:p.R70R,ENSG00000091831:ENST00000338799:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000443427:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000456483:exon4:c.T729C:p.R243R,ENSG00000091831:ENST00000440973:exon5:c.T729C:p.R243R	ESR1:NM_000125:exon3:c.T729C:p.R243R,ESR1:NM_001328100:exon3:c.T210C:p.R70R,ESR1:NM_001122740:exon4:c.T729C:p.R243R,ESR1:NM_001122741:exon4:c.T729C:p.R243R,ESR1:NM_001291230:exon4:c.T735C:p.R245R,ESR1:NM_001291241:exon4:c.T729C:p.R243R,ESR1:NM_001122742:exon5:c.T729C:p.R243R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9707	0.9708	0.985623	0.9679	.	.	.	.	.	.	.	.	ESR1:uc011eex.2:exon1:c.T72C:p.R24R,ESR1:uc010kis.3:exon2:c.T210C:p.R70R,ESR1:uc003qoo.4:exon3:c.T729C:p.R243R,ESR1:uc003qon.4:exon4:c.T729C:p.R243R,ESR1:uc010kin.3:exon4:c.T729C:p.R243R,ESR1:uc010kio.3:exon4:c.T735C:p.R245R,ESR1:uc010kip.3:exon4:c.T729C:p.R243R,ESR1:uc003qom.4:exon5:c.T729C:p.R243R	.	AFR:0.9929,AMR:0.9845,EAS:1,FIN:0.9562,NFE:0.9525,OTH:0.9633,ASJ:0.9437	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4805,4804,4803	.	.	.	.	.	.	6	MU81823068	hom
6	152265522	152265522	G	C	ESR1	exonic	synonymous SNV	ENSG00000091831	rs1801132	ENSG00000091831:ENST00000206249:exon4:c.G975C:p.P325P,ENSG00000091831:ENST00000427531:exon4:c.G456C:p.P152P,ENSG00000091831:ENST00000338799:exon5:c.G975C:p.P325P,ENSG00000091831:ENST00000443427:exon5:c.G975C:p.P325P,ENSG00000091831:ENST00000440973:exon6:c.G975C:p.P325P	ESR1:NM_000125:exon4:c.G975C:p.P325P,ESR1:NM_001328100:exon4:c.G456C:p.P152P,ESR1:NM_001122740:exon5:c.G975C:p.P325P,ESR1:NM_001122741:exon5:c.G975C:p.P325P,ESR1:NM_001291230:exon5:c.G981C:p.P327P,ESR1:NM_001291241:exon5:c.G972C:p.P324P,ESR1:NM_001122742:exon6:c.G975C:p.P325P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.7362	0.8144	0.717652	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ESR1:uc010kit.1:exon1:c.G186C:p.P62P,ESR1:uc011eey.2:exon1:c.G186C:p.P62P,ESR1:uc011eex.2:exon2:c.G318C:p.P106P,ESR1:uc003qoo.4:exon4:c.G975C:p.P325P,ESR1:uc003qon.4:exon5:c.G975C:p.P325P,ESR1:uc010kin.3:exon5:c.G975C:p.P325P,ESR1:uc010kio.3:exon5:c.G981C:p.P327P,ESR1:uc010kip.3:exon5:c.G972C:p.P324P,ESR1:uc003qom.4:exon6:c.G975C:p.P325P	.	AFR:0.7877,AMR:0.8925,EAS:0.7781,FIN:0.4950,NFE:0.7264,OTH:0.7793,ASJ:0.7124	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	,4805,4804,4803	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.7505
6	152443756	152443756	C	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2295191	ENSG00000131018:ENST00000539504:exon17:c.G2674A:p.G892S,ENSG00000131018:ENST00000354674:exon18:c.G2743A:p.G915S,ENSG00000131018:ENST00000356820:exon61:c.G9781A:p.G3261S,ENSG00000131018:ENST00000265368:exon146:c.G26209A:p.G8737S,ENSG00000131018:ENST00000367255:exon146:c.G26209A:p.G8737S,ENSG00000131018:ENST00000423061:exon146:c.G26065A:p.G8689S,ENSG00000131018:ENST00000341594:exon147:c.G25045A:p.G8349S,ENSG00000131018:ENST00000448038:exon147:c.G26065A:p.G8689S	SYNE1:NM_001347702:exon18:c.G2743A:p.G915S,SYNE1:NM_033071:exon146:c.G26065A:p.G8689S,SYNE1:NM_182961:exon146:c.G26209A:p.G8737S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0176	0.0012	0.033147	0.0160	-0.740	0.058	0.966	-4.76	0.071	.	.	.	SYNE1:uc003qos.4:exon61:c.G9781A:p.G3261S,SYNE1:uc003qot.4:exon146:c.G26065A:p.G8689S,SYNE1:uc003qou.4:exon146:c.G26209A:p.G8737S	-1.026	AFR:0.0006,AMR:0,EAS:0.1012,FIN:0.0676,NFE:0.0047,OTH:0.0193,ASJ:0.0033	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.001	0.58	0.025	1.15	6	MU12519158	unknown
6	152443761	152443761	C	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2295192	ENSG00000131018:ENST00000539504:exon17:c.G2669A:p.R890Q,ENSG00000131018:ENST00000354674:exon18:c.G2738A:p.R913Q,ENSG00000131018:ENST00000356820:exon61:c.G9776A:p.R3259Q,ENSG00000131018:ENST00000265368:exon146:c.G26204A:p.R8735Q,ENSG00000131018:ENST00000367255:exon146:c.G26204A:p.R8735Q,ENSG00000131018:ENST00000423061:exon146:c.G26060A:p.R8687Q,ENSG00000131018:ENST00000341594:exon147:c.G25040A:p.R8347Q,ENSG00000131018:ENST00000448038:exon147:c.G26060A:p.R8687Q	SYNE1:NM_001347702:exon18:c.G2738A:p.R913Q,SYNE1:NM_033071:exon146:c.G26060A:p.R8687Q,SYNE1:NM_182961:exon146:c.G26204A:p.R8735Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0509	0.0359	0.0648962	0.0495	1.625	13.99	0.222	1.27	0.005	.	.	.	SYNE1:uc003qos.4:exon61:c.G9776A:p.R3259Q,SYNE1:uc003qot.4:exon146:c.G26060A:p.R8687Q,SYNE1:uc003qou.4:exon146:c.G26204A:p.R8735Q	-0.998	AFR:0.0481,AMR:0.0716,EAS:0.0544,FIN:0.0656,NFE:0.0438,OTH:0.0652,ASJ:0.0430	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.004	0.61	0.029	-0.145	6	MU752887	unknown
6	152446487	152446487	C	T	ESR1	UTR3	.	ENSG00000091831	rs2813563	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1649	.	0.164137	2(breast)	.	.	.	.	.	.	.	.	.	.	AFR:MU26224832,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.1890,FIN:0.1897,NFE:0.1689,OTH:0.1235,ASJ:0.2055	133430	114480;157300;608446;615363;	785;227535;	785|-|-|Autosomal recessive|-|615363 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	6	5(soft_tissue)	0.2833
6	152489294	152489294	T	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs998147	ENSG00000131018:ENST00000354674:exon1:c.A46G:p.S16G,ENSG00000131018:ENST00000539504:exon1:c.A46G:p.S16G	SYNE1:NM_001347702:exon1:c.A46G:p.S16G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8278	0.8572	0.867013	0.8364	2.090	16.79	0.75	2.24	0.979	.	.	.	.	-0.952	AFR:0.9369,AMR:0.8361,EAS:0.8813,FIN:0.7483,NFE:0.7964,OTH:0.8101,ASJ:0.7833	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	4.66	0.001	.	6	MU81823126	het
6	152540278	152540278	A	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2147377	ENSG00000131018:ENST00000367251:exon5:c.T670G:p.F224V,ENSG00000131018:ENST00000356820:exon35:c.T5476G:p.F1826V,ENSG00000131018:ENST00000423061:exon119:c.T21691G:p.F7231V,ENSG00000131018:ENST00000265368:exon120:c.T21904G:p.F7302V,ENSG00000131018:ENST00000367255:exon120:c.T21904G:p.F7302V,ENSG00000131018:ENST00000448038:exon120:c.T21691G:p.F7231V,ENSG00000131018:ENST00000341594:exon121:c.T20740G:p.F6914V	SYNE1:NM_033071:exon119:c.T21691G:p.F7231V,SYNE1:NM_182961:exon120:c.T21904G:p.F7302V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9923	0.9931	0.995607	0.9922	-0.224	0.977	1.0	3.99	0.127	.	.	.	SYNE1:uc003qor.4:exon5:c.T604G:p.F202V,SYNE1:uc003qos.4:exon35:c.T5476G:p.F1826V,SYNE1:uc003qot.4:exon119:c.T21691G:p.F7231V,SYNE1:uc003qou.4:exon120:c.T21904G:p.F7302V	-0.974	AFR:0.9984,AMR:0.9905,EAS:1,FIN:0.9877,NFE:0.9892,OTH:0.9878,ASJ:0.9868	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	0.82	0.009	-2.32	6	MU81823155	hom
6	152555112	152555112	C	T	SYNE1	intronic	.	ENSG00000131018	rs2296254	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2374	0.1688	0.208866	0.1970	.	.	.	.	.	.	.	.	.	.	AFR:0.0781,AMR:0.4439,EAS:0.2189,FIN:0.2651,NFE:0.2297,OTH:0.2669,ASJ:0.1987	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU587251	hom
6	152629617	152629617	C	T	SYNE1	intronic	.	ENSG00000131018	rs9383985	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3236	0.2455	0.304313	0.2809	.	.	.	.	.	0	0	.	.	.	AFR:0.0884,AMR:0.3046,EAS:0.6065,FIN:0.3625,NFE:0.3338,OTH:0.3060,ASJ:0.4027	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU14055157	hom
6	152629773	152629773	A	-	SYNE1	intronic	.	ENSG00000131018	rs55633181	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4174	.	0.426518	0.4328	.	.	.	.	.	.	.	.	.	.	AFR:0.3111,AMR:0.5885,EAS:0.7624,FIN:0.4817,NFE:0.4450,OTH:0.4729,ASJ:0.5775	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	hom
6	152647681	152647681	A	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs2306916	ENSG00000131018:ENST00000423061:exon78:c.T14830A:p.L4944M,ENSG00000131018:ENST00000265368:exon79:c.T15043A:p.L5015M,ENSG00000131018:ENST00000367255:exon79:c.T15043A:p.L5015M,ENSG00000131018:ENST00000448038:exon79:c.T14830A:p.L4944M,ENSG00000131018:ENST00000341594:exon82:c.T14284A:p.L4762M	SYNE1:NM_033071:exon78:c.T14830A:p.L4944M,SYNE1:NM_182961:exon79:c.T15043A:p.L5015M	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7797	0.8105	0.814696	0.8331	1.978	16.07	0.607	3.2	0.996	.	.	.	SYNE1:uc010kiz.4:exon3:c.T2308A:p.L770M,SYNE1:uc003qot.4:exon78:c.T14830A:p.L4944M,SYNE1:uc003qou.4:exon79:c.T15043A:p.L5015M	-0.977	AFR:0.9341,AMR:0.8592,EAS:0.8358,FIN:0.8481,NFE:0.7754,OTH:0.7802,ASJ:0.6887	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.009	1.24	0.012	-0.165	6	MU641312	het
6	152651759	152651759	C	G	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs3734365	ENSG00000131018:ENST00000423061:exon77:c.G13848C:p.L4616L,ENSG00000131018:ENST00000265368:exon78:c.G14061C:p.L4687L,ENSG00000131018:ENST00000367255:exon78:c.G14061C:p.L4687L,ENSG00000131018:ENST00000448038:exon78:c.G13848C:p.L4616L,ENSG00000131018:ENST00000341594:exon81:c.G13302C:p.L4434L	SYNE1:NM_033071:exon77:c.G13848C:p.L4616L,SYNE1:NM_182961:exon78:c.G14061C:p.L4687L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0959	0.0547	0.165136	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	SYNE1:uc010kiz.4:exon2:c.G1326C:p.L442L,SYNE1:uc003qot.4:exon77:c.G13848C:p.L4616L,SYNE1:uc003qou.4:exon78:c.G14061C:p.L4687L	.	AFR:0.0780,AMR:0.0388,EAS:0.0530,FIN:0.4485,NFE:0.0733,OTH:0.0639,ASJ:0.0668	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.0682
6	152652034	152652034	A	T	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs6911096	ENSG00000131018:ENST00000423061:exon77:c.T13573A:p.S4525T,ENSG00000131018:ENST00000265368:exon78:c.T13786A:p.S4596T,ENSG00000131018:ENST00000367255:exon78:c.T13786A:p.S4596T,ENSG00000131018:ENST00000448038:exon78:c.T13573A:p.S4525T,ENSG00000131018:ENST00000341594:exon81:c.T13027A:p.S4343T	SYNE1:NM_033071:exon77:c.T13573A:p.S4525T,SYNE1:NM_182961:exon78:c.T13786A:p.S4596T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7760	0.7959	0.803315	COCA-CN|4|321|0.0124611	-5.477	0.001	0.568	-11.9	0.002	.	.	.	SYNE1:uc010kiz.4:exon2:c.T1051A:p.S351T,SYNE1:uc003qot.4:exon77:c.T13573A:p.S4525T,SYNE1:uc003qou.4:exon78:c.T13786A:p.S4596T	-1.024	AFR:0.8219,AMR:0.8947,EAS:0.6887,FIN:0.8465,NFE:0.8479,OTH:0.7745,ASJ:0.8568	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	1.35	0.008	0.025	6	1(urinary_tract)	0.7760
6	152658142	152658142	T	C	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs9479297	ENSG00000131018:ENST00000423061:exon75:c.A12149G:p.K4050R,ENSG00000131018:ENST00000265368:exon76:c.A12362G:p.K4121R,ENSG00000131018:ENST00000367255:exon76:c.A12362G:p.K4121R,ENSG00000131018:ENST00000448038:exon76:c.A12149G:p.K4050R,ENSG00000131018:ENST00000341594:exon78:c.A11957G:p.K3986R	SYNE1:NM_033071:exon75:c.A12149G:p.K4050R,SYNE1:NM_182961:exon76:c.A12362G:p.K4121R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7547	0.7882	0.793131	0.8208	0.371	6.360	1.0	4.48	0.964	.	.	.	SYNE1:uc010kja.2:exon19:c.A2477G:p.K826R,SYNE1:uc003qot.4:exon75:c.A12149G:p.K4050R,SYNE1:uc003qou.4:exon76:c.A12362G:p.K4121R	-0.969	AFR:0.9307,AMR:0.7081,EAS:0.8488,FIN:0.8345,NFE:0.7642,OTH:0.7515,ASJ:0.6788	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.0	1.37	0.009	-1.81	6	MU21289282	het
6	152665261	152665261	C	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs4645434	ENSG00000131018:ENST00000423061:exon73:c.G11967T:p.E3989D,ENSG00000131018:ENST00000265368:exon74:c.G12180T:p.E4060D,ENSG00000131018:ENST00000367255:exon74:c.G12180T:p.E4060D,ENSG00000131018:ENST00000448038:exon74:c.G11967T:p.E3989D,ENSG00000131018:ENST00000341594:exon76:c.G11775T:p.E3925D	SYNE1:NM_033071:exon73:c.G11967T:p.E3989D,SYNE1:NM_182961:exon74:c.G12180T:p.E4060D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5761	0.5673	0.545527	1(central_nervous_system)	0.235	5.046	0.071	-1.25	0.019	.	.	.	SYNE1:uc010kja.2:exon17:c.G2295T:p.E765D,SYNE1:uc003qot.4:exon73:c.G11967T:p.E3989D,SYNE1:uc003qou.4:exon74:c.G12180T:p.E4060D	-0.976	AFR:2(large_intestine),AMR:MU588841,EAS:0.5601,FIN:0.4517,NFE:0.6160,OTH:0.66,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.203	1.33	0.015	0.345	6	1(skin)	0.6582
6	152671475	152671475	A	C	SYNE1	intronic	.	ENSG00000131018	rs9478320	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5846	0.5962	0.58746	0.5913	.	.	.	.	.	0.7992	0.178	.	.	.	AFR:0.5714,AMR:0.6184,EAS:0.6219,FIN:0.5573,NFE:0.6074,OTH:0.5490,ASJ:0.6589	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU27526564	het
6	152671919	152671919	-	A	SYNE1	intronic	.	ENSG00000131018	rs5880967	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.5746	.	0.56889	0.5828	.	.	.	.	.	.	.	.	.	.	AFR:0.5302,AMR:0.6158,EAS:0.6216,FIN:0.5655,NFE:0.6112,OTH:0.5601,ASJ:0.6567	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	het
6	152673147	152673147	G	A	SYNE1	intronic	.	ENSG00000131018	rs6908392	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5790	0.5783	0.565895	MU26896544	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.5750,EAS:0.6169,FIN:0.6589,NFE:0.6222,OTH:0.5570,ASJ:0.5128	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6083
6	152675854	152675854	A	G	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs9397102	ENSG00000131018:ENST00000265368:exon67:c.T10866C:p.S3622S,ENSG00000131018:ENST00000367255:exon67:c.T10866C:p.S3622S,ENSG00000131018:ENST00000341594:exon70:c.T10779C:p.S3593S	SYNE1:NM_182961:exon67:c.T10866C:p.S3622S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5799	0.5812	0.568291	MU26896631	.	.	.	.	.	.	.	.	SYNE1:uc010kja.2:exon10:c.T981C:p.S327S,SYNE1:uc003qou.4:exon67:c.T10866C:p.S3622S	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.5777,EAS:0.6169,FIN:0.6567,NFE:0.6256,OTH:0.5568,ASJ:0.5229	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.6074
6	152683413	152683413	G	T	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs4407724	ENSG00000131018:ENST00000265368:exon64:c.C10191A:p.G3397G,ENSG00000131018:ENST00000367255:exon64:c.C10191A:p.G3397G,ENSG00000131018:ENST00000423061:exon64:c.C10212A:p.G3404G,ENSG00000131018:ENST00000448038:exon65:c.C10212A:p.G3404G	SYNE1:NM_033071:exon64:c.C10212A:p.G3404G,SYNE1:NM_182961:exon64:c.C10191A:p.G3397G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6541	0.6481	0.659145	SKCA-BR|1|100|0.01,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SYNE1:uc010kja.2:exon7:c.C306A:p.G102G,SYNE1:uc003qot.4:exon64:c.C10212A:p.G3404G,SYNE1:uc003qou.4:exon64:c.C10191A:p.G3397G	.	AFR:0.6496,AMR:0.5876,EAS:0.7384,FIN:0.7752,NFE:0.6216,OTH:0.6773,ASJ:0.6746	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	2(large_intestine)	0.6214
6	152694184	152694184	T	C	SYNE1	exonic	synonymous SNV	ENSG00000131018	rs6913579	ENSG00000131018:ENST00000265368:exon59:c.A9495G:p.E3165E,ENSG00000131018:ENST00000367255:exon59:c.A9495G:p.E3165E,ENSG00000131018:ENST00000423061:exon59:c.A9516G:p.E3172E,ENSG00000131018:ENST00000448038:exon60:c.A9516G:p.E3172E,ENSG00000131018:ENST00000341594:exon62:c.A9612G:p.E3204E	SYNE1:NM_033071:exon59:c.A9516G:p.E3172E,SYNE1:NM_182961:exon59:c.A9495G:p.E3165E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4993	0.5288	0.468251	3(lung)	.	.	.	.	.	.	.	.	SYNE1:uc003qov.3:exon4:c.A729G:p.E243E,SYNE1:uc003qot.4:exon59:c.A9516G:p.E3172E,SYNE1:uc003qou.4:exon59:c.A9495G:p.E3165E	.	AFR:MU29885722,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526,EAS:0.4821,FIN:0.5276,NFE:0.5298,OTH:0.4532,ASJ:0.5133	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	2(large_intestine)	0.5040
6	152697706	152697706	C	T	SYNE1	intronic	.	ENSG00000131018	rs214955	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5101	0.4883	0.529153	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.4989,AMR:0.5436,EAS:0.4801,FIN:0.5446,NFE:0.4974,OTH:0.4662,ASJ:0.4880	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(liver)	0.5460
6	152708310	152708310	G	A	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs214950	ENSG00000131018:ENST00000265368:exon54:c.C8384T:p.A2795V,ENSG00000131018:ENST00000367255:exon54:c.C8384T:p.A2795V,ENSG00000131018:ENST00000423061:exon54:c.C8405T:p.A2802V,ENSG00000131018:ENST00000448038:exon55:c.C8405T:p.A2802V,ENSG00000131018:ENST00000341594:exon57:c.C8501T:p.A2834V	SYNE1:NM_033071:exon54:c.C8405T:p.A2802V,SYNE1:NM_182961:exon54:c.C8384T:p.A2795V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2373	0.1984	0.249002	1(breast)	0.486	7.324	0.028	1.51	0.000	.	.	.	SYNE1:uc010kjb.1:exon52:c.C8333T:p.A2778V,SYNE1:uc003qot.4:exon54:c.C8405T:p.A2802V,SYNE1:uc003qou.4:exon54:c.C8384T:p.A2795V	-1.029	AFR:MU93209,AMR:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.1555,FIN:0.1866,NFE:0.2533,OTH:0.4410,ASJ:0.2061	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.007	1.27	0.017	1.95	6	1(haematopoietic_and_lymphoid_tissue)	0.1855
6	152711395	152711395	T	A	SYNE1	intronic	.	ENSG00000131018	rs214943	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4440	0.4833	0.561901	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4900,AMR:0.6936,EAS:0.4305,FIN:0.7853,NFE:0.3829,OTH:0.3795,ASJ:0.3209	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.4223
6	152712715	152712715	-	AAAAAAA	SYNE1	intronic	.	ENSG00000131018	rs768125041	.	.	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0448	.	.	0.1978	.	.	.	.	.	.	.	.	.	.	AFR:0.1473,AMR:0.1475,EAS:0.4007,FIN:0.0942,NFE:0.2054,OTH:0.2165,ASJ:0.2195	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	.	unknown
6	152772264	152772264	A	G	SYNE1	exonic	nonsynonymous SNV	ENSG00000131018	rs214976	ENSG00000131018:ENST00000367253:exon24:c.T3104C:p.V1035A,ENSG00000131018:ENST00000413186:exon24:c.T3104C:p.V1035A,ENSG00000131018:ENST00000367248:exon25:c.T3074C:p.V1025A,ENSG00000131018:ENST00000265368:exon26:c.T3104C:p.V1035A,ENSG00000131018:ENST00000367255:exon26:c.T3104C:p.V1035A,ENSG00000131018:ENST00000423061:exon26:c.T3125C:p.V1042A,ENSG00000131018:ENST00000448038:exon27:c.T3125C:p.V1042A,ENSG00000131018:ENST00000341594:exon29:c.T3302C:p.V1101A	SYNE1:NM_033071:exon26:c.T3125C:p.V1042A,SYNE1:NM_182961:exon26:c.T3104C:p.V1035A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4811	0.5325	0.607228	MU18833080	3.767	23.4	0.006	5.84	0.998	.	.	.	SYNE1:uc003qow.3:exon7:c.T989C:p.V330A,SYNE1:uc003qox.1:exon13:c.T1652C:p.V551A,SYNE1:uc010kjb.1:exon24:c.T3053C:p.V1018A,SYNE1:uc003qot.4:exon26:c.T3125C:p.V1042A,SYNE1:uc003qou.4:exon26:c.T3104C:p.V1035A	0.108	AFR:COCA-CN|5|321|0.0155763,AMR:0.5270,EAS:0.3565,FIN:0.5302,NFE:0.7779,OTH:0.3912,ASJ:0.7437	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	0.033	0.55	0.536	1.905	6	1(pancreas)	0.4198
6	152809527	152809527	A	T	SYNE1	intronic	.	ENSG00000131018	rs9397106	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4810	0.5072	0.589257	0.5097	.	.	.	.	.	0	0.028	.	.	.	AFR:0.6693,AMR:0.3537,EAS:0.7736,FIN:0.4046,NFE:0.4250,OTH:0.4551,ASJ:0.5232	608441	610743;612998;	261;98853;88644;	261|EDMD|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|181350 300696 310300 612998 612999 614302 616516 ~98853|EDMD2|-|Autosomal dominant|-|181350 612998 612999 614302 ~88644|ARCA1<br>Autosomal recessive cerebellar ataxia type 1<br>SCAR8|<1 / 1 000 000|Autosomal recessive|Adult|610743 ~	.	.	.	.	.	.	.	.	6	MU18839010	hom
6	157405930	157405930	G	A	ARID1B	exonic	synonymous SNV	ENSG00000049618	rs3734441	ENSG00000049618:ENST00000319584:exon3:c.G399A:p.A133A,ENSG00000049618:ENST00000275248:exon5:c.G1959A:p.A653A,ENSG00000049618:ENST00000350026:exon5:c.G2133A:p.A711A,ENSG00000049618:ENST00000367148:exon5:c.G2133A:p.A711A,ENSG00000049618:ENST00000414678:exon5:c.G630A:p.A210A,ENSG00000049618:ENST00000346085:exon6:c.G2172A:p.A724A	ARID1B:NM_001346813:exon5:c.G2133A:p.A711A,ARID1B:NM_017519:exon5:c.G2133A:p.A711A,ARID1B:NM_020732:exon6:c.G2172A:p.A724A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5190	0.4726	0.495208	1(breast)	.	.	.	.	.	.	.	.	ARID1B:uc003qqq.1:exon3:c.G285A:p.A95A,ARID1B:uc003qqn.3:exon5:c.G2133A:p.A711A,ARID1B:uc003qqp.3:exon5:c.G2133A:p.A711A,ARID1B:uc003qqo.3:exon6:c.G2172A:p.A724A	.	AFR:MU155753,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.3460,FIN:0.5730,NFE:0.6026,OTH:0.5256,ASJ:0.4492	614556	135900;	1465;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~	.	.	.	.	.	.	.	.	6	14(meninges)	0.3897
6	159188128	159188128	A	G	EZR	intronic	.	ENSG00000092820	rs2242318	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6369	0.6978	0.522963	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.6788,AMR:0.6095,EAS:0.5993,FIN:0.1592,NFE:0.8257,OTH:0.7540,ASJ:0.4149	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	2(lung)	0.7296
6	159188549	159188549	G	A	EZR	intronic	.	ENSG00000092820	rs3212310	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.1151	0.1212	0.0928514	0.1210	.	.	.	.	.	0	0.006	.	.	.	AFR:0.1137,AMR:0.0656,EAS:0.0006,FIN:0.1862,NFE:0.1254,OTH:0.1404,ASJ:0.0960	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	.	het
6	159190800	159190800	C	G	EZR	intronic	.	ENSG00000092820	rs3127177	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2280	0.2633	0.182508	0.2590	.	.	.	.	.	.	.	.	.	.	AFR:0.2541,AMR:0.1277,EAS:0.0148,FIN:0.3213,NFE:0.2798,OTH:0.2802,ASJ:0.26	123900	.	.	.	~ko04530 Tight junction~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko04971 Gastric acid secretion~ko05130 Pathogenic Escherichia coli infection~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	6	MU113356736	het
6	160113872	160113872	A	G	SOD2	exonic	nonsynonymous SNV	ENSG00000112096	rs4880	ENSG00000112096:ENST00000337404:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000367054:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000367055:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000444946:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000452684:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000535561:exon2:c.T116C:p.V39A,ENSG00000112096:ENST00000538183:exon2:c.T47C:p.V16A,ENSG00000112096:ENST00000545162:exon2:c.T116C:p.V39A,ENSG00000112096:ENST00000546260:exon2:c.T47C:p.V16A	SOD2:NM_000636:exon2:c.T47C:p.V16A,SOD2:NM_001024465:exon2:c.T47C:p.V16A,SOD2:NM_001024466:exon2:c.T47C:p.V16A,SOD2:NM_001322814:exon2:c.T47C:p.V16A,SOD2:NM_001322815:exon2:c.T47C:p.V16A,SOD2:NM_001322816:exon2:c.T47C:p.V16A	clinvar: drug_response 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5024	0.4731	0.410743	MU140155	-0.079	1.894	0.926	3.08	0.004	.	.	.	SOD2:uc003qsg.3:exon2:c.T47C:p.V16A,SOD2:uc003qsh.3:exon2:c.T47C:p.V16A,SOD2:uc003qsi.1:exon2:c.T47C:p.V16A,SOD2:uc003qsj.3:exon2:c.T47C:p.V16A,SOD2:uc011efu.1:exon2:c.T47C:p.V16A,SOD2:uc011efv.1:exon2:c.T47C:p.V16A	-0.931	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.4676,EAS:0.6062,FIN:0.5397,NFE:0.1510,OTH:0.4716,ASJ:0.4235	147460	612634;	.	.	.	.	.	.	0.0	2.8	0.008	.	6	3(lung)	0.5131
6	160114168	160114168	T	C	SOD2	intronic	.	ENSG00000112096	rs5746094	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2747	0.1897	0.273562	0.2406	.	.	.	.	.	.	.	.	.	.	AFR:0.1944,AMR:0.2056,EAS:0.3974,FIN:0.3188,NFE:0.2347,OTH:0.2480,ASJ:0.2013	147460	612634;	.	.	.	.	.	.	.	.	.	.	6	MU15246043	het
6	160448324	160448324	C	G	IGF2R	exonic	nonsynonymous SNV	ENSG00000197081	rs8191754	ENSG00000197081:ENST00000356956:exon6:c.C754G:p.L252V	IGF2R:NM_000876:exon6:c.C754G:p.L252V	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1405	0.1338	0.160343	MU13855532	5.260	25.7	0.019	4.34	0.378	.	.	Mannose-6-phosphate receptor binding domain	IGF2R:uc003qta.3:exon6:c.C754G:p.L252V	-1.188	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.1305,EAS:0.0752,FIN:0.1126,NFE:0.2160,OTH:0.1019,ASJ:0.1328	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	0.873	4.35	0.016	.	6	6(soft_tissue)	0.1312
6	160453978	160453978	A	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs1570070	ENSG00000197081:ENST00000356956:exon9:c.A1050G:p.S350S	IGF2R:NM_000876:exon9:c.A1050G:p.S350S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3753	0.3021	0.423922	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon9:c.A1050G:p.S350S	.	AFR:0.3321,AMR:0.2580,EAS:0.2682,FIN:0.7640,NFE:0.3156,OTH:0.3272,ASJ:0.4487	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(thyroid)	0.3347
6	160464289	160464289	G	A	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs894817	ENSG00000197081:ENST00000356956:exon12:c.G1590A:p.G530G	IGF2R:NM_000876:exon12:c.G1590A:p.G530G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3553	0.2971	0.423722	0.3197	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon12:c.G1590A:p.G530G	.	AFR:0.2720,AMR:0.4402,EAS:0.7655,FIN:0.2564,NFE:0.3095,OTH:0.3067,ASJ:0.2550	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU9524266	hom
6	160468278	160468278	A	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs998075	ENSG00000197081:ENST00000356956:exon16:c.A2139G:p.T713T	IGF2R:NM_000876:exon16:c.A2139G:p.T713T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5299	0.5167	0.577476	0.5485	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon16:c.A2139G:p.T713T	.	AFR:0.6179,AMR:0.5217,EAS:0.6582,FIN:0.5868,NFE:0.4919,OTH:0.5205,ASJ:0.4834	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU23691521	het
6	160468383	160468383	T	C	IGF2R	intronic	.	ENSG00000197081	rs998074	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5357	0.5080	0.573083	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU9524334,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.6046,FIN:0.5179,NFE:0.4735,OTH:0.6611,ASJ:0.5441	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(haematopoietic_and_lymphoid_tissue)	0.5873
6	160494409	160494409	A	G	IGF2R	exonic	nonsynonymous SNV	ENSG00000197081	rs629849	ENSG00000197081:ENST00000356956:exon34:c.A4855G:p.R1619G	IGF2R:NM_000876:exon34:c.A4855G:p.R1619G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8963	0.9107	0.903155	0.9115	-0.274	0.760	1.0	4.43	0.492	.	.	Mannose-6-phosphate receptor binding domain	IGF2R:uc003qta.3:exon34:c.A4855G:p.R1619G	-0.945	AFR:0.9723,AMR:0.9391,EAS:0.8269,FIN:0.9097,NFE:0.8832,OTH:0.9114,ASJ:0.9570	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	0.0	4.55	0.001	.	6	MU23691754	het
6	160505199	160505199	C	G	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs614754	ENSG00000197081:ENST00000356956:exon40:c.C6051G:p.L2017L	IGF2R:NM_000876:exon40:c.C6051G:p.L2017L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9918	0.9897	0.996006	0.9896	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon40:c.C6051G:p.L2017L	.	AFR:0.9954,AMR:0.9916,EAS:0.9994,FIN:0.9906,NFE:0.9845,OTH:0.9919,ASJ:1	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	MU81824095	unknown
6	160505207	160505207	A	G	IGF2R	exonic	nonsynonymous SNV	ENSG00000197081	rs1805075	ENSG00000197081:ENST00000356956:exon40:c.A6059G:p.N2020S	IGF2R:NM_000876:exon40:c.A6059G:p.N2020S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0980	0.0326	0.122604	0.0661	0.212	4.807	0.232	4.39	0.003	.	.	Mannose-6-phosphate receptor binding domain	IGF2R:uc003qta.3:exon40:c.A6059G:p.N2020S	-1.018	AFR:0.0139,AMR:0.2434,EAS:0.3323,FIN:0.0779,NFE:0.0550,OTH:0.0847,ASJ:0.0033	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	0.0	1.53	0.021	.	6	MU29506553	unknown
6	160517481	160517481	C	T	IGF2R	exonic	synonymous SNV	ENSG00000197081	rs1803989	ENSG00000197081:ENST00000356956:exon45:c.C6666T:p.L2222L	IGF2R:NM_000876:exon45:c.C6666T:p.L2222L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1492	0.1157	0.229433	MU16856501	.	.	.	.	.	.	.	.	IGF2R:uc003qta.3:exon45:c.C6666T:p.L2222L	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.1453,EAS:0.2828,FIN:0.0066,NFE:0.4101,OTH:0.0844,ASJ:0.2395	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	1(lung)	0.0735
6	160524773	160524773	T	A	IGF2R	intronic	.	ENSG00000197081	rs2297370	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2408	0.1781	0.222444	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	0	0.016	.	.	.	AFR:0.2029,AMR:0.1047,EAS:0.1523,FIN:0.4019,NFE:0.2385,OTH:0.2235,ASJ:0.3357	147280	114550;	449;88673;	449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	.	.	.	.	.	.	.	.	6	9(soft_tissue)	0.2150
6	162622197	162622197	C	T	PRKN	exonic	nonsynonymous SNV	ENSG00000185345	rs1801474	ENSG00000185345:ENST00000479615:exon3:c.G263A:p.S88N,ENSG00000185345:ENST00000366892:exon4:c.G500A:p.S167N,ENSG00000185345:ENST00000366897:exon4:c.G500A:p.S167N,ENSG00000185345:ENST00000366898:exon4:c.G500A:p.S167N	PRKN:NM_004562:exon4:c.G500A:p.S167N,PRKN:NM_013987:exon4:c.G500A:p.S167N	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0676	0.0392	0.117412	4(haematopoietic_and_lymphoid_tissue)	1.685	14.32	0.219	3.95	0.924	.	.	.	PARK2:uc003qtx.4:exon4:c.G500A:p.S167N,PARK2:uc003qty.4:exon4:c.G500A:p.S167N,PARK2:uc010kke.1:exon4:c.G500A:p.S167N,PARK2:uc021zhs.1:exon4:c.G500A:p.S167N,PARK2:uc021zhy.1:exon4:c.G500A:p.S167N,PARK2:uc021zhu.1:exon5:c.G641A:p.S214N,PARK2:uc021zhv.1:exon5:c.G263A:p.S88N,PARK2:uc031sqz.1:exon6:c.G695A:p.S232N	-0.592	AFR:MU141565,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.0747,FIN:0.1079,NFE:0.0629,OTH:0.4023,ASJ:0.0570	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	0.027	-2.82	0.457	1.16	6	7(soft_tissue)	0.0095
6	162622304	162622304	A	G	PRKN	intronic	.	ENSG00000185345	rs4709583	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9329	0.9403	0.950479	0.9475	.	.	.	.	.	.	.	.	.	.	AFR:0.9849,AMR:0.9642,EAS:0.9920,FIN:0.9473,NFE:0.9217,OTH:0.9206,ASJ:0.9536	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	6	MU81824308	hom
6	162683815	162683815	A	-	PRKN	intronic	.	ENSG00000185345	rs756249386	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0782	.	.	0.0489	.	.	.	.	.	.	.	.	.	.	AFR:0.0192,AMR:0.1099,EAS:0.1132,FIN:0.1765,NFE:0.0478,OTH:0.0992,ASJ:0.09	602544	167000;211980;600116;607572;	548;2828;	548|-|Unknown|Multigenic/multifactorial|All ages|246300 607572 609888 610988 613223 613407 ~2828|Early-onset Parkinson disease<br>YOPD|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|300557 600116 602404 605909 606324 606852 610297 613643 615528 616840 ~	.	.	.	.	.	.	.	.	6	.	het
6	166826255	166826255	G	A	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs909631	ENSG00000071242:ENST00000265678:exon21:c.C2197T:p.L733L,ENSG00000071242:ENST00000405189:exon21:c.C1930T:p.L644L,ENSG00000071242:ENST00000481261:exon21:c.C1930T:p.L644L,ENSG00000071242:ENST00000503859:exon22:c.C2221T:p.L741L,ENSG00000071242:ENST00000510118:exon23:c.C2272T:p.L758L	RPS6KA2:NM_001318937:exon19:c.C1903T:p.L635L,RPS6KA2:NM_001318938:exon21:c.C1930T:p.L644L,RPS6KA2:NM_021135:exon21:c.C2197T:p.L733L,RPS6KA2:NM_001006932:exon22:c.C2221T:p.L741L,RPS6KA2:NM_001318936:exon23:c.C2272T:p.L758L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6917	0.5785	0.620208	0.5670	.	.	.	.	.	.	.	.	RPS6KA2:uc010kkk.1:exon6:c.C493T:p.L165L,RPS6KA2:uc003qvb.1:exon21:c.C2197T:p.L733L,RPS6KA2:uc010kkl.1:exon21:c.C1930T:p.L644L,RPS6KA2:uc011ego.1:exon21:c.C1930T:p.L644L,RPS6KA2:uc003qvc.1:exon22:c.C2221T:p.L741L,RPS6KA2:uc003qvd.1:exon23:c.C2272T:p.L758L	.	AFR:0.3648,AMR:0.5837,EAS:0.7602,FIN:0.5688,NFE:0.6530,OTH:0.6577,ASJ:0.7285	601685	.	.	.	.	.	.	.	.	.	.	.	6	MU73172	het
6	166826304	166826304	T	C	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs760670	ENSG00000071242:ENST00000265678:exon21:c.A2148G:p.S716S,ENSG00000071242:ENST00000405189:exon21:c.A1881G:p.S627S,ENSG00000071242:ENST00000481261:exon21:c.A1881G:p.S627S,ENSG00000071242:ENST00000503859:exon22:c.A2172G:p.S724S,ENSG00000071242:ENST00000510118:exon23:c.A2223G:p.S741S	RPS6KA2:NM_001318937:exon19:c.A1854G:p.S618S,RPS6KA2:NM_001318938:exon21:c.A1881G:p.S627S,RPS6KA2:NM_021135:exon21:c.A2148G:p.S716S,RPS6KA2:NM_001006932:exon22:c.A2172G:p.S724S,RPS6KA2:NM_001318936:exon23:c.A2223G:p.S741S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7481	0.7414	0.795527	LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RPS6KA2:uc010kkk.1:exon6:c.A444G:p.S148S,RPS6KA2:uc003qvb.1:exon21:c.A2148G:p.S716S,RPS6KA2:uc010kkl.1:exon21:c.A1881G:p.S627S,RPS6KA2:uc011ego.1:exon21:c.A1881G:p.S627S,RPS6KA2:uc003qvc.1:exon22:c.A2172G:p.S724S,RPS6KA2:uc003qvd.1:exon23:c.A2223G:p.S741S	.	AFR:0.7166,AMR:0.8338,EAS:0.7417,FIN:0.8130,NFE:0.5989,OTH:0.6677,ASJ:0.6854	601685	.	.	.	.	.	.	.	.	.	.	.	6	3(large_intestine)	0.7043
6	166827436	166827436	T	C	RPS6KA2	intronic	.	ENSG00000071242	rs2235295	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6984	0.6625	0.726637	0.6510	.	.	.	.	.	.	.	.	.	.	AFR:0.6304,AMR:0.6706,EAS:0.7953,FIN:0.5956,NFE:0.6555,OTH:0.6828,ASJ:0.7351	601685	.	.	.	.	.	.	.	.	.	.	.	6	MU12549640	hom
6	166831694	166831694	C	T	RPS6KA2	intronic	.	ENSG00000071242	rs10946164	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3599	0.3324	0.253594	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3043,AMR:0.0806,EAS:0.4139,FIN:0.1900,NFE:0.3582,OTH:0.4302,ASJ:0.2434	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(upper_aerodigestive_tract)	0.3875
6	166952264	166952264	G	A	RPS6KA2	exonic	synonymous SNV	ENSG00000071242	rs1003857	ENSG00000071242:ENST00000265678:exon2:c.C108T:p.G36G,ENSG00000071242:ENST00000507371:exon2:c.C60T:p.G20G,ENSG00000071242:ENST00000503859:exon3:c.C132T:p.G44G,ENSG00000071242:ENST00000510118:exon4:c.C183T:p.G61G,ENSG00000071242:ENST00000506565:exon5:c.C183T:p.G61G	RPS6KA2:NM_021135:exon2:c.C108T:p.G36G,RPS6KA2:NM_001006932:exon3:c.C132T:p.G44G,RPS6KA2:NM_001318936:exon4:c.C183T:p.G61G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7924	0.7214	0.787939	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	RPS6KA2:uc003qvb.1:exon2:c.C108T:p.G36G,RPS6KA2:uc003qvc.1:exon3:c.C132T:p.G44G,RPS6KA2:uc003qvd.1:exon4:c.C183T:p.G61G	.	AFR:0.7292,AMR:0.6418,EAS:0.7649,FIN:0.9518,NFE:0.7648,OTH:0.7372,ASJ:0.8819	601685	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.7464
6	167271711	167271711	T	C	RPS6KA2	exonic	nonsynonymous SNV	ENSG00000071242;ENSG00000249141	rs943687	ENSG00000071242:ENST00000503859:exon2:c.A100G:p.T34A,ENSG00000071242:ENST00000510118:exon2:c.A100G:p.T34A,ENSG00000071242:ENST00000506565:exon3:c.A100G:p.T34A	RPS6KA2:NM_001006932:exon2:c.A100G:p.T34A,RPS6KA2:NM_001318936:exon2:c.A100G:p.T34A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9643	0.9407	0.922125	0.9515	-3.152	0.001	0.838	-9.48	0.000	.	.	.	RPS6KA2:uc003qvc.1:exon2:c.A100G:p.T34A,RPS6KA2:uc003qvd.1:exon2:c.A100G:p.T34A	-1.098	AFR:0.8527,AMR:0.9809,EAS:0.9604,FIN:0.9994,NFE:0.9933,OTH:0.9776,ASJ:0.9570	601685	.	.	.	.	.	.	.	0.0	-0.36	0.034	.	6	MU19401550	unknown
6	167271716	167271716	T	C	RPS6KA2	exonic	nonsynonymous SNV	ENSG00000071242;ENSG00000249141	rs9347162	ENSG00000071242:ENST00000503859:exon2:c.A95G:p.E32G,ENSG00000071242:ENST00000510118:exon2:c.A95G:p.E32G,ENSG00000071242:ENST00000506565:exon3:c.A95G:p.E32G	RPS6KA2:NM_001006932:exon2:c.A95G:p.E32G,RPS6KA2:NM_001318936:exon2:c.A95G:p.E32G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7054	0.5814	0.607628	0.6165	0.605	8.191	0.335	3.56	0.007	.	.	.	RPS6KA2:uc003qvc.1:exon2:c.A95G:p.E32G,RPS6KA2:uc003qvd.1:exon2:c.A95G:p.E32G	-1.027	AFR:0.2480,AMR:0.7912,EAS:0.8784,FIN:0.7153,NFE:0.7601,OTH:0.7357,ASJ:0.6854	601685	.	.	.	.	.	.	.	0.0	-0.5	0.024	.	6	MU19401625	unknown
6	167343106	167343106	G	T	RNASET2	exonic	nonsynonymous SNV	ENSG00000026297	rs140357917	ENSG00000026297:ENST00000508775:exon9:c.C741A:p.F247L,ENSG00000026297:ENST00000366855:exon10:c.C627A:p.F209L,ENSG00000026297:ENST00000476238:exon10:c.C741A:p.F247L,ENSG00000026297:ENST00000478180:exon10:c.C741A:p.F247L	RNASET2:NM_003730:exon9:c.C741A:p.F247L	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	0.0006	7.7e-05	0.00139776	0.0004	1.238	11.94	0.35	-5.47	0.866	.	.	.	RNASET2:uc003qve.3:exon9:c.C741A:p.F247L,RNASET2:uc003qvf.3:exon9:c.C465A:p.F155L	-1.011	AFR:0,AMR:0,EAS:0.0056,FIN:0,NFE:0.0002,OTH:0,ASJ:0	612944	612951;	85136;	85136|CLWM|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612951 ~	.	.	.	.	0.072	-0.19	0.049	1.965	6	.	het
6	167413539	167413539	T	C	FGFR1OP	intronic	.	ENSG00000272980	rs12212247	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3764	0.3620	0.26278	MU19411290	.	.	.	.	.	0.0001	0.024	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3574,EAS:0.3198,FIN:0.4238,NFE:0.2574,OTH:0.4175,ASJ:0.1707	605392	.	.	.	.	.	.	.	.	.	.	.	6	1(large_intestine)	0.4625
6	167424293	167424293	T	C	FGFR1OP	intronic	.	ENSG00000272980	rs1322077	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5258	0.3920	0.299321	0.3830	.	.	.	.	.	0.0002	0.058	.	.	.	AFR:0.2612,AMR:0.3246,EAS:0.2574,FIN:0.4182,NFE:0.4624,OTH:0.3817,ASJ:0.3874	605392	.	.	.	.	.	.	.	.	.	.	.	6	MU21296248	het
6	167453519	167453519	-	T	FGFR1OP	UTR3	.	ENSG00000272980	rs368396376	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5074	0.5145	0.520966	0.7698	.	.	.	.	.	.	.	.	.	.	AFR:0.5960,AMR:0.8240,EAS:0.8238,FIN:0.7609,NFE:0.8631,OTH:0.8096,ASJ:0.8346	605392	.	.	.	.	.	.	.	.	.	.	.	6	.	hom
7	1938031	1938031	G	A	MAD1L1	intronic	.	ENSG00000002822	rs73288773	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0358	0.0546	0.0800719	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.0555,AMR:0.1577,EAS:0.0033,FIN:0.0815,NFE:0.0135,OTH:0.0073,ASJ:0.0407	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	7	2(liver)	0.0173
7	1976457	1976457	C	T	MAD1L1	exonic	nonsynonymous SNV	ENSG00000002822	rs1801368	ENSG00000002822:ENST00000437877:exon2:c.G41A:p.R14H,ENSG00000002822:ENST00000450235:exon4:c.G326A:p.R109H,ENSG00000002822:ENST00000402746:exon15:c.G1397A:p.R466H,ENSG00000002822:ENST00000265854:exon16:c.G1673A:p.R558H,ENSG00000002822:ENST00000399654:exon17:c.G1673A:p.R558H,ENSG00000002822:ENST00000406869:exon17:c.G1673A:p.R558H	MAD1L1:NM_001304525:exon2:c.G41A:p.R14H,MAD1L1:NM_001304524:exon15:c.G1397A:p.R466H,MAD1L1:NM_001304523:exon16:c.G1673A:p.R558H,MAD1L1:NM_001013836:exon17:c.G1673A:p.R558H,MAD1L1:NM_001013837:exon17:c.G1673A:p.R558H,MAD1L1:NM_003550:exon17:c.G1673A:p.R558H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4088	0.2749	0.304712	MU109074	2.166	17.29	0.114	-0.002	0.014	.	.	.	MAD1L1:uc003sld.1:exon2:c.G41A:p.R14H,MAD1L1:uc003sle.1:exon9:c.G860A:p.R287H,MAD1L1:uc003sli.1:exon15:c.G1397A:p.R466H,MAD1L1:uc010ksi.1:exon15:c.G1532A:p.R511H,MAD1L1:uc010ksh.1:exon16:c.G1673A:p.R558H,MAD1L1:uc003slf.1:exon17:c.G1673A:p.R558H,MAD1L1:uc003slg.1:exon17:c.G1673A:p.R558H,MAD1L1:uc003slh.1:exon17:c.G1673A:p.R558H,MAD1L1:uc010ksj.3:exon17:c.G1673A:p.R558H	-0.910	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.2800,EAS:0.4248,FIN:0.2715,NFE:0.5105,OTH:0.2857,ASJ:0.0918	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	0.003	2.01	0.000	1.1	7	1(haematopoietic_and_lymphoid_tissue)	0.3522
7	2257612	2257612	G	A	MAD1L1	exonic	synonymous SNV	ENSG00000002822	rs6951493	ENSG00000002822:ENST00000429625:exon4:c.C450T:p.H150H,ENSG00000002822:ENST00000445959:exon4:c.C294T:p.H98H,ENSG00000002822:ENST00000402746:exon5:c.C387T:p.H129H,ENSG00000002822:ENST00000265854:exon6:c.C663T:p.H221H,ENSG00000002822:ENST00000399654:exon7:c.C663T:p.H221H,ENSG00000002822:ENST00000406869:exon7:c.C663T:p.H221H	MAD1L1:NM_001304524:exon5:c.C387T:p.H129H,MAD1L1:NM_001304523:exon6:c.C663T:p.H221H,MAD1L1:NM_001013836:exon7:c.C663T:p.H221H,MAD1L1:NM_001013837:exon7:c.C663T:p.H221H,MAD1L1:NM_003550:exon7:c.C663T:p.H221H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3496	0.3347	0.365615	0.3322	.	.	.	.	.	.	.	.	MAD1L1:uc003sli.1:exon5:c.C387T:p.H129H,MAD1L1:uc010ksi.1:exon5:c.C522T:p.H174H,MAD1L1:uc010ksh.1:exon6:c.C663T:p.H221H,MAD1L1:uc003slf.1:exon7:c.C663T:p.H221H,MAD1L1:uc003slg.1:exon7:c.C663T:p.H221H,MAD1L1:uc003slh.1:exon7:c.C663T:p.H221H,MAD1L1:uc010ksj.3:exon7:c.C663T:p.H221H	.	AFR:0.2777,AMR:0.4041,EAS:0.5341,FIN:0.2723,NFE:0.3526,OTH:0.3388,ASJ:0.2815	602686	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04114 Oocyte meiosis~ko04914 Progesterone-mediated oocyte maturation~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	7	MU109089	hom
7	2290314	2290314	C	T	NUDT1	exonic	synonymous SNV	ENSG00000106268	rs12699806	.	NUDT1:NM_001367555:exon4:c.C336T:p.L112L,NUDT1:NM_001367554:exon5:c.C336T:p.L112L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.610823	0.6427	.	.	.	.	.	.	.	.	.	.	AFR:0.4812,AMR:0.5955,EAS:0.7219,FIN:0.7434,NFE:0.7104,OTH:0.6798,ASJ:0.5714	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290317	2290317	T	G	NUDT1	exonic	nonsynonymous SNV	ENSG00000106268	rs60298419	.	NUDT1:NM_001367555:exon4:c.T339G:p.D113E,NUDT1:NM_001367554:exon5:c.T339G:p.D113E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.611222	0.6413	.	.	.	.	.	.	.	.	.	.	AFR:0.4801,AMR:0.5952,EAS:0.7207,FIN:0.7404,NFE:0.7096,OTH:0.6806,ASJ:0.568	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290320	2290320	C	-	NUDT1	exonic	frameshift deletion	ENSG00000106268	rs373496719	.	NUDT1:NM_001367555:exon4:c.342delC:p.L114fs,NUDT1:NM_001367554:exon5:c.342delC:p.L114fs	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.611022	0.6409	.	.	.	.	.	.	.	.	.	.	AFR:0.4799,AMR:0.5942,EAS:0.7204,FIN:0.7413,NFE:0.7086,OTH:0.6813,ASJ:0.5650	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2290328	2290328	C	T	NUDT1	exonic	nonsynonymous SNV	ENSG00000106268	rs10230814	.	NUDT1:NM_001367555:exon4:c.C350T:p.S117L,NUDT1:NM_001367554:exon5:c.C350T:p.S117L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.611422	0.6436	.	.	.	.	.	.	.	.	.	.	AFR:0.4818,AMR:0.5980,EAS:0.7212,FIN:0.7432,NFE:0.7114,OTH:0.6809,ASJ:0.5853	600312	.	.	.	.	.	.	.	.	.	.	.	7	MU14062065	unknown
7	2290336	2290336	T	G	NUDT1	UTR3	.	ENSG00000106268	rs10249180	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.311901	0.2812	.	.	.	.	.	.	.	.	.	.	AFR:0.1047,AMR:0.3793,EAS:0.5553,FIN:0.2879,NFE:0.3484,OTH:0.3185,ASJ:0.2810	600312	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	2946461	2946461	T	C	CARD11	exonic	synonymous SNV	ENSG00000198286	rs1124581	ENSG00000198286:ENST00000396946:exon25:c.A3276G:p.R1092R	CARD11:NM_032415:exon25:c.A3276G:p.R1092R,CARD11:NM_001324281:exon26:c.A3276G:p.R1092R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5163	0.5466	0.596446	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	CARD11:uc003smv.3:exon25:c.A3276G:p.R1092R	.	AFR:MU62210,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,EAS:0.6721,FIN:0.4880,NFE:0.4040,OTH:0.6410,ASJ:0.5349	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	2(large_intestine)	0.4029
7	2957005	2957005	T	C	CARD11	exonic	synonymous SNV	ENSG00000198286	rs3735124	ENSG00000198286:ENST00000396946:exon20:c.A2622G:p.P874P	CARD11:NM_032415:exon20:c.A2622G:p.P874P,CARD11:NM_001324281:exon21:c.A2622G:p.P874P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3154	0.3170	0.463059	MU803705	.	.	.	.	.	.	.	.	CARD11:uc003smv.3:exon20:c.A2622G:p.P874P	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.3181,EAS:0.3842,FIN:0.2649,NFE:0.6351,OTH:0.1469,ASJ:0.5336	607210	615206;616452;	464336;357237;	464336|B-cell expansion with NF-kB and T-cell anergy disease|-|Autosomal dominant|-|616452 ~357237|SCID due to CARD11 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615206 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.2008
7	6026384	6026384	C	T	PMS2	intronic	.	ENSG00000122512	rs111905775	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0818	0.0311	0.110423	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:0.0574,AMR:0.0194,EAS:0.0828,FIN:0.3358,NFE:0.0882,OTH:0.0437,ASJ:0.0275	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	3(soft_tissue)	0.0574
7	6026775	6026775	T	C	PMS2	exonic	nonsynonymous SNV	ENSG00000122512	rs2228006	ENSG00000122512:ENST00000441476:exon8:c.A1303G:p.K435E,ENSG00000122512:ENST00000265849:exon11:c.A1621G:p.K541E,ENSG00000122512:ENST00000406569:exon11:c.A1621G:p.K541E	PMS2:NM_001322008:exon9:c.A1303G:p.K435E,PMS2:NM_001322010:exon9:c.A1060G:p.K354E,PMS2:NM_001322004:exon10:c.A1216G:p.K406E,PMS2:NM_001322006:exon10:c.A1465G:p.K489E,PMS2:NM_001322007:exon10:c.A1303G:p.K435E,PMS2:NM_001322013:exon10:c.A1048G:p.K350E,PMS2:NM_000535:exon11:c.A1621G:p.K541E,PMS2:NM_001322003:exon11:c.A1216G:p.K406E,PMS2:NM_001322005:exon11:c.A1216G:p.K406E,PMS2:NM_001322009:exon11:c.A1216G:p.K406E,PMS2:NM_001322011:exon11:c.A688G:p.K230E,PMS2:NM_001322012:exon11:c.A688G:p.K230E,PMS2:NM_001322014:exon11:c.A1621G:p.K541E,PMS2:NM_001322015:exon11:c.A1312G:p.K438E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.8514	0.8704	0.883187	0.8722	-0.586	0.135	1.0	4.66	0.013	.	.	.	PMS2:uc003spj.3:exon8:c.A1303G:p.K435E,PMS2:uc011jwl.2:exon10:c.A1216G:p.K406E,PMS2:uc003spk.3:exon11:c.A1216G:p.K406E,PMS2:uc003spl.3:exon11:c.A1621G:p.K541E,PMS2:uc010ktf.2:exon11:c.A1621G:p.K541E,PMS2:uc010ktg.3:exon11:c.A688G:p.K230E	-0.949	AFR:0.9248,AMR:0.7213,EAS:0.9202,FIN:0.8447,NFE:0.8522,OTH:0.8507,ASJ:0.8974	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	0.0	1.0	0.000	-1.87	7	MU784023	hom
7	6026942	6026942	G	T	PMS2	exonic	nonsynonymous SNV	ENSG00000122512	rs1805323	ENSG00000122512:ENST00000441476:exon8:c.C1136A:p.T379K,ENSG00000122512:ENST00000265849:exon11:c.C1454A:p.T485K,ENSG00000122512:ENST00000406569:exon11:c.C1454A:p.T485K	PMS2:NM_001322008:exon9:c.C1136A:p.T379K,PMS2:NM_001322010:exon9:c.C893A:p.T298K,PMS2:NM_001322004:exon10:c.C1049A:p.T350K,PMS2:NM_001322006:exon10:c.C1298A:p.T433K,PMS2:NM_001322007:exon10:c.C1136A:p.T379K,PMS2:NM_001322013:exon10:c.C881A:p.T294K,PMS2:NM_000535:exon11:c.C1454A:p.T485K,PMS2:NM_001322003:exon11:c.C1049A:p.T350K,PMS2:NM_001322005:exon11:c.C1049A:p.T350K,PMS2:NM_001322009:exon11:c.C1049A:p.T350K,PMS2:NM_001322011:exon11:c.C521A:p.T174K,PMS2:NM_001322012:exon11:c.C521A:p.T174K,PMS2:NM_001322014:exon11:c.C1454A:p.T485K,PMS2:NM_001322015:exon11:c.C1145A:p.T382K	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0801	0.0335	0.112021	2(haematopoietic_and_lymphoid_tissue)	-1.560	0.002	0.934	-10.2	0.000	.	.	.	PMS2:uc003spj.3:exon8:c.C1136A:p.T379K,PMS2:uc011jwl.2:exon10:c.C1049A:p.T350K,PMS2:uc003spk.3:exon11:c.C1049A:p.T350K,PMS2:uc003spl.3:exon11:c.C1454A:p.T485K,PMS2:uc010ktf.2:exon11:c.C1454A:p.T485K,PMS2:uc010ktg.3:exon11:c.C521A:p.T174K	-1.025	AFR:1(breast),AMR:MU587310,EAS:0.0580,FIN:0.0196,NFE:0.0274,OTH:0.0828,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	0.0	1.13	0.000	0.55	7	3(soft_tissue)	0.3439
7	6036980	6036980	G	C	PMS2	exonic	synonymous SNV	ENSG00000122512	rs1805319	ENSG00000122512:ENST00000441476:exon4:c.C462G:p.S154S,ENSG00000122512:ENST00000265849:exon7:c.C780G:p.S260S,ENSG00000122512:ENST00000382321:exon7:c.C780G:p.S260S,ENSG00000122512:ENST00000406569:exon7:c.C780G:p.S260S	PMS2:NM_001322008:exon5:c.C462G:p.S154S,PMS2:NM_001322004:exon6:c.C375G:p.S125S,PMS2:NM_001322007:exon6:c.C462G:p.S154S,PMS2:NM_001322010:exon6:c.C375G:p.S125S,PMS2:NM_001322013:exon6:c.C207G:p.S69S,PMS2:NM_000535:exon7:c.C780G:p.S260S,PMS2:NM_001322003:exon7:c.C375G:p.S125S,PMS2:NM_001322005:exon7:c.C375G:p.S125S,PMS2:NM_001322006:exon7:c.C780G:p.S260S,PMS2:NM_001322009:exon7:c.C375G:p.S125S,PMS2:NM_001322014:exon7:c.C780G:p.S260S,PMS2:NM_001322015:exon7:c.C471G:p.S157S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8109	0.8238	0.83127	0.8205	.	.	.	.	.	.	.	.	PMS2:uc003spj.3:exon4:c.C462G:p.S154S,PMS2:uc011jwl.2:exon6:c.C375G:p.S125S,PMS2:uc003spk.3:exon7:c.C375G:p.S125S,PMS2:uc003spl.3:exon7:c.C780G:p.S260S,PMS2:uc010kte.3:exon7:c.C780G:p.S260S,PMS2:uc010ktf.2:exon7:c.C780G:p.S260S	.	AFR:0.8433,AMR:0.7031,EAS:0.9180,FIN:0.7911,NFE:0.8107,OTH:0.8010,ASJ:0.8444	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	MU4565970	hom
7	6037058	6037058	A	-	PMS2	intronic	.	ENSG00000122512	rs60794673	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0] 	0.4422	.	0.453075	0.4480	.	.	.	.	.	.	.	.	.	.	AFR:0.3371,AMR:0.4701,EAS:0.7010,FIN:0.4676,NFE:0.4763,OTH:0.4749,ASJ:0.4958	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	.	hom
7	6043386	6043386	G	A	PMS2	exonic	synonymous SNV	ENSG00000122512	rs12532895	ENSG00000122512:ENST00000265849:exon4:c.C288T:p.A96A,ENSG00000122512:ENST00000382321:exon4:c.C288T:p.A96A,ENSG00000122512:ENST00000406569:exon4:c.C288T:p.A96A	PMS2:NM_000535:exon4:c.C288T:p.A96A,PMS2:NM_001322006:exon4:c.C288T:p.A96A,PMS2:NM_001322014:exon4:c.C288T:p.A96A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0805	0.0245	0.113618	1(urinary_tract)	.	.	.	.	.	.	.	.	PMS2:uc003spl.3:exon4:c.C288T:p.A96A,PMS2:uc010kte.3:exon4:c.C288T:p.A96A,PMS2:uc010ktf.2:exon4:c.C288T:p.A96A	.	AFR:MU23701667,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.0198,FIN:0.0847,NFE:0.0166,OTH:0.3472,ASJ:0.0530	600259	276300;614337;	144;252202;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~252202|CMMR-D syndrome|-|Autosomal recessive|Childhood|276300 ~	.	.	.	.	.	.	.	.	7	1(biliary_tract)	0.0816
7	6431690	6431690	C	T	RAC1	intronic	.	ENSG00000136238	rs836478	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5603	0.5425	0.691494	0.5664	.	.	.	.	.	.	.	.	.	.	AFR:0.7118,AMR:0.6439,EAS:0.9142,FIN:0.4745,NFE:0.4697,OTH:0.4949,ASJ:0.3874	602048	.	.	.	~ko04010 MAPK signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04071 Sphingolipid signaling pathway~ko04145 Phagosome~ko04151 PI3K-Akt signaling pathway~ko04310 Wnt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04972 Pancreatic secretion~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05132 Salmonella infection~ko05135 Yersinia infection~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05231 Choline metabolism in cancer~ko05416 Viral myocarditis~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	7	MU18753436	hom
7	14025727	14025727	C	T	ETV1	intronic	.	ENSG00000006468	rs3823704	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5455	0.5528	0.563698	0.5822	.	.	.	.	.	.	.	.	.	.	AFR:0.6356,AMR:0.6687,EAS:0.5887,FIN:0.6230,NFE:0.5440,OTH:0.5398,ASJ:0.33	600541	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	MU12866402	hom
7	14025766	14025766	T	A	ETV1	exonic	synonymous SNV	ENSG00000006468	rs10215655	ENSG00000006468:ENST00000399357:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000403527:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000420159:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000438956:exon1:c.A36T:p.P12P,ENSG00000006468:ENST00000443608:exon1:c.A36T:p.P12P	ETV1:NM_001163150:exon1:c.A36T:p.P12P,ETV1:NM_001163151:exon1:c.A36T:p.P12P,ETV1:NM_001163152:exon1:c.A36T:p.P12P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5744	0.5544	0.564097	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ETV1:uc021zzt.1:exon1:c.A36T:p.P12P,ETV1:uc021zzu.1:exon1:c.A36T:p.P12P,ETV1:uc021zzv.1:exon1:c.A36T:p.P12P,ETV1:uc021zzw.1:exon1:c.A36T:p.P12P,ETV1:uc021zzx.1:exon1:c.A36T:p.P12P,ETV1:uc021zzy.1:exon1:c.A36T:p.P12P	.	AFR:MU159388,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.6351,FIN:0.6675,NFE:0.3278,OTH:0.5915,ASJ:0.5821	600541	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	1(thyroid)	0.6233
7	24756951	24756951	C	T	GSDME	exonic	nonsynonymous SNV	ENSG00000105928	rs12540919	ENSG00000105928:ENST00000411476:exon3:c.G388A:p.V130M,ENSG00000105928:ENST00000409970:exon4:c.G127A:p.V43M,ENSG00000105928:ENST00000419307:exon4:c.G127A:p.V43M,ENSG00000105928:ENST00000342947:exon5:c.G619A:p.V207M,ENSG00000105928:ENST00000409775:exon5:c.G619A:p.V207M,ENSG00000105928:ENST00000545231:exon7:c.G127A:p.V43M	GSDME:NM_001127454:exon4:c.G127A:p.V43M,GSDME:NM_001127453:exon5:c.G619A:p.V207M,GSDME:NM_004403:exon5:c.G619A:p.V207M	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0943	0.0783	0.0898562	1(stomach)	6.515	31	0.032	4.82	0.485	.	.	.	DFNA5:uc010kut.1:exon4:c.G127A:p.V43M,DFNA5:uc003sxa.1:exon5:c.G619A:p.V207M,DFNA5:uc010kus.1:exon5:c.G619A:p.V207M	-1.064	AFR:MU3888724,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,EAS:0.0435,FIN:0.0811,NFE:0.0695,OTH:0.1078,ASJ:0.0774	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.994	1.85	0.001	2.93	7	1(breast)	0.0759
7	24758753	24758753	C	T	GSDME	exonic	synonymous SNV	ENSG00000105928	rs754555	ENSG00000105928:ENST00000411476:exon2:c.G258A:p.T86T,ENSG00000105928:ENST00000342947:exon4:c.G489A:p.T163T,ENSG00000105928:ENST00000409775:exon4:c.G489A:p.T163T	GSDME:NM_001127453:exon4:c.G489A:p.T163T,GSDME:NM_004403:exon4:c.G489A:p.T163T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2056	0.1657	0.259185	2(large_intestine)	.	.	.	.	.	.	.	.	DFNA5:uc003sxa.1:exon4:c.G489A:p.T163T,DFNA5:uc010kus.1:exon4:c.G489A:p.T163T	.	AFR:MU61299,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.2004,FIN:0.1551,NFE:0.1026,OTH:0.4702,ASJ:0.1827	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	1(urinary_tract)	0.1613
7	24758795	24758795	T	C	GSDME	exonic	synonymous SNV	ENSG00000105928	rs876305	ENSG00000105928:ENST00000411476:exon2:c.A216G:p.E72E,ENSG00000105928:ENST00000342947:exon4:c.A447G:p.E149E,ENSG00000105928:ENST00000409775:exon4:c.A447G:p.E149E	GSDME:NM_001127453:exon4:c.A447G:p.E149E,GSDME:NM_004403:exon4:c.A447G:p.E149E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5712	0.5374	0.73762	0.5719	.	.	.	.	.	.	.	.	DFNA5:uc003sxa.1:exon4:c.A447G:p.E149E,DFNA5:uc010kus.1:exon4:c.A447G:p.E149E	.	AFR:0.7803,AMR:0.6770,EAS:0.9926,FIN:0.4538,NFE:0.4361,OTH:0.4857,ASJ:0.3742	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	MU81828348	hom
7	24758818	24758818	G	T	GSDME	exonic	nonsynonymous SNV	ENSG00000105928	rs754554	ENSG00000105928:ENST00000411476:exon2:c.C193A:p.P65T,ENSG00000105928:ENST00000342947:exon4:c.C424A:p.P142T,ENSG00000105928:ENST00000409775:exon4:c.C424A:p.P142T	GSDME:NM_001127453:exon4:c.C424A:p.P142T,GSDME:NM_004403:exon4:c.C424A:p.P142T	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2061	0.1657	0.259185	1(lung)	-1.558	0.002	0.926	0.252	0.000	.	.	.	DFNA5:uc003sxa.1:exon4:c.C424A:p.P142T,DFNA5:uc010kus.1:exon4:c.C424A:p.P142T	-0.927	AFR:MU815198,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.2005,FIN:0.1551,NFE:0.1026,OTH:0.4733,ASJ:0.1828	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	0.267	2.04	0.000	2.32	7	1(large_intestine)	0.1615
7	24758852	24758852	C	T	GSDME	intronic	.	ENSG00000105928	rs754553	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2054	0.1657	0.259784	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1828,AMR:0.2007,EAS:0.1026,FIN:0.4746,NFE:0.1616,OTH:0.1497,ASJ:0.1551	608798	600994;	90635;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	7	1(breast)	0.1721
7	45703971	45703971	G	A	ADCY1	exonic	synonymous SNV	ENSG00000164742	rs1042009	ENSG00000164742:ENST00000432715:exon10:c.G1014A:p.T338T	ADCY1:NM_001281768:exon10:c.G1014A:p.T338T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6815	.	0.472644	MU5454033	.	.	.	.	.	.	.	.	ADCY1:uc003tnd.3:exon10:c.G1014A:p.T338T	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.5516,EAS:0.6229,FIN:0.6490,NFE:0.2954,OTH:0.7317,ASJ:0.2343	103072	610154;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko00230 Purine metabolism~ko01100 Metabolic pathways~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04727 GABAergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05032 Morphine addiction~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	7	2(breast)	0.7067
7	45957055	45957055	G	C	IGFBP3	intronic	.	ENSG00000146674	rs2471551	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1980	0.2001	0.181709	0.1777	.	.	.	.	.	.	.	.	.	.	AFR:0.2016,AMR:0.1623,EAS:0.0327,FIN:0.1329,NFE:0.1898,OTH:0.1823,ASJ:0.2185	146732	.	.	.	~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	MU587416	het
7	45960323	45960323	C	A	IGFBP3	exonic	synonymous SNV	ENSG00000146674	rs6950868	ENSG00000146674:ENST00000381083:exon1:c.G417T:p.A139A	IGFBP3:NM_001013398:exon1:c.G417T:p.A139A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5572	.	0.190096	0.1800	.	.	.	.	.	.	.	.	IGFBP3:uc003tnr.3:exon1:c.G417T:p.A139A	.	AFR:0.2239,AMR:0.1650,EAS:0.0327,FIN:0.1335,NFE:0.1814,OTH:0.1789,ASJ:0.2152	146732	.	.	.	~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	7	MU67378611	het
7	45960645	45960645	G	C	IGFBP3	exonic	nonsynonymous SNV	ENSG00000146674	rs2854746	ENSG00000146674:ENST00000275521:exon1:c.C95G:p.A32G,ENSG00000146674:ENST00000381083:exon1:c.C95G:p.A32G	IGFBP3:NM_000598:exon1:c.C95G:p.A32G,IGFBP3:NM_001013398:exon1:c.C95G:p.A32G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4761	.	0.42512	0.3803	-0.320	0.598	0.38	0.626	0.150	.	.	.	IGFBP3:uc003tnr.3:exon1:c.C95G:p.A32G,IGFBP3:uc003tns.3:exon1:c.C95G:p.A32G	-0.970	AFR:0.3151,AMR:0.3047,EAS:0.7596,FIN:0.3377,NFE:0.3864,OTH:0.3909,ASJ:0.4933	146732	.	.	.	~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.006	2.37	0.000	0.805	7	MU4548620	het
7	50435777	50435777	T	G	IKZF1	exonic	synonymous SNV	ENSG00000185811	rs12669559	ENSG00000185811:ENST00000413698:exon4:c.T234G:p.P78P	IKZF1:NM_001291845:exon4:c.T234G:p.P78P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3607	.	0.292133	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	IKZF1:uc003tov.1:exon4:c.T234G:p.P78P	.	AFR:0.2991,AMR:0.2368,EAS:0.4404,FIN:0.1570,NFE:0.2557,OTH:0.3524,ASJ:0.3549	603023	616873;	317473;	317473|CID due to IKAROS deficiency<br>Combined immunodeficiency due to IKAROS deficiency|-|Autosomal dominant|-|616873 ~	.	,6183	.	.	.	.	.	.	7	1(thyroid)	0.3367
7	50436033	50436033	A	G	IKZF1	exonic	nonsynonymous SNV	ENSG00000185811	rs10899750	ENSG00000185811:ENST00000413698:exon4:c.A490G:p.R164G	IKZF1:NM_001291845:exon4:c.A490G:p.R164G	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.6862	.	0.717652	LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	-0.360	0.481	0.0	-6.26	0.000	.	.	.	IKZF1:uc003tov.1:exon4:c.A490G:p.R164G	-0.968	AFR:0.7485,AMR:0.9139,EAS:0.7351,FIN:0.5297,NFE:0.7467,OTH:0.6808,ASJ:0.7225	603023	616873;	317473;	317473|CID due to IKAROS deficiency<br>Combined immunodeficiency due to IKAROS deficiency|-|Autosomal dominant|-|616873 ~	.	,6183	.	.	0.0	.	0.000	.	7	1(liver)	0.7061
7	55214348	55214348	C	T	EGFR	exonic	synonymous SNV	ENSG00000146648	rs2072454	ENSG00000146648:ENST00000275493:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000342916:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000344576:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000420316:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000442591:exon4:c.C474T:p.N158N,ENSG00000146648:ENST00000450046:exon4:c.C315T:p.N105N,ENSG00000146648:ENST00000454757:exon4:c.C315T:p.N105N	EGFR:NM_001346898:exon4:c.C474T:p.N158N,EGFR:NM_001346900:exon4:c.C315T:p.N105N,EGFR:NM_005228:exon4:c.C474T:p.N158N,EGFR:NM_201282:exon4:c.C474T:p.N158N,EGFR:NM_201283:exon4:c.C474T:p.N158N,EGFR:NM_201284:exon4:c.C474T:p.N158N	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5090	0.5151	0.475439	2(central_nervous_system)	.	.	.	.	.	.	.	.	EGFR:uc003tqh.3:exon4:c.C474T:p.N158N,EGFR:uc003tqi.3:exon4:c.C474T:p.N158N,EGFR:uc003tqj.3:exon4:c.C474T:p.N158N,EGFR:uc003tqk.3:exon4:c.C474T:p.N158N,EGFR:uc011kco.2:exon4:c.C315T:p.N105N,EGFR:uc022adm.1:exon4:c.C474T:p.N158N	.	AFR:18(soft_tissue),AMR:1(prostate),EAS:1(large_intestine),FIN:MU4807633,NFE:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,OTH:0.5053,ASJ:1(lung)	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3244,3243,,3265,3242,3246,3231,3221,3227,3241,2507,3226,3234,3263,3213,2506,3218,3259,3225,3251,3257,2510,3217,3254,3267,3236,3230,3253,3245,3260,3258,3261,3232,2509,3222,3238,3220,3214,3266,3269,3252,3235,3223,3256,3219,3262,2508,3212,3255,3229,3237,3215,3228,3264,3233,3247,3216,3224,3240,3248,3268,3211,3239	.	,3249,3250	.	.	.	.	7	3(haematopoietic_and_lymphoid_tissue)	0.5028
7	55214443	55214443	G	A	EGFR	intronic	.	ENSG00000146648	rs7801956	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0768	0.0679	0.0553115	MU26248662	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,BRCA-KR|1|50|0.02,AMR:0.0624,EAS:0.0501,FIN:0.0894,NFE:0.0678,OTH:0.0567,ASJ:0.0214	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	7	4(soft_tissue)	0.0862
7	55238087	55238087	C	T	EGFR	exonic	synonymous SNV	ENSG00000146648	rs10258429	ENSG00000146648:ENST00000344576:exon16:c.C1968T:p.H656H	EGFR:NM_201284:exon16:c.C1968T:p.H656H	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.0830	0.1175	0.11242	1(lung)	.	.	.	.	.	.	.	.	EGFR:uc003tqj.3:exon16:c.C1968T:p.H656H	.	AFR:1(breast),AMR:1(large_intestine),EAS:LICA-CN|1|402|0.00248756,BRCA-KR|1|50|0.02,FIN:0.1086,NFE:0.2009,OTH:0.0646,ASJ:MU150501	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3244,3243,,3265,3242,3246,3231,3221,3227,3241,2507,3226,3234,3263,3213,2506,3218,3259,3225,3251,3257,2510,3217,3254,3267,3236,3230,3253,3245,3260,3258,3261,3232,2509,3222,3238,3220,3214,3266,3269,3252,3235,3223,3256,3219,3262,2508,3212,3255,3229,3237,3215,3228,3264,3233,3247,3216,3224,3240,3248,3268,3211,3239	.	,3249,3250	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.0530
7	55241755	55241755	G	A	EGFR	intronic	.	ENSG00000146648	rs17337107	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0371	0.0306	0.0227636	.	.	.	.	.	.	.	.	.	.	.	AFR:0.0285,AMR:0.0096,EAS:0.0464,FIN:0.0006,NFE:0.0255,OTH:0.0426,ASJ:0.0274	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	7	1(soft_tissue)	0.0356
7	55249063	55249063	G	A	EGFR	exonic	synonymous SNV	ENSG00000146648	rs1050171	ENSG00000146648:ENST00000455089:exon19:c.G2226A:p.Q742Q,ENSG00000146648:ENST00000275493:exon20:c.G2361A:p.Q787Q,ENSG00000146648:ENST00000454757:exon20:c.G2202A:p.Q734Q	EGFR:NM_001346941:exon14:c.G1560A:p.Q520Q,EGFR:NM_001346897:exon19:c.G2226A:p.Q742Q,EGFR:NM_001346899:exon19:c.G2226A:p.Q742Q,EGFR:NM_001346898:exon20:c.G2361A:p.Q787Q,EGFR:NM_001346900:exon20:c.G2202A:p.Q734Q,EGFR:NM_005228:exon20:c.G2361A:p.Q787Q	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5228	0.5424	0.432708	2(breast)	.	.	.	.	.	.	.	.	EGFR:uc022ado.1:exon1:c.G66A:p.Q22Q,EGFR:uc010kzg.2:exon19:c.G2226A:p.Q742Q,EGFR:uc022adn.1:exon19:c.G2226A:p.Q742Q,EGFR:uc003tqk.3:exon20:c.G2361A:p.Q787Q,EGFR:uc011kco.2:exon20:c.G2202A:p.Q734Q,EGFR:uc022adm.1:exon20:c.G2361A:p.Q787Q	.	AFR:2(biliary_tract),AMR:MU13012522,EAS:0.5005,FIN:0.4162,NFE:0.5692,OTH:0.6589,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3244,3243,,3265,3242,3246,3231,3221,3227,3241,2507,3226,3234,3263,3213,2506,3218,3259,3225,3251,3257,2510,3217,3254,3267,3236,3230,2712,3253,3245,3260,3258,3261,3232,2509,3222,3238,3220,3214,3370,3266,3269,3252,3235,3223,3256,3219,3262,2508,3212,3255,3229,3237,3215,3228,3264,3233,3247,2682,3216,3224,3240,3248,3268,3211,3239	.	,3249,3250	.	.	.	.	7	15(meninges)	0.1743
7	55266417	55266417	T	C	EGFR	exonic	synonymous SNV	ENSG00000146648	rs1140475	ENSG00000146648:ENST00000455089:exon22:c.T2574C:p.T858T,ENSG00000146648:ENST00000275493:exon23:c.T2709C:p.T903T,ENSG00000146648:ENST00000454757:exon23:c.T2550C:p.T850T	EGFR:NM_001346941:exon17:c.T1908C:p.T636T,EGFR:NM_001346897:exon22:c.T2574C:p.T858T,EGFR:NM_001346899:exon22:c.T2574C:p.T858T,EGFR:NM_001346898:exon23:c.T2709C:p.T903T,EGFR:NM_001346900:exon23:c.T2550C:p.T850T,EGFR:NM_005228:exon23:c.T2709C:p.T903T	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8957	0.8891	0.916733	SKCA-BR|1|100|0.01,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	EGFR:uc010kzg.2:exon22:c.T2574C:p.T858T,EGFR:uc022adn.1:exon22:c.T2574C:p.T858T,EGFR:uc003tqk.3:exon23:c.T2709C:p.T903T,EGFR:uc011kco.2:exon23:c.T2550C:p.T850T,EGFR:uc022adm.1:exon23:c.T2709C:p.T903T	.	AFR:0.8922,AMR:0.9260,EAS:0.9139,FIN:0.9228,NFE:0.8832,OTH:0.8703,ASJ:0.9103	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3244,3243,,3265,3242,3246,3231,3221,3227,3241,2507,3226,3234,3263,3213,2506,3218,3259,3225,3251,3257,2510,3217,3254,3267,3236,3230,3253,3245,3260,3258,3261,3232,2509,3222,3238,3220,3214,3266,3269,3252,3235,3223,3256,3219,3262,2508,3212,3255,3229,3237,3215,3228,3264,3233,3247,3216,3224,3240,3248,3268,3211,3239	.	,3249,3250	.	.	.	.	7	3(lung)	0.8878
7	55268916	55268916	C	T	EGFR	exonic	synonymous SNV	ENSG00000146648	rs2293347	ENSG00000146648:ENST00000455089:exon24:c.C2847T:p.D949D,ENSG00000146648:ENST00000275493:exon25:c.C2982T:p.D994D,ENSG00000146648:ENST00000454757:exon25:c.C2823T:p.D941D	EGFR:NM_001346941:exon19:c.C2181T:p.D727D,EGFR:NM_001346897:exon24:c.C2847T:p.D949D,EGFR:NM_001346899:exon24:c.C2847T:p.D949D,EGFR:NM_001346898:exon25:c.C2982T:p.D994D,EGFR:NM_001346900:exon25:c.C2823T:p.D941D,EGFR:NM_005228:exon25:c.C2982T:p.D994D	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1337	0.0704	0.141773	24(meninges)	.	.	.	.	.	.	.	.	EGFR:uc010kzg.2:exon24:c.C2847T:p.D949D,EGFR:uc022adn.1:exon24:c.C2847T:p.D949D,EGFR:uc003tqk.3:exon25:c.C2982T:p.D994D,EGFR:uc011kco.2:exon25:c.C2823T:p.D941D,EGFR:uc022adm.1:exon25:c.C2982T:p.D994D	.	AFR:3(haematopoietic_and_lymphoid_tissue),AMR:1(large_intestine),EAS:MU150515,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,GACA-JP|1|585|0.0017094,BRCA-KR|1|50|0.02,NFE:0.1010,OTH:0.0275,ASJ:1(breast)	131550	211980;616069;	294023;	294023|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614328 616069 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04214 Apoptosis - fly~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04520 Adherens junction~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05160 Hepatitis C~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	3244,3243,,3265,3242,3246,3231,3221,3227,3241,2507,3226,3234,3263,3213,2506,3218,3259,3225,3251,3257,2510,3217,3254,3267,3236,3230,2712,3253,3245,3260,3258,3261,3232,2509,3222,3238,3220,3214,3370,3266,3269,3252,3235,3223,3256,3219,3262,2508,3212,3255,3229,3237,3215,3228,3264,3233,3247,2682,3216,3224,3240,3248,3268,3211,3239	.	,3249,3250	.	.	.	.	7	4(lung)	0.1587
7	73467651	73467654	TGTG	-	ELN	intronic	.	ENSG00000049540	rs10579871	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3935	.	.	0.5303	.	.	.	.	.	.	.	.	.	.	AFR:0.4804,AMR:0.5388,EAS:0.5781,FIN:0.4950,NFE:0.5601,OTH:0.5215,ASJ:0.6318	130160	123700;185500;	3193;90348;	3193|SVAS|1-5 / 10 000|Autosomal dominant|All ages|185500 ~90348|ADCL|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123700 614434 616603 ~	.	.	.	.	.	.	.	.	7	.	unknown
7	73470782	73470782	C	T	ELN	intronic	.	ENSG00000049540	rs2856728	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7895	0.7932	0.756589	0.7980	.	.	.	.	.	.	.	.	.	.	AFR:0.7664,AMR:0.7739,EAS:0.6866,FIN:0.8373,NFE:0.8203,OTH:0.7898,ASJ:0.8377	130160	123700;185500;	3193;90348;	3193|SVAS|1-5 / 10 000|Autosomal dominant|All ages|185500 ~90348|ADCL|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123700 614434 616603 ~	.	.	.	.	.	.	.	.	7	MU81832477	het
7	75137097	75137097	A	G	PMS2P3	ncRNA_exonic	.	ENSG00000127957	rs62477735	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.44988	0.3287	.	.	.	.	.	.	.	.	.	.	AFR:0.0816,AMR:0.5565,EAS:0.8029,FIN:0.4723,NFE:0.3745,OTH:0.4344,ASJ:0.3586	.	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	75145411	75145411	T	C	PMS2P3	ncRNA_intronic	.	ENSG00000127957	rs794378	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9744	.	0.975839	0.9805	.	.	.	.	.	.	.	.	.	.	AFR:0.9886,AMR:0.9592,EAS:0.9507,FIN:0.9616,NFE:0.9844,OTH:0.9774,ASJ:0.9966	.	.	.	.	.	.	.	.	.	.	.	.	7	.	hom
7	75145495	75145495	G	A	PMS2P3	ncRNA_exonic	.	ENSG00000127957	rs794377	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4386	0.2710	0.408147	0.3578	.	.	.	.	.	.	.	.	.	.	AFR:0.0864,AMR:0.5921,EAS:0.6756,FIN:0.5270,NFE:0.4207,OTH:0.4785,ASJ:0.4060	.	.	.	.	.	.	.	.	.	.	.	.	7	MU13048068	het
7	75155300	75155300	G	A	PMS2P3	ncRNA_intronic	.	ENSG00000127957	rs1167823	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1857	0.1883	.	0.1766	.	.	.	.	.	.	.	.	.	.	AFR:0.0995,AMR:0.1098,EAS:0.0037,FIN:0.2377,NFE:0.2281,OTH:0.1965,ASJ:0.1987	.	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	75609677	75609677	A	G	POR	exonic	synonymous SNV	ENSG00000127948	rs1135612	ENSG00000127948:ENST00000412064:exon4:c.A387G:p.P129P,ENSG00000127948:ENST00000426184:exon4:c.A246G:p.P82P,ENSG00000127948:ENST00000454934:exon4:c.A387G:p.P129P,ENSG00000127948:ENST00000394893:exon5:c.A387G:p.P129P,ENSG00000127948:ENST00000414186:exon5:c.A387G:p.P129P,ENSG00000127948:ENST00000432753:exon5:c.A387G:p.P129P,ENSG00000127948:ENST00000439963:exon5:c.A387G:p.P129P,ENSG00000127948:ENST00000453773:exon5:c.A387G:p.P129P,ENSG00000127948:ENST00000461988:exon5:c.A387G:p.P129P,ENSG00000127948:ENST00000412521:exon6:c.A387G:p.P129P	POR:NM_000941:exon5:c.A387G:p.P129P,POR:NM_001367562:exon6:c.A387G:p.P129P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2659	0.1936	0.249401	MU13048582	.	.	.	.	.	.	.	.	POR:uc003udy.3:exon5:c.A387G:p.P129P	.	AFR:ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.2131,EAS:0.4091,FIN:0.2914,NFE:0.4708,OTH:0.2067,ASJ:0.0776	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	1(skin)	0.2511
7	75614082	75614082	C	G	POR	intronic	.	ENSG00000127948	rs4732516	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9091	0.8527	0.811901	0.8553	.	.	.	.	.	.	.	.	.	.	AFR:0.6054,AMR:0.8612,EAS:0.8585,FIN:0.9760,NFE:0.9643,OTH:0.9296,ASJ:0.9735	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	MU27551504	hom
7	75614288	75614288	C	T	POR	intronic	.	ENSG00000127948	rs2286822	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3082	0.2687	0.304313	3(lung)	.	.	.	.	.	.	.	.	.	.	AFR:MU749549,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|5|321|0.0155763,EAS:0.2101,FIN:0.3880,NFE:0.4007,OTH:0.4334,ASJ:0.2704	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	1(large_intestine)	0.2361
7	75614296	75614296	G	A	POR	intronic	.	ENSG00000127948	rs2286823	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3053	0.2628	0.299521	MU749547	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.2640,EAS:0.3837,FIN:0.4007,NFE:0.4315,OTH:0.2359,ASJ:0.1898	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.2856
7	75614953	75614953	T	C	POR	exonic	synonymous SNV	ENSG00000127948	rs2228104	ENSG00000127948:ENST00000439269:exon7:c.T669C:p.A223A,ENSG00000127948:ENST00000545601:exon8:c.T879C:p.A293A,ENSG00000127948:ENST00000450476:exon9:c.T1152C:p.A384A,ENSG00000127948:ENST00000394893:exon13:c.T1455C:p.A485A,ENSG00000127948:ENST00000419840:exon13:c.T897C:p.A299A,ENSG00000127948:ENST00000461988:exon13:c.T1455C:p.A485A	POR:NM_000941:exon13:c.T1455C:p.A485A,POR:NM_001367562:exon14:c.T1455C:p.A485A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9226	0.8729	0.835264	0.8763	.	.	.	.	.	.	.	.	POR:uc011kge.2:exon7:c.T669C:p.A223A,POR:uc011kgc.2:exon8:c.T879C:p.A293A,POR:uc003udy.3:exon13:c.T1455C:p.A485A	.	AFR:0.6665,AMR:0.8831,EAS:0.8631,FIN:0.9840,NFE:0.9676,OTH:0.9439,ASJ:0.9735	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	.	.	.	.	7	MU4554694	hom
7	75615006	75615006	C	T	POR	exonic	nonsynonymous SNV	ENSG00000127948	rs1057868	ENSG00000127948:ENST00000439269:exon7:c.C722T:p.A241V,ENSG00000127948:ENST00000545601:exon8:c.C932T:p.A311V,ENSG00000127948:ENST00000450476:exon9:c.C1205T:p.A402V,ENSG00000127948:ENST00000394893:exon13:c.C1508T:p.A503V,ENSG00000127948:ENST00000419840:exon13:c.C950T:p.A317V,ENSG00000127948:ENST00000461988:exon13:c.C1508T:p.A503V	POR:NM_000941:exon13:c.C1508T:p.A503V,POR:NM_001367562:exon14:c.C1508T:p.A503V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3639	0.2367	0.286142	1(oesophagus)	0.704	8.850	0.218	3.51	0.213	.	.	Ferredoxin reductase-type FAD-binding domain|Riboflavin synthase-like beta-barrel	POR:uc011kge.2:exon7:c.C722T:p.A241V,POR:uc011kgc.2:exon8:c.C932T:p.A311V,POR:uc003udy.3:exon13:c.C1508T:p.A503V	-1.038	AFR:1(large_intestine),AMR:MU132199,EAS:0.2805,FIN:0.1822,NFE:0.2632,OTH:0.2583,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,ESCA-CN|1|332|0.00301205	124015	201750;613571;	418;95699;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~95699|Congenital adrenal hyperplasia due to cytochrome POR deficiency<br>POR deficiency<br>PORD|Unknown|Autosomal recessive|Infancy<br>Neonatal|613571 ~	.	.	.	.	0.0	-1.64	0.000	1.195	7	1(prostate)	0.3778
7	77756580	77756580	T	C	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs2074641	ENSG00000187391:ENST00000419488:exon18:c.A3315G:p.L1105L,ENSG00000187391:ENST00000354212:exon19:c.A3357G:p.L1119L,ENSG00000187391:ENST00000522391:exon19:c.A3357G:p.L1119L	MAGI2:NM_001301128:exon18:c.A3315G:p.L1105L,MAGI2:NM_012301:exon19:c.A3357G:p.L1119L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8248	0.8840	0.786542	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon14:c.A2136G:p.L712L,MAGI2:uc003ugy.3:exon18:c.A3315G:p.L1105L,MAGI2:uc003ugx.3:exon19:c.A3357G:p.L1119L	.	AFR:0.8715,AMR:0.9082,EAS:0.8013,FIN:0.6043,NFE:0.8788,OTH:0.8868,ASJ:0.7362	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.8615
7	77756724	77756724	C	T	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs7812015	ENSG00000187391:ENST00000419488:exon18:c.G3171A:p.S1057S,ENSG00000187391:ENST00000354212:exon19:c.G3213A:p.S1071S,ENSG00000187391:ENST00000522391:exon19:c.G3213A:p.S1071S	MAGI2:NM_001301128:exon18:c.G3171A:p.S1057S,MAGI2:NM_012301:exon19:c.G3213A:p.S1071S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8244	0.8840	0.786342	MU116389	.	.	.	.	.	.	.	.	MAGI2:uc010ldx.1:exon14:c.G1992A:p.S664S,MAGI2:uc003ugy.3:exon18:c.G3171A:p.S1057S,MAGI2:uc003ugx.3:exon19:c.G3213A:p.S1071S	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.8715,EAS:0.7380,FIN:0.8013,NFE:0.6032,OTH:0.8789,ASJ:0.9082	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.8869
7	78119109	78119109	C	T	MAGI2	exonic	synonymous SNV	ENSG00000187391	rs3735442	ENSG00000187391:ENST00000535697:exon5:c.G525A:p.K175K,ENSG00000187391:ENST00000354212:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000419488:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000522391:exon6:c.G1014A:p.K338K,ENSG00000187391:ENST00000536571:exon6:c.G510A:p.K170K	MAGI2:NM_001301128:exon6:c.G1014A:p.K338K,MAGI2:NM_012301:exon6:c.G1014A:p.K338K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2942	0.3455	0.323083	1(stomach)	.	.	.	.	.	.	.	.	MAGI2:uc011kgs.1:exon5:c.G525A:p.K175K,MAGI2:uc003ugx.3:exon6:c.G1014A:p.K338K,MAGI2:uc003ugy.3:exon6:c.G1014A:p.K338K,MAGI2:uc011kgr.1:exon6:c.G510A:p.K170K	.	AFR:1(breast),AMR:MU30304050,EAS:0.3279,FIN:0.4237,NFE:0.2208,OTH:0.3543,ASJ:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	606382	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.2443
7	80290369	80290369	A	G	CD36	intronic	.	ENSG00000135218	rs3211892	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9649	0.9203	0.918331	0.9293	.	.	.	.	.	0	0	.	.	.	AFR:0.8000,AMR:0.9773,EAS:0.9994,FIN:0.9834,NFE:0.9777,OTH:0.9776,ASJ:0.9603	173510	608404;610938;611162;	673;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~	.	.	.	.	.	.	.	.	7	MU81833340	hom
7	81346685	81346685	T	C	HGF	intronic	.	ENSG00000019991	rs1800793	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8053	0.7530	0.798323	0.7671	.	.	.	.	.	0.0002	0.044	.	.	.	AFR:0.6746,AMR:0.8675,EAS:0.8335,FIN:0.7857,NFE:0.7983,OTH:0.8136,ASJ:0.8825	142409	608265;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05144 Malaria~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	MU26259331	het
7	81388042	81388042	T	C	HGF	exonic	synonymous SNV	ENSG00000019991	rs5745635	ENSG00000019991:ENST00000453018:exon2:c.A24G:p.E8E,ENSG00000019991:ENST00000222390:exon3:c.A333G:p.E111E,ENSG00000019991:ENST00000354224:exon3:c.A333G:p.E111E,ENSG00000019991:ENST00000423064:exon3:c.A333G:p.E111E,ENSG00000019991:ENST00000444829:exon3:c.A333G:p.E111E,ENSG00000019991:ENST00000453411:exon3:c.A333G:p.E111E,ENSG00000019991:ENST00000457544:exon3:c.A333G:p.E111E,ENSG00000019991:ENST00000412881:exon4:c.A333G:p.E111E,ENSG00000019991:ENST00000421558:exon4:c.A333G:p.E111E	HGF:NM_000601:exon3:c.A333G:p.E111E,HGF:NM_001010931:exon3:c.A333G:p.E111E,HGF:NM_001010932:exon3:c.A333G:p.E111E,HGF:NM_001010933:exon3:c.A333G:p.E111E,HGF:NM_001010934:exon3:c.A333G:p.E111E	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0417	0.1041	0.103435	0.0869	.	.	.	.	.	.	.	.	HGF:uc003uhl.3:exon3:c.A333G:p.E111E,HGF:uc003uhm.3:exon3:c.A333G:p.E111E,HGF:uc003uhn.1:exon3:c.A333G:p.E111E,HGF:uc003uho.1:exon3:c.A333G:p.E111E,HGF:uc003uhp.3:exon3:c.A333G:p.E111E,HGF:uc022agw.1:exon3:c.A333G:p.E111E	.	AFR:0.2843,AMR:0.0311,EAS:0.0149,FIN:0.0003,NFE:0.0081,OTH:0.0346,ASJ:0.0132	142409	608265;	90636;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05144 Malaria~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	MU67379353	het
7	87032613	87032613	A	G	ABCB4	intronic	.	ENSG00000005471	rs31653	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8775	0.9234	0.879992	0.9026	.	.	.	.	.	.	.	.	.	.	AFR:0.9733,AMR:0.8361,EAS:0.7247,FIN:0.8706,NFE:0.8926,OTH:0.8878,ASJ:0.9139	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU20973608	het
7	87053206	87053206	G	A	ABCB4	intronic	.	ENSG00000005471	rs31668	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8990	0.9260	0.873602	0.9132	.	.	.	.	.	.	.	.	.	.	AFR:0.9313,AMR:0.8840,EAS:0.7120,FIN:0.9407,NFE:0.9191,OTH:0.9224,ASJ:0.9139	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU20974205	het
7	87079406	87079406	T	A	ABCB4	exonic	synonymous SNV	ENSG00000005471	rs2109505	ENSG00000005471:ENST00000453593:exon7:c.A711T:p.I237I,ENSG00000005471:ENST00000545634:exon7:c.A711T:p.I237I,ENSG00000005471:ENST00000265723:exon8:c.A711T:p.I237I,ENSG00000005471:ENST00000358400:exon8:c.A711T:p.I237I,ENSG00000005471:ENST00000359206:exon8:c.A711T:p.I237I	ABCB4:NM_000443:exon8:c.A711T:p.I237I,ABCB4:NM_018849:exon8:c.A711T:p.I237I,ABCB4:NM_018850:exon8:c.A711T:p.I237I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2101	0.2249	0.261382	MU13075765	.	.	.	.	.	.	.	.	ABCB4:uc003uiv.1:exon8:c.A711T:p.I237I,ABCB4:uc003uiw.1:exon8:c.A711T:p.I237I,ABCB4:uc003uix.1:exon8:c.A711T:p.I237I	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.2227,EAS:0.1950,FIN:0.1821,NFE:0.2618,OTH:0.1949,ASJ:0.3068	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	3(haematopoietic_and_lymphoid_tissue)	0.1802
7	87082292	87082292	G	A	ABCB4	exonic	synonymous SNV	ENSG00000005471	rs1202283	ENSG00000005471:ENST00000453593:exon5:c.C504T:p.N168N,ENSG00000005471:ENST00000545634:exon5:c.C504T:p.N168N,ENSG00000005471:ENST00000265723:exon6:c.C504T:p.N168N,ENSG00000005471:ENST00000358400:exon6:c.C504T:p.N168N,ENSG00000005471:ENST00000359206:exon6:c.C504T:p.N168N	ABCB4:NM_000443:exon6:c.C504T:p.N168N,ABCB4:NM_018849:exon6:c.C504T:p.N168N,ABCB4:NM_018850:exon6:c.C504T:p.N168N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4765	0.4041	0.347843	MU149931	.	.	.	.	.	.	.	.	ABCB4:uc003uiy.3:exon5:c.C504T:p.N168N,ABCB4:uc003uiv.1:exon6:c.C504T:p.N168N,ABCB4:uc003uiw.1:exon6:c.C504T:p.N168N,ABCB4:uc003uix.1:exon6:c.C504T:p.N168N	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.4295,EAS:0.4356,FIN:0.4267,NFE:0.3747,OTH:0.6479,ASJ:0.1106	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	1(urinary_tract)	0.5617
7	87092185	87092185	G	A	ABCB4	exonic	synonymous SNV	ENSG00000005471	rs2302387	ENSG00000005471:ENST00000453593:exon3:c.C175T:p.L59L,ENSG00000005471:ENST00000545634:exon3:c.C175T:p.L59L,ENSG00000005471:ENST00000265723:exon4:c.C175T:p.L59L,ENSG00000005471:ENST00000358400:exon4:c.C175T:p.L59L,ENSG00000005471:ENST00000359206:exon4:c.C175T:p.L59L,ENSG00000005471:ENST00000417608:exon7:c.C175T:p.L59L	ABCB4:NM_000443:exon4:c.C175T:p.L59L,ABCB4:NM_018849:exon4:c.C175T:p.L59L,ABCB4:NM_018850:exon4:c.C175T:p.L59L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1752	0.2420	0.252396	0.2271	.	.	.	.	.	.	.	.	ABCB4:uc003uiy.3:exon3:c.C175T:p.L59L,ABCB4:uc003uiv.1:exon4:c.C175T:p.L59L,ABCB4:uc003uiw.1:exon4:c.C175T:p.L59L,ABCB4:uc003uix.1:exon4:c.C175T:p.L59L	.	AFR:0.4392,AMR:0.1635,EAS:0.1898,FIN:0.1370,NFE:0.1380,OTH:0.1578,ASJ:0.1788	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	MU749307	het
7	87105276	87105276	G	C	ABCB4	upstream	.	ENSG00000005471	rs2071645	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.340655	0.2938	.	.	.	.	.	.	.	.	.	.	AFR:0.5594,AMR:0.2248,EAS:0.2562,FIN:0.1926,NFE:0.1793,OTH:0.2058,ASJ:0.1854	171060	600803;602347;614972;	69665;172;79305;69663;	69665|Gravidic intrahepatic cholestasis<br>Pregnancy-related cholestasis<br>Recurrent intrahepatic cholestasis of pregnancy|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|147480 614972 ~172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79305|PFIC3|1-9 / 100 000|Autosomal recessive|All ages|602347 ~69663|ABCB4 gene mutation-associated cholelithiasis<br>Cholelithiasis with ABCB4 gene mutation|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|600803 ~	.	.	.	.	.	.	.	.	7	.	het
7	91630620	91630620	G	T	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs6964587	ENSG00000127914:ENST00000356239:exon8:c.G1389T:p.M463I,ENSG00000127914:ENST00000358100:exon9:c.G1425T:p.M475I,ENSG00000127914:ENST00000359028:exon9:c.G1425T:p.M475I	AKAP9:NM_005751:exon8:c.G1389T:p.M463I,AKAP9:NM_147185:exon8:c.G1389T:p.M463I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3829	0.4405	0.372204	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	-0.375	0.443	0.064	-3.46	0.045	.	.	ELK domain	AKAP9:uc003uli.3:exon1:c.G264T:p.M88I,AKAP9:uc003ulf.3:exon8:c.G1389T:p.M463I,AKAP9:uc003ulg.3:exon8:c.G1389T:p.M463I,AKAP9:uc003ule.2:exon9:c.G1425T:p.M475I	-0.965	AFR:0.4037,AMR:0.5064,EAS:0.5331,FIN:0.1745,NFE:0.3738,OTH:0.3782,ASJ:0.3213	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.002	3.93	0.000	0.805	7	1(haematopoietic_and_lymphoid_tissue)	0.3937
7	91632306	91632306	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs1989779	ENSG00000127914:ENST00000356239:exon8:c.C3075T:p.T1025T,ENSG00000127914:ENST00000358100:exon9:c.C3111T:p.T1037T,ENSG00000127914:ENST00000359028:exon9:c.C3111T:p.T1037T	AKAP9:NM_005751:exon8:c.C3075T:p.T1025T,AKAP9:NM_147185:exon8:c.C3075T:p.T1025T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8924	0.9064	0.935903	0.8912	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon1:c.C1950T:p.T650T,AKAP9:uc003ulf.3:exon8:c.C3075T:p.T1025T,AKAP9:uc003ulg.3:exon8:c.C3075T:p.T1025T,AKAP9:uc003ule.2:exon9:c.C3111T:p.T1037T	.	AFR:0.9731,AMR:0.9284,EAS:0.9728,FIN:0.8373,NFE:0.8471,OTH:0.8678,ASJ:0.8676	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	MU81834056	hom
7	91641928	91641928	A	G	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs13245393	ENSG00000127914:ENST00000356239:exon9:c.A3504G:p.E1168E,ENSG00000127914:ENST00000358100:exon10:c.A3540G:p.E1180E,ENSG00000127914:ENST00000359028:exon10:c.A3540G:p.E1180E	AKAP9:NM_005751:exon9:c.A3504G:p.E1168E,AKAP9:NM_147185:exon9:c.A3504G:p.E1168E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3838	0.4418	0.373802	1(large_intestine)	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon2:c.A2379G:p.E793E,AKAP9:uc003ulf.3:exon9:c.A3504G:p.E1168E,AKAP9:uc003ulg.3:exon9:c.A3504G:p.E1168E,AKAP9:uc003ule.2:exon10:c.A3540G:p.E1180E	.	AFR:MU13086418,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.5113,FIN:0.3198,NFE:0.53,OTH:0.1749,ASJ:0.4048	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(urinary_tract)	0.3733
7	91652178	91652178	-	AAC	AKAP9	exonic	nonframeshift insertion	ENSG00000127914	rs10644111	ENSG00000127914:ENST00000356239:exon14:c.4003_4004insAAC:p.K1335delinsKQ,ENSG00000127914:ENST00000358100:exon15:c.4039_4040insAAC:p.K1347delinsKQ,ENSG00000127914:ENST00000359028:exon15:c.4039_4040insAAC:p.K1347delinsKQ	AKAP9:NM_005751:exon14:c.4003_4004insAAC:p.K1335delinsKQ,AKAP9:NM_147185:exon14:c.4003_4004insAAC:p.K1335delinsKQ	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3989	0.4791	0.42472	0.4374	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon7:c.2878_2879insAAC:p.K960delinsKQ,AKAP9:uc003ulf.3:exon14:c.4003_4004insAAC:p.K1335delinsKQ,AKAP9:uc003ulg.3:exon14:c.4003_4004insAAC:p.K1335delinsKQ,AKAP9:uc003ule.2:exon15:c.4039_4040insAAC:p.K1347delinsKQ	.	AFR:0.6258,AMR:0.3266,EAS:0.1984,FIN:0.3726,NFE:0.3761,OTH:0.3957,ASJ:0.5298	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	.	het
7	91674302	91674302	G	A	AKAP9	intronic	.	ENSG00000127914	rs9785013	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3993	0.4832	0.428514	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4430,AMR:0.6401,EAS:0.5331,FIN:0.1981,NFE:0.3736,OTH:0.3781,ASJ:0.3301	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.3975
7	91691601	91691601	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs10236397	ENSG00000127914:ENST00000356239:exon24:c.C5778T:p.G1926G,ENSG00000127914:ENST00000358100:exon25:c.C5814T:p.G1938G,ENSG00000127914:ENST00000359028:exon25:c.C5814T:p.G1938G	AKAP9:NM_005751:exon24:c.C5778T:p.G1926G,AKAP9:NM_147185:exon24:c.C5778T:p.G1926G	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3795	0.4277	0.359824	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	AKAP9:uc003uli.3:exon17:c.C4647T:p.G1549G,AKAP9:uc003ulf.3:exon24:c.C5778T:p.G1926G,AKAP9:uc003ulg.3:exon24:c.C5778T:p.G1926G	.	AFR:0.3895,AMR:0.4581,EAS:0.5331,FIN:0.1741,NFE:0.3737,OTH:0.3776,ASJ:0.3169	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	2(large_intestine)	0.3904
7	91707197	91707197	C	T	AKAP9	intronic	.	ENSG00000127914	rs733957	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4076	0.4270	0.36242	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.006	.	.	.	AFR:0.3916,AMR:0.4648,EAS:0.53,FIN:0.1754,NFE:0.3729,OTH:0.3782,ASJ:0.3177	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.3896
7	91712698	91712698	A	G	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs6960867	ENSG00000127914:ENST00000394534:exon7:c.A1913G:p.N638S,ENSG00000127914:ENST00000356239:exon33:c.A8375G:p.N2792S,ENSG00000127914:ENST00000358100:exon34:c.A8411G:p.N2804S,ENSG00000127914:ENST00000359028:exon34:c.A8411G:p.N2804S	AKAP9:NM_005751:exon33:c.A8375G:p.N2792S,AKAP9:NM_147185:exon33:c.A8351G:p.N2784S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3593	0.3561	0.295927	1(kidney)	-0.076	1.912	0.232	-2.13	0.896	.	.	.	AKAP9:uc003ulk.3:exon1:c.A200G:p.N67S,AKAP9:uc003ulj.3:exon7:c.A1685G:p.N562S,AKAP9:uc003uli.3:exon26:c.A7244G:p.N2415S,AKAP9:uc003ulf.3:exon33:c.A8351G:p.N2784S,AKAP9:uc003ulg.3:exon33:c.A8375G:p.N2792S	-0.923	AFR:MU13086466,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,WT-US|1|102|0.00980392,AML-US|3|166|0.0180723,EAS:0.2494,FIN:0.3067,NFE:0.5331,OTH:0.1755,ASJ:0.3294	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.023	0.89	0.000	1.1	7	2(large_intestine)	0.3737
7	91713972	91713972	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs10228334	ENSG00000127914:ENST00000394534:exon8:c.C2203T:p.L735L,ENSG00000127914:ENST00000356239:exon34:c.C8665T:p.L2889L	AKAP9:NM_005751:exon34:c.C8665T:p.L2889L,AKAP9:NM_147185:exon34:c.C8641T:p.L2881L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3832	0.4410	0.373802	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	AKAP9:uc003ulk.3:exon2:c.C490T:p.L164L,AKAP9:uc003ulj.3:exon8:c.C1975T:p.L659L,AKAP9:uc003uli.3:exon27:c.C7534T:p.L2512L,AKAP9:uc003ulf.3:exon34:c.C8641T:p.L2881L,AKAP9:uc003ulg.3:exon34:c.C8665T:p.L2889L	.	AFR:0.4053,AMR:0.5114,EAS:0.5367,FIN:0.1759,NFE:0.3749,OTH:0.3782,ASJ:0.3209	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.3947
7	91714911	91714911	C	T	AKAP9	exonic	nonsynonymous SNV	ENSG00000127914	rs1063242	ENSG00000127914:ENST00000394534:exon10:c.C2473T:p.P825S,ENSG00000127914:ENST00000358100:exon35:c.C8785T:p.P2929S,ENSG00000127914:ENST00000356239:exon36:c.C8935T:p.P2979S,ENSG00000127914:ENST00000359028:exon36:c.C8947T:p.P2983S	AKAP9:NM_005751:exon36:c.C8935T:p.P2979S,AKAP9:NM_147185:exon36:c.C8911T:p.P2971S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9962	0.9974	0.998802	0.9959	-0.130	1.518	1.0	2.47	0.977	.	.	.	AKAP9:uc003ulk.3:exon4:c.C760T:p.P254S,AKAP9:uc003ulj.3:exon10:c.C2245T:p.P749S,AKAP9:uc003uli.3:exon29:c.C7804T:p.P2602S,AKAP9:uc003ulf.3:exon36:c.C8911T:p.P2971S,AKAP9:uc003ulg.3:exon36:c.C8935T:p.P2979S	-1.027	AFR:0.9997,AMR:1,EAS:1,FIN:0.9920,NFE:0.9942,OTH:0.9908,ASJ:1	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	4.21	0.000	-2.075	7	MU81834100	hom
7	91715662	91715662	C	T	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs28927678	ENSG00000127914:ENST00000394534:exon11:c.C2683T:p.L895L,ENSG00000127914:ENST00000358100:exon36:c.C8995T:p.L2999L,ENSG00000127914:ENST00000356239:exon37:c.C9145T:p.L3049L,ENSG00000127914:ENST00000359028:exon37:c.C9157T:p.L3053L	AKAP9:NM_005751:exon37:c.C9145T:p.L3049L,AKAP9:NM_147185:exon37:c.C9121T:p.L3041L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3589	0.3557	0.295727	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	AKAP9:uc003ulk.3:exon5:c.C970T:p.L324L,AKAP9:uc003ulj.3:exon11:c.C2455T:p.L819L,AKAP9:uc003uli.3:exon30:c.C8014T:p.L2672L,AKAP9:uc003ulf.3:exon37:c.C9121T:p.L3041L,AKAP9:uc003ulg.3:exon37:c.C9145T:p.L3049L	.	AFR:MU13086472,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.2481,FIN:0.3067,NFE:0.5331,OTH:0.1743,ASJ:0.3291	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.3733
7	91726927	91726927	A	C	AKAP9	exonic	synonymous SNV	ENSG00000127914	rs1063243	ENSG00000127914:ENST00000394534:exon16:c.A3964C:p.R1322R,ENSG00000127914:ENST00000358100:exon41:c.A10276C:p.R3426R,ENSG00000127914:ENST00000356239:exon42:c.A10426C:p.R3476R,ENSG00000127914:ENST00000359028:exon42:c.A10438C:p.R3480R	AKAP9:NM_005751:exon42:c.A10426C:p.R3476R,AKAP9:NM_147185:exon42:c.A10402C:p.R3468R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3846	0.4463	0.377396	1(urinary_tract)	.	.	.	.	.	.	.	.	AKAP9:uc003ull.3:exon4:c.A1114C:p.R372R,AKAP9:uc003ulj.3:exon16:c.A3736C:p.R1246R,AKAP9:uc003uli.3:exon35:c.A9295C:p.R3099R,AKAP9:uc003ulf.3:exon42:c.A10402C:p.R3468R,AKAP9:uc003ulg.3:exon42:c.A10426C:p.R3476R	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU183238,EAS:0.4072,FIN:0.5204,NFE:0.3210,OTH:0.5331,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EOPC-DE|1|202|0.0049505,BTCA-JP|1|239|0.0041841	604001	611820;	101016;768;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.1737
7	95800820	95800820	T	C	SLC25A13	exonic	synonymous SNV	ENSG00000004864	rs2301629	ENSG00000004864:ENST00000542654:exon11:c.A870G:p.L290L,ENSG00000004864:ENST00000265631:exon12:c.A1194G:p.L398L,ENSG00000004864:ENST00000416240:exon12:c.A1197G:p.L399L	SLC25A13:NM_001160210:exon12:c.A1197G:p.L399L,SLC25A13:NM_014251:exon12:c.A1194G:p.L398L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3958	0.3202	0.409145	0.3492	.	.	.	.	.	.	.	.	SLC25A13:uc011kik.2:exon11:c.A870G:p.L290L,SLC25A13:uc003uof.4:exon12:c.A1194G:p.L398L,SLC25A13:uc003uog.4:exon12:c.A1197G:p.L399L	.	AFR:0.2530,AMR:0.3612,EAS:0.5739,FIN:0.3732,NFE:0.3748,OTH:0.3806,ASJ:0.2450	603859	603471;605814;	247598;247585;	247598|NICCD<br>Neonatal intrahepatic cholestasis caused by citrin deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|605814 ~247585|Adult-onset citrin deficiency<br>Adult-onset type 2 citrullinemia<br>Adult-onset type II citrullinemia<br>CTLN2<br>Citrullinemia type 2|Unknown|Autosomal recessive|Adult|603471 ~	.	.	.	.	.	.	.	.	7	MU138872	het
7	95864108	95864108	T	C	SLC25A13	intronic	.	ENSG00000004864	rs6957975	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6179	0.6890	0.609824	0.6656	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7499,AMR:0.6481,EAS:0.4595,FIN:0.6518,NFE:0.6430,OTH:0.6328,ASJ:0.7633	603859	603471;605814;	247598;247585;	247598|NICCD<br>Neonatal intrahepatic cholestasis caused by citrin deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|605814 ~247585|Adult-onset citrin deficiency<br>Adult-onset type 2 citrullinemia<br>Adult-onset type II citrullinemia<br>CTLN2<br>Citrullinemia type 2|Unknown|Autosomal recessive|Adult|603471 ~	.	.	.	.	.	.	.	.	7	MU13094841	hom
7	98556962	98556962	C	T	TRRAP	intronic	.	ENSG00000196367	rs41633	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0932	0.0604	0.0888578	0.0732	.	.	.	.	.	0.0001	0.092	.	.	.	AFR:0.0162,AMR:0.1328,EAS:0.2519,FIN:0.0745,NFE:0.0830,OTH:0.0757,ASJ:0.0861	603015	.	.	.	.	.	.	.	.	.	.	.	7	MU813721	het
7	98558880	98558880	G	C	TRRAP	intronic	.	ENSG00000196367	rs160384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9007	0.9160	0.886981	0.9051	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.9094,AMR:0.8616,EAS:0.7432,FIN:0.9255,NFE:0.9166,OTH:0.9175,ASJ:0.9139	603015	.	.	.	.	.	.	.	.	.	.	.	7	MU18827407	het
7	98602990	98602990	G	C	TRRAP	intronic	.	ENSG00000196367	rs219838	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1913	0.3107	0.326478	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.2901,AMR:0.6809,EAS:0.1887,FIN:0.2571,NFE:0.1005,OTH:0.1271,ASJ:0.2029	603015	.	.	.	.	.	.	.	.	.	.	.	7	1(bone)	0.15
7	100410597	100410597	G	A	EPHB4	exonic	synonymous SNV	ENSG00000196411	rs2230585	ENSG00000196411:ENST00000358173:exon12:c.C1890T:p.C630C,ENSG00000196411:ENST00000360620:exon12:c.C1890T:p.C630C	EPHB4:NM_004444:exon12:c.C1890T:p.C630C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3403	0.3266	0.275559	0.3409	.	.	.	.	.	.	.	.	EPHB4:uc003uwm.1:exon11:c.C1611T:p.C537C,EPHB4:uc003uwn.1:exon12:c.C1890T:p.C630C,EPHB4:uc010lhj.1:exon12:c.C1890T:p.C630C	.	AFR:0.1981,AMR:0.2907,EAS:0.3189,FIN:0.4300,NFE:0.4049,OTH:0.3676,ASJ:0.43	600011	.	.	.	.	.	.	.	.	.	.	.	7	MU67380188	het
7	100411278	100411278	T	C	EPHB4	exonic	synonymous SNV	ENSG00000196411	rs314359	ENSG00000196411:ENST00000358173:exon10:c.A1752G:p.G584G,ENSG00000196411:ENST00000360620:exon10:c.A1752G:p.G584G	EPHB4:NM_004444:exon10:c.A1752G:p.G584G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6080	0.5660	0.575679	MU159236	.	.	.	.	.	.	.	.	EPHB4:uc003uwm.1:exon9:c.A1473G:p.G491G,EPHB4:uc003uwn.1:exon10:c.A1752G:p.G584G,EPHB4:uc010lhj.1:exon10:c.A1752G:p.G584G	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5625,EAS:0.6890,FIN:0.57,NFE:0.6458,OTH:0.5679,ASJ:0.4802	600011	.	.	.	.	.	.	.	.	.	.	.	7	1(lung)	0.5900
7	100416250	100416250	A	G	EPHB4	exonic	synonymous SNV	ENSG00000196411	rs144173	ENSG00000196411:ENST00000358173:exon7:c.T1314C:p.S438S,ENSG00000196411:ENST00000360620:exon7:c.T1314C:p.S438S	EPHB4:NM_004444:exon7:c.T1314C:p.S438S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6059	0.5553	0.563698	0.5521	.	.	.	.	.	.	.	.	EPHB4:uc011kkh.1:exon7:c.T1232C:p.L411P	.	AFR:0.4464,AMR:0.6842,EAS:0.6435,FIN:0.5676,NFE:0.5890,OTH:0.6072,ASJ:0.5662	600011	.	.	.	.	.	.	.	.	.	.	.	7	MU654988	het
7	100416332	100416332	T	A	EPHB4	intronic	.	ENSG00000196411	rs314364	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.234425	0.3743	.	.	.	.	.	.	.	.	.	.	AFR:0.1565,AMR:0.3443,EAS:0.0354,FIN:0.4595,NFE:0.5126,OTH:0.4698,ASJ:0.4730	600011	.	.	.	.	.	.	.	.	.	.	.	7	.	het
7	100424587	100424587	G	-	SLC12A9	UTR5	.	ENSG00000196411	rs35907339	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3477	.	.	0.2382	.	.	.	.	.	.	.	.	.	.	AFR:0.1606,AMR:0.1575,EAS:0.0019,FIN:0.3019,NFE:0.2944,OTH:0.3015,ASJ:0.3546	616861	.	.	.	.	.	.	.	.	.	.	.	7	MU29256393	het
7	100781084	100781084	T	C	SERPINE1	UTR3	.	ENSG00000106366	rs11178	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	.	.	0.430911	0.4457	.	.	.	.	.	.	.	.	.	.	AFR:0.4956,AMR:0.3246,EAS:0.4598,FIN:0.4218,NFE:0.4270,OTH:0.4327,ASJ:0.5132	173360	613329;	465;	465|Congenital PAI-1 deficiency|Unknown|Autosomal recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|613329 ~	.	.	.	.	.	.	.	.	7	MU87763021	hom
7	103124207	103124207	T	C	RELN	exonic	synonymous SNV	ENSG00000189056	rs1062831	ENSG00000189056:ENST00000343529:exon62:c.A10074G:p.A3358A,ENSG00000189056:ENST00000424685:exon62:c.A10074G:p.A3358A,ENSG00000189056:ENST00000428762:exon62:c.A10074G:p.A3358A	RELN:NM_005045:exon62:c.A10074G:p.A3358A,RELN:NM_173054:exon62:c.A10074G:p.A3358A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1389	0.1748	0.231629	1(large_intestine)	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon62:c.A10074G:p.A3358A,RELN:uc022ajq.1:exon62:c.A10074G:p.A3358A,RELN:uc022ajr.1:exon62:c.A10074G:p.A3358A	.	AFR:MU12779279,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.3454,FIN:0.1181,NFE:0.0762,OTH:0.2562,ASJ:0.1708	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	1(stomach)	0.0575
7	103138517	103138517	C	G	LOC101927870	ncRNA_intronic	.	ENSG00000234715	rs2711885	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9870	0.9909	0.995607	0.9867	.	.	.	.	.	0	0	.	.	.	AFR:0.9976,AMR:0.9940,EAS:1,FIN:0.9717,NFE:0.9826,OTH:0.9796,ASJ:0.9834	.	.	.	.	.	.	.	.	.	.	.	.	7	MU81837834	hom
7	103151436	103151436	T	C	RELN	exonic	synonymous SNV	ENSG00000189056	rs3808039	ENSG00000189056:ENST00000343529:exon51:c.A8136G:p.L2712L,ENSG00000189056:ENST00000424685:exon51:c.A8136G:p.L2712L,ENSG00000189056:ENST00000428762:exon51:c.A8136G:p.L2712L	RELN:NM_005045:exon51:c.A8136G:p.L2712L,RELN:NM_173054:exon51:c.A8136G:p.L2712L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0498	0.0476	0.0780751	LICA-CN|1|402|0.00248756	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon51:c.A8136G:p.L2712L,RELN:uc022ajq.1:exon51:c.A8136G:p.L2712L,RELN:uc022ajr.1:exon51:c.A8136G:p.L2712L	.	AFR:0.0508,AMR:0.0668,EAS:0.0066,FIN:0.1702,NFE:0.0238,OTH:0.0373,ASJ:0.0334	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	1(large_intestine)	0.0428
7	103155705	103155705	A	G	RELN	exonic	synonymous SNV	ENSG00000189056	rs2229864	ENSG00000189056:ENST00000343529:exon50:c.T8046C:p.H2682H,ENSG00000189056:ENST00000424685:exon50:c.T8046C:p.H2682H,ENSG00000189056:ENST00000428762:exon50:c.T8046C:p.H2682H	RELN:NM_005045:exon50:c.T8046C:p.H2682H,RELN:NM_173054:exon50:c.T8046C:p.H2682H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4722	0.4955	0.648363	0.5053	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon50:c.T8046C:p.H2682H,RELN:uc022ajq.1:exon50:c.T8046C:p.H2682H,RELN:uc022ajr.1:exon50:c.T8046C:p.H2682H	.	AFR:0.7569,AMR:0.4415,EAS:0.7974,FIN:0.3554,NFE:0.3733,OTH:0.4267,ASJ:0.3841	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	MU81837859	hom
7	103179595	103179595	A	G	RELN	exonic	synonymous SNV	ENSG00000189056	rs362746	ENSG00000189056:ENST00000343529:exon45:c.T7110C:p.V2370V,ENSG00000189056:ENST00000424685:exon45:c.T7110C:p.V2370V,ENSG00000189056:ENST00000428762:exon45:c.T7110C:p.V2370V	RELN:NM_005045:exon45:c.T7110C:p.V2370V,RELN:NM_173054:exon45:c.T7110C:p.V2370V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0394	0.0191	0.0621006	2(large_intestine)	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon45:c.T7110C:p.V2370V,RELN:uc022ajq.1:exon45:c.T7110C:p.V2370V,RELN:uc022ajr.1:exon45:c.T7110C:p.V2370V	.	AFR:MU655512,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,EAS:0.0037,FIN:0.0143,NFE:0.0066,OTH:0.2040,ASJ:0.0286	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	1(lung)	0.0215
7	103180872	103180872	A	G	RELN	exonic	synonymous SNV	ENSG00000189056	rs2075043	ENSG00000189056:ENST00000343529:exon44:c.T6702C:p.C2234C,ENSG00000189056:ENST00000424685:exon44:c.T6702C:p.C2234C,ENSG00000189056:ENST00000428762:exon44:c.T6702C:p.C2234C	RELN:NM_005045:exon44:c.T6702C:p.C2234C,RELN:NM_173054:exon44:c.T6702C:p.C2234C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0749	0.0467	0.109425	COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon44:c.T6702C:p.C2234C,RELN:uc022ajq.1:exon44:c.T6702C:p.C2234C,RELN:uc022ajr.1:exon44:c.T6702C:p.C2234C	.	AFR:0.0706,AMR:0.0477,EAS:0.0629,FIN:0.2634,NFE:0.1031,OTH:0.0532,ASJ:0.1062	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	1(breast)	0.0816
7	103202406	103202406	-	AA	RELN	intronic	.	ENSG00000189056	rs34125550	.	.	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0202	.	.	0.0009	.	.	.	.	.	.	.	.	.	.	AFR:0.0010,AMR:0,EAS:0,FIN:0,NFE:0.0009,OTH:0.0025,ASJ:0	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	.	het
7	103292224	103292224	T	C	RELN	exonic	synonymous SNV	ENSG00000189056	rs2072403	ENSG00000189056:ENST00000343529:exon15:c.A1776G:p.E592E,ENSG00000189056:ENST00000424685:exon15:c.A1776G:p.E592E,ENSG00000189056:ENST00000428762:exon15:c.A1776G:p.E592E	RELN:NM_005045:exon15:c.A1776G:p.E592E,RELN:NM_173054:exon15:c.A1776G:p.E592E	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0765	0.0936	0.120407	MU18840089	.	.	.	.	.	.	.	.	RELN:uc010liz.3:exon15:c.A1776G:p.E592E,RELN:uc022ajq.1:exon15:c.A1776G:p.E592E,RELN:uc022ajr.1:exon15:c.A1776G:p.E592E	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.0959,EAS:0.0935,FIN:0.0629,NFE:0.1416,OTH:0.0699,ASJ:0.1864	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	4(large_intestine)	0.0476
7	103629803	103629803	-	GCCGCCGCCGCCGCC	RELN	UTR5	.	ENSG00000189056	rs587780434	.	.	clinvar: Uncertain_significance 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0008	.	.	0.0285	.	.	.	.	.	.	.	.	.	.	AFR:0.0218,AMR:0.0560,EAS:0.0924,FIN:0.0188,NFE:0.0257,OTH:0.0340,ASJ:0.0347	600514	257320;616436;	101046;89844;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~89844|Microlissencephaly type A|Unknown|Autosomal recessive|Infancy<br>Neonatal|257320 ~	.	.	.	.	.	.	.	.	7	.	unknown
7	106508978	106508978	A	G	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs849389	ENSG00000105851:ENST00000359195:exon2:c.A972G:p.P324P,ENSG00000105851:ENST00000440650:exon2:c.A972G:p.P324P,ENSG00000105851:ENST00000496166:exon2:c.A972G:p.P324P	PIK3CG:NM_001282426:exon2:c.A972G:p.P324P,PIK3CG:NM_001282427:exon2:c.A972G:p.P324P,PIK3CG:NM_002649:exon2:c.A972G:p.P324P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9490	0.9174	0.939497	0.9283	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon2:c.A972G:p.P324P,PIK3CG:uc003vdv.4:exon2:c.A972G:p.P324P,PIK3CG:uc003vdw.3:exon2:c.A972G:p.P324P	.	AFR:0.8501,AMR:0.9664,EAS:0.9981,FIN:0.9607,NFE:0.9549,OTH:0.9389,ASJ:0.9636	601232	.	.	.	.	.	.	.	.	.	.	.	7	MU81838218	unknown
7	106508987	106508987	T	C	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs849390	ENSG00000105851:ENST00000359195:exon2:c.T981C:p.D327D,ENSG00000105851:ENST00000440650:exon2:c.T981C:p.D327D,ENSG00000105851:ENST00000496166:exon2:c.T981C:p.D327D	PIK3CG:NM_001282426:exon2:c.T981C:p.D327D,PIK3CG:NM_001282427:exon2:c.T981C:p.D327D,PIK3CG:NM_002649:exon2:c.T981C:p.D327D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9502	0.9187	0.940895	0.9295	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon2:c.T981C:p.D327D,PIK3CG:uc003vdv.4:exon2:c.T981C:p.D327D,PIK3CG:uc003vdw.3:exon2:c.T981C:p.D327D	.	AFR:0.8507,AMR:0.9665,EAS:0.9981,FIN:0.9613,NFE:0.9568,OTH:0.9420,ASJ:0.9636	601232	.	.	.	.	.	.	.	.	.	.	.	7	MU81838233	unknown
7	106513011	106513011	C	T	PIK3CG	exonic	synonymous SNV	ENSG00000105851	rs1129293	ENSG00000105851:ENST00000359195:exon3:c.C2025T:p.S675S,ENSG00000105851:ENST00000440650:exon3:c.C2025T:p.S675S,ENSG00000105851:ENST00000496166:exon3:c.C2025T:p.S675S	PIK3CG:NM_001282426:exon3:c.C2025T:p.S675S,PIK3CG:NM_001282427:exon3:c.C2025T:p.S675S,PIK3CG:NM_002649:exon3:c.C2025T:p.S675S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3104	0.2389	0.253794	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	PIK3CG:uc003vdu.3:exon3:c.C2025T:p.S675S,PIK3CG:uc003vdv.4:exon3:c.C2025T:p.S675S,PIK3CG:uc003vdw.3:exon3:c.C2025T:p.S675S	.	AFR:MU44519853,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.1232,FIN:0.4689,NFE:0.2119,OTH:0.3381,ASJ:0.2618	601232	.	.	.	.	.	.	.	.	.	.	.	7	2(lung)	0.3164
7	107414419	107414419	A	G	SLC26A3	exonic	synonymous SNV	ENSG00000091138	rs41669	ENSG00000091138:ENST00000340010:exon17:c.T1953C:p.L651L	SLC26A3:NM_000111:exon17:c.T1953C:p.L651L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9936	0.9916	0.998003	0.9937	.	.	.	.	.	.	.	.	SLC26A3:uc003ver.2:exon17:c.T1953C:p.L651L	.	AFR:0.9974,AMR:0.9928,EAS:1,FIN:0.9977,NFE:0.9899,OTH:0.9939,ASJ:1	126650	214700;	53689;	53689|-|-|Autosomal recessive|-|214700 ~	.	.	.	.	.	.	.	.	7	MU81838359	hom
7	107423254	107423254	C	T	SLC26A3	exonic	synonymous SNV	ENSG00000091138	rs3735605	ENSG00000091138:ENST00000340010:exon11:c.G1299A:p.A433A,ENSG00000091138:ENST00000422236:exon11:c.G1194A:p.A398A	SLC26A3:NM_000111:exon11:c.G1299A:p.A433A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1581	0.1423	0.150958	0.1361	.	.	.	.	.	.	.	.	SLC26A3:uc003ver.2:exon11:c.G1299A:p.A433A,SLC26A3:uc003ves.2:exon11:c.G1194A:p.A398A	.	AFR:0.0740,AMR:0.1360,EAS:0.2568,FIN:0.1394,NFE:0.1562,OTH:0.1466,ASJ:0.2219	126650	214700;	53689;	53689|-|-|Autosomal recessive|-|214700 ~	.	.	.	.	.	.	.	.	7	MU138957	het
7	107545799	107545799	T	C	DLD	intronic	.	ENSG00000091140	rs10263341	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6182	0.6485	0.716054	0.6630	.	.	.	.	.	0.0308	0.07	.	.	.	AFR:0.7964,AMR:0.5635,EAS:0.8418,FIN:0.6017,NFE:0.5913,OTH:0.6053,ASJ:0.5728	238331	246900;	2394;765;	2394|DLD deficiency<br>Dihydrolipoamide dehydrogenase deficiency<br>E3-deficient maple syrup urine disease|<1 / 1 000 000|Autosomal recessive|Childhood|246900 ~765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~	.	.	.	.	.	.	.	.	7	MU713564	hom
7	107559722	107559722	A	T	DLD	UTR3	.	ENSG00000091140	rs8721	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3602	0.2976	0.275759	0.3241	.	.	.	.	.	.	.	.	.	.	AFR:0.1185,AMR:0.3592,EAS:0.3259,FIN:0.3862,NFE:0.4233,OTH:0.3765,ASJ:0.37	238331	246900;	2394;765;	2394|DLD deficiency<br>Dihydrolipoamide dehydrogenase deficiency<br>E3-deficient maple syrup urine disease|<1 / 1 000 000|Autosomal recessive|Childhood|246900 ~765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~	.	.	.	.	.	.	.	.	7	MU12787282	het
7	116397572	116397572	A	G	MET	exonic	synonymous SNV	ENSG00000105976	rs13223756	ENSG00000105976:ENST00000436117:exon6:c.A1944G:p.Q648Q,ENSG00000105976:ENST00000318493:exon7:c.A1944G:p.Q648Q,ENSG00000105976:ENST00000397752:exon7:c.A1944G:p.Q648Q	MET:NM_001324402:exon6:c.A654G:p.Q218Q,MET:NM_000245:exon7:c.A1944G:p.Q648Q,MET:NM_001127500:exon7:c.A1944G:p.Q648Q,MET:NM_001324401:exon7:c.A1944G:p.Q648Q	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1878	0.1687	0.187899	1(lung)	.	.	.	.	.	.	.	.	MET:uc011knd.2:exon6:c.A1944G:p.Q648Q,MET:uc011kne.2:exon6:c.A1860G:p.Q620Q,MET:uc011knf.2:exon6:c.A1944G:p.Q648Q,MET:uc011kng.1:exon6:c.A1944G:p.Q648Q,MET:uc011knh.1:exon6:c.A1944G:p.Q648Q,MET:uc011kni.2:exon6:c.A1944G:p.Q648Q,MET:uc003vij.3:exon7:c.A1944G:p.Q648Q,MET:uc010lkh.3:exon7:c.A1944G:p.Q648Q,MET:uc011knj.2:exon7:c.A654G:p.Q218Q,MET:uc022akk.1:exon7:c.A1944G:p.Q648Q	.	AFR:61(meninges),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:LAML-KR|3|205|0.0146341,COCA-CN|1|321|0.00311526,FIN:0.1720,NFE:0.1247,OTH:0.0993,ASJ:MU12805326	164860	114550;605074;607278;616705;	90636;47044;449;88673;	90636|Autosomal recessive isolated neurosensory deafness type DFNB<br>Autosomal recessive isolated sensorineural deafness type DFNB<br>Autosomal recessive non-syndromic neurosensory deafness type DFNB|Unknown|Autosomal recessive|Infancy<br>Neonatal|220290 600060 600316 600791 600792 600971 600974 601071 601072 601386 601869 602092 603010 603098 603629 603678 603720 604060 605428 605818 607039 607084 607101 607239 607821 608219 608264 608265 608565 608653 609006 609439 609533 609646 609647 609706 609823 609941 609946 609952 610143 610153 610154 610212 610220 610248 610265 610419 611022 611451 612433 612645 612789 613079 613285 613307 613391 613392 613453 613685 613718 613865 613916 614035 614414 614617 614861 614899 614934 614944 614945 615429 615540 615837 615974 616042 616515 616705 616958 ~47044|HPRCC|-|Autosomal dominant|Adult|605074 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04360 Axon guidance~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05144 Malaria~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05218 Melanoma~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	7485,,7499,7498,7493,7501,7502,7504,7497,7496,7503,7489,7500,7495,7487,7486,7490,7492,7491,7488	.	.	.	.	.	.	7	1(biliary_tract)	0.2318
7	124486980	124486980	T	C	POT1	intronic	.	ENSG00000128513	rs7794637	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6950	0.7104	0.721845	0.7064	.	.	.	.	.	.	.	.	.	.	AFR:0.7353,AMR:0.6998,EAS:0.8092,FIN:0.7067,NFE:0.6792,OTH:0.6925,ASJ:0.7285	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	MU25063529	het
7	124499002	124499002	A	C	POT1	intronic	.	ENSG00000128513	rs6977407	ENSG00000128513:ENST00000487564:exon2:c.T201G:p.Y67X	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5903	0.0976	0.582069	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	0.434	6.906	.	-7.16	0.210	.	.	.	.	.	AFR:0.5920,AMR:0.6336,EAS:0.5772,FIN:0.4887,NFE:0.5055,OTH:0.6043,ASJ:0.5310	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	1(breast)	0.5710
7	124499003	124499003	T	A	POT1	intronic	.	ENSG00000128513	rs6959712	ENSG00000128513:ENST00000487564:exon2:c.A200T:p.Y67F	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5901	0.1507	0.582468	0.5920	0.678	8.682	.	1.56	0.325	0.0002	0.078	.	.	.	AFR:0.6339,AMR:0.5310,EAS:0.4893,FIN:0.5043,NFE:0.6043,OTH:0.5710,ASJ:0.5772	606478	615848;616568;	251627;251630;618;	251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~	.	.	.	.	.	.	.	.	7	MU787028	unknown
7	127250907	127250907	T	C	PAX4	exonic	stoploss	ENSG00000106331	rs712700	ENSG00000106331:ENST00000378740:exon10:c.A1022G:p.X341W	PAX4:NM_001366111:exon10:c.A1046G:p.X349W	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7632	.	0.669329	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	0.746	9.126	.	1.4	0.731	.	.	.	PAX4:uc003vmg.1:exon10:c.A1022G:p.X341W	.	AFR:0.7255,AMR:0.7065,EAS:0.8676,FIN:0.3628,NFE:0.7340,OTH:0.7704,ASJ:0.7220	167413	125853;612225;612227;	552;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~	.	.	.	.	.	.	.	.	7	1(thyroid)	0.7362
7	127251188	127251188	T	G	PAX4	exonic	nonsynonymous SNV	ENSG00000106331	rs712701	ENSG00000106331:ENST00000463946:exon8:c.A956C:p.H319P,ENSG00000106331:ENST00000341640:exon9:c.A962C:p.H321P	PAX4:NM_001366110:exon12:c.A986C:p.H329P	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7578	0.7689	0.670527	0.7266	-1.141	0.008	0.408	-3.35	0.000	.	.	.	PAX4:uc003vmf.2:exon8:c.A956C:p.H319P,PAX4:uc010lld.1:exon9:c.A962C:p.H321P	-0.966	AFR:0.7089,AMR:0.7220,EAS:0.3638,FIN:0.7345,NFE:0.7708,OTH:0.7347,ASJ:0.8676	167413	125853;612225;612227;	552;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~	.	.	.	.	0.0	-3.33	0.000	.	7	MU25588339	het
7	128846328	128846328	G	C	SMO	exonic	synonymous SNV	ENSG00000128602	rs2228617	ENSG00000128602:ENST00000462420:exon3:c.G246C:p.G82G,ENSG00000128602:ENST00000249373:exon6:c.G1164C:p.G388G	SMO:NM_005631:exon6:c.G1164C:p.G388G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7975	0.7896	0.75619	0.7929	.	.	.	.	.	.	.	.	SMO:uc003vos.3:exon2:c.G189C:p.G63G,SMO:uc003vor.3:exon6:c.G1164C:p.G388G	.	AFR:0.6895,AMR:0.7721,EAS:0.7674,FIN:0.8099,NFE:0.8520,OTH:0.7837,ASJ:0.8709	601500	601707;605462;	1553;	1553|Corpus callosum agenesis-polysyndactyly syndrome|<1 / 1 000 000|Not applicable|Neonatal|601707 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9748,9804,9806,9805	.	.	.	.	.	.	7	MU802754	het
7	137600690	137600690	C	T	CREB3L2	exonic	nonsynonymous SNV	ENSG00000182158	rs273957	ENSG00000182158:ENST00000330387:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000420629:exon3:c.G367A:p.V123I,ENSG00000182158:ENST00000452463:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000456390:exon3:c.G388A:p.V130I,ENSG00000182158:ENST00000458726:exon3:c.G199A:p.V67I	CREB3L2:NM_001253775:exon3:c.G388A:p.V130I,CREB3L2:NM_001318246:exon3:c.G199A:p.V67I,CREB3L2:NM_194071:exon3:c.G388A:p.V130I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6893	0.7151	0.804313	0.7149	-0.089	1.817	1.0	5.01	0.525	.	.	.	CREB3L2:uc003vtv.3:exon3:c.G199A:p.V67I,CREB3L2:uc003vtw.3:exon3:c.G388A:p.V130I,CREB3L2:uc003vtx.2:exon3:c.G388A:p.V130I,CREB3L2:uc003vty.4:exon3:c.G388A:p.V130I,CREB3L2:uc031szf.1:exon4:c.G199A:p.V67I	-0.976	AFR:0.9201,AMR:0.7662,EAS:0.9227,FIN:0.5615,NFE:0.6136,OTH:0.6268,ASJ:0.6093	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	0.0	0.42	0.000	-1.67	7	MU641291	het
7	137612914	137612916	TGG	-	CREB3L2	exonic	nonframeshift deletion	ENSG00000182158	rs3217268	ENSG00000182158:ENST00000420629:exon1:c.100_102del:p.34_34del,ENSG00000182158:ENST00000330387:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000452463:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000456390:exon2:c.299_301del:p.100_101del,ENSG00000182158:ENST00000458726:exon2:c.110_112del:p.37_38del	CREB3L2:NM_001253775:exon2:c.299_301del:p.100_101del,CREB3L2:NM_001318246:exon2:c.110_112del:p.37_38del,CREB3L2:NM_194071:exon2:c.299_301del:p.100_101del	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6918	0.6397	0.690695	0.6404	.	.	.	.	.	.	.	.	CREB3L2:uc003vtv.3:exon2:c.110_112del:p.37_38del,CREB3L2:uc003vtw.3:exon2:c.299_301del:p.100_101del,CREB3L2:uc003vtx.2:exon2:c.299_301del:p.100_101del,CREB3L2:uc003vty.4:exon2:c.299_301del:p.100_101del,CREB3L2:uc031szf.1:exon3:c.110_112del:p.37_38del	.	AFR:0.6728,AMR:0.7319,EAS:0.8470,FIN:0.6195,NFE:0.6021,OTH:0.6299,ASJ:0.52	608834	.	.	.	~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04668 TNF signaling pathway~ko04714 Thermogenesis~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04911 Insulin secretion~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04922 Glucagon signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04931 Insulin resistance~ko04934 Cushing syndrome~ko04962 Vasopressin-regulated water reabsorption~ko05016 Huntington disease~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05034 Alcoholism~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	7	MU28483034	hom
7	138200117	138200117	A	T	TRIM24	intronic	.	ENSG00000122779	rs3757381	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7660	0.8246	0.71905	0.7838	.	.	.	.	.	.	.	.	.	.	AFR:0.8205,AMR:0.7333,EAS:0.5149,FIN:0.7665,NFE:0.7985,OTH:0.7551,ASJ:0.8633	603406	.	.	.	.	.	.	.	.	.	.	.	7	MU12863507	hom
7	140426257	140426257	A	G	BRAF	UTR3	.	ENSG00000157764	rs3829814	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3356	.	0.221645	0.3768	.	.	.	.	.	.	.	.	.	.	AFR:0.0974,AMR:0.3055,EAS:0.1479,FIN:0.5049,NFE:0.5340,OTH:0.4346,ASJ:0.4040	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04150 mTOR signaling pathway~ko04214 Apoptosis - fly~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	MU12866811	het
7	140449071	140449071	C	G	BRAF	intronic	.	ENSG00000157764	rs3789806	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2095	0.3159	0.348043	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.2936,AMR:0.6643,EAS:0.1987,FIN:0.2067,NFE:0.1512,OTH:0.1408,ASJ:0.1124	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04150 mTOR signaling pathway~ko04214 Apoptosis - fly~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	7	5(large_intestine)	0.1677
7	140449150	140449150	T	C	BRAF	exonic	synonymous SNV	ENSG00000157764	rs9648696	ENSG00000157764:ENST00000479537:exon3:c.A213G:p.G71G,ENSG00000157764:ENST00000288602:exon16:c.A1929G:p.G643G	BRAF:NM_001354609:exon16:c.A1929G:p.G643G,BRAF:NM_004333:exon16:c.A1929G:p.G643G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2124	0.3200	0.351038	5(large_intestine)	.	.	.	.	.	.	.	.	BRAF:uc003vwc.4:exon16:c.A1929G:p.G643G	.	AFR:MU4566697,AMR:ESAD-UK|1|409|0.00244499,COCA-CN|3|321|0.00934579,EAS:0.6694,FIN:0.1172,NFE:0.2086,OTH:0.2079,ASJ:0.2960	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04150 mTOR signaling pathway~ko04214 Apoptosis - fly~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	1168,,1188,1203,1215,1167,1181,1207,1199,1212,1213,1219,1180,1184,1209,1174,1202,1224,1208,1201,1193,1223,1192,1177,1198,1218,1175,1226,1176,1246,1187,1200,1172,1214,1185,1225,1166,1186,1205,1206,1169,996,1165,1170,1171,1190,1195,1229,1217,1173,1204,1197,1182,1210,1222,1183,1211,1191,1216,1228,1196,1220,1221,1227,1179,1178,1189,1194	.	,1232,1231,1230	.	.	.	.	7	3(meninges)	0.1509
7	142457132	142457132	A	C	PRSS1	upstream	.	ENSG00000204983	rs4726576	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.409744	0.5722	.	.	.	.	.	.	.	.	.	.	AFR:0.5573,AMR:0.5593,EAS:0.2793,FIN:0.6039,NFE:0.5967,OTH:0.5862,ASJ:0.6014	276000	167800;614044;	676;	676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	MU24384021	hom
7	142460313	142460313	T	C	PRSS1	exonic	synonymous SNV	ENSG00000204983	rs6666	ENSG00000204983:ENST00000492062:exon3:c.T336C:p.D112D,ENSG00000204983:ENST00000311737:exon4:c.T486C:p.D162D,ENSG00000204983:ENST00000486171:exon5:c.T528C:p.D176D	PRSS1:NM_002769:exon4:c.T486C:p.D162D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3693	.	0.396565	0.4118	.	.	.	.	.	.	.	.	PRSS1:uc003wam.2:exon2:c.T306C:p.D102D,PRSS1:uc003wak.2:exon4:c.T486C:p.D162D	.	AFR:0.3514,AMR:0.3990,EAS:0.1832,FIN:0.4223,NFE:0.4676,OTH:0.4113,ASJ:0.5167	276000	167800;614044;	676;	676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	MU4550788	hom
7	142460865	142460865	T	C	PRSS1	exonic	synonymous SNV	ENSG00000204983	rs6667	ENSG00000204983:ENST00000311737:exon5:c.T738C:p.N246N,ENSG00000204983:ENST00000486171:exon6:c.T780C:p.N260N	PRSS1:NM_002769:exon5:c.T738C:p.N246N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5041	.	0.39377	0.5213	.	.	.	.	.	.	.	.	PRSS1:uc003wam.2:exon3:c.T558C:p.N186N,PRSS1:uc003wak.2:exon5:c.T738C:p.N246N	.	AFR:0.4502,AMR:0.5311,EAS:0.2094,FIN:0.5940,NFE:0.5740,OTH:0.5591,ASJ:0.5933	276000	167800;614044;	676;	676|-|1-9 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent|167800 ~	.	.	.	.	.	.	.	.	7	MU24384057	hom
7	142563253	142563253	T	G	EPHB6	exonic	nonsynonymous SNV	ENSG00000106123	rs8177146	ENSG00000106123:ENST00000411471:exon3:c.T139G:p.S47A,ENSG00000106123:ENST00000392957:exon8:c.T970G:p.S324A,ENSG00000106123:ENST00000442129:exon8:c.T970G:p.S324A	EPHB6:NM_001280795:exon4:c.T94G:p.S32A,EPHB6:NM_001280794:exon7:c.T94G:p.S32A,EPHB6:NM_004445:exon8:c.T970G:p.S324A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0399	0.0473	0.0682907	MU681238	.	.	.	.	.	.	.	.	EPHB6:uc003wbu.3:exon4:c.T94G:p.S32A,EPHB6:uc003wbs.3:exon7:c.T94G:p.S32A,EPHB6:uc011kst.2:exon8:c.T970G:p.S324A,EPHB6:uc011ksu.2:exon8:c.T970G:p.S324A	.	AFR:BRCA-KR|1|50|0.02,AMR:0.0478,EAS:0.0644,FIN:0.0331,NFE:0.0068,OTH:0.0361,ASJ:0.1099	602757	.	.	.	.	.	.	.	.	.	.	.	7	4(lung)	0.0190
7	142565385	142565385	G	A	EPHB6	exonic	synonymous SNV	ENSG00000106123	rs8177153	ENSG00000106123:ENST00000411471:exon7:c.G939A:p.P313P,ENSG00000106123:ENST00000392957:exon12:c.G1770A:p.P590P,ENSG00000106123:ENST00000442129:exon12:c.G1770A:p.P590P	EPHB6:NM_001280795:exon8:c.G894A:p.P298P,EPHB6:NM_001280794:exon11:c.G894A:p.P298P,EPHB6:NM_004445:exon12:c.G1770A:p.P590P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0343	0.0211	0.0435304	MU80610222	.	.	.	.	.	.	.	.	EPHB6:uc003wbu.3:exon8:c.G894A:p.P298P,EPHB6:uc003wbs.3:exon11:c.G894A:p.P298P,EPHB6:uc003wbt.3:exon11:c.G192A:p.P64P,EPHB6:uc011kst.2:exon12:c.G1770A:p.P590P,EPHB6:uc011ksu.2:exon12:c.G1770A:p.P590P	.	AFR:BRCA-KR|1|50|0.02,AMR:0.0254,EAS:0.0562,FIN:0.0331,NFE:0.0074,OTH:0.0361,ASJ:0.0325	602757	.	.	.	.	.	.	.	.	.	.	.	7	1(breast)	0.0186
7	142565776	142565776	G	A	EPHB6	exonic	synonymous SNV	ENSG00000106123	rs2229873	ENSG00000106123:ENST00000411471:exon8:c.G1056A:p.T352T,ENSG00000106123:ENST00000392957:exon13:c.G1887A:p.T629T,ENSG00000106123:ENST00000442129:exon13:c.G1887A:p.T629T	EPHB6:NM_001280795:exon9:c.G1011A:p.T337T,EPHB6:NM_001280794:exon12:c.G1011A:p.T337T,EPHB6:NM_004445:exon13:c.G1887A:p.T629T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0599	0.0204	0.04373	BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	EPHB6:uc003wbu.3:exon9:c.G1011A:p.T337T,EPHB6:uc003wbs.3:exon12:c.G1011A:p.T337T,EPHB6:uc003wbt.3:exon12:c.G309A:p.T103T,EPHB6:uc011kst.2:exon13:c.G1887A:p.T629T,EPHB6:uc011ksu.2:exon13:c.G1887A:p.T629T	.	AFR:0.0252,AMR:0.0328,EAS:0.0331,FIN:0.0074,NFE:0.0361,OTH:0.0181,ASJ:0.0550	602757	.	.	.	.	.	.	.	.	.	.	.	7	1(soft_tissue)	0.0296
7	142651469	142651469	G	A	KEL	intronic	.	ENSG00000197993	rs45533536	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0197	0.0098	0.0117812	0.0157	.	.	.	.	.	0	0	.	.	.	AFR:0.0018,AMR:0.0465,EAS:0,FIN:0.0361,NFE:0.0187,OTH:0.0235,ASJ:0.0066	613883	110900;	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	142651470	142651470	G	T	KEL	intronic	.	ENSG00000197993	rs144972578	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0197	0.0098	0.0117812	0.0157	.	.	.	.	.	0.0009	0.032	.	.	.	AFR:0.0018,AMR:0.0465,EAS:0,FIN:0.0358,NFE:0.0187,OTH:0.0235,ASJ:0.0066	613883	110900;	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	146805228	146805228	-	G	CNTNAP2	intronic	.	ENSG00000174469	rs35167289	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3982	.	0.377995	0.4293	.	.	.	.	.	.	.	.	.	.	AFR:0.4688,AMR:0.5694,EAS:0.3731,FIN:0.4132,NFE:0.4141,OTH:0.3901,ASJ:0.2649	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	.	het
7	147926734	147926734	A	G	CNTNAP2	intronic	.	ENSG00000174469	rs3779031	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2116	0.1615	0.221446	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	0	0.002	.	.	.	AFR:0.1909,AMR:0.1439,EAS:0.1,FIN:0.3366,NFE:0.2577,OTH:0.1802,ASJ:0.3254	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.2067
7	147926888	147926888	A	C	CNTNAP2	intronic	.	ENSG00000174469	rs3779032	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3755	0.4165	0.360224	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.3922,AMR:0.4085,EAS:0.3133,FIN:0.3313,NFE:0.3903,OTH:0.3979,ASJ:0.2962	604569	610042;612100;	163681;221150;	163681|-|Unknown|Autosomal recessive|Childhood|610042 ~221150|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610042 614325 ~	.	.	.	.	.	.	.	.	7	1(haematopoietic_and_lymphoid_tissue)	0.3724
7	148543694	148543694	A	-	EZH2	intronic	.	ENSG00000106462	rs3214332	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7134	.	0.761182	0.7479	.	.	.	.	.	.	.	.	.	.	AFR:0.9272,AMR:0.7404,EAS:0.6804,FIN:0.6355,NFE:0.6781,OTH:0.6721,ASJ:0.6926	601573	277590;	3447;	3447|Camptodactyly-overgrowth-unusual facies syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|277590 ~	.	.	.	.	.	.	.	.	7	.	het
7	150645534	150645534	T	G	KCNH2	exonic	nonsynonymous SNV	ENSG00000055118	rs1805123	ENSG00000055118:ENST00000330883:exon7:c.A1670C:p.K557T,ENSG00000055118:ENST00000392968:exon9:c.A2402C:p.K801T,ENSG00000055118:ENST00000262186:exon11:c.A2690C:p.K897T	KCNH2:NM_172057:exon7:c.A1670C:p.K557T,KCNH2:NM_000238:exon11:c.A2690C:p.K897T	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1871	0.1691	0.136182	1(lung)	2.039	16.46	0.225	-0.036	0.996	0	0.024	Ion transport domain	KCNH2:uc003wib.3:exon7:c.A1670C:p.K557T,KCNH2:uc011kux.2:exon9:c.A2402C:p.K801T,KCNH2:uc003wic.3:exon11:c.A2690C:p.K897T	-1.076	AFR:MU4549942,AMR:BRCA-KR|1|50|0.02,EAS:0.0537,FIN:0.1932,NFE:0.2428,OTH:0.0437,ASJ:0.1850	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	0.952	-4.79	0.002	1.735	7	2(thyroid)	0.2616
7	150648198	150648198	A	G	KCNH2	exonic	synonymous SNV	ENSG00000055118	rs1137617	ENSG00000055118:ENST00000330883:exon4:c.T936C:p.Y312Y,ENSG00000055118:ENST00000392968:exon6:c.T1668C:p.Y556Y,ENSG00000055118:ENST00000262186:exon8:c.T1956C:p.Y652Y,ENSG00000055118:ENST00000430723:exon8:c.T1956C:p.Y652Y	KCNH2:NM_001204798:exon4:c.T936C:p.Y312Y,KCNH2:NM_172057:exon4:c.T936C:p.Y312Y,KCNH2:NM_000238:exon8:c.T1956C:p.Y652Y,KCNH2:NM_172056:exon8:c.T1956C:p.Y652Y	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6658	0.6905	0.772165	0.7031	.	.	.	.	.	.	.	.	KCNH2:uc003wib.3:exon4:c.T936C:p.Y312Y,KCNH2:uc003wid.3:exon4:c.T936C:p.Y312Y,KCNH2:uc011kux.2:exon6:c.T1668C:p.Y556Y,KCNH2:uc003wic.3:exon8:c.T1956C:p.Y652Y,KCNH2:uc003wie.3:exon8:c.T1956C:p.Y652Y	.	AFR:0.8883,AMR:0.6766,EAS:0.9021,FIN:0.6263,NFE:0.6004,OTH:0.6222,ASJ:0.61	152427	609620;613688;	101016;768;51083;	101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~51083|SQTS|Unknown|Autosomal dominant|All ages|609620 609621 609622 ~	.	.	.	.	.	.	.	.	7	MU4567794	het
7	151478406	151478406	C	T	PRKAG2	exonic	nonsynonymous SNV	ENSG00000106617	rs79474211	ENSG00000106617:ENST00000287878:exon3:c.G298A:p.G100S,ENSG00000106617:ENST00000392801:exon3:c.G166A:p.G56S,ENSG00000106617:ENST00000488258:exon3:c.G298A:p.G100S	PRKAG2:NM_001040633:exon3:c.G166A:p.G56S,PRKAG2:NM_016203:exon3:c.G298A:p.G100S	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 1, 2, 1, 0, 0] 	0.0081	0.0008	0.0145767	0.0022	2.358	18.55	0.109	4.08	0.936	.	.	.	PRKAG2:uc003wkj.3:exon3:c.G166A:p.G56S,PRKAG2:uc003wkk.3:exon3:c.G298A:p.G100S,PRKAG2:uc003wkm.1:exon3:c.G298A:p.G100S	-0.503	AFR:0.0006,AMR:0,EAS:0.0284,FIN:0,NFE:0.0007,OTH:0.0072,ASJ:0.0033	602743	194200;261740;600858;	439854;	439854|Fatal congenital hypertrophic cardiomyopathy due to GSD<br>Fatal congenital hypertrophic cardiomyopathy due to glycogenosis|<1 / 1 000 000|Not applicable|Antenatal<br>Neonatal|261740 ~	.	.	.	.	0.907	-1.98	0.157	1.405	7	MU85282976	het
7	151842397	151842397	C	T	KMT2C	intronic	.	ENSG00000055609	rs2240819	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0713	0.1166	0.158347	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	.	.	AFR:0.1116,AMR:0.3167,EAS:0.0265,FIN:0.1501,NFE:0.0240,OTH:0.0173,ASJ:0.0766	606833	.	.	.	.	.	.	.	.	.	.	.	7	13(meninges)	0.0397
7	151873293	151873293	G	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs61730545	ENSG00000055609:ENST00000262189:exon38:c.C9245T:p.P3082L,ENSG00000055609:ENST00000355193:exon38:c.C9245T:p.P3082L	KMT2C:NM_170606:exon38:c.C9245T:p.P3082L	clinvar: not_provided 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.0045	0.0002	0.00878594	.	6.750	32	0.0	5.95	0.898	.	.	.	KMT2C:uc003wky.3:exon1:c.C1772T:p.P591L,KMT2C:uc003wkz.3:exon24:c.C6428T:p.P2143L,KMT2C:uc003wla.3:exon38:c.C9245T:p.P3082L	0.548	AFR:.,AMR:0.0007,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	606833	.	.	.	.	.	.	,6806	1.0	-1.82	0.750	1.995	7	1(meninges)	0.0007
7	151873853	151873853	C	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs6464211	ENSG00000055609:ENST00000262189:exon38:c.G8685A:p.Q2895Q,ENSG00000055609:ENST00000355193:exon38:c.G8685A:p.Q2895Q	KMT2C:NM_170606:exon38:c.G8685A:p.Q2895Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.2494	0.3412	0.382788	SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	KMT2C:uc003wky.3:exon1:c.G1212A:p.Q404Q,KMT2C:uc003wkz.3:exon24:c.G5868A:p.Q1956Q,KMT2C:uc003wla.3:exon38:c.G8685A:p.Q2895Q	.	AFR:0.3452,AMR:0.6988,EAS:0.2384,FIN:0.2983,NFE:0.2690,OTH:0.1798,ASJ:0.2188	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	6(large_intestine)	0.2281
7	151874498	151874498	C	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs10252263	ENSG00000055609:ENST00000262189:exon38:c.G8040A:p.Q2680Q,ENSG00000055609:ENST00000355193:exon38:c.G8040A:p.Q2680Q	KMT2C:NM_170606:exon38:c.G8040A:p.Q2680Q	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.0705	0.1165	0.158147	14(meninges)	.	.	.	.	.	.	.	.	KMT2C:uc003wky.3:exon1:c.G567A:p.Q189Q,KMT2C:uc003wkz.3:exon24:c.G5223A:p.Q1741Q,KMT2C:uc003wla.3:exon38:c.G8040A:p.Q2680Q	.	AFR:MU18879409,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,EAS:0.3165,FIN:0.0764,NFE:0.0265,OTH:0.1508,ASJ:0.1117	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	2(soft_tissue)	0.0241
7	151875101	151875102	AA	-	KMT2C	intronic	.	ENSG00000055609	rs747415858	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0747	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606833	.	.	.	.	.	.	.	.	.	.	.	7	.	unknown
7	151882735	151882735	G	A	KMT2C	intronic	.	ENSG00000055609	rs62481492	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4411	.	.	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU15106127,AMR:LICA-CN|5|402|0.0124378,LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,BTCA-JP|3|239|0.0125523,ESCA-CN|1|332|0.00301205,EAS:0,FIN:0,NFE:0,OTH:0.0006,ASJ:0.0001	606833	.	.	.	.	.	.	.	.	.	.	.	7	1(liver)	0.0006
7	151927021	151927021	C	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs28522267	ENSG00000055609:ENST00000262189:exon18:c.G2963T:p.C988F,ENSG00000055609:ENST00000355193:exon18:c.G2963T:p.C988F	KMT2C:NM_170606:exon18:c.G2963T:p.C988F	clinvar: Benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, -1, 2, 2, 1, 1] 	0.1065	.	.	20(upper_aerodigestive_tract)	7.018	33	0.0	4.67	1.000	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	KMT2C:uc003wkz.3:exon4:c.G146T:p.C49F,KMT2C:uc003wla.3:exon18:c.G2963T:p.C988F	0.852	AFR:24(central_nervous_system),AMR:3(thyroid),EAS:MU587659,FIN:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,NFE:0.4338,OTH:0.4036,ASJ:2(bone)	606833	.	.	.	.	.	.	,6806	0.999	-8.15	0.996	2.495	7	22(soft_tissue)	0.3934
7	151927026	151927026	T	C	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs28439884	ENSG00000055609:ENST00000262189:exon18:c.A2958G:p.P986P,ENSG00000055609:ENST00000355193:exon18:c.A2958G:p.P986P	KMT2C:NM_170606:exon18:c.A2958G:p.P986P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.1156	.	.	1(stomach)	.	.	.	.	.	.	.	.	KMT2C:uc003wkz.3:exon4:c.A141G:p.P47P,KMT2C:uc003wla.3:exon18:c.A2958G:p.P986P	.	AFR:1(upper_aerodigestive_tract),AMR:6(central_nervous_system),EAS:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,RECA-EU|1|422|0.00236967,FIN:0.4317,NFE:0.4026,OTH:0.3909,ASJ:MU587660	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	2(thyroid)	0.3976
7	151927127	151927127	A	G	KMT2C	intronic	.	ENSG00000055609	rs62481502	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4893	.	.	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU587661,AMR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.2777,FIN:0.3209,NFE:0.2929,OTH:0.4236,ASJ:0.3394	606833	.	.	.	.	.	.	.	.	.	.	.	7	1(stomach)	0.3022
7	151932908	151932908	T	C	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs112326730	ENSG00000055609:ENST00000262189:exon16:c.A2763G:p.L921L,ENSG00000055609:ENST00000355193:exon16:c.A2763G:p.L921L	KMT2C:NM_170606:exon16:c.A2763G:p.L921L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4790	.	.	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon16:c.A2763G:p.L921L	.	AFR:0.4823,AMR:0.4838,EAS:0.4857,FIN:0.4936,NFE:0.4439,OTH:0.4894,ASJ:0.4512	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	1(liver)	0.4753
7	151935853	151935853	T	C	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs4024420	ENSG00000055609:ENST00000262189:exon15:c.A2591G:p.E864G,ENSG00000055609:ENST00000355193:exon15:c.A2591G:p.E864G	KMT2C:NM_170606:exon15:c.A2591G:p.E864G	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.1442	.	.	MU67451171	4.196	23.9	0.077	5.53	1.000	.	.	.	KMT2C:uc003wla.3:exon15:c.A2591G:p.E864G	-0.013	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,AMR:0.2000,EAS:0.1244,FIN:0.2075,NFE:0.2175,OTH:0.0686,ASJ:0.1680	606833	.	.	.	.	.	.	,6806	0.986	-2.06	0.585	1.95	7	2(haematopoietic_and_lymphoid_tissue)	0.2686
7	151945007	151945007	C	T	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs2479172	ENSG00000055609:ENST00000262189:exon14:c.G2512A:p.G838S,ENSG00000055609:ENST00000355193:exon14:c.G2512A:p.G838S	KMT2C:NM_170606:exon14:c.G2512A:p.G838S	clinvar: UNK 	 CancerVar: 8#Tier_II_potential EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, 2, 1, 1] 	0.4944	.	.	1(large_intestine)	6.636	32	0.003	5.67	1.000	.	.	.	KMT2C:uc003wla.3:exon14:c.G2512A:p.G838S	-0.835	AFR:3(bone),AMR:MU31381223,EAS:0.4950,FIN:0.4995,NFE:0.5,OTH:0.4927,ASJ:SKCA-BR|1|100|0.01,COCA-CN|6|321|0.0186916	606833	.	.	.	.	.	.	,6806	1.0	-2.3	0.230	2.075	7	3(prostate)	0.4981
7	151945071	151945071	-	T	KMT2C	exonic	stopgain	ENSG00000055609	rs150073007	ENSG00000055609:ENST00000262189:exon14:c.2447dupA:p.Y816_I817delinsX,ENSG00000055609:ENST00000355193:exon14:c.2447dupA:p.Y816_I817delinsX,ENSG00000055609:ENST00000558084:exon14:c.2447dupA:p.Y816_I817delinsX	KMT2C:NM_170606:exon14:c.2447dupA:p.Y816_I817delinsX	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4901	.	.	0.4828	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon14:c.2447dupA:p.Y816_I817delinsX	.	AFR:0.4719,AMR:0.4904,EAS:0.4977,FIN:0.4841,NFE:0.4847,OTH:0.4893,ASJ:0.4902	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	MU2245504	het
7	151945167	151945167	G	T	KMT2C	exonic	synonymous SNV	ENSG00000055609	rs2537264	ENSG00000055609:ENST00000262189:exon14:c.C2352A:p.S784S,ENSG00000055609:ENST00000355193:exon14:c.C2352A:p.S784S,ENSG00000055609:ENST00000558084:exon14:c.C2352A:p.S784S	KMT2C:NM_170606:exon14:c.C2352A:p.S784S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.4776	.	.	1(prostate)	.	.	.	.	.	.	.	.	KMT2C:uc003wla.3:exon14:c.C2352A:p.S784S	.	AFR:MU4548885,AMR:COCA-CN|7|321|0.0218069,PRAD-CA|1|306|0.00326797,EAS:0.4972,FIN:0.4852,NFE:0.4530,OTH:0.4924,ASJ:0.4815	606833	.	.	.	.	.	.	,6806	.	.	.	.	7	2(large_intestine)	0.4671
7	151949068	151949068	C	G	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs3735156	ENSG00000055609:ENST00000262189:exon11:c.G1577C:p.R526P,ENSG00000055609:ENST00000355193:exon11:c.G1577C:p.R526P,ENSG00000055609:ENST00000558084:exon11:c.G1577C:p.R526P	KMT2C:NM_170606:exon11:c.G1577C:p.R526P	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.0768	0.1642	0.180911	1(soft_tissue)	1.927	15.75	1.0	5.75	0.972	.	.	.	KMT2C:uc003wla.3:exon11:c.G1577C:p.R526P	-0.998	AFR:MU813118,AMR:COCA-CN|1|321|0.00311526,EAS:0.4621,FIN:0.0835,NFE:0.0199,OTH:0.0783,ASJ:0.1483	606833	.	.	.	.	.	.	,6806	0.0	-1.66	0.000	-1.795	7	14(meninges)	0.0238
7	151970856	151970856	T	A	KMT2C	exonic	nonsynonymous SNV	ENSG00000055609	rs10454320	ENSG00000055609:ENST00000262189:exon7:c.A946T:p.T316S,ENSG00000055609:ENST00000355193:exon7:c.A946T:p.T316S,ENSG00000055609:ENST00000558084:exon7:c.A946T:p.T316S	KMT2C:NM_170606:exon7:c.A946T:p.T316S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.5276	.	.	1(bone)	3.363	22.9	0.415	3.71	0.842	.	.	Extended PHD (ePHD) domain|Zinc finger, PHD-type	KMT2C:uc003wla.3:exon7:c.A946T:p.T316S	-0.940	AFR:MU4218242,AMR:COCA-CN|5|321|0.0155763,EAS:0.4998,FIN:0.4988,NFE:0.4892,OTH:0.5006,ASJ:0.4945	606833	.	.	.	.	.	.	,6806	0.684	-0.5	0.162	1.15	7	2(kidney)	0.5
7	152346007	152346007	C	T	XRCC2	exonic	nonsynonymous SNV	ENSG00000196584	rs3218536	ENSG00000196584:ENST00000359321:exon3:c.G563A:p.R188H	XRCC2:NM_005431:exon3:c.G563A:p.R188H	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0655	0.0558	0.052516	0.0482	1.958	15.95	0.368	1.85	0.971	.	.	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase	XRCC2:uc003wld.3:exon3:c.G563A:p.R188H	-1.098	AFR:0.0155,AMR:0.0418,EAS:0,FIN:0.0295,NFE:0.0761,OTH:0.0621,ASJ:0.0596	600375	.	.	.	.	.	.	.	0.047	-0.18	0.005	0.345	7	.	het
7	154760369	154760369	A	G	PAXIP1	exonic	synonymous SNV	ENSG00000157212	rs935037	ENSG00000157212:ENST00000397192:exon7:c.T1542C:p.L514L,ENSG00000157212:ENST00000404141:exon7:c.T1542C:p.L514L	PAXIP1:NM_007349:exon7:c.T1542C:p.L514L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5995	0.5959	0.615415	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PAXIP1:uc003wlr.1:exon3:c.T1269C:p.L423L,PAXIP1:uc022aqi.1:exon5:c.T1434C:p.L478L,PAXIP1:uc022aqf.1:exon7:c.T1542C:p.L514L,PAXIP1:uc022aqg.1:exon7:c.T1542C:p.L514L,PAXIP1:uc022aqh.1:exon8:c.T1440C:p.L480L	.	AFR:0.5835,AMR:0.5346,EAS:0.6324,FIN:0.5944,NFE:0.6474,OTH:0.5861,ASJ:0.7356	608254	.	.	.	.	.	.	.	.	.	.	.	7	1(thyroid)	0.5869
8	6272399	6272399	G	T	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs2305022	ENSG00000147316:ENST00000344683:exon3:c.G228T:p.V76V,ENSG00000147316:ENST00000519480:exon3:c.G228T:p.V76V,ENSG00000147316:ENST00000522905:exon3:c.G228T:p.V76V	MCPH1:NM_001172574:exon3:c.G228T:p.V76V,MCPH1:NM_001172575:exon3:c.G228T:p.V76V,MCPH1:NM_001322042:exon3:c.G228T:p.V76V,MCPH1:NM_001322043:exon3:c.G222T:p.V74V,MCPH1:NM_001322045:exon3:c.G126T:p.V42V,MCPH1:NM_001363979:exon3:c.G228T:p.V76V,MCPH1:NM_001363980:exon3:c.G228T:p.V76V,MCPH1:NM_024596:exon3:c.G228T:p.V76V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7719	0.6980	0.678115	0.7172	.	.	.	.	.	.	.	.	MCPH1:uc003wqh.3:exon3:c.G228T:p.V76V,MCPH1:uc003wqi.3:exon3:c.G228T:p.V76V,MCPH1:uc011kwl.2:exon3:c.G228T:p.V76V	.	AFR:0.4414,AMR:0.8189,EAS:0.7833,FIN:0.8881,NFE:0.8188,OTH:0.8033,ASJ:0.6954	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU18893251	het
8	6296550	6296550	G	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2442513	ENSG00000147316:ENST00000344683:exon6:c.G513T:p.R171S,ENSG00000147316:ENST00000519480:exon6:c.G513T:p.R171S	MCPH1:NM_001172574:exon6:c.G513T:p.R171S,MCPH1:NM_001322042:exon6:c.G513T:p.R171S,MCPH1:NM_001322043:exon6:c.G507T:p.R169S,MCPH1:NM_001322045:exon6:c.G411T:p.R137S,MCPH1:NM_001363979:exon6:c.G513T:p.R171S,MCPH1:NM_001363980:exon6:c.G513T:p.R171S,MCPH1:NM_024596:exon6:c.G513T:p.R171S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9662	0.9251	0.916933	0.9276	-1.150	0.008	0.857	-4.59	0.012	.	.	BRCT domain	MCPH1:uc003wqh.3:exon6:c.G513T:p.R171S,MCPH1:uc003wqi.3:exon6:c.G513T:p.R171S	-1.032	AFR:0.7806,AMR:0.9797,EAS:0.9889,FIN:0.9865,NFE:0.9859,OTH:0.9695,ASJ:0.9768	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	3.78	0.000	-1.355	8	MU81846801	het
8	6302183	6302183	G	C	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs930557	ENSG00000147316:ENST00000522905:exon7:c.G796C:p.D266H,ENSG00000147316:ENST00000344683:exon8:c.G940C:p.D314H,ENSG00000147316:ENST00000519480:exon8:c.G940C:p.D314H	MCPH1:NM_001172575:exon7:c.G796C:p.D266H,MCPH1:NM_001172574:exon8:c.G940C:p.D314H,MCPH1:NM_001322042:exon8:c.G940C:p.D314H,MCPH1:NM_001322043:exon8:c.G934C:p.D312H,MCPH1:NM_001322045:exon8:c.G838C:p.D280H,MCPH1:NM_001363979:exon8:c.G940C:p.D314H,MCPH1:NM_001363980:exon8:c.G940C:p.D314H,MCPH1:NM_024596:exon8:c.G940C:p.D314H	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.7714	0.6758	0.644768	0.6908	3.901	23.5	0.056	2.68	0.032	.	.	.	MCPH1:uc011kwl.2:exon7:c.G796C:p.D266H,MCPH1:uc003wqh.3:exon8:c.G940C:p.D314H,MCPH1:uc003wqi.3:exon8:c.G940C:p.D314H	-1.055	AFR:0.3336,AMR:0.8222,EAS:0.7984,FIN:0.8821,NFE:0.8270,OTH:0.8092,ASJ:0.6933	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	1.0	2.69	0.000	2.125	8	MU18893493	het
8	6302418	6302418	A	G	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs2515569	ENSG00000147316:ENST00000522905:exon7:c.A1031G:p.D344G,ENSG00000147316:ENST00000344683:exon8:c.A1175G:p.D392G,ENSG00000147316:ENST00000519480:exon8:c.A1175G:p.D392G	MCPH1:NM_001172575:exon7:c.A1031G:p.D344G,MCPH1:NM_001172574:exon8:c.A1175G:p.D392G,MCPH1:NM_001322042:exon8:c.A1175G:p.D392G,MCPH1:NM_001322043:exon8:c.A1169G:p.D390G,MCPH1:NM_001322045:exon8:c.A1073G:p.D358G,MCPH1:NM_001363979:exon8:c.A1175G:p.D392G,MCPH1:NM_001363980:exon8:c.A1175G:p.D392G,MCPH1:NM_024596:exon8:c.A1175G:p.D392G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9980	0.9927	0.994409	0.9918	-1.735	0.002	0.573	-11.5	0.000	.	.	.	MCPH1:uc011kwl.2:exon7:c.A1031G:p.D344G,MCPH1:uc003wqh.3:exon8:c.A1175G:p.D392G,MCPH1:uc003wqi.3:exon8:c.A1175G:p.D392G	-0.923	AFR:0.9711,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	2.99	0.000	-1.355	8	MU81846820	hom
8	6302671	6302671	C	T	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs2920676	ENSG00000147316:ENST00000522905:exon7:c.C1284T:p.F428F,ENSG00000147316:ENST00000344683:exon8:c.C1428T:p.F476F,ENSG00000147316:ENST00000519480:exon8:c.C1428T:p.F476F	MCPH1:NM_001172575:exon7:c.C1284T:p.F428F,MCPH1:NM_001172574:exon8:c.C1428T:p.F476F,MCPH1:NM_001322042:exon8:c.C1428T:p.F476F,MCPH1:NM_001322043:exon8:c.C1422T:p.F474F,MCPH1:NM_001322045:exon8:c.C1326T:p.F442F,MCPH1:NM_001363979:exon8:c.C1428T:p.F476F,MCPH1:NM_001363980:exon8:c.C1428T:p.F476F,MCPH1:NM_024596:exon8:c.C1428T:p.F476F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0852	0.1347	0.208067	0.1420	.	.	.	.	.	.	.	.	MCPH1:uc011kwl.2:exon7:c.C1284T:p.F428F,MCPH1:uc003wqh.3:exon8:c.C1428T:p.F476F,MCPH1:uc003wqi.3:exon8:c.C1428T:p.F476F	.	AFR:0.4101,AMR:0.0788,EAS:0.1568,FIN:0.0372,NFE:0.0197,OTH:0.0665,ASJ:0.0430	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU18524025	het
8	6402992	6402992	A	G	ANGPT2;MCPH1	intronic	.	ENSG00000091879;ENSG00000147316	rs2442596	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.995807	0.9936	.	.	.	.	.	.	.	.	.	.	AFR:0.9777,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	.	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	6478956	6478956	A	G	MCPH1-AS1	ncRNA_exonic	.	ENSG00000249898	rs2936531	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4492	0.4218	0.490415	0.4565	.	.	.	.	.	.	.	.	.	.	AFR:0.4795,AMR:0.3900,EAS:0.6644,FIN:0.4382,NFE:0.4339,OTH:0.4211,ASJ:0.31	.	.	.	.	.	.	.	.	.	.	.	.	8	MU14129286	hom
8	6478960	6478960	C	G	MCPH1-AS1	ncRNA_exonic	.	ENSG00000249898	rs11137040	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2482	0.2625	0.203075	0.2606	.	.	.	.	.	.	.	.	.	.	AFR:0.2627,AMR:0.1480,EAS:0.0556,FIN:0.2619,NFE:0.2898,OTH:0.2474,ASJ:0.1867	.	.	.	.	.	.	.	.	.	.	.	.	8	MU19200555	het
8	6478986	6478986	C	T	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs2912010	ENSG00000147316:ENST00000344683:exon13:c.C2226T:p.S742S	MCPH1:NM_001363980:exon10:c.C1947T:p.S649S,MCPH1:NM_001322042:exon13:c.C2226T:p.S742S,MCPH1:NM_001363979:exon13:c.C2226T:p.S742S,MCPH1:NM_024596:exon13:c.C2226T:p.S742S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4292	0.3746	0.452875	0.4154	.	.	.	.	.	.	.	.	MCPH1:uc003wqi.3:exon13:c.C2226T:p.S742S	.	AFR:0.3650,AMR:0.3876,EAS:0.6557,FIN:0.4321,NFE:0.4187,OTH:0.4139,ASJ:0.3013	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU117658	hom
8	6479042	6479042	C	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs1057090	ENSG00000147316:ENST00000344683:exon13:c.C2282T:p.A761V	MCPH1:NM_001363980:exon10:c.C2003T:p.A668V,MCPH1:NM_001322042:exon13:c.C2282T:p.A761V,MCPH1:NM_001363979:exon13:c.C2282T:p.A761V,MCPH1:NM_024596:exon13:c.C2282T:p.A761V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4362	0.4098	0.482029	LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.693	8.779	1.0	-8.27	0.024	.	.	BRCT domain	MCPH1:uc003wqi.3:exon13:c.C2282T:p.A761V	-1.003	AFR:0.4424,AMR:0.4784,EAS:0.3079,FIN:0.6510,NFE:0.4015,OTH:0.4167,ASJ:0.3880	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	-2.34	0.000	.	8	1(soft_tissue)	0.4047
8	6479178	6479178	C	A	MCPH1	exonic	synonymous SNV	ENSG00000147316	rs2912016	ENSG00000147316:ENST00000344683:exon13:c.C2418A:p.A806A	MCPH1:NM_001363980:exon10:c.C2139A:p.A713A,MCPH1:NM_001322042:exon13:c.C2418A:p.A806A,MCPH1:NM_001363979:exon13:c.C2418A:p.A806A,MCPH1:NM_024596:exon13:c.C2418A:p.A806A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3681	0.3626	0.39377	0.3785	.	.	.	.	.	.	.	.	MCPH1:uc003wqi.3:exon13:c.C2418A:p.A806A	.	AFR:0.4265,AMR:0.3254,EAS:0.4291,FIN:0.3607,NFE:0.3560,OTH:0.3564,ASJ:0.2682	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	.	.	.	.	8	MU117691	hom
8	6483482	6483482	C	T	MCPH1-AS1	ncRNA_intronic	.	ENSG00000249898	rs2912057	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.507188	0.4638	.	.	.	.	.	.	.	.	.	.	AFR:0.5270,AMR:0.3768,EAS:0.6663,FIN:0.4378,NFE:0.4214,OTH:0.4242,ASJ:0.33	.	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	6500544	6500544	C	T	MCPH1	exonic	nonsynonymous SNV	ENSG00000147316	rs1057091	ENSG00000147316:ENST00000344683:exon14:c.C2482T:p.P828S	MCPH1:NM_001363980:exon11:c.C2203T:p.P735S,MCPH1:NM_024596:exon14:c.C2482T:p.P828S,MCPH1:NM_001322042:exon15:c.C2624T:p.P875L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2917	0.2649	0.24361	0.2661	-0.618	0.113	0.407	-1.42	0.228	.	.	BRCT domain	MCPH1:uc003wqi.3:exon14:c.C2482T:p.P828S	-1.034	AFR:0.1867,AMR:0.1974,EAS:0.1900,FIN:0.2756,NFE:0.3180,OTH:0.3098,ASJ:0.3233	607117	251200;	2512;52183;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~52183|-|-|-|-|251200 ~	.	.	.	.	0.0	-2.55	0.000	-0.51	8	MU23365881	het
8	11629119	11629119	T	C	NEIL2	intronic	.	ENSG00000154328	rs804269	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7141	0.6032	0.697883	0.6418	.	.	.	.	.	.	.	.	.	.	AFR:0.4632,AMR:0.8067,EAS:0.9690,FIN:0.7636,NFE:0.6712,OTH:0.6878,ASJ:0.5662	608933	.	.	.	.	.	.	.	.	.	.	.	8	MU81847463	hom
8	12948951	12948951	A	G	DLC1	intronic	.	ENSG00000164741	rs609020	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5562	0.6111	0.571486	MU587710	.	.	.	.	.	0.0002	0.034	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.5898,EAS:0.3735,FIN:0.6623,NFE:0.4107,OTH:0.5433,ASJ:0.7230	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(stomach)	0.5541
8	12950110	12950110	G	A	DLC1	intronic	.	ENSG00000164741	rs7829535	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4475	0.4115	0.336861	0.4052	.	.	.	.	.	.	.	.	.	.	AFR:0.2205,AMR:0.2990,EAS:0.3412,FIN:0.4662,NFE:0.5021,OTH:0.4908,ASJ:0.5762	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU32417843	het
8	12950315	12950315	G	T	DLC1	exonic	synonymous SNV	ENSG00000164741	rs568182	ENSG00000164741:ENST00000358919:exon9:c.C2235A:p.R745R,ENSG00000164741:ENST00000512044:exon9:c.C2337A:p.R779R,ENSG00000164741:ENST00000520226:exon9:c.C2013A:p.R671R,ENSG00000164741:ENST00000276297:exon13:c.C3546A:p.R1182R	DLC1:NM_001348084:exon8:c.C2013A:p.R671R,DLC1:NM_001164271:exon9:c.C2013A:p.R671R,DLC1:NM_001316668:exon9:c.C2337A:p.R779R,DLC1:NM_001348083:exon9:c.C2013A:p.R671R,DLC1:NM_006094:exon9:c.C2235A:p.R745R,DLC1:NM_001348082:exon12:c.C2013A:p.R671R,DLC1:NM_001348081:exon13:c.C3546A:p.R1182R,DLC1:NM_182643:exon13:c.C3546A:p.R1182R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0767	0.1127	0.113019	MU136399	.	.	.	.	.	.	.	.	DLC1:uc003wwk.1:exon9:c.C2235A:p.R745R,DLC1:uc003wwl.1:exon9:c.C2337A:p.R779R,DLC1:uc011kxx.1:exon9:c.C2013A:p.R671R,DLC1:uc003wwm.2:exon13:c.C3546A:p.R1182R	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,AMR:0.1078,EAS:0.0502,FIN:0.0867,NFE:0.0210,OTH:0.0762,ASJ:0.2459	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.0510
8	12950351	12950351	C	A	DLC1	intronic	.	ENSG00000164741	rs142024772	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0047	0.0005	0.00499201	0.0051	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0333,FIN:0.0197,NFE:0.0017,OTH:0.0092,ASJ:0	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	.	het
8	12952293	12952293	C	T	DLC1	exonic	synonymous SNV	ENSG00000164741	rs658856	ENSG00000164741:ENST00000358919:exon8:c.G2190A:p.S730S,ENSG00000164741:ENST00000512044:exon8:c.G2292A:p.S764S,ENSG00000164741:ENST00000520226:exon8:c.G1968A:p.S656S,ENSG00000164741:ENST00000276297:exon12:c.G3501A:p.S1167S	DLC1:NM_001348084:exon7:c.G1968A:p.S656S,DLC1:NM_001164271:exon8:c.G1968A:p.S656S,DLC1:NM_001316668:exon8:c.G2292A:p.S764S,DLC1:NM_001348083:exon8:c.G1968A:p.S656S,DLC1:NM_006094:exon8:c.G2190A:p.S730S,DLC1:NM_001348082:exon11:c.G1968A:p.S656S,DLC1:NM_001348081:exon12:c.G3501A:p.S1167S,DLC1:NM_182643:exon12:c.G3501A:p.S1167S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0715	0.1127	0.112819	MU114305632	.	.	.	.	.	.	.	.	DLC1:uc003wwk.1:exon8:c.G2190A:p.S730S,DLC1:uc003wwl.1:exon8:c.G2292A:p.S764S,DLC1:uc011kxx.1:exon8:c.G1968A:p.S656S,DLC1:uc003wwm.2:exon12:c.G3501A:p.S1167S	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,AMR:0.1072,EAS:0.0525,FIN:0.0861,NFE:0.0198,OTH:0.0707,ASJ:0.2486	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.0500
8	12957475	12957475	C	T	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs532841	ENSG00000164741:ENST00000358919:exon5:c.G1060A:p.V354M,ENSG00000164741:ENST00000512044:exon5:c.G1162A:p.V388M,ENSG00000164741:ENST00000520226:exon5:c.G838A:p.V280M,ENSG00000164741:ENST00000276297:exon9:c.G2371A:p.V791M	DLC1:NM_001348084:exon4:c.G838A:p.V280M,DLC1:NM_001164271:exon5:c.G838A:p.V280M,DLC1:NM_001316668:exon5:c.G1162A:p.V388M,DLC1:NM_001348083:exon5:c.G838A:p.V280M,DLC1:NM_006094:exon5:c.G1060A:p.V354M,DLC1:NM_001348082:exon8:c.G838A:p.V280M,DLC1:NM_001348081:exon9:c.G2371A:p.V791M,DLC1:NM_182643:exon9:c.G2371A:p.V791M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4935	0.5252	0.496605	28(soft_tissue)	-0.212	1.034	0.322	-6.1	0.746	.	.	.	DLC1:uc003wwk.1:exon5:c.G1060A:p.V354M,DLC1:uc003wwl.1:exon5:c.G1162A:p.V388M,DLC1:uc011kxx.1:exon5:c.G838A:p.V280M,DLC1:uc003wwm.2:exon9:c.G2371A:p.V791M	-0.963	AFR:1(pancreas),AMR:1(thyroid),EAS:MU55000,FIN:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,NFE:0.5114,OTH:0.6111,ASJ:4(large_intestine)	604258	114500;	.	.	.	.	.	.	0.0	3.64	0.000	0.11	8	1(stomach)	0.3246
8	12960281	12960281	T	C	DLC1	intronic	.	ENSG00000164741	rs2280335	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4335	0.3683	0.304712	0.3718	.	.	.	.	.	.	.	.	.	.	AFR:0.1033,AMR:0.2888,EAS:0.3401,FIN:0.4785,NFE:0.4997,OTH:0.4867,ASJ:0.5762	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU13156967	het
8	12973078	12973078	T	C	DLC1	intronic	.	ENSG00000164741	rs34462909	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4850	0.4305	0.394569	0.4342	.	.	.	.	.	.	.	.	.	.	AFR:0.2706,AMR:0.4402,EAS:0.3775,FIN:0.5123,NFE:0.5076,OTH:0.5286,ASJ:0.5933	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU803582	het
8	13356802	13356802	G	A	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs3816747	ENSG00000164741:ENST00000276297:exon2:c.C779T:p.T260I,ENSG00000164741:ENST00000316609:exon2:c.C779T:p.T260I,ENSG00000164741:ENST00000511869:exon2:c.C779T:p.T260I	DLC1:NM_001348081:exon2:c.C779T:p.T260I,DLC1:NM_024767:exon2:c.C779T:p.T260I,DLC1:NM_182643:exon2:c.C779T:p.T260I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8777	0.9101	0.815096	0.8937	-3.066	0.001	0.193	-9.96	0.001	.	.	.	DLC1:uc003wwm.2:exon2:c.C779T:p.T260I,DLC1:uc003wwn.3:exon2:c.C779T:p.T260I,DLC1:uc011kxy.2:exon2:c.C779T:p.T260I	-0.942	AFR:0.8611,AMR:0.7470,EAS:0.6101,FIN:0.9408,NFE:0.9387,OTH:0.9083,ASJ:0.9272	604258	114500;	.	.	.	.	.	.	0.0	3.65	0.000	-1.245	8	MU18918835	het
8	13356818	13356818	T	C	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs11203494	ENSG00000164741:ENST00000276297:exon2:c.A763G:p.N255D,ENSG00000164741:ENST00000316609:exon2:c.A763G:p.N255D,ENSG00000164741:ENST00000511869:exon2:c.A763G:p.N255D	DLC1:NM_001348081:exon2:c.A763G:p.N255D,DLC1:NM_024767:exon2:c.A763G:p.N255D,DLC1:NM_182643:exon2:c.A763G:p.N255D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9673	0.9461	0.958067	0.9540	-2.148	0.001	1.0	1.93	0.003	.	.	.	DLC1:uc003wwm.2:exon2:c.A763G:p.N255D,DLC1:uc003wwn.3:exon2:c.A763G:p.N255D,DLC1:uc011kxy.2:exon2:c.A763G:p.N255D	-0.998	AFR:0.9099,AMR:0.9761,EAS:1,FIN:0.9785,NFE:0.9664,OTH:0.9715,ASJ:0.9636	604258	114500;	.	.	.	.	.	.	0.0	3.92	0.000	-0.955	8	MU81847893	hom
8	13356819	13356819	T	G	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs11203495	ENSG00000164741:ENST00000276297:exon2:c.A762C:p.Q254H,ENSG00000164741:ENST00000316609:exon2:c.A762C:p.Q254H,ENSG00000164741:ENST00000511869:exon2:c.A762C:p.Q254H	DLC1:NM_001348081:exon2:c.A762C:p.Q254H,DLC1:NM_024767:exon2:c.A762C:p.Q254H,DLC1:NM_182643:exon2:c.A762C:p.Q254H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8558	0.8644	0.758387	0.8541	-1.363	0.004	0.208	-5.59	0.000	.	.	.	DLC1:uc003wwm.2:exon2:c.A762C:p.Q254H,DLC1:uc003wwn.3:exon2:c.A762C:p.Q254H,DLC1:uc011kxy.2:exon2:c.A762C:p.Q254H	-1.018	AFR:0.7255,AMR:0.7345,EAS:0.6110,FIN:0.9408,NFE:0.9375,OTH:0.8910,ASJ:0.9272	604258	114500;	.	.	.	.	.	.	0.005	3.38	0.000	1.055	8	MU18918882	het
8	13357340	13357340	G	C	DLC1	exonic	nonsynonymous SNV	ENSG00000164741	rs3816748	ENSG00000164741:ENST00000276297:exon2:c.C241G:p.L81V,ENSG00000164741:ENST00000316609:exon2:c.C241G:p.L81V,ENSG00000164741:ENST00000511869:exon2:c.C241G:p.L81V	DLC1:NM_001348081:exon2:c.C241G:p.L81V,DLC1:NM_024767:exon2:c.C241G:p.L81V,DLC1:NM_182643:exon2:c.C241G:p.L81V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0561	0.0125	0.0848642	0.0314	-2.449	0.001	1.0	-5.49	0.956	.	.	.	DLC1:uc003wwm.2:exon2:c.C241G:p.L81V,DLC1:uc003wwn.3:exon2:c.C241G:p.L81V,DLC1:uc011kxy.2:exon2:c.C241G:p.L81V	-0.950	AFR:0.0204,AMR:0.1468,EAS:0.2574,FIN:0.0249,NFE:0.0085,OTH:0.0377,ASJ:0.0166	604258	114500;	.	.	.	.	.	.	0.0	1.76	0.000	-0.895	8	MU700803	het
8	13357587	13357587	G	A	DLC1	UTR5	.	ENSG00000164741	rs1383942	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8562	0.8371	0.741613	0.8287	.	.	.	.	.	.	.	.	.	.	AFR:0.6355,AMR:0.7279,EAS:0.6098,FIN:0.9408,NFE:0.9376,OTH:0.8951,ASJ:0.9267	604258	114500;	.	.	.	.	.	.	.	.	.	.	8	MU18918940	het
8	15508200	15508200	T	C	TUSC3	intronic	.	ENSG00000104723	rs1035972	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3380	0.3072	0.293131	LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	0	0.01	.	.	.	AFR:0.3355,AMR:0.1799,EAS:0.3146,FIN:0.4431,NFE:0.4370,OTH:0.3872,ASJ:0.3481	601385	611093;	88616;	88616|AR-NSID<br>NS-ARID|-|Autosomal recessive|Infancy|249500 607417 608443 611090 611091 611092 611093 611095 611096 611097 611107 613192 614020 614202 614208 614249 614329 614333 614340 614341 614342 614343 614344 614345 614346 614347 614499 615802 615817 615942 615979 616116 616193 616460 616739 616887 617028 617125 ~	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.3849
8	15978063	15978063	C	T	MSR1	exonic	synonymous SNV	ENSG00000038945	rs4338104	ENSG00000038945:ENST00000262101:exon9:c.G1086A:p.R362R,ENSG00000038945:ENST00000445506:exon9:c.G1140A:p.R380R	MSR1:NM_001363744:exon9:c.G1140A:p.R380R,MSR1:NM_138715:exon9:c.G1086A:p.R362R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9992	0.9975	0.997404	0.9982	.	.	.	.	.	.	.	.	MSR1:uc003wwz.3:exon9:c.G1086A:p.R362R,MSR1:uc010lsu.3:exon9:c.G1140A:p.R380R	.	AFR:0.9936,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	MU81848037	hom
8	15978126	15978128	AAA	-	MSR1	intronic	.	ENSG00000038945	rs780071620	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0181	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	.	het
8	16012648	16012648	G	C	MSR1	exonic	nonsynonymous SNV	ENSG00000038945	rs2229388	ENSG00000038945:ENST00000522672:exon2:c.C193G:p.P65A,ENSG00000038945:ENST00000536385:exon4:c.C145G:p.P49A,ENSG00000038945:ENST00000355282:exon5:c.C823G:p.P275A,ENSG00000038945:ENST00000262101:exon6:c.C823G:p.P275A,ENSG00000038945:ENST00000350896:exon6:c.C823G:p.P275A,ENSG00000038945:ENST00000381998:exon6:c.C823G:p.P275A,ENSG00000038945:ENST00000445506:exon6:c.C877G:p.P293A	MSR1:NM_001363744:exon6:c.C877G:p.P293A,MSR1:NM_002445:exon6:c.C823G:p.P275A,MSR1:NM_138715:exon6:c.C823G:p.P275A,MSR1:NM_138716:exon6:c.C823G:p.P275A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1138	0.0697	0.165535	2(soft_tissue)	5.347	25.9	0.042	4.87	0.995	.	.	SRCR-like domain	MSR1:uc011kxz.2:exon4:c.C145G:p.P49A,MSR1:uc003wwz.3:exon6:c.C823G:p.P275A,MSR1:uc003wxa.3:exon6:c.C823G:p.P275A,MSR1:uc003wxb.3:exon6:c.C823G:p.P275A,MSR1:uc010lsu.3:exon6:c.C877G:p.P293A	-1.617	AFR:2(large_intestine),AMR:1(stomach),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,FIN:0.0738,NFE:0.0785,OTH:0.2225,ASJ:MU587713	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	1.0	-4.47	0.000	1.765	8	1(oesophagus)	0.0464
8	16043667	16043667	C	T	MSR1	splicing	.	ENSG00000038945	rs435815	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2588	.	0.398163	MU5477370	-0.071	1.954	.	0.054	0.016	0	0.002	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.2426,EAS:0.4593,FIN:0.1556,NFE:0.5336,OTH:0.0656,ASJ:0.4661	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	8	1(lung)	0.1171
8	16043686	16043686	G	C	MSR1	exonic	nonsynonymous SNV	ENSG00000038945	rs76917531	ENSG00000038945:ENST00000445506:exon1:c.C32G:p.S11C	MSR1:NM_001363744:exon1:c.C32G:p.S11C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1226	.	0.142572	0.0522	0.238	5.075	0.0	-1.41	0.059	.	.	.	MSR1:uc010lsu.3:exon1:c.C32G:p.S11C	-1.075	AFR:0.0233,AMR:0.2105,EAS:0.3093,FIN:0.0143,NFE:0.0417,OTH:0.0489,ASJ:0.0430	153622	176807;614266;	99976;1331;	99976|Esophageal adenocarcinoma|1-9 / 100 000|Not applicable|Adult|614266 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.003	-2.13	0.000	.	8	MU19603427	unknown
8	17796382	17796382	A	G	PCM1	exonic	nonsynonymous SNV	ENSG00000078674	rs412750	ENSG00000078674:ENST00000523055:exon4:c.A476G:p.N159S,ENSG00000078674:ENST00000524226:exon4:c.A476G:p.N159S,ENSG00000078674:ENST00000325083:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000517730:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000518537:exon5:c.A476G:p.N159S,ENSG00000078674:ENST00000519253:exon5:c.A476G:p.N159S	PCM1:NM_001352647:exon4:c.A476G:p.N159S,PCM1:NM_001352651:exon4:c.A476G:p.N159S,PCM1:NM_001352652:exon4:c.A476G:p.N159S,PCM1:NM_001315507:exon5:c.A476G:p.N159S,PCM1:NM_001315508:exon5:c.A476G:p.N159S,PCM1:NM_001352632:exon5:c.A476G:p.N159S,PCM1:NM_001352634:exon5:c.A476G:p.N159S,PCM1:NM_001352636:exon5:c.A476G:p.N159S,PCM1:NM_001352637:exon5:c.A476G:p.N159S,PCM1:NM_001352639:exon5:c.A476G:p.N159S,PCM1:NM_001352640:exon5:c.A476G:p.N159S,PCM1:NM_001352641:exon5:c.A476G:p.N159S,PCM1:NM_001352643:exon5:c.A476G:p.N159S,PCM1:NM_001352644:exon5:c.A476G:p.N159S,PCM1:NM_001352646:exon5:c.A476G:p.N159S,PCM1:NM_001352649:exon5:c.A476G:p.N159S,PCM1:NM_001352654:exon5:c.A476G:p.N159S,PCM1:NM_001352658:exon5:c.A476G:p.N159S,PCM1:NM_001352659:exon5:c.A476G:p.N159S,PCM1:NM_006197:exon5:c.A476G:p.N159S,PCM1:NM_001352638:exon6:c.A476G:p.N159S,PCM1:NM_001352655:exon6:c.A476G:p.N159S,PCM1:NM_001352633:exon7:c.A476G:p.N159S,PCM1:NM_001352635:exon7:c.A476G:p.N159S,PCM1:NM_001352642:exon7:c.A476G:p.N159S,PCM1:NM_001352645:exon7:c.A476G:p.N159S,PCM1:NM_001352648:exon7:c.A476G:p.N159S,PCM1:NM_001352650:exon7:c.A476G:p.N159S,PCM1:NM_001352653:exon7:c.A476G:p.N159S,PCM1:NM_001352656:exon7:c.A476G:p.N159S,PCM1:NM_001352657:exon7:c.A476G:p.N159S,PCM1:NM_001352660:exon7:c.A476G:p.N159S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7324	0.8139	0.690495	0.7933	-1.468	0.003	1.0	4.85	0.007	.	.	.	PCM1:uc022asj.1:exon3:c.A476G:p.N159S,PCM1:uc003wyg.2:exon4:c.A476G:p.N159S,PCM1:uc003wyj.4:exon4:c.A476G:p.N159S,PCM1:uc003wyh.3:exon5:c.A476G:p.N159S,PCM1:uc003wyi.4:exon5:c.A476G:p.N159S,PCM1:uc010lta.1:exon5:c.A476G:p.N159S,PCM1:uc011kyh.2:exon5:c.A476G:p.N159S	-0.976	AFR:0.8326,AMR:0.5493,EAS:0.6044,FIN:0.8153,NFE:0.8004,OTH:0.7920,ASJ:0.7351	600299	.	.	.	.	.	.	.	0.0	3.99	0.000	.	8	MU18922720	unknown
8	17796383	17796383	C	T	PCM1	exonic	synonymous SNV	ENSG00000078674	rs454755	ENSG00000078674:ENST00000523055:exon4:c.C477T:p.N159N,ENSG00000078674:ENST00000524226:exon4:c.C477T:p.N159N,ENSG00000078674:ENST00000325083:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000517730:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000518537:exon5:c.C477T:p.N159N,ENSG00000078674:ENST00000519253:exon5:c.C477T:p.N159N	PCM1:NM_001352647:exon4:c.C477T:p.N159N,PCM1:NM_001352651:exon4:c.C477T:p.N159N,PCM1:NM_001352652:exon4:c.C477T:p.N159N,PCM1:NM_001315507:exon5:c.C477T:p.N159N,PCM1:NM_001315508:exon5:c.C477T:p.N159N,PCM1:NM_001352632:exon5:c.C477T:p.N159N,PCM1:NM_001352634:exon5:c.C477T:p.N159N,PCM1:NM_001352636:exon5:c.C477T:p.N159N,PCM1:NM_001352637:exon5:c.C477T:p.N159N,PCM1:NM_001352639:exon5:c.C477T:p.N159N,PCM1:NM_001352640:exon5:c.C477T:p.N159N,PCM1:NM_001352641:exon5:c.C477T:p.N159N,PCM1:NM_001352643:exon5:c.C477T:p.N159N,PCM1:NM_001352644:exon5:c.C477T:p.N159N,PCM1:NM_001352646:exon5:c.C477T:p.N159N,PCM1:NM_001352649:exon5:c.C477T:p.N159N,PCM1:NM_001352654:exon5:c.C477T:p.N159N,PCM1:NM_001352658:exon5:c.C477T:p.N159N,PCM1:NM_001352659:exon5:c.C477T:p.N159N,PCM1:NM_006197:exon5:c.C477T:p.N159N,PCM1:NM_001352638:exon6:c.C477T:p.N159N,PCM1:NM_001352655:exon6:c.C477T:p.N159N,PCM1:NM_001352633:exon7:c.C477T:p.N159N,PCM1:NM_001352635:exon7:c.C477T:p.N159N,PCM1:NM_001352642:exon7:c.C477T:p.N159N,PCM1:NM_001352645:exon7:c.C477T:p.N159N,PCM1:NM_001352648:exon7:c.C477T:p.N159N,PCM1:NM_001352650:exon7:c.C477T:p.N159N,PCM1:NM_001352653:exon7:c.C477T:p.N159N,PCM1:NM_001352656:exon7:c.C477T:p.N159N,PCM1:NM_001352657:exon7:c.C477T:p.N159N,PCM1:NM_001352660:exon7:c.C477T:p.N159N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7324	0.8139	0.690495	0.7932	.	.	.	.	.	.	.	.	PCM1:uc022asj.1:exon3:c.C477T:p.N159N,PCM1:uc003wyg.2:exon4:c.C477T:p.N159N,PCM1:uc003wyj.4:exon4:c.C477T:p.N159N,PCM1:uc003wyh.3:exon5:c.C477T:p.N159N,PCM1:uc003wyi.4:exon5:c.C477T:p.N159N,PCM1:uc010lta.1:exon5:c.C477T:p.N159N,PCM1:uc011kyh.2:exon5:c.C477T:p.N159N	.	AFR:0.8327,AMR:0.5478,EAS:0.6039,FIN:0.8148,NFE:0.8004,OTH:0.7920,ASJ:0.7351	600299	.	.	.	.	.	.	.	.	.	.	.	8	MU803684	unknown
8	17799172	17799172	T	G	PCM1	intronic	.	ENSG00000078674	rs2467076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	hom
8	17799241	17799241	T	C	PCM1	intronic	.	ENSG00000078674	rs10108545	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.297125	0.4425	.	.	.	.	.	.	.	.	.	.	AFR:0.2216,AMR:0.2812,EAS:0.1253,FIN:0.5743,NFE:0.5776,OTH:0.5328,ASJ:0.4633	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	het
8	17814915	17814915	A	G	PCM1	exonic	nonsynonymous SNV	ENSG00000078674	rs208753	ENSG00000078674:ENST00000524226:exon11:c.A1789G:p.M597V,ENSG00000078674:ENST00000325083:exon12:c.A1789G:p.M597V,ENSG00000078674:ENST00000519253:exon12:c.A1789G:p.M597V,ENSG00000078674:ENST00000517730:exon13:c.A1906G:p.M636V	PCM1:NM_001352647:exon11:c.A1789G:p.M597V,PCM1:NM_001352652:exon11:c.A1789G:p.M597V,PCM1:NM_001315507:exon12:c.A1789G:p.M597V,PCM1:NM_001315508:exon12:c.A1789G:p.M597V,PCM1:NM_001352634:exon12:c.A1789G:p.M597V,PCM1:NM_001352639:exon12:c.A1789G:p.M597V,PCM1:NM_001352640:exon12:c.A1789G:p.M597V,PCM1:NM_001352641:exon12:c.A1789G:p.M597V,PCM1:NM_001352644:exon12:c.A1789G:p.M597V,PCM1:NM_001352646:exon12:c.A1789G:p.M597V,PCM1:NM_001352649:exon12:c.A1789G:p.M597V,PCM1:NM_001352651:exon12:c.A1906G:p.M636V,PCM1:NM_001352654:exon12:c.A1789G:p.M597V,PCM1:NM_001352658:exon12:c.A1789G:p.M597V,PCM1:NM_006197:exon12:c.A1789G:p.M597V,PCM1:NM_001352632:exon13:c.A1906G:p.M636V,PCM1:NM_001352636:exon13:c.A1906G:p.M636V,PCM1:NM_001352637:exon13:c.A1906G:p.M636V,PCM1:NM_001352643:exon13:c.A1906G:p.M636V,PCM1:NM_001352655:exon13:c.A1789G:p.M597V,PCM1:NM_001352635:exon14:c.A1789G:p.M597V,PCM1:NM_001352638:exon14:c.A1906G:p.M636V,PCM1:NM_001352642:exon14:c.A1789G:p.M597V,PCM1:NM_001352645:exon14:c.A1789G:p.M597V,PCM1:NM_001352648:exon14:c.A1789G:p.M597V,PCM1:NM_001352653:exon14:c.A1789G:p.M597V,PCM1:NM_001352656:exon14:c.A1789G:p.M597V,PCM1:NM_001352657:exon14:c.A1789G:p.M597V,PCM1:NM_001352633:exon15:c.A1906G:p.M636V,PCM1:NM_001352650:exon15:c.A1906G:p.M636V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7362	0.8150	0.692891	0.7961	-1.590	0.002	0.302	-4.09	0.892	.	.	.	PCM1:uc003wyj.4:exon11:c.A1789G:p.M597V,PCM1:uc022asj.1:exon11:c.A1906G:p.M636V,PCM1:uc003wyi.4:exon12:c.A1789G:p.M597V,PCM1:uc011kyh.2:exon12:c.A1789G:p.M597V,PCM1:uc010lta.1:exon13:c.A1906G:p.M636V	-1.018	AFR:0.8299,AMR:0.5502,EAS:0.6344,FIN:0.8192,NFE:0.8036,OTH:0.7943,ASJ:0.7318	600299	.	.	.	.	.	.	.	0.0	1.59	0.000	1.15	8	MU13207274	het
8	17819572	17819572	C	T	PCM1	exonic	synonymous SNV	ENSG00000078674	rs3780103	ENSG00000078674:ENST00000524226:exon15:c.C2355T:p.P785P,ENSG00000078674:ENST00000325083:exon16:c.C2352T:p.P784P,ENSG00000078674:ENST00000519253:exon16:c.C2352T:p.P784P	PCM1:NM_001352647:exon15:c.C2352T:p.P784P,PCM1:NM_001352652:exon15:c.C2352T:p.P784P,PCM1:NM_001315507:exon16:c.C2352T:p.P784P,PCM1:NM_001315508:exon16:c.C2355T:p.P785P,PCM1:NM_001352634:exon16:c.C2352T:p.P784P,PCM1:NM_001352639:exon16:c.C2352T:p.P784P,PCM1:NM_001352640:exon16:c.C2355T:p.P785P,PCM1:NM_001352641:exon16:c.C2352T:p.P784P,PCM1:NM_001352644:exon16:c.C2352T:p.P784P,PCM1:NM_001352646:exon16:c.C2352T:p.P784P,PCM1:NM_001352649:exon16:c.C2355T:p.P785P,PCM1:NM_001352651:exon16:c.C2469T:p.P823P,PCM1:NM_001352654:exon16:c.C2352T:p.P784P,PCM1:NM_001352658:exon16:c.C2352T:p.P784P,PCM1:NM_006197:exon16:c.C2352T:p.P784P,PCM1:NM_001352632:exon17:c.C2469T:p.P823P,PCM1:NM_001352636:exon17:c.C2472T:p.P824P,PCM1:NM_001352637:exon17:c.C2469T:p.P823P,PCM1:NM_001352643:exon17:c.C2469T:p.P823P,PCM1:NM_001352655:exon17:c.C2352T:p.P784P,PCM1:NM_001352635:exon18:c.C2355T:p.P785P,PCM1:NM_001352638:exon18:c.C2469T:p.P823P,PCM1:NM_001352642:exon18:c.C2352T:p.P784P,PCM1:NM_001352645:exon18:c.C2352T:p.P784P,PCM1:NM_001352648:exon18:c.C2355T:p.P785P,PCM1:NM_001352653:exon18:c.C2352T:p.P784P,PCM1:NM_001352656:exon18:c.C2352T:p.P784P,PCM1:NM_001352657:exon18:c.C2352T:p.P784P,PCM1:NM_001352633:exon19:c.C2469T:p.P823P,PCM1:NM_001352650:exon19:c.C2469T:p.P823P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4864	0.4950	0.30631	MU142341	.	.	.	.	.	.	.	.	PCM1:uc003wyj.4:exon15:c.C2355T:p.P785P,PCM1:uc022asj.1:exon15:c.C2469T:p.P823P,PCM1:uc003wyi.4:exon16:c.C2352T:p.P784P,PCM1:uc011kyh.2:exon16:c.C2352T:p.P784P	.	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,AMR:0.4660,EAS:0.2852,FIN:0.4702,NFE:0.1594,OTH:0.5796,ASJ:0.2783	600299	.	.	.	.	.	.	.	.	.	.	.	8	2(lung)	0.5866
8	17827260	17827260	-	C	PCM1	intronic	.	ENSG00000078674	rs3214087	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.7369	0.8232	0.698682	0.8076	.	.	.	.	.	.	.	.	.	.	AFR:0.8698,AMR:0.5601,EAS:0.6315,FIN:0.8201,NFE:0.8031,OTH:0.7959,ASJ:0.7417	600299	.	.	.	.	.	.	.	.	.	.	.	8	.	het
8	21964802	21964802	C	T	NUDT18	UTR3	.	ENSG00000173566	rs1552286	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9048	0.8733	0.920527	0.8847	.	.	.	.	.	.	.	.	.	.	AFR:0.8719,AMR:0.9305,EAS:0.9944,FIN:0.9147,NFE:0.8698,OTH:0.8953,ASJ:0.8940	615791	.	.	.	.	.	.	.	.	.	.	.	8	MU81848854	hom
8	21965113	21965113	T	C	NUDT18	exonic	nonsynonymous SNV	ENSG00000173566	rs3739435	ENSG00000173566:ENST00000522405:exon3:c.A439G:p.M147V,ENSG00000173566:ENST00000309188:exon5:c.A670G:p.M224V	NUDT18:NM_024815:exon5:c.A670G:p.M224V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5141	0.4747	0.554113	0.5037	-3.587	0.001	.	-2.23	0.553	.	.	.	NUDT18:uc003xaq.1:exon4:c.A670G:p.M224V	-0.939	AFR:0.5174,AMR:0.6938,EAS:0.6354,FIN:0.5838,NFE:0.4534,OTH:0.5154,ASJ:0.4033	615791	.	.	.	.	.	.	.	.	.	0.000	1.185	8	MU18563877	het
8	23049292	23049292	C	T	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs2230229	ENSG00000104689:ENST00000221132:exon10:c.G1322A:p.R441K	TNFRSF10A:NM_003844:exon10:c.G1322A:p.R441K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8782	0.8493	0.91254	0.8540	-1.070	0.011	1.0	-2.61	0.001	.	.	Death domain|Death-like domain|Tumour necrosis factor receptor 10A/B, death domain	TNFRSF10A:uc003xda.3:exon10:c.G1322A:p.R441K	-0.992	AFR:0.8633,AMR:0.9342,EAS:0.9808,FIN:0.8049,NFE:0.8418,OTH:0.8480,ASJ:0.8742	603611	.	.	.	.	.	.	.	0.0	-2.0	0.000	-1.345	8	MU81849571	het
8	23059324	23059324	C	G	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs20575	ENSG00000104689:ENST00000221132:exon4:c.G626C:p.R209T,ENSG00000104689:ENST00000524158:exon4:c.G20C:p.R7T	TNFRSF10A:NM_003844:exon4:c.G626C:p.R209T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5279	0.4103	0.579473	0.4435	-1.605	0.002	1.0	0.222	0.000	.	.	TNFR/NGFR cysteine-rich region;TNFR/NGFR cysteine-rich region|Tumor necrosis factor receptor 10, N-terminal	TNFRSF10A:uc003xda.3:exon4:c.G626C:p.R209T	-0.966	AFR:0.3146,AMR:0.6432,EAS:0.9735,FIN:0.4050,NFE:0.4544,OTH:0.4867,ASJ:0.4636	603611	.	.	.	.	.	.	.	0.0	-2.7	0.000	-1.105	8	MU64437	hom
8	23060256	23060256	T	C	TNFRSF10A	exonic	nonsynonymous SNV	ENSG00000104689	rs17620	ENSG00000104689:ENST00000221132:exon3:c.A422G:p.H141R	TNFRSF10A:NM_003844:exon3:c.A422G:p.H141R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5254	0.4000	0.571685	0.4325	-3.114	0.001	0.419	-6.96	0.000	.	.	Tumor necrosis factor receptor 10, N-terminal	TNFRSF10A:uc003xda.3:exon3:c.A422G:p.H141R	-0.910	AFR:0.2767,AMR:0.6435,EAS:0.9735,FIN:0.4044,NFE:0.4554,OTH:0.4847,ASJ:0.4636	603611	.	.	.	.	.	.	.	0.824	0.99	0.000	1.15	8	MU144012	hom
8	23540417	23540417	C	T	NKX3-1	UTR5	.	ENSG00000167034	rs11781886	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7480	0.8300	0.685903	0.7179	.	.	.	.	.	.	.	.	.	.	AFR:0.6950,AMR:0.6803,EAS:0.7186,FIN:0.6328,NFE:0.7556,OTH:0.6921,ASJ:0.6812	602041	.	.	.	~ko05200 Pathways in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	8	MU9652193	het
8	27634064	27634064	C	T	ESCO2	exonic	nonsynonymous SNV	ENSG00000171320	rs4732748	ENSG00000171320:ENST00000305188:exon3:c.C239T:p.A80V,ENSG00000171320:ENST00000519637:exon3:c.C239T:p.A80V,ENSG00000171320:ENST00000522378:exon3:c.C239T:p.A80V,ENSG00000171320:ENST00000523566:exon3:c.C239T:p.A80V	ESCO2:NM_001017420:exon3:c.C239T:p.A80V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1148	0.0987	0.139377	0.1033	-0.150	1.389	0.487	1.8	0.247	.	.	.	ESCO2:uc003xgh.3:exon2:c.C239T:p.A80V,ESCO2:uc003xgg.3:exon3:c.C239T:p.A80V	-1.060	AFR:0.0957,AMR:0.0998,EAS:0.2515,FIN:0.0862,NFE:0.0938,OTH:0.1141,ASJ:0.1755	609353	268300;269000;	3103;3103;	3103|Pseudothalidomide syndrome<br>Roberts-SC phocomelia syndrome<br>SC phocomelia<br>SC pseudothalidomide syndrome|Unknown|Autosomal recessive|Neonatal<br>Antenatal|268300 269000 ~3103|Pseudothalidomide syndrome<br>Roberts-SC phocomelia syndrome<br>SC phocomelia<br>SC pseudothalidomide syndrome|Unknown|Autosomal recessive|Neonatal<br>Antenatal|268300 269000 ~	.	.	.	.	0.023	0.71	0.000	1.995	8	MU151233	het
8	30469805	30469805	A	C	GTF2E2	intronic	.	ENSG00000197265	rs7815625	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4031	0.3503	0.333666	0.3542	.	.	.	.	.	.	.	.	.	.	AFR:0.1840,AMR:0.2757,EAS:0.2466,FIN:0.4787,NFE:0.4311,OTH:0.4348,ASJ:0.5530	189964	616943;	33364;	33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~	~ko03022 Basal transcription factors~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	MU717268	het
8	30924557	30924557	C	T	WRN	exonic	synonymous SNV	ENSG00000165392	rs1800389	ENSG00000165392:ENST00000298139:exon6:c.C513T:p.C171C	WRN:NM_000553:exon6:c.C513T:p.C171C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7032	0.6537	0.6873	0.6708	.	.	.	.	.	.	.	.	WRN:uc003xio.4:exon6:c.C513T:p.C171C	.	AFR:0.5312,AMR:0.7715,EAS:0.8622,FIN:0.7583,NFE:0.7012,OTH:0.7147,ASJ:0.7219	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU794190	hom
8	30938704	30938704	G	A	WRN	exonic	nonsynonymous SNV	ENSG00000165392	rs1800391	ENSG00000165392:ENST00000298139:exon9:c.G1161A:p.M387I	WRN:NM_000553:exon9:c.G1161A:p.M387I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0752	0.0575	0.0469249	0.0627	0.835	9.680	0.345	3.82	0.009	.	.	.	WRN:uc011lbd.1:exon1:c.G270A:p.M90I,WRN:uc003xio.4:exon9:c.G1161A:p.M387I	-1.079	AFR:0.0143,AMR:0.0644,EAS:0,FIN:0.0857,NFE:0.0915,OTH:0.0663,ASJ:0.0894	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	0.204	0.95	0.006	1.15	8	.	het
8	30958354	30958354	T	-	WRN	intronic	.	ENSG00000165392	rs397723919	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.9943	0.9784	0.98123	0.9825	.	.	.	.	.	.	.	.	.	.	AFR:0.9388,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	.	hom
8	30973957	30973957	G	T	WRN	exonic	synonymous SNV	ENSG00000165392	rs1800392	ENSG00000165392:ENST00000298139:exon20:c.G2361T:p.L787L	WRN:NM_000553:exon20:c.G2361T:p.L787L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4466	0.4482	0.471246	0.4285	.	.	.	.	.	.	.	.	WRN:uc010lvk.3:exon8:c.G762T:p.L254L,WRN:uc003xio.4:exon20:c.G2361T:p.L787L	.	AFR:0.4064,AMR:0.5598,EAS:0.6073,FIN:0.3639,NFE:0.4294,OTH:0.4255,ASJ:0.4570	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU131479	het
8	30999122	30999122	C	T	WRN	intronic	.	ENSG00000165392	rs3024239	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4704	0.3866	0.375	0.4182	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.1976,AMR:0.4031,EAS:0.3604,FIN:0.5664,NFE:0.5129,OTH:0.4908,ASJ:0.49	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU661076	unknown
8	30999123	30999123	G	A	WRN	intronic	.	ENSG00000165392	rs2737335	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4479	0.4660	0.494808	0.4445	.	.	.	.	.	0	0	.	.	.	AFR:0.4792,AMR:0.5514,EAS:0.6203,FIN:0.3598,NFE:0.4203,OTH:0.4235,ASJ:0.4533	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU18938553	unknown
8	30999280	30999280	G	T	WRN	exonic	nonsynonymous SNV	ENSG00000165392	rs1801195	ENSG00000165392:ENST00000298139:exon26:c.G3222T:p.L1074F	WRN:NM_000553:exon26:c.G3222T:p.L1074F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4492	0.4669	0.496006	0.4457	-0.691	0.076	0.764	1.4	0.007	.	.	Winged helix-turn-helix DNA-binding domain	WRN:uc010lvk.3:exon14:c.G1623T:p.L541F,WRN:uc003xio.4:exon26:c.G3222T:p.L1074F	-0.938	AFR:0.4802,AMR:0.5504,EAS:0.6186,FIN:0.3607,NFE:0.4221,OTH:0.4262,ASJ:0.4536	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	0.0	1.48	0.000	-1.24	8	MU131494	het
8	31024638	31024638	C	T	WRN	exonic	synonymous SNV	ENSG00000165392	rs1801196	ENSG00000165392:ENST00000298139:exon34:c.C4083T:p.S1361S	WRN:NM_000553:exon34:c.C4083T:p.S1361S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2989	0.2821	0.273562	0.2986	.	.	.	.	.	.	.	.	WRN:uc010lvk.3:exon22:c.C2484T:p.S828S,WRN:uc003xio.4:exon34:c.C4083T:p.S1361S	.	AFR:0.2714,AMR:0.2907,EAS:0.2360,FIN:0.3533,NFE:0.3079,OTH:0.3033,ASJ:0.3278	604611	277700;	902;	902|Adult progeria<br>WS|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Adult|277700 ~	.	.	.	.	.	.	.	.	8	MU147491	het
8	32453358	32453358	G	A	NRG1	exonic	nonsynonymous SNV	ENSG00000157168	rs3924999	ENSG00000157168:ENST00000287842:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000287845:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000338921:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000341377:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000356819:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000405005:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000518104:exon2:c.G50A:p.R17Q,ENSG00000157168:ENST00000519301:exon2:c.G50A:p.R17Q,ENSG00000157168:ENST00000520407:exon2:c.G758A:p.R253Q,ENSG00000157168:ENST00000521670:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000523079:exon2:c.G113A:p.R38Q,ENSG00000157168:ENST00000523534:exon2:c.G317A:p.R106Q	NRG1:NM_001160002:exon2:c.G113A:p.R38Q,NRG1:NM_001160004:exon2:c.G113A:p.R38Q,NRG1:NM_001160005:exon2:c.G113A:p.R38Q,NRG1:NM_001160007:exon2:c.G113A:p.R38Q,NRG1:NM_001160008:exon2:c.G113A:p.R38Q,NRG1:NM_004495:exon2:c.G113A:p.R38Q,NRG1:NM_013956:exon2:c.G113A:p.R38Q,NRG1:NM_013957:exon2:c.G113A:p.R38Q,NRG1:NM_013958:exon2:c.G113A:p.R38Q,NRG1:NM_013960:exon2:c.G113A:p.R38Q,NRG1:NM_013962:exon2:c.G758A:p.R253Q,NRG1:NM_013964:exon2:c.G113A:p.R38Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3913	0.3068	0.385184	MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611	5.399	26.0	0.044	5.65	0.998	.	.	Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin-like fold;Neuregulin, C-terminal	NRG1:uc010lvp.2:exon1:c.G11A:p.R4Q,NRG1:uc003xip.3:exon2:c.G758A:p.R253Q,NRG1:uc003xir.3:exon2:c.G113A:p.R38Q,NRG1:uc003xis.3:exon2:c.G113A:p.R38Q,NRG1:uc003xit.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiu.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiv.2:exon2:c.G113A:p.R38Q,NRG1:uc003xiw.2:exon2:c.G113A:p.R38Q,NRG1:uc010lvl.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvm.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvn.3:exon2:c.G113A:p.R38Q,NRG1:uc010lvo.2:exon2:c.G113A:p.R38Q,NRG1:uc011lbf.1:exon2:c.G113A:p.R38Q,NRG1:uc022ats.1:exon2:c.G50A:p.R17Q	-1.014	AFR:0.3166,AMR:0.1107,EAS:0.3841,FIN:0.7711,NFE:0.3321,OTH:0.3739,ASJ:0.4234	142445	603013;	.	.	.	.	.	.	0.381	1.02	0.000	0.41	8	1(skin)	0.3554
8	32505372	32505372	G	A	NRG1	exonic	nonsynonymous SNV	ENSG00000157168	rs3735774	ENSG00000157168:ENST00000520502:exon1:c.G136A:p.G46R,ENSG00000157168:ENST00000523041:exon1:c.G16A:p.G6R	NRG1:NM_001322205:exon1:c.G136A:p.G46R,NRG1:NM_001322206:exon1:c.G136A:p.G46R,NRG1:NM_001322207:exon1:c.G136A:p.G46R,NRG1:NM_013959:exon1:c.G136A:p.G46R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0052	0.0002	0.0179712	0.0041	0.142	4.059	0.406	5.15	0.007	.	.	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	NRG1:uc003xiy.3:exon1:c.G136A:p.G46R	-1.122	AFR:0.0001,AMR:0,EAS:0.0768,FIN:0,NFE:6.676e-05,OTH:0.0020,ASJ:0	142445	603013;	.	.	.	.	.	.	0.001	.	0.004	.	8	MU81850740	het
8	32614026	32614026	C	T	NRG1	exonic	synonymous SNV	ENSG00000157168	rs775162169	ENSG00000157168:ENST00000539990:exon5:c.C438T:p.P146P,ENSG00000157168:ENST00000287845:exon8:c.C822T:p.P274P,ENSG00000157168:ENST00000519301:exon8:c.C759T:p.P253P,ENSG00000157168:ENST00000287842:exon9:c.C900T:p.P300P,ENSG00000157168:ENST00000405005:exon9:c.C909T:p.P303P,ENSG00000157168:ENST00000518104:exon9:c.C810T:p.P270P,ENSG00000157168:ENST00000521670:exon9:c.C909T:p.P303P,ENSG00000157168:ENST00000523079:exon9:c.C900T:p.P300P,ENSG00000157168:ENST00000338921:exon10:c.C933T:p.P311P,ENSG00000157168:ENST00000356819:exon10:c.C924T:p.P308P,ENSG00000157168:ENST00000523534:exon10:c.C1128T:p.P376P	NRG1:NM_001159996:exon5:c.C447T:p.P149P,NRG1:NM_001322197:exon5:c.C438T:p.P146P,NRG1:NM_001322202:exon5:c.C135T:p.P45P,NRG1:NM_001322201:exon6:c.C135T:p.P45P,NRG1:NM_001322205:exon6:c.C1089T:p.P363P,NRG1:NM_001322206:exon6:c.C1089T:p.P363P,NRG1:NM_001322207:exon6:c.C1089T:p.P363P,NRG1:NM_001160004:exon9:c.C900T:p.P300P,NRG1:NM_001160008:exon9:c.C900T:p.P300P,NRG1:NM_013957:exon9:c.C900T:p.P300P,NRG1:NM_013960:exon9:c.C909T:p.P303P,NRG1:NM_013964:exon9:c.C909T:p.P303P,NRG1:NM_013956:exon10:c.C924T:p.P308P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	8.255e-06	.	.	.	.	.	.	.	.	.	.	.	NRG1:uc003xja.2:exon5:c.C342T:p.P114P,NRG1:uc010lvs.2:exon5:c.C135T:p.P45P,NRG1:uc011lbg.1:exon5:c.C447T:p.P149P,NRG1:uc011lbh.1:exon5:c.C438T:p.P146P,NRG1:uc010lvr.2:exon6:c.C135T:p.P45P,NRG1:uc010lvq.2:exon7:c.C699T:p.P233P,NRG1:uc010lvp.2:exon8:c.C771T:p.P257P,NRG1:uc022ats.1:exon8:c.C759T:p.P253P,NRG1:uc003xit.2:exon9:c.C909T:p.P303P,NRG1:uc003xiv.2:exon9:c.C909T:p.P303P,NRG1:uc003xiw.2:exon9:c.C900T:p.P300P,NRG1:uc010lvo.2:exon9:c.C900T:p.P300P,NRG1:uc011lbf.1:exon9:c.C900T:p.P300P,NRG1:uc003xiu.2:exon10:c.C924T:p.P308P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	142445	603013;	.	.	.	.	.	.	.	.	.	.	8	.	het
8	32621844	32621844	G	T	NRG1	exonic	nonsynonymous SNV	ENSG00000157168	rs75155858	ENSG00000157168:ENST00000539990:exon8:c.G1376T:p.G459V,ENSG00000157168:ENST00000287845:exon11:c.G1760T:p.G587V,ENSG00000157168:ENST00000519301:exon11:c.G1697T:p.G566V,ENSG00000157168:ENST00000287842:exon12:c.G1838T:p.G613V,ENSG00000157168:ENST00000405005:exon12:c.G1847T:p.G616V,ENSG00000157168:ENST00000338921:exon13:c.G1871T:p.G624V,ENSG00000157168:ENST00000356819:exon13:c.G1862T:p.G621V,ENSG00000157168:ENST00000523534:exon13:c.G2066T:p.G689V	NRG1:NM_001322197:exon8:c.G1376T:p.G459V,NRG1:NM_001322202:exon8:c.G1073T:p.G358V,NRG1:NM_001322201:exon9:c.G1073T:p.G358V,NRG1:NM_001322205:exon9:c.G2027T:p.G676V,NRG1:NM_013957:exon12:c.G1838T:p.G613V,NRG1:NM_013964:exon12:c.G1847T:p.G616V,NRG1:NM_013956:exon13:c.G1862T:p.G621V	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.0532	0.0098	0.104832	1(biliary_tract)	3.046	22.4	0.007	4.71	1.000	.	.	Neuregulin, C-terminal	NRG1:uc003xja.2:exon8:c.G1280T:p.G427V,NRG1:uc010lvs.2:exon8:c.G1073T:p.G358V,NRG1:uc011lbh.1:exon8:c.G1376T:p.G459V,NRG1:uc010lvr.2:exon9:c.G1073T:p.G358V,NRG1:uc010lvq.2:exon10:c.G1637T:p.G546V,NRG1:uc010lvp.2:exon11:c.G1709T:p.G570V,NRG1:uc022ats.1:exon11:c.G1697T:p.G566V,NRG1:uc003xiv.2:exon12:c.G1847T:p.G616V,NRG1:uc003xiw.2:exon12:c.G1838T:p.G613V,NRG1:uc003xiu.2:exon13:c.G1862T:p.G621V	-0.986	AFR:MU13242254,AMR:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,EAS:0.0262,FIN:0.1480,NFE:0,OTH:0.3453,ASJ:0.0310	142445	603013;	.	.	.	.	.	.	0.962	0.4	0.000	0.895	8	1(haematopoietic_and_lymphoid_tissue)	0.0034
8	37693302	37693302	T	C	ADGRA2	intronic	.	ENSG00000020181	rs10101560	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9539	0.9521	0.978834	0.9606	.	.	.	.	.	.	.	.	.	.	AFR:0.9885,AMR:0.9797,EAS:1,FIN:0.9613,NFE:0.9393,OTH:0.9488,ASJ:0.9768	606823	.	.	.	.	.	.	.	.	.	.	.	8	MU81850840	hom
8	37699195	37699195	C	G	ADGRA2	exonic	synonymous SNV	ENSG00000020181	rs4976898	ENSG00000020181:ENST00000315215:exon16:c.C2688G:p.G896G,ENSG00000020181:ENST00000412232:exon19:c.C3339G:p.G1113G	ADGRA2:NM_032777:exon19:c.C3339G:p.G1113G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7665	0.8037	0.798323	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	GPR124:uc010lvy.3:exon16:c.C2688G:p.G896G,GPR124:uc003xkj.3:exon19:c.C3339G:p.G1113G	.	AFR:0.7670,AMR:0.8245,EAS:0.6324,FIN:0.8885,NFE:0.7815,OTH:0.7189,ASJ:0.8036	606823	.	.	.	.	.	.	.	.	.	.	.	8	9(large_intestine)	0.7490
8	37699516	37699516	C	T	ADGRA2	exonic	synonymous SNV	ENSG00000020181	rs7010546	ENSG00000020181:ENST00000315215:exon16:c.C3009T:p.G1003G,ENSG00000020181:ENST00000412232:exon19:c.C3660T:p.G1220G	ADGRA2:NM_032777:exon19:c.C3660T:p.G1220G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4587	0.2834	0.464058	MU116072	.	.	.	.	.	.	.	.	GPR124:uc010lvy.3:exon16:c.C3009T:p.G1003G,GPR124:uc003xkj.3:exon19:c.C3660T:p.G1220G	.	AFR:COCA-CN|5|321|0.0155763,LINC-JP|1|394|0.00253807,AMR:0.3968,EAS:0.5024,FIN:0.3557,NFE:0.6519,OTH:0.4630,ASJ:0.3011	606823	.	.	.	.	.	.	.	.	.	.	.	8	2(thyroid)	0.4024
8	41166638	41166640	GCT	-	SFRP1	exonic	nonframeshift deletion	ENSG00000104332	rs3055861	ENSG00000104332:ENST00000220772:exon1:c.39_41del:p.13_14del	SFRP1:NM_003012:exon1:c.39_41del:p.13_14del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4030	0.0002	0.311102	0.3212	.	.	.	.	.	.	.	.	SFRP1:uc003xnt.3:exon1:c.39_41del:p.13_14del	.	AFR:0.0883,AMR:0.4007,EAS:0.4029,FIN:0.4585,NFE:0.4046,OTH:0.4411,ASJ:0.3013	604156	.	.	.	.	.	.	.	.	.	.	.	8	MU618803	het
8	41519462	41519462	A	G	ANK1	intronic	.	ENSG00000253389	rs515071	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7805	0.7499	0.786342	0.7661	.	.	.	.	.	0	0.002	.	.	.	AFR:0.7498,AMR:0.7799,EAS:0.8492,FIN:0.7946,NFE:0.7620,OTH:0.7643,ASJ:0.6291	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	MU21380244	hom
8	41529856	41529856	A	G	ANK1	intronic	.	ENSG00000029534	rs508112	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9921	0.9723	0.977636	0.9781	.	.	.	.	.	.	.	.	.	.	AFR:0.9241,AMR:0.9940,EAS:1,FIN:1,NFE:0.9995,OTH:0.9959,ASJ:1	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	MU81851353	hom
8	41553928	41553928	C	G	ANK1	exonic	synonymous SNV	ENSG00000029534	rs504574	ENSG00000029534:ENST00000289734:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000347528:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000352337:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000379758:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000396942:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000396945:exon26:c.G2913C:p.L971L,ENSG00000029534:ENST00000265709:exon27:c.G3036C:p.L1012L	ANK1:NM_000037:exon26:c.G2913C:p.L971L,ANK1:NM_020475:exon26:c.G2913C:p.L971L,ANK1:NM_020476:exon26:c.G2913C:p.L971L,ANK1:NM_020477:exon26:c.G2913C:p.L971L,ANK1:NM_001142446:exon27:c.G3036C:p.L1012L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4767	0.3628	0.407149	1(large_intestine)	.	.	.	.	.	.	.	.	ANK1:uc003xoh.3:exon10:c.G861C:p.L287L,ANK1:uc003xoi.3:exon26:c.G2913C:p.L971L,ANK1:uc003xoj.3:exon26:c.G2913C:p.L971L,ANK1:uc003xok.3:exon26:c.G2913C:p.L971L,ANK1:uc003xol.3:exon26:c.G2913C:p.L971L,ANK1:uc003xom.3:exon27:c.G3036C:p.L1012L	.	AFR:MU98129,AMR:LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,EAS:0.1422,FIN:0.5685,NFE:0.4106,OTH:0.5025,ASJ:0.3998	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(stomach)	0.5598
8	41585438	41585438	G	A	ANK1	exonic	synonymous SNV	ENSG00000029534	rs2304871	ENSG00000029534:ENST00000265709:exon4:c.C414T:p.N138N,ENSG00000029534:ENST00000289734:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000347528:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000352337:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000379758:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000396942:exon4:c.C315T:p.N105N,ENSG00000029534:ENST00000396945:exon4:c.C315T:p.N105N	ANK1:NM_000037:exon4:c.C315T:p.N105N,ANK1:NM_001142446:exon4:c.C414T:p.N138N,ANK1:NM_020475:exon4:c.C315T:p.N105N,ANK1:NM_020476:exon4:c.C315T:p.N105N,ANK1:NM_020477:exon4:c.C315T:p.N105N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2443	0.2497	0.228435	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	ANK1:uc003xoi.3:exon4:c.C315T:p.N105N,ANK1:uc003xoj.3:exon4:c.C315T:p.N105N,ANK1:uc003xok.3:exon4:c.C315T:p.N105N,ANK1:uc003xol.3:exon4:c.C315T:p.N105N,ANK1:uc003xom.3:exon4:c.C414T:p.N138N	.	AFR:0.2346,AMR:0.1844,EAS:0.3477,FIN:0.2208,NFE:0.2199,OTH:0.2695,ASJ:0.1615	612641	182900;	822;	822|Minkowski-Chauffard disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|182900 270970 612653 612690 616649 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	8	1(large_intestine)	0.2490
8	48732074	48732074	-	A	PRKDC	intronic	.	ENSG00000253729	rs769584868	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0364	.	.	0.0230	.	.	.	.	.	.	.	.	.	.	AFR:0.0173,AMR:0.0034,EAS:0.0123,FIN:0.0090,NFE:0.0282,OTH:0.0421,ASJ:0.0230	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	MU112564486	het
8	48846519	48846519	T	C	PRKDC	intronic	.	ENSG00000253729	rs1231202	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9598	0.9623	0.983626	0.9656	.	.	.	.	.	.	.	.	.	.	AFR:0.9926,AMR:0.9785,EAS:0.9994,FIN:0.9528,NFE:0.9498,OTH:0.9561,ASJ:0.9338	600899	615966;	317425;	317425|SCID due to DNA-PKcs deficiency|-|-|-|615966 ~	.	.	.	.	.	.	.	.	8	MU81851562	hom
8	48885436	48885436	T	A	MCM4	exonic	nonsynonymous SNV	ENSG00000104738	rs762679	ENSG00000104738:ENST00000262105:exon13:c.T1948A:p.L650M,ENSG00000104738:ENST00000523944:exon14:c.T1948A:p.L650M	MCM4:NM_005914:exon13:c.T1948A:p.L650M,MCM4:NM_182746:exon14:c.T1948A:p.L650M	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8669	0.8730	0.914137	0.8783	1.663	14.20	1.0	5.32	1.000	.	.	MCM domain|P-loop containing nucleoside triphosphate hydrolase	MCM4:uc003xql.2:exon13:c.T1948A:p.L650M,MCM4:uc003xqk.2:exon14:c.T1948A:p.L650M,MCM4:uc011ldi.2:exon15:c.T1909A:p.L637M	-0.942	AFR:0.9223,AMR:0.9308,EAS:0.9994,FIN:0.8306,NFE:0.8494,OTH:0.8635,ASJ:0.8444	602638	609981;	75391;	75391|Primary immunodeficiency due to MCM4 deficiency|<1 / 1 000 000|Autosomal recessive|Childhood|609981 ~	.	.	.	.	0.002	2.56	0.000	0.04	8	MU81851575	hom
8	56792159	56792159	T	C	LYN	upstream	.	ENSG00000254087	rs1450741	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.715655	0.6942	.	.	.	.	.	.	.	.	.	.	AFR:0.6917,AMR:0.7267,EAS:0.7954,FIN:0.6894,NFE:0.6821,OTH:0.6916,ASJ:0.7980	165120	.	.	.	~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04611 Platelet activation~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04730 Long-term depression~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	8	.	het
8	90958422	90958422	T	C	NBN	exonic	synonymous SNV	ENSG00000104320	rs1061302	ENSG00000104320:ENST00000265433:exon13:c.A2016G:p.P672P,ENSG00000104320:ENST00000409330:exon13:c.A1770G:p.P590P	NBN:NM_002485:exon13:c.A2016G:p.P672P,NBN:NM_001024688:exon14:c.A1770G:p.P590P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3451	0.2842	0.352835	9(meninges)	.	.	.	.	.	.	.	.	NBN:uc003yej.1:exon13:c.A2016G:p.P672P,NBN:uc011lgb.1:exon13:c.A2016G:p.P672P,NBN:uc003yei.1:exon14:c.A1770G:p.P590P	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU117817,EAS:0.3122,FIN:0.2281,NFE:0.3394,OTH:0.3311,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(stomach)	0.4275
8	90958530	90958530	T	C	NBN	intronic	.	ENSG00000104320	rs2308962	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3529	0.3131	0.378994	9(meninges)	.	.	.	.	.	0	0.036	.	.	.	AFR:MU13363873,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.3078,FIN:0.3484,NFE:0.34,OTH:0.4288,ASJ:0.3357	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.3612
8	90967711	90967711	A	G	NBN	exonic	synonymous SNV	ENSG00000104320	rs709816	ENSG00000104320:ENST00000265433:exon10:c.T1197C:p.D399D,ENSG00000104320:ENST00000409330:exon10:c.T951C:p.D317D	NBN:NM_002485:exon10:c.T1197C:p.D399D,NBN:NM_001024688:exon11:c.T951C:p.D317D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4676	0.4903	0.608626	1(lung)	.	.	.	.	.	.	.	.	NBN:uc003yej.1:exon10:c.T1197C:p.D399D,NBN:uc011lgb.1:exon10:c.T1197C:p.D399D,NBN:uc003yei.1:exon11:c.T951C:p.D317D	.	AFR:1(large_intestine),AMR:MU117828,EAS:0.5139,FIN:0.7626,NFE:0.5477,OTH:0.3675,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(haematopoietic_and_lymphoid_tissue)	0.6286
8	90970935	90970935	G	A	NBN	intronic	.	ENSG00000104320	rs2234744	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3446	0.2845	0.353035	MU13363877	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3125,EAS:0.3413,FIN:0.3344,NFE:0.4288,OTH:0.3617,ASJ:0.2273	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(meninges)	0.3334
8	90990479	90990479	C	G	NBN	exonic	nonsynonymous SNV	ENSG00000104320	rs1805794	ENSG00000104320:ENST00000517772:exon3:c.G307C:p.E103Q,ENSG00000104320:ENST00000265433:exon5:c.G553C:p.E185Q,ENSG00000104320:ENST00000409330:exon5:c.G307C:p.E103Q	NBN:NM_002485:exon5:c.G553C:p.E185Q,NBN:NM_001024688:exon6:c.G307C:p.E103Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3453	0.2866	0.357029	1(haematopoietic_and_lymphoid_tissue)	0.367	6.326	1.0	3.08	0.980	.	.	BRCT domain;SMAD/FHA domain	NBN:uc003yej.1:exon5:c.G553C:p.E185Q,NBN:uc011lgb.1:exon5:c.G553C:p.E185Q,NBN:uc003yei.1:exon6:c.G307C:p.E103Q	-0.961	AFR:9(meninges),AMR:2(lung),EAS:MU117841,FIN:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,NFE:0.3143,OTH:0.2339,ASJ:1(stomach)	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	0.0	0.43	0.000	-1.225	8	1(thyroid)	0.3434
8	90995019	90995019	C	T	NBN	exonic	synonymous SNV	ENSG00000104320	rs1063045	ENSG00000104320:ENST00000265433:exon2:c.G102A:p.L34L,ENSG00000104320:ENST00000519426:exon2:c.G102A:p.L34L,ENSG00000104320:ENST00000523444:exon2:c.G102A:p.L34L,ENSG00000104320:ENST00000396252:exon4:c.G102A:p.L34L	NBN:NM_002485:exon2:c.G102A:p.L34L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3527	0.3132	0.379193	9(meninges)	.	.	.	.	.	.	.	.	NBN:uc003yej.1:exon2:c.G102A:p.L34L,NBN:uc011lgb.1:exon2:c.G102A:p.L34L	.	AFR:1(large_intestine),AMR:MU117860,EAS:0.3349,FIN:0.3063,NFE:0.3501,OTH:0.3367,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	602667	251260;609135;613065;	513;88;647;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~647|AT V1<br>Ataxia-telangiectasia, variant 1<br>Berlin breakage syndrome<br>Immunodeficiency-microcephaly-chromosomal instability syndrome<br>Microcephaly-immunodeficiency-lymphoreticuloma syndrome<br>NBS<br>Seemanova syndrome type 2|Unknown|Autosomal recessive|Infancy<br>Neonatal|251260 ~	.	.	.	.	.	.	.	.	8	1(stomach)	0.4271
8	93004018	93004018	G	A	RUNX1T1	exonic	synonymous SNV	ENSG00000079102	rs73306020	ENSG00000079102:ENST00000422361:exon5:c.C729T:p.N243N,ENSG00000079102:ENST00000265814:exon6:c.C840T:p.N280N,ENSG00000079102:ENST00000360348:exon6:c.C729T:p.N243N,ENSG00000079102:ENST00000396218:exon6:c.C759T:p.N253N,ENSG00000079102:ENST00000436581:exon6:c.C873T:p.N291N,ENSG00000079102:ENST00000520724:exon6:c.C729T:p.N243N,ENSG00000079102:ENST00000523629:exon7:c.C840T:p.N280N,ENSG00000079102:ENST00000518844:exon10:c.C759T:p.N253N	RUNX1T1:NM_175636:exon5:c.C729T:p.N243N,RUNX1T1:NM_001198633:exon6:c.C780T:p.N260N,RUNX1T1:NM_001198634:exon6:c.C873T:p.N291N,RUNX1T1:NM_004349:exon6:c.C759T:p.N253N,RUNX1T1:NM_175635:exon6:c.C729T:p.N243N,RUNX1T1:NM_001198628:exon7:c.C840T:p.N280N,RUNX1T1:NM_001198629:exon7:c.C840T:p.N280N,RUNX1T1:NM_001198631:exon7:c.C840T:p.N280N,RUNX1T1:NM_001198632:exon7:c.C759T:p.N253N,RUNX1T1:NM_001198679:exon7:c.C1017T:p.N339N,RUNX1T1:NM_175634:exon7:c.C840T:p.N280N,RUNX1T1:NM_001198626:exon8:c.C840T:p.N280N,RUNX1T1:NM_001198630:exon8:c.C840T:p.N280N,RUNX1T1:NM_001198627:exon9:c.C840T:p.N280N,RUNX1T1:NM_001198625:exon10:c.C759T:p.N253N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0006	0.0031	0.00239617	.	.	.	.	.	.	.	.	.	RUNX1T1:uc003yfb.2:exon5:c.C729T:p.N243N,RUNX1T1:uc003yfc.2:exon6:c.C759T:p.N253N,RUNX1T1:uc003yfe.2:exon6:c.C729T:p.N243N,RUNX1T1:uc011lgi.2:exon6:c.C873T:p.N291N,RUNX1T1:uc022axu.1:exon6:c.C780T:p.N260N,RUNX1T1:uc010mam.3:exon7:c.C759T:p.N253N,RUNX1T1:uc022axo.1:exon7:c.C840T:p.N280N,RUNX1T1:uc022axr.1:exon7:c.C840T:p.N280N,RUNX1T1:uc022axs.1:exon7:c.C1017T:p.N339N,RUNX1T1:uc022axt.1:exon7:c.C840T:p.N280N,RUNX1T1:uc022axv.1:exon7:c.C840T:p.N280N,RUNX1T1:uc003yfd.3:exon8:c.C840T:p.N280N,RUNX1T1:uc022axq.1:exon8:c.C840T:p.N280N,RUNX1T1:uc022axp.1:exon9:c.C840T:p.N280N,RUNX1T1:uc010mao.3:exon10:c.C759T:p.N253N	.	AFR:0.0019,AMR:0.0064,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0.0012	133435	.	.	.	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	8	1(upper_aerodigestive_tract)	0.0010
8	102505658	102505670	CCCTCCCCCGCCT	-	GRHL2	intronic	.	ENSG00000083307	rs145209173	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.8018	.	.	.	.	.	.	.	.	.	.	AFR:0.5719,AMR:0.7888,EAS:0.6440,FIN:0.9188,NFE:0.9198,OTH:0.8755,ASJ:0.8741	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102505705	102505705	A	G	GRHL2	intronic	.	ENSG00000083307	rs581752	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.734824	0.8146	.	.	.	.	.	.	.	.	.	.	AFR:0.5949,AMR:0.7978,EAS:0.6573,FIN:0.9207,NFE:0.9266,OTH:0.8844,ASJ:0.8709	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	unknown
8	102505722	102505722	G	-	GRHL2	intronic	.	ENSG00000083307	rs35836856	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.730831	0.8068	.	.	.	.	.	.	.	.	.	.	AFR:0.5759,AMR:0.7928,EAS:0.6508,FIN:0.9198,NFE:0.9252,OTH:0.8835,ASJ:0.8709	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	unknown
8	102505996	102505996	G	T	GRHL2	intronic	.	ENSG00000083307	rs688757	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.6873	0.7719	.	.	.	.	.	.	.	.	.	.	AFR:0.4513,AMR:0.7824,EAS:0.6555,FIN:0.9197,NFE:0.9262,OTH:0.8830,ASJ:0.8733	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102506074	102506074	T	C	GRHL2	intronic	.	ENSG00000083307	rs688324	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.732228	0.8082	.	.	.	.	.	.	.	.	.	.	AFR:0.5793,AMR:0.7930,EAS:0.6554,FIN:0.9192,NFE:0.9263,OTH:0.8840,ASJ:0.8667	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102506093	102506093	C	T	GRHL2	intronic	.	ENSG00000083307	rs560407	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.374601	0.5084	.	.	.	.	.	.	.	.	.	.	AFR:0.1782,AMR:0.4303,EAS:0.2469,FIN:0.6637,NFE:0.6885,OTH:0.6033,ASJ:0.7215	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	MU80998021	het
8	102506265	102506265	C	T	GRHL2	intronic	.	ENSG00000083307	rs561484	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.729832	0.8074	.	.	.	.	.	.	.	.	.	.	AFR:0.5765,AMR:0.7924,EAS:0.6570,FIN:0.9194,NFE:0.9258,OTH:0.8850,ASJ:0.8676	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	102506321	102506321	G	A	GRHL2	intronic	.	ENSG00000083307	rs562319	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.730431	0.8075	.	.	.	.	.	.	.	.	.	.	AFR:0.5774,AMR:0.7924,EAS:0.6573,FIN:0.9193,NFE:0.9258,OTH:0.8855,ASJ:0.8667	608576	608641;616029;	423454;90635;	423454|Ectodermal dysplasia-short stature syndrome<br>Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome|<1 / 1 000 000|Autosomal recessive|Infancy|616029 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	8	.	hom
8	103220351	103220351	A	G	RRM2B	UTR3	.	ENSG00000048392	rs1265117	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9999	0.9999	1	1.0000	.	.	.	.	.	.	.	.	.	.	AFR:0.9999,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	604712	612075;613077;	254892;254803;255235;298;	254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~254803|mtDNA depletion syndrome, encephalomyopathic form|-|Autosomal recessive|Infancy<br>Neonatal|612073 612075 ~255235|mtDNA depletion syndrome, encephalomyopathic form with renal tubulopathy|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612075 ~298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	.	.	.	.	8	MU81854103	hom
8	103225125	103225125	G	T	RRM2B	intronic	.	ENSG00000048392	rs376542259	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 0, 0] 	0.0097	7.7e-05	0.0145767	0.0002	.	.	.	.	.	0.0001	0.028	.	.	.	AFR:0.0001,AMR:0,EAS:0,FIN:0.0003,NFE:6.684e-05,OTH:0.0031,ASJ:0	604712	612075;613077;	254892;254803;255235;298;	254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~254803|mtDNA depletion syndrome, encephalomyopathic form|-|Autosomal recessive|Infancy<br>Neonatal|612073 612075 ~255235|mtDNA depletion syndrome, encephalomyopathic form with renal tubulopathy|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612075 ~298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	.	.	.	.	8	.	het
8	103250775	103250775	G	C	RRM2B	intronic	.	ENSG00000048392	rs1037700	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0591	.	0.0515176	0.0737	.	.	.	.	.	.	.	.	.	.	AFR:0.0705,AMR:0.0573,EAS:0.0173,FIN:0.0615,NFE:0.0850,OTH:0.0751,ASJ:0.0894	604712	612075;613077;	254892;254803;255235;298;	254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~254803|mtDNA depletion syndrome, encephalomyopathic form|-|Autosomal recessive|Infancy<br>Neonatal|612073 612075 ~255235|mtDNA depletion syndrome, encephalomyopathic form with renal tubulopathy|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612075 ~298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	.	.	.	.	8	MU113474830	het
8	103250839	103250839	-	G	RRM2B	exonic	frameshift insertion	ENSG00000048392	rs5893603	UNKNOWN	RRM2B:NM_001172477:exon1:c.211dupC:p.R71fs	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0531	.	0.0513179	0.0736	.	.	.	.	.	.	.	.	RRM2B:uc022azl.1:exon1:c.211dupC:p.R71fs	.	AFR:0.0712,AMR:0.0585,EAS:0.0173,FIN:0.0616,NFE:0.0845,OTH:0.0739,ASJ:0.0828	604712	612075;613077;	254892;254803;255235;298;	254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~254803|mtDNA depletion syndrome, encephalomyopathic form|-|Autosomal recessive|Infancy<br>Neonatal|612073 612075 ~255235|mtDNA depletion syndrome, encephalomyopathic form with renal tubulopathy|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612075 ~298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	.	.	.	.	8	.	het
8	103250930	103250930	C	T	RRM2B	exonic	nonsynonymous SNV	ENSG00000048392	rs1037699	UNKNOWN	RRM2B:NM_001172477:exon1:c.G121A:p.A41T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1295	.	0.0513179	0.0734	.	.	.	.	.	.	.	.	RRM2B:uc022azl.1:exon1:c.G121A:p.A41T	.	AFR:0.0702,AMR:0.0586,EAS:0.0173,FIN:0.0617,NFE:0.0845,OTH:0.0746,ASJ:0.0828	604712	612075;613077;	254892;254803;255235;298;	254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~254803|mtDNA depletion syndrome, encephalomyopathic form|-|Autosomal recessive|Infancy<br>Neonatal|612073 612075 ~255235|mtDNA depletion syndrome, encephalomyopathic form with renal tubulopathy|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|612075 ~298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	.	.	.	.	8	.	het
8	103306033	103306033	T	C	UBR5	exonic	synonymous SNV	ENSG00000104517	rs16869352	ENSG00000104517:ENST00000220959:exon34:c.A4389G:p.V1463V,ENSG00000104517:ENST00000520539:exon34:c.A4389G:p.V1463V,ENSG00000104517:ENST00000521922:exon34:c.A4371G:p.V1457V	UBR5:NM_001282873:exon34:c.A4389G:p.V1463V,UBR5:NM_015902:exon34:c.A4389G:p.V1463V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0517	0.0483	0.024361	0.0483	.	.	.	.	.	.	.	.	UBR5:uc003ykr.2:exon34:c.A4389G:p.V1463V,UBR5:uc003yks.2:exon34:c.A4389G:p.V1463V	.	AFR:0.0104,AMR:0.0477,EAS:0.0167,FIN:0.0369,NFE:0.0754,OTH:0.0612,ASJ:0.0596	608413	.	.	.	.	.	.	.	.	.	.	.	8	.	het
8	108970367	108970367	A	G	RSPO2	exonic	nonsynonymous SNV	ENSG00000147655	rs601558	ENSG00000147655:ENST00000378439:exon4:c.T365C:p.L122P,ENSG00000147655:ENST00000517781:exon4:c.T365C:p.L122P,ENSG00000147655:ENST00000517939:exon4:c.T356C:p.L119P,ENSG00000147655:ENST00000521502:exon4:c.T356C:p.L119P,ENSG00000147655:ENST00000276659:exon5:c.T557C:p.L186P	RSPO2:NM_001282863:exon4:c.T365C:p.L122P,RSPO2:NM_001317942:exon4:c.T356C:p.L119P,RSPO2:NM_178565:exon5:c.T557C:p.L186P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5784	0.4729	0.490216	COCA-CN|6|321|0.0186916	2.545	19.76	0.655	4.95	0.759	.	.	Growth factor receptor cysteine-rich domain	RSPO2:uc003ymq.3:exon4:c.T356C:p.L119P,RSPO2:uc003ymr.3:exon4:c.T365C:p.L122P,RSPO2:uc003yms.3:exon5:c.T557C:p.L186P	-0.958	AFR:0.4824,AMR:0.1523,EAS:0.5894,FIN:0.7177,NFE:0.5967,OTH:0.6087,ASJ:0.6145	610575	.	.	.	.	.	.	.	0.0	-0.89	0.000	-1.44	8	1(large_intestine)	0.5543
8	109094747	109094747	C	T	RSPO2	intronic	.	ENSG00000147655	rs10955475	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2121	0.1575	0.195088	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.1799,AMR:0.0557,EAS:0.1854,FIN:0.4333,NFE:0.2109,OTH:0.2170,ASJ:0.1563	610575	.	.	.	.	.	.	.	.	.	.	.	8	1(biliary_tract)	0.2098
8	117864217	117864217	A	G	RAD21	exonic	synonymous SNV	ENSG00000164754	rs1050838	ENSG00000164754:ENST00000518055:exon1:c.T75C:p.A25A,ENSG00000164754:ENST00000297338:exon11:c.T1440C:p.A480A	RAD21:NM_006265:exon11:c.T1440C:p.A480A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.1728	0.1241	0.133187	1(large_intestine)	.	.	.	.	.	.	.	.	RAD21:uc003yod.3:exon11:c.T1440C:p.A480A	.	AFR:MU134726,AMR:LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,EAS:0.0303,FIN:0.2363,NFE:0.2450,OTH:0.1735,ASJ:0.1372	606462	614701;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	9365,	.	.	.	.	.	.	8	8(soft_tissue)	0.1703
8	117868532	117868532	A	-	RAD21	intronic	.	ENSG00000164754	rs35902828	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0313	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606462	614701;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	8	.	het
8	128751201	128751201	G	A	MYC	exonic	synonymous SNV	ENSG00000136997	rs2070582	ENSG00000136997:ENST00000259523:exon2:c.G693A:p.P231P,ENSG00000136997:ENST00000377970:exon2:c.G738A:p.P246P,ENSG00000136997:ENST00000524013:exon2:c.G735A:p.P245P	MYC:NM_001354870:exon2:c.G735A:p.P245P,MYC:NM_002467:exon2:c.G738A:p.P246P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0423	0.0384	0.0625	3(lung)	.	.	.	.	.	.	.	.	MYC:uc003ysi.3:exon2:c.G738A:p.P246P,MYC:uc022bbe.1:exon2:c.G693A:p.P231P	.	AFR:MU22359263,AMR:LUSC-KR|3|170|0.0176471,EAS:0.0840,FIN:0.0095,NFE:0.0795,OTH:0.0716,ASJ:0.0478	190080	113970;	543;	543|Small non-cleaved cell lymphoma|Unknown|Not applicable|All ages|113970 ~	~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04110 Cell cycle~ko04151 PI3K-Akt signaling pathway~ko04218 Cellular senescence~ko04310 Wnt signaling pathway~ko04350 TGF-beta signaling pathway~ko04390 Hippo signaling pathway~ko04391 Hippo signaling pathway - fly~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	8	4(prostate)	0.0625
8	134292516	134292516	A	G	NDRG1	intronic	.	ENSG00000104419	rs2272653	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5635	0.6678	0.613419	0.6519	.	.	.	.	.	0	0	.	.	.	AFR:0.8639,AMR:0.4952,EAS:0.4506,FIN:0.5755,NFE:0.5806,OTH:0.5906,ASJ:0.66	605262	601455;	99950;	99950|CMT4D<br>HMSN, Lom type<br>HMSN-Lom<br>Hereditary motor and sensory neuropathy, Lom type|Unknown|Autosomal recessive|Childhood<br>Adolescent|601455 ~	.	.	.	.	.	.	.	.	8	MU13169204	het
8	145004546	145004546	G	A	PLEC	intronic	.	ENSG00000178209	rs11780911	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7411	0.6988	0.571885	0.6622	.	.	.	.	.	0	0.004	.	.	.	AFR:0.3862,AMR:0.6411,EAS:0.6188,FIN:0.7603,NFE:0.7994,OTH:0.7162,ASJ:0.78	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	MU81858392	hom
8	145011201	145011201	G	A	PLEC	exonic	synonymous SNV	ENSG00000178209	rs185041864	ENSG00000178209:ENST00000322810:exon5:c.C792T:p.D264D,ENSG00000178209:ENST00000345136:exon5:c.C381T:p.D127D,ENSG00000178209:ENST00000354589:exon5:c.C381T:p.D127D,ENSG00000178209:ENST00000354958:exon5:c.C315T:p.D105D,ENSG00000178209:ENST00000356346:exon5:c.C339T:p.D113D,ENSG00000178209:ENST00000357649:exon5:c.C393T:p.D131D,ENSG00000178209:ENST00000398774:exon5:c.C285T:p.D95D,ENSG00000178209:ENST00000526416:exon5:c.C312T:p.D104D,ENSG00000178209:ENST00000527096:exon5:c.C462T:p.D154D,ENSG00000178209:ENST00000527816:exon5:c.C99T:p.D33D,ENSG00000178209:ENST00000528131:exon5:c.C432T:p.D144D,ENSG00000178209:ENST00000436759:exon6:c.C462T:p.D154D,ENSG00000178209:ENST00000528025:exon7:c.C513T:p.D171D	PLEC:NM_201378:exon5:c.C339T:p.D113D,PLEC:NM_201379:exon5:c.C315T:p.D105D,PLEC:NM_201380:exon5:c.C792T:p.D264D,PLEC:NM_201381:exon5:c.C285T:p.D95D,PLEC:NM_201382:exon5:c.C381T:p.D127D,PLEC:NM_201383:exon5:c.C393T:p.D131D,PLEC:NM_201384:exon5:c.C381T:p.D127D,PLEC:NM_000445:exon6:c.C462T:p.D154D	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	2.508e-05	0.0002	0.000199681	6.472e-05	.	.	.	.	.	.	.	.	PLEC:uc003zab.1:exon5:c.C381T:p.D127D,PLEC:uc003zac.1:exon5:c.C393T:p.D131D,PLEC:uc003zad.2:exon5:c.C381T:p.D127D,PLEC:uc003zae.1:exon5:c.C285T:p.D95D,PLEC:uc003zaf.1:exon5:c.C792T:p.D264D,PLEC:uc003zag.1:exon5:c.C315T:p.D105D,PLEC:uc003zah.2:exon5:c.C339T:p.D113D,PLEC:uc003zaj.2:exon6:c.C462T:p.D154D	.	AFR:0.0001,AMR:0.0012,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	601282	131950;226670;612138;613723;616487;	254361;158684;257;79401;	254361|Autosomal recessive limb-girdle muscular dystrophy due to plectin deficiency<br>LGMD2Q|<1 / 1 000 000|Autosomal recessive|Childhood|613723 ~158684|EBS-PA|Unknown|Autosomal recessive|Neonatal|612138 ~257|EBS-MD<br>Limb-girdle muscular dystrophy with epidermolysis bullosa simplex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|226670 ~79401|EBS-O|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|131950 ~	.	.	.	.	.	.	.	.	8	.	het
8	145737286	145737286	G	A	RECQL4	intronic	.	ENSG00000160957	rs756627	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4670	0.3500	0.400559	0.3818	-0.092	1.788	.	-1.53	0.005	0	0	.	.	.	AFR:0.1395,AMR:0.5561,EAS:0.4913,FIN:0.4966,NFE:0.4678,OTH:0.4795,ASJ:0.4040	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU684944	het
8	145737514	145737514	G	A	RECQL4	intronic	.	ENSG00000160957	rs4244610	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5063	0.3932	0.433307	0.4144	.	.	.	.	.	.	.	.	.	.	AFR:0.2530,AMR:0.5692,EAS:0.4672,FIN:0.4969,NFE:0.4705,OTH:0.4846,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU27648814	het
8	145737636	145737636	A	G	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs4925828	ENSG00000160957:ENST00000428558:exon19:c.T3127C:p.L1043L	RECQL4:NM_004260:exon19:c.T3127C:p.L1043L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9728	0.9984	0.946086	0.9838	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon19:c.T3127C:p.L1043L	.	AFR:0.9944,AMR:0.9224,EAS:0.7879,FIN:0.9960,NFE:0.9989,OTH:0.9878,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU4561850	hom
8	145737816	145737816	C	T	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs4251691	ENSG00000160957:ENST00000428558:exon18:c.G3014A:p.R1005Q	RECQL4:NM_004260:exon18:c.G3014A:p.R1005Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4612	0.3419	0.384385	0.3717	2.434	19.04	.	0.281	0.015	.	.	.	RECQL4:uc003zdj.3:exon18:c.G3014A:p.R1005Q	.	AFR:0.1265,AMR:0.5502,EAS:0.4412,FIN:0.4940,NFE:0.4624,OTH:0.4703,ASJ:0.3642	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	0.035	.	.	0.815	8	MU73030	het
8	145738582	145738582	G	-	RECQL4	intronic	.	ENSG00000265393	rs768353485	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0113	.	.	0.1002	.	.	.	.	.	.	.	.	.	.	AFR:0.2236,AMR:0.0728,EAS:0.0548,FIN:0.0586,NFE:0.0456,OTH:0.0512,ASJ:0.0577	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	.	het
8	145738768	145738768	G	-	RECQL4	splicing	.	ENSG00000160957;ENSG00000160957	rs11342077	ENSG00000160957:ENST00000428558:exon15:c.2296delC:p.R766fs	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9999	.	1	0.9999	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon15:c.2296delC:p.R766fs	.	AFR:1,AMR:1,EAS:1,FIN:0.9997,NFE:0.9999,OTH:1,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	.	hom
8	145739924	145739924	G	A	RECQL4	intronic	.	ENSG00000160957	rs4244611	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4802	0.3505	0.394569	0.3814	.	.	.	.	.	.	.	.	.	.	AFR:0.1378,AMR:0.5549,EAS:0.4703,FIN:0.4991,NFE:0.4696,OTH:0.4784,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU654936	het
8	145741130	145741130	C	T	RECQL4	intronic	.	ENSG00000160957	rs4251689	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4716	0.3650	0.400958	0.3905	.	.	.	.	.	.	.	.	.	.	AFR:0.1768,AMR:0.5549,EAS:0.4689,FIN:0.4966,NFE:0.4669,OTH:0.4775,ASJ:0.4073	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU18988417	het
8	145741702	145741702	C	G	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs4244612	ENSG00000160957:ENST00000428558:exon5:c.G801C:p.E267D	RECQL4:NM_004260:exon5:c.G801C:p.E267D	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4377	0.3919	0.447684	0.4191	-0.697	0.073	.	-2.99	0.000	.	.	.	RECQL4:uc003zdj.3:exon5:c.G801C:p.E267D	.	AFR:0.4289,AMR:0.5119,EAS:0.4586,FIN:0.4195,NFE:0.4052,OTH:0.4097,ASJ:0.3775	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	0.002	.	.	.	8	MU69391	het
8	145741765	145741765	G	A	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs4244613	ENSG00000160957:ENST00000428558:exon5:c.C738T:p.S246S	RECQL4:NM_004260:exon5:c.C738T:p.S246S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4394	0.3392	0.370008	0.3683	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon5:c.C738T:p.S246S	.	AFR:0.1637,AMR:0.5096,EAS:0.4592,FIN:0.4857,NFE:0.4376,OTH:0.4530,ASJ:0.34	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU78580	het
8	145742514	145742514	A	G	RECQL4	exonic	nonsynonymous SNV	ENSG00000160957	rs2721190	ENSG00000160957:ENST00000428558:exon4:c.T274C:p.S92P	RECQL4:NM_004260:exon4:c.T274C:p.S92P	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9733	0.9952	0.943291	0.9815	-1.106	0.010	.	1.99	0.000	.	.	.	RECQL4:uc003zdj.3:exon4:c.T274C:p.S92P	.	AFR:0.9837,AMR:0.9224,EAS:0.8006,FIN:0.9960,NFE:0.999,OTH:0.9857,ASJ:1	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU4561873	hom
8	145742879	145742879	T	C	RECQL4	exonic	synonymous SNV	ENSG00000160957	rs2306386	ENSG00000160957:ENST00000428558:exon3:c.A132G:p.E44E	RECQL4:NM_004260:exon3:c.A132G:p.E44E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5552	0.5507	0.57508	0.5372	.	.	.	.	.	.	.	.	RECQL4:uc003zdj.3:exon3:c.A132G:p.E44E	.	AFR:0.6164,AMR:0.6533,EAS:0.4931,FIN:0.5158,NFE:0.4973,OTH:0.5164,ASJ:0.4603	603780	218600;266280;268400;	2909;3021;1225;	2909|Poikiloderma of Rothmund-Thomson<br>RTS|Unknown|Autosomal recessive|Infancy<br>Neonatal|268400 ~3021|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|266280 ~1225|-|<1 / 1 000 000|Autosomal recessive|Neonatal|218600 ~	.	.	.	.	.	.	.	.	8	MU73049	het
9	271638	271638	C	T	DOCK8	exonic	nonsynonymous SNV	ENSG00000107099	rs506121	ENSG00000107099:ENST00000453981:exon2:c.C65T:p.A22V,ENSG00000107099:ENST00000469197:exon2:c.C65T:p.A22V	DOCK8:NM_203447:exon2:c.C65T:p.A22V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3245	0.3189	0.307708	ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579	4.843	24.8	.	4.05	0.971	.	.	.	DOCK8:uc003zgf.2:exon2:c.C65T:p.A22V,DOCK8:uc011lls.1:exon2:c.C65T:p.A22V	-0.952	AFR:0.3393,AMR:0.2787,EAS:0.2384,FIN:0.4333,NFE:0.4020,OTH:0.3550,ASJ:0.2703	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	0.001	.	0.000	2.325	9	2(haematopoietic_and_lymphoid_tissue)	0.35
9	328006	328006	T	C	DOCK8	intronic	.	ENSG00000107099	rs2296828	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6886	0.6684	0.695887	LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6703,AMR:0.6491,EAS:0.5331,FIN:0.7367,NFE:0.6710,OTH:0.6803,ASJ:0.6504	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(lung)	0.6531
9	368030	368030	T	C	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs10972587	ENSG00000107099:ENST00000469391:exon14:c.T1488C:p.Y496Y,ENSG00000107099:ENST00000432829:exon15:c.T1488C:p.Y496Y,ENSG00000107099:ENST00000453981:exon15:c.T1692C:p.Y564Y	DOCK8:NM_001190458:exon14:c.T1488C:p.Y496Y,DOCK8:NM_001193536:exon14:c.T1488C:p.Y496Y,DOCK8:NM_203447:exon15:c.T1692C:p.Y564Y	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0627	0.1482	0.130192	0.1283	.	.	.	.	.	.	.	.	DOCK8:uc010mgv.3:exon14:c.T1488C:p.Y496Y,DOCK8:uc022bcu.1:exon14:c.T1488C:p.Y496Y,DOCK8:uc003zgf.2:exon15:c.T1692C:p.Y564Y	.	AFR:0.3658,AMR:0.0490,EAS:0,FIN:0.0238,NFE:0.0404,OTH:0.0387,ASJ:0.0629	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	.	het
9	386414	386414	A	T	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs117610764	ENSG00000107099:ENST00000382331:exon9:c.A768T:p.P256P,ENSG00000107099:ENST00000382329:exon10:c.A1263T:p.P421P,ENSG00000107099:ENST00000432829:exon23:c.A2658T:p.P886P,ENSG00000107099:ENST00000453981:exon23:c.A2862T:p.P954P	DOCK8:NM_001193536:exon22:c.A2658T:p.P886P,DOCK8:NM_203447:exon23:c.A2862T:p.P954P	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0] 	0.0090	0.0066	0.0061901	0.0055	.	.	.	.	.	.	.	.	DOCK8:uc010mgw.2:exon9:c.A768T:p.P256P,DOCK8:uc003zgk.2:exon10:c.A1236T:p.P412P,DOCK8:uc010mgu.3:exon21:c.A768T:p.P256P,DOCK8:uc022bcu.1:exon22:c.A2658T:p.P886P,DOCK8:uc003zgf.2:exon23:c.A2862T:p.P954P	.	AFR:0.0010,AMR:0.0012,EAS:0,FIN:0.0049,NFE:0.0087,OTH:0.0051,ASJ:0.0199	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	.	het
9	399275	399275	-	C	DOCK8	intronic	.	ENSG00000107099	rs3831174	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2634	0.2666	.	0.3747	.	.	.	.	.	.	.	.	.	.	AFR:0.4678,AMR:0.3664,EAS:0.3310,FIN:0.3573,NFE:0.3246,OTH:0.3435,ASJ:0.1429	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	.	het
9	421032	421032	C	G	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs2297079	ENSG00000107099:ENST00000382329:exon19:c.C2508G:p.L836L,ENSG00000107099:ENST00000469391:exon30:c.C3807G:p.L1269L,ENSG00000107099:ENST00000432829:exon32:c.C3903G:p.L1301L,ENSG00000107099:ENST00000453981:exon32:c.C4107G:p.L1369L	DOCK8:NM_001190458:exon30:c.C3807G:p.L1269L,DOCK8:NM_001193536:exon31:c.C3903G:p.L1301L,DOCK8:NM_203447:exon32:c.C4107G:p.L1369L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5094	0.4626	0.391773	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon19:c.C2481G:p.L827L,DOCK8:uc010mgu.3:exon30:c.C2013G:p.L671L,DOCK8:uc010mgv.3:exon30:c.C3807G:p.L1269L,DOCK8:uc022bcu.1:exon31:c.C3903G:p.L1301L,DOCK8:uc003zgf.2:exon32:c.C4107G:p.L1369L	.	AFR:0.4491,AMR:0.1521,EAS:0.4801,FIN:0.5155,NFE:0.4814,OTH:0.6050,ASJ:0.4354	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.4837
9	429719	429719	T	C	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs7854035	ENSG00000107099:ENST00000382329:exon23:c.T2892C:p.F964F,ENSG00000107099:ENST00000469391:exon34:c.T4191C:p.F1397F,ENSG00000107099:ENST00000432829:exon36:c.T4287C:p.F1429F,ENSG00000107099:ENST00000453981:exon36:c.T4491C:p.F1497F	DOCK8:NM_001190458:exon34:c.T4191C:p.F1397F,DOCK8:NM_001193536:exon35:c.T4287C:p.F1429F,DOCK8:NM_203447:exon36:c.T4491C:p.F1497F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9978	0.9968	0.999401	0.9979	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon23:c.T2865C:p.F955F,DOCK8:uc010mgu.3:exon34:c.T2397C:p.F799F,DOCK8:uc010mgv.3:exon34:c.T4191C:p.F1397F,DOCK8:uc022bcu.1:exon35:c.T4287C:p.F1429F,DOCK8:uc003zgf.2:exon36:c.T4491C:p.F1497F	.	AFR:0.9993,AMR:0.9928,EAS:1,FIN:0.9997,NFE:0.9965,OTH:1,ASJ:1	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859376	hom
9	432330	432330	C	G	DOCK8	intronic	.	ENSG00000107099	rs7036567	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7577	0.6692	0.714257	0.7017	.	.	.	.	.	0.0001	0.042	.	.	.	AFR:0.4865,AMR:0.8305,EAS:0.9870,FIN:0.8003,NFE:0.7628,OTH:0.7351,ASJ:0.7417	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859387	het
9	433978	433978	A	G	DOCK8	intronic	.	ENSG00000107099	rs2360712	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7588	0.6749	0.721046	0.7071	.	.	.	.	.	0.0041	0.204	.	.	.	AFR:0.5078,AMR:0.8313,EAS:0.9871,FIN:0.7994,NFE:0.7610,OTH:0.7383,ASJ:0.7417	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU81859414	het
9	441952	441952	G	A	DOCK8	exonic	synonymous SNV	ENSG00000107099	rs1887957	ENSG00000107099:ENST00000382329:exon29:c.G3834A:p.E1278E,ENSG00000107099:ENST00000469391:exon40:c.G5133A:p.E1711E,ENSG00000107099:ENST00000432829:exon42:c.G5229A:p.E1743E,ENSG00000107099:ENST00000453981:exon42:c.G5433A:p.E1811E	DOCK8:NM_001190458:exon40:c.G5133A:p.E1711E,DOCK8:NM_001193536:exon41:c.G5229A:p.E1743E,DOCK8:NM_203447:exon42:c.G5433A:p.E1811E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8201	0.7429	0.803914	0.7641	.	.	.	.	.	.	.	.	DOCK8:uc003zgk.2:exon29:c.G3807A:p.E1269E,DOCK8:uc010mgu.3:exon40:c.G3339A:p.E1113E,DOCK8:uc010mgv.3:exon40:c.G5133A:p.E1711E,DOCK8:uc022bcu.1:exon41:c.G5229A:p.E1743E,DOCK8:uc003zgf.2:exon42:c.G5433A:p.E1811E	.	AFR:0.5880,AMR:0.8795,EAS:0.9981,FIN:0.8293,NFE:0.8162,OTH:0.8020,ASJ:0.8013	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU4566310	hom
9	446352	446352	G	C	DOCK8	intronic	.	ENSG00000107099	rs10814952	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6887	0.5583	0.632987	0.5990	.	.	.	.	.	.	.	.	.	.	AFR:0.2953,AMR:0.7852,EAS:0.9858,FIN:0.7018,NFE:0.6930,OTH:0.6837,ASJ:0.6457	611432	243700;	217390;	217390|CID due to DOCK8 deficiency<br>Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency<br>DOCK8 immunodeficiency syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243700 ~	.	.	.	.	.	.	.	.	9	MU32516518	hom
9	712060	712060	G	C	KANK1	exonic	nonsynonymous SNV	ENSG00000107104	rs4465020	ENSG00000107104:ENST00000382293:exon2:c.G820C:p.E274Q,ENSG00000107104:ENST00000382297:exon3:c.G1294C:p.E432Q,ENSG00000107104:ENST00000382303:exon7:c.G1294C:p.E432Q	KANK1:NM_001354335:exon2:c.G820C:p.E274Q,KANK1:NM_001354336:exon2:c.G820C:p.E274Q,KANK1:NM_001354337:exon2:c.G820C:p.E274Q,KANK1:NM_001354338:exon2:c.G820C:p.E274Q,KANK1:NM_001354339:exon2:c.G820C:p.E274Q,KANK1:NM_001354340:exon2:c.G820C:p.E274Q,KANK1:NM_001354341:exon2:c.G820C:p.E274Q,KANK1:NM_001354342:exon2:c.G820C:p.E274Q,KANK1:NM_001354343:exon2:c.G820C:p.E274Q,KANK1:NM_001354344:exon2:c.G820C:p.E274Q,KANK1:NM_153186:exon2:c.G820C:p.E274Q,KANK1:NM_001354331:exon3:c.G1294C:p.E432Q,KANK1:NM_001354332:exon3:c.G1294C:p.E432Q,KANK1:NM_001354333:exon3:c.G820C:p.E274Q,KANK1:NM_015158:exon3:c.G1294C:p.E432Q,KANK1:NM_001256877:exon4:c.G1294C:p.E432Q,KANK1:NM_001354334:exon4:c.G1294C:p.E432Q,KANK1:NM_001256876:exon7:c.G1294C:p.E432Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3392	0.2880	0.235224	0.2889	-0.550	0.166	0.093	4.81	0.013	.	.	.	KANK1:uc003zgq.2:exon2:c.G820C:p.E274Q,KANK1:uc003zgr.1:exon2:c.G820C:p.E274Q,KANK1:uc003zgs.2:exon2:c.G820C:p.E274Q,KANK1:uc003zgm.4:exon3:c.G1294C:p.E432Q,KANK1:uc003zgn.2:exon3:c.G1294C:p.E432Q,KANK1:uc003zgo.1:exon3:c.G1294C:p.E432Q,KANK1:uc003zgp.1:exon4:c.G1294C:p.E432Q,KANK1:uc031tct.1:exon4:c.G1294C:p.E432Q,KANK1:uc003zgl.2:exon7:c.G1294C:p.E432Q	-0.942	AFR:0.0792,AMR:0.2081,EAS:0.1267,FIN:0.3625,NFE:0.4079,OTH:0.3845,ASJ:0.3841	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	0.36	0.85	0.000	2.3	9	MU10850812	het
9	712599	712599	C	T	KANK1	exonic	synonymous SNV	ENSG00000107104	rs11789987	ENSG00000107104:ENST00000382293:exon2:c.C1359T:p.N453N,ENSG00000107104:ENST00000382297:exon3:c.C1833T:p.N611N,ENSG00000107104:ENST00000382303:exon7:c.C1833T:p.N611N	KANK1:NM_001354335:exon2:c.C1359T:p.N453N,KANK1:NM_001354336:exon2:c.C1359T:p.N453N,KANK1:NM_001354337:exon2:c.C1359T:p.N453N,KANK1:NM_001354338:exon2:c.C1359T:p.N453N,KANK1:NM_001354339:exon2:c.C1359T:p.N453N,KANK1:NM_001354340:exon2:c.C1359T:p.N453N,KANK1:NM_001354341:exon2:c.C1359T:p.N453N,KANK1:NM_001354342:exon2:c.C1359T:p.N453N,KANK1:NM_001354343:exon2:c.C1359T:p.N453N,KANK1:NM_001354344:exon2:c.C1359T:p.N453N,KANK1:NM_153186:exon2:c.C1359T:p.N453N,KANK1:NM_001354331:exon3:c.C1833T:p.N611N,KANK1:NM_001354332:exon3:c.C1833T:p.N611N,KANK1:NM_001354333:exon3:c.C1359T:p.N453N,KANK1:NM_015158:exon3:c.C1833T:p.N611N,KANK1:NM_001256877:exon4:c.C1833T:p.N611N,KANK1:NM_001354334:exon4:c.C1833T:p.N611N,KANK1:NM_001256876:exon7:c.C1833T:p.N611N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3486	0.3125	0.252995	0.3095	.	.	.	.	.	.	.	.	KANK1:uc003zgq.2:exon2:c.C1359T:p.N453N,KANK1:uc003zgr.1:exon2:c.C1359T:p.N453N,KANK1:uc003zgs.2:exon2:c.C1359T:p.N453N,KANK1:uc003zgm.4:exon3:c.C1833T:p.N611N,KANK1:uc003zgn.2:exon3:c.C1833T:p.N611N,KANK1:uc003zgo.1:exon3:c.C1833T:p.N611N,KANK1:uc003zgp.1:exon4:c.C1833T:p.N611N,KANK1:uc031tct.1:exon4:c.C1833T:p.N611N,KANK1:uc003zgl.2:exon7:c.C1833T:p.N611N	.	AFR:0.1373,AMR:0.2172,EAS:0.1270,FIN:0.3630,NFE:0.4153,OTH:0.3870,ASJ:0.3974	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU1788343	het
9	740771	740776	TTTTTT	-	KANK1	intronic	.	ENSG00000107104	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	.	unknown
9	740901	740901	C	T	KANK1	exonic	synonymous SNV	ENSG00000107104	rs2296049	ENSG00000107104:ENST00000382286:exon4:c.C420T:p.F140F,ENSG00000107104:ENST00000382289:exon5:c.C663T:p.F221F,ENSG00000107104:ENST00000382293:exon8:c.C3189T:p.F1063F,ENSG00000107104:ENST00000382297:exon9:c.C3663T:p.F1221F,ENSG00000107104:ENST00000382303:exon13:c.C3663T:p.F1221F	KANK1:NM_001354336:exon7:c.C2895T:p.F965F,KANK1:NM_001354339:exon7:c.C2949T:p.F983F,KANK1:NM_001354342:exon7:c.C2949T:p.F983F,KANK1:NM_001354343:exon7:c.C2949T:p.F983F,KANK1:NM_001354331:exon8:c.C3423T:p.F1141F,KANK1:NM_001354335:exon8:c.C3189T:p.F1063F,KANK1:NM_001354337:exon8:c.C3189T:p.F1063F,KANK1:NM_001354338:exon8:c.C3135T:p.F1045F,KANK1:NM_001354340:exon8:c.C3135T:p.F1045F,KANK1:NM_001354341:exon8:c.C3189T:p.F1063F,KANK1:NM_001354344:exon8:c.C3135T:p.F1045F,KANK1:NM_153186:exon8:c.C3189T:p.F1063F,KANK1:NM_001354332:exon9:c.C3609T:p.F1203F,KANK1:NM_001354333:exon9:c.C3189T:p.F1063F,KANK1:NM_015158:exon9:c.C3663T:p.F1221F,KANK1:NM_001256877:exon10:c.C3663T:p.F1221F,KANK1:NM_001354334:exon10:c.C3663T:p.F1221F,KANK1:NM_001256876:exon13:c.C3663T:p.F1221F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2418	0.2793	0.265974	0.2654	.	.	.	.	.	.	.	.	KANK1:uc003zgt.1:exon3:c.C399T:p.F133F,KANK1:uc010mgy.2:exon3:c.C399T:p.F133F,KANK1:uc010mgx.2:exon5:c.C597T:p.F199F,KANK1:uc003zgs.2:exon8:c.C3189T:p.F1063F,KANK1:uc003zgn.2:exon9:c.C3663T:p.F1221F,KANK1:uc031tct.1:exon10:c.C3663T:p.F1221F,KANK1:uc003zgl.2:exon13:c.C3663T:p.F1221F	.	AFR:0.3983,AMR:0.3732,EAS:0.2206,FIN:0.1804,NFE:0.2117,OTH:0.2086,ASJ:0.2020	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU587925	het
9	742342	742342	A	G	KANK1	exonic	synonymous SNV	ENSG00000107104	rs10733535	ENSG00000107104:ENST00000382286:exon5:c.A591G:p.G197G,ENSG00000107104:ENST00000382289:exon6:c.A834G:p.G278G,ENSG00000107104:ENST00000382293:exon9:c.A3360G:p.G1120G,ENSG00000107104:ENST00000382297:exon10:c.A3834G:p.G1278G,ENSG00000107104:ENST00000382303:exon14:c.A3834G:p.G1278G	KANK1:NM_001354336:exon8:c.A3066G:p.G1022G,KANK1:NM_001354339:exon8:c.A3120G:p.G1040G,KANK1:NM_001354342:exon8:c.A3120G:p.G1040G,KANK1:NM_001354343:exon8:c.A3120G:p.G1040G,KANK1:NM_001354331:exon9:c.A3594G:p.G1198G,KANK1:NM_001354335:exon9:c.A3360G:p.G1120G,KANK1:NM_001354337:exon9:c.A3360G:p.G1120G,KANK1:NM_001354338:exon9:c.A3306G:p.G1102G,KANK1:NM_001354340:exon9:c.A3306G:p.G1102G,KANK1:NM_001354341:exon9:c.A3360G:p.G1120G,KANK1:NM_001354344:exon9:c.A3306G:p.G1102G,KANK1:NM_153186:exon9:c.A3360G:p.G1120G,KANK1:NM_001354332:exon10:c.A3780G:p.G1260G,KANK1:NM_001354333:exon10:c.A3360G:p.G1120G,KANK1:NM_015158:exon10:c.A3834G:p.G1278G,KANK1:NM_001256877:exon11:c.A3834G:p.G1278G,KANK1:NM_001354334:exon11:c.A3834G:p.G1278G,KANK1:NM_001256876:exon14:c.A3834G:p.G1278G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9953	0.9934	0.997604	0.9934	.	.	.	.	.	.	.	.	KANK1:uc003zgt.1:exon4:c.A570G:p.G190G,KANK1:uc010mgy.2:exon4:c.A570G:p.G190G,KANK1:uc010mgx.2:exon6:c.A768G:p.G256G,KANK1:uc003zgs.2:exon9:c.A3360G:p.G1120G,KANK1:uc003zgn.2:exon10:c.A3834G:p.G1278G,KANK1:uc031tct.1:exon11:c.A3834G:p.G1278G,KANK1:uc003zgl.2:exon14:c.A3834G:p.G1278G	.	AFR:0.9989,AMR:0.9916,EAS:1,FIN:0.9989,NFE:0.9887,OTH:0.9878,ASJ:1	607704	612900;	210141;	210141|Inherited congenital spastic quadriplegia<br>Spastic quadriplegic cerebral palsy|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Unknown|Infancy<br>Neonatal|603513 612900 617008 ~	.	.	.	.	.	.	.	.	9	MU93460	hom
9	2029199	2029199	G	A	SMARCA2	exonic	synonymous SNV	ENSG00000080503	rs10964471	ENSG00000080503:ENST00000382194:exon1:c.G177A:p.T59T,ENSG00000080503:ENST00000349721:exon2:c.G177A:p.T59T,ENSG00000080503:ENST00000357248:exon2:c.G177A:p.T59T,ENSG00000080503:ENST00000382203:exon2:c.G177A:p.T59T,ENSG00000080503:ENST00000439732:exon2:c.G177A:p.T59T,ENSG00000080503:ENST00000450198:exon2:c.G177A:p.T59T,ENSG00000080503:ENST00000457226:exon2:c.G177A:p.T59T	SMARCA2:NM_001289396:exon2:c.G177A:p.T59T,SMARCA2:NM_001289397:exon2:c.G177A:p.T59T,SMARCA2:NM_003070:exon2:c.G177A:p.T59T,SMARCA2:NM_139045:exon2:c.G177A:p.T59T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1160	0.0666	0.108626	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	SMARCA2:uc003zhc.3:exon2:c.G177A:p.T59T,SMARCA2:uc003zhd.3:exon2:c.G177A:p.T59T,SMARCA2:uc010mha.3:exon2:c.G150A:p.T50T	.	AFR:0.0901,AMR:0.0267,EAS:0.0728,FIN:0.2370,NFE:0.1281,OTH:0.0999,ASJ:0.1002	600014	601358;	3051;	3051|Nicolaides-Baraitser syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601358 ~	.	.	.	.	.	.	.	.	9	1(salivary_gland)	0.1255
9	2039777	2039779	CAG	-	SMARCA2	exonic	nonframeshift deletion	ENSG00000080503	rs113070757	ENSG00000080503:ENST00000382194:exon3:c.667_669del:p.223_223del,ENSG00000080503:ENST00000349721:exon4:c.667_669del:p.223_223del,ENSG00000080503:ENST00000357248:exon4:c.667_669del:p.223_223del,ENSG00000080503:ENST00000382203:exon4:c.667_669del:p.223_223del,ENSG00000080503:ENST00000450198:exon4:c.667_669del:p.223_223del	SMARCA2:NM_001289396:exon4:c.667_669del:p.223_223del,SMARCA2:NM_001289397:exon4:c.667_669del:p.223_223del,SMARCA2:NM_003070:exon4:c.667_669del:p.223_223del,SMARCA2:NM_139045:exon4:c.667_669del:p.223_223del	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1370	.	.	0.1757	.	.	.	.	.	.	.	.	SMARCA2:uc003zhc.3:exon4:c.667_669del:p.223_223del,SMARCA2:uc003zhd.3:exon4:c.667_669del:p.223_223del,SMARCA2:uc010mha.3:exon4:c.640_642del:p.214_214del	.	AFR:0.2292,AMR:0.1975,EAS:0.3649,FIN:0.1898,NFE:0.1231,OTH:0.1628,ASJ:0.07	600014	601358;	3051;	3051|Nicolaides-Baraitser syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601358 ~	.	.	.	.	.	.	.	.	9	MU90238	het
9	2191246	2191246	T	C	SMARCA2	intronic	.	ENSG00000080503	rs3818384	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1010	0.1697	0.167332	MU13443565	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|3|402|0.00746269,COCA-CN|2|321|0.00623053,AMR:0.1487,EAS:0.0716,FIN:0.0762,NFE:0.1636,OTH:0.0687,ASJ:0.3177	600014	601358;	3051;	3051|Nicolaides-Baraitser syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601358 ~	.	.	.	.	.	.	.	.	9	20(meninges)	0.0780
9	2191309	2191309	C	G	SMARCA2	exonic	nonsynonymous SNV	ENSG00000080503	rs2296212	ENSG00000080503:ENST00000382183:exon6:c.C576G:p.D192E,ENSG00000080503:ENST00000302401:exon7:c.C702G:p.D234E,ENSG00000080503:ENST00000417599:exon7:c.C696G:p.D232E,ENSG00000080503:ENST00000324954:exon8:c.C576G:p.D192E,ENSG00000080503:ENST00000382185:exon8:c.C576G:p.D192E,ENSG00000080503:ENST00000382186:exon8:c.C630G:p.D210E,ENSG00000080503:ENST00000382194:exon31:c.C4584G:p.D1528E,ENSG00000080503:ENST00000357248:exon32:c.C4584G:p.D1528E,ENSG00000080503:ENST00000349721:exon33:c.C4638G:p.D1546E,ENSG00000080503:ENST00000382203:exon33:c.C4638G:p.D1546E	SMARCA2:NM_001289398:exon6:c.C612G:p.D204E,SMARCA2:NM_001289399:exon7:c.C696G:p.D232E,SMARCA2:NM_001289400:exon7:c.C702G:p.D234E,SMARCA2:NM_001289397:exon32:c.C4410G:p.D1470E,SMARCA2:NM_139045:exon32:c.C4584G:p.D1528E,SMARCA2:NM_001289396:exon33:c.C4638G:p.D1546E,SMARCA2:NM_003070:exon33:c.C4638G:p.D1546E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1684	0.1652	0.223642	1(haematopoietic_and_lymphoid_tissue)	2.083	16.74	1.0	3.76	0.997	.	.	.	SMARCA2:uc010mhb.3:exon6:c.C648G:p.D216E,SMARCA2:uc003zhe.3:exon7:c.C702G:p.D234E,SMARCA2:uc011llw.2:exon7:c.C696G:p.D232E,SMARCA2:uc011llx.2:exon8:c.C576G:p.D192E,SMARCA2:uc003zhd.3:exon32:c.C4584G:p.D1528E,SMARCA2:uc010mha.3:exon32:c.C4383G:p.D1461E,SMARCA2:uc003zhc.3:exon33:c.C4638G:p.D1546E	-1.098	AFR:1(liver),AMR:1(breast),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,FIN:0.1711,NFE:0.2721,OTH:0.2172,ASJ:MU10529735	600014	601358;	3051;	3051|Nicolaides-Baraitser syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|601358 ~	.	.	.	.	0.0	-2.13	0.000	-1.59	9	3(soft_tissue)	0.1093
9	5081780	5081780	G	A	JAK2	exonic	synonymous SNV	ENSG00000096968	rs2230724	ENSG00000096968:ENST00000544510:exon16:c.G2043A:p.L681L,ENSG00000096968:ENST00000539801:exon18:c.G2490A:p.L830L,ENSG00000096968:ENST00000381652:exon19:c.G2490A:p.L830L	JAK2:NM_001322204:exon16:c.G2043A:p.L681L,JAK2:NM_001322195:exon18:c.G2490A:p.L830L,JAK2:NM_001322196:exon18:c.G2490A:p.L830L,JAK2:NM_001322194:exon19:c.G2490A:p.L830L,JAK2:NM_001322198:exon19:c.G1275A:p.L425L,JAK2:NM_001322199:exon19:c.G1275A:p.L425L,JAK2:NM_004972:exon19:c.G2490A:p.L830L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5328	0.6243	0.616813	14(meninges)	.	.	.	.	.	.	.	.	JAK2:uc010mhm.3:exon18:c.G2490A:p.L830L,JAK2:uc003ziw.3:exon19:c.G2490A:p.L830L	.	AFR:3(large_intestine),AMR:1(breast),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.6108,NFE:0.8679,OTH:0.5096,ASJ:MU99782	147796	133100;254450;263300;600800;601626;614521;	3318;71493;519;729;824;90042;	3318|ET<br>Essential thrombocytosis|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|187950 601977 614521 ~71493|Familial thrombocythemia<br>Hereditary thrombocythemia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;X-linked recessive|Childhood|187950 300331 601977 614521 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~729|Acquired primary erythrocytosis<br>Osler-Vaquez disease<br>PV<br>Polycythemia rubra vera<br>Vaquez disease|1-5 / 10 000|Not applicable|All ages|263300 ~824|Agnogenic myeloid metaplasia<br>Idiopathic myelofibrosis<br>Myelofibrosis with myeloid metaplasia<br>Osteomyelofibrosis|1-9 / 100 000|-|Adult|254450 ~90042|Congenital erythrocytosis due to erythropoietin receptor mutation<br>Congenital polycythemia due to erythropoietin receptor mutation<br>Familial erythrocytosis<br>PFCP<br>Primary congenital erythrocytosis<br>Primary familial and congenital polycythemia|Unknown|Autosomal dominant|All ages|133100 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04725 Cholinergic synapse~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,6214	.	.	.	.	.	.	9	1(lung)	0.6159
9	5557672	5557672	T	C	PDCD1LG2	exonic	nonsynonymous SNV	ENSG00000197646	rs7854303	ENSG00000197646:ENST00000397745:exon4:c.T416C:p.F139S,ENSG00000197646:ENST00000397747:exon5:c.T686C:p.F229S	PDCD1LG2:NM_025239:exon5:c.T686C:p.F229S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9992	0.9988	0.997804	0.9989	-0.047	2.158	0.552	0.724	0.021	.	.	.	PDCD1LG2:uc010mho.1:exon3:c.T416C:p.F139S,PDCD1LG2:uc003zjg.4:exon5:c.T686C:p.F229S,PDCD1LG2:uc011lmc.2:exon5:c.T686C:p.F229S	-1.036	AFR:0.9975,AMR:0.9964,EAS:1,FIN:1,NFE:0.9995,OTH:0.9980,ASJ:1	605723	.	.	.	.	.	.	.	0.0	5.16	0.000	.	9	MU81859703	hom
9	8331574	8331574	-	AACTTACCATTCTTGAACTGT	PTPRD	intronic	.	ENSG00000153707	rs146237556	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1978	.	0.300919	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601598	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	8389364	8389364	C	G	PTPRD	exonic	synonymous SNV	ENSG00000153707	rs2279776	ENSG00000153707:ENST00000397606:exon20:c.G3033C:p.G1011G,ENSG00000153707:ENST00000397617:exon20:c.G3033C:p.G1011G,ENSG00000153707:ENST00000537002:exon20:c.G3024C:p.G1008G,ENSG00000153707:ENST00000397611:exon21:c.G3024C:p.G1008G,ENSG00000153707:ENST00000355233:exon22:c.G3036C:p.G1012G,ENSG00000153707:ENST00000358503:exon22:c.G4188C:p.G1396G,ENSG00000153707:ENST00000486161:exon22:c.G3033C:p.G1011G,ENSG00000153707:ENST00000360074:exon23:c.G4215C:p.G1405G,ENSG00000153707:ENST00000356435:exon26:c.G4254C:p.G1418G,ENSG00000153707:ENST00000540109:exon26:c.G4254C:p.G1418G,ENSG00000153707:ENST00000381196:exon34:c.G4254C:p.G1418G	PTPRD:NM_001171025:exon20:c.G3033C:p.G1011G,PTPRD:NM_130393:exon20:c.G3006C:p.G1002G,PTPRD:NM_001040712:exon21:c.G3024C:p.G1008G,PTPRD:NM_130391:exon22:c.G3033C:p.G1011G,PTPRD:NM_130392:exon22:c.G3036C:p.G1012G,PTPRD:NM_002839:exon37:c.G4254C:p.G1418G	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.4992	0.4847	0.55631	0.4920	.	.	.	.	.	.	.	.	PTPRD:uc003zkr.3:exon20:c.G3006C:p.G1002G,PTPRD:uc003zks.3:exon20:c.G3033C:p.G1011G,PTPRD:uc022bdj.1:exon21:c.G3024C:p.G1008G,PTPRD:uc003zkp.3:exon22:c.G3036C:p.G1012G,PTPRD:uc003zkq.3:exon22:c.G3033C:p.G1011G,PTPRD:uc003zkk.3:exon37:c.G4254C:p.G1418G	.	AFR:0.5735,AMR:0.5072,EAS:0.6897,FIN:0.4948,NFE:0.4231,OTH:0.4691,ASJ:0.5066	601598	.	.	.	.	,9359,9360	.	.	.	.	.	.	9	MU733175	het
9	8518143	8518143	T	C	PTPRD	exonic	synonymous SNV	ENSG00000153707	rs7026388	ENSG00000153707:ENST00000358503:exon7:c.A1209G:p.A403A,ENSG00000153707:ENST00000360074:exon7:c.A1209G:p.A403A,ENSG00000153707:ENST00000397606:exon8:c.A1218G:p.A406A,ENSG00000153707:ENST00000397617:exon8:c.A1218G:p.A406A,ENSG00000153707:ENST00000537002:exon8:c.A1239G:p.A413A,ENSG00000153707:ENST00000397611:exon9:c.A1239G:p.A413A,ENSG00000153707:ENST00000355233:exon10:c.A1248G:p.A416A,ENSG00000153707:ENST00000356435:exon10:c.A1248G:p.A416A,ENSG00000153707:ENST00000486161:exon10:c.A1248G:p.A416A,ENSG00000153707:ENST00000540109:exon10:c.A1248G:p.A416A,ENSG00000153707:ENST00000381196:exon18:c.A1248G:p.A416A	PTPRD:NM_001171025:exon8:c.A1218G:p.A406A,PTPRD:NM_001040712:exon9:c.A1239G:p.A413A,PTPRD:NM_130393:exon9:c.A1230G:p.A410A,PTPRD:NM_130391:exon10:c.A1248G:p.A416A,PTPRD:NM_130392:exon10:c.A1248G:p.A416A,PTPRD:NM_002839:exon21:c.A1248G:p.A416A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.2170	0.2327	0.307308	0.2349	.	.	.	.	.	.	.	.	PTPRD:uc003zks.3:exon8:c.A1218G:p.A406A,PTPRD:uc003zkr.3:exon9:c.A1230G:p.A410A,PTPRD:uc022bdj.1:exon9:c.A1239G:p.A413A,PTPRD:uc003zkp.3:exon10:c.A1248G:p.A416A,PTPRD:uc003zkq.3:exon10:c.A1248G:p.A416A,PTPRD:uc003zkk.3:exon21:c.A1248G:p.A416A	.	AFR:0.3983,AMR:0.2470,EAS:0.3927,FIN:0.1408,NFE:0.1482,OTH:0.1990,ASJ:0.1656	601598	.	.	.	.	,9359,9360	.	.	.	.	.	.	9	MU24757119	het
9	20414376	20414376	A	G	MLLT3	exonic	synonymous SNV	ENSG00000171843	rs1761445	ENSG00000171843:ENST00000380338:exon5:c.T468C:p.S156S,ENSG00000171843:ENST00000429426:exon5:c.T459C:p.S153S	MLLT3:NM_001286691:exon5:c.T459C:p.S153S,MLLT3:NM_004529:exon5:c.T468C:p.S156S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0019	.	0.121406	1(lung)	.	.	.	.	.	.	.	.	MLLT3:uc011lne.1:exon4:c.T372C:p.S124S,MLLT3:uc003zoe.2:exon5:c.T468C:p.S156S,MLLT3:uc011lnf.1:exon5:c.T459C:p.S153S	.	AFR:4(haematopoietic_and_lymphoid_tissue),AMR:MU42588399,EAS:0.0773,FIN:0.0811,NFE:0.0424,OTH:0.0580,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,BTCA-JP|1|239|0.0041841	159558	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	9	1(upper_aerodigestive_tract)	0.0221
9	21816758	21816758	G	A	MTAP	exonic	nonsynonymous SNV	ENSG00000099810;ENSG00000264545	rs7023954	ENSG00000099810:ENST00000380172:exon3:c.G166A:p.V56I,ENSG00000264545:ENST00000404796:exon3:c.G166A:p.V56I,ENSG00000099810:ENST00000460874:exon3:c.G217A:p.V73I,ENSG00000099810:ENST00000580718:exon3:c.G166A:p.V56I,ENSG00000099810:ENST00000580900:exon3:c.G166A:p.V56I	MTAP:NM_002451:exon3:c.G166A:p.V56I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.3944	0.4217	0.388179	2(urinary_tract)	3.766	23.4	0.125	5.44	0.943	.	.	Nucleoside phosphorylase domain	MTAP:uc003zph.3:exon3:c.G166A:p.V56I,MTAP:uc003zpi.1:exon3:c.G166A:p.V56I,MTAP:uc011lnk.2:exon3:c.G217A:p.V73I,MTAP:uc031tcz.1:exon3:c.G166A:p.V56I,MTAP:uc031tda.1:exon3:c.G166A:p.V56I,MTAP:uc031tdb.1:exon3:c.G166A:p.V56I,MTAP:uc031tdc.1:exon3:c.G166A:p.V56I,MTAP:uc031tdd.1:exon3:c.G166A:p.V56I,MTAP:uc031tde.1:exon3:c.G166A:p.V56I	-1.124	AFR:1(lung),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:MU119931,FIN:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,NFE:0.4323,OTH:0.4380,ASJ:1(oesophagus)	156540	112250;	85182;	85182|Bone dysplasia-medullary fibrosarcoma syndrome<br>Diaphyseal medullary stenosis-malignant fibrous histiocytoma syndrome<br>Hardcastle syndrome|-|Autosomal dominant|-|112250 ~	.	.	.	.	0.179	-2.6	0.000	2.2	9	1(large_intestine)	0.3906
9	27183463	27183463	A	C	TEK	exonic	nonsynonymous SNV	ENSG00000120156	rs682632	ENSG00000120156:ENST00000519080:exon5:c.A467C:p.Q156P,ENSG00000120156:ENST00000519097:exon6:c.A596C:p.Q199P,ENSG00000120156:ENST00000406359:exon7:c.A908C:p.Q303P,ENSG00000120156:ENST00000380036:exon8:c.A1037C:p.Q346P	TEK:NM_001290078:exon6:c.A596C:p.Q199P,TEK:NM_001290077:exon7:c.A908C:p.Q303P,TEK:NM_000459:exon8:c.A1037C:p.Q346P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9733	0.9727	0.989816	0.9758	1.658	14.17	0.411	5.52	0.985	.	.	Immunoglobulin-like fold	TEK:uc003zqj.1:exon6:c.A839C:p.Q280P,TEK:uc011lnp.2:exon6:c.A596C:p.Q199P,TEK:uc011lno.2:exon7:c.A908C:p.Q303P,TEK:uc003zqi.4:exon8:c.A1037C:p.Q346P	-0.934	AFR:0.9924,AMR:0.9905,EAS:1,FIN:0.9720,NFE:0.9639,OTH:0.9674,ASJ:0.9834	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	0.0	-0.81	0.000	-0.345	9	MU81860880	hom
9	27202870	27202870	A	G	TEK	exonic	synonymous SNV	ENSG00000120156	rs639225	ENSG00000120156:ENST00000519080:exon10:c.A1392G:p.S464S,ENSG00000120156:ENST00000519097:exon11:c.A1521G:p.S507S,ENSG00000120156:ENST00000406359:exon12:c.A1833G:p.S611S,ENSG00000120156:ENST00000380036:exon13:c.A1962G:p.S654S	TEK:NM_001290078:exon11:c.A1521G:p.S507S,TEK:NM_001290077:exon12:c.A1833G:p.S611S,TEK:NM_000459:exon13:c.A1962G:p.S654S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4649	0.4463	0.414337	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TEK:uc003zqj.1:exon11:c.A1764G:p.S588S,TEK:uc011lnp.2:exon11:c.A1521G:p.S507S,TEK:uc011lno.2:exon12:c.A1833G:p.S611S,TEK:uc003zqi.4:exon13:c.A1962G:p.S654S	.	AFR:0.4777,AMR:0.3685,EAS:0.4033,FIN:0.4114,NFE:0.6298,OTH:0.5107,ASJ:0.5024	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	1(lung)	0.5132
9	27203134	27203134	A	G	TEK	intronic	.	ENSG00000120156	rs638203	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4657	0.4471	0.414936	LAML-KR|1|205|0.00487805,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4779,AMR:0.3706,EAS:0.4007,FIN:0.4084,NFE:0.6302,OTH:0.5101,ASJ:0.5012	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	1(liver)	0.5133
9	27205021	27205021	G	A	TEK	exonic	synonymous SNV	ENSG00000120156	rs542913	ENSG00000120156:ENST00000519097:exon12:c.G1881A:p.R627R,ENSG00000120156:ENST00000406359:exon13:c.G2193A:p.R731R,ENSG00000120156:ENST00000380036:exon14:c.G2322A:p.R774R	TEK:NM_001290078:exon12:c.G1881A:p.R627R,TEK:NM_001290077:exon13:c.G2193A:p.R731R,TEK:NM_000459:exon14:c.G2322A:p.R774R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2114	0.2113	0.150958	0.2219	.	.	.	.	.	.	.	.	TEK:uc003zqj.1:exon12:c.G2124A:p.R708R,TEK:uc011lnp.2:exon12:c.G1881A:p.R627R,TEK:uc011lno.2:exon13:c.G2193A:p.R731R,TEK:uc003zqi.4:exon14:c.G2322A:p.R774R	.	AFR:0.1082,AMR:0.1420,EAS:0.1123,FIN:0.3393,NFE:0.2753,OTH:0.2510,ASJ:0.2185	600221	600195;	2451;	2451|Cutaneous and mucosal venous malformation<br>VMCM|<1 / 1 000 000|Autosomal dominant|All ages|600195 ~	.	.	.	.	.	.	.	.	9	MU82198451	hom
9	32891930	32891930	T	C	TMEM215;APTX	intergenic	.	ENSG00000236796;ENSG00000223807	rs10115224	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.602436	0.6777	.	.	.	.	.	.	.	.	.	.	AFR:0.6434,AMR:0.5502,EAS:0.2880,FIN:0.6624,NFE:0.7488,OTH:0.7168,ASJ:0.6391	.	.	.	.	.	.	.	.	.	.	.	.	9	MU10673410	unknown
9	32974570	32974570	-	A	APTX	intronic	.	ENSG00000137074	rs34600530	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6513	0.5835	0.688698	0.6408	.	.	.	.	.	.	.	.	.	.	AFR:0.5482,AMR:0.7017,EAS:0.8639,FIN:0.6968,NFE:0.6540,OTH:0.6840,ASJ:0.5567	606350	208920;	1168;	1168|AOA1|Unknown|Autosomal recessive|Childhood|208920 ~	.	.	.	.	.	.	.	.	9	.	hom
9	32986041	32986041	C	A	APTX	intronic	.	ENSG00000137074	rs10123944	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6263	.	.	0.6294	.	.	.	.	.	.	.	.	.	.	AFR:0.6194,AMR:0.6047,EAS:0.8446,FIN:0.4803,NFE:0.6213,OTH:0.6424,ASJ:0.5114	606350	208920;	1168;	1168|AOA1|Unknown|Autosomal recessive|Childhood|208920 ~	.	.	.	.	.	.	.	.	9	MU15306710	het
9	36840623	36840623	G	A	PAX5	exonic	nonsynonymous SNV	ENSG00000196092	rs3780135	ENSG00000196092:ENST00000520154:exon7:c.C791T:p.T264I,ENSG00000196092:ENST00000523241:exon8:c.C878T:p.T293I	PAX5:NM_001280550:exon7:c.C791T:p.T264I,PAX5:NM_001280549:exon8:c.C878T:p.T293I	clinvar: not_provided 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8687	0.7631	0.742013	COCA-CN|5|321|0.0155763	-0.039	2.223	0.215	2.41	0.999	.	.	.	PAX5:uc010mls.1:exon7:c.C791T:p.T264I,PAX5:uc010mlr.1:exon8:c.C878T:p.T293I	-0.922	AFR:0.7818,AMR:0.3822,EAS:0.8974,FIN:0.8837,NFE:0.9527,OTH:0.9467,ASJ:0.8816	167414	615545;	99860;	99860|B-ALL<br>Precursor B-cell acute lymphoblastic leukemia/lymphoma<br>Precursor B-cell acute lymphocytic leukemia<br>Precursor B-cell acute lymphocytic leukemia/lymphoma|-|-|-|615545 ~	~ko05202 Transcriptional misregulation in cancer ~	,8446	.	.	0.0	-4.59	0.000	.	9	1(thyroid)	0.8949
9	37020622	37020622	A	C	PAX5	intronic	.	ENSG00000196092	rs2297105	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4708	0.4694	0.551717	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.5008,AMR:0.6073,EAS:0.3245,FIN:0.5031,NFE:0.5444,OTH:0.4292,ASJ:0.5646	167414	615545;	99860;	99860|B-ALL<br>Precursor B-cell acute lymphoblastic leukemia/lymphoma<br>Precursor B-cell acute lymphocytic leukemia<br>Precursor B-cell acute lymphocytic leukemia/lymphoma|-|-|-|615545 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	9	1(liver)	0.4888
9	71831398	71831398	T	C	TJP2	intronic	.	ENSG00000119139	rs2498417	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9209	0.9038	0.894169	0.9094	.	.	.	.	.	.	.	.	.	.	AFR:0.8609,AMR:0.9081,EAS:0.9333,FIN:0.9479,NFE:0.9244,OTH:0.9328,ASJ:0.9205	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	MU81862766	hom
9	71843023	71843023	C	A	TJP2	exonic	nonsynonymous SNV	ENSG00000119139	rs2309428	ENSG00000119139:ENST00000265384:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000348208:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000377245:exon9:c.C1446A:p.D482E,ENSG00000119139:ENST00000535702:exon9:c.C1458A:p.D486E,ENSG00000119139:ENST00000539225:exon9:c.C1539A:p.D513E,ENSG00000119139:ENST00000453658:exon10:c.C1377A:p.D459E	TJP2:NM_001170415:exon9:c.C1458A:p.D486E,TJP2:NM_001170416:exon9:c.C1539A:p.D513E,TJP2:NM_001369872:exon9:c.C1446A:p.D482E,TJP2:NM_001369873:exon9:c.C1446A:p.D482E,TJP2:NM_001369874:exon9:c.C1458A:p.D486E,TJP2:NM_001369875:exon9:c.C1458A:p.D486E,TJP2:NM_004817:exon9:c.C1446A:p.D482E,TJP2:NM_201629:exon9:c.C1446A:p.D482E,TJP2:NM_001170414:exon10:c.C1377A:p.D459E,TJP2:NM_001369870:exon10:c.C1371A:p.D457E,TJP2:NM_001369871:exon11:c.C1377A:p.D459E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8115	0.7580	0.772165	0.7864	-0.778	0.048	1.0	-1.25	0.390	.	.	PDZ domain	TJP2:uc004ahd.3:exon9:c.C1446A:p.D482E,TJP2:uc004ahe.3:exon9:c.C1446A:p.D482E,TJP2:uc004ahf.3:exon9:c.C1446A:p.D482E,TJP2:uc011lru.2:exon9:c.C1458A:p.D486E,TJP2:uc011lrv.2:exon9:c.C1539A:p.D513E,TJP2:uc011lrs.2:exon10:c.C1377A:p.D459E,TJP2:uc011lrt.1:exon11:c.C1377A:p.D459E	-0.968	AFR:0.6611,AMR:0.8616,EAS:0.8906,FIN:0.8698,NFE:0.8210,OTH:0.8310,ASJ:0.7947	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	0.0	3.13	0.000	-0.485	9	MU10854686	hom
9	71861685	71861685	G	A	TJP2	exonic	synonymous SNV	ENSG00000119139	rs11788754	ENSG00000119139:ENST00000265384:exon18:c.G2646A:p.A882A,ENSG00000119139:ENST00000348208:exon18:c.G2646A:p.A882A,ENSG00000119139:ENST00000377245:exon18:c.G2646A:p.A882A,ENSG00000119139:ENST00000535702:exon18:c.G2658A:p.A886A,ENSG00000119139:ENST00000539225:exon18:c.G2739A:p.A913A,ENSG00000119139:ENST00000453658:exon19:c.G2577A:p.A859A	TJP2:NM_001170415:exon18:c.G2658A:p.A886A,TJP2:NM_001170416:exon18:c.G2739A:p.A913A,TJP2:NM_001369872:exon18:c.G2646A:p.A882A,TJP2:NM_001369873:exon18:c.G2646A:p.A882A,TJP2:NM_001369874:exon18:c.G2658A:p.A886A,TJP2:NM_001369875:exon18:c.G2658A:p.A886A,TJP2:NM_004817:exon18:c.G2646A:p.A882A,TJP2:NM_201629:exon18:c.G2646A:p.A882A,TJP2:NM_001170414:exon19:c.G2577A:p.A859A,TJP2:NM_001369870:exon19:c.G2571A:p.A857A,TJP2:NM_001369871:exon20:c.G2577A:p.A859A	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0143	0.0151	0.00698882	0.0114	.	.	.	.	.	.	.	.	TJP2:uc010mom.1:exon1:c.G126A:p.A42A,TJP2:uc004ahd.3:exon18:c.G2646A:p.A882A,TJP2:uc004ahe.3:exon18:c.G2646A:p.A882A,TJP2:uc004ahf.3:exon18:c.G2646A:p.A882A,TJP2:uc011lru.2:exon18:c.G2658A:p.A886A,TJP2:uc011lrv.2:exon18:c.G2739A:p.A913A,TJP2:uc011lrs.2:exon19:c.G2577A:p.A859A,TJP2:uc011lrt.1:exon20:c.G2577A:p.A859A	.	AFR:0.0038,AMR:0.0036,EAS:0.0006,FIN:0.0029,NFE:0.0195,OTH:0.0092,ASJ:0.0166	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	.	het
9	71863038	71863038	C	T	TJP2	exonic	synonymous SNV	ENSG00000119139	rs140442228	ENSG00000119139:ENST00000265384:exon19:c.C2778T:p.D926D,ENSG00000119139:ENST00000348208:exon19:c.C2778T:p.D926D,ENSG00000119139:ENST00000377245:exon19:c.C2778T:p.D926D,ENSG00000119139:ENST00000535702:exon19:c.C2790T:p.D930D,ENSG00000119139:ENST00000539225:exon19:c.C2871T:p.D957D,ENSG00000119139:ENST00000453658:exon20:c.C2709T:p.D903D	TJP2:NM_001170415:exon19:c.C2790T:p.D930D,TJP2:NM_001170416:exon19:c.C2871T:p.D957D,TJP2:NM_001369872:exon19:c.C2778T:p.D926D,TJP2:NM_001369874:exon19:c.C2790T:p.D930D,TJP2:NM_001369875:exon19:c.C2790T:p.D930D,TJP2:NM_004817:exon19:c.C2778T:p.D926D,TJP2:NM_201629:exon19:c.C2778T:p.D926D,TJP2:NM_001170414:exon20:c.C2709T:p.D903D,TJP2:NM_001369870:exon20:c.C2703T:p.D901D,TJP2:NM_001369871:exon21:c.C2709T:p.D903D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0143	0.0151	0.00698882	0.0110	.	.	.	.	.	.	.	.	TJP2:uc010mom.1:exon2:c.C258T:p.D86D,TJP2:uc004ahd.3:exon19:c.C2778T:p.D926D,TJP2:uc004ahe.3:exon19:c.C2778T:p.D926D,TJP2:uc004ahf.3:exon19:c.C2778T:p.D926D,TJP2:uc011lru.2:exon19:c.C2790T:p.D930D,TJP2:uc011lrv.2:exon19:c.C2871T:p.D957D,TJP2:uc011lrs.2:exon20:c.C2709T:p.D903D	.	AFR:0.0037,AMR:0.0036,EAS:0,FIN:0.0029,NFE:0.0189,OTH:0.0071,ASJ:0.0166	607709	607748;615878;	172;79304;238475;	172|PFIC|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Childhood<br>Adolescent|211600 601847 602347 615878 ~79304|BSEP deficiency<br>PFIC2|1-9 / 100 000|Autosomal recessive|Infancy<br>Neonatal|601847 615878 ~238475|Hereditary hypercholanemia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607748 ~	.	.	.	.	.	.	.	.	9	MU29607572	het
9	72897434	72897434	G	A	SMC5	exonic	nonsynonymous SNV	ENSG00000198887	rs1180116	ENSG00000198887:ENST00000361138:exon7:c.G916A:p.V306I	SMC5:NM_015110:exon7:c.G916A:p.V306I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8824	0.8558	0.855032	0.8686	0.072	3.315	0.655	-1.31	0.909	.	.	RecF/RecN/SMC, N-terminal	SMC5:uc004ahr.2:exon7:c.G916A:p.V306I	-1.035	AFR:0.7743,AMR:0.8849,EAS:0.8476,FIN:0.9321,NFE:0.9100,OTH:0.8845,ASJ:0.8146	609386	.	.	.	.	.	.	.	0.0	2.34	0.000	0	9	MU25197989	unknown
9	72897440	72897440	T	C	SMC5	exonic	nonsynonymous SNV	ENSG00000198887	rs1180117	ENSG00000198887:ENST00000361138:exon7:c.T922C:p.C308R	SMC5:NM_015110:exon7:c.T922C:p.C308R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2104	0.2154	0.246006	0.2132	-0.634	0.103	1.0	2.61	0.833	.	.	RecF/RecN/SMC, N-terminal	SMC5:uc004ahr.2:exon7:c.T922C:p.C308R	-0.917	AFR:0.2456,AMR:0.1456,EAS:0.2481,FIN:0.2002,NFE:0.1994,OTH:0.1953,ASJ:0.1788	609386	.	.	.	.	.	.	.	0.0	2.38	0.000	-0.59	9	MU13487471	unknown
9	72901096	72901096	T	C	SMC5	intronic	.	ENSG00000198887	rs1180123	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9933	0.9749	0.978235	0.9800	.	.	.	.	.	.	.	.	.	.	AFR:0.9295,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9927,ASJ:1	609386	.	.	.	.	.	.	.	.	.	.	.	9	MU81862879	hom
9	72929769	72929769	C	T	SMC5	intronic	.	ENSG00000198887	rs11142363	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2222	0.2002	0.246406	0.2137	.	.	.	.	.	.	.	.	.	.	AFR:0.2463,AMR:0.1459,EAS:0.2509,FIN:0.2001,NFE:0.1993,OTH:0.1971,ASJ:0.1788	609386	.	.	.	.	.	.	.	.	.	.	.	9	MU20828691	het
9	72933774	72933774	A	G	SMC5	exonic	nonsynonymous SNV	ENSG00000198887	rs11142365	ENSG00000198887:ENST00000361138:exon15:c.A2045G:p.H682R	SMC5:NM_015110:exon15:c.A2045G:p.H682R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0930	0.1295	0.0870607	0.1186	-0.699	0.072	0.674	0.161	0.493	.	.	RecF/RecN/SMC, N-terminal	SMC5:uc004ahr.2:exon15:c.A2045G:p.H682R	-0.962	AFR:0.1592,AMR:0.0513,EAS:0.0271,FIN:0.0962,NFE:0.1165,OTH:0.0949,ASJ:0.0629	609386	.	.	.	.	.	.	.	0.001	2.36	0.000	0.585	9	.	het
9	86617265	86617265	A	G	RMI1	exonic	nonsynonymous SNV	ENSG00000178966	rs1982151	ENSG00000178966:ENST00000325875:exon3:c.A1364G:p.N455S	RMI1:NM_001358291:exon3:c.A1364G:p.N455S,RMI1:NM_001358294:exon3:c.A1364G:p.N455S,RMI1:NM_024945:exon3:c.A1364G:p.N455S,RMI1:NM_001358292:exon4:c.A1364G:p.N455S,RMI1:NM_001358293:exon4:c.A1364G:p.N455S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7152	0.6857	0.671126	0.6902	-3.981	0.001	1.0	-2.97	0.162	.	.	.	RMI1:uc022bjb.1:exon1:c.A1364G:p.N455S,RMI1:uc004ans.4:exon2:c.A1364G:p.N455S,RMI1:uc004anp.4:exon3:c.A1364G:p.N455S,RMI1:uc004anq.4:exon3:c.A1364G:p.N455S,RMI1:uc004anr.4:exon4:c.A1364G:p.N455S	-0.986	AFR:0.5670,AMR:0.8381,EAS:0.7447,FIN:0.7441,NFE:0.7344,OTH:0.6944,ASJ:0.7119	610404	.	.	.	.	.	.	.	0.0	1.57	0.000	-1.15	9	MU14191257	hom
9	90255194	90255194	C	G	DAPK1	intronic	.	ENSG00000196730	rs2270404	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0119	0.0006	0.0259585	0.0047	.	.	.	.	.	.	.	.	.	.	AFR:0.0010,AMR:0.0239,EAS:0.0678,FIN:0,NFE:0.0002,OTH:0.0041,ASJ:0.0033	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	MU29964725	het
9	90265015	90265015	C	T	DAPK1	exonic	synonymous SNV	ENSG00000196730	rs3818584	ENSG00000196730:ENST00000491893:exon15:c.C1608T:p.D536D,ENSG00000196730:ENST00000358077:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000408954:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000469640:exon16:c.C1608T:p.D536D,ENSG00000196730:ENST00000472284:exon16:c.C1608T:p.D536D	DAPK1:NM_001288729:exon16:c.C1608T:p.D536D,DAPK1:NM_001288730:exon16:c.C1608T:p.D536D,DAPK1:NM_001288731:exon16:c.C1608T:p.D536D,DAPK1:NM_004938:exon16:c.C1608T:p.D536D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3895	0.3067	0.354034	LIRI-JP|1|258|0.00387597,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,PBCA-DE|1|499|0.00200401	.	.	.	.	.	.	.	.	DAPK1:uc004apf.1:exon2:c.C270T:p.D90D,DAPK1:uc011lth.2:exon14:c.C819T:p.D273D,DAPK1:uc011ltg.2:exon15:c.C1608T:p.D536D,DAPK1:uc004apc.3:exon16:c.C1608T:p.D536D,DAPK1:uc004apd.3:exon16:c.C1608T:p.D536D,DAPK1:uc004ape.3:exon16:c.C1608T:p.D536D	.	AFR:0.3442,AMR:0.1615,EAS:0.2848,FIN:0.6390,NFE:0.4332,OTH:0.3804,ASJ:0.5873	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	1(lung)	0.4255
9	90313717	90313717	G	T	DAPK1	intronic	.	ENSG00000196730	rs3128495	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4502	0.3445	0.348842	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3567,AMR:0.1152,EAS:0.48,FIN:0.4037,NFE:0.4845,OTH:0.4428,ASJ:0.6005	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	1(stomach)	0.4102
9	90321583	90321583	C	T	DAPK1	exonic	synonymous SNV	ENSG00000196730	rs3118863	ENSG00000196730:ENST00000491893:exon24:c.C3399T:p.R1133R,ENSG00000196730:ENST00000358077:exon26:c.C3597T:p.R1199R,ENSG00000196730:ENST00000408954:exon26:c.C3597T:p.R1199R,ENSG00000196730:ENST00000472284:exon26:c.C3597T:p.R1199R,ENSG00000196730:ENST00000469640:exon27:c.C3672T:p.R1224R	DAPK1:NM_001288729:exon26:c.C3597T:p.R1199R,DAPK1:NM_001288730:exon26:c.C3597T:p.R1199R,DAPK1:NM_001288731:exon26:c.C3597T:p.R1199R,DAPK1:NM_004938:exon26:c.C3597T:p.R1199R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4399	0.3619	0.356629	MU112652	.	.	.	.	.	.	.	.	DAPK1:uc004apg.2:exon1:c.C528T:p.R176R,DAPK1:uc011ltg.2:exon24:c.C3399T:p.R1133R,DAPK1:uc011lth.2:exon24:c.C2808T:p.R936R,DAPK1:uc004apc.3:exon26:c.C3597T:p.R1199R,DAPK1:uc004apd.3:exon26:c.C3597T:p.R1199R	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,AMR:0.3708,EAS:0.4892,FIN:0.4868,NFE:0.4056,OTH:0.4837,ASJ:0.1775	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	.	.	.	.	9	1(thyroid)	0.4420
9	90322023	90322023	G	A	DAPK1	exonic	nonsynonymous SNV	ENSG00000196730	rs1056719	ENSG00000196730:ENST00000491893:exon24:c.G3839A:p.S1280N,ENSG00000196730:ENST00000358077:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000408954:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000472284:exon26:c.G4037A:p.S1346N,ENSG00000196730:ENST00000469640:exon27:c.G4112A:p.S1371N	DAPK1:NM_001288729:exon26:c.G4037A:p.S1346N,DAPK1:NM_001288730:exon26:c.G4037A:p.S1346N,DAPK1:NM_001288731:exon26:c.G4037A:p.S1346N,DAPK1:NM_004938:exon26:c.G4037A:p.S1346N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6672	0.5858	0.65595	MU4558958	-2.158	0.001	0.528	-2.04	0.011	.	.	Death domain|Death-like domain	DAPK1:uc004apg.2:exon1:c.G968A:p.S323N,DAPK1:uc011ltg.2:exon24:c.G3839A:p.S1280N,DAPK1:uc011lth.2:exon24:c.G3248A:p.S1083N,DAPK1:uc004apc.3:exon26:c.G4037A:p.S1346N,DAPK1:uc004apd.3:exon26:c.G4037A:p.S1346N	-0.943	AFR:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763,AML-US|1|166|0.0060241,AMR:0.5999,EAS:0.7290,FIN:0.6424,NFE:0.8327,OTH:0.6407,ASJ:0.4523	600831	.	.	.	~ko04140 Autophagy - animal~ko05200 Pathways in cancer~ko05219 Bladder cancer ~	.	.	.	0.0	-1.98	0.000	-0.14	9	71(lung)	0.6415
9	93637015	93637015	C	T	SYK	exonic	synonymous SNV	ENSG00000165025	rs2290890	ENSG00000165025:ENST00000375747:exon8:c.C996T:p.P332P,ENSG00000165025:ENST00000375751:exon8:c.C996T:p.P332P,ENSG00000165025:ENST00000375746:exon9:c.C1065T:p.P355P,ENSG00000165025:ENST00000375754:exon9:c.C1065T:p.P355P	SYK:NM_001135052:exon8:c.C996T:p.P332P,SYK:NM_001174168:exon8:c.C996T:p.P332P,SYK:NM_001174167:exon9:c.C1065T:p.P355P,SYK:NM_003177:exon9:c.C1065T:p.P355P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1833	0.1641	0.195887	MU13514284	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon8:c.C996T:p.P332P,SYK:uc004arb.3:exon8:c.C996T:p.P332P,SYK:uc004aqz.3:exon9:c.C1065T:p.P355P,SYK:uc004arc.3:exon9:c.C1065T:p.P355P	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.1801,EAS:0.3513,FIN:0.2053,NFE:0.2587,OTH:0.1891,ASJ:0.2121	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	7(soft_tissue)	0.1410
9	93639846	93639846	C	G	SYK	intronic	.	ENSG00000165025	rs290223	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2504	0.2069	0.301518	0.2204	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.2107,AMR:0.1993,EAS:0.5286,FIN:0.2602,NFE:0.1853,OTH:0.2179,ASJ:0.2067	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	MU684467	het
9	93639973	93639973	G	C	SYK	exonic	synonymous SNV	ENSG00000165025	rs2290888	ENSG00000165025:ENST00000375747:exon9:c.G1233C:p.R411R,ENSG00000165025:ENST00000375751:exon9:c.G1233C:p.R411R,ENSG00000165025:ENST00000375746:exon10:c.G1302C:p.R434R,ENSG00000165025:ENST00000375754:exon10:c.G1302C:p.R434R	SYK:NM_001135052:exon9:c.G1233C:p.R411R,SYK:NM_001174168:exon9:c.G1233C:p.R411R,SYK:NM_001174167:exon10:c.G1302C:p.R434R,SYK:NM_003177:exon10:c.G1302C:p.R434R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1835	0.1652	0.196486	7(soft_tissue)	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon9:c.G1233C:p.R411R,SYK:uc004arb.3:exon9:c.G1233C:p.R411R,SYK:uc004aqz.3:exon10:c.G1302C:p.R434R,SYK:uc004arc.3:exon10:c.G1302C:p.R434R	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU93007,EAS:0.1812,FIN:0.2152,NFE:0.3532,OTH:0.2053,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	1(urinary_tract)	0.2553
9	93640009	93640009	G	A	SYK	exonic	synonymous SNV	ENSG00000165025	rs2290887	ENSG00000165025:ENST00000375747:exon9:c.G1269A:p.L423L,ENSG00000165025:ENST00000375751:exon9:c.G1269A:p.L423L,ENSG00000165025:ENST00000375746:exon10:c.G1338A:p.L446L,ENSG00000165025:ENST00000375754:exon10:c.G1338A:p.L446L	SYK:NM_001135052:exon9:c.G1269A:p.L423L,SYK:NM_001174168:exon9:c.G1269A:p.L423L,SYK:NM_001174167:exon10:c.G1338A:p.L446L,SYK:NM_003177:exon10:c.G1338A:p.L446L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1833	0.1648	0.196086	3(lung)	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon9:c.G1269A:p.L423L,SYK:uc004arb.3:exon9:c.G1269A:p.L423L,SYK:uc004aqz.3:exon10:c.G1338A:p.L446L,SYK:uc004arc.3:exon10:c.G1338A:p.L446L	.	AFR:MU93027,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|2|321|0.00623053,EAS:0.2134,FIN:0.3532,NFE:0.2053,OTH:0.2565,ASJ:0.1807	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	2(haematopoietic_and_lymphoid_tissue)	0.1899
9	93641175	93641175	C	T	SYK	exonic	synonymous SNV	ENSG00000165025	rs2306041	ENSG00000165025:ENST00000375747:exon10:c.C1452T:p.Y484Y,ENSG00000165025:ENST00000375751:exon10:c.C1452T:p.Y484Y,ENSG00000165025:ENST00000375746:exon11:c.C1521T:p.Y507Y,ENSG00000165025:ENST00000375754:exon11:c.C1521T:p.Y507Y	SYK:NM_001135052:exon10:c.C1452T:p.Y484Y,SYK:NM_001174168:exon10:c.C1452T:p.Y484Y,SYK:NM_001174167:exon11:c.C1521T:p.Y507Y,SYK:NM_003177:exon11:c.C1521T:p.Y507Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1844	0.1678	0.198283	4(lung)	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon10:c.C1452T:p.Y484Y,SYK:uc004arb.3:exon10:c.C1452T:p.Y484Y,SYK:uc004aqz.3:exon11:c.C1521T:p.Y507Y,SYK:uc004arc.3:exon11:c.C1521T:p.Y507Y	.	AFR:1(urinary_tract),AMR:MU93054,EAS:0.1841,FIN:0.2252,NFE:0.3517,OTH:0.2053,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|5|170|0.0294118,COCA-CN|2|321|0.00623053	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	2(haematopoietic_and_lymphoid_tissue)	0.2577
9	93641199	93641199	T	C	SYK	exonic	synonymous SNV	ENSG00000165025	rs2306040	ENSG00000165025:ENST00000375747:exon10:c.T1476C:p.L492L,ENSG00000165025:ENST00000375751:exon10:c.T1476C:p.L492L,ENSG00000165025:ENST00000375746:exon11:c.T1545C:p.L515L,ENSG00000165025:ENST00000375754:exon11:c.T1545C:p.L515L	SYK:NM_001135052:exon10:c.T1476C:p.L492L,SYK:NM_001174168:exon10:c.T1476C:p.L492L,SYK:NM_001174167:exon11:c.T1545C:p.L515L,SYK:NM_003177:exon11:c.T1545C:p.L515L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1097	0.0666	0.130791	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	SYK:uc004ara.3:exon10:c.T1476C:p.L492L,SYK:uc004arb.3:exon10:c.T1476C:p.L492L,SYK:uc004aqz.3:exon11:c.T1545C:p.L515L,SYK:uc004arc.3:exon11:c.T1545C:p.L515L	.	AFR:MU13514305,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.0745,FIN:0.2852,NFE:0.0927,OTH:0.2559,ASJ:0.0830	600085	.	.	.	~ko04064 NF-kappa B signaling pathway~ko04072 Phospholipase D signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko05152 Tuberculosis~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	9	4(soft_tissue)	0.0742
9	96000622	96000622	C	T	WNK2	intronic	.	ENSG00000165238	rs1539670	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9482	0.9682	0.94349	0.9599	.	.	.	.	.	.	.	.	.	.	AFR:0.9757,AMR:0.9773,EAS:0.8938,FIN:0.9550,NFE:0.9595,OTH:0.95,ASJ:0.9205	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU82109719	het
9	96015256	96015256	C	T	WNK2	exonic	synonymous SNV	ENSG00000165238	rs4744201	ENSG00000165238:ENST00000297954:exon8:c.C1926T:p.D642D,ENSG00000165238:ENST00000349097:exon8:c.C762T:p.D254D,ENSG00000165238:ENST00000395475:exon8:c.C1884T:p.D628D,ENSG00000165238:ENST00000395477:exon8:c.C1926T:p.D642D,ENSG00000165238:ENST00000427277:exon8:c.C762T:p.D254D,ENSG00000165238:ENST00000448039:exon8:c.C1926T:p.D642D	WNK2:NM_001282394:exon8:c.C1926T:p.D642D,WNK2:NM_006648:exon8:c.C1926T:p.D642D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4840	0.3729	0.316094	0.3945	.	.	.	.	.	.	.	.	WNK2:uc004atk.3:exon5:c.C837T:p.D279D,WNK2:uc004ati.1:exon8:c.C1926T:p.D642D,WNK2:uc004atj.3:exon8:c.C1926T:p.D642D,WNK2:uc010mrc.1:exon8:c.C1926T:p.D642D,WNK2:uc011lud.1:exon8:c.C1926T:p.D642D	.	AFR:0.1299,AMR:0.6067,EAS:0.4387,FIN:0.4745,NFE:0.5109,OTH:0.4356,ASJ:0.3940	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU684061	het
9	96015377	96015377	A	G	WNK2	intronic	.	ENSG00000165238	rs4744202	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9528	0.9707	0.948283	0.9646	.	.	.	.	.	.	.	.	.	.	AFR:0.9917,AMR:0.9785,EAS:0.8936,FIN:0.9548,NFE:0.9597,OTH:0.9499,ASJ:0.9238	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU81864351	het
9	96021312	96021312	G	A	WNK2	exonic	nonsynonymous SNV	ENSG00000165238	rs10761203	ENSG00000165238:ENST00000395475:exon10:c.G2284A:p.V762M,ENSG00000165238:ENST00000448039:exon10:c.G2326A:p.V776M,ENSG00000165238:ENST00000297954:exon11:c.G2482A:p.V828M,ENSG00000165238:ENST00000349097:exon11:c.G1318A:p.V440M,ENSG00000165238:ENST00000395477:exon11:c.G2482A:p.V828M,ENSG00000165238:ENST00000427277:exon11:c.G1318A:p.V440M	WNK2:NM_001282394:exon11:c.G2482A:p.V828M,WNK2:NM_006648:exon11:c.G2482A:p.V828M	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.4327	0.3680	0.313498	2(thyroid)	2.757	21.1	0.013	2.9	0.024	.	.	.	WNK2:uc004atk.3:exon8:c.G1393A:p.V465M,WNK2:uc010mrc.1:exon10:c.G2326A:p.V776M,WNK2:uc004ati.1:exon11:c.G2482A:p.V828M,WNK2:uc004atj.3:exon11:c.G2482A:p.V828M,WNK2:uc011lud.1:exon11:c.G2482A:p.V828M	-0.915	AFR:MU4551848,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,GACA-JP|1|585|0.0017094,EAS:0.1329,FIN:0.6014,NFE:0.3933,OTH:0.4368,ASJ:0.3837	606249	.	.	.	.	.	.	.	0.675	-0.72	0.000	2.35	9	52(lung)	0.4357
9	96051521	96051521	A	G	WNK2	exonic	synonymous SNV	ENSG00000165238	rs2169756	ENSG00000165238:ENST00000395477:exon19:c.A4485G:p.Q1495Q,ENSG00000165238:ENST00000427277:exon19:c.A3321G:p.Q1107Q,ENSG00000165238:ENST00000297954:exon20:c.A4596G:p.Q1532Q,ENSG00000165238:ENST00000349097:exon20:c.A3432G:p.Q1144Q	WNK2:NM_006648:exon19:c.A4485G:p.Q1495Q,WNK2:NM_001282394:exon20:c.A4596G:p.Q1532Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9500	0.9056	0.920527	0.9124	.	.	.	.	.	.	.	.	WNK2:uc004atl.1:exon1:c.A270G:p.Q90Q,WNK2:uc004atk.3:exon16:c.A3396G:p.Q1132Q,WNK2:uc004atj.3:exon19:c.A4485G:p.Q1495Q,WNK2:uc011lud.1:exon19:c.A4485G:p.Q1495Q,WNK2:uc004ati.1:exon20:c.A4596G:p.Q1532Q	.	AFR:0.7950,AMR:0.9749,EAS:1,FIN:0.9708,NFE:0.9491,OTH:0.9641,ASJ:0.9934	606249	.	.	.	.	.	.	.	.	.	.	.	9	MU67319	hom
9	98209594	98209594	G	A	PTCH1	exonic	nonsynonymous SNV	ENSG00000185920	rs357564	ENSG00000185920:ENST00000331920:exon23:c.C3944T:p.P1315L,ENSG00000185920:ENST00000375274:exon23:c.C3941T:p.P1314L,ENSG00000185920:ENST00000418258:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000421141:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000429896:exon23:c.C3491T:p.P1164L,ENSG00000185920:ENST00000430669:exon23:c.C3746T:p.P1249L,ENSG00000185920:ENST00000437951:exon23:c.C3746T:p.P1249L	PTCH1:NM_001354918:exon22:c.C3788T:p.P1263L,PTCH1:NM_000264:exon23:c.C3944T:p.P1315L,PTCH1:NM_001083602:exon23:c.C3746T:p.P1249L,PTCH1:NM_001083603:exon23:c.C3941T:p.P1314L,PTCH1:NM_001083604:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083605:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083606:exon23:c.C3491T:p.P1164L,PTCH1:NM_001083607:exon23:c.C3491T:p.P1164L	clinvar: Benign 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, 2, 1, 1] 	0.3855	0.2993	0.396765	1(biliary_tract)	6.218	28.8	0.025	4.83	0.995	.	.	.	PTCH1:uc010mrn.3:exon2:c.C320T:p.P107L,PTCH1:uc004avk.4:exon23:c.C3944T:p.P1315L,PTCH1:uc004avl.4:exon23:c.C3491T:p.P1164L,PTCH1:uc004avm.4:exon23:c.C3941T:p.P1314L,PTCH1:uc010mro.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrp.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrq.3:exon23:c.C3491T:p.P1164L,PTCH1:uc010mrr.3:exon23:c.C3746T:p.P1249L	-1.000	AFR:1(bone),AMR:2(pancreas),EAS:2(lung),FIN:11(soft_tissue),NFE:1(large_intestine),OTH:MU148935,ASJ:3(penis)	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9112,9114,9110,9113,9111	.	.	0.944	-2.76	0.000	2.295	9	3(haematopoietic_and_lymphoid_tissue)	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BOCA-UK|1|130|0.00769231,BRCA-KR|1|50|0.02
9	98211572	98211572	T	A	PTCH1	exonic	nonsynonymous SNV	ENSG00000185920	rs2236405	ENSG00000185920:ENST00000331920:exon22:c.A3583T:p.T1195S,ENSG00000185920:ENST00000375274:exon22:c.A3580T:p.T1194S,ENSG00000185920:ENST00000418258:exon22:c.A3130T:p.T1044S,ENSG00000185920:ENST00000421141:exon22:c.A3130T:p.T1044S,ENSG00000185920:ENST00000429896:exon22:c.A3130T:p.T1044S,ENSG00000185920:ENST00000430669:exon22:c.A3385T:p.T1129S,ENSG00000185920:ENST00000437951:exon22:c.A3385T:p.T1129S	PTCH1:NM_001354918:exon21:c.A3427T:p.T1143S,PTCH1:NM_000264:exon22:c.A3583T:p.T1195S,PTCH1:NM_001083602:exon22:c.A3385T:p.T1129S,PTCH1:NM_001083603:exon22:c.A3580T:p.T1194S,PTCH1:NM_001083604:exon22:c.A3130T:p.T1044S,PTCH1:NM_001083605:exon22:c.A3130T:p.T1044S,PTCH1:NM_001083606:exon22:c.A3130T:p.T1044S,PTCH1:NM_001083607:exon22:c.A3130T:p.T1044S	clinvar: Benign/Likely_benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 1] 	0.0546	0.0417	0.0784744	1(lung)	1.747	14.68	0.086	4.62	0.960	.	.	.	PTCH1:uc004avk.4:exon22:c.A3583T:p.T1195S,PTCH1:uc004avl.4:exon22:c.A3130T:p.T1044S,PTCH1:uc004avm.4:exon22:c.A3580T:p.T1194S,PTCH1:uc010mro.3:exon22:c.A3130T:p.T1044S,PTCH1:uc010mrp.3:exon22:c.A3130T:p.T1044S,PTCH1:uc010mrq.3:exon22:c.A3130T:p.T1044S,PTCH1:uc010mrr.3:exon22:c.A3385T:p.T1129S	-0.864	AFR:2(liver),AMR:1(skin),EAS:4(oesophagus),FIN:MU129285,NFE:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,OTH:0.0481,ASJ:1(meninges)	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9112,9114,9110,9113,9111	.	.	0.373	-2.71	0.004	2.295	9	2(penis)	0.1150
9	98220322	98220322	A	C	PTCH1	exonic	synonymous SNV	ENSG00000185920	rs2066835	ENSG00000185920:ENST00000331920:exon18:c.T3141G:p.L1047L,ENSG00000185920:ENST00000375274:exon18:c.T3138G:p.L1046L,ENSG00000185920:ENST00000418258:exon18:c.T2688G:p.L896L,ENSG00000185920:ENST00000421141:exon18:c.T2688G:p.L896L,ENSG00000185920:ENST00000429896:exon18:c.T2688G:p.L896L,ENSG00000185920:ENST00000430669:exon18:c.T2943G:p.L981L,ENSG00000185920:ENST00000437951:exon18:c.T2943G:p.L981L	PTCH1:NM_001354918:exon17:c.T2985G:p.L995L,PTCH1:NM_000264:exon18:c.T3141G:p.L1047L,PTCH1:NM_001083602:exon18:c.T2943G:p.L981L,PTCH1:NM_001083603:exon18:c.T3138G:p.L1046L,PTCH1:NM_001083604:exon18:c.T2688G:p.L896L,PTCH1:NM_001083605:exon18:c.T2688G:p.L896L,PTCH1:NM_001083606:exon18:c.T2688G:p.L896L,PTCH1:NM_001083607:exon18:c.T2688G:p.L896L	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.0239	0.0358	0.067492	0.0385	.	.	.	.	.	.	.	.	PTCH1:uc004avk.4:exon18:c.T3141G:p.L1047L,PTCH1:uc004avl.4:exon18:c.T2688G:p.L896L,PTCH1:uc004avm.4:exon18:c.T3138G:p.L1046L,PTCH1:uc010mro.3:exon18:c.T2688G:p.L896L,PTCH1:uc010mrp.3:exon18:c.T2688G:p.L896L,PTCH1:uc010mrq.3:exon18:c.T2688G:p.L896L,PTCH1:uc010mrr.3:exon18:c.T2943G:p.L981L	.	AFR:0.1128,AMR:0.0060,EAS:0.1057,FIN:0,NFE:0.0013,OTH:0.0122,ASJ:0	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	,9112,9114,9110,9113,9111	.	.	.	.	.	.	9	MU13520628	het
9	98229389	98229389	C	G	LOC100507346	ncRNA_exonic	.	ENSG00000185920	rs2066829	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3583	0.4539	0.390575	0.4487	.	.	.	.	.	.	.	.	.	.	AFR:0.6477,AMR:0.1854,EAS:0.3636,FIN:0.3830,NFE:0.3804,OTH:0.3367,ASJ:0.4007	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	.	.	.	.	.	.	.	.	9	MU21455694	het
9	98239147	98239147	A	G	PTCH1	intronic	.	ENSG00000185920	rs2277184	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0476	0.0738	0.105032	MU13520640	.	.	.	.	.	0	0	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,AMR:0.0697,EAS:0.0179,FIN:0.0464,NFE:0.1426,OTH:0.0072,ASJ:0.1890	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	9	1(skin)	0.0129
9	98270646	98270646	-	GCC	PTCH1	UTR5	.	ENSG00000185920	rs577405858	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0	.	0.202476	0.2365	.	.	.	.	.	.	.	.	.	.	AFR:0.2791,AMR:0.1,EAS:0.2378,FIN:0.2117,NFE:0.2222,OTH:0.1852,ASJ:0.28	601309	109400;605462;610828;	2162;377;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	9	MU128483933	het
9	100459578	100459578	T	C	XPA	UTR5	.	ENSG00000136936	rs1800975	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6335	0.7470	0.646366	ESAD-UK|1|409|0.00244499,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	.	.	AFR:0.6936,AMR:0.8036,EAS:0.6093,FIN:0.5068,NFE:0.6476,OTH:0.6669,ASJ:0.6286	611153	278700;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	9	1(large_intestine)	0.6765
9	101611335	101611335	G	C	GALNT12	exonic	synonymous SNV	ENSG00000119514	rs2273846	ENSG00000119514:ENST00000375011:exon10:c.G1707C:p.S569S	GALNT12:NM_024642:exon10:c.G1707C:p.S569S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0883	0.0832	0.141573	0.0973	.	.	.	.	.	.	.	.	GALNT12:uc004ayz.3:exon10:c.G1707C:p.S569S	.	AFR:0.1468,AMR:0.0835,EAS:0.3017,FIN:0.0842,NFE:0.0508,OTH:0.0898,ASJ:0.0960	610290	608812;	.	.	.	.	.	.	.	.	.	.	9	MU82693	hom
9	102591042	102591042	A	G	NR4A3	exonic	nonsynonymous SNV	ENSG00000119508	rs12344570	ENSG00000119508:ENST00000330847:exon2:c.A751G:p.S251G,ENSG00000119508:ENST00000338488:exon3:c.A718G:p.S240G,ENSG00000119508:ENST00000395097:exon3:c.A718G:p.S240G	NR4A3:NM_006981:exon3:c.A718G:p.S240G,NR4A3:NM_173199:exon3:c.A718G:p.S240G,NR4A3:NM_173200:exon4:c.A751G:p.S251G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4025	.	0.373203	.	-0.433	0.322	0.968	3.65	0.884	.	.	.	NR4A3:uc004bae.3:exon3:c.A718G:p.S240G,NR4A3:uc004baf.1:exon3:c.A718G:p.S240G,NR4A3:uc022bky.1:exon4:c.A751G:p.S251G	-1.001	AFR:0.4588,AMR:0.4667,EAS:0.5331,FIN:0.2364,NFE:0.4483,OTH:0.4872,ASJ:0.3198	600542	612237;	209916;	209916|-|1-9 / 1 000 000|Not applicable|Adult|612237 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.0	-2.29	0.000	-1.445	9	1(salivary_gland)	0.4512
9	102595685	102595685	C	T	NR4A3	exonic	synonymous SNV	ENSG00000119508	rs10988904	ENSG00000119508:ENST00000330847:exon4:c.C1236T:p.A412A,ENSG00000119508:ENST00000338488:exon5:c.C1203T:p.A401A,ENSG00000119508:ENST00000395097:exon5:c.C1203T:p.A401A	NR4A3:NM_006981:exon5:c.C1203T:p.A401A,NR4A3:NM_173199:exon5:c.C1203T:p.A401A,NR4A3:NM_173200:exon6:c.C1236T:p.A412A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3235	0.3693	0.290535	0.3520	.	.	.	.	.	.	.	.	NR4A3:uc004bae.3:exon5:c.C1203T:p.A401A,NR4A3:uc004baf.1:exon5:c.C1203T:p.A401A,NR4A3:uc022bky.1:exon6:c.C1236T:p.A412A	.	AFR:0.3707,AMR:0.2356,EAS:0.1551,FIN:0.3307,NFE:0.3733,OTH:0.3354,ASJ:0.44	600542	612237;	209916;	209916|-|1-9 / 1 000 000|Not applicable|Adult|612237 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	9	MU13379541	het
9	110081018	110081018	A	G	RAD23B	intronic	.	ENSG00000119318	rs1805335	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5495	0.5537	0.579073	0.5503	.	.	.	.	.	.	.	.	.	.	AFR:0.5487,AMR:0.5383,EAS:0.7920,FIN:0.5692,NFE:0.5193,OTH:0.5463,ASJ:0.6567	600062	.	.	.	.	.	.	.	.	.	.	.	9	MU81865700	het
9	131085373	131085373	G	C	COQ4	exonic	nonsynonymous SNV	ENSG00000167113	rs3003601	ENSG00000167113:ENST00000300452:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000372875:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000608951:exon2:c.G149C:p.G50A,ENSG00000167113:ENST00000609948:exon2:c.G149C:p.G50A	COQ4:NM_001305942:exon2:c.G149C:p.G50A,COQ4:NM_016035:exon2:c.G149C:p.G50A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9988	0.9970	0.998003	0.9967	-0.680	0.080	1.0	-2.65	0.956	.	.	.	COQ4:uc010mxy.3:exon1:c.G77C:p.G26A,COQ4:uc004bur.4:exon2:c.G149C:p.G50A,COQ4:uc011max.1:exon2:c.G149C:p.G50A	-1.009	AFR:0.9890,AMR:0.9988,EAS:1,FIN:1,NFE:0.9997,OTH:0.9980,ASJ:1	612898	616276;	457185;	457185|COQ4-related neonatal encephalomyopathy|<1 / 1 000 000|Autosomal recessive|Neonatal|616276 ~	.	.	.	.	0.001	1.13	0.000	-1.765	9	MU81869115	hom
9	131095112	131095112	A	C	COQ4	intronic	.	ENSG00000167113	rs7850697	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2450	0.3542	0.377796	0.3328	.	.	.	.	.	.	.	.	.	.	AFR:0.7013,AMR:0.2267,EAS:0.2689,FIN:0.1980,NFE:0.1726,OTH:0.1994,ASJ:0.2748	612898	616276;	457185;	457185|COQ4-related neonatal encephalomyopathy|<1 / 1 000 000|Autosomal recessive|Neonatal|616276 ~	.	.	.	.	.	.	.	.	9	MU81869124	het
9	131346218	131346218	A	C	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs10760566	ENSG00000197694:ENST00000358161:exon16:c.A2163C:p.A721A,ENSG00000197694:ENST00000372731:exon16:c.A2163C:p.A721A,ENSG00000197694:ENST00000372739:exon16:c.A2163C:p.A721A	SPTAN1:NM_001130438:exon16:c.A2163C:p.A721A,SPTAN1:NM_001195532:exon16:c.A2163C:p.A721A,SPTAN1:NM_001363759:exon16:c.A2163C:p.A721A,SPTAN1:NM_001363765:exon16:c.A2163C:p.A721A,SPTAN1:NM_003127:exon16:c.A2163C:p.A721A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9914	0.9701	0.969848	0.9713	.	.	.	.	.	.	.	.	SPTAN1:uc004bvl.4:exon16:c.A2163C:p.A721A,SPTAN1:uc004bvm.4:exon16:c.A2163C:p.A721A,SPTAN1:uc004bvn.4:exon16:c.A2163C:p.A721A,SPTAN1:uc011mbg.2:exon16:c.A2163C:p.A721A,SPTAN1:uc011mbh.2:exon17:c.A2199C:p.A733A	.	AFR:0.8996,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9939,ASJ:1	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU81869219	hom
9	131360750	131360750	C	T	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs2227864	ENSG00000197694:ENST00000358161:exon25:c.C3486T:p.L1162L,ENSG00000197694:ENST00000372731:exon25:c.C3486T:p.L1162L,ENSG00000197694:ENST00000372739:exon25:c.C3486T:p.L1162L	SPTAN1:NM_001195532:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001363765:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001130438:exon25:c.C3486T:p.L1162L,SPTAN1:NM_001363759:exon25:c.C3486T:p.L1162L,SPTAN1:NM_003127:exon25:c.C3486T:p.L1162L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8064	0.7604	0.642772	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon24:c.C3426T:p.L1142L,SPTAN1:uc011mbg.2:exon24:c.C3426T:p.L1142L,SPTAN1:uc004bvl.4:exon25:c.C3486T:p.L1162L,SPTAN1:uc004bvm.4:exon25:c.C3486T:p.L1162L,SPTAN1:uc011mbh.2:exon26:c.C3522T:p.L1174L	.	AFR:0.7491,AMR:0.4777,EAS:0.9172,FIN:0.5161,NFE:0.8242,OTH:0.9048,ASJ:0.7828	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	1(salivary_gland)	0.8160
9	131375701	131375701	A	G	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs1415568	ENSG00000197694:ENST00000372731:exon39:c.A5070G:p.L1690L,ENSG00000197694:ENST00000358161:exon40:c.A5085G:p.L1695L,ENSG00000197694:ENST00000372739:exon40:c.A5085G:p.L1695L	SPTAN1:NM_001195532:exon38:c.A5010G:p.L1670L,SPTAN1:NM_001363765:exon39:c.A5025G:p.L1675L,SPTAN1:NM_003127:exon39:c.A5070G:p.L1690L,SPTAN1:NM_001130438:exon40:c.A5085G:p.L1695L,SPTAN1:NM_001363759:exon40:c.A5085G:p.L1695L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9959	0.9854	0.984824	0.9846	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon38:c.A5010G:p.L1670L,SPTAN1:uc004bvl.4:exon39:c.A5070G:p.L1690L,SPTAN1:uc004bvm.4:exon40:c.A5085G:p.L1695L	.	AFR:0.9466,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	MU81869234	hom
9	131379967	131379967	C	T	SPTAN1	exonic	synonymous SNV	ENSG00000197694	rs2227862	ENSG00000197694:ENST00000372731:exon41:c.C5391T:p.T1797T,ENSG00000197694:ENST00000358161:exon42:c.C5406T:p.T1802T,ENSG00000197694:ENST00000372739:exon42:c.C5406T:p.T1802T	SPTAN1:NM_001195532:exon40:c.C5331T:p.T1777T,SPTAN1:NM_001363765:exon41:c.C5346T:p.T1782T,SPTAN1:NM_003127:exon41:c.C5391T:p.T1797T,SPTAN1:NM_001130438:exon42:c.C5406T:p.T1802T,SPTAN1:NM_001363759:exon42:c.C5406T:p.T1802T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7913	0.7328	0.617013	MU4566604	.	.	.	.	.	.	.	.	SPTAN1:uc004bvn.4:exon40:c.C5331T:p.T1777T,SPTAN1:uc004bvl.4:exon41:c.C5391T:p.T1797T,SPTAN1:uc004bvm.4:exon42:c.C5406T:p.T1802T	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.7233,EAS:0.7709,FIN:0.9133,NFE:0.5099,OTH:0.8235,ASJ:0.3892	182810	613477;	3451;	3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	9	1(thyroid)	0.9049
9	131454120	131454120	C	T	SET	intronic	.	ENSG00000119335	rs3750330	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9470	0.8618	0.846645	0.8696	.	.	.	.	.	.	.	.	.	.	AFR:0.5820,AMR:0.9570,EAS:0.9061,FIN:0.9716,NFE:0.9960,OTH:0.9593,ASJ:0.9801	600960	.	.	.	.	.	.	.	.	.	.	.	9	MU21478205	hom
9	131455903	131455903	C	T	SET	intronic	.	ENSG00000119335	rs4836618	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9465	0.8600	0.845248	0.8698	.	.	.	.	.	.	.	.	.	.	AFR:0.5824,AMR:0.9570,EAS:0.9068,FIN:0.9719,NFE:0.9959,OTH:0.9593,ASJ:0.9801	600960	.	.	.	.	.	.	.	.	.	.	.	9	MU21478277	hom
9	131456385	131456385	-	TA	SET	intronic	.	ENSG00000119335	rs10637043	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	.	0.8278	.	.	.	.	.	.	.	.	.	.	AFR:0.6190,AMR:0.7987,EAS:0.8946,FIN:0.7615,NFE:0.9507,OTH:0.8894,ASJ:0.9126	600960	.	.	.	.	.	.	.	.	.	.	.	9	.	het
9	133710819	133710819	-	C	ABL1	UTR5	.	ENSG00000097007	rs11433463	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	189980	.	.	.	~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04110 Cell cycle~ko04360 Axon guidance~ko04722 Neurotrophin signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05220 Chronic myeloid leukemia~ko05416 Viral myocarditis ~	.	.	.	.	.	.	.	9	.	unknown
9	133761001	133761001	A	G	ABL1	exonic	synonymous SNV	ENSG00000097007	rs1056171	ENSG00000097007:ENST00000318560:exon11:c.A3324G:p.P1108P,ENSG00000097007:ENST00000372348:exon11:c.A3381G:p.P1127P	ABL1:NM_005157:exon11:c.A3324G:p.P1108P,ABL1:NM_007313:exon11:c.A3381G:p.P1127P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.5490	0.5849	0.654153	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ABL1:uc004bzv.3:exon11:c.A3381G:p.P1127P,ABL1:uc004bzw.3:exon11:c.A3324G:p.P1108P	.	AFR:16(soft_tissue),AMR:MU27188632,EAS:0.5911,FIN:0.8308,NFE:0.6969,OTH:0.5099,ASJ:LAML-KR|2|205|0.0097561,COCA-CN|6|321|0.0186916	189980	.	.	.	~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04110 Cell cycle~ko04360 Axon guidance~ko04722 Neurotrophin signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05220 Chronic myeloid leukemia~ko05416 Viral myocarditis ~	,155	.	.	.	.	.	.	9	1(large_intestine)	0.6222
9	134020092	134020092	C	T	NUP214	exonic	nonsynonymous SNV	ENSG00000126883	rs103612	ENSG00000126883:ENST00000359428:exon12:c.C1720T:p.P574S,ENSG00000126883:ENST00000411637:exon12:c.C1720T:p.P574S,ENSG00000126883:ENST00000451030:exon12:c.C1720T:p.P574S	NUP214:NM_001318324:exon12:c.C1720T:p.P574S,NUP214:NM_005085:exon12:c.C1720T:p.P574S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6641	0.6687	0.641973	0.6707	3.049	22.4	0.225	1.78	0.261	.	.	.	NUP214:uc004cai.3:exon1:c.C7T:p.P3S,NUP214:uc004caf.1:exon12:c.C1720T:p.P574S,NUP214:uc004cag.3:exon12:c.C1720T:p.P574S,NUP214:uc004cah.3:exon12:c.C1720T:p.P574S	-0.996	AFR:0.6539,AMR:0.7572,EAS:0.6210,FIN:0.6907,NFE:0.6767,OTH:0.6806,ASJ:0.6167	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	0.002	1.51	0.000	1.92	9	MU82111232	het
9	134021630	134021630	A	G	NUP214	exonic	synonymous SNV	ENSG00000126883	rs2296710	ENSG00000126883:ENST00000359428:exon13:c.A1884G:p.T628T,ENSG00000126883:ENST00000411637:exon13:c.A1851G:p.T617T,ENSG00000126883:ENST00000451030:exon13:c.A1884G:p.T628T	NUP214:NM_001318324:exon13:c.A1851G:p.T617T,NUP214:NM_005085:exon13:c.A1884G:p.T628T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3309	0.3022	0.346446	0.3227	.	.	.	.	.	.	.	.	NUP214:uc004cai.3:exon2:c.A171G:p.T57T,NUP214:uc004caf.1:exon13:c.A1851G:p.T617T,NUP214:uc004cag.3:exon13:c.A1884G:p.T628T,NUP214:uc004cah.3:exon13:c.A1851G:p.T617T	.	AFR:0.2908,AMR:0.2416,EAS:0.4250,FIN:0.3437,NFE:0.3280,OTH:0.3299,ASJ:0.3833	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	9	MU588209	het
9	134062770	134062770	-	T	NUP214	intronic	.	ENSG00000126883	rs762584920	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0535	.	.	0.1108	.	.	.	.	.	.	.	.	.	.	AFR:0.0708,AMR:0.1273,EAS:0.2088,FIN:0.0212,NFE:0.1283,OTH:0.0906,ASJ:0.1465	114350	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	9	.	het
9	135773000	135773000	-	AA	TSC1	intronic	.	ENSG00000165699	rs397722330	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1533	.	.	0.5231	.	.	.	.	.	.	.	.	.	.	AFR:0.3307,AMR:0.4931,EAS:0.6234,FIN:0.3103,NFE:0.6008,OTH:0.6232,ASJ:0.6596	605284	191100;606690;	538;805;	538|LAM|1-9 / 1 000 000|Not applicable|Adult|606690 ~805|Bourneville syndrome<br>Tuberous sclerosis|1-5 / 10 000|Autosomal dominant|All ages|191100 613254 ~	~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	9	.	het
9	136637177	136637177	-	CACACGGCCCCGGCGGTCACTGCGTGAGGGC	VAV2	intronic	.	ENSG00000160293	rs367642598	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	0.3902	0.22524	0.3475	.	.	.	.	.	.	.	.	.	.	AFR:0.2947,AMR:0.2852,EAS:0.0377,FIN:0.3645,NFE:0.4099,OTH:0.3690,ASJ:0.3767	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU112597187	het
9	136643994	136643994	T	C	VAV2	exonic	nonsynonymous SNV	ENSG00000160293	rs602990	ENSG00000160293:ENST00000371851:exon20:c.A1750G:p.M584V,ENSG00000160293:ENST00000406606:exon20:c.A1750G:p.M584V,ENSG00000160293:ENST00000371850:exon22:c.A1780G:p.M594V	VAV2:NM_003371:exon20:c.A1750G:p.M584V,VAV2:NM_001134398:exon22:c.A1780G:p.M594V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5016	0.6222	0.495208	2(liver)	-0.716	0.066	0.805	1.91	0.853	.	.	SH3 domain;SH3 domain|Variant SH3 domain	VAV2:uc004cet.1:exon8:c.A397G:p.M133V,VAV2:uc004cer.3:exon20:c.A1750G:p.M584V,VAV2:uc004ces.3:exon22:c.A1780G:p.M594V	-1.032	AFR:MU588223,AMR:COCA-CN|2|321|0.00623053,EAS:0.7957,FIN:0.4653,NFE:0.56,OTH:0.0531,ASJ:0.5778	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	0.0	3.35	0.000	-0.655	9	1(stomach)	0.5003
9	136645079	136645079	G	C	VAV2	intronic	.	ENSG00000160293	rs540626	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2969	0.3162	0.241613	0.3013	.	.	.	.	.	.	.	.	.	.	AFR:0.2653,AMR:0.2249,EAS:0.0086,FIN:0.3247,NFE:0.3507,OTH:0.3143,ASJ:0.3675	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	.	het
9	136648606	136648606	G	A	VAV2	intronic	.	ENSG00000160293	rs1468128	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7246	0.6048	0.690096	0.6390	.	.	.	.	.	.	.	.	.	.	AFR:0.4276,AMR:0.7222,EAS:0.9639,FIN:0.6866,NFE:0.7070,OTH:0.6936,ASJ:0.7207	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU81871689	hom
9	136648611	136648611	-	G	VAV2	intronic	.	ENSG00000160293	rs56145872	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.8287	0.7097	0.131789	0.7542	.	.	.	.	.	.	.	.	.	.	AFR:0.4406,AMR:0.8017,EAS:0.9682,FIN:0.8421,NFE:0.8711,OTH:0.8333,ASJ:0.8699	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	.	hom
9	136654366	136654366	C	T	VAV2	intronic	.	ENSG00000160293	rs45607334	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1236	0.1067	0.0854633	0.1065	.	.	.	.	.	.	.	.	.	.	AFR:0.0447,AMR:0.1348,EAS:0.0129,FIN:0.1383,NFE:0.1414,OTH:0.1360,ASJ:0.1225	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU588224	het
9	136804211	136804211	G	A	VAV2	intronic	.	ENSG00000160293	rs2073886	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7450	0.7196	0.702676	0.7217	.	.	.	.	.	.	.	.	.	.	AFR:0.6228,AMR:0.7041,EAS:0.7892,FIN:0.7327,NFE:0.7658,OTH:0.7658,ASJ:0.8046	600428	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	9	MU19104859	hom
9	139391636	139391636	G	A	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs2229974	ENSG00000148400:ENST00000277541:exon34:c.C6555T:p.D2185D	NOTCH1:NM_017617:exon34:c.C6555T:p.D2185D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6187	0.5813	0.695088	1(breast)	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon34:c.C6555T:p.D2185D	.	AFR:1(large_intestine),AMR:MU123836,EAS:0.5914,FIN:0.6176,NFE:0.6734,OTH:0.5232,ASJ:ESAD-UK|1|409|0.00244499,COCA-CN|5|321|0.0155763	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7821,7810,7815,7812,7822,7820,7817,7811,7816,7823,7818	.	7819,,7813,7814	.	.	.	.	9	2(skin)	0.9635
9	139397707	139397707	G	A	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs10521	ENSG00000148400:ENST00000277541:exon27:c.C5094T:p.D1698D	NOTCH1:NM_017617:exon27:c.C5094T:p.D1698D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4443	0.4080	0.553514	13(soft_tissue)	.	.	.	.	.	.	.	.	NOTCH1:uc004cia.1:exon14:c.C2784T:p.D928D,NOTCH1:uc004chz.3:exon27:c.C5094T:p.D1698D	.	AFR:1(lung),AMR:12(haematopoietic_and_lymphoid_tissue),EAS:MU58034,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,NFE:0.4460,OTH:0.5089,ASJ:12(meninges)	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7821,7810,7815,7812,7822,7820,7817,7811,7816,7823,7818	.	7819,,7813,7814	.	.	.	.	9	1(liver)	0.5240
9	139405261	139405261	C	T	NOTCH1	intronic	.	ENSG00000148400	rs3125001	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4725	0.4549	0.585463	0.5007	.	.	.	.	.	0	0	.	.	.	AFR:0.6460,AMR:0.5372,EAS:0.8807,FIN:0.4638,NFE:0.3871,OTH:0.4418,ASJ:0.4040	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU677644	hom
9	139407932	139407932	A	G	NOTCH1	exonic	synonymous SNV	ENSG00000148400	rs2229971	ENSG00000148400:ENST00000277541:exon14:c.T2265C:p.N755N	NOTCH1:NM_017617:exon14:c.T2265C:p.N755N	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3977	0.3975	0.527756	MU123856	.	.	.	.	.	.	.	.	NOTCH1:uc004chz.3:exon14:c.T2265C:p.N755N	.	AFR:COCA-CN|5|321|0.0155763,AMR:0.4428,EAS:0.5024,FIN:0.2152,NFE:0.8152,OTH:0.4293,ASJ:0.6200	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	,7821,7810,7815,7812,7822,7820,7817,7811,7816,7823,7818	.	7819,,7813,7814	.	.	.	.	9	1(skin)	0.3095
9	139410177	139410177	T	C	NOTCH1	intronic	.	ENSG00000148400	rs3124603	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4361	0.3961	0.58726	0.4866	.	.	.	.	.	0	0.006	.	.	.	AFR:0.6389,AMR:0.5383,EAS:0.8663,FIN:0.4845,NFE:0.3626,OTH:0.4294,ASJ:0.2781	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU32592860	het
9	139410424	139410424	A	G	NOTCH1	intronic	.	ENSG00000148400	rs3125006	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8704	0.8733	0.883986	0.8911	.	.	.	.	.	.	.	.	.	.	AFR:0.8972,AMR:0.9153,EAS:0.9463,FIN:0.9257,NFE:0.8743,OTH:0.8867,ASJ:0.7980	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU81872781	hom
9	139411714	139411714	T	C	NOTCH1	intronic	.	ENSG00000148400	rs11145767	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5481	0.4280	0.605431	0.4993	.	.	.	.	.	.	.	.	.	.	AFR:0.7107,AMR:0.5180,EAS:0.8767,FIN:0.4902,NFE:0.3459,OTH:0.4308,ASJ:0.2450	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	MU26998549	het
9	139412197	139412197	G	A	NOTCH1	intronic	.	ENSG00000148400	rs9411208	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5768	0.5544	0.696286	COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0010	0.052	.	.	.	AFR:0.5928,AMR:0.7293,EAS:0.4603,FIN:0.9273,NFE:0.5904,OTH:0.4803,ASJ:0.6280	190198	109730;616028;	974;402075;	974|AOS<br>Congenital scalp defects with distal limb anomalies<br>Congenital scalp defects with distal limb reduction anomalies<br>Limb, scalp and skull defects|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|100300 614219 614814 615297 616028 616589 ~402075|-|-|Autosomal dominant|-|109730 614823 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04361 Axon regeneration~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05020 Prion diseases~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	9	13(meninges)	0.5612
10	14976414	14976414	G	A	DCLRE1C	exonic	synonymous SNV	ENSG00000152457	rs7076862	ENSG00000152457:ENST00000357717:exon6:c.C298T:p.L100L,ENSG00000152457:ENST00000378249:exon6:c.C298T:p.L100L,ENSG00000152457:ENST00000378246:exon7:c.C298T:p.L100L,ENSG00000152457:ENST00000378278:exon8:c.C643T:p.L215L,ENSG00000152457:ENST00000378289:exon8:c.C643T:p.L215L,ENSG00000152457:ENST00000453695:exon8:c.C283T:p.L95L,ENSG00000152457:ENST00000378254:exon9:c.C283T:p.L95L,ENSG00000152457:ENST00000378258:exon9:c.C283T:p.L95L,ENSG00000152457:ENST00000418843:exon9:c.C205T:p.L69L,ENSG00000152457:ENST00000378255:exon10:c.C283T:p.L95L,ENSG00000152457:ENST00000396817:exon10:c.C283T:p.L95L	DCLRE1C:NM_001289076:exon6:c.C298T:p.L100L,DCLRE1C:NM_001289078:exon6:c.C298T:p.L100L,DCLRE1C:NM_001350966:exon6:c.C298T:p.L100L,DCLRE1C:NM_022487:exon7:c.C298T:p.L100L,DCLRE1C:NM_001033855:exon8:c.C643T:p.L215L,DCLRE1C:NM_001350965:exon8:c.C643T:p.L215L,DCLRE1C:NM_001033857:exon9:c.C283T:p.L95L,DCLRE1C:NM_001289077:exon9:c.C283T:p.L95L,DCLRE1C:NM_001350967:exon9:c.C283T:p.L95L,DCLRE1C:NM_001033858:exon10:c.C283T:p.L95L,DCLRE1C:NM_001289079:exon10:c.C283T:p.L95L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4187	0.4497	0.5	0.4302	.	.	.	.	.	.	.	.	DCLRE1C:uc021pni.1:exon4:c.C298T:p.L100L,DCLRE1C:uc001inr.3:exon6:c.C298T:p.L100L,DCLRE1C:uc009xji.3:exon6:c.C298T:p.L100L,DCLRE1C:uc001ino.3:exon7:c.C298T:p.L100L,DCLRE1C:uc001inn.3:exon8:c.C643T:p.L215L,DCLRE1C:uc010qbx.2:exon8:c.C643T:p.L215L,DCLRE1C:uc001inl.3:exon9:c.C283T:p.L95L,DCLRE1C:uc001inp.3:exon9:c.C283T:p.L95L,DCLRE1C:uc001inm.3:exon10:c.C283T:p.L95L,DCLRE1C:uc001inq.3:exon10:c.C283T:p.L95L	.	AFR:0.6495,AMR:0.4796,EAS:0.4133,FIN:0.2474,NFE:0.3506,OTH:0.3276,ASJ:0.4503	605988	602450;603554;	39041;275;	39041|Combined immunodeficiency with hypereosinophilia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|603554 ~275|SCID due to ARTEMIS deficiency<br>SCID due to DCLRE1C deficiency<br>SCID, Athabascan type<br>SCID, Athabaskan type<br>Severe combined immunodeficiency due to ARTEMIS deficiency<br>Severe combined immunodeficiency, Athabascan type<br>Severe combined immunodeficiency, Athabaskan type|Unknown|Autosomal recessive|Infancy<br>Neonatal|602450 ~	.	.	.	.	.	.	.	.	10	MU19126674	het
10	14976727	14976727	G	C	DCLRE1C	exonic	nonsynonymous SNV	ENSG00000152457	rs35441642	ENSG00000152457:ENST00000357717:exon5:c.C167G:p.P56R,ENSG00000152457:ENST00000378249:exon5:c.C167G:p.P56R,ENSG00000152457:ENST00000378246:exon6:c.C167G:p.P56R,ENSG00000152457:ENST00000378278:exon7:c.C512G:p.P171R,ENSG00000152457:ENST00000378289:exon7:c.C512G:p.P171R,ENSG00000152457:ENST00000453695:exon7:c.C152G:p.P51R,ENSG00000152457:ENST00000378254:exon8:c.C152G:p.P51R,ENSG00000152457:ENST00000378258:exon8:c.C152G:p.P51R,ENSG00000152457:ENST00000418843:exon8:c.C74G:p.P25R,ENSG00000152457:ENST00000456122:exon8:c.C167G:p.P56R,ENSG00000152457:ENST00000378241:exon9:c.C152G:p.P51R,ENSG00000152457:ENST00000378255:exon9:c.C152G:p.P51R,ENSG00000152457:ENST00000396817:exon9:c.C152G:p.P51R	DCLRE1C:NM_001289076:exon5:c.C167G:p.P56R,DCLRE1C:NM_001289078:exon5:c.C167G:p.P56R,DCLRE1C:NM_001350966:exon5:c.C167G:p.P56R,DCLRE1C:NM_022487:exon6:c.C167G:p.P56R,DCLRE1C:NM_001033855:exon7:c.C512G:p.P171R,DCLRE1C:NM_001350965:exon7:c.C512G:p.P171R,DCLRE1C:NM_001033857:exon8:c.C152G:p.P51R,DCLRE1C:NM_001289077:exon8:c.C152G:p.P51R,DCLRE1C:NM_001350967:exon8:c.C152G:p.P51R,DCLRE1C:NM_001033858:exon9:c.C152G:p.P51R,DCLRE1C:NM_001289079:exon9:c.C152G:p.P51R	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0905	0.0912	0.116813	2(lung)	4.962	25.0	0.023	4.73	0.941	.	.	Metallo-beta-lactamase	DCLRE1C:uc021pni.1:exon3:c.C167G:p.P56R,DCLRE1C:uc001inr.3:exon5:c.C167G:p.P56R,DCLRE1C:uc009xji.3:exon5:c.C167G:p.P56R,DCLRE1C:uc001ino.3:exon6:c.C167G:p.P56R,DCLRE1C:uc001inn.3:exon7:c.C512G:p.P171R,DCLRE1C:uc010qbx.2:exon7:c.C512G:p.P171R,DCLRE1C:uc001inl.3:exon8:c.C152G:p.P51R,DCLRE1C:uc001inp.3:exon8:c.C152G:p.P51R,DCLRE1C:uc001inm.3:exon9:c.C152G:p.P51R,DCLRE1C:uc001inq.3:exon9:c.C152G:p.P51R	-1.280	AFR:MU581751,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.1323,FIN:0.1110,NFE:0.0894,OTH:0.1722,ASJ:0.0937	605988	602450;603554;	39041;275;	39041|Combined immunodeficiency with hypereosinophilia|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|603554 ~275|SCID due to ARTEMIS deficiency<br>SCID due to DCLRE1C deficiency<br>SCID, Athabascan type<br>SCID, Athabaskan type<br>Severe combined immunodeficiency due to ARTEMIS deficiency<br>Severe combined immunodeficiency, Athabascan type<br>Severe combined immunodeficiency, Athabaskan type|Unknown|Autosomal recessive|Infancy<br>Neonatal|602450 ~	.	.	.	.	0.589	-0.81	0.011	2.735	10	1(haematopoietic_and_lymphoid_tissue)	0.0504
10	27319465	27319465	T	C	ANKRD26	intronic	.	ENSG00000107890	rs10829165	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.857628	0.8220	.	.	.	.	.	.	.	.	.	.	AFR:0.8599,AMR:0.7133,EAS:0.9932,FIN:0.8683,NFE:0.7763,OTH:0.8378,ASJ:0.7833	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	.	hom
10	27326999	27326999	T	C	ANKRD26	intronic	.	ENSG00000107890	rs7096505	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8408	0.8289	0.865216	0.8452	.	.	.	.	.	.	.	.	.	.	AFR:0.8609,AMR:0.7321,EAS:0.9932,FIN:0.9057,NFE:0.8121,OTH:0.8612,ASJ:0.8067	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	.	.	.	.	10	MU19136977	hom
10	27389197	27389197	T	C	ANKRD26	exonic	nonsynonymous SNV	ENSG00000107890	rs7897309	ENSG00000107890:ENST00000376087:exon1:c.A59G:p.Q20R,ENSG00000107890:ENST00000436985:exon1:c.A59G:p.Q20R	ANKRD26:NM_001256053:exon1:c.A59G:p.Q20R,ANKRD26:NM_014915:exon1:c.A59G:p.Q20R	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8977	0.8935	0.944688	0.9039	-1.524	0.002	1.0	-1.08	0.003	.	.	.	ANKRD26:uc001ith.2:exon1:c.A59G:p.Q20R,ANKRD26:uc009xku.1:exon1:c.A59G:p.Q20R	-0.984	AFR:0.9727,AMR:0.9010,EAS:1,FIN:0.9275,NFE:0.8493,OTH:0.9043,ASJ:0.8477	610855	188000;	168629;268322;	168629|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|188000 273900 612004 ~268322|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|188000 273900 313900 612004 ~	.	.	.	.	0.0	1.63	0.000	-1.355	10	MU71687	hom
10	31750099	31750099	C	T	ZEB1	exonic	synonymous SNV	ENSG00000148516	rs7918614	ENSG00000148516:ENST00000320985:exon2:c.C192T:p.D64D,ENSG00000148516:ENST00000361642:exon2:c.C192T:p.D64D,ENSG00000148516:ENST00000424869:exon2:c.C192T:p.D64D,ENSG00000148516:ENST00000446923:exon2:c.C141T:p.D47D,ENSG00000148516:ENST00000558440:exon2:c.C192T:p.D64D,ENSG00000148516:ENST00000559476:exon2:c.C141T:p.D47D,ENSG00000148516:ENST00000560721:exon2:c.C192T:p.D64D,ENSG00000148516:ENST00000561212:exon2:c.C216T:p.D72D	ZEB1:NM_001128128:exon2:c.C141T:p.D47D,ZEB1:NM_001174093:exon2:c.C192T:p.D64D,ZEB1:NM_001174094:exon2:c.C141T:p.D47D,ZEB1:NM_001174096:exon2:c.C192T:p.D64D,ZEB1:NM_001323674:exon2:c.C192T:p.D64D,ZEB1:NM_001323675:exon2:c.C150T:p.D50D,ZEB1:NM_001323676:exon2:c.C150T:p.D50D,ZEB1:NM_001323677:exon2:c.C150T:p.D50D,ZEB1:NM_001323678:exon2:c.C141T:p.D47D,ZEB1:NM_030751:exon2:c.C192T:p.D64D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0322	0.0643	0.0858626	0.0560	.	.	.	.	.	.	.	.	ZEB1:uc001ivs.4:exon2:c.C192T:p.D64D,ZEB1:uc001ivu.4:exon2:c.C192T:p.D64D,ZEB1:uc001ivv.4:exon2:c.C192T:p.D64D,ZEB1:uc009xlj.1:exon2:c.C192T:p.D64D,ZEB1:uc009xlo.2:exon2:c.C141T:p.D47D,ZEB1:uc009xlp.3:exon2:c.C141T:p.D47D	.	AFR:0.1765,AMR:0.0227,EAS:0.0278,FIN:0.0037,NFE:0.0060,OTH:0.0224,ASJ:0.0132	189909	609141;613270;	98974;98973;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~98973|PPCD<br>Posterior polymorphous dystrophy<br>Schlichting dystrophy|Unknown|Autosomal dominant|Childhood|122000 609140 609141 ~	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	10	MU23457141	het
10	31803516	31803516	G	A	ZEB1	intronic	.	ENSG00000148516	rs220060	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9425	0.9154	0.921326	0.9197	.	.	.	.	.	.	.	.	.	.	AFR:0.8338,AMR:0.9725,EAS:1,FIN:0.9372,NFE:0.9520,OTH:0.9407,ASJ:0.9503	189909	609141;613270;	98974;98973;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~98973|PPCD<br>Posterior polymorphous dystrophy<br>Schlichting dystrophy|Unknown|Autosomal dominant|Childhood|122000 609140 609141 ~	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	10	MU81878063	hom
10	32311969	32311969	A	G	KIF5B	intronic	.	ENSG00000170759	rs176924	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9914	0.9677	0.967053	0.9753	.	.	.	.	.	0.0002	0.006	.	.	.	AFR:0.9135,AMR:0.9940,EAS:1,FIN:1,NFE:1,OTH:0.9939,ASJ:1	602809	.	.	.	.	.	.	.	.	.	.	.	10	MU81878086	hom
10	43595968	43595968	A	G	RET	exonic	synonymous SNV	ENSG00000165731	rs1800858	ENSG00000165731:ENST00000340058:exon2:c.A135G:p.A45A,ENSG00000165731:ENST00000355710:exon2:c.A135G:p.A45A	RET:NM_020630:exon2:c.A135G:p.A45A,RET:NM_020975:exon2:c.A135G:p.A45A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7365	0.8092	0.753594	1(breast)	.	.	.	.	.	.	.	.	RET:uc001jak.1:exon2:c.A135G:p.A45A,RET:uc001jal.3:exon2:c.A135G:p.A45A	.	AFR:17(meninges),AMR:MU4562096,EAS:0.7726,FIN:0.9506,NFE:0.7787,OTH:0.6656,ASJ:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9510,9514,9508,9513,9509,9511,9506,9507,9512	.	.	.	.	.	.	10	1(large_intestine)	0.5790
10	43604950	43604950	A	G	RET	intronic	.	ENSG00000165731	rs1864403	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.754193	0.7729	.	.	.	.	.	.	.	.	.	.	AFR:0.9488,AMR:0.7792,EAS:0.5774,FIN:0.6494,NFE:0.7265,OTH:0.7041,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43605392	43605392	G	A	RET	intronic	.	ENSG00000165731	rs2251674	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.72484	0.7456	.	.	.	.	.	.	.	.	.	.	AFR:0.8580,AMR:0.7745,EAS:0.5737,FIN:0.6429,NFE:0.7254,OTH:0.6973,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43605860	43605860	T	G	RET	intronic	.	ENSG00000165731	rs1864402	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.742412	0.7599	.	.	.	.	.	.	.	.	.	.	AFR:0.9029,AMR:0.7769,EAS:0.5978,FIN:0.6426,NFE:0.7258,OTH:0.7029,ASJ:0.6767	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43605902	43605902	A	G	RET	intronic	.	ENSG00000165731	rs1864401	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.743011	0.7603	.	.	.	.	.	.	.	.	.	.	AFR:0.9015,AMR:0.7799,EAS:0.5972,FIN:0.6460,NFE:0.7263,OTH:0.7100,ASJ:0.6755	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43606552	43606552	T	C	RET	intronic	.	ENSG00000165731	rs9282836	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.000199681	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43606687	43606687	A	G	RET	exonic	synonymous SNV	ENSG00000165731	rs1800860	ENSG00000165731:ENST00000340058:exon7:c.A1296G:p.A432A,ENSG00000165731:ENST00000355710:exon7:c.A1296G:p.A432A	RET:NM_001355216:exon4:c.A534G:p.A178A,RET:NM_020630:exon7:c.A1296G:p.A432A,RET:NM_020975:exon7:c.A1296G:p.A432A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7061	0.7486	0.77516	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RET:uc010qez.1:exon4:c.A534G:p.A178A,RET:uc001jak.1:exon7:c.A1296G:p.A432A,RET:uc001jal.3:exon7:c.A1296G:p.A432A	.	AFR:0.7388,AMR:0.8614,EAS:0.7351,FIN:0.7862,NFE:0.6981,OTH:0.6843,ASJ:0.5586	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9510,9514,9508,9513,9509,9511,9506,9507,9512	.	.	.	.	.	.	10	17(meninges)	0.7031
10	43607221	43607221	C	G	RET	intronic	.	ENSG00000165731	rs3026748	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.0175719	0.0328	.	.	.	.	.	.	.	.	.	.	AFR:0.0081,AMR:0.0227,EAS:0.0006,FIN:0.0584,NFE:0.0449,OTH:0.0439,ASJ:0.0166	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43607756	43607756	G	A	RET	intronic	.	ENSG00000165731	rs3026750	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.701677	0.7643	.	.	.	.	.	.	.	.	.	.	AFR:0.8353,AMR:0.7823,EAS:0.5280,FIN:0.7655,NFE:0.7497,OTH:0.7335,ASJ:0.7433	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	unknown
10	43607760	43607760	C	-	RET	intronic	.	ENSG00000165731	rs34827976	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.70008	0.7642	.	.	.	.	.	.	.	.	.	.	AFR:0.8353,AMR:0.7823,EAS:0.5287,FIN:0.7655,NFE:0.7493,OTH:0.7335,ASJ:0.7433	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	unknown
10	43610366	43610366	G	A	RET	intronic	.	ENSG00000165731	rs1864400	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.7498	0.8143	.	.	.	.	.	.	.	.	.	.	AFR:0.9094,AMR:0.8115,EAS:0.5405,FIN:0.7994,NFE:0.7951,OTH:0.7735,ASJ:0.7914	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	MU17394467	het
10	43610455	43610455	T	C	RET	intronic	.	ENSG00000165731	rs1864399	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.717851	0.7822	.	.	.	.	.	.	.	.	.	.	AFR:0.8892,AMR:0.7888,EAS:0.5442,FIN:0.7656,NFE:0.7523,OTH:0.7392,ASJ:0.7483	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43610558	43610558	C	T	RET	intronic	.	ENSG00000165731	rs2742233	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.71246	0.7797	.	.	.	.	.	.	.	.	.	.	AFR:0.8828,AMR:0.7876,EAS:0.5391,FIN:0.7659,NFE:0.7520,OTH:0.7347,ASJ:0.7483	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43611708	43611708	A	G	RET	intronic	.	ENSG00000165731	rs741968	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.752995	0.8220	.	.	.	.	.	.	.	.	.	.	AFR:0.9157,AMR:0.8138,EAS:0.5377,FIN:0.8102,NFE:0.8049,OTH:0.7796,ASJ:0.7914	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43611865	43611865	T	C	RET	intronic	.	ENSG00000165731	rs2256550	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.469449	MU17394675	.	.	.	.	.	.	.	.	.	.	AFR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|1|321|0.00311526,AMR:0.5585,EAS:0.4354,FIN:0.5199,NFE:0.3123,OTH:0.5117,ASJ:0.6646	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	1(skin)	0.5449
10	43612226	43612226	C	T	RET	intronic	.	ENSG00000165731	rs760466	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2144	0.2037	0.120607	LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.1874,AMR:0.0549,EAS:0.2585,FIN:0.0580,NFE:0.2073,OTH:0.2701,ASJ:0.2192	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	12(soft_tissue)	0.2179
10	43612609	43612609	C	T	RET	intronic	.	ENSG00000165731	rs2742234	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.690895	0.7585	.	.	.	.	.	.	.	.	.	.	AFR:0.8088,AMR:0.7864,EAS:0.5366,FIN:0.7662,NFE:0.7517,OTH:0.7372,ASJ:0.7351	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	.	het
10	43613843	43613843	G	T	RET	exonic	synonymous SNV	ENSG00000165731	rs1800861	ENSG00000165731:ENST00000340058:exon13:c.G2307T:p.L769L,ENSG00000165731:ENST00000355710:exon13:c.G2307T:p.L769L	RET:NM_001355216:exon10:c.G1545T:p.L515L,RET:NM_020630:exon13:c.G2307T:p.L769L,RET:NM_020975:exon13:c.G2307T:p.L769L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7419	0.8026	0.71246	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	RET:uc010qez.1:exon10:c.G1545T:p.L515L,RET:uc001jak.1:exon13:c.G2307T:p.L769L,RET:uc001jal.3:exon13:c.G2307T:p.L769L	.	AFR:17(meninges),AMR:1(breast),EAS:MU11676670,FIN:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,NFE:0.7799,OTH:0.8831,ASJ:3(biliary_tract)	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9510,9514,9508,9513,9509,9511,9506,9507,9512	.	.	.	.	.	.	10	1(soft_tissue)	0.7888
10	43613906	43613906	G	T	RET	exonic	nonsynonymous SNV	ENSG00000165731	rs75030001	ENSG00000165731:ENST00000340058:exon13:c.G2370T:p.L790F,ENSG00000165731:ENST00000355710:exon13:c.G2370T:p.L790F	RET:NM_001355216:exon10:c.G1608T:p.L536F,RET:NM_020630:exon13:c.G2370T:p.L790F,RET:NM_020975:exon13:c.G2370T:p.L790F	clinvar: UNK 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 1] 	1.667e-05	.	0.000199681	.	5.093	25.3	0.002	0.958	0.996	.	.	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase, catalytic domain|Tyrosine-protein kinase, catalytic domain	RET:uc010qez.1:exon10:c.G1608T:p.L536F,RET:uc001jak.1:exon13:c.G2370T:p.L790F,RET:uc001jal.3:exon13:c.G2370T:p.L790F	0.147	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	,9510,9514,9508,9513,9473,9509,9511,9506,9474,9507,9512	.	.	0.999	-2.87	0.671	1.1	10	.	het
10	43622217	43622217	T	C	RET	UTR3	.	ENSG00000165731	rs2075912	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8031	0.8533	0.754992	MU17395356	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.8233,EAS:0.8138,FIN:0.7781,NFE:0.5378,OTH:0.8112,ASJ:0.9165	164761	142623;155240;162300;171300;171400;209880;	661;99803;247698;653;29072;247709;653;653;99361;388;	661|CCHS<br>Central congenital hypoventilation syndrome<br>Congenital central alveolar hypoventilation syndrome<br>Ondine curse|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|209880 ~99803|Congenital central alveolar hypoventilation-Hirschsprung disease syndrome<br>Ondine-Hirschsprung disease<br>Ondine-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|209880 ~247698|MEN2A<br>PTC syndrome<br>Sipple syndrome|-|Autosomal dominant|Childhood|171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~247709|MEN2B<br>Multiple endocrine neoplasia type 3<br>Wagenmann-Froboese syndrome|Unknown|Autosomal dominant|Childhood|162300 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~653|MEN2|1-9 / 100 000|Autosomal dominant|All ages|155240 162300 171400 ~99361|Familial MTC|-|Autosomal dominant|-|155240 ~388|Aganglionic megacolon<br>Congenital intestinal aganglionosis<br>HSCR|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Infancy<br>Neonatal|142623 600155 600156 606874 606875 608462 611644 613711 613712 ~	~ko05200 Pathways in cancer~ko05216 Thyroid cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	1(breast)	0.8068
10	50667105	50667105	T	C	ERCC6	exonic	nonsynonymous SNV	ENSG00000225830	rs2228529	ENSG00000225830:ENST00000542458:exon15:c.A2348G:p.Q783R,ENSG00000225830:ENST00000355832:exon21:c.A4238G:p.Q1413R	ERCC6:NM_000124:exon21:c.A4238G:p.Q1413R,ERCC6:NM_001346440:exon21:c.A4238G:p.Q1413R	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.2178	0.1891	0.178914	MU4561288	-0.728	0.062	0.508	-4.93	0.011	.	.	.	ERCC6:uc009xod.4:exon11:c.A1718G:p.Q573R,ERCC6:uc001jhr.5:exon15:c.A2342G:p.Q781R,ERCC6:uc010qgr.3:exon15:c.A2348G:p.Q783R,ERCC6:uc001jhs.5:exon21:c.A4238G:p.Q1413R	-1.123	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,AMR:0.1952,EAS:0.1866,FIN:0.2467,NFE:0.0476,OTH:0.2679,ASJ:0.1259	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	0.128	-1.63	0.000	0.895	10	7(soft_tissue)	0.2302
10	50678369	50678369	T	C	ERCC6	exonic	nonsynonymous SNV	ENSG00000225830	rs2228527	ENSG00000225830:ENST00000542458:exon12:c.A1747G:p.R583G,ENSG00000225830:ENST00000355832:exon18:c.A3637G:p.R1213G	ERCC6:NM_000124:exon18:c.A3637G:p.R1213G,ERCC6:NM_001346440:exon18:c.A3637G:p.R1213G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 1] 	0.2203	0.1967	0.184704	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	1.449	13.04	0.117	1.87	0.319	.	.	.	ERCC6:uc009xod.4:exon8:c.A1117G:p.R373G,ERCC6:uc001jhr.5:exon12:c.A1741G:p.R581G,ERCC6:uc010qgr.3:exon12:c.A1747G:p.R583G,ERCC6:uc001jhs.5:exon18:c.A3637G:p.R1213G	-1.146	AFR:0.2016,AMR:0.1470,EAS:0.2517,FIN:0.0475,NFE:0.2680,OTH:0.2306,ASJ:0.1885	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	0.651	-1.74	0.000	2.8	10	1(large_intestine)	0.2561
10	50678717	50678717	T	C	ERCC6	exonic	nonsynonymous SNV	ENSG00000225830	rs2228526	ENSG00000225830:ENST00000542458:exon12:c.A1399G:p.M467V,ENSG00000225830:ENST00000355832:exon18:c.A3289G:p.M1097V	ERCC6:NM_000124:exon18:c.A3289G:p.M1097V,ERCC6:NM_001346440:exon18:c.A3289G:p.M1097V	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 1] 	0.2186	0.1909	0.182508	1(lung)	-1.845	0.002	0.519	-6.21	0.001	.	.	.	ERCC6:uc009xod.4:exon8:c.A769G:p.M257V,ERCC6:uc001jhr.5:exon12:c.A1393G:p.M465V,ERCC6:uc010qgr.3:exon12:c.A1399G:p.M467V,ERCC6:uc001jhs.5:exon18:c.A3289G:p.M1097V	-1.116	AFR:7(soft_tissue),AMR:MU151139,EAS:0.1964,FIN:0.1306,NFE:0.1874,OTH:0.2483,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	0.001	-1.55	0.000	-1.04	10	2(large_intestine)	0.0475
10	50701156	50701156	G	A	ERCC6	intronic	.	ENSG00000225830	rs4253132	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8887	0.8322	0.876997	0.8456	.	.	.	.	.	0.0003	0.004	.	.	.	AFR:0.7220,AMR:0.9269,EAS:0.9994,FIN:0.9026,NFE:0.8787,OTH:0.9057,ASJ:0.8642	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	.	.	.	.	.	.	.	10	MU81879491	hom
10	50723684	50723684	G	A	ERCC6;PGBD3	exonic	synonymous SNV	ENSG00000243251;ENSG00000258838	rs4253073	ENSG00000243251:ENST00000508005:exon1:c.C1477T:p.L493L,ENSG00000243251:ENST00000374127:exon2:c.C1477T:p.L493L,ENSG00000258838:ENST00000447839:exon6:c.C2881T:p.L961L,ENSG00000258838:ENST00000515869:exon6:c.C2881T:p.L961L,ENSG00000243251:ENST00000603152:exon6:c.C2881T:p.L961L	PGBD3:NM_170753:exon2:c.C1477T:p.L493L,ERCC6:NM_001277058:exon6:c.C2881T:p.L961L,ERCC6:NM_001277059:exon6:c.C2881T:p.L961L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.9070	0.8491	0.893371	0.8616	.	.	.	.	.	.	.	.	PGBD3:uc021pqe.1:exon1:c.C1477T:p.L493L,ERCC6-PGBD3:uc001jhu.3:exon6:c.C2881T:p.L961L,ERCC6-PGBD3:uc009xoe.4:exon6:c.C2881T:p.L961L	.	AFR:0.7277,AMR:0.9368,EAS:0.9994,FIN:0.9319,NFE:0.8994,OTH:0.9196,ASJ:0.8974	.	.	.	.	.	,4781	.	.	.	.	.	.	10	MU81879509	hom
10	50724016	50724016	C	T	ERCC6;PGBD3	exonic	nonsynonymous SNV	ENSG00000243251;ENSG00000258838	rs4253072	ENSG00000243251:ENST00000508005:exon1:c.G1145A:p.R382K,ENSG00000243251:ENST00000374127:exon2:c.G1145A:p.R382K,ENSG00000258838:ENST00000447839:exon6:c.G2549A:p.R850K,ENSG00000258838:ENST00000515869:exon6:c.G2549A:p.R850K,ENSG00000243251:ENST00000603152:exon6:c.G2549A:p.R850K	PGBD3:NM_170753:exon2:c.G1145A:p.R382K,ERCC6:NM_001277058:exon6:c.G2549A:p.R850K,ERCC6:NM_001277059:exon6:c.G2549A:p.R850K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 1] 	0.9983	0.9939	0.996206	0.9951	0.120	3.819	1.0	0.699	0.923	.	.	PiggyBac transposable element-derived protein	PGBD3:uc021pqe.1:exon1:c.G1145A:p.R382K,ERCC6-PGBD3:uc001jhu.3:exon6:c.G2549A:p.R850K,ERCC6-PGBD3:uc009xoe.4:exon6:c.G2549A:p.R850K	-1.056	AFR:0.9835,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9959,ASJ:1	.	.	.	.	.	,4781	.	.	0.0	2.35	0.000	-0.75	10	MU81879516	hom
10	50740876	50740876	G	C	ERCC6	exonic	synonymous SNV	ENSG00000225830;ENSG00000243251;ENSG00000258838	rs2228524	ENSG00000225830:ENST00000355832:exon2:c.C135G:p.L45L,ENSG00000258838:ENST00000447839:exon2:c.C135G:p.L45L,ENSG00000225830:ENST00000462247:exon2:c.C135G:p.L45L,ENSG00000258838:ENST00000515869:exon2:c.C135G:p.L45L,ENSG00000243251:ENST00000603152:exon2:c.C135G:p.L45L	ERCC6:NM_000124:exon2:c.C135G:p.L45L,ERCC6:NM_001277058:exon2:c.C135G:p.L45L,ERCC6:NM_001277059:exon2:c.C135G:p.L45L,ERCC6:NM_001346440:exon2:c.C135G:p.L45L	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.6946	0.6276	0.590855	0.6264	.	.	.	.	.	.	.	.	ERCC6:uc001jhs.5:exon2:c.C135G:p.L45L,ERCC6-PGBD3:uc001jhu.3:exon2:c.C135G:p.L45L,ERCC6-PGBD3:uc009xoe.4:exon2:c.C135G:p.L45L	.	AFR:0.3820,AMR:0.6595,EAS:0.5217,FIN:0.7570,NFE:0.7389,OTH:0.7286,ASJ:0.7219	609413	133540;211980;214150;278800;600630;613761;616946;	178338;1466;191;191;90321;90322;90324;	178338|-|<1 / 1 000 000|Autosomal recessive|Childhood|600630 614621 614640 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~90321|Cockayne syndrome type I|-|-|-|133540 216400 ~90322|Cockayne syndrome type II|-|Autosomal recessive|-|133540 216400 ~90324|Cockayne syndrome type III|-|-|-|133540 216400 216411 ~	.	,4781	.	.	.	.	.	.	10	MU786536	hom
10	51065337	51065337	C	T	PARG	intronic	.	ENSG00000227345	rs201470133	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0143	.	0.0145767	0.0146	.	.	.	.	.	.	.	.	.	.	AFR:0.0469,AMR:0,EAS:0.0006,FIN:0,NFE:0.0007,OTH:0.0107,ASJ:0	603501	.	.	.	.	.	.	.	.	.	.	.	10	MU113388334	het
10	51582894	51582894	C	T	NCOA4	exonic	synonymous SNV	ENSG00000138293	rs41306524	ENSG00000138293:ENST00000414907:exon4:c.C171T:p.D57D,ENSG00000138293:ENST00000430396:exon5:c.C369T:p.D123D,ENSG00000138293:ENST00000344348:exon7:c.C669T:p.D223D,ENSG00000138293:ENST00000374082:exon7:c.C669T:p.D223D,ENSG00000138293:ENST00000374087:exon7:c.C669T:p.D223D,ENSG00000138293:ENST00000443446:exon7:c.C669T:p.D223D,ENSG00000138293:ENST00000438493:exon8:c.C717T:p.D239D,ENSG00000138293:ENST00000452682:exon8:c.C717T:p.D239D	NCOA4:NM_001145262:exon7:c.C669T:p.D223D,NCOA4:NM_001145263:exon7:c.C669T:p.D223D,NCOA4:NM_005437:exon7:c.C669T:p.D223D,NCOA4:NM_001145260:exon8:c.C717T:p.D239D,NCOA4:NM_001145261:exon8:c.C717T:p.D239D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0923	0.0949	0.0786741	0.0909	.	.	.	0.901	0.084	.	.	.	NCOA4:uc010qhf.2:exon4:c.C171T:p.D57D,NCOA4:uc010qhe.2:exon5:c.C369T:p.D123D,NCOA4:uc001jis.4:exon7:c.C669T:p.D223D,NCOA4:uc001jit.3:exon7:c.C669T:p.D223D,NCOA4:uc009xoo.3:exon7:c.C669T:p.D223D,NCOA4:uc009xon.3:exon8:c.C717T:p.D239D,NCOA4:uc010qhd.2:exon8:c.C717T:p.D239D	.	AFR:0.0642,AMR:0.0859,EAS:0.0346,FIN:0.1051,NFE:0.1095,OTH:0.0949,ASJ:0.0828	601984	.	.	.	~ko04216 Ferroptosis~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	10	MU82269117	het
10	54074757	54074757	A	G	DKK1	exonic	synonymous SNV	ENSG00000107984	rs2241529	ENSG00000107984:ENST00000373970:exon2:c.A318G:p.A106A	DKK1:NM_012242:exon2:c.A318G:p.A106A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5383	0.6050	0.525359	0.5553	.	.	.	.	.	.	.	.	DKK1:uc001jjr.3:exon2:c.A318G:p.A106A	.	AFR:0.6948,AMR:0.4472,EAS:0.2718,FIN:0.4788,NFE:0.5297,OTH:0.5114,ASJ:0.6490	605189	.	.	.	.	.	.	.	.	.	.	.	10	MU731054	het
10	61552774	61552774	C	T	CCDC6	exonic	synonymous SNV	ENSG00000108091	rs1053265	ENSG00000108091:ENST00000263102:exon9:c.G1326A:p.P442P	CCDC6:NM_005436:exon9:c.G1326A:p.P442P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7276	0.6525	0.611621	LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	CCDC6:uc001jks.4:exon9:c.G1326A:p.P442P	.	AFR:0.6649,AMR:0.4247,EAS:0.7318,FIN:0.6781,NFE:0.7385,OTH:0.7733,ASJ:0.8094	601985	.	.	.	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	10	1(thyroid)	0.7163
10	61612467	61612467	A	-	CCDC6	intronic	.	ENSG00000108091	rs3215226	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3561	0.2819	0.313299	0.2585	.	.	.	.	.	.	.	.	.	.	AFR:0.4213,AMR:0.2048,EAS:0.2212,FIN:0.3118,NFE:0.1607,OTH:0.2128,ASJ:0.2481	601985	.	.	.	~ko05200 Pathways in cancer~ko05216 Thyroid cancer ~	.	.	.	.	.	.	.	10	.	het
10	61819668	61819668	G	C	ANK3	exonic	nonsynonymous SNV	ENSG00000151150	rs201845881	ENSG00000151150:ENST00000373820:exon7:c.C629G:p.S210C,ENSG00000151150:ENST00000355288:exon17:c.C2255G:p.S752C,ENSG00000151150:ENST00000373827:exon40:c.C4835G:p.S1612C,ENSG00000151150:ENST00000503366:exon40:c.C4856G:p.S1619C	ANK3:NM_001149:exon17:c.C2255G:p.S752C,ANK3:NM_001320874:exon39:c.C4853G:p.S1618C,ANK3:NM_001204403:exon40:c.C4835G:p.S1612C,ANK3:NM_001204404:exon40:c.C4856G:p.S1619C	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0006	.	0.000599042	0.0004	1.152	11.49	0.007	5.77	1.000	.	.	Ankyrin repeat-containing domain	ANK3:uc001jkv.3:exon7:c.C452G:p.S151C,ANK3:uc001jkw.3:exon17:c.C2255G:p.S752C,ANK3:uc009xpa.3:exon17:c.C2255G:p.S752C,ANK3:uc001jkx.3:exon19:c.C2387G:p.S796C,ANK3:uc001jkz.4:exon40:c.C4835G:p.S1612C,ANK3:uc010qih.2:exon40:c.C4856G:p.S1619C	-0.560	AFR:0,AMR:0,EAS:0.0068,FIN:0,NFE:0,OTH:0,ASJ:0	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	0.944	0.33	0.243	.	10	.	het
10	61956386	61956386	-	A	ANK3	intronic	.	ENSG00000151150	rs772920191	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2274	.	.	0.1186	.	.	.	.	.	.	.	.	.	.	AFR:0.1884,AMR:0.0826,EAS:0.0974,FIN:0.1146,NFE:0.0810,OTH:0.0917,ASJ:0.0991	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	10	MU111739664	het
10	62038544	62038544	A	G	ANK3	exonic	synonymous SNV	ENSG00000151150	rs1031688	ENSG00000151150:ENST00000280772:exon4:c.T402C:p.N134N,ENSG00000151150:ENST00000503366:exon4:c.T351C:p.N117N,ENSG00000151150:ENST00000503925:exon4:c.T324C:p.N108N,ENSG00000151150:ENST00000373827:exon5:c.T384C:p.N128N	ANK3:NM_001204404:exon4:c.T351C:p.N117N,ANK3:NM_001320874:exon4:c.T402C:p.N134N,ANK3:NM_020987:exon4:c.T402C:p.N134N,ANK3:NM_001204403:exon5:c.T384C:p.N128N	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0218	0.0263	0.0239617	0.0197	.	.	.	.	.	.	.	.	ANK3:uc001jky.3:exon4:c.T402C:p.N134N,ANK3:uc010qih.2:exon4:c.T351C:p.N117N,ANK3:uc001jkz.4:exon5:c.T384C:p.N128N	.	AFR:0.0205,AMR:0.0191,EAS:0.0006,FIN:0.0132,NFE:0.0236,OTH:0.0081,ASJ:0.0167	600465	615493;	356996;	356996|-|<1 / 1 000 000|Autosomal recessive|Childhood|615493 ~	~ko04624 Toll and Imd signaling pathway~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	10	.	het
10	64573771	64573771	C	T	EGR2	exonic	synonymous SNV	ENSG00000122877	rs224083	ENSG00000122877:ENST00000242480:exon2:c.G627A:p.P209P,ENSG00000122877:ENST00000411732:exon3:c.G477A:p.P159P,ENSG00000122877:ENST00000439032:exon4:c.G627A:p.P209P	EGR2:NM_000399:exon2:c.G627A:p.P209P,EGR2:NM_001136177:exon3:c.G627A:p.P209P,EGR2:NM_001136179:exon3:c.G477A:p.P159P,EGR2:NM_001321037:exon3:c.G477A:p.P159P,EGR2:NM_001136178:exon4:c.G627A:p.P209P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9953	0.9822	0.986022	0.9847	.	.	.	.	.	.	.	.	EGR2:uc001jmi.3:exon2:c.G627A:p.P209P,EGR2:uc010qim.2:exon3:c.G627A:p.P209P,EGR2:uc010qin.2:exon3:c.G477A:p.P159P,EGR2:uc010qio.2:exon3:c.G666A:p.P222P,EGR2:uc009xph.3:exon4:c.G627A:p.P209P	.	AFR:0.9457,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	129010	145900;605253;607678;	101084;99951;64748;	101084|CMT1D|-|Autosomal dominant|Adolescent<br>Infancy<br>Childhood<br>Adult|607678 ~99951|Autosomal recessive congenital hypomyelinating neuropathy<br>CMT4E|-|Autosomal recessive|Infancy<br>Neonatal|605253 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	~ko04625 C-type lectin receptor signaling pathway~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	10	MU81880257	hom
10	70225504	70225504	G	T	DNA2	exonic	synonymous SNV	ENSG00000138346	rs3758626	ENSG00000138346:ENST00000358410:exon4:c.C507A:p.A169A,ENSG00000138346:ENST00000399179:exon4:c.C507A:p.A169A,ENSG00000138346:ENST00000399180:exon4:c.C765A:p.A255A,ENSG00000138346:ENST00000551118:exon4:c.C507A:p.A169A	DNA2:NM_001080449:exon4:c.C507A:p.A169A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2867	0.2758	0.366414	MU136554	.	.	.	.	.	.	.	.	DNA2:uc001jog.3:exon4:c.C507A:p.A169A,DNA2:uc031pvh.1:exon4:c.C507A:p.A169A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.2914,EAS:0.3433,FIN:0.1954,NFE:0.4090,OTH:0.2734,ASJ:0.4193	601810	615156;615807;	808;352470;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~352470|Mitochondrial DNA deletion syndrome with limb-girdle weakness<br>mtDNA deletion syndrome with limb-girdle weakness<br>mtDNA deletion syndrome with progressive myopathy|<1 / 1 000 000|Autosomal dominant|All ages|615156 ~	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.2092
10	70227964	70227964	C	T	DNA2	exonic	synonymous SNV	ENSG00000138346	rs10998205	ENSG00000138346:ENST00000358410:exon3:c.G357A:p.L119L,ENSG00000138346:ENST00000399179:exon3:c.G357A:p.L119L,ENSG00000138346:ENST00000399180:exon3:c.G615A:p.L205L,ENSG00000138346:ENST00000551118:exon3:c.G357A:p.L119L	DNA2:NM_001080449:exon3:c.G357A:p.L119L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1311	0.0701	0.139177	MU32636269	.	.	.	.	.	.	.	.	DNA2:uc001jog.3:exon3:c.G357A:p.L119L,DNA2:uc031pvh.1:exon3:c.G357A:p.L119L	.	AFR:LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,AMR:0.0898,EAS:0.2230,FIN:0.0894,NFE:0.1530,OTH:0.1438,ASJ:0.0312	601810	615156;615807;	808;352470;	808|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|210600 600546 606744 613676 613823 615807 616051 616171 616777 ~352470|Mitochondrial DNA deletion syndrome with limb-girdle weakness<br>mtDNA deletion syndrome with limb-girdle weakness<br>mtDNA deletion syndrome with progressive myopathy|<1 / 1 000 000|Autosomal dominant|All ages|615156 ~	.	.	.	.	.	.	.	.	10	1(bone)	0.0949
10	70332672	70332672	T	A	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs12773594	ENSG00000138336:ENST00000373644:exon2:c.T577A:p.S193T	TET1:NM_030625:exon2:c.T577A:p.S193T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1788	0.1372	0.171725	0.1695	2.453	19.16	0.055	2.55	0.838	.	.	.	TET1:uc001jok.4:exon2:c.T577A:p.S193T	-0.922	AFR:0.0991,AMR:0.1851,EAS:0.1607,FIN:0.2527,NFE:0.1904,OTH:0.1984,ASJ:0.1126	607790	.	.	.	.	.	.	.	0.808	3.17	0.000	1.735	10	MU11738600	hom
10	70332862	70332862	C	T	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs12221107	ENSG00000138336:ENST00000373644:exon2:c.C767T:p.A256V	TET1:NM_030625:exon2:c.C767T:p.A256V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1122	0.0567	0.109425	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	1.916	15.68	0.094	4.63	0.883	.	.	.	TET1:uc001jok.4:exon2:c.C767T:p.A256V	-1.002	AFR:0.0892,AMR:0.0133,EAS:0.0762,FIN:0.1398,NFE:0.1623,OTH:0.1075,ASJ:0.1268	607790	.	.	.	.	.	.	.	0.022	3.08	0.000	1.43	10	2(large_intestine)	0.1133
10	70405237	70405237	G	A	TET1	exonic	synonymous SNV	ENSG00000138336	rs12241767	ENSG00000138336:ENST00000373644:exon4:c.G2751A:p.E917E	TET1:NM_030625:exon4:c.G2751A:p.E917E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1601	0.1894	0.212859	MU793310	.	.	.	.	.	.	.	.	TET1:uc001jok.4:exon4:c.G2751A:p.E917E	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.2136,EAS:0.1782,FIN:0.0695,NFE:0.1307,OTH:0.1950,ASJ:0.3645	607790	.	.	.	.	.	.	.	.	.	.	.	10	1(stomach)	0.1481
10	70405539	70405539	A	G	TET1	exonic	nonsynonymous SNV	ENSG00000138336	rs16925541	ENSG00000138336:ENST00000373644:exon4:c.A3053G:p.N1018S	TET1:NM_030625:exon4:c.A3053G:p.N1018S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1032	0.0541	0.0832668	1(stomach)	-0.621	0.111	0.09	0.475	0.059	.	.	.	TET1:uc001jok.4:exon4:c.A3053G:p.N1018S	-0.964	AFR:MU793307,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,EAS:0.0124,FIN:0.1325,NFE:0.0629,OTH:0.1153,ASJ:0.0868	607790	.	.	.	.	.	.	.	0.024	3.08	0.000	0.92	10	1(pancreas)	0.1638
10	72358577	72358577	G	A	PRF1	exonic	synonymous SNV	ENSG00000180644	rs885822	ENSG00000180644:ENST00000373209:exon3:c.C900T:p.H300H,ENSG00000180644:ENST00000441259:exon3:c.C900T:p.H300H	PRF1:NM_001083116:exon3:c.C900T:p.H300H,PRF1:NM_005041:exon3:c.C900T:p.H300H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6357	0.6624	0.695887	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	PRF1:uc001jrf.4:exon3:c.C900T:p.H300H,PRF1:uc009xqg.3:exon3:c.C900T:p.H300H	.	AFR:0.6730,AMR:0.8060,EAS:0.5705,FIN:0.7645,NFE:0.6571,OTH:0.5915,ASJ:0.6878	170280	603553;605027;609135;	88;547;540;	88|Idiopathic bone marrow failure|1-9 / 1 000 000|Unknown|Adult|609135 614742 614743 ~547|NHL|1-5 / 10 000|-|Adult|605027 ~540|Familial HLH|Unknown|Autosomal recessive|Infancy<br>Adolescent|267700 603552 603553 608898 613101 ~	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.6619
10	73104056	73104056	A	G	SLC29A3	intronic	.	ENSG00000198246	rs2243540	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8674	0.8794	0.814297	0.8696	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.8539,AMR:0.8640,EAS:0.7043,FIN:0.8585,NFE:0.8980,OTH:0.8806,ASJ:0.91	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14180483	het
10	73111408	73111408	C	T	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs780668	ENSG00000198246:ENST00000373189:exon4:c.C473T:p.S158F	SLC29A3:NM_001174098:exon4:c.C473T:p.S158F,SLC29A3:NM_001363518:exon4:c.C239T:p.S80F,SLC29A3:NM_018344:exon4:c.C473T:p.S158F	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.6384	0.6183	0.479832	MU139025	6.297	29.1	0.062	4.62	0.992	.	.	.	SLC29A3:uc010qjq.2:exon3:c.C35T:p.S12F,SLC29A3:uc001jrr.4:exon4:c.C473T:p.S158F,SLC29A3:uc001jrs.4:exon4:c.C473T:p.S158F	-0.969	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6241,EAS:0.5227,FIN:0.7417,NFE:0.4472,OTH:0.7288,ASJ:0.3520	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.656	0.33	0.000	3.085	10	1(liver)	0.7743
10	73115941	73115941	T	C	SLC29A3	exonic	synonymous SNV	ENSG00000198246	rs2252997	ENSG00000198246:ENST00000373189:exon5:c.T714C:p.T238T	SLC29A3:NM_001174098:exon5:c.T714C:p.T238T,SLC29A3:NM_001363518:exon5:c.T480C:p.T160T,SLC29A3:NM_018344:exon5:c.T714C:p.T238T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8294	0.8891	0.780751	0.8679	.	.	.	.	.	.	.	.	SLC29A3:uc001jrt.4:exon3:c.T96C:p.T32T,SLC29A3:uc010qjq.2:exon4:c.T276C:p.T92T,SLC29A3:uc001jrr.4:exon5:c.T714C:p.T238T,SLC29A3:uc001jrs.4:exon5:c.T714C:p.T238T	.	AFR:0.8897,AMR:0.6885,EAS:0.6926,FIN:0.8490,NFE:0.8879,OTH:0.8551,ASJ:0.93	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14239655	unknown
10	73115942	73115942	G	A	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2252996	ENSG00000198246:ENST00000373189:exon5:c.G715A:p.V239I	SLC29A3:NM_001174098:exon5:c.G715A:p.V239I,SLC29A3:NM_001363518:exon5:c.G481A:p.V161I,SLC29A3:NM_018344:exon5:c.G715A:p.V239I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8217	0.8616	0.760184	0.8453	-0.811	0.040	0.508	-2.2	0.000	.	.	.	SLC29A3:uc001jrt.4:exon3:c.G97A:p.V33I,SLC29A3:uc010qjq.2:exon4:c.G277A:p.V93I,SLC29A3:uc001jrr.4:exon5:c.G715A:p.V239I,SLC29A3:uc001jrs.4:exon5:c.G715A:p.V239I	-0.980	AFR:0.8111,AMR:0.6850,EAS:0.6926,FIN:0.8490,NFE:0.8875,OTH:0.8520,ASJ:0.93	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.002	-0.28	0.000	1.37	10	MU14239707	unknown
10	73121913	73121913	A	G	SLC29A3	exonic	nonsynonymous SNV	ENSG00000198246	rs2487068	ENSG00000198246:ENST00000373189:exon6:c.A976G:p.I326V	SLC29A3:NM_001363518:exon6:c.A742G:p.I248V,SLC29A3:NM_018344:exon6:c.A976G:p.I326V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8246	0.8923	0.792732	0.8745	-2.319	0.001	1.0	-9.0	0.003	.	.	.	SLC29A3:uc001jrt.4:exon4:c.A358G:p.I120V,SLC29A3:uc010qjq.2:exon5:c.A538G:p.I180V,SLC29A3:uc001jrr.4:exon6:c.A976G:p.I326V	-0.954	AFR:0.9235,AMR:0.6771,EAS:0.7228,FIN:0.8389,NFE:0.8824,OTH:0.8599,ASJ:0.8874	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	0.002	0.05	0.000	-0.515	10	MU14239795	hom
10	73121945	73121945	T	C	SLC29A3	exonic	synonymous SNV	ENSG00000198246	rs1084004	ENSG00000198246:ENST00000373189:exon6:c.T1008C:p.G336G	SLC29A3:NM_001363518:exon6:c.T774C:p.G258G,SLC29A3:NM_018344:exon6:c.T1008C:p.G336G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8302	0.8666	0.753794	0.8444	.	.	.	.	.	.	.	.	SLC29A3:uc001jrt.4:exon4:c.T390C:p.G130G,SLC29A3:uc010qjq.2:exon5:c.T570C:p.G190G,SLC29A3:uc001jrr.4:exon6:c.T1008C:p.G336G	.	AFR:0.7526,AMR:0.6758,EAS:0.7271,FIN:0.8288,NFE:0.9204,OTH:0.8643,ASJ:0.9338	612373	602782;	168569;	168569|-|<1 / 1 000 000|Autosomal recessive|Childhood|602782 ~	.	.	.	.	.	.	.	.	10	MU14239860	het
10	88635779	88635779	C	A	BMPR1A	exonic	nonsynonymous SNV	ENSG00000107779	rs11528010	ENSG00000107779:ENST00000372037:exon3:c.C4A:p.P2T	BMPR1A:NM_004329:exon3:c.C4A:p.P2T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3558	0.3895	0.4998	COCA-CN|5|321|0.0155763	0.677	8.674	1.0	5.3	0.971	.	.	.	BMPR1A:uc001kdy.3:exon3:c.C4A:p.P2T	-0.953	AFR:0.4141,AMR:0.6605,EAS:0.3974,FIN:0.7150,NFE:0.3735,OTH:0.2552,ASJ:0.3792	601299	174900;610069;	157794;2929;329971;	157794|HMPS|-|Autosomal dominant|Childhood|601228 610069 ~2929|JIP<br>JPS<br>Juvenile gastrointestinal polyposis<br>Juvenile intestinal polyposis|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|174900 175050 612242 ~329971|-|Unknown|Autosomal dominant|All ages|174900 ~	.	.	.	.	0.0	-1.5	0.000	-0.805	10	1(large_intestine)	0.3340
10	88683122	88683122	T	C	BMPR1A	intronic	.	ENSG00000107779	rs7074064	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3538	0.3898	0.496605	0.4136	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.6629,AMR:0.3556,EAS:0.7134,FIN:0.3741,NFE:0.2547,OTH:0.3340,ASJ:0.3867	601299	174900;610069;	157794;2929;329971;	157794|HMPS|-|Autosomal dominant|Childhood|601228 610069 ~2929|JIP<br>JPS<br>Juvenile gastrointestinal polyposis<br>Juvenile intestinal polyposis|Unknown|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|174900 175050 612242 ~329971|-|Unknown|Autosomal dominant|All ages|174900 ~	.	.	.	.	.	.	.	.	10	MU14485379	het
10	88911841	88911841	A	G	SHLD2	exonic	nonsynonymous SNV	ENSG00000122376	rs77879311	ENSG00000122376:ENST00000298784:exon3:c.A730G:p.S244G,ENSG00000122376:ENST00000298786:exon3:c.A730G:p.S244G	SHLD2:NM_001330112:exon3:c.A730G:p.S244G,SHLD2:NM_019054:exon3:c.A730G:p.S244G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1550	0.173	0.149161	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647	5.299	25.8	0.011	4.09	0.998	.	.	.	FAM35A:uc001kei.4:exon3:c.A730G:p.S244G	-1.081	AFR:0.1688,AMR:0.2193,EAS:0.1159,FIN:0.0222,NFE:0.1859,OTH:0.1568,ASJ:0.1086	.	.	.	.	.	.	.	.	0.987	1.52	0.000	1.79	10	1(haematopoietic_and_lymphoid_tissue)	0.1517
10	88930249	88930249	A	T	SHLD2	exonic	nonsynonymous SNV	ENSG00000122376	rs11202365	ENSG00000122376:ENST00000298784:exon5:c.A1648T:p.S550C,ENSG00000122376:ENST00000298786:exon5:c.A1648T:p.S550C	SHLD2:NM_001330112:exon5:c.A1648T:p.S550C,SHLD2:NM_019054:exon5:c.A1648T:p.S550C	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.3463	0.3246	0.275359	1(lung)	4.059	23.7	0.017	2.92	0.150	.	.	.	FAM35A:uc001kei.4:exon5:c.A1648T:p.S550C	-0.930	AFR:MU4559196,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,EAS:0.1987,FIN:0.2668,NFE:0.3543,OTH:0.1609,ASJ:0.3152	.	.	.	.	.	.	.	.	0.995	-0.13	0.000	2.3	10	2(thyroid)	0.3434
10	88939962	88939962	T	C	SHLD2	exonic	synonymous SNV	ENSG00000122376	rs7081609	ENSG00000122376:ENST00000298784:exon7:c.T2094C:p.G698G,ENSG00000122376:ENST00000298786:exon8:c.T2301C:p.G767G	SHLD2:NM_019054:exon7:c.T2094C:p.G698G,SHLD2:NM_001330112:exon8:c.T2301C:p.G767G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8356	0.8848	0.793331	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	FAM35A:uc001kej.4:exon5:c.T432C:p.G144G,FAM35A:uc001kei.4:exon7:c.T2094C:p.G698G	.	AFR:0.8588,AMR:0.9648,EAS:0.8758,FIN:0.3841,NFE:0.8222,OTH:0.8577,ASJ:0.8317	.	.	.	.	.	.	.	.	.	.	.	.	10	2(lung)	0.8632
10	88948760	88948760	T	-	SHLD2	intronic	.	ENSG00000122376	rs10708013	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.690695	0.6551	.	.	.	.	.	.	.	.	.	.	AFR:0.8409,AMR:0.6433,EAS:0.2805,FIN:0.2883,NFE:0.6237,OTH:0.5927,ASJ:0.5585	.	.	.	.	.	.	.	.	.	.	.	.	10	.	het
10	89623861	89623861	T	-	PTEN	splicing	.	ENSG00000171862	rs71022512	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, 0, 1, 0] 	.	.	1	0.9975	.	.	.	.	.	.	.	.	.	.	AFR:0.9993,AMR:0.9963,EAS:0.9969,FIN:0.9897,NFE:0.9986,OTH:0.9947,ASJ:0.9933	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04212 Longevity regulating pathway - worm~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04931 Insulin resistance~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05230 Central carbon metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	10	.	hom
10	89623901	89623901	G	C	PTEN	exonic	nonsynonymous SNV	ENSG00000171862	rs2943772	.	PTEN:NM_001304717:exon2:c.G194C:p.C65S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 1, 0, 0, 0, -1, 1, 0, 1, 1] 	.	.	1	0.9996	.	.	.	.	.	.	.	.	.	.	AFR:0.9998,AMR:0.9976,EAS:1,FIN:0.9983,NFE:0.9999,OTH:1,ASJ:1	601728	153480;155600;158350;176807;275355;276950;605309;607174;608089;613028;	182067;263662;210548;3412;67037;1331;201;2969;65285;404560;618;109;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~263662|-|Unknown|Autosomal dominant|All ages|607174 ~210548|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|605309 ~3412|Sujansky-Leonard syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|276950 314390 ~67037|HNSCC<br>Head and neck squamous cell carcinoma|1-5 / 10 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|275355 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~2969|Cohen-Hayden syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|158350 ~65285|Dysplastic gangliocytoma of the cerebellum<br>LDD|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|158350 ~404560|B-K mole syndrome<br>FAMM-PC syndrome<br>FAMMM syndrome<br>Familial Clark nevus syndrome<br>Familial atypical mole syndrome<br>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome<br>Familial dysplastic nevus syndrome<br>Melanoma-pancreatic cancer syndrome|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|155600 606719 ~618|-|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Adult|155600 155601 155700 608035 609048 613099 613972 615134 615848 ~109|BRRS<br>Myhre-Riley-Smith syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|153480 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04212 Longevity regulating pathway - worm~ko04218 Cellular senescence~ko04361 Axon regeneration~ko04510 Focal adhesion~ko04931 Insulin resistance~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05222 Small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05230 Central carbon metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	9304,9306,,9295,9325,9329,9294,9324,9328,9270,9317,9268,9297,9269,9293,9301,9273,9302,9323,9271,9330,9303,9299,9322,9272,9290,9276,9296,9305,9311,9291,9321,9327,9300,9310,9298,9326,9316,9275,9309,9315,9267,9314,9307,9274,9308,9313,9319,9292,9320	,9312	.	.	.	.	.	10	.	hom
10	90701645	90701645	A	G	ACTA2	intronic	.	ENSG00000107796;ENSG00000138134	rs714887	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1541	0.0699	0.169329	0.0811	.	.	.	.	.	.	.	.	.	.	AFR:0.0771,AMR:0.1002,EAS:0.2881,FIN:0.0441,NFE:0.0669,OTH:0.0898,ASJ:0.1424	102620	611788;613834;614042;	2573;404463;91387;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~404463|-|<1 / 1 000 000|Unknown|Infancy|613834 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	10	MU14552373	het
10	90749256	90749256	G	A	ACTA2	intronic	.	ENSG00000107796	rs2234767	.	.	clinvar: risk_factor 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1475	0.0978	0.184105	1(biliary_tract)	.	.	.	.	.	.	.	.	.	.	AFR:MU11775963,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,EAS:0.0530,FIN:0.1587,NFE:0.1159,OTH:0.4108,ASJ:0.1142	102620	611788;613834;614042;	2573;404463;91387;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~404463|-|<1 / 1 000 000|Unknown|Infancy|613834 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	10	2(lung)	0.1234
10	90750982	90750982	T	G	ACTA2	UTR5	.	ENSG00000107796	rs7079111	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.937899	0.9023	.	.	.	.	.	.	.	.	.	.	AFR:0.9738,AMR:0.8780,EAS:0.9957,FIN:0.8421,NFE:0.8684,OTH:0.8709,ASJ:0.8808	102620	611788;613834;614042;	2573;404463;91387;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~404463|-|<1 / 1 000 000|Unknown|Infancy|613834 ~91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	10	.	hom
10	90771829	90771829	T	C	FAS	exonic	synonymous SNV	ENSG00000026103	rs2234978	ENSG00000026103:ENST00000357339:exon6:c.T579C:p.T193T,ENSG00000026103:ENST00000352159:exon7:c.T642C:p.T214T,ENSG00000026103:ENST00000355279:exon7:c.T642C:p.T214T,ENSG00000026103:ENST00000355740:exon7:c.T642C:p.T214T	FAS:NM_152871:exon6:c.T579C:p.T193T,FAS:NM_000043:exon7:c.T642C:p.T214T,FAS:NM_152872:exon7:c.T642C:p.T214T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7561	0.6952	0.775359	0.7328	-0.976	0.018	.	-0.619	0.000	.	.	.	FAS:uc001kft.3:exon6:c.T579C:p.T193T,FAS:uc001kfr.3:exon7:c.T642C:p.T214T,FAS:uc001kfs.3:exon7:c.T642C:p.T214T	.	AFR:0.6849,AMR:0.8146,EAS:0.9840,FIN:0.7967,NFE:0.7117,OTH:0.7576,ASJ:0.7649	134637	601859;	3261;	3261|ALPS<br>Canale-Smith syndrome<br>FAS deficiency|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601859 603909 615559 ~	~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04217 Necroptosis~ko04650 Natural killer cell mediated cytotoxicity~ko04668 TNF signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04940 Type I diabetes mellitus~ko05010 Alzheimer disease~ko05130 Pathogenic Escherichia coli infection~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05320 Autoimmune thyroid disease~ko05330 Allograft rejection~ko05332 Graft-versus-host disease ~	.	.	.	.	.	.	.	10	MU67395980	hom
10	95549836	95549836	-	TT	LGI1	intronic	.	ENSG00000108231	rs371933363	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4481	.	0.453075	0.8264	.	.	.	.	.	.	.	.	.	.	AFR:0.6826,AMR:0.9059,EAS:0.8932,FIN:0.7581,NFE:0.9027,OTH:0.8843,ASJ:0.8578	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	.	unknown
10	95552653	95552653	T	C	LGI1	exonic	synonymous SNV	ENSG00000108231	rs1111820	ENSG00000108231:ENST00000542308:exon4:c.T513C:p.F171F,ENSG00000108231:ENST00000371413:exon6:c.T657C:p.F219F,ENSG00000108231:ENST00000371418:exon6:c.T657C:p.F219F	LGI1:NM_001308276:exon4:c.T513C:p.F171F,LGI1:NM_001308275:exon6:c.T657C:p.F219F,LGI1:NM_005097:exon6:c.T657C:p.F219F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9928	0.9769	0.977436	0.9798	.	.	.	.	.	.	.	.	LGI1:uc010qnv.2:exon4:c.T513C:p.F171F,LGI1:uc001kjc.4:exon6:c.T657C:p.F219F,LGI1:uc021pwk.1:exon6:c.T657C:p.F219F	.	AFR:0.9302,AMR:0.9964,EAS:1,FIN:0.9997,NFE:0.9995,OTH:0.9959,ASJ:1	604619	600512;	101046;	101046|ADEAF<br>ADLTE<br>ADPEAF<br>Autosomal dominant lateral temporal lobe epilepsy<br>Partial epilepsy with auditory aura<br>Partial epilepsy with auditory features|Unknown|Autosomal dominant|Childhood<br>Adolescent<br>Adult|600512 616436 616461 ~	.	.	.	.	.	.	.	.	10	MU81883389	hom
10	95931087	95931087	G	T	PLCE1	exonic	nonsynonymous SNV	ENSG00000138193	rs17417407	ENSG00000138193:ENST00000371375:exon3:c.G719T:p.R240L,ENSG00000138193:ENST00000371380:exon3:c.G1643T:p.R548L,ENSG00000138193:ENST00000371385:exon3:c.G719T:p.R240L,ENSG00000138193:ENST00000260766:exon4:c.G1643T:p.R548L	PLCE1:NM_001165979:exon3:c.G719T:p.R240L,PLCE1:NM_001288989:exon4:c.G1643T:p.R548L,PLCE1:NM_016341:exon4:c.G1643T:p.R548L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.1782	0.1717	0.201078	MU146233	6.231	28.8	0.049	4.91	0.908	.	.	Ras guanine nucleotide exchange factor domain|Ras guanine-nucleotide exchange factors catalytic domain	PLCE1:uc001kjm.3:exon3:c.G719T:p.R240L,PLCE1:uc010qnx.2:exon3:c.G1643T:p.R548L,PLCE1:uc001kjk.3:exon4:c.G1643T:p.R548L	-1.129	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.1553,EAS:0.0955,FIN:0.1987,NFE:0.1136,OTH:0.1260,ASJ:0.1897	608414	610725;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05205 Proteoglycans in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.997	1.41	0.000	1.59	10	1(lung)	0.1483
10	96541616	96541616	G	A	CYP2C19	exonic	synonymous SNV	ENSG00000165841	rs4244285	ENSG00000165841:ENST00000371321:exon5:c.G681A:p.P227P	CYP2C19:NM_000769:exon5:c.G681A:p.P227P	clinvar: drug_response 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1856	0.1541	0.221446	0.1673	.	.	.	.	.	.	.	.	CYP2C19:uc009xus.1:exon3:c.G276A:p.P92P,CYP2C19:uc010qnz.2:exon5:c.G681A:p.P227P,CYP2C19:uc010qny.2:exon10:c.G615A:p.P205P	.	AFR:0.1792,AMR:0.1220,EAS:0.3125,FIN:0.1816,NFE:0.1439,OTH:0.1728,ASJ:0.1556	124020	609535;	240935;	240935|-|-|-|-|609535 ~	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	MU749853	het
10	96602622	96602622	C	T	CYP2C19	exonic	synonymous SNV	ENSG00000165841	rs3758580	ENSG00000165841:ENST00000371321:exon7:c.C990T:p.V330V	CYP2C19:NM_000769:exon7:c.C990T:p.V330V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1835	0.1542	0.221246	0.1664	.	.	.	.	.	.	.	.	CYP2C19:uc010qnz.2:exon7:c.C990T:p.V330V,CYP2C19:uc010qny.2:exon12:c.C924T:p.V308V	.	AFR:0.1794,AMR:0.1223,EAS:0.3137,FIN:0.1793,NFE:0.1421,OTH:0.1731,ASJ:0.1556	124020	609535;	240935;	240935|-|-|-|-|609535 ~	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	MU11785153	het
10	96827119	96827119	-	A	CYP2C8	intronic	.	ENSG00000138115	rs11572078	ENSG00000138115:ENST00000539050:exon2:c.68dupT:p.L23fs	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2679	0.3041	0.34984	0.2909	.	.	.	.	.	.	.	.	CYP2C8:uc010qob.2:exon2:c.68dupT:p.L23fs,CYP2C8:uc010qod.1:exon2:c.68dupT:p.L23fs	.	AFR:0.4530,AMR:0.1882,EAS:0.3807,FIN:0.2096,NFE:0.2130,OTH:0.2556,ASJ:0.3179	601129	.	.	.	~ko00590 Arachidonic acid metabolism~ko00591 Linoleic acid metabolism~ko00830 Retinol metabolism~ko00982 Drug metabolism - cytochrome P450~ko01100 Metabolic pathways~ko04726 Serotonergic synapse~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	10	.	het
10	99220707	99220707	C	T	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs3740526	ENSG00000155229:ENST00000327238:exon22:c.G2075A:p.G692D,ENSG00000155229:ENST00000355839:exon23:c.G2240A:p.G747D,ENSG00000155229:ENST00000438925:exon24:c.G2369A:p.G790D,ENSG00000155229:ENST00000370782:exon25:c.G2369A:p.G790D	MMS19:NM_001330128:exon22:c.G2075A:p.G692D,MMS19:NM_001289403:exon23:c.G2240A:p.G747D,MMS19:NM_001289404:exon23:c.G1892A:p.G631D,MMS19:NM_001351357:exon23:c.G1895A:p.G632D,MMS19:NM_001351358:exon23:c.G1277A:p.G426D,MMS19:NM_001351359:exon24:c.G1277A:p.G426D,MMS19:NM_022362:exon24:c.G2369A:p.G790D,MMS19:NM_001289405:exon25:c.G2369A:p.G790D,MMS19:NM_001351356:exon25:c.G2486A:p.G829D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4288	0.3420	0.330072	1(pancreas)	1.394	12.76	0.406	3.64	0.256	.	.	Armadillo-like helical|Armadillo-type fold|MMS19, C-terminal;Armadillo-like helical|MMS19, C-terminal	MMS19:uc001knq.3:exon2:c.G158A:p.G53D,MMS19:uc009xvs.3:exon11:c.G1124A:p.G375D,MMS19:uc009xvt.3:exon21:c.G1601A:p.G534D,MMS19:uc001knr.3:exon23:c.G1892A:p.G631D,MMS19:uc010qox.3:exon23:c.G2240A:p.G747D,MMS19:uc001kns.4:exon24:c.G2369A:p.G790D,MMS19:uc001knt.3:exon25:c.G2369A:p.G790D	-0.937	AFR:MU581955,AMR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.2058,FIN:0.4701,NFE:0.3609,OTH:0.3984,ASJ:0.3559	614777	.	.	.	.	.	.	.	0.103	1.62	0.000	-0.805	10	1(prostate)	0.4042
10	99240758	99240758	G	C	MMS19	exonic	nonsynonymous SNV	ENSG00000155229	rs2275586	ENSG00000155229:ENST00000327238:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000355839:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000422685:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000437002:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000438925:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000439048:exon3:c.C203G:p.A68G,ENSG00000155229:ENST00000448660:exon3:c.C197G:p.A66G,ENSG00000155229:ENST00000370782:exon4:c.C203G:p.A68G	MMS19:NM_001289403:exon3:c.C203G:p.A68G,MMS19:NM_001330128:exon3:c.C203G:p.A68G,MMS19:NM_001351356:exon3:c.C203G:p.A68G,MMS19:NM_022362:exon3:c.C203G:p.A68G,MMS19:NM_001289405:exon4:c.C203G:p.A68G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9649	0.9468	0.9375	0.9507	1.135	11.40	1.0	6.08	0.993	.	.	Armadillo-like helical;Armadillo-like helical|Armadillo-type fold	MMS19:uc001kns.4:exon3:c.C203G:p.A68G,MMS19:uc010qox.3:exon3:c.C203G:p.A68G,MMS19:uc001knt.3:exon4:c.C203G:p.A68G	-0.955	AFR:0.8826,AMR:0.9821,EAS:0.9796,FIN:0.9614,NFE:0.9804,OTH:0.9827,ASJ:0.9669	614777	.	.	.	.	.	.	.	0.0	-0.57	0.000	-0.515	10	MU81883983	het
10	101544447	101544447	A	T	ABCC2	exonic	nonsynonymous SNV	ENSG00000023839	rs927344	ENSG00000023839:ENST00000370434:exon2:c.A116T:p.Y39F,ENSG00000023839:ENST00000370449:exon2:c.A116T:p.Y39F	ABCC2:NM_000392:exon2:c.A116T:p.Y39F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9980	0.9935	0.994609	0.9944	1.609	13.90	1.0	5.58	0.991	.	.	.	ABCC2:uc001kqf.2:exon2:c.A116T:p.Y39F	-0.937	AFR:0.9802,AMR:1,EAS:1,FIN:1,NFE:1,OTH:0.9980,ASJ:1	601107	237500;	234;	234|Dubin-Sprinz disease<br>Hyperbilirubinemia type 2<br>Sprinz-Nelson syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|237500 ~	.	.	.	.	0.0	0.5	0.000	-1.375	10	MU81884479	hom
10	101563815	101563815	G	A	ABCC2	exonic	nonsynonymous SNV	ENSG00000023839	rs2273697	ENSG00000023839:ENST00000370449:exon10:c.G1249A:p.V417I	ABCC2:NM_000392:exon10:c.G1249A:p.V417I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1953	0.1921	0.186502	0.1759	-0.011	2.478	0.161	-10.3	0.657	.	.	ABC transporter type 1, transmembrane domain	ABCC2:uc001kqf.2:exon10:c.G1249A:p.V417I	-1.097	AFR:0.1791,AMR:0.1595,EAS:0.0962,FIN:0.1639,NFE:0.1857,OTH:0.1765,ASJ:0.2020	601107	237500;	234;	234|Dubin-Sprinz disease<br>Hyperbilirubinemia type 2<br>Sprinz-Nelson syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|237500 ~	.	.	.	.	0.008	-2.76	0.001	0.245	10	MU150011	hom
10	102506070	102506070	G	C	PAX2	intronic	.	ENSG00000075891	rs4472867	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8365	0.7750	0.846645	0.8077	.	.	.	.	.	.	.	.	.	.	AFR:0.7489,AMR:0.8086,EAS:1,FIN:0.8548,NFE:0.8090,OTH:0.8160,ASJ:0.8311	167409	120330;616002;	656;1475;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~1475|Coloboma of optic nerve with renal disease<br>Papillo-renal syndrome|Unknown|Autosomal dominant|Childhood|120330 ~	.	.	.	.	.	.	.	.	10	MU81884534	het
10	102891390	102891390	G	A	TLX1	exonic	nonsynonymous SNV	ENSG00000107807	rs140202357	ENSG00000107807:ENST00000370196:exon1:c.G92A:p.G31D,ENSG00000107807:ENST00000463716:exon1:c.G92A:p.G31D,ENSG00000107807:ENST00000467928:exon1:c.G92A:p.G31D	TLX1:NM_001195517:exon1:c.G92A:p.G31D,TLX1:NM_005521:exon1:c.G92A:p.G31D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0124	0.0066	0.00479233	0.0118	3.232	22.8	0.638	3.73	0.990	.	.	.	TLX1:uc001ksw.3:exon1:c.G92A:p.G31D,TLX1:uc021pxd.1:exon1:c.G92A:p.G31D	-0.518	AFR:0.0013,AMR:0.0012,EAS:0,FIN:0.0388,NFE:0.0131,OTH:0.0174,ASJ:0.0099	186770	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.048	-2.53	0.369	0.82	10	.	het
10	103340144	103340144	A	G	POLL	exonic	synonymous SNV	ENSG00000166169	rs3730476	ENSG00000166169:ENST00000370168:exon2:c.T243C:p.S81S,ENSG00000166169:ENST00000339310:exon4:c.T393C:p.S131S,ENSG00000166169:ENST00000370158:exon4:c.T399C:p.S133S,ENSG00000166169:ENST00000429502:exon5:c.T393C:p.S131S,ENSG00000166169:ENST00000456836:exon6:c.T435C:p.S145S,ENSG00000166169:ENST00000370169:exon7:c.T1224C:p.S408S,ENSG00000166169:ENST00000415897:exon7:c.T948C:p.S316S,ENSG00000166169:ENST00000299206:exon8:c.T1224C:p.S408S,ENSG00000166169:ENST00000370162:exon8:c.T1224C:p.S408S,ENSG00000166169:ENST00000370172:exon8:c.T960C:p.S320S	POLL:NM_001308382:exon5:c.T399C:p.S133S,POLL:NM_001174084:exon8:c.T1224C:p.S408S,POLL:NM_001174085:exon8:c.T948C:p.S316S,POLL:NM_013274:exon8:c.T1224C:p.S408S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2306	0.2654	0.163139	MU11561798	.	.	.	.	.	.	.	.	POLL:uc001ktd.1:exon2:c.T243C:p.S81S,POLL:uc001kte.1:exon3:c.T300C:p.S100S,POLL:uc001kth.1:exon4:c.T399C:p.S133S,POLL:uc010qqa.2:exon6:c.T441C:p.S147S,POLL:uc001ktg.1:exon7:c.T1224C:p.S408S,POLL:uc010qqc.2:exon7:c.T300C:p.S100S,POLL:uc001ktf.3:exon8:c.T948C:p.S316S,POLL:uc001kti.2:exon8:c.T1224C:p.S408S,POLL:uc001ktj.2:exon8:c.T1224C:p.S408S,POLL:uc001ktl.3:exon8:c.T960C:p.S320S,POLL:uc001ktm.3:exon8:c.T1224C:p.S408S	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.2408,EAS:0.1802,FIN:0.2682,NFE:0.0340,OTH:0.2447,ASJ:0.1788	606343	.	.	.	.	.	.	.	.	.	.	.	10	1(stomach)	0.3005
10	103340179	103340179	A	G	POLL	intronic	.	ENSG00000166169;ENSG00000166171	rs3730475	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2320	0.2597	0.163339	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	.	.	.	.	.	0	0.002	.	.	.	AFR:0.2412,AMR:0.1791,EAS:0.2682,FIN:0.0340,NFE:0.2447,OTH:0.3010,ASJ:0.1806	606343	.	.	.	.	.	.	.	.	.	.	.	10	1(haematopoietic_and_lymphoid_tissue)	0.2531
10	103344589	103344589	T	G	POLL	exonic	nonsynonymous SNV	ENSG00000166169	rs3730463	ENSG00000166169:ENST00000370169:exon4:c.A661C:p.T221P,ENSG00000166169:ENST00000299206:exon5:c.A661C:p.T221P,ENSG00000166169:ENST00000370162:exon5:c.A661C:p.T221P,ENSG00000166169:ENST00000370172:exon5:c.A397C:p.T133P,ENSG00000166169:ENST00000413344:exon5:c.A661C:p.T221P,ENSG00000166169:ENST00000426919:exon5:c.A694C:p.T232P	POLL:NM_001174084:exon5:c.A661C:p.T221P,POLL:NM_013274:exon5:c.A661C:p.T221P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0644	0.0812	0.0583067	.	-0.519	0.197	0.191	3.61	0.362	.	.	.	POLL:uc001ktg.1:exon4:c.A661C:p.T221P,POLL:uc001kti.2:exon5:c.A661C:p.T221P,POLL:uc001ktj.2:exon5:c.A661C:p.T221P,POLL:uc001ktl.3:exon5:c.A397C:p.T133P,POLL:uc001ktm.3:exon5:c.A661C:p.T221P	-1.107	AFR:0.0768,AMR:0.1020,EAS:0.0331,FIN:0.0031,NFE:0.0575,OTH:0.0775,ASJ:0.0489	606343	.	.	.	.	.	.	.	0.229	2.69	0.002	1.375	10	1(thyroid)	0.0697
10	104157727	104157727	C	T	NFKB2	intronic	.	ENSG00000077150	rs4919632	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9646	0.9222	0.922125	0.9335	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.8030,AMR:0.9678,EAS:1,FIN:0.9963,NFE:0.9820,OTH:0.9785,ASJ:0.9636	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU81884905	hom
10	104159196	104159196	A	G	NFKB2	exonic	synonymous SNV	ENSG00000077150	rs4919633	ENSG00000077150:ENST00000189444:exon13:c.A1269G:p.P423P,ENSG00000077150:ENST00000369966:exon13:c.A1269G:p.P423P,ENSG00000077150:ENST00000428099:exon13:c.A1269G:p.P423P	NFKB2:NM_001261403:exon12:c.A1269G:p.P423P,NFKB2:NM_001322935:exon12:c.A1143G:p.P381P,NFKB2:NM_001077494:exon13:c.A1269G:p.P423P,NFKB2:NM_001288724:exon13:c.A1269G:p.P423P,NFKB2:NM_001322934:exon13:c.A1269G:p.P423P,NFKB2:NM_002502:exon13:c.A1269G:p.P423P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9971	0.9919	0.986821	0.9893	.	.	.	.	.	.	.	.	NFKB2:uc009xxc.4:exon12:c.A1269G:p.P423P,NFKB2:uc001kva.4:exon13:c.A1269G:p.P423P,NFKB2:uc001kvb.4:exon13:c.A1269G:p.P423P,NFKB2:uc001kvd.4:exon13:c.A1269G:p.P423P	.	AFR:0.9632,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU68086	hom
10	104160434	104160434	A	G	NFKB2	exonic	synonymous SNV	ENSG00000077150	rs4919634	ENSG00000077150:ENST00000189444:exon17:c.A1821G:p.A607A,ENSG00000077150:ENST00000369966:exon17:c.A1821G:p.A607A,ENSG00000077150:ENST00000428099:exon17:c.A1821G:p.A607A	NFKB2:NM_001261403:exon16:c.A1821G:p.A607A,NFKB2:NM_001322935:exon16:c.A1695G:p.A565A,NFKB2:NM_001077494:exon17:c.A1821G:p.A607A,NFKB2:NM_001288724:exon17:c.A1821G:p.A607A,NFKB2:NM_001322934:exon17:c.A1821G:p.A607A,NFKB2:NM_002502:exon17:c.A1821G:p.A607A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9968	0.9895	0.986821	0.9894	.	.	.	.	.	.	.	.	NFKB2:uc009xxc.4:exon16:c.A1821G:p.A607A,NFKB2:uc001kva.4:exon17:c.A1821G:p.A607A,NFKB2:uc001kvb.4:exon17:c.A1821G:p.A607A,NFKB2:uc001kvd.4:exon17:c.A1821G:p.A607A	.	AFR:0.9636,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	164012	615577;	1572;293978;	1572|CVID<br>Idiopathic immunoglobulin deficiency<br>Primary antibody deficiency<br>Primary hypogammaglobulinemia|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|All ages|146830 240500 607594 613493 613494 613495 613496 614699 615577 616576 ~293978|DAVID syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615577 ~	~ko04010 MAPK signaling pathway~ko04064 NF-kappa B signaling pathway~ko04380 Osteoclast differentiation~ko04625 C-type lectin receptor signaling pathway~ko05134 Legionellosis~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05224 Breast cancer ~	.	.	.	.	.	.	.	10	MU4556917	hom
10	104264107	104264107	C	T	SUFU	intronic	.	ENSG00000107882	rs2274351	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4857	0.4795	0.396166	0.4626	.	.	.	.	.	.	.	.	.	.	AFR:0.3195,AMR:0.3652,EAS:0.3451,FIN:0.5258,NFE:0.5417,OTH:0.5103,ASJ:0.6854	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU26588926	het
10	104387019	104387019	T	C	SUFU	intronic	.	ENSG00000107882	rs12414407	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6628	0.6811	0.719649	0.6861	.	.	.	.	.	.	.	.	.	.	AFR:0.7605,AMR:0.5979,EAS:0.7627,FIN:0.6097,NFE:0.6594,OTH:0.6510,ASJ:0.6967	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU23889391	het
10	104389932	104389932	T	G	SUFU	UTR3	.	ENSG00000107882	rs4917980	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9994	0.9978	0.997404	0.9983	.	.	.	.	.	.	.	.	.	.	AFR:0.9940,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	607035	109400;155255;607174;	263662;251858;251863;251867;616;377;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~377|Basal cell nevus syndrome<br>Gorlin-Goltz syndrome<br>NBCCS<br>Nevoid basal cell carcinoma syndrome|1-9 / 100 000|Autosomal dominant|Adolescent<br>Adult|109400 ~	~ko04340 Hedgehog signaling pathway~ko04341 Hedgehog signaling pathway - fly~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	.	.	.	.	10	MU81885050	hom
10	104592249	104592249	A	C	CYP17A1	intronic	.	ENSG00000148795	rs4919686	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2238	0.2204	0.138778	0.2242	.	.	.	.	.	.	.	.	.	.	AFR:0.0703,AMR:0.2093,EAS:0.1642,FIN:0.2716,NFE:0.3051,OTH:0.2673,ASJ:0.34	609300	202110;	418;90793;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~90793|CAH due to 17-alpha-hydroxylase deficiency<br>Combined 17-hydroxylase/17,20-lyase deficiency|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|202110 ~	.	.	.	.	.	.	.	.	10	MU82115785	het
10	104596924	104596924	C	A	CYP17A1	exonic	synonymous SNV	ENSG00000148795	rs6163	ENSG00000148795:ENST00000369887:exon1:c.G195T:p.S65S	CYP17A1:NM_000102:exon1:c.G195T:p.S65S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3974	0.3833	0.410343	0.4008	.	.	.	.	.	.	.	.	CYP17A1:uc001kwg.3:exon1:c.G195T:p.S65S	.	AFR:0.3645,AMR:0.3962,EAS:0.5989,FIN:0.3584,NFE:0.4089,OTH:0.4180,ASJ:0.4470	609300	202110;	418;90793;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~90793|CAH due to 17-alpha-hydroxylase deficiency<br>Combined 17-hydroxylase/17,20-lyase deficiency|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|202110 ~	.	.	.	.	.	.	.	.	10	MU61497	het
10	104596981	104596981	G	A	CYP17A1	exonic	synonymous SNV	ENSG00000148795	rs6162	ENSG00000148795:ENST00000369887:exon1:c.C138T:p.H46H	CYP17A1:NM_000102:exon1:c.C138T:p.H46H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4248	0.3949	0.442492	0.4116	.	.	.	.	.	.	.	.	CYP17A1:uc001kwg.3:exon1:c.C138T:p.H46H	.	AFR:0.3683,AMR:0.4117,EAS:0.5963,FIN:0.3645,NFE:0.4254,OTH:0.4305,ASJ:0.4735	609300	202110;	418;90793;	418|CAH|1-9 / 100 000|Autosomal recessive|All ages|201710 201810 201910 202010 202110 613571 ~90793|CAH due to 17-alpha-hydroxylase deficiency<br>Combined 17-hydroxylase/17,20-lyase deficiency|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|202110 ~	.	.	.	.	.	.	.	.	10	MU135047	het
10	112343591	112343591	G	A	SMC3	intronic	.	ENSG00000108055	rs11195199	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1490	0.0973	0.148163	0.1170	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.0806,AMR:0.2153,EAS:0.2330,FIN:0.1345,NFE:0.1169,OTH:0.1112,ASJ:0.0993	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	10	MU20249066	het
10	112343923	112343923	T	C	SMC3	intronic	.	ENSG00000108055	rs11195200	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1489	0.0981	0.148163	0.1168	.	.	.	.	.	.	.	.	.	.	AFR:0.0804,AMR:0.2172,EAS:0.2337,FIN:0.1343,NFE:0.1163,OTH:0.1110,ASJ:0.0993	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	10	MU11573771	het
10	112360316	112360316	T	-	SMC3	intronic	.	ENSG00000108055	rs397847637	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.3748	.	0.388179	0.1393	.	.	.	.	.	.	.	.	.	.	AFR:0.0928,AMR:0.3123,EAS:0.278,FIN:0.2411,NFE:0.1327,OTH:0.1515,ASJ:0.1423	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	10	.	het
10	112361870	112361870	A	G	SMC3	exonic	synonymous SNV	ENSG00000108055	rs2419565	ENSG00000108055:ENST00000361804:exon25:c.A3039G:p.S1013S	SMC3:NM_005445:exon25:c.A3039G:p.S1013S	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 1] 	0.9963	0.9899	0.986821	0.9897	.	.	.	.	.	.	.	.	SMC3:uc001kze.3:exon25:c.A3039G:p.S1013S	.	AFR:0.9651,AMR:0.9976,EAS:1,FIN:1,NFE:0.9997,OTH:0.9990,ASJ:0.9834	606062	610759;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	9741,	.	.	.	.	.	.	10	MU81885879	hom
10	115609915	115609915	C	G	DCLRE1A	exonic	nonsynonymous SNV	ENSG00000198924	rs3750898	ENSG00000198924:ENST00000361384:exon2:c.G949C:p.D317H,ENSG00000198924:ENST00000369305:exon3:c.G949C:p.D317H	DCLRE1A:NM_014881:exon2:c.G949C:p.D317H,DCLRE1A:NM_001271816:exon3:c.G949C:p.D317H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.7562	0.6379	0.657748	0.6768	5.545	26.4	0.007	4.13	0.506	.	.	.	DCLRE1A:uc001law.3:exon2:c.G949C:p.D317H,DCLRE1A:uc031pxf.1:exon3:c.G949C:p.D317H	-1.003	AFR:0.3802,AMR:0.8508,EAS:0.8776,FIN:0.7975,NFE:0.7802,OTH:0.7704,ASJ:0.8367	609682	.	.	.	.	.	.	.	0.993	-0.29	0.000	1.59	10	MU23502967	hom
10	123239112	123239112	G	A	FGFR2	exonic	synonymous SNV	ENSG00000066468	rs1047057	ENSG00000066468:ENST00000357555:exon17:c.C2107T:p.L703L	FGFR2:NM_001144915:exon17:c.C2107T:p.L703L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5311	0.4345	0.414337	14(meninges)	.	.	.	.	.	.	.	.	FGFR2:uc021pzx.1:exon17:c.C2107T:p.L703L	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU582048,EAS:0.4191,FIN:0.1433,NFE:0.7254,OTH:0.5567,ASJ:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,5284,5280,5286,5281,5287,5293,5283,5288,5294,5282,5285,5295,5291,5290,5219,5292,5323,5289	.	.	.	.	.	.	10	1(stomach)	0.3736
10	123239422	123239422	G	A	FGFR2	exonic	synonymous SNV	ENSG00000066468	rs558460047	ENSG00000066468:ENST00000429361:exon9:c.C1085T:p.T362M	FGFR2:NM_001144914:exon15:c.C2079T:p.Y693Y,FGFR2:NM_001144916:exon15:c.C2070T:p.Y690Y,FGFR2:NM_001144917:exon16:c.C2067T:p.Y689Y,FGFR2:NM_001144918:exon16:c.C2064T:p.Y688Y,FGFR2:NM_023029:exon16:c.C2148T:p.Y716Y,FGFR2:NM_001320654:exon17:c.C1731T:p.Y577Y,FGFR2:NM_000141:exon18:c.C2415T:p.Y805Y,FGFR2:NM_001320658:exon18:c.C2409T:p.Y803Y,FGFR2:NM_022970:exon18:c.C2418T:p.Y806Y	clinvar: Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 1] 	0.0003	.	0.000399361	MU1797786	-0.169	1.269	0.673	-5.86	0.990	.	.	Protein kinase domain	FGFR2:uc001lfg.4:exon11:c.C1239T:p.Y413Y,FGFR2:uc021pzv.1:exon15:c.C2079T:p.Y693Y,FGFR2:uc021pzw.1:exon15:c.C2070T:p.Y690Y,FGFR2:uc010qtl.2:exon16:c.C2067T:p.Y689Y,FGFR2:uc010qtm.2:exon16:c.C2064T:p.Y688Y,FGFR2:uc031pxk.1:exon16:c.C2148T:p.Y716Y,FGFR2:uc001lfn.5:exon17:c.C1245T:p.Y415Y,FGFR2:uc021pzy.1:exon18:c.C2418T:p.Y806Y,FGFR2:uc021pzz.1:exon18:c.C2415T:p.Y805Y	-0.410	AFR:UCEC-US|1|531|0.00188324,READ-US|1|143|0.00699301,AMR:6.459e-05,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,5284,5280,5286,5281,5287,5293,5283,5288,5294,5282,5285,5295,5291,5290,5219,5292,5323,5289	.	.	.	-1.21	0.390	.	10	1(prostate)	0.0001
10	123243197	123243197	G	A	FGFR2	intronic	.	ENSG00000066468	rs2278202	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5614	0.4544	0.423123	1(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	.	.	AFR:MU582049,AMR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,EAS:0.1718,FIN:0.7375,NFE:0.5795,OTH:0.3275,ASJ:0.4422	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	10	1(stomach)	0.5
10	123298158	123298158	T	C	FGFR2	exonic	synonymous SNV	ENSG00000066468	rs1047100	ENSG00000066468:ENST00000356226:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000369059:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000604236:exon4:c.A351G:p.V117V,ENSG00000066468:ENST00000336553:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000346997:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000357555:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000360144:exon5:c.A429G:p.V143V,ENSG00000066468:ENST00000369056:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000369061:exon5:c.A696G:p.V232V,ENSG00000066468:ENST00000351936:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000358487:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000359354:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000369058:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000369060:exon6:c.A696G:p.V232V,ENSG00000066468:ENST00000457416:exon6:c.A696G:p.V232V	FGFR2:NM_001144916:exon3:c.A351G:p.V117V,FGFR2:NM_001144918:exon4:c.A351G:p.V117V,FGFR2:NM_023029:exon4:c.A429G:p.V143V,FGFR2:NM_001144913:exon5:c.A696G:p.V232V,FGFR2:NM_001144914:exon5:c.A696G:p.V232V,FGFR2:NM_001144915:exon5:c.A429G:p.V143V,FGFR2:NM_001144919:exon5:c.A429G:p.V143V,FGFR2:NM_000141:exon6:c.A696G:p.V232V,FGFR2:NM_001144917:exon6:c.A696G:p.V232V,FGFR2:NM_001320658:exon6:c.A696G:p.V232V,FGFR2:NM_022970:exon6:c.A696G:p.V232V	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7797	0.7667	0.795327	0.7635	.	.	.	.	.	.	.	.	FGFR2:uc010qto.2:exon3:c.A408G:p.V136V,FGFR2:uc021pzw.1:exon3:c.A351G:p.V117V,FGFR2:uc010qtm.2:exon4:c.A351G:p.V117V,FGFR2:uc031pxk.1:exon4:c.A429G:p.V143V,FGFR2:uc010qtn.2:exon5:c.A753G:p.V251V,FGFR2:uc010qtp.2:exon5:c.A753G:p.V251V,FGFR2:uc010qtq.2:exon5:c.A753G:p.V251V,FGFR2:uc021pzv.1:exon5:c.A696G:p.V232V,FGFR2:uc021pzx.1:exon5:c.A429G:p.V143V,FGFR2:uc021qaa.1:exon5:c.A696G:p.V232V,FGFR2:uc021qab.1:exon5:c.A429G:p.V143V,FGFR2:uc021qac.1:exon5:c.A486G:p.V162V,FGFR2:uc001lfo.1:exon6:c.A753G:p.V251V,FGFR2:uc010qtl.2:exon6:c.A696G:p.V232V,FGFR2:uc021pzy.1:exon6:c.A696G:p.V232V,FGFR2:uc021pzz.1:exon6:c.A696G:p.V232V	.	AFR:0.7530,AMR:0.8126,EAS:0.9030,FIN:0.7590,NFE:0.7519,OTH:0.7459,ASJ:0.8676	176943	101200;101400;101600;123150;123500;123790;149730;207410;609579;613659;614592;	313855;168624;83;2363;1555;207;1540;710;794;87;	313855|Perinatal lethal bent bone dysplasia|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614592 ~168624|Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609579 ~83|-|<1 / 1 000 000|Autosomal recessive|Neonatal|207410 ~2363|LADD syndrome<br>LARD syndrome<br>Lacrimoauriculoradiodental syndrome<br>Levy-Hollister syndrome|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal<br>Infancy<br>Childhood|149730 ~1555|Beare-Stevenson cutis gyrata syndrome|<1 / 1 000 000|Autosomal dominant|Neonatal|123790 ~207|Crouzon craniofacial dysostosis|1-9 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|123500 ~1540|Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome<br>JWS|<1 / 1 000 000|Autosomal dominant|Neonatal|123150 ~710|ACS5<br>Acrocephalosyndactyly type 5|Unknown|Autosomal dominant|Antenatal<br>Neonatal|101600 ~794|ACS3<br>Acrocephalosyndactyly type 3<br>SCS|1-9 / 100 000|Autosomal dominant|Neonatal|101400 ~87|ACS1<br>Acrocephalosyndactyly type 1|1-9 / 100 000|Autosomal dominant|Antenatal<br>Neonatal|101200 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04144 Endocytosis~ko04151 PI3K-Akt signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05215 Prostate cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,5284,5280,5286,5281,5287,5293,5283,5288,5294,5282,5285,5295,5291,5290,5219,5292,5323,5289	.	.	.	.	.	.	10	MU81887223	hom
10	124271589	124271589	G	A	HTRA1	intronic	.	ENSG00000166033	rs2672586	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9998	0.9994	0.999401	0.9996	.	.	.	.	.	0.0001	0.076	.	.	.	AFR:0.9986,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	MU81887516	unknown
10	124271595	124271595	G	A	HTRA1	intronic	.	ENSG00000166033	rs2272599	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6113	0.6506	0.627995	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,ESCA-CN|1|332|0.00301205	.	.	.	.	.	.	.	.	.	.	AFR:0.6342,AMR:0.7012,EAS:0.6391,FIN:0.6190,NFE:0.6070,OTH:0.6126,ASJ:0.4892	602194	600142;610149;616779;	199354;	199354|Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy<br>Maeda syndrome|Unknown|Autosomal recessive|Adolescent<br>Adult|600142 ~	.	.	.	.	.	.	.	.	10	2(lung)	0.6133
10	131565064	131565064	A	G	MGMT	exonic	nonsynonymous SNV	ENSG00000170430	rs2308321	ENSG00000170430:ENST00000306010:exon5:c.A520G:p.I174V	MGMT:NM_002412:exon5:c.A427G:p.I143V	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0988	0.0925	0.0513179	0.0833	-0.330	0.567	0.505	-0.425	0.971	.	.	Methylated-DNA-[protein]-cysteine S-methyltransferase, DNA binding|Winged helix-turn-helix DNA-binding domain	MGMT:uc001lkh.2:exon5:c.A520G:p.I174V	-0.906	AFR:0.0216,AMR:0.0610,EAS:0.0117,FIN:0.1291,NFE:0.1173,OTH:0.0845,ASJ:0.0927	156569	.	.	.	.	.	.	.	0.035	2.57	0.000	-0.455	10	.	het
10	131565170	131565170	A	G	MGMT	exonic	nonsynonymous SNV	ENSG00000170430	rs2308327	ENSG00000170430:ENST00000306010:exon5:c.A626G:p.K209R	MGMT:NM_002412:exon5:c.A533G:p.K178R	clinvar: UNK 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0947	0.0925	0.0513179	0.0833	0.757	9.194	0.046	-3.61	0.026	.	.	Winged helix-turn-helix DNA-binding domain	MGMT:uc001lkh.2:exon5:c.A626G:p.K209R	-0.952	AFR:0.0216,AMR:0.0609,EAS:0.0117,FIN:0.1291,NFE:0.1173,OTH:0.0845,ASJ:0.0927	156569	.	.	.	.	.	.	.	0.001	3.39	0.000	0.695	10	.	het
11	534197	534197	C	T	HRAS	intronic	.	ENSG00000174775	rs41258054	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0676	0.0321	0.0766773	MU19240624	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526,AMR:0.0413,EAS:0.1683,FIN:0.0331,NFE:0.1310,OTH:0.0260,ASJ:0.0080	190020	109800;137550;162900;163200;188470;218040;	3071;319487;2612;79414;626;	3071|FCS syndrome<br>Faciocutaneoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|218040 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	11	2(meninges)	0.0474
11	534242	534242	A	G	HRAS	exonic	synonymous SNV	ENSG00000174775	rs12628	ENSG00000174775:ENST00000397594:exon1:c.T81C:p.H27H,ENSG00000174775:ENST00000311189:exon2:c.T81C:p.H27H,ENSG00000174775:ENST00000397596:exon2:c.T81C:p.H27H,ENSG00000174775:ENST00000417302:exon2:c.T81C:p.H27H,ENSG00000174775:ENST00000451590:exon2:c.T81C:p.H27H,ENSG00000174775:ENST00000493230:exon2:c.T81C:p.H27H	HRAS:NM_001130442:exon2:c.T81C:p.H27H,HRAS:NM_005343:exon2:c.T81C:p.H27H,HRAS:NM_176795:exon2:c.T81C:p.H27H	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3135	0.3545	0.297125	1(thyroid)	.	.	.	.	.	.	.	.	HRAS:uc001lpv.3:exon2:c.T81C:p.H27H,HRAS:uc010qvw.2:exon2:c.T81C:p.H27H,HRAS:uc010qvx.2:exon2:c.T81C:p.H27H	.	AFR:26(urinary_tract),AMR:3(haematopoietic_and_lymphoid_tissue),EAS:11(meninges),FIN:1(liver),NFE:2(biliary_tract),OTH:MU107046,ASJ:1(skin)	190020	109800;137550;162900;163200;188470;218040;	3071;319487;2612;79414;626;	3071|FCS syndrome<br>Faciocutaneoskeletal syndrome|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|218040 ~319487|FNMTC<br>Familial pure nonmedullary thyroid carcinoma|-|-|-|188470 188550 603386 603744 606240 616534 616535 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~79414|Wooly hair nevus|-|Not applicable|Neonatal<br>Infancy|162900 ~626|Congenital pigmented nevus<br>GMN<br>Giant congenital melanocytic nevus<br>Giant pigmented hairy nevus<br>LCMN|1-9 / 100 000|-|Infancy<br>Neonatal|137550 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	5972,5967,5966,,5969,5968,5970,5965,5975,5961,5974,5964,5962,5973,5971,5963	.	.	.	.	.	.	11	1(large_intestine)	LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611
11	2016908	2016908	G	A	H19	ncRNA_exonic	.	ENSG00000130600	rs217727	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2000	0.1551	0.202077	0.1737	.	.	.	.	.	.	.	.	.	.	AFR:0.0944,AMR:0.2536,EAS:0.3391,FIN:0.1815,NFE:0.1946,OTH:0.2047,ASJ:0.1233	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	MU782426	hom
11	2022519	2022519	A	G	H19	ncRNA_exonic	.	ENSG00000130600	rs145181743	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.00379393	0.0126	.	.	.	.	.	.	.	.	.	.	AFR:0.0026,AMR:0.0084,EAS:0,FIN:0.0238,NFE:0.0174,OTH:0.0163,ASJ:0	103280	130650;180860;194071;	654;813;116;	654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~813|Silver-Russell dwarfism|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|180860 312780 ~116|BWS<br>Exomphalos-macroglossia-gigantism syndrome<br>Wiedemann-Beckwith syndrome|1-5 / 10 000|Unknown<br>or&nbsp;Autosomal dominant|Neonatal<br>Antenatal|130650 ~	.	.	.	.	.	.	.	.	11	.	het
11	6629665	6629665	C	T	ILK	exonic	synonymous SNV	ENSG00000166333	rs1043388	ENSG00000166333:ENST00000396751:exon3:c.C297T:p.H99H,ENSG00000166333:ENST00000299421:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000420936:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000527327:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000527394:exon4:c.C297T:p.H99H,ENSG00000166333:ENST00000528995:exon4:c.C297T:p.H99H	ILK:NM_001014795:exon3:c.C297T:p.H99H,ILK:NM_001014794:exon4:c.C297T:p.H99H,ILK:NM_001278441:exon4:c.C297T:p.H99H,ILK:NM_004517:exon4:c.C297T:p.H99H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2677	0.2950	0.314696	0.2953	.	.	.	.	.	.	.	.	ILK:uc001meh.3:exon3:c.C297T:p.H99H,ILK:uc001mee.3:exon4:c.C297T:p.H99H,ILK:uc001mef.3:exon4:c.C297T:p.H99H,ILK:uc010raq.2:exon4:c.C297T:p.H99H	.	AFR:0.3774,AMR:0.2053,EAS:0.3455,FIN:0.2407,NFE:0.2609,OTH:0.2755,ASJ:0.3079	602366	.	.	.	.	.	.	.	.	.	.	.	11	MU108851	hom
11	6630029	6630029	C	-	TAF10	UTR3	.	ENSG00000166333	rs11314683	ENSG00000166333:ENST00000527327:exon5:c.457delC:p.P153fs,ENSG00000166333:ENST00000527394:exon5:c.457delC:p.P153fs	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600475	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	6630833	6630833	G	A	ILK	exonic	synonymous SNV	ENSG00000166333	rs1043390	ENSG00000166333:ENST00000528995:exon7:c.G636A:p.P212P,ENSG00000166333:ENST00000396751:exon8:c.G819A:p.P273P,ENSG00000166333:ENST00000537806:exon8:c.G417A:p.P139P,ENSG00000166333:ENST00000299421:exon9:c.G819A:p.P273P,ENSG00000166333:ENST00000420936:exon9:c.G819A:p.P273P	ILK:NM_001278441:exon7:c.G636A:p.P212P,ILK:NM_001014795:exon8:c.G819A:p.P273P,ILK:NM_001278442:exon8:c.G417A:p.P139P,ILK:NM_001014794:exon9:c.G819A:p.P273P,ILK:NM_004517:exon9:c.G819A:p.P273P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2782	0.3269	0.347444	0.3227	.	.	.	.	.	.	.	.	ILK:uc010raq.2:exon7:c.G636A:p.P212P,ILK:uc001meh.3:exon8:c.G819A:p.P273P,ILK:uc010rap.2:exon8:c.G417A:p.P139P,ILK:uc001mee.3:exon9:c.G819A:p.P273P,ILK:uc001mef.3:exon9:c.G819A:p.P273P	.	AFR:0.4732,AMR:0.2076,EAS:0.3462,FIN:0.2414,NFE:0.2613,OTH:0.2787,ASJ:0.3079	602366	.	.	.	.	.	.	.	.	.	.	.	11	MU108871	hom
11	8251921	8251921	G	C	LMO1	exonic	synonymous SNV	ENSG00000166407	rs3750952	ENSG00000166407:ENST00000335790:exon2:c.C156G:p.A52A,ENSG00000166407:ENST00000428101:exon2:c.C153G:p.A51A,ENSG00000166407:ENST00000534484:exon2:c.C123G:p.A41A	LMO1:NM_001270428:exon2:c.C153G:p.A51A,LMO1:NM_002315:exon2:c.C156G:p.A52A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4466	0.3592	0.333866	1(stomach)	.	.	.	.	.	.	.	.	LMO1:uc001mgg.2:exon2:c.C156G:p.A52A,LMO1:uc001mgh.2:exon2:c.C153G:p.A51A	.	AFR:1(lung),AMR:MU728619,EAS:0.3704,FIN:0.1079,NFE:0.5096,OTH:0.4768,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	186921	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.3315
11	8256125	8256125	C	G	LMO1	intronic	.	ENSG00000166407	rs204925	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.595847	0.6416	.	.	.	.	.	.	.	.	.	.	AFR:0.4044,AMR:0.6340,EAS:0.6163,FIN:0.7532,NFE:0.7485,OTH:0.7276,ASJ:0.7815	186921	.	.	.	.	.	.	.	.	.	.	.	11	MU87154591	hom
11	8256255	8256255	A	C	LMO1	intronic	.	ENSG00000166407	rs204924	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.995807	0.9964	.	.	.	.	.	.	.	.	.	.	AFR:0.9877,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	186921	.	.	.	.	.	.	.	.	.	.	.	11	.	unknown
11	8751640	8751640	G	C	ST5	exonic	nonsynonymous SNV	ENSG00000166444	rs3812762	ENSG00000166444:ENST00000313726:exon3:c.C1197G:p.D399E,ENSG00000166444:ENST00000357665:exon4:c.C1197G:p.D399E,ENSG00000166444:ENST00000534127:exon6:c.C1197G:p.D399E	ST5:NM_213618:exon3:c.C1197G:p.D399E,ST5:NM_005418:exon6:c.C1197G:p.D399E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3119	0.2586	0.265375	1(skin)	0.700	8.829	0.747	5.25	1.000	.	.	.	ST5:uc001mgt.3:exon3:c.C1197G:p.D399E,ST5:uc001mgv.3:exon6:c.C1197G:p.D399E,ST5:uc001mgw.1:exon7:c.C1197G:p.D399E	-0.921	AFR:MU4552266,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.1477,FIN:0.3484,NFE:0.4040,OTH:0.2009,ASJ:0.2639	140750	.	.	.	.	.	.	.	0.02	3.61	0.000	1.59	11	1(thyroid)	0.3100
11	8752598	8752598	G	C	ST5	exonic	nonsynonymous SNV	ENSG00000166444	rs61751342	ENSG00000166444:ENST00000313726:exon3:c.C239G:p.P80R,ENSG00000166444:ENST00000527930:exon3:c.C329G:p.P110R,ENSG00000166444:ENST00000528523:exon3:c.C239G:p.P80R,ENSG00000166444:ENST00000533016:exon3:c.C299G:p.P100R,ENSG00000166444:ENST00000533580:exon3:c.C290G:p.P97R,ENSG00000166444:ENST00000533681:exon3:c.C239G:p.P80R,ENSG00000166444:ENST00000357665:exon4:c.C239G:p.P80R,ENSG00000166444:ENST00000526155:exon4:c.C239G:p.P80R,ENSG00000166444:ENST00000526241:exon4:c.C239G:p.P80R,ENSG00000166444:ENST00000527473:exon4:c.C239G:p.P80R,ENSG00000166444:ENST00000534248:exon4:c.C239G:p.P80R,ENSG00000166444:ENST00000527347:exon5:c.C239G:p.P80R,ENSG00000166444:ENST00000530959:exon5:c.C239G:p.P80R,ENSG00000166444:ENST00000527516:exon6:c.C239G:p.P80R,ENSG00000166444:ENST00000534127:exon6:c.C239G:p.P80R	ST5:NM_213618:exon3:c.C239G:p.P80R,ST5:NM_005418:exon6:c.C239G:p.P80R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0384	0.0402	0.0177716	0.0331	0.602	8.170	0.091	4.59	0.737	.	.	.	ST5:uc001mgt.3:exon3:c.C239G:p.P80R,ST5:uc001mgv.3:exon6:c.C239G:p.P80R,ST5:uc001mgw.1:exon7:c.C239G:p.P80R	-1.002	AFR:0.0105,AMR:0.0274,EAS:0,FIN:0.0255,NFE:0.0517,OTH:0.0387,ASJ:0.0232	140750	.	.	.	.	.	.	.	0.838	3.5	0.003	1.78	11	.	het
11	10786142	10786142	C	T	CTR9	exonic	synonymous SNV	ENSG00000198730	rs3736326	ENSG00000198730:ENST00000361367:exon12:c.C1461T:p.H487H	CTR9:NM_001346279:exon12:c.C1461T:p.H487H,CTR9:NM_014633:exon12:c.C1461T:p.H487H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6377	0.5111	0.611621	0.5535	.	.	.	.	.	.	.	.	CTR9:uc001mja.3:exon12:c.C1461T:p.H487H	.	AFR:0.3711,AMR:0.7184,EAS:0.8395,FIN:0.6282,NFE:0.5961,OTH:0.6255,ASJ:0.6192	609366	.	.	.	.	.	.	.	.	.	.	.	11	MU4555501	hom
11	11986061	11986061	T	C	DKK3	exonic	nonsynonymous SNV	ENSG00000050165	rs3206824	ENSG00000050165:ENST00000450094:exon6:c.A919G:p.R307G,ENSG00000050165:ENST00000326932:exon8:c.A1003G:p.R335G,ENSG00000050165:ENST00000396505:exon8:c.A1003G:p.R335G,ENSG00000050165:ENST00000525493:exon8:c.A1045G:p.R349G	DKK3:NM_001018057:exon7:c.A1003G:p.R335G,DKK3:NM_001330220:exon8:c.A1045G:p.R349G,DKK3:NM_013253:exon8:c.A1003G:p.R335G,DKK3:NM_015881:exon8:c.A1003G:p.R335G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7781	0.7718	0.812101	1(liver)	-0.421	0.344	0.693	-2.65	0.008	.	.	.	DKK3:uc010rcf.2:exon6:c.A919G:p.R307G,DKK3:uc001mju.3:exon7:c.A1003G:p.R335G,DKK3:uc001mjv.3:exon8:c.A1003G:p.R335G,DKK3:uc001mjw.3:exon8:c.A1003G:p.R335G,DKK3:uc010rcg.1:exon8:c.A1045G:p.R349G	-1.001	AFR:1(thyroid),AMR:MU751806,EAS:0.7566,FIN:0.8232,NFE:0.8711,OTH:0.8676,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	605416	.	.	.	.	.	.	.	0.0	2.29	0.000	-2.08	11	1(urinary_tract)	0.8019
11	14303282	14303282	T	A	RRAS2	intronic	.	ENSG00000133818	rs2303972	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4165	0.3645	0.338458	SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.3537,AMR:0.1989,EAS:0.3907,FIN:0.3213,NFE:0.3285,OTH:0.4365,ASJ:0.5933	600098	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.3912
11	20623156	20623156	C	G	SLC6A5	exonic	nonsynonymous SNV	ENSG00000165970	rs1443549	ENSG00000165970:ENST00000298923:exon2:c.C485G:p.A162G,ENSG00000165970:ENST00000525748:exon2:c.C485G:p.A162G	SLC6A5:NM_004211:exon2:c.C485G:p.A162G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9983	0.9932	0.99361	0.9951	1.483	13.22	1.0	5.59	0.995	.	.	.	SLC6A5:uc001mqd.3:exon2:c.C485G:p.A162G	-0.929	AFR:0.9829,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	0.0	-0.5	0.000	-1.845	11	MU81897454	hom
11	20639400	20639400	A	G	SLC6A5	exonic	synonymous SNV	ENSG00000165970	rs7925597	ENSG00000165970:ENST00000525748:exon7:c.A1230G:p.S410S	SLC6A5:NM_001318369:exon6:c.A528G:p.S176S,SLC6A5:NM_004211:exon7:c.A1230G:p.S410S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9989	0.9950	0.997404	0.9969	.	.	.	.	.	.	.	.	SLC6A5:uc009yic.3:exon6:c.A525G:p.S175S,SLC6A5:uc001mqd.3:exon7:c.A1230G:p.S410S	.	AFR:0.9891,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU81897460	hom
11	20648364	20648364	G	C	SLC6A5	exonic	nonsynonymous SNV	ENSG00000165970	rs3740870	ENSG00000165970:ENST00000525748:exon8:c.G1371C:p.K457N	SLC6A5:NM_001318369:exon7:c.G669C:p.K223N,SLC6A5:NM_004211:exon8:c.G1371C:p.K457N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1339	0.1167	0.0904553	0.1226	3.246	22.8	0.021	5.12	0.998	.	.	.	SLC6A5:uc009yic.3:exon7:c.G666C:p.K222N,SLC6A5:uc001mqd.3:exon8:c.G1371C:p.K457N	-1.089	AFR:0.0256,AMR:0.1050,EAS:0.0698,FIN:0.1906,NFE:0.1679,OTH:0.1670,ASJ:0.08	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	0.043	-0.74	0.001	0.435	11	MU139389	unknown
11	20648380	20648380	G	A	SLC6A5	exonic	nonsynonymous SNV	ENSG00000165970	rs1805091	ENSG00000165970:ENST00000525748:exon8:c.G1387A:p.D463N	SLC6A5:NM_001318369:exon7:c.G685A:p.D229N,SLC6A5:NM_004211:exon8:c.G1387A:p.D463N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2258	0.2323	0.16274	0.2221	3.831	23.4	0.399	6.04	0.997	.	.	.	SLC6A5:uc009yic.3:exon7:c.G682A:p.D228N,SLC6A5:uc001mqd.3:exon8:c.G1387A:p.D463N	-1.128	AFR:0.1202,AMR:0.1711,EAS:0.0766,FIN:0.2954,NFE:0.2794,OTH:0.2597,ASJ:0.2748	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	0.094	-0.85	0.000	0.5	11	MU139401	unknown
11	20676253	20676253	T	C	SLC6A5	intronic	.	ENSG00000165970	rs2276432	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1583	0.1807	0.159944	0.1767	.	.	.	.	.	0	0.016	.	.	.	AFR:0.1993,AMR:0.1122,EAS:0.0499,FIN:0.2115,NFE:0.1736,OTH:0.1874,ASJ:0.1067	604159	614618;	3197;	3197|Congenital stiff man syndrome<br>Familial startle disease<br>Hereditary hyperexplexia<br>Hyperekplexia<br>Kok disease<br>Stiff baby syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|149400 614618 614619 ~	.	.	.	.	.	.	.	.	11	MU82206230	het
11	22646571	22646571	T	C	FANCF	exonic	synonymous SNV	ENSG00000183161	rs11026706	ENSG00000183161:ENST00000327470:exon1:c.A786G:p.L262L	FANCF:NM_022725:exon1:c.A786G:p.L262L	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0094	0.0006	0.0225639	0.0043	.	.	.	.	.	.	.	.	FANCF:uc001mql.1:exon1:c.A786G:p.L262L	.	AFR:0.0007,AMR:0,EAS:0.0771,FIN:0,NFE:6.664e-05,OTH:0.0010,ASJ:0	613897	603467;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	11	MU11876985	het
11	31811460	31811460	-	T	PAX6	exonic	frameshift insertion	ENSG00000007372	rs766383236	.	PAX6:NM_001368929:exon9:c.731dupA:p.K244fs,PAX6:NM_001368911:exon10:c.1184dupA:p.K395fs,PAX6:NM_001368916:exon11:c.1139dupA:p.K380fs,PAX6:NM_001368913:exon12:c.1181dupA:p.K394fs,PAX6:NM_001368915:exon12:c.1139dupA:p.K380fs,PAX6:NM_001368917:exon12:c.1139dupA:p.K380fs,PAX6:NM_001368912:exon13:c.1181dupA:p.K394fs,PAX6:NM_001368914:exon13:c.1181dupA:p.K394fs,PAX6:NM_001368921:exon13:c.980dupA:p.K327fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0002	.	.	0.0579	.	.	.	.	.	.	.	.	.	.	AFR:0.1846,AMR:0.0159,EAS:0.0179,FIN:0,NFE:0.0038,OTH:0.0142,ASJ:0.0101	607108	106210;120200;120430;136520;148190;165550;604229;	708;137902;2334;2253;35737;194;98942;98944;250923;	708|Peters congenital glaucoma|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|604229 ~137902|-|-|Autosomal dominant|-|165550 ~2334|Hereditary keratitis|Unknown|Autosomal dominant|Childhood|148190 ~2253|O'Donnell-Pappas syndrome|<1 / 1 000 000|Autosomal dominant|Adult|136520 ~35737|Ectasic coloboma<br>Volubilis syndrome|Unknown|Autosomal dominant|Childhood|120430 ~194|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|120200 216820 ~98942|-|-|-|-|120200 ~98944|-|-|-|-|120200 ~250923|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|106210 617141 617142 ~	.	.	.	.	.	.	.	.	11	.	het
11	32449486	32449486	C	T	WT1	intronic	.	ENSG00000184937	rs1799933	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2203	0.2871	0.261382	.	.	.	.	.	.	.	.	.	.	.	AFR:0.2460,AMR:0.5820,EAS:0.1755,FIN:0.0260,NFE:0.0768,OTH:0.1294,ASJ:0.1146	607102	136680;156240;194070;194080;256370;608978;	3097;656;220;654;50251;347;	3097|Meacham-Winn-Culler syndrome<br>Rhabdomyomatous dysplasia-cardiopathy-genital anomalies syndrome|<1 / 1 000 000|-|Infancy<br>Neonatal|608978 ~656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~220|Drash syndrome<br>Wilms tumor and pseudohermaphroditism|<1 / 1 000 000|-|Infancy<br>Neonatal|194080 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~347|-|<1 / 1 000 000|Autosomal dominant|Childhood|136680 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	5(soft_tissue)	0.1415
11	32456694	32456694	C	A	WT1	exonic	synonymous SNV	ENSG00000184937	rs2234582	ENSG00000184937:ENST00000332351:exon1:c.G198T:p.P66P,ENSG00000184937:ENST00000379077:exon1:c.G198T:p.P66P,ENSG00000184937:ENST00000448076:exon1:c.G198T:p.P66P,ENSG00000184937:ENST00000452863:exon1:c.G198T:p.P66P	WT1:NM_000378:exon1:c.G213T:p.P71P,WT1:NM_024424:exon1:c.G213T:p.P71P,WT1:NM_024426:exon1:c.G213T:p.P71P	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.3299	0.2860	0.301717	0.2960	.	.	.	.	.	.	.	.	WT1:uc001mtn.2:exon1:c.G198T:p.P66P,WT1:uc001mto.2:exon1:c.G198T:p.P66P,WT1:uc001mtq.2:exon1:c.G198T:p.P66P	.	AFR:0.5898,AMR:0.1427,EAS:0.0663,FIN:0.1324,NFE:0.2034,OTH:0.2146,ASJ:0.23	607102	136680;156240;194070;194080;256370;608978;	3097;656;220;654;50251;347;	3097|Meacham-Winn-Culler syndrome<br>Rhabdomyomatous dysplasia-cardiopathy-genital anomalies syndrome|<1 / 1 000 000|-|Infancy<br>Neonatal|608978 ~656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~220|Drash syndrome<br>Wilms tumor and pseudohermaphroditism|<1 / 1 000 000|-|Infancy<br>Neonatal|194080 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~50251|-|1-9 / 100 000|Not applicable|All ages|156240 ~347|-|<1 / 1 000 000|Autosomal dominant|Childhood|136680 ~	~ko05202 Transcriptional misregulation in cancer ~	,10422	.	.	.	.	.	.	11	.	het
11	33881016	33881016	T	C	LMO2	exonic	synonymous SNV	ENSG00000135363	rs3740617	ENSG00000135363:ENST00000395833:exon3:c.A363G:p.K121K,ENSG00000135363:ENST00000257818:exon6:c.A570G:p.K190K	LMO2:NM_001142316:exon3:c.A363G:p.K121K,LMO2:NM_001142315:exon4:c.A363G:p.K121K,LMO2:NM_005574:exon6:c.A570G:p.K190K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6001	0.5722	0.5625	1(stomach)	.	.	.	.	.	.	.	.	LMO2:uc001mvc.3:exon2:c.A342G:p.K114K,LMO2:uc001mvd.3:exon3:c.A342G:p.K114K,LMO2:uc001mve.3:exon3:c.A363G:p.K121K,LMO2:uc010rel.2:exon4:c.A363G:p.K121K,LMO2:uc010rem.2:exon6:c.A570G:p.K190K	.	AFR:MU582199,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,EAS:0.5070,FIN:0.7410,NFE:0.6987,OTH:0.5317,ASJ:0.5711	180385	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	18(soft_tissue)	0.4894
11	43911365	43911365	T	C	ALKBH3	exonic	synonymous SNV	ENSG00000166199	rs2434478	ENSG00000166199:ENST00000529366:exon5:c.T354C:p.T118T,ENSG00000166199:ENST00000302708:exon6:c.T357C:p.T119T,ENSG00000166199:ENST00000378840:exon6:c.T354C:p.T118T,ENSG00000166199:ENST00000530803:exon6:c.T354C:p.T118T,ENSG00000166199:ENST00000532962:exon6:c.T357C:p.T119T	ALKBH3:NM_139178:exon6:c.T357C:p.T119T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9990	0.9968	0.997604	0.9968	.	.	.	.	.	.	.	.	ALKBH3:uc001mxs.2:exon6:c.T357C:p.T119T	.	AFR:0.9888,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	610603	.	.	.	.	.	.	.	.	.	.	.	11	MU81898914	hom
11	43940602	43940602	C	G	ALKBH3	exonic	nonsynonymous SNV	ENSG00000166199	rs1130290	ENSG00000166199:ENST00000302708:exon9:c.C684G:p.D228E	ALKBH3:NM_139178:exon9:c.C684G:p.D228E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1985	0.2058	0.138978	0.1951	6.838	33	0.005	5.91	0.988	.	.	Alpha-ketoglutarate-dependent dioxygenase AlkB-like|Oxoglutarate/iron-dependent dioxygenase	ALKBH3:uc001mxs.2:exon9:c.C684G:p.D228E	-1.210	AFR:0.0947,AMR:0.0990,EAS:0.0833,FIN:0.2284,NFE:0.2621,OTH:0.1990,ASJ:0.2351	610603	.	.	.	.	.	.	.	0.898	2.58	0.000	2.36	11	MU151117	het
11	43940644	43940644	G	T	ALKBH3	exonic	synonymous SNV	ENSG00000166199	rs1048928	ENSG00000166199:ENST00000302708:exon9:c.G726T:p.G242G	ALKBH3:NM_139178:exon9:c.G726T:p.G242G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6514	0.5354	0.616214	0.5714	.	.	.	.	.	.	.	.	ALKBH3:uc001mxs.2:exon9:c.G726T:p.G242G	.	AFR:0.3515,AMR:0.7387,EAS:0.8282,FIN:0.6657,NFE:0.6325,OTH:0.6782,ASJ:0.6060	610603	.	.	.	.	.	.	.	.	.	.	.	11	MU728136	het
11	47238522	47238522	T	C	DDB2	exonic	synonymous SNV	ENSG00000134574	rs326212	ENSG00000134574:ENST00000256996:exon3:c.T378C:p.T126T,ENSG00000134574:ENST00000378600:exon3:c.T378C:p.T126T,ENSG00000134574:ENST00000378601:exon3:c.T378C:p.T126T	DDB2:NM_000107:exon3:c.T378C:p.T126T,DDB2:NM_001300734:exon3:c.T378C:p.T126T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9987	0.9953	0.994209	0.9963	.	.	.	.	.	.	.	.	DDB2:uc001nef.2:exon2:c.T336C:p.T112T,DDB2:uc001neb.2:exon3:c.T378C:p.T126T,DDB2:uc001nee.2:exon3:c.T378C:p.T126T	.	AFR:0.9869,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600811	278740;	910;	910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	~ko03420 Nucleotide excision repair~ko04115 p53 signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko05161 Hepatitis B~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05216 Thyroid cancer~ko05217 Basal cell carcinoma~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	MU81899467	hom
11	47354787	47354787	C	T	MYBPC3	exonic	synonymous SNV	ENSG00000134571	rs1052373	ENSG00000134571:ENST00000256993:exon28:c.G3285A:p.E1095E,ENSG00000134571:ENST00000399249:exon29:c.G3288A:p.E1096E,ENSG00000134571:ENST00000545968:exon30:c.G3288A:p.E1096E	MYBPC3:NM_000256:exon29:c.G3288A:p.E1096E	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4707	0.3550	0.476238	0.3986	.	.	.	.	.	.	.	.	MYBPC3:uc021qir.1:exon28:c.G2244A:p.E748E,MYBPC3:uc021qis.1:exon30:c.G3288A:p.E1096E	.	AFR:0.4834,AMR:0.4010,EAS:0.6979,FIN:0.4185,NFE:0.3157,OTH:0.3914,ASJ:0.2517	600958	115197;615396;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	11	MU120858	het
11	47371485	47371485	G	-	MYBPC3	intronic	.	ENSG00000134571	rs11570050	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6879	0.6200	0.610823	0.6108	.	.	.	.	.	.	.	.	.	.	AFR:0.3940,AMR:0.6396,EAS:0.6646,FIN:0.6201,NFE:0.7226,OTH:0.6398,ASJ:0.7450	600958	115197;615396;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	11	.	het
11	48002318	48002318	G	-	PTPRJ	UTR5	.	ENSG00000149177	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600925	114500;	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	48145166	48145166	G	A	PTPRJ	exonic	synonymous SNV	ENSG00000149177	rs2270993	ENSG00000149177:ENST00000527952:exon4:c.G354A:p.E118E,ENSG00000149177:ENST00000418331:exon5:c.G618A:p.E206E,ENSG00000149177:ENST00000440289:exon5:c.G618A:p.E206E	PTPRJ:NM_001098503:exon5:c.G618A:p.E206E,PTPRJ:NM_002843:exon5:c.G618A:p.E206E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1403	0.1633	0.155551	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,GACA-JP|1|585|0.0017094	.	.	.	.	.	0.0001	0.02	.	PTPRJ:uc001ngo.4:exon5:c.G618A:p.E206E,PTPRJ:uc001ngp.4:exon5:c.G618A:p.E206E	.	AFR:0.1657,AMR:0.2409,EAS:0.1026,FIN:0.1660,NFE:0.1616,OTH:0.1282,ASJ:0.1158	600925	114500;	.	.	.	.	.	.	.	.	.	.	11	2(stomach)	0.1493
11	48145375	48145375	A	C	PTPRJ	exonic	nonsynonymous SNV	ENSG00000149177	rs1566734	ENSG00000149177:ENST00000418331:exon5:c.A827C:p.Q276P,ENSG00000149177:ENST00000440289:exon5:c.A827C:p.Q276P	PTPRJ:NM_001098503:exon5:c.A827C:p.Q276P,PTPRJ:NM_002843:exon5:c.A827C:p.Q276P	clinvar: Pathogenic 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, -1, 0, 0] 	0.1694	0.1475	0.189896	1(prostate)	-0.709	0.069	0.237	1.54	0.002	.	.	Fibronectin type III|Immunoglobulin-like fold	PTPRJ:uc001ngo.4:exon5:c.A827C:p.Q276P,PTPRJ:uc001ngp.4:exon5:c.A827C:p.Q276P	-0.983	AFR:1(lung),AMR:1(pancreas),EAS:MU14713834,FIN:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,NFE:0.1398,OTH:0.1199,ASJ:1(large_intestine)	600925	114500;	.	.	.	.	.	.	0.001	2.56	0.000	0.895	11	2(haematopoietic_and_lymphoid_tissue)	0.1205
11	48146622	48146622	G	A	PTPRJ	exonic	nonsynonymous SNV	ENSG00000149177	rs1503185	ENSG00000149177:ENST00000418331:exon6:c.G977A:p.R326Q,ENSG00000149177:ENST00000440289:exon6:c.G977A:p.R326Q	PTPRJ:NM_001098503:exon6:c.G977A:p.R326Q,PTPRJ:NM_002843:exon6:c.G977A:p.R326Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1807	0.1922	0.242812	1(urinary_tract)	-2.199	0.001	0.491	-10.3	0.000	.	.	Fibronectin type III|Immunoglobulin-like fold	PTPRJ:uc001ngo.4:exon6:c.G977A:p.R326Q,PTPRJ:uc001ngp.4:exon6:c.G977A:p.R326Q	-0.987	AFR:1(stomach),AMR:MU149213,EAS:0.1762,FIN:0.2477,NFE:0.1256,OTH:0.2384,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	600925	114500;	.	.	.	.	.	.	0.0	3.64	0.000	0.315	11	1(large_intestine)	0.2921
11	57571232	57571232	C	T	CTNND1	exonic	synonymous SNV	ENSG00000198561	rs11229137	ENSG00000198561:ENST00000525902:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000526772:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000527467:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000531014:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000533667:exon3:c.C591T:p.H197H,ENSG00000198561:ENST00000532245:exon5:c.C1257T:p.H419H,ENSG00000198561:ENST00000415361:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000426142:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000528232:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000529986:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000530094:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000532463:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000532787:exon6:c.C1257T:p.H419H,ENSG00000198561:ENST00000428599:exon7:c.C1560T:p.H520H,ENSG00000198561:ENST00000526357:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000526938:exon7:c.C1560T:p.H520H,ENSG00000198561:ENST00000528621:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000529873:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000530748:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000532844:exon7:c.C1398T:p.H466H,ENSG00000198561:ENST00000358694:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000360682:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361332:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361391:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000361796:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000399039:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000399050:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000524630:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000529526:exon8:c.C1398T:p.H466H,ENSG00000198561:ENST00000529919:exon8:c.C1560T:p.H520H,ENSG00000198561:ENST00000532649:exon8:c.C1398T:p.H466H,ENSG00000198561:ENST00000534579:exon8:c.C1398T:p.H466H	CTNND1:NM_001085469:exon5:c.C1257T:p.H419H,CTNND1:NM_001085463:exon6:c.C1257T:p.H419H,CTNND1:NM_001085464:exon6:c.C1257T:p.H419H,CTNND1:NM_001085465:exon6:c.C1257T:p.H419H,CTNND1:NM_001085466:exon6:c.C1257T:p.H419H,CTNND1:NM_001085467:exon6:c.C1257T:p.H419H,CTNND1:NM_001085468:exon6:c.C1257T:p.H419H,CTNND1:NM_001206890:exon6:c.C1257T:p.H419H,CTNND1:NM_001085462:exon7:c.C1560T:p.H520H,CTNND1:NM_001206883:exon7:c.C1398T:p.H466H,CTNND1:NM_001206884:exon7:c.C1398T:p.H466H,CTNND1:NM_001206886:exon7:c.C1398T:p.H466H,CTNND1:NM_001206887:exon7:c.C1398T:p.H466H,CTNND1:NM_001206888:exon7:c.C1398T:p.H466H,CTNND1:NM_001085458:exon8:c.C1560T:p.H520H,CTNND1:NM_001085459:exon8:c.C1560T:p.H520H,CTNND1:NM_001085460:exon8:c.C1560T:p.H520H,CTNND1:NM_001085461:exon8:c.C1560T:p.H520H,CTNND1:NM_001206885:exon8:c.C1560T:p.H520H,CTNND1:NM_001206889:exon8:c.C1398T:p.H466H,CTNND1:NM_001206891:exon8:c.C1398T:p.H466H,CTNND1:NM_001331:exon8:c.C1560T:p.H520H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9992	0.9979	0.996206	0.9972	.	.	.	.	.	.	.	.	CTNND1:uc001nlx.4:exon3:c.C591T:p.H197H,CTNND1:uc001nly.4:exon3:c.C591T:p.H197H,CTNND1:uc001nlz.4:exon3:c.C591T:p.H197H,CTNND1:uc001nma.4:exon3:c.C591T:p.H197H,CTNND1:uc001nmb.4:exon3:c.C591T:p.H197H,CTNND1:uc009ymn.3:exon3:c.C591T:p.H197H,CTNND1:uc001nlw.4:exon5:c.C1257T:p.H419H,CTNND1:uc001nlo.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlq.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nls.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlt.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlu.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlv.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nmi.4:exon6:c.C1257T:p.H419H,CTNND1:uc001nlj.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nlk.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nln.4:exon7:c.C1560T:p.H520H,CTNND1:uc001nlp.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nlr.4:exon7:c.C1398T:p.H466H,CTNND1:uc001nmd.4:exon7:c.C1398T:p.H466H,TMX2-CTNND1:uc001nlh.1:exon8:c.C1560T:p.H520H,CTNND1:uc001nli.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nll.4:exon8:c.C1398T:p.H466H,CTNND1:uc001nlm.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmc.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nme.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmf.4:exon8:c.C1560T:p.H520H,CTNND1:uc001nmg.4:exon8:c.C1398T:p.H466H,CTNND1:uc001nmh.4:exon8:c.C1560T:p.H520H,CTNND1:uc021qjk.1:exon8:c.C1560T:p.H520H,TMX2-CTNND1:uc001nlf.2:exon9:c.C1560T:p.H520H	.	AFR:0.9899,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	601045	.	.	.	.	.	.	.	.	.	.	.	11	MU81901822	hom
11	60666116	60666116	G	T	PRPF19	intronic	.	ENSG00000110107	rs3763841	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3711	0.3298	0.309904	0.3285	.	.	.	.	.	.	.	.	.	.	AFR:0.1902,AMR:0.4427,EAS:0.2856,FIN:0.3985,NFE:0.3850,OTH:0.3778,ASJ:0.4570	608330	.	.	.	.	.	.	.	.	.	.	.	11	MU30007000	hom
11	60666341	60666341	G	A	PRPF19	exonic	synonymous SNV	ENSG00000110107	rs3763840	ENSG00000110107:ENST00000535326:exon1:c.C63T:p.S21S,ENSG00000110107:ENST00000227524:exon12:c.C1047T:p.S349S	PRPF19:NM_014502:exon12:c.C1047T:p.S349S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4315	0.3265	0.308506	LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	PRPF19:uc001nqf.3:exon12:c.C1047T:p.S349S	.	AFR:0.3279,AMR:0.1864,EAS:0.4570,FIN:0.2853,NFE:0.4,OTH:0.3860,ASJ:0.4400	608330	.	.	.	.	.	.	.	.	.	.	.	11	1(stomach)	0.3765
11	60673868	60673868	T	C	PRPF19	UTR5	.	ENSG00000110107	rs17155470	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4474	0.3585	0.357428	COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	.	.	AFR:0.3669,AMR:0.3223,EAS:0.4636,FIN:0.2886,NFE:0.3991,OTH:0.3859,ASJ:0.4487	608330	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.3875
11	62292882	62292882	G	T	AHNAK	exonic	nonsynonymous SNV	ENSG00000124942	rs566144	ENSG00000124942:ENST00000378024:exon5:c.C9007A:p.Q3003K	AHNAK:NM_001346445:exon5:c.C9007A:p.Q3003K,AHNAK:NM_001346446:exon5:c.C9007A:p.Q3003K,AHNAK:NM_001620:exon5:c.C9007A:p.Q3003K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	1	.	1	0.9999	-0.671	0.084	1.0	3.97	0.067	.	.	.	AHNAK:uc001ntl.3:exon5:c.C9007A:p.Q3003K	-1.013	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	103390	.	.	.	.	.	.	.	0.0	2.88	0.000	-2.045	11	MU81903251	hom
11	62293948	62293948	G	A	AHNAK	exonic	synonymous SNV	ENSG00000124942	rs486903	ENSG00000124942:ENST00000378024:exon5:c.C7941T:p.S2647S	AHNAK:NM_001346445:exon5:c.C7941T:p.S2647S,AHNAK:NM_001346446:exon5:c.C7941T:p.S2647S,AHNAK:NM_001620:exon5:c.C7941T:p.S2647S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6638	0.5583	0.473043	1(large_intestine)	.	.	.	.	.	.	.	.	AHNAK:uc001ntl.3:exon5:c.C7941T:p.S2647S	.	AFR:MU150832,AMR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.1716,FIN:0.6845,NFE:0.6093,OTH:0.2963,ASJ:0.5748	103390	.	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.8322
11	64572018	64572018	T	C	MEN1	exonic	nonsynonymous SNV	ENSG00000133895	rs2959656	ENSG00000133895:ENST00000377316:exon8:c.A1456G:p.T486A,ENSG00000133895:ENST00000377313:exon9:c.A1636G:p.T546A,ENSG00000133895:ENST00000377326:exon9:c.A1621G:p.T541A,ENSG00000133895:ENST00000312049:exon10:c.A1621G:p.T541A,ENSG00000133895:ENST00000315422:exon10:c.A1621G:p.T541A,ENSG00000133895:ENST00000337652:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000377321:exon10:c.A1516G:p.T506A,ENSG00000133895:ENST00000394374:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000443283:exon10:c.A1636G:p.T546A,ENSG00000133895:ENST00000394376:exon11:c.A1636G:p.T546A	MEN1:NM_000244:exon10:c.A1636G:p.T546A,MEN1:NM_001370259:exon10:c.A1621G:p.T541A,MEN1:NM_001370260:exon10:c.A1621G:p.T541A,MEN1:NM_001370261:exon10:c.A1621G:p.T541A,MEN1:NM_001370262:exon10:c.A1516G:p.T506A,MEN1:NM_001370263:exon10:c.A1516G:p.T506A,MEN1:NM_130799:exon10:c.A1621G:p.T541A,MEN1:NM_130800:exon10:c.A1636G:p.T546A,MEN1:NM_130801:exon10:c.A1636G:p.T546A,MEN1:NM_130802:exon10:c.A1636G:p.T546A,MEN1:NM_130803:exon10:c.A1636G:p.T546A,MEN1:NM_001370251:exon11:c.A1747G:p.T583A,MEN1:NM_130804:exon11:c.A1636G:p.T546A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9378	0.9084	0.834465	MU17436755	-0.869	0.030	0.866	3.35	0.004	.	.	.	MEN1:uc001obj.3:exon10:c.A1636G:p.T546A,MEN1:uc001obk.3:exon10:c.A1636G:p.T546A,MEN1:uc001obl.3:exon10:c.A1516G:p.T506A,MEN1:uc001obm.3:exon10:c.A1621G:p.T541A,MEN1:uc001obn.3:exon10:c.A1636G:p.T546A,MEN1:uc001obo.3:exon10:c.A1636G:p.T546A,MEN1:uc001obr.3:exon10:c.A1636G:p.T546A,MEN1:uc001obq.3:exon11:c.A1636G:p.T546A	-0.936	AFR:LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.8934,EAS:0.8986,FIN:0.9967,NFE:0.6936,OTH:0.9814,ASJ:0.7058	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.0	-5.71	0.000	-0.69	11	22(soft_tissue)	0.9959
11	64572557	64572557	A	G	MEN1	exonic	synonymous SNV	ENSG00000133895	rs540012	ENSG00000133895:ENST00000377313:exon8:c.T1314C:p.H438H,ENSG00000133895:ENST00000377326:exon8:c.T1299C:p.H433H,ENSG00000133895:ENST00000312049:exon9:c.T1299C:p.H433H,ENSG00000133895:ENST00000315422:exon9:c.T1299C:p.H433H,ENSG00000133895:ENST00000337652:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000377321:exon9:c.T1194C:p.H398H,ENSG00000133895:ENST00000394374:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000443283:exon9:c.T1314C:p.H438H,ENSG00000133895:ENST00000394376:exon10:c.T1314C:p.H438H	MEN1:NM_000244:exon9:c.T1314C:p.H438H,MEN1:NM_001370259:exon9:c.T1299C:p.H433H,MEN1:NM_001370260:exon9:c.T1299C:p.H433H,MEN1:NM_001370261:exon9:c.T1299C:p.H433H,MEN1:NM_001370262:exon9:c.T1194C:p.H398H,MEN1:NM_001370263:exon9:c.T1194C:p.H398H,MEN1:NM_130799:exon9:c.T1299C:p.H433H,MEN1:NM_130800:exon9:c.T1314C:p.H438H,MEN1:NM_130801:exon9:c.T1314C:p.H438H,MEN1:NM_130802:exon9:c.T1314C:p.H438H,MEN1:NM_130803:exon9:c.T1314C:p.H438H,MEN1:NM_001370251:exon10:c.T1425C:p.H475H,MEN1:NM_130804:exon10:c.T1314C:p.H438H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9927	0.9761	0.976038	0.9768	.	.	.	.	.	.	.	.	MEN1:uc001obj.3:exon9:c.T1314C:p.H438H,MEN1:uc001obk.3:exon9:c.T1314C:p.H438H,MEN1:uc001obl.3:exon9:c.T1194C:p.H398H,MEN1:uc001obm.3:exon9:c.T1299C:p.H433H,MEN1:uc001obn.3:exon9:c.T1314C:p.H438H,MEN1:uc001obo.3:exon9:c.T1314C:p.H438H,MEN1:uc001obr.3:exon9:c.T1314C:p.H438H,MEN1:uc001obq.3:exon10:c.T1314C:p.H438H	.	AFR:0.9185,AMR:0.9976,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	MU81904595	hom
11	64572602	64572602	G	A	MEN1	exonic	synonymous SNV	ENSG00000133895	rs2071313	ENSG00000133895:ENST00000377313:exon8:c.C1269T:p.D423D,ENSG00000133895:ENST00000377326:exon8:c.C1254T:p.D418D,ENSG00000133895:ENST00000312049:exon9:c.C1254T:p.D418D,ENSG00000133895:ENST00000315422:exon9:c.C1254T:p.D418D,ENSG00000133895:ENST00000337652:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000377321:exon9:c.C1149T:p.D383D,ENSG00000133895:ENST00000394374:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000443283:exon9:c.C1269T:p.D423D,ENSG00000133895:ENST00000394376:exon10:c.C1269T:p.D423D	MEN1:NM_000244:exon9:c.C1269T:p.D423D,MEN1:NM_001370259:exon9:c.C1254T:p.D418D,MEN1:NM_001370260:exon9:c.C1254T:p.D418D,MEN1:NM_001370261:exon9:c.C1254T:p.D418D,MEN1:NM_001370262:exon9:c.C1149T:p.D383D,MEN1:NM_001370263:exon9:c.C1149T:p.D383D,MEN1:NM_130799:exon9:c.C1254T:p.D418D,MEN1:NM_130800:exon9:c.C1269T:p.D423D,MEN1:NM_130801:exon9:c.C1269T:p.D423D,MEN1:NM_130802:exon9:c.C1269T:p.D423D,MEN1:NM_130803:exon9:c.C1269T:p.D423D,MEN1:NM_001370251:exon10:c.C1380T:p.D460D,MEN1:NM_130804:exon10:c.C1269T:p.D423D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3934	0.3040	0.307907	1(liver)	.	.	.	.	.	.	.	.	MEN1:uc001obj.3:exon9:c.C1269T:p.D423D,MEN1:uc001obk.3:exon9:c.C1269T:p.D423D,MEN1:uc001obl.3:exon9:c.C1149T:p.D383D,MEN1:uc001obm.3:exon9:c.C1254T:p.D418D,MEN1:uc001obn.3:exon9:c.C1269T:p.D423D,MEN1:uc001obo.3:exon9:c.C1269T:p.D423D,MEN1:uc001obr.3:exon9:c.C1269T:p.D423D,MEN1:uc001obq.3:exon10:c.C1269T:p.D423D	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:1(breast),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.3262,NFE:0.0877,OTH:0.3285,ASJ:MU90806	613733	131100;	652;	652|MEN1<br>Wermer syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|131100 ~	~ko04934 Cushing syndrome~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	11	3(lung)	0.3576
11	65628334	65628334	G	A	MUS81	exonic	nonsynonymous SNV	ENSG00000172732	rs13817	ENSG00000172732:ENST00000308110:exon1:c.G110A:p.R37H,ENSG00000172732:ENST00000529857:exon3:c.G305A:p.R102H	MUS81:NM_001350283:exon1:c.G110A:p.R37H,MUS81:NM_025128:exon1:c.G110A:p.R37H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.6667	0.5526	0.427915	COCA-CN|3|321|0.00934579	3.885	23.5	0.17	3.44	0.998	.	.	DNA polymerase beta-like, N-terminal domain	MUS81:uc001ofv.4:exon1:c.G110A:p.R37H	-0.948	AFR:0.5323,AMR:0.2558,EAS:0.6722,FIN:0.3086,NFE:0.7028,OTH:0.6765,ASJ:0.4014	606591	.	.	.	.	.	.	.	0.999	0.84	0.000	2.42	11	3(large_intestine)	0.6148
11	65629932	65629932	T	C	MUS81	exonic	synonymous SNV	ENSG00000172732	rs659857	ENSG00000172732:ENST00000525768:exon5:c.T312C:p.A104A,ENSG00000172732:ENST00000308110:exon6:c.T537C:p.A179A,ENSG00000172732:ENST00000533035:exon6:c.T312C:p.A104A	MUS81:NM_001350283:exon6:c.T537C:p.A179A,MUS81:NM_025128:exon6:c.T537C:p.A179A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5752	0.5247	0.428115	COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon6:c.T537C:p.A179A	.	AFR:0.5305,AMR:0.2557,EAS:0.6722,FIN:0.3077,NFE:0.7027,OTH:0.6739,ASJ:0.4017	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(thyroid)	0.6167
11	65629934	65629934	G	C	MUS81	exonic	nonsynonymous SNV	ENSG00000172732	rs545500	ENSG00000172732:ENST00000525768:exon5:c.G314C:p.R105P,ENSG00000172732:ENST00000308110:exon6:c.G539C:p.R180P,ENSG00000172732:ENST00000533035:exon6:c.G314C:p.R105P	MUS81:NM_001350283:exon6:c.G539C:p.R180P,MUS81:NM_025128:exon6:c.G539C:p.R180P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5752	0.5262	0.428115	MU115031	1.935	15.80	0.087	-1.98	0.337	.	.	Winged helix-turn-helix DNA-binding domain	MUS81:uc001ofv.4:exon6:c.G539C:p.R180P	-0.973	AFR:COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874,AMR:0.5303,EAS:0.4017,FIN:0.6722,NFE:0.3077,OTH:0.7027,ASJ:0.2555	606591	.	.	.	.	.	.	.	0.678	2.47	0.000	1.79	11	1(large_intestine)	0.6738
11	65631167	65631167	C	T	MUS81	exonic	synonymous SNV	ENSG00000172732	rs648732	ENSG00000172732:ENST00000308110:exon9:c.C936T:p.A312A,ENSG00000172732:ENST00000533035:exon9:c.C711T:p.A237A	MUS81:NM_001350283:exon9:c.C936T:p.A312A,MUS81:NM_025128:exon9:c.C936T:p.A312A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5789	0.5302	0.428115	MU89872	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon9:c.C936T:p.A312A	.	AFR:LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,AMR:0.5327,EAS:0.3998,FIN:0.6722,NFE:0.3105,OTH:0.7029,ASJ:0.2562	606591	.	.	.	.	.	.	.	.	.	.	.	11	4(lung)	0.6772
11	65631973	65631973	G	A	MUS81	exonic	synonymous SNV	ENSG00000172732	rs630303	ENSG00000172732:ENST00000308110:exon11:c.G1065A:p.R355R,ENSG00000172732:ENST00000533035:exon11:c.G840A:p.R280R	MUS81:NM_001350283:exon11:c.G1068A:p.R356R,MUS81:NM_025128:exon11:c.G1065A:p.R355R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5793	0.5308	0.429912	1(breast)	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon11:c.G1065A:p.R355R	.	AFR:2(large_intestine),AMR:MU115052,EAS:0.5330,FIN:0.2591,NFE:0.4007,OTH:0.6722,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(lung)	0.3088
11	65632262	65632262	G	T	MUS81	exonic	synonymous SNV	ENSG00000172732	rs558114	ENSG00000172732:ENST00000308110:exon12:c.G1248T:p.T416T,ENSG00000172732:ENST00000533035:exon12:c.G1023T:p.T341T	MUS81:NM_001350283:exon12:c.G1251T:p.T417T,MUS81:NM_025128:exon12:c.G1248T:p.T416T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5789	0.5299	0.428315	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	MUS81:uc001ofv.4:exon12:c.G1248T:p.T416T	.	AFR:0.5323,AMR:0.2571,EAS:0.6722,FIN:0.3093,NFE:0.7030,OTH:0.6762,ASJ:0.4017	606591	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.6111
11	65664346	65664346	T	C	FOSL1	exonic	synonymous SNV	ENSG00000175592	rs637571	ENSG00000175592:ENST00000312562:exon2:c.A231G:p.Q77Q,ENSG00000175592:ENST00000531493:exon2:c.A231G:p.Q77Q,ENSG00000175592:ENST00000532401:exon2:c.A231G:p.Q77Q	FOSL1:NM_001300844:exon2:c.A231G:p.Q77Q,FOSL1:NM_001300855:exon2:c.A231G:p.Q77Q,FOSL1:NM_005438:exon2:c.A231G:p.Q77Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5077	0.4840	0.56849	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FOSL1:uc001ogg.1:exon2:c.A231G:p.Q77Q	.	AFR:0.4865,AMR:0.5561,EAS:0.4570,FIN:0.7665,NFE:0.3964,OTH:0.4281,ASJ:0.6679	136515	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.4743
11	67257823	67257823	C	A	AIP	exonic	nonsynonymous SNV	ENSG00000110711	rs641081	ENSG00000110711:ENST00000525341:exon3:c.C334A:p.Q112K,ENSG00000110711:ENST00000528641:exon4:c.C493A:p.Q165K,ENSG00000110711:ENST00000279146:exon5:c.C682A:p.Q228K	AIP:NM_001302959:exon5:c.C505A:p.Q169K,AIP:NM_001302960:exon5:c.C682A:p.Q228K,AIP:NM_003977:exon5:c.C682A:p.Q228K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9550	0.8343	0.845447	0.8508	-1.180	0.007	1.0	1.08	0.068	.	.	Tetratricopeptide-like helical domain	AIP:uc001olv.3:exon5:c.C682A:p.Q228K	-0.952	AFR:0.4803,AMR:0.9582,EAS:0.9994,FIN:1,NFE:0.9977,OTH:0.9755,ASJ:1	605555	102200;219090;600634;	314777;96253;314777;96256;963;99725;	314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96253|Corticotroph pituitary adenoma<br>Pituitary corticotroph micro-adenoma<br>Pituitary-dependent Cushing syndrome|1-9 / 100 000|Not applicable|Adult|219090 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	.	.	.	.	0.0	-0.72	0.000	0.42	11	MU4550249	hom
11	67258391	67258391	A	G	AIP	exonic	nonsynonymous SNV	ENSG00000110711	rs4930199	ENSG00000110711:ENST00000279146:exon6:c.A920G:p.Q307R	AIP:NM_001302959:exon6:c.A743G:p.Q248R,AIP:NM_003977:exon6:c.A920G:p.Q307R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9999	0.9998	0.999401	0.9998	.	.	.	.	.	.	.	.	AIP:uc001olv.3:exon6:c.A920G:p.Q307R	.	AFR:0.9995,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	605555	102200;219090;600634;	314777;96253;314777;96256;963;99725;	314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96253|Corticotroph pituitary adenoma<br>Pituitary corticotroph micro-adenoma<br>Pituitary-dependent Cushing syndrome|1-9 / 100 000|Not applicable|Adult|219090 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	.	.	.	.	.	.	.	.	11	MU4550266	hom
11	67351585	67351585	C	G	GSTP1	intronic	.	ENSG00000084207	rs4147581	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4913	0.3879	0.424321	0.4018	.	.	.	.	.	.	.	.	.	.	AFR:0.1433,AMR:0.3816,EAS:0.7071,FIN:0.5032,NFE:0.4885,OTH:0.4815,ASJ:0.5933	134660	.	.	.	~ko00480 Glutathione metabolism~ko00980 Metabolism of xenobiotics by cytochrome P450~ko00982 Drug metabolism - cytochrome P450~ko00983 Drug metabolism - other enzymes~ko01100 Metabolic pathways~ko01524 Platinum drug resistance~ko04212 Longevity regulating pathway - worm~ko05200 Pathways in cancer~ko05204 Chemical carcinogenesis~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	11	MU796812	hom
11	67352689	67352689	A	G	GSTP1	exonic	nonsynonymous SNV	ENSG00000084207	rs1695	ENSG00000084207:ENST00000398603:exon5:c.A313G:p.I105V,ENSG00000084207:ENST00000398606:exon5:c.A313G:p.I105V	GSTP1:NM_000852:exon5:c.A313G:p.I105V	clinvar: drug_response 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 1] 	0.3335	0.3608	0.352636	1(lung)	-2.678	0.001	1.0	-1.16	0.009	.	.	Glutathione S-transferase, C-terminal-like;Glutathione S-transferase, C-terminal|Glutathione S-transferase, C-terminal-like	GSTP1:uc001omf.3:exon5:c.A313G:p.I105V	-0.938	AFR:MU104662,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.4496,FIN:0.4737,NFE:0.25,OTH:0.1718,ASJ:0.3537	134660	.	.	.	~ko00480 Glutathione metabolism~ko00980 Metabolism of xenobiotics by cytochrome P450~ko00982 Drug metabolism - cytochrome P450~ko00983 Drug metabolism - other enzymes~ko01100 Metabolic pathways~ko01524 Platinum drug resistance~ko04212 Longevity regulating pathway - worm~ko05200 Pathways in cancer~ko05204 Chemical carcinogenesis~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	,5925	.	.	0.0	3.96	0.000	-0.095	11	1(large_intestine)	0.2695
11	68171013	68171013	T	C	LRP5	exonic	synonymous SNV	ENSG00000162337	rs545382	ENSG00000162337:ENST00000294304:exon8:c.T1647C:p.F549F	LRP5:NM_002335:exon8:c.T1647C:p.F549F	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9001	0.8154	0.841454	0.8459	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon8:c.T1647C:p.F549F	.	AFR:0.6314,AMR:0.9320,EAS:0.9883,FIN:0.9645,NFE:0.9169,OTH:0.9153,ASJ:0.9073	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	MU4557319	hom
11	68192690	68192690	G	A	LRP5	exonic	synonymous SNV	ENSG00000162337	rs556442	ENSG00000162337:ENST00000294304:exon15:c.G3357A:p.V1119V	LRP5:NM_001291902:exon15:c.G1614A:p.V538V,LRP5:NM_002335:exon15:c.G3357A:p.V1119V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6755	0.5265	0.579273	2(large_intestine)	.	.	.	.	.	.	.	.	LRP5:uc001ont.3:exon15:c.G3357A:p.V1119V	.	AFR:MU64296,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.2359,FIN:0.6675,NFE:0.6258,OTH:0.7689,ASJ:0.5925	603506	144750;166710;259770;601813;601884;607634;607636;	3416;2783;891;2788;2790;	3416|Van Buchem disease|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent|239100 607636 ~2783|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Childhood|607634 ~891|Criswick-Schepens syndrome<br>FEVR|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|133780 305390 601813 605750 613310 616468 ~2788|OPPG<br>Ocular form of osteogenesis imperfecta|<1 / 1 000 000|Autosomal recessive|Childhood|259770 ~2790|Endosteal hyperostosis, Worth type<br>Worth syndrome|-|Autosomal dominant|-|144750 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	1(skin)	0.8595
11	68822739	68822739	T	C	TPCN2	exonic	synonymous SNV	ENSG00000162341	rs1470892	ENSG00000162341:ENST00000294309:exon4:c.T348C:p.A116A,ENSG00000162341:ENST00000542467:exon4:c.T348C:p.A116A	TPCN2:NM_139075:exon4:c.T348C:p.A116A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9994	0.9975	0.998802	0.9977	.	.	.	.	.	.	.	.	TPCN2:uc001oos.2:exon4:c.T348C:p.A116A,TPCN2:uc010rqg.1:exon4:c.T348C:p.A116A	.	AFR:0.9921,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU81906316	hom
11	68825037	68825037	A	C	TPCN2	intronic	.	ENSG00000162341	rs3750973	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8786	0.9005	0.747804	0.8742	.	.	.	.	.	0.0001	0.028	.	.	.	AFR:0.7215,AMR:0.6026,EAS:0.5278,FIN:0.9797,NFE:0.9844,OTH:0.9399,ASJ:0.9768	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU726998	hom
11	68834968	68834968	T	C	TPCN2	intronic	.	ENSG00000162341	rs6591368	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9577	0.9435	0.898363	0.9415	.	.	.	.	.	0.0001	0.02	.	.	.	AFR:0.8347,AMR:0.9296,EAS:0.8609,FIN:0.9926,NFE:0.9974,OTH:0.9827,ASJ:0.9901	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	MU23558361	hom
11	68840160	68840160	A	G	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs3750965	ENSG00000162341:ENST00000294309:exon12:c.A1127G:p.K376R,ENSG00000162341:ENST00000542467:exon12:c.A1127G:p.K376R	TPCN2:NM_139075:exon12:c.A1127G:p.K376R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2934	0.2917	0.290735	MU23558422	-0.014	2.458	0.5	2.61	0.618	.	.	.	TPCN2:uc001oor.2:exon10:c.A872G:p.K291R,TPCN2:uc001oos.2:exon12:c.A1127G:p.K376R,TPCN2:uc010rqg.1:exon12:c.A1127G:p.K376R	-1.154	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.2626,EAS:0.1719,FIN:0.2833,NFE:0.2160,OTH:0.2224,ASJ:0.2376	612163	612267;	.	.	.	.	.	.	0.287	-4.16	0.000	1.95	11	1(upper_aerodigestive_tract)	0.2962
11	68840487	68840487	C	T	TPCN2	intronic	.	ENSG00000162341	rs566318610	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0004	.	0.000399361	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	612163	612267;	.	.	.	.	.	.	.	.	.	.	11	.	het
11	68851414	68851414	T	C	TPCN2	exonic	nonsynonymous SNV	ENSG00000162341	rs2376558	ENSG00000162341:ENST00000294309:exon19:c.T1691C:p.L564P	TPCN2:NM_139075:exon19:c.T1691C:p.L564P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8797	0.9113	0.752995	LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763	1.001	10.67	0.245	2.65	0.031	0.0001	0.01	Ion transport domain	TPCN2:uc001oos.2:exon19:c.T1691C:p.L564P	-0.952	AFR:0.8821,AMR:0.7519,EAS:0.9768,FIN:0.5155,NFE:0.9797,OTH:0.9843,ASJ:0.6014	612163	612267;	.	.	.	.	.	.	0.001	-4.93	0.000	.	11	1(haematopoietic_and_lymphoid_tissue)	0.9409
11	69625385	69625385	C	T	FGF3	exonic	synonymous SNV	ENSG00000186895	rs35420992	ENSG00000186895:ENST00000334134:exon3:c.G408A:p.T136T	FGF3:NM_005247:exon3:c.G408A:p.T136T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0851	0.0841	0.0521166	MELA-AU|1|183|0.00546448,ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	FGF3:uc001oph.3:exon3:c.G408A:p.T136T	.	AFR:0.0874,AMR:0.0466,EAS:0.0464,FIN:0.0056,NFE:0.1208,OTH:0.1151,ASJ:0.0465	164950	610706;	90024;	90024|LAMM syndrome<br>Microdontia-type I microtia-deafness syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610706 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	1(lung)	0.0910
11	69625473	69625473	G	A	FGF3	intronic	.	ENSG00000186895	rs61749187	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0257	0.0242	0.0133786	0.0241	.	.	.	.	.	0.0013	0.004	.	.	.	AFR:0.0063,AMR:0.0179,EAS:0,FIN:0.0249,NFE:0.0366,OTH:0.0265,ASJ:0.0530	164950	610706;	90024;	90024|LAMM syndrome<br>Microdontia-type I microtia-deafness syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610706 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	.	het
11	69633633	69633633	C	A	FGF3	exonic	synonymous SNV	ENSG00000186895	rs41538178	ENSG00000186895:ENST00000334134:exon1:c.G69T:p.A23A	FGF3:NM_005247:exon1:c.G69T:p.A23A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0826	.	0.0742812	0.1085	.	.	.	.	.	.	.	.	FGF3:uc001oph.3:exon1:c.G69T:p.A23A	.	AFR:0.1198,AMR:0.0510,EAS:0.0056,FIN:0.1208,NFE:0.1156,OTH:0.0945,ASJ:0.0470	164950	610706;	90024;	90024|LAMM syndrome<br>Microdontia-type I microtia-deafness syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|610706 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	11	.	het
11	74329615	74329615	T	C	POLD3	exonic	synonymous SNV	ENSG00000077514	rs4944052	ENSG00000077514:ENST00000531615:exon4:c.T309C:p.P103P,ENSG00000077514:ENST00000532497:exon5:c.T108C:p.P36P,ENSG00000077514:ENST00000263681:exon6:c.T426C:p.P142P,ENSG00000077514:ENST00000527458:exon6:c.T309C:p.P103P,ENSG00000077514:ENST00000528481:exon6:c.T309C:p.P103P,ENSG00000077514:ENST00000530511:exon6:c.T309C:p.P103P	POLD3:NM_001363597:exon6:c.T309C:p.P103P,POLD3:NM_006591:exon6:c.T426C:p.P142P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3710	0.4061	0.449081	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	POLD3:uc009yua.2:exon5:c.T108C:p.P36P,POLD3:uc001ovf.2:exon6:c.T426C:p.P142P,POLD3:uc031qcr.1:exon6:c.T309C:p.P103P	.	AFR:MU132016,AMR:SKCA-BR|1|100|0.01,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,EAS:0.5660,FIN:0.4200,NFE:0.2616,OTH:0.3259,ASJ:0.3766	611415	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.2702
11	74379809	74379809	-	T	POLD3;CHRDL2	intergenic	.	ENSG00000077514	rs397716648	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2404	.	0.208466	0.1921	.	.	.	.	.	.	.	.	.	.	AFR:0.2631,AMR:0.1146,EAS:0.0943,FIN:0.1125,NFE:0.1880,OTH:0.1509,ASJ:0.1367	611415	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	76227182	76227182	G	A	EMSY	intronic	.	ENSG00000158636	rs2508740	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6438	0.5499	0.636182	0.5850	.	.	.	.	.	0	0	.	.	.	AFR:0.4349,AMR:0.7339,EAS:0.8422,FIN:0.6299,NFE:0.6216,OTH:0.6612,ASJ:0.53	608574	.	.	.	.	.	.	.	.	.	.	.	11	MU81907639	hom
11	85977117	85977117	G	A	EED	intronic	.	ENSG00000074266	rs10898460	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7872	0.8184	0.764976	0.8069	.	.	.	.	.	0	0.032	.	.	.	AFR:0.8129,AMR:0.6504,EAS:0.7118,FIN:0.7643,NFE:0.8347,OTH:0.8200,ASJ:0.65	605984	.	.	.	.	.	.	.	.	.	.	.	11	MU17479112	het
11	92227198	92227200	TTT	-	FAT3	intronic	.	ENSG00000165323	rs201710620	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.4738	.	.	.	.	.	.	.	.	.	.	AFR:0.4523,AMR:0.5763,EAS:0.5728,FIN:0.4808,NFE:0.4673,OTH:0.4742,ASJ:0.5752	612483	.	.	.	.	.	.	.	.	.	.	.	11	.	hom
11	92531356	92531356	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs7949157	ENSG00000165323:ENST00000298047:exon9:c.A5177G:p.Q1726R,ENSG00000165323:ENST00000409404:exon9:c.A5177G:p.Q1726R,ENSG00000165323:ENST00000525166:exon9:c.A4727G:p.Q1576R	FAT3:NM_001008781:exon9:c.A5177G:p.Q1726R,FAT3:NM_001367949:exon10:c.A5177G:p.Q1726R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8230	0.7982	0.769768	0.8011	-0.294	0.685	0.348	0.257	0.132	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon9:c.A5177G:p.Q1726R	-1.004	AFR:0.6949,AMR:0.8589,EAS:0.7438,FIN:0.8701,NFE:0.8467,OTH:0.8371,ASJ:0.8212	612483	.	.	.	.	.	.	.	0.0	0.75	0.000	0.215	11	MU17485846	het
11	92532677	92532677	T	C	FAT3	exonic	synonymous SNV	ENSG00000165323	rs12362722	ENSG00000165323:ENST00000298047:exon9:c.T6498C:p.P2166P,ENSG00000165323:ENST00000409404:exon9:c.T6498C:p.P2166P,ENSG00000165323:ENST00000525166:exon9:c.T6048C:p.P2016P	FAT3:NM_001008781:exon9:c.T6498C:p.P2166P,FAT3:NM_001367949:exon10:c.T6498C:p.P2166P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8272	0.8269	0.799321	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FAT3:uc001pdj.4:exon9:c.T6498C:p.P2166P	.	AFR:0.8210,AMR:0.7962,EAS:0.8179,FIN:0.7469,NFE:0.8353,OTH:0.8374,ASJ:0.8652	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(upper_aerodigestive_tract)	0.8238
11	92534442	92534442	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs3847531	ENSG00000165323:ENST00000298047:exon9:c.A8263G:p.I2755V,ENSG00000165323:ENST00000409404:exon9:c.A8263G:p.I2755V,ENSG00000165323:ENST00000525166:exon9:c.A7813G:p.I2605V	FAT3:NM_001008781:exon9:c.A8263G:p.I2755V,FAT3:NM_001367949:exon10:c.A8263G:p.I2755V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8637	0.8229	0.85643	0.8408	-0.756	0.054	1.0	4.8	0.559	.	.	Cadherin|Cadherin-like	FAT3:uc001pdj.4:exon9:c.A8263G:p.I2755V	-0.957	AFR:0.7577,AMR:0.8699,EAS:0.9543,FIN:0.9124,NFE:0.8554,OTH:0.8735,ASJ:0.8907	612483	.	.	.	.	.	.	.	0.0	0.18	0.000	-0.49	11	MU23948427	het
11	92570812	92570812	T	A	FAT3	intronic	.	ENSG00000165323	rs11020075	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4042	0.3166	0.385383	MU12019188	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.3892,EAS:0.4414,FIN:0.4967,NFE:0.4631,OTH:0.4487,ASJ:0.3152	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(haematopoietic_and_lymphoid_tissue)	0.4020
11	92570813	92570813	C	A	FAT3	intronic	.	ENSG00000165323	rs11020076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4041	0.3148	0.385383	1(lung)	.	.	.	.	.	.	.	.	.	.	AFR:MU12019194,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.3154,FIN:0.4414,NFE:0.4967,OTH:0.4625,ASJ:0.3894	612483	.	.	.	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.4489
11	92590448	92590448	A	G	FAT3	exonic	nonsynonymous SNV	ENSG00000165323	rs4753069	ENSG00000165323:ENST00000533797:exon2:c.A439G:p.S147G,ENSG00000165323:ENST00000298047:exon19:c.A11434G:p.S3812G,ENSG00000165323:ENST00000409404:exon19:c.A11434G:p.S3812G,ENSG00000165323:ENST00000525166:exon19:c.A10984G:p.S3662G	FAT3:NM_001008781:exon19:c.A11434G:p.S3812G,FAT3:NM_001367949:exon20:c.A11434G:p.S3812G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8175	0.8418	0.828474	0.8266	1.015	10.75	0.872	4.1	0.893	.	.	EGF-like domain	FAT3:uc001pdi.4:exon3:c.A754G:p.S252G,FAT3:uc001pdj.4:exon19:c.A11434G:p.S3812G	-1.008	AFR:0.9099,AMR:0.8278,EAS:0.6755,FIN:0.7872,NFE:0.8031,OTH:0.8200,ASJ:0.8676	612483	.	.	.	.	.	.	.	0.0	1.64	0.000	-1.04	11	MU737516	het
11	92623877	92623877	G	A	FAT3	exonic	synonymous SNV	ENSG00000165323	rs12277422	ENSG00000165323:ENST00000533797:exon8:c.G2277A:p.P759P,ENSG00000165323:ENST00000409404:exon25:c.G13272A:p.P4424P,ENSG00000165323:ENST00000298047:exon27:c.G13368A:p.P4456P,ENSG00000165323:ENST00000525166:exon27:c.G12918A:p.P4306P	FAT3:NM_001008781:exon25:c.G13272A:p.P4424P,FAT3:NM_001367949:exon28:c.G13368A:p.P4456P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2439	0.2399	0.226238	1(large_intestine)	.	.	.	.	.	.	.	.	FAT3:uc001pdi.4:exon11:c.G2688A:p.P896P,FAT3:uc001pdj.4:exon25:c.G13272A:p.P4424P	.	AFR:MU12019243,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.2369,FIN:0.2864,NFE:0.2649,OTH:0.2491,ASJ:0.2541	612483	.	.	.	.	.	.	.	.	.	.	.	11	2(lung)	0.2595
11	93517874	93517874	C	G	MED17	exonic	synonymous SNV	ENSG00000042429	rs7116967	ENSG00000042429:ENST00000251871:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000530819:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000533133:exon1:c.C195G:p.G65G,ENSG00000042429:ENST00000533359:exon1:c.C195G:p.G65G	MED17:NM_004268:exon1:c.C195G:p.G65G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6174	0.5453	0.565695	0.5575	.	.	.	.	.	.	.	.	MED17:uc001pel.2:exon1:c.C195G:p.G65G,MED17:uc001pem.4:exon1:c.C195G:p.G65G	.	AFR:0.3368,AMR:0.7902,EAS:0.7509,FIN:0.6596,NFE:0.6234,OTH:0.6386,ASJ:0.54	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU90907	unknown
11	93517886	93517886	G	C	MED17	exonic	nonsynonymous SNV	ENSG00000042429	rs2848477	ENSG00000042429:ENST00000251871:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000530819:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000533133:exon1:c.G207C:p.E69D,ENSG00000042429:ENST00000533359:exon1:c.G207C:p.E69D	MED17:NM_004268:exon1:c.G207C:p.E69D	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6183	0.5506	0.565695	0.5573	0.495	7.396	0.867	1.67	0.309	.	.	.	MED17:uc001pel.2:exon1:c.G207C:p.E69D,MED17:uc001pem.4:exon1:c.G207C:p.E69D	-0.952	AFR:0.3363,AMR:0.7902,EAS:0.7491,FIN:0.6591,NFE:0.6237,OTH:0.6380,ASJ:0.54	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	0.0	0.51	0.000	1.445	11	MU90893	unknown
11	93527219	93527219	T	C	MED17	intronic	.	ENSG00000042429	rs657177	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9826	0.9399	0.933107	0.9455	.	.	.	.	.	.	.	.	.	.	AFR:0.8101,AMR:0.9856,EAS:1,FIN:0.9994,NFE:0.9992,OTH:0.9949,ASJ:1	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU81909259	hom
11	93534990	93534990	G	A	MED17	intronic	.	ENSG00000042429	rs655699	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6075	0.4893	0.527556	0.5235	.	.	.	.	.	0.0008	0.006	.	.	.	AFR:0.2167,AMR:0.7709,EAS:0.7481,FIN:0.6594,NFE:0.6247,OTH:0.6260,ASJ:0.5397	603810	613668;	402364;	402364|-|<1 / 1 000 000|Autosomal recessive|Infancy|613668 ~	.	.	.	.	.	.	.	.	11	MU19347293	hom
11	94197260	94197260	A	G	MRE11	intronic	.	ENSG00000020922	rs641936	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3783	0.3521	0.388778	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:1(large_intestine),AMR:MU14901128,EAS:0.3562,FIN:0.3732,NFE:0.4366,OTH:0.3874,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|4|321|0.0124611	600814	604391;	251347;	251347|ATLD|Unknown|Autosomal recessive|Infancy<br>Neonatal|604391 ~	.	.	.	.	.	.	.	.	11	1(upper_aerodigestive_tract)	0.3964
11	94200962	94200962	A	G	MRE11	intronic	.	ENSG00000020922	rs1805365	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0273	0.0559	0.0539137	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:0.0446,EAS:0.0179,FIN:0.0199,NFE:0,OTH:0.0003,ASJ:0.1402	600814	604391;	251347;	251347|ATLD|Unknown|Autosomal recessive|Infancy<br>Neonatal|604391 ~	.	.	.	.	.	.	.	.	11	6(prostate)	0.0081
11	94212048	94212048	C	T	MRE11	intronic	.	ENSG00000020922	rs535801	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3252	0.2696	0.313099	1(oesophagus)	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:MU16125001,AMR:LICA-CN|2|402|0.00497512,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.2035,FIN:0.4209,NFE:0.3543,OTH:0.3858,ASJ:0.2863	600814	604391;	251347;	251347|ATLD|Unknown|Autosomal recessive|Infancy<br>Neonatal|604391 ~	.	.	.	.	.	.	.	.	11	1(breast)	0.3499
11	94212930	94212930	-	A	MRE11	intronic	.	ENSG00000020922	rs35062043	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0722	0.0553	.	0.0486	.	.	.	.	.	.	.	.	.	.	AFR:0.1380,AMR:0.0290,EAS:0,FIN:0.0086,NFE:0.0092,OTH:0.0179,ASJ:0.0194	600814	604391;	251347;	251347|ATLD|Unknown|Autosomal recessive|Infancy<br>Neonatal|604391 ~	.	.	.	.	.	.	.	.	11	.	het
11	102094424	102094424	C	T	YAP1	exonic	synonymous SNV	ENSG00000137693	rs61749258	ENSG00000137693:ENST00000345877:exon5:c.C954T:p.P318P,ENSG00000137693:ENST00000526343:exon5:c.C942T:p.P314P,ENSG00000137693:ENST00000531439:exon6:c.C1056T:p.P352P,ENSG00000137693:ENST00000537274:exon6:c.C1068T:p.P356P,ENSG00000137693:ENST00000282441:exon7:c.C1104T:p.P368P,ENSG00000137693:ENST00000524575:exon7:c.C570T:p.P190P	YAP1:NM_001282098:exon5:c.C954T:p.P318P,YAP1:NM_006106:exon5:c.C942T:p.P314P,YAP1:NM_001195044:exon6:c.C1056T:p.P352P,YAP1:NM_001282097:exon6:c.C990T:p.P330P,YAP1:NM_001282099:exon6:c.C1002T:p.P334P,YAP1:NM_001282100:exon6:c.C1068T:p.P356P,YAP1:NM_001130145:exon7:c.C1104T:p.P368P,YAP1:NM_001195045:exon7:c.C570T:p.P190P,YAP1:NM_001282101:exon7:c.C1116T:p.P372P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0049	0.0072	0.00299521	4(meninges)	.	.	.	.	.	.	.	.	YAP1:uc031qdl.1:exon3:c.C339T:p.P113P,YAP1:uc010rup.1:exon4:c.C399T:p.P133P,YAP1:uc031qdk.1:exon4:c.C453T:p.P151P,YAP1:uc031qdn.1:exon4:c.C387T:p.P129P,YAP1:uc001pgv.3:exon5:c.C942T:p.P314P,YAP1:uc031qdm.1:exon5:c.C501T:p.P167P,YAP1:uc001pgu.3:exon6:c.C1056T:p.P352P,YAP1:uc001pgw.2:exon6:c.C576T:p.P192P,YAP1:uc021qpf.1:exon6:c.C990T:p.P330P,YAP1:uc001pgt.3:exon7:c.C1104T:p.P368P,YAP1:uc010ruo.2:exon7:c.C570T:p.P190P	.	AFR:.,AMR:.,EAS:0.0019,FIN:0.0048,NFE:0,OTH:0,ASJ:0.0046	606608	120433;	1473;	1473|-|<1 / 1 000 000|Autosomal dominant|Neonatal|120433 ~	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.0023
11	108121410	108121410	-	T	ATM	intronic	.	ENSG00000149311	rs34325032	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.3717	0.3252	0.40595	0.5019	.	.	.	.	.	.	.	.	.	.	AFR:0.4265,AMR:0.5668,EAS:0.4125,FIN:0.4710,NFE:0.5539,OTH:0.5839,ASJ:0.5875	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	11	.	hom
11	108151707	108151707	-	A	ATM	intronic	.	ENSG00000149311	rs3218681	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.5675	0.5562	0.542133	0.5369	.	.	.	.	.	.	.	.	.	.	AFR:0.4641,AMR:0.6383,EAS:0.3782,FIN:0.6205,NFE:0.5659,OTH:0.6052,ASJ:0.6324	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	11	.	unknown
11	108183167	108183167	A	G	ATM	exonic	nonsynonymous SNV	ENSG00000149311	rs659243	ENSG00000149311:ENST00000278616:exon40:c.A5948G:p.N1983S,ENSG00000149311:ENST00000452508:exon41:c.A5948G:p.N1983S	ATM:NM_000051:exon40:c.A5948G:p.N1983S,ATM:NM_001351834:exon41:c.A5948G:p.N1983S	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	1	.	1	MU81910525	.	.	.	.	.	.	.	.	ATM:uc009yxt.1:exon3:c.A290G:p.N97S,ATM:uc001pkg.1:exon8:c.A1019G:p.N340S,ATM:uc001pke.2:exon14:c.A1904G:p.N635S,ATM:uc001pkb.1:exon40:c.A5948G:p.N1983S,ATM:uc009yxr.1:exon41:c.A5948G:p.N1983S	.	AFR:COCA-CN|5|321|0.0155763,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	,906,895,899,903,904,908,910,900,912,911,907,909,893,901,877,898,894,902	.	,896,897	.	.	.	.	11	85(lung)	1
11	108236070	108236070	C	T	ATM	exonic	synonymous SNV	ENSG00000149311	rs540172506	ENSG00000149311:ENST00000278616:exon63:c.C9006T:p.F3002F,ENSG00000149311:ENST00000452508:exon64:c.C9006T:p.F3002F	ATM:NM_000051:exon63:c.C9006T:p.F3002F,ATM:NM_001351834:exon64:c.C9006T:p.F3002F	clinvar: Benign/Likely_benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 1, -1, 1, 0, 1, 1] 	0.0003	.	.	3.228e-05	.	.	.	.	.	.	.	.	ATM:uc001pke.2:exon37:c.C4962T:p.F1654F,ATM:uc001pkb.1:exon63:c.C9006T:p.F3002F,ATM:uc009yxr.1:exon64:c.C9006T:p.F3002F	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.663e-05,OTH:0,ASJ:0	607585	114480;208900;	100;227535;	100|Louis-Bar syndrome|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Childhood|208900 208910 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01524 Platinum drug resistance~ko03440 Homologous recombination~ko04064 NF-kappa B signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04115 p53 signaling pathway~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	,906,895,899,903,904,908,910,900,912,911,907,909,893,901,877,898,894,902	.	,896,897	.	.	.	.	11	.	het
11	111963860	111963860	A	G	SDHD	exonic	nonsynonymous SNV	ENSG00000204370	rs592626	ENSG00000204370:ENST00000526592:exon4:c.A371G:p.Q124R	SDHD:NM_001276506:exon4:c.A371G:p.Q124R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9967	.	0.945487	0.9510	-0.354	0.498	0.269	-0.298	0.000	.	.	.	SDHD:uc031qee.1:exon4:c.A371G:p.Q124R	-0.867	AFR:0.8286,AMR:0.9866,EAS:0.9988,FIN:1,NFE:0.9995,OTH:0.9907,ASJ:1	602690	114900;168000;171300;252011;606864;615106;	201;97286;3208;29072;29072;100093;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~97286|Carney dyad<br>Carney-Stratakis dyad<br>GIST-paraganglioma dyad<br>Paraganglioma and gastric stromal sarcoma|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|606864 ~3208|Isolated mitochondrial respiratory chain complex II deficiency<br>Isolated succinate-coenzyme Q reductase deficiency<br>Isolated succinate-ubiquinone reductase deficiency|<1 / 1 000 000|Autosomal recessive|-|252011 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~29072|Familial pheochromocytoma-paraganglioma|1-9 / 1 000 000|Autosomal dominant|Childhood|115310 168000 171300 601650 605373 614165 ~100093|-|-|-|-|114900 ~	.	.	.	.	.	-2.93	0.000	.	11	MU81910959	hom
11	118625532	118625532	T	C	DDX6	exonic	synonymous SNV	ENSG00000110367	rs781928315	ENSG00000110367:ENST00000264018:exon13:c.A1341G:p.K447K,ENSG00000110367:ENST00000526070:exon13:c.A1341G:p.K447K,ENSG00000110367:ENST00000534980:exon13:c.A1341G:p.K447K	DDX6:NM_001257191:exon13:c.A1341G:p.K447K,DDX6:NM_004397:exon13:c.A1341G:p.K447K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	8.287e-06	.	.	.	.	.	.	.	.	.	.	.	DDX6:uc001pua.2:exon5:c.A441G:p.K147K,DDX6:uc001pub.2:exon13:c.A1341G:p.K447K,DDX6:uc001puc.2:exon13:c.A1341G:p.K447K	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600326	.	.	.	.	.	.	.	.	.	.	.	11	.	het
11	118625609	118625609	C	T	DDX6	intronic	.	ENSG00000110367	rs580079	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8909	.	0.88758	0.8687	.	.	.	.	.	.	.	.	.	.	AFR:0.7968,AMR:0.9141,EAS:0.9994,FIN:0.9066,NFE:0.8832,OTH:0.8941,ASJ:0.8742	600326	.	.	.	.	.	.	.	.	.	.	.	11	MU81912502	hom
11	119148573	119148573	G	T	CBL	intronic	.	ENSG00000110395	rs2510152	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6011	0.6246	0.728634	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:1(bone),AMR:MU21722970,EAS:0.6228,FIN:0.8009,NFE:0.4055,OTH:0.6523,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	165360	607785;613563;	363972;86834;	363972|CBL syndrome<br>Noonan syndrome-like disorder with JMML|-|Autosomal dominant|-|613563 ~86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~	~ko04012 ErbB signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko04910 Insulin signaling pathway~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	11	1(lung)	0.8846
11	120292570	120292570	T	A	ARHGEF12	intronic	.	ENSG00000196914	rs532006	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9964	0.9865	0.985024	0.9891	.	.	.	.	.	.	.	.	.	.	AFR:0.9618,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	MU81913066	hom
11	120319064	120319064	A	C	ARHGEF12	intronic	.	ENSG00000196914	rs2305008	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4203	0.4354	0.427716	MU11826432	.	.	.	.	.	0.0001	0	.	ARHGEF12:uc021qrm.1:exon19:c.A1687C:p.M563L	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.4342,EAS:0.3457,FIN:0.4467,NFE:0.2976,OTH:0.4504,ASJ:0.5346	604763	.	.	.	~ko04270 Vascular smooth muscle contraction~ko04360 Axon guidance~ko04361 Axon regeneration~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05130 Pathogenic Escherichia coli infection~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	11	3(haematopoietic_and_lymphoid_tissue)	0.3905
11	125525195	125525195	A	G	CHEK1	exonic	nonsynonymous SNV	ENSG00000149554	rs506504	ENSG00000149554:ENST00000278916:exon11:c.A1279G:p.I427V,ENSG00000149554:ENST00000427383:exon12:c.A1459G:p.I487V,ENSG00000149554:ENST00000524737:exon12:c.A1411G:p.I471V,ENSG00000149554:ENST00000544373:exon12:c.A1309G:p.I437V,ENSG00000149554:ENST00000428830:exon13:c.A1411G:p.I471V,ENSG00000149554:ENST00000438015:exon13:c.A1411G:p.I471V,ENSG00000149554:ENST00000534070:exon13:c.A1411G:p.I471V	CHEK1:NM_001244846:exon12:c.A1309G:p.I437V,CHEK1:NM_001330427:exon12:c.A1459G:p.I487V,CHEK1:NM_001330428:exon12:c.A1129G:p.I377V,CHEK1:NM_001114121:exon13:c.A1411G:p.I471V,CHEK1:NM_001114122:exon13:c.A1411G:p.I471V,CHEK1:NM_001274:exon13:c.A1411G:p.I471V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9726	0.9738	0.985823	0.9774	-0.257	0.830	1.0	1.8	0.993	.	.	.	CHEK1:uc010sbh.2:exon12:c.A1459G:p.I487V,CHEK1:uc010sbi.2:exon12:c.A1309G:p.I437V,CHEK1:uc001qcf.4:exon13:c.A1411G:p.I471V,CHEK1:uc001qcg.4:exon13:c.A1411G:p.I471V,CHEK1:uc009zbo.3:exon13:c.A1411G:p.I471V,CHEK1:uc009zbp.3:exon13:c.A1411G:p.I471V	-0.951	AFR:0.9928,AMR:0.9761,EAS:1,FIN:0.9694,NFE:0.9683,OTH:0.9776,ASJ:0.9603	603078	.	.	.	~ko04110 Cell cycle~ko04111 Cell cycle - yeast~ko04113 Meiosis - yeast~ko04115 p53 signaling pathway~ko04218 Cellular senescence~ko05166 Human T-cell leukemia virus 1 infection~ko05170 Human immunodeficiency virus 1 infection~ko05203 Viral carcinogenesis ~	.	.	.	0.0	-0.5	0.000	-1.155	11	MU81914120	hom
11	125830970	125830970	A	T	CDON	exonic	nonsynonymous SNV	ENSG00000064309	rs684535	ENSG00000064309:ENST00000531738:exon11:c.T1793A:p.I598N,ENSG00000064309:ENST00000263577:exon20:c.T3662A:p.I1221N,ENSG00000064309:ENST00000392693:exon20:c.T3731A:p.I1244N	CDON:NM_001243597:exon20:c.T3731A:p.I1244N,CDON:NM_016952:exon20:c.T3662A:p.I1221N	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7310	0.73	.	COCA-CN|5|321|0.0155763	-0.119	1.592	1.0	4.34	0.018	.	.	.	CDON:uc001qdb.4:exon11:c.T1793A:p.I598N,CDON:uc001qdc.4:exon20:c.T3662A:p.I1221N,CDON:uc009zbw.3:exon20:c.T3731A:p.I1244N	-0.950	AFR:0.7411,AMR:0.8439,EAS:0.7318,FIN:0.9321,NFE:0.6754,OTH:0.6769,ASJ:0.7792	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	0.0	-0.03	0.000	-2.05	11	1(salivary_gland)	0.6939
11	125831701	125831701	G	A	CDON	exonic	synonymous SNV	ENSG00000064309	rs2276061	ENSG00000064309:ENST00000531738:exon10:c.C1680T:p.V560V,ENSG00000064309:ENST00000263577:exon19:c.C3549T:p.V1183V,ENSG00000064309:ENST00000392693:exon19:c.C3549T:p.V1183V	CDON:NM_001243597:exon19:c.C3549T:p.V1183V,CDON:NM_016952:exon19:c.C3549T:p.V1183V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2906	0.2531	0.242212	LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	CDON:uc001qdb.4:exon10:c.C1680T:p.V560V,CDON:uc001qdc.4:exon19:c.C3549T:p.V1183V,CDON:uc009zbw.3:exon19:c.C3549T:p.V1183V	.	AFR:0.2547,AMR:0.1235,EAS:0.2980,FIN:0.2954,NFE:0.3078,OTH:0.3128,ASJ:0.2554	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	1(lung)	0.2627
11	125848261	125848261	C	T	CDON	exonic	synonymous SNV	ENSG00000064309	rs3740904	ENSG00000064309:ENST00000531738:exon9:c.G1425A:p.T475T,ENSG00000064309:ENST00000263577:exon18:c.G3294A:p.T1098T,ENSG00000064309:ENST00000392693:exon18:c.G3294A:p.T1098T	CDON:NM_001243597:exon18:c.G3294A:p.T1098T,CDON:NM_016952:exon18:c.G3294A:p.T1098T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4143	0.3565	0.399561	1(large_intestine)	.	.	.	.	.	.	.	.	CDON:uc001qdb.4:exon9:c.G1425A:p.T475T,CDON:uc001qdc.4:exon18:c.G3294A:p.T1098T,CDON:uc009zbw.3:exon18:c.G3294A:p.T1098T	.	AFR:MU77425,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.3498,FIN:0.4415,NFE:0.3467,OTH:0.3958,ASJ:0.3650	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	1(lung)	0.4055
11	125885389	125885389	A	C	CDON	exonic	synonymous SNV	ENSG00000064309	rs577839746	ENSG00000064309:ENST00000263577:exon7:c.T945G:p.S315S,ENSG00000064309:ENST00000392693:exon7:c.T945G:p.S315S	CDON:NM_001243597:exon7:c.T945G:p.S315S,CDON:NM_016952:exon7:c.T945G:p.S315S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	2.508e-05	.	0.000199681	.	.	.	.	.	.	.	.	.	CDON:uc001qdc.4:exon7:c.T945G:p.S315S,CDON:uc009zbw.3:exon7:c.T945G:p.S315S,CDON:uc009zbx.3:exon7:c.T945G:p.S315S	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	.	.	.	.	11	.	het
11	125891269	125891269	C	T	CDON	exonic	nonsynonymous SNV	ENSG00000064309	rs3740912	ENSG00000064309:ENST00000263577:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000392693:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000527967:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000531586:exon3:c.G223A:p.V75I,ENSG00000064309:ENST00000534818:exon3:c.G223A:p.V75I	CDON:NM_001243597:exon3:c.G223A:p.V75I,CDON:NM_016952:exon3:c.G223A:p.V75I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5573	0.6452	0.572284	0.6357	-0.550	0.165	0.792	1.84	0.002	.	.	Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	CDON:uc001qdc.4:exon3:c.G223A:p.V75I,CDON:uc009zbw.3:exon3:c.G223A:p.V75I,CDON:uc009zbx.3:exon3:c.G223A:p.V75I	-0.960	AFR:0.8210,AMR:0.5538,EAS:0.3190,FIN:0.6323,NFE:0.5715,OTH:0.5784,ASJ:0.6093	608707	614226;	2162;	2162|HPE|Unknown|Multigenic/multifactorial<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|142945 142946 147250 157170 236100 605934 609408 609637 610828 610829 612530 614226 ~	.	.	.	.	0.0	1.08	0.000	0.645	11	MU582469	het
11	126162862	126162862	C	T	TIRAP	exonic	synonymous SNV	ENSG00000150455	rs7932766	ENSG00000150455:ENST00000479770:exon2:c.C558T:p.A186A,ENSG00000150455:ENST00000392679:exon4:c.C558T:p.A186A,ENSG00000150455:ENST00000392678:exon5:c.C558T:p.A186A,ENSG00000150455:ENST00000392680:exon5:c.C558T:p.A186A	TIRAP:NM_001318776:exon4:c.C558T:p.A186A,TIRAP:NM_001318777:exon4:c.C558T:p.A186A,TIRAP:NM_001039661:exon5:c.C558T:p.A186A,TIRAP:NM_148910:exon5:c.C558T:p.A186A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1835	0.2037	0.133986	LICA-CN|1|402|0.00248756,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	TIRAP:uc001qdo.1:exon4:c.C558T:p.A186A,TIRAP:uc009zcb.1:exon4:c.C558T:p.A186A,TIRAP:uc001qdl.1:exon5:c.C558T:p.A186A,TIRAP:uc001qdm.1:exon5:c.C558T:p.A186A,TIRAP:uc001qdn.1:exon5:c.C558T:p.A186A	.	AFR:0.1910,AMR:0.1319,EAS:0.1556,FIN:0.0271,NFE:0.2026,OTH:0.2443,ASJ:0.1181	606252	607948;610799;611162;614382;	673;3389;	673|-|1-9 / 100 000|Not applicable|All ages|611162 ~3389|-|1-5 / 10 000|Not applicable|All ages|607948 ~	.	.	.	.	.	.	.	.	11	1(large_intestine)	0.2045
11	128333503	128333503	T	C	ETS1	exonic	synonymous SNV	ENSG00000134954	rs2230004	ENSG00000134954:ENST00000535549:exon3:c.A363G:p.L121L,ENSG00000134954:ENST00000345075:exon6:c.A750G:p.L250L,ENSG00000134954:ENST00000526145:exon6:c.A750G:p.L250L,ENSG00000134954:ENST00000319397:exon7:c.A1011G:p.L337L,ENSG00000134954:ENST00000392668:exon9:c.A1143G:p.L381L	ETS1:NM_001162422:exon3:c.A363G:p.L121L,ETS1:NM_001330451:exon6:c.A750G:p.L250L,ETS1:NM_005238:exon7:c.A1011G:p.L337L,ETS1:NM_001143820:exon9:c.A1143G:p.L381L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4668	0.4712	0.479633	0.4959	.	.	.	.	.	.	.	.	ETS1:uc009zch.2:exon3:c.A363G:p.L121L,ETS1:uc010sbs.1:exon7:c.A1011G:p.L337L,ETS1:uc001qej.2:exon9:c.A1143G:p.L381L	.	AFR:0.4745,AMR:0.3385,EAS:0.5700,FIN:0.5507,NFE:0.4991,OTH:0.4898,ASJ:0.38	164720	.	.	.	~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	11	MU20946672	hom
11	128781339	128781339	T	C	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs6590357	ENSG00000120457:ENST00000533599:exon1:c.T171C:p.S57S,ENSG00000120457:ENST00000529694:exon2:c.T171C:p.S57S,ENSG00000120457:ENST00000338350:exon3:c.T171C:p.S57S	KCNJ5:NM_000890:exon2:c.T171C:p.S57S,KCNJ5:NM_001354169:exon3:c.T171C:p.S57S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8436	0.8483	0.869808	0.8476	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T171C:p.S57S,KCNJ5:uc001qet.3:exon2:c.T171C:p.S57S,KCNJ5:uc009zck.3:exon3:c.T171C:p.S57S	.	AFR:0.9048,AMR:0.8162,EAS:0.8915,FIN:0.7991,NFE:0.8249,OTH:0.8218,ASJ:0.8179	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU19381753	het
11	128781978	128781978	T	G	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs7118824	ENSG00000120457:ENST00000533599:exon1:c.T810G:p.L270L,ENSG00000120457:ENST00000529694:exon2:c.T810G:p.L270L,ENSG00000120457:ENST00000338350:exon3:c.T810G:p.L270L	KCNJ5:NM_000890:exon2:c.T810G:p.L270L,KCNJ5:NM_001354169:exon3:c.T810G:p.L270L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8414	0.8427	0.866214	0.8424	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T810G:p.L270L,KCNJ5:uc001qet.3:exon2:c.T810G:p.L270L,KCNJ5:uc009zck.3:exon3:c.T810G:p.L270L	.	AFR:0.8930,AMR:0.8150,EAS:0.8912,FIN:0.7990,NFE:0.8212,OTH:0.8203,ASJ:0.8167	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU19381815	unknown
11	128782002	128782002	T	C	KCNJ5	exonic	synonymous SNV	ENSG00000120457	rs7118833	ENSG00000120457:ENST00000533599:exon1:c.T834C:p.H278H,ENSG00000120457:ENST00000529694:exon2:c.T834C:p.H278H,ENSG00000120457:ENST00000338350:exon3:c.T834C:p.H278H	KCNJ5:NM_000890:exon2:c.T834C:p.H278H,KCNJ5:NM_001354169:exon3:c.T834C:p.H278H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8416	0.8440	0.867013	0.8435	.	.	.	.	.	.	.	.	KCNJ5:uc001qew.3:exon1:c.T834C:p.H278H,KCNJ5:uc001qet.3:exon2:c.T834C:p.H278H,KCNJ5:uc009zck.3:exon3:c.T834C:p.H278H	.	AFR:0.8970,AMR:0.8182,EAS:0.8912,FIN:0.7991,NFE:0.8211,OTH:0.8193,ASJ:0.8167	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU16066762	unknown
11	128782012	128782012	C	G	KCNJ5	exonic	nonsynonymous SNV	ENSG00000120457	rs7102584	ENSG00000120457:ENST00000533599:exon1:c.C844G:p.Q282E,ENSG00000120457:ENST00000529694:exon2:c.C844G:p.Q282E,ENSG00000120457:ENST00000338350:exon3:c.C844G:p.Q282E	KCNJ5:NM_000890:exon2:c.C844G:p.Q282E,KCNJ5:NM_001354169:exon3:c.C844G:p.Q282E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9865	0.9871	0.995008	0.9849	0.157	4.219	1.0	5.46	0.990	.	.	Immunoglobulin E-set|Potassium channel, inwardly rectifying, Kir, cytoplasmic	KCNJ5:uc001qew.3:exon1:c.C844G:p.Q282E,KCNJ5:uc001qet.3:exon2:c.C844G:p.Q282E,KCNJ5:uc009zck.3:exon3:c.C844G:p.Q282E	-0.907	AFR:0.9984,AMR:0.9940,EAS:1,FIN:0.9728,NFE:0.9776,OTH:0.9805,ASJ:1	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	0.0	-2.58	0.000	-1.455	11	MU194151	unknown
11	128786294	128786294	G	A	KCNJ5	intronic	.	ENSG00000120457	rs4937391	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7346	0.7478	0.735823	0.7394	.	.	.	.	.	0	0.002	.	.	.	AFR:0.7966,AMR:0.7022,EAS:0.6720,FIN:0.6878,NFE:0.7287,OTH:0.7274,ASJ:0.7219	600734	613485;613677;	251274;101016;768;	251274|FH-III<br>FH3<br>Familial hyperaldosteronism type 3|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood<br>Adolescent|613677 ~101016|Romano-Ward long QT syndrome|1-5 / 10 000|Autosomal dominant|All ages|192500 600919 603830 611818 611819 611820 612955 613485 613688 613693 613695 616247 616249 ~768|Congenital long QT syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|192500 220400 600919 601005 603830 611818 611819 611820 612347 612955 613485 613688 613693 613695 616247 616249 ~	.	.	.	.	.	.	.	.	11	MU17126561	het
12	432376	432376	-	AAAAAAAAAAAAAAAAAAAAAAAAAAAA	KDM5A	intronic	.	ENSG00000073614	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	180202	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	498269	498269	G	-	KDM5A	UTR5	.	ENSG00000073614	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	180202	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	862989	862989	T	C	WNK1	exonic	synonymous SNV	ENSG00000060237	rs3168640	ENSG00000060237:ENST00000315939:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000447667:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000530271:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000535572:exon1:c.T258C:p.C86C,ENSG00000060237:ENST00000537687:exon1:c.T258C:p.C86C	WNK1:NM_001184985:exon1:c.T258C:p.C86C,WNK1:NM_014823:exon1:c.T258C:p.C86C,WNK1:NM_018979:exon1:c.T258C:p.C86C,WNK1:NM_213655:exon1:c.T258C:p.C86C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9924	0.9724	0.975639	0.9784	.	.	.	.	.	.	.	.	WNK1:uc001qin.3:exon1:c.T258C:p.C86C,WNK1:uc001qio.4:exon1:c.T258C:p.C86C,WNK1:uc001qip.4:exon1:c.T258C:p.C86C,WNK1:uc021qss.1:exon1:c.T258C:p.C86C,WNK1:uc021qst.1:exon1:c.T258C:p.C86C,WNK1:uc031qfk.1:exon1:c.T258C:p.C86C	.	AFR:0.9240,AMR:0.9976,EAS:1,FIN:1,NFE:1,OTH:0.9949,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU81915326	hom
12	939302	939302	A	G	WNK1	exonic	synonymous SNV	ENSG00000060237	rs10774466	ENSG00000060237:ENST00000315939:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000530271:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000535572:exon4:c.A1287G:p.A429A,ENSG00000060237:ENST00000537687:exon4:c.A1287G:p.A429A	WNK1:NM_001184985:exon4:c.A1287G:p.A429A,WNK1:NM_014823:exon4:c.A1287G:p.A429A,WNK1:NM_018979:exon4:c.A1287G:p.A429A,WNK1:NM_213655:exon4:c.A1287G:p.A429A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7451	0.6855	0.69349	0.7201	.	.	.	.	.	.	.	.	WNK1:uc001qio.4:exon4:c.A1287G:p.A429A,WNK1:uc001qip.4:exon4:c.A1287G:p.A429A,WNK1:uc021qss.1:exon4:c.A1287G:p.A429A,WNK1:uc021qst.1:exon4:c.A1287G:p.A429A,WNK1:uc031qfk.1:exon4:c.A1287G:p.A429A	.	AFR:0.5713,AMR:0.7757,EAS:0.8843,FIN:0.8041,NFE:0.7632,OTH:0.7796,ASJ:0.6689	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU147437	hom
12	974355	974355	-	C	WNK1	exonic	frameshift insertion	ENSG00000060237	rs11441897	ENSG00000060237:ENST00000530271:exon9:c.2220dupC:p.L740fs	WNK1:NM_213655:exon9:c.2220dupC:p.L740fs	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5445	.	0.518371	0.5581	.	.	.	.	.	.	.	.	WNK1:uc021qst.1:exon9:c.2220dupC:p.L740fs	.	AFR:0.4628,AMR:0.4189,EAS:0.5392,FIN:0.6465,NFE:0.6012,OTH:0.5969,ASJ:0.5133	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	.	hom
12	974404	974404	T	C	WNK1	exonic	synonymous SNV	ENSG00000060237	rs7300829	ENSG00000060237:ENST00000530271:exon9:c.T2268C:p.P756P	WNK1:NM_213655:exon9:c.T2268C:p.P756P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6031	.	0.653954	LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	WNK1:uc021qst.1:exon9:c.T2268C:p.P756P	.	AFR:0.6457,AMR:0.7034,EAS:0.5596,FIN:0.5876,NFE:0.6814,OTH:0.6158,ASJ:0.5871	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	3(haematopoietic_and_lymphoid_tissue)	0.6350
12	987482	987482	G	A	WNK1	exonic	synonymous SNV	ENSG00000060237	rs1012729	ENSG00000060237:ENST00000535698:exon2:c.G138A:p.Q46Q,ENSG00000060237:ENST00000340908:exon7:c.G1107A:p.Q369Q,ENSG00000060237:ENST00000315939:exon10:c.G2328A:p.Q776Q,ENSG00000060237:ENST00000535572:exon10:c.G2325A:p.Q775Q,ENSG00000060237:ENST00000537687:exon11:c.G3567A:p.Q1189Q,ENSG00000060237:ENST00000530271:exon12:c.G3822A:p.Q1274Q	WNK1:NM_014823:exon10:c.G2325A:p.Q775Q,WNK1:NM_018979:exon10:c.G2328A:p.Q776Q,WNK1:NM_001184985:exon11:c.G3567A:p.Q1189Q,WNK1:NM_213655:exon12:c.G3822A:p.Q1274Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7340	0.6795	0.679513	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon3:c.G585A:p.Q195Q,WNK1:uc001qio.4:exon10:c.G2328A:p.Q776Q,WNK1:uc001qip.4:exon10:c.G2325A:p.Q775Q,WNK1:uc021qss.1:exon11:c.G3567A:p.Q1189Q,WNK1:uc031qfk.1:exon11:c.G3567A:p.Q1189Q,WNK1:uc021qst.1:exon12:c.G3822A:p.Q1274Q	.	AFR:0.7141,AMR:0.5771,EAS:0.6433,FIN:0.8181,NFE:0.8038,OTH:0.7559,ASJ:0.7715	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.7740
12	987533	987533	-	T	WNK1	intronic	.	ENSG00000060237	rs398116010	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4607	.	0.442093	0.6757	.	.	.	.	.	.	.	.	.	.	AFR:0.5438,AMR:0.6859,EAS:0.8054,FIN:0.6491,NFE:0.7405,OTH:0.7359,ASJ:0.6194	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	.	hom
12	988894	988894	G	A	WNK1	exonic	synonymous SNV	ENSG00000060237	rs9804992	ENSG00000060237:ENST00000535698:exon3:c.G339A:p.Q113Q,ENSG00000060237:ENST00000340908:exon8:c.G1308A:p.Q436Q,ENSG00000060237:ENST00000315939:exon11:c.G2529A:p.Q843Q,ENSG00000060237:ENST00000530271:exon13:c.G4023A:p.Q1341Q	WNK1:NM_018979:exon11:c.G2529A:p.Q843Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1542	0.1478	0.145767	1(large_intestine)	.	.	.	.	.	.	.	.	WNK1:uc001qio.4:exon11:c.G2529A:p.Q843Q,WNK1:uc031qfk.1:exon12:c.G3768A:p.Q1256Q	.	AFR:MU100931,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,EAS:0.1256,FIN:0.2117,NFE:0.1333,OTH:0.0776,ASJ:0.1407	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	2(haematopoietic_and_lymphoid_tissue)	0.1065
12	990912	990912	A	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs956868	ENSG00000060237:ENST00000340908:exon10:c.A1945C:p.T649P,ENSG00000060237:ENST00000535572:exon11:c.A2425C:p.T809P,ENSG00000060237:ENST00000315939:exon13:c.A3166C:p.T1056P,ENSG00000060237:ENST00000537687:exon13:c.A3946C:p.T1316P,ENSG00000060237:ENST00000530271:exon15:c.A4660C:p.T1554P	WNK1:NM_014823:exon11:c.A2425C:p.T809P,WNK1:NM_001184985:exon13:c.A3946C:p.T1316P,WNK1:NM_018979:exon13:c.A3166C:p.T1056P,WNK1:NM_213655:exon13:c.A3922C:p.T1308P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8314	0.8526	0.852835	0.8317	-0.728	0.062	1.0	0.635	0.064	.	.	.	WNK1:uc001qir.4:exon4:c.A685C:p.T229P,WNK1:uc001qip.4:exon11:c.A2425C:p.T809P,WNK1:uc001qio.4:exon13:c.A3166C:p.T1056P,WNK1:uc021qss.1:exon13:c.A3946C:p.T1316P,WNK1:uc021qst.1:exon13:c.A3922C:p.T1308P,WNK1:uc031qfk.1:exon14:c.A4405C:p.T1469P	-1.004	AFR:0.8503,AMR:0.8783,EAS:0.8021,FIN:0.7460,NFE:0.8424,OTH:0.8194,ASJ:0.8212	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	2.86	0.000	-1.445	12	MU777778	hom
12	992229	992229	C	T	WNK1	intronic	.	ENSG00000060237	rs34032084	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1183	0.1078	0.101038	MU582492	.	.	.	.	.	0.0002	0.016	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,AMR:0.1014,EAS:0.0742,FIN:0.0960,NFE:0.0765,OTH:0.0879,ASJ:0.0428	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	29(meninges)	0.1402
12	993930	993930	C	T	WNK1	exonic	synonymous SNV	ENSG00000060237	rs7300444	ENSG00000060237:ENST00000340908:exon16:c.C2739T:p.N913N,ENSG00000060237:ENST00000535572:exon17:c.C3219T:p.N1073N,ENSG00000060237:ENST00000315939:exon19:c.C3960T:p.N1320N,ENSG00000060237:ENST00000537687:exon19:c.C4740T:p.N1580N,ENSG00000060237:ENST00000530271:exon21:c.C5454T:p.N1818N	WNK1:NM_014823:exon17:c.C3219T:p.N1073N,WNK1:NM_001184985:exon19:c.C4740T:p.N1580N,WNK1:NM_018979:exon19:c.C3960T:p.N1320N,WNK1:NM_213655:exon19:c.C4716T:p.N1572N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4192	0.3917	0.398962	MU147462	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon10:c.C1479T:p.N493N,WNK1:uc001qip.4:exon17:c.C3219T:p.N1073N,WNK1:uc001qio.4:exon19:c.C3960T:p.N1320N,WNK1:uc021qss.1:exon19:c.C4740T:p.N1580N,WNK1:uc021qst.1:exon19:c.C4716T:p.N1572N,WNK1:uc031qfk.1:exon20:c.C5199T:p.N1733N	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.4107,EAS:0.4402,FIN:0.3642,NFE:0.5438,OTH:0.4436,ASJ:0.3114	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.4451
12	994487	994487	G	C	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs7955371	ENSG00000060237:ENST00000340908:exon16:c.G3296C:p.C1099S,ENSG00000060237:ENST00000535572:exon17:c.G3776C:p.C1259S,ENSG00000060237:ENST00000315939:exon19:c.G4517C:p.C1506S,ENSG00000060237:ENST00000537687:exon19:c.G5297C:p.C1766S,ENSG00000060237:ENST00000530271:exon21:c.G6011C:p.C2004S	WNK1:NM_014823:exon17:c.G3776C:p.C1259S,WNK1:NM_001184985:exon19:c.G5297C:p.C1766S,WNK1:NM_018979:exon19:c.G4517C:p.C1506S,WNK1:NM_213655:exon19:c.G5273C:p.C1758S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9963	0.9861	0.986821	0.9877	-1.695	0.002	1.0	5.3	0.235	.	.	.	WNK1:uc001qir.4:exon10:c.G2036C:p.C679S,WNK1:uc001qip.4:exon17:c.G3776C:p.C1259S,WNK1:uc001qio.4:exon19:c.G4517C:p.C1506S,WNK1:uc021qss.1:exon19:c.G5297C:p.C1766S,WNK1:uc021qst.1:exon19:c.G5273C:p.C1758S,WNK1:uc031qfk.1:exon20:c.G5756C:p.C1919S	-0.954	AFR:0.9570,AMR:0.9964,EAS:1,FIN:1,NFE:0.9998,OTH:0.9990,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	-0.2	0.000	-1.79	12	MU81915388	hom
12	998365	998365	G	T	WNK1	exonic	nonsynonymous SNV	ENSG00000060237	rs12828016	ENSG00000060237:ENST00000340908:exon18:c.G4203T:p.M1401I,ENSG00000060237:ENST00000535572:exon19:c.G4683T:p.M1561I,ENSG00000060237:ENST00000315939:exon21:c.G5424T:p.M1808I,ENSG00000060237:ENST00000537687:exon21:c.G6204T:p.M2068I,ENSG00000060237:ENST00000530271:exon23:c.G6918T:p.M2306I	WNK1:NM_014823:exon19:c.G4683T:p.M1561I,WNK1:NM_001184985:exon21:c.G6204T:p.M2068I,WNK1:NM_018979:exon21:c.G5424T:p.M1808I,WNK1:NM_213655:exon21:c.G6180T:p.M2060I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.3766	0.4314	0.417532	1(large_intestine)	1.329	12.42	0.207	2.16	0.311	.	.	.	WNK1:uc001qir.4:exon12:c.G2943T:p.M981I,WNK1:uc001qip.4:exon19:c.G4683T:p.M1561I,WNK1:uc001qio.4:exon21:c.G5424T:p.M1808I,WNK1:uc021qss.1:exon21:c.G6204T:p.M2068I,WNK1:uc021qst.1:exon21:c.G6180T:p.M2060I,WNK1:uc031qfk.1:exon22:c.G6663T:p.M2221I	-0.925	AFR:MU131371,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.4944,FIN:0.2978,NFE:0.3967,OTH:0.2581,ASJ:0.3909	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	0.0	1.71	0.000	-0.69	12	59(lung)	0.2836
12	1017197	1017197	C	T	WNK1	exonic	synonymous SNV	ENSG00000060237	rs4766334	ENSG00000060237:ENST00000340908:exon24:c.C5607T:p.Y1869Y,ENSG00000060237:ENST00000535572:exon25:c.C6084T:p.Y2028Y,ENSG00000060237:ENST00000315939:exon27:c.C6828T:p.Y2276Y,ENSG00000060237:ENST00000537687:exon27:c.C7608T:p.Y2536Y,ENSG00000060237:ENST00000530271:exon29:c.C8322T:p.Y2774Y	WNK1:NM_014823:exon25:c.C6084T:p.Y2028Y,WNK1:NM_001184985:exon27:c.C7608T:p.Y2536Y,WNK1:NM_018979:exon27:c.C6828T:p.Y2276Y,WNK1:NM_213655:exon27:c.C7584T:p.Y2528Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9964	0.9862	0.987021	0.9884	.	.	.	.	.	.	.	.	WNK1:uc001qir.4:exon18:c.C4347T:p.Y1449Y,WNK1:uc001qip.4:exon25:c.C6084T:p.Y2028Y,WNK1:uc001qio.4:exon27:c.C6828T:p.Y2276Y,WNK1:uc021qss.1:exon27:c.C7608T:p.Y2536Y,WNK1:uc021qst.1:exon27:c.C7584T:p.Y2528Y,WNK1:uc031qfk.1:exon30:c.C8181T:p.Y2727Y	.	AFR:0.9597,AMR:0.9952,EAS:1,FIN:1,NFE:0.9998,OTH:0.9990,ASJ:1	605232	201300;614492;	757;88940;970;	757|Chloride shunt syndrome<br>Familial hyperkalemic hypertension<br>Gordon hyperkalemia-hypertension syndrome<br>Hyperkalemia-hypertension syndrome, Gordon type<br>Hypertensive hyperkalemia<br>Mineralocorticoid resistant hyperkalemia<br>PHA2<br>PHAII<br>Spitzer-Weinstein syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|145260 614491 614492 614495 614496 ~88940|PHA2C|-|-|-|614492 ~970|Autosomal recessive sensory radicular neuropathy<br>HSAN2<br>Neurogenic acroosteolysis|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|201300 243000 613115 614213 ~	.	.	.	.	.	.	.	.	12	MU4552882	hom
12	1035947	1035947	C	A	RAD52	intronic	.	ENSG00000002016	rs6489763	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9969	0.9937	0.992812	0.9935	.	.	.	.	.	.	.	.	.	.	AFR:0.9773,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	600392	.	.	.	.	.	.	.	.	.	.	.	12	MU81915469	hom
12	1038978	1038978	-	T	RAD52	intronic	.	ENSG00000002016	rs35278212	ENSG00000002016:ENST00000397230:exon5:c.354_355insA:p.G119fs,ENSG00000002016:ENST00000461568:exon5:c.354_355insA:p.G119fs,ENSG00000002016:ENST00000468231:exon6:c.354_355insA:p.G119fs	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1099	0.1143	0.0864617	0.1029	.	.	.	.	.	.	.	.	.	.	AFR:0.0877,AMR:0.0706,EAS:0.0438,FIN:0.0822,NFE:0.1235,OTH:0.1235,ASJ:0.0933	600392	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	1040373	1040373	T	C	RAD52	intronic	.	ENSG00000002016	rs7303748	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5490	0.5512	0.544928	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.5323,AMR:0.5221,EAS:0.6126,FIN:0.4588,NFE:0.5437,OTH:0.5467,ASJ:0.4185	600392	.	.	.	.	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.5575
12	4543361	4543361	G	A	FGF6	UTR3	.	ENSG00000111241	rs2241286	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0214	0.0015	0.0439297	0.0165	.	.	.	.	.	.	.	.	.	.	AFR:0.0013,AMR:0.0048,EAS:0.2305,FIN:0.0178,NFE:0.0032,OTH:0.0112,ASJ:0.0067	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	MU20949677	het
12	4554548	4554548	G	C	FGF6	exonic	synonymous SNV	ENSG00000111241	rs7358740	ENSG00000111241:ENST00000228837:exon1:c.C189G:p.A63A	FGF6:NM_020996:exon1:c.C189G:p.A63A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9721	0.9056	0.903155	0.9177	.	.	.	.	.	.	.	.	FGF6:uc001qmr.1:exon1:c.C189G:p.A63A	.	AFR:0.7134,AMR:0.9821,EAS:1,FIN:1,NFE:0.9993,OTH:0.9764,ASJ:0.9967	134921	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	12	MU4555769	hom
12	7065576	7065576	G	A	PTPN6	intronic	.	ENSG00000111679	rs2110071	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9141	0.7978	0.816094	0.8137	.	.	.	.	.	0	0.042	.	.	.	AFR:0.4921,AMR:0.9296,EAS:0.9994,FIN:0.9304,NFE:0.9366,OTH:0.9184,ASJ:0.9735	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	12	MU81917016	hom
12	7065635	7065635	T	C	PTPN6	exonic	synonymous SNV	ENSG00000111679	rs2110072	ENSG00000111679:ENST00000447931:exon8:c.T861C:p.G287G,ENSG00000111679:ENST00000318974:exon9:c.T978C:p.G326G,ENSG00000111679:ENST00000399448:exon9:c.T984C:p.G328G,ENSG00000111679:ENST00000456013:exon9:c.T978C:p.G326G	PTPN6:NM_002831:exon9:c.T978C:p.G326G,PTPN6:NM_080548:exon9:c.T984C:p.G328G,PTPN6:NM_080549:exon9:c.T978C:p.G326G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9499	0.9216	0.948682	0.9221	.	.	.	.	.	.	.	.	PTPN6:uc010sfr.1:exon8:c.T861C:p.G287G,PTPN6:uc010sfs.1:exon8:c.T942C:p.G314G,PTPN6:uc001qsa.1:exon9:c.T984C:p.G328G,PTPN6:uc001qsb.2:exon9:c.T978C:p.G326G,PTPN6:uc009zfl.1:exon9:c.T978C:p.G326G	.	AFR:0.8686,AMR:0.9606,EAS:1,FIN:0.9306,NFE:0.9383,OTH:0.9409,ASJ:0.9768	176883	.	.	.	~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko05130 Pathogenic Escherichia coli infection~ko05140 Leishmaniasis~ko05205 Proteoglycans in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	12	MU81917038	hom
12	12301898	12301898	C	T	LRP6	exonic	nonsynonymous SNV	ENSG00000070018	rs2302685	ENSG00000070018:ENST00000261349:exon14:c.G3184A:p.V1062I,ENSG00000070018:ENST00000543091:exon14:c.G3184A:p.V1062I	LRP6:NM_002336:exon14:c.G3184A:p.V1062I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8474	0.8400	0.885583	0.8348	2.258	17.89	1.0	5.45	1.000	.	.	Six-bladed beta-propeller, TolB-like	LRP6:uc001rah.4:exon14:c.G3184A:p.V1062I,LRP6:uc010shl.1:exon14:c.G3184A:p.V1062I	-0.936	AFR:0.8707,AMR:0.9113,EAS:0.9376,FIN:0.8148,NFE:0.8037,OTH:0.8227,ASJ:0.85	603507	610947;616724;	99798;	99798|Selective tooth agenesis|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|106600 150400 313500 604625 610926 616724 617073 ~	~ko04150 mTOR signaling pathway~ko04310 Wnt signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko05200 Pathways in cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	0.0	-2.67	0.000	-2.195	12	MU25428801	hom
12	12871099	12871099	T	G	CDKN1B	exonic	nonsynonymous SNV	ENSG00000111276	rs2066827	ENSG00000111276:ENST00000228872:exon1:c.T326G:p.V109G,ENSG00000111276:ENST00000396340:exon1:c.T326G:p.V109G	CDKN1B:NM_004064:exon1:c.T326G:p.V109G	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.2746	0.3919	0.359225	1(thyroid)	1.127	11.36	0.217	-0.898	1.000	.	.	.	CDKN1B:uc001rat.2:exon1:c.T326G:p.V109G	-0.955	AFR:2(lung),AMR:1(stomach),EAS:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,BRCA-KR|1|50|0.02,ALL-US|1|150|0.00666667,FIN:0.3594,NFE:0.7208,OTH:0.1921,ASJ:MU4556981	600778	610755;	276152;	276152|MEN4|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|-|610755 ~	~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04151 PI3K-Akt signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko05162 Measles~ko05165 Human papillomavirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05226 Gastric cancer ~	,1973	.	.	0.047	0.27	0.000	1.67	12	2(haematopoietic_and_lymphoid_tissue)	0.2583
12	15656832	15656832	T	A	PTPRO	intronic	.	ENSG00000151490	rs4764199	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8496	0.8513	0.786342	0.8396	.	.	.	.	.	0.1606	0.498	.	.	.	AFR:0.7807,AMR:0.8198,EAS:0.6214,FIN:0.8987,NFE:0.8816,OTH:0.8668,ASJ:0.9007	600579	614196;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	12	MU12093012	hom
12	15733669	15733669	G	A	PTPRO	exonic	synonymous SNV	ENSG00000151490	rs3748299	ENSG00000151490:ENST00000542557:exon9:c.G519A:p.G173G,ENSG00000151490:ENST00000544244:exon9:c.G519A:p.G173G,ENSG00000151490:ENST00000442921:exon10:c.G603A:p.G201G,ENSG00000151490:ENST00000445537:exon10:c.G603A:p.G201G,ENSG00000151490:ENST00000348962:exon21:c.G2952A:p.G984G,ENSG00000151490:ENST00000281171:exon22:c.G3036A:p.G1012G	PTPRO:NM_030668:exon9:c.G519A:p.G173G,PTPRO:NM_030670:exon9:c.G519A:p.G173G,PTPRO:NM_030669:exon10:c.G603A:p.G201G,PTPRO:NM_030671:exon10:c.G603A:p.G201G,PTPRO:NM_002848:exon21:c.G2952A:p.G984G,PTPRO:NM_030667:exon22:c.G3036A:p.G1012G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0988	0.0810	0.132588	0.0858	.	.	.	.	.	.	.	.	PTPRO:uc001rcz.2:exon9:c.G519A:p.G173G,PTPRO:uc001rda.2:exon9:c.G519A:p.G173G,PTPRO:uc001rcx.2:exon10:c.G603A:p.G201G,PTPRO:uc001rcy.2:exon10:c.G603A:p.G201G,PTPRO:uc001rcw.2:exon21:c.G2952A:p.G984G,PTPRO:uc001rcv.2:exon22:c.G3036A:p.G1012G	.	AFR:0.0694,AMR:0.0621,EAS:0.3139,FIN:0.0386,NFE:0.0841,OTH:0.0767,ASJ:0.0728	600579	614196;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	12	MU12093552	het
12	18435399	18435401	CCC	-	PIK3C2G	exonic	nonframeshift deletion	ENSG00000139144	rs35277916	ENSG00000139144:ENST00000266497:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000538779:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000546003:exon1:c.384_386del:p.128_129del,ENSG00000139144:ENST00000433979:exon2:c.384_386del:p.128_129del,ENSG00000139144:ENST00000535651:exon2:c.384_386del:p.128_129del	PIK3C2G:NM_001288772:exon2:c.384_386del:p.128_129del,PIK3C2G:NM_004570:exon2:c.384_386del:p.128_129del	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.3732	0.3424	0.308307	0.3505	.	.	.	.	.	.	.	.	PIK3C2G:uc010sib.2:exon1:c.384_386del:p.128_129del,PIK3C2G:uc001rdt.3:exon2:c.384_386del:p.128_129del	.	AFR:0.2142,AMR:0.3759,EAS:0.2612,FIN:0.4338,NFE:0.4158,OTH:0.3887,ASJ:0.3758	609001	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	18435452	18435452	C	T	PIK3C2G	exonic	nonsynonymous SNV	ENSG00000139144	rs11044004	ENSG00000139144:ENST00000266497:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000538779:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000546003:exon1:c.C437T:p.P146L,ENSG00000139144:ENST00000433979:exon2:c.C437T:p.P146L,ENSG00000139144:ENST00000535651:exon2:c.C437T:p.P146L	PIK3C2G:NM_001288772:exon2:c.C437T:p.P146L,PIK3C2G:NM_004570:exon2:c.C437T:p.P146L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3865	0.3859	0.353235	2(haematopoietic_and_lymphoid_tissue)	0.582	8.028	0.047	3.9	0.050	.	.	.	PIK3C2G:uc010sib.2:exon1:c.C437T:p.P146L,PIK3C2G:uc001rdt.3:exon2:c.C437T:p.P146L	-1.054	AFR:18(lung),AMR:MU718438,EAS:0.3920,FIN:0.3533,NFE:0.3858,OTH:0.3841,ASJ:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	609001	.	.	.	.	.	.	.	0.003	1.22	0.000	1.5	12	1(large_intestine)	0.2627
12	18499777	18499777	C	G	PIK3C2G	intronic	.	ENSG00000139144	rs10770357	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	0.0002	0.032	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	609001	.	.	.	.	.	.	.	.	.	.	.	12	MU81920074	hom
12	18649057	18649057	C	T	PIK3C2G	exonic	nonsynonymous SNV	ENSG00000139144	rs12312266	ENSG00000139144:ENST00000266497:exon19:c.C2732T:p.P911L,ENSG00000139144:ENST00000433979:exon20:c.C2732T:p.P911L,ENSG00000139144:ENST00000538779:exon20:c.C2855T:p.P952L	PIK3C2G:NM_004570:exon20:c.C2732T:p.P911L,PIK3C2G:NM_001288772:exon21:c.C2855T:p.P952L,PIK3C2G:NM_001288774:exon21:c.C2189T:p.P730L	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0] 	0.3560	0.2933	0.374401	1(haematopoietic_and_lymphoid_tissue)	7.430	34	0.017	4.37	1.000	.	.	Protein kinase-like domain	PIK3C2G:uc001rdt.3:exon20:c.C2732T:p.P911L,PIK3C2G:uc010sib.2:exon20:c.C2855T:p.P952L,PIK3C2G:uc010sic.2:exon20:c.C2189T:p.P730L	-1.157	AFR:6(meninges),AMR:9(lung),EAS:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523,FIN:0.2980,NFE:0.4763,OTH:0.3210,ASJ:MU130618	609001	.	.	.	.	.	.	.	1.0	-1.55	0.000	3.08	12	1(large_intestine)	0.2384
12	18719939	18719939	A	G	PIK3C2G	exonic	nonsynonymous SNV	ENSG00000139144	rs563891575	ENSG00000139144:ENST00000266497:exon27:c.A3836G:p.D1279G,ENSG00000139144:ENST00000433979:exon28:c.A3836G:p.D1279G,ENSG00000139144:ENST00000538779:exon28:c.A3959G:p.D1320G	PIK3C2G:NM_004570:exon28:c.A3836G:p.D1279G,PIK3C2G:NM_001288772:exon29:c.A3959G:p.D1320G,PIK3C2G:NM_001288774:exon29:c.A3293G:p.D1098G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0] 	0.0021	.	0.00459265	6.457e-05	5.394	26.0	0.006	4.01	0.985	.	.	Phox homologous domain	PIK3C2G:uc001rdt.3:exon28:c.A3836G:p.D1279G,PIK3C2G:uc010sib.2:exon28:c.A3959G:p.D1320G,PIK3C2G:uc010sic.2:exon28:c.A3293G:p.D1098G	-0.907	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0020,ASJ:0	609001	.	.	.	.	.	.	.	1.0	1.16	0.138	2.595	12	.	het
12	18868668	18868668	G	C	PLCZ1	intronic	.	ENSG00000255648	rs11044266	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.264577	0.1957	.	.	.	.	.	.	.	.	.	.	AFR:0.1969,AMR:0.2852,EAS:0.3985,FIN:0.1641,NFE:0.1732,OTH:0.1878,ASJ:0.3278	608075	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	21011480	21011480	T	G	SLCO1B3;SLCO1B3-SLCO1B7	exonic	nonsynonymous SNV	ENSG00000111700;ENSG00000205754;ENSG00000257046	rs4149117	ENSG00000257046:ENST00000381541:exon3:c.T334G:p.S112A,ENSG00000257046:ENST00000540229:exon3:c.T334G:p.S112A,ENSG00000111700:ENST00000553473:exon3:c.T334G:p.S112A,ENSG00000205754:ENST00000554957:exon3:c.T334G:p.S112A,ENSG00000111700:ENST00000261196:exon4:c.T334G:p.S112A,ENSG00000111700:ENST00000540853:exon4:c.T334G:p.S112A,ENSG00000111700:ENST00000381545:exon5:c.T334G:p.S112A	SLCO1B3:NM_001349920:exon3:c.T250G:p.S84A,SLCO1B3-SLCO1B7:NM_001371097:exon3:c.T334G:p.S112A,SLCO1B3:NM_019844:exon5:c.T334G:p.S112A	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8045	0.7229	0.702476	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.800	9.463	1.0	3.99	0.885	.	.	Major facilitator superfamily domain	SLCO1B3:uc010sil.2:exon3:c.T334G:p.S112A,SLCO1B7:uc010sim.2:exon3:c.T334G:p.S112A,SLCO1B3:uc031qgp.1:exon4:c.T334G:p.S112A,SLCO1B3:uc001rel.4:exon5:c.T334G:p.S112A	-0.938	AFR:0.7021,AMR:0.4330,EAS:0.8841,FIN:0.7351,NFE:0.7477,OTH:0.8294,ASJ:0.8007	.	.	.	.	.	.	.	.	0.0	0.68	0.000	-1.73	12	1(haematopoietic_and_lymphoid_tissue)	0.7924
12	21013948	21013948	C	T	SLCO1B3;SLCO1B3-SLCO1B7	intronic	.	ENSG00000111700;ENSG00000205754;ENSG00000257046	rs3764009	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8066	0.7222	0.702276	0.7025	.	.	.	.	.	0.0003	0.02	.	.	.	AFR:0.4334,AMR:0.7998,EAS:0.7364,FIN:0.7469,NFE:0.8296,OTH:0.7929,ASJ:0.8841	.	.	.	.	.	.	.	.	.	.	.	.	12	MU12102388	hom
12	21015760	21015760	G	A	SLCO1B3;SLCO1B3-SLCO1B7	exonic	nonsynonymous SNV	ENSG00000111700;ENSG00000257046	rs7311358	ENSG00000111700:ENST00000544370:exon2:c.G171A:p.M57I,ENSG00000257046:ENST00000540229:exon6:c.G699A:p.M233I,ENSG00000111700:ENST00000553473:exon6:c.G699A:p.M233I,ENSG00000111700:ENST00000261196:exon7:c.G699A:p.M233I,ENSG00000111700:ENST00000540853:exon7:c.G699A:p.M233I,ENSG00000111700:ENST00000381545:exon8:c.G699A:p.M233I	SLCO1B3:NM_001349920:exon6:c.G615A:p.M205I,SLCO1B3-SLCO1B7:NM_001371097:exon6:c.G699A:p.M233I,SLCO1B3:NM_019844:exon8:c.G699A:p.M233I	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8044	0.7228	0.702476	COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	0.775	9.308	0.447	-2.0	0.910	.	.	Major facilitator superfamily domain	SLCO1B3:uc010sil.2:exon6:c.G699A:p.M233I,SLCO1B3:uc031qgp.1:exon7:c.G699A:p.M233I,SLCO1B3:uc001rel.4:exon8:c.G699A:p.M233I	-1.046	AFR:0.7024,AMR:0.4328,EAS:0.8833,FIN:0.7379,NFE:0.7470,OTH:0.8296,ASJ:0.8002	.	.	.	.	.	.	.	.	0.092	1.31	0.000	0.33	12	1(haematopoietic_and_lymphoid_tissue)	0.7933
12	21036411	21036411	A	G	SLCO1B3;SLCO1B3-SLCO1B7	exonic	synonymous SNV	ENSG00000111700;ENSG00000257046	rs2053098	ENSG00000111700:ENST00000544370:exon7:c.A1029G:p.A343A,ENSG00000257046:ENST00000540229:exon11:c.A1557G:p.A519A,ENSG00000111700:ENST00000553473:exon11:c.A1557G:p.A519A,ENSG00000111700:ENST00000261196:exon12:c.A1557G:p.A519A,ENSG00000111700:ENST00000381545:exon13:c.A1557G:p.A519A	SLCO1B3:NM_001349920:exon11:c.A1473G:p.A491A,SLCO1B3-SLCO1B7:NM_001371097:exon11:c.A1557G:p.A519A,SLCO1B3:NM_019844:exon13:c.A1557G:p.A519A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8047	0.7231	0.702875	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SLCO1B3:uc010sil.2:exon11:c.A1557G:p.A519A,SLCO1B3:uc001rel.4:exon13:c.A1557G:p.A519A	.	AFR:0.7023,AMR:0.4326,EAS:0.8841,FIN:0.7348,NFE:0.7468,OTH:0.8298,ASJ:0.8002	.	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.7904
12	21054369	21054369	G	A	SLCO1B3;SLCO1B3-SLCO1B7	exonic	synonymous SNV	ENSG00000111700;ENSG00000257046	rs3764006	ENSG00000111700:ENST00000544370:exon9:c.G1305A:p.G435G,ENSG00000257046:ENST00000540229:exon13:c.G1833A:p.G611G,ENSG00000111700:ENST00000553473:exon13:c.G1833A:p.G611G,ENSG00000111700:ENST00000261196:exon14:c.G1833A:p.G611G,ENSG00000111700:ENST00000381545:exon15:c.G1833A:p.G611G	SLCO1B3:NM_001349920:exon13:c.G1749A:p.G583G,SLCO1B3-SLCO1B7:NM_001371097:exon13:c.G1833A:p.G611G,SLCO1B3:NM_019844:exon15:c.G1833A:p.G611G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8182	0.7124	0.678714	COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	SLCO1B3:uc010sil.2:exon13:c.G1833A:p.G611G,SLCO1B3:uc001rel.4:exon15:c.G1833A:p.G611G	.	AFR:0.7044,AMR:0.3483,EAS:0.9172,FIN:0.7531,NFE:0.7802,OTH:0.8721,ASJ:0.7769	.	.	.	.	.	.	.	.	.	.	.	.	12	1(stomach)	0.8173
12	21327652	21327652	-	A	SLCO1B1	intronic	.	ENSG00000134538;ENSG00000257062	rs34728625	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0] 	0.4002	0.3504	0.370607	0.4005	.	.	.	.	.	.	.	.	.	.	AFR:0.2754,AMR:0.4601,EAS:0.4438,FIN:0.4279,NFE:0.4551,OTH:0.5057,ASJ:0.5296	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	.	.	.	.	.	.	.	12	.	hom
12	21331599	21331599	T	C	SLCO1B1	exonic	synonymous SNV	ENSG00000134538	rs4149057	ENSG00000134538:ENST00000256958:exon6:c.T571C:p.L191L	SLCO1B1:NM_006446:exon6:c.T571C:p.L191L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5260	0.4881	0.367412	0.4538	.	.	.	.	.	.	.	.	SLCO1B1:uc001req.4:exon6:c.T571C:p.L191L	.	AFR:0.2051,AMR:0.5287,EAS:0.2478,FIN:0.5014,NFE:0.5976,OTH:0.5194,ASJ:0.6424	604843	237450;	3111;	3111|Hyperbilirubinemia, Rotor type|<1 / 1 000 000|Autosomal recessive|All ages|237450 ~	.	.	.	.	.	.	.	.	12	MU139556	hom
12	21623122	21623122	T	G	PYROXD1;RECQL	UTR3	.	ENSG00000004700;ENSG00000121350	rs13035	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4280	0.3396	0.369409	0.3718	.	.	.	.	.	.	.	.	.	.	AFR:0.1470,AMR:0.4029,EAS:0.4245,FIN:0.5281,NFE:0.4527,OTH:0.4534,ASJ:0.5	.	.	.	.	.	.	.	.	.	.	.	.	12	MU12104130	het
12	21623179	21623179	T	C	RECQL	exonic	synonymous SNV	ENSG00000004700	rs17849408	ENSG00000004700:ENST00000444129:exon15:c.A1899G:p.Q633Q,ENSG00000004700:ENST00000421138:exon16:c.A1899G:p.Q633Q	RECQL:NM_002907:exon15:c.A1899G:p.Q633Q,RECQL:NM_032941:exon16:c.A1899G:p.Q633Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1116	0.0746	0.150759	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	RECQL:uc001rey.3:exon15:c.A1899G:p.Q633Q,RECQL:uc001rex.3:exon16:c.A1899G:p.Q633Q	.	AFR:0.1137,AMR:0.1254,EAS:0.1014,FIN:0.3388,NFE:0.0983,OTH:0.0868,ASJ:0.1220	600537	.	.	.	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.1048
12	21623284	21623284	-	AAAA	PYROXD1	UTR3	.	ENSG00000121350	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0181	.	.	0.0036	.	.	.	.	.	.	.	.	.	.	AFR:0.0008,AMR:0.0040,EAS:0.0202,FIN:0,NFE:0.0029,OTH:0.0107,ASJ:0	.	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	21623969	21623969	A	G	RECQL	exonic	synonymous SNV	ENSG00000004700	rs6500	ENSG00000004700:ENST00000444129:exon14:c.T1731C:p.N577N,ENSG00000004700:ENST00000421138:exon15:c.T1731C:p.N577N	RECQL:NM_002907:exon14:c.T1731C:p.N577N,RECQL:NM_032941:exon15:c.T1731C:p.N577N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1120	0.0990	0.151358	MU135242	.	.	.	.	.	.	.	.	RECQL:uc001rey.3:exon14:c.T1731C:p.N577N,RECQL:uc001rex.3:exon15:c.T1731C:p.N577N	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,AMR:0.1148,EAS:0.1220,FIN:0.1026,NFE:0.3414,OTH:0.1020,ASJ:0.1265	600537	.	.	.	.	.	.	.	.	.	.	.	12	2(haematopoietic_and_lymphoid_tissue)	0.0872
12	21644667	21644667	G	A	RECQL	intronic	.	ENSG00000004700	rs10841834	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4692	0.3667	0.373203	1(large_intestine)	.	.	.	.	.	.	.	.	.	.	AFR:1(liver),AMR:MU582602,EAS:0.3902,FIN:0.1789,NFE:0.4353,OTH:0.5232,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	600537	.	.	.	.	.	.	.	.	.	.	.	12	1(prostate)	0.4446
12	25368462	25368462	C	T	KRAS	exonic	synonymous SNV	ENSG00000133703	rs4362222	ENSG00000133703:ENST00000256078:exon5:c.G483A:p.R161R	KRAS:NM_001369786:exon5:c.G483A:p.R161R,KRAS:NM_033360:exon5:c.G483A:p.R161R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9995	0.9985	0.997604	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	KRAS:uc001rgp.1:exon5:c.G483A:p.R161R	.	AFR:0.9985,AMR:0.9948,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04113 Meiosis - yeast~ko04137 Mitophagy - animal~ko04138 Autophagy - yeast~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04214 Apoptosis - fly~ko04218 Cellular senescence~ko04320 Dorso-ventral axis formation~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	,7036,7029,7001,7028,7059,7052,7053,7030,7061,7006,7004,7064,7017,7024,6998,7021,7060,7044,7015,7056,7037,7027,7051,6840,7055,7054,6836,7014,7038,7058,7040,7010,7057,7050,7045,7039,7012,6835,6845,6999,7019,7023,6839,6837,7063,7035,7016,7005,7034,7022,7048,6842,7008,6843,7041,7042,7003,6844,7007,7025,7002,7009,7013,7031,7000,6841,7049,7032,6997,7043,7062,7033,7018,7047,7046,6838	.	,7020,7026,7011	.	.	.	.	12	4(meninges)	1
12	40619082	40619082	G	A	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs2256408	ENSG00000188906:ENST00000298910:exon1:c.G149A:p.R50H,ENSG00000188906:ENST00000343742:exon1:c.G149A:p.R50H	LRRK2:NM_198578:exon1:c.G149A:p.R50H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9911	0.9655	0.969249	0.9708	1.601	13.86	1.0	-1.31	0.559	0	0	Armadillo-like helical|Armadillo-type fold;Armadillo-type fold	LRRK2:uc001rmg.4:exon1:c.G149A:p.R50H	-0.974	AFR:0.8981,AMR:0.9916,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.0	0.7	0.000	-0.255	12	MU81922046	hom
12	40631791	40631791	T	C	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs10878245	ENSG00000188906:ENST00000298910:exon5:c.T457C:p.L153L,ENSG00000188906:ENST00000343742:exon5:c.T457C:p.L153L,ENSG00000188906:ENST00000416796:exon5:c.T244C:p.L82L	LRRK2:NM_198578:exon5:c.T457C:p.L153L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5263	0.5291	0.452875	LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	LRRK2:uc001rmg.4:exon5:c.T457C:p.L153L	.	AFR:0.5142,AMR:0.3922,EAS:0.5166,FIN:0.3601,NFE:0.5112,OTH:0.6100,ASJ:0.3612	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	1(prostate)	0.5297
12	40645257	40645257	C	A	LRRK2	intronic	.	ENSG00000188906	rs7955902	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3622	0.3182	0.319489	0.3368	.	.	.	.	.	0.0076	0.038	.	.	.	AFR:0.2174,AMR:0.2375,EAS:0.3544,FIN:0.3829,NFE:0.3978,OTH:0.3577,ASJ:0.3467	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU14313152	het
12	40681142	40681142	-	T	LRRK2	intronic	.	ENSG00000188906	rs397692808	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.4361	0.4043	0.386382	0.4133	.	.	.	.	.	.	.	.	.	.	AFR:0.3012,AMR:0.2763,EAS:0.355,FIN:0.4558,NFE:0.4821,OTH:0.4381,ASJ:0.3642	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	.	het
12	40688695	40688695	T	C	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs7966550	ENSG00000188906:ENST00000298910:exon22:c.T2857C:p.L953L,ENSG00000188906:ENST00000343742:exon22:c.T2857C:p.L953L	LRRK2:NM_198578:exon22:c.T2857C:p.L953L	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.1060	0.0949	0.0900559	0.0907	.	.	.	.	.	.	.	.	LRRK2:uc001rmh.1:exon13:c.T1723C:p.L575L,LRRK2:uc001rmg.4:exon22:c.T2857C:p.L953L	.	AFR:0.0277,AMR:0.1002,EAS:0.1694,FIN:0.0900,NFE:0.1186,OTH:0.0951,ASJ:0.0795	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU582631	het
12	40713834	40713834	C	A	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs1427263	ENSG00000188906:ENST00000298910:exon34:c.C4872A:p.G1624G	LRRK2:NM_198578:exon34:c.C4872A:p.G1624G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6781	0.6859	0.682907	0.7114	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon9:c.C1371A:p.G457G,LRRK2:uc009zjw.3:exon13:c.C1386A:p.G462G,LRRK2:uc001rmg.4:exon34:c.C4872A:p.G1624G	.	AFR:0.7787,AMR:0.7344,EAS:0.5075,FIN:0.7790,NFE:0.6787,OTH:0.7243,ASJ:0.5894	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU108484	het
12	40713873	40713873	A	G	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs11176013	ENSG00000188906:ENST00000298910:exon34:c.A4911G:p.K1637K	LRRK2:NM_198578:exon34:c.A4911G:p.K1637K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5734	0.5517	0.585663	0.5647	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon9:c.A1410G:p.K470K,LRRK2:uc009zjw.3:exon13:c.A1425G:p.K475K,LRRK2:uc001rmg.4:exon34:c.A4911G:p.K1637K	.	AFR:0.5966,AMR:0.6514,EAS:0.4805,FIN:0.5359,NFE:0.5579,OTH:0.5584,ASJ:0.5367	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU108500	het
12	40713901	40713901	T	A	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs11564148	ENSG00000188906:ENST00000298910:exon34:c.T4939A:p.S1647T	LRRK2:NM_198578:exon34:c.T4939A:p.S1647T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2983	0.2577	0.285942	0.2888	0.057	3.160	0.953	0.447	0.986	.	.	C-terminal of Roc (COR) domain	LRRK2:uc001rmi.3:exon9:c.T1438A:p.S480T,LRRK2:uc009zjw.3:exon13:c.T1453A:p.S485T,LRRK2:uc001rmg.4:exon34:c.T4939A:p.S1647T	-1.033	AFR:0.1896,AMR:0.2129,EAS:0.3543,FIN:0.3685,NFE:0.3254,OTH:0.3070,ASJ:0.2285	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.0	-0.61	0.000	0.39	12	MU4129146	het
12	40716260	40716260	T	C	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs10878371	ENSG00000188906:ENST00000298910:exon37:c.T5457C:p.G1819G	LRRK2:NM_198578:exon37:c.T5457C:p.G1819G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5733	0.5534	0.585264	0.5631	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon12:c.T1956C:p.G652G,LRRK2:uc009zjw.3:exon16:c.T1971C:p.G657G,LRRK2:uc001rmg.4:exon37:c.T5457C:p.G1819G	.	AFR:0.5938,AMR:0.6506,EAS:0.4783,FIN:0.5362,NFE:0.5567,OTH:0.5603,ASJ:0.5331	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU12139841	het
12	40742254	40742254	G	A	LRRK2	exonic	synonymous SNV	ENSG00000188906	rs10878405	ENSG00000188906:ENST00000298910:exon43:c.G6324A:p.E2108E	LRRK2:NM_198578:exon43:c.G6324A:p.E2108E	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3001	0.2561	0.273762	0.2919	.	.	.	.	.	.	.	.	LRRK2:uc001rmi.3:exon18:c.G2823A:p.E941E,LRRK2:uc009zjw.3:exon22:c.G2838A:p.E946E,LRRK2:uc001rmg.4:exon43:c.G6324A:p.E2108E	.	AFR:0.1564,AMR:0.2253,EAS:0.3550,FIN:0.3786,NFE:0.3455,OTH:0.3395,ASJ:0.2384	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU4129165	het
12	40753044	40753044	-	T	LRRK2	intronic	.	ENSG00000188906	rs111612315	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6216	0.6696	0.592252	0.7410	.	.	.	.	.	.	.	.	.	.	AFR:0.5599,AMR:0.6227,EAS:0.6724,FIN:0.7778,NFE:0.8499,OTH:0.8063,ASJ:0.8111	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	MU41962212	hom
12	40757187	40757187	T	-	LRRK2	intronic	.	ENSG00000188906	rs11317573	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.6319	.	0.551318	0.6344	.	.	.	.	.	.	.	.	.	.	AFR:0.5420,AMR:0.5242,EAS:0.4879,FIN:0.7517,NFE:0.6796,OTH:0.6883,ASJ:0.5993	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	.	.	.	.	12	.	het
12	40758652	40758652	T	C	LRRK2	exonic	nonsynonymous SNV	ENSG00000188906	rs3761863	ENSG00000188906:ENST00000298910:exon49:c.T7190C:p.M2397T	LRRK2:NM_198578:exon49:c.T7190C:p.M2397T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.6240	0.6123	0.551717	0.6344	-1.254	0.005	0.466	3.03	0.137	.	.	WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	LRRK2:uc001rmi.3:exon24:c.T3689C:p.M1230T,LRRK2:uc009zjw.3:exon28:c.T3704C:p.M1235T,LRRK2:uc001rmg.4:exon49:c.T7190C:p.M2397T	-0.923	AFR:0.5410,AMR:0.5193,EAS:0.4828,FIN:0.7524,NFE:0.6807,OTH:0.6914,ASJ:0.5993	609007	607060;	411602;	411602|Autosomal dominant late-onset Parkinson disease<br>LOPD|Unknown|Autosomal dominant|Adult<br>Elderly|168601 605543 607060 607688 614203 614251 616361 ~	.	.	.	.	0.0	-0.53	0.000	1.735	12	MU108529	het
12	46123606	46123606	C	G	ARID2	UTR5	.	ENSG00000189079	rs375590924	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0232	.	0.013778	0.0003	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.679e-05,OTH:0.0092,ASJ:0	609539	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	48375568	48375568	A	G	COL2A1	exonic	synonymous SNV	ENSG00000139219	rs1635553	ENSG00000139219:ENST00000337299:exon35:c.T2193C:p.N731N,ENSG00000139219:ENST00000380518:exon36:c.T2400C:p.N800N	COL2A1:NM_033150:exon35:c.T2193C:p.N731N,COL2A1:NM_001844:exon36:c.T2400C:p.N800N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4896	0.4528	0.482827	LAML-KR|2|205|0.0097561,COCA-CN|5|321|0.0155763,LINC-JP|2|394|0.00507614	.	.	.	.	.	.	.	.	COL2A1:uc001rqv.3:exon35:c.T2193C:p.N731N,COL2A1:uc001rqu.3:exon36:c.T2400C:p.N800N	.	AFR:0.4612,AMR:0.4612,EAS:0.4338,FIN:0.6179,NFE:0.3937,OTH:0.4698,ASJ:0.3230	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	1(thyroid)	0.4395
12	48376291	48376291	G	A	COL2A1	exonic	synonymous SNV	ENSG00000139219	rs2276454	ENSG00000139219:ENST00000337299:exon33:c.C2088T:p.G696G,ENSG00000139219:ENST00000380518:exon34:c.C2295T:p.G765G	COL2A1:NM_033150:exon33:c.C2088T:p.G696G,COL2A1:NM_001844:exon34:c.C2295T:p.G765G	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3958	0.3868	0.429712	0.3773	.	.	.	.	.	.	.	.	COL2A1:uc001rqv.3:exon33:c.C2088T:p.G696G,COL2A1:uc001rqu.3:exon34:c.C2295T:p.G765G	.	AFR:0.3455,AMR:0.3007,EAS:0.6190,FIN:0.3174,NFE:0.3877,OTH:0.3668,ASJ:0.4272	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	MU17231064	het
12	48380682	48380682	G	A	COL2A1	intronic	.	ENSG00000139219	rs10875714	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1960	0.2077	0.203674	0.1939	.	.	.	.	.	0	0	.	.	.	AFR:0.1711,AMR:0.1559,EAS:0.3414,FIN:0.1478,NFE:0.2047,OTH:0.1748,ASJ:0.2252	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	MU860285	het
12	48389643	48389643	A	C	COL2A1	intronic	.	ENSG00000139219	rs1034762	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7489	0.8209	0.682708	0.7858	.	.	.	.	.	.	.	.	.	.	AFR:0.7785,AMR:0.6062,EAS:0.5261,FIN:0.7533,NFE:0.8354,OTH:0.7782,ASJ:0.8146	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	MU12153333	het
12	48391416	48391416	G	T	COL2A1	exonic	synonymous SNV	ENSG00000139219	rs3737548	ENSG00000139219:ENST00000337299:exon6:c.C297A:p.G99G,ENSG00000139219:ENST00000380518:exon7:c.C504A:p.G168G	COL2A1:NM_033150:exon6:c.C297A:p.G99G,COL2A1:NM_001844:exon7:c.C504A:p.G168G	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2052	0.2014	0.219249	MU61690	.	.	.	.	.	.	.	.	COL2A1:uc001rqv.3:exon6:c.C297A:p.G99G,COL2A1:uc001rqu.3:exon7:c.C504A:p.G168G	.	AFR:LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,AMR:0.1925,EAS:0.1730,FIN:0.2333,NFE:0.3567,OTH:0.1533,ASJ:0.1589	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	1(thyroid)	0.2038
12	48398002	48398002	G	C	COL2A1	intronic	.	ENSG00000139219	rs3803184	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7712	0.7842	0.685903	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,LINC-JP|3|394|0.00761421	.	.	.	.	.	.	.	.	.	.	AFR:0.7536,AMR:0.6662,EAS:0.7947,FIN:0.6135,NFE:0.7450,OTH:0.8263,ASJ:0.6199	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.7848
12	48398080	48398080	T	A	COL2A1	exonic	nonsynonymous SNV	ENSG00000139219	rs3803183	ENSG00000139219:ENST00000337299:exon1:c.A25T:p.T9S,ENSG00000139219:ENST00000380518:exon1:c.A25T:p.T9S	COL2A1:NM_001844:exon1:c.A25T:p.T9S,COL2A1:NM_033150:exon1:c.A25T:p.T9S	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7726	0.7891	0.685304	COCA-CN|5|321|0.0155763	2.078	16.71	0.645	2.88	0.995	.	.	.	COL2A1:uc001rqu.3:exon1:c.A25T:p.T9S,COL2A1:uc001rqv.3:exon1:c.A25T:p.T9S	-0.948	AFR:0.7543,AMR:0.6675,EAS:0.7947,FIN:0.6134,NFE:0.7461,OTH:0.8267,ASJ:0.6193	120140	108300;132450;150600;151210;156550;183900;184250;200610;215150;271700;604864;608805;609162;609508;616583;	459051;209867;828;90653;137678;86820;93279;1856;1427;932;93296;93297;93346;94068;485;85166;2380;166011;828;90653;	459051|SED, Stanescu type|-|Autosomal dominant|-|616583 ~209867|-|<1 / 1 000 000|Autosomal dominant|Adult|609508 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~137678|-|<1 / 1 000 000|Autosomal dominant|Childhood|609162 ~86820|Familial osteonecrosis of the femoral head|Unknown|Autosomal dominant|Adult|608805 ~93279|-|-|Autosomal dominant|-|604864 ~1856|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy|271700 ~1427|OSMED|<1 / 1 000 000|Autosomal recessive|Neonatal|215150 ~932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93296|Achondrogenesis, Langer-Saldino type|Unknown|Autosomal dominant|Antenatal<br>Neonatal|200610 ~93297|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|200610 ~93346|-|<1 / 1 000 000|Autosomal dominant|-|184250 ~94068|Congenital spondyloepiphyseal dysplasia<br>SEDC<br>Spranger-Wiedemann disease|Unknown|Autosomal dominant|Neonatal|183900 ~485|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|156550 ~85166|PLSD-T<br>Platyspondylic dysplasia, Torrance-Luton type<br>Platyspondylic lethal skeletal dysplasia, Torrance type|Unknown|Autosomal dominant|Infancy<br>Neonatal|151210 ~2380|Aseptic necrosis of the capital femoral epiphysis<br>Osteochondritis of the capital femoral epiphysis<br>Osteochondrosis of the capital femoral epiphysis<br>Perthes disease|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Childhood|150600 ~166011|Multiple epiphyseal dysplasia-myopia-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|132450 ~828|Hereditary progressive arthroophthalmopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|108300 604841 609508 614134 614284 ~90653|-|-|Autosomal dominant|-|108300 609508 ~	.	.	.	.	0.0	-2.49	0.000	-0.345	12	1(thyroid)	0.7869
12	48399403	48399403	T	C	COL2A1;SENP1	intergenic	.	ENSG00000258203	rs1859444	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.702077	0.7673	.	.	.	.	.	.	.	.	.	.	AFR:0.7114,AMR:0.6196,EAS:0.6157,FIN:0.7464,NFE:0.8272,OTH:0.7883,ASJ:0.8	.	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	49416047	49416047	C	-	KMT2D	intronic	.	ENSG00000167548	rs34546217	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3221	0.2555	0.274561	0.2772	.	.	.	.	.	.	.	.	.	.	AFR:0.0802,AMR:0.2434,EAS:0.4504,FIN:0.3604,NFE:0.3514,OTH:0.3541,ASJ:0.2483	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU114556438	het
12	49424534	49424534	G	A	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs11168830	ENSG00000167548:ENST00000301067:exon41:c.C13689T:p.P4563P	KMT2D:NM_003482:exon41:c.C13689T:p.P4563P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0946	0.0381	0.122804	0.0611	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon41:c.C13689T:p.P4563P	.	AFR:0.0522,AMR:0.2470,EAS:0.2587,FIN:0.0678,NFE:0.0323,OTH:0.0676,ASJ:0.0762	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU112100	het
12	49425978	49425978	T	C	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs3741622	ENSG00000167548:ENST00000301067:exon39:c.A12510G:p.P4170P	KMT2D:NM_003482:exon39:c.A12510G:p.P4170P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3192	0.2507	0.275359	0.2777	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon39:c.A12510G:p.P4170P	.	AFR:0.0801,AMR:0.2464,EAS:0.4498,FIN:0.3607,NFE:0.3524,OTH:0.3525,ASJ:0.2483	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU582657	het
12	49427652	49427652	C	T	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs3782357	ENSG00000167548:ENST00000301067:exon39:c.G10836A:p.Q3612Q	KMT2D:NM_003482:exon39:c.G10836A:p.Q3612Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4616	0.4217	0.44349	0.4374	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon39:c.G10836A:p.Q3612Q	.	AFR:0.5324,AMR:0.3067,EAS:0.4504,FIN:0.4064,NFE:0.3999,OTH:0.4199,ASJ:0.2682	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118941	het
12	49434074	49434074	C	A	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs10747559	ENSG00000167548:ENST00000301067:exon31:c.G7479T:p.G2493G	KMT2D:NM_003482:exon31:c.G7479T:p.G2493G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4197	0.4165	0.435503	0.4423	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon31:c.G7479T:p.G2493G	.	AFR:0.4714,AMR:0.3377,EAS:0.4647,FIN:0.4266,NFE:0.4355,OTH:0.4448,ASJ:0.2914	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118954	het
12	49444545	49444545	G	A	KMT2D	exonic	synonymous SNV	ENSG00000167548	rs2241726	ENSG00000167548:ENST00000301067:exon11:c.C2826T:p.I942I	KMT2D:NM_003482:exon11:c.C2826T:p.I942I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3796	0.3854	0.403554	0.4069	.	.	.	.	.	.	.	.	KMT2D:uc001rta.4:exon11:c.C2826T:p.I942I	.	AFR:0.4267,AMR:0.3010,EAS:0.4382,FIN:0.4082,NFE:0.3998,OTH:0.4177,ASJ:0.2682	602113	147920;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	.	.	.	.	.	.	.	.	12	MU118972	het
12	52369300	52369300	C	T	ACVR1B	intronic	.	ENSG00000135503	rs2242106	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2887	0.2314	0.29353	1(liver)	.	.	.	.	.	.	.	.	.	.	AFR:MU673284,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,EAS:0.2294,FIN:0.5251,NFE:0.2053,OTH:0.2754,ASJ:0.2431	601300	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.2225
12	56079084	56079084	C	G	ITGA7	intronic	.	ENSG00000135424	rs3852533	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5841	0.4394	0.594649	0.5018	.	.	.	.	.	0.0001	0.038	.	.	.	AFR:0.2954,AMR:0.6400,EAS:0.9442,FIN:0.6297,NFE:0.5333,OTH:0.5684,ASJ:0.4536	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926243	het
12	56088773	56088773	C	T	ITGA7	intronic	.	ENSG00000135424	rs2293410	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5900	0.4380	0.589257	0.5015	.	.	.	.	.	.	.	.	.	.	AFR:0.2915,AMR:0.6379,EAS:0.9442,FIN:0.6311,NFE:0.5346,OTH:0.5647,ASJ:0.4463	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926272	het
12	56089357	56089357	C	T	ITGA7	exonic	nonsynonymous SNV	ENSG00000135424	rs1800974	ENSG00000135424:ENST00000257879:exon14:c.G1952A:p.R651H,ENSG00000135424:ENST00000347027:exon14:c.G1934A:p.R645H,ENSG00000135424:ENST00000394229:exon14:c.G1952A:p.R651H,ENSG00000135424:ENST00000394230:exon14:c.G1964A:p.R655H,ENSG00000135424:ENST00000452168:exon14:c.G1673A:p.R558H,ENSG00000135424:ENST00000553804:exon14:c.G1964A:p.R655H,ENSG00000135424:ENST00000257880:exon15:c.G2084A:p.R695H,ENSG00000135424:ENST00000555728:exon15:c.G2084A:p.R695H	ITGA7:NM_001367994:exon13:c.G608A:p.R203H,ITGA7:NM_001144996:exon14:c.G1964A:p.R655H,ITGA7:NM_001144997:exon14:c.G1673A:p.R558H,ITGA7:NM_002206:exon14:c.G1952A:p.R651H,ITGA7:NM_001367993:exon15:c.G1625A:p.R542H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5854	0.4513	0.599441	0.5134	2.355	18.52	0.281	-0.706	0.124	.	.	Integrin alpha-2|Integrin domain	ITGA7:uc009znx.3:exon12:c.G1595A:p.R532H,ITGA7:uc001shg.3:exon14:c.G1952A:p.R651H,ITGA7:uc001shh.3:exon14:c.G1964A:p.R655H,ITGA7:uc010sps.2:exon14:c.G1673A:p.R558H	-1.002	AFR:0.3328,AMR:0.6423,EAS:0.9455,FIN:0.6320,NFE:0.5344,OTH:0.5661,ASJ:0.45	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	0.0	0.84	0.000	0.345	12	MU4556768	het
12	56091617	56091617	A	G	ITGA7	intronic	.	ENSG00000135424	rs2293412	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6206	0.5648	0.702676	0.6065	.	.	.	.	.	0.0041	0	.	.	.	AFR:0.6506,AMR:0.6790,EAS:0.9524,FIN:0.6341,NFE:0.5370,OTH:0.5792,ASJ:0.4765	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU4326330	het
12	56096816	56096816	T	C	ITGA7	intronic	.	ENSG00000135424	rs2293413	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5902	0.4637	0.612021	0.5229	.	.	.	.	.	.	.	.	.	.	AFR:0.3660,AMR:0.6456,EAS:0.9431,FIN:0.6318,NFE:0.5344,OTH:0.5676,ASJ:0.48	600536	613204;	34520;	34520|Congenital muscular dystrophy with ITGA7 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|613204 ~	.	.	.	.	.	.	.	.	12	MU81926323	het
12	56477694	56477694	A	T	ERBB3	intronic	.	ENSG00000065361	rs2271194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6173	0.4955	0.592252	0.5370	.	.	.	.	.	0	0	.	.	.	AFR:0.3344,AMR:0.7279,EAS:0.7841,FIN:0.5922,NFE:0.6002,OTH:0.6074,ASJ:0.5199	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	MU28644046	het
12	56487560	56487560	A	T	ERBB3	exonic	nonsynonymous SNV	ENSG00000065361	rs146593760	ENSG00000065361:ENST00000267101:exon13:c.A1493T:p.K498I,ENSG00000065361:ENST00000551085:exon13:c.A1493T:p.K498I,ENSG00000065361:ENST00000415288:exon14:c.A1316T:p.K439I	ERBB3:NM_001982:exon13:c.A1493T:p.K498I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.0008	.	0.00139776	2(stomach)	2.504	19.49	0.394	2.87	1.000	.	.	Leucine-rich repeat domain, L domain-like|Receptor L-domain	ERBB3:uc001sjj.1:exon2:c.A197T:p.K66I,ERBB3:uc001sjh.3:exon13:c.A1493T:p.K498I,ERBB3:uc010sqc.2:exon14:c.A1316T:p.K439I	-1.036	AFR:.,AMR:.,EAS:0,FIN:0,NFE:0,OTH:0.0111,ASJ:0.0006	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	0.018	0.91	0.062	2.485	12	1(haematopoietic_and_lymphoid_tissue)	0
12	56493822	56493822	A	C	ERBB3	intronic	.	ENSG00000065361	rs2292238	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3612	0.3357	0.295128	MU12166149	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,AMR:0.3482,EAS:0.3914,FIN:0.4834,NFE:0.3468,OTH:0.3983,ASJ:0.1849	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	2(breast)	0.4231
12	56494991	56494991	G	A	ERBB3	exonic	synonymous SNV	ENSG00000065361	rs2271189	ENSG00000065361:ENST00000549832:exon5:c.G708A:p.R236R,ENSG00000065361:ENST00000553131:exon10:c.G1071A:p.R357R,ENSG00000065361:ENST00000550070:exon12:c.G1269A:p.R423R,ENSG00000065361:ENST00000450146:exon14:c.G1419A:p.R473R,ENSG00000065361:ENST00000267101:exon27:c.G3348A:p.R1116R,ENSG00000065361:ENST00000415288:exon28:c.G3171A:p.R1057R	ERBB3:NM_001982:exon27:c.G3348A:p.R1116R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3417	0.3101	0.252196	75(meninges)	.	.	.	.	.	.	.	.	ERBB3:uc001sjl.3:exon5:c.G708A:p.R236R,ERBB3:uc001sjk.3:exon10:c.G1071A:p.R357R,ERBB3:uc009zok.3:exon12:c.G1143A:p.R381R,ERBB3:uc010sqb.2:exon14:c.G1419A:p.R473R,ERBB3:uc001sjh.3:exon27:c.G3348A:p.R1116R,ERBB3:uc010sqc.2:exon28:c.G3171A:p.R1057R	.	AFR:MU82274902,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.1251,FIN:0.3744,NFE:0.4195,OTH:0.3222,ASJ:0.3256	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	12	3(lung)	0.3949
12	56495047	56495047	A	G	ERBB3	exonic	nonsynonymous SNV	ENSG00000065361	rs779413213	ENSG00000065361:ENST00000549832:exon5:c.A764G:p.Q255R,ENSG00000065361:ENST00000553131:exon10:c.A1127G:p.Q376R,ENSG00000065361:ENST00000550070:exon12:c.A1325G:p.Q442R,ENSG00000065361:ENST00000450146:exon14:c.A1475G:p.Q492R,ENSG00000065361:ENST00000267101:exon27:c.A3404G:p.Q1135R,ENSG00000065361:ENST00000415288:exon28:c.A3227G:p.Q1076R	ERBB3:NM_001982:exon27:c.A3404G:p.Q1135R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 0] 	8.244e-06	.	.	.	5.373	25.9	0.005	6.17	1.000	.	.	.	ERBB3:uc001sjl.3:exon5:c.A764G:p.Q255R,ERBB3:uc001sjk.3:exon10:c.A1127G:p.Q376R,ERBB3:uc009zok.3:exon12:c.A1199G:p.Q400R,ERBB3:uc010sqb.2:exon14:c.A1475G:p.Q492R,ERBB3:uc001sjh.3:exon27:c.A3404G:p.Q1135R,ERBB3:uc010sqc.2:exon28:c.A3227G:p.Q1076R	0.159	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	190151	607598;	137776;	137776|LCCS2<br>Multiple contracture syndrome, Israeli-Bedouin type|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|607598 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04151 PI3K-Akt signaling pathway~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	0.996	-1.2	0.550	0.805	12	.	het
12	57496710	57496710	G	A	STAT6	intronic	.	ENSG00000166888	rs147704041	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0056	0.0004	0.00978435	0.0031	.	.	.	.	.	0.0001	0.018	.	.	.	AFR:0.0006,AMR:0.0283,EAS:0.0387,FIN:0,NFE:0,OTH:0.0021,ASJ:0	601512	.	.	.	~ko04217 Necroptosis~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	12	.	het
12	57499258	57499258	C	T	STAT6	exonic	nonsynonymous SNV	ENSG00000166888	rs118014438	ENSG00000166888:ENST00000538913:exon6:c.G475A:p.V159I,ENSG00000166888:ENST00000537215:exon7:c.G475A:p.V159I,ENSG00000166888:ENST00000300134:exon8:c.G805A:p.V269I,ENSG00000166888:ENST00000454075:exon8:c.G805A:p.V269I,ENSG00000166888:ENST00000543873:exon8:c.G805A:p.V269I,ENSG00000166888:ENST00000556155:exon8:c.G805A:p.V269I	STAT6:NM_001178081:exon6:c.G475A:p.V159I,STAT6:NM_001178080:exon7:c.G475A:p.V159I,STAT6:NM_001178078:exon8:c.G805A:p.V269I,STAT6:NM_001178079:exon8:c.G805A:p.V269I,STAT6:NM_003153:exon8:c.G805A:p.V269I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0055	0.0004	0.00938498	0.0031	2.340	18.43	0.265	3.36	0.954	.	.	STAT transcription factor, coiled coil;STAT transcription factor, coiled coil|p53-like transcription factor, DNA-binding	STAT6:uc010srd.2:exon6:c.G475A:p.V159I,STAT6:uc010srb.2:exon7:c.G475A:p.V159I,STAT6:uc010src.2:exon7:c.G475A:p.V159I,STAT6:uc001sna.3:exon8:c.G805A:p.V269I,STAT6:uc009zpe.3:exon8:c.G805A:p.V269I,STAT6:uc009zpf.3:exon8:c.G805A:p.V269I,STAT6:uc009zpg.3:exon8:c.G952A:p.V318I	-1.088	AFR:0.0008,AMR:0.0251,EAS:0.0402,FIN:0,NFE:0,OTH:0.0020,ASJ:0	601512	.	.	.	~ko04217 Necroptosis~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	0.012	0.24	0.031	1.985	12	.	het
12	57500108	57500108	T	C	STAT6	exonic	synonymous SNV	ENSG00000166888	rs117195019	ENSG00000166888:ENST00000538913:exon5:c.A216G:p.L72L,ENSG00000166888:ENST00000537215:exon6:c.A216G:p.L72L,ENSG00000166888:ENST00000300134:exon7:c.A546G:p.L182L,ENSG00000166888:ENST00000454075:exon7:c.A546G:p.L182L,ENSG00000166888:ENST00000543873:exon7:c.A546G:p.L182L,ENSG00000166888:ENST00000556155:exon7:c.A546G:p.L182L	STAT6:NM_001178081:exon5:c.A216G:p.L72L,STAT6:NM_001178080:exon6:c.A216G:p.L72L,STAT6:NM_001178078:exon7:c.A546G:p.L182L,STAT6:NM_001178079:exon7:c.A546G:p.L182L,STAT6:NM_003153:exon7:c.A546G:p.L182L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0025	.	0.00499201	0.0020	.	.	.	.	.	.	.	.	STAT6:uc010srd.2:exon5:c.A216G:p.L72L,STAT6:uc010srb.2:exon6:c.A216G:p.L72L,STAT6:uc010src.2:exon6:c.A216G:p.L72L,STAT6:uc001sna.3:exon7:c.A546G:p.L182L,STAT6:uc009zpe.3:exon7:c.A546G:p.L182L,STAT6:uc009zpf.3:exon7:c.A546G:p.L182L,STAT6:uc009zpg.3:exon7:c.A693G:p.L231L	.	AFR:0,AMR:0,EAS:0.0382,FIN:0,NFE:0,OTH:0,ASJ:0	601512	.	.	.	~ko04217 Necroptosis~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05200 Pathways in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	12	.	het
12	57864321	57864321	G	T	GLI1	exonic	nonsynonymous SNV	ENSG00000111087	rs147997893	ENSG00000111087:ENST00000528467:exon10:c.G1675T:p.G559C,ENSG00000111087:ENST00000543426:exon10:c.G1414T:p.G472C,ENSG00000111087:ENST00000546141:exon11:c.G1675T:p.G559C,ENSG00000111087:ENST00000228682:exon12:c.G1798T:p.G600C	GLI1:NM_001160045:exon10:c.G1414T:p.G472C,GLI1:NM_001167609:exon11:c.G1675T:p.G559C,GLI1:NM_005269:exon12:c.G1798T:p.G600C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 1, 0] 	0.0002	0.0002	.	3.232e-05	4.673	24.5	0.076	0.809	0.587	.	.	.	GLI1:uc009zpq.3:exon10:c.G1414T:p.G472C,GLI1:uc021qzi.1:exon11:c.G1675T:p.G559C,GLI1:uc001snx.3:exon12:c.G1798T:p.G600C	-1.124	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	165220	.	.	.	~ko04024 cAMP signaling pathway~ko04340 Hedgehog signaling pathway~ko05200 Pathways in cancer~ko05217 Basal cell carcinoma ~	.	.	.	0.958	2.47	0.058	2.38	12	.	het
12	57911160	57911160	G	A	DDIT3	exonic	synonymous SNV	ENSG00000175197	rs697221	ENSG00000175197:ENST00000552740:exon2:c.C99T:p.F33F,ENSG00000175197:ENST00000346473:exon3:c.C30T:p.F10F,ENSG00000175197:ENST00000547303:exon3:c.C30T:p.F10F,ENSG00000175197:ENST00000547526:exon3:c.C99T:p.F33F,ENSG00000175197:ENST00000551116:exon3:c.C99T:p.F33F	DDIT3:NM_001195056:exon2:c.C99T:p.F33F,DDIT3:NM_001195053:exon3:c.C99T:p.F33F,DDIT3:NM_001195054:exon3:c.C99T:p.F33F,DDIT3:NM_001195055:exon3:c.C99T:p.F33F,DDIT3:NM_001195057:exon3:c.C30T:p.F10F,DDIT3:NM_004083:exon3:c.C30T:p.F10F	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1669	0.1698	0.201478	11(soft_tissue)	1.445	13.03	.	-7.58	0.981	.	.	.	DDIT3:uc009zps.3:exon2:c.C99T:p.F33F,DDIT3:uc001soi.3:exon3:c.C30T:p.F10F,DDIT3:uc009zpt.3:exon3:c.C99T:p.F33F,DDIT3:uc021qzj.1:exon3:c.C30T:p.F10F,DDIT3:uc021qzk.1:exon3:c.C99T:p.F33F,DDIT3:uc021qzl.1:exon3:c.C99T:p.F33F	.	AFR:MU12167322,AMR:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,EAS:0.2187,FIN:0.1184,NFE:0.1623,OTH:0.3096,ASJ:0.1920	126337	613488;	69078;99967;	69078|-|Unknown|Unknown|All ages|613488 ~99967|MRCLS|Unknown|Not applicable|Adult|613488 ~	~ko04010 MAPK signaling pathway~ko04141 Protein processing in endoplasmic reticulum~ko04210 Apoptosis~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.2355
12	65514266	65514266	T	C	WIF1	exonic	synonymous SNV	ENSG00000156076	rs7301320	ENSG00000156076:ENST00000546001:exon1:c.A33G:p.A11A,ENSG00000156076:ENST00000286574:exon2:c.A219G:p.A73A	WIF1:NM_007191:exon2:c.A219G:p.A73A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7765	0.7476	0.824081	0.7638	.	.	.	.	.	.	.	.	WIF1:uc001ssk.3:exon2:c.A219G:p.A73A	.	AFR:0.7632,AMR:0.7005,EAS:0.9981,FIN:0.7507,NFE:0.7451,OTH:0.7612,ASJ:0.7881	605186	.	.	.	.	.	.	.	.	.	.	.	12	MU81927819	hom
12	66308644	66308644	A	G	HMGA2	exonic	nonsynonymous SNV	ENSG00000149948	rs10878345	ENSG00000149948:ENST00000536545:exon4:c.A394G:p.R132G	HMGA2:NM_001300919:exon4:c.A394G:p.R132G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4869	.	0.417732	COCA-CN|2|321|0.00623053	-0.460	0.275	1.0	-0.47	0.003	.	.	.	HMGA2:uc001ssu.1:exon4:c.A394G:p.R132G	-0.904	AFR:0.3533,AMR:0.6060,EAS:0.2881,FIN:0.2729,NFE:0.2328,OTH:0.2503,ASJ:0.3122	600698	150699;	.	.	~ko05202 Transcriptional misregulation in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	0.003	1.2	0.000	.	12	8(upper_aerodigestive_tract)	0.3027
12	88454594	88454594	-	A	CEP290	intronic	.	ENSG00000198707	rs11405846	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.8612	0.7616	0.761581	0.7892	.	.	.	.	.	.	.	.	.	.	AFR:0.4244,AMR:0.9159,EAS:0.9685,FIN:0.9578,NFE:0.9262,OTH:0.9165,ASJ:0.8885	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	88483273	88483273	A	-	CEP290	intronic	.	ENSG00000198707	rs10717563	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9161	0.8720	0.873602	0.8910	.	.	.	.	.	.	.	.	.	.	AFR:0.7273,AMR:0.9426,EAS:0.9852,FIN:0.9845,NFE:0.9472,OTH:0.9499,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	88505078	88505078	T	C	CEP290	exonic	synonymous SNV	ENSG00000198707	rs2468255	ENSG00000198707:ENST00000604024:exon14:c.A1527G:p.S509S,ENSG00000198707:ENST00000309041:exon22:c.A2274G:p.S758S,ENSG00000198707:ENST00000552810:exon22:c.A2268G:p.S756S	CEP290:NM_025114:exon22:c.A2268G:p.S756S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8888	0.7713	0.764577	0.7923	.	.	.	.	.	.	.	.	CEP290:uc001tat.3:exon14:c.A1647G:p.S549S,CEP290:uc001tar.3:exon22:c.A2268G:p.S756S	.	AFR:0.4264,AMR:0.9199,EAS:0.9746,FIN:0.9595,NFE:0.9282,OTH:0.9194,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	MU81929253	hom
12	88522823	88522823	-	C	CEP290	intronic	.	ENSG00000198707	rs71082425	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9284	0.8705	0.873602	0.8899	.	.	.	.	.	.	.	.	.	.	AFR:0.7247,AMR:0.9415,EAS:0.9856,FIN:0.9846,NFE:0.9472,OTH:0.9489,ASJ:0.8907	610142	610188;610189;611134;611755;615991;	110;65;564;3156;2318;	110|BBS|1-9 / 1 000 000|Oligogenic<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|209900 600151 605231 615981 615982 615983 615984 615985 615986 615987 615988 615989 615990 615991 615992 615993 615994 615995 615996 617119 ~65|Amaurosis congenita of Leber|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|179900 204000 204100 604232 604393 604537 608553 610612 611755 612712 613341 613826 613829 613835 613837 613843 614186 615360 ~564|Meckel-Gruber syndrome|<1 / 1 000 000|Autosomal recessive|Antenatal|249000 603194 607361 611134 611561 612284 613885 614175 614209 615397 ~3156|Nephronophthisis with retinal dystrophy<br>Renal dysplasia-retinal aplasia syndrome<br>SLSN|<1 / 1 000 000|Autosomal recessive|Childhood|266900 606995 606996 609254 610189 613615 614845 616307 616629 ~2318|Arima syndrome<br>CORS<br>Cerebello-oculo-renal syndrome<br>Dekaban-Arima syndrome<br>JS type B<br>JS-OR<br>Joubert syndrome with Senior-Loken syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|243910 608091 610188 612285 614424 614465 614844 ~	.	.	.	.	.	.	.	.	12	.	hom
12	89743223	89743223	G	A	DUSP6	exonic	synonymous SNV	ENSG00000139318	rs704075	ENSG00000139318:ENST00000308385:exon2:c.C516T:p.D172D,ENSG00000139318:ENST00000547291:exon2:c.C579T:p.D193D,ENSG00000139318:ENST00000279488:exon3:c.C954T:p.D318D	DUSP6:NM_022652:exon2:c.C516T:p.D172D,DUSP6:NM_001946:exon3:c.C954T:p.D318D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9965	0.9882	0.985024	0.9884	.	.	.	.	.	.	.	.	DUSP6:uc001taz.3:exon2:c.C516T:p.D172D,DUSP6:uc001tay.3:exon3:c.C954T:p.D318D	.	AFR:0.9594,AMR:0.9976,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	602748	615269;	432;478;	432|Gonadotropic deficiency<br>Isolated congenital gonadotropin deficiency<br>Normosmic idiopathic hypogonadotropic hypogonadism<br>nIHH|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|146110 147950 244200 308700 610628 612370 612702 614837 614838 614839 614840 614841 614842 614858 614880 615266 615269 615270 ~478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	~ko04010 MAPK signaling pathway~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	12	MU81929270	hom
12	89745477	89745477	C	A	DUSP6	exonic	nonsynonymous SNV	ENSG00000139318	rs2279574	ENSG00000139318:ENST00000279488:exon1:c.G340T:p.V114L,ENSG00000139318:ENST00000308385:exon1:c.G340T:p.V114L,ENSG00000139318:ENST00000548755:exon2:c.G340T:p.V114L	DUSP6:NM_001946:exon1:c.G340T:p.V114L,DUSP6:NM_022652:exon1:c.G340T:p.V114L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5378	0.4316	0.466254	COCA-CN|5|321|0.0155763	3.920	23.5	0.014	5.09	0.966	.	.	Rhodanese-like domain	DUSP6:uc001tay.3:exon1:c.G340T:p.V114L,DUSP6:uc001taz.3:exon1:c.G340T:p.V114L	-0.909	AFR:0.4826,AMR:0.2928,EAS:0.5433,FIN:0.6555,NFE:0.6344,OTH:0.5332,ASJ:0.4988	602748	615269;	432;478;	432|Gonadotropic deficiency<br>Isolated congenital gonadotropin deficiency<br>Normosmic idiopathic hypogonadotropic hypogonadism<br>nIHH|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Multigenic/multifactorial|Infancy<br>Neonatal|146110 147950 244200 308700 610628 612370 612702 614837 614838 614839 614840 614841 614842 614858 614880 615266 615269 615270 ~478|Congenital hypogonadotropic hypogonadism with anosmia<br>Olfacto-genital pathological sequence|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|147950 244200 308700 610628 612370 612702 614837 614838 614840 614858 614880 614897 615266 615267 615269 615270 615271 616030 ~	~ko04010 MAPK signaling pathway~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	0.086	2.06	0.000	1.525	12	1(thyroid)	0.5348
12	93803873	93803873	C	A	UBE2N	intronic	.	ENSG00000177889	rs141176920	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0064	0.0046	0.00339457	0.0079	.	.	.	.	.	.	.	.	.	.	AFR:0.0017,AMR:0.0072,EAS:0,FIN:0.0229,NFE:0.0089,OTH:0.0071,ASJ:0.0132	603679	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	102875569	102875569	A	G	IGF1;LINC00485	intergenic	.	ENSG00000017427;ENSG00000257254	rs35767	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.696286	0.7437	.	.	.	.	.	.	.	.	.	.	AFR:0.5698,AMR:0.7513,EAS:0.6484,FIN:0.8014,NFE:0.8411,OTH:0.7927,ASJ:0.7886	.	.	.	.	.	.	.	.	.	.	.	.	12	MU19938323	het
12	104373728	104373728	-	A	TDG	exonic	frameshift insertion	ENSG00000139372	rs151041931	ENSG00000139372:ENST00000392872:exon3:c.287dupA:p.E96fs,ENSG00000139372:ENST00000537100:exon3:c.287dupA:p.E96fs,ENSG00000139372:ENST00000266775:exon4:c.275dupA:p.E92fs,ENSG00000139372:ENST00000436021:exon4:c.212dupA:p.E71fs	TDG:NM_003211:exon3:c.287dupA:p.E96fs	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4489	0.4450	0.472244	0.4495	.	.	.	.	.	.	.	.	TDG:uc001tkg.3:exon3:c.287dupA:p.E96fs,TDG:uc010swh.1:exon3:c.287dupA:p.E96fs,TDG:uc009zuk.3:exon4:c.275dupA:p.E92fs	.	AFR:0.4909,AMR:0.4854,EAS:0.4795,FIN:0.4457,NFE:0.4199,OTH:0.4259,ASJ:0.4409	601423	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	104379506	104379506	-	TTGAGAGC	TDG	exonic	frameshift insertion	ENSG00000139372	rs765686214	ENSG00000139372:ENST00000542036:exon6:c.478_479insTTGAGAGC:p.I160fs,ENSG00000139372:ENST00000544861:exon8:c.661_662insTTGAGAGC:p.I221fs,ENSG00000139372:ENST00000392872:exon9:c.1090_1091insTTGAGAGC:p.I364fs,ENSG00000139372:ENST00000266775:exon10:c.1078_1079insTTGAGAGC:p.I360fs	TDG:NM_001363612:exon8:c.661_662insTTGAGAGC:p.I221fs,TDG:NM_003211:exon9:c.1090_1091insTTGAGAGC:p.I364fs	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0120	.	.	0.0101	.	.	.	.	.	.	.	.	TDG:uc010swj.2:exon6:c.454_455insTTGAGAGC:p.I152fs,TDG:uc010swi.2:exon8:c.661_662insTTGAGAGC:p.I221fs,TDG:uc001tkg.3:exon9:c.1090_1091insTTGAGAGC:p.I364fs,TDG:uc009zuk.3:exon10:c.1078_1079insTTGAGAGC:p.I360fs	.	AFR:0.0139,AMR:0.0120,EAS:0.0105,FIN:0.0149,NFE:0.0069,OTH:0.0094,ASJ:0.0074	601423	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	104379508	104379508	-	GGAGTTAAGAGGAGAATCAGCTTTCAGTGGCATTCCTA	TDG	splicing	.	ENSG00000139372	rs749286024	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0003	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601423	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	109577735	109577735	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs2878960	ENSG00000076555:ENST00000377848:exon1:c.C525T:p.S175S,ENSG00000076555:ENST00000377854:exon1:c.C525T:p.S175S,ENSG00000076555:ENST00000338432:exon2:c.C525T:p.S175S	ACACB:NM_001093:exon2:c.C525T:p.S175S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5578	0.5455	0.397764	1(lung)	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon1:c.C525T:p.S175S,ACACB:uc001tob.3:exon2:c.C525T:p.S175S	.	AFR:1(thyroid),AMR:2(large_intestine),EAS:LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,FIN:0.5347,NFE:0.2944,OTH:0.4222,ASJ:MU4553372	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(breast)	0.6126
12	109605730	109605730	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs4766516	ENSG00000076555:ENST00000377848:exon3:c.C816T:p.A272A,ENSG00000076555:ENST00000377854:exon3:c.C816T:p.A272A,ENSG00000076555:ENST00000544726:exon3:c.C210T:p.A70A,ENSG00000076555:ENST00000338432:exon4:c.C816T:p.A272A	ACACB:NM_001093:exon4:c.C816T:p.A272A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2280	0.1571	0.231629	MU668362	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon3:c.C816T:p.A272A,ACACB:uc001tob.3:exon4:c.C816T:p.A272A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.1855,EAS:0.2506,FIN:0.2550,NFE:0.5685,OTH:0.2227,ASJ:0.0723	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.1947
12	109617865	109617865	T	C	ACACB	exonic	synonymous SNV	ENSG00000076555	rs11065772	ENSG00000076555:ENST00000377848:exon10:c.T1791C:p.D597D,ENSG00000076555:ENST00000377854:exon10:c.T1791C:p.D597D,ENSG00000076555:ENST00000338432:exon11:c.T1791C:p.D597D	ACACB:NM_001093:exon11:c.T1791C:p.D597D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7715	0.7400	0.677316	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon10:c.T1791C:p.D597D,ACACB:uc001tob.3:exon11:c.T1791C:p.D597D	.	AFR:0.7444,AMR:0.5579,EAS:0.9067,FIN:0.7333,NFE:0.8340,OTH:0.8309,ASJ:0.6587	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(thyroid)	0.7996
12	109623516	109623516	G	A	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs2300455	ENSG00000076555:ENST00000377848:exon11:c.G1951A:p.A651T,ENSG00000076555:ENST00000377854:exon11:c.G1951A:p.A651T,ENSG00000076555:ENST00000338432:exon12:c.G1951A:p.A651T	ACACB:NM_001093:exon12:c.G1951A:p.A651T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1889	0.1462	0.159545	MU724553	4.805	24.8	0.052	4.44	0.968	.	.	Biotin carboxylase, C-terminal|Biotin carboxylation domain|Rudiment single hybrid motif	ACACB:uc001toc.3:exon11:c.G1951A:p.A651T,ACACB:uc001tob.3:exon12:c.G1951A:p.A651T	-1.256	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,AMR:0.1528,EAS:0.1706,FIN:0.2384,NFE:0.2976,OTH:0.1759,ASJ:0.0404	601557	.	.	.	.	.	.	.	1.0	-1.67	0.000	2.06	12	3(large_intestine)	0.1927
12	109625976	109625976	-	TCCT	ACACB	intronic	.	ENSG00000076555	rs764603674	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0021	.	.	0.0439	.	.	.	.	.	.	.	.	.	.	AFR:0.0418,AMR:0.0996,EAS:0.0601,FIN:0.0363,NFE:0.0424,OTH:0.0483,ASJ:0.0230	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU111834241	het
12	109629457	109629457	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs7135947	ENSG00000076555:ENST00000377848:exon13:c.C2184T:p.G728G,ENSG00000076555:ENST00000377854:exon13:c.C2184T:p.G728G,ENSG00000076555:ENST00000338432:exon14:c.C2184T:p.G728G	ACACB:NM_001093:exon14:c.C2184T:p.G728G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4891	0.4450	0.38139	3(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	ACACB:uc001toc.3:exon13:c.C2184T:p.G728G,ACACB:uc001tob.3:exon14:c.C2184T:p.G728G	.	AFR:MU4553399,AMR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.2543,FIN:0.5361,NFE:0.5397,OTH:0.2611,ASJ:0.4447	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(thyroid)	0.5198
12	109637188	109637188	G	C	ACACB	intronic	.	ENSG00000076555	rs7299171	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5686	0.6176	0.571086	0.5994	.	.	.	.	.	.	.	.	.	.	AFR:0.7023,AMR:0.5863,EAS:0.2957,FIN:0.5544,NFE:0.5851,OTH:0.5767,ASJ:0.5927	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU12049097	het
12	109670468	109670468	T	C	ACACB	intronic	.	ENSG00000076555	rs3742027	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8819	0.9263	0.866414	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.022	.	.	.	AFR:0.9149,AMR:0.9797,EAS:0.9040,FIN:0.7463,NFE:0.8896,OTH:0.9024,ASJ:0.9308	601557	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.8857
12	109675029	109675029	T	C	ACACB	exonic	synonymous SNV	ENSG00000076555	rs2241220	ENSG00000076555:ENST00000543201:exon6:c.T504C:p.L168L,ENSG00000076555:ENST00000377854:exon32:c.T4296C:p.L1432L,ENSG00000076555:ENST00000377848:exon33:c.T4506C:p.L1502L,ENSG00000076555:ENST00000338432:exon34:c.T4506C:p.L1502L	ACACB:NM_001093:exon34:c.T4506C:p.L1502L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8239	0.8030	0.779153	0.8114	.	.	.	.	.	.	.	.	ACACB:uc010sxm.2:exon7:c.T504C:p.L168L,ACACB:uc001toc.3:exon33:c.T4506C:p.L1502L,ACACB:uc001tob.3:exon34:c.T4506C:p.L1502L	.	AFR:0.7388,AMR:0.8914,EAS:0.7469,FIN:0.8231,NFE:0.8507,OTH:0.8340,ASJ:0.8642	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU16253196	hom
12	109693982	109693982	C	T	ACACB	exonic	synonymous SNV	ENSG00000076555	rs3742023	ENSG00000076555:ENST00000543201:exon17:c.C2202T:p.H734H,ENSG00000076555:ENST00000377854:exon43:c.C5994T:p.H1998H,ENSG00000076555:ENST00000377848:exon44:c.C6204T:p.H2068H,ENSG00000076555:ENST00000338432:exon45:c.C6204T:p.H2068H	ACACB:NM_001093:exon45:c.C6204T:p.H2068H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3267	0.2893	0.255192	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	ACACB:uc010sxm.2:exon18:c.C2202T:p.H734H,ACACB:uc001toc.3:exon44:c.C6204T:p.H2068H,ACACB:uc001tob.3:exon45:c.C6204T:p.H2068H	.	AFR:0.3050,AMR:0.1502,EAS:0.3775,FIN:0.2780,NFE:0.4404,OTH:0.3594,ASJ:0.3505	601557	.	.	.	.	.	.	.	.	.	.	.	12	5(large_intestine)	0.3501
12	109696838	109696838	G	A	ACACB	exonic	nonsynonymous SNV	ENSG00000076555	rs2075260	ENSG00000076555:ENST00000543201:exon19:c.G2419A:p.V807I,ENSG00000076555:ENST00000377854:exon45:c.G6211A:p.V2071I,ENSG00000076555:ENST00000377848:exon46:c.G6421A:p.V2141I,ENSG00000076555:ENST00000338432:exon47:c.G6421A:p.V2141I	ACACB:NM_001093:exon47:c.G6421A:p.V2141I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7891	0.7810	0.738818	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	2.067	16.64	1.0	5.07	0.992	.	.	Acetyl-CoA carboxylase|Acetyl-coenzyme A carboxyltransferase, C-terminal|ClpP/crotonase-like domain	ACACB:uc010sxm.2:exon20:c.G2419A:p.V807I,ACACB:uc001toc.3:exon46:c.G6421A:p.V2141I,ACACB:uc001tob.3:exon47:c.G6421A:p.V2141I	-0.903	AFR:0.7894,AMR:0.7096,EAS:0.8642,FIN:0.7373,NFE:0.8456,OTH:0.8210,ASJ:0.8711	601557	.	.	.	.	.	.	.	0.002	-4.36	0.000	-3.51	12	1(lung)	0.8084
12	109704177	109704177	G	A	ACACB	UTR3	.	ENSG00000076555	rs2075262	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4828	0.5209	0.359824	0.5063	.	.	.	.	.	.	.	.	.	.	AFR:0.4857,AMR:0.4833,EAS:0.3697,FIN:0.5662,NFE:0.5204,OTH:0.4877,ASJ:0.56	601557	.	.	.	.	.	.	.	.	.	.	.	12	MU668314	het
12	110019338	110019338	C	T	MVK	exonic	synonymous SNV	ENSG00000110921	rs2287218	ENSG00000110921:ENST00000228510:exon5:c.C510T:p.D170D,ENSG00000110921:ENST00000539335:exon5:c.C510T:p.D170D,ENSG00000110921:ENST00000546277:exon5:c.C510T:p.D170D	MVK:NM_000431:exon5:c.C510T:p.D170D,MVK:NM_001114185:exon5:c.C510T:p.D170D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1618	0.1776	0.163339	0.1668	.	.	.	.	.	.	.	.	MVK:uc021rdo.1:exon4:c.C510T:p.D170D,MVK:uc001toy.4:exon5:c.C510T:p.D170D,MVK:uc009zvk.3:exon5:c.C510T:p.D170D	.	AFR:0.1924,AMR:0.1527,EAS:0.1493,FIN:0.1060,NFE:0.1711,OTH:0.1339,ASJ:0.1623	251170	175900;260920;610377;	29;343;735;79152;	29|Complete mevalonate kinase deficiency<br>MVA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|610377 ~343|HIDS<br>Hyper-IgD syndrome<br>Hyperimmunoglobinemia D with recurrent fever<br>Hyperimmunoglobulinemia D syndrome<br>Partial mevalonate kinase deficiency|Unknown|Autosomal recessive|Infancy|260920 ~735|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|175800 175900 ~79152|-|Unknown|Autosomal dominant|Adult|175900 607728 612293 612353 614714 616063 616631 ~	.	.	.	.	.	.	.	.	12	MU663414	het
12	110024541	110024541	A	G	MVK	intronic	.	ENSG00000110921	rs2270375	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2339	0.2720	0.228634	0.2532	.	.	.	.	.	.	.	.	.	.	AFR:0.3150,AMR:0.2088,EAS:0.1681,FIN:0.1790,NFE:0.2505,OTH:0.2026,ASJ:0.2119	251170	175900;260920;610377;	29;343;735;79152;	29|Complete mevalonate kinase deficiency<br>MVA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|610377 ~343|HIDS<br>Hyper-IgD syndrome<br>Hyperimmunoglobinemia D with recurrent fever<br>Hyperimmunoglobulinemia D syndrome<br>Partial mevalonate kinase deficiency|Unknown|Autosomal recessive|Infancy|260920 ~735|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|175800 175900 ~79152|-|Unknown|Autosomal dominant|Adult|175900 607728 612293 612353 614714 616063 616631 ~	.	.	.	.	.	.	.	.	12	MU21446883	het
12	110029186	110029186	G	A	MVK	intronic	.	ENSG00000110921	rs2270374	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1490	0.1289	0.111422	MU28687517	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|2|409|0.00488998,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.1214,EAS:0.1384,FIN:0.1623,NFE:0.1506,OTH:0.1062,ASJ:0.0331	251170	175900;260920;610377;	29;343;735;79152;	29|Complete mevalonate kinase deficiency<br>MVA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|610377 ~343|HIDS<br>Hyper-IgD syndrome<br>Hyperimmunoglobinemia D with recurrent fever<br>Hyperimmunoglobulinemia D syndrome<br>Partial mevalonate kinase deficiency|Unknown|Autosomal recessive|Infancy|260920 ~735|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|175800 175900 ~79152|-|Unknown|Autosomal dominant|Adult|175900 607728 612293 612353 614714 616063 616631 ~	.	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.1711
12	111353556	111353556	A	G	MYL2	exonic	synonymous SNV	ENSG00000111245	rs2301610	ENSG00000111245:ENST00000228841:exon3:c.T132C:p.I44I	MYL2:NM_000432:exon3:c.T132C:p.I44I	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1025	0.0764	0.115216	0.0931	.	.	.	.	.	.	.	.	MYL2:uc001trx.4:exon2:c.T75C:p.I25I,MYL2:uc001try.4:exon3:c.T132C:p.I44I	.	AFR:0.0700,AMR:0.0513,EAS:0.2432,FIN:0.1064,NFE:0.0908,OTH:0.0898,ASJ:0.0464	160781	608758;	.	.	.	.	.	.	.	.	.	.	12	MU121128	het
12	112036754	112036756	GCT	-	ATXN2	exonic	nonframeshift deletion	ENSG00000204842	rs10560189	ENSG00000204842:ENST00000377617:exon1:c.563_565del:p.188_189del,ENSG00000204842:ENST00000550104:exon1:c.563_565del:p.188_189del,ENSG00000204842:ENST00000608853:exon1:c.83_85del:p.28_29del	ATXN2:NM_002973:exon1:c.83_85del:p.28_29del	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.5912	0.9081	0.951078	0.8379	.	.	.	.	.	.	.	.	ATXN2:uc001tsj.3:exon1:c.563_565del:p.188_189del	.	AFR:0.6558,AMR:0.8634,EAS:0.9291,FIN:0.9112,NFE:0.9045,OTH:0.8974,ASJ:0.9148	601517	168600;183090;	98756;	98756|SCA2|1-9 / 100 000|Autosomal dominant|All ages|183090 ~	.	.	.	.	.	.	.	.	12	.	unknown
12	112036797	112036797	C	T	ATXN2	exonic	synonymous SNV	ENSG00000204842	rs4098854	ENSG00000204842:ENST00000377617:exon1:c.G522A:p.Q174Q,ENSG00000204842:ENST00000550104:exon1:c.G522A:p.Q174Q,ENSG00000204842:ENST00000608853:exon1:c.G42A:p.Q14Q	ATXN2:NM_002973:exon1:c.G42A:p.Q14Q	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6209	.	0.656749	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ATXN2:uc001tsj.3:exon1:c.G522A:p.Q174Q	.	AFR:0.7523,AMR:0.7127,EAS:0.8596,FIN:0.6469,NFE:0.7924,OTH:0.7792,ASJ:0.7054	601517	168600;183090;	98756;	98756|SCA2|1-9 / 100 000|Autosomal dominant|All ages|183090 ~	.	.	.	.	.	.	.	.	12	1(large_intestine)	0.7306
12	118463653	118463653	-	T	RFC5	intronic	.	ENSG00000111445	rs762856035	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0978	.	.	0.0957	.	.	.	.	.	.	.	.	.	.	AFR:0.0300,AMR:0.1538,EAS:0.1095,FIN:0.0733,NFE:0.1316,OTH:0.1261,ASJ:0.1767	600407	.	.	.	.	.	.	.	.	.	.	.	12	MU111829293	het
12	118464688	118464688	A	G	RFC5	intronic	.	ENSG00000111445	rs5745870	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3610	0.3278	0.409545	0.3382	.	.	.	.	.	0.0006	0.008	.	.	.	AFR:0.3623,AMR:0.3717,EAS:0.5155,FIN:0.3209,NFE:0.3070,OTH:0.3452,ASJ:0.3311	600407	.	.	.	.	.	.	.	.	.	.	.	12	MU12062845	hom
12	121416622	121416622	C	G	HNF1A	exonic	synonymous SNV	ENSG00000135100	rs1169289	ENSG00000135100:ENST00000257555:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000400024:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000402929:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000538626:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000538646:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000540108:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000541395:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000541924:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000544413:exon1:c.C51G:p.L17L,ENSG00000135100:ENST00000544574:exon1:c.C51G:p.L17L	HNF1A:NM_000545:exon1:c.C51G:p.L17L,HNF1A:NM_001306179:exon1:c.C51G:p.L17L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4722	0.4175	0.428514	MU94809	.	.	.	.	.	.	.	.	HNF1A:uc001tze.2:exon1:c.C51G:p.L17L,HNF1A:uc001tzf.3:exon1:c.C51G:p.L17L,HNF1A:uc001tzg.3:exon1:c.C51G:p.L17L,HNF1A:uc010szn.2:exon1:c.C51G:p.L17L,HNF1A:uc021rez.1:exon1:c.C51G:p.L17L,HNF1A:uc021rfa.1:exon1:c.C51G:p.L17L	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,AMR:0.4253,EAS:0.4713,FIN:0.5533,NFE:0.3823,OTH:0.4897,ASJ:0.3333	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	12	15(liver)	0.4598
12	121416650	121416650	A	C	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs1169288	ENSG00000135100:ENST00000257555:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000400024:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000402929:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000538646:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000540108:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000541395:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000541924:exon1:c.A79C:p.I27L,ENSG00000135100:ENST00000544413:exon1:c.A79C:p.I27L	HNF1A:NM_000545:exon1:c.A79C:p.I27L,HNF1A:NM_001306179:exon1:c.A79C:p.I27L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.3533	0.2625	0.298522	4(prostate)	5.234	25.6	0.082	4.45	0.999	.	.	Hepatocyte nuclear factor 1, N-terminal|Hepatocyte nuclear factor 1, dimerisation domain	HNF1A:uc001tze.2:exon1:c.A79C:p.I27L,HNF1A:uc001tzf.3:exon1:c.A79C:p.I27L,HNF1A:uc001tzg.3:exon1:c.A79C:p.I27L,HNF1A:uc010szn.2:exon1:c.A79C:p.I27L,HNF1A:uc021rfa.1:exon1:c.A79C:p.I27L	-1.199	AFR:10(soft_tissue),AMR:1(urinary_tract),EAS:COCA-CN|4|321|0.0124611,FIN:0.2924,NFE:0.1228,OTH:0.3648,ASJ:MU94794	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.02	-4.99	0.000	2.125	12	1(large_intestine)	0.43
12	121432117	121432117	G	C	HNF1A	exonic	synonymous SNV	ENSG00000135100	rs56348580	ENSG00000135100:ENST00000538646:exon3:c.G677C:p.G226A	HNF1A:NM_000545:exon4:c.G864C:p.G288G,HNF1A:NM_001306179:exon4:c.G864C:p.G288G	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2788	0.2358	0.18111	13(meninges)	.	.	.	.	.	.	.	.	HNF1A:uc021rfb.1:exon3:c.G480C:p.G160G,HNF1A:uc001tze.2:exon4:c.G864C:p.G288G,HNF1A:uc001tzf.3:exon4:c.G864C:p.G288G,HNF1A:uc001tzg.3:exon4:c.G864C:p.G288G,HNF1A:uc010szn.2:exon4:c.G864C:p.G288G,HNF1A:uc021rfa.1:exon4:c.G864C:p.G288G	.	AFR:MU28769429,AMR:LUSC-KR|1|170|0.00588235,EAS:0.2079,FIN:0.4201,NFE:0.3167,OTH:0.0006,ASJ:0.2484	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	12	1(lung)	0.2733
12	121435342	121435342	C	T	HNF1A	exonic	synonymous SNV	ENSG00000135100	rs2259820	ENSG00000135100:ENST00000535955:exon2:c.C91T:p.L31L,ENSG00000135100:ENST00000538626:exon2:c.C121T:p.L41L,ENSG00000135100:ENST00000257555:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000400024:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000541395:exon7:c.C1375T:p.L459L,ENSG00000135100:ENST00000544413:exon7:c.C1375T:p.L459L	HNF1A:NM_000545:exon7:c.C1375T:p.L459L,HNF1A:NM_001306179:exon7:c.C1375T:p.L459L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3368	0.2464	0.316693	1(large_intestine)	.	.	.	.	.	.	.	.	HNF1A:uc021rey.1:exon2:c.C22T:p.L8L,HNF1A:uc021rez.1:exon2:c.C121T:p.L41L,HNF1A:uc021rex.1:exon3:c.C163T:p.L55L,HNF1A:uc021rfb.1:exon6:c.C991T:p.L331L,HNF1A:uc001tzf.3:exon7:c.C1375T:p.L459L,HNF1A:uc001tzg.3:exon7:c.C1375T:p.L459L,HNF1A:uc010szn.2:exon7:c.C1375T:p.L459L,HNF1A:uc021rfa.1:exon7:c.C1375T:p.L459L	.	AFR:MU4605555,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874,EAS:0.1214,FIN:0.3624,NFE:0.4533,OTH:0.4839,ASJ:0.2679	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	.	.	.	12	1(urinary_tract)	0.3200
12	121435427	121435427	G	A	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs2464196	ENSG00000135100:ENST00000535955:exon2:c.G176A:p.S59N,ENSG00000135100:ENST00000538626:exon2:c.G206A:p.S69N,ENSG00000135100:ENST00000257555:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000400024:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000541395:exon7:c.G1460A:p.S487N,ENSG00000135100:ENST00000544413:exon7:c.G1460A:p.S487N	HNF1A:NM_000545:exon7:c.G1460A:p.S487N,HNF1A:NM_001306179:exon7:c.G1460A:p.S487N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3465	0.2473	0.317692	1(thymus)	1.856	15.32	0.111	3.53	0.998	.	.	Hepatocyte nuclear factor 1, beta isoform, C-terminal	HNF1A:uc021rey.1:exon2:c.G107A:p.S36N,HNF1A:uc021rez.1:exon2:c.G206A:p.S69N,HNF1A:uc021rex.1:exon3:c.G248A:p.S83N,HNF1A:uc021rfb.1:exon6:c.G1076A:p.S359N,HNF1A:uc001tzf.3:exon7:c.G1460A:p.S487N,HNF1A:uc001tzg.3:exon7:c.G1460A:p.S487N,HNF1A:uc010szn.2:exon7:c.G1460A:p.S487N,HNF1A:uc021rfa.1:exon7:c.G1460A:p.S487N	-1.097	AFR:1(large_intestine),AMR:MU30045786,EAS:0.2682,FIN:0.1233,NFE:0.3628,OTH:0.4536,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	-4.39	0.000	1.1	12	11(soft_tissue)	0.4839
12	121435475	121435475	G	A	HNF1A	intronic	.	ENSG00000135100	rs2464195	ENSG00000135100:ENST00000535955:exon2:c.G224A:p.R75H,ENSG00000135100:ENST00000538626:exon2:c.G254A:p.R85H,ENSG00000135100:ENST00000400024:exon7:c.G1508A:p.R503H	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4347	0.2901	0.359625	0.3080	-0.684	0.078	.	-8.98	0.005	0	0.002	.	HNF1A:uc021rey.1:exon2:c.G155A:p.R52H,HNF1A:uc021rez.1:exon2:c.G254A:p.R85H,HNF1A:uc021rex.1:exon3:c.G296A:p.R99H,HNF1A:uc001tzf.3:exon7:c.G1508A:p.R503H	-1.027	AFR:0.1407,AMR:0.4069,EAS:0.4851,FIN:0.3794,NFE:0.3552,OTH:0.3867,ASJ:0.5	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	.	0.000	.	12	MU30045803	het
12	121437221	121437221	T	C	HNF1A	intronic	.	ENSG00000135100	rs1169304	ENSG00000135100:ENST00000541395:exon8:c.T1652C:p.L551S	.	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8145	0.7439	0.776957	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	-0.395	0.398	0.046	-10.8	0.000	.	.	.	HNF1A:uc021rfa.1:exon8:c.T1652C:p.L551S	-0.976	AFR:0.7423,AMR:0.5893,EAS:0.8808,FIN:0.8666,NFE:0.8200,OTH:0.7835,ASJ:0.8986	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	.	-5.3	0.000	.	12	18(meninges)	0.8170
12	121437382	121437382	A	G	HNF1A	exonic	nonsynonymous SNV	ENSG00000135100	rs1169305	ENSG00000135100:ENST00000541395:exon8:c.A1813G:p.S605G,ENSG00000135100:ENST00000257555:exon9:c.A1720G:p.S574G,ENSG00000135100:ENST00000544413:exon9:c.A1741G:p.S581G	HNF1A:NM_000545:exon9:c.A1720G:p.S574G,HNF1A:NM_001306179:exon9:c.A1741G:p.S581G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9958	0.9869	0.985224	0.9870	0.272	5.414	0.779	2.58	0.047	.	.	Hepatocyte nuclear factor 1, alpha isoform C-terminal	HNF1A:uc021rfa.1:exon8:c.A1813G:p.S605G,HNF1A:uc021rfb.1:exon8:c.A1336G:p.S446G,HNF1A:uc001tzg.3:exon9:c.A1720G:p.S574G,HNF1A:uc010szn.2:exon9:c.A1741G:p.S581G	-0.950	AFR:0.9548,AMR:0.9940,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	142410	125853;142330;144700;222100;600496;612520;	552;422526;	552|Maturity-onset diabetes of the young|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood<br>Adolescent<br>Adult|125850 125851 600496 606391 606392 606394 609812 610508 612225 613370 613375 616329 616511 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~	.	.	.	.	0.0	-2.86	0.000	.	12	MU81933200	hom
12	121840360	121840360	-	A	RNF34	intronic	.	ENSG00000170633	rs201268373	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.262181	0.2284	.	.	.	.	.	.	.	.	.	.	AFR:0.5201,AMR:0.1097,EAS:0.1062,FIN:0.1158,NFE:0.1008,OTH:0.1361,ASJ:0.0821	608299	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	121867928	121867928	C	T	KDM2B	exonic	synonymous SNV	ENSG00000089094;ENSG00000170633	rs372455591	ENSG00000170633:ENST00000392464:exon7:c.C1155T:p.S385S,ENSG00000089094:ENST00000377069:exon23:c.G3789A:p.G1263G	KDM2B:NM_001005366:exon23:c.G3789A:p.G1263G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0018	.	0.00539137	9.683e-05	.	.	.	.	.	.	.	.	KDM2B:uc001uaq.3:exon13:c.G2365A:p.G789R	.	AFR:0,AMR:0,EAS:0.0018,FIN:0,NFE:0,OTH:0,ASJ:0	609078	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	121878659	121878659	C	T	KDM2B	exonic	synonymous SNV	ENSG00000089094	rs1064951	ENSG00000089094:ENST00000542973:exon11:c.G1674A:p.Q558Q,ENSG00000089094:ENST00000377069:exon20:c.G3363A:p.Q1121Q,ENSG00000089094:ENST00000377071:exon21:c.G3570A:p.Q1190Q	KDM2B:NM_001005366:exon20:c.G3363A:p.Q1121Q,KDM2B:NM_032590:exon21:c.G3570A:p.Q1190Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3833	0.3160	0.334465	1(breast)	.	.	.	.	.	.	.	.	KDM2B:uc001uao.3:exon6:c.G1314A:p.Q438Q,KDM2B:uc010szx.2:exon6:c.G1314A:p.Q438Q,KDM2B:uc001uaq.3:exon10:c.G1890A:p.Q630Q,KDM2B:uc010szy.2:exon10:c.G1890A:p.Q630Q,KDM2B:uc001uar.3:exon11:c.G2343A:p.Q781Q,KDM2B:uc001uas.3:exon20:c.G3363A:p.Q1121Q,KDM2B:uc021rfd.1:exon20:c.G3363A:p.Q1121Q,KDM2B:uc001uat.3:exon21:c.G3570A:p.Q1190Q,KDM2B:uc021rfe.1:exon21:c.G3570A:p.Q1190Q	.	AFR:2(large_intestine),AMR:MU111083,EAS:0.3629,FIN:0.2031,NFE:0.4451,OTH:0.4233,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	609078	.	.	.	.	.	.	.	.	.	.	.	12	1(lung)	0.4635
12	121880520	121880520	G	A	KDM2B	exonic	synonymous SNV	ENSG00000089094	rs3751131	ENSG00000089094:ENST00000542973:exon9:c.C828T:p.D276D,ENSG00000089094:ENST00000377069:exon18:c.C2517T:p.D839D,ENSG00000089094:ENST00000377071:exon19:c.C2724T:p.D908D	KDM2B:NM_001005366:exon18:c.C2517T:p.D839D,KDM2B:NM_032590:exon19:c.C2724T:p.D908D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4126	0.3174	0.334465	0.3623	.	.	.	.	.	.	.	.	KDM2B:uc001uao.3:exon4:c.C468T:p.D156D,KDM2B:uc010szx.2:exon4:c.C468T:p.D156D,KDM2B:uc001uaq.3:exon8:c.C1044T:p.D348D,KDM2B:uc010szy.2:exon8:c.C1044T:p.D348D,KDM2B:uc001uar.3:exon9:c.C1497T:p.D499D,KDM2B:uc001uas.3:exon18:c.C2517T:p.D839D,KDM2B:uc021rfd.1:exon18:c.C2517T:p.D839D,KDM2B:uc001uat.3:exon19:c.C2724T:p.D908D,KDM2B:uc021rfe.1:exon19:c.C2724T:p.D908D	.	AFR:0.2014,AMR:0.4451,EAS:0.4637,FIN:0.4951,NFE:0.4041,OTH:0.4252,ASJ:0.4218	609078	.	.	.	.	.	.	.	.	.	.	.	12	MU111111	hom
12	121881848	121881848	G	A	KDM2B	exonic	synonymous SNV	ENSG00000089094	rs10849885	ENSG00000089094:ENST00000542973:exon6:c.C522T:p.Y174Y,ENSG00000089094:ENST00000377069:exon16:c.C2325T:p.Y775Y,ENSG00000089094:ENST00000377071:exon16:c.C2418T:p.Y806Y	KDM2B:NM_001005366:exon16:c.C2325T:p.Y775Y,KDM2B:NM_032590:exon16:c.C2418T:p.Y806Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3738	0.3083	0.322883	1(large_intestine)	.	.	.	.	.	.	.	.	KDM2B:uc001uao.3:exon1:c.C162T:p.Y54Y,KDM2B:uc010szx.2:exon1:c.C162T:p.Y54Y,KDM2B:uc001uaq.3:exon5:c.C738T:p.Y246Y,KDM2B:uc010szy.2:exon5:c.C738T:p.Y246Y,KDM2B:uc001uar.3:exon6:c.C1191T:p.Y397Y,KDM2B:uc001uas.3:exon16:c.C2325T:p.Y775Y,KDM2B:uc001uat.3:exon16:c.C2418T:p.Y806Y,KDM2B:uc021rfd.1:exon16:c.C2325T:p.Y775Y,KDM2B:uc021rfe.1:exon16:c.C2418T:p.Y806Y	.	AFR:MU111126,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.1965,FIN:0.4330,NFE:0.4040,OTH:0.4591,ASJ:0.3563	609078	.	.	.	.	.	.	.	.	.	.	.	12	1(haematopoietic_and_lymphoid_tissue)	0.4920
12	121882098	121882098	T	G	MIR7107	ncRNA_exonic	.	ENSG00000089094	rs3817551	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3855	0.3172	0.335264	0.3638	.	.	.	.	.	.	.	.	.	.	AFR:0.2038,AMR:0.4448,EAS:0.4653,FIN:0.4957,NFE:0.4056,OTH:0.4262,ASJ:0.4238	609078	.	.	.	.	.	.	.	.	.	.	.	12	MU28546880	hom
12	121987563	121987563	A	G	KDM2B	intronic	.	ENSG00000089094	rs113672052	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0165	0.0177	0.0327476	0.0167	.	.	.	.	.	.	.	.	.	.	AFR:0.0410,AMR:0.0084,EAS:0.0037,FIN:0.0026,NFE:0.0082,OTH:0.0092,ASJ:0.0132	609078	.	.	.	.	.	.	.	.	.	.	.	12	.	het
12	122762763	122762763	-	AA	CLIP1	intronic	.	ENSG00000130779	rs3066171	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2663	.	.	0.3475	.	.	.	.	.	.	.	.	.	.	AFR:0.2724,AMR:0.2883,EAS:0.7166,FIN:0.3460,NFE:0.3470,OTH:0.3646,ASJ:0.3640	179838	.	.	.	.	.	.	.	.	.	.	.	12	.	unknown
12	122807369	122807369	A	C	CLIP1	intronic	.	ENSG00000256304	rs868181	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.436901	0.5076	.	.	.	.	.	.	.	.	.	.	AFR:0.1974,AMR:0.5286,EAS:0.3930,FIN:0.7046,NFE:0.6419,OTH:0.6367,ASJ:0.6490	179838	.	.	.	.	.	.	.	.	.	.	.	12	.	hom
12	122807572	122807572	C	T	CLIP1	intronic	.	ENSG00000256304	rs11057522	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.436502	0.5075	.	.	.	.	.	.	.	.	.	.	AFR:0.1971,AMR:0.5288,EAS:0.3904,FIN:0.7040,NFE:0.6422,OTH:0.6378,ASJ:0.6490	179838	.	.	.	.	.	.	.	.	.	.	.	12	MU27354982	hom
12	122812503	122812503	G	C	CLIP1	exonic	nonsynonymous SNV	ENSG00000130779	rs1129167	ENSG00000130779:ENST00000545889:exon12:c.C1965G:p.D655E,ENSG00000130779:ENST00000302528:exon15:c.C3207G:p.D1069E,ENSG00000130779:ENST00000361654:exon15:c.C2874G:p.D958E,ENSG00000130779:ENST00000537178:exon15:c.C3102G:p.D1034E,ENSG00000130779:ENST00000358808:exon16:c.C3207G:p.D1069E,ENSG00000130779:ENST00000540338:exon16:c.C3240G:p.D1080E	CLIP1:NM_198240:exon15:c.C3102G:p.D1034E,CLIP1:NM_002956:exon16:c.C3207G:p.D1069E,CLIP1:NM_001247997:exon17:c.C3240G:p.D1080E	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.5625	0.4683	0.40655	MU12068476	-0.563	0.154	0.428	0.728	0.376	.	.	.	CLIP1:uc001ucj.1:exon12:c.C1965G:p.D655E,CLIP1:uc001uci.1:exon15:c.C3102G:p.D1034E,CLIP1:uc001uch.1:exon16:c.C3207G:p.D1069E,CLIP1:uc001ucg.2:exon17:c.C3240G:p.D1080E	-0.930	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,AMR:0.4857,EAS:0.5191,FIN:0.6324,NFE:0.3775,OTH:0.7017,ASJ:0.1444	179838	.	.	.	.	.	.	.	0.0	1.26	0.000	0.145	12	4(lung)	0.6316
12	124144395	124144395	A	G	GTF2H3	exonic	synonymous SNV	ENSG00000111358	rs1051793	ENSG00000111358:ENST00000543415:exon10:c.A592G:p.S198G	GTF2H3:NM_001271866:exon9:c.A609G:p.P203P,GTF2H3:NM_001271867:exon10:c.A615G:p.P205P,GTF2H3:NM_001271868:exon10:c.A300G:p.P100P,GTF2H3:NM_001516:exon11:c.A738G:p.P246P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3648	0.4673	0.351038	0.4285	.	.	.	.	.	.	.	.	GTF2H3:uc031qkd.1:exon9:c.A609G:p.P203P,GTF2H3:uc010tau.2:exon10:c.A615G:p.P205P,GTF2H3:uc031qkc.1:exon10:c.A300G:p.P100P,GTF2H3:uc001ufo.2:exon11:c.A738G:p.P246P	.	AFR:0.6014,AMR:0.2993,EAS:0.0692,FIN:0.3079,NFE:0.409,OTH:0.3520,ASJ:0.3377	601750	.	.	.	~ko03022 Basal transcription factors~ko03420 Nucleotide excision repair~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	12	MU666011	het
12	133233705	133233705	T	C	POLE	intronic	.	ENSG00000177084	rs5744889	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9712	0.9729	0.983826	0.9764	.	.	.	.	.	.	.	.	.	.	AFR:0.9929,AMR:0.9749,EAS:1,FIN:0.9625,NFE:0.9678,OTH:0.9694,ASJ:0.9868	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU81935649	hom
12	133252796	133252796	C	G	POLE	intronic	.	ENSG00000177084	rs4077170	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6307	0.6821	0.571685	0.6435	.	.	.	.	.	0.0001	0.018	.	.	.	AFR:0.6422,AMR:0.5251,EAS:0.3015,FIN:0.6059,NFE:0.6933,OTH:0.6436,ASJ:0.8133	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU13664180	hom
12	133263825	133263825	G	A	POLE	intronic	.	ENSG00000177084	rs2075784	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4901	.	0.378794	0.4355	.	.	.	.	.	.	.	.	.	.	AFR:0.2512,AMR:0.3955,EAS:0.2926,FIN:0.5271,NFE:0.5325,OTH:0.5011,ASJ:0.61	174762	615083;615139;	352712;220460;447877;	352712|FILS syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615139 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	12	MU81935707	hom
13	21562482	21562482	-	GGGGCG	LATS2	exonic	nonframeshift insertion	ENSG00000150457	rs550642106	ENSG00000150457:ENST00000382592:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP,ENSG00000150457:ENST00000542899:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	LATS2:NM_014572:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0072	0.1606	0.254393	0.4392	.	.	.	.	.	.	.	.	LATS2:uc001unr.4:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP,LATS2:uc009zzs.3:exon4:c.1436_1437insCGCCCC:p.P479delinsPAP	.	AFR:0.2789,AMR:0.4558,EAS:0.3763,FIN:0.4664,NFE:0.5314,OTH:0.4918,ASJ:0.5584	604861	.	.	.	.	.	.	.	.	.	.	.	13	MU3892220	hom
13	21562832	21562832	C	T	LATS2	exonic	nonsynonymous SNV	ENSG00000150457	rs2770928	ENSG00000150457:ENST00000382592:exon4:c.G1087A:p.G363S,ENSG00000150457:ENST00000542899:exon4:c.G1087A:p.G363S	LATS2:NM_014572:exon4:c.G1087A:p.G363S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8729	0.8326	0.85024	MU64421	-0.186	1.173	0.472	-1.07	0.002	.	.	.	LATS2:uc001unr.4:exon4:c.G1087A:p.G363S,LATS2:uc009zzs.3:exon4:c.G1087A:p.G363S	-0.913	AFR:COCA-CN|5|321|0.0155763,AMR:0.8239,EAS:0.9270,FIN:0.9503,NFE:0.9981,OTH:0.8210,ASJ:0.7116	604861	.	.	.	.	.	.	.	0.002	0.4	0.000	0.38	13	1(thyroid)	0.8614
13	21562948	21562948	G	A	LATS2	exonic	nonsynonymous SNV	ENSG00000150457	rs558614	ENSG00000150457:ENST00000382592:exon4:c.C971T:p.A324V,ENSG00000150457:ENST00000542899:exon4:c.C971T:p.A324V	LATS2:NM_014572:exon4:c.C971T:p.A324V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7345	0.7346	0.629593	1(peritoneum)	1.454	13.07	0.194	2.72	0.215	.	.	.	LATS2:uc001unr.4:exon4:c.C971T:p.A324V,LATS2:uc009zzs.3:exon4:c.C971T:p.A324V	-0.968	AFR:MU60225,AMR:COCA-CN|3|321|0.00934579,EAS:0.5518,FIN:0.6842,NFE:0.8733,OTH:0.5211,ASJ:0.6984	604861	.	.	.	.	.	.	.	0.216	0.29	0.000	0.345	13	1(thyroid)	0.7110
13	21620085	21620085	T	C	LATS2	exonic	synonymous SNV	ENSG00000150457	rs7317471	ENSG00000150457:ENST00000382592:exon2:c.A81G:p.K27K,ENSG00000150457:ENST00000542899:exon2:c.A81G:p.K27K	LATS2:NM_014572:exon2:c.A81G:p.K27K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8496	0.7806	0.807508	0.8142	.	.	.	.	.	.	.	.	LATS2:uc001unr.4:exon2:c.A81G:p.K27K,LATS2:uc009zzs.3:exon2:c.A81G:p.K27K	.	AFR:0.6717,AMR:0.8969,EAS:0.9047,FIN:0.8845,NFE:0.8646,OTH:0.8661,ASJ:0.7185	604861	.	.	.	.	.	.	.	.	.	.	.	13	MU114292	hom
13	22249144	22249144	C	G	FGF9	intronic	.	ENSG00000102678	rs12430456	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.834864	0.8289	.	.	.	.	.	.	.	.	.	.	AFR:0.7127,AMR:0.8990,EAS:1,FIN:0.8364,NFE:0.8634,OTH:0.8610,ASJ:0.8214	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	.	hom
13	22255167	22255167	C	T	FGF9	intronic	.	ENSG00000102678	rs3818460	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3215	0.2470	0.253395	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.2789,AMR:0.0628,EAS:0.3245,FIN:0.4146,NFE:0.3756,OTH:0.3576,ASJ:0.3744	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	1(haematopoietic_and_lymphoid_tissue)	0.3354
13	22255301	22255301	C	T	FGF9	intronic	.	ENSG00000102678	rs2274296	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3269	0.2592	0.265575	0.2894	.	.	.	.	.	.	.	.	.	.	AFR:0.0976,AMR:0.3792,EAS:0.4144,FIN:0.3759,NFE:0.3583,OTH:0.3388,ASJ:0.3344	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU13665465	het
13	22275394	22275394	A	G	FGF9	exonic	synonymous SNV	ENSG00000102678	rs9509841	ENSG00000102678:ENST00000382353:exon3:c.A447G:p.S149S	FGF9:NM_002010:exon3:c.A447G:p.S149S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8398	0.7740	0.832468	0.7863	.	.	.	.	.	.	.	.	FGF9:uc001uog.2:exon3:c.A447G:p.S149S	.	AFR:0.6565,AMR:0.9067,EAS:0.9561,FIN:0.7947,NFE:0.8312,OTH:0.8259,ASJ:0.8278	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU28813827	hom
13	22275583	22275583	G	A	FGF9	UTR3	.	ENSG00000102678	rs9509842	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9948	0.9805	0.981829	0.9831	.	.	.	.	.	.	.	.	.	.	AFR:0.9409,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:0.9967	600921	612961;	3237;	3237|Deafness-Hermann type symphalangism syndrome<br>Facio-audio-symphalangism<br>Symphalangism-brachydactyly syndrome<br>WL syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|186500 610017 612961 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05200 Pathways in cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	MU81936344	hom
13	26125490	26125490	G	A	ATP8A2	exonic	synonymous SNV	ENSG00000132932	rs9581388	ENSG00000132932:ENST00000255283:exon10:c.G786A:p.A262A,ENSG00000132932:ENST00000281620:exon10:c.G426A:p.A142A,ENSG00000132932:ENST00000381655:exon11:c.G906A:p.A302A	ATP8A2:NM_001313741:exon11:c.G786A:p.A262A,ATP8A2:NM_016529:exon11:c.G906A:p.A302A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0584	0.0602	0.0846645	0.0566	.	.	.	.	.	.	.	.	ATP8A2:uc001uql.1:exon10:c.G786A:p.A262A,ATP8A2:uc001uqk.3:exon11:c.G906A:p.A302A,ATP8A2:uc010tdi.2:exon11:c.G786A:p.A262A	.	AFR:0.1154,AMR:0.0692,EAS:0.0006,FIN:0.0530,NFE:0.0286,OTH:0.0573,ASJ:0.06	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU80632170	het
13	26148966	26148966	C	T	ATP8A2	exonic	synonymous SNV	ENSG00000132932	rs6491066	ENSG00000132932:ENST00000255283:exon18:c.C1563T:p.F521F,ENSG00000132932:ENST00000281620:exon18:c.C1203T:p.F401F,ENSG00000132932:ENST00000381655:exon19:c.C1683T:p.F561F	ATP8A2:NM_001313741:exon19:c.C1563T:p.F521F,ATP8A2:NM_016529:exon19:c.C1683T:p.F561F	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6287	0.7083	0.536342	MU12280117	.	.	.	.	.	.	.	.	ATP8A2:uc010aaj.1:exon4:c.C213T:p.F71F,ATP8A2:uc001uqk.3:exon19:c.C1683T:p.F561F,ATP8A2:uc010tdi.2:exon19:c.C1563T:p.F521F	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.6729,EAS:0.5805,FIN:0.72,NFE:0.1,OTH:0.6735,ASJ:0.6978	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	1(large_intestine)	0.7251
13	26155953	26155953	G	C	ATP8A2	intronic	.	ENSG00000132932	rs7335339	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5764	0.6578	0.43111	LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	0	0	.	.	.	AFR:0.6009,AMR:0.5279,EAS:0.6733,FIN:0.0105,NFE:0.6420,OTH:0.7033,ASJ:0.4450	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	1(large_intestine)	0.6260
13	26273385	26273385	G	C	ATP8A2	exonic	synonymous SNV	ENSG00000132932	rs6491088	ENSG00000132932:ENST00000255283:exon24:c.G2166C:p.L722L,ENSG00000132932:ENST00000281620:exon24:c.G1806C:p.L602L,ENSG00000132932:ENST00000381655:exon25:c.G2286C:p.L762L	ATP8A2:NM_001313741:exon25:c.G2166C:p.L722L,ATP8A2:NM_016529:exon25:c.G2286C:p.L762L	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9973	0.9898	0.98742	0.9919	.	.	.	.	.	.	.	.	ATP8A2:uc010aaj.1:exon11:c.G936C:p.L312L,ATP8A2:uc001uqk.3:exon25:c.G2286C:p.L762L,ATP8A2:uc010tdi.2:exon25:c.G2166C:p.L722L	.	AFR:0.9715,AMR:0.9988,EAS:1,FIN:1,NFE:1,OTH:0.9990,ASJ:1	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU81937382	hom
13	26436641	26436641	C	T	ATP8A2	intronic	.	ENSG00000132932	rs2249800	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.503195	0.5360	.	.	.	.	.	.	.	.	.	.	AFR:0.4786,AMR:0.3864,EAS:0.6225,FIN:0.6073,NFE:0.5490,OTH:0.5898,ASJ:0.5	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU12280346	het
13	26586775	26586775	C	T	ATP8A2	intronic	.	ENSG00000132932	rs2274135	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4948	0.4447	0.534545	0.5218	.	.	.	.	.	.	.	.	.	.	AFR:0.4039,AMR:0.6131,EAS:0.7478,FIN:0.6004,NFE:0.5386,OTH:0.5867,ASJ:0.4422	605870	615268;	1766;	1766|CAMRQ syndrome<br>Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome<br>Non-progressive cerebellar ataxia-intellectual disability syndrome|<1 / 1 000 000|Autosomal recessive|Neonatal|224050 610185 613227 615268 ~	.	.	.	.	.	.	.	.	13	MU18447171	unknown
13	28636084	28636084	G	A	FLT3	exonic	synonymous SNV	ENSG00000122025	rs7338903	ENSG00000122025:ENST00000241453:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000380982:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000380987:exon3:c.C288T:p.D96D,ENSG00000122025:ENST00000537084:exon3:c.C288T:p.D96D	FLT3:NM_004119:exon3:c.C288T:p.D96D	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9827	0.9599	0.958067	0.9662	.	.	.	.	.	.	.	.	FLT3:uc001urw.3:exon3:c.C288T:p.D96D,FLT3:uc010tdn.2:exon3:c.C288T:p.D96D	.	AFR:0.9027,AMR:0.9869,EAS:0.9994,FIN:0.9957,NFE:0.9893,OTH:0.9898,ASJ:0.9967	136351	601626;613065;	513;519;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04640 Hematopoietic cell lineage~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05230 Central carbon metabolism in cancer ~	5783,5790,5781,5791,5789,,5779,5782,5786,5780,5795,5787,5784,5785,5788	.	.	.	.	.	.	13	MU81937601	hom
13	28883061	28883061	G	A	FLT1	exonic	synonymous SNV	ENSG00000102755	rs7993418	ENSG00000102755:ENST00000543394:exon8:c.C708T:p.Y236Y,ENSG00000102755:ENST00000540678:exon15:c.C1293T:p.Y431Y,ENSG00000102755:ENST00000282397:exon28:c.C3639T:p.Y1213Y	FLT1:NM_002019:exon28:c.C3639T:p.Y1213Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7921	0.6465	0.730831	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	FLT1:uc010aap.2:exon7:c.C654T:p.Y218Y,FLT1:uc010aaq.2:exon10:c.C1014T:p.Y338Y,FLT1:uc001usa.3:exon15:c.C1293T:p.Y431Y,FLT1:uc001usb.3:exon28:c.C3639T:p.Y1213Y	.	AFR:0.6798,AMR:0.3548,EAS:0.8477,FIN:0.9969,NFE:0.7871,OTH:0.7888,ASJ:0.8433	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	1(lung)	0.7990
13	28886113	28886113	A	G	FLT1	intronic	.	ENSG00000102755	rs7328692	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9929	0.9751	0.974042	0.9748	.	.	.	.	.	.	.	.	.	.	AFR:0.9122,AMR:0.9952,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:0.9967	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	MU81937639	hom
13	28964198	28964198	C	T	FLT1	exonic	synonymous SNV	ENSG00000102755	rs17537350	ENSG00000102755:ENST00000282397:exon13:c.G1704A:p.T568T,ENSG00000102755:ENST00000541932:exon13:c.G1704A:p.T568T	FLT1:NM_001159920:exon13:c.G1704A:p.T568T,FLT1:NM_001160030:exon13:c.G1704A:p.T568T,FLT1:NM_002019:exon13:c.G1704A:p.T568T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0823	0.0484	0.0601038	0.0524	.	.	.	.	.	.	.	.	FLT1:uc010aat.1:exon4:c.G153A:p.T51T,FLT1:uc001usb.3:exon13:c.G1704A:p.T568T,FLT1:uc001usc.3:exon13:c.G1704A:p.T568T,FLT1:uc010aar.1:exon13:c.G1704A:p.T568T	.	AFR:0.0147,AMR:0.2344,EAS:0.0210,FIN:0.0502,NFE:0.0679,OTH:0.0652,ASJ:0.0199	165070	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko05202 Transcriptional misregulation in cancer~ko05323 Rheumatoid arthritis ~	.	.	.	.	.	.	.	13	.	het
13	32911888	32911888	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs1801406	ENSG00000139618:ENST00000380152:exon11:c.A3396G:p.K1132K,ENSG00000139618:ENST00000544455:exon11:c.A3396G:p.K1132K	BRCA2:NM_000059:exon11:c.A3396G:p.K1132K	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2945	0.2798	0.266773	0.2984	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.A3396G:p.K1132K	.	AFR:0.2348,AMR:0.2100,EAS:0.3863,FIN:0.3113,NFE:0.3267,OTH:0.3108,ASJ:0.3212	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	1830,,1819,1844,1836,1826,1825,1845,1820,1841,1831,1834,1837,1840,1824,1838,1827,1832,1829,1835,1833,1842,1839,1843,1828,1823	.	,1822,1821	.	.	.	.	13	MU12290327	hom
13	32912750	32912750	G	T	BRCA2	exonic	nonsynonymous SNV	ENSG00000139618	rs28897727	ENSG00000139618:ENST00000380152:exon11:c.G4258T:p.D1420Y,ENSG00000139618:ENST00000544455:exon11:c.G4258T:p.D1420Y	BRCA2:NM_000059:exon11:c.G4258T:p.D1420Y	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 1, -1, 1, 1] 	0.0068	0.0040	0.00399361	0.0081	1.380	12.68	0.03	1.06	0.710	.	.	.	BRCA2:uc001uub.1:exon11:c.G4258T:p.D1420Y	-0.910	AFR:0.0015,AMR:0.0012,EAS:0,FIN:0.0209,NFE:0.0100,OTH:0.0133,ASJ:0	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	1830,,1819,1844,1836,1826,1825,1845,1820,1841,1831,1834,1837,1840,1824,1838,1827,1832,1829,1835,1833,1842,1839,1843,1828,1823	.	,1822,1821	0.03	5.71	0.003	2.15	13	.	het
13	32913055	32913055	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs206075	ENSG00000139618:ENST00000380152:exon11:c.A4563G:p.L1521L,ENSG00000139618:ENST00000544455:exon11:c.A4563G:p.L1521L	BRCA2:NM_000059:exon11:c.A4563G:p.L1521L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9931	0.9758	0.974042	0.9799	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.A4563G:p.L1521L	.	AFR:0.9301,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9959,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	1830,,1819,1844,1836,1826,1825,1845,1820,1841,1831,1834,1837,1840,1824,1838,1827,1832,1829,1835,1833,1842,1839,1843,1828,1823	.	,1822,1821	.	.	.	.	13	MU81938056	hom
13	32914478	32914478	G	A	BRCA2	exonic	nonsynonymous SNV	ENSG00000139618	rs80358833	ENSG00000139618:ENST00000380152:exon11:c.G5986A:p.A1996T,ENSG00000139618:ENST00000544455:exon11:c.G5986A:p.A1996T	BRCA2:NM_000059:exon11:c.G5986A:p.A1996T	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 10#Tier_II_potential EVS=[1, 0, 1, 1, 0, 0, 1, 1, 2, 1, 1, 1] 	0.0005	.	0.00139776	6.462e-05	5.220	25.6	0.058	3.95	0.992	.	.	.	BRCA2:uc001uub.1:exon11:c.G5986A:p.A1996T	0.141	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	1830,,1819,1844,1836,1826,1825,1845,1820,1841,1831,1834,1837,1840,1824,1838,1827,1832,1829,1835,1833,1842,1839,1843,1828,1823	.	,1822,1821	0.996	-1.67	0.582	1.645	13	MU129341565	het
13	32915005	32915005	G	C	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs206076	ENSG00000139618:ENST00000380152:exon11:c.G6513C:p.V2171V,ENSG00000139618:ENST00000544455:exon11:c.G6513C:p.V2171V	BRCA2:NM_000059:exon11:c.G6513C:p.V2171V	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9930	0.9755	0.973642	0.9798	.	.	.	.	.	.	.	.	BRCA2:uc001uub.1:exon11:c.G6513C:p.V2171V	.	AFR:0.9299,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9959,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	1830,,1819,1844,1836,1826,1825,1845,1820,1841,1831,1834,1837,1840,1824,1838,1827,1832,1829,1835,1833,1842,1839,1843,1828,1823	.	,1822,1821	.	.	.	.	13	MU4551142	hom
13	32929232	32929232	A	G	BRCA2	exonic	synonymous SNV	ENSG00000139618	rs1799955	ENSG00000139618:ENST00000380152:exon14:c.A7242G:p.S2414S,ENSG00000139618:ENST00000544455:exon14:c.A7242G:p.S2414S	BRCA2:NM_000059:exon14:c.A7242G:p.S2414S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2244	0.2114	0.232628	0.2299	.	.	.	.	.	.	.	.	BRCA2:uc031qky.1:exon1:c.A66G:p.S22S,BRCA2:uc001uub.1:exon14:c.A7242G:p.S2414S	.	AFR:0.2206,AMR:0.1627,EAS:0.3837,FIN:0.2261,NFE:0.2239,OTH:0.2255,ASJ:0.2219	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	1830,,1819,1844,1836,1826,1825,1845,1820,1841,1831,1834,1837,1840,1824,1838,1827,1832,1829,1835,1833,1842,1839,1843,1828,1823	.	,1822,1821	.	.	.	.	13	MU12290415	het
13	32929387	32929387	T	C	BRCA2	exonic	nonsynonymous SNV	ENSG00000139618	rs169547	ENSG00000139618:ENST00000380152:exon14:c.T7397C:p.V2466A,ENSG00000139618:ENST00000544455:exon14:c.T7397C:p.V2466A	BRCA2:NM_000059:exon14:c.T7397C:p.V2466A	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.9937	0.9777	0.975839	0.9819	-0.407	0.372	1.0	5.07	0.005	.	.	.	BRCA2:uc031qky.1:exon1:c.T221C:p.V74A,BRCA2:uc001uub.1:exon14:c.T7397C:p.V2466A	-0.930	AFR:0.9369,AMR:0.9976,EAS:0.9994,FIN:1,NFE:0.9997,OTH:0.9980,ASJ:1	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	1830,,1819,1844,1836,1826,1825,1845,1820,1841,1831,1834,1837,1840,1824,1838,1827,1832,1829,1835,1833,1842,1839,1843,1828,1823	.	,1822,1821	.	5.95	0.000	.	13	MU81938081	hom
13	32936646	32936646	T	C	BRCA2	intronic	.	ENSG00000139618	rs9534262	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5208	0.5202	0.53155	0.5470	.	.	.	.	.	.	.	.	.	.	AFR:0.5768,AMR:0.5167,EAS:0.5527,FIN:0.5659,NFE:0.5281,OTH:0.5468,ASJ:0.4633	600185	114480;155255;176807;194070;605724;612555;613029;613347;	1333;182067;360;145;227535;319462;654;1331;251858;251863;251867;616;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~319462|-|-|-|-|605724 ~654|Renal embryonic tumor<br>Wilms tumor|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|194070 194071 194090 601363 601583 616806 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~251858|MBEN|-|Not applicable|Infancy<br>Childhood|155255 ~251863|-|-|Not applicable|Adult|155255 ~251867|-|-|-|Childhood|155255 ~616|-|1-9 / 100 000|Not applicable|All ages|155255 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	13	MU734294	het
13	33590851	33590851	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs2772364	ENSG00000133116:ENST00000380099:exon1:c.T273C:p.D91D	KL:NM_004795:exon1:c.T273C:p.D91D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9865	0.9475	0.944089	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon1:c.T273C:p.D91D	.	AFR:0.9500,AMR:0.8254,EAS:1,FIN:1,NFE:1,OTH:0.9993,ASJ:0.9892	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	2(thyroid)	0.9927
13	33635463	33635463	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs648202	ENSG00000133116:ENST00000380099:exon4:c.T2247C:p.A749A	KL:NM_004795:exon4:c.T2247C:p.A749A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8036	0.7690	0.710863	0.7635	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon4:c.T2247C:p.A749A	.	AFR:0.5728,AMR:0.7955,EAS:0.6103,FIN:0.8794,NFE:0.8528,OTH:0.8514,ASJ:0.9205	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	MU13667379	hom
13	33635835	33635835	T	C	KL	exonic	synonymous SNV	ENSG00000133116	rs649964	ENSG00000133116:ENST00000380099:exon4:c.T2619C:p.N873N	KL:NM_004795:exon4:c.T2619C:p.N873N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9919	0.9683	0.976238	0.9760	.	.	.	.	.	.	.	.	KL:uc001uus.3:exon4:c.T2619C:p.N873N	.	AFR:0.9164,AMR:0.9893,EAS:0.9994,FIN:1,NFE:0.9997,OTH:1,ASJ:1	604824	211900;	306661;53715;	306661|Hypercalcemic tumoral calcinosis|-|Autosomal recessive|-|211900 ~53715|-|Unknown|Autosomal recessive|Childhood|211900 610455 ~	.	.	.	.	.	.	.	.	13	MU81938143	hom
13	48914792	48914792	A	G	RB1	intronic	.	ENSG00000139687	rs198636	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.914137	0.9411	.	.	.	.	.	.	.	.	.	.	AFR:0.8226,AMR:0.9461,EAS:0.9957,FIN:0.9991,NFE:0.9882,OTH:0.9845,ASJ:0.9404	614041	109800;180200;182280;259500;	668;70573;790;	668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~70573|SCLC|1-5 / 10 000|Not applicable|Adult|182280 ~790|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Childhood<br>Antenatal|180200 ~	~ko01522 Endocrine resistance~ko04110 Cell cycle~ko04218 Cellular senescence~ko04934 Cushing syndrome~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05212 Pancreatic cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	13	.	hom
13	52523878	52523878	T	C	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs534960245	ENSG00000123191:ENST00000400370:exon4:c.A1495G:p.I499V,ENSG00000123191:ENST00000417240:exon6:c.A601G:p.I201V,ENSG00000123191:ENST00000448424:exon11:c.A2551G:p.I851V,ENSG00000123191:ENST00000242839:exon12:c.A2785G:p.I929V,ENSG00000123191:ENST00000418097:exon12:c.A2785G:p.I929V,ENSG00000123191:ENST00000400366:exon13:c.A2452G:p.I818V	ATP7B:NM_001330579:exon10:c.A2533G:p.I845V,ATP7B:NM_001330578:exon11:c.A2551G:p.I851V,ATP7B:NM_000053:exon12:c.A2785G:p.I929V,ATP7B:NM_001243182:exon13:c.A2452G:p.I818V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0010	.	0.00139776	0.0009	0.057	3.158	1.0	3.63	1.000	.	.	P-type ATPase,  transmembrane domain;P-type ATPase, A  domain	ATP7B:uc010adv.2:exon4:c.A1495G:p.I499V,ATP7B:uc001vfv.2:exon5:c.A601G:p.I201V,ATP7B:uc010tgs.1:exon6:c.A601G:p.I201V,ATP7B:uc010tgv.1:exon11:c.A2551G:p.I851V,ATP7B:uc001vfw.2:exon12:c.A2785G:p.I929V,ATP7B:uc010tgt.1:exon12:c.A2785G:p.I929V,ATP7B:uc010tgu.1:exon12:c.A2641G:p.I881V,ATP7B:uc001vfy.2:exon13:c.A2452G:p.I818V	-0.512	AFR:0,AMR:0,EAS:0.0179,FIN:0,NFE:0,OTH:0,ASJ:0	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.371	-2.59	0.415	0.4	13	MU81939822	het
13	52548140	52548140	A	C	ATP7B	exonic	nonsynonymous SNV	ENSG00000123191	rs1801243	ENSG00000123191:ENST00000542656:exon1:c.T1120G:p.S374A,ENSG00000123191:ENST00000242839:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000344297:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000400370:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000418097:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000448424:exon2:c.T1216G:p.S406A,ENSG00000123191:ENST00000400366:exon3:c.T883G:p.S295A	ATP7B:NM_000053:exon2:c.T1216G:p.S406A,ATP7B:NM_001005918:exon2:c.T1216G:p.S406A,ATP7B:NM_001330578:exon2:c.T1216G:p.S406A,ATP7B:NM_001330579:exon2:c.T1216G:p.S406A,ATP7B:NM_001243182:exon3:c.T883G:p.S295A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4388	0.4012	0.376198	0.4155	-0.551	0.164	0.753	-0.027	0.946	.	.	Heavy metal-associated domain, HMA|Heavy metal-associated domain, copper ion-binding	ATP7B:uc001vfw.2:exon2:c.T1216G:p.S406A,ATP7B:uc001vfx.2:exon2:c.T1216G:p.S406A,ATP7B:uc010adv.2:exon2:c.T1216G:p.S406A,ATP7B:uc010tgt.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgu.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgv.1:exon2:c.T1216G:p.S406A,ATP7B:uc010tgw.1:exon2:c.T1120G:p.S374A,ATP7B:uc001vfy.2:exon3:c.T883G:p.S295A	-0.999	AFR:0.1954,AMR:0.4069,EAS:0.5285,FIN:0.5421,NFE:0.4971,OTH:0.4744,ASJ:0.4901	606882	277900;	905;	905|Hepatolenticular degeneration|1-9 / 100 000|Autosomal recessive|Childhood|277900 ~	.	.	.	.	0.003	-2.09	0.000	0.695	13	MU155008	het
13	73343039	73343039	C	T	DIS3	exonic	synonymous SNV	ENSG00000083520	rs2196979	ENSG00000083520:ENST00000377767:exon14:c.G1767A:p.T589T,ENSG00000083520:ENST00000377780:exon14:c.G1677A:p.T559T,ENSG00000083520:ENST00000545453:exon15:c.G1281A:p.T427T	DIS3:NM_001322348:exon13:c.G1398A:p.T466T,DIS3:NM_001128226:exon14:c.G1677A:p.T559T,DIS3:NM_014953:exon14:c.G1767A:p.T589T,DIS3:NM_001322349:exon15:c.G1281A:p.T427T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7373	0.7476	0.770168	0.7393	.	.	.	.	.	.	.	.	DIS3:uc001vix.4:exon14:c.G1767A:p.T589T,DIS3:uc001viy.4:exon14:c.G1677A:p.T559T	.	AFR:0.8187,AMR:0.8098,EAS:0.7503,FIN:0.6790,NFE:0.7044,OTH:0.7026,ASJ:0.7384	607533	.	.	.	.	.	.	.	.	.	.	.	13	MU20994899	hom
13	73349359	73349359	G	C	DIS3	exonic	nonsynonymous SNV	ENSG00000083520	rs7332388	ENSG00000083520:ENST00000377767:exon6:c.C977G:p.T326R,ENSG00000083520:ENST00000377780:exon6:c.C887G:p.T296R,ENSG00000083520:ENST00000490646:exon6:c.C977G:p.T326R,ENSG00000083520:ENST00000545453:exon7:c.C491G:p.T164R	DIS3:NM_001322348:exon5:c.C608G:p.T203R,DIS3:NM_001128226:exon6:c.C887G:p.T296R,DIS3:NM_014953:exon6:c.C977G:p.T326R,DIS3:NM_001322349:exon7:c.C491G:p.T164R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4007	0.5039	0.432708	0.4716	0.740	9.085	0.584	-3.74	0.977	.	.	Nucleic acid-binding, OB-fold|Rrp44-like cold shock domain	DIS3:uc001vix.4:exon6:c.C977G:p.T326R,DIS3:uc001viy.4:exon6:c.C887G:p.T296R	-0.959	AFR:0.6854,AMR:0.2955,EAS:0.2667,FIN:0.3698,NFE:0.4068,OTH:0.3924,ASJ:0.5232	607533	.	.	.	.	.	.	.	0.0	0.87	0.000	0.445	13	MU82276684	het
13	73350079	73350079	T	C	DIS3	exonic	nonsynonymous SNV	ENSG00000083520	rs4883918	ENSG00000083520:ENST00000377767:exon5:c.A806G:p.N269S,ENSG00000083520:ENST00000377780:exon5:c.A716G:p.N239S,ENSG00000083520:ENST00000490646:exon5:c.A806G:p.N269S,ENSG00000083520:ENST00000545453:exon6:c.A320G:p.N107S	DIS3:NM_001322348:exon4:c.A437G:p.N146S,DIS3:NM_001128226:exon5:c.A716G:p.N239S,DIS3:NM_014953:exon5:c.A806G:p.N269S,DIS3:NM_001322349:exon6:c.A320G:p.N107S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3363	0.2346	0.327077	0.2589	-1.853	0.002	0.464	-8.07	0.645	.	.	Nucleic acid-binding, OB-fold|Rrp44-like cold shock domain	DIS3:uc001vix.4:exon5:c.A806G:p.N269S,DIS3:uc001viy.4:exon5:c.A716G:p.N239S	-0.938	AFR:0.1060,AMR:0.5084,EAS:0.4807,FIN:0.3083,NFE:0.2964,OTH:0.3108,ASJ:0.2152	607533	.	.	.	.	.	.	.	0.0	2.09	0.000	-0.59	13	MU742526	het
13	96329587	96329587	C	T	DNAJC3	exonic	synonymous SNV	ENSG00000102580	rs146543814	ENSG00000102580:ENST00000376795:exon1:c.C78T:p.Y26Y,ENSG00000102580:ENST00000602402:exon1:c.C78T:p.Y26Y	DNAJC3:NM_006260:exon1:c.C78T:p.Y26Y	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0038	0.0014	0.00439297	0.0014	.	.	.	.	.	.	.	.	DNAJC3:uc001vmp.3:exon1:c.C78T:p.Y26Y,DNAJC3:uc001vmq.3:exon1:c.C78T:p.Y26Y	.	AFR:0.0005,AMR:0.0036,EAS:0,FIN:0.0006,NFE:0.0019,OTH:0.0041,ASJ:0	601184	616192;	445062;	445062|Combined cerebellar and peripheral ataxia-hearing loss-diabetes mellitus syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood<br>Adolescent|616192 ~	.	.	.	.	.	.	.	.	13	.	het
13	101735211	101735211	G	A	NALCN	exonic	synonymous SNV	ENSG00000102452	rs17677552	ENSG00000102452:ENST00000251127:exon33:c.C3714T:p.T1238T	NALCN:NM_001350750:exon32:c.C3627T:p.T1209T,NALCN:NM_001350751:exon32:c.C3627T:p.T1209T,NALCN:NM_001350749:exon33:c.C3714T:p.T1238T,NALCN:NM_052867:exon33:c.C3714T:p.T1238T,NALCN:NM_001350748:exon34:c.C3801T:p.T1267T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3513	0.2759	0.326078	MU58304	.	.	.	.	.	.	.	.	NALCN:uc001vox.1:exon33:c.C3714T:p.T1238T	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|5|170|0.0294118,COCA-CN|2|321|0.00623053,AMR:0.3076,EAS:0.2458,FIN:0.3411,NFE:0.4629,OTH:0.4281,ASJ:0.1309	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	4(lung)	0.3645
13	101736075	101736075	A	G	NALCN	exonic	synonymous SNV	ENSG00000102452	rs686141	ENSG00000102452:ENST00000251127:exon31:c.T3570C:p.L1190L	NALCN:NM_001350750:exon30:c.T3483C:p.L1161L,NALCN:NM_001350751:exon30:c.T3483C:p.L1161L,NALCN:NM_001350749:exon31:c.T3570C:p.L1190L,NALCN:NM_052867:exon31:c.T3570C:p.L1190L,NALCN:NM_001350748:exon32:c.T3657C:p.L1219L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6992	0.7610	0.724641	1(thyroid)	.	.	.	.	.	.	.	.	NALCN:uc001vox.1:exon31:c.T3570C:p.L1190L	.	AFR:MU117493,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,THCA-SA|1|243|0.00411523,EAS:0.8418,FIN:0.5,NFE:0.7682,OTH:0.6006,ASJ:0.7478	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	2(haematopoietic_and_lymphoid_tissue)	0.7252
13	101795422	101795422	A	G	NALCN	intronic	.	ENSG00000102452	rs661585	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4910	0.5050	0.521765	0.5118	.	.	.	.	.	.	.	.	NALCN:uc001voy.3:exon17:c.T1272C:p.S424S	.	AFR:0.6003,AMR:0.3998,EAS:0.5087,FIN:0.5146,NFE:0.4689,OTH:0.4836,ASJ:0.4768	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	MU13671660	het
13	101999939	101999939	A	G	NALCN	intronic	.	ENSG00000102452	rs9582475	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.388778	0.3415	.	.	.	.	.	.	.	.	.	.	AFR:0.3471,AMR:0.4820,EAS:0.3717,FIN:0.2897,NFE:0.3368,OTH:0.3569,ASJ:0.4172	611549	615419;616266;	371364;	371364|IHPRF syndrome<br>Infantile hypotonia-psychomotor retardation-characteristic facies syndrome|Unknown|Autosomal recessive|Infancy<br>Neonatal|615419 616801 ~	.	.	.	.	.	.	.	.	13	.	hom
13	102480271	102480271	T	A	FGF14	exonic	nonsynonymous SNV	ENSG00000102466	rs9518577	.	FGF14:NM_001321937:exon4:c.A425T:p.K142I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.405152	0.3289	.	.	.	.	.	.	.	.	.	.	AFR:0.2408,AMR:0.3343,EAS:0.5505,FIN:0.2417,NFE:0.3681,OTH:0.3659,ASJ:0.2959	601515	609307;	98764;	98764|SCA27|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|609307 ~	.	.	.	.	.	.	.	.	13	.	hom
13	103504517	103504517	T	C	BIVM-ERCC5;ERCC5	exonic	synonymous SNV	ENSG00000134899;ENSG00000270181	rs1047768	ENSG00000134899:ENST00000355739:exon2:c.T138C:p.H46H,ENSG00000134899:ENST00000535557:exon2:c.T138C:p.H46H	ERCC5:NM_000123:exon2:c.T138C:p.H46H,BIVM-ERCC5:NM_001204425:exon10:c.T1500C:p.H500H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5291	0.6118	0.493011	ESAD-UK|1|409|0.00244499,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ERCC5:uc001vpw.3:exon2:c.T138C:p.H46H,ERCC5:uc010tjb.2:exon2:c.T138C:p.H46H,BIVM-ERCC5:uc001vpu.2:exon10:c.T1500C:p.H500H	.	AFR:0.5913,AMR:0.6566,EAS:0.5795,FIN:0.2574,NFE:0.6019,OTH:0.6009,ASJ:0.3732	.	.	.	.	.	.	.	.	.	.	.	.	13	2(large_intestine)	0.5682
13	103524762	103524762	C	T	BIVM-ERCC5;ERCC5	intronic	.	ENSG00000134899	rs4150360	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4513	0.4345	0.317093	0.4289	.	.	.	.	.	.	.	.	.	.	AFR:0.2296,AMR:0.3258,EAS:0.1947,FIN:0.5338,NFE:0.5461,OTH:0.4765,ASJ:0.5331	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	13	MU29059313	het
13	103527849	103527849	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899	rs9514066	ENSG00000134899:ENST00000375954:exon6:c.G856C:p.G286R,ENSG00000134899:ENST00000355739:exon15:c.G3157C:p.G1053R	ERCC5:NM_000123:exon15:c.G3157C:p.G1053R,BIVM-ERCC5:NM_001204425:exon23:c.G4519C:p.G1507R	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.9994	0.9975	0.998203	0.9981	3.453	23.0	0.039	4.28	0.996	.	.	.	ERCC5:uc001vpw.3:exon15:c.G3157C:p.G1053R,BIVM-ERCC5:uc001vpu.2:exon23:c.G4519C:p.G1507R	-0.856	AFR:0.9934,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.926	3.59	0.000	2.14	13	MU81941476	hom
13	103527930	103527930	G	C	BIVM-ERCC5;ERCC5	exonic	nonsynonymous SNV	ENSG00000134899	rs9514067	ENSG00000134899:ENST00000375954:exon6:c.G937C:p.G313R,ENSG00000134899:ENST00000355739:exon15:c.G3238C:p.G1080R	ERCC5:NM_000123:exon15:c.G3238C:p.G1080R,BIVM-ERCC5:NM_001204425:exon23:c.G4600C:p.G1534R	clinvar: not_provided 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9993	0.9975	0.997204	0.9981	-0.838	0.035	0.588	0.141	0.016	.	.	.	ERCC5:uc001vpw.3:exon15:c.G3238C:p.G1080R,BIVM-ERCC5:uc001vpu.2:exon23:c.G4600C:p.G1534R	-1.004	AFR:0.9934,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:1,ASJ:1	133530	278780;616570;	1466;191;1466;191;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	0.0	3.65	0.000	-0.205	13	MU81941490	hom
13	110435231	110435231	C	T	IRS2	exonic	nonsynonymous SNV	ENSG00000185950	rs1805097	ENSG00000185950:ENST00000375856:exon1:c.G3170A:p.G1057D	IRS2:NM_003749:exon1:c.G3170A:p.G1057D	clinvar: risk_factor 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3821	0.2326	0.283347	0.2955	-0.829	0.037	0.221	2.11	0.002	.	.	.	IRS2:uc001vqv.3:exon1:c.G3170A:p.G1057D	-0.960	AFR:0.1275,AMR:0.4589,EAS:0.3943,FIN:0.3603,NFE:0.3552,OTH:0.3190,ASJ:0.3926	600797	125853;	.	.	.	.	.	.	0.089	0.81	0.000	1.61	13	MU99277	het
13	110435914	110435914	G	A	IRS2	exonic	synonymous SNV	ENSG00000185950	rs12853546	ENSG00000185950:ENST00000375856:exon1:c.C2487T:p.P829P	IRS2:NM_003749:exon1:c.C2487T:p.P829P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3112	0.2078	0.22504	0.2169	.	.	.	.	.	.	.	.	IRS2:uc001vqv.3:exon1:c.C2487T:p.P829P	.	AFR:0.1950,AMR:0.1667,EAS:0.2370,FIN:0.2443,NFE:0.2218,OTH:0.2423,ASJ:0.2417	600797	125853;	.	.	.	.	.	.	.	.	.	.	13	MU93852	het
13	110435953	110435953	A	G	IRS2	exonic	synonymous SNV	ENSG00000185950	rs4773092	ENSG00000185950:ENST00000375856:exon1:c.T2448C:p.C816C	IRS2:NM_003749:exon1:c.T2448C:p.C816C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5871	0.6018	0.563898	0.6108	.	.	.	.	.	.	.	.	IRS2:uc001vqv.3:exon1:c.T2448C:p.C816C	.	AFR:0.6150,AMR:0.6885,EAS:0.4623,FIN:0.6269,NFE:0.6172,OTH:0.6031,ASJ:0.5960	600797	125853;	.	.	.	.	.	.	.	.	.	.	13	MU119589	het
13	110436232	110436232	G	A	IRS2	exonic	synonymous SNV	ENSG00000185950	rs3742210	ENSG00000185950:ENST00000375856:exon1:c.C2169T:p.S723S	IRS2:NM_003749:exon1:c.C2169T:p.S723S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5537	0.6395	0.559505	0.6035	.	.	.	.	.	.	.	.	IRS2:uc001vqv.3:exon1:c.C2169T:p.S723S	.	AFR:0.5998,AMR:0.6901,EAS:0.4602,FIN:0.6204,NFE:0.6130,OTH:0.5973,ASJ:0.5933	600797	125853;	.	.	.	.	.	.	.	.	.	.	13	MU66862	het
13	113888201	113888201	T	C	CUL4A	intronic	.	ENSG00000139842	rs2146408	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9753	0.9108	0.911941	0.9240	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7357,AMR:0.9809,EAS:1,FIN:1,NFE:0.9987,OTH:0.9878,ASJ:0.9901	603137	.	.	.	.	.	.	.	.	.	.	.	13	MU81942591	hom
13	113889474	113889474	C	T	CUL4A	intronic	.	ENSG00000139842	rs2287250	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6738	0.7040	0.573283	MU732829	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.6723,EAS:0.5767,FIN:0.8344,NFE:0.4093,OTH:0.7117,ASJ:0.5802	603137	.	.	.	.	.	.	.	.	.	.	.	13	1(haematopoietic_and_lymphoid_tissue)	0.7467
13	113893729	113893729	G	A	CUL4A	intronic	.	ENSG00000139842	rs3794422	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2665	0.1693	0.252396	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.2048,AMR:0.0449,EAS:0.1556,FIN:0.3670,NFE:0.2806,OTH:0.2510,ASJ:0.3337	603137	.	.	.	.	.	.	.	.	.	.	.	13	1(lung)	0.2908
13	113897320	113897320	C	T	CUL4A	exonic	synonymous SNV	ENSG00000139842	rs3764124	ENSG00000139842:ENST00000326335:exon11:c.C774T:p.D258D,ENSG00000139842:ENST00000375440:exon11:c.C1074T:p.D358D,ENSG00000139842:ENST00000375441:exon11:c.C774T:p.D258D,ENSG00000139842:ENST00000451881:exon11:c.C774T:p.D258D	CUL4A:NM_001008895:exon11:c.C1074T:p.D358D,CUL4A:NM_001278513:exon11:c.C774T:p.D258D,CUL4A:NM_001278514:exon11:c.C798T:p.D266D,CUL4A:NM_001354938:exon11:c.C774T:p.D258D,CUL4A:NM_001354939:exon11:c.C774T:p.D258D,CUL4A:NM_001354940:exon11:c.C774T:p.D258D,CUL4A:NM_001354941:exon11:c.C639T:p.D213D,CUL4A:NM_001354942:exon11:c.C639T:p.D213D,CUL4A:NM_003589:exon11:c.C774T:p.D258D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2692	0.1788	0.260982	1(breast)	.	.	.	.	.	.	.	.	CUL4A:uc010tjz.2:exon3:c.C111T:p.D37D,CUL4A:uc010agu.3:exon8:c.C657T:p.D219D,CUL4A:uc021rmu.1:exon11:c.C774T:p.D258D,CUL4A:uc021rmv.1:exon11:c.C1074T:p.D358D	.	AFR:MU157346,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.0734,FIN:0.3365,NFE:0.1556,OTH:0.3669,ASJ:0.2130	603137	.	.	.	.	.	.	.	.	.	.	.	13	1(thyroid)	0.2801
13	113907391	113907391	A	G	CUL4A	intronic	.	ENSG00000139842	rs9549365	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2943	0.1802	0.3125	0.2293	.	.	.	.	.	0	0	.	.	.	AFR:0.0775,AMR:0.4038,EAS:0.5898,FIN:0.2894,NFE:0.2519,OTH:0.3020,ASJ:0.1556	603137	.	.	.	.	.	.	.	.	.	.	.	13	MU17327153	het
13	113909339	113909339	A	G	CUL4A	exonic	nonsynonymous SNV	ENSG00000139842	rs2302757	ENSG00000139842:ENST00000326335:exon18:c.A1631G:p.K544R,ENSG00000139842:ENST00000375440:exon18:c.A1931G:p.K644R,ENSG00000139842:ENST00000375441:exon18:c.A1631G:p.K544R,ENSG00000139842:ENST00000451881:exon18:c.A1631G:p.K544R	CUL4A:NM_001008895:exon18:c.A1931G:p.K644R,CUL4A:NM_001278513:exon18:c.A1631G:p.K544R,CUL4A:NM_001278514:exon18:c.A1655G:p.K552R,CUL4A:NM_001354938:exon18:c.A1631G:p.K544R,CUL4A:NM_001354939:exon18:c.A1631G:p.K544R,CUL4A:NM_001354940:exon18:c.A1631G:p.K544R,CUL4A:NM_001354941:exon18:c.A1496G:p.K499R,CUL4A:NM_001354942:exon18:c.A1496G:p.K499R,CUL4A:NM_003589:exon18:c.A1631G:p.K544R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2663	0.1693	0.251597	MU157353	1.207	11.79	0.194	3.77	0.992	.	.	Cullin homology|Cullin, N-terminal;Cullin homology|Cullin, N-terminal|Winged helix-turn-helix DNA-binding domain	CUL4A:uc010tjz.2:exon10:c.A968G:p.K323R,CUL4A:uc010agu.3:exon15:c.A1514G:p.K505R,CUL4A:uc021rmu.1:exon18:c.A1631G:p.K544R,CUL4A:uc021rmv.1:exon18:c.A1931G:p.K644R	-1.072	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.2048,EAS:0.3341,FIN:0.1556,NFE:0.3659,OTH:0.2803,ASJ:0.0450	603137	.	.	.	.	.	.	.	0.004	-0.87	0.000	1.605	13	2(lung)	0.2510
13	113965176	113965176	C	A	LAMP1	exonic	synonymous SNV	ENSG00000185896	rs9577503	ENSG00000185896:ENST00000332556:exon4:c.C556A:p.R186R	LAMP1:NM_005561:exon4:c.C556A:p.R186R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9916	0.9809	0.979233	0.9753	.	.	.	.	.	.	.	.	LAMP1:uc001vtm.1:exon4:c.C556A:p.R186R	.	AFR:0.9157,AMR:0.9905,EAS:1,FIN:1,NFE:0.9989,OTH:0.9928,ASJ:1	153330	.	.	.	.	.	.	.	.	.	.	.	13	MU81942635	hom
14	20815013	20815013	C	T	PARP2	intronic	.	ENSG00000254846	rs1713430	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4150	0.4595	0.516573	MU12429369	.	.	.	.	.	0	0	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|5|170|0.0294118,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.4596,EAS:0.4387,FIN:0.3389,NFE:0.3596,OTH:0.3623,ASJ:0.7040	607725	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.3599
14	20824181	20824181	T	C	PARP2	exonic	synonymous SNV	ENSG00000129484	rs3093930	ENSG00000129484:ENST00000250416:exon11:c.T1131C:p.Y377Y,ENSG00000129484:ENST00000429687:exon11:c.T1092C:p.Y364Y,ENSG00000129484:ENST00000527915:exon11:c.T1131C:p.Y377Y	PARP2:NM_001042618:exon11:c.T1092C:p.Y364Y,PARP2:NM_005484:exon11:c.T1131C:p.Y377Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6122	0.5709	0.510583	0.5719	.	.	.	.	.	.	.	.	PARP2:uc010tle.2:exon4:c.T381C:p.Y127Y,PARP2:uc001vxb.1:exon11:c.T1131C:p.Y377Y,PARP2:uc001vxc.3:exon11:c.T1131C:p.Y377Y,PARP2:uc001vxd.3:exon11:c.T1092C:p.Y364Y	.	AFR:0.3305,AMR:0.5923,EAS:0.6390,FIN:0.6626,NFE:0.6760,OTH:0.6493,ASJ:0.6523	607725	.	.	.	.	.	.	.	.	.	.	.	14	MU19551106	het
14	20824859	20824859	T	C	PARP2	intronic	.	ENSG00000129484	rs878156	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1331	0.1752	0.228035	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1685,AMR:0.3878,EAS:0.1159,FIN:0.1716,NFE:0.0662,OTH:0.0707,ASJ:0.1603	607725	.	.	.	.	.	.	.	.	.	.	.	14	2(haematopoietic_and_lymphoid_tissue)	0.0969
14	20916958	20916958	T	C	OSGEP	exonic	synonymous SNV	ENSG00000092094	rs938883	ENSG00000092094:ENST00000554249:exon2:c.A24G:p.L8L,ENSG00000092094:ENST00000555223:exon5:c.A24G:p.L8L,ENSG00000092094:ENST00000206542:exon6:c.A570G:p.L190L	OSGEP:NM_017807:exon6:c.A570G:p.L190L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5355	0.5574	0.495607	2(stomach)	.	.	.	.	.	.	.	.	OSGEP:uc001vxf.3:exon6:c.A570G:p.L190L	.	AFR:1(lung),AMR:1(upper_aerodigestive_tract),EAS:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,ESCA-CN|1|332|0.00301205,FIN:0.5455,NFE:0.5360,OTH:0.4187,ASJ:MU583115	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(oesophagus)	0.6291
14	20916987	20916987	G	A	OSGEP	intronic	.	ENSG00000092094	rs938882	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5073	0.5279	0.433506	MU12429740	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.5067,EAS:0.4091,FIN:0.6126,NFE:0.2327,OTH:0.5893,ASJ:0.4647	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.5415
14	20917442	20917442	A	T	OSGEP	intronic	.	ENSG00000092094	rs938881	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5757	0.6050	0.546126	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.5894,AMR:0.6048,EAS:0.6821,FIN:0.3966,NFE:0.6667,OTH:0.5876,ASJ:0.4415	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.6191
14	20920250	20920250	T	C	OSGEP	exonic	synonymous SNV	ENSG00000092094	rs2275007	ENSG00000092094:ENST00000206542:exon3:c.A294G:p.Q98Q,ENSG00000092094:ENST00000488532:exon3:c.A294G:p.Q98Q,ENSG00000092094:ENST00000553640:exon3:c.A294G:p.Q98Q	OSGEP:NM_017807:exon3:c.A294G:p.Q98Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5802	0.6050	0.553115	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	OSGEP:uc001vxf.3:exon3:c.A294G:p.Q98Q	.	AFR:0.5896,AMR:0.6022,EAS:0.6867,FIN:0.3973,NFE:0.6661,OTH:0.5878,ASJ:0.4689	610107	.	.	.	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.6207
14	20925154	20925154	T	G	APEX1	exonic	nonsynonymous SNV	ENSG00000100823	rs1130409	ENSG00000100823:ENST00000216714:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000398030:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000553681:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000555414:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000556054:exon5:c.T444G:p.D148E,ENSG00000100823:ENST00000557150:exon5:c.T393G:p.D131E,ENSG00000100823:ENST00000557592:exon5:c.T393G:p.D131E	APEX1:NM_001244249:exon5:c.T444G:p.D148E,APEX1:NM_001641:exon5:c.T444G:p.D148E,APEX1:NM_080648:exon5:c.T444G:p.D148E,APEX1:NM_080649:exon5:c.T444G:p.D148E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4280	0.4356	0.375599	COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	-1.666	0.002	1.0	-2.6	0.267	.	.	Endonuclease/exonuclease/phosphatase	APEX1:uc001vxg.3:exon5:c.T444G:p.D148E,APEX1:uc001vxh.3:exon5:c.T444G:p.D148E,APEX1:uc001vxi.3:exon5:c.T444G:p.D148E,APEX1:uc021rnr.1:exon5:c.T444G:p.D148E	-1.027	AFR:0.4400,AMR:0.3563,EAS:0.3675,FIN:0.3941,NFE:0.5232,OTH:0.4764,ASJ:0.4141	107748	.	.	.	.	.	.	.	0.0	-1.31	0.000	0.625	14	1(large_intestine)	0.4508
14	21871653	21871653	C	T	CHD8	exonic	synonymous SNV	ENSG00000100888	rs8022395	ENSG00000100888:ENST00000399982:exon16:c.G3477A:p.V1159V,ENSG00000100888:ENST00000430710:exon17:c.G2640A:p.V880V,ENSG00000100888:ENST00000557364:exon17:c.G3477A:p.V1159V	CHD8:NM_001170629:exon17:c.G3477A:p.V1159V,CHD8:NM_020920:exon17:c.G2640A:p.V880V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9093	0.9410	0.907348	0.9174	.	.	.	.	.	.	.	.	CHD8:uc001wav.1:exon7:c.G966A:p.V322V,CHD8:uc001war.2:exon16:c.G3477A:p.V1159V,CHD8:uc001was.2:exon17:c.G2640A:p.V880V	.	AFR:0.9449,AMR:0.7943,EAS:0.8552,FIN:0.8938,NFE:0.9202,OTH:0.9121,ASJ:0.9536	610528	615032;	.	.	.	.	.	.	.	.	.	.	14	MU14351469	hom
14	23777099	23777099	G	A	BCL2L2;BCL2L2-PABPN1	exonic	synonymous SNV	ENSG00000129473;ENSG00000258643	rs2231301	ENSG00000129473:ENST00000554635:exon2:c.G123A:p.P41P,ENSG00000258643:ENST00000557008:exon2:c.G123A:p.P41P,ENSG00000129473:ENST00000250405:exon3:c.G123A:p.P41P,ENSG00000258643:ENST00000553781:exon3:c.G123A:p.P41P,ENSG00000258643:ENST00000556100:exon3:c.G123A:p.P41P,ENSG00000129473:ENST00000557236:exon3:c.G123A:p.P41P,ENSG00000129473:ENST00000557579:exon3:c.G123A:p.P41P,ENSG00000129473:ENST00000553824:exon4:c.G123A:p.P41P	BCL2L2:NM_001199839:exon3:c.G123A:p.P41P,BCL2L2-PABPN1:NM_001199864:exon3:c.G123A:p.P41P,BCL2L2:NM_004050:exon3:c.G123A:p.P41P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2611	0.1787	0.249002	MU154552	.	.	.	.	.	.	.	.	BCL2L2:uc001wji.4:exon2:c.G123A:p.P41P,BCL2L2:uc001wjg.4:exon3:c.G123A:p.P41P,BCL2L2-PABPN1:uc001wjh.4:exon3:c.G123A:p.P41P,BCL2L2:uc021rqx.1:exon3:c.G123A:p.P41P	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.2167,EAS:0.3484,FIN:0.2185,NFE:0.5286,OTH:0.3300,ASJ:0.0810	.	.	.	.	.	.	.	.	.	.	.	.	14	9(soft_tissue)	0.2261
14	23777374	23777374	A	G	BCL2L2;BCL2L2-PABPN1	exonic	nonsynonymous SNV	ENSG00000129473;ENSG00000258643	rs910332	ENSG00000258643:ENST00000557008:exon2:c.A398G:p.Q133R,ENSG00000129473:ENST00000250405:exon3:c.A398G:p.Q133R,ENSG00000258643:ENST00000553781:exon3:c.A398G:p.Q133R,ENSG00000258643:ENST00000556100:exon3:c.A398G:p.Q133R,ENSG00000129473:ENST00000557236:exon3:c.A398G:p.Q133R,ENSG00000129473:ENST00000557579:exon3:c.A398G:p.Q133R	BCL2L2:NM_001199839:exon3:c.A398G:p.Q133R,BCL2L2-PABPN1:NM_001199864:exon3:c.A398G:p.Q133R,BCL2L2:NM_004050:exon3:c.A398G:p.Q133R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9979	0.9977	0.999401	0.9983	-0.797	0.043	0.187	1.43	0.992	.	.	.	BCL2L2:uc001wji.4:exon2:c.A398G:p.Q133R,BCL2L2:uc001wjg.4:exon3:c.A398G:p.Q133R,BCL2L2-PABPN1:uc001wjh.4:exon3:c.A398G:p.Q133R,BCL2L2:uc021rqx.1:exon3:c.A398G:p.Q133R	-1.011	AFR:0.9993,AMR:0.9988,EAS:1,FIN:1,NFE:0.9970,OTH:0.9990,ASJ:1	.	.	.	.	.	.	.	.	0.0	1.1	0.000	0.11	14	MU4559093	hom
14	23902753	23902753	G	A	MYH7	exonic	synonymous SNV	ENSG00000092054	rs2069540	ENSG00000092054:ENST00000355349:exon3:c.C189T:p.T63T	MYH7:NM_000257:exon3:c.C189T:p.T63T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4888	0.5275	0.520367	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MYH7:uc001wjx.3:exon3:c.C189T:p.T63T	.	AFR:0.5085,AMR:0.6281,EAS:0.4603,FIN:0.3933,NFE:0.4186,OTH:0.4778,ASJ:0.4510	160760	160500;181430;192600;255160;608358;613426;	154;54260;53698;53698;437572;59135;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~53698|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|255160 608358 ~437572|MYH7-related late-onset SPMD<br>MYH7-related late-onset scapuloperoneal syndrome|<1 / 1 000 000|Autosomal dominant|Adult|181430 ~59135|Distal myopathy type 1<br>Gowers disease<br>MPD1|Unknown|Autosomal dominant|Childhood|160500 ~	.	.	.	.	.	.	.	.	14	1(large_intestine)	0.4898
14	30194899	30194899	T	C	PRKD1	intronic	.	ENSG00000184304	rs11626603	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1972	0.1821	0.164537	0.1821	.	.	.	.	.	.	.	.	.	.	AFR:0.1315,AMR:0.2584,EAS:0.0438,FIN:0.1874,NFE:0.2180,OTH:0.2138,ASJ:0.2285	605435	.	.	.	.	.	.	.	.	.	.	.	14	MU82277372	het
14	35242828	35242828	G	A	BAZ1A	exonic	synonymous SNV	ENSG00000198604	rs2275145	ENSG00000198604:ENST00000358716:exon19:c.C3006T:p.D1002D,ENSG00000198604:ENST00000382422:exon19:c.C3102T:p.D1034D,ENSG00000198604:ENST00000360310:exon20:c.C3102T:p.D1034D	BAZ1A:NM_182648:exon19:c.C3006T:p.D1002D,BAZ1A:NM_013448:exon20:c.C3102T:p.D1034D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5180	0.4943	0.515375	0.5217	.	.	.	.	.	.	.	.	BAZ1A:uc001wsl.3:exon19:c.C3006T:p.D1002D,BAZ1A:uc001wsk.3:exon20:c.C3102T:p.D1034D	.	AFR:0.4800,AMR:0.5744,EAS:0.4715,FIN:0.5963,NFE:0.5292,OTH:0.5609,ASJ:0.5	605680	.	.	.	.	.	.	.	.	.	.	.	14	MU643123	het
14	35871217	35871217	G	A	NFKBIA	UTR3	.	ENSG00000100906	rs8904	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4011	0.4449	0.447883	MU4606592	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874,AMR:0.4551,EAS:0.3246,FIN:0.41,NFE:0.4278,OTH:0.4064,ASJ:0.6007	164008	612132;	238468;98813;	238468|Anhidrotic ectodermal dysplasia<br>HED|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|129490 224900 300291 305100 612132 614940 614941 ~98813|Anhidrotic ectodermal dysplasia with immunodeficiency<br>EDA-ID<br>HED-ID|Unknown|Autosomal dominant<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300291 612132 ~	~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04210 Apoptosis~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	14	1(urinary_tract)	0.3957
14	35873770	35873770	G	A	NFKBIA	exonic	synonymous SNV	ENSG00000100906	rs1957106	ENSG00000100906:ENST00000216797:exon1:c.C81T:p.D27D,ENSG00000100906:ENST00000553342:exon1:c.C81T:p.D27D,ENSG00000100906:ENST00000554001:exon1:c.C81T:p.D27D,ENSG00000100906:ENST00000557140:exon1:c.C81T:p.D27D	NFKBIA:NM_020529:exon1:c.C81T:p.D27D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3431	0.2287	0.244409	12(soft_tissue)	.	.	.	.	.	.	.	.	NFKBIA:uc001wtf.4:exon1:c.C81T:p.D27D	.	AFR:1(stomach),AMR:MU122904,EAS:0.2779,FIN:0.1469,NFE:0.2062,OTH:0.2033,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	164008	612132;	238468;98813;	238468|Anhidrotic ectodermal dysplasia<br>HED|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|129490 224900 300291 305100 612132 614940 614941 ~98813|Anhidrotic ectodermal dysplasia with immunodeficiency<br>EDA-ID<br>HED-ID|Unknown|Autosomal dominant<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300291 612132 ~	~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04064 NF-kappa B signaling pathway~ko04210 Apoptosis~ko04380 Osteoclast differentiation~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04623 Cytosolic DNA-sensing pathway~ko04624 Toll and Imd signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04926 Relaxin signaling pathway~ko04931 Insulin resistance~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05130 Pathogenic Escherichia coli infection~ko05131 Shigellosis~ko05134 Legionellosis~ko05135 Yersinia infection~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05222 Small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	14	1(large_intestine)	0.2491
14	39650234	39650234	A	T	PNN	exonic	nonsynonymous SNV	ENSG00000100941	rs2180792	ENSG00000100941:ENST00000216832:exon9:c.A1321T:p.T441S	PNN:NM_002687:exon9:c.A1321T:p.T441S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9155	0.9383	0.902955	0.9305	-1.118	0.009	0.642	3.5	0.998	.	.	.	PNN:uc001wuw.4:exon9:c.A1321T:p.T441S	-0.938	AFR:0.9297,AMR:0.8473,EAS:0.95,FIN:0.9210,NFE:0.9360,OTH:0.9277,ASJ:0.9238	603154	.	.	.	.	.	.	.	.	0.95	0.000	.	14	MU81947250	hom
14	39650824	39650824	C	T	PNN	exonic	synonymous SNV	ENSG00000100941	rs1050136	ENSG00000100941:ENST00000216832:exon9:c.C1911T:p.G637G	PNN:NM_002687:exon9:c.C1911T:p.G637G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0813	0.0573	0.0984425	0.0613	.	.	.	.	.	.	.	.	PNN:uc001wuw.4:exon9:c.C1911T:p.G637G	.	AFR:0.0153,AMR:0.0800,EAS:0.3302,FIN:0.0335,NFE:0.0644,OTH:0.0583,ASJ:0.0894	603154	.	.	.	.	.	.	.	.	.	.	.	14	MU12464953	het
14	39650924	39650924	A	G	PNN	exonic	nonsynonymous SNV	ENSG00000100941	rs13021	ENSG00000100941:ENST00000216832:exon9:c.A2011G:p.S671G	PNN:NM_002687:exon9:c.A2011G:p.S671G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1066	0.0979	0.125998	MU12464962	2.934	22.0	0.017	4.74	1.000	.	.	.	PNN:uc001wuw.4:exon9:c.A2011G:p.S671G	-0.902	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.0945,EAS:0.0895,FIN:0.0993,NFE:0.3294,OTH:0.0625,ASJ:0.0680	603154	.	.	.	.	.	.	.	0.924	2.53	0.000	0.46	14	2(breast)	0.0928
14	45645715	45645715	A	G	FANCM	exonic	nonsynonymous SNV	ENSG00000187790	rs45604036	ENSG00000187790:ENST00000556250:exon7:c.A2306G:p.N769S,ENSG00000187790:ENST00000542564:exon13:c.A3680G:p.N1227S,ENSG00000187790:ENST00000267430:exon14:c.A3758G:p.N1253S	FANCM:NM_001308133:exon13:c.A3680G:p.N1227S,FANCM:NM_020937:exon14:c.A3758G:p.N1253S	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0253	0.0207	0.0129792	0.0263	-2.101	0.001	0.395	-3.85	0.000	.	.	.	FANCM:uc010ang.3:exon1:c.A1400G:p.N467S,FANCM:uc001wwe.4:exon7:c.A2366G:p.N789S,FANCM:uc010anf.3:exon13:c.A3680G:p.N1227S,FANCM:uc001wwd.4:exon14:c.A3758G:p.N1253S	-1.036	AFR:0.0044,AMR:0.0095,EAS:0,FIN:0.0446,NFE:0.0384,OTH:0.0316,ASJ:0.0199	609644	.	.	.	.	.	.	.	0.0	2.85	0.010	1.69	14	.	het
14	50585574	50585574	-	A	SOS2	intronic	.	ENSG00000100485	rs10658395	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.5487	0.5416	0.503195	0.5770	.	.	.	.	.	.	.	.	.	.	AFR:0.4899,AMR:0.6117,EAS:0.4665,FIN:0.5593,NFE:0.6352,OTH:0.5907,ASJ:0.7143	601247	616559;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04926 Relaxin signaling pathway~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	14	.	hom
14	50616878	50616878	G	A	SOS2	exonic	synonymous SNV	ENSG00000100485	rs2229869	ENSG00000100485:ENST00000543680:exon13:c.C2133T:p.N711N,ENSG00000100485:ENST00000216373:exon14:c.C2232T:p.N744N	SOS2:NM_006939:exon14:c.C2232T:p.N744N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6215	0.6080	0.518371	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	SOS2:uc010tql.2:exon13:c.C2133T:p.N711N,SOS2:uc001wxs.4:exon14:c.C2232T:p.N744N	.	AFR:0.5881,AMR:0.4507,EAS:0.7318,FIN:0.4173,NFE:0.5965,OTH:0.6749,ASJ:0.6555	601247	616559;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04926 Relaxin signaling pathway~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	14	1(lung)	0.6306
14	50671133	50671133	A	G	SOS2	intronic	.	ENSG00000100485	rs12888783	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3437	0.3188	0.242013	0.3229	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.1315,AMR:0.2200,EAS:0.2107,FIN:0.3932,NFE:0.4303,OTH:0.3839,ASJ:0.4007	601247	616559;	648;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04062 Chemokine signaling pathway~ko04068 FoxO signaling pathway~ko04072 Phospholipase D signaling pathway~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04320 Dorso-ventral axis formation~ko04510 Focal adhesion~ko04540 Gap junction~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04714 Thermogenesis~ko04722 Neurotrophin signaling pathway~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04926 Relaxin signaling pathway~ko05034 Alcoholism~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05231 Choline metabolism in cancer ~	.	.	.	.	.	.	.	14	MU44570373	het
14	51192659	51192659	G	A	NIN	exonic	synonymous SNV	ENSG00000100503	rs1983764	ENSG00000100503:ENST00000382043:exon28:c.C4065T:p.P1355P,ENSG00000100503:ENST00000382041:exon30:c.C6204T:p.P2068P	NIN:NM_016350:exon29:c.C4065T:p.P1355P,NIN:NM_182946:exon30:c.C6204T:p.P2068P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3321	0.2643	0.244609	ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	NIN:uc001wyk.3:exon29:c.C4065T:p.P1355P,NIN:uc001wym.2:exon30:c.C6204T:p.P2068P	.	AFR:0.2928,AMR:0.0781,EAS:0.3067,FIN:0.3238,NFE:0.4203,OTH:0.3811,ASJ:0.2835	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	1(large_intestine)	0.3538
14	51204996	51204996	C	T	NIN	exonic	synonymous SNV	ENSG00000100503	rs11376	ENSG00000100503:ENST00000485005:exon2:c.G90A:p.Q30Q,ENSG00000100503:ENST00000382043:exon25:c.G3498A:p.Q1166Q,ENSG00000100503:ENST00000530997:exon25:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000389868:exon26:c.G3498A:p.Q1166Q,ENSG00000100503:ENST00000245441:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000324330:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000382041:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000453196:exon27:c.G5637A:p.Q1879Q,ENSG00000100503:ENST00000476352:exon27:c.G5637A:p.Q1879Q	NIN:NM_016350:exon26:c.G3498A:p.Q1166Q,NIN:NM_020921:exon27:c.G5637A:p.Q1879Q,NIN:NM_182944:exon27:c.G5637A:p.Q1879Q,NIN:NM_182946:exon27:c.G5637A:p.Q1879Q	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5044	0.5779	0.508786	0.5656	.	.	.	.	.	.	.	.	NIN:uc001wyk.3:exon26:c.G3498A:p.Q1166Q,NIN:uc001wyi.3:exon27:c.G5637A:p.Q1879Q,NIN:uc001wym.2:exon27:c.G5637A:p.Q1879Q,NIN:uc001wyo.3:exon27:c.G5637A:p.Q1879Q	.	AFR:0.6990,AMR:0.4125,EAS:0.3525,FIN:0.5467,NFE:0.5282,OTH:0.5092,ASJ:0.5533	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU23624074	hom
14	51206021	51206021	A	G	NIN	intronic	.	ENSG00000100503	rs3015485	.	.	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9976	0.9913	0.992612	0.9927	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.9748,AMR:0.9988,EAS:1,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU81947943	hom
14	51219398	51219398	A	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs199684809	ENSG00000100503:ENST00000382043:exon19:c.T2649C:p.L883L,ENSG00000100503:ENST00000530997:exon19:c.T4788C:p.L1596L,ENSG00000100503:ENST00000389868:exon20:c.T2649C:p.L883L,ENSG00000100503:ENST00000245441:exon21:c.T4788C:p.L1596L,ENSG00000100503:ENST00000324330:exon21:c.T4788C:p.L1596L,ENSG00000100503:ENST00000382041:exon21:c.T4788C:p.L1596L,ENSG00000100503:ENST00000453196:exon21:c.T4788C:p.L1596L,ENSG00000100503:ENST00000476352:exon21:c.T4788C:p.L1596L	NIN:NM_016350:exon20:c.T2649C:p.L883L,NIN:NM_020921:exon21:c.T4788C:p.L1596L,NIN:NM_182944:exon21:c.T4788C:p.L1596L,NIN:NM_182946:exon21:c.T4788C:p.L1596L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0051	.	0.00998403	0.0002	.	.	.	.	.	.	.	.	NIN:uc001wyk.3:exon20:c.T2649C:p.L883L,NIN:uc001wyi.3:exon21:c.T4788C:p.L1596L,NIN:uc001wym.2:exon21:c.T4788C:p.L1596L,NIN:uc001wyo.3:exon21:c.T4788C:p.L1596L	.	AFR:0.0001,AMR:0,EAS:0.0006,FIN:0,NFE:0.0001,OTH:0.0031,ASJ:0	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	.	het
14	51223789	51223789	C	T	NIN	exonic	nonsynonymous SNV	ENSG00000100503	rs2073347	ENSG00000100503:ENST00000530997:exon16:c.G3959A:p.G1320E,ENSG00000100503:ENST00000245441:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000324330:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000382041:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000453196:exon18:c.G3959A:p.G1320E,ENSG00000100503:ENST00000476352:exon18:c.G3959A:p.G1320E	NIN:NM_020921:exon18:c.G3959A:p.G1320E,NIN:NM_182944:exon18:c.G3959A:p.G1320E,NIN:NM_182946:exon18:c.G3959A:p.G1320E	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7454	0.7922	0.764377	MU28671496	1.353	12.54	1.0	6.06	0.945	.	.	.	NIN:uc001wyi.3:exon18:c.G3959A:p.G1320E,NIN:uc001wym.2:exon18:c.G3959A:p.G1320E,NIN:uc001wyo.3:exon18:c.G3959A:p.G1320E	-0.997	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7599,EAS:0.8353,FIN:0.8245,NFE:0.6617,OTH:0.6770,ASJ:0.8613	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	0.0	3.8	0.000	-2.085	14	2(lung)	0.7277
14	51224289	51224289	C	T	NIN	exonic	synonymous SNV	ENSG00000100503	rs41310342	ENSG00000100503:ENST00000530997:exon16:c.G3459A:p.R1153R,ENSG00000100503:ENST00000245441:exon18:c.G3459A:p.R1153R,ENSG00000100503:ENST00000324330:exon18:c.G3459A:p.R1153R,ENSG00000100503:ENST00000382041:exon18:c.G3459A:p.R1153R,ENSG00000100503:ENST00000453196:exon18:c.G3459A:p.R1153R,ENSG00000100503:ENST00000476352:exon18:c.G3459A:p.R1153R	NIN:NM_020921:exon18:c.G3459A:p.R1153R,NIN:NM_182944:exon18:c.G3459A:p.R1153R,NIN:NM_182946:exon18:c.G3459A:p.R1153R	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0162	0.0151	0.00778754	0.0229	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon18:c.G3459A:p.R1153R,NIN:uc001wym.2:exon18:c.G3459A:p.R1153R,NIN:uc001wyo.3:exon18:c.G3459A:p.R1153R	.	AFR:0.0040,AMR:0.0036,EAS:0,FIN:0.0601,NFE:0.0289,OTH:0.0245,ASJ:0.0133	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	.	het
14	51224374	51224374	T	G	NIN	exonic	nonsynonymous SNV	ENSG00000100503	rs12882191	ENSG00000100503:ENST00000530997:exon16:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000245441:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000324330:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000382041:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000453196:exon18:c.A3374C:p.Q1125P,ENSG00000100503:ENST00000476352:exon18:c.A3374C:p.Q1125P	NIN:NM_020921:exon18:c.A3374C:p.Q1125P,NIN:NM_182944:exon18:c.A3374C:p.Q1125P,NIN:NM_182946:exon18:c.A3374C:p.Q1125P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7533	0.8076	0.784944	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	-2.411	0.001	1.0	4.07	0.000	.	.	.	NIN:uc001wyi.3:exon18:c.A3374C:p.Q1125P,NIN:uc001wym.2:exon18:c.A3374C:p.Q1125P,NIN:uc001wyo.3:exon18:c.A3374C:p.Q1125P	-1.024	AFR:0.7732,AMR:0.9003,EAS:0.8245,FIN:0.6792,NFE:0.6768,OTH:0.7299,ASJ:0.8421	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	0.0	3.58	0.000	-2.125	14	1(liver)	0.7281
14	51226730	51226730	G	A	NIN	exonic	synonymous SNV	ENSG00000100503	rs200278498	ENSG00000100503:ENST00000530997:exon15:c.C2244T:p.S748S,ENSG00000100503:ENST00000382043:exon16:c.C2244T:p.S748S,ENSG00000100503:ENST00000245441:exon17:c.C2244T:p.S748S,ENSG00000100503:ENST00000324330:exon17:c.C2244T:p.S748S,ENSG00000100503:ENST00000382041:exon17:c.C2244T:p.S748S,ENSG00000100503:ENST00000389868:exon17:c.C2244T:p.S748S,ENSG00000100503:ENST00000453196:exon17:c.C2244T:p.S748S,ENSG00000100503:ENST00000476352:exon17:c.C2244T:p.S748S	NIN:NM_016350:exon17:c.C2244T:p.S748S,NIN:NM_020921:exon17:c.C2244T:p.S748S,NIN:NM_182944:exon17:c.C2244T:p.S748S,NIN:NM_182946:exon17:c.C2244T:p.S748S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0050	.	0.00998403	0.0002	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon17:c.C2244T:p.S748S,NIN:uc001wyk.3:exon17:c.C2244T:p.S748S,NIN:uc001wym.2:exon17:c.C2244T:p.S748S,NIN:uc001wyo.3:exon17:c.C2244T:p.S748S	.	AFR:0.0001,AMR:0,EAS:0.0006,FIN:0,NFE:0.0001,OTH:0.0031,ASJ:0	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	.	het
14	51237701	51237701	A	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs17793018	ENSG00000100503:ENST00000530997:exon9:c.T1128C:p.V376V,ENSG00000100503:ENST00000382043:exon10:c.T1128C:p.V376V,ENSG00000100503:ENST00000245441:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000324330:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000382041:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000389868:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000453196:exon11:c.T1128C:p.V376V,ENSG00000100503:ENST00000453401:exon11:c.T1014C:p.V338V,ENSG00000100503:ENST00000476352:exon11:c.T1128C:p.V376V	NIN:NM_016350:exon11:c.T1128C:p.V376V,NIN:NM_020921:exon11:c.T1128C:p.V376V,NIN:NM_182944:exon11:c.T1128C:p.V376V,NIN:NM_182946:exon11:c.T1128C:p.V376V	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6207	0.5033	0.577276	0.5651	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon11:c.T1128C:p.V376V,NIN:uc001wyk.3:exon11:c.T1128C:p.V376V,NIN:uc001wym.2:exon11:c.T1128C:p.V376V,NIN:uc001wyo.3:exon11:c.T1128C:p.V376V,NIN:uc001wyp.1:exon11:c.T1014C:p.V338V	.	AFR:0.2872,AMR:0.6611,EAS:0.8744,FIN:0.6938,NFE:0.6522,OTH:0.6663,ASJ:0.5232	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU123123	het
14	51239067	51239067	C	G	NIN	exonic	synonymous SNV	ENSG00000100503	rs8020503	ENSG00000100503:ENST00000530997:exon7:c.G933C:p.L311L,ENSG00000100503:ENST00000382043:exon8:c.G933C:p.L311L,ENSG00000100503:ENST00000245441:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000324330:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000382041:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000389868:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000453196:exon9:c.G933C:p.L311L,ENSG00000100503:ENST00000453401:exon9:c.G819C:p.L273L,ENSG00000100503:ENST00000476352:exon9:c.G933C:p.L311L	NIN:NM_016350:exon9:c.G933C:p.L311L,NIN:NM_020921:exon9:c.G933C:p.L311L,NIN:NM_182944:exon9:c.G933C:p.L311L,NIN:NM_182946:exon9:c.G933C:p.L311L	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9973	0.9907	0.992412	0.9924	.	.	.	.	.	.	.	.	NIN:uc001wyi.3:exon9:c.G933C:p.L311L,NIN:uc001wyk.3:exon9:c.G933C:p.L311L,NIN:uc001wym.2:exon9:c.G933C:p.L311L,NIN:uc001wyo.3:exon9:c.G933C:p.L311L,NIN:uc001wyp.1:exon9:c.G819C:p.L273L	.	AFR:0.9735,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9980,ASJ:1	608684	614851;	319675;	319675|-|<1 / 1 000 000|-|Antenatal<br>Neonatal|614851 ~	.	.	.	.	.	.	.	.	14	MU81947976	hom
14	51372099	51372099	A	-	PYGL	UTR3	.	ENSG00000100504	rs3216001	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3614	0.3356	0.458866	0.3574	.	.	.	.	.	.	.	.	.	.	AFR:0.4598,AMR:0.5871,EAS:0.5943,FIN:0.2935,NFE:0.2785,OTH:0.3323,ASJ:0.2550	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	MU116276890	unknown
14	51372103	51372103	C	G	PYGL	UTR3	.	ENSG00000100504	rs1042266	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2357	0.1501	0.250998	0.1783	.	.	.	.	.	.	.	.	.	.	AFR:0.0687,AMR:0.4606,EAS:0.4414,FIN:0.2011,NFE:0.1895,OTH:0.2285,ASJ:0.1788	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	MU30067353	unknown
14	51378591	51378591	T	-	PYGL	splicing	.	ENSG00000100504	rs11356035	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4379	0.4435	0.551917	0.4559	.	.	.	.	.	.	.	.	.	.	AFR:0.6589,AMR:0.6253,EAS:0.6043,FIN:0.3460,NFE:0.3433,OTH:0.4031,ASJ:0.3576	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	MU149537	het
14	51383432	51383432	G	A	PYGL	exonic	synonymous SNV	ENSG00000100504	rs2075643	ENSG00000100504:ENST00000544180:exon8:c.C918T:p.D306D,ENSG00000100504:ENST00000216392:exon9:c.C1020T:p.D340D,ENSG00000100504:ENST00000532462:exon9:c.C1020T:p.D340D	PYGL:NM_001163940:exon8:c.C918T:p.D306D,PYGL:NM_002863:exon9:c.C1020T:p.D340D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2253	0.1382	0.235423	LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	PYGL:uc010anz.1:exon5:c.C429T:p.D143D,PYGL:uc010tqq.2:exon8:c.C918T:p.D306D,PYGL:uc001wyu.3:exon9:c.C1020T:p.D340D	.	AFR:0.1684,AMR:0.0619,EAS:0.1556,FIN:0.4379,NFE:0.1943,OTH:0.1782,ASJ:0.4258	613741	232700;	369;	369|GSD due to liver glycogen phosphorylase deficiency<br>GSD type 6<br>GSD type VI<br>Glycogen storage disease type 6<br>Glycogen storage disease type VI<br>Glycogenosis due to liver glycogen phosphorylase deficiency<br>Glycogenosis type 6<br>Glycogenosis type VI<br>Hepatic glycogen phosphorylase deficiency<br>Hepatic phosphorylase deficiency<br>Hers disease<br>Liver glycogen phosphorylase deficiency|Unknown|Autosomal recessive|Childhood|232700 ~	.	.	.	.	.	.	.	.	14	1(urinary_tract)	0.2173
14	58768333	58768333	C	T	ARID4A	exonic	synonymous SNV	ENSG00000032219	rs45562837	ENSG00000032219:ENST00000431317:exon2:c.C42T:p.T14T,ENSG00000032219:ENST00000348476:exon3:c.C42T:p.T14T,ENSG00000032219:ENST00000355431:exon3:c.C42T:p.T14T,ENSG00000032219:ENST00000395168:exon3:c.C42T:p.T14T,ENSG00000032219:ENST00000424658:exon3:c.C42T:p.T14T,ENSG00000032219:ENST00000431612:exon3:c.C42T:p.T14T	ARID4A:NM_002892:exon3:c.C42T:p.T14T,ARID4A:NM_023000:exon3:c.C42T:p.T14T,ARID4A:NM_023001:exon3:c.C42T:p.T14T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0661	0.0557	0.0459265	0.0538	.	.	.	.	.	.	.	.	ARID4A:uc001xdo.3:exon3:c.C42T:p.T14T,ARID4A:uc001xdp.3:exon3:c.C42T:p.T14T,ARID4A:uc001xdq.3:exon3:c.C42T:p.T14T	.	AFR:0.0199,AMR:0.0299,EAS:0.0018,FIN:0.0711,NFE:0.0767,OTH:0.0460,ASJ:0.0629	180201	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	58831142	58831142	A	G	ARID4A	exonic	nonsynonymous SNV	ENSG00000032219	rs1051858	ENSG00000032219:ENST00000417477:exon10:c.A1369G:p.T457A,ENSG00000032219:ENST00000431317:exon19:c.A2335G:p.T779A,ENSG00000032219:ENST00000348476:exon20:c.A2335G:p.T779A,ENSG00000032219:ENST00000355431:exon20:c.A2335G:p.T779A,ENSG00000032219:ENST00000395168:exon20:c.A2335G:p.T779A	ARID4A:NM_002892:exon20:c.A2335G:p.T779A,ARID4A:NM_023000:exon20:c.A2335G:p.T779A,ARID4A:NM_023001:exon20:c.A2335G:p.T779A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3469	0.3343	0.349441	ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,COCA-CN|6|321|0.0186916	-0.834	0.036	1.0	1.52	0.981	.	.	.	ARID4A:uc010apg.1:exon10:c.A1369G:p.T457A,ARID4A:uc001xdo.3:exon20:c.A2335G:p.T779A,ARID4A:uc001xdp.3:exon20:c.A2335G:p.T779A,ARID4A:uc001xdq.3:exon20:c.A2335G:p.T779A	-0.927	AFR:0.3607,AMR:0.3597,EAS:0.2252,FIN:0.4833,NFE:0.4114,OTH:0.3438,ASJ:0.2957	180201	.	.	.	.	.	.	.	0.0	2.59	0.000	-0.345	14	1(pancreas)	0.3447
14	61445967	61445967	A	G	TRMT5	exonic	nonsynonymous SNV	ENSG00000126814	rs7142228	ENSG00000126814:ENST00000261249:exon2:c.T649C:p.S217P	TRMT5:NM_001350253:exon2:c.T733C:p.S245P,TRMT5:NM_001350254:exon2:c.T730C:p.S244P,TRMT5:NM_020810:exon2:c.T649C:p.S217P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	TRMT5:uc001xff.4:exon2:c.T649C:p.S217P	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	611023	616539;	.	.	.	.	.	.	.	.	.	.	14	MU81949241	hom
14	67147816	67147816	T	C	GPHN	intronic	.	ENSG00000171723	rs3759753	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2661	0.3141	0.45028	MU583252	.	.	.	.	.	0.0001	0.024	.	.	.	AFR:COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.3165,EAS:0.4017,FIN:0.2483,NFE:0.4813,OTH:0.1581,ASJ:0.6641	603930	615501;	308400;833;99732;	308400|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C<br>MOCOD type C|-|-|-|615501 ~833|-|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|252150 252160 272300 615501 ~99732|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase<br>MOCOD|-|-|-|252150 252160 615501 ~	.	.	.	.	.	.	.	.	14	2(haematopoietic_and_lymphoid_tissue)	0.1373
14	67291186	67291186	T	C	GPHN	intronic	.	ENSG00000171723	rs3784075	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1856	0.2184	0.38119	MU645105	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.2249,EAS:0.3301,FIN:0.0695,NFE:0.4763,OTH:0.0866,ASJ:0.5662	603930	615501;	308400;833;99732;	308400|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C<br>MOCOD type C|-|-|-|615501 ~833|-|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|252150 252160 272300 615501 ~99732|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase<br>MOCOD|-|-|-|252150 252160 615501 ~	.	.	.	.	.	.	.	.	14	1(haematopoietic_and_lymphoid_tissue)	0.0364
14	67390981	67390981	A	G	GPHN	exonic	nonsynonymous SNV	ENSG00000171723	rs41285470	ENSG00000171723:ENST00000459628:exon8:c.A746G:p.N249S,ENSG00000171723:ENST00000478722:exon8:c.A800G:p.N267S	GPHN:NM_020806:exon8:c.A800G:p.N267S	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0065	0.0056	0.00499201	0.0055	-0.343	0.527	1.0	-6.2	0.998	.	.	.	GPHN:uc010tsu.2:exon6:c.A470G:p.N157S,GPHN:uc001xiw.3:exon8:c.A746G:p.N249S,GPHN:uc001xix.3:exon8:c.A800G:p.N267S	-1.059	AFR:0.0018,AMR:0.0024,EAS:0,FIN:0.0086,NFE:0.0074,OTH:0.0071,ASJ:0.0099	603930	615501;	308400;833;99732;	308400|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C<br>MOCOD type C|-|-|-|615501 ~833|-|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|252150 252160 272300 615501 ~99732|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase<br>MOCOD|-|-|-|252150 252160 615501 ~	.	.	.	.	0.0	.	0.068	.	14	.	het
14	67646281	67646281	A	T	GPHN	intronic	.	ENSG00000171723	rs56264248	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0630	0.0709	0.0411342	0.0663	.	.	.	.	.	.	.	.	.	.	AFR:0.0498,AMR:0.0467,EAS:0.0056,FIN:0.0640,NFE:0.0839,OTH:0.0729,ASJ:0.0530	603930	615501;	308400;833;99732;	308400|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C<br>MOCOD type C|-|-|-|615501 ~833|-|Unknown|Autosomal recessive|Infancy<br>Neonatal<br>Antenatal|252150 252160 272300 615501 ~99732|Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase<br>MOCOD|-|-|-|252150 252160 615501 ~	.	.	.	.	.	.	.	.	14	MU113414017	unknown
14	75483812	75483812	T	C	MLH3	exonic	synonymous SNV	ENSG00000119684	rs13712	ENSG00000119684:ENST00000554697:exon4:c.A348G:p.Q116Q,ENSG00000119684:ENST00000556257:exon7:c.A3801G:p.Q1267Q,ENSG00000119684:ENST00000238662:exon12:c.A4263G:p.Q1421Q,ENSG00000119684:ENST00000380968:exon12:c.A1149G:p.Q383Q,ENSG00000119684:ENST00000556740:exon12:c.A4335G:p.Q1445Q,ENSG00000119684:ENST00000355774:exon13:c.A4335G:p.Q1445Q	MLH3:NM_014381:exon12:c.A4263G:p.Q1421Q,MLH3:NM_001040108:exon13:c.A4335G:p.Q1445Q	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5634	0.5019	0.580072	0.5295	.	.	.	.	.	.	.	.	MLH3:uc001xre.1:exon12:c.A4263G:p.Q1421Q,MLH3:uc001xrd.1:exon13:c.A4335G:p.Q1445Q	.	AFR:0.4433,AMR:0.7076,EAS:0.8401,FIN:0.5384,NFE:0.5341,OTH:0.5491,ASJ:0.4570	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	.	.	.	.	14	MU16492371	het
14	75513828	75513828	G	A	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	rs175080	ENSG00000119684:ENST00000556740:exon1:c.C2531T:p.P844L,ENSG00000119684:ENST00000238662:exon2:c.C2531T:p.P844L,ENSG00000119684:ENST00000355774:exon2:c.C2531T:p.P844L,ENSG00000119684:ENST00000556257:exon2:c.C2531T:p.P844L	MLH3:NM_001040108:exon2:c.C2531T:p.P844L,MLH3:NM_014381:exon2:c.C2531T:p.P844L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4126	0.4426	0.363818	MU112082	0.239	5.081	0.286	4.12	0.920	.	.	.	MLH3:uc001xrd.1:exon2:c.C2531T:p.P844L,MLH3:uc001xre.1:exon2:c.C2531T:p.P844L	-0.979	AFR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,AMR:0.4205,EAS:0.2788,FIN:0.5397,NFE:0.1481,OTH:0.4607,ASJ:0.3988	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.01	-1.43	0.000	1.15	14	2(lung)	0.4575
14	75513883	75513883	T	C	MLH3	exonic	nonsynonymous SNV	ENSG00000119684	rs175081	ENSG00000119684:ENST00000556740:exon1:c.A2476G:p.N826D,ENSG00000119684:ENST00000238662:exon2:c.A2476G:p.N826D,ENSG00000119684:ENST00000355774:exon2:c.A2476G:p.N826D,ENSG00000119684:ENST00000556257:exon2:c.A2476G:p.N826D	MLH3:NM_001040108:exon2:c.A2476G:p.N826D,MLH3:NM_014381:exon2:c.A2476G:p.N826D	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9968	0.9888	0.990415	0.9902	-0.981	0.017	0.848	1.33	0.019	.	.	.	MLH3:uc001xrd.1:exon2:c.A2476G:p.N826D,MLH3:uc001xre.1:exon2:c.A2476G:p.N826D	-0.969	AFR:0.9660,AMR:0.9988,EAS:0.9994,FIN:1,NFE:0.9999,OTH:0.9969,ASJ:1	604395	114500;608089;614385;	144;	144|-|Unknown|Autosomal dominant|Adult|120435 609310 613244 614331 614337 614350 614385 ~	.	.	.	.	0.001	-1.3	0.000	0	14	MU81951479	hom
14	81422178	81422178	C	A	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs2234919	ENSG00000165409:ENST00000298171:exon1:c.C154A:p.P52T,ENSG00000165409:ENST00000342443:exon1:c.C154A:p.P52T,ENSG00000165409:ENST00000554263:exon1:c.C154A:p.P52T,ENSG00000165409:ENST00000554435:exon1:c.C154A:p.P52T,ENSG00000165409:ENST00000555326:exon1:c.C154A:p.P52T,ENSG00000165409:ENST00000541158:exon2:c.C154A:p.P52T	TSHR:NM_000369:exon1:c.C154A:p.P52T,TSHR:NM_001018036:exon1:c.C154A:p.P52T,TSHR:NM_001142626:exon1:c.C154A:p.P52T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0696	0.0466	0.0617013	.	1.177	11.63	0.619	0.664	0.974	.	.	Leucine-rich repeat domain, L domain-like	TSHR:uc001xvb.1:exon1:c.C154A:p.P52T,TSHR:uc001xvc.3:exon1:c.C154A:p.P52T,TSHR:uc001xvd.1:exon1:c.C154A:p.P52T,TSHR:uc010tvs.2:exon1:c.C154A:p.P52T	-1.091	AFR:0.0424,AMR:0.0131,EAS:0.1391,FIN:0.0105,NFE:0.0467,OTH:0.0592,ASJ:0.0263	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.007	0.2	0.014	0.55	14	1(soft_tissue)	0.0663
14	81558965	81558965	A	G	TSHR	intronic	.	ENSG00000165409	rs2241119	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1887	0.2688	0.29972	0.2612	.	.	.	.	.	.	.	.	.	.	AFR:0.5320,AMR:0.1050,EAS:0.3348,FIN:0.1544,NFE:0.1398,OTH:0.1531,ASJ:0.1225	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	MU13685464	hom
14	81562998	81562998	T	C	TSHR	exonic	synonymous SNV	ENSG00000165409	rs2075179	ENSG00000165409:ENST00000298171:exon7:c.T561C:p.N187N,ENSG00000165409:ENST00000342443:exon7:c.T561C:p.N187N,ENSG00000165409:ENST00000554263:exon7:c.T561C:p.N187N,ENSG00000165409:ENST00000554435:exon7:c.T561C:p.N187N,ENSG00000165409:ENST00000541158:exon8:c.T561C:p.N187N	TSHR:NM_000369:exon7:c.T561C:p.N187N,TSHR:NM_001018036:exon7:c.T561C:p.N187N,TSHR:NM_001142626:exon7:c.T561C:p.N187N	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1913	0.2697	0.30012	1(thyroid)	.	.	.	.	.	.	.	.	TSHR:uc001xvb.1:exon7:c.T561C:p.N187N,TSHR:uc001xvc.3:exon7:c.T561C:p.N187N,TSHR:uc001xvd.1:exon7:c.T561C:p.N187N,TSHR:uc010tvs.2:exon7:c.T561C:p.N187N	.	AFR:2(large_intestine),AMR:MU145337,EAS:0.2662,FIN:0.5338,NFE:0.1050,OTH:0.1225,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	3(soft_tissue)	0.3342
14	81574959	81574959	A	G	TSHR	exonic	synonymous SNV	ENSG00000165409	rs3783942	ENSG00000165409:ENST00000342443:exon9:c.A696G:p.L232L,ENSG00000165409:ENST00000554435:exon9:c.A759G:p.L253L	TSHR:NM_001018036:exon9:c.A696G:p.L232L,TSHR:NM_001142626:exon9:c.A759G:p.L253L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6468	0.6438	0.611222	0.6259	.	.	.	.	.	.	.	.	TSHR:uc001xvc.3:exon9:c.A696G:p.L232L,TSHR:uc010tvs.2:exon9:c.A759G:p.L253L	.	AFR:0.6285,AMR:0.6635,EAS:0.3247,FIN:0.6673,NFE:0.6404,OTH:0.6612,ASJ:0.7583	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	.	.	.	.	14	MU16499962	het
14	81575005	81575005	C	A	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs3783941	ENSG00000165409:ENST00000342443:exon9:c.C742A:p.R248S,ENSG00000165409:ENST00000554435:exon9:c.C805A:p.R269S	TSHR:NM_001018036:exon9:c.C742A:p.R248S,TSHR:NM_001142626:exon9:c.C805A:p.R269S	clinvar: not_provided 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6465	0.6425	0.610224	0.6233	0.085	3.453	1.0	-8.59	0.000	.	.	Leucine-rich repeat domain, L domain-like	TSHR:uc001xvc.3:exon9:c.C742A:p.R248S,TSHR:uc010tvs.2:exon9:c.C805A:p.R269S	-1.021	AFR:0.6213,AMR:0.6623,EAS:0.3224,FIN:0.6665,NFE:0.6397,OTH:0.6608,ASJ:0.7583	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.0	-1.17	0.000	.	14	MU16500020	het
14	81610583	81610583	G	C	TSHR	exonic	nonsynonymous SNV	ENSG00000165409	rs1991517	ENSG00000165409:ENST00000298171:exon10:c.G2181C:p.E727D,ENSG00000165409:ENST00000541158:exon11:c.G2181C:p.E727D	TSHR:NM_000369:exon10:c.G2181C:p.E727D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9004	0.9233	0.896765	0.8977	-1.490	0.003	1.0	2.08	0.751	.	.	.	TSHR:uc001xvd.1:exon10:c.G2181C:p.E727D	-0.975	AFR:0.9392,AMR:0.8675,EAS:0.8100,FIN:0.8495,NFE:0.8968,OTH:0.8798,ASJ:0.9106	603372	275200;603373;609152;	424;99819;90673;	424|Familial non-immune hyperthyroidism<br>Resistance to thyroid stimulating hormone|Unknown|Autosomal dominant|All ages|609152 ~99819|-|-|Autosomal dominant|-|603373 ~90673|-|Unknown|Autosomal recessive<br>or&nbsp;Autosomal dominant|Infancy<br>Neonatal|275200 ~	.	.	.	.	0.0	-0.92	0.000	.	14	MU19600230	hom
14	92441066	92441066	C	T	TRIP11	exonic	nonsynonymous SNV	ENSG00000100815	rs1051340	ENSG00000100815:ENST00000267622:exon19:c.G5479A:p.G1827S	TRIP11:NM_001321851:exon19:c.G5476A:p.G1826S,TRIP11:NM_004239:exon19:c.G5479A:p.G1827S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 1, 0] 	0.3155	0.2933	0.271366	0.2923	3.315	22.9	0.045	3.9	0.123	.	.	.	TRIP11:uc010auf.2:exon13:c.G4687A:p.G1563S,TRIP11:uc001xzy.3:exon19:c.G5479A:p.G1827S	-0.973	AFR:0.2330,AMR:0.2012,EAS:0.3263,FIN:0.3179,NFE:0.3196,OTH:0.3033,ASJ:0.3940	604505	200600;	932;93299;	932|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|200600 200610 600972 ~93299|Achondrogenesis, Houston-Harris type|Unknown|Autosomal recessive|Antenatal<br>Neonatal|200600 ~	.	.	.	.	0.973	3.52	0.000	1.805	14	MU126413	hom
14	93276654	93276654	T	C	GOLGA5	exonic	nonsynonymous SNV	ENSG00000066455	rs1040835	ENSG00000066455:ENST00000163416:exon5:c.T1048C:p.F350L,ENSG00000066455:ENST00000355976:exon5:c.T1048C:p.F350L	GOLGA5:NM_005113:exon5:c.T1048C:p.F350L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.7999	0.7962	0.859625	MU103194	1.303	12.28	1.0	4.75	0.990	.	.	.	GOLGA5:uc001yaz.1:exon5:c.T1048C:p.F350L	-0.989	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.8175,EAS:0.8484,FIN:0.7252,NFE:0.8802,OTH:0.8143,ASJ:0.9357	606918	.	.	.	.	.	.	.	0.0	2.73	0.000	-1.975	14	1(thyroid)	0.7439
14	94844843	94844843	T	G	SERPINA1	exonic	nonsynonymous SNV	ENSG00000197249	rs1303	ENSG00000197249:ENST00000355814:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000393087:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000440909:exon5:c.A1200C:p.E400D,ENSG00000197249:ENST00000404814:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000437397:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000449399:exon6:c.A1200C:p.E400D,ENSG00000197249:ENST00000393088:exon7:c.A1200C:p.E400D,ENSG00000197249:ENST00000448921:exon7:c.A1200C:p.E400D	SERPINA1:NM_000295:exon5:c.A1200C:p.E400D,SERPINA1:NM_001002235:exon5:c.A1200C:p.E400D,SERPINA1:NM_001127700:exon5:c.A1200C:p.E400D,SERPINA1:NM_001127702:exon6:c.A1200C:p.E400D,SERPINA1:NM_001127706:exon6:c.A1200C:p.E400D,SERPINA1:NM_001127707:exon6:c.A1200C:p.E400D,SERPINA1:NM_001002236:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127701:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127703:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127704:exon7:c.A1200C:p.E400D,SERPINA1:NM_001127705:exon7:c.A1200C:p.E400D	clinvar: Benign/Likely_benign,_other 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2747	0.2071	0.280351	3(stomach)	-2.890	0.001	1.0	-9.02	0.000	.	.	Serpin domain	SERPINA1:uc001ycx.4:exon5:c.A1200C:p.E400D,SERPINA1:uc001ycz.4:exon5:c.A1200C:p.E400D,SERPINA1:uc010aux.3:exon5:c.A1200C:p.E400D,SERPINA1:uc001ydc.4:exon6:c.A1200C:p.E400D,SERPINA1:uc010auz.3:exon6:c.A1200C:p.E400D,SERPINA1:uc010avb.3:exon6:c.A1200C:p.E400D,SERPINA1:uc001ycy.4:exon7:c.A1200C:p.E400D,SERPINA1:uc001ydb.4:exon7:c.A1200C:p.E400D,SERPINA1:uc010auw.3:exon7:c.A1200C:p.E400D,SERPINA1:uc010auy.3:exon7:c.A1200C:p.E400D,SERPINA1:uc010ava.3:exon7:c.A1200C:p.E400D	-0.918	AFR:4(haematopoietic_and_lymphoid_tissue),AMR:1(large_intestine),EAS:MU158468,FIN:LAML-KR|2|205|0.0097561,GACA-CN|1|123|0.00813008,COCA-CN|3|321|0.00934579,NFE:0.2132,OTH:0.1141,ASJ:1(biliary_tract)	107400	606963;613490;	60;	60|Deficiency in Alpa-1-proteinase inhibitor|1-5 / 10 000|Autosomal recessive|All ages|613490 ~	.	.	.	.	0.0	-2.13	0.000	-0.585	14	1(prostate)	0.3441
14	94849201	94849201	C	T	SERPINA1	exonic	nonsynonymous SNV	ENSG00000197249	rs709932	ENSG00000197249:ENST00000489769:exon1:c.G374A:p.R125H,ENSG00000197249:ENST00000355814:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000393087:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000402629:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000440909:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000554720:exon2:c.G116A:p.R39H,ENSG00000197249:ENST00000556091:exon2:c.G374A:p.R125H,ENSG00000197249:ENST00000404814:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000437397:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000449399:exon3:c.G374A:p.R125H,ENSG00000197249:ENST00000393088:exon4:c.G374A:p.R125H,ENSG00000197249:ENST00000448921:exon4:c.G374A:p.R125H,ENSG00000197249:ENST00000557492:exon4:c.G374A:p.R125H	SERPINA1:NM_000295:exon2:c.G374A:p.R125H,SERPINA1:NM_001002235:exon2:c.G374A:p.R125H,SERPINA1:NM_001127700:exon2:c.G374A:p.R125H,SERPINA1:NM_001127702:exon3:c.G374A:p.R125H,SERPINA1:NM_001127706:exon3:c.G374A:p.R125H,SERPINA1:NM_001127707:exon3:c.G374A:p.R125H,SERPINA1:NM_001002236:exon4:c.G374A:p.R125H,SERPINA1:NM_001127701:exon4:c.G374A:p.R125H,SERPINA1:NM_001127703:exon4:c.G374A:p.R125H,SERPINA1:NM_001127704:exon4:c.G374A:p.R125H,SERPINA1:NM_001127705:exon4:c.G374A:p.R125H	clinvar: Benign/Likely_benign,_other 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1631	0.1216	0.160543	6(haematopoietic_and_lymphoid_tissue)	-0.526	0.190	1.0	-2.82	0.000	.	.	Serpin domain	SERPINA1:uc001ycx.4:exon2:c.G374A:p.R125H,SERPINA1:uc001ycz.4:exon2:c.G374A:p.R125H,SERPINA1:uc001yda.1:exon2:c.G374A:p.R125H,SERPINA1:uc010aux.3:exon2:c.G374A:p.R125H,SERPINA1:uc001ydc.4:exon3:c.G374A:p.R125H,SERPINA1:uc010auz.3:exon3:c.G374A:p.R125H,SERPINA1:uc010avb.3:exon3:c.G374A:p.R125H,SERPINA1:uc001ycy.4:exon4:c.G374A:p.R125H,SERPINA1:uc001ydb.4:exon4:c.G374A:p.R125H,SERPINA1:uc010auw.3:exon4:c.G374A:p.R125H,SERPINA1:uc010auy.3:exon4:c.G374A:p.R125H,SERPINA1:uc010ava.3:exon4:c.G374A:p.R125H	-1.077	AFR:2(large_intestine),AMR:MU12568955,EAS:0.1219,FIN:0.0372,NFE:0.1388,OTH:0.1589,ASJ:LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763	107400	606963;613490;	60;	60|Deficiency in Alpa-1-proteinase inhibitor|1-5 / 10 000|Autosomal recessive|All ages|613490 ~	.	.	.	.	0.0	-1.77	0.000	-1.17	14	3(soft_tissue)	0.2074
14	95566104	95566104	C	-	DICER1	intronic	.	ENSG00000100697	rs35300142	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2971	.	.	0.4139	.	.	.	.	.	.	.	.	.	.	AFR:0.2451,AMR:0.4189,EAS:0.4108,FIN:0.4285,NFE:0.5062,OTH:0.4602,ASJ:0.4394	606241	138800;180295;601200;	284343;64742;276399;	284343|DICER1 syndrome<br>PPB familial tumor susceptibility syndrome<br>PPBFTDS<br>Pleuro-pulmonary blastoma familial tumor susceptibility syndrome|-|Autosomal dominant|Adolescent<br>Childhood<br>Adult|601200 ~64742|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|601200 ~276399|FMNG<br>Familial MNG|Unknown|Autosomal dominant|Adolescent|138800 ~	.	.	.	.	.	.	.	.	14	MU114385099	het
14	96157187	96157187	G	A	TCL1B	exonic	nonsynonymous SNV	ENSG00000213231	rs1064017	ENSG00000213231:ENST00000340722:exon2:c.G277A:p.G93R	TCL1B:NM_004918:exon2:c.G277A:p.G93R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3571	0.3941	0.262181	3(haematopoietic_and_lymphoid_tissue)	4.004	23.6	0.886	0.758	0.000	.	.	.	TCL1B:uc001yez.3:exon2:c.G277A:p.G93R,TCL1B:uc001yfa.3:exon2:c.G277A:p.G93R	-0.965	AFR:1(pancreas),AMR:1(large_intestine),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,FIN:0.3541,NFE:0.2762,OTH:0.3282,ASJ:MU639316	603769	.	.	.	.	.	.	.	0.946	1.67	0.000	1.645	14	1(urinary_tract)	0.4603
14	97299853	97299853	A	G	VRK1	exonic	synonymous SNV	ENSG00000100749	rs2145635	ENSG00000100749:ENST00000216639:exon2:c.A45G:p.A15A	VRK1:NM_003384:exon2:c.A45G:p.A15A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3565	0.3309	0.289537	MU130355	.	.	.	.	.	.	.	.	VRK1:uc001yft.3:exon2:c.A45G:p.A15A	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.3264,EAS:0.3520,FIN:0.2933,NFE:0.1040,OTH:0.3974,ASJ:0.2168	602168	607596;	2254;	2254|Norman disease<br>PCH1|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607596 614678 616081 ~	.	.	.	.	.	.	.	.	14	1(lung)	0.3943
14	97321689	97321689	C	T	VRK1	exonic	synonymous SNV	ENSG00000100749	rs2230532	ENSG00000100749:ENST00000216639:exon8:c.C705T:p.G235G	VRK1:NM_003384:exon8:c.C705T:p.G235G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3892	0.2903	0.416733	0.3425	.	.	.	.	.	.	.	.	VRK1:uc001yft.3:exon8:c.C705T:p.G235G	.	AFR:0.1756,AMR:0.4701,EAS:0.8554,FIN:0.3877,NFE:0.3620,OTH:0.3827,ASJ:0.4371	602168	607596;	2254;	2254|Norman disease<br>PCH1|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|607596 614678 616081 ~	.	.	.	.	.	.	.	.	14	MU19610309	het
14	99642360	99642360	C	G	BCL11B	exonic	synonymous SNV	ENSG00000127152	rs1152783	ENSG00000127152:ENST00000443726:exon2:c.G231C:p.P77P,ENSG00000127152:ENST00000345514:exon3:c.G600C:p.P200P,ENSG00000127152:ENST00000357195:exon4:c.G813C:p.P271P	BCL11B:NM_001282238:exon3:c.G597C:p.P199P,BCL11B:NM_022898:exon3:c.G600C:p.P200P,BCL11B:NM_001282237:exon4:c.G810C:p.P270P,BCL11B:NM_138576:exon4:c.G813C:p.P271P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3493	0.1645	0.248203	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	BCL11B:uc001ygb.3:exon3:c.G600C:p.P200P,BCL11B:uc031qqi.1:exon3:c.G597C:p.P199P,BCL11B:uc001yga.3:exon4:c.G813C:p.P271P,BCL11B:uc031qqh.1:exon4:c.G810C:p.P270P	.	AFR:0.1926,AMR:0.1837,EAS:0.2285,FIN:0.3451,NFE:0.1728,OTH:0.1746,ASJ:0.3489	606558	.	.	.	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	14	2(large_intestine)	0.2194
14	101295830	101295830	G	C	MEG3	ncRNA_exonic	.	ENSG00000214548	rs941575	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.955671	0.9330	.	.	.	.	.	.	.	.	.	.	AFR:0.9362,AMR:0.9594,EAS:0.9790,FIN:0.9390,NFE:0.9228,OTH:0.9338,ASJ:0.9570	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101302211	101302211	G	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs11859	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.351038	0.2551	.	.	.	.	.	.	.	.	.	.	AFR:0.3916,AMR:0.1770,EAS:0.4522,FIN:0.1464,NFE:0.1890,OTH:0.1861,ASJ:0.2367	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	het
14	101315972	101315972	C	T	MEG3	ncRNA_exonic	.	ENSG00000214548	rs138913315	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.00379393	0.0015	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0.0278,FIN:0,NFE:0,OTH:0,ASJ:0	605636	.	.	.	.	.	.	.	.	.	.	.	14	MU24556011	het
14	101319424	101319424	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs7158663	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.515375	0.4184	.	.	.	.	.	.	.	.	.	.	AFR:0.2245,AMR:0.5668,EAS:0.7553,FIN:0.4255,NFE:0.4807,OTH:0.4796,ASJ:0.4338	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101319655	101319655	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs3742396	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.227436	0.1256	.	.	.	.	.	.	.	.	.	.	AFR:0.0666,AMR:0.1053,EAS:0.4415,FIN:0.1057,NFE:0.1302,OTH:0.1507,ASJ:0.1258	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101320034	101320034	A	G	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs1998053	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.936901	0.9265	.	.	.	.	.	.	.	.	.	.	AFR:0.9848,AMR:0.9582,EAS:0.8832,FIN:0.8650,NFE:0.9116,OTH:0.8921,ASJ:0.9536	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	101320319	101320319	G	A	MEG3	ncRNA_exonic	.	ENSG00000214548;ENSG00000258663	rs2400942	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.39996	0.3599	.	.	.	.	.	.	.	.	.	.	AFR:0.3129,AMR:0.3225,EAS:0.5589,FIN:0.3736,NFE:0.3645,OTH:0.3589,ASJ:0.3709	605636	.	.	.	.	.	.	.	.	.	.	.	14	.	hom
14	103338324	103338324	T	A	TRAF3	intronic	.	ENSG00000131323	rs2295402	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2673	0.3552	0.39976	1(breast)	.	.	.	.	.	.	.	.	.	.	AFR:1(large_intestine),AMR:MU23643680,EAS:0.3526,FIN:0.6786,NFE:0.3385,OTH:0.2583,ASJ:MALY-DE|1|241|0.00414938,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02	601896	614849;	1930;	1930|HSV encephalitis<br>Herpes simplex meningo-encephalitis<br>Herpes simplex neuroinvasion<br>Herpetic encephalitis|Unknown|Not applicable<br>or&nbsp;Multigenic/multifactorial|All ages|610551 613002 614849 614850 616532 ~	~ko04064 NF-kappa B signaling pathway~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	14	2(haematopoietic_and_lymphoid_tissue)	0.4125
14	103342049	103342049	T	C	TRAF3	exonic	nonsynonymous SNV	ENSG00000131323	rs1131877	ENSG00000131323:ENST00000559734:exon1:c.T26C:p.M9T,ENSG00000131323:ENST00000558700:exon2:c.T131C:p.M44T,ENSG00000131323:ENST00000351691:exon4:c.T386C:p.M129T,ENSG00000131323:ENST00000539721:exon4:c.T386C:p.M129T,ENSG00000131323:ENST00000560371:exon4:c.T386C:p.M129T,ENSG00000131323:ENST00000347662:exon5:c.T386C:p.M129T,ENSG00000131323:ENST00000392745:exon5:c.T386C:p.M129T	TRAF3:NM_001199427:exon4:c.T386C:p.M129T,TRAF3:NM_003300:exon4:c.T386C:p.M129T,TRAF3:NM_145725:exon5:c.T386C:p.M129T,TRAF3:NM_145726:exon5:c.T386C:p.M129T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3155	0.4308	0.469848	1(large_intestine)	-0.918	0.024	0.847	3.64	0.170	.	.	TRAF-like|Zinc finger, RING/FYVE/PHD-type	TRAF3:uc001ymd.2:exon4:c.T386C:p.M129T,TRAF3:uc010txy.2:exon4:c.T386C:p.M129T,TRAF3:uc001ymc.2:exon5:c.T386C:p.M129T,TRAF3:uc001yme.2:exon5:c.T386C:p.M129T	-1.024	AFR:1(lung),AMR:MU23643733,EAS:0.4289,FIN:0.8337,NFE:0.4390,OTH:0.2767,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	601896	614849;	1930;	1930|HSV encephalitis<br>Herpes simplex meningo-encephalitis<br>Herpes simplex neuroinvasion<br>Herpetic encephalitis|Unknown|Not applicable<br>or&nbsp;Multigenic/multifactorial|All ages|610551 613002 614849 614850 616532 ~	~ko04064 NF-kappa B signaling pathway~ko04620 Toll-like receptor signaling pathway~ko04621 NOD-like receptor signaling pathway~ko04622 RIG-I-like receptor signaling pathway~ko04657 IL-17 signaling pathway~ko04668 TNF signaling pathway~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05222 Small cell lung cancer ~	.	.	.	0.0	1.88	0.000	-1.78	14	1(breast)	0.4163
14	105239894	105239894	C	T	AKT1	exonic	synonymous SNV	ENSG00000142208	rs1130233	ENSG00000142208:ENST00000544168:exon7:c.G540A:p.E180E,ENSG00000142208:ENST00000554581:exon8:c.G726A:p.E242E,ENSG00000142208:ENST00000402615:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000407796:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000554848:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000555528:exon9:c.G726A:p.E242E,ENSG00000142208:ENST00000349310:exon10:c.G726A:p.E242E	AKT1:NM_001014431:exon9:c.G726A:p.E242E,AKT1:NM_005163:exon9:c.G726A:p.E242E,AKT1:NM_001014432:exon10:c.G726A:p.E242E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3141	0.2016	0.322484	54(meninges)	.	.	.	.	.	.	.	.	AKT1:uc010tyk.2:exon7:c.G540A:p.E180E,AKT1:uc001ypl.3:exon8:c.G726A:p.E242E,AKT1:uc001ypk.3:exon9:c.G726A:p.E242E,AKT1:uc001ypn.3:exon9:c.G726A:p.E242E,AKT1:uc010axa.3:exon9:c.G726A:p.E242E,AKT1:uc001ypm.3:exon10:c.G726A:p.E242E	.	AFR:1(oesophagus),AMR:1(urinary_tract),EAS:3(lung),FIN:MU4606458,NFE:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,BTCA-JP|1|239|0.0041841,ESCA-CN|1|332|0.00301205,BLCA-CN|1|103|0.00970874,OTH:0.2264,ASJ:1(stomach)	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	396,,391,395,390,392,394,393	.	.	.	.	.	.	14	1(breast)	0.1037
14	105246407	105246407	G	A	AKT1	intronic	.	ENSG00000142208	rs3730358	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1589	0.1726	0.174121	COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.1555,AMR:0.2023,EAS:0.1788,FIN:0.0469,NFE:0.1193,OTH:0.1451,ASJ:0.2351	164730	114480;114500;167000;176920;181500;615109;	201;744;227535;	201|Cowden disease<br>Multiple hamartoma syndrome|1-9 / 1 000 000|Autosomal dominant|All ages|158350 612359 615106 615107 615108 615109 616858 ~744|Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome|<1 / 1 000 000|Not applicable|Infancy|176920 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04212 Longevity regulating pathway - worm~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04261 Adrenergic signaling in cardiomyocytes~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04728 Dopaminergic synapse~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04920 Adipocytokine signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04973 Carbohydrate digestion and absorption~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	14	3(soft_tissue)	0.1327
15	28359744	28359744	G	A	HERC2	intronic	.	ENSG00000128731	rs7495441	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9275	0.8259	0.790935	0.8527	.	.	.	.	.	.	.	.	.	.	AFR:0.4982,AMR:0.9618,EAS:0.9759,FIN:0.9997,NFE:0.9947,OTH:0.9633,ASJ:0.9633	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU81958444	hom
15	28380836	28380836	C	T	HERC2	exonic	synonymous SNV	ENSG00000128731	rs548081273	ENSG00000128731:ENST00000261609:exon79:c.G12018A:p.L4006L	HERC2:NM_004667:exon79:c.G12018A:p.L4006L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	0.0006	.	0.000998403	3.229e-05	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon79:c.G12018A:p.L4006L	.	AFR:0.0001,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	.	het
15	28397812	28397812	A	G	HERC2	intronic	.	ENSG00000128731	rs7165158	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2253	0.1807	0.3125	0.1935	.	.	.	.	.	.	.	.	.	.	AFR:0.4999,AMR:0.1017,EAS:0.4183,FIN:0.0172,NFE:0.0471,OTH:0.0888,ASJ:0.0728	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU17311270	het
15	28414665	28414665	T	C	HERC2	exonic	synonymous SNV	ENSG00000128731	rs7494786	ENSG00000128731:ENST00000261609:exon66:c.A10194G:p.S3398S	HERC2:NM_004667:exon66:c.A10194G:p.S3398S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9524	0.9188	0.88119	0.9316	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon66:c.A10194G:p.S3398S	.	AFR:0.7761,AMR:0.9725,EAS:0.9895,FIN:0.9994,NFE:0.9941,OTH:0.9755,ASJ:0.9636	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU81958486	hom
15	28419746	28419746	G	A	HERC2	exonic	synonymous SNV	ENSG00000128731	rs139335991	ENSG00000128731:ENST00000261609:exon65:c.C9852T:p.N3284N	HERC2:NM_004667:exon65:c.C9852T:p.N3284N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1384	.	.	0.0830	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon65:c.C9852T:p.N3284N	.	AFR:0.0881,AMR:0.2342,EAS:0.4082,FIN:0.0822,NFE:0.0406,OTH:0.0630,ASJ:0.0398	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU17131536	het
15	28422609	28422609	C	T	HERC2	exonic	synonymous SNV	ENSG00000128731	rs61756153	ENSG00000128731:ENST00000261609:exon60:c.G9210A:p.S3070S	HERC2:NM_004667:exon60:c.G9210A:p.S3070S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1020	0.0420	0.154353	0.0537	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon60:c.G9210A:p.S3070S	.	AFR:0.0205,AMR:0.0680,EAS:0.4021,FIN:0.0157,NFE:0.0428,OTH:0.0611,ASJ:0.0695	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU23662115	het
15	28443658	28443658	G	T	HERC2	intronic	.	ENSG00000128731	rs8041209	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1526	0.2185	0.321685	0.2025	.	.	.	.	.	0.0002	0.122	.	.	.	AFR:0.5333,AMR:0.1062,EAS:0.4121,FIN:0.0169,NFE:0.0469,OTH:0.0888,ASJ:0.0728	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU21036675	het
15	28456306	28456306	A	T	HERC2	intronic	.	ENSG00000128731	rs58921212	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1229	.	0.148163	0.0496	.	.	.	.	.	.	.	.	.	.	AFR:0.0205,AMR:0.0679,EAS:0.3418,FIN:0.0161,NFE:0.0422,OTH:0.0556,ASJ:0.0584	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU38043965	het
15	28467246	28467246	T	C	HERC2	exonic	synonymous SNV	ENSG00000128731	rs7163444	ENSG00000128731:ENST00000261609:exon36:c.A5580G:p.G1860G	HERC2:NM_004667:exon36:c.A5580G:p.G1860G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3729	.	0.326078	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon36:c.A5580G:p.G1860G	.	AFR:0.6631,AMR:0.2819,EAS:0.7520,FIN:0.2591,NFE:0.9618,OTH:0.8727,ASJ:0.5874	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	2(thyroid)	0.8
15	28502279	28502279	A	G	HERC2	exonic	synonymous SNV	ENSG00000128731	rs11631797	ENSG00000128731:ENST00000261609:exon17:c.T2445C:p.G815G	HERC2:NM_004667:exon17:c.T2445C:p.G815G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6876	0.6671	0.442492	0.6865	.	.	.	.	.	.	.	.	HERC2:uc001zbj.4:exon17:c.T2445C:p.G815G,HERC2:uc001zbl.2:exon18:c.T1530C:p.G510G	.	AFR:0.2970,AMR:0.6127,EAS:0.2889,FIN:0.9628,NFE:0.8841,OTH:0.8218,ASJ:0.7781	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU15035966	het
15	28510895	28510895	G	A	HERC2	intronic	.	ENSG00000128731	rs2240202	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1037	0.0424	0.152356	0.0534	.	.	.	.	.	.	.	.	.	.	AFR:0.0142,AMR:0.0692,EAS:0.3974,FIN:0.0166,NFE:0.0459,OTH:0.0612,ASJ:0.0695	605837	227220;615516;	329195;	329195|Developmental delay with ASD and gait instability|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615516 ~	.	.	.	.	.	.	.	.	15	MU23662754	het
15	31197564	31197564	G	A	FAN1	exonic	nonsynonymous SNV	ENSG00000198690	rs4779794	ENSG00000198690:ENST00000362065:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000561594:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000561607:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000565280:exon2:c.G698A:p.G233E,ENSG00000198690:ENST00000565466:exon2:c.G698A:p.G233E	FAN1:NM_001146094:exon2:c.G698A:p.G233E,FAN1:NM_001146095:exon2:c.G698A:p.G233E,FAN1:NM_001146096:exon2:c.G698A:p.G233E,FAN1:NM_014967:exon2:c.G698A:p.G233E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4594	0.3195	0.422524	MU4560159	-1.462	0.003	0.791	-2.16	0.002	.	.	.	FAN1:uc001zfc.3:exon2:c.G698A:p.G233E,FAN1:uc001zfd.3:exon2:c.G698A:p.G233E,FAN1:uc001zff.3:exon2:c.G698A:p.G233E,FAN1:uc010azw.2:exon2:c.G698A:p.G233E	-0.903	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523,AMR:0.3667,EAS:0.5456,FIN:0.54,NFE:0.8103,OTH:0.4811,ASJ:0.1055	613534	614817;	401996;	401996|KIN<br>Systemic karyomegaly|<1 / 1 000 000|Autosomal recessive|Adult|614817 ~	.	.	.	.	0.146	1.01	0.000	2.045	15	2(pancreas)	0.4257
15	31229420	31229420	T	C	FAN1	exonic	synonymous SNV	ENSG00000198690	rs2955795	ENSG00000198690:ENST00000362065:exon14:c.T3015C:p.H1005H	FAN1:NM_014967:exon14:c.T3015C:p.H1005H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4755	0.3482	0.457069	MU20615899	.	.	.	.	.	.	.	.	FAN1:uc001zff.3:exon14:c.T3015C:p.H1005H,FAN1:uc001zfe.3:exon15:c.T1830C:p.H610H	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3958,EAS:0.5585,FIN:0.5563,NFE:0.8583,OTH:0.4911,ASJ:0.1658	613534	614817;	401996;	401996|KIN<br>Systemic karyomegaly|<1 / 1 000 000|Autosomal recessive|Adult|614817 ~	.	.	.	.	.	.	.	.	15	1(urinary_tract)	0.4408
15	35083511	35083526	CACACACACACACACA	-	LOC101928174	ncRNA_intronic	.	ENSG00000250007	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	.	.	.	.	.	.	.	.	.	.	.	.	15	.	unknown
15	40462780	40462780	G	A	BUB1B	exonic	synonymous SNV	ENSG00000156970	rs1801389	ENSG00000156970:ENST00000287598:exon4:c.G282A:p.K94K,ENSG00000156970:ENST00000412359:exon4:c.G324A:p.K108K	BUB1B:NM_001211:exon4:c.G282A:p.K94K	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1211	0.1437	0.0874601	LUSC-KR|2|170|0.0117647	.	.	.	.	.	.	.	.	BUB1B:uc001zkx.4:exon4:c.G282A:p.K94K	.	AFR:0.1376,AMR:0.1272,EAS:0.2219,FIN:0.0031,NFE:0.1770,OTH:0.1497,ASJ:0.0859	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	.	.	.	.	15	5(soft_tissue)	0.1456
15	40477831	40477831	G	A	BUB1B	exonic	nonsynonymous SNV	ENSG00000156970	rs1801376	ENSG00000156970:ENST00000287598:exon8:c.G1046A:p.R349Q,ENSG00000156970:ENST00000412359:exon8:c.G1088A:p.R363Q	BUB1B:NM_001211:exon8:c.G1046A:p.R349Q	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.6566	0.7360	0.628195	72(lung)	2.297	18.15	1.0	4.72	0.977	.	.	.	BUB1B:uc010ucl.1:exon4:c.G635A:p.R212Q,BUB1B:uc001zkx.4:exon8:c.G1046A:p.R349Q	-0.980	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU20627954,EAS:0.7235,FIN:0.8293,NFE:0.6325,OTH:0.6159,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	0.0	2.74	0.000	-2.255	15	1(large_intestine)	0.3188
15	40500986	40500986	C	T	BUB1B	intronic	.	ENSG00000156970	rs11630664	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4916	0.4667	0.396965	0.4666	.	.	.	.	.	.	.	.	.	.	AFR:0.3045,AMR:0.5072,EAS:0.2349,FIN:0.5516,NFE:0.5612,OTH:0.5327,ASJ:0.3874	602860	114500;176430;257300;	1052;	1052|Warburton-Anyane-Yeboa syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal<br>Antenatal|257300 614114 ~	.	.	.	.	.	.	.	.	15	MU20628209	het
15	40898643	40898643	G	C	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs7177192	ENSG00000137812:ENST00000346991:exon4:c.G128C:p.R43T,ENSG00000137812:ENST00000399668:exon4:c.G128C:p.R43T,ENSG00000137812:ENST00000527044:exon4:c.G128C:p.R43T	KNL1:NM_144508:exon4:c.G128C:p.R43T,KNL1:NM_170589:exon4:c.G128C:p.R43T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7456	0.8222	0.653754	1(haematopoietic_and_lymphoid_tissue)	-1.469	0.003	0.53	-4.84	0.891	.	.	.	CASC5:uc001zme.3:exon4:c.G128C:p.R43T,CASC5:uc010bbs.1:exon4:c.G128C:p.R43T,CASC5:uc010bbt.1:exon4:c.G128C:p.R43T	-0.968	AFR:1(large_intestine),AMR:MU583520,EAS:0.7939,FIN:0.7709,NFE:0.5634,OTH:0.8046,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	1.93	0.000	-1.61	15	2(prostate)	0.2983
15	40913840	40913840	G	T	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs2412541	ENSG00000137812:ENST00000399668:exon10:c.G1378T:p.A460S,ENSG00000137812:ENST00000346991:exon11:c.G1456T:p.A486S	KNL1:NM_144508:exon10:c.G1378T:p.A460S,KNL1:NM_170589:exon11:c.G1456T:p.A486S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7455	0.8217	0.653954	0.7942	-1.118	0.009	1.0	1.67	0.975	.	.	.	CASC5:uc010ucq.1:exon9:c.G928T:p.A310S,CASC5:uc001zme.3:exon10:c.G1378T:p.A460S,CASC5:uc010bbt.1:exon10:c.G1378T:p.A460S,CASC5:uc010bbs.1:exon11:c.G1456T:p.A486S	-1.032	AFR:0.7706,AMR:0.5621,EAS:0.3,FIN:0.8417,NFE:0.8617,OTH:0.8008,ASJ:0.8046	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	3.69	0.000	-0.46	15	MU25432617	het
15	40914177	40914177	T	C	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs11858113	ENSG00000137812:ENST00000399668:exon10:c.T1715C:p.M572T,ENSG00000137812:ENST00000346991:exon11:c.T1793C:p.M598T	KNL1:NM_144508:exon10:c.T1715C:p.M572T,KNL1:NM_170589:exon11:c.T1793C:p.M598T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.3924	0.3915	0.351438	1(haematopoietic_and_lymphoid_tissue)	-0.133	1.498	0.196	0.769	0.987	.	.	.	CASC5:uc010ucq.1:exon9:c.T1265C:p.M422T,CASC5:uc001zme.3:exon10:c.T1715C:p.M572T,CASC5:uc010bbt.1:exon10:c.T1715C:p.M572T,CASC5:uc010bbs.1:exon11:c.T1793C:p.M598T	-0.938	AFR:MU154932,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.3778,FIN:0.2883,NFE:0.3841,OTH:0.2184,ASJ:0.4074	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.001	2.16	0.000	1.795	15	1(bone)	0.4624
15	40914772	40914772	C	T	KNL1	exonic	synonymous SNV	ENSG00000137812	rs11855334	ENSG00000137812:ENST00000399668:exon10:c.C2310T:p.V770V,ENSG00000137812:ENST00000346991:exon11:c.C2388T:p.V796V	KNL1:NM_144508:exon10:c.C2310T:p.V770V,KNL1:NM_170589:exon11:c.C2388T:p.V796V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3928	0.3899	0.350839	1(lung)	.	.	.	.	.	.	.	.	CASC5:uc010ucq.1:exon9:c.C1860T:p.V620V,CASC5:uc001zme.3:exon10:c.C2310T:p.V770V,CASC5:uc010bbt.1:exon10:c.C2310T:p.V770V,CASC5:uc010bbs.1:exon11:c.C2388T:p.V796V	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU154937,EAS:0.4067,FIN:0.3741,NFE:0.2883,OTH:0.3867,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	15	1(stomach)	0.2191
15	40915045	40915045	T	G	KNL1	exonic	synonymous SNV	ENSG00000137812	rs8041534	ENSG00000137812:ENST00000399668:exon10:c.T2583G:p.T861T,ENSG00000137812:ENST00000346991:exon11:c.T2661G:p.T887T	KNL1:NM_144508:exon10:c.T2583G:p.T861T,KNL1:NM_170589:exon11:c.T2661G:p.T887T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3923	0.3932	0.351238	MU154943	.	.	.	.	.	.	.	.	CASC5:uc010ucq.1:exon9:c.T2133G:p.T711T,CASC5:uc001zme.3:exon10:c.T2583G:p.T861T,CASC5:uc010bbt.1:exon10:c.T2583G:p.T861T,CASC5:uc010bbs.1:exon11:c.T2661G:p.T887T	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526,AMR:0.4067,EAS:0.2859,FIN:0.38,NFE:0.2184,OTH:0.4628,ASJ:0.3755	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	15	2(haematopoietic_and_lymphoid_tissue)	0.4373
15	40915190	40915190	A	G	KNL1	exonic	nonsynonymous SNV	ENSG00000137812	rs8040502	ENSG00000137812:ENST00000399668:exon10:c.A2728G:p.R910G,ENSG00000137812:ENST00000346991:exon11:c.A2806G:p.R936G	KNL1:NM_144508:exon10:c.A2728G:p.R910G,KNL1:NM_170589:exon11:c.A2806G:p.R936G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7589	0.8695	0.705671	1(prostate)	0.453	7.062	1.0	3.03	0.884	.	.	.	CASC5:uc010ucq.1:exon9:c.A2278G:p.R760G,CASC5:uc001zme.3:exon10:c.A2728G:p.R910G,CASC5:uc010bbt.1:exon10:c.A2728G:p.R910G,CASC5:uc010bbs.1:exon11:c.A2806G:p.R936G	-1.015	AFR:1(stomach),AMR:2(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.8352,NFE:0.9146,OTH:0.5680,ASJ:MU583521	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	0.0	2.57	0.000	-1.59	15	1(lung)	0.8046
15	40915894	40915894	T	C	KNL1	exonic	synonymous SNV	ENSG00000137812	rs11070285	ENSG00000137812:ENST00000399668:exon10:c.T3432C:p.N1144N,ENSG00000137812:ENST00000346991:exon11:c.T3510C:p.N1170N	KNL1:NM_144508:exon10:c.T3432C:p.N1144N,KNL1:NM_170589:exon11:c.T3510C:p.N1170N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3935	0.3928	0.351837	0.4079	.	.	.	.	.	.	.	.	CASC5:uc010ucq.1:exon9:c.T2982C:p.N994N,CASC5:uc001zme.3:exon10:c.T3432C:p.N1144N,CASC5:uc010bbt.1:exon10:c.T3432C:p.N1144N,CASC5:uc010bbs.1:exon11:c.T3510C:p.N1170N	.	AFR:0.3764,AMR:0.2871,EAS:0.2208,FIN:0.4624,NFE:0.4385,OTH:0.4398,ASJ:0.3974	609173	604321;	2512;	2512|MCPH<br>Microcephalia vera<br>Microcephaly vera<br>True microcephaly|Unknown|Autosomal recessive|Neonatal<br>Antenatal|251200 603802 604317 604321 604804 608393 608716 612703 614673 614852 615414 616080 616402 616486 616681 617090 ~	.	.	.	.	.	.	.	.	15	MU154948	het
15	40993986	40993986	-	AA	RAD51	intronic	.	ENSG00000051180	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	179617	114480;614508;	238722;227535;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko03440 Homologous recombination~ko03460 Fanconi anemia pathway~ko05200 Pathways in cancer~ko05212 Pancreatic cancer ~	.	.	.	.	.	.	.	15	.	het
15	41372055	41372055	G	T	INO80	exonic	synonymous SNV	ENSG00000128908	rs34467689	ENSG00000128908:ENST00000361937:exon9:c.C975A:p.A325A,ENSG00000128908:ENST00000401393:exon9:c.C975A:p.A325A,ENSG00000128908:ENST00000558357:exon9:c.C975A:p.A325A	INO80:NM_017553:exon9:c.C975A:p.A325A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0041	0.0118	0.00998403	0.0081	.	.	.	.	.	.	.	.	INO80:uc001zni.3:exon9:c.C975A:p.A325A	.	AFR:0.0272,AMR:0.0012,EAS:0,FIN:0,NFE:0.0005,OTH:0.0041,ASJ:0	610169	.	.	.	.	.	.	.	.	.	.	.	15	.	het
15	41857216	41857216	G	A	TYRO3	intronic	.	ENSG00000092445	rs11639399	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2691	0.2436	0.159744	0.2240	.	.	.	.	.	0.0003	0.012	.	.	.	AFR:0.1222,AMR:0.1866,EAS:0.0173,FIN:0.3016,NFE:0.2832,OTH:0.2832,ASJ:0.3477	600341	.	.	.	.	.	.	.	.	.	.	.	15	MU12623019	het
15	41860411	41860411	G	A	TYRO3	intronic	.	ENSG00000092445	rs7171675	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3679	0.4417	0.332668	0.4087	.	.	.	.	.	0	0	.	.	.	AFR:0.4962,AMR:0.3113,EAS:0.0193,FIN:0.4139,NFE:0.4032,OTH:0.4227,ASJ:0.4167	600341	.	.	.	.	.	.	.	.	.	.	.	15	MU25623926	het
15	41860490	41860490	T	A	TYRO3	exonic	nonsynonymous SNV	ENSG00000092445	rs12148316	ENSG00000092445:ENST00000263798:exon8:c.T1037A:p.I346N,ENSG00000092445:ENST00000559066:exon8:c.T902A:p.I301N	TYRO3:NM_001330264:exon8:c.T902A:p.I301N,TYRO3:NM_006293:exon8:c.T1037A:p.I346N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2264	0.2348	0.154752	.	2.834	21.5	0.474	3.95	0.988	.	.	Fibronectin type III|Immunoglobulin-like fold	TYRO3:uc001zof.2:exon8:c.T1037A:p.I346N	-1.052	AFR:.,AMR:0.2159,EAS:0.1862,FIN:0.3411,NFE:0.0173,OTH:0.2907,ASJ:0.1191	600341	.	.	.	.	.	.	.	0.408	-0.67	0.000	1.79	15	34(lung)	0.2726
15	41865488	41865488	C	T	TYRO3	intronic	.	ENSG00000092445	rs2246444	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4163	0.3897	0.446685	0.4406	.	.	.	.	.	.	.	.	.	.	AFR:0.4291,AMR:0.4339,EAS:0.7968,FIN:0.3794,NFE:0.4245,OTH:0.4156,ASJ:0.3442	600341	.	.	.	.	.	.	.	.	.	.	.	15	MU4328220	het
15	43720197	43720197	C	T	TP53BP1	intronic	.	ENSG00000067369	rs550239	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2075	0.2879	0.380391	0.2747	.	.	.	.	.	.	.	.	.	.	AFR:0.6461,AMR:0.2160,EAS:0.4006,FIN:0.0795,NFE:0.1041,OTH:0.1232,ASJ:0.2053	605230	.	.	.	.	.	.	.	.	.	.	.	15	MU703379	het
15	43724646	43724646	T	G	TP53BP1	exonic	nonsynonymous SNV	ENSG00000067369	rs2602141	ENSG00000067369:ENST00000263801:exon17:c.A3406C:p.K1136Q,ENSG00000067369:ENST00000382039:exon17:c.A3421C:p.K1141Q,ENSG00000067369:ENST00000382044:exon17:c.A3421C:p.K1141Q,ENSG00000067369:ENST00000450115:exon17:c.A3421C:p.K1141Q	TP53BP1:NM_001141979:exon17:c.A3421C:p.K1141Q,TP53BP1:NM_001141980:exon17:c.A3421C:p.K1141Q,TP53BP1:NM_005657:exon17:c.A3406C:p.K1136Q,TP53BP1:NM_001355001:exon18:c.A541C:p.K181Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3750	0.4836	0.526358	4(haematopoietic_and_lymphoid_tissue)	1.331	12.43	1.0	4.45	0.961	.	.	.	TP53BP1:uc010udp.2:exon16:c.A3406C:p.K1136Q,TP53BP1:uc001zrq.4:exon17:c.A3421C:p.K1141Q,TP53BP1:uc001zrr.4:exon17:c.A3421C:p.K1141Q,TP53BP1:uc001zrs.3:exon17:c.A3406C:p.K1136Q,TP53BP1:uc010udq.1:exon17:c.A3421C:p.K1141Q	-1.000	AFR:MU125397,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.8481,FIN:0.3353,NFE:0.3907,OTH:0.3995,ASJ:0.4422	605230	.	.	.	.	.	.	.	0.0	3.86	0.000	-2.28	15	1(pancreas)	0.2126
15	43748304	43748304	A	G	TP53BP1	exonic	synonymous SNV	ENSG00000067369	rs690367	ENSG00000067369:ENST00000263801:exon12:c.T2487C:p.D829D,ENSG00000067369:ENST00000382039:exon12:c.T2502C:p.D834D,ENSG00000067369:ENST00000382044:exon12:c.T2502C:p.D834D,ENSG00000067369:ENST00000413546:exon12:c.T2502C:p.D834D,ENSG00000067369:ENST00000450115:exon12:c.T2502C:p.D834D	TP53BP1:NM_001141979:exon12:c.T2502C:p.D834D,TP53BP1:NM_001141980:exon12:c.T2502C:p.D834D,TP53BP1:NM_005657:exon12:c.T2487C:p.D829D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3739	0.4882	0.526158	4(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	TP53BP1:uc010udp.2:exon11:c.T2487C:p.D829D,TP53BP1:uc001zrq.4:exon12:c.T2502C:p.D834D,TP53BP1:uc001zrr.4:exon12:c.T2502C:p.D834D,TP53BP1:uc001zrs.3:exon12:c.T2487C:p.D829D,TP53BP1:uc010udq.1:exon12:c.T2502C:p.D834D	.	AFR:MU125412,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.8642,FIN:0.3349,NFE:0.3907,OTH:0.4004,ASJ:0.4464	605230	.	.	.	.	.	.	.	.	.	.	.	15	2(lung)	0.2127
15	43762196	43762196	C	T	TP53BP1	exonic	nonsynonymous SNV	ENSG00000067369	rs689647	ENSG00000067369:ENST00000263801:exon11:c.G1234A:p.G412S,ENSG00000067369:ENST00000382039:exon11:c.G1249A:p.G417S,ENSG00000067369:ENST00000382044:exon11:c.G1249A:p.G417S,ENSG00000067369:ENST00000413546:exon11:c.G1249A:p.G417S,ENSG00000067369:ENST00000450115:exon11:c.G1249A:p.G417S	TP53BP1:NM_001141979:exon11:c.G1249A:p.G417S,TP53BP1:NM_001141980:exon11:c.G1249A:p.G417S,TP53BP1:NM_005657:exon11:c.G1234A:p.G412S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2064	0.2881	0.382388	1(lung)	1.910	15.65	0.049	5.31	0.837	.	.	.	TP53BP1:uc010udp.2:exon10:c.G1234A:p.G412S,TP53BP1:uc001zrq.4:exon11:c.G1249A:p.G417S,TP53BP1:uc001zrr.4:exon11:c.G1249A:p.G417S,TP53BP1:uc001zrs.3:exon11:c.G1234A:p.G412S,TP53BP1:uc010udq.1:exon11:c.G1249A:p.G417S	-1.046	AFR:2(large_intestine),AMR:MU64385,EAS:0.2743,FIN:0.6468,NFE:0.2105,OTH:0.2067,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	605230	.	.	.	.	.	.	.	0.0	3.83	0.000	-0.69	15	1(urinary_tract)	0.3989
15	43767774	43767774	G	C	TP53BP1	exonic	nonsynonymous SNV	ENSG00000067369	rs560191	ENSG00000067369:ENST00000263801:exon9:c.C1059G:p.D353E,ENSG00000067369:ENST00000382039:exon9:c.C1074G:p.D358E,ENSG00000067369:ENST00000382044:exon9:c.C1074G:p.D358E,ENSG00000067369:ENST00000413546:exon9:c.C1074G:p.D358E,ENSG00000067369:ENST00000450115:exon9:c.C1074G:p.D358E	TP53BP1:NM_001141979:exon9:c.C1074G:p.D358E,TP53BP1:NM_001141980:exon9:c.C1074G:p.D358E,TP53BP1:NM_005657:exon9:c.C1059G:p.D353E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3737	0.4881	0.525759	2(large_intestine)	1.026	10.81	1.0	1.95	0.996	.	.	.	TP53BP1:uc010udp.2:exon8:c.C1059G:p.D353E,TP53BP1:uc001zrq.4:exon9:c.C1074G:p.D358E,TP53BP1:uc001zrr.4:exon9:c.C1074G:p.D358E,TP53BP1:uc001zrs.3:exon9:c.C1059G:p.D353E,TP53BP1:uc010udq.1:exon9:c.C1074G:p.D358E	-1.012	AFR:MU125433,AMR:SKCA-BR|1|100|0.01,LIRI-JP|1|258|0.00387597,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.8644,FIN:0.3353,NFE:0.39,OTH:0.3983,ASJ:0.4462	605230	.	.	.	.	.	.	.	0.0	4.33	0.000	-1.4	15	1(lung)	0.2127
15	43784475	43784475	C	T	TP53BP1	intronic	.	ENSG00000067369	rs2439831	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2003	0.2706	0.369409	MU12625859	.	.	.	.	.	0	0	.	.	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,ESCA-CN|1|332|0.00301205,AMR:0.2608,EAS:0.2081,FIN:0.1987,NFE:0.3989,OTH:0.0767,ASJ:0.6070	605230	.	.	.	.	.	.	.	.	.	.	.	15	4(haematopoietic_and_lymphoid_tissue)	0.1011
15	48720526	48720526	G	C	FBN1	intronic	.	ENSG00000166147	rs363832	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7404	0.6784	0.65595	0.6718	.	.	.	.	.	.	.	.	.	.	AFR:0.4800,AMR:0.7847,EAS:0.6314,FIN:0.7437,NFE:0.7594,OTH:0.7219,ASJ:0.7616	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	MU12633444	het
15	48779402	48779402	C	T	FBN1	intronic	.	ENSG00000166147	rs11853943	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1709	0.1487	0.196486	MU23682726	.	.	.	.	.	0	0	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.1764,EAS:0.1718,FIN:0.0662,NFE:0.3315,OTH:0.2095,ASJ:0.1712	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	1(lung)	0.1557
15	48779530	48779530	G	C	FBN1	exonic	nonsynonymous SNV	ENSG00000166147	rs140598	ENSG00000166147:ENST00000316623:exon28:c.C3442G:p.P1148A	FBN1:NM_000138:exon28:c.C3442G:p.P1148A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0288	0.0036	0.0597045	MU12634042	3.171	22.7	0.3	5.6	0.997	.	.	EGF-like calcium-binding domain|EGF-like domain|Growth factor receptor cysteine-rich domain	FBN1:uc001zwx.2:exon28:c.C3442G:p.P1148A	-1.071	AFR:LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.0187,EAS:0.0632,FIN:0,NFE:0.2395,OTH:0.0034,ASJ:0.0098	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	0.002	-2.89	0.000	0.8	15	2(haematopoietic_and_lymphoid_tissue)	0.0016
15	48797307	48797307	A	G	FBN1	exonic	synonymous SNV	ENSG00000166147	rs25458	ENSG00000166147:ENST00000316623:exon16:c.T1875C:p.N625N	FBN1:NM_000138:exon16:c.T1875C:p.N625N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2006	0.2444	0.296925	1(breast)	.	.	.	.	.	.	.	.	FBN1:uc001zwx.2:exon16:c.T1875C:p.N625N	.	AFR:MU4560566,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.4571,FIN:0.1787,NFE:0.0662,OTH:0.3323,ASJ:0.2590	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	1(skin)	0.2102
15	48807637	48807637	C	T	FBN1	exonic	nonsynonymous SNV	ENSG00000166147	rs4775765	ENSG00000166147:ENST00000316623:exon12:c.G1415A:p.C472Y	FBN1:NM_000138:exon12:c.G1415A:p.C472Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	1	.	1	1	.	.	.	.	.	.	.	.	FBN1:uc001zwx.2:exon12:c.G1415A:p.C472Y	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	134797	102370;129600;154700;184900;604308;608328;614185;616914;	300382;2623;2084;3449;2833;284963;558;1885;969;	300382|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616914 ~2623|Geleophysic dwarfism|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Childhood|231050 614185 ~2084|GEMSS syndrome|<1 / 1 000 000|Autosomal dominant|All ages|608328 ~3449|Spherophakia-brachymorphia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|277600 608328 614819 ~2833|-|-|-|-|184900 228020 ~284963|MFS1|-|Autosomal dominant|All ages|154700 ~558|MFS|1-5 / 10 000|Autosomal dominant|All ages|154700 610168 ~1885|Ectopia lentis syndrome<br>Familial ectopia lentis|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|129600 225100 225200 ~969|-|<1 / 1 000 000|Autosomal dominant|Neonatal|102370 ~	.	.	.	.	.	.	.	.	15	MU81961571	hom
15	51502986	51502986	G	A	MIR4713HG	ncRNA_intronic	.	ENSG00000259240	rs10046	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4492	0.4329	0.362819	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4477,AMR:0.2428,EAS:0.5331,FIN:0.5267,NFE:0.5272,OTH:0.5416,ASJ:0.3305	.	.	.	.	.	.	.	.	.	.	.	.	15	1(haematopoietic_and_lymphoid_tissue)	0.4949
15	51510868	51510868	A	C	MIR4713HG	ncRNA_intronic	.	ENSG00000259240	rs4324076	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4867	0.3976	0.367212	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU23684803,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,EAS:0.2364,FIN:0.3301,NFE:0.5298,OTH:0.5249,ASJ:0.4418	.	.	.	.	.	.	.	.	.	.	.	.	15	1(lung)	0.5011
15	51529112	51529112	T	C	CYP19A1	exonic	synonymous SNV	ENSG00000137869	rs700518	ENSG00000137869:ENST00000405913:exon2:c.A240G:p.V80V,ENSG00000137869:ENST00000559878:exon2:c.A240G:p.V80V,ENSG00000137869:ENST00000260433:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000396402:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000557858:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000557934:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000558328:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000559646:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000561075:exon3:c.A240G:p.V80V,ENSG00000137869:ENST00000396404:exon4:c.A240G:p.V80V,ENSG00000137869:ENST00000405011:exon4:c.A240G:p.V80V,ENSG00000137869:ENST00000439712:exon4:c.A240G:p.V80V,ENSG00000137869:ENST00000453807:exon4:c.A240G:p.V80V,ENSG00000137869:ENST00000559980:exon5:c.A240G:p.V80V	CYP19A1:NM_001347256:exon2:c.A240G:p.V80V,CYP19A1:NM_000103:exon3:c.A240G:p.V80V,CYP19A1:NM_001347248:exon3:c.A240G:p.V80V,CYP19A1:NM_001347249:exon3:c.A240G:p.V80V,CYP19A1:NM_001347250:exon3:c.A240G:p.V80V,CYP19A1:NM_001347251:exon3:c.A240G:p.V80V,CYP19A1:NM_001347252:exon3:c.A240G:p.V80V,CYP19A1:NM_001347253:exon3:c.A240G:p.V80V,CYP19A1:NM_001347254:exon3:c.A240G:p.V80V,CYP19A1:NM_001347255:exon3:c.A240G:p.V80V,CYP19A1:NM_031226:exon4:c.A240G:p.V80V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4253	0.4046	0.325879	1(stomach)	.	.	.	.	.	.	.	.	CYP19A1:uc001zzd.3:exon2:c.A240G:p.V80V,CYP19A1:uc001zza.4:exon3:c.A240G:p.V80V,CYP19A1:uc001zyz.4:exon4:c.A240G:p.V80V,CYP19A1:uc001zzb.2:exon4:c.A240G:p.V80V,CYP19A1:uc010bey.1:exon5:c.A240G:p.V80V	.	AFR:MU583554,AMR:SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,EAS:0.1972,FIN:0.3098,NFE:0.5099,OTH:0.4479,ASJ:0.4174	107910	139300;613546;	91;178345;	91|Congenital estrogen deficiency|<1 / 1 000 000|Autosomal recessive|All ages|613546 ~178345|AEXS<br>Familial hyperestrogenism<br>Hereditary prepubertal gynecomastia|-|Autosomal dominant|-|139300 ~	.	.	.	.	.	.	.	.	15	1(prostate)	0.4997
15	58253062	58253062	C	T	ALDH1A2	intronic	.	ENSG00000128918	rs3784263	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3757	0.4237	0.305911	0.4160	.	.	.	.	.	.	.	.	.	.	AFR:0.3627,AMR:0.2888,EAS:0.2011,FIN:0.4547,NFE:0.4686,OTH:0.4276,ASJ:0.3642	603687	.	.	.	.	.	.	.	.	.	.	.	15	MU12654125	het
15	58256127	58256127	C	T	ALDH1A2	exonic	nonsynonymous SNV	ENSG00000128918	rs4646626	ENSG00000128918:ENST00000559517:exon7:c.G754A:p.V252I,ENSG00000128918:ENST00000347587:exon8:c.G928A:p.V310I,ENSG00000128918:ENST00000249750:exon9:c.G1042A:p.V348I,ENSG00000128918:ENST00000558231:exon9:c.G955A:p.V319I,ENSG00000128918:ENST00000537372:exon10:c.G979A:p.V327I	ALDH1A2:NM_170697:exon7:c.G754A:p.V252I,ALDH1A2:NM_170696:exon8:c.G928A:p.V310I,ALDH1A2:NM_003888:exon9:c.G1042A:p.V348I,ALDH1A2:NM_001206897:exon10:c.G979A:p.V327I	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4462	0.4719	0.372804	0.4684	2.958	22.1	0.37	4.49	0.998	.	.	Aldehyde dehydrogenase N-terminal domain|Aldehyde dehydrogenase domain|Aldehyde/histidinol dehydrogenase;Aldehyde dehydrogenase domain|Aldehyde/histidinol dehydrogenase	ALDH1A2:uc002aew.3:exon7:c.G754A:p.V252I,ALDH1A2:uc002aey.3:exon8:c.G928A:p.V310I,ALDH1A2:uc002aex.3:exon9:c.G1042A:p.V348I,ALDH1A2:uc010ugw.2:exon9:c.G955A:p.V319I,ALDH1A2:uc010ugv.2:exon10:c.G979A:p.V327I	-0.926	AFR:0.3776,AMR:0.3652,EAS:0.3255,FIN:0.5238,NFE:0.5294,OTH:0.4807,ASJ:0.4338	603687	.	.	.	.	.	.	.	0.0	-1.01	0.000	1.87	15	MU727447	het
15	63351840	63351840	C	A	TPM1	exonic	synonymous SNV	ENSG00000140416	rs1071646	ENSG00000140416:ENST00000558264:exon2:c.C75A:p.A25A,ENSG00000140416:ENST00000317516:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000334895:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000404484:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000559281:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000559831:exon3:c.C225A:p.A75A,ENSG00000140416:ENST00000560615:exon3:c.C75A:p.A25A,ENSG00000140416:ENST00000560959:exon3:c.C345A:p.A115A,ENSG00000140416:ENST00000267996:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000288398:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000358278:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000403994:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000559397:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000559556:exon4:c.C453A:p.A151A,ENSG00000140416:ENST00000357980:exon5:c.C579A:p.A193A	TPM1:NM_001018008:exon3:c.C345A:p.A115A,TPM1:NM_001301289:exon3:c.C345A:p.A115A,TPM1:NM_001330344:exon3:c.C345A:p.A115A,TPM1:NM_001330346:exon3:c.C345A:p.A115A,TPM1:NM_001330351:exon3:c.C345A:p.A115A,TPM1:NM_001365780:exon3:c.C345A:p.A115A,TPM1:NM_001365781:exon3:c.C345A:p.A115A,TPM1:NM_001365782:exon3:c.C345A:p.A115A,TPM1:NM_000366:exon4:c.C453A:p.A151A,TPM1:NM_001018004:exon4:c.C453A:p.A151A,TPM1:NM_001018005:exon4:c.C453A:p.A151A,TPM1:NM_001018006:exon4:c.C453A:p.A151A,TPM1:NM_001018007:exon4:c.C453A:p.A151A,TPM1:NM_001018020:exon4:c.C453A:p.A151A,TPM1:NM_001301244:exon4:c.C453A:p.A151A,TPM1:NM_001365776:exon4:c.C453A:p.A151A,TPM1:NM_001365777:exon4:c.C453A:p.A151A,TPM1:NM_001365779:exon4:c.C453A:p.A151A,TPM1:NM_001365778:exon5:c.C579A:p.A193A	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6737	0.6357	0.705671	0.6615	.	.	.	.	.	.	.	.	TPM1:uc002alr.3:exon3:c.C345A:p.A115A,TPM1:uc002als.3:exon3:c.C345A:p.A115A,TPM1:uc002alt.3:exon3:c.C345A:p.A115A,TPM1:uc010uif.2:exon3:c.C345A:p.A115A,TPM1:uc010uig.2:exon3:c.C345A:p.A115A,TPM1:uc002alg.3:exon4:c.C453A:p.A151A,TPM1:uc002alh.3:exon4:c.C453A:p.A151A,TPM1:uc002ali.3:exon4:c.C453A:p.A151A,TPM1:uc002alj.3:exon4:c.C453A:p.A151A,TPM1:uc002alk.3:exon4:c.C453A:p.A151A,TPM1:uc002all.3:exon4:c.C453A:p.A151A,TPM1:uc002alp.3:exon4:c.C453A:p.A151A,TPM1:uc010uie.2:exon4:c.C453A:p.A151A,TPM1:uc002alm.3:exon5:c.C579A:p.A193A	.	AFR:0.6124,AMR:0.5610,EAS:0.9604,FIN:0.6959,NFE:0.6548,OTH:0.6741,ASJ:0.6490	191010	115196;611878;	154;54260;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~54260|LVNC<br>Left ventricular hypertrabeculation<br>Spongy myocardium|-|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|601493 601494 604169 609470 611878 613424 613426 615092 615373 615396 ~	.	.	.	.	.	.	.	.	15	MU125580	hom
15	66745890	66745890	G	A	MAP2K1	intronic	.	ENSG00000169032	rs7169326	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.9989	.	0.983227	0.9869	.	.	.	.	.	.	.	.	.	.	AFR:0.9543,AMR:0.9976,EAS:1,FIN:1,NFE:0.9998,OTH:0.9969,ASJ:1	176872	615279;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04320 Dorso-ventral axis formation~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04626 Plant-pathogen interaction~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05034 Alcoholism~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	15	.	hom
15	67457335	67457335	A	G	SMAD3	exonic	synonymous SNV	ENSG00000166949	rs1065080	ENSG00000166949:ENST00000559092:exon2:c.A254G:p.Y85C	SMAD3:NM_001145103:exon2:c.A177G:p.L59L,SMAD3:NM_005902:exon2:c.A309G:p.L103L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8635	0.88	0.834065	0.8640	0.949	10.37	.	2.36	0.993	.	.	.	SMAD3:uc002aqj.3:exon2:c.A309G:p.L103L,SMAD3:uc010ujs.2:exon2:c.A177G:p.L59L	.	AFR:0.8614,AMR:0.9177,EAS:0.7472,FIN:0.8660,NFE:0.8754,OTH:0.8582,ASJ:0.8477	603109	613795;	284984;	284984|-|<1 / 1 000 000|Autosomal dominant|All ages|613795 ~	~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04144 Endocytosis~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04659 Th17 cell differentiation~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	15	MU675295	hom
15	74325005	74325005	A	G	PML	exonic	synonymous SNV	ENSG00000140464	.	ENSG00000140464:ENST00000268058:exon5:c.A1347G:p.A449A,ENSG00000140464:ENST00000268059:exon5:c.A1347G:p.A449A,ENSG00000140464:ENST00000395135:exon5:c.A1347G:p.A449A,ENSG00000140464:ENST00000435786:exon5:c.A1347G:p.A449A,ENSG00000140464:ENST00000436891:exon5:c.A1347G:p.A449A,ENSG00000140464:ENST00000569477:exon5:c.A1347G:p.A449A,ENSG00000140464:ENST00000569965:exon5:c.A1347G:p.A449A	PML:NM_002675:exon5:c.A1347G:p.A449A,PML:NM_033238:exon5:c.A1347G:p.A449A,PML:NM_033239:exon5:c.A1347G:p.A449A,PML:NM_033240:exon5:c.A1347G:p.A449A,PML:NM_033244:exon5:c.A1347G:p.A449A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	PML:uc010ule.2:exon2:c.A30G:p.A10A,PML:uc002awk.3:exon5:c.A1347G:p.A449A,PML:uc002awm.3:exon5:c.A1347G:p.A449A,PML:uc002awn.3:exon5:c.A1347G:p.A449A,PML:uc002awq.3:exon5:c.A1347G:p.A449A,PML:uc002awr.3:exon5:c.A1347G:p.A449A,PML:uc002awv.3:exon5:c.A1347G:p.A449A	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	102578	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko05164 Influenza A~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	.	.	.	.	15	.	het
15	74336633	74336633	T	C	PML	exonic	nonsynonymous SNV	ENSG00000140464	rs5742915	ENSG00000140464:ENST00000565898:exon8:c.T1789C:p.F597L,ENSG00000140464:ENST00000268058:exon9:c.T1933C:p.F645L	PML:NM_033238:exon9:c.T1933C:p.F645L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3505	0.3416	0.192292	11(soft_tissue)	-0.685	0.078	0.221	-3.26	0.064	.	.	.	PML:uc010ule.2:exon6:c.T616C:p.F206L,PML:uc002awu.3:exon8:c.T1789C:p.F597L,PML:uc002awv.3:exon9:c.T1933C:p.F645L	-0.978	AFR:.,AMR:.,EAS:0.0969,FIN:0.3369,NFE:0.4433,OTH:0.0050,ASJ:0.3066	102578	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko04144 Endocytosis~ko05164 Influenza A~ko05168 Herpes simplex virus 1 infection~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia ~	.	.	.	0.0	1.01	0.000	1.155	15	1(thyroid)	0.4053
15	74836316	74836316	A	G	ARID3B	exonic	synonymous SNV	ENSG00000179361	rs8043032	ENSG00000179361:ENST00000346246:exon2:c.A39G:p.Q13Q	ARID3B:NM_001307939:exon2:c.A39G:p.Q13Q,ARID3B:NM_006465:exon2:c.A39G:p.Q13Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1884	0.1398	0.360823	0.2159	.	.	.	.	.	.	.	.	ARID3B:uc002ayc.3:exon2:c.A39G:p.Q13Q,ARID3B:uc002ayd.3:exon2:c.A39G:p.Q13Q,ARID3B:uc002aye.3:exon2:c.A39G:p.Q13Q	.	AFR:0.3483,AMR:0.4146,EAS:0.5316,FIN:0.1312,NFE:0.1177,OTH:0.1887,ASJ:0.1567	612457	.	.	.	.	.	.	.	.	.	.	.	15	MU698715	hom
15	75640569	75640569	A	G	NEIL1	intronic	.	ENSG00000140398	rs8030014	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.466054	0.4325	.	.	.	.	.	.	.	.	.	.	AFR:0.2957,AMR:0.6235,EAS:0.5410,FIN:0.4885,NFE:0.4757,OTH:0.4504,ASJ:0.42	608844	.	.	.	.	.	.	.	.	.	.	.	15	.	het
15	75664570	75664570	A	T	SIN3A	intronic	.	ENSG00000169375	rs4886696	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6939	0.4284	0.58726	0.6572	.	.	.	.	.	.	.	.	.	.	AFR:0.4607,AMR:0.7392,EAS:0.5546,FIN:0.7828,NFE:0.7481,OTH:0.6780,ASJ:0.6093	607776	613406;	94065;	94065|Del(15)(q24)<br>Monosomy 15q24|<1 / 1 000 000|Not applicable<br>or&nbsp;Unknown|Childhood|613406 ~	~ko04139 Mitophagy - yeast~ko04919 Thyroid hormone signaling pathway~ko05016 Huntington disease~ko05169 Epstein-Barr virus infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	15	MU677604	unknown
15	85186877	85186894	CTTGGCTCCGTGTTCCAT	-	WDR73	exonic	nonframeshift deletion	ENSG00000177082	rs11267906	ENSG00000177082:ENST00000434634:exon8:c.944_961del:p.315_321del	WDR73:NM_032856:exon8:c.944_961del:p.315_321del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1852	0.1324	0.158546	0.1668	.	.	.	.	.	.	.	.	WDR73:uc002bkw.2:exon8:c.944_961del:p.315_321del	.	AFR:0.1276,AMR:0.1038,EAS:0.1101,FIN:0.2208,NFE:0.1850,OTH:0.1906,ASJ:0.1689	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	.	.	.	.	15	MU47803	het
15	85188994	85188994	T	C	WDR73	exonic	synonymous SNV	ENSG00000177082	rs2271432	ENSG00000177082:ENST00000434634:exon7:c.A591G:p.S197S	WDR73:NM_032856:exon7:c.A591G:p.S197S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8550	0.8788	0.895367	0.8747	.	.	.	.	.	.	.	.	AL357213:uc002bky.1:exon1:c.T486C:p.P162P,WDR73:uc002bkw.2:exon7:c.A591G:p.S197S	.	AFR:0.9672,AMR:0.9117,EAS:0.9407,FIN:0.7903,NFE:0.8342,OTH:0.8259,ASJ:0.8874	616144	251300;	2065;	2065|Galloway syndrome<br>Microcephaly-hiatus hernia-nephrotic syndrome<br>Nephrosis-neuronal dysmigration syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal<br>Childhood|251300 ~	.	.	.	.	.	.	.	.	15	MU4561231	hom
15	88451765	88451765	A	G	NTRK3	intronic	.	ENSG00000140538	rs3784441	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.713259	0.7411	.	.	.	.	.	.	.	.	.	.	AFR:0.7618,AMR:0.6794,EAS:0.6981,FIN:0.7182,NFE:0.7455,OTH:0.7020,ASJ:0.7185	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	.	hom
15	88576185	88576185	G	T	NTRK3	exonic	synonymous SNV	ENSG00000140538	rs2229910	ENSG00000140538:ENST00000557856:exon11:c.C1464A:p.A488A,ENSG00000140538:ENST00000558676:exon11:c.C1464A:p.A488A,ENSG00000140538:ENST00000357724:exon12:c.C1464A:p.A488A,ENSG00000140538:ENST00000540489:exon12:c.C1488A:p.A496A,ENSG00000140538:ENST00000542733:exon12:c.C1194A:p.A398A,ENSG00000140538:ENST00000317501:exon13:c.C1488A:p.A496A,ENSG00000140538:ENST00000355254:exon13:c.C1488A:p.A496A,ENSG00000140538:ENST00000360948:exon13:c.C1488A:p.A496A,ENSG00000140538:ENST00000394480:exon14:c.C1488A:p.A496A	NTRK3:NM_001320134:exon12:c.C1488A:p.A496A,NTRK3:NM_001320135:exon12:c.C1194A:p.A398A,NTRK3:NM_001243101:exon13:c.C1464A:p.A488A,NTRK3:NM_001007156:exon14:c.C1488A:p.A496A,NTRK3:NM_001012338:exon14:c.C1488A:p.A496A,NTRK3:NM_002530:exon14:c.C1488A:p.A496A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0008	.	0.00159744	0.0009	.	.	.	.	.	.	.	.	NTRK3:uc002bmh.2:exon11:c.C1464A:p.A488A,NTRK3:uc010bnh.1:exon11:c.C1464A:p.A488A,NTRK3:uc010upl.1:exon12:c.C1194A:p.A398A,NTRK3:uc021sua.1:exon13:c.C1464A:p.A488A,NTRK3:uc002bme.2:exon14:c.C1488A:p.A496A,NTRK3:uc002bmf.2:exon14:c.C1488A:p.A496A,NTRK3:uc002bmg.3:exon14:c.C1488A:p.A496A	.	AFR:0.0012,AMR:0,EAS:0.0101,FIN:0,NFE:0,OTH:0,ASJ:0	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	.	het
15	88679785	88679785	G	A	NTRK3	exonic	synonymous SNV	ENSG00000140538	rs1863480	ENSG00000140538:ENST00000540489:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000542733:exon6:c.C384T:p.N128N,ENSG00000140538:ENST00000557856:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000558676:exon6:c.C678T:p.N226N,ENSG00000140538:ENST00000317501:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000355254:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000357724:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000360948:exon7:c.C678T:p.N226N,ENSG00000140538:ENST00000394480:exon8:c.C678T:p.N226N	NTRK3:NM_001320134:exon6:c.C678T:p.N226N,NTRK3:NM_001320135:exon6:c.C384T:p.N128N,NTRK3:NM_001007156:exon8:c.C678T:p.N226N,NTRK3:NM_001012338:exon8:c.C678T:p.N226N,NTRK3:NM_001243101:exon8:c.C678T:p.N226N,NTRK3:NM_002530:exon8:c.C678T:p.N226N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9967	0.9958	0.998203	0.9971	.	.	.	.	.	.	.	.	NTRK3:uc002bmh.2:exon6:c.C678T:p.N226N,NTRK3:uc010bnh.1:exon6:c.C678T:p.N226N,NTRK3:uc010upl.1:exon6:c.C384T:p.N128N,NTRK3:uc002bme.2:exon8:c.C678T:p.N226N,NTRK3:uc002bmf.2:exon8:c.C678T:p.N226N,NTRK3:uc002bmg.3:exon8:c.C678T:p.N226N,NTRK3:uc021sua.1:exon8:c.C678T:p.N226N	.	AFR:0.9995,AMR:0.9988,EAS:1,FIN:0.9977,NFE:0.9951,OTH:0.9969,ASJ:0.9967	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	MU4561260	hom
15	88733280	88733280	G	A	NTRK3	intronic	.	ENSG00000140538	rs142288716	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.000599042	0.0004	.	.	.	.	.	.	.	.	.	.	AFR:0.0001,AMR:0,EAS:0.0068,FIN:0,NFE:6.667e-05,OTH:0,ASJ:0	191316	.	.	.	~ko04722 Neurotrophin signaling pathway~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	15	.	het
15	89838236	89838236	G	A	FANCI	exonic	synonymous SNV	ENSG00000140525	rs7183618	ENSG00000140525:ENST00000310775:exon24:c.G2547A:p.K849K	FANCI:NM_001113378:exon24:c.G2547A:p.K849K	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9593	0.9601	0.980831	0.9538	.	.	.	.	.	.	.	.	FANCI:uc002bnq.1:exon10:c.G786A:p.K262K,FANCI:uc010bnp.1:exon24:c.G2547A:p.K849K	.	AFR:0.9905,AMR:0.9821,EAS:1,FIN:0.8758,NFE:0.9457,OTH:0.9274,ASJ:0.9636	611360	609053;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	15	MU81967158	hom
15	89860691	89860691	G	A	POLG	exonic	nonsynonymous SNV	ENSG00000140521	rs369544574	ENSG00000140521:ENST00000268124:exon22:c.C3559T:p.R1187W,ENSG00000140521:ENST00000442287:exon22:c.C3559T:p.R1187W	POLG:NM_001126131:exon22:c.C3559T:p.R1187W,POLG:NM_002693:exon22:c.C3559T:p.R1187W	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 1, 1, 1, 0, 0] 	0.0011	.	0.00119808	6.457e-05	7.397	34	0.017	6.05	1.000	.	.	.	POLG:uc002bnr.4:exon22:c.C3559T:p.R1187W,POLG:uc002bns.4:exon22:c.C3559T:p.R1187W	0.976	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.663e-05,OTH:0.0010,ASJ:0	174763	157640;203700;258450;607459;613662;	298;254881;70595;254886;726;254892;	298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~254881|MSCAE<br>Mitochondrial spinocerebellar ataxia with epilepsy<br>SCAE|-|Autosomal recessive|Adolescent<br>Childhood|607459 ~70595|SANDO|Unknown|Autosomal recessive|Adult|607459 ~254886|arPEO|-|Autosomal recessive|All ages|258450 617069 ~726|Alpers progressive sclerosing poliodystrophy<br>Alpers syndrome<br>Progressive neuronal degeneration of childhood with liver disease|<1 / 1 000 000|Autosomal recessive|Infancy<br>Childhood<br>Adolescent<br>Adult|203700 ~254892|adPEO|-|-|-|157640 609283 609286 610131 613077 ~	.	.	.	.	0.978	-5.0	0.866	1.385	15	.	het
15	91428290	91428290	C	T	FES	exonic	synonymous SNV	ENSG00000182511	rs11539637	ENSG00000182511:ENST00000394300:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000444422:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000450438:exon1:c.C15T:p.S5S,ENSG00000182511:ENST00000328850:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000394302:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000414248:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000416779:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000443697:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000452243:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000464684:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000470152:exon2:c.C15T:p.S5S,ENSG00000182511:ENST00000559355:exon2:c.C15T:p.S5S	FES:NM_001143783:exon1:c.C15T:p.S5S,FES:NM_001143784:exon1:c.C15T:p.S5S,FES:NM_001143785:exon2:c.C15T:p.S5S,FES:NM_002005:exon2:c.C15T:p.S5S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5849	0.4937	0.58746	1(cervix)	.	.	.	.	.	.	.	.	FES:uc002bpx.3:exon1:c.C15T:p.S5S,FES:uc002bpy.3:exon1:c.C15T:p.S5S,FES:uc010bny.3:exon1:c.C15T:p.S5S,FES:uc002bpv.3:exon2:c.C15T:p.S5S,FES:uc010uqj.2:exon2:c.C15T:p.S5S,FES:uc010uqk.2:exon2:c.C15T:p.S5S	.	AFR:MU4326664,AMR:COCA-CN|5|321|0.0155763,EAS:0.4141,FIN:0.7416,NFE:0.5033,OTH:0.8063,ASJ:0.5301	190030	.	.	.	.	.	.	.	.	.	.	.	15	1(urinary_tract)	0.6337
15	91428636	91428636	G	A	FES	intronic	.	ENSG00000182511	rs7177338	ENSG00000182511:ENST00000470152:exon2:c.G361A:p.V121I	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5809	0.5079	0.587859	17(soft_tissue)	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:MU10889595,AMR:COCA-CN|5|321|0.0155763,EAS:0.4676,FIN:0.6687,NFE:0.5,OTH:0.8016,ASJ:0.5425	190030	.	.	.	.	.	.	.	.	.	.	.	15	20(lung)	0.6343
15	91430436	91430436	T	C	FES	exonic	synonymous SNV	ENSG00000182511	rs2071383	ENSG00000182511:ENST00000394300:exon3:c.T330C:p.A110A,ENSG00000182511:ENST00000450438:exon3:c.T330C:p.A110A,ENSG00000182511:ENST00000394302:exon4:c.T330C:p.A110A,ENSG00000182511:ENST00000414248:exon4:c.T330C:p.A110A,ENSG00000182511:ENST00000444422:exon4:c.T504C:p.A168A,ENSG00000182511:ENST00000328850:exon5:c.T504C:p.A168A,ENSG00000182511:ENST00000464684:exon5:c.T504C:p.A168A,ENSG00000182511:ENST00000559355:exon5:c.T504C:p.A168A	FES:NM_001143783:exon3:c.T330C:p.A110A,FES:NM_001143784:exon4:c.T504C:p.A168A,FES:NM_001143785:exon4:c.T330C:p.A110A,FES:NM_002005:exon5:c.T504C:p.A168A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9608	0.9552	0.9377	0.9534	.	.	.	.	.	.	.	.	FES:uc002bpy.3:exon3:c.T330C:p.A110A,FES:uc010bny.3:exon3:c.T330C:p.A110A,FES:uc002bpx.3:exon4:c.T504C:p.A168A,FES:uc010uqj.2:exon4:c.T330C:p.A110A,FES:uc002bpv.3:exon5:c.T504C:p.A168A,FES:uc010uqk.2:exon5:c.T450C:p.A150A	.	AFR:0.9307,AMR:0.9821,EAS:0.8909,FIN:0.9533,NFE:0.9708,OTH:0.9664,ASJ:0.9603	190030	.	.	.	.	.	.	.	.	.	.	.	15	MU82136926	hom
15	91430617	91430617	G	A	FES	intronic	.	ENSG00000182511	rs2071384	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4634	0.2910	0.453674	0.3484	.	.	.	.	.	.	.	.	.	.	AFR:0.1717,AMR:0.6193,EAS:0.7797,FIN:0.4327,NFE:0.3646,OTH:0.4287,ASJ:0.3467	190030	.	.	.	.	.	.	.	.	.	.	.	15	MU29420728	hom
15	93510603	93510603	A	G	CHD2	exonic	synonymous SNV	ENSG00000173575	rs4777755	ENSG00000173575:ENST00000394196:exon17:c.A2049G:p.E683E,ENSG00000173575:ENST00000557381:exon17:c.A2049G:p.E683E	CHD2:NM_001271:exon17:c.A2049G:p.E683E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8419	0.7656	0.826478	0.7708	.	.	.	.	.	.	.	.	CHD2:uc002bso.1:exon17:c.A2049G:p.E683E,CHD2:uc002bsp.3:exon17:c.A2049G:p.E683E	.	AFR:0.6178,AMR:0.9105,EAS:0.9981,FIN:0.7596,NFE:0.8233,OTH:0.8219,ASJ:0.9305	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU81967798	hom
15	93521604	93521604	A	G	CHD2	exonic	synonymous SNV	ENSG00000173575	rs11074121	ENSG00000173575:ENST00000557116:exon3:c.A258G:p.Q86Q,ENSG00000173575:ENST00000394196:exon21:c.A2718G:p.Q906Q,ENSG00000173575:ENST00000557381:exon21:c.A2718G:p.Q906Q	CHD2:NM_001271:exon21:c.A2718G:p.Q906Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8353	0.7477	0.809105	0.7534	.	.	.	.	.	.	.	.	CHD2:uc010bog.1:exon4:c.A539G:p.K180R	.	AFR:0.5632,AMR:0.9069,EAS:0.9981,FIN:0.7585,NFE:0.8202,OTH:0.8112,ASJ:0.9272	602119	615369;	1942;2382;	1942|Doose syndrome<br>EMAS<br>Epilepsy with myoclonic-astatic seizures<br>Epilepsy with myoclonic-atonic seizures<br>MAE<br>Myoclonic atonic epilepsy<br>Myoclonic-astatic epilepsy in early childhood|Unknown|Unknown|Childhood|615369 616421 ~2382|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Childhood|615369 616346 617113 ~	.	.	.	.	.	.	.	.	15	MU81967815	hom
15	99251356	99251356	C	T	IGF1R	intronic	.	ENSG00000140443	rs7174918	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2907	0.2642	0.233427	COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2568,AMR:0.1319,EAS:0.3974,FIN:0.2311,NFE:0.2657,OTH:0.3260,ASJ:0.2356	147370	270450;	73273;	73273|Resistance to IGF-1|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|270450 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04510 Focal adhesion~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04730 Long-term depression~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	15	9(soft_tissue)	0.2957
15	99456253	99456253	T	C	IGF1R	intronic	.	ENSG00000140443	rs2272037	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5775	0.4694	0.511182	MU20714555	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5149,EAS:0.6160,FIN:0.5099,NFE:0.7108,OTH:0.6427,ASJ:0.2497	147370	270450;	73273;	73273|Resistance to IGF-1|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|270450 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04114 Oocyte meiosis~ko04140 Autophagy - animal~ko04144 Endocytosis~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04510 Focal adhesion~ko04520 Adherens junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04730 Long-term depression~ko04913 Ovarian steroidogenesis~ko04914 Progesterone-mediated oocyte maturation~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05205 Proteoglycans in cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma ~	.	.	.	.	.	.	.	15	17(soft_tissue)	0.6059
15	100218867	100218867	A	G	MEF2A	exonic	nonsynonymous SNV	ENSG00000068305	rs2581470	.	MEF2A:NM_001365210:exon8:c.A691G:p.K231E,MEF2A:NM_001365211:exon8:c.A685G:p.K229E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.630791	0.6681	.	.	.	.	.	.	.	.	.	.	AFR:0.3552,AMR:0.7045,EAS:0.7109,FIN:0.8311,NFE:0.7923,OTH:0.8143,ASJ:0.8510	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU12577973	hom
15	100246936	100246936	T	C	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325408	ENSG00000068305:ENST00000449277:exon7:c.T657C:p.N219N,ENSG00000068305:ENST00000453228:exon8:c.T861C:p.N287N,ENSG00000068305:ENST00000558812:exon8:c.T681C:p.N227N,ENSG00000068305:ENST00000354410:exon9:c.T867C:p.N289N,ENSG00000068305:ENST00000557785:exon9:c.T861C:p.N287N,ENSG00000068305:ENST00000338042:exon10:c.T888C:p.N296N,ENSG00000068305:ENST00000557942:exon10:c.T885C:p.N295N	MEF2A:NM_001130928:exon6:c.T657C:p.N219N,MEF2A:NM_001130926:exon8:c.T861C:p.N287N,MEF2A:NM_001130927:exon8:c.T681C:p.N227N,MEF2A:NM_001365206:exon8:c.T879C:p.N293N,MEF2A:NM_001365207:exon8:c.T867C:p.N289N,MEF2A:NM_001352616:exon9:c.T885C:p.N295N,MEF2A:NM_001352617:exon9:c.T867C:p.N289N,MEF2A:NM_001352618:exon9:c.T879C:p.N293N,MEF2A:NM_001365202:exon9:c.T903C:p.N301N,MEF2A:NM_001365204:exon9:c.T891C:p.N297N,MEF2A:NM_001365205:exon9:c.T885C:p.N295N,MEF2A:NM_001365208:exon9:c.T861C:p.N287N,MEF2A:NM_001365209:exon9:c.T681C:p.N227N,MEF2A:NM_005587:exon9:c.T867C:p.N289N,MEF2A:NM_001171894:exon10:c.T861C:p.N287N,MEF2A:NM_001319206:exon10:c.T885C:p.N295N,MEF2A:NM_001352614:exon10:c.T861C:p.N287N,MEF2A:NM_001365201:exon10:c.T903C:p.N301N,MEF2A:NM_001365203:exon10:c.T891C:p.N297N,MEF2A:NM_001352615:exon11:c.T861C:p.N287N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7471	0.6406	0.61242	0.6476	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon6:c.T657C:p.N219N,MEF2A:uc002bvi.3:exon8:c.T861C:p.N287N,MEF2A:uc010bos.3:exon8:c.T861C:p.N287N,MEF2A:uc010urv.2:exon8:c.T681C:p.N227N,MEF2A:uc002bvf.3:exon9:c.T867C:p.N289N,MEF2A:uc010urw.2:exon9:c.T891C:p.N297N,MEF2A:uc002bve.3:exon10:c.T885C:p.N295N,MEF2A:uc002bvg.3:exon10:c.T861C:p.N287N	.	AFR:0.2872,AMR:0.6974,EAS:0.7153,FIN:0.8232,NFE:0.7910,OTH:0.8086,ASJ:0.8477	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU700988	unknown
15	100246942	100246942	G	A	MEF2A	exonic	synonymous SNV	ENSG00000068305	rs325407	ENSG00000068305:ENST00000449277:exon7:c.G663A:p.Q221Q,ENSG00000068305:ENST00000453228:exon8:c.G867A:p.Q289Q,ENSG00000068305:ENST00000558812:exon8:c.G687A:p.Q229Q,ENSG00000068305:ENST00000354410:exon9:c.G873A:p.Q291Q,ENSG00000068305:ENST00000557785:exon9:c.G867A:p.Q289Q,ENSG00000068305:ENST00000338042:exon10:c.G894A:p.Q298Q,ENSG00000068305:ENST00000557942:exon10:c.G891A:p.Q297Q	MEF2A:NM_001130928:exon6:c.G663A:p.Q221Q,MEF2A:NM_001130926:exon8:c.G867A:p.Q289Q,MEF2A:NM_001130927:exon8:c.G687A:p.Q229Q,MEF2A:NM_001365206:exon8:c.G885A:p.Q295Q,MEF2A:NM_001365207:exon8:c.G873A:p.Q291Q,MEF2A:NM_001352616:exon9:c.G891A:p.Q297Q,MEF2A:NM_001352617:exon9:c.G873A:p.Q291Q,MEF2A:NM_001352618:exon9:c.G885A:p.Q295Q,MEF2A:NM_001365202:exon9:c.G909A:p.Q303Q,MEF2A:NM_001365204:exon9:c.G897A:p.Q299Q,MEF2A:NM_001365205:exon9:c.G891A:p.Q297Q,MEF2A:NM_001365208:exon9:c.G867A:p.Q289Q,MEF2A:NM_001365209:exon9:c.G687A:p.Q229Q,MEF2A:NM_005587:exon9:c.G873A:p.Q291Q,MEF2A:NM_001171894:exon10:c.G867A:p.Q289Q,MEF2A:NM_001319206:exon10:c.G891A:p.Q297Q,MEF2A:NM_001352614:exon10:c.G867A:p.Q289Q,MEF2A:NM_001365201:exon10:c.G909A:p.Q303Q,MEF2A:NM_001365203:exon10:c.G897A:p.Q299Q,MEF2A:NM_001352615:exon11:c.G867A:p.Q289Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9669	0.8850	0.886781	0.8929	.	.	.	.	.	.	.	.	MEF2A:uc010bot.3:exon6:c.G663A:p.Q221Q,MEF2A:uc002bvi.3:exon8:c.G867A:p.Q289Q,MEF2A:uc010bos.3:exon8:c.G867A:p.Q289Q,MEF2A:uc010urv.2:exon8:c.G687A:p.Q229Q,MEF2A:uc002bvf.3:exon9:c.G873A:p.Q291Q,MEF2A:uc010urw.2:exon9:c.G897A:p.Q299Q,MEF2A:uc002bve.3:exon10:c.G891A:p.Q297Q,MEF2A:uc002bvg.3:exon10:c.G867A:p.Q289Q	.	AFR:0.6237,AMR:0.9821,EAS:1,FIN:1,NFE:0.9985,OTH:0.9868,ASJ:1	600660	608320;	.	.	.	.	.	.	.	.	.	.	15	MU81968211	unknown
16	347931	347931	G	A	AXIN1	exonic	synonymous SNV	ENSG00000103126	rs1805102	ENSG00000103126:ENST00000262320:exon6:c.C1575T:p.D525D,ENSG00000103126:ENST00000354866:exon6:c.C1575T:p.D525D	AXIN1:NM_003502:exon6:c.C1575T:p.D525D,AXIN1:NM_181050:exon6:c.C1575T:p.D525D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0101	0.0006	0.00559105	0.0028	.	.	.	.	.	.	.	.	AXIN1:uc002cgp.2:exon6:c.C1575T:p.D525D,AXIN1:uc002cgq.2:exon6:c.C1575T:p.D525D	.	AFR:0.0008,AMR:0.0609,EAS:0.0160,FIN:0,NFE:0.0001,OTH:0.0020,ASJ:0	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU113438891	het
16	349221	349221	T	C	AXIN1	intronic	.	ENSG00000103126	rs214247	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.388179	0.4249	.	.	.	.	.	.	.	.	.	.	AFR:0.6136,AMR:0.2488,EAS:0.2110,FIN:0.3297,NFE:0.3773,OTH:0.3452,ASJ:0.3278	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU10930938	het
16	354287	354287	C	T	AXIN1	intronic	.	ENSG00000103126	rs62032881	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.1426	0.1268	0.125799	0.1233	.	.	.	.	.	.	.	.	.	.	AFR:0.0643,AMR:0.0835,EAS:0.1545,FIN:0.1258,NFE:0.1563,OTH:0.1155,ASJ:0.1325	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU10931196	het
16	359953	359953	A	G	AXIN1	intronic	.	ENSG00000103126	rs2301522	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6387	0.7276	0.649161	0.6909	.	.	.	.	.	.	.	.	.	.	AFR:0.8845,AMR:0.5647,EAS:0.3653,FIN:0.6372,NFE:0.6400,OTH:0.6235,ASJ:0.5430	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU27447663	hom
16	396264	396264	A	G	AXIN1	exonic	synonymous SNV	ENSG00000103126	rs1805105	ENSG00000103126:ENST00000262320:exon2:c.T762C:p.D254D,ENSG00000103126:ENST00000354866:exon2:c.T762C:p.D254D	AXIN1:NM_003502:exon2:c.T762C:p.D254D,AXIN1:NM_181050:exon2:c.T762C:p.D254D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6218	0.7141	0.638978	0.6766	.	.	.	.	.	.	.	.	AXIN1:uc002cgp.2:exon2:c.T762C:p.D254D,AXIN1:uc002cgq.2:exon2:c.T762C:p.D254D	.	AFR:0.8682,AMR:0.4940,EAS:0.3050,FIN:0.6045,NFE:0.6388,OTH:0.6109,ASJ:0.5497	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU152642	het
16	397044	397044	G	T	AXIN1	UTR5	.	ENSG00000103126	rs758033	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2252	0.2248	0.201478	0.2089	.	.	.	.	.	.	.	.	.	.	AFR:0.1701,AMR:0.1535,EAS:0.1259,FIN:0.2017,NFE:0.2444,OTH:0.2102,ASJ:0.2384	603816	114550;607864;	1756;449;88673;	1756|Dipygus<br>Split notochord syndrome|Unknown|Not applicable|Neonatal<br>Antenatal|607864 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	MU583737	het
16	2108755	2108755	A	G	TSC2	exonic	nonsynonymous SNV	ENSG00000103197	rs1800748	ENSG00000103197:ENST00000467949:exon4:c.A292G:p.M98V,ENSG00000103197:ENST00000382538:exon9:c.A709G:p.M237V,ENSG00000103197:ENST00000439673:exon9:c.A745G:p.M249V,ENSG00000103197:ENST00000219476:exon10:c.A856G:p.M286V,ENSG00000103197:ENST00000350773:exon10:c.A856G:p.M286V,ENSG00000103197:ENST00000353929:exon10:c.A856G:p.M286V,ENSG00000103197:ENST00000401874:exon10:c.A856G:p.M286V,ENSG00000103197:ENST00000568454:exon10:c.A889G:p.M297V	TSC2:NM_001318831:exon7:c.A256G:p.M86V,TSC2:NM_001318827:exon9:c.A745G:p.M249V,TSC2:NM_001318829:exon9:c.A709G:p.M237V,TSC2:NM_000548:exon10:c.A856G:p.M286V,TSC2:NM_001077183:exon10:c.A856G:p.M286V,TSC2:NM_001114382:exon10:c.A856G:p.M286V,TSC2:NM_001318832:exon10:c.A889G:p.M297V,TSC2:NM_001363528:exon10:c.A856G:p.M286V,TSC2:NM_001370404:exon10:c.A856G:p.M286V,TSC2:NM_001370405:exon10:c.A856G:p.M286V,TSC2:NM_021055:exon10:c.A856G:p.M286V	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 1] 	0.0036	0.0005	0.0061901	0.0015	0.254	5.239	0.06	5.12	0.991	.	.	Armadillo-like helical|Armadillo-type fold|Tuberin, N-terminal;Tuberin, N-terminal	TSC2:uc002cop.3:exon7:c.A256G:p.M86V,TSC2:uc010uvv.2:exon9:c.A745G:p.M249V,TSC2:uc010uvw.2:exon9:c.A709G:p.M237V,TSC2:uc002con.3:exon10:c.A856G:p.M286V,TSC2:uc002coo.3:exon10:c.A856G:p.M286V,TSC2:uc010bsd.3:exon10:c.A856G:p.M286V	-0.726	AFR:0,AMR:0.0012,EAS:0.0204,FIN:0,NFE:0.0007,OTH:0,ASJ:0	191092	606690;613254;	805;538;	805|Bourneville syndrome<br>Tuberous sclerosis|1-5 / 10 000|Autosomal dominant|All ages|191100 613254 ~538|LAM|1-9 / 1 000 000|Not applicable|Adult|606690 ~	~ko04072 Phospholipase D signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04211 Longevity regulating pathway~ko04218 Cellular senescence~ko04714 Thermogenesis~ko04910 Insulin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05168 Herpes simplex virus 1 infection~ko05231 Choline metabolism in cancer ~	,10354,10356,10350,10357,10352,10353,10355	.	.	0.019	-0.27	0.120	1.79	16	.	het
16	2144182	2144182	G	A	PKD1	exonic	nonsynonymous SNV	ENSG00000008710	rs45478794	ENSG00000008710:ENST00000262304:exon35:c.C10529T:p.T3510M,ENSG00000008710:ENST00000423118:exon35:c.C10526T:p.T3509M	PKD1:NM_000296:exon35:c.C10526T:p.T3509M,PKD1:NM_001009944:exon35:c.C10529T:p.T3510M	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0287	0.0052	0.0383387	COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02	0.357	6.235	0.047	0.474	0.000	.	.	.	PKD1:uc002cos.1:exon35:c.C10529T:p.T3510M,PKD1:uc002cot.1:exon35:c.C10526T:p.T3509M	-1.074	AFR:0.0116,AMR:0.0014,EAS:0.0033,FIN:0.0629,NFE:0.0063,OTH:0.0134,ASJ:0.0024	601313	173900;	.	.	.	.	.	.	0.857	1.19	0.005	0.665	16	1(large_intestine)	0.0204
16	2162979	2162979	G	A	PKD1	intronic	.	ENSG00000261240	rs2855349	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0539	0.0172	0.101637	0.0286	.	.	.	.	.	.	.	.	.	.	AFR:0.0230,AMR:0.0442,EAS:0.2413,FIN:0.0080,NFE:0.0128,OTH:0.0356,ASJ:0.0132	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	MU25578792	het
16	2164808	2164808	C	T	PKD1	exonic	nonsynonymous SNV	ENSG00000008710	rs40433	ENSG00000008710:ENST00000262304:exon11:c.G2216A:p.R739Q,ENSG00000008710:ENST00000423118:exon11:c.G2216A:p.R739Q	PKD1:NM_000296:exon11:c.G2216A:p.R739Q,PKD1:NM_001009944:exon11:c.G2216A:p.R739Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9586	.	0.979233	.	-0.560	0.156	0.719	-2.55	0.000	.	.	Polycystin cation channel	PKD1:uc002cos.1:exon11:c.G2216A:p.R739Q,PKD1:uc002cot.1:exon11:c.G2216A:p.R739Q	-0.965	AFR:0.9693,AMR:0.9926,EAS:0.9133,FIN:0.9994,NFE:0.9653,OTH:0.9545,ASJ:0.9758	601313	173900;	.	.	.	.	.	.	0.005	1.27	0.000	-0.625	16	22(upper_aerodigestive_tract)	0.9629
16	2167874	2167874	G	A	PKD1	exonic	synonymous SNV	ENSG00000008710	rs35842	ENSG00000008710:ENST00000568591:exon1:c.C87T:p.L29L,ENSG00000008710:ENST00000262304:exon5:c.C1119T:p.L373L,ENSG00000008710:ENST00000423118:exon5:c.C1119T:p.L373L	PKD1:NM_000296:exon5:c.C1119T:p.L373L,PKD1:NM_001009944:exon5:c.C1119T:p.L373L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9051	.	0.944289	.	.	.	.	.	.	.	.	.	PKD1:uc002cos.1:exon5:c.C1119T:p.L373L,PKD1:uc002cot.1:exon5:c.C1119T:p.L373L	.	AFR:0.8356,AMR:0.9129,EAS:0.7743,FIN:0.9515,NFE:0.8171,OTH:0.7820,ASJ:0.8883	601313	173900;	.	.	.	.	.	.	.	.	.	.	16	1(upper_aerodigestive_tract)	0.8191
16	3632335	3632335	T	C	SLX4	UTR3	.	ENSG00000261938	rs3751839	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0725	0.0821	0.072484	0.0833	.	.	.	.	.	.	.	.	.	.	AFR:0.1123,AMR:0.0706,EAS:0.0296,FIN:0.0817,NFE:0.0759,OTH:0.0684,ASJ:0.0099	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	.	het
16	3639139	3639139	A	G	SLX4	exonic	synonymous SNV	ENSG00000188827	rs3810812	ENSG00000188827:ENST00000294008:exon12:c.T4500C:p.N1500N	SLX4:NM_032444:exon12:c.T4500C:p.N1500N	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6116	0.6266	0.739617	0.6327	.	.	.	.	.	.	.	.	SLX4:uc002cvp.2:exon12:c.T4500C:p.N1500N	.	AFR:0.8818,AMR:0.6244,EAS:0.7336,FIN:0.5011,NFE:0.5156,OTH:0.5608,ASJ:0.47	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	MU25678123	hom
16	3639977	3639977	G	A	SLX4	exonic	nonsynonymous SNV	ENSG00000188827	rs3827530	ENSG00000188827:ENST00000294008:exon12:c.C3662T:p.A1221V	SLX4:NM_032444:exon12:c.C3662T:p.A1221V	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0586	0.0493	0.0411342	0.0532	0.218	4.867	0.296	-3.84	0.001	.	.	.	SLX4:uc002cvp.2:exon12:c.C3662T:p.A1221V	-1.039	AFR:0.0127,AMR:0.0573,EAS:0.0291,FIN:0.0814,NFE:0.0733,OTH:0.0562,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.019	1.87	0.003	-0.345	16	MU133260	het
16	3640274	3640274	G	A	SLX4	exonic	nonsynonymous SNV	ENSG00000188827	rs714181	ENSG00000188827:ENST00000294008:exon12:c.C3365T:p.P1122L	SLX4:NM_032444:exon12:c.C3365T:p.P1122L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1347	0.2116	0.239617	0.1994	0.797	9.446	0.818	-0.664	0.075	.	.	.	SLX4:uc002cvp.2:exon12:c.C3365T:p.P1122L	-0.948	AFR:0.4771,AMR:0.1112,EAS:0.0861,FIN:0.0936,NFE:0.0891,OTH:0.1069,ASJ:0.0464	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.003	2.31	0.000	-0.145	16	MU25342933	het
16	3640784	3640784	G	A	SLX4	exonic	nonsynonymous SNV	ENSG00000188827	rs78637028	ENSG00000188827:ENST00000294008:exon12:c.C2855T:p.A952V	SLX4:NM_032444:exon12:c.C2855T:p.A952V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 0, 0] 	0.0584	0.0477	0.0411342	0.0532	2.801	21.4	0.019	3.18	0.009	.	.	.	SLX4:uc002cvp.2:exon12:c.C2855T:p.A952V	-0.899	AFR:0.0126,AMR:0.0574,EAS:0.0296,FIN:0.0816,NFE:0.0732,OTH:0.0552,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.926	4.88	0.001	1.75	16	.	unknown
16	3640785	3640785	C	T	SLX4	exonic	nonsynonymous SNV	ENSG00000188827	rs59939128	ENSG00000188827:ENST00000294008:exon12:c.G2854A:p.A952T	SLX4:NM_032444:exon12:c.G2854A:p.A952T	clinvar: Benign/Likely_benign 	 CancerVar: -1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0672	0.0799	0.0670927	0.0794	0.920	10.20	0.23	-1.42	0.014	.	.	.	SLX4:uc002cvp.2:exon12:c.G2854A:p.A952T	-0.909	AFR:0.1046,AMR:0.0612,EAS:0.0296,FIN:0.0816,NFE:0.0733,OTH:0.0603,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.056	4.97	0.000	0.505	16	.	unknown
16	3645607	3645607	A	G	SLX4	exonic	nonsynonymous SNV	ENSG00000188827	rs77985244	ENSG00000188827:ENST00000294008:exon9:c.T2012C:p.L671S	SLX4:NM_032444:exon9:c.T2012C:p.L671S	clinvar: Benign/Likely_benign 	 CancerVar: -1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0661	0.0757	0.0621006	0.0744	-1.233	0.006	0.595	0.88	0.155	0	0	.	SLX4:uc002cvp.2:exon9:c.T2012C:p.L671S	-0.963	AFR:0.0870,AMR:0.0609,EAS:0.0297,FIN:0.0814,NFE:0.0733,OTH:0.0605,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.0	5.46	0.000	-1.2	16	.	het
16	3647692	3647692	A	C	SLX4	exonic	nonsynonymous SNV	ENSG00000188827	rs74319927	ENSG00000188827:ENST00000294008:exon7:c.T1371G:p.N457K	SLX4:NM_032444:exon7:c.T1371G:p.N457K	clinvar: Benign/Likely_benign 	 CancerVar: -1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, -1, 0, 0] 	0.0628	0.0651	0.0549121	0.0665	1.253	12.02	1.0	5.19	0.995	.	.	.	SLX4:uc002cvp.2:exon7:c.T1371G:p.N457K	-0.962	AFR:0.0590,AMR:0.0597,EAS:0.0297,FIN:0.0814,NFE:0.0736,OTH:0.0570,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.0	2.35	0.001	-2.31	16	.	het
16	3647787	3647787	A	G	SLX4	intronic	.	ENSG00000188827	rs76350200	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0709	0.0870	0.0756789	0.0866	.	.	.	.	.	.	.	.	.	.	AFR:0.1242,AMR:0.0704,EAS:0.0297,FIN:0.0814,NFE:0.0758,OTH:0.0692,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	.	het
16	3648619	3648619	T	C	SLX4	intronic	.	ENSG00000188827	rs60298844	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0664936	0.0781	.	.	.	.	.	.	.	.	.	.	AFR:0.0996,AMR:0.0609,EAS:0.0296,FIN:0.0814,NFE:0.0734,OTH:0.0613,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	.	het
16	3650970	3650970	G	A	SLX4	intronic	.	ENSG00000188827	rs80116508	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0644	0.0686	0.0589058	0.0701	.	.	.	.	.	.	.	.	.	.	AFR:0.0718,AMR:0.0600,EAS:0.0297,FIN:0.0814,NFE:0.0736,OTH:0.0574,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	.	het
16	3650987	3650987	T	C	SLX4	exonic	nonsynonymous SNV	ENSG00000188827	rs113490934	ENSG00000188827:ENST00000294008:exon5:c.A1156G:p.M386V	SLX4:NM_032444:exon5:c.A1156G:p.M386V	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0628	0.0651	0.0545128	0.0665	-2.087	0.001	0.653	2.41	0.000	.	.	.	SLX4:uc002cvp.2:exon5:c.A1156G:p.M386V	-0.975	AFR:0.0597,AMR:0.0598,EAS:0.0297,FIN:0.0808,NFE:0.0734,OTH:0.0560,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	0.0	2.19	0.002	-1.39	16	MU25343458	unknown
16	3650991	3650991	T	C	SLX4	exonic	synonymous SNV	ENSG00000188827	rs112511042	ENSG00000188827:ENST00000294008:exon5:c.A1152G:p.P384P	SLX4:NM_032444:exon5:c.A1152G:p.P384P	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0627	0.0652	0.0547125	0.0665	.	.	.	.	.	.	.	.	SLX4:uc002cvp.2:exon5:c.A1152G:p.P384P	.	AFR:0.0597,AMR:0.0597,EAS:0.0297,FIN:0.0808,NFE:0.0734,OTH:0.0560,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	.	unknown
16	3656625	3656625	G	A	SLX4	exonic	nonsynonymous SNV	ENSG00000188827	rs79842542	ENSG00000188827:ENST00000294008:exon3:c.C610T:p.R204C	SLX4:NM_032444:exon3:c.C610T:p.R204C	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0642	0.0713	0.0597045	0.0706	4.875	24.9	0.0	3.11	0.212	.	.	.	SLX4:uc002cvp.2:exon3:c.C610T:p.R204C,SLX4:uc002cvq.1:exon3:c.C610T:p.R204C	-1.223	AFR:0.0736,AMR:0.0586,EAS:0.0296,FIN:0.0813,NFE:0.0736,OTH:0.0580,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	1.0	3.49	0.003	2.455	16	MU25343507	het
16	3656680	3656680	G	A	SLX4	exonic	synonymous SNV	ENSG00000188827	rs74640850	ENSG00000188827:ENST00000294008:exon3:c.C555T:p.D185D	SLX4:NM_032444:exon3:c.C555T:p.D185D	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0586	0.0498	0.0419329	0.0534	.	.	.	.	.	.	.	.	SLX4:uc002cvp.2:exon3:c.C555T:p.D185D,SLX4:uc002cvq.1:exon3:c.C555T:p.D185D	.	AFR:0.0128,AMR:0.0573,EAS:0.0296,FIN:0.0814,NFE:0.0736,OTH:0.0550,ASJ:0.0066	613278	613951;	84;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~	.	.	.	.	.	.	.	.	16	.	het
16	3778427	3778427	T	C	CREBBP	exonic	synonymous SNV	ENSG00000005339	rs55960450	ENSG00000005339:ENST00000382070:exon30:c.A6507G:p.Q2169Q,ENSG00000005339:ENST00000262367:exon31:c.A6621G:p.Q2207Q	CREBBP:NM_001079846:exon30:c.A6507G:p.Q2169Q,CREBBP:NM_004380:exon31:c.A6621G:p.Q2207Q	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0171	0.0092	0.0229633	0.0087	.	.	.	.	.	.	.	.	CREBBP:uc002cvw.3:exon30:c.A6507G:p.Q2169Q,CREBBP:uc002cvv.3:exon31:c.A6621G:p.Q2207Q	.	AFR:0.0169,AMR:0.0036,EAS:0.0087,FIN:0.0023,NFE:0.0052,OTH:0.0093,ASJ:0.0331	600140	180849;	353277;783;	353277|-|-|-|-|180849 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	,2062	.	.	.	.	.	.	16	.	het
16	3779060	3779060	G	A	CREBBP	exonic	synonymous SNV	ENSG00000005339	rs181646656	ENSG00000005339:ENST00000382070:exon30:c.C5874T:p.A1958A,ENSG00000005339:ENST00000262367:exon31:c.C5988T:p.A1996A	CREBBP:NM_001079846:exon30:c.C5874T:p.A1958A,CREBBP:NM_004380:exon31:c.C5988T:p.A1996A	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0245	0.0061	0.0179712	0.0041	.	.	.	.	.	.	.	.	CREBBP:uc002cvw.3:exon30:c.C5874T:p.A1958A,CREBBP:uc002cvv.3:exon31:c.C5988T:p.A1996A	.	AFR:0.0013,AMR:0.0024,EAS:0.0074,FIN:0.0023,NFE:0.0052,OTH:0.0051,ASJ:0.0331	600140	180849;	353277;783;	353277|-|-|-|-|180849 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	,2062	.	.	.	.	.	.	16	.	het
16	5122072	5122072	-	GTCT	ALG1	intronic	.	ENSG00000033011	rs112683515	ENSG00000033011:ENST00000591822:exon1:c.222_223insGTCT:p.R74fs	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6041	0.5126	0.583466	0.5624	.	.	.	.	.	.	.	.	.	.	AFR:0.5416,AMR:0.4556,EAS:0.6941,FIN:0.5931,NFE:0.5623,OTH:0.5484,ASJ:0.4536	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	.	het
16	5132636	5132636	C	T	ALG1	exonic	synonymous SNV	ENSG00000033011	rs1047732	ENSG00000033011:ENST00000262374:exon11:c.C1149T:p.F383F,ENSG00000033011:ENST00000544428:exon11:c.C816T:p.F272F,ENSG00000033011:ENST00000588623:exon12:c.C816T:p.F272F	ALG1:NM_001330504:exon11:c.C816T:p.F272F,ALG1:NM_019109:exon11:c.C1149T:p.F383F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5243	0.4694	0.519768	0.5046	.	.	.	.	.	.	.	.	ALG1:uc002cym.3:exon11:c.C1149T:p.F383F,ALG1:uc010bue.3:exon11:c.C816T:p.F272F,ALG1:uc002cyj.3:exon12:c.C816T:p.F272F	.	AFR:0.4030,AMR:0.4400,EAS:0.6658,FIN:0.5702,NFE:0.5350,OTH:0.5204,ASJ:0.4404	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	.	.	.	.	16	MU62996	het
16	5134774	5134774	T	A	ALG1	exonic	nonsynonymous SNV	ENSG00000033011	rs9745522	ENSG00000033011:ENST00000262374:exon13:c.T1287A:p.D429E,ENSG00000033011:ENST00000544428:exon13:c.T954A:p.D318E,ENSG00000033011:ENST00000588623:exon14:c.T954A:p.D318E	ALG1:NM_001330504:exon13:c.T954A:p.D318E,ALG1:NM_019109:exon13:c.T1287A:p.D429E	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 0, 0] 	0.1174	0.1136	0.126997	0.1174	0.413	6.728	0.313	0.753	0.794	.	.	Glycosyl transferase, family 1	ALG1:uc002cym.3:exon13:c.T1287A:p.D429E,ALG1:uc010bue.3:exon13:c.T954A:p.D318E,ALG1:uc002cyj.3:exon14:c.T954A:p.D318E	-1.072	AFR:0.1452,AMR:0.1706,EAS:0.0364,FIN:0.1266,NFE:0.1044,OTH:0.1245,ASJ:0.1126	605907	608540;	79327;	79327|CDG syndrome type Ik<br>CDG-Ik<br>CDG1K<br>Carbohydrate deficient glycoprotein syndrome type Ik<br>Congenital disorder of glycosylation type 1k<br>Congenital disorder of glycosylation type Ik<br>Mannosyltransferase 1 deficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|608540 ~	.	.	.	.	0.048	-0.95	0.001	1.85	16	.	het
16	9858502	9858502	C	G	GRIN2A	exonic	nonsynonymous SNV	ENSG00000183454	rs61731465	ENSG00000183454:ENST00000396575:exon12:c.G2899C:p.V967L,ENSG00000183454:ENST00000535259:exon12:c.G2428C:p.V810L,ENSG00000183454:ENST00000562109:exon12:c.G2899C:p.V967L,ENSG00000183454:ENST00000330684:exon13:c.G2899C:p.V967L,ENSG00000183454:ENST00000404927:exon13:c.G2899C:p.V967L,ENSG00000183454:ENST00000396573:exon14:c.G2899C:p.V967L	GRIN2A:NM_001134407:exon13:c.G2899C:p.V967L,GRIN2A:NM_001134408:exon13:c.G2899C:p.V967L,GRIN2A:NM_000833:exon14:c.G2899C:p.V967L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.0057	0.0064	0.00279553	0.0050	0.207	4.751	1.0	4.47	1.000	.	.	Glutamate [NMDA] receptor, epsilon subunit, C-terminal	GRIN2A:uc010uyn.2:exon12:c.G2428C:p.V810L,GRIN2A:uc002czo.4:exon13:c.G2899C:p.V967L,GRIN2A:uc002czr.4:exon13:c.G2899C:p.V967L,GRIN2A:uc010uym.2:exon14:c.G2899C:p.V967L	-1.027	AFR:0.0017,AMR:0.0048,EAS:0,FIN:0.0034,NFE:0.0078,OTH:0.0082,ASJ:0	138253	245570;	163721;1945;725;98818;	163721|-|-|Autosomal dominant<br>or&nbsp;X-linked dominant|-|245570 300643 ~1945|BECRS<br>BECTS<br>BRE<br>Benign epilepsy of childhood with centrotemporal spikes<br>Benign familial epilepsy of childhood with rolandic spikes<br>Benign rolandic epilepsy<br>Centrotemporal epilepsy|Unknown|Autosomal dominant|Childhood|117100 245570 ~725|CSWS<br>CSWSS syndrome<br>Continuous spikes and waves during slow-wave sleep<br>Epileptic encephalopathy with continuous spike-and-wave during slow sleep|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|245570 ~98818|Acquired epileptic aphasia<br>LKS|-|Autosomal dominant|Childhood|245570 ~	.	.	.	.	0.0	2.91	0.011	-0.06	16	.	het
16	9934671	9934671	A	-	GRIN2A	intronic	.	ENSG00000183454	rs745951746	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0219	.	.	0.0181	.	.	.	.	.	.	.	.	.	.	AFR:0.0112,AMR:0.0294,EAS:0.0023,FIN:0.0377,NFE:0.0251,OTH:0.0181,ASJ:0	138253	245570;	163721;1945;725;98818;	163721|-|-|Autosomal dominant<br>or&nbsp;X-linked dominant|-|245570 300643 ~1945|BECRS<br>BECTS<br>BRE<br>Benign epilepsy of childhood with centrotemporal spikes<br>Benign familial epilepsy of childhood with rolandic spikes<br>Benign rolandic epilepsy<br>Centrotemporal epilepsy|Unknown|Autosomal dominant|Childhood|117100 245570 ~725|CSWS<br>CSWSS syndrome<br>Continuous spikes and waves during slow-wave sleep<br>Epileptic encephalopathy with continuous spike-and-wave during slow sleep|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|245570 ~98818|Acquired epileptic aphasia<br>LKS|-|Autosomal dominant|Childhood|245570 ~	.	.	.	.	.	.	.	.	16	.	het
16	10989219	10989219	C	G	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs2229317	ENSG00000179583:ENST00000324288:exon2:c.C133G:p.L45V,ENSG00000179583:ENST00000381835:exon2:c.C133G:p.L45V,ENSG00000179583:ENST00000571186:exon2:c.C133G:p.L45V,ENSG00000179583:ENST00000576601:exon2:c.C61G:p.L21V	CIITA:NM_000246:exon2:c.C133G:p.L45V,CIITA:NM_001286402:exon2:c.C133G:p.L45V,CIITA:NM_001286403:exon2:c.C133G:p.L45V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0966	0.0306	0.145168	2(lung)	1.387	12.72	0.076	-4.35	0.000	.	.	.	CIITA:uc002dag.2:exon2:c.C133G:p.L45V,CIITA:uc002dah.2:exon2:c.C133G:p.L45V,CIITA:uc002dai.4:exon2:c.C133G:p.L45V,CIITA:uc002daj.4:exon2:c.C133G:p.L45V,CIITA:uc002dak.4:exon2:c.C133G:p.L45V,CIITA:uc010bup.1:exon2:c.C133G:p.L45V	-1.008	AFR:2(soft_tissue),AMR:MU583766,EAS:0.0599,FIN:0.0680,NFE:0.4200,OTH:0.0132,ASJ:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	0.999	-1.63	0.000	1.815	16	1(large_intestine)	0.3344
16	10989374	10989374	C	T	CIITA	intronic	.	ENSG00000179583	rs11074937	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.949681	0.9548	.	.	.	.	.	.	.	.	.	.	AFR:0.8423,AMR:0.9893,EAS:0.9994,FIN:1,NFE:0.9994,OTH:0.9980,ASJ:0.9901	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	.	hom
16	10995933	10995933	A	G	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs8046121	ENSG00000179583:ENST00000324288:exon7:c.A520G:p.R174G,ENSG00000179583:ENST00000576601:exon7:c.A448G:p.R150G	CIITA:NM_000246:exon7:c.A520G:p.R174G,CIITA:NM_001286402:exon7:c.A523G:p.R175G	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9959	0.9831	0.98722	0.9861	.	.	.	.	.	.	.	.	CIITA:uc002dag.2:exon7:c.A520G:p.R174G,CIITA:uc002dai.4:exon7:c.A520G:p.R174G,CIITA:uc002daj.4:exon7:c.A523G:p.R175G,CIITA:uc010bup.1:exon7:c.A520G:p.R174G	.	AFR:0.9511,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU4561336	hom
16	11001421	11001421	C	A	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs78108426	ENSG00000179583:ENST00000324288:exon11:c.C2072A:p.A691D	CIITA:NM_000246:exon11:c.C2072A:p.A691D,CIITA:NM_001286402:exon11:c.C2075A:p.A692D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0222	0.0105	0.0447284	LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	0.262	5.317	0.164	3.26	0.026	.	.	NACHT nucleoside triphosphatase	CIITA:uc002dah.2:exon10:c.C1928A:p.A643D,CIITA:uc002dag.2:exon11:c.C2072A:p.A691D,CIITA:uc002dai.4:exon11:c.C2072A:p.A691D,CIITA:uc002daj.4:exon11:c.C2075A:p.A692D	-0.920	AFR:0.0162,AMR:0.0186,EAS:0.0132,FIN:0.1207,NFE:0.0029,OTH:0.0069,ASJ:0.0155	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	0.105	-0.74	0.006	1.905	16	1(ovary)	0.0132
16	11001743	11001743	G	A	CIITA	exonic	synonymous SNV	ENSG00000179583	rs2229320	ENSG00000179583:ENST00000324288:exon11:c.G2394A:p.P798P	CIITA:NM_000246:exon11:c.G2394A:p.P798P,CIITA:NM_001286402:exon11:c.G2397A:p.P799P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2122	0.1512	0.189297	MU90735	.	.	.	.	.	.	.	.	CIITA:uc002dah.2:exon10:c.G2250A:p.P750P,CIITA:uc002dag.2:exon11:c.G2394A:p.P798P,CIITA:uc002dai.4:exon11:c.G2394A:p.P798P,CIITA:uc002daj.4:exon11:c.G2397A:p.P799P	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.1683,EAS:0.1396,FIN:0.1954,NFE:0.3030,OTH:0.2417,ASJ:0.0527	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	6(soft_tissue)	0.2022
16	11002904	11002904	G	A	CIITA	exonic	synonymous SNV	ENSG00000179583	rs2228238	ENSG00000179583:ENST00000381835:exon10:c.G924A:p.T308T,ENSG00000179583:ENST00000324288:exon12:c.G2676A:p.T892T	CIITA:NM_001286403:exon10:c.G924A:p.T308T,CIITA:NM_000246:exon12:c.G2676A:p.T892T,CIITA:NM_001286402:exon12:c.G2679A:p.T893T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6840	0.6347	0.663139	0.6606	.	.	.	.	.	.	.	.	CIITA:uc002dak.4:exon10:c.G924A:p.T308T,CIITA:uc002dai.4:exon12:c.G2676A:p.T892T,CIITA:uc002daj.4:exon12:c.G2679A:p.T893T	.	AFR:0.5082,AMR:0.5490,EAS:0.8681,FIN:0.7666,NFE:0.7023,OTH:0.7336,ASJ:0.7267	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	MU27455469	hom
16	11002927	11002927	A	G	CIITA	exonic	nonsynonymous SNV	ENSG00000179583	rs7197779	ENSG00000179583:ENST00000381835:exon10:c.A947G:p.Q316R,ENSG00000179583:ENST00000324288:exon12:c.A2699G:p.Q900R	CIITA:NM_001286403:exon10:c.A947G:p.Q316R,CIITA:NM_000246:exon12:c.A2699G:p.Q900R,CIITA:NM_001286402:exon12:c.A2702G:p.Q901R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.9787	0.9199	0.928714	0.9325	-0.355	0.495	0.518	-0.248	0.010	.	.	.	CIITA:uc002dak.4:exon10:c.A947G:p.Q316R,CIITA:uc002dai.4:exon12:c.A2699G:p.Q900R,CIITA:uc002daj.4:exon12:c.A2702G:p.Q901R	-0.980	AFR:0.7626,AMR:0.9928,EAS:1,FIN:1,NFE:0.9994,OTH:0.9949,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	0.001	-0.68	0.000	1.3	16	MU81973165	hom
16	11012734	11012734	T	C	CIITA	intronic	.	ENSG00000179583	rs8062961	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.978435	0.9790	.	.	.	.	.	.	.	.	.	.	AFR:0.9259,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:0.9980,ASJ:1	600005	180300;209920;	572;	572|Bare lymphocyte syndrome type 2<br>HLA class 2-negative severe combined immunodeficiency|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|209920 ~	.	.	.	.	.	.	.	.	16	.	hom
16	12060163	12060163	A	G	TNFRSF17	exonic	nonsynonymous SNV	ENSG00000048462	rs373496	ENSG00000048462:ENST00000053243:exon2:c.A242G:p.N81S	TNFRSF17:NM_001192:exon2:c.A242G:p.N81S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9792	0.9581	0.961262	0.9635	-2.420	0.001	1.0	-3.14	0.038	.	.	.	TNFRSF17:uc002dbv.3:exon2:c.A242G:p.N81S,TNFRSF17:uc010buy.3:exon2:c.A242G:p.N81S	-0.975	AFR:0.9007,AMR:0.9881,EAS:1,FIN:0.9917,NFE:0.9861,OTH:0.9868,ASJ:0.9901	109545	.	.	.	.	.	.	.	0.0	2.97	0.000	-0.345	16	MU81973453	hom
16	14014240	14014240	G	A	ERCC4	intronic	.	ENSG00000175595	rs762521	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3330	0.2314	0.220248	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.2310,AMR:0.1747,EAS:0.2980,FIN:0.2609,NFE:0.2174,OTH:0.2639,ASJ:0.1643	133520	278760;610965;615272;	84;220295;910;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	16	1(lung)	0.2648
16	14026007	14026007	G	A	ERCC4	intronic	.	ENSG00000262732	rs254942	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9661	0.9846	0.946486	0.9716	.	.	.	.	.	0.0002	0.002	.	.	.	AFR:0.9954,AMR:0.9857,EAS:0.7519,FIN:0.9754,NFE:0.9797,OTH:0.9745,ASJ:0.9669	133520	278760;610965;615272;	84;220295;910;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	.	.	.	.	.	.	.	16	MU25355495	hom
16	14041958	14041958	T	C	ERCC4	exonic	synonymous SNV	ENSG00000175595	rs1799801	ENSG00000175595:ENST00000311895:exon11:c.T2505C:p.S835S	ERCC4:NM_005236:exon11:c.T2505C:p.S835S	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2723	0.2532	0.241214	LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	ERCC4:uc010uyz.1:exon6:c.T1155C:p.S385S,ERCC4:uc002dce.2:exon11:c.T2505C:p.S835S	.	AFR:0.2433,AMR:0.1744,EAS:0.3245,FIN:0.2429,NFE:0.2291,OTH:0.2802,ASJ:0.2661	133520	278760;610965;615272;	84;220295;910;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	4780,	.	.	.	.	.	.	16	1(haematopoietic_and_lymphoid_tissue)	0.2984
16	15789748	15789748	T	G	NDE1	intronic	.	ENSG00000072864	rs60982882	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0	.	0.123403	0.0782	.	.	.	.	.	.	.	.	.	.	AFR:0.0635,AMR:0.0825,EAS:0.2723,FIN:0.0378,NFE:0.0748,OTH:0.0796,ASJ:0.0861	609449	605013;614019;	1083;443162;	1083|-|Unknown|Autosomal recessive|Infancy<br>Neonatal|614019 616212 ~443162|MHAC|<1 / 1 000 000|Autosomal recessive|Antenatal<br>Neonatal|605013 ~	.	.	.	.	.	.	.	.	16	MU29500883	hom
16	15818842	15818842	A	G	MYH11	exonic	nonsynonymous SNV	ENSG00000133392	rs16967510	ENSG00000133392:ENST00000300036:exon29:c.T3866C:p.V1289A,ENSG00000133392:ENST00000576790:exon29:c.T3866C:p.V1289A,ENSG00000133392:ENST00000396324:exon30:c.T3887C:p.V1296A,ENSG00000133392:ENST00000452625:exon30:c.T3887C:p.V1296A	MYH11:NM_002474:exon29:c.T3866C:p.V1289A,MYH11:NM_022844:exon29:c.T3866C:p.V1289A,MYH11:NM_001040113:exon30:c.T3887C:p.V1296A,MYH11:NM_001040114:exon30:c.T3887C:p.V1296A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0398	0.0477	0.0201677	0.0386	2.493	19.42	0.161	5.17	0.983	.	.	Myosin tail	MYH11:uc002ddw.3:exon29:c.T3866C:p.V1289A,MYH11:uc002ddy.3:exon29:c.T3866C:p.V1289A,MYH11:uc002ddv.3:exon30:c.T3887C:p.V1296A,MYH11:uc002ddx.3:exon30:c.T3887C:p.V1296A,MYH11:uc010bvg.3:exon30:c.T3362C:p.V1121A	-0.929	AFR:0.0115,AMR:0.0239,EAS:0,FIN:0.0132,NFE:0.0646,OTH:0.0410,ASJ:0.0633	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	0.233	-1.04	0.034	0.28	16	MU88169467	het
16	15820786	15820786	C	T	MYH11	exonic	synonymous SNV	ENSG00000133392	rs370031545	ENSG00000133392:ENST00000300036:exon28:c.G3777A:p.A1259A,ENSG00000133392:ENST00000576790:exon28:c.G3777A:p.A1259A,ENSG00000133392:ENST00000396324:exon29:c.G3798A:p.A1266A,ENSG00000133392:ENST00000452625:exon29:c.G3798A:p.A1266A	MYH11:NM_002474:exon28:c.G3777A:p.A1259A,MYH11:NM_022844:exon28:c.G3777A:p.A1259A,MYH11:NM_001040113:exon29:c.G3798A:p.A1266A,MYH11:NM_001040114:exon29:c.G3798A:p.A1266A	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 1, 0] 	9.062e-05	7.7e-05	.	3.238e-05	.	.	.	.	.	.	.	.	MYH11:uc002ddw.3:exon28:c.G3777A:p.A1259A,MYH11:uc002ddy.3:exon28:c.G3777A:p.A1259A,MYH11:uc002ddv.3:exon29:c.G3798A:p.A1266A,MYH11:uc002ddx.3:exon29:c.G3798A:p.A1266A,MYH11:uc010bvg.3:exon29:c.G3273A:p.A1091A	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	.	het
16	15841773	15841773	G	A	MYH11	exonic	synonymous SNV	ENSG00000133392	rs12931799	ENSG00000133392:ENST00000300036:exon18:c.C2208T:p.I736I,ENSG00000133392:ENST00000576790:exon18:c.C2208T:p.I736I,ENSG00000133392:ENST00000396324:exon19:c.C2229T:p.I743I,ENSG00000133392:ENST00000452625:exon19:c.C2229T:p.I743I	MYH11:NM_002474:exon18:c.C2208T:p.I736I,MYH11:NM_022844:exon18:c.C2208T:p.I736I,MYH11:NM_001040113:exon19:c.C2229T:p.I743I,MYH11:NM_001040114:exon19:c.C2229T:p.I743I	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0562	0.0727	0.0966454	MELA-AU|1|183|0.00546448,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MYH11:uc002ddw.3:exon18:c.C2208T:p.I736I,MYH11:uc002ddy.3:exon18:c.C2208T:p.I736I,MYH11:uc002ddv.3:exon19:c.C2229T:p.I743I,MYH11:uc002ddx.3:exon19:c.C2229T:p.I743I,MYH11:uc010bvg.3:exon19:c.C1704T:p.I568I	.	AFR:0.0711,AMR:0.1457,EAS:0.0166,FIN:0.1064,NFE:0.0367,OTH:0.0371,ASJ:0.0382	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(skin)	0.0400
16	15850204	15850204	A	G	MYH11	exonic	synonymous SNV	ENSG00000133392	rs2272554	ENSG00000133392:ENST00000300036:exon14:c.T1743C:p.A581A,ENSG00000133392:ENST00000576790:exon14:c.T1743C:p.A581A,ENSG00000133392:ENST00000396324:exon15:c.T1764C:p.A588A,ENSG00000133392:ENST00000452625:exon15:c.T1764C:p.A588A	MYH11:NM_002474:exon14:c.T1743C:p.A581A,MYH11:NM_022844:exon14:c.T1743C:p.A581A,MYH11:NM_001040113:exon15:c.T1764C:p.A588A,MYH11:NM_001040114:exon15:c.T1764C:p.A588A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4437	0.4990	0.548123	MU4561662	.	.	.	.	.	.	.	.	MYH11:uc002dea.1:exon9:c.T861C:p.A287A,MYH11:uc002ddw.3:exon14:c.T1743C:p.A581A,MYH11:uc002ddy.3:exon14:c.T1743C:p.A581A,MYH11:uc002ddv.3:exon15:c.T1764C:p.A588A,MYH11:uc002ddx.3:exon15:c.T1764C:p.A588A,MYH11:uc010bvg.3:exon15:c.T1239C:p.A413A	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916,AMR:0.5053,EAS:0.3453,FIN:0.4205,NFE:0.7153,OTH:0.3848,ASJ:0.6841	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(thyroid)	0.4232
16	15853596	15853596	C	G	MYH11	intronic	.	ENSG00000133392	rs2280764	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4164	0.4732	0.534345	MU14395645	.	.	.	.	.	0	0	.	.	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|6|321|0.0186916,AMR:0.4711,EAS:0.3294,FIN:0.4139,NFE:0.7022,OTH:0.3394,ASJ:0.6661	160745	132900;	91387;	91387|Familial TAAD|-|Autosomal dominant|-|132900 607086 607087 609192 610168 611788 613780 614816 615436 615582 616166 617168 ~	.	.	.	.	.	.	.	.	16	1(large_intestine)	0.3780
16	27456613	27456613	G	C	IL21R	intronic	.	ENSG00000103522	rs963154	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2894	0.3616	0.273163	0.3520	.	.	.	.	.	.	.	.	.	.	AFR:0.4802,AMR:0.2536,EAS:0.0977,FIN:0.3331,NFE:0.3198,OTH:0.3047,ASJ:0.2550	605383	147050;615207;	357329;	357329|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615207 ~	.	.	.	.	.	.	.	.	16	MU82139320	het
16	28617128	28617128	T	C	SULT1A1	UTR3	.	ENSG00000196502	rs6839	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3110	.	0.23123	2(lung)	.	.	.	.	.	.	.	.	.	.	AFR:MU10921022,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,EAS:0.2176,FIN:0.3855,NFE:0.2685,OTH:0.0587,ASJ:0.3232	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	4(large_intestine)	0.4657
16	28617361	28617361	G	A	SULT1A1	intronic	.	ENSG00000196502	rs41278162	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2949	0.2598	0.221246	0.3084	.	.	.	.	.	.	.	.	.	.	AFR:0.2122,AMR:0.3775,EAS:0.0502,FIN:0.4426,NFE:0.3591,OTH:0.3153,ASJ:0.2657	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	MU21077428	het
16	28617485	28617485	C	T	SULT1A1	exonic	nonsynonymous SNV	ENSG00000196502	rs1801030	ENSG00000196502:ENST00000350842:exon5:c.G433A:p.V145M,ENSG00000196502:ENST00000569554:exon6:c.G667A:p.V223M,ENSG00000196502:ENST00000314752:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000395607:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000566189:exon7:c.G667A:p.V223M,ENSG00000196502:ENST00000395609:exon9:c.G667A:p.V223M	SULT1A1:NM_177536:exon5:c.G433A:p.V145M,SULT1A1:NM_177534:exon6:c.G667A:p.V223M,SULT1A1:NM_001055:exon7:c.G667A:p.V223M,SULT1A1:NM_177529:exon7:c.G667A:p.V223M,SULT1A1:NM_177530:exon7:c.G667A:p.V223M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9714	0.8729	.	0.9256	2.497	19.45	0.093	2.18	0.007	.	.	P-loop containing nucleoside triphosphate hydrolase|Sulfotransferase domain	SULT1A1:uc002dqm.3:exon5:c.G433A:p.V145M,SULT1A1:uc002dqi.3:exon6:c.G667A:p.V223M,SULT1A1:uc002dqj.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dqk.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dql.3:exon7:c.G667A:p.V223M,SULT1A1:uc002dqp.3:exon9:c.G667A:p.V223M,SULT1A1:uc002dqn.3:exon10:c.G940A:p.V314M	-1.034	AFR:0.7421,AMR:0.9808,EAS:1,FIN:1,NFE:0.9987,OTH:0.9907,ASJ:0.9901	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	0.036	4.53	0.000	2.515	16	MU81975347	hom
16	28617514	28617514	C	T	SULT1A1	exonic	nonsynonymous SNV	ENSG00000196502	rs1042028	ENSG00000196502:ENST00000350842:exon5:c.G404A:p.R135H,ENSG00000196502:ENST00000569554:exon6:c.G638A:p.R213H,ENSG00000196502:ENST00000314752:exon7:c.G638A:p.R213H,ENSG00000196502:ENST00000395607:exon7:c.G638A:p.R213H,ENSG00000196502:ENST00000566189:exon7:c.G638A:p.R213H,ENSG00000196502:ENST00000395609:exon9:c.G638A:p.R213H	SULT1A1:NM_177536:exon5:c.G404A:p.R135H,SULT1A1:NM_177534:exon6:c.G638A:p.R213H,SULT1A1:NM_001055:exon7:c.G638A:p.R213H,SULT1A1:NM_177529:exon7:c.G638A:p.R213H,SULT1A1:NM_177530:exon7:c.G638A:p.R213H	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.2208	0.2401	.	0.3130	4.269	23.9	0.052	2.18	0.443	.	.	P-loop containing nucleoside triphosphate hydrolase|Sulfotransferase domain	SULT1A1:uc002dqm.3:exon5:c.G404A:p.R135H,SULT1A1:uc002dqi.3:exon6:c.G638A:p.R213H,SULT1A1:uc002dqj.3:exon7:c.G638A:p.R213H,SULT1A1:uc002dqk.3:exon7:c.G638A:p.R213H,SULT1A1:uc002dql.3:exon7:c.G638A:p.R213H,SULT1A1:uc002dqp.3:exon9:c.G638A:p.R213H,SULT1A1:uc002dqn.3:exon10:c.G911A:p.R304H	-1.035	AFR:0.2290,AMR:0.3765,EAS:0.0504,FIN:0.4422,NFE:0.3589,OTH:0.3121,ASJ:0.2517	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	0.088	-1.62	0.000	1.85	16	.	het
16	28617552	28617552	C	G	SULT1A1	exonic	synonymous SNV	ENSG00000196502	rs3176926	ENSG00000196502:ENST00000350842:exon5:c.G366C:p.P122P,ENSG00000196502:ENST00000567512:exon6:c.G474C:p.P158P,ENSG00000196502:ENST00000569554:exon6:c.G600C:p.P200P,ENSG00000196502:ENST00000314752:exon7:c.G600C:p.P200P,ENSG00000196502:ENST00000395607:exon7:c.G600C:p.P200P,ENSG00000196502:ENST00000566189:exon7:c.G600C:p.P200P,ENSG00000196502:ENST00000395609:exon9:c.G600C:p.P200P	SULT1A1:NM_177536:exon5:c.G366C:p.P122P,SULT1A1:NM_177534:exon6:c.G600C:p.P200P,SULT1A1:NM_001055:exon7:c.G600C:p.P200P,SULT1A1:NM_177529:exon7:c.G600C:p.P200P,SULT1A1:NM_177530:exon7:c.G600C:p.P200P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2928	.	.	1(thyroid)	.	.	.	.	.	.	.	.	SULT1A1:uc002dqm.3:exon5:c.G366C:p.P122P,SULT1A1:uc002dqi.3:exon6:c.G600C:p.P200P,SULT1A1:uc002dqj.3:exon7:c.G600C:p.P200P,SULT1A1:uc002dqk.3:exon7:c.G600C:p.P200P,SULT1A1:uc002dql.3:exon7:c.G600C:p.P200P,SULT1A1:uc002dqp.3:exon9:c.G600C:p.P200P,SULT1A1:uc002dqn.3:exon10:c.G873C:p.P291P	.	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:1(upper_aerodigestive_tract),EAS:MU5059297,FIN:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,RECA-EU|1|422|0.00236967,NFE:0.3723,OTH:0.2810,ASJ:11(soft_tissue)	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	1(kidney)	0.4768
16	28617574	28617574	C	T	SULT1A1	intronic	.	ENSG00000196502	rs4149394	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3342	0.2648	0.289936	MU12772814	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,AMR:0.3550,EAS:0.4695,FIN:0.3129,NFE:0.2302,OTH:0.4791,ASJ:0.2256	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	1(haematopoietic_and_lymphoid_tissue)	0.4079
16	28617595	28617595	A	G	SULT1A1	intronic	.	ENSG00000196502	rs4149393	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3463	0.3317	0.290935	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.3569,AMR:0.2275,EAS:0.3154,FIN:0.2330,NFE:0.4804,OTH:0.4100,ASJ:0.4710	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	1(breast)	0.3660
16	28618065	28618065	A	T	SULT1A1	intronic	.	ENSG00000196502	rs3020806	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3460	0.2345	0.290735	0.3547	.	.	.	.	.	.	.	.	.	.	AFR:0.2286,AMR:0.4671,EAS:0.2373,FIN:0.4794,NFE:0.4060,OTH:0.3626,ASJ:0.3108	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	MU12772852	unknown
16	28618068	28618068	G	A	SULT1A1	intronic	.	ENSG00000196502	rs74752114	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3459	.	0.291134	LICA-CN|3|402|0.00746269,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.3554,AMR:0.2297,EAS:0.3108,FIN:0.2359,NFE:0.4797,OTH:0.4068,ASJ:0.4670	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	1(liver)	0.3592
16	28618071	28618071	C	G	SULT1A1	intronic	.	ENSG00000196502	rs3020805	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3459	.	0.290935	LICA-CN|3|402|0.00746269,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.3551,AMR:0.2289,EAS:0.3121,FIN:0.2380,NFE:0.4794,OTH:0.4067,ASJ:0.4681	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	1(liver)	0.3592
16	28619911	28619911	T	C	SULT1A1	exonic	synonymous SNV	ENSG00000196502	rs1126447	ENSG00000196502:ENST00000569554:exon2:c.A162G:p.V54V,ENSG00000196502:ENST00000314752:exon3:c.A162G:p.V54V,ENSG00000196502:ENST00000395607:exon3:c.A162G:p.V54V,ENSG00000196502:ENST00000566189:exon3:c.A162G:p.V54V,ENSG00000196502:ENST00000395609:exon5:c.A162G:p.V54V	SULT1A1:NM_177534:exon2:c.A162G:p.V54V,SULT1A1:NM_001055:exon3:c.A162G:p.V54V,SULT1A1:NM_177529:exon3:c.A162G:p.V54V,SULT1A1:NM_177530:exon3:c.A162G:p.V54V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3523	0.2916	0.290535	1(stomach)	.	.	.	.	.	.	.	.	SULT1A1:uc002dqi.3:exon2:c.A162G:p.V54V,SULT1A1:uc002dqj.3:exon3:c.A162G:p.V54V,SULT1A1:uc002dqk.3:exon3:c.A162G:p.V54V,SULT1A1:uc002dql.3:exon3:c.A162G:p.V54V,SULT1A1:uc002dqp.3:exon5:c.A162G:p.V54V,SULT1A1:uc002dqn.3:exon6:c.A435G:p.V145V	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU583838,EAS:0.3558,FIN:0.2296,NFE:0.4696,OTH:0.3121,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	1(lung)	0.2423
16	28619920	28619920	A	G	SULT1A1	exonic	synonymous SNV	ENSG00000196502	rs1126446	ENSG00000196502:ENST00000569554:exon2:c.T153C:p.T51T,ENSG00000196502:ENST00000314752:exon3:c.T153C:p.T51T,ENSG00000196502:ENST00000395607:exon3:c.T153C:p.T51T,ENSG00000196502:ENST00000566189:exon3:c.T153C:p.T51T,ENSG00000196502:ENST00000395609:exon5:c.T153C:p.T51T	SULT1A1:NM_177534:exon2:c.T153C:p.T51T,SULT1A1:NM_001055:exon3:c.T153C:p.T51T,SULT1A1:NM_177529:exon3:c.T153C:p.T51T,SULT1A1:NM_177530:exon3:c.T153C:p.T51T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3516	0.2812	0.290735	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	SULT1A1:uc002dqi.3:exon2:c.T153C:p.T51T,SULT1A1:uc002dqj.3:exon3:c.T153C:p.T51T,SULT1A1:uc002dqk.3:exon3:c.T153C:p.T51T,SULT1A1:uc002dql.3:exon3:c.T153C:p.T51T,SULT1A1:uc002dqp.3:exon5:c.T153C:p.T51T,SULT1A1:uc002dqn.3:exon6:c.T426C:p.T142T	.	AFR:1(large_intestine),AMR:1(breast),EAS:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,FIN:0.3558,NFE:0.2309,OTH:0.4699,ASJ:MU583839	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	13(soft_tissue)	0.3108
16	28621311	28621311	T	C	SULT1A1	UTR5	.	ENSG00000196502;ENSG00000196502	rs2077412	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6819	.	0.676518	MU25371586	.	.	.	.	.	.	.	.	SULT1A1:uc002dqn.3:exon3:c.A137G:p.N46S	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.7180,EAS:0.7653,FIN:0.7682,NFE:0.5227,OTH:0.7194,ASJ:0.7639	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	22(upper_aerodigestive_tract)	0.7106
16	28631383	28631383	C	G	SULT1A1	splicing	.	ENSG00000196502	rs79527462	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0086	0.0005	0.0199681	MU44340045	2.105	16.89	.	1.01	0.392	0.0003	0.024	.	.	.	AFR:LICA-CN|1|402|0.00248756,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,AMR:0.0067,EAS:0.0049,FIN:0,NFE:0.1216,OTH:0,ASJ:0.0003	171150	.	.	.	~ko05204 Chemical carcinogenesis ~	.	.	.	.	.	.	.	16	1(biliary_tract)	0.0001
16	30081367	30081367	G	T	ALDOA;LOC112694756	intronic	.	ENSG00000149925	rs2071390	ENSG00000149925:ENST00000569798:exon8:c.G1016T:p.R339M	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1938	0.1192	0.192093	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	-1.148	0.008	0.051	-5.4	0.000	.	.	Aldolase-type TIM barrel	.	.	AFR:0.1620,AMR:0.0364,EAS:0.1192,FIN:0.4238,NFE:0.2726,OTH:0.1747,ASJ:0.2309	103850	611881;	57;	57|GSD due to aldolase A deficiency<br>GSD type 12<br>GSD type XII<br>Glycogen storage disease type 12<br>Glycogen storage disease type XII<br>Glycogenosis due to aldolase A deficiency<br>Glycogenosis type 12<br>Glycogenosis type XII|Unknown|Autosomal recessive|Neonatal|611881 ~	.	.	.	.	.	-1.98	.	.	16	2(haematopoietic_and_lymphoid_tissue)	0.2147
16	31195279	31195279	C	T	FUS	exonic	synonymous SNV	ENSG00000089280	rs1052352	ENSG00000089280:ENST00000254108:exon4:c.C291T:p.Y97Y,ENSG00000089280:ENST00000380244:exon4:c.C288T:p.Y96Y,ENSG00000089280:ENST00000566605:exon4:c.C291T:p.Y97Y,ENSG00000089280:ENST00000568685:exon4:c.C291T:p.Y97Y	FUS:NM_001170634:exon4:c.C288T:p.Y96Y,FUS:NM_001170937:exon4:c.C291T:p.Y97Y,FUS:NM_004960:exon4:c.C291T:p.Y97Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5186	0.4584	0.473842	ESAD-UK|1|409|0.00244499,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	FUS:uc002ebe.2:exon4:c.C291T:p.Y97Y,FUS:uc002ebf.3:exon4:c.C291T:p.Y97Y,FUS:uc002ebh.3:exon4:c.C288T:p.Y96Y	.	AFR:0.4526,AMR:0.2611,EAS:0.6954,FIN:0.7423,NFE:0.4782,OTH:0.5138,ASJ:0.5477	137070	608030;614782;	275872;803;	275872|FTD-ALS<br>FTD-MND<br>Frontotemporal dementia with amyotrophic lateral sclerosis|Unknown|Autosomal dominant|Adult|105550 608030 612069 613954 615911 616437 616439 ~803|ALS<br>Charcot disease<br>Lou Gehrig disease|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Adult|105400 205250 300857 606070 606640 608030 608031 608627 611895 612069 612577 613435 613954 614696 614808 615426 615515 616208 616437 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	16	1(stomach)	0.4959
16	50827518	50827518	C	T	CYLD	exonic	synonymous SNV	ENSG00000083799	rs2066852	ENSG00000083799:ENST00000568704:exon12:c.C1857T:p.D619D,ENSG00000083799:ENST00000564326:exon15:c.C2403T:p.D801D,ENSG00000083799:ENST00000398568:exon16:c.C2403T:p.D801D,ENSG00000083799:ENST00000427738:exon16:c.C2412T:p.D804D,ENSG00000083799:ENST00000566206:exon16:c.C2403T:p.D801D,ENSG00000083799:ENST00000569418:exon16:c.C2403T:p.D801D,ENSG00000083799:ENST00000540145:exon17:c.C2412T:p.D804D,ENSG00000083799:ENST00000311559:exon18:c.C2412T:p.D804D	CYLD:NM_001042355:exon16:c.C2403T:p.D801D,CYLD:NM_001042412:exon16:c.C2403T:p.D801D,CYLD:NM_015247:exon18:c.C2412T:p.D804D	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0855	0.0630	0.0790735	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	CYLD:uc021tib.1:exon15:c.C2412T:p.D804D,CYLD:uc002egq.1:exon16:c.C2403T:p.D801D,CYLD:uc002egr.1:exon16:c.C2403T:p.D801D,CYLD:uc010cbs.1:exon16:c.C2403T:p.D801D,CYLD:uc002egp.1:exon17:c.C2403T:p.D801D	.	AFR:0.0519,AMR:0.0282,EAS:0.1325,FIN:0.0309,NFE:0.0458,OTH:0.0679,ASJ:0.0358	605018	132700;601606;605041;	79493;79493;867;211;79493;	79493|CYLD cutaneous syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|132700 601606 605041 612099 ~79493|CYLD cutaneous syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|132700 601606 605041 612099 ~867|-|Unknown|Autosomal dominant|Childhood|601606 612099 ~211|Turban tumor syndrome|-|Autosomal dominant|-|132700 ~79493|CYLD cutaneous syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|132700 601606 605041 612099 ~	.	.	.	.	.	.	.	.	16	1(lung)	0.0643
16	55536687	55536687	A	G	MMP2	intronic	.	ENSG00000087245	rs243834	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4841	0.4432	0.48762	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.4569,AMR:0.3905,EAS:0.44,FIN:0.6386,NFE:0.5221,OTH:0.4596,ASJ:0.4519	120360	259600;	3460;371428;85196;	3460|Winchester syndrome|<1 / 1 000 000|-|Childhood|259600 277950 ~371428|MONA spectrum|Unknown|Autosomal recessive|Infancy<br>Childhood|259600 277950 ~85196|Multicentric osteolysis-nodulosis-arthropathy syndrome<br>NAO syndrome|-|-|-|259600 277950 ~	~ko01522 Endocrine resistance~ko04670 Leukocyte transendothelial migration~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	16	1(lung)	0.4836
16	55730124	55730124	A	C	SLC6A2	intronic	.	ENSG00000103546	rs5568	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3156	0.2670	0.252396	LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.2719,AMR:0.1007,EAS:0.4139,FIN:0.2726,NFE:0.3620,OTH:0.3406,ASJ:0.3305	163970	604715;	443236;	443236|Familial orthostatic tachycardia due to norepinephrine transporter deficiency<br>Postural tachycardia syndrome due to NET deficiency|<1 / 1 000 000|Autosomal dominant|Adult|604715 ~	.	.	.	.	.	.	.	.	16	2(haematopoietic_and_lymphoid_tissue)	0.3282
16	56855496	56855496	C	G	NUP93	exonic	synonymous SNV	ENSG00000102900	rs2118017	ENSG00000102900:ENST00000563858:exon3:c.C24G:p.L8L,ENSG00000102900:ENST00000542526:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000564887:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000567641:exon5:c.C276G:p.L92L,ENSG00000102900:ENST00000569863:exon6:c.C276G:p.L92L,ENSG00000102900:ENST00000308159:exon7:c.C645G:p.L215L,ENSG00000102900:ENST00000569842:exon7:c.C645G:p.L215L	NUP93:NM_001242795:exon5:c.C276G:p.L92L,NUP93:NM_001242796:exon5:c.C276G:p.L92L,NUP93:NM_014669:exon7:c.C645G:p.L215L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8299	0.8329	0.875799	0.8261	.	.	.	.	.	.	.	.	NUP93:uc002ekb.3:exon5:c.C276G:p.L92L,NUP93:uc010vhi.2:exon5:c.C276G:p.L92L,NUP93:uc002eka.3:exon7:c.C645G:p.L215L	.	AFR:0.8848,AMR:0.8568,EAS:0.9137,FIN:0.7923,NFE:0.7896,OTH:0.8035,ASJ:0.8467	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	MU116544	hom
16	56863027	56863027	G	A	NUP93	intronic	.	ENSG00000102900	rs3816116	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0270	0.0072	0.0341454	0.0202	.	.	.	.	.	0.0004	0.026	.	.	.	AFR:0.0034,AMR:0.0024,EAS:0.0828,FIN:0.0418,NFE:0.0185,OTH:0.0356,ASJ:0	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	MU82222849	het
16	56868700	56868700	A	G	NUP93	intronic	.	ENSG00000102900	rs1347591	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4775	0.4722	0.541733	ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4610,AMR:0.5376,EAS:0.3974,FIN:0.7051,NFE:0.3354,OTH:0.4230,ASJ:0.4472	614351	616892;	656;	656|Familial idiopathic nephrotic syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|256370 600995 603278 603965 607832 610725 613237 614131 614196 615244 615573 615861 616002 616032 616220 616730 616892 616893 ~	.	.	.	.	.	.	.	.	16	1(haematopoietic_and_lymphoid_tissue)	0.4375
16	65005462	65005462	G	A	CDH11	intronic	.	ENSG00000140937	rs12597529	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5274	0.4151	0.547324	0.4590	.	.	.	.	.	.	.	.	.	.	AFR:0.3247,AMR:0.6110,EAS:0.7916,FIN:0.5542,NFE:0.4681,OTH:0.5061,ASJ:0.4305	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU21091308	hom
16	65016087	65016087	A	C	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs35213	ENSG00000140937:ENST00000566827:exon7:c.T739G:p.S247A,ENSG00000140937:ENST00000268603:exon8:c.T1117G:p.S373A,ENSG00000140937:ENST00000394156:exon8:c.T1117G:p.S373A	CDH11:NM_001330576:exon7:c.T739G:p.S247A,CDH11:NM_001308392:exon8:c.T1117G:p.S373A,CDH11:NM_001797:exon8:c.T1117G:p.S373A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8043	0.6928	0.745407	0.7215	-0.605	0.122	0.716	1.34	0.089	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon7:c.T739G:p.S247A,CDH11:uc002eoi.3:exon8:c.T1117G:p.S373A,CDH11:uc002eoj.3:exon8:c.T1117G:p.S373A	-0.969	AFR:0.4484,AMR:0.8213,EAS:0.9981,FIN:0.7975,NFE:0.8188,OTH:0.8184,ASJ:0.8046	600023	.	.	.	.	.	.	.	0.001	4.7	0.000	1.52	16	MU81978235	hom
16	65022234	65022234	C	T	CDH11	exonic	nonsynonymous SNV	ENSG00000140937	rs1130821	ENSG00000140937:ENST00000566827:exon6:c.G447A:p.M149I,ENSG00000140937:ENST00000268603:exon7:c.G825A:p.M275I,ENSG00000140937:ENST00000394156:exon7:c.G825A:p.M275I	CDH11:NM_001330576:exon6:c.G447A:p.M149I,CDH11:NM_001308392:exon7:c.G825A:p.M275I,CDH11:NM_001797:exon7:c.G825A:p.M275I	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 0] 	0.1824	0.1153	0.217252	4(stomach)	6.014	27.9	0.039	5.75	1.000	.	.	Cadherin|Cadherin-like	CDH11:uc010vin.2:exon6:c.G447A:p.M149I,CDH11:uc002eoi.3:exon7:c.G825A:p.M275I,CDH11:uc002eoj.3:exon7:c.G825A:p.M275I	-0.566	AFR:1(lung),AMR:MU155566,EAS:0.1546,FIN:0.0987,NFE:0.3565,OTH:0.0894,ASJ:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|7|321|0.0218069	600023	.	.	.	.	.	.	.	0.94	4.71	0.000	0.21	16	1(oesophagus)	0.4493
16	65025658	65025658	T	C	CDH11	intronic	.	ENSG00000140937	rs35196	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9150	0.9021	0.926917	0.9068	.	.	.	.	.	.	.	.	.	.	AFR:0.8999,AMR:0.8998,EAS:1,FIN:0.8955,NFE:0.9033,OTH:0.9124,ASJ:0.9106	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU81978243	hom
16	65025849	65025849	A	G	CDH11	intronic	.	ENSG00000140937	rs35194	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9144	0.8999	0.925919	0.9052	.	.	.	.	.	0.0008	0.006	.	.	.	AFR:0.8951,AMR:0.8995,EAS:1,FIN:0.8955,NFE:0.9029,OTH:0.9121,ASJ:0.9106	600023	.	.	.	.	.	.	.	.	.	.	.	16	MU81978256	hom
16	68771372	68771372	C	T	CDH1	intronic	.	ENSG00000039068	rs3743674	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8111	0.8603	0.763379	16(meninges)	.	.	.	.	.	0	0.032	.	.	.	AFR:1(lung),AMR:MU51154082,EAS:0.7976,FIN:0.6539,NFE:0.7548,OTH:0.9367,ASJ:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	192090	114480;137215;167000;176807;608089;	1331;26106;227535;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko04015 Rap1 signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04514 Cell adhesion molecules (CAMs)~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	16	1(breast)	0.7605
16	68857441	68857441	T	C	CDH1	exonic	synonymous SNV	ENSG00000039068	rs1801552	ENSG00000039068:ENST00000422392:exon12:c.T1893C:p.A631A,ENSG00000039068:ENST00000261769:exon13:c.T2076C:p.A692A	CDH1:NM_001317184:exon12:c.T1893C:p.A631A,CDH1:NM_001317186:exon12:c.T111C:p.A37A,CDH1:NM_001317185:exon13:c.T528C:p.A176A,CDH1:NM_004360:exon13:c.T2076C:p.A692A	clinvar: Benign 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 1, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6548	0.7161	0.71865	MU166733	.	.	.	.	.	.	.	.	CDH1:uc010cfg.1:exon12:c.T1893C:p.A631A,CDH1:uc002ewg.1:exon13:c.T2076C:p.A692A	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,AMR:0.6961,EAS:0.6615,FIN:0.5927,NFE:0.6658,OTH:0.5878,ASJ:0.8838	192090	114480;137215;167000;176807;608089;	1331;26106;227535;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	~ko04015 Rap1 signaling pathway~ko04371 Apelin signaling pathway~ko04390 Hippo signaling pathway~ko04514 Cell adhesion molecules (CAMs)~ko04520 Adherens junction~ko05100 Bacterial invasion of epithelial cells~ko05200 Pathways in cancer~ko05213 Endometrial cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05226 Gastric cancer ~	1944,,1948,1945	,1946	,1947	.	.	.	.	16	13(meninges)	0.6235
16	70287177	70287177	A	G	AARS	exonic	synonymous SNV	ENSG00000090861	rs4081753	ENSG00000090861:ENST00000261772:exon20:c.T2715C:p.V905V	AARS:NM_001605:exon20:c.T2715C:p.V905V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8241	0.8492	0.88119	0.8640	.	.	.	.	.	.	.	.	AARS:uc010vlu.1:exon16:c.T2253C:p.V751V,AARS:uc002eyn.1:exon20:c.T2715C:p.V905V	.	AFR:0.9664,AMR:0.8549,EAS:0.9697,FIN:0.8542,NFE:0.8008,OTH:0.8153,ASJ:0.7616	601065	613287;616339;	442835;228174;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~228174|CMT2N|<1 / 1 000 000|Autosomal dominant|All ages|613287 ~	.	.	.	.	.	.	.	.	16	MU4563135	het
16	72821593	72821593	-	GCCGCC	ZFHX3	exonic	nonframeshift insertion	ENSG00000140836	rs775101099	ENSG00000140836:ENST00000397992:exon9:c.7839_7840insGGCGGC:p.S2614delinsGGS,ENSG00000140836:ENST00000268489:exon10:c.10581_10582insGGCGGC:p.S3528delinsGGS	ZFHX3:NM_001164766:exon9:c.7839_7840insGGCGGC:p.S2614delinsGGS,ZFHX3:NM_006885:exon10:c.10581_10582insGGCGGC:p.S3528delinsGGS	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0240	.	.	0.0142	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon9:c.7839_7840insGGCGGC:p.S2614delinsGGS,ZFHX3:uc002fck.3:exon10:c.10581_10582insGGCGGC:p.S3528delinsGGS	.	AFR:0.0013,AMR:0.0139,EAS:0.0965,FIN:0.0392,NFE:0.0082,OTH:0.0207,ASJ:0	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	.	unknown
16	72827758	72827758	T	C	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs699444	ENSG00000140836:ENST00000397992:exon8:c.A6081G:p.G2027G,ENSG00000140836:ENST00000268489:exon9:c.A8823G:p.G2941G	ZFHX3:NM_001164766:exon8:c.A6081G:p.G2027G,ZFHX3:NM_006885:exon9:c.A8823G:p.G2941G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8771	0.8816	0.920727	0.8969	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.A6081G:p.G2027G,ZFHX3:uc002fck.3:exon9:c.A8823G:p.G2941G	.	AFR:0.9704,AMR:0.8950,EAS:0.9981,FIN:0.9041,NFE:0.8456,OTH:0.8676,ASJ:0.7914	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU81979263	hom
16	72831358	72831363	TTGTTG	-	ZFHX3	exonic	nonframeshift deletion	ENSG00000140836	rs568545014	ENSG00000140836:ENST00000397992:exon8:c.2476_2481del:p.826_827del,ENSG00000140836:ENST00000268489:exon9:c.5218_5223del:p.1740_1741del	ZFHX3:NM_001164766:exon8:c.2476_2481del:p.826_827del,ZFHX3:NM_006885:exon9:c.5218_5223del:p.1740_1741del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0308	.	0.0403355	0.0076	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.2476_2481del:p.826_827del,ZFHX3:uc002fck.3:exon9:c.5218_5223del:p.1740_1741del	.	AFR:0.0037,AMR:0.0122,EAS:0.0520,FIN:0.0006,NFE:0.0061,OTH:0.0135,ASJ:0.0067	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	.	hom
16	72832135	72832135	T	A	ZFHX3	exonic	synonymous SNV	ENSG00000140836	rs740178	ENSG00000140836:ENST00000397992:exon8:c.A1704T:p.A568A,ENSG00000140836:ENST00000268489:exon9:c.A4446T:p.A1482A	ZFHX3:NM_001164766:exon8:c.A1704T:p.A568A,ZFHX3:NM_006885:exon9:c.A4446T:p.A1482A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8362	0.8548	0.886182	0.8673	.	.	.	.	.	.	.	.	ZFHX3:uc002fcl.3:exon8:c.A1704T:p.A568A,ZFHX3:uc002fck.3:exon9:c.A4446T:p.A1482A	.	AFR:0.9647,AMR:0.8373,EAS:0.9710,FIN:0.8709,NFE:0.8043,OTH:0.8350,ASJ:0.7649	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	.	.	.	.	16	MU81979273	hom
16	72993831	72993831	A	C	ZFHX3	exonic	nonsynonymous SNV	ENSG00000140836	rs7193297	ENSG00000140836:ENST00000268489:exon2:c.T214G:p.S72A	ZFHX3:NM_006885:exon2:c.T214G:p.S72A	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4014	0.4739	0.470447	1(lung)	0.001	2.598	1.0	5.11	0.788	.	.	.	ZFHX3:uc002fck.3:exon2:c.T214G:p.S72A	-0.963	AFR:MU71249,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,EAS:0.7036,FIN:0.2542,NFE:0.4503,OTH:0.2667,ASJ:0.4903	104155	176807;	1331;	1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~	.	.	.	.	0.006	-0.66	0.000	0.345	16	1(thyroid)	0.4885
16	78198192	78198192	T	C	WWOX	intronic	.	ENSG00000186153	rs2303191	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7482	0.7435	0.789137	0.7460	.	.	.	.	.	0.0002	0.046	.	.	.	AFR:0.8026,AMR:0.8158,EAS:0.8854,FIN:0.6865,NFE:0.7112,OTH:0.7261,ASJ:0.6556	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	MU772162	hom
16	78312489	78312489	G	T	WWOX	intronic	.	ENSG00000186153	rs8048830	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1035	0.0975	0.131789	0.1066	.	.	.	.	.	0.0001	0.008	.	.	.	AFR:0.1647,AMR:0.0680,EAS:0.1344,FIN:0.0841,NFE:0.0786,OTH:0.0890,ASJ:0.0960	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	MU12844875	het
16	78312497	78312497	C	A	WWOX	intronic	.	ENSG00000186153	rs8050128	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4595	0.4620	0.472244	0.4589	.	.	.	.	.	0	0	.	.	.	AFR:0.5141,AMR:0.4284,EAS:0.5,FIN:0.4225,NFE:0.4315,OTH:0.4541,ASJ:0.5364	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	.	.	.	.	16	MU25384686	hom
16	78312527	78312527	A	G	WWOX	exonic	nonsynonymous SNV	ENSG00000186153	rs77067228	ENSG00000186153:ENST00000355860:exon6:c.A544G:p.K182E	WWOX:NM_130791:exon6:c.A544G:p.K182E	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.0804	0.0519	0.0646965	0.0597	0.118	3.806	0.0	1.18	0.015	.	.	NAD(P)-binding domain	WWOX:uc002ffj.2:exon6:c.A544G:p.K182E	-0.917	AFR:0.0178,AMR:0.0537,EAS:0.0600,FIN:0.0839,NFE:0.0773,OTH:0.0724,ASJ:0.0960	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	0.0	-1.46	0.025	.	16	MU12844881	het
16	78420775	78420775	G	A	WWOX	exonic	nonsynonymous SNV	ENSG00000186153	rs11545029	ENSG00000186153:ENST00000408984:exon6:c.G535A:p.A179T,ENSG00000186153:ENST00000566780:exon6:c.G535A:p.A179T	WWOX:NM_001291997:exon5:c.G196A:p.A66T,WWOX:NM_016373:exon6:c.G535A:p.A179T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4507	0.4593	0.263379	LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647	3.034	22.3	0.534	5.52	1.000	.	.	NAD(P)-binding domain	WWOX:uc010vnk.2:exon5:c.G196A:p.A66T,WWOX:uc002ffk.3:exon6:c.G535A:p.A179T	-0.928	AFR:0.4448,AMR:0.1962,EAS:0.5132,FIN:0.0525,NFE:0.5757,OTH:0.5974,ASJ:0.4117	605131	133239;614322;616211;	442835;284282;99977;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~284282|Autosomal recessive spinocerebellar ataxia type 12<br>SCAR12|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614322 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	.	.	.	.	0.098	-2.28	0.000	0.56	16	1(cervix)	0.5143
16	79619835	79619835	G	A	WWOX;MAF	intergenic	.	ENSG00000178573	rs60533944	ENSG00000178573:ENST00000569649:exon2:c.C1122T:p.Y374Y	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2483	.	0.268371	0.2042	.	.	.	.	.	.	.	.	.	.	AFR:0.1312,AMR:0.3612,EAS:0.4196,FIN:0.1787,NFE:0.2196,OTH:0.2035,ASJ:0.2583	177075	601088;610202;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	.	.	.	.	.	.	.	.	16	MU4563391	het
16	79633806	79633808	GCC	-	MAF	UTR5	.	ENSG00000178573	rs5818251	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.7107	.	0.808706	0.7762	.	.	.	.	.	.	.	.	.	.	AFR:0.7969,AMR:0.7631,EAS:0.9253,FIN:0.8126,NFE:0.7421,OTH:0.7653,ASJ:0.7138	177075	601088;610202;	91492;	91492|-|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|115650 115660 115665 115700 115800 115900 116100 116200 116300 116400 116600 116700 116800 212500 302200 600881 601202 601547 601885 604219 604307 605387 605728 605749 607304 609376 609741 610019 610202 610425 610623 611391 611544 611597 612968 613763 614422 614691 615188 615274 615277 616279 616509 616851 ~	~ko04658 Th1 and Th2 cell differentiation~ko05202 Transcriptional misregulation in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	16	.	hom
16	81819768	81819768	T	C	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143685	ENSG00000197943:ENST00000359376:exon2:c.T174C:p.A58A,ENSG00000197943:ENST00000565054:exon3:c.T174C:p.A58A	PLCG2:NM_002661:exon2:c.T174C:p.A58A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7248	0.6680	0.733227	0.6846	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon1:c.T174C:p.A58A,PLCG2:uc002fgt.3:exon2:c.T174C:p.A58A	.	AFR:0.6496,AMR:0.7566,EAS:0.8813,FIN:0.7388,NFE:0.6671,OTH:0.6898,ASJ:0.6589	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU21476980	hom
16	81892708	81892708	T	A	PLCG2	intronic	.	ENSG00000197943	rs4888183	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5509	0.5570	0.541134	0.5554	.	.	.	.	.	.	.	.	.	.	AFR:0.5220,AMR:0.5490,EAS:0.6235,FIN:0.6192,NFE:0.5506,OTH:0.5703,ASJ:0.6258	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU19853130	hom
16	81929488	81929488	C	T	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143688	ENSG00000197943:ENST00000359376:exon13:c.C1149T:p.D383D	PLCG2:NM_002661:exon13:c.C1149T:p.D383D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.4158	0.2885	0.40655	0.3500	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon12:c.C1149T:p.D383D,PLCG2:uc002fgt.3:exon13:c.C1149T:p.D383D	.	AFR:0.1426,AMR:0.6005,EAS:0.7348,FIN:0.4361,NFE:0.3913,OTH:0.4090,ASJ:0.3543	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU19853194	het
16	81941319	81941319	C	T	PLCG2	exonic	synonymous SNV	ENSG00000197943	rs1143689	ENSG00000197943:ENST00000359376:exon16:c.C1497T:p.A499A	PLCG2:NM_002661:exon16:c.C1497T:p.A499A	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.7837	0.7225	0.77496	0.7313	.	.	.	.	.	.	.	.	PLCG2:uc010chg.1:exon15:c.C1497T:p.A499A,PLCG2:uc002fgt.3:exon16:c.C1497T:p.A499A	.	AFR:0.6046,AMR:0.8708,EAS:0.9765,FIN:0.7461,NFE:0.7639,OTH:0.7699,ASJ:0.7748	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	,9076	.	.	.	.	16	MU22636505	het
16	81953081	81953081	T	C	PLCG2	intronic	.	ENSG00000197943	rs12448130	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9969	0.9884	0.988618	0.9912	.	.	.	.	.	0	0	.	.	.	AFR:0.9698,AMR:0.9952,EAS:1,FIN:1,NFE:0.9997,OTH:1,ASJ:1	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU17469065	hom
16	81954789	81954789	C	G	PLCG2	intronic	.	ENSG00000197943	rs12446127	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5893	0.4681	0.519768	0.4890	.	.	.	.	.	.	.	.	.	.	AFR:0.2226,AMR:0.6763,EAS:0.7893,FIN:0.5656,NFE:0.5750,OTH:0.5713,ASJ:0.6133	600220	614468;614878;	324530;300359;	324530|APLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614878 ~300359|FACU<br>Familial atypical cold urticaria<br>Familial cold urticaria with common variable immunodeficiency<br>PLAID|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614468 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	16	MU81980644	het
16	85953845	85953845	-	T	IRF8	intronic	.	ENSG00000140968	rs746676844	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	7.908e-05	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	601565	614893;614894;	319600;	319600|MSMD due to partial IRF8 deficiency<br>MSMD due to partial interferon regulatory factor 8 deficiency<br>Mendelian susceptibility to mycobacterial diseases due to partial interferon regulatory factor 8 deficiency|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|614893 ~	.	.	.	.	.	.	.	.	16	.	het
16	88872145	88872145	T	C	CDT1	exonic	nonsynonymous SNV	ENSG00000167513	rs507329	ENSG00000167513:ENST00000301019:exon5:c.T700C:p.C234R	CDT1:NM_030928:exon5:c.T700C:p.C234R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9993	0.9995	0.9998	0.9996	-0.295	0.681	1.0	3.83	0.188	.	.	CDT1 Geminin-binding domain-like|Winged helix-turn-helix DNA-binding domain	CDT1:uc002flu.3:exon5:c.T700C:p.C234R	-0.972	AFR:0.9998,AMR:1,EAS:1,FIN:0.9997,NFE:0.9995,OTH:0.9990,ASJ:1	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	0.001	1.7	0.000	-2.455	16	MU81982302	hom
16	88872511	88872511	T	C	CDT1	exonic	synonymous SNV	ENSG00000167513	rs510862	ENSG00000167513:ENST00000301019:exon6:c.T915C:p.H305H	CDT1:NM_030928:exon6:c.T915C:p.H305H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8183	0.8476	0.870208	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	CDT1:uc002flu.3:exon6:c.T915C:p.H305H	.	AFR:0.8308,AMR:0.9556,EAS:0.8510,FIN:0.9142,NFE:0.7572,OTH:0.7749,ASJ:0.7146	605525	613804;	2554;	2554|Meier-Gorlin syndrome|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;Autosomal dominant|Antenatal<br>Neonatal|224690 613800 613803 613804 613805 616835 617063 ~	.	.	.	.	.	.	.	.	16	1(thyroid)	0.7912
16	89345822	89345822	G	C	ANKRD11	exonic	nonsynonymous SNV	ENSG00000167522	rs4785560	ENSG00000167522:ENST00000301030:exon9:c.C7128G:p.D2376E,ENSG00000167522:ENST00000378330:exon10:c.C7128G:p.D2376E	ANKRD11:NM_001256183:exon9:c.C7128G:p.D2376E,ANKRD11:NM_013275:exon9:c.C7128G:p.D2376E,ANKRD11:NM_001256182:exon10:c.C7128G:p.D2376E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.1635	.	0.185903	0.1089	-1.009	0.015	1.0	-2.53	0.016	.	.	.	AX748291:uc002fna.1:exon1:c.C123G:p.D41E,ANKRD11:uc002fnb.1:exon6:c.C6999G:p.D2333E,ANKRD11:uc002fmx.2:exon9:c.C7128G:p.D2376E,ANKRD11:uc002fnc.2:exon9:c.C7128G:p.D2376E,ANKRD11:uc002fmy.2:exon10:c.C7128G:p.D2376E	-1.021	AFR:0.1374,AMR:0.0627,EAS:0.4074,FIN:0.0781,NFE:0.0716,OTH:0.0979,ASJ:0.0548	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	0.001	1.63	0.000	-0.62	16	MU4554632	het
16	89350178	89350178	G	A	ANKRD11	exonic	synonymous SNV	ENSG00000167522	rs2279349	ENSG00000167522:ENST00000301030:exon9:c.C2772T:p.T924T,ENSG00000167522:ENST00000378330:exon10:c.C2772T:p.T924T	ANKRD11:NM_001256183:exon9:c.C2772T:p.T924T,ANKRD11:NM_013275:exon9:c.C2772T:p.T924T,ANKRD11:NM_001256182:exon10:c.C2772T:p.T924T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7981	0.8522	0.763578	0.8195	.	.	.	.	.	.	.	.	ANKRD11:uc002fnb.1:exon6:c.C2643T:p.T881T,ANKRD11:uc002fmx.2:exon9:c.C2772T:p.T924T,ANKRD11:uc002fnc.2:exon9:c.C2772T:p.T924T,ANKRD11:uc002fmy.2:exon10:c.C2772T:p.T924T	.	AFR:0.8567,AMR:0.7208,EAS:0.6056,FIN:0.7905,NFE:0.8313,OTH:0.8102,ASJ:0.9470	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	.	.	.	.	16	MU21099320	het
16	89350445	89350445	G	A	ANKRD11	exonic	synonymous SNV	ENSG00000167522	rs544199816	ENSG00000167522:ENST00000301030:exon9:c.C2505T:p.D835D,ENSG00000167522:ENST00000378330:exon10:c.C2505T:p.D835D	ANKRD11:NM_001256183:exon9:c.C2505T:p.D835D,ANKRD11:NM_013275:exon9:c.C2505T:p.D835D,ANKRD11:NM_001256182:exon10:c.C2505T:p.D835D	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 2, 0, 0, 0] 	0.0003	.	0.000599042	6.455e-05	.	.	.	.	.	.	.	.	ANKRD11:uc002fnb.1:exon6:c.C2376T:p.D792D,ANKRD11:uc002fmx.2:exon9:c.C2505T:p.D835D,ANKRD11:uc002fnc.2:exon9:c.C2505T:p.D835D,ANKRD11:uc002fmy.2:exon10:c.C2505T:p.D835D	.	AFR:0,AMR:0,EAS:0,FIN:0.0003,NFE:6.659e-05,OTH:0,ASJ:0	611192	148050;	2332;	2332|Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Childhood|148050 ~	.	.	.	.	.	.	.	.	16	MU129078893	het
17	423051	423051	T	C	VPS53	intronic	.	ENSG00000141252	rs2034088	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6120	0.6207	0.726637	0.6106	.	.	.	.	.	.	.	.	.	.	AFR:0.8862,AMR:0.7022,EAS:0.8327,FIN:0.4173,NFE:0.4712,OTH:0.5418,ASJ:0.5927	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	MU22359267	hom
17	465740	465740	C	T	VPS53	intronic	.	ENSG00000141252	rs77612078	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0050	.	0.00998403	0.0028	.	.	.	.	.	0	0	.	.	.	AFR:0,AMR:0,EAS:0.0533,FIN:0,NFE:6.675e-05,OTH:0.0010,ASJ:0	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	MU85520923	het
17	505035	505035	T	C	VPS53	exonic	synonymous SNV	ENSG00000141252	rs61748635	ENSG00000141252:ENST00000570650:exon4:c.A531G:p.Q177Q,ENSG00000141252:ENST00000401468:exon5:c.A387G:p.Q129Q,ENSG00000141252:ENST00000291074:exon11:c.A1131G:p.Q377Q,ENSG00000141252:ENST00000389040:exon11:c.A1074G:p.Q358Q,ENSG00000141252:ENST00000437048:exon12:c.A1218G:p.Q406Q,ENSG00000141252:ENST00000571805:exon12:c.A1218G:p.Q406Q,ENSG00000141252:ENST00000446250:exon13:c.A624G:p.Q208Q	VPS53:NM_018289:exon11:c.A1131G:p.Q377Q,VPS53:NM_001128159:exon12:c.A1218G:p.Q406Q,VPS53:NM_001366253:exon12:c.A1218G:p.Q406Q,VPS53:NM_001366254:exon13:c.A624G:p.Q208Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0094	0.0129	0.0189696	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	.	.	.	.	.	0	0.008	.	VPS53:uc010cjp.1:exon5:c.A387G:p.Q129Q,VPS53:uc002frm.2:exon11:c.A1131G:p.Q377Q,VPS53:uc002frn.2:exon12:c.A1218G:p.Q406Q,VPS53:uc010cjo.2:exon12:c.A1218G:p.Q406Q,VPS53:uc002fro.2:exon13:c.A624G:p.Q208Q	.	AFR:0.0137,AMR:0.0365,EAS:0.0364,FIN:0.0494,NFE:0,OTH:0.0004,ASJ:0.0048	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	.	.	.	.	17	1(stomach)	0.0031
17	526907	526907	G	T	VPS53	exonic	nonsynonymous SNV	ENSG00000141252	rs16954056	ENSG00000141252:ENST00000570650:exon3:c.C295A:p.L99I,ENSG00000141252:ENST00000291074:exon10:c.C895A:p.L299I,ENSG00000141252:ENST00000389040:exon10:c.C838A:p.L280I,ENSG00000141252:ENST00000437048:exon11:c.C982A:p.L328I,ENSG00000141252:ENST00000571805:exon11:c.C982A:p.L328I,ENSG00000141252:ENST00000446250:exon12:c.C388A:p.L130I	VPS53:NM_018289:exon10:c.C895A:p.L299I,VPS53:NM_001128159:exon11:c.C982A:p.L328I,VPS53:NM_001366253:exon11:c.C982A:p.L328I,VPS53:NM_001366254:exon12:c.C388A:p.L130I	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 1, 0, 0] 	0.1116	0.0936	0.0942492	2(liver)	6.444	29.8	0.005	5.7	1.000	.	.	Vps53-like, N-terminal	VPS53:uc002frm.2:exon10:c.C895A:p.L299I,VPS53:uc002frn.2:exon11:c.C982A:p.L328I,VPS53:uc010cjo.2:exon11:c.C982A:p.L328I,VPS53:uc002fro.2:exon12:c.C388A:p.L130I	-1.214	AFR:MU146926,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.0605,FIN:0.0921,NFE:0.1192,OTH:0.2447,ASJ:0.1053	615850	615851;	247198;	247198|PCCA|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615851 ~	.	.	.	.	0.999	1.02	0.000	2.075	17	1(large_intestine)	0.1814
17	1557316	1557316	G	C	PRPF8	intronic	.	ENSG00000174231	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.9685	0.586	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	607300	600059;	791;	791|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|Childhood<br>Adolescent<br>Adult|180100 180104 180105 180210 268000 268025 268060 300029 300155 300424 300605 312600 312612 400004 600059 600105 600132 600138 600852 601414 601718 602594 602772 604232 604393 606068 607921 608133 608380 609913 609923 610282 610359 610599 611131 612095 612165 612572 612712 612943 613194 613341 613428 613464 613575 613581 613582 613617 613660 613731 613750 613756 613758 613767 613769 613794 613801 613809 613810 613827 613861 613862 613983 614180 614181 614494 614500 615233 615434 615565 615725 615780 615922 616188 616394 616469 616544 616562 617023 617123 ~	.	.	.	.	.	.	.	.	17	.	het
17	1782957	1782957	C	T	RPA1	exonic	synonymous SNV	ENSG00000132383	rs2230930	ENSG00000132383:ENST00000574049:exon3:c.C324T:p.S108S,ENSG00000132383:ENST00000254719:exon11:c.C1056T:p.S352S	RPA1:NM_001355120:exon11:c.C1017T:p.S339S,RPA1:NM_001355121:exon11:c.C1056T:p.S352S,RPA1:NM_002945:exon11:c.C1056T:p.S352S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2223	0.1628	0.270966	0.1960	.	.	.	.	.	.	.	.	RPA1:uc002fto.2:exon11:c.C1056T:p.S352S	.	AFR:0.1810,AMR:0.2990,EAS:0.4270,FIN:0.2394,NFE:0.1610,OTH:0.2337,ASJ:0.2152	179835	.	.	.	.	.	.	.	.	.	.	.	17	MU18319768	het
17	1795180	1795180	T	C	RPA1	exonic	synonymous SNV	ENSG00000132383	rs2230931	ENSG00000132383:ENST00000574049:exon6:c.T696C:p.S232S,ENSG00000132383:ENST00000254719:exon15:c.T1605C:p.S535S	RPA1:NM_001355121:exon14:c.T1428C:p.S476S,RPA1:NM_001355120:exon15:c.T1566C:p.S522S,RPA1:NM_002945:exon15:c.T1605C:p.S535S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2344	0.2384	0.29393	0.2507	.	.	.	.	.	.	.	.	RPA1:uc002fto.2:exon15:c.T1605C:p.S535S	.	AFR:0.3731,AMR:0.2955,EAS:0.2522,FIN:0.2208,NFE:0.1864,OTH:0.2240,ASJ:0.2185	179835	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	4455500	4455500	T	C	MYBBP1A	exonic	synonymous SNV	ENSG00000132382	rs7206974	ENSG00000132382:ENST00000254718:exon7:c.A825G:p.A275A,ENSG00000132382:ENST00000381556:exon7:c.A825G:p.A275A	MYBBP1A:NM_001105538:exon7:c.A825G:p.A275A,MYBBP1A:NM_014520:exon7:c.A825G:p.A275A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9977	0.9906	0.992812	0.9914	.	.	.	.	.	.	.	.	MYBBP1A:uc002fxz.4:exon7:c.A825G:p.A275A,MYBBP1A:uc002fyb.4:exon7:c.A825G:p.A275A	.	AFR:0.9704,AMR:1,EAS:1,FIN:1,NFE:0.9997,OTH:0.9969,ASJ:1	604885	.	.	.	.	.	.	.	.	.	.	.	17	MU4564618	hom
17	4457580	4457580	G	A	MYBBP1A	intronic	.	ENSG00000132382	rs2306270	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1425	0.0978	0.20028	1(stomach)	.	.	.	.	.	0.0001	0.044	.	.	.	AFR:MU584003,AMR:LICA-CN|2|402|0.00497512,LAML-KR|3|205|0.0146341,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,EAS:0.1205,FIN:0.1217,NFE:0.0960,OTH:0.4436,ASJ:0.1249	604885	.	.	.	.	.	.	.	.	.	.	.	17	3(haematopoietic_and_lymphoid_tissue)	0.1236
17	4458598	4458598	G	C	MYBBP1A	exonic	nonsynonymous SNV	ENSG00000132382	rs3809849	ENSG00000132382:ENST00000254718:exon1:c.C22G:p.Q8E,ENSG00000132382:ENST00000381556:exon1:c.C22G:p.Q8E	MYBBP1A:NM_001105538:exon1:c.C22G:p.Q8E,MYBBP1A:NM_014520:exon1:c.C22G:p.Q8E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2632	0.2147	0.211861	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053	-1.067	0.012	1.0	4.08	0.000	.	.	.	MYBBP1A:uc002fxz.4:exon1:c.C22G:p.Q8E,MYBBP1A:uc002fyb.4:exon1:c.C22G:p.Q8E	-0.970	AFR:0.2158,AMR:0.2383,EAS:0.1623,FIN:0.1512,NFE:0.2080,OTH:0.2163,ASJ:0.1730	604885	.	.	.	.	.	.	.	0.0	2.4	0.000	-1.495	17	1(haematopoietic_and_lymphoid_tissue)	0.1945
17	5036272	5036272	A	C	USP6	exonic	nonsynonymous SNV	ENSG00000129204	rs150182797	ENSG00000129204:ENST00000250066:exon5:c.A263C:p.K88T,ENSG00000129204:ENST00000572949:exon5:c.A263C:p.K88T,ENSG00000129204:ENST00000575709:exon5:c.A263C:p.K88T,ENSG00000129204:ENST00000332776:exon13:c.A263C:p.K88T,ENSG00000129204:ENST00000574788:exon13:c.A263C:p.K88T	USP6:NM_004505:exon5:c.A263C:p.K88T,USP6:NM_001304284:exon13:c.A263C:p.K88T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0024	0.0036	0.00159744	0.0020	1.387	12.72	0.078	0.046	0.013	.	.	Rab-GTPase-TBC domain	USP6:uc002gav.1:exon5:c.A263C:p.K88T,USP6:uc002gaw.3:exon6:c.A446C:p.K149T,USP6:uc002gau.1:exon13:c.A263C:p.K88T	-1.047	AFR:0.0005,AMR:0,EAS:0,FIN:0.0003,NFE:0.0037,OTH:0.0010,ASJ:0.0066	604334	.	.	.	.	.	.	.	0.898	1.34	0.067	3.04	17	.	het
17	5042894	5042894	T	C	USP6	exonic	nonsynonymous SNV	ENSG00000129204	rs8073787	ENSG00000129204:ENST00000250066:exon14:c.T1423C:p.W475R,ENSG00000129204:ENST00000572949:exon14:c.T1423C:p.W475R,ENSG00000129204:ENST00000304328:exon15:c.T472C:p.W158R,ENSG00000129204:ENST00000332776:exon22:c.T1423C:p.W475R,ENSG00000129204:ENST00000574788:exon22:c.T1423C:p.W475R	USP6:NM_004505:exon14:c.T1423C:p.W475R,USP6:NM_001304284:exon22:c.T1423C:p.W475R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6492	0.6377	0.77496	MU9249277	-0.312	0.625	0.067	-0.532	0.000	.	.	.	USP6:uc002gav.1:exon14:c.T1423C:p.W475R,USP6:uc010ckz.1:exon15:c.T472C:p.W158R,USP6:uc002gau.1:exon22:c.T1423C:p.W475R	-1.065	AFR:COCA-CN|5|321|0.0155763,AMR:0.6723,EAS:0.5791,FIN:0.5662,NFE:0.8974,OTH:0.6812,ASJ:0.8215	604334	.	.	.	.	.	.	.	0.003	3.11	0.000	0.69	17	1(salivary_gland)	0.5679
17	5044749	5044749	G	A	USP6	exonic	nonsynonymous SNV	ENSG00000129204	rs200519817	ENSG00000129204:ENST00000250066:exon15:c.G1528A:p.E510K,ENSG00000129204:ENST00000572949:exon15:c.G1528A:p.E510K,ENSG00000129204:ENST00000304328:exon16:c.G577A:p.E193K,ENSG00000129204:ENST00000332776:exon23:c.G1528A:p.E510K,ENSG00000129204:ENST00000574788:exon23:c.G1528A:p.E510K	USP6:NM_004505:exon15:c.G1528A:p.E510K,USP6:NM_001304284:exon23:c.G1528A:p.E510K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0] 	0.0052	.	0.00678914	0.0003	2.195	17.47	0.031	2.63	0.996	.	.	.	USP6:uc002gav.1:exon15:c.G1528A:p.E510K,USP6:uc010ckz.1:exon16:c.G577A:p.E193K,USP6:uc002gau.1:exon23:c.G1528A:p.E510K	-1.083	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0061,ASJ:0	604334	.	.	.	.	.	.	.	0.925	2.86	0.030	1.04	17	.	het
17	5073910	5073910	G	A	USP6	exonic	synonymous SNV	ENSG00000129204	rs138559331	ENSG00000129204:ENST00000250066:exon28:c.G3654A:p.P1218P,ENSG00000129204:ENST00000304328:exon29:c.G2703A:p.P901P,ENSG00000129204:ENST00000574788:exon36:c.G3654A:p.P1218P	USP6:NM_004505:exon28:c.G3654A:p.P1218P,USP6:NM_001304284:exon36:c.G3654A:p.P1218P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0123	.	0.0189696	0.0003	.	.	.	.	.	.	.	.	USP6:uc002gav.1:exon28:c.G3654A:p.P1218P,USP6:uc010ckz.1:exon29:c.G2703A:p.P901P,USP6:uc002gau.1:exon36:c.G3654A:p.P1218P	.	AFR:0.0003,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0071,ASJ:0	604334	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	5418107	5418107	G	A	NLRP1	exonic	synonymous SNV	ENSG00000091592	rs74929853	ENSG00000091592:ENST00000577119:exon15:c.C4167T:p.G1389G,ENSG00000091592:ENST00000345221:exon16:c.C4257T:p.G1419G,ENSG00000091592:ENST00000354411:exon16:c.C4299T:p.G1433G,ENSG00000091592:ENST00000269280:exon17:c.C4257T:p.G1419G,ENSG00000091592:ENST00000572272:exon17:c.C4389T:p.G1463G	NLRP1:NM_033007:exon15:c.C4167T:p.G1389G,NLRP1:NM_014922:exon16:c.C4257T:p.G1419G,NLRP1:NM_033006:exon16:c.C4299T:p.G1433G,NLRP1:NM_033004:exon17:c.C4389T:p.G1463G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0328	0.0015	0.0696885	0.0088	.	.	.	.	.	.	.	.	NLRP1:uc002gcl.3:exon15:c.C4167T:p.G1389G,NLRP1:uc002gcj.3:exon16:c.C4299T:p.G1433G,NLRP1:uc002gck.3:exon16:c.C4257T:p.G1419G,NLRP1:uc002gch.4:exon17:c.C4257T:p.G1419G,NLRP1:uc002gci.3:exon17:c.C4389T:p.G1463G	.	AFR:0.0031,AMR:0.0012,EAS:0.1372,FIN:0,NFE:0.0005,OTH:0.0154,ASJ:0	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	.	.	.	.	17	MU81986150	het
17	5418799	5418799	G	A	NLRP1	exonic	nonsynonymous SNV	ENSG00000091592	rs2137722	ENSG00000091592:ENST00000577119:exon14:c.C3874T:p.R1292C,ENSG00000091592:ENST00000345221:exon15:c.C3964T:p.R1322C,ENSG00000091592:ENST00000354411:exon15:c.C4006T:p.R1336C,ENSG00000091592:ENST00000269280:exon16:c.C3964T:p.R1322C,ENSG00000091592:ENST00000572272:exon16:c.C4096T:p.R1366C	NLRP1:NM_033007:exon14:c.C3874T:p.R1292C,NLRP1:NM_014922:exon15:c.C3964T:p.R1322C,NLRP1:NM_033006:exon15:c.C4006T:p.R1336C,NLRP1:NM_033004:exon16:c.C4096T:p.R1366C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0777	0.0515	0.101238	0.0568	1.063	11.01	0.114	-4.28	0.001	.	.	FIIND domain	NLRP1:uc002gcl.3:exon14:c.C3874T:p.R1292C,NLRP1:uc002gcj.3:exon15:c.C4006T:p.R1336C,NLRP1:uc002gck.3:exon15:c.C3964T:p.R1322C,NLRP1:uc002gch.4:exon16:c.C3964T:p.R1322C,NLRP1:uc002gci.3:exon16:c.C4096T:p.R1366C	-1.106	AFR:0.0520,AMR:0.0394,EAS:0.1383,FIN:0.0547,NFE:0.0517,OTH:0.0622,ASJ:0.0695	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	0.002	-0.48	0.002	0.345	17	MU18333347	het
17	5424886	5424886	G	A	NLRP1	exonic	synonymous SNV	ENSG00000091592	rs2301583	ENSG00000091592:ENST00000354411:exon12:c.C3651T:p.T1217T,ENSG00000091592:ENST00000577119:exon12:c.C3651T:p.T1217T,ENSG00000091592:ENST00000262467:exon13:c.C3753T:p.T1251T,ENSG00000091592:ENST00000345221:exon13:c.C3741T:p.T1247T,ENSG00000091592:ENST00000544378:exon13:c.C3753T:p.T1251T,ENSG00000091592:ENST00000572272:exon13:c.C3741T:p.T1247T,ENSG00000091592:ENST00000269280:exon14:c.C3741T:p.T1247T	NLRP1:NM_033006:exon12:c.C3651T:p.T1217T,NLRP1:NM_033007:exon12:c.C3651T:p.T1217T,NLRP1:NM_001033053:exon13:c.C3753T:p.T1251T,NLRP1:NM_014922:exon13:c.C3741T:p.T1247T,NLRP1:NM_033004:exon13:c.C3741T:p.T1247T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0322	.	0.0688898	0.0084	.	.	.	.	.	.	.	.	NLRP1:uc002gcj.3:exon12:c.C3651T:p.T1217T,NLRP1:uc002gcl.3:exon12:c.C3651T:p.T1217T,NLRP1:uc002gcg.1:exon13:c.C3753T:p.T1251T,NLRP1:uc002gci.3:exon13:c.C3741T:p.T1247T,NLRP1:uc002gck.3:exon13:c.C3741T:p.T1247T,NLRP1:uc002gch.4:exon14:c.C3741T:p.T1247T	.	AFR:0.0017,AMR:0.0012,EAS:0.1401,FIN:0,NFE:0.0002,OTH:0.0153,ASJ:0	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	.	.	.	.	17	MU18333608	het
17	5425077	5425077	T	C	NLRP1	exonic	nonsynonymous SNV	ENSG00000091592	rs11651270	ENSG00000091592:ENST00000354411:exon12:c.A3460G:p.M1154V,ENSG00000091592:ENST00000577119:exon12:c.A3460G:p.M1154V,ENSG00000091592:ENST00000262467:exon13:c.A3562G:p.M1188V,ENSG00000091592:ENST00000345221:exon13:c.A3550G:p.M1184V,ENSG00000091592:ENST00000544378:exon13:c.A3562G:p.M1188V,ENSG00000091592:ENST00000572272:exon13:c.A3550G:p.M1184V,ENSG00000091592:ENST00000269280:exon14:c.A3550G:p.M1184V	NLRP1:NM_033006:exon12:c.A3460G:p.M1154V,NLRP1:NM_033007:exon12:c.A3460G:p.M1154V,NLRP1:NM_001033053:exon13:c.A3562G:p.M1188V,NLRP1:NM_014922:exon13:c.A3550G:p.M1184V,NLRP1:NM_033004:exon13:c.A3550G:p.M1184V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4549	0.4826	0.417931	MU12944592	-0.778	0.048	1.0	2.26	0.973	.	.	FIIND domain	NLRP1:uc002gcj.3:exon12:c.A3460G:p.M1154V,NLRP1:uc002gcl.3:exon12:c.A3460G:p.M1154V,NLRP1:uc002gcg.1:exon13:c.A3562G:p.M1188V,NLRP1:uc002gci.3:exon13:c.A3550G:p.M1184V,NLRP1:uc002gck.3:exon13:c.A3550G:p.M1184V,NLRP1:uc002gch.4:exon14:c.A3550G:p.M1184V	-0.940	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.4631,EAS:0.4474,FIN:0.4967,NFE:0.2407,OTH:0.4631,ASJ:0.5107	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	0.0	2.82	0.000	-2.87	17	2(lung)	0.4601
17	5440197	5440197	T	C	NLRP1	exonic	synonymous SNV	ENSG00000091592	rs7215856	ENSG00000091592:ENST00000262467:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000345221:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000544378:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000571451:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000572272:exon8:c.A2934G:p.K978K,ENSG00000091592:ENST00000269280:exon9:c.A2934G:p.K978K	NLRP1:NM_001033053:exon8:c.A2934G:p.K978K,NLRP1:NM_014922:exon8:c.A2934G:p.K978K,NLRP1:NM_033004:exon8:c.A2934G:p.K978K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0795	0.0659	0.119209	0.0663	.	.	.	.	.	.	.	.	NLRP1:uc002gcg.1:exon8:c.A2934G:p.K978K,NLRP1:uc002gci.3:exon8:c.A2934G:p.K978K,NLRP1:uc002gck.3:exon8:c.A2934G:p.K978K,NLRP1:uc002gch.4:exon9:c.A2934G:p.K978K,NLRP1:uc010clh.3:exon9:c.A2934G:p.K978K	.	AFR:0.0877,AMR:0.0394,EAS:0.1460,FIN:0.0545,NFE:0.0497,OTH:0.0633,ASJ:0.0629	606636	606579;615225;	352662;247871;	352662|-|<1 / 1 000 000|Autosomal dominant|All ages|615225 ~247871|-|-|-|Childhood<br>Adolescent<br>Adult|193200 606579 607836 608391 608392 609400 ~	.	.	.	.	.	.	.	.	17	MU22370800	het
17	7154534	7154534	G	A	CTDNEP1	exonic	synonymous SNV	ENSG00000175826	rs414206	ENSG00000175826:ENST00000570380:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000574205:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000574322:exon1:c.C82T:p.L28L,ENSG00000175826:ENST00000318988:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000571409:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000573600:exon2:c.C82T:p.L28L,ENSG00000175826:ENST00000575783:exon2:c.C82T:p.L28L	CTDNEP1:NM_001143775:exon1:c.C82T:p.L28L,CTDNEP1:NM_015343:exon2:c.C82T:p.L28L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6607	0.6938	0.701078	0.6985	.	.	.	.	.	.	.	.	CTDNEP1:uc002gfd.2:exon1:c.C82T:p.L28L,CTDNEP1:uc002gfe.2:exon2:c.C82T:p.L28L	.	AFR:0.8422,AMR:0.6017,EAS:0.6611,FIN:0.6675,NFE:0.6355,OTH:0.6478,ASJ:0.6589	610684	.	.	.	.	.	.	.	.	.	.	.	17	MU18201074	het
17	7788409	7788409	C	G	CHD3;NAA38	intronic	.	ENSG00000170004;ENSG00000183011	rs201772788	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	1	.	.	0.9997	.	.	.	.	.	0.0002	0.004	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9996,OTH:0.9984,ASJ:1	.	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	7811998	7811998	T	C	CHD3	intronic	.	ENSG00000170004	rs4239111	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8852	0.8802	0.944888	0.9012	.	.	.	.	.	.	.	.	.	.	AFR:0.9727,AMR:0.9105,EAS:0.9988,FIN:0.8931,NFE:0.8527,OTH:0.8918,ASJ:0.8212	602120	.	.	.	.	.	.	.	.	.	.	.	17	MU81987243	hom
17	7983969	7983969	G	C	ALOX12B	intronic	.	ENSG00000214999	rs2304908	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3760	0.4093	0.454473	MU773379	.	.	.	.	.	0.0001	0	.	.	.	AFR:LUSC-KR|4|170|0.0235294,COCA-CN|4|321|0.0124611,AMR:0.4256,EAS:0.5167,FIN:0.2967,NFE:0.4083,OTH:0.3867,ASJ:0.5941	603741	242100;	281122;79394;	281122|SHCB|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|242100 242300 606545 ~79394|CIE<br>Erythrodermic ichthyosis<br>Non-bullous congenital ichthyosiform erythroderma|1-9 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|242100 606545 612281 615022 615023 615024 ~	.	.	.	.	.	.	.	.	17	13(soft_tissue)	0.3392
17	8046772	8046772	C	G	PER1	exonic	nonsynonymous SNV	ENSG00000179094	rs2585405	ENSG00000179094:ENST00000581082:exon18:c.G2815C:p.A939P,ENSG00000179094:ENST00000317276:exon19:c.G2884C:p.A962P	PER1:NM_002616:exon19:c.G2884C:p.A962P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8544	0.8592	0.771765	MU650358	0.259	5.289	0.581	3.22	0.001	.	.	.	PER1:uc002gkd.3:exon19:c.G2884C:p.A962P	-1.042	AFR:COCA-CN|4|321|0.0124611,AMR:0.8581,EAS:0.8091,FIN:0.7848,NFE:0.5131,OTH:0.9364,ASJ:0.8049	602260	.	.	.	.	.	.	.	0.0	2.59	0.000	-1.665	17	1(bone)	0.9092
17	8048169	8048169	T	C	PER1	exonic	synonymous SNV	ENSG00000179094	rs2253820	ENSG00000179094:ENST00000583559:exon2:c.A210G:p.T70T,ENSG00000179094:ENST00000581082:exon17:c.A2301G:p.T767T,ENSG00000179094:ENST00000317276:exon18:c.A2361G:p.T787T,ENSG00000179094:ENST00000354903:exon18:c.A2313G:p.T771T,ENSG00000179094:ENST00000582719:exon18:c.A2361G:p.T787T	PER1:NM_002616:exon18:c.A2361G:p.T787T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7486	0.7404	0.570288	MU4550577	.	.	.	.	.	.	.	.	PER1:uc002gkd.3:exon18:c.A2361G:p.T787T,PER1:uc010vur.1:exon18:c.A2313G:p.T771T	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.7271,EAS:0.4582,FIN:0.6433,NFE:0.2971,OTH:0.8701,ASJ:0.5607	602260	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.8475
17	8048283	8048283	G	A	PER1	exonic	synonymous SNV	ENSG00000179094	rs2735611	ENSG00000179094:ENST00000583559:exon2:c.C96T:p.G32G,ENSG00000179094:ENST00000581082:exon17:c.C2187T:p.G729G,ENSG00000179094:ENST00000317276:exon18:c.C2247T:p.G749G,ENSG00000179094:ENST00000354903:exon18:c.C2199T:p.G733G,ENSG00000179094:ENST00000582719:exon18:c.C2247T:p.G749G	PER1:NM_002616:exon18:c.C2247T:p.G749G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7253	0.7423	0.570487	MU657495	.	.	.	.	.	.	.	.	PER1:uc002gkd.3:exon18:c.C2247T:p.G749G,PER1:uc010vur.1:exon18:c.C2199T:p.G733G	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|6|321|0.0186916,AMR:0.7275,EAS:0.4582,FIN:0.6467,NFE:0.2966,OTH:0.8698,ASJ:0.5619	602260	.	.	.	.	.	.	.	.	.	.	.	17	2(thyroid)	0.8477
17	8108331	8108331	A	G	AURKB	exonic	nonsynonymous SNV	ENSG00000178999	rs1059476	ENSG00000178999:ENST00000534871:exon8:c.T770C:p.M257T,ENSG00000178999:ENST00000578549:exon8:c.T797C:p.M266T,ENSG00000178999:ENST00000316199:exon9:c.T896C:p.M299T,ENSG00000178999:ENST00000585124:exon9:c.T893C:p.M298T	AURKB:NM_001313955:exon7:c.T389C:p.M130T,AURKB:NM_001256834:exon8:c.T770C:p.M257T,AURKB:NM_001313952:exon8:c.T773C:p.M258T,AURKB:NM_001284526:exon9:c.T896C:p.M299T,AURKB:NM_001313950:exon9:c.T893C:p.M298T,AURKB:NM_001313951:exon9:c.T770C:p.M257T,AURKB:NM_001313953:exon9:c.T797C:p.M266T,AURKB:NM_001313954:exon9:c.T437C:p.M146T,AURKB:NM_004217:exon9:c.T893C:p.M298T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8306	0.8219	0.736022	MU656579	-1.014	0.015	0.39	-1.93	0.312	.	.	Protein kinase domain|Protein kinase-like domain	AURKB:uc010cnu.3:exon7:c.T353C:p.M118T,AURKB:uc010vuu.3:exon8:c.T770C:p.M257T,AURKB:uc021tpy.1:exon8:c.T797C:p.M266T,AURKB:uc002gkm.4:exon9:c.T893C:p.M298T,AURKB:uc002gkn.4:exon9:c.T896C:p.M299T	-0.992	AFR:LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,AMR:0.8160,EAS:0.7728,FIN:0.76,NFE:0.5252,OTH:0.9068,ASJ:0.6942	604970	.	.	.	.	.	.	.	0.0	-0.07	0.000	-0.44	17	33(lung)	0.8955
17	8108339	8108339	G	A	AURKB	exonic	synonymous SNV	ENSG00000178999	rs2241909	ENSG00000178999:ENST00000534871:exon8:c.C762T:p.S254S,ENSG00000178999:ENST00000578549:exon8:c.C789T:p.S263S,ENSG00000178999:ENST00000316199:exon9:c.C888T:p.S296S,ENSG00000178999:ENST00000585124:exon9:c.C885T:p.S295S	AURKB:NM_001313955:exon7:c.C381T:p.S127S,AURKB:NM_001256834:exon8:c.C762T:p.S254S,AURKB:NM_001313952:exon8:c.C765T:p.S255S,AURKB:NM_001284526:exon9:c.C888T:p.S296S,AURKB:NM_001313950:exon9:c.C885T:p.S295S,AURKB:NM_001313951:exon9:c.C762T:p.S254S,AURKB:NM_001313953:exon9:c.C789T:p.S263S,AURKB:NM_001313954:exon9:c.C429T:p.S143S,AURKB:NM_004217:exon9:c.C885T:p.S295S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6547	0.6183	0.620807	2(thyroid)	.	.	.	.	.	.	.	.	AURKB:uc010cnu.3:exon7:c.C345T:p.S115S,AURKB:uc010vuu.3:exon8:c.C762T:p.S254S,AURKB:uc021tpy.1:exon8:c.C789T:p.S263S,AURKB:uc002gkm.4:exon9:c.C885T:p.S295S,AURKB:uc002gkn.4:exon9:c.C888T:p.S296S	.	AFR:MU773382,AMR:LAML-KR|4|205|0.0195122,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,EAS:0.5578,FIN:0.6719,NFE:0.5403,OTH:0.4729,ASJ:0.6398	604970	.	.	.	.	.	.	.	.	.	.	.	17	1(breast)	0.7446
17	8387438	8387438	-	ATGA	MYH10	intronic	.	ENSG00000133026;ENSG00000166579	rs113838551	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9900	0.9616	0.971246	0.9685	.	.	.	.	.	.	.	.	.	.	AFR:0.8902,AMR:0.9940,EAS:1,FIN:1,NFE:0.9996,OTH:0.9918,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	8390733	8390733	A	G	MYH10	intronic	.	ENSG00000133026;ENSG00000166579	rs3826463	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5619	0.5012	0.496605	MU81987538	.	.	.	.	.	.	.	.	.	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.5070,EAS:0.6017,FIN:0.6887,NFE:0.5841,OTH:0.5613,ASJ:0.3239	160776	.	.	.	.	.	.	.	.	.	.	.	17	1(bone)	0.5782
17	8424270	8424270	G	A	MYH10	exonic	synonymous SNV	ENSG00000133026	rs8067456	ENSG00000133026:ENST00000269243:exon17:c.C2106T:p.N702N,ENSG00000133026:ENST00000379980:exon18:c.C2154T:p.N718N,ENSG00000133026:ENST00000396239:exon18:c.C2169T:p.N723N,ENSG00000133026:ENST00000360416:exon19:c.C2199T:p.N733N	MYH10:NM_005964:exon17:c.C2106T:p.N702N,MYH10:NM_001256095:exon18:c.C2133T:p.N711N,MYH10:NM_001256012:exon19:c.C2199T:p.N733N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9923	0.9700	0.979433	0.9765	.	.	.	.	.	.	.	.	MYH10:uc002gll.4:exon17:c.C2106T:p.N702N,MYH10:uc010cnx.4:exon18:c.C2133T:p.N711N,MYH10:uc002glm.4:exon19:c.C2199T:p.N733N	.	AFR:0.9179,AMR:0.9964,EAS:1,FIN:1,NFE:0.9997,OTH:0.9969,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	MU81987554	hom
17	8451745	8451745	A	-	MYH10	intronic	.	ENSG00000133026	rs398030289	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.9907	.	0.97484	0.9711	.	.	.	.	.	.	.	.	.	.	AFR:0.8999,AMR:0.9952,EAS:1,FIN:0.9997,NFE:0.9994,OTH:0.9949,ASJ:1	160776	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	9830100	9830100	A	G	GAS7	intronic	.	ENSG00000007237	rs7218907	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0273	0.0271	0.0607029	LAML-KR|2|205|0.0097561,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.0318,AMR:0.0808,EAS:0.0132,FIN:0.0815,NFE:0.0017,OTH:0.0021,ASJ:0.1112	603127	.	.	.	.	.	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.0143
17	9843521	9843521	C	A	GAS7	intronic	.	ENSG00000007237	.	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	3.232e-05	.	.	.	.	.	0.0002	0.014	.	.	.	AFR:0,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0,ASJ:0	603127	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	9872978	9872978	C	T	GAS7	intronic	.	ENSG00000007237	rs2277688	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0403	0.0059	0.0523163	0.0182	.	.	.	.	.	.	.	.	.	.	AFR:0.0048,AMR:0.1962,EAS:0.1459,FIN:0.0060,NFE:0.0051,OTH:0.0193,ASJ:0.0132	603127	.	.	.	.	.	.	.	.	.	.	.	17	MU19048433	het
17	10415840	10415840	A	G	MYH1	exonic	synonymous SNV	ENSG00000109061	rs2007027	ENSG00000109061:ENST00000226207:exon12:c.T1032C:p.F344F	MYH1:NM_005963:exon12:c.T1032C:p.F344F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9288	0.8759	0.88139	0.8945	.	.	.	.	.	.	.	.	MYH1:uc002gmo.3:exon12:c.T1032C:p.F344F	.	AFR:0.7410,AMR:0.9436,EAS:0.9988,FIN:0.9805,NFE:0.9471,OTH:0.9318,ASJ:0.9040	160730	.	.	.	.	.	.	.	.	.	.	.	17	MU81988040	hom
17	17122327	17122327	G	A	FLCN	intronic	.	ENSG00000154803;ENSG00000264187	rs8065832	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5023	0.4491	0.502995	0.4924	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3692,AMR:0.5525,EAS:0.6512,FIN:0.6579,NFE:0.5025,OTH:0.5305,ASJ:0.4834	607273	114500;135150;144700;173600;	2903;422526;122;	2903|-|-|Autosomal dominant|-|173600 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~122|Fibrofolliculomas with trichodiscomas and acrochordons|1-9 / 1 000 000|Autosomal dominant|Adult|135150 ~	.	.	.	.	.	.	.	.	17	MU19893918	het
17	17124815	17124815	C	T	FLCN	exonic	nonsynonymous SNV	ENSG00000154803	rs3744124	ENSG00000154803:ENST00000389169:exon8:c.G907A:p.G303R	FLCN:NM_144606:exon8:c.G907A:p.G303R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.0725	0.0775	0.0996406	1(breast)	-0.012	2.469	0.377	-4.69	0.000	.	.	.	FLCN:uc002grb.4:exon8:c.G907A:p.G303R	-1.005	AFR:MU4553464,AMR:LICA-CN|2|402|0.00497512,LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.1312,FIN:0.0322,NFE:0.0265,OTH:0.2020,ASJ:0.0743	607273	114500;135150;144700;173600;	2903;422526;122;	2903|-|-|Autosomal dominant|-|173600 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~122|Fibrofolliculomas with trichodiscomas and acrochordons|1-9 / 1 000 000|Autosomal dominant|Adult|135150 ~	.	,5615,5614	.	.	0.002	-3.3	0.003	.	17	3(soft_tissue)	0.0258
17	17127471	17127471	G	A	FLCN	intronic	.	ENSG00000154803;ENSG00000264187	rs1736219	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4841	0.3738	0.405152	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.4296,AMR:0.1533,EAS:0.4834,FIN:0.6512,NFE:0.6583,OTH:0.5001,ASJ:0.5419	607273	114500;135150;144700;173600;	2903;422526;122;	2903|-|-|Autosomal dominant|-|173600 ~422526|Hereditary clear cell renal cell adenocarcinoma|Unknown|Unknown|Adult|144700 ~122|Fibrofolliculomas with trichodiscomas and acrochordons|1-9 / 1 000 000|Autosomal dominant|Adult|135150 ~	.	.	.	.	.	.	.	.	17	1(prostate)	0.5194
17	17960011	17960011	C	T	GID4	intronic	.	ENSG00000141034	rs16960835	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2409	.	0.142173	0.0923	.	.	.	.	.	0.0013	0.066	.	.	.	AFR:0.0215,AMR:0.0764,EAS:0.0933,FIN:0.1265,NFE:0.1243,OTH:0.1191,ASJ:0.1060	.	.	.	.	.	.	.	.	.	.	.	.	17	MU19061387	het
17	18194011	18194011	C	A	TOP3A	intronic	.	ENSG00000177302	rs3817992	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2469	0.2201	0.213858	0.2213	.	.	.	.	.	0	0	.	.	.	AFR:0.1533,AMR:0.2649,EAS:0.3169,FIN:0.2873,NFE:0.2311,OTH:0.2403,ASJ:0.2384	601243	.	.	.	.	.	.	.	.	.	.	.	17	MU812885	het
17	20000131	20000131	G	T	SPECC1	intronic	.	ENSG00000128487	rs4925085	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4945	0.5249	0.413938	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	.	.	AFR:0.4808,AMR:0.4341,EAS:0.5828,FIN:0.1912,NFE:0.4702,OTH:0.5386,ASJ:0.4952	608793	.	.	.	.	.	.	.	.	.	.	.	17	1(lung)	0.4847
17	20013802	20013802	G	A	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs3764436	ENSG00000128487:ENST00000261503:exon3:c.G210A:p.V70V,ENSG00000128487:ENST00000395527:exon3:c.G210A:p.V70V,ENSG00000128487:ENST00000395529:exon3:c.G210A:p.V70V,ENSG00000128487:ENST00000580934:exon3:c.G210A:p.V70V,ENSG00000128487:ENST00000581973:exon3:c.G210A:p.V70V,ENSG00000128487:ENST00000583463:exon4:c.G210A:p.V70V,ENSG00000128487:ENST00000583482:exon4:c.G210A:p.V70V,ENSG00000128487:ENST00000583528:exon5:c.G210A:p.V70V	SPECC1:NM_001033553:exon3:c.G210A:p.V70V,SPECC1:NM_001243439:exon3:c.G210A:p.V70V,SPECC1:NM_152904:exon3:c.G210A:p.V70V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1155	0.1180	0.108826	MU11086842	.	.	.	.	.	.	.	.	SPECC1:uc002gwq.3:exon3:c.G210A:p.V70V,SPECC1:uc002gwr.3:exon3:c.G210A:p.V70V,SPECC1:uc002gws.3:exon3:c.G210A:p.V70V,SPECC1:uc010cqx.3:exon3:c.G210A:p.V70V	.	AFR:LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,AMR:0.1140,EAS:0.1348,FIN:0.0530,NFE:0.1037,OTH:0.1061,ASJ:0.0860	608793	.	.	.	.	.	.	.	.	.	.	.	17	1(liver)	0.1336
17	20107773	20107773	T	C	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703805	ENSG00000128487:ENST00000395522:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000395525:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000395530:exon2:c.T168C:p.S56S,ENSG00000128487:ENST00000261503:exon4:c.T411C:p.S137S,ENSG00000128487:ENST00000395527:exon4:c.T411C:p.S137S,ENSG00000128487:ENST00000395529:exon4:c.T411C:p.S137S	SPECC1:NM_001033554:exon2:c.T168C:p.S56S,SPECC1:NM_001033555:exon2:c.T168C:p.S56S,SPECC1:NM_001243438:exon2:c.T168C:p.S56S,SPECC1:NM_001033553:exon4:c.T411C:p.S137S,SPECC1:NM_001243439:exon4:c.T411C:p.S137S,SPECC1:NM_152904:exon4:c.T411C:p.S137S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4782	0.3982	0.539936	LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SPECC1:uc002gwt.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwu.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwv.3:exon2:c.T168C:p.S56S,SPECC1:uc002gwq.3:exon4:c.T411C:p.S137S,SPECC1:uc002gwr.3:exon4:c.T411C:p.S137S,SPECC1:uc002gws.3:exon4:c.T411C:p.S137S,SPECC1:uc010cqx.3:exon4:c.T411C:p.S137S	.	AFR:0.4545,AMR:0.4073,EAS:0.4305,FIN:0.8220,NFE:0.5049,OTH:0.4264,ASJ:0.4964	608793	.	.	.	.	.	.	.	.	.	.	.	17	2(urinary_tract)	0.4867
17	20108184	20108184	C	G	SPECC1	exonic	nonsynonymous SNV	ENSG00000128487	rs9908032	ENSG00000128487:ENST00000395522:exon2:c.C579G:p.S193R,ENSG00000128487:ENST00000395525:exon2:c.C579G:p.S193R,ENSG00000128487:ENST00000395530:exon2:c.C579G:p.S193R,ENSG00000128487:ENST00000261503:exon4:c.C822G:p.S274R,ENSG00000128487:ENST00000395527:exon4:c.C822G:p.S274R,ENSG00000128487:ENST00000395529:exon4:c.C822G:p.S274R	SPECC1:NM_001033554:exon2:c.C579G:p.S193R,SPECC1:NM_001033555:exon2:c.C579G:p.S193R,SPECC1:NM_001243438:exon2:c.C579G:p.S193R,SPECC1:NM_001033553:exon4:c.C822G:p.S274R,SPECC1:NM_001243439:exon4:c.C822G:p.S274R,SPECC1:NM_152904:exon4:c.C822G:p.S274R	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.1182	0.1276	0.113618	0.1192	4.110	23.7	0.111	5.38	0.993	.	.	.	SPECC1:uc002gwt.3:exon2:c.C579G:p.S193R,SPECC1:uc002gwu.3:exon2:c.C579G:p.S193R,SPECC1:uc002gwv.3:exon2:c.C579G:p.S193R,SPECC1:uc002gwq.3:exon4:c.C822G:p.S274R,SPECC1:uc002gwr.3:exon4:c.C822G:p.S274R,SPECC1:uc002gws.3:exon4:c.C822G:p.S274R,SPECC1:uc010cqx.3:exon4:c.C822G:p.S274R	-0.961	AFR:0.1036,AMR:0.1348,EAS:0.1020,FIN:0.1060,NFE:0.1340,OTH:0.1143,ASJ:0.0530	608793	.	.	.	.	.	.	.	0.999	-0.25	0.010	2.585	17	MU12898041	het
17	20108239	20108239	A	T	SPECC1	exonic	nonsynonymous SNV	ENSG00000128487	rs2703806	ENSG00000128487:ENST00000395522:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000395525:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000395530:exon2:c.A634T:p.M212L,ENSG00000128487:ENST00000261503:exon4:c.A877T:p.M293L,ENSG00000128487:ENST00000395527:exon4:c.A877T:p.M293L,ENSG00000128487:ENST00000395529:exon4:c.A877T:p.M293L	SPECC1:NM_001033554:exon2:c.A634T:p.M212L,SPECC1:NM_001033555:exon2:c.A634T:p.M212L,SPECC1:NM_001243438:exon2:c.A634T:p.M212L,SPECC1:NM_001033553:exon4:c.A877T:p.M293L,SPECC1:NM_001243439:exon4:c.A877T:p.M293L,SPECC1:NM_152904:exon4:c.A877T:p.M293L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6741	0.6898	0.819289	0.7198	-3.117	0.001	1.0	-10.8	0.053	.	.	.	SPECC1:uc002gwt.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwu.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwv.3:exon2:c.A634T:p.M212L,SPECC1:uc002gwq.3:exon4:c.A877T:p.M293L,SPECC1:uc002gwr.3:exon4:c.A877T:p.M293L,SPECC1:uc002gws.3:exon4:c.A877T:p.M293L,SPECC1:uc010cqx.3:exon4:c.A877T:p.M293L	-0.902	AFR:0.9190,AMR:0.6722,EAS:0.9914,FIN:0.6289,NFE:0.6068,OTH:0.6516,ASJ:0.5166	608793	.	.	.	.	.	.	.	0.0	0.16	0.000	-2.28	17	MU81989794	hom
17	20109189	20109189	C	T	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703807	ENSG00000128487:ENST00000584527:exon1:c.C81T:p.N27N,ENSG00000128487:ENST00000395522:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000395525:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000395530:exon2:c.C1584T:p.N528N,ENSG00000128487:ENST00000261503:exon4:c.C1827T:p.N609N,ENSG00000128487:ENST00000395527:exon4:c.C1827T:p.N609N,ENSG00000128487:ENST00000395529:exon4:c.C1827T:p.N609N	SPECC1:NM_001033554:exon2:c.C1584T:p.N528N,SPECC1:NM_001033555:exon2:c.C1584T:p.N528N,SPECC1:NM_001243438:exon2:c.C1584T:p.N528N,SPECC1:NM_001033553:exon4:c.C1827T:p.N609N,SPECC1:NM_001243439:exon4:c.C1827T:p.N609N,SPECC1:NM_152904:exon4:c.C1827T:p.N609N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4747	0.3805	0.522764	PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	SPECC1:uc002gwt.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwu.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwv.3:exon2:c.C1584T:p.N528N,SPECC1:uc002gwq.3:exon4:c.C1827T:p.N609N,SPECC1:uc002gwr.3:exon4:c.C1827T:p.N609N,SPECC1:uc002gws.3:exon4:c.C1827T:p.N609N,SPECC1:uc010cqx.3:exon4:c.C1827T:p.N609N	.	AFR:0.4403,AMR:0.3638,EAS:0.4305,FIN:0.8201,NFE:0.5006,OTH:0.4247,ASJ:0.4905	608793	.	.	.	.	.	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.4786
17	20160925	20160925	C	T	SPECC1	intronic	.	ENSG00000263494	rs3751979	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1892	0.2792	0.251398	LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053	.	.	.	.	.	0.0005	0.026	.	.	.	AFR:0.2502,AMR:0.4681,EAS:0.0861,FIN:0.1038,NFE:0.1277,OTH:0.1812,ASJ:0.1766	608793	.	.	.	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.1633
17	20163529	20163529	A	G	SPECC1	exonic	synonymous SNV	ENSG00000128487	rs2703791	ENSG00000128487:ENST00000536879:exon9:c.A882G:p.A294A,ENSG00000128487:ENST00000395530:exon10:c.A2619G:p.A873A,ENSG00000128487:ENST00000261503:exon12:c.A2862G:p.A954A,ENSG00000128487:ENST00000395527:exon12:c.A2862G:p.A954A	SPECC1:NM_001033555:exon10:c.A2619G:p.A873A,SPECC1:NM_001033553:exon12:c.A2862G:p.A954A,SPECC1:NM_001243439:exon12:c.A2862G:p.A954A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6741	0.6896	0.819289	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SPECC1:uc010vzf.2:exon9:c.A882G:p.A294A,SPECC1:uc002gwv.3:exon10:c.A2619G:p.A873A,SPECC1:uc002gwq.3:exon12:c.A2862G:p.A954A,SPECC1:uc002gws.3:exon12:c.A2862G:p.A954A	.	AFR:0.7198,AMR:0.9185,EAS:0.5166,FIN:0.9914,NFE:0.6289,OTH:0.6070,ASJ:0.6718	608793	.	.	.	.	.	.	.	.	.	.	.	17	1(breast)	0.6517
17	20163616	20163616	C	T	SPECC1	intronic	.	ENSG00000263494	rs11868429	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1858	0.2715	0.242612	0.2432	.	.	.	.	.	.	.	.	.	.	AFR:0.4436,AMR:0.1766,EAS:0.1042,FIN:0.1276,NFE:0.1811,OTH:0.1650,ASJ:0.0861	608793	.	.	.	.	.	.	.	.	.	.	.	17	MU12898182	het
17	20216095	20216095	T	C	SPECC1	intronic	.	ENSG00000263494	rs11870147	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.819289	0.7198	.	.	.	.	.	.	.	.	.	.	AFR:0.9192,AMR:0.6706,EAS:0.9914,FIN:0.6285,NFE:0.6069,OTH:0.6496,ASJ:0.5166	608793	.	.	.	.	.	.	.	.	.	.	.	17	.	hom
17	29508775	29508775	G	A	NF1	exonic	synonymous SNV	ENSG00000196712	rs1801052	ENSG00000196712:ENST00000356175:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000358273:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000431387:exon7:c.G702A:p.L234L,ENSG00000196712:ENST00000579081:exon7:c.G804A:p.L268L	NF1:NM_000267:exon7:c.G702A:p.L234L,NF1:NM_001042492:exon7:c.G702A:p.L234L,NF1:NM_001128147:exon7:c.G702A:p.L234L	clinvar: Benign/Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6228	0.5744	0.511781	3(large_intestine)	.	.	.	.	.	.	.	.	NF1:uc010csn.2:exon5:c.G282A:p.L94L,NF1:uc002hge.2:exon7:c.G702A:p.L234L,NF1:uc002hgf.2:exon7:c.G702A:p.L234L,NF1:uc002hgg.3:exon7:c.G702A:p.L234L,NF1:uc002hgh.3:exon7:c.G702A:p.L234L	.	AFR:MU120056,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,EAS:0.3000,FIN:0.5365,NFE:0.7285,OTH:0.5877,ASJ:0.5603	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	,7728,7717,7710,7729,7733,7732,7725,7730,7724,7716,7736,7704,7737,7713,7735,7718,7707,7720,7722,7727,7721,7726,7719,7723,7705,7714,7711,7734,7706,7709,7731,7715,7712,7708	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.6524
17	29508819	29508819	-	T	NF1	intronic	.	ENSG00000196712	rs373999174	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.3108	.	.	0.4967	.	.	.	.	.	.	.	.	.	.	AFR:0.1881,AMR:0.5038,EAS:0.5859,FIN:0.5072,NFE:0.6616,OTH:0.6062,ASJ:0.7246	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	.	.	.	.	.	.	.	17	.	het
17	29654876	29654876	T	A	NF1	intronic	.	ENSG00000196712	rs2285894	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5364	0.5162	0.431909	8(meninges)	.	.	.	.	.	.	.	.	.	.	AFR:1(lung),AMR:MU695061,EAS:0.4925,FIN:0.2920,NFE:0.4221,OTH:0.6788,ASJ:ESAD-UK|1|409|0.00244499,PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916	613113	162200;162210;193520;601321;607785;	86834;638;636;363700;636;	86834|JMML<br>Juvenile chronic myelomonocytic leukemia|1-9 / 1 000 000|Not applicable|Childhood<br>Infancy|607785 ~638|NFNS<br>Neurofibromatosis type 1-Noonan syndrome|Unknown|Autosomal dominant|Infancy<br>Neonatal|601321 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~363700|Von Recklinghausen disease due to NF1 mutation or intragenic deletion|-|-|-|162200 ~636|NF1<br>Von Recklinghausen disease|1-5 / 10 000|Autosomal dominant|Infancy<br>Neonatal|162200 162210 613675 ~	.	.	.	.	.	.	.	.	17	1(pancreas)	0.3480
17	30264388	30264388	C	G	SUZ12	exonic	synonymous SNV	ENSG00000178691	rs752005012	ENSG00000178691:ENST00000322652:exon1:c.C123G:p.S41S,ENSG00000178691:ENST00000580398:exon1:c.C123G:p.S41S	SUZ12:NM_001321207:exon1:c.C123G:p.S41S,SUZ12:NM_015355:exon1:c.C123G:p.S41S	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1] 	9.076e-05	.	.	.	.	.	.	.	.	.	.	.	SUZ12:uc002hgs.2:exon1:c.C123G:p.S41S,SUZ12:uc002hgt.2:exon1:c.C123G:p.S41S	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	606245	.	.	.	.	,9961	.	.	.	.	.	.	17	.	het
17	33307586	33307586	G	A	LIG3	UTR5	.	ENSG00000005156	rs12945428	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3654	.	0.306709	0.3954	.	.	.	.	.	.	.	.	.	.	AFR:0.1524,AMR:0.4349,EAS:0.2829,FIN:0.5753,NFE:0.4994,OTH:0.5,ASJ:0.32	600940	.	.	.	.	.	.	.	.	.	.	.	17	MU113836440	het
17	33310547	33310547	G	A	LIG3	exonic	nonsynonymous SNV	ENSG00000005156	rs573822077	ENSG00000005156:ENST00000262327:exon2:c.G523A:p.E175K,ENSG00000005156:ENST00000378526:exon2:c.G523A:p.E175K,ENSG00000005156:ENST00000585941:exon2:c.G550A:p.E184K,ENSG00000005156:ENST00000592690:exon2:c.G262A:p.E88K	LIG3:NM_002311:exon2:c.G523A:p.E175K,LIG3:NM_013975:exon2:c.G523A:p.E175K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	6.415e-05	.	0.000199681	.	2.858	21.7	0.182	5.21	1.000	.	.	Zinc finger, PARP-type	LIG3:uc002hii.3:exon2:c.G523A:p.E175K,LIG3:uc002hij.3:exon2:c.G523A:p.E175K,LIG3:uc002hik.2:exon2:c.G523A:p.E175K,LIG3:uc010cth.1:exon2:c.G550A:p.E184K	-1.073	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600940	.	.	.	.	.	.	.	0.007	1.38	0.067	0.87	17	.	het
17	33445549	33445549	G	A	RAD51D	exonic	synonymous SNV	ENSG00000185379	rs9901455	ENSG00000185379:ENST00000345365:exon3:c.C234T:p.S78S,ENSG00000185379:ENST00000357906:exon3:c.C234T:p.S78S,ENSG00000185379:ENST00000360276:exon3:c.C234T:p.S78S,ENSG00000185379:ENST00000586210:exon3:c.C234T:p.S78S,ENSG00000185379:ENST00000587977:exon3:c.C234T:p.S78S,ENSG00000185379:ENST00000592577:exon3:c.C240T:p.S80S,ENSG00000185379:ENST00000394589:exon4:c.C234T:p.S78S	RAD51D:NM_002878:exon3:c.C234T:p.S78S	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1184	0.1585	0.1875	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	RAD51D:uc002hir.2:exon3:c.C234T:p.S78S	.	AFR:0.1624,AMR:0.3035,EAS:0.1556,FIN:0.2270,NFE:0.1090,OTH:0.0906,ASJ:0.1253	602954	614291;	145;	145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~	.	.	.	.	.	.	.	.	17	1(stomach)	0.1217
17	36861983	36861983	T	C	MLLT6	exonic	nonsynonymous SNV	ENSG00000108292	rs17855918	ENSG00000108292:ENST00000325718:exon1:c.T98C:p.V33A,ENSG00000108292:ENST00000378137:exon1:c.T98C:p.V33A	MLLT6:NM_005937:exon1:c.T98C:p.V33A	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	MLLT6:uc002hqi.4:exon1:c.T98C:p.V33A,MLLT6:uc010cvm.1:exon1:c.T98C:p.V33A,MLLT6:uc010wdr.2:exon1:c.T98C:p.V33A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600328	.	.	.	.	.	.	.	.	.	.	.	17	1(thyroid)	1
17	36874110	36874110	G	A	MLLT6	exonic	nonsynonymous SNV	ENSG00000108292	.	ENSG00000108292:ENST00000325718:exon12:c.G1846A:p.A616T	MLLT6:NM_005937:exon12:c.G1846A:p.A616T	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	4.027	23.6	.	5.48	1.000	.	.	.	MLLT6:uc002hqj.3:exon3:c.G151A:p.A51T,MLLT6:uc002hqi.4:exon12:c.G1846A:p.A616T	-1.172	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600328	.	.	.	.	.	.	.	0.994	.	0.049	1.67	17	.	het
17	37855834	37855834	C	A	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	rs4252596	ENSG00000141736:ENST00000541774:exon1:c.C22A:p.P8T	ERBB2:NM_001289936:exon5:c.C22A:p.P8T	clinvar: not_provided 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 1] 	0.1762	.	0.0658946	MU29217893	2.305	18.20	0.809	-2.17	0.031	.	.	.	ERBB2:uc010cwa.3:exon5:c.C22A:p.P8T	-1.099	AFR:GACA-JP|1|585|0.0017094,AMR:0.0832,EAS:0.0561,FIN:0.1523,NFE:0.0012,OTH:0.0747,ASJ:0.0183	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,4439,4458,4473,4444,4461,4446,4485,4500,4482,4452,4494,4481,4450,4408,4421,4403,4391,4445,4415,4464,4436,4427,4429,4395,4462,4383,4475,4377,4443,4420,4448,4457,4463,4460,4501,4384,4378,4392,4381,4449,4468,4495,4491,4388,4434,4410,4401,4486,4416,4437,4487,4386,4426,4467,4454,4504,4472,4398,4433,4479,4489,4406,4440,4490,4412,4438,4430,4512,4423,4411,4503,4379,4483,4484,4513,4397,4456,4417,4476,4382,4424,4419,4510,4466,4413,4465,4471,4402,4509,4469,4396,4387,4496,4389,4499,4428,4511,4502,4492,4451,4399,4432,4470,4493,4488,4394,4393,4453,4497,4405,4447,4435,4407,4400,4480,4404,4441,4422,4414,4418,4425,4498,4442,4474,4431,4455,4380,4409,4477,4385,4478,4459,4390	.	.	0.0	-0.85	0.004	.	17	1(stomach)	0.1301
17	37868715	37868715	C	T	ERBB2	intronic	.	ENSG00000141736	rs4252627	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6058	0.5123	0.444489	3(lung)	.	.	.	.	.	.	.	.	.	.	AFR:20(soft_tissue),AMR:MU584146,EAS:0.5113,FIN:0.2147,NFE:0.5573,OTH:0.6358,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|4|170|0.0235294,COCA-CN|5|321|0.0155763	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	.	.	.	.	.	.	.	17	1(liver)	0.3486
17	37884037	37884037	C	G	ERBB2	exonic	nonsynonymous SNV	ENSG00000141736	rs1058808	ENSG00000141736:ENST00000445658:exon21:c.C2680G:p.P894A,ENSG00000141736:ENST00000269571:exon27:c.C3508G:p.P1170A,ENSG00000141736:ENST00000540147:exon27:c.C3418G:p.P1140A,ENSG00000141736:ENST00000541774:exon27:c.C3463G:p.P1155A,ENSG00000141736:ENST00000406381:exon29:c.C3418G:p.P1140A,ENSG00000141736:ENST00000584601:exon31:c.C3418G:p.P1140A	ERBB2:NM_004448:exon27:c.C3508G:p.P1170A,ERBB2:NM_001005862:exon30:c.C3418G:p.P1140A,ERBB2:NM_001289936:exon31:c.C3463G:p.P1155A	clinvar: not_provided 	 CancerVar: 7#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 1, 1, 1] 	0.6070	0.5135	0.452077	2(oesophagus)	4.041	23.7	0.03	5.04	0.999	.	.	.	ERBB2:uc010wek.2:exon21:c.C2680G:p.P894A,ERBB2:uc002hso.3:exon27:c.C3508G:p.P1170A,ERBB2:uc002hsp.3:exon27:c.C2917G:p.P973A,ERBB2:uc002hsm.3:exon30:c.C3418G:p.P1140A,ERBB2:uc010cwa.3:exon31:c.C3463G:p.P1155A	-0.881	AFR:MU774596,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,ESCA-CN|2|332|0.0060241,EAS:0.2211,FIN:0.5589,NFE:0.6358,OTH:0.3504,ASJ:0.5139	164870	137800;211980;613659;	182067;251627;251630;301;360;94;	182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04020 Calcium signaling pathway~ko04066 HIF-1 signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05215 Prostate cancer~ko05219 Bladder cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer ~	,4439,4458,4473,4444,4461,4446,4485,4500,4482,4452,4494,4481,4450,4408,4421,4403,4391,4445,4415,4464,4436,4427,4429,4395,4462,4383,4475,4377,4443,4420,4448,4457,4463,4460,4501,4384,4378,4392,4381,4449,4468,4495,4491,4388,4434,4410,4401,4486,4416,4437,4487,4386,4426,4467,4454,4504,4472,4398,4433,4479,4489,4406,4440,4490,4412,4438,4430,4512,4423,4411,4503,4379,4483,4484,4513,4397,4456,4417,4476,4382,4424,4419,4510,4466,4413,4465,4471,4402,4509,4469,4396,4387,4496,4389,4499,4428,4511,4502,4492,4451,4399,4432,4470,4493,4488,4394,4393,4453,4497,4405,4447,4435,4407,4400,4480,4404,4441,4422,4414,4418,4425,4498,4442,4474,4431,4455,4380,4409,4477,4385,4478,4459,4390	.	.	0.941	-0.81	0.000	0.695	17	1(biliary_tract)	0.6785
17	38556770	38556770	T	C	TOP2A	intronic	.	ENSG00000131747	rs471692	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7958	0.8615	0.812899	0.8623	.	.	.	.	.	.	.	.	.	.	AFR:0.9581,AMR:0.6770,EAS:0.7426,FIN:0.8749,NFE:0.8294,OTH:0.8330,ASJ:0.8344	126430	.	.	.	.	.	.	.	.	.	.	.	17	MU19923769	hom
17	39923614	39923614	A	G	JUP	intronic	.	ENSG00000173801	rs12942034	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7638	0.8343	0.744209	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.8105,AMR:0.8903,EAS:0.8033,FIN:0.4975,NFE:0.7995,OTH:0.8146,ASJ:0.5704	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	1(lung)	0.7980
17	39925925	39925925	A	G	JUP	exonic	synonymous SNV	ENSG00000173801	rs7405731	ENSG00000173801:ENST00000540235:exon2:c.T213C:p.D71D,ENSG00000173801:ENST00000310706:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000393930:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000393931:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000420370:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000437187:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000449889:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000591690:exon3:c.T213C:p.D71D,ENSG00000173801:ENST00000424457:exon4:c.T213C:p.D71D,ENSG00000173801:ENST00000437369:exon4:c.T213C:p.D71D	JUP:NM_001352773:exon3:c.T213C:p.D71D,JUP:NM_001352774:exon3:c.T213C:p.D71D,JUP:NM_001352775:exon3:c.T213C:p.D71D,JUP:NM_001352777:exon3:c.T213C:p.D71D,JUP:NM_002230:exon3:c.T213C:p.D71D,JUP:NM_021991:exon3:c.T213C:p.D71D,JUP:NM_001352776:exon4:c.T213C:p.D71D	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7364	0.7956	0.715655	1(breast)	.	.	.	.	.	.	.	.	JUP:uc010wfs.2:exon2:c.T213C:p.D71D,JUP:uc002hxq.2:exon3:c.T213C:p.D71D,JUP:uc002hxr.2:exon3:c.T213C:p.D71D,JUP:uc002hxs.2:exon3:c.T213C:p.D71D	.	AFR:MU23590898,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,EAS:0.8828,FIN:0.5632,NFE:0.8278,OTH:0.5056,ASJ:0.7654	173325	601214;611528;	217656;34217;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~34217|KWWH type I<br>Keratoderma with woolly hair type I<br>Keratosis palmoplantaris with arrythmogenic cardiomyopathy<br>Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy<br>Palmoplantar keratoderma with arrythmogenic cardiomyopathy|-|Autosomal recessive|Infancy<br>Neonatal|601214 ~	~ko05200 Pathways in cancer~ko05202 Transcriptional misregulation in cancer~ko05221 Acute myeloid leukemia~ko05226 Gastric cancer~ko05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) ~	.	.	.	.	.	.	.	17	2(lung)	0.6822
17	40481529	40481529	G	C	STAT3	intronic	.	ENSG00000168610	rs2293152	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.6025	0.6879	0.653754	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.6533,AMR:0.8458,EAS:0.5596,FIN:0.5218,NFE:0.5835,OTH:0.5875,ASJ:0.4462	102582	147060;615952;	438159;2314;	438159|-|-|Autosomal dominant|-|615952 ~2314|AD-HIES<br>Autosomal dominant HIES<br>Autosomal dominant hyperimmunoglobulin E syndrome<br>Buckley syndrome<br>Hyperimmunoglobulin E syndrome type 1<br>Hyperimmunoglobulin E-recurrent infection syndrome<br>Job syndrome<br>STAT3 deficiency|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|147060 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	.	.	.	.	.	.	.	17	1(breast)	0.6166
17	40483527	40483527	A	G	STAT3	exonic	synonymous SNV	ENSG00000168610	.	ENSG00000168610:ENST00000389272:exon10:c.T778C:p.L260L,ENSG00000168610:ENST00000264657:exon11:c.T1072C:p.L358L,ENSG00000168610:ENST00000404395:exon11:c.T1072C:p.L358L,ENSG00000168610:ENST00000585517:exon11:c.T1072C:p.L358L,ENSG00000168610:ENST00000588969:exon11:c.T1072C:p.L358L	STAT3:NM_001369512:exon11:c.T1072C:p.L358L,STAT3:NM_001369513:exon11:c.T1072C:p.L358L,STAT3:NM_001369514:exon11:c.T1072C:p.L358L,STAT3:NM_001369516:exon11:c.T1072C:p.L358L,STAT3:NM_001369517:exon11:c.T1072C:p.L358L,STAT3:NM_001369518:exon11:c.T1072C:p.L358L,STAT3:NM_001369519:exon11:c.T1072C:p.L358L,STAT3:NM_001369520:exon11:c.T1072C:p.L358L,STAT3:NM_003150:exon11:c.T1072C:p.L358L,STAT3:NM_139276:exon11:c.T1072C:p.L358L,STAT3:NM_213662:exon11:c.T1072C:p.L358L	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1] 	.	.	.	.	.	.	.	.	.	.	.	.	STAT3:uc010wgh.1:exon10:c.T778C:p.L260L,STAT3:uc002hzk.1:exon11:c.T1072C:p.L358L,STAT3:uc002hzl.1:exon11:c.T1072C:p.L358L,STAT3:uc002hzm.1:exon11:c.T1072C:p.L358L,STAT3:uc002hzn.1:exon11:c.T1072C:p.L358L	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	102582	147060;615952;	438159;2314;	438159|-|-|Autosomal dominant|-|615952 ~2314|AD-HIES<br>Autosomal dominant HIES<br>Autosomal dominant hyperimmunoglobulin E syndrome<br>Buckley syndrome<br>Hyperimmunoglobulin E syndrome type 1<br>Hyperimmunoglobulin E-recurrent infection syndrome<br>Job syndrome<br>STAT3 deficiency|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal|147060 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04659 Th17 cell differentiation~ko04917 Prolactin signaling pathway~ko04920 Adipocytokine signaling pathway~ko04931 Insulin resistance~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05145 Toxoplasmosis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05212 Pancreatic cancer~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05321 Inflammatory bowel disease (IBD) ~	,9918	.	.	.	.	.	.	17	.	het
17	40835819	40835819	-	T	CNTNAP1	intronic	.	ENSG00000267765	rs36108420	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5941	0.5652	0.547324	0.5643	.	.	.	.	.	.	.	.	.	.	AFR:0.5075,AMR:0.5144,EAS:0.4491,FIN:0.6350,NFE:0.5958,OTH:0.6160,ASJ:0.4172	602346	616286;	2680;	2680|Boylan-Dew syndrome|-|-|-|616286 616287 ~	.	.	.	.	.	.	.	.	17	MU113836025	het
17	40835922	40835922	A	C	CNTNAP1	exonic	synonymous SNV	ENSG00000108797	rs2271029	ENSG00000108797:ENST00000264638:exon2:c.A151C:p.R51R,ENSG00000108797:ENST00000591662:exon2:c.A151C:p.R51R	CNTNAP1:NM_003632:exon2:c.A151C:p.R51R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5981	0.5985	0.578275	1(large_intestine)	.	.	.	.	.	.	.	.	CNTNAP1:uc002iay.3:exon2:c.A151C:p.R51R	.	AFR:MU78204,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.5912,FIN:0.5180,NFE:0.4305,OTH:0.4522,ASJ:0.5899	602346	616286;	2680;	2680|Boylan-Dew syndrome|-|-|-|616286 616287 ~	.	.	.	.	.	.	.	.	17	1(liver)	0.6354
17	41223094	41223094	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs1799966	ENSG00000012048:ENST00000591534:exon3:c.A310G:p.S104G,ENSG00000012048:ENST00000484087:exon9:c.A1150G:p.S384G,ENSG00000012048:ENST00000351666:exon11:c.A1288G:p.S430G,ENSG00000012048:ENST00000309486:exon14:c.A3949G:p.S1317G,ENSG00000012048:ENST00000352993:exon14:c.A1411G:p.S471G,ENSG00000012048:ENST00000493795:exon14:c.A4696G:p.S1566G,ENSG00000012048:ENST00000493919:exon14:c.A1387G:p.S463G,ENSG00000012048:ENST00000357654:exon15:c.A4837G:p.S1613G,ENSG00000012048:ENST00000468300:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000478531:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000491747:exon15:c.A1525G:p.S509G,ENSG00000012048:ENST00000471181:exon16:c.A4900G:p.S1634G	BRCA1:NM_007297:exon14:c.A4696G:p.S1566G,BRCA1:NM_007298:exon14:c.A1525G:p.S509G,BRCA1:NM_007294:exon15:c.A4837G:p.S1613G,BRCA1:NM_007299:exon15:c.A1525G:p.S509G,BRCA1:NM_007300:exon16:c.A4900G:p.S1634G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3496	0.2982	0.355831	1(urinary_tract)	-0.337	0.547	0.032	1.5	0.030	.	.	BRCA1, serine-rich domain;BRCT domain	BRCA1:uc010whn.2:exon3:c.A310G:p.S104G,BRCA1:uc010whq.1:exon9:c.A1024G:p.S342G,BRCA1:uc010cyx.3:exon14:c.A4696G:p.S1566G,BRCA1:uc010whl.2:exon14:c.A1525G:p.S509G,BRCA1:uc010whp.2:exon14:c.A1384G:p.S462G,BRCA1:uc010whr.1:exon14:c.A1387G:p.S463G,BRCA1:uc002icp.4:exon15:c.A4624G:p.S1542G,BRCA1:uc002icq.3:exon15:c.A4837G:p.S1613G,BRCA1:uc002icu.3:exon15:c.A1525G:p.S509G,BRCA1:uc002idc.1:exon15:c.A1525G:p.S509G,BRCA1:uc002ict.3:exon16:c.A4900G:p.S1634G	-1.080	AFR:3(haematopoietic_and_lymphoid_tissue),AMR:1(breast),EAS:9(meninges),FIN:MU153243,NFE:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,PRAD-CN|1|65|0.0153846,OTH:0.3179,ASJ:1(thymus)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1786,1799,1788,1777,1791,1784,1778,1780,1792,1798,1776,1773,1772,1789,1795,1796,1785,1782,1783,1787,1779,1781,1793,1797,1794,1790	.	1775,,1774	0.002	-1.93	0.000	1.845	17	2(large_intestine)	0.2330
17	41234470	41234470	A	G	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs1060915	ENSG00000012048:ENST00000484087:exon6:c.T621C:p.S207S,ENSG00000012048:ENST00000487825:exon6:c.T624C:p.S208S,ENSG00000012048:ENST00000351666:exon8:c.T759C:p.S253S,ENSG00000012048:ENST00000309486:exon11:c.T3420C:p.S1140S,ENSG00000012048:ENST00000352993:exon11:c.T882C:p.S294S,ENSG00000012048:ENST00000493795:exon11:c.T4167C:p.S1389S,ENSG00000012048:ENST00000493919:exon11:c.T858C:p.S286S,ENSG00000012048:ENST00000346315:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000354071:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000357654:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000468300:exon12:c.T999C:p.S333S,ENSG00000012048:ENST00000471181:exon12:c.T4308C:p.S1436S,ENSG00000012048:ENST00000478531:exon12:c.T996C:p.S332S,ENSG00000012048:ENST00000491747:exon12:c.T999C:p.S333S	BRCA1:NM_007297:exon11:c.T4167C:p.S1389S,BRCA1:NM_007298:exon11:c.T999C:p.S333S,BRCA1:NM_007294:exon12:c.T4308C:p.S1436S,BRCA1:NM_007299:exon12:c.T999C:p.S333S,BRCA1:NM_007300:exon12:c.T4308C:p.S1436S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3431	0.2796	0.336262	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	BRCA1:uc010whq.1:exon6:c.T495C:p.S165S,BRCA1:uc010cyx.3:exon11:c.T4167C:p.S1389S,BRCA1:uc010whl.2:exon11:c.T999C:p.S333S,BRCA1:uc010whp.2:exon11:c.T858C:p.S286S,BRCA1:uc010whr.1:exon11:c.T858C:p.S286S,BRCA1:uc002icp.4:exon12:c.T4095C:p.S1365S,BRCA1:uc002icq.3:exon12:c.T4308C:p.S1436S,BRCA1:uc002ict.3:exon12:c.T4308C:p.S1436S,BRCA1:uc002icu.3:exon12:c.T999C:p.S333S,BRCA1:uc002idc.1:exon12:c.T996C:p.S332S	.	AFR:9(meninges),AMR:MU12924798,EAS:0.3011,FIN:0.1748,NFE:0.3210,OTH:0.3179,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1786,1799,1788,1777,1791,1784,1778,1780,1792,1798,1776,1773,1772,1789,1795,1796,1785,1782,1783,1787,1779,1781,1793,1797,1794,1790	.	1775,,1774	.	.	.	.	17	1(liver)	0.3675
17	41244000	41244000	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs16942	ENSG00000012048:ENST00000309486:exon9:c.A2660G:p.K887R,ENSG00000012048:ENST00000493795:exon9:c.A3407G:p.K1136R,ENSG00000012048:ENST00000346315:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000354071:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000357654:exon10:c.A3548G:p.K1183R,ENSG00000012048:ENST00000471181:exon10:c.A3548G:p.K1183R	BRCA1:NM_007297:exon9:c.A3407G:p.K1136R,BRCA1:NM_007294:exon10:c.A3548G:p.K1183R,BRCA1:NM_007300:exon10:c.A3548G:p.K1183R	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3490	0.2952	0.352636	1(ovary)	-2.334	0.001	1.0	-2.35	0.005	.	.	.	BRCA1:uc010wht.1:exon2:c.A2660G:p.K887R,BRCA1:uc002ide.1:exon4:c.A3041G:p.K1014R,BRCA1:uc002idd.3:exon9:c.A3548G:p.K1183R,BRCA1:uc010cyx.3:exon9:c.A3407G:p.K1136R,BRCA1:uc010cza.2:exon9:c.A3470G:p.K1157R,BRCA1:uc002icp.4:exon10:c.A3335G:p.K1112R,BRCA1:uc002icq.3:exon10:c.A3548G:p.K1183R,BRCA1:uc002ict.3:exon10:c.A3548G:p.K1183R,BRCA1:uc010cyy.1:exon10:c.A3548G:p.K1183R,BRCA1:uc010whs.1:exon10:c.A3548G:p.K1183R,BRCA1:uc010cyz.2:exon11:c.A3407G:p.K1136R	-1.024	AFR:1(stomach),AMR:2(prostate),EAS:14(soft_tissue),FIN:40(lung),NFE:1(thyroid),OTH:MU153252,ASJ:4(large_intestine)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1786,1799,1788,1777,1791,1784,1778,1780,1792,1798,1776,1773,1772,1789,1795,1796,1785,1782,1783,1787,1779,1781,1793,1797,1794,1790	.	1775,,1774	0.0	-0.35	0.000	-0.485	17	1(breast)	LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579
17	41244435	41244435	T	C	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs16941	ENSG00000012048:ENST00000309486:exon9:c.A2225G:p.E742G,ENSG00000012048:ENST00000493795:exon9:c.A2972G:p.E991G,ENSG00000012048:ENST00000346315:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000354071:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000357654:exon10:c.A3113G:p.E1038G,ENSG00000012048:ENST00000471181:exon10:c.A3113G:p.E1038G	BRCA1:NM_007297:exon9:c.A2972G:p.E991G,BRCA1:NM_007294:exon10:c.A3113G:p.E1038G,BRCA1:NM_007300:exon10:c.A3113G:p.E1038G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3429	0.2790	0.335663	3(haematopoietic_and_lymphoid_tissue)	2.989	22.2	0.028	-0.974	0.952	.	.	.	BRCA1:uc010wht.1:exon2:c.A2225G:p.E742G,BRCA1:uc002ide.1:exon4:c.A2606G:p.E869G,BRCA1:uc002idd.3:exon9:c.A3113G:p.E1038G,BRCA1:uc010cyx.3:exon9:c.A2972G:p.E991G,BRCA1:uc010cza.2:exon9:c.A3035G:p.E1012G,BRCA1:uc002icp.4:exon10:c.A2900G:p.E967G,BRCA1:uc002icq.3:exon10:c.A3113G:p.E1038G,BRCA1:uc002ict.3:exon10:c.A3113G:p.E1038G,BRCA1:uc010cyy.1:exon10:c.A3113G:p.E1038G,BRCA1:uc010whs.1:exon10:c.A3113G:p.E1038G,BRCA1:uc010cyz.2:exon11:c.A2972G:p.E991G	-1.094	AFR:1(thymus),AMR:1(breast),EAS:MU153259,FIN:LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,NFE:0.3004,OTH:0.1749,ASJ:9(meninges)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1786,1799,1788,1777,1791,1784,1778,1780,1792,1798,1776,1773,1772,1789,1795,1796,1785,1782,1783,1787,1779,1781,1793,1797,1794,1790	.	1775,,1774	0.012	-1.24	0.000	2.275	17	35(lung)	0.3182
17	41244936	41244936	G	A	BRCA1	exonic	nonsynonymous SNV	ENSG00000012048	rs799917	ENSG00000012048:ENST00000309486:exon9:c.C1724T:p.P575L,ENSG00000012048:ENST00000493795:exon9:c.C2471T:p.P824L,ENSG00000012048:ENST00000346315:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000354071:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000357654:exon10:c.C2612T:p.P871L,ENSG00000012048:ENST00000471181:exon10:c.C2612T:p.P871L	BRCA1:NM_007297:exon9:c.C2471T:p.P824L,BRCA1:NM_007294:exon10:c.C2612T:p.P871L,BRCA1:NM_007300:exon10:c.C2612T:p.P871L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.4100	0.4932	0.54393	1(stomach)	1.633	14.03	1.0	5.04	0.979	.	.	.	BRCA1:uc010wht.1:exon2:c.C1724T:p.P575L,BRCA1:uc002ide.1:exon4:c.C2105T:p.P702L,BRCA1:uc002idd.3:exon9:c.C2612T:p.P871L,BRCA1:uc010cyx.3:exon9:c.C2471T:p.P824L,BRCA1:uc010cza.2:exon9:c.C2534T:p.P845L,BRCA1:uc002icp.4:exon10:c.C2399T:p.P800L,BRCA1:uc002icq.3:exon10:c.C2612T:p.P871L,BRCA1:uc002ict.3:exon10:c.C2612T:p.P871L,BRCA1:uc010cyy.1:exon10:c.C2612T:p.P871L,BRCA1:uc010whs.1:exon10:c.C2612T:p.P871L,BRCA1:uc010cyz.2:exon11:c.C2471T:p.P824L	-0.937	AFR:3(haematopoietic_and_lymphoid_tissue),AMR:9(meninges),EAS:4(large_intestine),FIN:1(peritoneum),NFE:1(breast),OTH:MU153268,ASJ:1(skin)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1786,1799,1788,1777,1791,1784,1778,1780,1792,1798,1776,1773,1772,1789,1795,1796,1785,1782,1783,1787,1779,1781,1793,1797,1794,1790	.	1775,,1774	0.0	-0.05	0.000	-3.445	17	14(soft_tissue)	LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579
17	41245237	41245237	A	G	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs16940	ENSG00000012048:ENST00000309486:exon9:c.T1423C:p.L475L,ENSG00000012048:ENST00000493795:exon9:c.T2170C:p.L724L,ENSG00000012048:ENST00000346315:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000354071:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000357654:exon10:c.T2311C:p.L771L,ENSG00000012048:ENST00000471181:exon10:c.T2311C:p.L771L	BRCA1:NM_007297:exon9:c.T2170C:p.L724L,BRCA1:NM_007294:exon10:c.T2311C:p.L771L,BRCA1:NM_007300:exon10:c.T2311C:p.L771L	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3420	0.2776	0.335264	9(meninges)	.	.	.	.	.	.	.	.	BRCA1:uc010wht.1:exon2:c.T1423C:p.L475L,BRCA1:uc002ide.1:exon4:c.T1804C:p.L602L,BRCA1:uc002idd.3:exon9:c.T2311C:p.L771L,BRCA1:uc010cyx.3:exon9:c.T2170C:p.L724L,BRCA1:uc010cza.2:exon9:c.T2233C:p.L745L,BRCA1:uc002icp.4:exon10:c.T2098C:p.L700L,BRCA1:uc002icq.3:exon10:c.T2311C:p.L771L,BRCA1:uc002ict.3:exon10:c.T2311C:p.L771L,BRCA1:uc010cyy.1:exon10:c.T2311C:p.L771L,BRCA1:uc010whs.1:exon10:c.T2311C:p.L771L,BRCA1:uc010cyz.2:exon11:c.T2170C:p.L724L	.	AFR:1(lung),AMR:MU153274,EAS:0.2998,FIN:0.1749,NFE:0.3206,OTH:0.3179,ASJ:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1786,1799,1788,1777,1791,1784,1778,1780,1792,1798,1776,1773,1772,1789,1795,1796,1785,1782,1783,1787,1779,1781,1793,1797,1794,1790	.	1775,,1774	.	.	.	.	17	2(large_intestine)	0.3657
17	41245466	41245466	G	A	BRCA1	exonic	synonymous SNV	ENSG00000012048	rs1799949	ENSG00000012048:ENST00000309486:exon9:c.C1194T:p.S398S,ENSG00000012048:ENST00000493795:exon9:c.C1941T:p.S647S,ENSG00000012048:ENST00000346315:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000354071:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000357654:exon10:c.C2082T:p.S694S,ENSG00000012048:ENST00000471181:exon10:c.C2082T:p.S694S	BRCA1:NM_007297:exon9:c.C1941T:p.S647S,BRCA1:NM_007294:exon10:c.C2082T:p.S694S,BRCA1:NM_007300:exon10:c.C2082T:p.S694S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3483	0.2957	0.336462	13(soft_tissue)	.	.	.	.	.	.	.	.	BRCA1:uc010wht.1:exon2:c.C1194T:p.S398S,BRCA1:uc002ide.1:exon4:c.C1575T:p.S525S,BRCA1:uc002idd.3:exon9:c.C2082T:p.S694S,BRCA1:uc010cyx.3:exon9:c.C1941T:p.S647S,BRCA1:uc010cza.2:exon9:c.C2004T:p.S668S,BRCA1:uc002icp.4:exon10:c.C1869T:p.S623S,BRCA1:uc002icq.3:exon10:c.C2082T:p.S694S,BRCA1:uc002ict.3:exon10:c.C2082T:p.S694S,BRCA1:uc010cyy.1:exon10:c.C2082T:p.S694S,BRCA1:uc010whs.1:exon10:c.C2082T:p.S694S,BRCA1:uc010cyz.2:exon11:c.C1941T:p.S647S	.	AFR:3(lung),AMR:1(breast),EAS:MU153282,FIN:LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,NFE:0.3160,OTH:0.2290,ASJ:2(large_intestine)	113705	604370;614320;	1333;145;227535;	1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~145|-|1-5 / 10 000|Autosomal dominant|All ages|604370 612555 613399 614291 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	,1786,1799,1788,1777,1791,1784,1778,1780,1792,1798,1776,1773,1772,1789,1795,1796,1785,1782,1783,1787,1779,1781,1793,1797,1794,1790	.	1775,,1774	.	.	.	.	17	3(haematopoietic_and_lymphoid_tissue)	0.3234
17	42961009	42961009	C	T	EFTUD2	intronic	.	ENSG00000108883	rs2289677	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5693	0.6431	0.560503	0.6292	.	.	.	.	.	0.0001	0.012	.	.	.	AFR:0.7327,AMR:0.4654,EAS:0.4950,FIN:0.5642,NFE:0.6115,OTH:0.5622,ASJ:0.6523	603892	610536;	79113;	79113|Growth delay-intellectual disability-mandibulofacial dysostosis-microcephaly-cleft palate syndrome<br>MFDM syndrome<br>Mandibulofacial dysostosis, Guion-Almeida type|<1 / 1 000 000|Autosomal dominant|Neonatal|610536 ~	.	.	.	.	.	.	.	.	17	MU12926862	het
17	45385012	45385012	C	T	THCAT158	ncRNA_intronic	.	ENSG00000263293	rs3809863	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4383	0.4790	0.398962	0.4653	.	.	.	.	.	.	.	.	.	.	AFR:0.4784,AMR:0.3508,EAS:0.2419,FIN:0.4986,NFE:0.4800,OTH:0.4817,ASJ:0.4305	.	.	.	.	.	.	.	.	.	.	.	.	17	MU27804922	hom
17	48263021	48263021	C	T	COL1A1	intronic	.	ENSG00000108821	rs2249492	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5828	0.5103	0.485024	0.5145	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.2833,AMR:0.6835,EAS:0.5075,FIN:0.6341,NFE:0.6035,OTH:0.5969,ASJ:0.6722	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU797249	hom
17	48265495	48265495	T	C	COL1A1	exonic	nonsynonymous SNV	ENSG00000108821	rs1800215	ENSG00000108821:ENST00000225964:exon44:c.A3223G:p.T1075A	COL1A1:NM_000088:exon44:c.A3223G:p.T1075A	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9848	0.9710	0.978834	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon44:c.A3223G:p.T1075A	.	AFR:0.9727,AMR:0.9433,EAS:0.9967,FIN:1,NFE:0.9794,OTH:0.9834,ASJ:0.9869	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	1(thyroid)	0.9836
17	48267291	48267291	G	C	COL1A1	intronic	.	ENSG00000108821	rs2075559	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5261	0.5249	0.541334	0.5101	.	.	.	.	.	.	.	.	.	.	AFR:0.5630,AMR:0.6492,EAS:0.5143,FIN:0.4616,NFE:0.4831,OTH:0.4969,ASJ:0.51	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU699787	hom
17	48268223	48268223	A	G	COL1A1	exonic	synonymous SNV	ENSG00000108821	rs2734272	ENSG00000108821:ENST00000225964:exon33:c.T2298C:p.T766T	COL1A1:NM_000088:exon33:c.T2298C:p.T766T	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9998	0.9998	0.9998	0.9996	.	.	.	.	.	.	.	.	COL1A1:uc002iqm.3:exon33:c.T2298C:p.T766T	.	AFR:0.9991,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU4564816	hom
17	48276971	48276971	G	C	COL1A1	intronic	.	ENSG00000108821	rs2256835	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6187	0.5531	0.518171	0.5630	.	.	.	.	.	.	.	.	.	.	AFR:0.2800,AMR:0.6160,EAS:0.6118,FIN:0.7435,NFE:0.6685,OTH:0.6794,ASJ:0.6225	120150	114000;130000;130060;166200;166210;166220;166710;259420;	216812;666;216820;666;216804;666;216796;666;1899;99875;99876;287;1310;	216812|OI type 3<br>Progressive deforming osteogenesis imperfecta<br>Severe osteogenesis imperfecta|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|259420 259440 610682 610915 610968 613848 613982 614856 615220 616229 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216820|OI type 4|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166220 259440 610682 610968 613849 613982 615066 615220 616507 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216804|Lethal osteogenesis imperfecta<br>OI type 2|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|166210 259440 610682 610915 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~216796|Adair-Dighton syndrome<br>Mild osteogenesis imperfecta<br>Non-deforming osteogenesis imperfecta<br>OI type 1<br>Van der Hoeve syndrome|Unknown|Autosomal dominant|Childhood|166200 166230 ~666|Brittle bone disease<br>Glass bone disease<br>Lobstein disease<br>OI<br>Osteopsathyrosis<br>Porak and Durante disease|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|166200 166210 166220 166230 259420 259440 610682 610915 610967 610968 613848 613849 613982 614856 615066 615220 616229 616507 ~1899|EDS VII<br>Ehlers-Danlos syndrome type 7<br>Ehlers-Danlos syndrome, arthrochalasia type|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130060 ~99875|EDS VIIA|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~99876|EDS VIIB|-|Autosomal dominant|Infancy<br>Neonatal|130060 ~287|EDS, classic type|1-9 / 100 000|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|130000 ~1310|Infantile cortical hyperostosis|Unknown|Autosomal dominant<br>or&nbsp;Unknown|Infancy<br>Neonatal<br>Antenatal<br>Childhood|114000 ~	~ko04151 PI3K-Akt signaling pathway~ko04510 Focal adhesion~ko04512 ECM-receptor interaction~ko04611 Platelet activation~ko04926 Relaxin signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04974 Protein digestion and absorption~ko05146 Amoebiasis~ko05165 Human papillomavirus infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	17	MU762212	hom
17	48431032	48431032	G	A	XYLT2	exonic	synonymous SNV	ENSG00000015532	rs739990	ENSG00000015532:ENST00000017003:exon2:c.G177A:p.E59E,ENSG00000015532:ENST00000376550:exon2:c.G177A:p.E59E,ENSG00000015532:ENST00000507602:exon2:c.G177A:p.E59E,ENSG00000015532:ENST00000509778:exon2:c.G132A:p.E44E	XYLT2:NM_022167:exon2:c.G177A:p.E59E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2529	0.1675	0.131789	LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	XYLT2:uc002iqo.3:exon2:c.G177A:p.E59E	.	AFR:0.1887,AMR:0.0768,EAS:0.1026,FIN:0.0723,NFE:0.2933,OTH:0.2383,ASJ:0.2410	608125	264800;605822;	85194;758;	85194|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|605822 ~758|Gronblad-Strandberg-Touraine syndrome<br>PXE|1-9 / 100 000|Autosomal recessive|All ages|177850 264800 ~	.	.	.	.	.	.	.	.	17	1(biliary_tract)	0.2271
17	48431197	48431197	C	T	XYLT2	exonic	synonymous SNV	ENSG00000015532	rs739989	ENSG00000015532:ENST00000017003:exon2:c.C342T:p.P114P,ENSG00000015532:ENST00000376550:exon2:c.C342T:p.P114P,ENSG00000015532:ENST00000507602:exon2:c.C342T:p.P114P	XYLT2:NM_022167:exon2:c.C342T:p.P114P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3036	0.1561	0.132388	0.1885	.	.	.	.	.	.	.	.	XYLT2:uc002iqo.3:exon2:c.C342T:p.P114P	.	AFR:0.0765,AMR:0.2410,EAS:0.0711,FIN:0.2943,NFE:0.2381,OTH:0.2265,ASJ:0.1026	608125	264800;605822;	85194;758;	85194|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|605822 ~758|Gronblad-Strandberg-Touraine syndrome<br>PXE|1-9 / 100 000|Autosomal recessive|All ages|177850 264800 ~	.	.	.	.	.	.	.	.	17	MU94072	het
17	48432324	48432324	G	C	XYLT2	exonic	nonsynonymous SNV	ENSG00000015532	rs12451299	ENSG00000015532:ENST00000017003:exon4:c.G914C:p.R305T,ENSG00000015532:ENST00000376550:exon4:c.G914C:p.R305T,ENSG00000015532:ENST00000507602:exon4:c.G914C:p.R305T	XYLT2:NM_022167:exon4:c.G914C:p.R305T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2081	0.1726	0.13139	LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	0.834	9.671	0.607	3.57	0.990	.	.	.	XYLT2:uc002iqo.3:exon4:c.G914C:p.R305T	-0.902	AFR:0.1876,AMR:0.0766,EAS:0.0993,FIN:0.0709,NFE:0.2939,OTH:0.2366,ASJ:0.2368	608125	264800;605822;	85194;758;	85194|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|605822 ~758|Gronblad-Strandberg-Touraine syndrome<br>PXE|1-9 / 100 000|Autosomal recessive|All ages|177850 264800 ~	.	.	.	.	0.001	2.78	0.000	-1.12	17	1(skin)	0.2249
17	48433958	48433958	T	C	XYLT2	exonic	synonymous SNV	ENSG00000015532	rs4794136	ENSG00000015532:ENST00000511654:exon2:c.T165C:p.Y55Y,ENSG00000015532:ENST00000017003:exon8:c.T1569C:p.Y523Y,ENSG00000015532:ENST00000376550:exon8:c.T1569C:p.Y523Y,ENSG00000015532:ENST00000507602:exon8:c.T1569C:p.Y523Y	XYLT2:NM_022167:exon8:c.T1569C:p.Y523Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4363	0.4846	0.382588	MU147644	.	.	.	.	.	.	.	.	XYLT2:uc002iqo.3:exon8:c.T1569C:p.Y523Y	.	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.4428,EAS:0.5598,FIN:0.4437,NFE:0.1038,OTH:0.3997,ASJ:0.5081	608125	264800;605822;	85194;758;	85194|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|605822 ~758|Gronblad-Strandberg-Touraine syndrome<br>PXE|1-9 / 100 000|Autosomal recessive|All ages|177850 264800 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.4459
17	48452776	48452776	A	C	EME1	exonic	nonsynonymous SNV	ENSG00000154920	rs3760413	ENSG00000154920:ENST00000511648:exon1:c.A207C:p.E69D,ENSG00000154920:ENST00000338165:exon2:c.A207C:p.E69D,ENSG00000154920:ENST00000393271:exon2:c.A207C:p.E69D,ENSG00000154920:ENST00000511519:exon2:c.A207C:p.E69D,ENSG00000154920:ENST00000511711:exon2:c.A207C:p.E69D	EME1:NM_001166131:exon2:c.A207C:p.E69D,EME1:NM_152463:exon2:c.A207C:p.E69D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8180	0.9213	0.745407	0.8630	-3.075	0.001	1.0	-6.36	0.000	.	.	.	EME1:uc002iqs.2:exon2:c.A207C:p.E69D,EME1:uc010dbp.2:exon2:c.A207C:p.E69D	-0.955	AFR:0.9767,AMR:0.8819,EAS:0.2217,FIN:0.8308,NFE:0.8721,OTH:0.8480,ASJ:0.9106	610885	.	.	.	.	.	.	.	0.0	2.87	0.000	-1.04	17	MU25489170	het
17	48452978	48452978	-	AGC	EME1	exonic	nonframeshift insertion	ENSG00000154920	rs3060668	ENSG00000154920:ENST00000511648:exon1:c.409_410insAGC:p.K137delinsKQ,ENSG00000154920:ENST00000338165:exon2:c.409_410insAGC:p.K137delinsKQ,ENSG00000154920:ENST00000393271:exon2:c.409_410insAGC:p.K137delinsKQ	EME1:NM_001166131:exon2:c.409_410insAGC:p.K137delinsKQ,EME1:NM_152463:exon2:c.409_410insAGC:p.K137delinsKQ	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4524	0.5434	0.445887	0.4936	.	.	.	.	.	.	.	.	EME1:uc002iqs.2:exon2:c.409_410insAGC:p.K137delinsKQ,EME1:uc010dbp.2:exon2:c.409_410insAGC:p.K137delinsKQ	.	AFR:0.6910,AMR:0.5789,EAS:0.1033,FIN:0.3989,NFE:0.4433,OTH:0.4429,ASJ:0.44	610885	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	48455985	48455985	A	T	EME1	exonic	synonymous SNV	ENSG00000154920	rs2189712	ENSG00000154920:ENST00000511519:exon4:c.A457T:p.S153C	EME1:NM_001166131:exon4:c.A933T:p.T311T,EME1:NM_152463:exon4:c.A933T:p.T311T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2241	0.1999	0.142772	MU584208	-1.619	0.002	0.0	-1.3	0.005	.	.	.	EME1:uc002iqs.2:exon4:c.A933T:p.T311T,EME1:uc010dbp.2:exon4:c.A933T:p.T311T	-0.953	AFR:LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.2095,EAS:0.2482,FIN:0.1457,NFE:0.0717,OTH:0.3029,ASJ:0.0843	610885	.	.	.	.	.	.	.	.	2.15	0.000	.	17	1(lung)	0.2725
17	48456193	48456193	T	C	EME1	exonic	nonsynonymous SNV	ENSG00000154920	rs12450550	ENSG00000154920:ENST00000511648:exon4:c.T1049C:p.I350T,ENSG00000154920:ENST00000338165:exon5:c.T1049C:p.I350T,ENSG00000154920:ENST00000393271:exon5:c.T1049C:p.I350T	EME1:NM_001166131:exon5:c.T1049C:p.I350T,EME1:NM_152463:exon5:c.T1049C:p.I350T	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.2240	0.2000	0.142572	9(soft_tissue)	0.434	6.904	0.093	2.1	0.607	.	.	ERCC4 domain	EME1:uc002iqs.2:exon5:c.T1049C:p.I350T,EME1:uc010dbp.2:exon5:c.T1049C:p.I350T	-1.022	AFR:4(prostate),AMR:1(pancreas),EAS:LUSC-KR|5|170|0.0294118,COCA-CN|2|321|0.00623053,FIN:0.2096,NFE:0.0845,OTH:0.2482,ASJ:MU584209	610885	.	.	.	.	.	.	.	0.804	1.89	0.000	2.28	17	1(stomach)	0.14
17	57065401	57065401	G	A	TRIM37	intronic	.	ENSG00000108395	rs7214892	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.60024	0.6428	.	.	.	.	.	.	.	.	.	.	AFR:0.7150,AMR:0.4330,EAS:0.4981,FIN:0.6466,NFE:0.6300,OTH:0.6202,ASJ:0.5695	605073	253250;	2576;	2576|MULIBREY dwarfism<br>Muscle-liver-brain-eye nanism<br>Perheentupa syndrome<br>Pericardial constriction-growth failure syndrome|Unknown|Autosomal recessive|Infancy<br>Neonata253250 ~	.	.	.	.	.	.	.	.	17	MU14145121	hom
17	57128625	57128625	A	G	TRIM37	exonic	synonymous SNV	ENSG00000108395	rs74586224	ENSG00000108395:ENST00000393065:exon13:c.T1162C:p.L388L,ENSG00000108395:ENST00000262294:exon14:c.T1264C:p.L422L,ENSG00000108395:ENST00000376149:exon14:c.T898C:p.L300L,ENSG00000108395:ENST00000393066:exon14:c.T1264C:p.L422L	TRIM37:NM_001353085:exon12:c.T802C:p.L268L,TRIM37:NM_001320987:exon13:c.T1162C:p.L388L,TRIM37:NM_001353082:exon13:c.T1162C:p.L388L,TRIM37:NM_001353086:exon13:c.T1213C:p.L405L,TRIM37:NM_001005207:exon14:c.T1264C:p.L422L,TRIM37:NM_001320988:exon14:c.T1264C:p.L422L,TRIM37:NM_001320989:exon14:c.T1264C:p.L422L,TRIM37:NM_001353083:exon14:c.T529C:p.L177L,TRIM37:NM_001353084:exon14:c.T1264C:p.L422L,TRIM37:NM_015294:exon14:c.T1264C:p.L422L,TRIM37:NM_001320990:exon15:c.T898C:p.L300L	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0166	0.0119	0.0125799	0.0112	.	.	.	.	.	.	.	.	TRIM37:uc010woc.2:exon13:c.T1162C:p.L388L,TRIM37:uc002iwy.4:exon14:c.T1264C:p.L422L,TRIM37:uc002iwz.4:exon14:c.T1264C:p.L422L,TRIM37:uc002ixa.4:exon15:c.T898C:p.L300L	.	AFR:0.0017,AMR:0.0119,EAS:0,FIN:0.0261,NFE:0.0138,OTH:0.0153,ASJ:0.0331	605073	253250;	2576;	2576|MULIBREY dwarfism<br>Muscle-liver-brain-eye nanism<br>Perheentupa syndrome<br>Pericardial constriction-growth failure syndrome|Unknown|Autosomal recessive|Infancy<br>Neonata253250 ~	.	.	.	.	.	.	.	.	17	.	het
17	57140015	57140015	G	A	TRIM37	intronic	.	ENSG00000108395	rs145324030	.	.	clinvar: Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0170	0.0118	0.0125799	0.0113	.	.	.	.	.	0	0	.	.	.	AFR:0.0017,AMR:0.0119,EAS:0,FIN:0.0262,NFE:0.0138,OTH:0.0154,ASJ:0.0331	605073	253250;	2576;	2576|MULIBREY dwarfism<br>Muscle-liver-brain-eye nanism<br>Perheentupa syndrome<br>Pericardial constriction-growth failure syndrome|Unknown|Autosomal recessive|Infancy<br>Neonata253250 ~	.	.	.	.	.	.	.	.	17	.	het
17	57141768	57141768	-	A	TRIM37	splicing	.	ENSG00000108395	rs546873621	.	.	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0711	0.0510	.	0.0269	.	.	.	.	.	.	.	.	.	.	AFR:0.0436,AMR:0.0246,EAS:0.0006,FIN:0.0668,NFE:0.0163,OTH:0.0234,ASJ:0.0417	605073	253250;	2576;	2576|MULIBREY dwarfism<br>Muscle-liver-brain-eye nanism<br>Perheentupa syndrome<br>Pericardial constriction-growth failure syndrome|Unknown|Autosomal recessive|Infancy<br>Neonata253250 ~	.	.	.	.	.	.	.	.	17	.	het
17	59760996	59760996	A	G	BRIP1	exonic	synonymous SNV	ENSG00000136492	rs4986763	ENSG00000136492:ENST00000259008:exon20:c.T3411C:p.Y1137Y	BRIP1:NM_032043:exon20:c.T3411C:p.Y1137Y	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5941	0.6060	0.620807	0.5824	.	.	.	.	.	.	.	.	BRIP1:uc002izk.2:exon20:c.T3411C:p.Y1137Y	.	AFR:0.6486,AMR:0.7584,EAS:0.7076,FIN:0.4205,NFE:0.5619,OTH:0.5133,ASJ:0.6291	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	MU67347164	het
17	59763347	59763347	A	G	BRIP1	exonic	nonsynonymous SNV	ENSG00000136492	rs4986764	ENSG00000136492:ENST00000577598:exon18:c.T2755C:p.S919P,ENSG00000136492:ENST00000259008:exon19:c.T2755C:p.S919P	BRIP1:NM_032043:exon19:c.T2755C:p.S919P	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5972	0.6134	0.627796	LICA-CN|1|402|0.00248756,COCA-CN|6|321|0.0186916	-0.521	0.195	0.154	0.71	0.000	.	.	.	BRIP1:uc002izl.1:exon8:c.T898C:p.S300P,BRIP1:uc002izk.2:exon19:c.T2755C:p.S919P	-0.937	AFR:0.5893,AMR:0.6691,EAS:0.6490,FIN:0.7063,NFE:0.4212,OTH:0.5632,ASJ:0.7655	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	0.0	-0.86	0.000	.	17	1(stomach)	0.5173
17	59763465	59763465	T	C	BRIP1	exonic	synonymous SNV	ENSG00000136492	rs4986765	ENSG00000136492:ENST00000577598:exon18:c.A2637G:p.E879E,ENSG00000136492:ENST00000259008:exon19:c.A2637G:p.E879E	BRIP1:NM_032043:exon19:c.A2637G:p.E879E	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7188	0.7343	0.815096	0.7178	.	.	.	.	.	.	.	.	BRIP1:uc002izl.1:exon8:c.A780G:p.E260E,BRIP1:uc002izk.2:exon19:c.A2637G:p.E879E	.	AFR:0.9073,AMR:0.8473,EAS:0.8812,FIN:0.5120,NFE:0.6355,OTH:0.6307,ASJ:0.7483	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	MU13758307	het
17	59856129	59856129	G	A	BRIP1	intronic	.	ENSG00000136492	rs4968449	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	.	.	0.989816	0.9893	.	.	.	.	.	.	.	.	.	.	AFR:0.9623,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9990,ASJ:1	605882	114480;609054;	84;227535;	84|Fanconi pancytopenia|1-9 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked recessive|Childhood|227645 227646 227650 300514 600901 603467 609053 609054 610832 613390 613951 614082 614083 615272 616435 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	17	.	hom
17	60033217	60033217	A	-	MED13	intronic	.	ENSG00000108510	rs557700319	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0048	.	0.0483227	0.0653	.	.	.	.	.	.	.	.	.	.	AFR:0.0756,AMR:0.0517,EAS:0.0258,FIN:0,NFE:0.0650,OTH:0.1042,ASJ:0	603808	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	60043884	60043884	G	A	MED13	exonic	synonymous SNV	ENSG00000108510	rs671347	ENSG00000108510:ENST00000397786:exon19:c.C4320T:p.D1440D	MED13:NM_005121:exon19:c.C4320T:p.D1440D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9983	0.9931	0.996206	0.9943	.	.	.	.	.	.	.	.	MED13:uc002izo.3:exon19:c.C4320T:p.D1440D	.	AFR:0.9796,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	603808	.	.	.	.	.	.	.	.	.	.	.	17	MU81997073	hom
17	62007498	62007498	A	G	CD79B	exonic	synonymous SNV	ENSG00000007312	rs2070776	ENSG00000007312:ENST00000006750:exon3:c.T366C:p.C122C,ENSG00000007312:ENST00000392795:exon3:c.T369C:p.C123C	CD79B:NM_000626:exon3:c.T366C:p.C122C,CD79B:NM_001039933:exon3:c.T369C:p.C123C	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5952	0.6596	0.561701	1(lung)	.	.	.	.	.	.	.	.	CD79B:uc002jdp.1:exon3:c.T369C:p.C123C,CD79B:uc002jdq.1:exon3:c.T366C:p.C122C	.	AFR:20(soft_tissue),AMR:MU584252,EAS:0.6411,FIN:0.6678,NFE:0.5203,OTH:0.6656,ASJ:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02	147245	612692;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	.	,1939	.	.	.	.	.	.	17	1(breast)	0.4424
17	63533789	63533789	T	C	AXIN2	exonic	synonymous SNV	ENSG00000168646	rs9915936	ENSG00000168646:ENST00000375702:exon5:c.A1365G:p.P455P,ENSG00000168646:ENST00000307078:exon6:c.A1365G:p.P455P	AXIN2:NM_001363813:exon6:c.A1365G:p.P455P,AXIN2:NM_004655:exon6:c.A1365G:p.P455P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9144	0.9109	0.909744	0.8961	.	.	.	.	.	.	.	.	AXIN2:uc002jfh.3:exon5:c.A1365G:p.P455P,AXIN2:uc002jfi.3:exon6:c.A1365G:p.P455P	.	AFR:0.9306,AMR:0.8971,EAS:0.8079,FIN:0.9022,NFE:0.8823,OTH:0.9061,ASJ:0.9536	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	.	.	.	.	17	MU94566	hom
17	63554591	63554591	G	A	AXIN2	exonic	nonsynonymous SNV	ENSG00000168646	rs2240308	ENSG00000168646:ENST00000375702:exon1:c.C148T:p.P50S,ENSG00000168646:ENST00000307078:exon2:c.C148T:p.P50S,ENSG00000168646:ENST00000544103:exon2:c.C148T:p.P50S,ENSG00000168646:ENST00000577278:exon2:c.C148T:p.P50S,ENSG00000168646:ENST00000580513:exon2:c.C148T:p.P50S,ENSG00000168646:ENST00000585045:exon2:c.C148T:p.P50S	AXIN2:NM_001363813:exon2:c.C148T:p.P50S,AXIN2:NM_004655:exon2:c.C148T:p.P50S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.4737	0.3948	0.33766	0.4049	-0.922	0.023	0.366	2.75	0.062	.	.	Axin-1/2, tankyrase-binding domain	AXIN2:uc002jfh.3:exon1:c.C148T:p.P50S,AXIN2:uc002jfi.3:exon2:c.C148T:p.P50S,AXIN2:uc002jfj.1:exon2:c.C148T:p.P50S,AXIN2:uc010den.1:exon4:c.C148T:p.P50S	-0.975	AFR:0.1314,AMR:0.5468,EAS:0.3360,FIN:0.5069,NFE:0.5315,OTH:0.5103,ASJ:0.4934	604025	114500;608615;	300576;	300576|Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome|<1 / 1 000 000|Autosomal dominant|-|608615 ~	~ko04310 Wnt signaling pathway~ko04390 Hippo signaling pathway~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04934 Cushing syndrome~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05210 Colorectal cancer~ko05213 Endometrial cancer~ko05217 Basal cell carcinoma~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer ~	.	.	.	0.0	-0.05	0.000	.	17	MU790515	het
17	66519857	66519857	-	T	PRKAR1A	intronic	.	ENSG00000108946	rs3841514	ENSG00000108946:ENST00000585608:exon4:c.352dupT:p.F117fs	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.2224	0.2268	0.22524	0.2330	.	.	.	.	.	.	.	.	.	.	AFR:0.2381,AMR:0.1850,EAS:0.1321,FIN:0.2615,NFE:0.2362,OTH:0.2561,ASJ:0.2020	188830	101800;160980;255960;610489;	189439;615;1359;280651;950;	189439|PPNAD|<1 / 1 000 000|Autosomal dominant|All ages|610475 610489 614190 615830 ~615|-|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|255960 ~1359|Carney syndrome<br>Myxoma-spotty pigmentation-endocrine overactivity syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|160980 605244 ~280651|-|<1 / 1 000 000|Autosomal dominant|Childhood|101800 614613 ~950|Acrodysplasia<br>Arkless-Graham syndrome<br>Maroteaux-Malamut syndrome|Unknown|Autosomal dominant|Neonatal<br>Antenatal|101800 614613 ~	.	.	.	.	.	.	.	.	17	.	het
17	72862705	72862705	G	A	FDXR	intronic	.	ENSG00000161513	rs2070918	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5912	0.5738	0.449481	0.5852	.	.	.	.	.	.	.	.	.	.	AFR:0.3835,AMR:0.6005,EAS:0.2417,FIN:0.7467,NFE:0.6982,OTH:0.6646,ASJ:0.4834	103270	.	.	.	.	.	.	.	.	.	.	.	17	MU18446144	het
17	72868389	72868389	C	G	FDXR	exonic	nonsynonymous SNV	ENSG00000161513	rs751542310	ENSG00000161513:ENST00000413947:exon2:c.G132C:p.R44S	FDXR:NM_001258013:exon2:c.G132C:p.R44S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, -1, 0, 0] 	7.944e-05	.	.	.	0.930	10.26	0.373	0.916	0.438	.	.	.	FDXR:uc010wrk.2:exon2:c.G132C:p.R44S	-0.906	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	103270	.	.	.	.	.	.	.	0.006	3.29	0.010	.	17	.	het
17	73625430	73625430	G	A	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs4788902	ENSG00000108469:ENST00000582548:exon1:c.C93T:p.H31H,ENSG00000108469:ENST00000580707:exon9:c.C540T:p.H180H,ENSG00000108469:ENST00000317905:exon16:c.C2073T:p.H691H,ENSG00000108469:ENST00000423245:exon16:c.C1992T:p.H664H	RECQL5:NM_004259:exon16:c.C2073T:p.H691H	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6127	0.4752	0.525958	0.5025	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon15:c.C1992T:p.H664H,RECQL5:uc010dgl.3:exon16:c.C2073T:p.H691H	.	AFR:0.2075,AMR:0.6507,EAS:0.8189,FIN:0.6151,NFE:0.6010,OTH:0.5789,ASJ:0.4834	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU75672	hom
17	73625478	73625478	T	C	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs820191	ENSG00000108469:ENST00000582548:exon1:c.A45G:p.T15T,ENSG00000108469:ENST00000580707:exon9:c.A492G:p.T164T,ENSG00000108469:ENST00000317905:exon16:c.A2025G:p.T675T,ENSG00000108469:ENST00000423245:exon16:c.A1944G:p.T648T	RECQL5:NM_004259:exon16:c.A2025G:p.T675T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9968	0.9896	0.989217	0.9894	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon15:c.A1944G:p.T648T,RECQL5:uc010dgl.3:exon16:c.A2025G:p.T675T	.	AFR:0.9629,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU4565309	hom
17	73626922	73626922	-	T	RECQL5	intronic	.	ENSG00000108469	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4182	.	0.539936	0.5894	.	.	.	.	.	.	.	.	.	.	AFR:0.5300,AMR:0.5507,EAS:0.5989,FIN:0.6203,NFE:0.6076,OTH:0.5986,ASJ:0.5488	603781	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	73626923	73626923	-	T	RECQL5	intronic	.	ENSG00000108469	rs55982817	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1247	.	0.539936	0.4526	.	.	.	.	.	.	.	.	.	.	AFR:0.2492,AMR:0.4331,EAS:0.5013,FIN:0.5298,NFE:0.5315,OTH:0.4974,ASJ:0.3761	603781	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	73627539	73627539	T	C	RECQL5	exonic	nonsynonymous SNV	ENSG00000108469	rs820196	ENSG00000108469:ENST00000578201:exon8:c.A1439G:p.D480G,ENSG00000108469:ENST00000317905:exon9:c.A1439G:p.D480G,ENSG00000108469:ENST00000423245:exon9:c.A1358G:p.D453G	RECQL5:NM_004259:exon9:c.A1439G:p.D480G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2536	0.2013	0.265775	0.2116	1.615	13.94	1.0	5.97	0.933	.	.	Winged helix-turn-helix DNA-binding domain	RECQL5:uc010dgk.3:exon8:c.A1358G:p.D453G,RECQL5:uc010dgl.3:exon9:c.A1439G:p.D480G	-1.019	AFR:0.1812,AMR:0.3317,EAS:0.2642,FIN:0.2039,NFE:0.2175,OTH:0.2219,ASJ:0.2384	603781	.	.	.	.	.	.	.	0.0	0.24	0.000	-0.975	17	MU25518356	het
17	73627565	73627565	A	G	RECQL5	exonic	synonymous SNV	ENSG00000108469	rs820197	ENSG00000108469:ENST00000578201:exon8:c.T1413C:p.Y471Y,ENSG00000108469:ENST00000317905:exon9:c.T1413C:p.Y471Y,ENSG00000108469:ENST00000423245:exon9:c.T1332C:p.Y444Y	RECQL5:NM_004259:exon9:c.T1413C:p.Y471Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9968	0.9896	0.988618	0.9890	.	.	.	.	.	.	.	.	RECQL5:uc010dgk.3:exon8:c.T1332C:p.Y444Y,RECQL5:uc010dgl.3:exon9:c.T1413C:p.Y471Y	.	AFR:0.9615,AMR:1,EAS:1,FIN:1,NFE:0.9999,OTH:0.9959,ASJ:1	603781	.	.	.	.	.	.	.	.	.	.	.	17	MU4565311	hom
17	74475024	74475024	G	A	RHBDF2	exonic	nonsynonymous SNV	ENSG00000129667	rs3744045	ENSG00000129667:ENST00000313080:exon6:c.C623T:p.P208L,ENSG00000129667:ENST00000389760:exon6:c.C536T:p.P179L,ENSG00000129667:ENST00000591885:exon6:c.C536T:p.P179L	RHBDF2:NM_001005498:exon5:c.C536T:p.P179L,RHBDF2:NM_024599:exon6:c.C623T:p.P208L	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8787	0.7952	0.765176	0.8090	2.245	17.80	0.078	4.57	0.047	.	.	.	RHBDF2:uc002jrr.1:exon3:c.C179T:p.P60L,RHBDF2:uc002jrs.1:exon3:c.C608T:p.P203L,RHBDF2:uc010wtf.1:exon5:c.C536T:p.P179L,RHBDF2:uc021udh.1:exon5:c.C536T:p.P179L,RHBDF2:uc002jrq.2:exon6:c.C623T:p.P208L	-1.042	AFR:0.5027,AMR:0.8804,EAS:0.9523,FIN:0.9178,NFE:0.9344,OTH:0.8891,ASJ:0.9272	614404	148500;	2198;	2198|Bennion-Patterson syndrome<br>Howell-Evans syndrome<br>Keratosis palmoplantaris-esophageal carcinoma syndrome<br>Palmoplantar hyperkeratosis-esophageal carcinoma syndrome<br>Tylosis-oesophageal carcinoma syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|148500 ~	.	.	.	.	0.247	-0.18	0.000	1.81	17	MU4552271	hom
17	74477620	74477620	C	T	RHBDF2	UTR5	.	ENSG00000129667	rs12943385	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1525	0.1244	0.14976	0.1329	.	.	.	.	.	.	.	.	.	.	AFR:0.0996,AMR:0.0835,EAS:0.2151,FIN:0.1781,NFE:0.1339,OTH:0.1558,ASJ:0.1457	614404	148500;	2198;	2198|Bennion-Patterson syndrome<br>Howell-Evans syndrome<br>Keratosis palmoplantaris-esophageal carcinoma syndrome<br>Palmoplantar hyperkeratosis-esophageal carcinoma syndrome<br>Tylosis-oesophageal carcinoma syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|148500 ~	.	.	.	.	.	.	.	.	17	MU82000103	hom
17	74732507	74732507	A	G	SRSF2	exonic	synonymous SNV	ENSG00000161547	rs237058	ENSG00000161547:ENST00000358156:exon2:c.T381C:p.S127S,ENSG00000161547:ENST00000359995:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000392485:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000452355:exon2:c.T402C:p.S134S,ENSG00000161547:ENST00000508921:exon2:c.T366C:p.S122S,ENSG00000161547:ENST00000583836:exon2:c.T345C:p.S115S,ENSG00000161547:ENST00000585202:exon2:c.T402C:p.S134S	SRSF2:NM_001195427:exon2:c.T402C:p.S134S,SRSF2:NM_003016:exon2:c.T402C:p.S134S	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.9973	0.9911	0.990615	0.9916	.	.	.	.	.	.	.	.	SRSF2:uc002jsv.3:exon2:c.T402C:p.S134S,SRSF2:uc002jsy.4:exon2:c.T402C:p.S134S,SRSF2:uc010wtg.2:exon2:c.T366C:p.S122S	.	AFR:0.9703,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	600813	.	.	.	.	,9888,9887,9889,9882,9886	.	,9885,9884,9883	.	.	.	.	17	MU4554584	hom
17	74733099	74733099	G	A	SRSF2	exonic	synonymous SNV	ENSG00000161547	rs237057	ENSG00000161547:ENST00000358156:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000359995:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000392485:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000452355:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000508921:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000583836:exon1:c.C144T:p.D48D,ENSG00000161547:ENST00000585202:exon1:c.C144T:p.D48D	SRSF2:NM_001195427:exon1:c.C144T:p.D48D,SRSF2:NM_003016:exon1:c.C144T:p.D48D	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.8886	0.7970	0.785543	0.8039	.	.	.	.	.	.	.	.	SRSF2:uc002jsv.3:exon1:c.C144T:p.D48D,SRSF2:uc002jsy.4:exon1:c.C144T:p.D48D,SRSF2:uc010wtg.2:exon1:c.C144T:p.D48D	.	AFR:0.4961,AMR:0.9033,EAS:0.9210,FIN:0.8920,NFE:0.9347,OTH:0.8901,ASJ:0.9669	600813	.	.	.	.	,9888,9887,9889,9882,9886	.	,9885,9884,9883	.	.	.	.	17	MU82000212	hom
17	75303298	75303298	T	C	SEPTIN9	intronic	.	ENSG00000184640	rs4789439	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8853	0.8623	0.91873	0.8897	.	.	.	.	.	.	.	.	.	.	AFR:0.9079,AMR:0.9129,EAS:0.9889,FIN:0.9123,NFE:0.8646,OTH:0.8837,ASJ:0.7682	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	.	.	.	.	17	MU82000309	hom
17	75401190	75401190	G	A	SEPTIN9	exonic	nonsynonymous SNV	ENSG00000184640	rs2164449	ENSG00000184640:ENST00000585930:exon1:c.G17A:p.C6Y	SEPTIN9:NM_001293696:exon1:c.G17A:p.C6Y	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2972	.	0.296725	0.3966	0.240	5.096	.	-0.828	0.010	.	.	.	SEPT9:uc010wtl.2:exon1:c.G17A:p.C6Y	-0.927	AFR:0.4845,AMR:0.2285,EAS:0.0309,FIN:0.3753,NFE:0.4025,OTH:0.3534,ASJ:0.3940	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	0.0	0.94	0.000	.	17	MU82000330	het
17	75494705	75494705	A	G	SEPTIN9	exonic	nonsynonymous SNV	ENSG00000184640	rs2627223	ENSG00000184640:ENST00000427180:exon10:c.A1390G:p.M464V,ENSG00000184640:ENST00000541152:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000585930:exon10:c.A1054G:p.M352V,ENSG00000184640:ENST00000591088:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000592951:exon10:c.A973G:p.M325V,ENSG00000184640:ENST00000329047:exon11:c.A1672G:p.M558V,ENSG00000184640:ENST00000423034:exon11:c.A1705G:p.M569V,ENSG00000184640:ENST00000427674:exon11:c.A1234G:p.M412V,ENSG00000184640:ENST00000588690:exon11:c.A1234G:p.M412V,ENSG00000184640:ENST00000590294:exon11:c.A1672G:p.M558V,ENSG00000184640:ENST00000591198:exon11:c.A1669G:p.M557V,ENSG00000184640:ENST00000427177:exon12:c.A1726G:p.M576V,ENSG00000184640:ENST00000431235:exon12:c.A1234G:p.M412V,ENSG00000184640:ENST00000449803:exon12:c.A1234G:p.M412V	SEPTIN9:NM_001113495:exon10:c.A1390G:p.M464V,SEPTIN9:NM_001113496:exon10:c.A973G:p.M325V,SEPTIN9:NM_001293696:exon10:c.A1054G:p.M352V,SEPTIN9:NM_001293697:exon10:c.A973G:p.M325V,SEPTIN9:NM_001293698:exon10:c.A973G:p.M325V,SEPTIN9:NM_001113493:exon11:c.A1705G:p.M569V,SEPTIN9:NM_001113494:exon11:c.A1234G:p.M412V,SEPTIN9:NM_001293695:exon11:c.A1669G:p.M557V,SEPTIN9:NM_006640:exon11:c.A1672G:p.M558V,SEPTIN9:NM_001113491:exon12:c.A1726G:p.M576V,SEPTIN9:NM_001113492:exon12:c.A1234G:p.M412V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9371	0.8923	0.90655	0.8893	-0.847	0.034	1.0	2.77	0.063	.	.	P-loop containing nucleoside triphosphate hydrolase|Septin-type guanine nucleotide-binding (G) domain;Septin-type guanine nucleotide-binding (G) domain	SEPT9:uc002jty.4:exon10:c.A973G:p.M325V,SEPT9:uc010dhd.3:exon10:c.A1390G:p.M464V,SEPT9:uc010wtl.2:exon10:c.A1054G:p.M352V,SEPT9:uc010wtm.2:exon10:c.A973G:p.M325V,SEPT9:uc010wtn.2:exon10:c.A973G:p.M325V,SEPT9:uc002jtu.4:exon11:c.A1672G:p.M558V,SEPT9:uc002jtv.3:exon11:c.A1705G:p.M569V,SEPT9:uc002jtw.3:exon11:c.A1234G:p.M412V,SEPT9:uc010wtk.2:exon11:c.A1669G:p.M557V,SEPT9:uc002jts.4:exon12:c.A1726G:p.M576V,SEPT9:uc002jtt.4:exon12:c.A1234G:p.M412V	-0.966	AFR:0.7668,AMR:0.9614,EAS:1,FIN:0.9147,NFE:0.9343,OTH:0.9255,ASJ:0.9503	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	0.0	1.55	0.000	-2.36	17	MU4565432	hom
17	75494746	75494746	A	G	SEPTIN9	UTR3	.	ENSG00000184640	rs1059485	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5267	0.3937	0.561701	0.4535	.	.	.	.	.	.	.	.	.	.	AFR:0.337,AMR:0.6783,EAS:0.9082,FIN:0.5047,NFE:0.4478,OTH:0.4405,ASJ:0.4333	604061	162100;	2901;	2901|Acute brachial plexus neuritis<br>Brachial plexus neuritis<br>Immune brachial plexus neuropathy<br>Mononeuritis multiplex with brachial predilection<br>Neuralgic shoulder amyotrophy<br>Winged scapula|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|162100 ~	.	.	.	.	.	.	.	.	17	MU17423690	het
17	76993546	76993546	A	G	CANT1	exonic	synonymous SNV	ENSG00000171302	rs8077024	ENSG00000171302:ENST00000302345:exon2:c.T159C:p.A53A,ENSG00000171302:ENST00000592228:exon2:c.T159C:p.A53A,ENSG00000171302:ENST00000392446:exon3:c.T159C:p.A53A,ENSG00000171302:ENST00000588075:exon3:c.T159C:p.A53A,ENSG00000171302:ENST00000590370:exon4:c.T159C:p.A53A,ENSG00000171302:ENST00000591773:exon4:c.T159C:p.A53A,ENSG00000171302:ENST00000586916:exon5:c.T159C:p.A53A	CANT1:NM_138793:exon2:c.T159C:p.A53A,CANT1:NM_001159773:exon3:c.T159C:p.A53A,CANT1:NM_001159772:exon4:c.T159C:p.A53A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3791	0.3210	0.44349	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	CANT1:uc002jwj.3:exon2:c.T159C:p.A53A,CANT1:uc002jwk.3:exon3:c.T159C:p.A53A,CANT1:uc002jwn.3:exon4:c.T159C:p.A53A	.	AFR:0.3461,AMR:0.4217,EAS:0.2384,FIN:0.6803,NFE:0.2368,OTH:0.2886,ASJ:0.4462	613165	251450;	1425;	1425|Desbuquois dysplasia|<1 / 1 000 000|Autosomal recessive|Antenatal<br>Neonatal|251450 300881 615777 ~	.	.	.	.	.	.	.	.	17	1(large_intestine)	0.3384
17	78293193	78293193	C	T	RNF213	exonic	synonymous SNV	ENSG00000173821	rs138461014	ENSG00000173821:ENST00000319921:exon17:c.C3105T:p.H1035H	RNF213:NM_020954:exon17:c.C3105T:p.H1035H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0002	7.7e-05	0.000199681	.	.	.	.	.	.	.	.	.	RNF213:uc002jyf.4:exon17:c.C3105T:p.H1035H	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	.	het
17	78298938	78298938	A	G	RNF213	exonic	nonsynonymous SNV	ENSG00000173821	rs6565674	ENSG00000173821:ENST00000456466:exon18:c.A3133G:p.N1045D,ENSG00000173821:ENST00000582970:exon18:c.A3133G:p.N1045D,ENSG00000173821:ENST00000508628:exon19:c.A3280G:p.N1094D	RNF213:NM_001256071:exon18:c.A3133G:p.N1045D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9999	.	0.999401	0.9999	.	.	.	.	.	.	.	.	RNF213:uc002jyg.1:exon15:c.A2326G:p.N776D,RNF213:uc021uen.2:exon18:c.A3133G:p.N1045D	.	AFR:1,AMR:1,EAS:0.9981,FIN:1,NFE:1,OTH:1,ASJ:1	613768	607151;	2573;	2573|-|1-9 / 1 000 000|Multigenic/multifactorial<br>or&nbsp;Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|252350 607151 608796 614042 ~	.	.	.	.	.	.	.	.	17	MU82001690	hom
17	78410833	78410833	G	A	ENDOV	UTR3	.	ENSG00000173818	rs41303566	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.0708866	0.0611	.	.	.	.	.	.	.	.	.	.	AFR:0.0189,AMR:0.1611,EAS:0.0494,FIN:0.0641,NFE:0.0804,OTH:0.0765,ASJ:0.0166	.	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	78820329	78820329	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs3751945	ENSG00000141564:ENST00000537330:exon10:c.C714T:p.G238G,ENSG00000141564:ENST00000306801:exon11:c.C1269T:p.G423G,ENSG00000141564:ENST00000544334:exon11:c.C1269T:p.G423G	RPTOR:NM_001163034:exon11:c.C1269T:p.G423G,RPTOR:NM_020761:exon11:c.C1269T:p.G423G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5777	0.4962	0.436701	1(thyroid)	.	.	.	.	.	.	.	.	RPTOR:uc010wuf.1:exon10:c.C714T:p.G238G,RPTOR:uc002jyt.1:exon11:c.C1269T:p.G423G,RPTOR:uc010wug.1:exon11:c.C1269T:p.G423G	.	AFR:1(large_intestine),AMR:MU153336,EAS:0.5072,FIN:0.2247,NFE:0.6065,OTH:0.4901,ASJ:SKCA-BR|1|100|0.01,LAML-KR|3|205|0.0146341,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,BLCA-CN|1|103|0.00970874	607130	.	.	.	.	.	.	.	.	.	.	.	17	2(lung)	0.4466
17	78820374	78820374	G	A	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs2589156	ENSG00000141564:ENST00000537330:exon10:c.G759A:p.Q253Q,ENSG00000141564:ENST00000306801:exon11:c.G1314A:p.Q438Q,ENSG00000141564:ENST00000544334:exon11:c.G1314A:p.Q438Q	RPTOR:NM_001163034:exon11:c.G1314A:p.Q438Q,RPTOR:NM_020761:exon11:c.G1314A:p.Q438Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1021	0.1205	0.0772764	.	.	.	.	.	.	0.5423	0.504	.	RPTOR:uc010wuf.1:exon10:c.G759A:p.Q253Q,RPTOR:uc002jyt.1:exon11:c.G1314A:p.Q438Q,RPTOR:uc010wug.1:exon11:c.G1314A:p.Q438Q	.	AFR:.,AMR:0.0973,EAS:0.0644,FIN:0.1887,NFE:0.0056,OTH:0.0931,ASJ:0.0852	607130	.	.	.	.	.	.	.	.	.	.	.	17	2(prostate)	0.1145
17	78896529	78896529	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs2271603	ENSG00000141564:ENST00000576366:exon1:c.C6T:p.T2T,ENSG00000141564:ENST00000544334:exon18:c.C2052T:p.T684T,ENSG00000141564:ENST00000306801:exon22:c.C2526T:p.T842T	RPTOR:NM_001163034:exon18:c.C2052T:p.T684T,RPTOR:NM_020761:exon22:c.C2526T:p.T842T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3670	0.2726	0.245407	3(lung)	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon18:c.C2052T:p.T684T,RPTOR:uc002jyt.1:exon22:c.C2526T:p.T842T	.	AFR:11(soft_tissue),AMR:MU98342,EAS:0.2760,FIN:0.1690,NFE:0.2679,OTH:0.4139,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	607130	.	.	.	.	.	.	.	.	.	.	.	17	1(haematopoietic_and_lymphoid_tissue)	0.1922
17	78919558	78919558	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs1567962	ENSG00000141564:ENST00000544334:exon22:c.C2643T:p.A881A,ENSG00000141564:ENST00000306801:exon26:c.C3117T:p.A1039A	RPTOR:NM_001163034:exon22:c.C2643T:p.A881A,RPTOR:NM_020761:exon26:c.C3117T:p.A1039A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3595	0.3622	0.374601	1(stomach)	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon22:c.C2643T:p.A881A,RPTOR:uc002jyt.1:exon26:c.C3117T:p.A1039A	.	AFR:MU730207,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.3922,FIN:0.3321,NFE:0.3767,OTH:0.4504,ASJ:0.3587	607130	.	.	.	.	.	.	.	.	.	.	.	17	2(haematopoietic_and_lymphoid_tissue)	0.2964
17	78921117	78921117	C	T	RPTOR	exonic	synonymous SNV	ENSG00000141564	rs4969231	ENSG00000141564:ENST00000544334:exon23:c.C2757T:p.N919N,ENSG00000141564:ENST00000306801:exon27:c.C3231T:p.N1077N	RPTOR:NM_001163034:exon23:c.C2757T:p.N919N,RPTOR:NM_020761:exon27:c.C3231T:p.N1077N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2749	0.2367	0.197684	1(lung)	.	.	.	.	.	.	.	.	RPTOR:uc010wug.1:exon23:c.C2757T:p.N919N,RPTOR:uc002jyt.1:exon27:c.C3231T:p.N1077N	.	AFR:MU93712,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.0681,FIN:0.2721,NFE:0.3642,OTH:0.2006,ASJ:0.2375	607130	.	.	.	.	.	.	.	.	.	.	.	17	1(stomach)	0.2734
17	79508400	79508400	T	C	FAAP100	exonic	nonsynonymous SNV	ENSG00000185504	rs14422	ENSG00000185504:ENST00000425898:exon4:c.A1396G:p.T466A,ENSG00000185504:ENST00000327787:exon8:c.A2449G:p.T817A,ENSG00000185504:ENST00000537152:exon8:c.A1996G:p.T666A	FAAP100:NM_025161:exon8:c.A2449G:p.T817A	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9258	0.9239	0.946486	0.9253	-0.334	0.554	1.0	2.88	0.014	.	.	.	C17orf70:uc002kao.1:exon4:c.A1396G:p.T466A,C17orf70:uc002kap.3:exon8:c.A1996G:p.T666A,C17orf70:uc002kaq.3:exon8:c.A2449G:p.T817A	-1.002	AFR:0.9493,AMR:0.9451,EAS:1,FIN:0.8901,NFE:0.9112,OTH:0.9276,ASJ:0.8709	611301	.	.	.	.	.	.	.	0.0	1.82	0.000	-2.595	17	MU4565620	hom
17	79511135	79511135	A	G	FAAP100	exonic	synonymous SNV	ENSG00000185504	rs8077430	ENSG00000185504:ENST00000425898:exon3:c.T1269C:p.T423T,ENSG00000185504:ENST00000327787:exon7:c.T2322C:p.T774T,ENSG00000185504:ENST00000537152:exon7:c.T1869C:p.T623T	FAAP100:NM_025161:exon7:c.T2322C:p.T774T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7571	0.6971	0.704473	MU9296095	.	.	.	.	.	.	.	.	C17orf70:uc002kao.1:exon3:c.T1269C:p.T423T,C17orf70:uc002kap.3:exon7:c.T1869C:p.T623T,C17orf70:uc002kaq.3:exon7:c.T2322C:p.T774T	.	AFR:COCA-CN|5|321|0.0155763,BTCA-JP|1|239|0.0041841,AMR:0.7152,EAS:0.8261,FIN:0.69,NFE:0.7673,OTH:0.7745,ASJ:0.5533	611301	.	.	.	.	.	.	.	.	.	.	.	17	1(biliary_tract)	0.7801
17	79514129	79514129	G	A	FAAP100	exonic	nonsynonymous SNV	ENSG00000185504	rs11552304	ENSG00000185504:ENST00000425898:exon1:c.C926T:p.P309L,ENSG00000185504:ENST00000545865:exon1:c.C101T:p.P34L,ENSG00000185504:ENST00000327787:exon5:c.C1979T:p.P660L,ENSG00000185504:ENST00000537152:exon5:c.C1526T:p.P509L	FAAP100:NM_025161:exon5:c.C1979T:p.P660L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6217	0.5780	0.55631	1(thyroid)	0.156	4.215	0.358	0.069	0.001	.	.	.	C17orf70:uc002kao.1:exon1:c.C926T:p.P309L,C17orf70:uc002kap.3:exon5:c.C1526T:p.P509L,C17orf70:uc002kaq.3:exon5:c.C1979T:p.P660L	-0.955	AFR:1(urinary_tract),AMR:MU109692,EAS:0.5992,FIN:0.4122,NFE:0.4880,OTH:0.5728,ASJ:COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	611301	.	.	.	.	.	.	.	0.394	1.53	0.000	1.5	17	1(breast)	0.6735
17	79974731	79974731	T	C	ASPSCR1	exonic	synonymous SNV	ENSG00000169696	rs13087	ENSG00000169696:ENST00000584454:exon15:c.T1351C:p.C451R	ASPSCR1:NM_001330528:exon13:c.T1305C:p.D435D,ASPSCR1:NM_024083:exon14:c.T1461C:p.D487D,ASPSCR1:NM_001251888:exon15:c.T1743C:p.D581D	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5906	0.6464	0.580272	1(urinary_tract)	.	.	.	.	.	.	.	.	ASPSCR1:uc002kda.3:exon13:c.T1305C:p.D435D,ASPSCR1:uc021ufj.1:exon13:c.T1230C:p.D410D,ASPSCR1:uc002kcx.3:exon14:c.T1461C:p.D487D,ASPSCR1:uc002kcy.3:exon15:c.T1743C:p.D581D	.	AFR:1(stomach),AMR:2(lung),EAS:LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,FIN:0.6414,NFE:0.7619,OTH:0.5167,ASJ:MU796615	606236	606243;	163699;	163699|ASPS<br>Alveolar soft-part sarcoma|-|-|All ages|606243 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	17	1(thyroid)	0.6093
17	80039028	80039028	A	G	FASN	intronic	.	ENSG00000169710	rs4246445	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6901	0.7545	0.664337	0.7443	.	.	.	.	.	.	.	.	.	.	AFR:0.8027,AMR:0.7464,EAS:0.4422,FIN:0.7504,NFE:0.7442,OTH:0.7362,ASJ:0.6258	600212	.	.	.	.	.	.	.	.	.	.	.	17	MU16099716	het
17	80039481	80039481	G	A	FASN	exonic	synonymous SNV	ENSG00000169710	rs1140616	ENSG00000169710:ENST00000306749:exon37:c.C6402T:p.I2134I	FASN:NM_004104:exon37:c.C6402T:p.I2134I	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4254	0.4224	0.303914	MU816391	.	.	.	.	.	.	.	.	FASN:uc002kdu.3:exon37:c.C6402T:p.I2134I	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,AMR:0.4258,EAS:0.2840,FIN:0.3609,NFE:0.3325,OTH:0.5198,ASJ:0.2187	600212	.	.	.	.	.	.	.	.	.	.	.	17	1(salivary_gland)	0.5391
17	80043349	80043349	C	T	FASN	intronic	.	ENSG00000169710	rs17848939	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5105	0.5704	0.422125	0.5185	.	.	.	.	.	.	.	.	.	.	AFR:0.5097,AMR:0.2926,EAS:0.3548,FIN:0.5418,NFE:0.5509,OTH:0.5339,ASJ:0.35	600212	.	.	.	.	.	.	.	.	.	.	.	17	MU20220915	het
17	80048961	80048961	C	T	FASN	intronic	.	ENSG00000169710	rs17848927	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0214	0.0214	0.0493211	0.0210	.	.	.	.	.	.	.	.	.	.	AFR:0.0648,AMR:0.0119,EAS:0.0111,FIN:0,NFE:0.0023,OTH:0.0204,ASJ:0.0033	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	het
17	80050555	80050556	GG	-	FASN	intronic	.	ENSG00000169710	rs10591316	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.8259	.	.	0.9578	.	.	.	.	.	.	.	.	.	.	AFR:0.9723,AMR:0.9644,EAS:0.9889,FIN:0.9440,NFE:0.9507,OTH:0.9350,ASJ:0.9195	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	unknown
17	80050561	80050561	G	T	FASN	intronic	.	ENSG00000169710	rs17848924	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0008	.	0.00119808	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600212	.	.	.	.	.	.	.	.	.	.	.	17	.	het
18	724612	724612	A	G	YES1	exonic	synonymous SNV	ENSG00000176105	rs537141	ENSG00000176105:ENST00000314574:exon12:c.T1444C:p.L482L,ENSG00000176105:ENST00000577961:exon12:c.T1459C:p.L487L,ENSG00000176105:ENST00000584307:exon12:c.T1444C:p.L482L	YES1:NM_005433:exon12:c.T1444C:p.L482L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9973	0.9913	0.989816	0.9924	.	.	.	.	.	.	.	.	YES1:uc002kky.3:exon12:c.T1444C:p.L482L,YES1:uc002kkz.3:exon12:c.T1444C:p.L482L	.	AFR:0.9731,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	164880	.	.	.	.	.	.	.	.	.	.	.	18	MU82003345	hom
18	22775185	22775185	C	T	ZNF521	exonic	synonymous SNV	ENSG00000198795	rs1140026	ENSG00000198795:ENST00000399425:exon6:c.G3677A:p.S1226N	ZNF521:NM_001308225:exon4:c.G2937A:p.K979K,ZNF521:NM_015461:exon5:c.G3597A:p.K1199K	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2427	0.2088	0.226637	0.2121	.	.	.	.	.	.	.	.	ZNF521:uc002kvl.2:exon4:c.G2937A:p.K979K,ZNF521:uc002kvk.2:exon5:c.G3597A:p.K1199K,ZNF521:uc010dly.2:exon5:c.G3597A:p.K1199K	.	AFR:0.1366,AMR:0.2017,EAS:0.2774,FIN:0.2345,NFE:0.2409,OTH:0.2520,ASJ:0.2682	610974	.	.	.	.	.	.	.	.	.	.	.	18	MU21621172	het
18	28648970	28648970	C	A	DSC2	exonic	nonsynonymous SNV	ENSG00000134755	rs565136635	ENSG00000134755:ENST00000251081:exon15:c.G2398T:p.A800S,ENSG00000134755:ENST00000280904:exon15:c.G2398T:p.A800S	DSC2:NM_004949:exon15:c.G2398T:p.A800S,DSC2:NM_024422:exon15:c.G2398T:p.A800S	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, 0, 1, -1, 0, 0] 	8.241e-05	.	0.000399361	3.232e-05	0.597	8.137	0.1	1.37	0.008	.	.	.	DSC2:uc002kwk.4:exon15:c.G2398T:p.A800S,DSC2:uc002kwl.4:exon15:c.G2398T:p.A800S	-0.805	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.671e-05,OTH:0,ASJ:0	125645	610476;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.008	-0.97	0.286	1.965	18	.	het
18	28671095	28671095	G	A	DSC2	exonic	nonsynonymous SNV	ENSG00000134755	rs371443698	ENSG00000134755:ENST00000251081:exon4:c.C370T:p.H124Y,ENSG00000134755:ENST00000280904:exon4:c.C370T:p.H124Y	DSC2:NM_004949:exon4:c.C370T:p.H124Y,DSC2:NM_024422:exon4:c.C370T:p.H124Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 1, -1, 1, -1, 0, 0] 	0.0020	.	0.00319489	3.232e-05	0.430	6.872	0.256	4.0	0.221	.	.	Cadherin-like	DSC2:uc002kwk.4:exon4:c.C370T:p.H124Y,DSC2:uc002kwl.4:exon4:c.C370T:p.H124Y	-0.916	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	125645	610476;	217656;	217656|Familial isolated ARVC<br>Familial isolated ARVD<br>Familial isolated arrhythmogenic right ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular cardiomyopathy<br>Familial isolated arrhythmogenic ventricular dysplasia|Unknown|Autosomal dominant|-|107970 600996 602086 602087 604400 604401 607450 609040 610193 610476 611528 615616 ~	.	.	.	.	0.048	0.16	0.181	2.575	18	.	het
18	42529996	42529996	G	C	SETBP1	exonic	nonsynonymous SNV	ENSG00000152217	rs11082414	ENSG00000152217:ENST00000282030:exon4:c.G691C:p.V231L	SETBP1:NM_015559:exon4:c.G691C:p.V231L	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 1, 0, 0, 0, -1, 1, -1, 1, 1] 	0.1934	0.1853	0.156749	0.1822	-1.244	0.006	0.029	-5.47	0.557	.	.	.	SETBP1:uc010dni.3:exon4:c.G691C:p.V231L	-1.011	AFR:0.1540,AMR:0.1885,EAS:0.0123,FIN:0.2212,NFE:0.2064,OTH:0.2076,ASJ:0.1567	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9647,9646	0.006	1.33	0.000	0	18	.	het
18	42532923	42532923	T	C	SETBP1	exonic	synonymous SNV	ENSG00000152217	rs34882016	ENSG00000152217:ENST00000282030:exon4:c.T3618C:p.H1206H	SETBP1:NM_015559:exon4:c.T3618C:p.H1206H	clinvar: Likely_benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 1, 0, 1, 1] 	0.0063	0.0091	0.00379393	0.0054	.	.	.	.	.	.	.	.	SETBP1:uc010dni.3:exon4:c.T3618C:p.H1206H	.	AFR:0.0024,AMR:0.0060,EAS:0,FIN:0.0029,NFE:0.0077,OTH:0.0051,ASJ:0.0333	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9647,9646	.	.	.	.	18	.	het
18	42533130	42533130	A	G	SETBP1	exonic	synonymous SNV	ENSG00000152217	rs8096662	ENSG00000152217:ENST00000282030:exon4:c.A3825G:p.S1275S	SETBP1:NM_015559:exon4:c.A3825G:p.S1275S	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8775	0.8996	0.906949	0.9062	.	.	.	.	.	.	.	.	SETBP1:uc010dni.3:exon4:c.A3825G:p.S1275S	.	AFR:0.9722,AMR:0.9427,EAS:0.9560,FIN:0.8886,NFE:0.8676,OTH:0.8663,ASJ:0.8775	611060	269150;616078;	436151;798;	436151|Intellectual disability-loss of expressive language-facial dysmorphism syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|616078 616083 ~798|SGS|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Antenatal<br>Neonatal<br>Infancy|269150 ~	.	,9643	.	,9647,9646	.	.	.	.	18	MU21144927	het
18	49867224	49867224	T	C	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs9951523	ENSG00000187323:ENST00000442544:exon1:c.T67C:p.F23L	DCC:NM_005215:exon1:c.T67C:p.F23L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9862	0.9892	0.995807	0.9833	1.932	15.79	1.0	4.83	0.995	.	.	Immunoglobulin-like domain	DCC:uc002lfe.2:exon1:c.T67C:p.F23L	-0.966	AFR:0.9979,AMR:0.9904,EAS:1,FIN:0.9399,NFE:0.9834,OTH:0.9735,ASJ:0.9801	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.0	0.84	0.000	0	18	MU82007106	hom
18	50432602	50432602	C	G	DCC	exonic	nonsynonymous SNV	ENSG00000187323	rs2229080	ENSG00000187323:ENST00000412726:exon3:c.C145G:p.R49G,ENSG00000187323:ENST00000442544:exon3:c.C601G:p.R201G	DCC:NM_005215:exon3:c.C601G:p.R201G	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4447	0.3594	0.477436	MU788932	2.708	20.9	0.114	-0.494	0.993	.	.	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	DCC:uc002lfe.2:exon3:c.C601G:p.R201G,DCC:uc010xdr.1:exon3:c.C145G:p.R49G	-0.913	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3620,EAS:0.5769,FIN:0.4867,NFE:0.5330,OTH:0.3907,ASJ:0.3290	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	0.083	1.11	0.000	0.405	18	1(haematopoietic_and_lymphoid_tissue)	0.3401
18	50450240	50450240	T	G	DCC	intronic	.	ENSG00000187323	rs2276204	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3735	0.4217	0.289137	1(biliary_tract)	.	.	.	.	.	.	.	.	.	.	AFR:1(breast),AMR:1(large_intestine),EAS:MU584430,FIN:PACA-CA|1|268|0.00373134,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,NFE:0.4153,OTH:0.3339,ASJ:1(pancreas)	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	1(stomach)	0.2620
18	50592552	50592552	C	A	DCC	intronic	.	ENSG00000187323	rs563121962	.	.	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 1, 0] 	0.0002	.	0.000798722	3.248e-05	.	.	.	.	.	.	.	.	.	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0010,ASJ:0	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	MU83216968	het
18	50734032	50734032	G	A	DCC	intronic	.	ENSG00000187323	rs8096698	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0042	0.0094	0.0101837	0.0075	.	.	.	.	.	.	.	.	.	.	AFR:0.0259,AMR:0.0012,EAS:0,FIN:0,NFE:6.67e-05,OTH:0.0041,ASJ:0	120470	114500;133239;157600;	238722;99977;	238722|Familial congenital controlateral synkinesia<br>Hereditary congenital controlateral synkinesia<br>Hereditary congenital mirror movements<br>Isolated congenital controlateral synkinesia<br>Isolated congenital mirror movements|<1 / 1 000 000|Autosomal dominant|Infancy<br>Childhood|157600 614508 616059 ~99977|ESCC<br>Esophageal epidermoid carcinoma<br>Esophageal squamous cell carcinoma|1-9 / 100 000|Not applicable|Adult|133239 ~	~ko04360 Axon guidance~ko05200 Pathways in cancer~ko05210 Colorectal cancer ~	.	.	.	.	.	.	.	18	.	het
18	51795958	51795960	CGA	-	POLI	exonic	nonframeshift deletion	ENSG00000101751	rs10584411	ENSG00000101751:ENST00000406285:exon1:c.42_44del:p.14_15del,ENSG00000101751:ENST00000579534:exon1:c.42_44del:p.14_15del	POLI:NM_001351610:exon1:c.42_44del:p.14_15del,POLI:NM_001351613:exon1:c.42_44del:p.14_15del,POLI:NM_001351616:exon1:c.42_44del:p.14_15del,POLI:NM_001351621:exon1:c.42_44del:p.14_15del,POLI:NM_007195:exon1:c.42_44del:p.14_15del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7635	0.7612	0.783946	0.7640	.	.	.	.	.	.	.	.	POLI:uc002lfj.4:exon1:c.42_44del:p.14_15del,POLI:uc010xds.2:exon1:c.42_44del:p.14_15del	.	AFR:0.9280,AMR:0.6019,EAS:0.7032,FIN:0.7334,NFE:0.6922,OTH:0.7330,ASJ:0.8079	605252	.	.	.	.	.	.	.	.	.	.	.	18	MU99873	hom
18	51820805	51820805	G	A	POLI	exonic	nonsynonymous SNV	ENSG00000101751	rs8305	ENSG00000101751:ENST00000217800:exon9:c.G1813A:p.A605T,ENSG00000101751:ENST00000406285:exon9:c.G1954A:p.A652T,ENSG00000101751:ENST00000579434:exon9:c.G1882A:p.A628T,ENSG00000101751:ENST00000579534:exon10:c.G2191A:p.A731T	POLI:NM_001351616:exon8:c.G1828A:p.A610T,POLI:NM_001351610:exon9:c.G2065A:p.A689T,POLI:NM_001351613:exon9:c.G1954A:p.A652T,POLI:NM_001351614:exon9:c.G1882A:p.A628T,POLI:NM_001351615:exon9:c.G1882A:p.A628T,POLI:NM_001351617:exon9:c.G1648A:p.A550T,POLI:NM_001351620:exon9:c.G1411A:p.A471T,POLI:NM_001351611:exon10:c.G1987A:p.A663T,POLI:NM_001351612:exon10:c.G1987A:p.A663T,POLI:NM_001351618:exon10:c.G1648A:p.A550T,POLI:NM_001351619:exon10:c.G1648A:p.A550T,POLI:NM_001351632:exon10:c.G2116A:p.A706T,POLI:NM_007195:exon10:c.G2191A:p.A731T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7282	0.7780	0.789137	LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,WT-US|1|102|0.00980392	-0.572	0.146	0.892	-5.15	0.278	.	.	.	POLI:uc010dpg.3:exon6:c.G979A:p.A327T,POLI:uc002lfk.4:exon9:c.G1882A:p.A628T,POLI:uc010xds.2:exon9:c.G1954A:p.A652T,POLI:uc002lfj.4:exon10:c.G2191A:p.A731T	-0.992	AFR:0.7686,AMR:0.9401,EAS:0.8079,FIN:0.7055,NFE:0.7325,OTH:0.6945,ASJ:0.6041	605252	.	.	.	.	.	.	.	0.001	1.12	0.000	-0.345	18	2(lung)	0.7311
18	52895531	52895531	T	C	TCF4	exonic	synonymous SNV	ENSG00000196628	rs8766	ENSG00000196628:ENST00000457482:exon12:c.A1461G:p.S487S,ENSG00000196628:ENST00000561831:exon12:c.A1449G:p.S483S,ENSG00000196628:ENST00000570287:exon12:c.A1449G:p.S483S,ENSG00000196628:ENST00000537856:exon14:c.A1539G:p.S513S,ENSG00000196628:ENST00000570177:exon14:c.A1539G:p.S513S,ENSG00000196628:ENST00000544241:exon15:c.A1728G:p.S576S,ENSG00000196628:ENST00000561992:exon15:c.A1539G:p.S513S,ENSG00000196628:ENST00000564228:exon15:c.A1716G:p.S572S,ENSG00000196628:ENST00000567880:exon16:c.A1749G:p.S583S,ENSG00000196628:ENST00000543082:exon17:c.A1803G:p.S601S,ENSG00000196628:ENST00000566279:exon17:c.A1761G:p.S587S,ENSG00000196628:ENST00000537578:exon18:c.A1869G:p.S623S,ENSG00000196628:ENST00000540999:exon18:c.A1857G:p.S619S,ENSG00000196628:ENST00000566286:exon18:c.A1920G:p.S640S,ENSG00000196628:ENST00000568673:exon18:c.A1869G:p.S623S,ENSG00000196628:ENST00000568740:exon18:c.A1854G:p.S618S,ENSG00000196628:ENST00000354452:exon19:c.A1941G:p.S647S,ENSG00000196628:ENST00000356073:exon19:c.A1929G:p.S643S,ENSG00000196628:ENST00000564403:exon19:c.A1959G:p.S653S,ENSG00000196628:ENST00000564999:exon19:c.A1929G:p.S643S,ENSG00000196628:ENST00000565018:exon19:c.A1941G:p.S647S,ENSG00000196628:ENST00000398339:exon20:c.A2247G:p.S749S	TCF4:NM_001243234:exon12:c.A1461G:p.S487S,TCF4:NM_001243235:exon12:c.A1449G:p.S483S,TCF4:NM_001243236:exon12:c.A1449G:p.S483S,TCF4:NM_001348214:exon12:c.A1446G:p.S482S,TCF4:NM_001348215:exon12:c.A1293G:p.S431S,TCF4:NM_001348216:exon12:c.A1461G:p.S487S,TCF4:NM_001330605:exon14:c.A1551G:p.S517S,TCF4:NM_001243232:exon15:c.A1728G:p.S576S,TCF4:NM_001243233:exon15:c.A1539G:p.S513S,TCF4:NM_001306208:exon15:c.A1716G:p.S572S,TCF4:NM_001348212:exon15:c.A1539G:p.S513S,TCF4:NM_001348213:exon15:c.A1551G:p.S517S,TCF4:NM_001243231:exon17:c.A1803G:p.S601S,TCF4:NM_001348211:exon17:c.A1815G:p.S605S,TCF4:NM_001243227:exon18:c.A1869G:p.S623S,TCF4:NM_001243230:exon18:c.A1920G:p.S640S,TCF4:NM_001306207:exon18:c.A1857G:p.S619S,TCF4:NM_001348217:exon18:c.A1869G:p.S623S,TCF4:NM_001348218:exon18:c.A1869G:p.S623S,TCF4:NM_001348219:exon18:c.A1857G:p.S619S,TCF4:NM_001348220:exon18:c.A1854G:p.S618S,TCF4:NM_001369575:exon18:c.A1869G:p.S623S,TCF4:NM_001369576:exon18:c.A1866G:p.S622S,TCF4:NM_001369577:exon18:c.A1866G:p.S622S,TCF4:NM_001369578:exon18:c.A1866G:p.S622S,TCF4:NM_001369579:exon18:c.A1866G:p.S622S,TCF4:NM_001369580:exon18:c.A1866G:p.S622S,TCF4:NM_001369581:exon18:c.A1866G:p.S622S,TCF4:NM_001369582:exon18:c.A1857G:p.S619S,TCF4:NM_001369583:exon18:c.A1857G:p.S619S,TCF4:NM_001369584:exon18:c.A1854G:p.S618S,TCF4:NM_001369585:exon18:c.A1854G:p.S618S,TCF4:NM_001369586:exon18:c.A1872G:p.S624S,TCF4:NM_001083962:exon19:c.A1941G:p.S647S,TCF4:NM_001243228:exon19:c.A1959G:p.S653S,TCF4:NM_001330604:exon19:c.A1938G:p.S646S,TCF4:NM_001369567:exon19:c.A1941G:p.S647S,TCF4:NM_001369568:exon19:c.A1941G:p.S647S,TCF4:NM_001369569:exon19:c.A1938G:p.S646S,TCF4:NM_001369570:exon19:c.A1938G:p.S646S,TCF4:NM_001369571:exon19:c.A1929G:p.S643S,TCF4:NM_001369572:exon19:c.A1929G:p.S643S,TCF4:NM_001369573:exon19:c.A1926G:p.S642S,TCF4:NM_001369574:exon19:c.A1926G:p.S642S,TCF4:NM_003199:exon19:c.A1929G:p.S643S,TCF4:NM_001243226:exon20:c.A2247G:p.S749S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3714	0.3647	0.342452	MU19123238	.	.	.	.	.	.	.	.	TCF4:uc002lfw.4:exon12:c.A1461G:p.S487S,TCF4:uc021ukg.1:exon12:c.A1449G:p.S483S,TCF4:uc021ukh.1:exon12:c.A1449G:p.S483S,TCF4:uc010xdu.1:exon14:c.A1539G:p.S513S,TCF4:uc010xdv.1:exon14:c.A1539G:p.S513S,TCF4:uc002lfx.2:exon15:c.A1728G:p.S576S,TCF4:uc010xdw.1:exon15:c.A1539G:p.S513S,TCF4:uc021uki.1:exon15:c.A1716G:p.S572S,TCF4:uc021ukj.1:exon16:c.A1749G:p.S583S,TCF4:uc021ukk.1:exon16:c.A1761G:p.S587S,TCF4:uc002lfy.2:exon17:c.A1803G:p.S601S,TCF4:uc010xdx.1:exon18:c.A1857G:p.S619S,TCF4:uc010xdy.1:exon18:c.A1869G:p.S623S,TCF4:uc021ukl.1:exon18:c.A1920G:p.S640S,TCF4:uc002lfz.2:exon19:c.A1929G:p.S643S,TCF4:uc010dph.1:exon19:c.A1941G:p.S647S,TCF4:uc010dpi.3:exon19:c.A1959G:p.S653S,TCF4:uc002lga.3:exon20:c.A2247G:p.S749S	.	AFR:LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02,AMR:0.3747,EAS:0.3565,FIN:0.3874,NFE:0.4709,OTH:0.3934,ASJ:0.3184	602272	610954;613267;	98974;2896;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~2896|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610954 ~	.	.	.	.	.	.	.	.	18	1(lung)	0.3953
18	53303101	53303101	C	G	TCF4	exonic	nonsynonymous SNV	ENSG00000196628	rs611326	ENSG00000196628:ENST00000398339:exon1:c.G28C:p.A10P,ENSG00000196628:ENST00000565124:exon1:c.G28C:p.A10P	TCF4:NM_001243226:exon1:c.G28C:p.A10P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9994	0.9988	0.996805	0.9987	.	.	.	.	.	.	.	.	TCF4:uc002lga.3:exon1:c.G28C:p.A10P,TCF4:uc021ukp.1:exon1:c.G28C:p.A10P	.	AFR:0.9953,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	602272	610954;613267;	98974;2896;	98974|Endoepithelial corneal dystrophy<br>FECD<br>Late hereditary endothelial dystrophy|Unknown|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial<br>or&nbsp;Not applicable|Adult|136800 610158 613267 613268 613269 613270 613271 615523 ~2896|-|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|610954 ~	.	.	.	.	.	.	.	.	18	MU82007295	hom
18	60505996	60505997	TC	-	PHLPP1	intronic	.	ENSG00000081913	rs10561006	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1342	0.2135	0.178514	0.2057	.	.	.	.	.	.	.	.	.	.	AFR:0.4203,AMR:0.0778,EAS:0.0006,FIN:0.1511,NFE:0.1276,OTH:0.1592,ASJ:0.1391	609396	.	.	.	.	.	.	.	.	.	.	.	18	.	het
18	60562298	60562298	A	T	PHLPP1	exonic	synonymous SNV	ENSG00000081913	rs624821	ENSG00000081913:ENST00000262719:exon5:c.A2121T:p.P707P,ENSG00000081913:ENST00000400316:exon5:c.A585T:p.P195P	PHLPP1:NM_194449:exon5:c.A2121T:p.P707P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5547	0.5873	0.486222	MU13087612	.	.	.	.	.	.	.	.	PHLPP1:uc021ule.1:exon5:c.A2121T:p.P707P	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02,AMR:0.5775,EAS:0.5346,FIN:0.7285,NFE:0.3595,OTH:0.5576,ASJ:0.5394	609396	.	.	.	.	.	.	.	.	.	.	.	18	1(breast)	0.6255
18	60572438	60572438	T	-	PHLPP1	intronic	.	ENSG00000081913	rs3217528	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.5439	.	0.41893	0.4674	.	.	.	.	.	.	.	.	.	.	AFR:0.3979,AMR:0.5208,EAS:0.3503,FIN:0.4792,NFE:0.5103,OTH:0.5220,ASJ:0.6585	609396	.	.	.	.	.	.	.	.	.	.	.	18	.	het
18	60970036	60970036	C	A	BCL2	intronic	.	ENSG00000171791	rs4941195	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.583067	0.5089	.	.	.	.	.	.	.	.	.	.	AFR:0.6602,AMR:0.4544,EAS:0.7348,FIN:0.4121,NFE:0.4239,OTH:0.4561,ASJ:0.6026	151430	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04141 Protein processing in endoplasmic reticulum~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04261 Adrenergic signaling in cardiomyocytes~ko04340 Hedgehog signaling pathway~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04915 Estrogen signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05215 Prostate cancer~ko05222 Small cell lung cancer~ko05226 Gastric cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	18	MU13088314	hom
18	60985879	60985879	T	C	BCL2	exonic	synonymous SNV	ENSG00000171791	rs1801018	ENSG00000171791:ENST00000398117:exon1:c.A21G:p.T7T,ENSG00000171791:ENST00000589955:exon1:c.A21G:p.T7T,ENSG00000171791:ENST00000333681:exon2:c.A21G:p.T7T,ENSG00000171791:ENST00000444484:exon2:c.A21G:p.T7T	BCL2:NM_000633:exon2:c.A21G:p.T7T,BCL2:NM_000657:exon2:c.A21G:p.T7T	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.3688	0.3104	0.243211	2(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	BCL2:uc002liu.1:exon1:c.A21G:p.T7T,BCL2:uc021ulf.1:exon1:c.A21G:p.T7T,BCL2:uc002lit.1:exon2:c.A21G:p.T7T,BCL2:uc002liv.1:exon2:c.A21G:p.T7T	.	AFR:MU13088333,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,EAS:0.0841,FIN:0.4055,NFE:0.3113,OTH:0.0953,ASJ:0.3240	151430	.	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04071 Sphingolipid signaling pathway~ko04115 p53 signaling pathway~ko04140 Autophagy - animal~ko04141 Protein processing in endoplasmic reticulum~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04261 Adrenergic signaling in cardiomyocytes~ko04340 Hedgehog signaling pathway~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04915 Estrogen signaling pathway~ko04928 Parathyroid hormone synthesis, secretion and action~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05014 Amyotrophic lateral sclerosis (ALS)~ko05145 Toxoplasmosis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05162 Measles~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05215 Prostate cancer~ko05222 Small cell lung cancer~ko05226 Gastric cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	966,	.	.	.	.	18	2(lung)	0.4679
18	67718688	67718688	A	G	RTTN	exonic	nonsynonymous SNV	ENSG00000176225	rs4891392	ENSG00000176225:ENST00000255674:exon39:c.T5282C:p.F1761S	RTTN:NM_001318520:exon38:c.T2546C:p.F849S,RTTN:NM_173630:exon39:c.T5282C:p.F1761S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9184	0.8027	0.790735	0.8082	-0.332	0.561	0.978	-1.23	0.000	.	.	Armadillo-like helical	RTTN:uc010dqp.2:exon5:c.T38C:p.F13S,RTTN:uc010xfb.1:exon38:c.T2546C:p.F849S,RTTN:uc002lkp.2:exon39:c.T5282C:p.F1761S	-1.032	AFR:0.4213,AMR:0.9391,EAS:1,FIN:0.9619,NFE:0.9574,OTH:0.9439,ASJ:0.9404	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	0.0	0.93	0.000	-0.65	18	MU82008699	hom
18	67753931	67753945	AAAAAAAAAAAAAAA	-	RTTN	intronic	.	ENSG00000176225	rs768452992	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0147	.	.	0.3739	.	.	.	.	.	.	.	.	.	.	AFR:0.3004,AMR:0.3427,EAS:0.6305,FIN:0.05,NFE:0.3849,OTH:0.3669,ASJ:0.2662	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	hom
18	67863850	67863850	-	CTC	RTTN	exonic	nonframeshift insertion	ENSG00000176225	rs58913700	ENSG00000176225:ENST00000583043:exon2:c.97_98insGAG:p.D33delinsGD,ENSG00000176225:ENST00000255674:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000437017:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000454359:exon7:c.727_728insGAG:p.D243delinsGD,ENSG00000176225:ENST00000581161:exon7:c.727_728insGAG:p.D243delinsGD	RTTN:NM_173630:exon7:c.727_728insGAG:p.D243delinsGD	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.9870	0.9540	0.952676	0.9584	.	.	.	.	.	.	.	.	RTTN:uc002lkp.2:exon7:c.727_728insGAG:p.D243delinsGD,RTTN:uc002lkq.1:exon7:c.727_728insGAG:p.D243delinsGD	.	AFR:0.8541,AMR:0.9892,EAS:1,FIN:1,NFE:0.9994,OTH:0.9969,ASJ:1	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	.	.	.	.	18	.	hom
18	67871343	67871343	A	C	RTTN	exonic	nonsynonymous SNV	ENSG00000176225	rs3911730	ENSG00000176225:ENST00000255674:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000437017:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000454359:exon3:c.T376G:p.S126A,ENSG00000176225:ENST00000581161:exon3:c.T376G:p.S126A	RTTN:NM_173630:exon3:c.T376G:p.S126A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8654	0.7273	0.71226	0.7339	-0.692	0.075	0.698	-1.54	0.175	.	.	Armadillo-like helical	RTTN:uc002lkp.2:exon3:c.T376G:p.S126A,RTTN:uc002lkq.1:exon3:c.T376G:p.S126A	-0.920	AFR:0.2612,AMR:0.8747,EAS:0.9994,FIN:0.9160,NFE:0.9166,OTH:0.8798,ASJ:0.8940	610436	614833;	208447;268940;	208447|-|-|Autosomal recessive|-|614833 ~268940|-|Unknown|-|-|300388 606854 610031 612691 614833 615752 616531 ~	.	.	.	.	0.0	0.58	0.000	1.43	18	MU82008748	hom
18	72343008	72343008	T	C	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs7243081	ENSG00000215421:ENST00000299687:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000309902:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000577538:exon1:c.T33C:p.D11D,ENSG00000215421:ENST00000582337:exon2:c.T33C:p.D11D	ZNF407:NM_001146189:exon1:c.T33C:p.D11D,ZNF407:NM_001146190:exon1:c.T33C:p.D11D,ZNF407:NM_017757:exon1:c.T33C:p.D11D	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9898	0.9987	0.99361	0.9969	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon1:c.T33C:p.D11D,ZNF407:uc010dqu.2:exon1:c.T33C:p.D11D,ZNF407:uc010xfc.2:exon1:c.T33C:p.D11D,ZNF407:uc002llu.2:exon2:c.T30C:p.D10D	.	AFR:0.9984,AMR:0.9093,EAS:1,FIN:1,NFE:0.9999,OTH:0.9939,ASJ:1	615894	.	.	.	.	.	.	.	.	.	.	.	18	MU82009013	hom
18	72347482	72347482	T	C	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs12327359	ENSG00000215421:ENST00000299687:exon1:c.T4507C:p.L1503L,ENSG00000215421:ENST00000309902:exon1:c.T4507C:p.L1503L,ENSG00000215421:ENST00000577538:exon1:c.T4507C:p.L1503L,ENSG00000215421:ENST00000582337:exon2:c.T4507C:p.L1503L	ZNF407:NM_001146189:exon1:c.T4507C:p.L1503L,ZNF407:NM_001146190:exon1:c.T4507C:p.L1503L,ZNF407:NM_017757:exon1:c.T4507C:p.L1503L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4198	0.5108	0.423922	1(large_intestine)	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon1:c.T4507C:p.L1503L,ZNF407:uc010dqu.2:exon1:c.T4507C:p.L1503L,ZNF407:uc010xfc.2:exon1:c.T4507C:p.L1503L,ZNF407:uc002llu.2:exon2:c.T4504C:p.L1502L	.	AFR:MU148628,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,EAS:0.6882,FIN:0.2804,NFE:0.4338,OTH:0.1917,ASJ:0.4802	615894	.	.	.	.	.	.	.	.	.	.	.	18	2(lung)	0.3587
18	72776121	72776121	G	A	ZNF407	exonic	synonymous SNV	ENSG00000215421	rs3744913	ENSG00000215421:ENST00000299687:exon8:c.G6444A:p.T2148T	ZNF407:NM_017757:exon8:c.G6444A:p.T2148T	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8322	0.7615	0.760383	0.7835	.	.	.	.	.	.	.	.	ZNF407:uc002llw.2:exon8:c.G6444A:p.T2148T	.	AFR:0.5472,AMR:0.8022,EAS:0.9116,FIN:0.9124,NFE:0.8690,OTH:0.8637,ASJ:0.8477	615894	.	.	.	.	.	.	.	.	.	.	.	18	MU4566146	hom
18	74962645	74962645	T	C	GALR1	exonic	synonymous SNV	ENSG00000166573	rs5374	ENSG00000166573:ENST00000299727:exon1:c.T141C:p.G47G	GALR1:NM_001480:exon1:c.T141C:p.G47G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5824	0.5881	0.489816	2(lung)	.	.	.	.	.	.	.	.	GALR1:uc002lms.4:exon1:c.T141C:p.G47G	.	AFR:MU96341,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.4728,FIN:0.3926,NFE:0.7583,OTH:0.3617,ASJ:0.5746	600377	.	.	.	.	.	.	.	.	.	.	.	18	2(large_intestine)	0.6352
18	74980809	74980809	G	A	GALR1	exonic	nonsynonymous SNV	ENSG00000166573	rs5376	ENSG00000166573:ENST00000299727:exon3:c.G1001A:p.S334N	GALR1:NM_001480:exon3:c.G1001A:p.S334N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9731	0.8956	0.90615	0.9156	-0.581	0.139	0.882	1.01	0.007	.	.	.	GALR1:uc002lms.4:exon3:c.G1001A:p.S334N	-0.988	AFR:0.7061,AMR:0.9749,EAS:1,FIN:1,NFE:0.9992,OTH:0.9807,ASJ:1	600377	.	.	.	.	.	.	.	0.0	-0.49	0.000	-0.845	18	MU82009144	hom
19	676521	676521	C	T	FSTL3	exonic	nonsynonymous SNV	ENSG00000070404	rs199661221	ENSG00000070404:ENST00000166139:exon1:c.C98T:p.A33V	FSTL3:NM_005860:exon1:c.C98T:p.A33V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, -1, 1, 0] 	0.0239	0.0061	0.000998403	0.0046	2.280	18.03	0.897	0.382	0.100	.	.	.	FSTL3:uc002lpk.1:exon1:c.C98T:p.A33V	-0.946	AFR:0.0021,AMR:0.0030,EAS:0,FIN:0.0018,NFE:0.0074,OTH:0.0022,ASJ:0.0037	605343	.	.	.	.	.	.	.	0.001	2.29	0.006	0.27	19	.	het
19	680378	680378	C	T	FSTL3	exonic	synonymous SNV	ENSG00000070404	rs7246311	ENSG00000070404:ENST00000588773:exon2:c.C128T:p.A43V	FSTL3:NM_005860:exon3:c.C394T:p.L132L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5719	.	0.348842	0.3951	.	.	.	.	.	.	.	.	FSTL3:uc002lpk.1:exon3:c.C394T:p.L132L	.	AFR:0.2872,AMR:0.3487,EAS:0.2271,FIN:0.4825,NFE:0.4570,OTH:0.4435,ASJ:0.3412	605343	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	929678	929678	G	A	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs3826948	ENSG00000116017:ENST00000263620:exon2:c.G150A:p.E50E	ARID3A:NM_005224:exon2:c.G150A:p.E50E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6249	0.4235	0.460863	LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon2:c.G150A:p.E50E	.	AFR:0.5016,AMR:0.1950,EAS:0.5671,FIN:0.6404,NFE:0.625,OTH:0.6324,ASJ:0.4450	603265	.	.	.	.	.	.	.	.	.	.	.	19	2(large_intestine)	0.5983
19	929753	929753	A	G	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs1799595	ENSG00000116017:ENST00000263620:exon2:c.A225G:p.P75P	ARID3A:NM_005224:exon2:c.A225G:p.P75P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8572	0.8751	0.884185	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon2:c.A225G:p.P75P	.	AFR:0.8675,AMR:0.9034,EAS:0.8344,FIN:0.9994,NFE:0.8457,OTH:0.8432,ASJ:0.8077	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.8415
19	965043	965043	T	C	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs12608658	ENSG00000116017:ENST00000587532:exon4:c.T702C:p.N234N,ENSG00000116017:ENST00000263620:exon6:c.T1161C:p.N387N	ARID3A:NM_005224:exon6:c.T1161C:p.N387N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9575	0.9483	0.938898	0.9532	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon6:c.T1161C:p.N387N	.	AFR:0.8858,AMR:0.8699,EAS:1,FIN:0.9951,NFE:0.9802,OTH:0.9735,ASJ:0.9868	603265	.	.	.	.	.	.	.	.	.	.	.	19	MU82010062	hom
19	966693	966693	C	T	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs6510986	ENSG00000116017:ENST00000263620:exon7:c.C1320T:p.A440A	ARID3A:NM_005224:exon7:c.C1320T:p.A440A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7977	0.8170	0.714856	MU70212	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon7:c.C1320T:p.A440A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,AMR:0.7864,EAS:0.6304,FIN:0.9007,NFE:0.5902,OTH:0.7896,ASJ:0.7121	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(liver)	0.8559
19	971933	971933	A	G	ARID3A	exonic	synonymous SNV	ENSG00000116017	rs1051504	ENSG00000116017:ENST00000263620:exon9:c.A1650G:p.G550G	ARID3A:NM_005224:exon9:c.A1650G:p.G550G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6590	0.7290	0.594848	2(lung)	.	.	.	.	.	.	.	.	ARID3A:uc002lql.3:exon9:c.A1650G:p.G550G	.	AFR:MU1781969,AMR:LICA-CN|3|402|0.00746269,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,EAS:0.6337,FIN:0.5725,NFE:0.8033,OTH:0.4660,ASJ:0.6893	603265	.	.	.	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.6883
19	971949	971949	G	A	ARID3A	exonic	nonsynonymous SNV	ENSG00000116017	rs1051505	ENSG00000116017:ENST00000263620:exon9:c.G1666A:p.G556S	ARID3A:NM_005224:exon9:c.G1666A:p.G556S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7812	0.8295	0.71865	1(lung)	-0.025	2.348	0.369	-7.15	0.000	.	.	.	ARID3A:uc002lql.3:exon9:c.G1666A:p.G556S	-0.998	AFR:MU98751,AMR:LIRI-JP|1|258|0.00387597,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.7094,FIN:0.6337,NFE:0.8974,OTH:0.5896,ASJ:0.7803	603265	.	.	.	.	.	.	.	0.0	1.17	0.000	-0.405	19	1(thyroid)	0.7743
19	1222012	1222012	G	C	STK11	intronic	.	ENSG00000118046	rs2075607	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2428	0.1380	0.170527	3(lung)	.	.	.	.	.	0.0001	0.006	.	.	.	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU21349348,EAS:0.1638,FIN:0.0530,NFE:0.1492,OTH:0.1689,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	602216	175200;260350;273300;	363483;363494;363504;842;876;99865;1333;2869;	363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2869|Hamartomatous intestinal polyposis<br>PJS<br>Polyps and spots syndrome|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Childhood|175200 ~	.	.	.	.	.	.	.	.	19	1(liver)	0.3315
19	1619339	1619339	T	C	TCF3	exonic	synonymous SNV	ENSG00000071564	rs8140	ENSG00000071564:ENST00000453954:exon11:c.A1050G:p.S350S,ENSG00000071564:ENST00000395423:exon12:c.A1149G:p.S383S,ENSG00000071564:ENST00000588136:exon14:c.A1302G:p.S434S,ENSG00000071564:ENST00000262965:exon15:c.A1302G:p.S434S,ENSG00000071564:ENST00000344749:exon15:c.A1302G:p.S434S	TCF3:NM_001136139:exon15:c.A1302G:p.S434S,TCF3:NM_001351778:exon15:c.A1299G:p.S433S,TCF3:NM_001351779:exon15:c.A1302G:p.S434S,TCF3:NM_003200:exon15:c.A1302G:p.S434S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4963	0.4902	0.623802	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TCF3:uc002lto.3:exon6:c.A585G:p.S195S,TCF3:uc002lts.1:exon11:c.A1050G:p.S350S,TCF3:uc002ltq.3:exon12:c.A1149G:p.S383S,TCF3:uc002ltt.4:exon14:c.A1302G:p.S434S,TCF3:uc002ltr.3:exon15:c.A1302G:p.S434S	.	AFR:0.5347,AMR:0.7222,EAS:0.4533,FIN:0.8829,NFE:0.4464,OTH:0.4131,ASJ:0.5300	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	1(lung)	0.4897
19	1622116	1622116	G	A	TCF3	exonic	synonymous SNV	ENSG00000071564	rs2240590	ENSG00000071564:ENST00000453954:exon6:c.C507T:p.S169S,ENSG00000071564:ENST00000395423:exon7:c.C606T:p.S202S,ENSG00000071564:ENST00000588136:exon9:c.C759T:p.S253S,ENSG00000071564:ENST00000262965:exon10:c.C759T:p.S253S,ENSG00000071564:ENST00000344749:exon10:c.C759T:p.S253S	TCF3:NM_001136139:exon10:c.C759T:p.S253S,TCF3:NM_001351778:exon10:c.C759T:p.S253S,TCF3:NM_001351779:exon10:c.C759T:p.S253S,TCF3:NM_003200:exon10:c.C759T:p.S253S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2973	0.2314	0.339058	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	TCF3:uc002lto.3:exon1:c.C45T:p.S15S,TCF3:uc002lts.1:exon6:c.C507T:p.S169S,TCF3:uc002ltq.3:exon7:c.C606T:p.S202S,TCF3:uc002ltt.4:exon9:c.C759T:p.S253S,TCF3:uc002ltr.3:exon10:c.C759T:p.S253S	.	AFR:0.2416,AMR:0.5231,EAS:0.0767,FIN:0.2142,NFE:0.0981,OTH:0.1189,ASJ:0.3305	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.1540
19	1625558	1625558	G	A	TCF3	intronic	.	ENSG00000071564	rs4807123	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0687	0.0511	0.11881	0.0642	.	.	.	.	.	.	.	.	.	.	AFR:0.1772,AMR:0.1337,EAS:0.1766,FIN:0,NFE:0.0010,OTH:0.0305,ASJ:0	147141	616941;	229717;33110;	229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~33110|Agammaglobulinemia, non-Bruton type|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|All ages|601495 612692 613500 613501 613502 613506 615214 616941 ~	~ko04550 Signaling pathways regulating pluripotency of stem cells~ko05166 Human T-cell leukemia virus 1 infection~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	19	MU50884763	het
19	2226676	2226676	G	A	DOT1L	exonic	nonsynonymous SNV	ENSG00000104885	rs3815308	ENSG00000104885:ENST00000457590:exon4:c.G796A:p.G266S,ENSG00000104885:ENST00000398665:exon27:c.G4156A:p.G1386S	DOT1L:NM_032482:exon27:c.G4156A:p.G1386S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.3989	0.3212	0.225639	0.3153	-0.196	1.121	1.0	0.43	0.001	.	.	.	DOT1L:uc002lvc.1:exon13:c.G2038A:p.G680S,DOT1L:uc002lvb.4:exon27:c.G4156A:p.G1386S	-0.920	AFR:0.0887,AMR:0.2847,EAS:0.1572,FIN:0.3526,NFE:0.4493,OTH:0.4010,ASJ:0.4371	607375	.	.	.	~ko00310 Lysine degradation~ko05202 Transcriptional misregulation in cancer ~	.	.	.	0.105	2.06	0.000	0.97	19	MU64635	het
19	3119184	3119184	T	G	GNA11	intronic	.	ENSG00000267139	rs308046	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8340	0.8159	0.773562	0.8281	.	.	.	.	.	.	.	.	.	.	AFR:0.7489,AMR:0.8914,EAS:0.7451,FIN:0.8723,NFE:0.8656,OTH:0.8801,ASJ:0.8411	139313	145981;615361;	2238;428;101049;405;	2238|-|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|All ages|146200 307700 601198 615361 ~428|AD hypocalcemia|Unknown|Autosomal dominant|All ages|601198 615361 ~101049|FHH type 2|-|Autosomal dominant|-|145981 ~405|FBH<br>FBHH<br>FHH<br>Familial benign hypercalcemia<br>Familial benign hypocalciuric hypercalcemia|Unknown|Autosomal dominant|All ages|145980 145981 600740 ~	~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04270 Vascular smooth muscle contraction~ko04540 Gap junction~ko04725 Cholinergic synapse~ko04730 Long-term depression~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04925 Aldosterone synthesis and secretion~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer ~	.	.	.	.	.	.	.	19	MU21352930	hom
19	3533274	3533274	G	A	FZR1	intronic	.	ENSG00000105325	rs740681	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3405	0.2002	0.353435	0.2694	.	.	.	.	.	.	.	.	.	.	AFR:0.0594,AMR:0.5227,EAS:0.8459,FIN:0.3465,NFE:0.2934,OTH:0.3190,ASJ:0.2867	603619	.	.	.	.	.	.	.	.	.	.	.	19	MU82012116	het
19	3534842	3534842	G	A	FZR1	UTR3	.	ENSG00000105325	rs10155	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3344	0.2001	0.348043	0.2691	.	.	.	.	.	.	.	.	.	.	AFR:0.0592,AMR:0.5203,EAS:0.8396,FIN:0.3474,NFE:0.2943,OTH:0.3143,ASJ:0.2881	603619	.	.	.	.	.	.	.	.	.	.	.	19	MU736221	het
19	4094775	4094775	G	A	MAP2K2	intronic	.	ENSG00000126934	rs350916	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	.	.	0.454473	0.4512	.	.	.	.	.	.	.	.	.	.	AFR:0.3008,AMR:0.5755,EAS:0.6532,FIN:0.4736,NFE:0.5002,OTH:0.4929,ASJ:0.54	601263	615280;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	19	.	hom
19	4099187	4099187	T	C	MAP2K2	intronic	.	ENSG00000126934	rs350911	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7718	0.7441	0.773562	0.7575	.	.	.	.	.	.	.	.	.	.	AFR:0.7408,AMR:0.8493,EAS:0.9270,FIN:0.7614,NFE:0.7420,OTH:0.7788,ASJ:0.7252	601263	615280;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	.	.	.	.	.	.	.	19	MU50776075	hom
19	4101062	4101062	G	T	MAP2K2	exonic	synonymous SNV	ENSG00000126934	rs10250	ENSG00000126934:ENST00000262948:exon6:c.C660A:p.I220I,ENSG00000126934:ENST00000394867:exon7:c.C369A:p.I123I	MAP2K2:NM_030662:exon6:c.C660A:p.I220I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5472	0.4179	0.433307	LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916	.	.	.	.	.	.	.	.	MAP2K2:uc002lzj.3:exon3:c.C90A:p.I30I,MAP2K2:uc002lzk.3:exon6:c.C660A:p.I220I	.	AFR:0.4250,AMR:0.2672,EAS:0.5633,FIN:0.5919,NFE:0.4575,OTH:0.4772,ASJ:0.5659	601263	615280;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7233,	.	.	.	.	.	.	19	1(lung)	0.4773
19	4102449	4102449	G	A	MAP2K2	exonic	synonymous SNV	ENSG00000126934	rs17851657	ENSG00000126934:ENST00000262948:exon4:c.C453T:p.D151D,ENSG00000126934:ENST00000394867:exon5:c.C162T:p.D54D	MAP2K2:NM_030662:exon4:c.C453T:p.D151D	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2315	0.1428	0.111222	.	.	.	.	.	.	.	.	.	MAP2K2:uc002lzk.3:exon4:c.C453T:p.D151D	.	AFR:.,AMR:0.1341,EAS:0.0947,FIN:0.2152,NFE:0.0340,OTH:0.1853,ASJ:0.0439	601263	615280;	1340;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04010 MAPK signaling pathway~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04210 Apoptosis~ko04218 Cellular senescence~ko04270 Vascular smooth muscle contraction~ko04370 VEGF signaling pathway~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04620 Toll-like receptor signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04720 Long-term potentiation~ko04722 Neurotrophin signaling pathway~ko04730 Long-term depression~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04934 Cushing syndrome~ko05020 Prion diseases~ko05135 Yersinia infection~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05216 Thyroid cancer~ko05218 Melanoma~ko05219 Bladder cancer~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer ~	7233,	.	.	.	.	.	.	19	1(prostate)	0.1837
19	4362691	4362691	G	C	SH3GL1	exonic	synonymous SNV	ENSG00000141985	rs243261	ENSG00000141985:ENST00000417295:exon7:c.C627G:p.P209P,ENSG00000141985:ENST00000269886:exon8:c.C771G:p.P257P,ENSG00000141985:ENST00000598564:exon8:c.C579G:p.P193P	SH3GL1:NM_001199943:exon7:c.C627G:p.P209P,SH3GL1:NM_001199944:exon8:c.C579G:p.P193P,SH3GL1:NM_003025:exon8:c.C771G:p.P257P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3346	0.3021	0.391573	0.3198	.	.	.	.	.	.	.	.	SH3GL1:uc010xig.2:exon7:c.C627G:p.P209P,SH3GL1:uc002maj.3:exon8:c.C771G:p.P257P,SH3GL1:uc002mak.3:exon8:c.C579G:p.P193P	.	AFR:0.3323,AMR:0.4484,EAS:0.5743,FIN:0.3356,NFE:0.2734,OTH:0.3340,ASJ:0.3133	601768	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	19	MU4612009	het
19	4400314	4400314	C	T	SH3GL1	intronic	.	ENSG00000141985	rs62129356	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2038	0.1663	0.138179	0.1645	.	.	.	.	.	0	0	.	.	.	AFR:0.0466,AMR:0.2150,EAS:0.0706,FIN:0.1589,NFE:0.2405,OTH:0.1818,ASJ:0.1757	601768	601626;	519;	519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~	.	.	.	.	.	.	.	.	19	MU82328667	het
19	5595354	5595354	T	C	SAFB2	intronic	.	ENSG00000130254	rs10413286	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7299	0.7219	0.809305	0.7275	.	.	.	.	.	.	.	.	.	.	AFR:0.8615,AMR:0.7780,EAS:0.8908,FIN:0.6507,NFE:0.6490,OTH:0.6837,ASJ:0.77	608066	.	.	.	.	.	.	.	.	.	.	.	19	MU19175690	hom
19	5696146	5696146	G	A	LONP1	exonic	synonymous SNV	ENSG00000196365	rs3745624	ENSG00000196365:ENST00000360614:exon13:c.C1932T:p.T644T,ENSG00000196365:ENST00000540670:exon13:c.C1344T:p.T448T,ENSG00000196365:ENST00000590729:exon13:c.C1542T:p.T514T,ENSG00000196365:ENST00000585374:exon14:c.C1590T:p.T530T,ENSG00000196365:ENST00000593119:exon14:c.C1740T:p.T580T	LONP1:NM_001276480:exon13:c.C1344T:p.T448T,LONP1:NM_004793:exon13:c.C1932T:p.T644T,LONP1:NM_001276479:exon14:c.C1740T:p.T580T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2055	0.2432	0.199081	MU4546873	.	.	.	.	.	.	.	.	LONP1:uc002mcx.4:exon13:c.C1932T:p.T644T,LONP1:uc002mcz.3:exon13:c.C1344T:p.T448T,LONP1:uc010duh.4:exon13:c.C1155T:p.T385T,LONP1:uc031riz.1:exon13:c.C1542T:p.T514T,LONP1:uc002mcy.3:exon14:c.C1740T:p.T580T,LONP1:uc031rja.1:exon14:c.C1734T:p.T578T	.	AFR:COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.2114,EAS:0.2053,FIN:0.2450,NFE:0.0996,OTH:0.1261,ASJ:0.2432	605490	600373;	1458;	1458|Cerebro-oculo-dento-auriculo-skeletal syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|600373 ~	.	.	.	.	.	.	.	.	19	1(thyroid)	0.2258
19	5696245	5696245	A	G	LONP1	intronic	.	ENSG00000196365	rs4073993	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6030	0.6852	0.540735	MU734612	.	.	.	.	.	.	.	.	.	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,AMR:0.6411,EAS:0.5156,FIN:0.6358,NFE:0.2515,OTH:0.5842,ASJ:0.6682	605490	600373;	1458;	1458|Cerebro-oculo-dento-auriculo-skeletal syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|600373 ~	.	.	.	.	.	.	.	.	19	1(liver)	0.6880
19	6586268	6586268	G	A	CD70	exonic	synonymous SNV	ENSG00000125726	rs1862511	ENSG00000125726:ENST00000245903:exon3:c.C345T:p.C115C,ENSG00000125726:ENST00000423145:exon3:c.C345T:p.C115C	CD70:NM_001252:exon3:c.C345T:p.C115C,CD70:NM_001330332:exon3:c.C345T:p.C115C	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3201	0.2632	0.350639	0.2883	.	.	.	.	.	.	.	.	CD70:uc002mfi.3:exon3:c.C345T:p.C115C,CD70:uc010xjf.1:exon3:c.C345T:p.C115C	.	AFR:0.1934,AMR:0.2279,EAS:0.6958,FIN:0.3762,NFE:0.2822,OTH:0.2971,ASJ:0.2616	602840	.	.	.	.	.	.	.	.	.	.	.	19	MU4574437	hom
19	6772872	6772872	G	C	VAV1	exonic	synonymous SNV	ENSG00000141968	rs45448796	ENSG00000141968:ENST00000304076:exon1:c.G54C:p.P18P,ENSG00000141968:ENST00000596764:exon1:c.G54C:p.P18P,ENSG00000141968:ENST00000602142:exon1:c.G54C:p.P18P	VAV1:NM_001258206:exon1:c.G54C:p.P18P,VAV1:NM_001258207:exon1:c.G54C:p.P18P,VAV1:NM_005428:exon1:c.G54C:p.P18P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1149	0.1116	0.107628	0.0964	.	.	.	.	.	.	.	.	VAV1:uc002mfu.2:exon1:c.G54C:p.P18P,VAV1:uc010dva.2:exon1:c.G54C:p.P18P,VAV1:uc010xjh.2:exon1:c.G54C:p.P18P	.	AFR:0.0781,AMR:0.0668,EAS:0.0025,FIN:0.1017,NFE:0.1157,OTH:0.1112,ASJ:0.1457	164875	.	.	.	~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04510 Focal adhesion~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04810 Regulation of actin cytoskeleton~ko05135 Yersinia infection~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	.	het
19	10247973	10247973	G	T	DNMT1	intronic	.	ENSG00000130816	rs79585069	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0092	.	0.00838658	0.0091	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0,EAS:0.0272,FIN:0.0415,NFE:0.0049,OTH:0.0173,ASJ:0	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	.	unknown
19	10247975	10247975	C	G	DNMT1	intronic	.	ENSG00000130816	rs2290683	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0091	.	0.00838658	0.0091	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0,EAS:0.0272,FIN:0.0415,NFE:0.0049,OTH:0.0173,ASJ:0	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	.	unknown
19	10260337	10260337	G	A	DNMT1	intronic	.	ENSG00000130816	rs74505694	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0077	0.0006	0.00858626	0.0091	.	.	.	.	.	0.0001	0.014	.	.	.	AFR:0.0002,AMR:0,EAS:0.0266,FIN:0.0418,NFE:0.0049,OTH:0.0173,ASJ:0	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	.	het
19	10265248	10265248	T	C	DNMT1	intronic	.	ENSG00000130816	rs2114724	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5180	0.4882	0.533347	ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	.	.	AFR:0.5121,AMR:0.4941,EAS:0.5267,FIN:0.7122,NFE:0.5213,OTH:0.4972,ASJ:0.5168	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5276
19	10265312	10265312	T	C	DNMT1	exonic	synonymous SNV	ENSG00000130816	rs721186	ENSG00000130816:ENST00000340748:exon20:c.A1734G:p.T578T,ENSG00000130816:ENST00000540357:exon20:c.A1734G:p.T578T,ENSG00000130816:ENST00000359526:exon21:c.A1782G:p.T594T	DNMT1:NM_001318730:exon20:c.A1734G:p.T578T,DNMT1:NM_001379:exon20:c.A1734G:p.T578T,DNMT1:NM_001130823:exon21:c.A1782G:p.T594T,DNMT1:NM_001318731:exon21:c.A1419G:p.T473T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9910	0.9897	0.995807	0.9905	.	.	.	.	.	.	.	.	DNMT1:uc002mng.3:exon20:c.A1734G:p.T578T,DNMT1:uc010xld.2:exon20:c.A1734G:p.T578T,DNMT1:uc002mnh.3:exon21:c.A1419G:p.T473T,DNMT1:uc010xlc.2:exon21:c.A1782G:p.T594T	.	AFR:0.9961,AMR:0.9916,EAS:1,FIN:0.9888,NFE:0.9862,OTH:0.9969,ASJ:0.9901	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	MU82016881	hom
19	10265725	10265725	G	A	DNMT1	exonic	synonymous SNV	ENSG00000130816	rs75443147	ENSG00000130816:ENST00000340748:exon19:c.C1452T:p.A484A,ENSG00000130816:ENST00000540357:exon19:c.C1452T:p.A484A,ENSG00000130816:ENST00000359526:exon20:c.C1500T:p.A500A	DNMT1:NM_001318730:exon19:c.C1452T:p.A484A,DNMT1:NM_001379:exon19:c.C1452T:p.A484A,DNMT1:NM_001130823:exon20:c.C1500T:p.A500A,DNMT1:NM_001318731:exon20:c.C1137T:p.A379A	clinvar: Benign/Likely_benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0077	0.0006	0.00858626	0.0092	.	.	.	.	.	.	.	.	DNMT1:uc002mng.3:exon19:c.C1452T:p.A484A,DNMT1:uc010xld.2:exon19:c.C1452T:p.A484A,DNMT1:uc002mnh.3:exon20:c.C1137T:p.A379A,DNMT1:uc010xlc.2:exon20:c.C1500T:p.A500A	.	AFR:0.0003,AMR:0,EAS:0.0271,FIN:0.0418,NFE:0.0049,OTH:0.0174,ASJ:0	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	.	het
19	10267077	10267077	T	C	DNMT1	exonic	synonymous SNV	ENSG00000130816	rs2228611	ENSG00000130816:ENST00000340748:exon17:c.A1341G:p.P447P,ENSG00000130816:ENST00000540357:exon17:c.A1341G:p.P447P,ENSG00000130816:ENST00000359526:exon18:c.A1389G:p.P463P	DNMT1:NM_001318730:exon17:c.A1341G:p.P447P,DNMT1:NM_001379:exon17:c.A1341G:p.P447P,DNMT1:NM_001130823:exon18:c.A1389G:p.P463P,DNMT1:NM_001318731:exon18:c.A1026G:p.P342P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5188	0.4912	0.533946	MU13784738	.	.	.	.	.	.	.	.	DNMT1:uc002mng.3:exon17:c.A1341G:p.P447P,DNMT1:uc010xld.2:exon17:c.A1341G:p.P447P,DNMT1:uc002mnh.3:exon18:c.A1026G:p.P342P,DNMT1:uc010xlc.2:exon18:c.A1389G:p.P463P	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|5|321|0.0155763,AMR:0.5138,EAS:0.5169,FIN:0.5298,NFE:0.7114,OTH:0.5205,ASJ:0.5008	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	2(urinary_tract)	0.4972
19	10270747	10270747	A	-	DNMT1	intronic	.	ENSG00000130816	rs59599980	.	.	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.6388	.	0.579473	0.6856	.	.	.	.	.	.	.	.	.	.	AFR:0.7983,AMR:0.4665,EAS:0.4509,FIN:0.6087,NFE:0.6775,OTH:0.6387,ASJ:0.6577	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	.	hom
19	10292698	10292698	A	G	DNMT1	intronic	.	ENSG00000130816	rs77954383	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0077	0.0005	0.00858626	0.0091	.	.	.	.	.	.	.	.	.	.	AFR:0.0002,AMR:0,EAS:0.0272,FIN:0.0419,NFE:0.0049,OTH:0.0173,ASJ:0	126375	604121;614116;	456318;314404;	456318|HSAN1E<br>HSN1E<br>Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome|<1 / 1 000 000|Autosomal dominant|Adolescent<br>Adult|614116 ~314404|ADCA-DN<br>Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Adult|604121 ~	.	.	.	.	.	.	.	.	19	MU50835458	het
19	10465257	10465257	C	G	TYK2	exonic	synonymous SNV	ENSG00000105397	rs184567726	ENSG00000105397:ENST00000530560:exon2:c.G75C:p.P25P,ENSG00000105397:ENST00000524462:exon15:c.G2091C:p.P697P,ENSG00000105397:ENST00000264818:exon17:c.G2646C:p.P882P,ENSG00000105397:ENST00000525621:exon19:c.G2646C:p.P882P	TYK2:NM_003331:exon19:c.G2646C:p.P882P	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, -1, 1, 0, 0, 0] 	0.0002	.	0.00119808	3.232e-05	.	.	.	.	.	.	.	.	TYK2:uc010dxe.3:exon15:c.G2091C:p.P697P,TYK2:uc002moc.4:exon19:c.G2646C:p.P882P	.	AFR:0,AMR:0,EAS:0.0006,FIN:0,NFE:0,OTH:0,ASJ:0	176941	611521;	331226;	331226|Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency|-|Autosomal recessive|-|611521 ~	.	.	.	.	.	.	.	.	19	.	het
19	10472933	10472933	A	G	TYK2	intronic	.	ENSG00000105397	rs280519	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5082	0.5264	0.533147	0.5251	.	.	.	.	.	0	0	.	.	.	AFR:0.5636,AMR:0.3401,EAS:0.6213,FIN:0.5195,NFE:0.5036,OTH:0.5287,ASJ:0.5331	176941	611521;	331226;	331226|Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency|-|Autosomal recessive|-|611521 ~	.	.	.	.	.	.	.	.	19	MU23957937	het
19	10473138	10473138	A	G	TYK2	intronic	.	ENSG00000105397	rs280520	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3217	0.2730	0.329872	ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	0	0	.	.	.	AFR:0.2844,AMR:0.3772,EAS:0.1954,FIN:0.4287,NFE:0.2797,OTH:0.2232,ASJ:0.2019	176941	611521;	331226;	331226|Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency|-|Autosomal recessive|-|611521 ~	.	.	.	.	.	.	.	.	19	1(breast)	0.2710
19	10475652	10475652	C	A	TYK2	exonic	nonsynonymous SNV	ENSG00000105397	rs2304256	ENSG00000105397:ENST00000524462:exon4:c.G529T:p.V177F,ENSG00000105397:ENST00000264818:exon6:c.G1084T:p.V362F,ENSG00000105397:ENST00000525621:exon8:c.G1084T:p.V362F,ENSG00000105397:ENST00000529370:exon8:c.G1084T:p.V362F	TYK2:NM_003331:exon8:c.G1084T:p.V362F	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2768	0.2246	0.265775	1(prostate)	1.112	11.28	0.092	-0.832	0.000	.	.	FERM domain	TYK2:uc010dxe.3:exon4:c.G529T:p.V177F,TYK2:uc002moc.4:exon8:c.G1084T:p.V362F,TYK2:uc002mod.2:exon8:c.G1084T:p.V362F	-0.915	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:1(large_intestine),EAS:MU64157,FIN:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EOPC-DE|1|202|0.0049505,BRCA-KR|1|50|0.02,NFE:0.2370,OTH:0.1106,ASJ:1(breast)	176941	611521;	331226;	331226|Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency|-|Autosomal recessive|-|611521 ~	.	.	.	.	0.421	2.93	0.000	1.04	19	42(lung)	0.2005
19	10599965	10599965	G	A	KEAP1	exonic	synonymous SNV	ENSG00000079999	rs11545829	ENSG00000079999:ENST00000171111:exon5:c.C1611T:p.Y537Y,ENSG00000079999:ENST00000393623:exon5:c.C1611T:p.Y537Y	KEAP1:NM_012289:exon5:c.C1611T:p.Y537Y,KEAP1:NM_203500:exon5:c.C1611T:p.Y537Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.0388	0.0033	0.0816693	2(lung)	.	.	.	.	.	.	.	.	KEAP1:uc002moq.1:exon5:c.C1611T:p.Y537Y,KEAP1:uc002mor.1:exon5:c.C1611T:p.Y537Y	.	AFR:1(urinary_tract),AMR:2(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,BLCA-CN|1|103|0.00970874,FIN:0.0217,NFE:0.0077,OTH:0.0791,ASJ:MU4611125	606016	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	1(breast)	0
19	10600442	10600442	G	C	KEAP1	exonic	synonymous SNV	ENSG00000079999	rs1048290	ENSG00000079999:ENST00000171111:exon4:c.C1413G:p.L471L,ENSG00000079999:ENST00000393623:exon4:c.C1413G:p.L471L	KEAP1:NM_012289:exon4:c.C1413G:p.L471L,KEAP1:NM_203500:exon4:c.C1413G:p.L471L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4203	0.4780	0.508187	1(urinary_tract)	.	.	.	.	.	.	.	.	KEAP1:uc002mop.1:exon2:c.C567G:p.L189L,KEAP1:uc002moq.1:exon4:c.C1413G:p.L471L,KEAP1:uc002mor.1:exon4:c.C1413G:p.L471L	.	AFR:3(lung),AMR:17(soft_tissue),EAS:MU111229,FIN:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,COCA-CN|5|321|0.0155763,BRCA-KR|1|50|0.02,NFE:0.4760,OTH:0.6959,ASJ:1(haematopoietic_and_lymphoid_tissue)	606016	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	2(breast)	0.3230
19	10602950	10602950	G	-	KEAP1	intronic	.	ENSG00000079999	rs78238324	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0068	0.0010	0.00858626	0.0081	.	.	.	.	.	.	.	.	.	.	AFR:0.0009,AMR:0.0024,EAS:0.0360,FIN:0.0352,NFE:0.0034,OTH:0.0102,ASJ:0	606016	.	.	.	~ko04120 Ubiquitin mediated proteolysis~ko05200 Pathways in cancer~ko05225 Hepatocellular carcinoma~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	.	het
19	10939792	10939792	T	C	DNM2	exonic	synonymous SNV	ENSG00000079805	rs2229920	ENSG00000079805:ENST00000359692:exon18:c.T2127C:p.A709A,ENSG00000079805:ENST00000408974:exon18:c.T2127C:p.A709A,ENSG00000079805:ENST00000314646:exon19:c.T2139C:p.A713A,ENSG00000079805:ENST00000355667:exon19:c.T2139C:p.A713A,ENSG00000079805:ENST00000389253:exon19:c.T2139C:p.A713A,ENSG00000079805:ENST00000585892:exon19:c.T2139C:p.A713A	DNM2:NM_001005362:exon18:c.T2127C:p.A709A,DNM2:NM_004945:exon18:c.T2127C:p.A709A,DNM2:NM_001005360:exon19:c.T2139C:p.A713A,DNM2:NM_001005361:exon19:c.T2139C:p.A713A,DNM2:NM_001190716:exon19:c.T2139C:p.A713A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3115	0.2808	0.338259	1(thyroid)	.	.	.	.	.	.	.	.	DNM2:uc002mpx.1:exon3:c.T207C:p.A69A,DNM2:uc031rji.1:exon5:c.T960C:p.A320A,DNM2:uc031rjj.1:exon5:c.T960C:p.A320A,DNM2:uc002mpw.3:exon13:c.T1326C:p.A442A,DNM2:uc002mpu.2:exon18:c.T2127C:p.A709A,DNM2:uc002mpv.2:exon18:c.T2127C:p.A709A,DNM2:uc002mps.2:exon19:c.T2139C:p.A713A,DNM2:uc002mpt.2:exon19:c.T2139C:p.A713A,DNM2:uc010dxl.2:exon19:c.T2139C:p.A713A	.	AFR:1(liver),AMR:MU4548800,EAS:0.3020,FIN:0.2841,NFE:0.2536,OTH:0.3510,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,BLCA-CN|2|103|0.0194175	602378	160150;606482;615368;	363409;100044;228179;169189;	363409|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|615368 ~100044|CMTDIB|<1 / 1 000 000|Autosomal dominant|Childhood<br>Adolescent<br>Adult|606482 ~228179|CMT2M|<1 / 1 000 000|Autosomal dominant|All ages|606482 ~169189|AD-CNM|Unknown|Autosomal dominant|Adolescent<br>Infancy<br>Childhood|160150 614408 ~	.	.	.	.	.	.	.	.	19	2(urinary_tract)	0.5886
19	11105608	11105608	T	C	SMARCA4	exonic	synonymous SNV	ENSG00000127616	rs7935	ENSG00000127616:ENST00000413806:exon8:c.T1524C:p.H508H,ENSG00000127616:ENST00000450717:exon8:c.T1524C:p.H508H,ENSG00000127616:ENST00000344626:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000358026:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000590574:exon9:c.T1524C:p.H508H,ENSG00000127616:ENST00000429416:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000444061:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000541122:exon10:c.T1524C:p.H508H,ENSG00000127616:ENST00000589677:exon10:c.T1524C:p.H508H	SMARCA4:NM_001128845:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128846:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128848:exon8:c.T1524C:p.H508H,SMARCA4:NM_001128847:exon9:c.T1524C:p.H508H,SMARCA4:NM_001128849:exon9:c.T1524C:p.H508H,SMARCA4:NM_003072:exon9:c.T1524C:p.H508H,SMARCA4:NM_001128844:exon10:c.T1524C:p.H508H	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3353	0.3283	0.311502	11(soft_tissue)	.	.	.	.	.	.	.	.	SMARCA4:uc002mqg.1:exon8:c.T1524C:p.H508H,SMARCA4:uc002mqj.4:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxq.3:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxr.3:exon8:c.T1524C:p.H508H,SMARCA4:uc010dxs.3:exon8:c.T1524C:p.H508H,SMARCA4:uc002mqe.2:exon9:c.T1524C:p.H508H,SMARCA4:uc002mqf.4:exon9:c.T1524C:p.H508H,SMARCA4:uc010dxo.3:exon9:c.T1524C:p.H508H,SMARCA4:uc010dxp.3:exon10:c.T1524C:p.H508H	.	AFR:96(meninges),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,FIN:0.3248,NFE:0.3065,OTH:0.2127,ASJ:MU763313	603254	613325;614609;	1465;231108;69077;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~231108|RTPS<br>Rhabdoid tumor predisposition syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|609322 613325 ~69077|Malignant rhabdoid tumor|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 613325 ~	.	,9728	,9727	.	.	.	.	.	19	1(liver)	0.3808
19	11170839	11170839	T	C	SMARCA4	exonic	synonymous SNV	ENSG00000127616	rs7275	ENSG00000127616:ENST00000413806:exon32:c.T4797C:p.D1599D,ENSG00000127616:ENST00000450717:exon32:c.T4794C:p.D1598D,ENSG00000127616:ENST00000590574:exon33:c.T4788C:p.D1596D,ENSG00000127616:ENST00000344626:exon34:c.T4887C:p.D1629D,ENSG00000127616:ENST00000444061:exon34:c.T4785C:p.D1595D,ENSG00000127616:ENST00000541122:exon34:c.T4797C:p.D1599D,ENSG00000127616:ENST00000589677:exon34:c.T4794C:p.D1598D,ENSG00000127616:ENST00000358026:exon35:c.T4983C:p.D1661D,ENSG00000127616:ENST00000429416:exon35:c.T4887C:p.D1629D	SMARCA4:NM_001128845:exon32:c.T4797C:p.D1599D,SMARCA4:NM_001128846:exon32:c.T4794C:p.D1598D,SMARCA4:NM_001128848:exon32:c.T4785C:p.D1595D,SMARCA4:NM_001128847:exon33:c.T4788C:p.D1596D,SMARCA4:NM_003072:exon34:c.T4887C:p.D1629D,SMARCA4:NM_001128844:exon35:c.T4887C:p.D1629D,SMARCA4:NM_001128849:exon35:c.T4983C:p.D1661D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 1, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3090	0.2595	0.2498	83(meninges)	.	.	.	.	.	.	.	.	SMARCA4:uc002mqh.4:exon16:c.T2157C:p.D719D,SMARCA4:uc002mqj.4:exon32:c.T4797C:p.D1599D,SMARCA4:uc010dxq.3:exon32:c.T4788C:p.D1596D,SMARCA4:uc010dxr.3:exon32:c.T4785C:p.D1595D,SMARCA4:uc010dxs.3:exon32:c.T4794C:p.D1598D,SMARCA4:uc002mqf.4:exon34:c.T4887C:p.D1629D,SMARCA4:uc010dxo.3:exon35:c.T4983C:p.D1661D,SMARCA4:uc010dxp.3:exon35:c.T4887C:p.D1629D	.	AFR:3(large_intestine),AMR:MU93285,EAS:0.2731,FIN:0.2948,NFE:0.1814,OTH:0.2748,ASJ:COCA-CN|1|321|0.00311526	603254	613325;614609;	1465;231108;69077;	1465|CSS|<1 / 1 000 000|Autosomal dominant|Neonatal|135900 614607 614608 614609 615866 616938 ~231108|RTPS<br>Rhabdoid tumor predisposition syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|609322 613325 ~69077|Malignant rhabdoid tumor|Unknown|-|Antenatal<br>Neonatal<br>Infancy<br>Childhood|609322 613325 ~	.	,9728	,9727	.	.	.	.	.	19	7(soft_tissue)	0.0884
19	11221454	11221454	T	C	LDLR	intronic	.	ENSG00000130164	rs2738442	.	.	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0] 	0.9999	.	1	0.9999	.	.	.	.	.	0	0.006	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:0.9998,OTH:1,ASJ:1	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82017144	unknown
19	11221457	11221457	G	C	LDLR	intronic	.	ENSG00000130164	rs12710260	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3849	0.3377	0.276957	0.3290	.	.	.	.	.	.	.	.	.	.	AFR:0.0849,AMR:0.4021,EAS:0.1947,FIN:0.4894,NFE:0.4385,OTH:0.3929,ASJ:0.4139	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82287187	unknown
19	11224265	11224265	A	G	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5930	ENSG00000130164:ENST00000455727:exon8:c.A909G:p.R303R,ENSG00000130164:ENST00000535915:exon9:c.A1290G:p.R430R,ENSG00000130164:ENST00000545707:exon9:c.A1032G:p.R344R,ENSG00000130164:ENST00000557933:exon10:c.A1413G:p.R471R,ENSG00000130164:ENST00000558013:exon10:c.A1413G:p.R471R,ENSG00000130164:ENST00000558518:exon10:c.A1413G:p.R471R	LDLR:NM_001195800:exon8:c.A909G:p.R303R,LDLR:NM_001195799:exon9:c.A1290G:p.R430R,LDLR:NM_001195803:exon9:c.A1032G:p.R344R,LDLR:NM_000527:exon10:c.A1413G:p.R471R,LDLR:NM_001195798:exon10:c.A1413G:p.R471R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6266	0.6566	0.654952	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon8:c.A909G:p.R303R,LDLR:uc010xll.2:exon9:c.A1290G:p.R430R,LDLR:uc010xlm.2:exon9:c.A972G:p.R324R,LDLR:uc010xln.2:exon9:c.A1032G:p.R344R,LDLR:uc021upc.1:exon9:c.A1050G:p.R350R,LDLR:uc002mqk.4:exon10:c.A1413G:p.R471R,LDLR:uc010xlk.2:exon10:c.A1413G:p.R471R,LDLR:uc021upd.1:exon10:c.A624G:p.R208R	.	AFR:0.6454,AMR:0.7415,EAS:0.5762,FIN:0.6163,NFE:0.6376,OTH:0.5965,ASJ:0.6933	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5900
19	11227602	11227602	C	T	LDLR	exonic	synonymous SNV	ENSG00000130164	rs688	ENSG00000130164:ENST00000455727:exon10:c.C1269T:p.N423N,ENSG00000130164:ENST00000535915:exon11:c.C1650T:p.N550N,ENSG00000130164:ENST00000545707:exon11:c.C1392T:p.N464N,ENSG00000130164:ENST00000557933:exon12:c.C1773T:p.N591N,ENSG00000130164:ENST00000558013:exon12:c.C1773T:p.N591N,ENSG00000130164:ENST00000558518:exon12:c.C1773T:p.N591N	LDLR:NM_001195800:exon10:c.C1269T:p.N423N,LDLR:NM_001195799:exon11:c.C1650T:p.N550N,LDLR:NM_001195803:exon11:c.C1392T:p.N464N,LDLR:NM_000527:exon12:c.C1773T:p.N591N,LDLR:NM_001195798:exon12:c.C1773T:p.N591N	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3781	0.3352	0.275759	0.3273	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon10:c.C1269T:p.N423N,LDLR:uc010xll.2:exon11:c.C1650T:p.N550N,LDLR:uc010xlm.2:exon11:c.C1332T:p.N444N,LDLR:uc010xln.2:exon11:c.C1392T:p.N464N,LDLR:uc021upc.1:exon11:c.C1410T:p.N470N,LDLR:uc002mqk.4:exon12:c.C1773T:p.N591N,LDLR:uc010xlk.2:exon12:c.C1773T:p.N591N,LDLR:uc021upd.1:exon12:c.C984T:p.N328N	.	AFR:0.1001,AMR:0.3995,EAS:0.1960,FIN:0.4782,NFE:0.4299,OTH:0.3842,ASJ:0.3808	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU82017159	het
19	11230881	11230881	T	C	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5925	ENSG00000130164:ENST00000455727:exon11:c.T1455C:p.V485V,ENSG00000130164:ENST00000535915:exon12:c.T1836C:p.V612V,ENSG00000130164:ENST00000545707:exon12:c.T1578C:p.V526V,ENSG00000130164:ENST00000557933:exon13:c.T1959C:p.V653V,ENSG00000130164:ENST00000558013:exon13:c.T1959C:p.V653V,ENSG00000130164:ENST00000558518:exon13:c.T1959C:p.V653V	LDLR:NM_001195800:exon11:c.T1455C:p.V485V,LDLR:NM_001195799:exon12:c.T1836C:p.V612V,LDLR:NM_001195803:exon12:c.T1578C:p.V526V,LDLR:NM_000527:exon13:c.T1959C:p.V653V,LDLR:NM_001195798:exon13:c.T1959C:p.V653V	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4092	0.3662	0.335863	0.3620	.	.	.	.	.	.	.	.	LDLR:uc010xlo.2:exon11:c.T1455C:p.V485V,LDLR:uc010xll.2:exon12:c.T1836C:p.V612V,LDLR:uc010xlm.2:exon12:c.T1518C:p.V506V,LDLR:uc010xln.2:exon12:c.T1578C:p.V526V,LDLR:uc021upc.1:exon12:c.T1596C:p.V532V,LDLR:uc002mqk.4:exon13:c.T1959C:p.V653V,LDLR:uc010xlk.2:exon13:c.T1959C:p.V653V,LDLR:uc021upd.1:exon13:c.T1170C:p.V390V	.	AFR:0.1938,AMR:0.5036,EAS:0.2416,FIN:0.4828,NFE:0.4338,OTH:0.4010,ASJ:0.3833	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	MU27837937	het
19	11233941	11233941	A	G	LDLR	exonic	synonymous SNV	ENSG00000130164	rs5927	ENSG00000130164:ENST00000455727:exon13:c.A1728G:p.R576R,ENSG00000130164:ENST00000545707:exon13:c.A1698G:p.R566R,ENSG00000130164:ENST00000535915:exon14:c.A2109G:p.R703R,ENSG00000130164:ENST00000557933:exon15:c.A2232G:p.R744R,ENSG00000130164:ENST00000558013:exon15:c.A2232G:p.R744R,ENSG00000130164:ENST00000558518:exon15:c.A2232G:p.R744R	LDLR:NM_001195800:exon13:c.A1728G:p.R576R,LDLR:NM_001195803:exon13:c.A1698G:p.R566R,LDLR:NM_001195799:exon14:c.A2109G:p.R703R,LDLR:NM_000527:exon15:c.A2232G:p.R744R,LDLR:NM_001195798:exon15:c.A2232G:p.R744R	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7762	0.7387	0.780152	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LDLR:uc010xln.2:exon13:c.A1698G:p.R566R,LDLR:uc010xlo.2:exon13:c.A1728G:p.R576R,LDLR:uc010xll.2:exon14:c.A2109G:p.R703R,LDLR:uc010xlm.2:exon14:c.A1791G:p.R597R,LDLR:uc021upc.1:exon14:c.A1869G:p.R623R,LDLR:uc002mqk.4:exon15:c.A2232G:p.R744R,LDLR:uc010xlk.2:exon15:c.A2232G:p.R744R,LDLR:uc021upd.1:exon15:c.A1443G:p.R481R	.	AFR:0.7480,AMR:0.6849,EAS:0.7053,FIN:0.9491,NFE:0.7702,OTH:0.7530,ASJ:0.8484	606945	143890;	391665;	391665|HoFH|1-9 / 1 000 000|Autosomal recessive|-|143890 602247 603813 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.75
19	13318673	13318690	CTGCTGCTGCTGCTGCTG	-	CACNA1A	exonic	nonframeshift deletion	ENSG00000141837	rs765169827	ENSG00000141837:ENST00000587525:exon19:c.2383_2400del:p.795_800del,ENSG00000141837:ENST00000585802:exon23:c.2980_2997del:p.994_999del,ENSG00000141837:ENST00000360228:exon47:c.6958_6975del:p.2320_2325del	CACNA1A:NM_001127222:exon47:c.6958_6975del:p.2320_2325del	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0300	.	.	0.0997	.	.	.	.	.	.	.	.	CACNA1A:uc002mwv.3:exon19:c.2473_2490del:p.825_830del,CACNA1A:uc002mwx.3:exon23:c.3040_3057del:p.1014_1019del,CACNA1A:uc010dzc.2:exon38:c.5536_5553del:p.1846_1851del,CACNA1A:uc002mwy.3:exon47:c.6958_6975del:p.2320_2325del,CACNA1A:uc010xne.2:exon47:c.6967_6984del:p.2323_2328del	.	AFR:0.0560,AMR:0.0693,EAS:0.0783,FIN:0.1930,NFE:0.1071,OTH:0.1373,ASJ:0.1053	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	.	unknown
19	13319693	13319693	A	G	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs16051	ENSG00000141837:ENST00000587525:exon18:c.T2082C:p.H694H,ENSG00000141837:ENST00000585802:exon22:c.T2679C:p.H893H,ENSG00000141837:ENST00000360228:exon46:c.T6657C:p.H2219H,ENSG00000141837:ENST00000573710:exon46:c.T6660C:p.H2220H	CACNA1A:NM_001127221:exon46:c.T6660C:p.H2220H,CACNA1A:NM_001127222:exon46:c.T6657C:p.H2219H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6160	0.6088	0.686901	COCA-CN|8|321|0.0249221	.	.	.	.	.	.	.	.	CACNA1A:uc002mwv.3:exon18:c.T2172C:p.H724H,CACNA1A:uc002mwx.3:exon22:c.T2739C:p.H913H,CACNA1A:uc010dzc.2:exon37:c.T5235C:p.H1745H,CACNA1A:uc002mwy.3:exon46:c.T6657C:p.H2219H,CACNA1A:uc010dze.2:exon46:c.T6657C:p.H2219H,CACNA1A:uc010xnd.2:exon46:c.T6666C:p.H2222H,CACNA1A:uc010xne.2:exon46:c.T6666C:p.H2222H,CACNA1A:uc021ups.1:exon46:c.T6657C:p.H2219H,CACNA1A:uc021upt.1:exon46:c.T6660C:p.H2220H	.	AFR:0.6902,AMR:0.7687,EAS:0.5352,FIN:0.7786,NFE:0.7115,OTH:0.6401,ASJ:0.6079	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	4(large_intestine)	0.6366
19	13411482	13411482	G	A	CACNA1A	intronic	.	ENSG00000141837	rs16018	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7491	0.6452	0.739217	0.6801	.	.	.	.	.	0	0.006	.	.	.	AFR:0.5061,AMR:0.7955,EAS:0.9981,FIN:0.7861,NFE:0.7122,OTH:0.7209,ASJ:0.7219	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	MU82017954	hom
19	13414594	13414594	C	T	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs16016	ENSG00000141837:ENST00000360228:exon16:c.G2091A:p.T697T,ENSG00000141837:ENST00000573710:exon16:c.G2094A:p.T698T	CACNA1A:NM_001127221:exon16:c.G2094A:p.T698T,CACNA1A:NM_001127222:exon16:c.G2091A:p.T697T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1607	0.1141	0.185104	1(thyroid)	.	.	.	.	.	.	.	.	CACNA1A:uc010dzc.2:exon7:c.G669A:p.T223T,CACNA1A:uc002mwy.3:exon16:c.G2091A:p.T697T,CACNA1A:uc010dze.2:exon16:c.G2091A:p.T697T,CACNA1A:uc010xnd.2:exon16:c.G2091A:p.T697T,CACNA1A:uc010xne.2:exon16:c.G2091A:p.T697T,CACNA1A:uc021ups.1:exon16:c.G2091A:p.T697T,CACNA1A:uc021upt.1:exon16:c.G2094A:p.T698T	.	AFR:MU4566431,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.0831,FIN:0.2255,NFE:0.1523,OTH:0.2919,ASJ:0.1230	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	1(lung)	0.1160
19	13445208	13445208	C	T	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs2248069	ENSG00000141837:ENST00000360228:exon8:c.G1182A:p.E394E,ENSG00000141837:ENST00000573710:exon8:c.G1182A:p.E394E	CACNA1A:NM_001127221:exon8:c.G1182A:p.E394E,CACNA1A:NM_001127222:exon8:c.G1182A:p.E394E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6857	0.6437	0.641174	0.6399	.	.	.	.	.	.	.	.	CACNA1A:uc002mwy.3:exon8:c.G1182A:p.E394E,CACNA1A:uc010dze.2:exon8:c.G1182A:p.E394E,CACNA1A:uc010xnd.2:exon8:c.G1182A:p.E394E,CACNA1A:uc010xne.2:exon8:c.G1182A:p.E394E,CACNA1A:uc021ups.1:exon8:c.G1182A:p.E394E,CACNA1A:uc021upt.1:exon8:c.G1182A:p.E394E	.	AFR:0.5194,AMR:0.7596,EAS:0.6225,FIN:0.6723,NFE:0.6930,OTH:0.7108,ASJ:0.6391	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	MU20064845	het
19	13470522	13470522	T	C	CACNA1A	exonic	synonymous SNV	ENSG00000141837	rs16006	ENSG00000141837:ENST00000360228:exon6:c.A876G:p.E292E,ENSG00000141837:ENST00000573710:exon6:c.A876G:p.E292E	CACNA1A:NM_001127221:exon6:c.A876G:p.E292E,CACNA1A:NM_001127222:exon6:c.A876G:p.E292E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0961	0.0702	0.112021	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	CACNA1A:uc002mwy.3:exon6:c.A876G:p.E292E,CACNA1A:uc010dze.2:exon6:c.A876G:p.E292E,CACNA1A:uc010xnd.2:exon6:c.A876G:p.E292E,CACNA1A:uc010xne.2:exon6:c.A876G:p.E292E,CACNA1A:uc021ups.1:exon6:c.A876G:p.E292E,CACNA1A:uc021upt.1:exon6:c.A876G:p.E292E	.	AFR:0.0879,AMR:0.1864,EAS:0.0695,FIN:0.1689,NFE:0.0341,OTH:0.0399,ASJ:0.0395	601011	108500;141500;183086;617106;	442835;98758;569;97;	442835|Undetermined EOEE|-|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy|614558 615833 615871 615905 616056 616211 616339 616346 616366 616409 617105 617106 617132 617153 617162 617166 ~98758|SCA6|1-9 / 1 000 000|Autosomal dominant|Adolescent<br>Adult<br>Elderly|183086 ~569|-|1-5 / 10 000|Autosomal dominant|Childhood|141500 602481 607516 609634 ~97|Episodic ataxia type 2|Unknown|Autosomal dominant|Childhood|108500 ~	.	.	.	.	.	.	.	.	19	2(haematopoietic_and_lymphoid_tissue)	0.0540
19	15271771	15271771	G	A	NOTCH3	exonic	nonsynonymous SNV	ENSG00000074181	rs1044009	ENSG00000074181:ENST00000263388:exon33:c.C6668T:p.A2223V	NOTCH3:NM_000435:exon33:c.C6668T:p.A2223V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.7591	0.7349	0.629393	0.7049	0.823	9.604	0.175	0.427	0.005	.	.	Domain of unknown function DUF3454, notch	NOTCH3:uc002nan.3:exon33:c.C6668T:p.A2223V	-0.953	AFR:0.5350,AMR:0.5943,EAS:0.5856,FIN:0.8099,NFE:0.7920,OTH:0.7813,ASJ:0.7682	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	0.001	-1.47	0.000	0.895	19	MU75620	het
19	15273381	15273381	A	G	NOTCH3	intronic	.	ENSG00000074181	rs4809030	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8745	0.9233	0.86901	0.9108	.	.	.	.	.	0	0	.	.	.	AFR:0.9753,AMR:0.7578,EAS:0.8047,FIN:0.8885,NFE:0.9008,OTH:0.8801,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU23789083	het
19	15276919	15276919	G	A	NOTCH3	intronic	.	ENSG00000074181	rs2074619	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8717	0.9222	0.866613	0.9094	.	.	.	.	.	.	.	.	.	.	AFR:0.9718,AMR:0.7578,EAS:0.8025,FIN:0.8884,NFE:0.9003,OTH:0.8788,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU649788	unknown
19	15278057	15278057	A	G	NOTCH3	intronic	.	ENSG00000074181	rs1548555	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8741	0.9237	0.870008	0.9112	.	.	.	.	.	0.0001	0.034	.	.	.	AFR:0.9764,AMR:0.7566,EAS:0.8049,FIN:0.8884,NFE:0.9009,OTH:0.8786,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU19223798	het
19	15285052	15285052	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1044006	ENSG00000074181:ENST00000263388:exon25:c.A4563G:p.P1521P	NOTCH3:NM_000435:exon25:c.A4563G:p.P1521P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8812	0.9261	0.871805	0.9112	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon25:c.A4563G:p.P1521P	.	AFR:0.9774,AMR:0.7560,EAS:0.8045,FIN:0.8885,NFE:0.9005,OTH:0.8798,ASJ:0.8974	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU72607	het
19	15292437	15292437	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043997	ENSG00000074181:ENST00000601011:exon16:c.A2583G:p.P861P,ENSG00000074181:ENST00000263388:exon17:c.A2742G:p.P914P	NOTCH3:NM_000435:exon17:c.A2742G:p.P914P	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8019	0.7905	0.739018	0.7822	.	.	.	.	.	.	.	.	NOTCH3:uc002nao.1:exon16:c.A2586G:p.P862P,NOTCH3:uc002nan.3:exon17:c.A2742G:p.P914P	.	AFR:0.6053,AMR:0.7076,EAS:0.8340,FIN:0.8445,NFE:0.8651,OTH:0.8187,ASJ:0.8709	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU4550901	hom
19	15295134	15295134	G	A	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043996	ENSG00000074181:ENST00000263388:exon16:c.C2538T:p.C846C	NOTCH3:NM_000435:exon16:c.C2538T:p.C846C	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6427	0.5664	0.519968	0.5867	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon16:c.C2538T:p.C846C	.	AFR:0.2616,AMR:0.5395,EAS:0.6050,FIN:0.7516,NFE:0.7284,OTH:0.6988,ASJ:0.6887	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU786918	het
19	15300069	15300069	T	C	NOTCH3	intronic	.	ENSG00000074181	rs10423702	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8572	0.8891	0.854233	0.8807	.	.	.	.	.	.	.	.	.	.	AFR:0.9086,AMR:0.7434,EAS:0.8798,FIN:0.8635,NFE:0.8780,OTH:0.8449,ASJ:0.9040	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU19224492	hom
19	15302844	15302844	T	C	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs1043994	ENSG00000074181:ENST00000263388:exon4:c.A606G:p.A202A,ENSG00000074181:ENST00000601011:exon4:c.A603G:p.A201A	NOTCH3:NM_000435:exon4:c.A606G:p.A202A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8581	0.8893	0.855831	0.8808	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon4:c.A606G:p.A202A,NOTCH3:uc002nao.1:exon4:c.A606G:p.A202A	.	AFR:0.9088,AMR:0.7452,EAS:0.8795,FIN:0.8643,NFE:0.8779,OTH:0.8469,ASJ:0.9073	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU763505	hom
19	15303225	15303225	G	A	NOTCH3	exonic	synonymous SNV	ENSG00000074181	rs3815188	ENSG00000074181:ENST00000263388:exon3:c.C303T:p.T101T,ENSG00000074181:ENST00000601011:exon3:c.C300T:p.T100T	NOTCH3:NM_000435:exon3:c.C303T:p.T101T	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1822	0.1834	0.224042	0.1787	.	.	.	.	.	.	.	.	NOTCH3:uc002nan.3:exon3:c.C303T:p.T101T,NOTCH3:uc002nao.1:exon3:c.C303T:p.T101T	.	AFR:0.2575,AMR:0.1790,EAS:0.3546,FIN:0.0920,NFE:0.1376,OTH:0.1214,ASJ:0.1854	600276	125310;130720;615293;	2591;2789;136;	2591|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy<br>Neonatal|228550 615293 ~2789|Lehman syndrome|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|130720 ~136|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy<br>Hereditary multi-infarct dementia|1-9 / 100 000|Autosomal dominant|Adult|125310 ~	~ko01522 Endocrine resistance~ko04320 Dorso-ventral axis formation~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04919 Thyroid hormone signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05206 MicroRNAs in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	19	MU805526	het
19	15350717	15350717	T	-	BRD4	intronic	.	ENSG00000141867	rs776518007	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	9.146e-05	.	.	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	608749	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	15367060	15367060	G	A	BRD4	exonic	synonymous SNV	ENSG00000141867	rs193215766	ENSG00000141867:ENST00000263377:exon9:c.C1566T:p.H522H,ENSG00000141867:ENST00000360016:exon9:c.C1566T:p.H522H,ENSG00000141867:ENST00000371835:exon9:c.C1566T:p.H522H,ENSG00000141867:ENST00000594841:exon9:c.C1566T:p.H522H	BRD4:NM_001330384:exon9:c.C1566T:p.H522H,BRD4:NM_014299:exon9:c.C1566T:p.H522H,BRD4:NM_058243:exon9:c.C1566T:p.H522H	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	0.0002	.	0.000798722	6.466e-05	.	.	.	.	.	.	.	.	BRD4:uc002nar.3:exon9:c.C1566T:p.H522H,BRD4:uc002nas.3:exon9:c.C1566T:p.H522H,BRD4:uc002nat.3:exon9:c.C1566T:p.H522H,BRD4:uc002nau.4:exon9:c.C1566T:p.H522H	.	AFR:0,AMR:0,EAS:0.0012,FIN:0,NFE:0,OTH:0,ASJ:0	608749	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	17392894	17392894	G	A	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs8100241	ENSG00000160117:ENST00000394458:exon2:c.G91A:p.A31T,ENSG00000160117:ENST00000404085:exon2:c.G157A:p.A53T,ENSG00000160117:ENST00000404261:exon2:c.G91A:p.A31T,ENSG00000160117:ENST00000433424:exon2:c.G253A:p.A85T,ENSG00000160117:ENST00000594072:exon2:c.G58A:p.A20T,ENSG00000160117:ENST00000598347:exon2:c.G91A:p.A31T	ANKLE1:NM_001278443:exon2:c.G58A:p.A20T,ANKLE1:NM_001278444:exon2:c.G91A:p.A31T,ANKLE1:NM_001278445:exon2:c.G49A:p.A17T,ANKLE1:NM_152363:exon2:c.G91A:p.A31T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4908	0.4351	0.427316	LICA-CN|2|402|0.00497512,COCA-CN|3|321|0.00934579	4.739	24.7	.	1.65	0.145	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon2:c.G58A:p.A20T,ANKLE1:uc002nga.2:exon2:c.G91A:p.A31T,ANKLE1:uc010eao.1:exon2:c.G157A:p.A53T,ANKLE1:uc010xpn.1:exon2:c.G253A:p.A85T	-0.912	AFR:0.4815,AMR:0.4017,EAS:0.4934,FIN:0.3410,NFE:0.5655,OTH:0.5252,ASJ:0.4159	.	.	.	.	.	.	.	.	0.634	-0.13	0.000	2.555	19	9(large_intestine)	0.5082
19	17393015	17393015	C	T	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs1864116	ENSG00000160117:ENST00000394458:exon2:c.C212T:p.A71V,ENSG00000160117:ENST00000404085:exon2:c.C278T:p.A93V,ENSG00000160117:ENST00000404261:exon2:c.C212T:p.A71V,ENSG00000160117:ENST00000433424:exon2:c.C374T:p.A125V,ENSG00000160117:ENST00000594072:exon2:c.C179T:p.A60V,ENSG00000160117:ENST00000598347:exon2:c.C212T:p.A71V	ANKLE1:NM_001278443:exon2:c.C179T:p.A60V,ANKLE1:NM_001278444:exon2:c.C212T:p.A71V,ANKLE1:NM_001278445:exon2:c.C170T:p.A57V,ANKLE1:NM_152363:exon2:c.C212T:p.A71V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7176	0.8695	0.635383	COCA-CN|3|321|0.00934579	2.020	16.34	.	0.796	0.923	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon2:c.C179T:p.A60V,ANKLE1:uc002nga.2:exon2:c.C212T:p.A71V,ANKLE1:uc010eao.1:exon2:c.C278T:p.A93V,ANKLE1:uc010xpn.1:exon2:c.C374T:p.A125V	-1.007	AFR:0.7910,AMR:0.7959,EAS:0.8245,FIN:0.3402,NFE:0.8764,OTH:0.8288,ASJ:0.5694	.	.	.	.	.	.	.	.	0.005	1.6	0.000	1.29	19	5(large_intestine)	0.7853
19	17393504	17393504	G	C	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs1864113	ENSG00000160117:ENST00000394458:exon3:c.G255C:p.A85A,ENSG00000160117:ENST00000404085:exon3:c.G321C:p.A107A,ENSG00000160117:ENST00000404261:exon3:c.G255C:p.A85A,ENSG00000160117:ENST00000433424:exon3:c.G417C:p.A139A,ENSG00000160117:ENST00000594072:exon3:c.G222C:p.A74A,ENSG00000160117:ENST00000598347:exon3:c.G255C:p.A85A	ANKLE1:NM_001278443:exon3:c.G222C:p.A74A,ANKLE1:NM_001278444:exon3:c.G255C:p.A85A,ANKLE1:NM_001278445:exon3:c.G213C:p.A71A,ANKLE1:NM_152363:exon3:c.G255C:p.A85A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7006	0.8398	0.635383	3(lung)	.	.	.	.	.	.	.	.	ANKLE1:uc002nfy.2:exon3:c.G222C:p.A74A,ANKLE1:uc002nga.2:exon3:c.G255C:p.A85A,ANKLE1:uc010eao.1:exon3:c.G321C:p.A107A,ANKLE1:uc010xpn.1:exon3:c.G417C:p.A139A	.	AFR:MU112067,AMR:LICA-CN|2|402|0.00497512,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.7954,FIN:0.5680,NFE:0.8245,OTH:0.3397,ASJ:0.7911	.	.	.	.	.	.	.	.	.	.	.	.	19	5(large_intestine)	0.8759
19	17393530	17393530	T	A	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs8108174	ENSG00000160117:ENST00000394458:exon3:c.T281A:p.L94Q,ENSG00000160117:ENST00000404085:exon3:c.T347A:p.L116Q,ENSG00000160117:ENST00000404261:exon3:c.T281A:p.L94Q,ENSG00000160117:ENST00000433424:exon3:c.T443A:p.L148Q,ENSG00000160117:ENST00000594072:exon3:c.T248A:p.L83Q,ENSG00000160117:ENST00000598347:exon3:c.T281A:p.L94Q	ANKLE1:NM_001278443:exon3:c.T248A:p.L83Q,ANKLE1:NM_001278444:exon3:c.T281A:p.L94Q,ANKLE1:NM_001278445:exon3:c.T239A:p.L80Q,ANKLE1:NM_152363:exon3:c.T281A:p.L94Q	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 1, 0, 0] 	0.5191	0.5679	0.460663	1(lung)	5.385	26.0	.	4.27	0.033	.	.	Ankyrin repeat-containing domain	ANKLE1:uc002nfy.2:exon3:c.T248A:p.L83Q,ANKLE1:uc002nga.2:exon3:c.T281A:p.L94Q,ANKLE1:uc010eao.1:exon3:c.T347A:p.L116Q,ANKLE1:uc010xpn.1:exon3:c.T443A:p.L148Q	-0.867	AFR:MU67496,AMR:ESAD-UK|1|409|0.00244499,LICA-CN|2|402|0.00497512,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.4994,FIN:0.4248,NFE:0.4967,OTH:0.3399,ASJ:0.5102	.	.	.	.	.	.	.	.	0.793	.	0.000	2.605	19	12(large_intestine)	0.5665
19	17394124	17394124	T	G	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs2363956	ENSG00000160117:ENST00000394458:exon5:c.T551G:p.L184W,ENSG00000160117:ENST00000404085:exon5:c.T617G:p.L206W,ENSG00000160117:ENST00000404261:exon5:c.T551G:p.L184W,ENSG00000160117:ENST00000433424:exon5:c.T713G:p.L238W,ENSG00000160117:ENST00000594072:exon5:c.T518G:p.L173W,ENSG00000160117:ENST00000598347:exon5:c.T551G:p.L184W	ANKLE1:NM_001278443:exon5:c.T518G:p.L173W,ANKLE1:NM_001278444:exon5:c.T551G:p.L184W,ANKLE1:NM_001278445:exon5:c.T509G:p.L170W,ANKLE1:NM_152363:exon5:c.T551G:p.L184W	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4869	0.5125	0.460663	3(lung)	3.307	22.9	.	2.26	0.002	.	.	.	ANKLE1:uc002nfy.2:exon5:c.T518G:p.L173W,ANKLE1:uc002nga.2:exon5:c.T551G:p.L184W,ANKLE1:uc010eao.1:exon5:c.T617G:p.L206W,ANKLE1:uc010xpn.1:exon5:c.T713G:p.L238W	-0.933	AFR:MU151415,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,PEME-CA|1|112|0.00892857,EAS:0.5,FIN:0.4269,NFE:0.4934,OTH:0.3395,ASJ:0.5096	.	.	.	.	.	.	.	.	0.246	.	0.000	1.65	19	1(thyroid)	0.5662
19	17394504	17394504	A	C	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs891017	ENSG00000160117:ENST00000394458:exon5:c.A931C:p.T311P,ENSG00000160117:ENST00000404085:exon5:c.A997C:p.T333P,ENSG00000160117:ENST00000404261:exon5:c.A931C:p.T311P,ENSG00000160117:ENST00000433424:exon5:c.A1093C:p.T365P,ENSG00000160117:ENST00000594072:exon5:c.A898C:p.T300P,ENSG00000160117:ENST00000598347:exon5:c.A931C:p.T311P	ANKLE1:NM_001278443:exon5:c.A898C:p.T300P,ANKLE1:NM_001278444:exon5:c.A931C:p.T311P,ANKLE1:NM_001278445:exon5:c.A889C:p.T297P,ANKLE1:NM_152363:exon5:c.A931C:p.T311P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7211	0.8005	0.635383	LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	-0.449	0.293	.	0.314	0.003	.	.	LEM domain|LEM/LEM-like domain	ANKLE1:uc002nfz.2:exon4:c.A49C:p.T17P,ANKLE1:uc002nfy.2:exon5:c.A898C:p.T300P,ANKLE1:uc002nga.2:exon5:c.A931C:p.T311P,ANKLE1:uc010eao.1:exon5:c.A997C:p.T333P,ANKLE1:uc010xpn.1:exon5:c.A1093C:p.T365P	-0.972	AFR:0.7912,AMR:0.7954,EAS:0.8245,FIN:0.3402,NFE:0.8756,OTH:0.8296,ASJ:0.5680	.	.	.	.	.	.	.	.	0.0	.	0.000	-1.15	19	1(haematopoietic_and_lymphoid_tissue)	0.7848
19	17395003	17395003	A	G	ANKLE1	exonic	nonsynonymous SNV	ENSG00000160117	rs11086065	ENSG00000160117:ENST00000394458:exon6:c.A1304G:p.Q435R,ENSG00000160117:ENST00000404085:exon6:c.A1292G:p.Q431R,ENSG00000160117:ENST00000594072:exon6:c.A1193G:p.Q398R,ENSG00000160117:ENST00000598347:exon6:c.A1226G:p.Q409R	ANKLE1:NM_001278443:exon6:c.A1193G:p.Q398R,ANKLE1:NM_001278444:exon6:c.A1226G:p.Q409R,ANKLE1:NM_001278445:exon6:c.A1184G:p.Q395R,ANKLE1:NM_152363:exon6:c.A1304G:p.Q435R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7206	0.8009	0.635184	1(haematopoietic_and_lymphoid_tissue)	-2.006	0.001	.	-7.51	0.017	.	.	GIY-YIG nuclease superfamily	ANKLE1:uc002nfz.2:exon5:c.A422G:p.Q141R,ANKLE1:uc002nfy.2:exon6:c.A1193G:p.Q398R,ANKLE1:uc002nga.2:exon6:c.A1304G:p.Q435R,ANKLE1:uc010eao.1:exon6:c.A1292G:p.Q431R,ANKLE1:uc010xpn.1:exon6:c.A1388G:p.Q463R	-0.963	AFR:MU4566639,AMR:LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,EAS:0.7954,FIN:0.5680,NFE:0.8233,OTH:0.3398,ASJ:0.7908	.	.	.	.	.	.	.	.	0.0	.	0.000	0.475	19	1(breast)	0.8756
19	17395055	17395055	C	G	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs11882562	ENSG00000160117:ENST00000394458:exon6:c.C1356G:p.T452T,ENSG00000160117:ENST00000404085:exon6:c.C1344G:p.T448T,ENSG00000160117:ENST00000594072:exon6:c.C1245G:p.T415T,ENSG00000160117:ENST00000598347:exon6:c.C1278G:p.T426T	ANKLE1:NM_001278443:exon6:c.C1245G:p.T415T,ANKLE1:NM_001278444:exon6:c.C1278G:p.T426T,ANKLE1:NM_001278445:exon6:c.C1236G:p.T412T,ANKLE1:NM_152363:exon6:c.C1356G:p.T452T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7208	0.8008	0.635383	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ANKLE1:uc002nfz.2:exon5:c.C474G:p.T158T,ANKLE1:uc002nfy.2:exon6:c.C1245G:p.T415T,ANKLE1:uc002nga.2:exon6:c.C1356G:p.T452T,ANKLE1:uc010eao.1:exon6:c.C1344G:p.T448T,ANKLE1:uc010xpn.1:exon6:c.C1440G:p.T480T	.	AFR:0.7910,AMR:0.7954,EAS:0.8221,FIN:0.3418,NFE:0.8756,OTH:0.8289,ASJ:0.5680	.	.	.	.	.	.	.	.	.	.	.	.	19	3(lung)	0.7867
19	17396549	17396549	T	C	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs751599	ENSG00000160117:ENST00000394458:exon8:c.T1596C:p.G532G,ENSG00000160117:ENST00000404085:exon8:c.T1584C:p.G528G,ENSG00000160117:ENST00000594072:exon8:c.T1485C:p.G495G	ANKLE1:NM_001278443:exon8:c.T1485C:p.G495G,ANKLE1:NM_001278445:exon8:c.T1476C:p.G492G,ANKLE1:NM_152363:exon8:c.T1596C:p.G532G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7214	0.8006	0.635383	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	ANKLE1:uc002nfz.2:exon7:c.T714C:p.G238G,ANKLE1:uc002nfy.2:exon8:c.T1485C:p.G495G,ANKLE1:uc002nga.2:exon8:c.T1596C:p.G532G,ANKLE1:uc010eao.1:exon8:c.T1584C:p.G528G	.	AFR:0.7914,AMR:0.7960,EAS:0.8245,FIN:0.3420,NFE:0.8757,OTH:0.8300,ASJ:0.5680	.	.	.	.	.	.	.	.	.	.	.	.	19	1(lung)	0.7857
19	17397479	17397479	G	T	ANKLE1	exonic	synonymous SNV	ENSG00000160117	rs11880549	ENSG00000160117:ENST00000598347:exon8:c.G1749T:p.V583V	ANKLE1:NM_001278444:exon8:c.G1749T:p.V583V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1589	.	.	MU4566643	.	.	.	.	.	.	.	.	ANKLE1:uc010xpn.1:exon8:c.G1911T:p.V637V	.	AFR:COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,THCA-SA|1|243|0.00411523,AMR:0.2598,EAS:0.0962,FIN:0.2,NFE:0.2114,OTH:0.2276,ASJ:0.3992	.	.	.	.	.	.	.	.	.	.	.	.	19	3(thyroid)	0.1996
19	17946870	17946870	-	G	JAK3	intronic	.	ENSG00000105639	rs397839895	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0387	0.0234	0.0908546	0.0361	.	.	.	.	.	.	.	.	.	.	AFR:0.0550,AMR:0.0119,EAS:0.2774,FIN:0.0235,NFE:0.0046,OTH:0.0297,ASJ:0.0033	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	19	.	hom
19	17948732	17948732	T	C	JAK3	intronic	.	ENSG00000105639	rs3212752	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0850	0.1270	0.11222	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	.	.	AFR:MU113315370,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,EAS:0.2297,FIN:0.0632,NFE:0.0430,OTH:0.0804,ASJ:0.1253	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	19	1(soft_tissue)	0.0998
19	17952185	17952185	G	T	JAK3	intronic	.	ENSG00000105639	rs3212733	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1616	0.1190	0.113818	LICA-CN|1|402|0.00248756	.	.	.	.	.	.	.	.	.	.	AFR:0.1317,AMR:0.0352,EAS:0.1987,FIN:0.0370,NFE:0.1700,OTH:0.1789,ASJ:0.2279	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	19	7(soft_tissue)	0.1885
19	17953237	17953237	G	A	JAK3	exonic	nonsynonymous SNV	ENSG00000105639	.	ENSG00000105639:ENST00000527670:exon5:c.C749T:p.A250V,ENSG00000105639:ENST00000458235:exon6:c.C749T:p.A250V,ENSG00000105639:ENST00000534444:exon6:c.C749T:p.A250V	JAK3:NM_000215:exon6:c.C749T:p.A250V	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 1, 0, 1, -1, 1, 1] 	.	.	.	.	1.495	13.29	0.088	0.607	0.147	.	.	Band 4.1 domain|FERM domain	JAK3:uc002nhn.4:exon6:c.C749T:p.A250V,JAK3:uc002nho.2:exon6:c.C749T:p.A250V,JAK3:uc010xpx.1:exon6:c.C749T:p.A250V	-1.036	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	6258,	.	.	0.465	0.27	0.101	1.79	19	.	het
19	17958777	17958777	T	C	JAK3	UTR5	.	ENSG00000105639	rs7254346	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	.	.	0.28155	0.2145	.	.	.	.	.	.	.	.	.	.	AFR:0.5543,AMR:0.1065,EAS:0.2164,FIN:0.0341,NFE:0.0747,OTH:0.0990,ASJ:0.0993	600173	600802;	35078;	35078|T-B+ SCID due to JAK3 deficiency|Unknown|Autosomal recessive|Infancy<br>Neonatal|600802 ~	~ko04062 Chemokine signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04217 Necroptosis~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04630 JAK-STAT signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko05161 Hepatitis B~ko05162 Measles~ko05166 Human T-cell leukemia virus 1 infection~ko05169 Epstein-Barr virus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05223 Non-small cell lung cancer~ko05340 Primary immunodeficiency ~	.	.	.	.	.	.	.	19	MU30174704	het
19	18272190	18272190	A	C	PIK3R2	exonic	nonsynonymous SNV	ENSG00000105647;ENSG00000268173	rs2241088	ENSG00000105647:ENST00000426902:exon5:c.A700C:p.S234R,ENSG00000105647:ENST00000222254:exon6:c.A700C:p.S234R,ENSG00000268173:ENST00000593731:exon6:c.A700C:p.S234R	PIK3R2:NM_005027:exon6:c.A700C:p.S234R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 1, -1, 1, 0] 	0.8961	.	0.923922	0.9373	1.371	12.64	0.315	2.02	0.732	.	.	Rho GTPase activation protein|Rho GTPase-activating protein domain	PIK3R2:uc002nia.2:exon6:c.A700C:p.S234R	-1.064	AFR:0.9734,AMR:0.9224,EAS:0.8998,FIN:0.8977,NFE:0.9293,OTH:0.9072,ASJ:0.9375	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	2.17	0.000	0.295	19	.	hom
19	18273047	18273047	T	C	PIK3R2	exonic	nonsynonymous SNV	ENSG00000105647;ENSG00000268173	rs1011320	ENSG00000105647:ENST00000426902:exon7:c.T937C:p.S313P,ENSG00000105647:ENST00000222254:exon8:c.T937C:p.S313P,ENSG00000268173:ENST00000593731:exon8:c.T937C:p.S313P	PIK3R2:NM_005027:exon8:c.T937C:p.S313P	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9501	0.9552	0.953474	0.9570	-1.239	0.006	0.722	-1.99	0.006	.	.	.	PIK3R2:uc002nia.2:exon8:c.T937C:p.S313P	-1.020	AFR:0.9703,AMR:0.9737,EAS:0.9635,FIN:0.9587,NFE:0.9480,OTH:0.9418,ASJ:0.9667	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	0.88	0.000	-1.04	19	MU82021073	hom
19	18279638	18279638	T	C	PIK3R2	exonic	synonymous SNV	ENSG00000105647;ENSG00000268173	rs273269	ENSG00000105647:ENST00000222254:exon15:c.T1911C:p.S637S,ENSG00000268173:ENST00000593731:exon15:c.T1911C:p.S637S	PIK3R2:NM_005027:exon15:c.T1911C:p.S637S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8800	0.8511	0.86242	0.8614	.	.	.	.	.	.	.	.	PIK3R2:uc002nia.2:exon15:c.T1911C:p.S637S	.	AFR:0.7798,AMR:0.9021,EAS:0.9227,FIN:0.9186,NFE:0.8861,OTH:0.8666,ASJ:0.8709	603157	603387;	83473;	83473|MPPH syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|603387 615937 615938 ~	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko01524 Platinum drug resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04062 Chemokine signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04140 Autophagy - animal~ko04150 mTOR signaling pathway~ko04151 PI3K-Akt signaling pathway~ko04152 AMPK signaling pathway~ko04210 Apoptosis~ko04211 Longevity regulating pathway~ko04213 Longevity regulating pathway - multiple species~ko04218 Cellular senescence~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04380 Osteoclast differentiation~ko04510 Focal adhesion~ko04550 Signaling pathways regulating pluripotency of stem cells~ko04611 Platelet activation~ko04620 Toll-like receptor signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04630 JAK-STAT signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04660 T cell receptor signaling pathway~ko04662 B cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04668 TNF signaling pathway~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04725 Cholinergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04910 Insulin signaling pathway~ko04914 Progesterone-mediated oocyte maturation~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04926 Relaxin signaling pathway~ko04929 GnRH secretion~ko04930 Type II diabetes mellitus~ko04931 Insulin resistance~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04960 Aldosterone-regulated sodium reabsorption~ko04973 Carbohydrate digestion and absorption~ko05100 Bacterial invasion of epithelial cells~ko05135 Yersinia infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05160 Hepatitis C~ko05161 Hepatitis B~ko05162 Measles~ko05163 Human cytomegalovirus infection~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05169 Epstein-Barr virus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05213 Endometrial cancer~ko05214 Glioma~ko05215 Prostate cancer~ko05218 Melanoma~ko05220 Chronic myeloid leukemia~ko05221 Acute myeloid leukemia~ko05222 Small cell lung cancer~ko05223 Non-small cell lung cancer~ko05224 Breast cancer~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05230 Central carbon metabolism in cancer~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	19	MU4566745	hom
19	18876208	18876208	C	G	CRTC1	intronic	.	ENSG00000105662	rs79054960	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0507	0.0524	0.028754	0.0408	.	.	.	.	.	0.0002	0.022	.	.	.	AFR:0.0159,AMR:0.0430,EAS:0.0006,FIN:0.0212,NFE:0.0618,OTH:0.0479,ASJ:0.1258	607536	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	31768941	31768941	C	T	TSHZ3	exonic	synonymous SNV	ENSG00000121297	rs540753819	ENSG00000121297:ENST00000240587:exon2:c.G1758A:p.T586T	TSHZ3:NM_020856:exon2:c.G1758A:p.T586T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0010	.	0.000998403	BLCA-US|1|411|0.00243309	.	.	.	.	.	.	.	.	TSHZ3:uc002nsy.4:exon2:c.G1758A:p.T586T	.	AFR:3.235e-05,AMR:0.0001,EAS:0,FIN:0,NFE:0,OTH:0,ASJ:0	614119	.	.	.	.	.	.	.	.	.	.	.	19	1(skin)	0
19	31769763	31769763	G	A	TSHZ3	exonic	synonymous SNV	ENSG00000121297	rs12461253	ENSG00000121297:ENST00000240587:exon2:c.C936T:p.V312V	TSHZ3:NM_020856:exon2:c.C936T:p.V312V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3156	0.2691	0.35004	MU145347	.	.	.	.	.	.	.	.	TSHZ3:uc002nsy.4:exon2:c.C936T:p.V312V	.	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,BRCA-KR|1|50|0.02,AMR:0.2985,EAS:0.2828,FIN:0.3079,NFE:0.5668,OTH:0.3321,ASJ:0.2317	614119	.	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.2999
19	31770009	31770009	C	T	TSHZ3	exonic	synonymous SNV	ENSG00000121297	rs28609894	ENSG00000121297:ENST00000240587:exon2:c.G690A:p.T230T	TSHZ3:NM_020856:exon2:c.G690A:p.T230T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2503	0.2834	0.314696	1(lung)	.	.	.	.	.	.	.	.	TSHZ3:uc002nsy.4:exon2:c.G690A:p.T230T	.	AFR:1(urinary_tract),AMR:MU126805,EAS:0.2566,FIN:0.4071,NFE:0.2053,OTH:0.4040,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|6|321|0.0186916	614119	.	.	.	.	.	.	.	.	.	.	.	19	1(thyroid)	0.2351
19	33464225	33464225	C	T	FAAP24	intronic	.	ENSG00000131944	rs73037453	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1541	0.2035	0.136182	0.1790	.	.	.	.	.	.	.	.	.	.	AFR:0.2502,AMR:0.0803,EAS:0.0012,FIN:0.1509,NFE:0.1719,OTH:0.1622,ASJ:0.0894	610884	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	35836600	35836600	C	A	CD22	exonic	synonymous SNV	ENSG00000012124	rs34826052	ENSG00000012124:ENST00000594250:exon9:c.C1773A:p.P591P,ENSG00000012124:ENST00000341773:exon10:c.C1773A:p.P591P,ENSG00000012124:ENST00000419549:exon11:c.C1788A:p.P596P,ENSG00000012124:ENST00000536635:exon11:c.C2040A:p.P680P,ENSG00000012124:ENST00000085219:exon12:c.C2304A:p.P768P	CD22:NM_001185101:exon10:c.C1773A:p.P591P,CD22:NM_001185099:exon11:c.C2040A:p.P680P,CD22:NM_001278417:exon11:c.C1788A:p.P596P,CD22:NM_001771:exon12:c.C2304A:p.P768P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0401	0.0229	0.0607029	0.0310	.	.	.	.	.	.	.	.	CD22:uc002nzb.4:exon10:c.C1773A:p.P591P,CD22:uc010edu.3:exon11:c.C2040A:p.P680P,CD22:uc010edt.3:exon12:c.C2304A:p.P768P,CD22:uc010xst.2:exon12:c.C1788A:p.P596P	.	AFR:0.0193,AMR:0.0119,EAS:0.1525,FIN:0.0269,NFE:0.0271,OTH:0.0336,ASJ:0.0099	107266	.	.	.	.	.	.	.	.	.	.	.	19	MU584603	het
19	36223111	36223111	C	G	KMT2B	intronic	.	ENSG00000105663	rs61351824	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1006	0.0822	0.0319489	0.0790	.	.	.	.	.	0.0003	0.114	.	.	.	AFR:0.0214,AMR:0.0719,EAS:0.0012,FIN:0.0668,NFE:0.1235,OTH:0.0828,ASJ:0.1126	606834	.	.	.	.	.	.	.	.	.	.	.	19	.	het
19	36224705	36224705	A	G	KMT2B	exonic	nonsynonymous SNV	ENSG00000272333	rs231591	ENSG00000272333:ENST00000222270:exon30:c.A7091G:p.D2364G,ENSG00000272333:ENST00000420124:exon30:c.A7091G:p.D2364G	KMT2B:NM_014727:exon30:c.A7091G:p.D2364G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5331	0.5792	0.620407	1(pleura)	-0.588	0.134	1.0	1.66	0.103	.	.	.	KMT2B:uc021usv.1:exon30:c.A7091G:p.D2364G	-0.961	AFR:1(lung),AMR:1(stomach),EAS:MU112187,FIN:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,NFE:0.5734,OTH:0.7952,ASJ:1(haematopoietic_and_lymphoid_tissue)	606834	.	.	.	.	.	.	.	0.0	-1.64	0.000	-0.69	19	1(large_intestine)	0.4209
19	36228954	36228954	G	T	KMT2B	intronic	.	ENSG00000105663	rs2242522	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4597	0.4054	0.377995	LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.01	.	.	.	AFR:0.4194,AMR:0.2030,EAS:0.4669,FIN:0.5105,NFE:0.5020,OTH:0.5032,ASJ:0.5909	606834	.	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.4537
19	38935280	38935280	A	G	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229139	ENSG00000196218:ENST00000355481:exon7:c.A594G:p.L198L,ENSG00000196218:ENST00000359596:exon7:c.A594G:p.L198L,ENSG00000196218:ENST00000360985:exon7:c.A594G:p.L198L	RYR1:NM_000540:exon7:c.A594G:p.L198L,RYR1:NM_001042723:exon7:c.A594G:p.L198L	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6074	0.6030	0.543331	MU17314527	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon7:c.A594G:p.L198L,RYR1:uc002oiu.3:exon7:c.A594G:p.L198L	.	AFR:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611,AMR:0.6056,EAS:0.6882,FIN:0.6192,NFE:0.6322,OTH:0.6549,ASJ:0.5109	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.6400
19	38939408	38939408	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs10406027	ENSG00000196218:ENST00000355481:exon11:c.T1077C:p.A359A,ENSG00000196218:ENST00000359596:exon11:c.T1077C:p.A359A,ENSG00000196218:ENST00000360985:exon11:c.T1077C:p.A359A	RYR1:NM_000540:exon11:c.T1077C:p.A359A,RYR1:NM_001042723:exon11:c.T1077C:p.A359A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8844	0.8952	0.903954	0.9058	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon11:c.T1077C:p.A359A,RYR1:uc002oiu.3:exon11:c.T1077C:p.A359A	.	AFR:0.9348,AMR:0.9165,EAS:0.9938,FIN:0.9272,NFE:0.8741,OTH:0.8937,ASJ:0.9272	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	MU4567228	hom
19	38946182	38946182	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2288888	ENSG00000196218:ENST00000355481:exon15:c.G1668A:p.S556S,ENSG00000196218:ENST00000359596:exon15:c.G1668A:p.S556S,ENSG00000196218:ENST00000360985:exon15:c.G1668A:p.S556S	RYR1:NM_000540:exon15:c.G1668A:p.S556S,RYR1:NM_001042723:exon15:c.G1668A:p.S556S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6366	0.6321	0.571286	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon15:c.G1668A:p.S556S,RYR1:uc002oiu.3:exon15:c.G1668A:p.S556S	.	AFR:0.6389,AMR:0.5420,EAS:0.6954,FIN:0.6088,NFE:0.7077,OTH:0.6745,ASJ:0.7100	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.6838
19	38949904	38949904	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs3745847	ENSG00000196218:ENST00000355481:exon19:c.C2286T:p.P762P,ENSG00000196218:ENST00000359596:exon19:c.C2286T:p.P762P,ENSG00000196218:ENST00000360985:exon19:c.C2286T:p.P762P	RYR1:NM_000540:exon19:c.C2286T:p.P762P,RYR1:NM_001042723:exon19:c.C2286T:p.P762P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6211	0.6170	0.554113	MU4567230	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon19:c.C2286T:p.P762P,RYR1:uc002oiu.3:exon19:c.C2286T:p.P762P	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.6271,EAS:0.7005,FIN:0.6623,NFE:0.5893,OTH:0.6999,ASJ:0.5264	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.6645
19	38956803	38956803	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2228069	ENSG00000196218:ENST00000355481:exon24:c.G2943A:p.T981T,ENSG00000196218:ENST00000359596:exon24:c.G2943A:p.T981T,ENSG00000196218:ENST00000360985:exon24:c.G2943A:p.T981T	RYR1:NM_000540:exon24:c.G2943A:p.T981T,RYR1:NM_001042723:exon24:c.G2943A:p.T981T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5962	0.5971	0.545527	1(liver)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon24:c.G2943A:p.T981T,RYR1:uc002oiu.3:exon24:c.G2943A:p.T981T	.	AFR:MU153475,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.5620,FIN:0.6993,NFE:0.6556,OTH:0.5235,ASJ:0.5968	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5798
19	38991516	38991516	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2228072	ENSG00000196218:ENST00000355481:exon47:c.G7500A:p.A2500A,ENSG00000196218:ENST00000359596:exon47:c.G7500A:p.A2500A,ENSG00000196218:ENST00000360985:exon47:c.G7500A:p.A2500A	RYR1:NM_000540:exon47:c.G7500A:p.A2500A,RYR1:NM_001042723:exon47:c.G7500A:p.A2500A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1140	0.0976	0.150759	MU30180040	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon47:c.G7500A:p.A2500A,RYR1:uc002oiu.3:exon47:c.G7500A:p.A2500A	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,AMR:0.0902,EAS:0.0764,FIN:0.0762,NFE:0.1722,OTH:0.0481,ASJ:0.1135	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(lung)	0.0800
19	38991543	38991543	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2071088	ENSG00000196218:ENST00000355481:exon47:c.G7527A:p.V2509V,ENSG00000196218:ENST00000359596:exon47:c.G7527A:p.V2509V,ENSG00000196218:ENST00000360985:exon47:c.G7527A:p.V2509V	RYR1:NM_000540:exon47:c.G7527A:p.V2509V,RYR1:NM_001042723:exon47:c.G7527A:p.V2509V	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1116	0.0882	0.135982	LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon47:c.G7527A:p.V2509V,RYR1:uc002oiu.3:exon47:c.G7527A:p.V2509V	.	AFR:0.0810,AMR:0.0812,EAS:0.0767,FIN:0.1702,NFE:0.0482,OTH:0.0801,ASJ:0.0764	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.0686
19	38993372	38993372	A	G	RYR1	intronic	.	ENSG00000196218	rs1469695	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3366	0.3140	0.421925	LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579	.	.	.	.	.	0	0.002	.	.	.	AFR:0.3469,AMR:0.4794,EAS:0.2598,FIN:0.3839,NFE:0.3440,OTH:0.2664,ASJ:0.4137	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.3201
19	38993547	38993547	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229142	ENSG00000196218:ENST00000355481:exon49:c.C7863T:p.H2621H,ENSG00000196218:ENST00000359596:exon49:c.C7863T:p.H2621H,ENSG00000196218:ENST00000360985:exon49:c.C7863T:p.H2621H	RYR1:NM_000540:exon49:c.C7863T:p.H2621H,RYR1:NM_001042723:exon49:c.C7863T:p.H2621H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1821	0.1579	0.237819	1(breast)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon49:c.C7863T:p.H2621H,RYR1:uc002oiu.3:exon49:c.C7863T:p.H2621H	.	AFR:1(large_intestine),AMR:MU153489,EAS:0.1636,FIN:0.1830,NFE:0.1289,OTH:0.1722,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.3225
19	38994910	38994910	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229144	ENSG00000196218:ENST00000355481:exon50:c.G7977A:p.T2659T,ENSG00000196218:ENST00000359596:exon50:c.G7977A:p.T2659T,ENSG00000196218:ENST00000360985:exon50:c.G7977A:p.T2659T	RYR1:NM_000540:exon50:c.G7977A:p.T2659T,RYR1:NM_001042723:exon50:c.G7977A:p.T2659T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3261	0.3195	0.41234	MU584624	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon50:c.G7977A:p.T2659T,RYR1:uc002oiu.3:exon50:c.G7977A:p.T2659T	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.3252,EAS:0.3493,FIN:0.2550,NFE:0.3786,OTH:0.2901,ASJ:0.4657	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(stomach)	0.2477
19	38995438	38995438	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2960340	ENSG00000196218:ENST00000355481:exon51:c.T8118C:p.I2706I,ENSG00000196218:ENST00000359596:exon51:c.T8118C:p.I2706I,ENSG00000196218:ENST00000360985:exon51:c.T8118C:p.I2706I	RYR1:NM_000540:exon51:c.T8118C:p.I2706I,RYR1:NM_001042723:exon51:c.T8118C:p.I2706I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3264	0.3198	0.415136	1(large_intestine)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon51:c.T8118C:p.I2706I,RYR1:uc002oiu.3:exon51:c.T8118C:p.I2706I	.	AFR:MU153496,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|2|205|0.0097561,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,EAS:0.4660,FIN:0.3505,NFE:0.2533,OTH:0.3778,ASJ:0.3253	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(oesophagus)	0.2904
19	38995510	38995510	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2915951	ENSG00000196218:ENST00000355481:exon51:c.T8190C:p.D2730D,ENSG00000196218:ENST00000359596:exon51:c.T8190C:p.D2730D,ENSG00000196218:ENST00000360985:exon51:c.T8190C:p.D2730D	RYR1:NM_000540:exon51:c.T8190C:p.D2730D,RYR1:NM_001042723:exon51:c.T8190C:p.D2730D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3294	0.3236	0.417133	MU584625	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon51:c.T8190C:p.D2730D,RYR1:uc002oiu.3:exon51:c.T8190C:p.D2730D	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|3|205|0.0146341,COCA-CN|3|321|0.00934579,AMR:0.3285,EAS:0.3505,FIN:0.2583,NFE:0.3755,OTH:0.2993,ASJ:0.4675	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(stomach)	0.2510
19	38995975	38995975	G	A	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2915952	ENSG00000196218:ENST00000355481:exon53:c.G8337A:p.E2779E,ENSG00000196218:ENST00000359596:exon53:c.G8337A:p.E2779E,ENSG00000196218:ENST00000360985:exon53:c.G8337A:p.E2779E	RYR1:NM_000540:exon53:c.G8337A:p.E2779E,RYR1:NM_001042723:exon53:c.G8337A:p.E2779E	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3294	0.3082	0.40595	MU153503	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon53:c.G8337A:p.E2779E,RYR1:uc002oiu.3:exon53:c.G8337A:p.E2779E	.	AFR:LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.3169,EAS:0.3496,FIN:0.2384,NFE:0.3776,OTH:0.2898,ASJ:0.4375	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.2472
19	38996990	38996990	T	C	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2229146	ENSG00000196218:ENST00000355481:exon55:c.T8589C:p.S2863S,ENSG00000196218:ENST00000359596:exon55:c.T8589C:p.S2863S,ENSG00000196218:ENST00000360985:exon55:c.T8589C:p.S2863S	RYR1:NM_000540:exon55:c.T8589C:p.S2863S,RYR1:NM_001042723:exon55:c.T8589C:p.S2863S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3265	0.3136	0.408147	1(large_intestine)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon55:c.T8589C:p.S2863S,RYR1:uc002oiu.3:exon55:c.T8589C:p.S2863S	.	AFR:MU153510,AMR:LAML-KR|3|205|0.0146341,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.4390,FIN:0.3498,NFE:0.2417,OTH:0.3758,ASJ:0.3204	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	2(lung)	0.3
19	38997459	38997459	G	C	RYR1	intronic	.	ENSG00000196218	rs2915958	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3243	0.3086	0.40615	0.3169	.	.	.	.	.	0.0095	0.052	.	.	.	AFR:0.4380,AMR:0.3501,EAS:0.3784,FIN:0.2899,NFE:0.2469,OTH:0.3008,ASJ:0.2384	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	MU25908965	het
19	38997609	38997609	T	A	RYR1	intronic	.	ENSG00000196218	rs2915959	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3219	0.3072	0.404952	MU25909011	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3169,EAS:0.3493,FIN:0.2384,NFE:0.3756,OTH:0.2899,ASJ:0.4385	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(large_intestine)	0.2470
19	39002725	39002725	A	G	RYR1	exonic	synonymous SNV	ENSG00000196218	rs2071089	ENSG00000196218:ENST00000355481:exon62:c.A9186G:p.P3062P,ENSG00000196218:ENST00000359596:exon62:c.A9186G:p.P3062P,ENSG00000196218:ENST00000360985:exon62:c.A9186G:p.P3062P	RYR1:NM_000540:exon62:c.A9186G:p.P3062P,RYR1:NM_001042723:exon62:c.A9186G:p.P3062P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3251	0.3109	0.406949	3(lung)	.	.	.	.	.	.	.	.	RYR1:uc002oit.3:exon62:c.A9186G:p.P3062P,RYR1:uc002oiu.3:exon62:c.A9186G:p.P3062P	.	AFR:MU153517,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,EAS:0.4374,FIN:0.3508,NFE:0.2384,OTH:0.3770,ASJ:0.3203	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(thyroid)	0.3012
19	39010053	39010053	C	T	RYR1	exonic	synonymous SNV	ENSG00000196218	rs41274330	ENSG00000196218:ENST00000355481:exon67:c.C10218T:p.Y3406Y,ENSG00000196218:ENST00000359596:exon67:c.C10218T:p.Y3406Y,ENSG00000196218:ENST00000360985:exon67:c.C10218T:p.Y3406Y	RYR1:NM_000540:exon67:c.C10218T:p.Y3406Y,RYR1:NM_001042723:exon67:c.C10218T:p.Y3406Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1055	0.0344	0.102236	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RYR1:uc010xuf.1:exon6:c.C978T:p.Y326Y,RYR1:uc002oit.3:exon67:c.C10218T:p.Y3406Y,RYR1:uc002oiu.3:exon67:c.C10218T:p.Y3406Y	.	AFR:0.0395,AMR:0.0127,EAS:0.0563,FIN:0.1846,NFE:0.0195,OTH:0.0419,ASJ:0.0621	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	3(large_intestine)	0.0468
19	39018277	39018277	C	T	RYR1	intronic	.	ENSG00000269445	rs77592501	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0817	0.0409	0.10643	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053	.	.	.	.	.	0.0001	0.006	.	.	.	AFR:0.0460,AMR:0.0261,EAS:0.0563,FIN:0.1842,NFE:0.0309,OTH:0.0447,ASJ:0.0668	180901	117000;145600;255320;	598;98905;423;99741;178145;597;598;	598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~98905|-|-|-|-|255320 ~423|Hyperthermia of anesthesia|Unknown|Autosomal dominant|All ages|145600 154275 154276 600467 601887 601888 ~99741|Koussef-Nichols syndrome|-|Autosomal dominant|-|145600 ~178145|-|-|-|-|117000 ~597|-|1-9 / 1 000 000|Autosomal dominant|Childhood|117000 ~598|MmD<br>Multiminicore disease|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Antenatal<br>Neonatal<br>Infancy<br>Childhood|117000 255320 602771 ~	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.0489
19	39905903	39905903	A	G	PLEKHG2	intronic	.	ENSG00000090924	rs3859551	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2609	0.1958	0.179712	0.2033	.	.	.	.	.	0.0111	0.144	.	.	.	AFR:0.2454,AMR:0.2291,EAS:0.0241,FIN:0.2090,NFE:0.1977,OTH:0.1694,ASJ:0.1987	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	MU87255653	hom
19	39906985	39906985	T	C	PLEKHG2	intronic	.	ENSG00000090924	rs10401595	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.1888	0.1934	0.176318	0.1990	.	.	.	.	.	0.0014	0.006	.	.	.	AFR:0.2329,AMR:0.2267,EAS:0.0235,FIN:0.2082,NFE:0.1967,OTH:0.1667,ASJ:0.2	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	.	hom
19	39907036	39907036	C	T	PLEKHG2	exonic	synonymous SNV	ENSG00000090924	rs2277743	ENSG00000090924:ENST00000451354:exon4:c.C531T:p.A177A,ENSG00000090924:ENST00000378550:exon5:c.C528T:p.A176A,ENSG00000090924:ENST00000409794:exon5:c.C528T:p.A176A,ENSG00000090924:ENST00000409797:exon5:c.C528T:p.A176A,ENSG00000090924:ENST00000425673:exon5:c.C528T:p.A176A,ENSG00000090924:ENST00000458508:exon5:c.C351T:p.A117A	PLEKHG2:NM_001351693:exon5:c.C351T:p.A117A,PLEKHG2:NM_001351694:exon5:c.C528T:p.A176A,PLEKHG2:NM_022835:exon5:c.C528T:p.A176A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1884	0.1930	0.176318	LUSC-KR|1|170|0.00588235	.	.	.	.	.	.	.	.	PLEKHG2:uc002olj.3:exon5:c.C528T:p.A176A,PLEKHG2:uc010xuy.2:exon5:c.C351T:p.A117A,PLEKHG2:uc010xuz.2:exon5:c.C528T:p.A176A	.	AFR:0.1974,AMR:0.2318,EAS:0.1987,FIN:0.0242,NFE:0.2081,OTH:0.1942,ASJ:0.2267	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	3(urinary_tract)	0.1677
19	39908574	39908574	C	T	PLEKHG2	exonic	synonymous SNV	ENSG00000090924	rs35466645	ENSG00000090924:ENST00000378550:exon9:c.C912T:p.T304T,ENSG00000090924:ENST00000409794:exon9:c.C912T:p.T304T,ENSG00000090924:ENST00000409797:exon9:c.C912T:p.T304T,ENSG00000090924:ENST00000425673:exon9:c.C912T:p.T304T,ENSG00000090924:ENST00000458508:exon9:c.C735T:p.T245T	PLEKHG2:NM_001351693:exon9:c.C735T:p.T245T,PLEKHG2:NM_001351694:exon9:c.C912T:p.T304T,PLEKHG2:NM_022835:exon9:c.C912T:p.T304T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2254	0.1554	0.157348	0.1784	.	.	.	.	.	.	.	.	PLEKHG2:uc010xva.2:exon7:c.C333T:p.T111T,PLEKHG2:uc002olj.3:exon9:c.C912T:p.T304T,PLEKHG2:uc010xuy.2:exon9:c.C735T:p.T245T,PLEKHG2:uc010xuz.2:exon9:c.C912T:p.T304T	.	AFR:0.1895,AMR:0.2213,EAS:0.0235,FIN:0.1800,NFE:0.1867,OTH:0.1595,ASJ:0.1987	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	MU116992633	hom
19	39914308	39914308	C	T	PLEKHG2	intronic	.	ENSG00000090924	rs31725	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5017	0.5200	0.579073	0.5340	.	.	.	.	.	.	.	.	.	.	AFR:0.6675,AMR:0.5012,EAS:0.5318,FIN:0.5330,NFE:0.4606,OTH:0.5092,ASJ:0.5232	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	MU635556	het
19	39914748	39914748	G	A	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs31726	ENSG00000090924:ENST00000425673:exon17:c.G2888A:p.R963K,ENSG00000090924:ENST00000409794:exon19:c.G2975A:p.R992K,ENSG00000090924:ENST00000458508:exon19:c.G2798A:p.R933K	PLEKHG2:NM_001351693:exon19:c.G2798A:p.R933K,PLEKHG2:NM_022835:exon19:c.G2975A:p.R992K	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5083	0.5226	0.575879	2(large_intestine)	0.257	5.263	0.101	0.404	0.001	.	.	.	PLEKHG2:uc010xva.2:exon15:c.G2309A:p.R770K,PLEKHG2:uc010xuy.2:exon19:c.G2798A:p.R933K,PLEKHG2:uc010xuz.2:exon19:c.G2975A:p.R992K	-0.924	AFR:MU146422,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.6473,FIN:0.5119,NFE:0.5232,OTH:0.5702,ASJ:0.5393	611893	616763;	.	.	.	.	.	.	0.004	-0.57	0.000	1.835	19	1(biliary_tract)	0.5350
19	39915637	39915637	G	A	PLEKHG2	exonic	synonymous SNV	ENSG00000090924	rs31727	ENSG00000090924:ENST00000425673:exon17:c.G3777A:p.Q1259Q,ENSG00000090924:ENST00000409794:exon19:c.G3864A:p.Q1288Q	PLEKHG2:NM_022835:exon19:c.G3864A:p.Q1288Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5511	0.5581	0.596845	MU146433	.	.	.	.	.	.	.	.	PLEKHG2:uc010xva.2:exon15:c.G3198A:p.Q1066Q,PLEKHG2:uc010xuz.2:exon19:c.G3864A:p.Q1288Q	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,AMR:0.5804,EAS:0.5346,FIN:0.55,NFE:0.5713,OTH:0.6101,ASJ:0.6601	611893	616763;	.	.	.	.	.	.	.	.	.	.	19	1(haematopoietic_and_lymphoid_tissue)	0.5333
19	39915758	39915758	C	G	PLEKHG2	exonic	nonsynonymous SNV	ENSG00000090924	rs31728	ENSG00000090924:ENST00000425673:exon17:c.C3898G:p.P1300A,ENSG00000090924:ENST00000409794:exon19:c.C3985G:p.P1329A	PLEKHG2:NM_022835:exon19:c.C3985G:p.P1329A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5527	0.5783	0.592252	MU74687	4.517	24.3	.	3.03	0.954	.	.	.	PLEKHG2:uc010xva.2:exon15:c.C3319G:p.P1107A,PLEKHG2:uc010xuz.2:exon19:c.C3985G:p.P1329A	-0.846	AFR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874,AMR:0.5787,EAS:0.5288,FIN:0.5364,NFE:0.5760,OTH:0.6131,ASJ:0.6577	611893	616763;	.	.	.	.	.	.	0.582	.	0.000	1.04	19	3(large_intestine)	0.5309
19	40900865	40900865	C	T	PRX	exonic	nonsynonymous SNV	ENSG00000105227	rs268674	ENSG00000105227:ENST00000324001:exon7:c.G3394A:p.G1132R	PRX:NM_181882:exon7:c.G3394A:p.G1132R	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9469	0.9538	0.965455	0.9599	0.019	2.769	0.129	3.64	0.017	.	.	.	PRX:uc002onq.3:exon3:c.G2977A:p.G993R,PRX:uc002onr.3:exon7:c.G3394A:p.G1132R	-1.009	AFR:0.9899,AMR:0.9678,EAS:0.9691,FIN:0.9472,NFE:0.9444,OTH:0.9561,ASJ:0.9437	605725	145900;614895;	99952;64748;	99952|CMT4F|<1 / 1 000 000|Autosomal recessive|Childhood|614895 ~64748|Charcot-Marie-Tooth disease type 3<br>HMSN 3<br>HMSN III<br>Hereditary motor and sensory neuropathy type 3<br>Hereditary motor and sensory neuropathy type III|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Not applicable|Infancy|145900 ~	.	.	.	.	0.0	4.2	0.000	-0.625	19	MU69136	hom
19	41512792	41512792	C	T	CYP2B6	intronic	.	ENSG00000197408	rs4803419	.	.	clinvar: drug_response 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3353	0.2394	0.289137	0.2824	.	.	.	.	.	.	.	.	.	.	AFR:0.1143,AMR:0.4617,EAS:0.4512,FIN:0.3721,NFE:0.3277,OTH:0.3224,ASJ:0.3013	123930	614546;	240869;	240869|-|-|-|-|614546 ~	.	.	.	.	.	.	.	.	19	MU30125766	het
19	41743861	41743861	A	G	AXL	exonic	nonsynonymous SNV	ENSG00000167601	rs7249222	ENSG00000167601:ENST00000301178:exon7:c.A796G:p.N266D,ENSG00000167601:ENST00000359092:exon7:c.A796G:p.N266D	AXL:NM_001699:exon7:c.A796G:p.N266D,AXL:NM_021913:exon7:c.A796G:p.N266D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	AXL:uc010ehi.1:exon7:c.A796G:p.N266D,AXL:uc010ehj.3:exon7:c.A796G:p.N266D,AXL:uc010ehk.3:exon7:c.A796G:p.N266D	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	109135	.	.	.	.	.	.	.	.	.	.	.	19	23(upper_aerodigestive_tract)	1
19	41759632	41759632	C	-	AXL	intronic	.	ENSG00000167601	rs770636352	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0824	.	.	0.1114	.	.	.	.	.	.	.	.	.	.	AFR:0.1108,AMR:0.1937,EAS:0.0958,FIN:0.1784,NFE:0.0942,OTH:0.1019,ASJ:0.0894	109135	.	.	.	.	.	.	.	.	.	.	.	19	MU75290710	het
19	41838206	41838206	G	A	TGFB1	intronic	.	ENSG00000105329	rs8179181	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1817	0.1789	0.0760783	0.1726	.	.	.	.	.	.	.	.	.	.	AFR:0.0462,AMR:0.1169,EAS:0,FIN:0.2372,NFE:0.2509,OTH:0.1963,ASJ:0.1987	190180	131300;219700;	586;1328;	586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~1328|Progressive diaphyseal dysplasia|Unknown|Autosomal dominant|All ages|131300 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04659 Th17 cell differentiation~ko04672 Intestinal immune network for IgA production~ko04926 Relaxin signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05144 Malaria~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD)~ko05323 Rheumatoid arthritis~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	.	.	.	19	.	het
19	41858921	41858921	G	A	TGFB1	exonic	nonsynonymous SNV	ENSG00000105329	rs1800470	ENSG00000105329:ENST00000221930:exon1:c.C29T:p.P10L	TGFB1:NM_000660:exon1:c.C29T:p.P10L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 1, 0] 	0.5623	.	0.545327	1(pancreas)	2.279	18.03	0.83	1.45	1.000	.	.	.	TGFB1:uc002oqh.2:exon1:c.C29T:p.P10L	-0.945	AFR:MU68390,AMR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.5855,FIN:0.4856,NFE:0.5066,OTH:0.4199,ASJ:0.5998	190180	131300;219700;	586;1328;	586|CF<br>Mucoviscidosis|1-9 / 100 000|Autosomal recessive|All ages|219700 ~1328|Progressive diaphyseal dysplasia|Unknown|Autosomal dominant|All ages|131300 ~	~ko04010 MAPK signaling pathway~ko04060 Cytokine-cytokine receptor interaction~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04218 Cellular senescence~ko04350 TGF-beta signaling pathway~ko04380 Osteoclast differentiation~ko04390 Hippo signaling pathway~ko04659 Th17 cell differentiation~ko04672 Intestinal immune network for IgA production~ko04926 Relaxin signaling pathway~ko04932 Non-alcoholic fatty liver disease (NAFLD)~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05140 Leishmaniasis~ko05142 Chagas disease (American trypanosomiasis)~ko05144 Malaria~ko05145 Toxoplasmosis~ko05146 Amoebiasis~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05210 Colorectal cancer~ko05211 Renal cell carcinoma~ko05212 Pancreatic cancer~ko05220 Chronic myeloid leukemia~ko05225 Hepatocellular carcinoma~ko05226 Gastric cancer~ko05321 Inflammatory bowel disease (IBD)~ko05323 Rheumatoid arthritis~ko05410 Hypertrophic cardiomyopathy (HCM)~ko05414 Dilated cardiomyopathy (DCM) ~	.	.	.	.	1.73	0.000	.	19	1(thyroid)	0.7066
19	42799049	42799049	C	T	CIC	exonic	synonymous SNV	ENSG00000079432	rs1052023	ENSG00000079432:ENST00000573349:exon5:c.C714T:p.I238I,ENSG00000079432:ENST00000160740:exon20:c.C4527T:p.I1509I,ENSG00000079432:ENST00000575354:exon20:c.C4533T:p.I1511I,ENSG00000079432:ENST00000572681:exon21:c.C7251T:p.I2417I	CIC:NM_015125:exon20:c.C4533T:p.I1511I,CIC:NM_001304815:exon21:c.C7260T:p.I2420I	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2587	0.2756	0.119808	1(lung)	.	.	.	.	.	.	.	.	CIC:uc002otf.1:exon20:c.C4533T:p.I1511I	.	AFR:1(urinary_tract),AMR:1(haematopoietic_and_lymphoid_tissue),EAS:MU156195,FIN:LUSC-KR|1|170|0.00588235,NFE:0.2638,OTH:0.0669,ASJ:13(meninges)	612082	.	.	.	.	.	.	.	.	.	.	.	19	1(upper_aerodigestive_tract)	0.1875
19	44047550	44047550	T	C	XRCC1	exonic	synonymous SNV	ENSG00000073050	rs3547	ENSG00000073050:ENST00000543982:exon16:c.A1803G:p.Q601Q,ENSG00000073050:ENST00000262887:exon17:c.A1896G:p.Q632Q	XRCC1:NM_006297:exon17:c.A1896G:p.Q632Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6365	0.6075	0.710663	0.6135	.	.	.	.	.	.	.	.	XRCC1:uc010xwp.1:exon16:c.A1803G:p.Q601Q,XRCC1:uc002owt.2:exon17:c.A1896G:p.Q632Q	.	AFR:0.6640,AMR:0.7849,EAS:0.8777,FIN:0.5536,NFE:0.5609,OTH:0.5935,ASJ:0.6556	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU168901	hom
19	44047826	44047826	T	A	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs2682557	ENSG00000073050:ENST00000543982:exon15:c.A1633T:p.N545Y,ENSG00000073050:ENST00000262887:exon16:c.A1726T:p.N576Y	XRCC1:NM_006297:exon16:c.A1726T:p.N576Y	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1.0000	0.9999	1	1	.	.	.	.	.	.	.	.	XRCC1:uc010xwp.1:exon15:c.A1633T:p.N545Y,XRCC1:uc002owt.2:exon16:c.A1726T:p.N576Y	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	194360	.	.	.	.	.	.	.	.	.	.	.	19	MU82026153	hom
19	44055726	44055726	T	C	XRCC1	exonic	nonsynonymous SNV	ENSG00000073050	rs25487	ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R	XRCC1:NM_006297:exon10:c.A1196G:p.Q399R	clinvar: drug_response 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, 0, 2, -1, 0, 1] 	0.6834	0.7092	0.739617	0.7200	0.745	9.117	1.0	4.13	0.976	.	.	BRCT domain	XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R	-0.976	AFR:0.8520,AMR:0.7231,EAS:0.7370,FIN:0.7022,NFE:0.6510,OTH:0.6691,ASJ:0.5960	194360	.	.	.	.	,10431	.	,10432	0.0	2.81	0.000	.	19	MU71535	het
19	45251156	45251156	A	C	BCL3	upstream	.	ENSG00000069399	rs2965169	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.534545	0.4760	.	.	.	.	.	.	.	.	.	.	AFR:0.6915,AMR:0.5683,EAS:0.4152,FIN:0.3566,NFE:0.3829,OTH:0.4138,ASJ:0.5167	109560	.	.	.	.	.	.	.	.	.	.	.	19	MU9424118	hom
19	45867259	45867259	C	T	ERCC2	exonic	nonsynonymous SNV	ENSG00000104884	rs1799793	ENSG00000104884:ENST00000391944:exon8:c.G700A:p.D234N,ENSG00000104884:ENST00000391941:exon9:c.G862A:p.D288N,ENSG00000104884:ENST00000485403:exon9:c.G862A:p.D288N,ENSG00000104884:ENST00000391940:exon10:c.G862A:p.D288N,ENSG00000104884:ENST00000391945:exon10:c.G934A:p.D312N,ENSG00000104884:ENST00000586131:exon10:c.G862A:p.D288N	ERCC2:NM_001130867:exon9:c.G862A:p.D288N,ERCC2:NM_000400:exon10:c.G934A:p.D312N	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.3788	0.2438	0.194489	MU68959	4.308	24.0	0.174	5.15	0.880	.	.	Helical and beta-bridge domain	ERCC2:uc010ejz.2:exon8:c.G700A:p.D234N,ERCC2:uc002pbk.2:exon9:c.G862A:p.D288N,ERCC2:uc002pbl.4:exon9:c.G862A:p.D288N,ERCC2:uc002pbj.2:exon10:c.G934A:p.D312N	-1.005	AFR:ESAD-UK|1|409|0.00244499,AMR:0.2648,EAS:0.2103,FIN:0.3709,NFE:0.0438,OTH:0.3671,ASJ:0.1080	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	,4779,4778	.	.	0.065	-0.1	0.000	1.825	19	1(thyroid)	0.3541
19	45868309	45868309	T	G	ERCC2	exonic	synonymous SNV	ENSG00000104884	rs238406	ENSG00000104884:ENST00000586856:exon4:c.A318C:p.R106R,ENSG00000104884:ENST00000391941:exon5:c.A396C:p.R132R,ENSG00000104884:ENST00000485403:exon5:c.A396C:p.R132R,ENSG00000104884:ENST00000391940:exon6:c.A396C:p.R132R,ENSG00000104884:ENST00000391945:exon6:c.A468C:p.R156R,ENSG00000104884:ENST00000586131:exon6:c.A396C:p.R132R	ERCC2:NM_001130867:exon5:c.A396C:p.R132R,ERCC2:NM_000400:exon6:c.A468C:p.R156R	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5898	0.6625	0.636182	0.6449	.	.	.	.	.	.	.	.	ERCC2:uc002pbk.2:exon5:c.A396C:p.R132R,ERCC2:uc002pbl.4:exon5:c.A396C:p.R132R,ERCC2:uc002pbj.2:exon6:c.A468C:p.R156R	.	AFR:0.8673,AMR:0.5143,EAS:0.5068,FIN:0.5899,NFE:0.5556,OTH:0.5717,ASJ:0.6060	126340	278730;601675;610756;	1466;191;33364;220295;910;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~33364|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|234050 300953 601675 616390 616395 616943 ~220295|XP/CS complex|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|278730 278760 278780 610651 ~910|XP|-|Autosomal recessive|All ages|278700 278720 278730 278740 278760 278780 610651 ~	.	,4779,4778	.	.	.	.	.	.	19	MU21174602	het
19	45923653	45923653	A	G	ERCC1	exonic	synonymous SNV	ENSG00000012061	rs11615	ENSG00000012061:ENST00000589381:exon2:c.T138C:p.N46N,ENSG00000012061:ENST00000013807:exon3:c.T354C:p.N118N,ENSG00000012061:ENST00000423698:exon3:c.T138C:p.N46N,ENSG00000012061:ENST00000591636:exon3:c.T354C:p.N118N,ENSG00000012061:ENST00000300853:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000340192:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000589165:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000589214:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000592023:exon4:c.T354C:p.N118N,ENSG00000012061:ENST00000592083:exon5:c.T354C:p.N118N	ERCC1:NM_001369411:exon3:c.T354C:p.N118N,ERCC1:NM_001369416:exon3:c.T354C:p.N118N,ERCC1:NM_001369419:exon3:c.T354C:p.N118N,ERCC1:NM_202001:exon3:c.T354C:p.N118N,ERCC1:NM_001166049:exon4:c.T354C:p.N118N,ERCC1:NM_001369408:exon4:c.T354C:p.N118N,ERCC1:NM_001369409:exon4:c.T354C:p.N118N,ERCC1:NM_001369410:exon4:c.T354C:p.N118N,ERCC1:NM_001369412:exon4:c.T354C:p.N118N,ERCC1:NM_001369415:exon4:c.T354C:p.N118N,ERCC1:NM_001369418:exon4:c.T354C:p.N118N,ERCC1:NM_001983:exon4:c.T354C:p.N118N,ERCC1:NM_001369413:exon5:c.T354C:p.N118N,ERCC1:NM_001369414:exon5:c.T354C:p.N118N,ERCC1:NM_001369417:exon5:c.T354C:p.N118N	clinvar: drug_response 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 1] 	0.5085	0.5401	0.66893	0.5425	.	.	.	.	.	.	.	.	ERCC1:uc002pbu.2:exon3:c.T138C:p.N46N,ERCC1:uc002pbv.3:exon3:c.T354C:p.N118N,ERCC1:uc002pbs.2:exon4:c.T354C:p.N118N,ERCC1:uc002pbt.2:exon4:c.T354C:p.N118N	.	AFR:0.875,AMR:0.6691,EAS:0.7413,FIN:0.3622,NFE:0.3723,OTH:0.4187,ASJ:0.4338	126380	610758;	1466;191;	1466|Cerebrooculofacioskeletal syndrome<br>Pena-Shokeir syndrome type 2|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Antenatal|214150 278780 610756 610758 616570 ~191|-|Unknown|Autosomal recessive|All ages|133540 214150 216400 216411 278780 610756 610758 616570 ~	.	,4775,4774	.	.	.	.	.	.	19	MU19278464	hom
19	48621036	48621036	C	G	LIG1	exonic	synonymous SNV	ENSG00000105486	rs13436	ENSG00000105486:ENST00000536218:exon24:c.G2238C:p.A746A,ENSG00000105486:ENST00000427526:exon25:c.G2349C:p.A783A,ENSG00000105486:ENST00000263274:exon26:c.G2442C:p.A814A	LIG1:NM_001289064:exon24:c.G2238C:p.A746A,LIG1:NM_001289063:exon25:c.G2349C:p.A783A,LIG1:NM_001320971:exon25:c.G2352C:p.A784A,LIG1:NM_000234:exon26:c.G2442C:p.A814A,LIG1:NM_001320970:exon26:c.G2439C:p.A813A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4747	0.4595	0.544529	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LIG1:uc010xze.1:exon21:c.G1521C:p.A507A,LIG1:uc010xzf.1:exon24:c.G2238C:p.A746A,LIG1:uc010xzg.1:exon25:c.G2349C:p.A783A,LIG1:uc002pia.1:exon26:c.G2442C:p.A814A	.	AFR:0.4895,AMR:0.5486,EAS:0.3974,FIN:0.7577,NFE:0.4928,OTH:0.4324,ASJ:0.3974	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.4888
19	48622375	48622375	C	T	LIG1	intronic	.	ENSG00000269534	rs3729512	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1408	0.1525	0.157748	0.1504	.	.	.	.	.	.	.	.	.	.	AFR:0.2525,AMR:0.1229,EAS:0.1219,FIN:0.0893,NFE:0.1143,OTH:0.1020,ASJ:0.0894	126391	.	.	.	.	.	.	.	.	.	.	.	19	MU82156334	het
19	48622427	48622427	A	G	LIG1	exonic	synonymous SNV	ENSG00000105486	rs20581	ENSG00000105486:ENST00000536218:exon23:c.T2202C:p.D734D,ENSG00000105486:ENST00000427526:exon24:c.T2313C:p.D771D,ENSG00000105486:ENST00000263274:exon25:c.T2406C:p.D802D	LIG1:NM_001289064:exon23:c.T2202C:p.D734D,LIG1:NM_001289063:exon24:c.T2313C:p.D771D,LIG1:NM_001320971:exon24:c.T2316C:p.D772D,LIG1:NM_000234:exon25:c.T2406C:p.D802D,LIG1:NM_001320970:exon25:c.T2403C:p.D801D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6228	0.6380	0.718051	1(pancreas)	.	.	.	.	.	.	.	.	LIG1:uc010xze.1:exon20:c.T1485C:p.D495D,LIG1:uc010xzf.1:exon23:c.T2202C:p.D734D,LIG1:uc010xzg.1:exon24:c.T2313C:p.D771D,LIG1:uc002pia.1:exon25:c.T2406C:p.D802D	.	AFR:1(thyroid),AMR:MU27558186,EAS:0.6542,FIN:0.8492,NFE:0.5251,OTH:0.4868,ASJ:COCA-CN|5|321|0.0155763,THCA-SA|1|243|0.00411523	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(prostate)	0.8826
19	48634319	48634319	T	A	LIG1	intronic	.	ENSG00000105486	rs392891	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4684	0.4646	0.549121	0.4918	.	.	.	.	.	.	.	.	.	.	AFR:0.5584,AMR:0.3962,EAS:0.7550,FIN:0.4926,NFE:0.4322,OTH:0.4857,ASJ:0.3974	126391	.	.	.	.	.	.	.	.	.	.	.	19	MU23821406	het
19	48654553	48654553	G	T	LIG1	exonic	synonymous SNV	ENSG00000105486	rs20580	ENSG00000105486:ENST00000427526:exon6:c.C417A:p.A139A,ENSG00000105486:ENST00000542460:exon6:c.C414A:p.A138A,ENSG00000105486:ENST00000263274:exon7:c.C510A:p.A170A,ENSG00000105486:ENST00000594759:exon7:c.C507A:p.A169A,ENSG00000105486:ENST00000601091:exon7:c.C510A:p.A170A	LIG1:NM_001289063:exon6:c.C417A:p.A139A,LIG1:NM_001320971:exon6:c.C420A:p.A140A,LIG1:NM_000234:exon7:c.C510A:p.A170A,LIG1:NM_001320970:exon7:c.C507A:p.A169A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4875	0.5066	0.532947	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	LIG1:uc010xzg.1:exon6:c.C417A:p.A139A,LIG1:uc002pia.1:exon7:c.C510A:p.A170A	.	AFR:0.5190,AMR:0.5483,EAS:0.4067,FIN:0.6944,NFE:0.5161,OTH:0.4918,ASJ:0.4329	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(salivary_gland)	0.5031
19	48660244	48660251	AAGGGGCA	-	LIG1	intronic	.	ENSG00000105486	rs3730867	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.4760	0.4378	0.510383	0.4796	.	.	.	.	.	.	.	.	.	.	AFR:0.4413,AMR:0.4279,EAS:0.6863,FIN:0.5038,NFE:0.4788,OTH:0.4764,ASJ:0.3897	126391	.	.	.	.	.	.	.	.	.	.	.	19	.	hom
19	48668795	48668795	G	A	LIG1	intronic	.	ENSG00000105486	rs3730849	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3548	0.2846	0.317292	0.3193	.	.	.	.	.	.	.	.	.	.	AFR:0.1153,AMR:0.2931,EAS:0.5666,FIN:0.4274,NFE:0.3833,OTH:0.4029,ASJ:0.3079	126391	.	.	.	.	.	.	.	.	.	.	.	19	MU23821673	het
19	48668830	48668830	G	A	LIG1	UTR5	.	ENSG00000105486	rs20579	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1355	0.1845	0.173123	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|2|321|0.00623053,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	.	.	AFR:0.1654,AMR:0.2863,EAS:0.1291,FIN:0.1293,NFE:0.0926,OTH:0.1214,ASJ:0.1435	126391	.	.	.	.	.	.	.	.	.	.	.	19	1(urinary_tract)	0.1094
19	50139119	50139119	G	C	RRAS	intronic	.	ENSG00000126458	rs731861	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3564	0.2423	0.250599	0.2295	.	.	.	.	.	0	0.006	.	.	.	AFR:0.3419,AMR:0.1142,EAS:0.0367,FIN:0.1945,NFE:0.2021,OTH:0.2259,ASJ:0.1678	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	MU113433341	het
19	50140068	50140068	C	T	RRAS	intronic	.	ENSG00000126458	rs1368464	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7034	0.6968	0.738219	0.7241	.	.	.	.	.	.	.	.	.	.	AFR:0.7666,AMR:0.8341,EAS:0.8300,FIN:0.6882,NFE:0.6942,OTH:0.6814,ASJ:0.6577	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	MU21511377	unknown
19	50140092	50140092	G	A	RRAS	exonic	synonymous SNV	ENSG00000126458	rs1865077	ENSG00000126458:ENST00000246792:exon3:c.C333T:p.N111N	RRAS:NM_006270:exon3:c.C333T:p.N111N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.7034	0.6968	0.738219	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	RRAS:uc002pop.1:exon3:c.C333T:p.N111N	.	AFR:0.7243,AMR:0.7670,EAS:0.6577,FIN:0.8284,NFE:0.6881,OTH:0.6947,ASJ:0.8329	165090	.	.	.	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04137 Mitophagy - animal~ko04140 Autophagy - animal~ko04218 Cellular senescence~ko04360 Axon guidance~ko04371 Apelin signaling pathway~ko04625 C-type lectin receptor signaling pathway~ko04810 Regulation of actin cytoskeleton~ko05205 Proteoglycans in cancer ~	.	.	.	.	.	.	.	19	1(large_intestine)	0.6814
19	50726570	50726570	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs4801822	ENSG00000105357:ENST00000262269:exon4:c.G657A:p.A219A,ENSG00000105357:ENST00000596571:exon4:c.G657A:p.A219A,ENSG00000105357:ENST00000376970:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000425460:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000440075:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000598205:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000599920:exon5:c.G657A:p.A219A,ENSG00000105357:ENST00000601313:exon5:c.G657A:p.A219A	MYH14:NM_001077186:exon5:c.G657A:p.A219A,MYH14:NM_001145809:exon5:c.G657A:p.A219A,MYH14:NM_024729:exon5:c.G657A:p.A219A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6057	0.4933	0.472843	1(large_intestine)	.	.	.	.	.	.	.	.	MYH14:uc002prq.1:exon5:c.G657A:p.A219A,MYH14:uc002prr.1:exon5:c.G657A:p.A219A,MYH14:uc010enu.1:exon5:c.G657A:p.A219A	.	AFR:MU115546,AMR:LICA-CN|1|402|0.00248756,LAML-KR|3|205|0.0146341,COCA-CN|5|321|0.0155763,EAS:0.2085,FIN:0.4233,NFE:0.5099,OTH:0.5513,ASJ:0.4990	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	1(prostate)	0.6498
19	50762418	50762418	A	G	MYH14	exonic	synonymous SNV	ENSG00000105357	rs1651553	ENSG00000105357:ENST00000596571:exon16:c.A2127G:p.P709P,ENSG00000105357:ENST00000262269:exon18:c.A2250G:p.P750P,ENSG00000105357:ENST00000376970:exon18:c.A2226G:p.P742P,ENSG00000105357:ENST00000425460:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000598205:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000599920:exon18:c.A2151G:p.P717P,ENSG00000105357:ENST00000440075:exon19:c.A2250G:p.P750P,ENSG00000105357:ENST00000601313:exon19:c.A2250G:p.P750P	MYH14:NM_024729:exon17:c.A2127G:p.P709P,MYH14:NM_001077186:exon18:c.A2151G:p.P717P,MYH14:NM_001145809:exon19:c.A2250G:p.P750P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7719	0.7375	0.761182	0.7616	.	.	.	.	.	.	.	.	MYH14:uc002prr.1:exon17:c.A2127G:p.P709P,MYH14:uc002prq.1:exon18:c.A2151G:p.P717P,MYH14:uc010enu.1:exon19:c.A2250G:p.P750P	.	AFR:0.7206,AMR:0.8365,EAS:0.8255,FIN:0.8212,NFE:0.7614,OTH:0.7939,ASJ:0.6126	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU17693652	hom
19	50763889	50763889	C	T	MYH14	intronic	.	ENSG00000105357	rs12981413	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4480	0.4355	0.439097	MU28841252	.	.	.	.	.	.	.	.	.	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,AMR:0.4598,EAS:0.6463,FIN:0.2583,NFE:0.3088,OTH:0.5229,ASJ:0.4728	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	3(lung)	0.4460
19	50771609	50771609	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs3745504	ENSG00000105357:ENST00000596571:exon21:c.G2895A:p.L965L,ENSG00000105357:ENST00000262269:exon23:c.G3018A:p.L1006L,ENSG00000105357:ENST00000376970:exon23:c.G2994A:p.L998L,ENSG00000105357:ENST00000425460:exon23:c.G2919A:p.L973L,ENSG00000105357:ENST00000598205:exon23:c.G2919A:p.L973L,ENSG00000105357:ENST00000599920:exon23:c.G2919A:p.L973L,ENSG00000105357:ENST00000440075:exon24:c.G3018A:p.L1006L,ENSG00000105357:ENST00000601313:exon24:c.G3018A:p.L1006L	MYH14:NM_024729:exon22:c.G2895A:p.L965L,MYH14:NM_001077186:exon23:c.G2919A:p.L973L,MYH14:NM_001145809:exon24:c.G3018A:p.L1006L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5980	0.5314	0.484425	0.5229	.	.	.	.	.	.	.	.	MYH14:uc002prr.1:exon22:c.G2895A:p.L965L,MYH14:uc002prq.1:exon23:c.G2919A:p.L973L,MYH14:uc010enu.1:exon24:c.G3018A:p.L1006L	.	AFR:0.4426,AMR:0.7172,EAS:0.3970,FIN:0.5859,NFE:0.5567,OTH:0.5564,ASJ:0.4636	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU89704	hom
19	50771635	50771635	T	C	MYH14	intronic	.	ENSG00000105357	rs930086	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8757	0.8753	0.864617	0.8758	.	.	.	.	.	.	.	.	.	.	AFR:0.8629,AMR:0.9177,EAS:0.8422,FIN:0.8987,NFE:0.8784,OTH:0.8988,ASJ:0.8411	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU17694162	hom
19	50796905	50796905	G	A	MYH14	exonic	synonymous SNV	ENSG00000105357	rs3745509	ENSG00000105357:ENST00000596571:exon36:c.G5307A:p.S1769S,ENSG00000105357:ENST00000262269:exon38:c.G5430A:p.S1810S,ENSG00000105357:ENST00000376970:exon38:c.G5406A:p.S1802S,ENSG00000105357:ENST00000425460:exon38:c.G5331A:p.S1777S,ENSG00000105357:ENST00000598205:exon38:c.G5331A:p.S1777S,ENSG00000105357:ENST00000440075:exon39:c.G5430A:p.S1810S,ENSG00000105357:ENST00000601313:exon39:c.G5430A:p.S1810S	MYH14:NM_024729:exon37:c.G5307A:p.S1769S,MYH14:NM_001077186:exon38:c.G5331A:p.S1777S,MYH14:NM_001145809:exon39:c.G5430A:p.S1810S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7480	0.6146	0.682109	0.6579	.	.	.	.	.	.	.	.	MYH14:uc002prs.1:exon6:c.G360A:p.S120S,MYH14:uc010ycb.2:exon8:c.G360A:p.S120S,MYH14:uc002prr.1:exon37:c.G5307A:p.S1769S,MYH14:uc002prq.1:exon38:c.G5331A:p.S1777S,MYH14:uc010enu.1:exon39:c.G5430A:p.S1810S	.	AFR:0.3589,AMR:0.8313,EAS:0.9247,FIN:0.7665,NFE:0.7606,OTH:0.7546,ASJ:0.6921	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU82029104	hom
19	50796960	50796960	C	T	MYH14	intronic	.	ENSG00000105357	rs3745510	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.7496	0.6257	0.694489	0.6671	.	.	.	.	.	.	.	.	.	.	AFR:0.3895,AMR:0.8349,EAS:0.9258,FIN:0.7672,NFE:0.7611,OTH:0.7622,ASJ:0.6954	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU26334128	hom
19	50805138	50805138	C	T	MYH14	intronic	.	ENSG00000105357	rs3826772	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8300	0.7947	0.750799	0.7877	.	.	.	.	.	.	.	.	.	.	AFR:0.6329,AMR:0.8577,EAS:0.8077,FIN:0.8333,NFE:0.8556,OTH:0.8429,ASJ:0.87	608568	600652;614369;	397744;90635;	397744|Peripheral neuropathy-myopathy-hoarseness-deafness syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|614369 ~90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~	.	.	.	.	.	.	.	.	19	MU82029120	het
19	50905762	50905762	T	C	POLD1	exonic	synonymous SNV	ENSG00000062822	rs1143666	ENSG00000062822:ENST00000595904:exon6:c.T810C:p.A270A,ENSG00000062822:ENST00000440232:exon7:c.T810C:p.A270A,ENSG00000062822:ENST00000599857:exon7:c.T810C:p.A270A,ENSG00000062822:ENST00000600859:exon7:c.T810C:p.A270A	POLD1:NM_001308632:exon6:c.T810C:p.A270A,POLD1:NM_001256849:exon7:c.T810C:p.A270A,POLD1:NM_002691:exon7:c.T810C:p.A270A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0532	0.1262	0.138379	0.1103	.	.	.	.	.	.	.	.	POLD1:uc010eny.4:exon6:c.T810C:p.A270A,POLD1:uc002psb.5:exon7:c.T810C:p.A270A,POLD1:uc002psc.5:exon7:c.T810C:p.A270A	.	AFR:0.3822,AMR:0.0310,EAS:0.0031,FIN:0,NFE:0.0016,OTH:0.0214,ASJ:0.0199	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	.	hom
19	50916772	50916772	T	C	POLD1	exonic	synonymous SNV	ENSG00000062822	rs1274607	ENSG00000062822:ENST00000595904:exon17:c.T2322C:p.S774S,ENSG00000062822:ENST00000440232:exon18:c.T2244C:p.S748S,ENSG00000062822:ENST00000599857:exon18:c.T2244C:p.S748S,ENSG00000062822:ENST00000600859:exon18:c.T2244C:p.S748S	POLD1:NM_001308632:exon17:c.T2322C:p.S774S,POLD1:NM_001256849:exon18:c.T2244C:p.S748S,POLD1:NM_002691:exon18:c.T2244C:p.S748S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0450	0.1093	0.118411	0.0969	.	.	.	.	.	.	.	.	POLD1:uc010eny.4:exon17:c.T2322C:p.S774S,POLD1:uc002psb.5:exon18:c.T2244C:p.S748S,POLD1:uc002psc.5:exon18:c.T2244C:p.S748S	.	AFR:0.3357,AMR:0.0298,EAS:0.0012,FIN:0,NFE:0.0014,OTH:0.0195,ASJ:0.0167	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	.	het
19	50918969	50918969	A	G	POLD1	intronic	.	ENSG00000062822	rs3219433	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2659	0.2094	0.282149	0.4502	.	.	.	.	.	0	0.004	.	.	.	AFR:0.6608,AMR:0.3268,EAS:0.3840,FIN:0.1611,NFE:0.2007,OTH:0.3065,ASJ:0.2756	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	MU18465562	het
19	50920410	50920410	C	T	POLD1	intronic	.	ENSG00000062822;ENSG00000142539	rs3212330	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0764	0.0935	0.108427	0.0839	.	.	.	.	.	.	.	.	.	.	AFR:0.2884,AMR:0.0286,EAS:0.0012,FIN:0,NFE:0.0025,OTH:0.0194,ASJ:0.0166	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	.	het
19	50920536	50920536	A	G	POLD1	intronic	.	ENSG00000062822;ENSG00000142539	rs2463239	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.0569	0.1151	0.128594	0.1022	.	.	.	.	.	.	.	.	.	.	AFR:0.3524,AMR:0.0334,EAS:0.0031,FIN:0,NFE:0.0026,OTH:0.0214,ASJ:0.0199	174761	612591;615381;	363649;220460;447877;	363649|MDP syndrome|<1 / 1 000 000|Autosomal dominant|Childhood|615381 ~220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~447877|PPAP|-|Autosomal dominant|-|612591 615083 ~	.	.	.	.	.	.	.	.	19	.	het
19	55665584	55665584	A	C	TNNI3	intronic	.	ENSG00000129991	rs7252610	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	1.0000	.	1	1	.	.	.	.	.	0.0052	0.15	.	.	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	191044	115210;611880;613286;613690;	154;154;75249;	154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~75249|Familial or idiopathic restrictive cardiomyopathy|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|115210 609578 612422 615248 617047 ~	.	.	.	.	.	.	.	.	19	MU82031742	hom
20	3193842	3193842	C	A	ITPA	exonic	nonsynonymous SNV	ENSG00000125877	rs1127354	ENSG00000125877:ENST00000380113:exon2:c.C94A:p.P32T,ENSG00000125877:ENST00000455664:exon2:c.C43A:p.P15T	ITPA:NM_001324240:exon2:c.C94A:p.P32T,ITPA:NM_033453:exon2:c.C94A:p.P32T,ITPA:NM_181493:exon2:c.C43A:p.P15T	clinvar: drug_response 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0771	0.0590	0.0894569	1(stomach)	5.001	25.1	0.094	5.64	1.000	.	.	.	ITPA:uc002wid.4:exon2:c.C94A:p.P32T,ITPA:uc002wie.4:exon2:c.C43A:p.P15T	-1.046	AFR:2(haematopoietic_and_lymphoid_tissue),AMR:MU585444,EAS:0.0700,FIN:0.0440,NFE:0.0310,OTH:0.0927,ASJ:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	0.791	.	0.006	1.39	20	7(soft_tissue)	0.1875
20	3193978	3193978	G	A	ITPA	exonic	synonymous SNV	ENSG00000125877	rs8362	ENSG00000125877:ENST00000380113:exon3:c.G138A:p.Q46Q,ENSG00000125877:ENST00000455664:exon3:c.G87A:p.Q29Q	ITPA:NM_001324240:exon3:c.G138A:p.Q46Q,ITPA:NM_033453:exon3:c.G138A:p.Q46Q,ITPA:NM_181493:exon3:c.G87A:p.Q29Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3520	0.3399	0.470447	MU99581	.	.	.	.	.	.	.	.	ITPA:uc002wid.4:exon3:c.G138A:p.Q46Q,ITPA:uc002wie.4:exon3:c.G87A:p.Q29Q	.	AFR:LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,AMR:0.3449,EAS:0.2950,FIN:0.3411,NFE:0.5827,OTH:0.1970,ASJ:0.4528	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	1(urinary_tract)	0.2981
20	3202069	3202069	C	T	ITPA	intronic	.	ENSG00000125877	rs6139034	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.309704	0.2150	.	.	.	.	.	.	.	.	.	.	AFR:0.0912,AMR:0.2578,EAS:0.4727,FIN:0.1921,NFE:0.2589,OTH:0.2428,ASJ:0.2947	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU88198053	het
20	3202129	3202129	T	C	ITPA	intronic	.	ENSG00000125877	rs6139035	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.332668	0.2501	.	.	.	.	.	.	.	.	.	.	AFR:0.1039,AMR:0.2794,EAS:0.4702,FIN:0.2160,NFE:0.3144,OTH:0.2721,ASJ:0.3543	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU114150678	het
20	3204084	3204084	G	A	ITPA	exonic	nonsynonymous SNV	ENSG00000125877	rs9101	ENSG00000125877:ENST00000399838:exon6:c.G438A:p.E146E,ENSG00000125877:ENST00000380113:exon8:c.G561A:p.E187E,ENSG00000125877:ENST00000455664:exon8:c.G510A:p.E170E	ITPA:NM_001324236:exon7:c.G224A:p.S75N,ITPA:NM_001324238:exon7:c.G224A:p.S75N,ITPA:NM_001351739:exon7:c.G224A:p.S75N,ITPA:NM_001324237:exon8:c.G224A:p.S75N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3257	0.2270	0.340455	0.2473	.	.	.	.	.	.	.	.	ITPA:uc031rsg.1:exon6:c.G438A:p.E146E,ITPA:uc002wid.4:exon8:c.G561A:p.E187E,ITPA:uc002wie.4:exon8:c.G510A:p.E170E	.	AFR:0.1036,AMR:0.2691,EAS:0.4938,FIN:0.2136,NFE:0.3077,OTH:0.2695,ASJ:0.3533	147520	613850;616647;	457375;	457375|-|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|616647 ~	.	.	.	.	.	.	.	.	20	MU21200389	het
20	5798114	5798114	-	TA	SHLD1	intronic	.	ENSG00000171984	.	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	.	0.1936	.	.	.	.	.	.	.	.	.	.	AFR:0.0586,AMR:0.2152,EAS:0.2359,FIN:0.3184,NFE:0.2551,OTH:0.2374,ASJ:0.1348	.	.	.	.	.	.	.	.	.	.	.	.	20	.	het
20	5939214	5939214	A	C	MCM8	exonic	synonymous SNV	ENSG00000125885	rs3761873	ENSG00000125885:ENST00000265187:exon7:c.A631C:p.R211R,ENSG00000125885:ENST00000378883:exon7:c.A631C:p.R211R,ENSG00000125885:ENST00000378886:exon7:c.A631C:p.R211R,ENSG00000125885:ENST00000378896:exon7:c.A631C:p.R211R	MCM8:NM_001281520:exon7:c.A631C:p.R211R,MCM8:NM_001281521:exon7:c.A631C:p.R211R,MCM8:NM_001281522:exon7:c.A631C:p.R211R,MCM8:NM_032485:exon7:c.A631C:p.R211R,MCM8:NM_182802:exon7:c.A631C:p.R211R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0760	0.0702	0.120008	LICA-CN|1|402|0.00248756,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MCM8:uc002wmi.3:exon7:c.A631C:p.R211R,MCM8:uc002wmj.3:exon7:c.A631C:p.R211R,MCM8:uc002wmk.3:exon7:c.A631C:p.R211R,MCM8:uc002wml.3:exon7:c.A631C:p.R211R,MCM8:uc010gbp.3:exon7:c.A631C:p.R211R	.	AFR:0.0779,AMR:0.1054,EAS:0.0861,FIN:0.2454,NFE:0.0495,OTH:0.0530,ASJ:0.0489	608187	612885;	.	.	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.0622
20	5943956	5943956	G	C	MCM8	exonic	nonsynonymous SNV	ENSG00000125885	rs61752028	ENSG00000125885:ENST00000265187:exon8:c.G826C:p.A276P,ENSG00000125885:ENST00000378883:exon8:c.G826C:p.A276P,ENSG00000125885:ENST00000378886:exon8:c.G826C:p.A276P,ENSG00000125885:ENST00000378896:exon8:c.G826C:p.A276P	MCM8:NM_001281520:exon8:c.G826C:p.A276P,MCM8:NM_001281521:exon8:c.G826C:p.A276P,MCM8:NM_001281522:exon8:c.G826C:p.A276P,MCM8:NM_032485:exon8:c.G826C:p.A276P,MCM8:NM_182802:exon8:c.G826C:p.A276P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0242	0.0045	0.0654952	0.0176	-0.702	0.071	1.0	1.49	0.012	.	.	MCM OB domain|Nucleic acid-binding, OB-fold	MCM8:uc002wmi.3:exon8:c.G826C:p.A276P,MCM8:uc002wmj.3:exon8:c.G826C:p.A276P,MCM8:uc002wmk.3:exon8:c.G826C:p.A276P,MCM8:uc002wml.3:exon8:c.G826C:p.A276P,MCM8:uc010gbp.3:exon8:c.G826C:p.A276P	-0.903	AFR:0.0117,AMR:0,EAS:0.2413,FIN:0.0060,NFE:0.0013,OTH:0.0122,ASJ:0.0066	608187	612885;	.	.	.	.	.	.	0.0	3.73	0.000	-1.35	20	MU14532416	het
20	5948542	5948542	G	A	MCM8	exonic	nonsynonymous SNV	ENSG00000125885	rs28403619	ENSG00000125885:ENST00000265187:exon10:c.G1046A:p.S349N,ENSG00000125885:ENST00000378883:exon10:c.G1094A:p.S365N,ENSG00000125885:ENST00000378886:exon10:c.G1094A:p.S365N,ENSG00000125885:ENST00000378896:exon10:c.G1094A:p.S365N	MCM8:NM_001281520:exon10:c.G1094A:p.S365N,MCM8:NM_001281521:exon10:c.G1094A:p.S365N,MCM8:NM_001281522:exon10:c.G1094A:p.S365N,MCM8:NM_032485:exon10:c.G1094A:p.S365N,MCM8:NM_182802:exon10:c.G1046A:p.S349N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0238	0.0045	0.0650958	0.0176	1.575	13.71	0.347	3.75	1.000	.	.	Nucleic acid-binding, OB-fold	MCM8:uc002wmi.3:exon10:c.G1094A:p.S365N,MCM8:uc002wmj.3:exon10:c.G1046A:p.S349N,MCM8:uc002wmk.3:exon10:c.G1094A:p.S365N,MCM8:uc002wml.3:exon10:c.G1094A:p.S365N,MCM8:uc010gbp.3:exon10:c.G1094A:p.S365N	-0.877	AFR:0.0117,AMR:0,EAS:0.2413,FIN:0.0060,NFE:0.0013,OTH:0.0112,ASJ:0.0066	608187	612885;	.	.	.	.	.	.	0.0	4.12	0.000	0.815	20	MU11287811	het
20	5953260	5953260	G	T	MCM8	exonic	nonsynonymous SNV	ENSG00000125885	rs370800757	ENSG00000125885:ENST00000378886:exon11:c.G1262T:p.G421V	MCM8:NM_001281521:exon11:c.G1262T:p.G421V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 0, 0] 	0.0560	.	0.0145767	0.0003	-0.474	0.255	0.217	-0.663	0.004	.	.	MCM domain|P-loop containing nucleoside triphosphate hydrolase	MCM8:uc002wmk.3:exon11:c.G1262T:p.G421V	-0.958	AFR:0.0002,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0082,ASJ:0	608187	612885;	.	.	.	.	.	.	0.994	0.89	0.208	.	20	.	het
20	5953833	5953833	A	G	MCM8	exonic	synonymous SNV	ENSG00000125885	rs16991617	ENSG00000125885:ENST00000265187:exon12:c.A1338G:p.Q446Q,ENSG00000125885:ENST00000378886:exon12:c.A1506G:p.Q502Q,ENSG00000125885:ENST00000378896:exon12:c.A1386G:p.Q462Q	MCM8:NM_001281520:exon12:c.A1386G:p.Q462Q,MCM8:NM_001281521:exon12:c.A1506G:p.Q502Q,MCM8:NM_032485:exon12:c.A1386G:p.Q462Q,MCM8:NM_182802:exon12:c.A1338G:p.Q446Q	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0752	0.0675	0.117812	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	MCM8:uc002wmi.3:exon12:c.A1386G:p.Q462Q,MCM8:uc002wmj.3:exon12:c.A1338G:p.Q446Q,MCM8:uc002wmk.3:exon12:c.A1506G:p.Q502Q,MCM8:uc002wml.3:exon12:c.A1386G:p.Q462Q	.	AFR:0.0759,AMR:0.0983,EAS:0.0861,FIN:0.2460,NFE:0.0493,OTH:0.0530,ASJ:0.0490	608187	612885;	.	.	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.0622
20	6096695	6096695	C	T	FERMT1	intronic	.	ENSG00000101311	rs2295435	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4489	0.4070	0.419329	0.3801	.	.	.	.	.	0.0002	0.006	.	.	.	AFR:0.3611,AMR:0.4291,EAS:0.2906,FIN:0.3177,NFE:0.4083,OTH:0.3953,ASJ:0.5464	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	MU655370	hom
20	6100088	6100088	A	G	FERMT1	exonic	synonymous SNV	ENSG00000101311	rs10373	ENSG00000101311:ENST00000217289:exon2:c.T114C:p.H38H,ENSG00000101311:ENST00000378844:exon2:c.T114C:p.H38H	FERMT1:NM_017671:exon2:c.T114C:p.H38H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5243	0.5324	0.524561	ESAD-UK|1|409|0.00244499,SKCA-BR|1|100|0.01,LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	FERMT1:uc002wmr.3:exon2:c.T114C:p.H38H,FERMT1:uc002wms.3:exon2:c.T114C:p.H38H	.	AFR:0.5005,AMR:0.5294,EAS:0.6225,FIN:0.3752,NFE:0.4129,OTH:0.5169,ASJ:0.4845	607900	173650;	306539;	306539|-|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|173650 ~	.	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.4878
20	8737734	8737734	G	A	PLCB1	exonic	synonymous SNV	ENSG00000182621	rs2076413	ENSG00000182621:ENST00000338037:exon24:c.G2565A:p.A855A,ENSG00000182621:ENST00000378637:exon24:c.G2565A:p.A855A,ENSG00000182621:ENST00000378641:exon24:c.G2565A:p.A855A	PLCB1:NM_015192:exon24:c.G2565A:p.A855A,PLCB1:NM_182734:exon24:c.G2565A:p.A855A	clinvar: Benign/Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2718	0.2519	0.21226	0.2527	.	.	.	.	.	.	.	.	PLCB1:uc002wnd.1:exon12:c.G1296A:p.A432A,PLCB1:uc002wnc.1:exon22:c.G2262A:p.A754A,PLCB1:uc002wna.4:exon24:c.G2565A:p.A855A,PLCB1:uc002wnb.4:exon24:c.G2565A:p.A855A,PLCB1:uc010zrb.1:exon24:c.G2262A:p.A754A	.	AFR:0.1320,AMR:0.2279,EAS:0.1702,FIN:0.2871,NFE:0.3213,OTH:0.2843,ASJ:0.3367	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	MU11294585	hom
20	8755243	8755243	T	C	PLCB1	exonic	synonymous SNV	ENSG00000182621	rs2235613	ENSG00000182621:ENST00000338037:exon27:c.T2988C:p.A996A,ENSG00000182621:ENST00000378637:exon27:c.T2988C:p.A996A,ENSG00000182621:ENST00000378641:exon27:c.T2988C:p.A996A	PLCB1:NM_015192:exon27:c.T2988C:p.A996A,PLCB1:NM_182734:exon27:c.T2988C:p.A996A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6155	0.6402	0.613219	MU146166	.	.	.	.	.	.	.	.	PLCB1:uc002wnd.1:exon15:c.T1719C:p.A573A,PLCB1:uc002wnc.1:exon25:c.T2685C:p.A895A,PLCB1:uc002wna.4:exon27:c.T2988C:p.A996A,PLCB1:uc002wnb.4:exon27:c.T2988C:p.A996A,PLCB1:uc010zrb.1:exon27:c.T2685C:p.A895A	.	AFR:LICA-CN|3|402|0.00746269,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.6163,EAS:0.5096,FIN:0.7119,NFE:0.5167,OTH:0.5516,ASJ:0.6384	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	1(prostate)	0.6330
20	8769180	8769180	C	T	PLCB1	intronic	.	ENSG00000182621	rs2327089	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9408	0.8914	0.896965	0.9039	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.7424,AMR:0.9630,EAS:0.9988,FIN:0.9820,NFE:0.9625,OTH:0.9481,ASJ:0.9371	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	MU82035692	hom
20	8770822	8770822	C	T	PLCB1	exonic	synonymous SNV	ENSG00000182621	rs2294597	ENSG00000182621:ENST00000338037:exon31:c.C3337T:p.L1113L,ENSG00000182621:ENST00000378637:exon31:c.C3337T:p.L1113L,ENSG00000182621:ENST00000378641:exon31:c.C3337T:p.L1113L	PLCB1:NM_015192:exon31:c.C3337T:p.L1113L,PLCB1:NM_182734:exon31:c.C3337T:p.L1113L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2970	0.2533	0.228634	LAML-KR|4|205|0.0195122,LUSC-KR|1|170|0.00588235	.	.	.	.	.	0.0008	0.19	.	PLCB1:uc002wna.4:exon31:c.C3337T:p.L1113L,PLCB1:uc002wnb.4:exon31:c.C3337T:p.L1113L	.	AFR:0.2549,AMR:0.1392,EAS:0.3377,FIN:0.1706,NFE:0.2873,OTH:0.3211,ASJ:0.2291	607120	613722;	293181;3451;	293181|MMPEI<br>MMPSI<br>MPEI<br>MPSI<br>Malignant migrating partial epilepsy of infancy<br>Migrating partial epilepsy of infancy<br>Migrating partial seizures of infancy|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|613722 614959 615338 616645 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04022 cGMP-PKG signaling pathway~ko04062 Chemokine signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04071 Sphingolipid signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04310 Wnt signaling pathway~ko04361 Axon regeneration~ko04371 Apelin signaling pathway~ko04540 Gap junction~ko04611 Platelet activation~ko04621 NOD-like receptor signaling pathway~ko04713 Circadian entrainment~ko04720 Long-term potentiation~ko04723 Retrograde endocannabinoid signaling~ko04724 Glutamatergic synapse~ko04725 Cholinergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04745 Phototransduction - fly~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04929 GnRH secretion~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04973 Carbohydrate digestion and absorption~ko05010 Alzheimer disease~ko05016 Huntington disease~ko05142 Chagas disease (American trypanosomiasis)~ko05143 African trypanosomiasis~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05200 Pathways in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	.	.	.	.	20	2(haematopoietic_and_lymphoid_tissue)	0.2929
20	10620275	10620275	G	A	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1051421	ENSG00000101384:ENST00000423891:exon24:c.C3051T:p.Y1017Y,ENSG00000101384:ENST00000254958:exon26:c.C3528T:p.Y1176Y	JAG1:NM_000214:exon26:c.C3528T:p.Y1176Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2383	0.2281	0.180112	1(large_intestine)	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon26:c.C3528T:p.Y1176Y	.	AFR:MU110190,AMR:LAML-KR|2|205|0.0097561,COCA-CN|2|321|0.00623053,EAS:0.1109,FIN:0.2184,NFE:0.31,OTH:0.1391,ASJ:0.2145	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	1(urinary_tract)	0.2191
20	10620386	10620386	A	G	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1051419	ENSG00000101384:ENST00000423891:exon24:c.T2940C:p.Y980Y,ENSG00000101384:ENST00000254958:exon26:c.T3417C:p.Y1139Y	JAG1:NM_000214:exon26:c.T3417C:p.Y1139Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.6592	0.7272	0.71266	3(lung)	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon26:c.T3417C:p.Y1139Y	.	AFR:1(large_intestine),AMR:MU110199,EAS:0.6923,FIN:0.9037,NFE:0.6146,OTH:0.5828,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	1(urinary_tract)	0.4141
20	10633237	10633237	G	A	JAG1	exonic	synonymous SNV	ENSG00000101384	rs1131695	ENSG00000101384:ENST00000423891:exon4:c.C288T:p.Y96Y,ENSG00000101384:ENST00000254958:exon6:c.C765T:p.Y255Y	JAG1:NM_000214:exon6:c.C765T:p.Y255Y	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4541	0.4247	0.423323	LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	JAG1:uc002wnw.2:exon6:c.C765T:p.Y255Y	.	AFR:0.4224,AMR:0.3535,EAS:0.4934,FIN:0.3276,NFE:0.4487,OTH:0.4636,ASJ:0.4177	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	3(large_intestine)	0.4507
20	10639385	10639385	A	G	JAG1	intronic	.	ENSG00000101384	rs2273060	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.4375	0.4240	0.457668	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4235,AMR:0.4592,EAS:0.4404,FIN:0.4095,NFE:0.4096,OTH:0.4062,ASJ:0.4678	601920	118450;187500;	3303;261600;261619;52;	3303|-|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Multigenic/multifactorial|Neonatal<br>Antenatal|187500 ~261600|Alagille syndrome due to del(20)(p12)<br>Alagille syndrome due to monosomy 20p12<br>Alagille-Watson syndrome due to monosomy 20p12<br>Arteriohepatic dysplasia due to monosomy 20p12<br>Syndromic bile duct paucity due to monosomy 20p12|Unknown|-|-|118450 ~261619|Alagille-Watson syndrome due to a JAG1 point mutation<br>Arteriohepatic dysplasia due to a JAG1 point mutation<br>Syndromic bile duct paucity due to a JAG1 point mutation|-|-|-|118450 ~52|Alagille-Watson syndrome<br>Arteriohepatic dysplasia<br>Syndromic bile duct paucity|Unknown|Autosomal dominant|All ages|118450 610205 ~	~ko01522 Endocrine resistance~ko04330 Notch signaling pathway~ko04371 Apelin signaling pathway~ko04658 Th1 and Th2 cell differentiation~ko04668 TNF signaling pathway~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	1(haematopoietic_and_lymphoid_tissue)	0.4012
20	31022959	31022959	T	C	ASXL1	exonic	nonsynonymous SNV	ENSG00000171456	rs6058694	ENSG00000171456:ENST00000306058:exon12:c.T2429C:p.L810P,ENSG00000171456:ENST00000375687:exon13:c.T2444C:p.L815P	ASXL1:NM_001363734:exon11:c.T2261C:p.L754P,ASXL1:NM_015338:exon12:c.T2444C:p.L815P	clinvar: not_provided 	 CancerVar: 8#Tier_II_potential EVS=[1, 1, 1, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	1.0000	0.9999	1	1	.	.	.	.	.	.	.	.	ASXL1:uc010geb.3:exon9:c.T2117C:p.L706P,ASXL1:uc002wxs.3:exon12:c.T2441C:p.L814P,ASXL1:uc021wbw.1:exon13:c.T2444C:p.L815P	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	612990	605039;614286;	52688;97297;	52688|-|1-9 / 100 000|-|All ages|614286 ~97297|BOS syndrome<br>Bohring syndrome<br>C-like syndrome<br>Oberklaid-Danks syndrome<br>Opitz trigonocephaly-like syndrome|<1 / 1 000 000|-|-|605039 ~	.	,842,839,844	,853	,845,846,852,851,848,843,849,850,847,854	.	.	.	.	20	MU82037741	hom
20	31383353	31383353	T	G	DNMT3B	intronic	.	ENSG00000088305	rs910085	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4836	0.4029	0.584864	0.4343	.	.	.	.	.	.	.	.	.	.	AFR:0.4486,AMR:0.6499,EAS:0.9406,FIN:0.3651,NFE:0.3789,OTH:0.3990,ASJ:0.3818	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU25969455	hom
20	31386347	31386347	T	C	DNMT3B	exonic	synonymous SNV	ENSG00000088305	rs6058891	ENSG00000088305:ENST00000456297:exon12:c.T1284C:p.C428C,ENSG00000088305:ENST00000443239:exon13:c.T1386C:p.C462C,ENSG00000088305:ENST00000201963:exon14:c.T1548C:p.C516C,ENSG00000088305:ENST00000344505:exon14:c.T1512C:p.C504C,ENSG00000088305:ENST00000348286:exon14:c.T1512C:p.C504C,ENSG00000088305:ENST00000353855:exon14:c.T1512C:p.C504C,ENSG00000088305:ENST00000328111:exon15:c.T1572C:p.C524C	DNMT3B:NM_001207056:exon12:c.T1284C:p.C428C,DNMT3B:NM_001207055:exon13:c.T1386C:p.C462C,DNMT3B:NM_175848:exon14:c.T1512C:p.C504C,DNMT3B:NM_175849:exon14:c.T1512C:p.C504C,DNMT3B:NM_175850:exon14:c.T1548C:p.C516C,DNMT3B:NM_006892:exon15:c.T1572C:p.C524C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5806	0.5791	0.755791	0.5962	.	.	.	.	.	.	.	.	DNMT3B:uc002wyg.3:exon8:c.T669C:p.C223C,DNMT3B:uc010zua.2:exon12:c.T1284C:p.C428C,DNMT3B:uc010ztz.2:exon13:c.T1386C:p.C462C,DNMT3B:uc002wyd.3:exon14:c.T1512C:p.C504C,DNMT3B:uc002wye.3:exon14:c.T1512C:p.C504C,DNMT3B:uc002wyf.3:exon14:c.T1548C:p.C516C,DNMT3B:uc002wyc.3:exon15:c.T1572C:p.C524C	.	AFR:0.8523,AMR:0.7050,EAS:0.9957,FIN:0.4335,NFE:0.4437,OTH:0.5102,ASJ:0.47	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU4554871	hom
20	31386449	31386449	T	C	DNMT3B	exonic	synonymous SNV	ENSG00000088305	rs2424922	ENSG00000088305:ENST00000456297:exon12:c.T1386C:p.Y462Y,ENSG00000088305:ENST00000443239:exon13:c.T1488C:p.Y496Y,ENSG00000088305:ENST00000201963:exon14:c.T1650C:p.Y550Y,ENSG00000088305:ENST00000344505:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000348286:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000353855:exon14:c.T1614C:p.Y538Y,ENSG00000088305:ENST00000328111:exon15:c.T1674C:p.Y558Y	DNMT3B:NM_001207056:exon12:c.T1386C:p.Y462Y,DNMT3B:NM_001207055:exon13:c.T1488C:p.Y496Y,DNMT3B:NM_175848:exon14:c.T1614C:p.Y538Y,DNMT3B:NM_175849:exon14:c.T1614C:p.Y538Y,DNMT3B:NM_175850:exon14:c.T1650C:p.Y550Y,DNMT3B:NM_006892:exon15:c.T1674C:p.Y558Y	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5792	0.5777	0.755791	0.5958	.	.	.	.	.	0.0001	0.2	.	DNMT3B:uc002wyg.3:exon8:c.T771C:p.Y257Y,DNMT3B:uc010zua.2:exon12:c.T1386C:p.Y462Y,DNMT3B:uc010ztz.2:exon13:c.T1488C:p.Y496Y,DNMT3B:uc002wyd.3:exon14:c.T1614C:p.Y538Y,DNMT3B:uc002wye.3:exon14:c.T1614C:p.Y538Y,DNMT3B:uc002wyf.3:exon14:c.T1650C:p.Y550Y,DNMT3B:uc002wyc.3:exon15:c.T1674C:p.Y558Y	.	AFR:0.8515,AMR:0.7064,EAS:0.9957,FIN:0.4333,NFE:0.4433,OTH:0.5102,ASJ:0.4702	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU4554877	hom
20	31387954	31387954	C	G	DNMT3B	intronic	.	ENSG00000088305	rs1997797	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5663	0.5340	0.714058	0.5577	.	.	.	.	.	0.0005	0.056	.	.	.	AFR:0.7205,AMR:0.6986,EAS:0.9957,FIN:0.4313,NFE:0.4426,OTH:0.5031,ASJ:0.4636	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU30256080	hom
20	31388636	31388636	T	C	DNMT3B	intronic	.	ENSG00000088305	rs2424928	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5737	0.5621	0.742612	0.5818	.	.	.	.	.	0.0001	0.004	.	.	.	AFR:0.8052,AMR:0.7014,EAS:0.9951,FIN:0.4303,NFE:0.4430,OTH:0.5071,ASJ:0.4636	602900	242860;	2268;	2268|Immunodeficiency-centromeric instability-facial anomalies syndrome|<1 / 1 000 000|Autosomal recessive|Childhood|242860 614069 616910 616911 ~	.	.	.	.	.	.	.	.	20	MU30256113	hom
20	36030939	36030939	G	C	SRC	exonic	synonymous SNV	ENSG00000197122	rs1885257	ENSG00000197122:ENST00000358208:exon10:c.G1218C:p.A406A,ENSG00000197122:ENST00000373558:exon10:c.G1236C:p.A412A,ENSG00000197122:ENST00000373567:exon10:c.G1218C:p.A406A,ENSG00000197122:ENST00000360723:exon11:c.G1236C:p.A412A,ENSG00000197122:ENST00000445403:exon11:c.G1218C:p.A406A,ENSG00000197122:ENST00000373578:exon12:c.G1218C:p.A406A	SRC:NM_005417:exon12:c.G1218C:p.A406A,SRC:NM_198291:exon12:c.G1218C:p.A406A	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	1	.	1	1	.	.	.	.	.	.	.	.	SRC:uc002xgx.3:exon12:c.G1218C:p.A406A,SRC:uc002xgy.3:exon12:c.G1218C:p.A406A	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	190090	114500;616937;	.	.	~ko01521 EGFR tyrosine kinase inhibitor resistance~ko01522 Endocrine resistance~ko04012 ErbB signaling pathway~ko04013 MAPK signaling pathway - fly~ko04015 Rap1 signaling pathway~ko04062 Chemokine signaling pathway~ko04137 Mitophagy - animal~ko04144 Endocytosis~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04510 Focal adhesion~ko04520 Adherens junction~ko04530 Tight junction~ko04540 Gap junction~ko04611 Platelet activation~ko04625 C-type lectin receptor signaling pathway~ko04727 GABAergic synapse~ko04750 Inflammatory mediator regulation of TRP channels~ko04810 Regulation of actin cytoskeleton~ko04912 GnRH signaling pathway~ko04915 Estrogen signaling pathway~ko04917 Prolactin signaling pathway~ko04919 Thyroid hormone signaling pathway~ko04921 Oxytocin signaling pathway~ko04926 Relaxin signaling pathway~ko05100 Bacterial invasion of epithelial cells~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05131 Shigellosis~ko05135 Yersinia infection~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05163 Human cytomegalovirus infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05168 Herpes simplex virus 1 infection~ko05203 Viral carcinogenesis~ko05205 Proteoglycans in cancer~ko05219 Bladder cancer~ko05418 Fluid shear stress and atherosclerosis ~	,9875,9873,9872,9876,9878,9870,9869,9879,9880,9871,9874,9877	.	.	.	.	.	.	20	MU82038480	hom
20	39792063	39792063	A	G	PLCG1	exonic	nonsynonymous SNV	ENSG00000124181	rs2228246	ENSG00000124181:ENST00000373271:exon9:c.A835G:p.S279G,ENSG00000124181:ENST00000373272:exon9:c.A835G:p.S279G,ENSG00000124181:ENST00000244007:exon10:c.A835G:p.S279G	PLCG1:NM_002660:exon9:c.A835G:p.S279G,PLCG1:NM_182811:exon9:c.A835G:p.S279G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.1363	0.1379	0.0788738	1(breast)	1.103	11.23	0.178	4.6	1.000	.	.	EF-hand domain pair	PLCG1:uc002xjo.1:exon9:c.A835G:p.S279G,PLCG1:uc002xjp.1:exon9:c.A835G:p.S279G	-1.066	AFR:1(thyroid),AMR:MU4556900,EAS:0.1571,FIN:0.1037,NFE:0.1328,OTH:0.1325,ASJ:SKCA-BR|1|100|0.01,LUSC-KR|1|170|0.00588235	172420	.	.	.	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05135 Yersinia infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	0.97	0.000	0.755	20	5(soft_tissue)	0.0037
20	39797465	39797465	T	C	PLCG1	exonic	nonsynonymous SNV	ENSG00000124181	rs753381	ENSG00000124181:ENST00000373271:exon21:c.T2438C:p.I813T,ENSG00000124181:ENST00000373272:exon21:c.T2438C:p.I813T,ENSG00000124181:ENST00000244007:exon22:c.T2438C:p.I813T	PLCG1:NM_002660:exon21:c.T2438C:p.I813T,PLCG1:NM_182811:exon21:c.T2438C:p.I813T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6155	0.6693	0.732827	0.6790	1.643	14.09	0.547	5.82	0.998	.	.	Pleckstrin homology domain|SH3 domain	PLCG1:uc010ggf.3:exon4:c.T410C:p.I137T,PLCG1:uc010zwe.1:exon10:c.T1316C:p.I439T,PLCG1:uc002xjo.1:exon21:c.T2438C:p.I813T,PLCG1:uc002xjp.1:exon21:c.T2438C:p.I813T	-0.938	AFR:0.9256,AMR:0.6031,EAS:0.8300,FIN:0.5917,NFE:0.5500,OTH:0.6043,ASJ:0.58	172420	.	.	.	~ko00562 Inositol phosphate metabolism~ko01100 Metabolic pathways~ko01521 EGFR tyrosine kinase inhibitor resistance~ko04012 ErbB signaling pathway~ko04014 Ras signaling pathway~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04064 NF-kappa B signaling pathway~ko04066 HIF-1 signaling pathway~ko04070 Phosphatidylinositol signaling system~ko04072 Phospholipase D signaling pathway~ko04360 Axon guidance~ko04370 VEGF signaling pathway~ko04650 Natural killer cell mediated cytotoxicity~ko04658 Th1 and Th2 cell differentiation~ko04659 Th17 cell differentiation~ko04660 T cell receptor signaling pathway~ko04664 Fc epsilon RI signaling pathway~ko04666 Fc gamma R-mediated phagocytosis~ko04670 Leukocyte transendothelial migration~ko04722 Neurotrophin signaling pathway~ko04750 Inflammatory mediator regulation of TRP channels~ko04919 Thyroid hormone signaling pathway~ko04933 AGE-RAGE signaling pathway in diabetic complications~ko05110 Vibrio cholerae infection~ko05120 Epithelial cell signaling in Helicobacter pylori~~ko05135 Yersinia infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05170 Human immunodeficiency virus 1 infection~ko05200 Pathways in cancer~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer~ko05214 Glioma~ko05223 Non-small cell lung cancer~ko05225 Hepatocellular carcinoma~ko05231 Choline metabolism in cancer~ko05235 PD-L1 expression and PD-1 checkpoint pathway in cancer~~M00130 Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3~ ~	.	.	.	0.0	0.91	0.000	-1.165	20	MU17685332	hom
20	41306488	41306488	-	AA	PTPRT	intronic	.	ENSG00000196090	rs111229158	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.4277	.	0.477236	0.5209	.	.	.	.	.	.	.	.	.	.	AFR:0.5062,AMR:0.5315,EAS:0.5224,FIN:0.4946,NFE:0.5329,OTH:0.5231,ASJ:0.5906	608712	.	.	.	.	.	.	.	.	.	.	.	20	.	hom
20	42320881	42320881	C	T	MYBL2	exonic	synonymous SNV	ENSG00000101057	rs2229036	ENSG00000101057:ENST00000396863:exon5:c.C513T:p.D171D,ENSG00000101057:ENST00000217026:exon6:c.C585T:p.D195D	MYBL2:NM_001278610:exon5:c.C513T:p.D171D,MYBL2:NM_002466:exon6:c.C585T:p.D195D	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0472	0.0405	0.0505192	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	MYBL2:uc010zwj.1:exon5:c.C513T:p.D171D,MYBL2:uc002xlb.1:exon6:c.C585T:p.D195D	.	AFR:0.0385,AMR:0.0259,EAS:0.0596,FIN:0.0760,NFE:0.0309,OTH:0.0434,ASJ:0.0346	601415	.	.	.	.	.	.	.	.	.	.	.	20	2(haematopoietic_and_lymphoid_tissue)	0.0388
20	42328639	42328639	T	C	MYBL2	exonic	synonymous SNV	ENSG00000101057	rs285162	ENSG00000101057:ENST00000396863:exon6:c.T834C:p.P278P,ENSG00000101057:ENST00000217026:exon7:c.T906C:p.P302P	MYBL2:NM_001278610:exon6:c.T834C:p.P278P,MYBL2:NM_002466:exon7:c.T906C:p.P302P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9141	0.9372	0.932109	0.9385	.	.	.	.	.	.	.	.	MYBL2:uc010zwj.1:exon6:c.T834C:p.P278P,MYBL2:uc002xlb.1:exon7:c.T906C:p.P302P	.	AFR:0.9724,AMR:0.7602,EAS:0.9082,FIN:0.9505,NFE:0.9297,OTH:0.9235,ASJ:0.9570	601415	.	.	.	.	.	.	.	.	.	.	.	20	MU25976801	het
20	42331457	42331457	A	G	MYBL2	exonic	nonsynonymous SNV	ENSG00000101057	rs2070235	ENSG00000101057:ENST00000396863:exon7:c.A1207G:p.S403G,ENSG00000101057:ENST00000217026:exon8:c.A1279G:p.S427G	MYBL2:NM_001278610:exon7:c.A1207G:p.S403G,MYBL2:NM_002466:exon8:c.A1279G:p.S427G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1080	0.1525	0.15655	1(breast)	1.102	11.22	0.55	2.73	0.923	.	.	.	MYBL2:uc010zwj.1:exon7:c.A1207G:p.S403G,MYBL2:uc002xlb.1:exon8:c.A1279G:p.S427G	-0.903	AFR:MU4557321,AMR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,EAS:0.2664,FIN:0.0694,NFE:0.1159,OTH:0.0883,ASJ:0.1377	601415	.	.	.	.	.	.	.	0.002	2.52	0.000	0.805	20	1(haematopoietic_and_lymphoid_tissue)	0.0922
20	43604003	43604003	C	T	STK4	intronic	.	ENSG00000101109	rs6017452	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.488618	0.5479	.	.	.	.	.	.	.	.	.	.	AFR:0.6839,AMR:0.2728,EAS:0.3373,FIN:0.6083,NFE:0.4954,OTH:0.5356,ASJ:0.4603	604965	614868;	314689;	314689|CID due to STK4 deficiency|<1 / 1 000 000|Autosomal recessive|Childhood|614868 ~	~ko04010 MAPK signaling pathway~ko04014 Ras signaling pathway~ko04068 FoxO signaling pathway~ko05200 Pathways in cancer~ko05223 Non-small cell lung cancer ~	.	.	.	.	.	.	.	20	MU19615533	hom
20	43964407	43964407	G	C	SDC4	intronic	.	ENSG00000124145	rs2072791	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.7710	0.7280	0.769369	0.7446	.	.	.	.	.	.	.	.	.	.	AFR:0.6624,AMR:0.7912,EAS:0.9618,FIN:0.7983,NFE:0.7548,OTH:0.7377,ASJ:0.7067	600017	.	.	.	~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	.	.	.	.	20	MU71379439	hom
20	43976991	43976991	A	G	SDC4	exonic	nonsynonymous SNV	ENSG00000124145	rs2228384	ENSG00000124145:ENST00000372733:exon1:c.T34C:p.F12L	SDC4:NM_002999:exon1:c.T34C:p.F12L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.4449	0.2800	0.3123	0.3122	1.585	13.77	1.0	1.9	0.796	.	.	.	SDC4:uc002xnu.3:exon1:c.T34C:p.F12L	-0.934	AFR:0.1663,AMR:0.3687,EAS:0.4062,FIN:0.3779,NFE:0.3641,OTH:0.3548,ASJ:0.39	600017	.	.	.	~ko04512 ECM-receptor interaction~ko04514 Cell adhesion molecules (CAMs)~ko05205 Proteoglycans in cancer~ko05418 Fluid shear stress and atherosclerosis ~	.	.	.	0.0	1.72	0.000	-1.905	20	MU69597	hom
20	46267950	46267950	C	T	NCOA3	intronic	.	ENSG00000124151	rs4810648	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.9411	0.9406	0.978435	0.9373	.	.	.	.	.	0.0002	0.034	.	.	.	AFR:0.9842,AMR:0.9533,EAS:1,FIN:0.9273,NFE:0.9051,OTH:0.9257,ASJ:0.9570	601937	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	MU82039696	hom
20	46279860	46279860	-	CAA	NCOA3	exonic	nonframeshift insertion	ENSG00000124151	rs753491875	ENSG00000124151:ENST00000341724:exon19:c.3564_3565insCAA:p.Q1188delinsQQ,ENSG00000124151:ENST00000371997:exon20:c.3759_3760insCAA:p.Q1253delinsQQ,ENSG00000124151:ENST00000371998:exon20:c.3786_3787insCAA:p.Q1262delinsQQ,ENSG00000124151:ENST00000372004:exon20:c.3774_3775insCAA:p.Q1258delinsQQ	NCOA3:NM_001174087:exon20:c.3783_3784insCAA:p.Q1261delinsQQ,NCOA3:NM_001174088:exon20:c.3759_3760insCAA:p.Q1253delinsQQ,NCOA3:NM_006534:exon20:c.3774_3775insCAA:p.Q1258delinsQQ,NCOA3:NM_181659:exon20:c.3786_3787insCAA:p.Q1262delinsQQ	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.0079	.	.	0.0017	.	.	.	.	.	.	.	.	NCOA3:uc010zyc.2:exon15:c.3171_3172insCAA:p.Q1057delinsQQ,NCOA3:uc002xtk.3:exon20:c.3786_3787insCAA:p.Q1262delinsQQ,NCOA3:uc002xtl.3:exon20:c.3774_3775insCAA:p.Q1258delinsQQ,NCOA3:uc002xtm.3:exon20:c.3771_3772insCAA:p.Q1257delinsQQ,NCOA3:uc002xtn.3:exon20:c.3783_3784insCAA:p.Q1261delinsQQ,NCOA3:uc010ght.2:exon20:c.3759_3760insCAA:p.Q1253delinsQQ	.	AFR:0.0020,AMR:0.0120,EAS:0.0087,FIN:0,NFE:0.0003,OTH:0.0041,ASJ:0.0103	601937	.	.	.	~ko01522 Endocrine resistance~ko04915 Estrogen signaling pathway~ko04919 Thyroid hormone signaling pathway~ko05200 Pathways in cancer~ko05224 Breast cancer ~	.	.	.	.	.	.	.	20	.	het
20	47604825	47604825	G	A	ARFGEF2	intronic	.	ENSG00000124198	rs4810905	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3062	0.2178	0.290735	0.2368	.	.	.	.	.	.	.	.	.	.	AFR:0.1178,AMR:0.4045,EAS:0.4770,FIN:0.2652,NFE:0.2597,OTH:0.3057,ASJ:0.2233	605371	608097;	2149;98892;	2149|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|All ages|300049 608097 608098 612881 615544 ~98892|-|Unknown|Autosomal recessive<br>or&nbsp;X-linked dominant|-|300049 608097 608098 612881 615544 ~	.	.	.	.	.	.	.	.	20	MU585566	het
20	50408482	50408482	A	G	SALL4	exonic	synonymous SNV	ENSG00000101115	rs6013281	ENSG00000101115:ENST00000217086:exon2:c.T540C:p.N180N,ENSG00000101115:ENST00000395997:exon2:c.T540C:p.N180N	SALL4:NM_001318031:exon2:c.T540C:p.N180N,SALL4:NM_020436:exon2:c.T540C:p.N180N	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9965	0.9956	0.997404	0.9967	.	.	.	.	.	.	.	.	SALL4:uc002xwh.4:exon2:c.T540C:p.N180N,SALL4:uc010gii.3:exon2:c.T540C:p.N180N	.	AFR:0.9976,AMR:0.9988,EAS:1,FIN:0.9991,NFE:0.9953,OTH:0.9980,ASJ:0.9901	607343	147750;607323;	93293;959;2307;	93293|Duane-radial ray syndrome|-|Autosomal dominant|-|607323 ~959|-|<1 / 1 000 000|Autosomal dominant|Neonatal<br>Antenatal|607323 ~2307|Oculo-oto-radial syndrome<br>Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia|<1 / 1 000 000|Autosomal dominant|Antenatal<br>Neonatal|147750 ~	.	.	.	.	.	.	.	.	20	MU82040420	hom
20	52185814	52185814	C	A	LOC101927770	ncRNA_intronic	.	ENSG00000197670	rs4602270	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7256	.	0.779153	0.7405	.	.	.	.	.	0	0	.	.	.	AFR:0.8270,AMR:0.7626,EAS:0.8209,FIN:0.7318,NFE:0.6834,OTH:0.7301,ASJ:0.7152	.	.	.	.	.	.	.	.	.	.	.	.	20	MU14541605	het
20	54961463	54961463	T	C	AURKA	exonic	nonsynonymous SNV	ENSG00000087586	rs1047972	ENSG00000087586:ENST00000347343:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395907:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395913:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000395915:exon3:c.A169G:p.I57V,ENSG00000087586:ENST00000312783:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000371356:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395911:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395914:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000422322:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000441357:exon4:c.A169G:p.I57V,ENSG00000087586:ENST00000395909:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000420474:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000451915:exon5:c.A169G:p.I57V,ENSG00000087586:ENST00000456249:exon5:c.A169G:p.I57V	AURKA:NM_003600:exon3:c.A169G:p.I57V,AURKA:NM_198435:exon3:c.A169G:p.I57V,AURKA:NM_198437:exon3:c.A169G:p.I57V,AURKA:NM_001323303:exon4:c.A169G:p.I57V,AURKA:NM_001323304:exon4:c.A169G:p.I57V,AURKA:NM_198434:exon4:c.A169G:p.I57V,AURKA:NM_198436:exon4:c.A169G:p.I57V,AURKA:NM_001323305:exon5:c.A169G:p.I57V,AURKA:NM_198433:exon5:c.A169G:p.I57V	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8482	0.8378	0.84984	COCA-CN|5|321|0.0155763	-2.027	0.001	1.0	1.97	0.069	.	.	.	AURKA:uc002xxg.1:exon3:c.A169G:p.I57V,AURKA:uc002xxh.1:exon3:c.A169G:p.I57V,AURKA:uc002xxi.1:exon3:c.A169G:p.I57V,AURKA:uc002xxe.1:exon4:c.A169G:p.I57V,AURKA:uc002xxf.1:exon4:c.A169G:p.I57V,AURKA:uc002xxj.1:exon4:c.A169G:p.I57V,AURKA:uc002xxd.1:exon5:c.A169G:p.I57V	-0.937	AFR:0.8413,AMR:0.8405,EAS:0.8676,FIN:0.8881,NFE:0.8129,OTH:0.8406,ASJ:0.8986	603072	114500;	.	.	.	.	.	.	0.0	-0.1	0.000	.	20	1(stomach)	0.8262
20	54961541	54961541	A	T	AURKA	exonic	nonsynonymous SNV	ENSG00000087586	rs2273535	ENSG00000087586:ENST00000347343:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395907:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395913:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000395915:exon3:c.T91A:p.F31I,ENSG00000087586:ENST00000312783:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000371356:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395911:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395914:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000422322:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000441357:exon4:c.T91A:p.F31I,ENSG00000087586:ENST00000395909:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000420474:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000451915:exon5:c.T91A:p.F31I,ENSG00000087586:ENST00000456249:exon5:c.T91A:p.F31I	AURKA:NM_003600:exon3:c.T91A:p.F31I,AURKA:NM_198435:exon3:c.T91A:p.F31I,AURKA:NM_198437:exon3:c.T91A:p.F31I,AURKA:NM_001323303:exon4:c.T91A:p.F31I,AURKA:NM_001323304:exon4:c.T91A:p.F31I,AURKA:NM_198434:exon4:c.T91A:p.F31I,AURKA:NM_198436:exon4:c.T91A:p.F31I,AURKA:NM_001323305:exon5:c.T91A:p.F31I,AURKA:NM_198433:exon5:c.T91A:p.F31I	clinvar: risk_factor 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2735	0.1882	0.309704	1(skin)	-1.212	0.006	0.497	-7.55	0.093	.	.	.	AURKA:uc002xxg.1:exon3:c.T91A:p.F31I,AURKA:uc002xxh.1:exon3:c.T91A:p.F31I,AURKA:uc002xxi.1:exon3:c.T91A:p.F31I,AURKA:uc002xxe.1:exon4:c.T91A:p.F31I,AURKA:uc002xxf.1:exon4:c.T91A:p.F31I,AURKA:uc002xxj.1:exon4:c.T91A:p.F31I,AURKA:uc002xxd.1:exon5:c.T91A:p.F31I	-0.990	AFR:MU714003,AMR:LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,EAS:0.1428,FIN:0.3341,NFE:0.1689,OTH:0.6750,ASJ:0.2338	603072	114500;	.	.	.	.	.	.	0.0	-0.1	0.000	0.69	20	8(soft_tissue)	0.2761
20	57415455	57415455	C	T	GNAS	exonic	synonymous SNV	ENSG00000087460	rs1800902	ENSG00000087460:ENST00000313949:exon1:c.C294T:p.P98P,ENSG00000087460:ENST00000371075:exon1:c.C294T:p.P98P,ENSG00000087460:ENST00000371098:exon1:c.C294T:p.P98P,ENSG00000087460:ENST00000453292:exon1:c.C57T:p.P19P	GNAS:NM_016592:exon1:c.C294T:p.P98P	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1] 	0.0332	0.0518	0.0467252	1(breast)	.	.	.	.	.	.	.	.	GNAS:uc021wfl.1:exon1:c.C294T:p.P98P,GNAS:uc021wfm.1:exon1:c.C294T:p.P98P	.	AFR:MU113464579,AMR:LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,EAS:0.1051,FIN:0.0382,NFE:0.0099,OTH:0.0123,ASJ:0.0464	139320	102200;103580;166350;174800;219080;603233;612462;612463;	79445;79444;94089;189427;562;2762;79443;314777;96256;963;99725;	79445|AHO-PPHP syndrome<br>Albright hereditary osteodystrophy-PPHP syndrome|Unknown|Autosomal dominant|All ages|612463 ~79444|-|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|612462 ~94089|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Infancy<br>Childhood<br>Adolescent|603233 ~189427|Primary bilateral macronodular adrenal hyperplasia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|219080 615954 ~562|Gonadotropin-independent female-limited sexual precocity|1-9 / 1 000 000|Not applicable|Childhood|174800 ~2762|Familial ectopic ossification<br>POH|-|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|166350 ~79443|AHO-PHP syndrome Ia<br>Albright hereditary osteodystrophy-PHP syndrome Ia|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|103580 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04361 Axon regeneration~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04724 Glutamatergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04962 Vasopressin-regulated water reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05032 Morphine addiction~ko05034 Alcoholism~ko05110 Vibrio cholerae infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	5904,,5905	.	.	.	.	.	.	20	1(soft_tissue)	0.0089
20	57429748	57429748	C	G	GNAS	exonic	nonsynonymous SNV	ENSG00000087460	rs559714658	ENSG00000087460:ENST00000306120:exon1:c.C1238G:p.P413R	GNAS:NM_001077490:exon1:c.C1241G:p.P414R,GNAS:NM_001309883:exon1:c.C1241G:p.P414R	clinvar: UNK 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 1] 	0.0042	.	0.000599042	.	0.785	9.372	0.006	-0.44	0.013	.	.	.	GNAS:uc002xzw.3:exon1:c.C1428G:p.A476A	-0.968	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	139320	102200;103580;166350;174800;219080;603233;612462;612463;	79445;79444;94089;189427;562;2762;79443;314777;96256;963;99725;	79445|AHO-PPHP syndrome<br>Albright hereditary osteodystrophy-PPHP syndrome|Unknown|Autosomal dominant|All ages|612463 ~79444|-|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|612462 ~94089|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Infancy<br>Childhood<br>Adolescent|603233 ~189427|Primary bilateral macronodular adrenal hyperplasia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|219080 615954 ~562|Gonadotropin-independent female-limited sexual precocity|1-9 / 1 000 000|Not applicable|Childhood|174800 ~2762|Familial ectopic ossification<br>POH|-|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|166350 ~79443|AHO-PHP syndrome Ia<br>Albright hereditary osteodystrophy-PHP syndrome Ia|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|103580 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04361 Axon regeneration~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04724 Glutamatergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04962 Vasopressin-regulated water reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05032 Morphine addiction~ko05034 Alcoholism~ko05110 Vibrio cholerae infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	5904,,5905	.	.	.	.	0.096	.	20	.	hom
20	57478807	57478807	C	T	GNAS	exonic	synonymous SNV	ENSG00000087460	rs7121	ENSG00000087460:ENST00000265620:exon4:c.C348T:p.I116I,ENSG00000087460:ENST00000371095:exon4:c.C351T:p.I117I,ENSG00000087460:ENST00000371102:exon4:c.C2280T:p.I760I,ENSG00000087460:ENST00000306090:exon5:c.C351T:p.I117I,ENSG00000087460:ENST00000349036:exon5:c.C444T:p.I148I,ENSG00000087460:ENST00000354359:exon5:c.C396T:p.I132I,ENSG00000087460:ENST00000371085:exon5:c.C393T:p.I131I,ENSG00000087460:ENST00000371100:exon5:c.C2322T:p.I774I,ENSG00000087460:ENST00000603546:exon5:c.C216T:p.I72I,ENSG00000087460:ENST00000604005:exon5:c.C216T:p.I72I	GNAS:NM_001077489:exon4:c.C348T:p.I116I,GNAS:NM_080426:exon4:c.C351T:p.I117I,GNAS:NM_000516:exon5:c.C393T:p.I131I,GNAS:NM_001077488:exon5:c.C396T:p.I132I,GNAS:NM_001309840:exon5:c.C216T:p.I72I,GNAS:NM_001309861:exon5:c.C216T:p.I72I,GNAS:NM_080425:exon5:c.C2322T:p.I774I	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.5473	0.5794	0.644369	15(meninges)	.	.	.	.	.	.	.	.	GNAS:uc002yae.3:exon2:c.C168T:p.I56I,GNAS:uc002yad.3:exon3:c.C66T:p.I22I,GNAS:uc002yaa.3:exon4:c.C348T:p.I116I,GNAS:uc021wfp.1:exon4:c.C351T:p.I117I,GNAS:uc002xzt.3:exon5:c.C297T:p.I99I,GNAS:uc002xzw.3:exon5:c.C2322T:p.I774I,GNAS:uc002xzx.3:exon5:c.C216T:p.I72I,GNAS:uc010gjq.3:exon5:c.C216T:p.I72I,GNAS:uc021wfn.1:exon5:c.C393T:p.I131I,GNAS:uc021wfo.1:exon5:c.C396T:p.I132I	.	AFR:1(eye),AMR:MU84578,EAS:0.5563,FIN:0.7561,NFE:0.6235,OTH:0.64,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	139320	102200;103580;166350;174800;219080;603233;612462;612463;	79445;79444;94089;189427;562;2762;79443;314777;96256;963;99725;	79445|AHO-PPHP syndrome<br>Albright hereditary osteodystrophy-PPHP syndrome|Unknown|Autosomal dominant|All ages|612463 ~79444|-|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|612462 ~94089|-|Unknown|Autosomal dominant<br>or&nbsp;Not applicable|Neonatal<br>Infancy<br>Childhood<br>Adolescent|603233 ~189427|Primary bilateral macronodular adrenal hyperplasia|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Not applicable|All ages|219080 615954 ~562|Gonadotropin-independent female-limited sexual precocity|1-9 / 1 000 000|Not applicable|Childhood|174800 ~2762|Familial ectopic ossification<br>POH|-|Autosomal dominant|Infancy<br>Childhood<br>Adolescent<br>Adult|166350 ~79443|AHO-PHP syndrome Ia<br>Albright hereditary osteodystrophy-PHP syndrome Ia|Unknown|Autosomal dominant|Infancy<br>Neonatal<br>Childhood|103580 ~314777|FIPA|Unknown|Autosomal dominant|All ages|102200 600634 ~96256|Somatotropinoma|-|-|-|102200 ~963|-|1-9 / 100 000|Not applicable|Adult|102200 300943 ~99725|Hypophyseal gigantism<br>Infantile and juvenile forms of acromegaly|-|-|-|102200 ~	~ko01522 Endocrine resistance~ko04015 Rap1 signaling pathway~ko04020 Calcium signaling pathway~ko04024 cAMP signaling pathway~ko04072 Phospholipase D signaling pathway~ko04261 Adrenergic signaling in cardiomyocytes~ko04270 Vascular smooth muscle contraction~ko04361 Axon regeneration~ko04540 Gap junction~ko04611 Platelet activation~ko04713 Circadian entrainment~ko04714 Thermogenesis~ko04724 Glutamatergic synapse~ko04726 Serotonergic synapse~ko04728 Dopaminergic synapse~ko04730 Long-term depression~ko04750 Inflammatory mediator regulation of TRP channels~ko04911 Insulin secretion~ko04912 GnRH signaling pathway~ko04913 Ovarian steroidogenesis~ko04915 Estrogen signaling pathway~ko04916 Melanogenesis~ko04918 Thyroid hormone synthesis~ko04921 Oxytocin signaling pathway~ko04922 Glucagon signaling pathway~ko04923 Regulation of lipolysis in adipocytes~ko04924 Renin secretion~ko04925 Aldosterone synthesis and secretion~ko04926 Relaxin signaling pathway~ko04927 Cortisol synthesis and secretion~ko04928 Parathyroid hormone synthesis, secretion and action~ko04934 Cushing syndrome~ko04961 Endocrine and other factor-regulated calcium reabsorption~ko04962 Vasopressin-regulated water reabsorption~ko04970 Salivary secretion~ko04971 Gastric acid secretion~ko04972 Pancreatic secretion~ko04976 Bile secretion~ko05030 Cocaine addiction~ko05031 Amphetamine addiction~ko05032 Morphine addiction~ko05034 Alcoholism~ko05110 Vibrio cholerae infection~ko05142 Chagas disease (American trypanosomiasis)~ko05146 Amoebiasis~ko05163 Human cytomegalovirus infection~ko05165 Human papillomavirus infection~ko05200 Pathways in cancer~ko05414 Dilated cardiomyopathy (DCM) ~	5904,,5905	.	.	.	.	.	.	20	1(urinary_tract)	0.6584
20	62331989	62331989	T	G	ARFRP1	exonic	synonymous SNV	ENSG00000101246	rs1048665	ENSG00000101246:ENST00000359715:exon6:c.A483C:p.R161R,ENSG00000101246:ENST00000607873:exon6:c.A342C:p.R114R,ENSG00000101246:ENST00000324228:exon7:c.A483C:p.R161R,ENSG00000101246:ENST00000440854:exon7:c.A483C:p.R161R,ENSG00000101246:ENST00000609142:exon7:c.A483C:p.R161R	ARFRP1:NM_001267546:exon6:c.A342C:p.R114R,ARFRP1:NM_001134758:exon7:c.A483C:p.R161R,ARFRP1:NM_001267547:exon7:c.A483C:p.R161R,ARFRP1:NM_001267548:exon7:c.A483C:p.R161R,ARFRP1:NM_001267549:exon7:c.A483C:p.R161R,ARFRP1:NM_003224:exon7:c.A483C:p.R161R	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2464	0.1755	0.264776	COCA-CN|5|321|0.0155763,BLCA-CN|1|103|0.00970874	.	.	.	.	.	.	.	.	ARFRP1:uc002yga.3:exon6:c.A483C:p.R161R,ARFRP1:uc031ruq.1:exon6:c.A342C:p.R114R,ARFRP1:uc002ygc.4:exon7:c.A483C:p.R161R,ARFRP1:uc002ygf.4:exon7:c.A483C:p.R161R,ARFRP1:uc002ygh.5:exon7:c.A483C:p.R161R,ARFRP1:uc011abg.3:exon7:c.A483C:p.R161R,ARFRP1:uc031rup.1:exon7:c.A483C:p.R161R	.	AFR:0.1977,AMR:0.0629,EAS:0.2219,FIN:0.6562,NFE:0.2077,OTH:0.2209,ASJ:0.2506	604699	.	.	.	.	.	.	.	.	.	.	.	20	8(soft_tissue)	0.1967
21	39870310	39870310	G	A	ERG	UTR5	.	ENSG00000157554	rs2836441	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.8707	0.8875	0.890775	0.8875	.	.	.	.	.	.	.	.	.	.	AFR:0.9436,AMR:0.8103,EAS:0.8129,FIN:0.9064,NFE:0.8628,OTH:0.8727,ASJ:0.9404	165080	.	.	.	~ko05202 Transcriptional misregulation in cancer~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	21	MU13675292	het
21	40191431	40191431	T	G	ETS2	exonic	synonymous SNV	ENSG00000157557	rs457705	ENSG00000157557:ENST00000360938:exon8:c.T816G:p.T272T,ENSG00000157557:ENST00000360214:exon9:c.T816G:p.T272T	ETS2:NM_005239:exon8:c.T816G:p.T272T,ETS2:NM_001256295:exon9:c.T1236G:p.T412T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7220	0.7713	0.58107	MU748847	.	.	.	.	.	.	.	.	ETS2:uc002yxg.4:exon8:c.T816G:p.T272T,ETS2:uc002yxf.3:exon9:c.T1236G:p.T412T	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|4|321|0.0124611,AMR:0.7428,EAS:0.5943,FIN:0.8543,NFE:0.4708,OTH:0.7596,ASJ:0.6169	164740	.	.	.	.	.	.	.	.	.	.	.	21	1(liver)	0.8457
21	40191638	40191638	A	G	ETS2	exonic	synonymous SNV	ENSG00000157557	rs461155	ENSG00000157557:ENST00000360938:exon8:c.A1023G:p.P341P,ENSG00000157557:ENST00000360214:exon9:c.A1023G:p.P341P	ETS2:NM_005239:exon8:c.A1023G:p.P341P,ETS2:NM_001256295:exon9:c.A1443G:p.P481P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7228	0.7706	0.580671	LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	ETS2:uc002yxg.4:exon8:c.A1023G:p.P341P,ETS2:uc002yxf.3:exon9:c.A1443G:p.P481P	.	AFR:0.7422,AMR:0.6138,EAS:0.8543,FIN:0.4721,NFE:0.7594,OTH:0.8462,ASJ:0.5943	164740	.	.	.	.	.	.	.	.	.	.	.	21	2(lung)	0.7658
21	41684090	41684090	C	T	DSCAM	exonic	synonymous SNV	ENSG00000171587	rs34336407	ENSG00000171587:ENST00000404019:exon5:c.G1236A:p.S412S,ENSG00000171587:ENST00000400454:exon9:c.G1980A:p.S660S	DSCAM:NM_001271534:exon9:c.G1980A:p.S660S,DSCAM:NM_001389:exon9:c.G1980A:p.S660S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0759	0.0702	0.0798722	0.0705	.	.	.	.	.	.	.	.	DSCAM:uc002yyq.1:exon9:c.G1980A:p.S660S,DSCAM:uc031rvr.1:exon9:c.G1980A:p.S660S	.	AFR:0.0495,AMR:0.0646,EAS:0.1179,FIN:0.0755,NFE:0.0766,OTH:0.0725,ASJ:0.0728	602523	.	.	.	.	.	.	.	.	.	.	.	21	.	het
21	44837551	44837551	G	A	SIK1;SIK1B	exonic	synonymous SNV	ENSG00000142178	rs430552	ENSG00000142178:ENST00000270162:exon13:c.C1848T:p.P616P	SIK1B:NM_001320643:exon13:c.C1848T:p.P616P,SIK1:NM_173354:exon13:c.C1848T:p.P616P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8000	0.7241	0.725439	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	SIK1:uc002zdf.2:exon13:c.C1848T:p.P616P	.	AFR:0.7315,AMR:0.5034,EAS:0.7162,FIN:0.8904,NFE:0.8819,OTH:0.7974,ASJ:0.8702	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	21	2(large_intestine)	0.8364
21	44837555	44837555	G	A	SIK1;SIK1B	exonic	nonsynonymous SNV	ENSG00000142178	rs430554	ENSG00000142178:ENST00000270162:exon13:c.C1844T:p.A615V	SIK1B:NM_001320643:exon13:c.C1844T:p.A615V,SIK1:NM_173354:exon13:c.C1844T:p.A615V	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, -1, 0, 0] 	0.8900	0.8455	0.830671	3(lung)	1.313	12.34	0.005	2.25	0.200	.	.	.	SIK1:uc002zdf.2:exon13:c.C1844T:p.A615V	-1.004	AFR:MU9773887,AMR:COCA-CN|5|321|0.0155763,EAS:0.7171,FIN:0.9173,NFE:0.8221,OTH:0.9047,ASJ:0.8533	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	0.281	-0.59	0.000	1.04	21	1(liver)	0.9561
21	44838330	44838330	C	A	SIK1;SIK1B	exonic	synonymous SNV	ENSG00000142178	rs34487963	ENSG00000142178:ENST00000270162:exon12:c.G1554T:p.A518A	SIK1B:NM_001320643:exon12:c.G1554T:p.A518A,SIK1:NM_173354:exon12:c.G1554T:p.A518A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0349	0.0161	0.0535144	0.0159	.	.	.	.	.	.	.	.	SIK1:uc002zdf.2:exon12:c.G1554T:p.A518A	.	AFR:0.0137,AMR:0.0084,EAS:0.0580,FIN:0.0049,NFE:0.0150,OTH:0.0246,ASJ:0.0199	605705	616341;	1934;1935;3451;	1934|EIEE<br>Early infantile epileptic encephalopathy with suppression-bursts<br>Ohtahara syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal|300672 308350 609304 612164 613402 613721 615473 616341 ~1935|Early myoclonic encephalopathy with suppression-bursts|<1 / 1 000 000|Autosomal recessive|Neonatal<br>Infancy|609304 616341 617105 ~3451|Infantile spasms<br>Intellectual disability-hypsarrhythmia syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal<br>Childhood|300672 308350 613477 613722 615006 616139 616341 617065 ~	.	.	.	.	.	.	.	.	21	MU749038	het
21	46875564	46875564	T	C	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs914230	ENSG00000182871:ENST00000355480:exon1:c.T120C:p.H40H,ENSG00000182871:ENST00000359759:exon1:c.T120C:p.H40H	COL18A1:NM_030582:exon1:c.T120C:p.H40H,COL18A1:NM_130444:exon1:c.T120C:p.H40H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9705	0.9693	0.988419	0.9678	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon1:c.T120C:p.H40H	.	AFR:0.9925,AMR:0.9785,EAS:1,FIN:0.9631,NFE:0.9510,OTH:0.9551,ASJ:0.9801	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU82046823	hom
21	46876083	46876083	A	G	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs2236451	ENSG00000182871:ENST00000355480:exon1:c.A639G:p.P213P,ENSG00000182871:ENST00000359759:exon1:c.A639G:p.P213P	COL18A1:NM_030582:exon1:c.A639G:p.P213P,COL18A1:NM_130444:exon1:c.A639G:p.P213P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3437	0.3829	0.375599	MU780688	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon1:c.A639G:p.P213P	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,BLCA-CN|1|103|0.00970874,AMR:0.3843,EAS:0.2691,FIN:0.3967,NFE:0.3727,OTH:0.3307,ASJ:0.5270	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(stomach)	0.3244
21	46876173	46876173	C	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs2236452	ENSG00000182871:ENST00000359759:exon1:c.C729T:p.P243P	COL18A1:NM_130444:exon1:c.C729T:p.P243P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2640	0.2063	0.208267	MU4553470	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.2074,EAS:0.2079,FIN:0.2318,NFE:0.1578,OTH:0.1660,ASJ:0.2517	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(thyroid)	0.1978
21	46876306	46876306	G	A	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs11702494	ENSG00000182871:ENST00000359759:exon1:c.G862A:p.A288T	COL18A1:NM_130444:exon1:c.G862A:p.A288T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2257	0.2534	0.200879	0.2300	0.283	5.528	0.472	-9.89	0.000	.	.	.	.	-1.015	AFR:0.2522,AMR:0.1423,EAS:0.1282,FIN:0.2101,NFE:0.2377,OTH:0.2194,ASJ:0.2550	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	0.006	-2.55	0.000	.	21	MU4551873	het
21	46876580	46876580	C	T	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs8133886	ENSG00000182871:ENST00000359759:exon1:c.C1136T:p.T379M	COL18A1:NM_130444:exon1:c.C1136T:p.T379M	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 1, 0, 0] 	0.3559	.	0.426518	1(oesophagus)	1.608	13.89	0.002	5.16	0.034	.	.	Collagen alpha-1(XVIII) chain, frizzled domain|Frizzled domain	.	-0.906	AFR:MU15587686,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,ESCA-CN|1|332|0.00301205,BRCA-KR|1|50|0.02,EAS:0.5508,FIN:0.3425,NFE:0.3767,OTH:0.4839,ASJ:0.3778	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	1.0	-1.35	0.000	.	21	1(liver)	0.2912
21	46899842	46899842	C	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1131100	ENSG00000182871:ENST00000355480:exon9:c.C1815T:p.P605P,ENSG00000182871:ENST00000359759:exon9:c.C2520T:p.P840P,ENSG00000182871:ENST00000400337:exon10:c.C1275T:p.P425P	COL18A1:NM_030582:exon9:c.C1815T:p.P605P,COL18A1:NM_130444:exon9:c.C2520T:p.P840P,COL18A1:NM_130445:exon10:c.C1275T:p.P425P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0933	0.1310	0.163139	MU749678	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon9:c.C1815T:p.P605P,COL18A1:uc002zhg.3:exon10:c.C1275T:p.P425P	.	AFR:ESAD-UK|1|409|0.00244499,LINC-JP|1|394|0.00253807,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,AMR:0.1225,EAS:0.1208,FIN:0.0695,NFE:0.0898,OTH:0.0209,ASJ:0.2759	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(liver)	0.0646
21	46899857	46899857	C	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1131101	ENSG00000182871:ENST00000355480:exon9:c.C1830T:p.D610D,ENSG00000182871:ENST00000359759:exon9:c.C2535T:p.D845D,ENSG00000182871:ENST00000400337:exon10:c.C1290T:p.D430D	COL18A1:NM_030582:exon9:c.C1830T:p.D610D,COL18A1:NM_130444:exon9:c.C2535T:p.D845D,COL18A1:NM_130445:exon10:c.C1290T:p.D430D	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0881	0.1306	0.157348	ESAD-UK|1|409|0.00244499,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon9:c.C1830T:p.D610D,COL18A1:uc002zhg.3:exon10:c.C1290T:p.D430D	.	AFR:0.1195,AMR:0.2704,EAS:0.0695,FIN:0.0861,NFE:0.0206,OTH:0.0640,ASJ:0.0873	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(biliary_tract)	0.0792
21	46899872	46899872	C	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1131102	ENSG00000182871:ENST00000355480:exon9:c.C1845A:p.G615G,ENSG00000182871:ENST00000359759:exon9:c.C2550A:p.G850G,ENSG00000182871:ENST00000400337:exon10:c.C1305A:p.G435G	COL18A1:NM_030582:exon9:c.C1845A:p.G615G,COL18A1:NM_130444:exon9:c.C2550A:p.G850G,COL18A1:NM_130445:exon10:c.C1305A:p.G435G	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0832	0.1142	0.140375	MU673649	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon9:c.C1845A:p.G615G,COL18A1:uc002zhg.3:exon10:c.C1305A:p.G435G	.	AFR:ESAD-UK|1|409|0.00244499,LAML-KR|1|205|0.00487805,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,AMR:0.1033,EAS:0.0863,FIN:0.0695,NFE:0.0853,OTH:0.0206,ASJ:0.2139	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(biliary_tract)	0.0639
21	46900410	46900410	C	T	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs2236467	ENSG00000182871:ENST00000355480:exon11:c.C1968T:p.F656F,ENSG00000182871:ENST00000359759:exon11:c.C2673T:p.F891F,ENSG00000182871:ENST00000400337:exon12:c.C1428T:p.F476F	COL18A1:NM_030582:exon11:c.C1968T:p.F656F,COL18A1:NM_130444:exon11:c.C2673T:p.F891F,COL18A1:NM_130445:exon12:c.C1428T:p.F476F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0876	0.1296	0.15595	1(haematopoietic_and_lymphoid_tissue)	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon11:c.C1968T:p.F656F,COL18A1:uc002zhg.3:exon12:c.C1428T:p.F476F	.	AFR:MU11355673,AMR:ESAD-UK|1|409|0.00244499,LUSC-KR|1|170|0.00588235,BRCA-KR|1|50|0.02,EAS:0.2682,FIN:0.0871,NFE:0.0695,OTH:0.0853,ASJ:0.1189	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(breast)	0.0206
21	46908355	46908355	T	C	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs11702425	ENSG00000182871:ENST00000355480:exon17:c.T2460C:p.L820L,ENSG00000182871:ENST00000359759:exon17:c.T3165C:p.L1055L,ENSG00000182871:ENST00000400337:exon18:c.T1920C:p.L640L	COL18A1:NM_030582:exon17:c.T2460C:p.L820L,COL18A1:NM_130444:exon17:c.T3165C:p.L1055L,COL18A1:NM_130445:exon18:c.T1920C:p.L640L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3052	0.3129	0.319888	2(breast)	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon17:c.T2460C:p.L820L,COL18A1:uc002zhg.3:exon18:c.T1920C:p.L640L	.	AFR:MU156625,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,BTCA-JP|1|239|0.0041841,BRCA-KR|1|50|0.02,EAS:0.3687,FIN:0.2613,NFE:0.3233,OTH:0.2420,ASJ:0.3220	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(thyroid)	0.3456
21	46909426	46909426	G	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs61731167	ENSG00000182871:ENST00000355480:exon18:c.G2490A:p.P830P,ENSG00000182871:ENST00000359759:exon18:c.G3195A:p.P1065P,ENSG00000182871:ENST00000400337:exon19:c.G1950A:p.P650P	COL18A1:NM_030582:exon18:c.G2490A:p.P830P,COL18A1:NM_130444:exon18:c.G3195A:p.P1065P,COL18A1:NM_130445:exon19:c.G1950A:p.P650P	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0942	0.0453	0.0459265	0.0651	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon18:c.G2490A:p.P830P,COL18A1:uc002zhg.3:exon19:c.G1950A:p.P650P	.	AFR:0.0287,AMR:0.0323,EAS:0.0099,FIN:0.1469,NFE:0.0738,OTH:0.0777,ASJ:0.0762	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU117063561	het
21	46910210	46910210	G	A	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs62000962	ENSG00000182871:ENST00000342220:exon1:c.G22A:p.V8I,ENSG00000182871:ENST00000355480:exon19:c.G2521A:p.V841I,ENSG00000182871:ENST00000359759:exon19:c.G3226A:p.V1076I,ENSG00000182871:ENST00000400337:exon20:c.G1981A:p.V661I	COL18A1:NM_030582:exon19:c.G2521A:p.V841I,COL18A1:NM_130444:exon19:c.G3226A:p.V1076I,COL18A1:NM_130445:exon20:c.G1981A:p.V661I	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.2169	0.1234	0.115615	SKCA-BR|1|100|0.01	-0.436	0.315	0.424	-2.52	0.008	.	.	.	COL18A1:uc002zhi.3:exon19:c.G2521A:p.V841I,COL18A1:uc002zhg.3:exon20:c.G1981A:p.V661I	-0.859	AFR:0.1330,AMR:0.1533,EAS:0.1358,FIN:0.0144,NFE:0.1644,OTH:0.1285,ASJ:0.0974	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	0.048	-3.2	0.004	0.05	21	1(liver)	0.1360
21	46911188	46911188	C	G	COL18A1	exonic	nonsynonymous SNV	ENSG00000182871	rs79980197	ENSG00000182871:ENST00000342220:exon3:c.C158G:p.P53R,ENSG00000182871:ENST00000355480:exon21:c.C2657G:p.P886R,ENSG00000182871:ENST00000359759:exon21:c.C3362G:p.P1121R,ENSG00000182871:ENST00000400337:exon22:c.C2117G:p.P706R	COL18A1:NM_030582:exon21:c.C2657G:p.P886R,COL18A1:NM_130444:exon21:c.C3362G:p.P1121R,COL18A1:NM_130445:exon22:c.C2117G:p.P706R	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.0877	0.0598	0.0688898	0.0785	5.006	25.1	0.094	3.85	0.004	.	.	.	COL18A1:uc002zhi.3:exon21:c.C2657G:p.P886R,COL18A1:uc002zhg.3:exon22:c.C2117G:p.P706R	-0.339	AFR:0.0342,AMR:0.0370,EAS:0.0729,FIN:0.1571,NFE:0.0883,OTH:0.0835,ASJ:0.0894	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	1.0	-3.09	0.242	2.3	21	MU4555974	het
21	46924426	46924434	GGCCCCCCA	-	COL18A1	exonic	frameshift deletion	ENSG00000182871	rs149296338	ENSG00000182871:ENST00000342220:exon15:c.865_873del:p.289_291del,ENSG00000182871:ENST00000355480:exon33:c.3364_3372del:p.1122_1124del,ENSG00000182871:ENST00000359759:exon33:c.4069_4077del:p.1357_1359del,ENSG00000182871:ENST00000400337:exon34:c.2824_2832del:p.942_944del	COL18A1:NM_030582:exon33:c.3364delG:p.G1122fs,COL18A1:NM_130444:exon33:c.4069delG:p.G1357fs,COL18A1:NM_130445:exon34:c.2824delG:p.G942fs	clinvar: Likely_benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9693	0.8055	.	0.9637	.	.	.	.	.	.	.	.	COL18A1:uc002zhi.3:exon33:c.3364_3372del:p.1122_1124del,COL18A1:uc002zhg.3:exon34:c.2824_2832del:p.942_944del	.	AFR:0.9550,AMR:0.9737,EAS:0.9994,FIN:0.9728,NFE:0.9608,OTH:0.9762,ASJ:0.9868	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU56575	hom
21	46929467	46929467	G	A	COL18A1	exonic	synonymous SNV	ENSG00000182871	rs1050351	ENSG00000182871:ENST00000342220:exon20:c.G1491A:p.A497A,ENSG00000182871:ENST00000355480:exon38:c.G3987A:p.A1329A,ENSG00000182871:ENST00000359759:exon38:c.G4692A:p.A1564A,ENSG00000182871:ENST00000400337:exon39:c.G3447A:p.A1149A	COL18A1:NM_030582:exon39:c.G3978A:p.A1326A,COL18A1:NM_130444:exon39:c.G4683A:p.A1561A,COL18A1:NM_130445:exon40:c.G3438A:p.A1146A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5110	0.3778	0.503594	MU77662	.	.	.	.	.	.	.	.	COL18A1:uc002zhj.3:exon6:c.G381A:p.A127A,COL18A1:uc002zhi.3:exon38:c.G3987A:p.A1329A,COL18A1:uc002zhg.3:exon39:c.G3447A:p.A1149A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841,AMR:0.4346,EAS:0.5613,FIN:0.3675,NFE:0.5509,OTH:0.4365,ASJ:0.4536	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(thyroid)	0.4068
21	46929523	46929523	C	-	COL18A1	intronic	.	ENSG00000173638;ENSG00000182871	rs3835286	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4859	0.4999	0.554912	0.4949	.	.	.	.	.	.	.	.	.	.	AFR:0.6141,AMR:0.4606,EAS:0.5893,FIN:0.4610,NFE:0.4306,OTH:0.4486,ASJ:0.3841	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	MU117081558	hom
21	46932328	46932328	G	A	COL18A1	UTR3	.	ENSG00000182871	rs7499	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4461	0.4030	0.467252	ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,BTCA-JP|1|239|0.0041841	.	.	.	.	.	.	.	.	.	.	AFR:0.4212,AMR:0.4371,EAS:0.3576,FIN:0.5584,NFE:0.4191,OTH:0.4000,ASJ:0.4330	120328	267750;	1571;	1571|Knobloch-Layer syndrome<br>Retinal detachment-occipital encephalocele syndrome|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|267750 ~	.	.	.	.	.	.	.	.	21	1(biliary_tract)	0.3959
22	18900669	18900669	A	G	LOC102724788;PRODH	UTR3	.	ENSG00000100033;ENSG00000183628	rs383964	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9212	0.9154	0.907548	0.9076	.	.	.	.	.	.	.	.	.	.	AFR:0.8428,AMR:0.9582,EAS:0.9540,FIN:0.9162,NFE:0.9332,OTH:0.9284,ASJ:0.9470	.	.	.	.	.	.	.	.	.	.	.	.	22	MU82047850	het
22	18900750	18900750	G	A	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs372055	ENSG00000100033:ENST00000334029:exon14:c.C1417T:p.L473L,ENSG00000100033:ENST00000357068:exon14:c.C1741T:p.L581L,ENSG00000100033:ENST00000420436:exon14:c.C1417T:p.L473L	PRODH:NM_001195226:exon14:c.C1417T:p.L473L,LOC102724788:NM_001368250:exon14:c.C1417T:p.L473L,LOC102724788:NM_001368249:exon15:c.C1741T:p.L581L,PRODH:NM_016335:exon15:c.C1741T:p.L581L	clinvar: Uncertain_significance 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7890	0.7588	0.763379	0.7524	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon14:c.C1417T:p.L473L,PRODH:uc002zol.4:exon14:c.C1417T:p.L473L,PRODH:uc002zok.4:exon15:c.C1741T:p.L581L	.	AFR:0.6254,AMR:0.7757,EAS:0.8455,FIN:0.7544,NFE:0.8110,OTH:0.7900,ASJ:0.7914	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU4559149	het
22	18901004	18901004	C	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs450046	ENSG00000100033:ENST00000334029:exon13:c.G1238A:p.R413Q,ENSG00000100033:ENST00000357068:exon13:c.G1562A:p.R521Q,ENSG00000100033:ENST00000420436:exon13:c.G1238A:p.R413Q	PRODH:NM_001195226:exon13:c.G1238A:p.R413Q,LOC102724788:NM_001368250:exon13:c.G1238A:p.R413Q,LOC102724788:NM_001368249:exon14:c.G1562A:p.R521Q,PRODH:NM_016335:exon14:c.G1562A:p.R521Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9171	0.9042	0.905551	0.9057	3.411	23.0	0.455	4.67	0.202	.	.	FAD-linked oxidoreductase-like|Proline dehydrogenase domain	PRODH:uc002zoj.5:exon13:c.G1238A:p.R413Q,PRODH:uc002zol.4:exon13:c.G1238A:p.R413Q,PRODH:uc002zok.4:exon14:c.G1562A:p.R521Q	-0.985	AFR:0.8372,AMR:0.9570,EAS:0.9530,FIN:0.9155,NFE:0.9328,OTH:0.9283,ASJ:0.9470	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.0	1.63	0.000	.	22	MU4615939	het
22	18904414	18904414	A	G	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs455072	ENSG00000100033:ENST00000334029:exon12:c.T1191C:p.F397F,ENSG00000100033:ENST00000357068:exon12:c.T1515C:p.F505F,ENSG00000100033:ENST00000420436:exon12:c.T1191C:p.F397F	PRODH:NM_001195226:exon12:c.T1191C:p.F397F,LOC102724788:NM_001368250:exon12:c.T1191C:p.F397F,LOC102724788:NM_001368249:exon13:c.T1515C:p.F505F,PRODH:NM_016335:exon13:c.T1515C:p.F505F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.9034	.	0.83746	COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon12:c.T1191C:p.F397F,PRODH:uc002zol.4:exon12:c.T1191C:p.F397F,PRODH:uc002zok.4:exon13:c.T1515C:p.F505F	.	AFR:0.8495,AMR:0.6583,EAS:0.9404,FIN:0.9016,NFE:0.9156,OTH:0.9287,ASJ:0.9474	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	1(thyroid)	0.9084
22	18907124	18907124	G	A	LOC102724788;PRODH	intronic	.	ENSG00000100033	rs1076466	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4689	0.4110	0.525958	0.4203	.	.	.	.	.	.	.	.	.	.	AFR:0.4126,AMR:0.4053,EAS:0.7574,FIN:0.3869,NFE:0.3974,OTH:0.4018,ASJ:0.4533	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU26626450	hom
22	18908875	18908875	A	G	LOC102724788;PRODH	exonic	synonymous SNV	ENSG00000100033	rs1808320	ENSG00000100033:ENST00000334029:exon8:c.T667C:p.L223L,ENSG00000100033:ENST00000357068:exon8:c.T991C:p.L331L,ENSG00000100033:ENST00000420436:exon8:c.T667C:p.L223L	PRODH:NM_001195226:exon8:c.T667C:p.L223L,LOC102724788:NM_001368250:exon8:c.T667C:p.L223L,LOC102724788:NM_001368249:exon9:c.T991C:p.L331L,PRODH:NM_016335:exon9:c.T991C:p.L331L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6781	0.6645	0.73143	0.6492	.	.	.	.	.	.	.	.	PRODH:uc002zoj.5:exon8:c.T667C:p.L223L,PRODH:uc002zol.4:exon8:c.T667C:p.L223L,PRODH:uc002zok.4:exon9:c.T991C:p.L331L	.	AFR:0.8364,AMR:0.5692,EAS:0.8062,FIN:0.5492,NFE:0.5560,OTH:0.5749,ASJ:0.6424	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU82163080	hom
22	18910355	18910355	G	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs5747933	ENSG00000100033:ENST00000334029:exon6:c.C500A:p.T167N,ENSG00000100033:ENST00000357068:exon6:c.C824A:p.T275N,ENSG00000100033:ENST00000420436:exon6:c.C500A:p.T167N,ENSG00000100033:ENST00000450579:exon6:c.C347A:p.T116N	PRODH:NM_001195226:exon6:c.C500A:p.T167N,LOC102724788:NM_001368250:exon6:c.C500A:p.T167N,LOC102724788:NM_001368249:exon7:c.C824A:p.T275N,PRODH:NM_016335:exon7:c.C824A:p.T275N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0579	0.0333	0.0720847	MU750197	0.353	6.194	0.604	0.756	0.085	.	.	FAD-linked oxidoreductase-like|Proline dehydrogenase domain;Proline dehydrogenase domain	PRODH:uc002zoj.5:exon6:c.C500A:p.T167N,PRODH:uc002zol.4:exon6:c.C500A:p.T167N,PRODH:uc002zok.4:exon7:c.C824A:p.T275N	-1.014	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,AMR:0.0376,EAS:0.1468,FIN:0.0894,NFE:0.1807,OTH:0.0077,ASJ:0.0126	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.355	1.43	0.000	1.67	22	1(lung)	0.0362
22	18910451	18910451	A	-	LOC102724788;PRODH	intronic	.	ENSG00000100033	rs3216765	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.2381	0.3126	0.28734	0.2780	.	.	.	.	.	.	.	.	.	.	AFR:0.4684,AMR:0.3089,EAS:0.2092,FIN:0.1748,NFE:0.2007,OTH:0.2209,ASJ:0.3046	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	.	.	.	22	MU114637233	het
22	18912678	18912678	A	G	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs386819653	ENSG00000100033:ENST00000334029:exon4:c.T229C:p.W77R,ENSG00000100033:ENST00000357068:exon4:c.T553C:p.W185R,ENSG00000100033:ENST00000420436:exon4:c.T229C:p.W77R,ENSG00000100033:ENST00000450579:exon4:c.T76C:p.W26R	PRODH:NM_001195226:exon4:c.T229C:p.W77R,LOC102724788:NM_001368250:exon4:c.T229C:p.W77R,LOC102724788:NM_001368249:exon5:c.T553C:p.W185R,PRODH:NM_016335:exon5:c.T553C:p.W185R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6417	0.6739	0.78095	0.6509	-0.442	0.306	0.503	2.88	0.105	.	.	FAD-linked oxidoreductase-like	PRODH:uc002zoj.5:exon4:c.T229C:p.W77R,PRODH:uc002zol.4:exon4:c.T229C:p.W77R,PRODH:uc002zok.4:exon5:c.T553C:p.W185R	-0.991	AFR:0.8626,AMR:0.6583,EAS:0.9617,FIN:0.4811,NFE:0.5384,OTH:0.5685,ASJ:0.6424	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	0.0	-0.92	0.000	.	22	MU82047927	hom
22	18923745	18923745	G	T	LOC102724788;PRODH	exonic	nonsynonymous SNV	ENSG00000100033	rs2008720	ENSG00000100033:ENST00000357068:exon1:c.C56A:p.P19Q	LOC102724788:NM_001368249:exon2:c.C56A:p.P19Q,PRODH:NM_016335:exon2:c.C56A:p.P19Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.6653	.	0.553315	0.4404	0.360	6.258	0.369	-0.024	0.000	.	.	.	PRODH:uc002zok.4:exon2:c.C56A:p.P19Q	-1.088	AFR:0.3919,AMR:0.5025,EAS:0.8088,FIN:0.3811,NFE:0.4376,OTH:0.4397,ASJ:0.4767	606810	239500;600850;	419;	419|Proline oxidase deficiency|Unknown|Autosomal recessive|All ages|239500 ~	.	.	.	.	.	2.31	0.000	.	22	MU4585894	het
22	19789541	19789541	A	C	GNB1L	exonic	nonsynonymous SNV	ENSG00000185838	rs2073770	ENSG00000185838:ENST00000403325:exon6:c.T715G:p.W239G,ENSG00000185838:ENST00000329517:exon7:c.T715G:p.W239G	GNB1L:NM_053004:exon7:c.T715G:p.W239G	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2697	0.0877	0.20607	0.1128	1.065	11.03	0.544	4.78	0.598	.	.	WD40-repeat-containing domain	GNB1L:uc002zqf.1:exon7:c.T715G:p.W239G	-0.944	AFR:0.0381,AMR:0.2990,EAS:0.4759,FIN:0.0647,NFE:0.1176,OTH:0.0980,ASJ:0.1788	610778	.	.	.	.	.	.	.	0.0	2.33	0.000	-1.36	22	MU131611	het
22	21343983	21344019	GGGGAGCCAGGGCGCAGGTAGAGGAGGTGAGGGGCAC	-	LZTR1	intronic	.	ENSG00000099949	rs138025454	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.5810	0.8134	.	0.6272	.	.	.	.	.	.	.	.	.	.	AFR:0.6289,AMR:0.5974,EAS:0.7554,FIN:0.6237,NFE:0.6136,OTH:0.6087,ASJ:0.5329	600574	615670;616564;	648;93921;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	.	.	.	.	.	.	.	22	.	het
22	21348275	21348275	G	A	LZTR1	exonic	synonymous SNV	ENSG00000099949	rs367740343	ENSG00000099949:ENST00000389355:exon12:c.G1359A:p.R453R,ENSG00000099949:ENST00000215739:exon13:c.G1416A:p.R472R	LZTR1:NM_006767:exon13:c.G1416A:p.R472R	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 1, 0] 	0.0007	7.7e-05	0.000798722	3.233e-05	.	.	.	.	.	.	.	.	LZTR1:uc010gsr.1:exon10:c.G1029A:p.R343R,LZTR1:uc011ahy.2:exon12:c.G1359A:p.R453R,LZTR1:uc002zto.3:exon13:c.G1416A:p.R472R,LZTR1:uc002ztn.3:exon14:c.G1293A:p.R431R	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:6.678e-05,OTH:0,ASJ:0	600574	615670;616564;	648;93921;	648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~93921|NF3<br>Neurilemmomatosis<br>Schwannomatosis|Unknown|Autosomal dominant|Adult<br>Elderly|162091 162260 615670 ~	.	.	.	.	.	.	.	.	22	MU48997500	het
22	23627369	23627369	A	G	BCR	exonic	nonsynonymous SNV	ENSG00000186716	rs140504	ENSG00000186716:ENST00000305877:exon10:c.A2387G:p.N796S,ENSG00000186716:ENST00000359540:exon10:c.A2387G:p.N796S	BCR:NM_004327:exon10:c.A2387G:p.N796S,BCR:NM_021574:exon10:c.A2387G:p.N796S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 1, 0] 	0.8186	0.8774	0.79373	1(large_intestine)	0.337	6.042	1.0	1.63	0.908	.	.	PH domain-like|Pleckstrin homology domain	BCR:uc002zwy.2:exon2:c.A245G:p.N82S,BCR:uc010gtx.1:exon8:c.A788G:p.N263S,BCR:uc002zww.3:exon10:c.A2387G:p.N796S,BCR:uc002zwx.3:exon10:c.A2387G:p.N796S,BCR:uc011aiy.2:exon10:c.A1154G:p.N385S	-0.964	AFR:MU152970,AMR:LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763,THCA-CN|1|50|0.02,EAS:0.9315,FIN:0.8496,NFE:0.8974,OTH:0.5118,ASJ:0.8471	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	0.002	1.85	0.000	-0.975	22	1(lung)	0.8400
22	23631801	23631801	T	C	BCR	exonic	synonymous SNV	ENSG00000186716	rs2227939	ENSG00000186716:ENST00000305877:exon13:c.T2700C:p.N900N,ENSG00000186716:ENST00000359540:exon13:c.T2700C:p.N900N	BCR:NM_004327:exon13:c.T2700C:p.N900N,BCR:NM_021574:exon13:c.T2700C:p.N900N	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2964	0.3688	0.322684	MU152980	-0.021	2.391	.	2.7	0.992	.	.	.	BCR:uc002zwy.2:exon5:c.T558C:p.N186N,BCR:uc002zww.3:exon13:c.T2700C:p.N900N,BCR:uc002zwx.3:exon13:c.T2700C:p.N900N,BCR:uc011aiy.2:exon13:c.T1467C:p.N489N	.	AFR:LUSC-KR|1|170|0.00588235,AMR:0.3254,EAS:0.2990,FIN:0.3642,NFE:0.0580,OTH:0.1924,ASJ:0.5199	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	1(large_intestine)	0.2766
22	23631813	23631813	-	C	BCR	intronic	.	ENSG00000186716	rs113087899	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0] 	0.2965	0.3638	0.31849	0.3199	.	.	.	.	.	.	.	.	BCR:uc002zwy.2:exon5:c.571dupC:p.G190fs	.	AFR:0.5050,AMR:0.2990,EAS:0.0580,FIN:0.1924,NFE:0.2745,OTH:0.2684,ASJ:0.3609	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	.	unknown
22	23631823	23631823	T	C	BCR	intronic	.	ENSG00000186716	rs62219796	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3055	0.3661	0.322684	MU9796380	.	.	.	.	.	.	.	.	BCR:uc002zwy.2:exon5:c.T580C:p.F194L	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.3231,EAS:0.2990,FIN:0.3609,NFE:0.0580,OTH:0.1923,ASJ:0.5165	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	4(large_intestine)	0.2745
22	23637200	23637200	T	C	BCR	intronic	.	ENSG00000186716	rs2239666	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3210	0.3528	0.341454	0.3275	.	.	.	.	.	0	0.018	.	.	.	AFR:0.4510,AMR:0.3473,EAS:0.1829,FIN:0.2331,NFE:0.2946,OTH:0.2929,ASJ:0.3146	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU718621	het
22	23653975	23653975	-	CCGG	BCR	exonic	frameshift insertion	ENSG00000186716	rs372013175	ENSG00000186716:ENST00000359540:exon18:c.3142_3143insCCGG:p.S1048fs,ENSG00000186716:ENST00000305877:exon19:c.3274_3275insCCGG:p.S1092fs	BCR:NM_021574:exon18:c.3142_3143insCCGG:p.S1048fs,BCR:NM_004327:exon19:c.3274_3275insCCGG:p.S1092fs	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	.	0.0311	.	.	.	.	.	.	.	.	BCR:uc002zwx.3:exon18:c.3142_3143insCCGG:p.S1048fs,BCR:uc002zww.3:exon19:c.3274_3275insCCGG:p.S1092fs,BCR:uc011aiy.2:exon19:c.2041_2042insCCGG:p.S681fs	.	AFR:0.0219,AMR:0.0222,EAS:0.0894,FIN:0.0211,NFE:0.0353,OTH:0.0176,ASJ:0.0474	151410	608232;613065;	513;521;	513|ALL<br>Acute lymphoblastic leukemia/lymphoma<br>Acute lymphocytic leukemia|1-5 / 10 000|-|All ages|247640 613065 613067 ~521|CML<br>Chronic granulocytic leukemia<br>Chronic myelogenous leukemia|1-9 / 100 000|Not applicable|Adult|608232 ~	~ko05200 Pathways in cancer~ko05220 Chronic myeloid leukemia ~	.	.	.	.	.	.	.	22	MU112765516	het
22	26159289	26159289	G	A	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs133885	ENSG00000133454:ENST00000539302:exon2:c.G131A:p.G44E,ENSG00000133454:ENST00000335473:exon3:c.G131A:p.G44E,ENSG00000133454:ENST00000407587:exon3:c.G131A:p.G44E,ENSG00000133454:ENST00000536101:exon3:c.G131A:p.G44E	MYO18B:NM_001318245:exon3:c.G131A:p.G44E,MYO18B:NM_032608:exon3:c.G131A:p.G44E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.5433	0.5709	0.701677	COCA-CN|6|321|0.0186916,BRCA-KR|1|50|0.02	1.100	11.22	1.0	5.09	0.991	.	.	.	MYO18B:uc003abz.1:exon3:c.G131A:p.G44E	-0.942	AFR:0.5802,AMR:0.8419,EAS:0.5367,FIN:0.8333,NFE:0.4200,OTH:0.4408,ASJ:0.6623	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-1.38	0.000	-2.125	22	1(breast)	0.4744
22	26159370	26159372	AAG	-	MYO18B	intronic	.	ENSG00000133454	rs141996383	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0232	0.0051	0.038738	0.0116	.	.	.	.	.	.	.	.	.	.	AFR:0.0022,AMR:0.0728,EAS:0.1168,FIN:0.0017,NFE:0.0046,OTH:0.0153,ASJ:0	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	.	het
22	26160901	26160902	AG	-	MYO18B	intronic	.	ENSG00000133454	rs133895	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.230232	0.2344	.	.	.	.	.	.	.	.	.	.	AFR:0.3207,AMR:0.2100,EAS:0.1667,FIN:0.1535,NFE:0.2133,OTH:0.1855,ASJ:0.3179	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	.	het
22	26164079	26164079	C	T	MYO18B	intronic	.	ENSG00000133454	rs133902	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.5407	0.5710	0.697883	0.5739	.	.	.	.	.	0.0002	0.002	.	.	.	AFR:0.84,AMR:0.6567,EAS:0.8377,FIN:0.4192,NFE:0.4300,OTH:0.4694,ASJ:0.5232	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU27577034	hom
22	26166900	26166900	G	C	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs3859866	ENSG00000133454:ENST00000539302:exon5:c.G1641C:p.W547C,ENSG00000133454:ENST00000335473:exon6:c.G1641C:p.W547C,ENSG00000133454:ENST00000407587:exon6:c.G1641C:p.W547C,ENSG00000133454:ENST00000536101:exon6:c.G1641C:p.W547C	MYO18B:NM_001318245:exon6:c.G1641C:p.W547C,MYO18B:NM_032608:exon6:c.G1641C:p.W547C	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9579	0.9776	0.938498	0.9730	1.276	12.14	0.049	3.72	0.972	.	.	P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon2:c.G180C:p.W60C,MYO18B:uc003aca.1:exon4:c.G1284C:p.W428C,MYO18B:uc010guy.1:exon4:c.G1284C:p.W428C,MYO18B:uc010guz.1:exon4:c.G1284C:p.W428C,MYO18B:uc003abz.1:exon6:c.G1641C:p.W547C	-0.952	AFR:0.9534,AMR:0.9857,EAS:0.8844,FIN:0.9914,NFE:0.9891,OTH:0.9715,ASJ:0.9768	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-0.56	0.000	-1.245	22	MU28574395	het
22	26173661	26173661	T	C	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs5761170	ENSG00000133454:ENST00000539302:exon7:c.T1981C:p.W661R,ENSG00000133454:ENST00000335473:exon8:c.T1981C:p.W661R,ENSG00000133454:ENST00000407587:exon8:c.T1981C:p.W661R,ENSG00000133454:ENST00000536101:exon8:c.T1981C:p.W661R	MYO18B:NM_001318245:exon8:c.T1981C:p.W661R,MYO18B:NM_032608:exon8:c.T1981C:p.W661R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9647	0.9714	0.932508	0.9680	-1.452	0.003	1.0	-0.033	0.975	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon4:c.T520C:p.W174R,MYO18B:uc003aca.1:exon6:c.T1624C:p.W542R,MYO18B:uc010guy.1:exon6:c.T1624C:p.W542R,MYO18B:uc010guz.1:exon6:c.T1624C:p.W542R,MYO18B:uc003abz.1:exon8:c.T1981C:p.W661R	-0.944	AFR:0.9366,AMR:0.9857,EAS:0.8820,FIN:0.9914,NFE:0.9888,OTH:0.9684,ASJ:0.9768	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-2.18	0.000	.	22	MU635506	het
22	26193982	26193982	C	G	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs738642	ENSG00000133454:ENST00000335473:exon12:c.C2439G:p.L813L,ENSG00000133454:ENST00000407587:exon12:c.C2439G:p.L813L,ENSG00000133454:ENST00000536101:exon12:c.C2439G:p.L813L	MYO18B:NM_001318245:exon12:c.C2439G:p.L813L,MYO18B:NM_032608:exon12:c.C2439G:p.L813L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7296	0.6482	0.684305	0.6554	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon8:c.C978G:p.L326L,MYO18B:uc003aca.1:exon10:c.C2082G:p.L694L,MYO18B:uc010guy.1:exon10:c.C2082G:p.L694L,MYO18B:uc010guz.1:exon10:c.C2082G:p.L694L,MYO18B:uc003abz.1:exon12:c.C2439G:p.L813L	.	AFR:0.4509,AMR:0.7931,EAS:0.8969,FIN:0.6795,NFE:0.7307,OTH:0.7383,ASJ:0.5833	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU20292388	hom
22	26194045	26194045	T	C	MYO18B	exonic	synonymous SNV	ENSG00000133454	rs738643	ENSG00000133454:ENST00000335473:exon12:c.T2502C:p.G834G,ENSG00000133454:ENST00000407587:exon12:c.T2502C:p.G834G,ENSG00000133454:ENST00000536101:exon12:c.T2502C:p.G834G	MYO18B:NM_001318245:exon12:c.T2502C:p.G834G,MYO18B:NM_032608:exon12:c.T2502C:p.G834G	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6636	0.5936	0.56889	0.5952	.	.	.	.	.	.	.	.	MYO18B:uc011akb.1:exon8:c.T1041C:p.G347G,MYO18B:uc003aca.1:exon10:c.T2145C:p.G715G,MYO18B:uc010guy.1:exon10:c.T2145C:p.G715G,MYO18B:uc010guz.1:exon10:c.T2145C:p.G715G,MYO18B:uc003abz.1:exon12:c.T2502C:p.G834G	.	AFR:0.3391,AMR:0.6806,EAS:0.6966,FIN:0.6597,NFE:0.7093,OTH:0.6834,ASJ:0.5232	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	MU13839222	het
22	26239850	26239850	C	A	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs5761268	ENSG00000133454:ENST00000335473:exon18:c.C3357A:p.H1119Q,ENSG00000133454:ENST00000407587:exon18:c.C3360A:p.H1120Q,ENSG00000133454:ENST00000536101:exon18:c.C3357A:p.H1119Q	MYO18B:NM_001318245:exon18:c.C3360A:p.H1120Q,MYO18B:NM_032608:exon18:c.C3357A:p.H1119Q	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7340	0.6421	0.723442	0.6653	-0.536	0.179	1.0	-3.23	0.984	.	.	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	MYO18B:uc011akb.1:exon14:c.C1896A:p.H632Q,MYO18B:uc011aka.1:exon15:c.C819A:p.H273Q,MYO18B:uc003aca.1:exon16:c.C3000A:p.H1000Q,MYO18B:uc010guy.1:exon16:c.C3003A:p.H1001Q,MYO18B:uc010guz.1:exon16:c.C3000A:p.H1000Q,MYO18B:uc003abz.1:exon18:c.C3357A:p.H1119Q	-0.932	AFR:0.4657,AMR:0.7721,EAS:0.9975,FIN:0.7676,NFE:0.7124,OTH:0.7352,ASJ:0.5927	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-2.06	0.000	-2.535	22	MU4555172	het
22	26342232	26342232	T	C	MYO18B	intronic	.	ENSG00000133454	rs9613047	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1923	0.1593	0.17512	LICA-CN|3|402|0.00746269,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	.	.	AFR:0.1749,AMR:0.1925,EAS:0.1867,FIN:0.2544,NFE:0.1885,OTH:0.1564,ASJ:0.1301	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	1(liver)	0.1569
22	26343805	26343805	A	G	MYO18B	intronic	.	ENSG00000133454	rs2072007	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.8055	0.8749	0.711861	MU585744	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|3|205|0.0146341,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02,AMR:0.8292,EAS:0.6124,FIN:0.9603,NFE:0.4714,OTH:0.7786,ASJ:0.8210	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	.	.	.	.	22	3(haematopoietic_and_lymphoid_tissue)	0.8942
22	26422980	26422980	A	G	MYO18B	exonic	nonsynonymous SNV	ENSG00000133454	rs2236005	ENSG00000133454:ENST00000335473:exon43:c.A7040G:p.Q2347R,ENSG00000133454:ENST00000407587:exon43:c.A7043G:p.Q2348R,ENSG00000133454:ENST00000536101:exon43:c.A7040G:p.Q2347R	MYO18B:NM_001318245:exon43:c.A7043G:p.Q2348R,MYO18B:NM_032608:exon43:c.A7040G:p.Q2347R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2570	0.3497	0.426318	1(breast)	-1.521	0.002	1.0	3.78	0.464	.	.	.	MYO18B:uc010gva.1:exon4:c.A989G:p.Q330R,MYO18B:uc011akb.1:exon39:c.A5579G:p.Q1860R,MYO18B:uc011aka.1:exon40:c.A4502G:p.Q1501R,MYO18B:uc003aca.1:exon41:c.A6683G:p.Q2228R,MYO18B:uc010guy.1:exon41:c.A6686G:p.Q2229R,MYO18B:uc010guz.1:exon41:c.A6680G:p.Q2227R,MYO18B:uc003abz.1:exon43:c.A7040G:p.Q2347R	-0.944	AFR:1(thyroid),AMR:MU4555165,EAS:0.3534,FIN:0.8016,NFE:0.2780,OTH:0.1523,ASJ:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,BRCA-KR|1|50|0.02	607295	616549;	447974;	447974|-|<1 / 1 000 000|Autosomal recessive|Infancy|616549 ~	.	.	.	.	0.0	-1.86	0.000	-1.935	22	1(lung)	0.1771
22	28194933	28194933	-	TGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGC	MN1	exonic	nonframeshift insertion	ENSG00000169184	.	ENSG00000169184:ENST00000302326:exon1:c.1598_1599insGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.Q533delinsQQQQQQQQQQQQQQQQQQ	MN1:NM_002430:exon1:c.1598_1599insGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.Q533delinsQQQQQQQQQQQQQQQQQQ	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	MN1:uc003adj.3:exon1:c.1598_1599insGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA:p.Q533delinsQQQQQQQQQQQQQQQQQQ	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	156100	607174;	263662;	263662|-|Unknown|Autosomal dominant|All ages|607174 ~	.	.	.	.	.	.	.	.	22	.	het
22	29108229	29108229	A	G	CHEK2	intronic	.	ENSG00000183765	rs5752776	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	.	.	0.682308	0.6598	.	.	.	.	.	.	.	.	.	.	AFR:0.4911,AMR:0.6575,EAS:0.8455,FIN:0.7517,NFE:0.7095,OTH:0.7255,ASJ:0.8013	604373	114480;176807;259500;609265;	524;668;1331;227535;	524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1331|-|-|-|Adult|176807 300147 300704 601518 602759 603688 608656 608658 609299 609558 610321 610997 611100 611868 611928 611955 611958 611959 614731 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	.	.	.	.	.	.	.	.	22	MU117008065	het
22	31741067	31741067	G	A	PATZ1	exonic	synonymous SNV	ENSG00000100105	rs714909	ENSG00000100105:ENST00000215919:exon1:c.C522T:p.L174L,ENSG00000100105:ENST00000266269:exon1:c.C522T:p.L174L,ENSG00000100105:ENST00000351933:exon1:c.C522T:p.L174L,ENSG00000100105:ENST00000405309:exon1:c.C522T:p.L174L	PATZ1:NM_014323:exon1:c.C522T:p.L174L,PATZ1:NM_032050:exon1:c.C522T:p.L174L,PATZ1:NM_032051:exon1:c.C522T:p.L174L,PATZ1:NM_032052:exon1:c.C522T:p.L174L	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2406	0.2008	0.155152	MU4548042	.	.	.	.	.	.	.	.	PATZ1:uc003akp.3:exon1:c.C522T:p.L174L,PATZ1:uc003akq.3:exon1:c.C522T:p.L174L,PATZ1:uc003akr.3:exon1:c.C522T:p.L174L,PATZ1:uc003aks.3:exon1:c.C522T:p.L174L	.	AFR:LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053,AMR:0.2269,EAS:0.2584,FIN:0.2715,NFE:0.1400,OTH:0.3454,ASJ:0.0539	605165	.	.	.	.	.	.	.	.	.	.	.	22	1(lung)	0.3023
22	33253280	33253280	T	C	TIMP3	exonic	synonymous SNV	ENSG00000100234	rs9862	ENSG00000100234:ENST00000266085:exon3:c.T249C:p.H83H	TIMP3:NM_000362:exon3:c.T249C:p.H83H	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5518	0.6127	0.650958	LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	TIMP3:uc003anb.3:exon3:c.T249C:p.H83H	.	AFR:0.5980,AMR:0.8374,EAS:0.5629,FIN:0.5945,NFE:0.4422,OTH:0.4965,ASJ:0.6993	188826	136900;	59181;	59181|-|Unknown|Autosomal dominant|Adult|136900 264420 ~	~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	22	1(haematopoietic_and_lymphoid_tissue)	0.5051
22	33253292	33253292	C	T	TIMP3	exonic	synonymous SNV	ENSG00000100234	rs11547635	ENSG00000100234:ENST00000266085:exon3:c.C261T:p.S87S	TIMP3:NM_000362:exon3:c.C261T:p.S87S	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.1046	0.0694	0.143371	LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	TIMP3:uc003anb.3:exon3:c.C261T:p.S87S	.	AFR:0.0829,AMR:0.0604,EAS:0.0430,FIN:0.3348,NFE:0.0581,OTH:0.0682,ASJ:0.2303	188826	136900;	59181;	59181|-|Unknown|Autosomal dominant|Adult|136900 264420 ~	~ko05205 Proteoglycans in cancer~ko05206 MicroRNAs in cancer ~	.	.	.	.	.	.	.	22	1(lung)	0.0684
22	36684331	36684331	C	T	MYH9	exonic	synonymous SNV	ENSG00000100345	rs5756130	ENSG00000100345:ENST00000216181:exon34:c.G4899A:p.R1633R	MYH9:NM_002473:exon34:c.G4899A:p.R1633R	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.0702	0.0607	0.096246	0.0770	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon34:c.G4899A:p.R1633R	.	AFR:0.1228,AMR:0.0933,EAS:0.0878,FIN:0.0647,NFE:0.0527,OTH:0.0621,ASJ:0.0430	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82292477	unknown
22	36684354	36684354	T	C	MYH9	exonic	nonsynonymous SNV	ENSG00000100345	rs2269529	ENSG00000100345:ENST00000216181:exon34:c.A4876G:p.I1626V	MYH9:NM_002473:exon34:c.A4876G:p.I1626V	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.2584	0.1555	0.294129	0.1759	0.134	3.970	0.332	4.47	0.359	.	.	Myosin tail	MYH9:uc003apg.3:exon34:c.A4876G:p.I1626V	-0.911	AFR:0.0724,AMR:0.2440,EAS:0.6067,FIN:0.1758,NFE:0.1814,OTH:0.2137,ASJ:0.3179	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	0.042	-1.05	0.000	0.805	22	MU14584538	unknown
22	36684358	36684358	C	A	MYH9	exonic	synonymous SNV	ENSG00000100345	rs2269530	ENSG00000100345:ENST00000216181:exon34:c.G4872T:p.A1624A	MYH9:NM_002473:exon34:c.G4872T:p.A1624A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2582	0.1552	0.29373	0.1754	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon34:c.G4872T:p.A1624A	.	AFR:0.0712,AMR:0.2440,EAS:0.6068,FIN:0.1755,NFE:0.1813,OTH:0.2137,ASJ:0.3179	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU14584585	unknown
22	36691607	36691607	A	C	MYH9	exonic	synonymous SNV	ENSG00000100345	rs710181	ENSG00000100345:ENST00000216181:exon26:c.T3429G:p.A1143A	MYH9:NM_002473:exon26:c.T3429G:p.A1143A	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9766	0.9712	0.982628	0.9725	.	.	.	.	.	.	.	.	MYH9:uc003apg.3:exon26:c.T3429G:p.A1143A	.	AFR:0.9718,AMR:0.9773,EAS:0.9994,FIN:0.9673,NFE:0.9719,OTH:0.9693,ASJ:0.9404	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82051855	hom
22	36708084	36708084	C	T	MYH9	intronic	.	ENSG00000100345	rs2413396	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8714	0.7555	0.760783	0.7779	.	.	.	.	.	.	.	.	.	.	AFR:0.4512,AMR:0.9021,EAS:0.9030,FIN:0.8967,NFE:0.9108,OTH:0.8755,ASJ:0.8874	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU14584855	hom
22	36710183	36710183	T	C	MYH9	intronic	.	ENSG00000100345	rs3752462	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.5614	0.5347	0.39357	0.5361	.	.	.	.	.	0	0	.	.	.	AFR:0.2688,AMR:0.6367,EAS:0.2249,FIN:0.6641,NFE:0.6840,OTH:0.6176,ASJ:0.5533	160775	153640;153650;155100;600208;603622;605249;	90635;182050;	90635|Autosomal dominant isolated neurosensory deafness type DFNA<br>Autosomal dominant isolated neurosensory hearing loss type DFNA<br>Autosomal dominant isolated sensorineural deafness type DFNA<br>Autosomal dominant isolated sensorineural hearing loss type DFNA<br>Autosomal dominant non-syndromic neurosensory deafness type DFNA<br>Autosomal dominant non-syndromic neurosensory hearing loss type DFNA<br>Autosomal dominant non-syndromic sensorineural hearing loss type DFNA|Unknown|Autosomal dominant|Childhood|124900 600101 600652 600965 600994 601316 601317 601369 601412 601543 601544 601868 602459 603622 603964 604717 605192 605583 606012 606282 606346 606451 606705 607017 607197 607453 607683 607841 608224 608372 608394 608641 608645 608652 609129 609965 612431 612642 612643 612644 613074 613558 614152 614211 614614 615629 615649 615654 616044 616340 616357 616697 616707 616968 616969 ~182050|MYH9-RD<br>MYH9-related disorder<br>MYH9-related syndrome<br>MYH9-related syndromic thrombocytopenia|1-9 / 1 000 000|Autosomal dominant|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|600208 ~	.	.	.	.	.	.	.	.	22	MU82240671	het
22	38369976	38369976	A	G	SOX10	exonic	synonymous SNV	ENSG00000100146	rs139884	ENSG00000100146:ENST00000396884:exon4:c.T927C:p.H309H,ENSG00000100146:ENST00000360880:exon5:c.T927C:p.H309H	SOX10:NM_006941:exon4:c.T927C:p.H309H	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.6537	0.6958	0.713259	0.6920	.	.	.	.	.	.	.	.	SOX10:uc003aun.1:exon4:c.T927C:p.H309H,SOX10:uc003auo.1:exon5:c.T927C:p.H309H	.	AFR:0.8266,AMR:0.6244,EAS:0.7833,FIN:0.6317,NFE:0.6281,OTH:0.6207,ASJ:0.6033	602229	609136;611584;613266;	897;3440;895;163746;	897|Shah-Waardenburg syndrome<br>WS4<br>Waardenburg syndrome type 4<br>Waardenburg-Hirschsprung syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Neonatal|277580 613265 613266 ~3440|-|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Infancy<br>Neonatal|148820 193500 193510 600193 606662 608890 611584 ~895|WS2<br>Waardenburg syndrome type II|Unknown|Autosomal dominant|Neonatal|193510 600193 606662 608890 611584 ~163746|PCWH<br>Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Hirschsprung disease-Waardenburg syndrome<br>WS4 plus|<1 / 1 000 000|Autosomal dominant|Infancy<br>Neonatal|609136 ~	.	.	.	.	.	.	.	.	22	MU4560542	hom
22	38905446	38905446	G	A	DDX17;DMC1	intergenic	.	ENSG00000100201;ENSG00000100206	rs138462	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.934904	0.9569	.	.	.	.	.	.	.	.	.	.	AFR:0.9021,AMR:0.9821,EAS:0.8983,FIN:0.9954,NFE:0.9827,OTH:0.9806,ASJ:0.9801	.	.	.	.	.	.	.	.	.	.	.	.	22	.	hom
22	39357581	39357581	C	T	APOBEC3A;APOBEC3A_B	exonic	synonymous SNV	ENSG00000128383	rs35994173	ENSG00000128383:ENST00000249116:exon3:c.C364T:p.L122L,ENSG00000128383:ENST00000402255:exon4:c.C364T:p.L122L	APOBEC3A_B:NM_001193289:exon3:c.C364T:p.L122L,APOBEC3A:NM_001270406:exon3:c.C310T:p.L104L,APOBEC3A:NM_145699:exon3:c.C364T:p.L122L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.2039	0.2064	0.245807	0.1331	.	.	.	.	.	.	.	.	APOBEC3A:uc003awn.2:exon3:c.C364T:p.L122L,APOBEC3A:uc011aob.1:exon3:c.C310T:p.L104L,APOBEC3A_B:uc011aoc.2:exon3:c.C364T:p.L122L	.	AFR:0.1947,AMR:0.0863,EAS:0.1918,FIN:0.0887,NFE:0.1086,OTH:0.1307,ASJ:0.1131	607109	.	.	.	.	.	.	.	.	.	.	.	22	.	hom
22	39357634	39357634	A	G	APOBEC3A;APOBEC3A_B	exonic	synonymous SNV	ENSG00000128383	rs2294363	ENSG00000128383:ENST00000249116:exon3:c.A417G:p.A139A,ENSG00000128383:ENST00000402255:exon4:c.A417G:p.A139A	APOBEC3A_B:NM_001193289:exon3:c.A417G:p.A139A,APOBEC3A:NM_001270406:exon3:c.A363G:p.A121A,APOBEC3A:NM_145699:exon3:c.A417G:p.A139A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0070	.	.	SKCA-BR|1|100|0.01,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	APOBEC3A:uc003awn.2:exon3:c.A417G:p.A139A,APOBEC3A:uc011aob.1:exon3:c.A363G:p.A121A,APOBEC3A_B:uc011aoc.2:exon3:c.A417G:p.A139A	.	AFR:0.4060,AMR:0.6103,EAS:0.3346,FIN:0.4211,NFE:0.2963,OTH:0.3346,ASJ:0.2877	607109	.	.	.	.	.	.	.	.	.	.	.	22	1(skin)	0.3591
22	39381826	39381826	A	G	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs2076109	ENSG00000179750:ENST00000333467:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000335760:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000402182:exon3:c.A184G:p.K62E,ENSG00000179750:ENST00000407298:exon3:c.A184G:p.K62E	APOBEC3B:NM_001270411:exon3:c.A184G:p.K62E,APOBEC3B:NM_004900:exon3:c.A184G:p.K62E	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.6016	0.6057	0.641174	0.6012	-1.879	0.002	0.72	-1.15	0.000	.	.	APOBEC-like, N-terminal|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.A184G:p.K62E,APOBEC3B:uc003awp.2:exon3:c.A184G:p.K62E	-0.903	AFR:0.6745,AMR:0.5195,EAS:0.6416,FIN:0.6176,NFE:0.5592,OTH:0.5826,ASJ:0.4796	607110	.	.	.	.	.	.	.	0.032	-0.14	0.000	0.185	22	MU151842	hom
22	39381999	39381999	T	C	APOBEC3B	exonic	synonymous SNV	ENSG00000179750	rs2076111	ENSG00000179750:ENST00000333467:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000335760:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000402182:exon3:c.T357C:p.S119S,ENSG00000179750:ENST00000407298:exon3:c.T357C:p.S119S	APOBEC3B:NM_001270411:exon3:c.T357C:p.S119S,APOBEC3B:NM_004900:exon3:c.T357C:p.S119S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5857	.	.	0.5927	.	.	.	.	.	.	.	.	APOBEC3B:uc003awo.2:exon3:c.T357C:p.S119S,APOBEC3B:uc003awp.2:exon3:c.T357C:p.S119S	.	AFR:0.6495,AMR:0.5225,EAS:0.6783,FIN:0.6151,NFE:0.5550,OTH:0.5689,ASJ:0.4755	607110	.	.	.	.	.	.	.	.	.	.	.	22	MU4559442	hom
22	39382079	39382079	C	A	APOBEC3B	exonic	nonsynonymous SNV	ENSG00000179750	rs5995649	ENSG00000179750:ENST00000333467:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000335760:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000402182:exon3:c.C437A:p.T146K,ENSG00000179750:ENST00000407298:exon3:c.C437A:p.T146K	APOBEC3B:NM_001270411:exon3:c.C437A:p.T146K,APOBEC3B:NM_004900:exon3:c.C437A:p.T146K	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 1, 0] 	0.9492	0.9511	0.949681	0.9538	-0.635	0.103	1.0	-4.25	0.000	.	.	APOBEC-like, N-terminal|Cytidine deaminase-like	APOBEC3B:uc003awo.2:exon3:c.C437A:p.T146K,APOBEC3B:uc003awp.2:exon3:c.C437A:p.T146K	-0.995	AFR:0.9398,AMR:0.9526,EAS:0.9757,FIN:0.9672,NFE:0.9586,OTH:0.9557,ASJ:0.87	607110	.	.	.	.	.	.	.	0.0	-0.02	0.000	-1.695	22	MU82052701	hom
22	39387558	39387558	C	T	APOBEC3B	exonic	synonymous SNV	ENSG00000179750	rs1065184	ENSG00000179750:ENST00000333467:exon6:c.C945T:p.Y315Y,ENSG00000179750:ENST00000402182:exon6:c.C945T:p.Y315Y,ENSG00000179750:ENST00000407298:exon6:c.C870T:p.Y290Y	APOBEC3B:NM_001270411:exon6:c.C870T:p.Y290Y,APOBEC3B:NM_004900:exon6:c.C945T:p.Y315Y	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4729	0.4836	.	0.4854	.	.	.	.	.	.	.	.	APOBEC3B:uc003awo.2:exon6:c.C945T:p.Y315Y,APOBEC3B:uc003awp.2:exon6:c.C870T:p.Y290Y	.	AFR:0.5375,AMR:0.4413,EAS:0.5290,FIN:0.4868,NFE:0.4591,OTH:0.4378,ASJ:0.4034	607110	.	.	.	.	.	.	.	.	.	.	.	22	MU151851	het
22	39414166	39414166	A	G	APOBEC3C	intronic	.	ENSG00000243811;ENSG00000244509	rs4820361	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	.	.	0.647564	0.6780	.	.	.	.	.	.	.	.	.	.	AFR:0.6676,AMR:0.7201,EAS:0.6938,FIN:0.7478,NFE:0.6645,OTH:0.6855,ASJ:0.6192	607750	.	.	.	.	.	.	.	.	.	.	.	22	MU26443964	het
22	39414224	39414224	A	G	APOBEC3C	intronic	.	ENSG00000243811;ENSG00000244509	rs4821854	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6487	0.6434	0.647764	0.6781	.	.	.	.	.	.	.	.	.	.	AFR:0.6680,AMR:0.7201,EAS:0.6948,FIN:0.7477,NFE:0.6645,OTH:0.6824,ASJ:0.6192	607750	.	.	.	.	.	.	.	.	.	.	.	22	MU26546283	het
22	39477123	39477123	T	C	APOBEC3G	exonic	synonymous SNV	ENSG00000239713	rs5757465	ENSG00000239713:ENST00000407997:exon3:c.T357C:p.F119F,ENSG00000239713:ENST00000452957:exon3:c.T357C:p.F119F	APOBEC3G:NM_001349437:exon2:c.T156C:p.F52F,APOBEC3G:NM_001349436:exon3:c.T324C:p.F108F,APOBEC3G:NM_001349438:exon3:c.T357C:p.F119F,APOBEC3G:NM_021822:exon3:c.T357C:p.F119F	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3717	0.3175	0.284545	0.2919	.	.	.	.	.	.	.	.	APOBEC3G:uc003awy.3:exon1:c.T156C:p.F52F,APOBEC3G:uc003awx.3:exon3:c.T357C:p.F119F,APOBEC3G:uc021wpr.1:exon3:c.T357C:p.F119F	.	AFR:0.0804,AMR:0.3923,EAS:0.2228,FIN:0.2858,NFE:0.4120,OTH:0.3498,ASJ:0.4233	607113	.	.	.	.	.	.	.	.	.	.	.	22	MU151858	het
22	39496323	39496325	AAC	-	APOBEC3H	exonic	nonframeshift deletion	ENSG00000100298	rs139292	ENSG00000100298:ENST00000348946:exon2:c.40_42del:p.14_14del,ENSG00000100298:ENST00000401756:exon2:c.40_42del:p.14_14del,ENSG00000100298:ENST00000421988:exon2:c.40_42del:p.14_14del,ENSG00000100298:ENST00000442487:exon2:c.40_42del:p.14_14del	APOBEC3H:NM_001166002:exon2:c.40_42del:p.14_14del,APOBEC3H:NM_001166003:exon2:c.40_42del:p.14_14del,APOBEC3H:NM_001166004:exon2:c.40_42del:p.14_14del,APOBEC3H:NM_181773:exon2:c.40_42del:p.14_14del	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3430	0.3248	0.317492	0.3345	.	.	.	.	.	.	.	.	APOBEC3H:uc021wps.1:exon2:c.40_42del:p.14_14del,APOBEC3H:uc021wpt.1:exon2:c.40_42del:p.14_14del,APOBEC3H:uc021wpu.1:exon2:c.40_42del:p.14_14del,APOBEC3H:uc021wpv.1:exon2:c.40_42del:p.14_14del	.	AFR:0.3115,AMR:0.2758,EAS:0.2719,FIN:0.4296,NFE:0.3361,OTH:0.3416,ASJ:0.2867	610976	.	.	.	.	.	.	.	.	.	.	.	22	MU156031	het
22	39496336	39496336	G	T	APOBEC3H	exonic	nonsynonymous SNV	ENSG00000100298	rs139293	ENSG00000100298:ENST00000348946:exon2:c.G53T:p.R18L,ENSG00000100298:ENST00000401756:exon2:c.G53T:p.R18L,ENSG00000100298:ENST00000421988:exon2:c.G53T:p.R18L,ENSG00000100298:ENST00000442487:exon2:c.G53T:p.R18L	APOBEC3H:NM_001166002:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166003:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166004:exon2:c.G53T:p.R18L,APOBEC3H:NM_181773:exon2:c.G53T:p.R18L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.2685	0.2090	0.201677	MU156027	2.007	16.25	0.142	-0.212	0.000	.	.	Cytidine and deoxycytidylate deaminase domain	APOBEC3H:uc021wps.1:exon2:c.G53T:p.R18L,APOBEC3H:uc021wpt.1:exon2:c.G53T:p.R18L,APOBEC3H:uc021wpu.1:exon2:c.G53T:p.R18L,APOBEC3H:uc021wpv.1:exon2:c.G53T:p.R18L	-1.017	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|1|321|0.00311526,AMR:0.2325,EAS:0.2416,FIN:0.2318,NFE:0.1642,OTH:0.3842,ASJ:0.0817	610976	.	.	.	.	.	.	.	0.989	0.04	0.000	1.845	22	8(soft_tissue)	0.2881
22	39496412	39496412	G	C	APOBEC3H	exonic	synonymous SNV	ENSG00000100298	rs139294	ENSG00000100298:ENST00000348946:exon2:c.G129C:p.T43T,ENSG00000100298:ENST00000401756:exon2:c.G129C:p.T43T,ENSG00000100298:ENST00000421988:exon2:c.G129C:p.T43T,ENSG00000100298:ENST00000442487:exon2:c.G129C:p.T43T	APOBEC3H:NM_001166002:exon2:c.G129C:p.T43T,APOBEC3H:NM_001166003:exon2:c.G129C:p.T43T,APOBEC3H:NM_001166004:exon2:c.G129C:p.T43T,APOBEC3H:NM_181773:exon2:c.G129C:p.T43T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4772	0.5600	0.514776	MU156022	.	.	.	.	.	.	.	.	APOBEC3H:uc021wps.1:exon2:c.G129C:p.T43T,APOBEC3H:uc021wpt.1:exon2:c.G129C:p.T43T,APOBEC3H:uc021wpu.1:exon2:c.G129C:p.T43T,APOBEC3H:uc021wpv.1:exon2:c.G129C:p.T43T	.	AFR:ESAD-UK|1|409|0.00244499,LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,AMR:0.5530,EAS:0.3640,FIN:0.4901,NFE:0.3625,OTH:0.5436,ASJ:0.7686	610976	.	.	.	.	.	.	.	.	.	.	.	22	2(lung)	0.4649
22	39497404	39497404	G	C	APOBEC3H	exonic	nonsynonymous SNV	ENSG00000100298	rs139297	ENSG00000100298:ENST00000348946:exon3:c.G313C:p.G105R,ENSG00000100298:ENST00000401756:exon3:c.G313C:p.G105R,ENSG00000100298:ENST00000421988:exon3:c.G313C:p.G105R,ENSG00000100298:ENST00000442487:exon3:c.G313C:p.G105R	APOBEC3H:NM_001166002:exon3:c.G313C:p.G105R,APOBEC3H:NM_001166003:exon3:c.G313C:p.G105R,APOBEC3H:NM_001166004:exon3:c.G313C:p.G105R,APOBEC3H:NM_181773:exon3:c.G313C:p.G105R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4818	0.5795	0.52476	1(haematopoietic_and_lymphoid_tissue)	-1.664	0.002	1.0	-4.63	0.000	.	.	APOBEC-like, N-terminal|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3H:uc021wps.1:exon3:c.G313C:p.G105R,APOBEC3H:uc021wpt.1:exon3:c.G313C:p.G105R,APOBEC3H:uc021wpu.1:exon3:c.G313C:p.G105R,APOBEC3H:uc021wpv.1:exon3:c.G313C:p.G105R	-0.968	AFR:MU156016,AMR:LICA-CN|1|402|0.00248756,COCA-CN|4|321|0.0124611,ESCA-CN|1|332|0.00301205,EAS:0.8187,FIN:0.3744,NFE:0.4932,OTH:0.3319,ASJ:0.5719	610976	.	.	.	.	.	.	.	0.0	0.03	0.000	-2.595	22	1(large_intestine)	0.5531
22	39497452	39497452	A	G	APOBEC3H	exonic	nonsynonymous SNV	ENSG00000100298	rs139298	ENSG00000100298:ENST00000348946:exon3:c.A361G:p.K121E,ENSG00000100298:ENST00000401756:exon3:c.A361G:p.K121E,ENSG00000100298:ENST00000421988:exon3:c.A361G:p.K121E,ENSG00000100298:ENST00000442487:exon3:c.A361G:p.K121E	APOBEC3H:NM_001166002:exon3:c.A361G:p.K121E,APOBEC3H:NM_001166003:exon3:c.A361G:p.K121E,APOBEC3H:NM_001166004:exon3:c.A361G:p.K121E,APOBEC3H:NM_181773:exon3:c.A361G:p.K121E	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4851	0.5750	0.529752	1(lung)	-2.505	0.001	1.0	-6.67	0.001	.	.	APOBEC-like, N-terminal|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3H:uc021wps.1:exon3:c.A361G:p.K121E,APOBEC3H:uc021wpt.1:exon3:c.A361G:p.K121E,APOBEC3H:uc021wpu.1:exon3:c.A361G:p.K121E,APOBEC3H:uc021wpv.1:exon3:c.A361G:p.K121E	-1.033	AFR:MU156010,AMR:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,EAS:0.8187,FIN:0.3780,NFE:0.5,OTH:0.3342,ASJ:0.5736	610976	.	.	.	.	.	.	.	0.0	0.12	0.000	-1.45	22	3(thyroid)	0.5537
22	39497454	39497454	G	C	APOBEC3H	exonic	nonsynonymous SNV	ENSG00000100298	rs139299	ENSG00000100298:ENST00000348946:exon3:c.G363C:p.K121N,ENSG00000100298:ENST00000401756:exon3:c.G363C:p.K121N,ENSG00000100298:ENST00000421988:exon3:c.G363C:p.K121N,ENSG00000100298:ENST00000442487:exon3:c.G363C:p.K121N	APOBEC3H:NM_001166002:exon3:c.G363C:p.K121N,APOBEC3H:NM_001166003:exon3:c.G363C:p.K121N,APOBEC3H:NM_001166004:exon3:c.G363C:p.K121N,APOBEC3H:NM_181773:exon3:c.G363C:p.K121N	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4852	0.5763	0.529752	COCA-CN|4|321|0.0124611	2.209	17.57	0.014	1.26	0.023	.	.	APOBEC-like, N-terminal|Cytidine and deoxycytidylate deaminase domain|Cytidine deaminase-like	APOBEC3H:uc021wps.1:exon3:c.G363C:p.K121N,APOBEC3H:uc021wpt.1:exon3:c.G363C:p.K121N,APOBEC3H:uc021wpu.1:exon3:c.G363C:p.K121N,APOBEC3H:uc021wpv.1:exon3:c.G363C:p.K121N	-1.034	AFR:0.5722,AMR:0.8182,EAS:0.4966,FIN:0.3321,NFE:0.5531,OTH:0.4747,ASJ:0.3762	610976	.	.	.	.	.	.	.	0.154	-0.22	0.000	0.935	22	3(thyroid)	0.5213
22	39497509	39497509	A	G	APOBEC3H	splicing	.	ENSG00000100298	rs139300	ENSG00000100298:ENST00000348946:exon3:c.A418G:p.K140E,ENSG00000100298:ENST00000401756:exon3:c.A418G:p.K140E,ENSG00000100298:ENST00000421988:exon3:c.A418G:p.N140D,ENSG00000100298:ENST00000442487:exon3:c.A418G:p.K140E	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	1	.	1	COCA-CN|5|321|0.0155763	.	.	.	.	.	0	0.006	.	APOBEC3H:uc021wps.1:exon3:c.A418G:p.N140D,APOBEC3H:uc021wpt.1:exon3:c.A418G:p.K140E,APOBEC3H:uc021wpu.1:exon3:c.A418G:p.K140E,APOBEC3H:uc021wpv.1:exon3:c.A418G:p.K140E	.	AFR:0.9998,AMR:0.9998,EAS:1,FIN:1,NFE:1,OTH:0.9998,ASJ:1	610976	.	.	.	.	.	.	.	.	.	.	.	22	1(thyroid)	1
22	39498038	39498038	G	C	APOBEC3H	exonic	nonsynonymous SNV	ENSG00000100298	rs139302	ENSG00000100298:ENST00000348946:exon4:c.G534C:p.E178D,ENSG00000100298:ENST00000401756:exon4:c.G534C:p.E178D,ENSG00000100298:ENST00000442487:exon4:c.G534C:p.E178D	APOBEC3H:NM_001166002:exon4:c.G534C:p.E178D,APOBEC3H:NM_001166003:exon4:c.G534C:p.E178D,APOBEC3H:NM_181773:exon4:c.G534C:p.E178D	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4786	0.5709	0.515575	0.5635	-1.565	0.002	0.328	-6.12	0.000	.	.	APOBEC-like, N-terminal	APOBEC3H:uc021wpt.1:exon4:c.G534C:p.E178D,APOBEC3H:uc021wpu.1:exon4:c.G534C:p.E178D,APOBEC3H:uc021wpv.1:exon4:c.G534C:p.E178D	-1.012	AFR:0.7992,AMR:0.3389,EAS:0.3592,FIN:0.5505,NFE:0.4691,OTH:0.5184,ASJ:0.4934	610976	.	.	.	.	.	.	.	0.006	-0.08	0.000	0.59	22	MU155996	het
22	41537234	41537234	G	T	EP300	intronic	.	ENSG00000100393	rs6002267	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.9892	.	0.961661	0.9661	.	.	.	.	.	0	0	.	.	.	AFR:0.8811,AMR:0.9988,EAS:1,FIN:1,NFE:0.9998,OTH:0.9919,ASJ:1	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	22	MU82053044	hom
22	41551039	41551039	T	A	EP300	exonic	synonymous SNV	ENSG00000100393	rs20552	ENSG00000100393:ENST00000263253:exon17:c.T3183A:p.T1061T	EP300:NM_001362843:exon16:c.T3105A:p.T1035T,EP300:NM_001429:exon17:c.T3183A:p.T1061T	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.6572	0.5831	0.673922	0.5925	.	.	.	.	.	.	.	.	EP300:uc003azl.4:exon17:c.T3183A:p.T1061T	.	AFR:0.5116,AMR:0.8122,EAS:0.8058,FIN:0.6084,NFE:0.5985,OTH:0.6133,ASJ:0.6225	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	,3901	.	.	.	.	.	.	22	MU13931129	hom
22	41569609	41569609	C	T	EP300	intronic	.	ENSG00000232754	rs2076578	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3085	0.2582	0.264177	0.2586	.	.	.	.	.	.	.	.	.	.	AFR:0.0917,AMR:0.2320,EAS:0.4607,FIN:0.2785,NFE:0.3278,OTH:0.3131,ASJ:0.2351	602700	114500;613684;	353284;783;	353284|-|-|-|-|613684 ~783|Broad thumb-hallux syndrome<br>Broad thumbs-halluces syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Unknown|All ages|180849 610543 613684 ~	~ko04024 cAMP signaling pathway~ko04066 HIF-1 signaling pathway~ko04068 FoxO signaling pathway~ko04110 Cell cycle~ko04310 Wnt signaling pathway~ko04330 Notch signaling pathway~ko04350 TGF-beta signaling pathway~ko04520 Adherens junction~ko04630 JAK-STAT signaling pathway~ko04720 Long-term potentiation~ko04916 Melanogenesis~ko04919 Thyroid hormone signaling pathway~ko04922 Glucagon signaling pathway~ko05016 Huntington disease~ko05152 Tuberculosis~ko05161 Hepatitis B~ko05164 Influenza A~ko05165 Human papillomavirus infection~ko05166 Human T-cell leukemia virus 1 infection~ko05167 Kaposi sarcoma-associated herpesvirus infection~ko05200 Pathways in cancer~ko05203 Viral carcinogenesis~ko05206 MicroRNAs in cancer~ko05211 Renal cell carcinoma~ko05215 Prostate cancer ~	.	.	.	.	.	.	.	22	MU13931522	hom
22	41903813	41903813	A	C	ACO2	exonic	synonymous SNV	ENSG00000100412	rs137831	ENSG00000100412:ENST00000216254:exon3:c.A192C:p.T64T,ENSG00000100412:ENST00000396512:exon3:c.A192C:p.T64T	ACO2:NM_001098:exon3:c.A192C:p.T64T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3211	0.2580	0.418331	0.2820	.	.	.	.	.	.	.	.	ACO2:uc003bac.3:exon3:c.A192C:p.T64T	.	AFR:0.3553,AMR:0.5800,EAS:0.5795,FIN:0.2552,NFE:0.1987,OTH:0.2520,ASJ:0.2947	100850	614559;616289;	313850;	313850|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614559 ~	.	.	.	.	.	.	.	.	22	MU24294420	het
22	41914593	41914593	C	T	ACO2	intronic	.	ENSG00000100412	rs203319	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3371	0.3239	0.484425	0.3372	.	.	.	.	.	.	.	.	.	.	AFR:0.5479,AMR:0.5931,EAS:0.5769,FIN:0.2543,NFE:0.1991,OTH:0.2643,ASJ:0.31	100850	614559;616289;	313850;	313850|-|<1 / 1 000 000|Autosomal recessive|Infancy<br>Neonatal|614559 ~	.	.	.	.	.	.	.	.	22	MU14588993	hom
22	42042882	42042882	C	A	XRCC6	intronic	.	ENSG00000196419	rs572128806	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0001	.	0.000998403	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	152690	.	.	.	.	.	.	.	.	.	.	.	22	.	unknown
22	42042890	42042890	A	-	XRCC6	intronic	.	ENSG00000196419	rs538130878	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	0.0001	.	0.000998403	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	152690	.	.	.	.	.	.	.	.	.	.	.	22	.	unknown
22	50657010	50657010	C	G	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs4838864	ENSG00000128159:ENST00000425018:exon7:c.G919C:p.V307L,ENSG00000128159:ENST00000248846:exon22:c.G4861C:p.V1621L	TUBGCP6:NM_020461:exon22:c.G4861C:p.V1621L	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 2, -1, 0, 0] 	0.9956	0.9947	0.998802	0.9955	1.233	11.92	1.0	1.61	0.999	.	.	.	TUBGCP6:uc003bka.1:exon7:c.G2122C:p.V708L,TUBGCP6:uc003bkb.1:exon22:c.G4861C:p.V1621L,TUBGCP6:uc010har.1:exon22:c.G4837C:p.V1613L	-1.016	AFR:0.9985,AMR:0.9976,EAS:1,FIN:0.9994,NFE:0.9922,OTH:0.9949,ASJ:1	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.003	3.43	0.000	-2.67	22	MU82055240	hom
22	50658053	50658053	A	G	TUBGCP6	intronic	.	ENSG00000128159	rs6537642	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9660	0.9595	0.982428	0.9677	.	.	.	.	.	.	.	.	.	.	AFR:0.9885,AMR:0.9665,EAS:1,FIN:0.9891,NFE:0.9481,OTH:0.9663,ASJ:0.9272	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	.	.	.	22	MU82055281	hom
22	50658424	50658424	T	C	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs11703226	ENSG00000128159:ENST00000425018:exon2:c.A187G:p.T63A,ENSG00000128159:ENST00000248846:exon17:c.A4129G:p.T1377A	TUBGCP6:NM_020461:exon17:c.A4129G:p.T1377A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.4319	0.4577	0.427117	1(haematopoietic_and_lymphoid_tissue)	-1.682	0.002	0.787	-1.43	0.000	.	.	.	TUBGCP6:uc003bka.1:exon2:c.A1390G:p.T464A,TUBGCP6:uc003bkb.1:exon17:c.A4129G:p.T1377A,TUBGCP6:uc010har.1:exon17:c.A4105G:p.T1369A	-0.921	AFR:MU4553506,AMR:LAML-KR|1|205|0.00487805,COCA-CN|3|321|0.00934579,EAS:0.4854,FIN:0.4010,NFE:0.4272,OTH:0.4042,ASJ:0.4489	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.005	3.14	0.000	0.83	22	1(thyroid)	0.4332
22	50664612	50664612	A	G	TUBGCP6	exonic	nonsynonymous SNV	ENSG00000128159	rs4838865	ENSG00000128159:ENST00000248846:exon9:c.T1700C:p.L567S,ENSG00000128159:ENST00000439308:exon9:c.T1700C:p.L567S	TUBGCP6:NM_020461:exon9:c.T1700C:p.L567S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7912	0.8244	0.858826	0.8162	-1.386	0.003	0.692	-5.69	0.055	.	.	.	TUBGCP6:uc003bkb.1:exon9:c.T1700C:p.L567S,TUBGCP6:uc010har.1:exon9:c.T1700C:p.L567S	-1.069	AFR:0.9504,AMR:0.6563,EAS:0.8241,FIN:0.7956,NFE:0.7544,OTH:0.7888,ASJ:0.7318	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	0.005	3.31	0.000	-0.51	22	MU67370157	hom
22	50682865	50682865	G	A	TUBGCP6	exonic	synonymous SNV	ENSG00000128159	rs5771270	ENSG00000128159:ENST00000248846:exon1:c.C24T:p.F8F,ENSG00000128159:ENST00000439308:exon1:c.C24T:p.F8F	TUBGCP6:NM_020461:exon1:c.C24T:p.F8F	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3600	0.3046	0.28155	0.3137	.	.	.	.	.	.	.	.	TUBGCP6:uc003bkb.1:exon1:c.C24T:p.F8F,TUBGCP6:uc010har.1:exon1:c.C24T:p.F8F,TUBGCP6:uc010hau.1:exon1:c.C24T:p.F8F	.	AFR:0.1362,AMR:0.2560,EAS:0.3710,FIN:0.3747,NFE:0.3943,OTH:0.3717,ASJ:0.3974	610053	251270;	2518;	2518|Pseudotoxoplasmosis syndrome|-|Autosomal recessive|-|251270 616335 ~	.	.	.	.	.	.	.	.	22	MU670488	hom
22	50964236	50964236	G	A	TYMP	exonic	nonsynonymous SNV	ENSG00000025708	rs11479	ENSG00000025708:ENST00000425169:exon9:c.C1313T:p.S438L,ENSG00000025708:ENST00000252029:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395678:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395680:exon10:c.C1412T:p.S471L,ENSG00000025708:ENST00000395681:exon10:c.C1427T:p.S476L	TYMP:NM_001113756:exon9:c.C1412T:p.S471L,TYMP:NM_001113755:exon10:c.C1412T:p.S471L,TYMP:NM_001257988:exon10:c.C1412T:p.S471L,TYMP:NM_001257989:exon10:c.C1427T:p.S476L,TYMP:NM_001953:exon10:c.C1412T:p.S471L	clinvar: Benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.1393	0.0684	0.142772	MU26811700	4.372	24.1	0.398	2.19	0.047	.	.	Pyrimidine nucleoside phosphorylase, C-terminal	TYMP:uc003bmb.5:exon9:c.C1412T:p.S471L,TYMP:uc003bmc.5:exon10:c.C1412T:p.S471L,TYMP:uc003bmd.5:exon10:c.C1412T:p.S471L,TYMP:uc003bme.5:exon10:c.C1427T:p.S476L,TYMP:uc010hbd.4:exon10:c.C1412T:p.S471L	-0.663	AFR:LAML-KR|1|205|0.00487805,THCA-CN|1|50|0.02,AMR:0.0932,EAS:0.1918,FIN:0.0927,NFE:0.2414,OTH:0.0967,ASJ:0.0498	131222	603041;	298;	298|MNGIE|1-9 / 1 000 000|Autosomal recessive|Adolescent<br>Childhood<br>Adult|603041 612075 613662 ~	.	.	.	.	0.986	-1.57	0.000	1.725	22	2(thyroid)	0.0946
X	1317404	1317404	T	C	CRLF2	intronic	.	ENSG00000205755	rs9778721	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.4778	0.5515	0.507788	MU13539217	.	.	.	.	.	.	.	.	.	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|1|170|0.00588235,AMR:0.5134,EAS:0.4038,FIN:0.5795,NFE:0.3682,OTH:0.3971,ASJ:0.6345	400023	.	.	.	.	.	.	.	.	.	.	.	X	12(soft_tissue)	0.4930
X	19364644	19364644	C	T	PDHA1	exonic	nonsynonymous SNV	ENSG00000131828	rs7883320	ENSG00000131828:ENST00000379806:exon2:c.C74T:p.T25M,ENSG00000131828:ENST00000423505:exon2:c.C74T:p.T25M	PDHA1:NM_001173454:exon2:c.C74T:p.T25M	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, 0, 1, -1, 1, 0] 	0.1375	.	0.247947	0.2065	-0.327	0.577	0.336	-0.854	0.001	.	.	.	PDHA1:uc004czh.4:exon2:c.C74T:p.T25M	-0.933	AFR:0.6692,AMR:0.0891,EAS:0.0068,FIN:0.0292,NFE:0.0324,OTH:0.0834,ASJ:0.1444	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	0.0	-4.72	0.000	.	X	.	het
X	19373789	19373789	C	A	PDHA1	intronic	.	ENSG00000131828	rs7058209	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1155	0.2614	0.247947	0.2065	.	.	.	.	.	.	.	.	.	.	AFR:0.6648,AMR:0.0884,EAS:0.0068,FIN:0.0293,NFE:0.0323,OTH:0.0764,ASJ:0.1568	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	.	.	.	.	X	.	het
X	19373839	19373839	A	G	PDHA1	exonic	synonymous SNV	ENSG00000131828	rs1126565	ENSG00000131828:ENST00000540249:exon7:c.A702G:p.A234A,ENSG00000131828:ENST00000422285:exon8:c.A795G:p.A265A,ENSG00000131828:ENST00000545074:exon8:c.A816G:p.A272A,ENSG00000131828:ENST00000379806:exon9:c.A909G:p.A303A	PDHA1:NM_001173456:exon7:c.A702G:p.A234A,PDHA1:NM_000284:exon8:c.A795G:p.A265A,PDHA1:NM_001173455:exon8:c.A816G:p.A272A,PDHA1:NM_001173454:exon9:c.A909G:p.A303A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.1339	0.3246	0.304636	0.2591	.	.	.	.	.	.	.	.	PDHA1:uc010nfl.3:exon2:c.A168G:p.A56A,PDHA1:uc011mjd.2:exon7:c.A702G:p.A234A,PDHA1:uc004czg.4:exon8:c.A795G:p.A265A,PDHA1:uc011mjc.2:exon8:c.A816G:p.A272A,PDHA1:uc004czh.4:exon9:c.A909G:p.A303A	.	AFR:0.8521,AMR:0.1077,EAS:0.0067,FIN:0.0292,NFE:0.0330,OTH:0.0882,ASJ:0.1444	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	.	.	.	.	X	.	het
X	19375782	19375782	A	C	PDHA1	exonic	nonsynonymous SNV	ENSG00000131828	rs2229137	ENSG00000131828:ENST00000379804:exon2:c.A1C:p.M1L,ENSG00000131828:ENST00000540249:exon8:c.A751C:p.M251L,ENSG00000131828:ENST00000422285:exon9:c.A844C:p.M282L,ENSG00000131828:ENST00000545074:exon9:c.A865C:p.M289L,ENSG00000131828:ENST00000379806:exon10:c.A958C:p.M320L	PDHA1:NM_001173456:exon8:c.A751C:p.M251L,PDHA1:NM_000284:exon9:c.A844C:p.M282L,PDHA1:NM_001173455:exon9:c.A865C:p.M289L,PDHA1:NM_001173454:exon10:c.A958C:p.M320L	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 0] 	0.0207	0.0011	0.0495364	2(lung)	1.754	14.71	0.744	5.53	0.999	.	.	Dehydrogenase, E1 component;Dehydrogenase, E1 component|Thiamin diphosphate-binding fold	PDHA1:uc010nfl.3:exon3:c.A217C:p.M73L,PDHA1:uc011mjd.2:exon8:c.A751C:p.M251L,PDHA1:uc004czg.4:exon9:c.A844C:p.M282L,PDHA1:uc011mjc.2:exon9:c.A865C:p.M289L,PDHA1:uc004czh.4:exon10:c.A958C:p.M320L	-0.618	AFR:MU778318,AMR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|2|321|0.00623053,EAS:0.0012,FIN:0.0016,NFE:0.0053,OTH:0.2839,ASJ:0.0155	300502	312170;	765;79243;	765|PDH<br>PDHC<br>Pyruvate dehydrogenase complex deficiency|<1 / 1 000 000|Autosomal recessive<br>or&nbsp;X-linked dominant<br>or&nbsp;Not applicable|Childhood<br>Infancy<br>Neonatal|245348 245349 246900 312170 608782 614111 ~79243|PDHAD<br>Pyruvate decarboxylase deficiency<br>Pyruvate dehydrogenase complex E1 component subunit alpha deficiency|Unknown|X-linked dominant|Infancy<br>Neonatal|312170 ~	~ko00010 Glycolysis / Gluconeogenesis~ko00020 Citrate cycle (TCA cycle)~ko00620 Pyruvate metabolism~ko01100 Metabolic pathways~ko01110 Biosynthesis of secondary metabolites~ko01120 Microbial metabolism in diverse environments~ko01130 Biosynthesis of antibiotics~ko01200 Carbon metabolism~ko04066 HIF-1 signaling pathway~ko04922 Glucagon signaling pathway~ko05230 Central carbon metabolism in cancer~~M00307 Pyruvate oxidation, pyruvate => acetyl-CoA ~	.	.	.	0.001	-3.92	0.011	-1.045	X	2(haematopoietic_and_lymphoid_tissue)	0.0072
X	21488933	21488933	T	C	CNKSR2	intronic	.	ENSG00000149970	.	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	0.0001	0.002	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300724	.	.	.	.	.	.	.	.	.	.	.	X	.	hom
X	30327367	30327367	G	A	NR0B1	exonic	synonymous SNV	ENSG00000169297	rs6150	ENSG00000169297:ENST00000378970:exon1:c.C114T:p.C38C,ENSG00000169297:ENST00000453287:exon1:c.C114T:p.C38C	NR0B1:NM_000475:exon1:c.C114T:p.C38C	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1638	0.1425	0.0956291	0.1562	.	.	.	.	.	.	.	.	NR0B1:uc004dcf.4:exon1:c.C114T:p.C38C	.	AFR:0.0408,AMR:0.0656,EAS:0.1307,FIN:0.2637,NFE:0.2005,OTH:0.1761,ASJ:0.2162	300473	300018;300200;	95702;242;	95702|X-linked congenital adrenal hypoplasia|-|X-linked recessive|-|202155 300200 ~242|46,XY CGD<br>46,XY pure gonadal dysgenesis<br>Swyer syndrome|Unknown|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;Y-linked<br>or&nbsp;X-linked recessive|Adolescent<br>Adult|154230 233420 300018 400044 612965 613080 613762 616425 ~	.	.	.	.	.	.	.	.	X	MU2246332	het
X	31213723	31213723	C	T	DMD	intronic	.	ENSG00000198947	rs5972332	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.94649	0.9636	.	.	.	.	.	.	.	.	.	.	AFR:0.9022,AMR:0.9900,EAS:0.9700,FIN:0.9954,NFE:0.9868,OTH:0.9747,ASJ:0.9622	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	.	hom
X	31224684	31224684	A	G	DMD	intronic	.	ENSG00000198947	rs2293668	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.8836	0.8265	0.803974	LICA-CN|2|402|0.00497512,LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.8406,AMR:0.7370,EAS:0.8723,FIN:0.7939,NFE:0.8858,OTH:0.8864,ASJ:0.9152	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	1(haematopoietic_and_lymphoid_tissue)	0.8396
X	31496350	31496350	C	T	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs1800280	ENSG00000198947:ENST00000358062:exon12:c.G1898A:p.R633Q,ENSG00000198947:ENST00000343523:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000359836:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000378707:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000474231:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000541735:exon16:c.G1430A:p.R477Q,ENSG00000198947:ENST00000357033:exon59:c.G8810A:p.R2937Q,ENSG00000198947:ENST00000378677:exon59:c.G8798A:p.R2933Q	DMD:NM_004014:exon5:c.G623A:p.R208Q,DMD:NM_004013:exon16:c.G1430A:p.R477Q,DMD:NM_004020:exon16:c.G1430A:p.R477Q,DMD:NM_004021:exon16:c.G1430A:p.R477Q,DMD:NM_004022:exon16:c.G1430A:p.R477Q,DMD:NM_004023:exon16:c.G1430A:p.R477Q,DMD:NM_004011:exon31:c.G4787A:p.R1596Q,DMD:NM_004012:exon31:c.G4778A:p.R1593Q,DMD:NM_000109:exon59:c.G8786A:p.R2929Q,DMD:NM_004006:exon59:c.G8810A:p.R2937Q,DMD:NM_004009:exon59:c.G8798A:p.R2933Q,DMD:NM_004010:exon59:c.G8441A:p.R2814Q	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.9045	0.9568	0.881854	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	2.138	17.10	0.624	4.23	0.995	.	.	.	DMD:uc004dcq.1:exon5:c.G623A:p.R208Q,DMD:uc004dcr.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcs.1:exon16:c.G1430A:p.R477Q,DMD:uc004dct.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcu.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcv.1:exon16:c.G1430A:p.R477Q,DMD:uc004dcw.2:exon31:c.G4778A:p.R1593Q,DMD:uc004dcx.2:exon31:c.G4787A:p.R1596Q,DMD:uc004dcy.1:exon59:c.G8798A:p.R2933Q,DMD:uc004dcz.2:exon59:c.G8441A:p.R2814Q,DMD:uc004dda.1:exon59:c.G8810A:p.R2937Q,DMD:uc004ddb.1:exon59:c.G8786A:p.R2929Q	-0.945	AFR:0.9524,AMR:0.9879,EAS:0.9565,FIN:0.9268,NFE:0.9410,OTH:0.9457,ASJ:0.8336	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.0	1.01	0.000	.	X	1(lung)	0.9392
X	31496426	31496426	T	C	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs1800278	ENSG00000198947:ENST00000358062:exon12:c.A1822G:p.N608D,ENSG00000198947:ENST00000343523:exon16:c.A1354G:p.N452D,ENSG00000198947:ENST00000359836:exon16:c.A1354G:p.N452D,ENSG00000198947:ENST00000378707:exon16:c.A1354G:p.N452D,ENSG00000198947:ENST00000474231:exon16:c.A1354G:p.N452D,ENSG00000198947:ENST00000541735:exon16:c.A1354G:p.N452D,ENSG00000198947:ENST00000357033:exon59:c.A8734G:p.N2912D,ENSG00000198947:ENST00000378677:exon59:c.A8722G:p.N2908D	DMD:NM_004014:exon5:c.A547G:p.N183D,DMD:NM_004013:exon16:c.A1354G:p.N452D,DMD:NM_004020:exon16:c.A1354G:p.N452D,DMD:NM_004021:exon16:c.A1354G:p.N452D,DMD:NM_004022:exon16:c.A1354G:p.N452D,DMD:NM_004023:exon16:c.A1354G:p.N452D,DMD:NM_004011:exon31:c.A4711G:p.N1571D,DMD:NM_004012:exon31:c.A4702G:p.N1568D,DMD:NM_000109:exon59:c.A8710G:p.N2904D,DMD:NM_004006:exon59:c.A8734G:p.N2912D,DMD:NM_004009:exon59:c.A8722G:p.N2908D,DMD:NM_004010:exon59:c.A8365G:p.N2789D	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 1, 2, -1, 0, 0] 	0.0222	0.0315	0.0370861	0.0299	1.799	14.98	0.167	1.66	1.000	.	.	.	DMD:uc004dcq.1:exon5:c.A547G:p.N183D,DMD:uc004dcr.1:exon16:c.A1354G:p.N452D,DMD:uc004dcs.1:exon16:c.A1354G:p.N452D,DMD:uc004dct.1:exon16:c.A1354G:p.N452D,DMD:uc004dcu.1:exon16:c.A1354G:p.N452D,DMD:uc004dcv.1:exon16:c.A1354G:p.N452D,DMD:uc004dcw.2:exon31:c.A4702G:p.N1568D,DMD:uc004dcx.2:exon31:c.A4711G:p.N1571D,DMD:uc004dcy.1:exon59:c.A8722G:p.N2908D,DMD:uc004dcz.2:exon59:c.A8365G:p.N2789D,DMD:uc004dda.1:exon59:c.A8734G:p.N2912D,DMD:uc004ddb.1:exon59:c.A8710G:p.N2904D	-1.038	AFR:0.0683,AMR:0.0178,EAS:0.0545,FIN:0.0148,NFE:0.0117,OTH:0.0139,ASJ:0.0317	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.281	1.25	0.004	0	X	MU30228218	unknown
X	31496431	31496431	T	A	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs41305353	ENSG00000198947:ENST00000358062:exon12:c.A1817T:p.E606V,ENSG00000198947:ENST00000343523:exon16:c.A1349T:p.E450V,ENSG00000198947:ENST00000359836:exon16:c.A1349T:p.E450V,ENSG00000198947:ENST00000378707:exon16:c.A1349T:p.E450V,ENSG00000198947:ENST00000474231:exon16:c.A1349T:p.E450V,ENSG00000198947:ENST00000541735:exon16:c.A1349T:p.E450V,ENSG00000198947:ENST00000357033:exon59:c.A8729T:p.E2910V,ENSG00000198947:ENST00000378677:exon59:c.A8717T:p.E2906V	DMD:NM_004014:exon5:c.A542T:p.E181V,DMD:NM_004013:exon16:c.A1349T:p.E450V,DMD:NM_004020:exon16:c.A1349T:p.E450V,DMD:NM_004021:exon16:c.A1349T:p.E450V,DMD:NM_004022:exon16:c.A1349T:p.E450V,DMD:NM_004023:exon16:c.A1349T:p.E450V,DMD:NM_004011:exon31:c.A4706T:p.E1569V,DMD:NM_004012:exon31:c.A4697T:p.E1566V,DMD:NM_000109:exon59:c.A8705T:p.E2902V,DMD:NM_004006:exon59:c.A8729T:p.E2910V,DMD:NM_004009:exon59:c.A8717T:p.E2906V,DMD:NM_004010:exon59:c.A8360T:p.E2787V	clinvar: Conflicting_interpretations_of_pathogenicity 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, 1, 2, -1, 0, 0] 	0.0219	0.0303	0.0357616	0.0288	5.718	26.9	0.004	5.4	1.000	.	.	.	DMD:uc004dcq.1:exon5:c.A542T:p.E181V,DMD:uc004dcr.1:exon16:c.A1349T:p.E450V,DMD:uc004dcs.1:exon16:c.A1349T:p.E450V,DMD:uc004dct.1:exon16:c.A1349T:p.E450V,DMD:uc004dcu.1:exon16:c.A1349T:p.E450V,DMD:uc004dcv.1:exon16:c.A1349T:p.E450V,DMD:uc004dcw.2:exon31:c.A4697T:p.E1566V,DMD:uc004dcx.2:exon31:c.A4706T:p.E1569V,DMD:uc004dcy.1:exon59:c.A8717T:p.E2906V,DMD:uc004dcz.2:exon59:c.A8360T:p.E2787V,DMD:uc004dda.1:exon59:c.A8729T:p.E2910V,DMD:uc004ddb.1:exon59:c.A8705T:p.E2902V	-1.040	AFR:0.0644,AMR:0.0179,EAS:0.0520,FIN:0.0148,NFE:0.0119,OTH:0.0126,ASJ:0.0319	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.119	1.18	0.008	0.88	X	MU30228234	unknown
X	31676096	31676096	G	A	DMD	intronic	.	ENSG00000198947	rs2270672	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3398	0.3389	0.328477	0.3560	.	.	.	.	.	.	.	.	.	.	AFR:0.3183,AMR:0.2039,EAS:0.3036,FIN:0.4195,NFE:0.3714,OTH:0.4003,ASJ:0.3770	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	MU14600441	het
X	32380996	32380996	C	T	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs1801187	ENSG00000198947:ENST00000357033:exon37:c.G5234A:p.R1745H,ENSG00000198947:ENST00000378677:exon37:c.G5222A:p.R1741H	DMD:NM_004011:exon9:c.G1211A:p.R404H,DMD:NM_004012:exon9:c.G1202A:p.R401H,DMD:NM_000109:exon37:c.G5210A:p.R1737H,DMD:NM_004006:exon37:c.G5234A:p.R1745H,DMD:NM_004009:exon37:c.G5222A:p.R1741H,DMD:NM_004010:exon37:c.G4865A:p.R1622H	clinvar: Benign/Likely_benign 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, 1, 0, 0] 	0.5142	0.3331	0.465166	LUSC-KR|1|170|0.00588235,COCA-CN|5|321|0.0155763	6.788	32	0.006	5.24	0.940	.	.	.	DMD:uc004dcw.2:exon9:c.G1202A:p.R401H,DMD:uc004dcx.2:exon9:c.G1211A:p.R404H,DMD:uc004dcy.1:exon37:c.G5222A:p.R1741H,DMD:uc004dcz.2:exon37:c.G4865A:p.R1622H,DMD:uc004dda.1:exon37:c.G5234A:p.R1745H,DMD:uc004ddb.1:exon37:c.G5210A:p.R1737H	-0.904	AFR:0.3913,AMR:0.0789,EAS:0.4293,FIN:0.7234,NFE:0.5224,OTH:0.4730,ASJ:0.6987	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.999	0.74	0.000	2.64	X	1(lung)	0.5245
X	32503194	32503194	T	C	DMD	exonic	nonsynonymous SNV	ENSG00000198947	rs228406	ENSG00000198947:ENST00000357033:exon21:c.A2645G:p.D882G,ENSG00000198947:ENST00000378677:exon21:c.A2633G:p.D878G	DMD:NM_000109:exon21:c.A2621G:p.D874G,DMD:NM_004006:exon21:c.A2645G:p.D882G,DMD:NM_004009:exon21:c.A2633G:p.D878G,DMD:NM_004010:exon21:c.A2276G:p.D759G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.7211	0.6502	0.748344	0.6958	0.631	8.366	0.523	3.07	0.978	.	.	.	DMD:uc004dcy.1:exon21:c.A2633G:p.D878G,DMD:uc004dcz.2:exon21:c.A2276G:p.D759G,DMD:uc004dda.1:exon21:c.A2645G:p.D882G,DMD:uc004ddb.1:exon21:c.A2621G:p.D874G	-0.978	AFR:0.6291,AMR:0.8068,EAS:0.8869,FIN:0.8215,NFE:0.6750,OTH:0.7336,ASJ:0.6243	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	0.0	0.73	0.000	0	X	MU4584954	het
X	32563263	32563263	A	G	DMD	intronic	.	ENSG00000198947	rs228373	.	.	clinvar: Benign/Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3203	0.3247	0.412185	LUSC-KR|6|170|0.0352941,COCA-CN|3|321|0.00934579,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.3193,AMR:0.4698,EAS:0.2742,FIN:0.5252,NFE:0.2816,OTH:0.2242,ASJ:0.4092	300377	300376;302045;310200;	98896;154;98895;	98896|DMD<br>Severe dystrophinopathy, Duchenne type|1-9 / 100 000|X-linked recessive|Childhood|310200 ~154|Familial or idiopathic dilated cardiomyopathy|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive<br>or&nbsp;Mitochondrial inheritance|All ages|302045 600884 601154 601493 601494 604145 604288 604765 605582 606685 607482 608569 609909 609915 611407 611615 611878 611879 611880 612158 612877 613122 613172 613252 613286 613424 613426 613642 613694 613697 613740 613881 614672 615184 615235 615248 615373 615396 615916 ~98895|BMD<br>Becker dystrophinopathy|1-9 / 100 000|X-linked recessive|Childhood|159050 300376 ~	.	.	.	.	.	.	.	.	X	1(breast)	0.2640
X	39932907	39932907	T	C	BCOR	exonic	synonymous SNV	ENSG00000183337	rs6520618	ENSG00000183337:ENST00000342274:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000378444:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000378455:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000397354:exon4:c.A1692G:p.A564A,ENSG00000183337:ENST00000406200:exon4:c.A1692G:p.A564A	BCOR:NM_001123383:exon4:c.A1692G:p.A564A,BCOR:NM_001123384:exon4:c.A1692G:p.A564A,BCOR:NM_001123385:exon4:c.A1692G:p.A564A,BCOR:NM_017745:exon4:c.A1692G:p.A564A	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.2671	0.3615	0.523974	MU14602427	.	.	.	.	.	.	.	.	BCOR:uc004dem.4:exon4:c.A1692G:p.A564A,BCOR:uc004den.4:exon4:c.A1692G:p.A564A,BCOR:uc004deo.4:exon4:c.A1692G:p.A564A,BCOR:uc004dep.4:exon4:c.A1692G:p.A564A,BCOR:uc004deq.4:exon4:c.A1692G:p.A564A	.	AFR:LICA-CN|1|402|0.00248756,LAML-KR|1|205|0.00487805,COCA-CN|5|321|0.0155763,AMR:0.3308,EAS:0.1980,FIN:0.1323,NFE:0.7143,OTH:0.1283,ASJ:0.8037	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	,969,972	.	,971,970	.	.	.	.	X	8(soft_tissue)	0.0976
X	39933339	39933339	A	G	BCOR	exonic	synonymous SNV	ENSG00000183337	rs5917933	ENSG00000183337:ENST00000342274:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000378444:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000378455:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000397354:exon4:c.T1260C:p.D420D,ENSG00000183337:ENST00000406200:exon4:c.T1260C:p.D420D	BCOR:NM_001123383:exon4:c.T1260C:p.D420D,BCOR:NM_001123384:exon4:c.T1260C:p.D420D,BCOR:NM_001123385:exon4:c.T1260C:p.D420D,BCOR:NM_017745:exon4:c.T1260C:p.D420D	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[1, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.8952	0.8957	0.903046	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	BCOR:uc004dem.4:exon4:c.T1260C:p.D420D,BCOR:uc004den.4:exon4:c.T1260C:p.D420D,BCOR:uc004deo.4:exon4:c.T1260C:p.D420D,BCOR:uc004dep.4:exon4:c.T1260C:p.D420D,BCOR:uc004deq.4:exon4:c.T1260C:p.D420D	.	AFR:0.9153,AMR:0.9232,EAS:0.8771,FIN:0.9756,NFE:0.9487,OTH:0.8959,ASJ:0.9469	300485	300166;	2712;568;	2712|Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome<br>OFCD syndrome|Unknown|X-linked dominant|Infancy<br>Neonatal|300166 ~568|Lenz microphthalmia|Unknown|X-linked recessive|Neonatal|300166 309800 ~	.	,969,972	.	,971,970	.	.	.	.	X	1(thyroid)	0.9042
X	44929077	44929077	C	A	KDM6A	exonic	nonsynonymous SNV	ENSG00000147050	rs2230018	ENSG00000147050:ENST00000543216:exon15:c.C1940A:p.T647K,ENSG00000147050:ENST00000536777:exon16:c.C2042A:p.T681K,ENSG00000147050:ENST00000377967:exon17:c.C2177A:p.T726K,ENSG00000147050:ENST00000382899:exon17:c.C2198A:p.T733K	KDM6A:NM_001291418:exon15:c.C1940A:p.T647K,KDM6A:NM_001291421:exon15:c.C1289A:p.T430K,KDM6A:NM_001291417:exon16:c.C2042A:p.T681K,KDM6A:NM_001291416:exon17:c.C2198A:p.T733K,KDM6A:NM_021140:exon17:c.C2177A:p.T726K,KDM6A:NM_001291415:exon18:c.C2333A:p.T778K	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, -1, 2, -1, 1, 1] 	0.1376	0.0928	0.155497	4(lung)	1.424	12.91	0.056	-2.48	0.912	.	.	.	KDM6A:uc011mld.2:exon6:c.C1094A:p.T365K,KDM6A:uc022bvi.1:exon14:c.C1187A:p.T396K,KDM6A:uc011mlc.2:exon15:c.C1289A:p.T430K,KDM6A:uc022bvj.1:exon15:c.C1940A:p.T647K,KDM6A:uc010nhk.2:exon16:c.C2075A:p.T692K,KDM6A:uc011mla.2:exon16:c.C2042A:p.T681K,KDM6A:uc004dge.4:exon17:c.C2177A:p.T726K,KDM6A:uc011mlb.2:exon17:c.C2198A:p.T733K,KDM6A:uc011mkz.2:exon18:c.C2333A:p.T778K	-1.010	AFR:3(soft_tissue),AMR:1(stomach),EAS:MU111211,FIN:LAML-KR|2|205|0.0097561,LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526,NFE:0.1177,OTH:0.0424,ASJ:1(large_intestine)	300128	300867;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	~ko05202 Transcriptional misregulation in cancer ~	,6286	.	.	0.0	0.89	0.000	0.345	X	29(meninges)	0.0532
X	44935925	44935926	TT	-	KDM6A	intronic	.	ENSG00000147050	rs571223110	.	.	clinvar: Likely_benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 1, 0] 	0.3341	.	0.276556	0.1431	.	.	.	.	.	.	.	.	.	.	AFR:0.0783,AMR:0.0777,EAS:0.3571,FIN:0.2504,NFE:0.1469,OTH:0.1845,ASJ:0.1935	300128	300867;	2322;	2322|Kabuki make-up syndrome<br>Niikawa-Kuroki syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Not applicable|Infancy<br>Neonatal|147920 300867 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	X	.	hom
X	47030498	47030498	C	T	RBM10	exonic	synonymous SNV	ENSG00000182872	rs782211187	ENSG00000182872:ENST00000377604:exon4:c.C273T:p.T91T	RBM10:NM_001204467:exon4:c.C273T:p.T91T,RBM10:NM_001204468:exon4:c.C468T:p.T156T,RBM10:NM_005676:exon4:c.C273T:p.T91T	clinvar: UNK 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, 0, 1, 0] 	1.307e-05	.	.	.	.	.	.	.	.	.	.	.	RBM10:uc004dhf.3:exon4:c.C273T:p.T91T,RBM10:uc004dhh.3:exon4:c.C273T:p.T91T,RBM10:uc004dhi.3:exon4:c.C468T:p.T156T	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300080	311900;	2886;	2886|Pierre Robin sequence-congenital heart defect-talipes syndrome<br>Pierre Robin syndrome-congenital heart defect-talipes syndrome<br>Talipes equinovarus-atrial septal defect-Robin sequence-persistence of the left superior vena cava syndrome|-|-|-|311900 ~	.	.	.	.	.	.	.	.	X	MU1944403	het
X	48125798	48125798	T	C	SSX1	exonic	synonymous SNV	ENSG00000126752	rs5952493	ENSG00000126752:ENST00000376919:exon7:c.T543C:p.S181S	SSX1:NM_005635:exon7:c.T543C:p.S181S,SSX1:NM_001278691:exon8:c.T543C:p.S181S	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.5025	0.4724	0.486093	0.4912	.	.	.	.	.	.	.	.	SSX1:uc004djb.1:exon7:c.T543C:p.S181S	.	AFR:0.4634,AMR:0.5637,EAS:0.6101,FIN:0.5306,NFE:0.4816,OTH:0.4979,ASJ:0.4420	312820	300813;	3273;	3273|Synovialosarcoma|Unknown|Not applicable|All ages|300813 ~	~ko05202 Transcriptional misregulation in cancer ~	.	.	.	.	.	.	.	X	MU729878	hom
X	48676839	48676839	G	A	HDAC6	intronic	.	ENSG00000094631	rs2075837	.	.	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.2293	0.2438	0.244238	0.2349	.	.	.	.	.	.	.	.	.	.	AFR:0.3379,AMR:0.1403,EAS:0.1663,FIN:0.2245,NFE:0.1964,OTH:0.1807,ASJ:0.1913	300272	300863;	163966;	163966|X-linked dominant chondrodysplasia-hydrocephaly-microphthalmia syndrome|<1 / 1 000 000|X-linked dominant|Infancy<br>Neonatal|300863 ~	~ko05034 Alcoholism~ko05203 Viral carcinogenesis ~	.	.	.	.	.	.	.	X	MU778028	het
X	48888074	48888074	T	C	TFE3	exonic	synonymous SNV	ENSG00000068323	rs3027472	ENSG00000068323:ENST00000315869:exon10:c.A1323G:p.V441V	TFE3:NM_001282142:exon10:c.A1008G:p.V336V,TFE3:NM_006521:exon10:c.A1323G:p.V441V	clinvar: UNK 	 CancerVar: 3#Tier_III_Uncertain EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0] 	0.3921	0.3650	0.231258	LUSC-KR|4|170|0.0235294,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	TFE3:uc004dmb.3:exon10:c.A1323G:p.V441V,TFE3:uc004dmc.3:exon10:c.A1008G:p.V336V	.	AFR:0.3553,AMR:0.0703,EAS:0.5824,FIN:0.0832,NFE:0.4753,OTH:0.5083,ASJ:0.3203	314310	300854;	319308;	319308|Carcinoma associated with MITF/TFE translocation<br>Translocation carcinoma|-|-|-|300854 ~	~ko04137 Mitophagy - animal~ko05202 Transcriptional misregulation in cancer~ko05211 Renal cell carcinoma ~	.	.	.	.	.	.	.	X	1(breast)	0.4226
X	53228148	53228148	C	A	KDM5C	intronic	.	ENSG00000126012	rs1977364	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.8920	0.7829	0.730331	0.8161	.	.	.	.	.	.	.	.	.	.	AFR:0.4295,AMR:0.8821,EAS:0.7619,FIN:0.9883,NFE:0.9786,OTH:0.9393,ASJ:0.9227	314690	300534;	85279;	85279|-|<1 / 1 000 000|X-linked recessive|Childhood|300534 ~	.	.	.	.	.	.	.	.	X	MU14608707	hom
X	53449568	53449568	G	A	SMC1A	UTR5	.	ENSG00000072501	rs1264011	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.5163	0.4060	0.398411	LICA-CN|2|402|0.00497512,LUSC-KR|5|170|0.0294118,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	.	.	AFR:0.4571,AMR:0.0840,EAS:0.5430,FIN:0.5238,NFE:0.6082,OTH:0.6118,ASJ:0.5494	300040	300590;	199;	199|Brachmann-de Lange syndrome|1-9 / 100 000|Autosomal dominant<br>or&nbsp;X-linked recessive<br>or&nbsp;Not applicable|Neonatal<br>Antenatal|122470 300590 300882 610759 614701 ~	.	.	.	.	.	.	.	.	X	1(haematopoietic_and_lymphoid_tissue)	0.5676
X	53563589	53563589	A	G	HUWE1	exonic	synonymous SNV	ENSG00000086758	rs426298	ENSG00000086758:ENST00000342160:exon78:c.T12177C:p.G4059G,ENSG00000086758:ENST00000262854:exon79:c.T12177C:p.G4059G	HUWE1:NM_031407:exon79:c.T12177C:p.G4059G	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9973	0.9920	0.994967	0.9942	.	.	.	.	.	.	.	.	HUWE1:uc004dsn.4:exon48:c.T8601C:p.G2867G,HUWE1:uc004dsp.4:exon79:c.T12177C:p.G4059G	.	AFR:0.9787,AMR:0.9984,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	MU82057962	hom
X	53611282	53611282	T	C	HUWE1	exonic	synonymous SNV	ENSG00000086758	rs782240883	ENSG00000086758:ENST00000342160:exon40:c.A5025G:p.R1675R,ENSG00000086758:ENST00000262854:exon41:c.A5025G:p.R1675R	HUWE1:NM_031407:exon41:c.A5025G:p.R1675R	clinvar: Benign 	 CancerVar: 0#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 1, 0, 0, 0] 	0.0037	.	0.00768212	0.0001	.	.	.	.	.	.	.	.	HUWE1:uc004dsn.4:exon10:c.A1500G:p.R500R,HUWE1:uc004dsp.4:exon41:c.A5025G:p.R1675R	.	AFR:0,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0.0042,ASJ:0	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	.	het
X	53641647	53641647	T	C	HUWE1	exonic	synonymous SNV	ENSG00000086758	rs6638360	ENSG00000086758:ENST00000342160:exon22:c.A2109G:p.S703S,ENSG00000086758:ENST00000218328:exon23:c.A2109G:p.S703S,ENSG00000086758:ENST00000262854:exon23:c.A2109G:p.S703S	HUWE1:NM_031407:exon23:c.A2109G:p.S703S	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4895	0.3779	0.389669	LICA-CN|1|402|0.00248756,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579	.	.	.	.	.	.	.	.	HUWE1:uc004dsp.4:exon23:c.A2109G:p.S703S	.	AFR:0.4342,AMR:0.0918,EAS:0.5222,FIN:0.5035,NFE:0.5784,OTH:0.5694,ASJ:0.5237	300697	300706;	85328;	85328|-|<1 / 1 000 000|X-linked dominant|-|300706 ~	.	.	.	.	.	.	.	.	X	2(haematopoietic_and_lymphoid_tissue)	0.5319
X	76937963	76937963	G	C	ATRX	exonic	nonsynonymous SNV	ENSG00000085224	rs3088074	ENSG00000085224:ENST00000395603:exon8:c.C2671G:p.Q891E,ENSG00000085224:ENST00000373344:exon9:c.C2785G:p.Q929E	ATRX:NM_138270:exon8:c.C2671G:p.Q891E,ATRX:NM_000489:exon9:c.C2785G:p.Q929E	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 1, 0, 1, 0, 0, 0, -1, 2, 0, 1, 0] 	0.3924	0.5083	0.552318	78(meninges)	.	.	.	.	.	.	.	.	ATRX:uc004ecq.4:exon8:c.C2671G:p.Q891E,ATRX:uc010nly.1:exon8:c.C2620G:p.Q874E,ATRX:uc004ecp.4:exon9:c.C2785G:p.Q929E,ATRX:uc004ecr.2:exon9:c.C2581G:p.Q861E,ATRX:uc004eco.4:exon10:c.C2140G:p.Q714E,ATRX:uc010nlx.1:exon10:c.C2698G:p.Q900E	.	AFR:2(urinary_tract),AMR:MU152592,EAS:0.4765,FIN:0.8691,NFE:0.2512,OTH:0.3161,ASJ:COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	300504	.	.	.	.	.	,933	.	.	.	.	.	X	1(large_intestine)	0.4430
X	96139406	96139406	G	A	RPA4	exonic	nonsynonymous SNV	ENSG00000204086	rs2642219	ENSG00000204086:ENST00000373040:exon1:c.G97A:p.A33T	RPA4:NM_013347:exon1:c.G97A:p.A33T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3297	0.4205	0.401854	LICA-CN|1|402|0.00248756,LUSC-KR|1|170|0.00588235,COCA-CN|2|321|0.00623053	-0.340	0.538	0.222	1.31	0.000	.	.	.	RPA4:uc004efv.4:exon1:c.G97A:p.A33T	-1.004	AFR:0.3766,AMR:0.6483,EAS:0.2414,FIN:0.3333,NFE:0.2502,OTH:0.2741,ASJ:0.4013	300767	.	.	.	.	.	.	.	0.18	2.21	0.000	0.695	X	1(lung)	0.2553
X	96139459	96139459	T	C	RPA4	exonic	synonymous SNV	ENSG00000204086	rs2642218	ENSG00000204086:ENST00000373040:exon1:c.T150C:p.N50N	RPA4:NM_013347:exon1:c.T150C:p.N50N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3313	0.4232	0.406093	LICA-CN|1|402|0.00248756,COCA-CN|2|321|0.00623053	.	.	.	.	.	.	.	.	RPA4:uc004efv.4:exon1:c.T150C:p.N50N	.	AFR:0.3798,AMR:0.6565,EAS:0.2363,FIN:0.3277,NFE:0.2487,OTH:0.2743,ASJ:0.4142	300767	.	.	.	.	.	.	.	.	.	.	.	X	1(stomach)	0.2566
X	100608191	100608191	G	A	BTK	exonic	synonymous SNV	ENSG00000010671	rs1135363	ENSG00000010671:ENST00000372880:exon16:c.C1371T:p.C457C,ENSG00000010671:ENST00000308731:exon18:c.C1899T:p.C633C	BTK:NM_001287345:exon16:c.C1371T:p.C457C,BTK:NM_000061:exon18:c.C1899T:p.C633C,BTK:NM_001287344:exon18:c.C2001T:p.C667C	clinvar: Benign 	 CancerVar: 4#Tier_III_Uncertain EVS=[0, 0, 1, 0, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3208	0.3904	0.508079	MU20355874	.	.	.	.	.	.	.	.	BTK:uc010nnl.2:exon5:c.C327T:p.C109C,BTK:uc004ehf.2:exon6:c.C399T:p.C133C,BTK:uc010nnn.2:exon16:c.C1371T:p.C457C,BTK:uc004ehg.2:exon18:c.C1899T:p.C633C,BTK:uc010nno.2:exon18:c.C2001T:p.C667C	.	AFR:LAML-KR|1|205|0.00487805,LUSC-KR|3|170|0.0176471,COCA-CN|3|321|0.00934579,AMR:0.3666,EAS:0.5041,FIN:0.1492,NFE:0.4289,OTH:0.1658,ASJ:0.8149	300300	300755;307200;	231692;631;632;229717;47;	231692|Congenital IGHD type III<br>Congenital isolated GH deficiency type III<br>Congenital isolated growth hormone deficiency type III<br>X-linked IGHD<br>X-linked isolated growth hormone deficiency|-|X-linked recessive|Infancy<br>Neonatal|300123 307200 ~631|Congenital IGHD<br>Congenital isolated GH deficiency<br>Congenital isolated growth hormone deficiency|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal|173100 262400 262650 300123 307200 612781 ~632|-|-|X-linked recessive|Infancy<br>Neonatal|307200 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~47|BTK-deficiency<br>Bruton type agammaglobulinemia|1-9 / 1 000 000|X-linked recessive<br>or&nbsp;Not applicable|Childhood|300310 300755 ~	.	.	.	1857,	.	.	.	.	X	1(haematopoietic_and_lymphoid_tissue)	0.1657
X	100645467	100645467	T	C	BTK	exonic	nonsynonymous SNV	ENSG00000241343;ENSG00000257529	rs5951308	.	BTK:NM_001287344:exon1:c.A71G:p.E24G	clinvar: Benign 	 CancerVar: 5#Tier_III_Uncertain EVS=[0, 0, 1, 1, 0, 0, 0, -1, 2, 0, 1, 1] 	0.3387	.	0.399205	0.3149	-0.099	1.736	.	-0.875	0.000	0.0001	0	PH domain-like|Pleckstrin homology domain	BTK:uc010nno.2:exon1:c.A71G:p.E24G	.	AFR:0.7493,AMR:0.3268,EAS:0.1166,FIN:0.1100,NFE:0.1542,OTH:0.1903,ASJ:0.1330	300300	300755;307200;	231692;631;632;229717;47;	231692|Congenital IGHD type III<br>Congenital isolated GH deficiency type III<br>Congenital isolated growth hormone deficiency type III<br>X-linked IGHD<br>X-linked isolated growth hormone deficiency|-|X-linked recessive|Infancy<br>Neonatal|300123 307200 ~631|Congenital IGHD<br>Congenital isolated GH deficiency<br>Congenital isolated growth hormone deficiency|1-5 / 10 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal|173100 262400 262650 300123 307200 612781 ~632|-|-|X-linked recessive|Infancy<br>Neonatal|307200 ~229717|Isolated hypogammaglobulinemia|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|300310 300755 601495 612692 613500 613501 613502 613506 615214 616941 ~47|BTK-deficiency<br>Bruton type agammaglobulinemia|1-9 / 1 000 000|X-linked recessive<br>or&nbsp;Not applicable|Childhood|300310 300755 ~	.	.	.	1857,	.	.	.	.	X	MU13522464	het
X	100653950	100653950	T	C	GLA;RPL36A-HNRNPH2	intronic	.	ENSG00000102393;ENSG00000257529	rs2071397	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1447	0.1307	0.16106	LAML-KR|1|205|0.00487805,COCA-CN|1|321|0.00311526	.	.	.	.	.	.	.	.	.	.	AFR:0.1234,AMR:0.1412,EAS:0.1223,FIN:0.0890,NFE:0.0995,OTH:0.1226,ASJ:0.1361	.	.	.	.	.	.	.	.	.	.	.	.	X	2(haematopoietic_and_lymphoid_tissue)	0.1151
X	100662901	100662901	G	A	GLA	UTR5	.	ENSG00000102393	rs2071225	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.0955	0.0628	0.124503	0.0654	.	.	.	.	.	.	.	.	.	.	AFR:0.0627,AMR:0.1,EAS:0.0750,FIN:0.0712,NFE:0.0609,OTH:0.0956,ASJ:0.0376	300644	301500;	324;	324|Alpha-galactosidase A deficiency<br>Anderson-Fabry disease<br>Angiokeratoma corporis diffusum<br>Diffuse angiokeratoma<br>FD|1-5 / 10 000|X-linked recessive|Childhood|301500 ~	.	.	.	.	.	.	.	.	X	MU13522484	het
X	118985711	118985711	-	TTTTTTTTTTTTTT	UPF3B	intronic	.	ENSG00000125351	rs779620679	.	.	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0] 	.	.	0.255629	.	.	.	.	.	.	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300298	300676;	776;	776|Lujan syndrome<br>Lujan-Fryns syndrome<br>X-linked mental retardation with marfanoid habitus<br>XLMR with marfanoid habitus|Unknown|X-linked recessive|Infancy<br>Neonatal|300676 309520 ~	.	.	.	.	.	.	.	.	X	.	hom
X	123041043	123041043	A	G	XIAP	UTR3	.	ENSG00000101966	rs28382740	.	.	clinvar: Benign 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 1, 0] 	0.2695	0.1868	0.267285	0.1955	.	.	.	.	.	.	.	.	.	.	AFR:0.1521,AMR:0.1967,EAS:0.3477,FIN:0.2493,NFE:0.1916,OTH:0.2025,ASJ:0.1892	300079	300635;	2442;	2442|Duncan disease<br>Purtilo syndrome<br>XLP|<1 / 1 000 000|X-linked recessive|Childhood|300635 308240 ~	~ko01524 Platinum drug resistance~ko04064 NF-kappa B signaling pathway~ko04120 Ubiquitin mediated proteolysis~ko04210 Apoptosis~ko04214 Apoptosis - fly~ko04215 Apoptosis - multiple species~ko04217 Necroptosis~ko04510 Focal adhesion~ko04621 NOD-like receptor signaling pathway~ko05145 Toxoplasmosis~ko05166 Human T-cell leukemia virus 1 infection~ko05200 Pathways in cancer~ko05222 Small cell lung cancer ~	.	.	.	.	.	.	.	X	MU697625	het
X	129147079	129147079	T	C	BCORL1	exonic	nonsynonymous SNV	ENSG00000085185	rs4830173	ENSG00000085185:ENST00000540052:exon3:c.T331C:p.F111L,ENSG00000085185:ENST00000218147:exon4:c.T331C:p.F111L,ENSG00000085185:ENST00000303743:exon4:c.T331C:p.F111L,ENSG00000085185:ENST00000359304:exon4:c.T331C:p.F111L	BCORL1:NM_001184772:exon3:c.T331C:p.F111L,BCORL1:NM_021946:exon3:c.T331C:p.F111L	clinvar: UNK 	 CancerVar: 6#Tier_III_Uncertain EVS=[1, 0, 0, 1, 0, 0, 0, 0, 2, 0, 1, 1] 	1.0000	.	1	1	.	.	.	.	.	.	.	.	BCORL1:uc010nrd.1:exon1:c.T37C:p.F13L,BCORL1:uc022cdu.1:exon3:c.T331C:p.F111L	.	AFR:1,AMR:1,EAS:1,FIN:1,NFE:1,OTH:1,ASJ:1	300688	.	.	.	.	,968	.	.	.	.	.	.	X	MU82059516	hom
X	140983064	140983064	G	A	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs176024	ENSG00000165509:ENST00000448920:exon4:c.G175A:p.A59T,ENSG00000165509:ENST00000298296:exon5:c.G919A:p.A307T	MAGEC3:NM_138702:exon5:c.G919A:p.A307T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.8454	0.8996	0.713907	1(stomach)	0.945	10.34	0.21	0.007	0.000	.	.	MAGE homology domain	MAGEC3:uc011mwp.2:exon5:c.G919A:p.A307T	-1.058	AFR:1(haematopoietic_and_lymphoid_tissue),AMR:MU4555845,EAS:0.8706,FIN:0.8067,NFE:0.7443,OTH:0.9399,ASJ:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	300469	.	.	.	.	.	.	.	0.001	4.02	0.000	-0.505	X	1(large_intestine)	0.4662
X	140983127	140983127	G	A	MAGEC3	exonic	nonsynonymous SNV	ENSG00000165509	rs176026	ENSG00000165509:ENST00000448920:exon4:c.G238A:p.A80T,ENSG00000165509:ENST00000298296:exon5:c.G982A:p.A328T	MAGEC3:NM_138702:exon5:c.G982A:p.A328T	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.7950	0.7776	0.616689	1(lung)	2.885	21.8	0.019	0.684	0.001	.	.	MAGE homology domain	MAGEC3:uc011mwp.2:exon5:c.G982A:p.A328T	-0.972	AFR:MU128713,AMR:LICA-CN|1|402|0.00248756,LAML-KR|2|205|0.0097561,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579,EAS:0.5052,FIN:0.7178,NFE:0.8913,OTH:0.4501,ASJ:0.7762	300469	.	.	.	.	.	.	.	0.98	3.78	0.000	1.885	X	1(stomach)	0.9066
X	140993852	140993852	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176038	ENSG00000155495:ENST00000285879:exon4:c.C662G:p.T221S	MAGEC1:NM_005462:exon4:c.C662G:p.T221S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3109	.	.	5(biliary_tract)	-1.617	0.002	0.612	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C662G:p.T221S	-0.928	AFR:18(upper_aerodigestive_tract),AMR:1(skin),EAS:MU24313706,FIN:SKCA-BR|1|100|0.01,LICA-CN|5|402|0.0124378,LAML-KR|1|205|0.00487805,LUSC-KR|2|170|0.0117647,COCA-CN|3|321|0.00934579,THCA-CN|2|50|0.04,NFE:0.4042,OTH:0.4465,ASJ:1(haematopoietic_and_lymphoid_tissue)	300223	.	.	.	.	.	.	.	0.002	3.86	0.005	1.1	X	4(thyroid)	0.4260
X	140993858	140993858	G	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs751644848	ENSG00000155495:ENST00000285879:exon4:c.G668A:p.S223N	MAGEC1:NM_005462:exon4:c.G668A:p.S223N	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 2, -1, 0, 0] 	0	.	0.000264901	.	0.449	7.032	0.006	.	0.001	.	.	.	MAGEC1:uc004fbt.3:exon4:c.G668A:p.S223N	-0.918	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	300223	.	.	.	.	.	.	.	0.034	4.27	0.005	1.65	X	MU85155170	het
X	140993859	140993859	T	A	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs6634333	ENSG00000155495:ENST00000285879:exon4:c.T669A:p.S223R	MAGEC1:NM_005462:exon4:c.T669A:p.S223R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3075	.	0.410861	1(skin)	1.014	10.74	0.352	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T669A:p.S223R	-0.927	AFR:MU29513613,AMR:SKCA-BR|1|100|0.01,LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,THCA-CN|1|50|0.02,EAS:0.4339,FIN:0.3969,NFE:0.3649,OTH:0.3150,ASJ:0.4004	300223	.	.	.	.	.	.	.	0.162	4.26	0.004	1.65	X	1(bone)	0.3734
X	140993864	140993864	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs34836042	ENSG00000155495:ENST00000285879:exon4:c.T674C:p.F225S	MAGEC1:NM_005462:exon4:c.T674C:p.F225S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.3129	.	.	2(thyroid)	-1.227	0.006	0.41	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T674C:p.F225S	-0.927	AFR:1(pancreas),AMR:1(kidney),EAS:LICA-CN|1|402|0.00248756,LUSC-KR|2|170|0.0117647,COCA-CN|1|321|0.00311526,THCA-CN|1|50|0.02,FIN:0.4010,NFE:0.4345,OTH:0.3969,ASJ:MU633586	300223	.	.	.	.	.	.	.	0.002	4.41	0.003	1.1	X	1(haematopoietic_and_lymphoid_tissue)	0.3649
X	140993877	140993877	C	A	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs176039	ENSG00000155495:ENST00000285879:exon4:c.C687A:p.A229A	MAGEC1:NM_005462:exon4:c.C687A:p.A229A	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.3381	.	.	1(upper_aerodigestive_tract)	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C687A:p.A229A	.	AFR:1(skin),AMR:MU624431,EAS:0.3915,FIN:0.4299,NFE:0.4207,OTH:0.3662,ASJ:SKCA-BR|1|100|0.01,LICA-CN|3|402|0.00746269,LUSC-KR|1|170|0.00588235,COCA-CN|3|321|0.00934579	300223	.	.	.	.	.	.	.	.	.	.	.	X	2(large_intestine)	0.3098
X	140993905	140993905	C	T	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176040	ENSG00000155495:ENST00000285879:exon4:c.C715T:p.P239S	MAGEC1:NM_005462:exon4:c.C715T:p.P239S	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.4364	.	0.329272	2(large_intestine)	-1.155	0.008	0.465	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C715T:p.P239S	-0.926	AFR:MU578592,AMR:LICA-CN|3|402|0.00746269,LUSC-KR|2|170|0.0117647,EAS:0.4115,FIN:0.4096,NFE:0.3731,OTH:0.2952,ASJ:0.4009	300223	.	.	.	.	.	.	.	0.002	4.35	0.000	0	X	2(stomach)	0.3991
X	140993913	140993913	C	G	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs176041	ENSG00000155495:ENST00000285879:exon4:c.C723G:p.S241S	MAGEC1:NM_005462:exon4:c.C723G:p.S241S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.4509	.	.	MU578589	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C723G:p.S241S	.	AFR:LICA-CN|3|402|0.00746269,LUSC-KR|3|170|0.0176471,AMR:0.3260,EAS:0.3477,FIN:0.3594,NFE:0.2277,OTH:0.3174,ASJ:0.3468	300223	.	.	.	.	.	.	.	.	.	.	.	X	1(stomach)	0.3273
X	140993989	140993989	T	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs77648555	ENSG00000155495:ENST00000285879:exon4:c.T799C:p.S267P	MAGEC1:NM_005462:exon4:c.T799C:p.S267P	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1739	0.4526	0.536159	LAML-KR|1|205|0.00487805,THCA-CN|1|50|0.02	-2.009	0.001	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T799C:p.S267P	-0.951	AFR:0.1795,AMR:0.1165,EAS:0.2683,FIN:0.1216,NFE:0.1693,OTH:0.2173,ASJ:0.2087	300223	.	.	.	.	.	.	.	0.0	4.22	0.000	-0.77	X	2(thyroid)	0.2324
X	140993991	140993991	T	A	MAGEC1	exonic	synonymous SNV	ENSG00000155495	rs146036055	ENSG00000155495:ENST00000285879:exon4:c.T801A:p.S267S	MAGEC1:NM_005462:exon4:c.T801A:p.S267S	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.0068	0.0253	0.121589	0.0047	.	.	.	.	.	.	.	.	MAGEC1:uc004fbt.3:exon4:c.T801A:p.S267S	.	AFR:0.0067,AMR:0.0137,EAS:0.0044,FIN:0.0071,NFE:0.0023,OTH:0.0027,ASJ:0	300223	.	.	.	.	.	.	.	.	.	.	.	X	MU30446139	het
X	140994011	140994011	C	G	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176043	ENSG00000155495:ENST00000285879:exon4:c.C821G:p.P274R	MAGEC1:NM_005462:exon4:c.C821G:p.P274R	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0032	.	0.0768212	LUSC-KR|2|170|0.0117647	-0.305	0.647	0.585	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.C821G:p.P274R	-0.960	AFR:0.0029,AMR:0.0029,EAS:0,FIN:0.0014,NFE:0.0041,OTH:0.0030,ASJ:0	300223	.	.	.	.	.	.	.	0.969	4.29	0.001	1.24	X	4(haematopoietic_and_lymphoid_tissue)	0.0024
X	140994031	140994031	G	C	MAGEC1	exonic	nonsynonymous SNV	ENSG00000155495	rs176044	ENSG00000155495:ENST00000285879:exon4:c.G841C:p.V281L	MAGEC1:NM_005462:exon4:c.G841C:p.V281L	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.0236	0.1037	0.182517	1(biliary_tract)	-1.663	0.002	1.0	.	0.000	.	.	.	MAGEC1:uc004fbt.3:exon4:c.G841C:p.V281L	-0.982	AFR:MU3662006,AMR:LIRI-JP|1|258|0.00387597,LICA-CN|2|402|0.00497512,COCA-CN|2|321|0.00623053,EAS:0.0237,FIN:0.2110,NFE:0,OTH:0.0773,ASJ:0.0264	300223	.	.	.	.	.	.	.	0.002	4.21	0.000	-1.3	X	2(thyroid)	0.0192
X	141290865	141290865	C	T	MAGEC2	exonic	synonymous SNV	ENSG00000046774	rs3765272	ENSG00000046774:ENST00000247452:exon3:c.G909A:p.P303P	MAGEC2:NM_016249:exon3:c.G909A:p.P303P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.7018	0.6634	0.713377	0.6605	.	.	.	.	.	.	.	.	MAGEC2:uc022cfj.1:exon1:c.G909A:p.P303P,MAGEC2:uc004fbu.2:exon3:c.G909A:p.P303P	.	AFR:0.6071,AMR:0.7406,EAS:0.8593,FIN:0.6454,NFE:0.6685,OTH:0.6695,ASJ:0.7111	300468	.	.	.	.	.	.	.	.	.	.	.	X	MU4558141	het
X	147018146	147018146	C	T	FMR1	intronic	.	ENSG00000102081	rs25714	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.1639	0.0900	0.261192	LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611,BRCA-KR|1|50|0.02	.	.	.	.	.	.	.	.	.	.	AFR:0.1211,AMR:0.1197,EAS:0.0588,FIN:0.7473,NFE:0.0561,OTH:0.0716,ASJ:0.2570	309550	300623;300624;311360;	449291;908;93256;	449291|-|Unknown|X-linked dominant|Neonatal<br>Infancy<br>Childhood|300624 ~908|FRAXA syndrome<br>FXS<br>FraX syndrome<br>Martin-Bell syndrome|1-5 / 10 000|X-linked dominant|Neonatal<br>Infancy<br>Childhood|300624 ~93256|FXTAS syndrome|1-9 / 100 000|X-linked dominant|Adult|300623 ~	.	.	.	.	.	.	.	.	X	1(lung)	0.1033
X	150884620	150884620	C	T	FATE1	exonic	nonsynonymous SNV	ENSG00000147378	rs3810715	ENSG00000147378:ENST00000370350:exon1:c.C29T:p.A10V,ENSG00000147378:ENST00000417321:exon1:c.C5T:p.A2V	FATE1:NM_033085:exon1:c.C29T:p.A10V	clinvar: UNK 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, -1, 0, 0] 	0.1027	0.0874	0.117881	0.1166	2.065	16.63	0.242	3.0	0.028	.	.	.	FATE1:uc004fex.3:exon1:c.C29T:p.A10V	-1.057	AFR:0.0584,AMR:0.1100,EAS:0.2347,FIN:0.1615,NFE:0.1252,OTH:0.1296,ASJ:0.1514	300450	.	.	.	.	.	.	.	0.767	0.86	0.000	0	X	MU160094	het
X	150889857	150889857	C	T	FATE1	intronic	.	ENSG00000147378	rs72612761	.	.	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.1130	0.1236	0.132715	0.1091	.	.	.	.	.	0.0001	0	.	.	.	AFR:0.1296,AMR:0.0905,EAS:0.2108,FIN:0.0634,NFE:0.1002,OTH:0.1088,ASJ:0.1164	300450	.	.	.	.	.	.	.	.	.	.	.	X	MU16320943	het
X	153132842	153132842	C	G	L1CAM	exonic	synonymous SNV	ENSG00000198910	.	ENSG00000198910:ENST00000361981:exon15:c.G2091C:p.P697P,ENSG00000198910:ENST00000361699:exon16:c.G2106C:p.P702P,ENSG00000198910:ENST00000370055:exon16:c.G2091C:p.P697P,ENSG00000198910:ENST00000370057:exon16:c.G2106C:p.P702P,ENSG00000198910:ENST00000538883:exon16:c.G2112C:p.P704P,ENSG00000198910:ENST00000543994:exon16:c.G2112C:p.P704P,ENSG00000198910:ENST00000370060:exon17:c.G2106C:p.P702P	L1CAM:NM_001143963:exon15:c.G2091C:p.P697P,L1CAM:NM_000425:exon16:c.G2106C:p.P702P,L1CAM:NM_024003:exon16:c.G2106C:p.P702P,L1CAM:NM_001278116:exon17:c.G2106C:p.P702P	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0] 	.	.	.	.	.	.	.	.	.	.	.	.	L1CAM:uc010nuo.4:exon15:c.G2091C:p.P697P,L1CAM:uc004fjb.4:exon16:c.G2106C:p.P702P,L1CAM:uc004fjc.4:exon16:c.G2106C:p.P702P,L1CAM:uc031tks.1:exon17:c.G2106C:p.P702P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,ASJ:.	308840	303350;304100;307000;	2182;275543;1497;275543;2466;275543;	2182|Bickers-Adams syndrome<br>HSAS<br>X-linked HSAS<br>X-linked acqueductal stenosis<br>X-linked hydrocephalus<br>X-linked hydrocephalus with stenosis of aqueduct of Sylvius|1-9 / 100 000|X-linked recessive|Antenatal<br>Neonatal|307000 ~275543|CRASH syndrome<br>Corpus callosum hypoplasia-retardation-adducted thumbs-spasticity-hydrocephalus syndrome<br>L1CAM syndrome|Unknown|X-linked recessive|Infancy<br>Neonatal|303350 304100 307000 ~1497|-|<1 / 1 000 000|X-linked recessive|Neonatal<br>Antenatal|304100 ~275543|CRASH syndrome<br>Corpus callosum hypoplasia-retardation-adducted thumbs-spasticity-hydrocephalus syndrome<br>L1CAM syndrome|Unknown|X-linked recessive|Infancy<br>Neonatal|303350 304100 307000 ~2466|Intellectual disability-aphasia-shuffling gait-adducted thumbs syndrome|Unknown|X-linked recessive|Neonatal|303350 ~275543|CRASH syndrome<br>Corpus callosum hypoplasia-retardation-adducted thumbs-spasticity-hydrocephalus syndrome<br>L1CAM syndrome|Unknown|X-linked recessive|Infancy<br>Neonatal|303350 304100 307000 ~	.	.	.	.	.	.	.	.	X	.	het
X	153218365	153218365	C	A	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs3027878	ENSG00000172534:ENST00000310441:exon19:c.G4542T:p.L1514L,ENSG00000172534:ENST00000369984:exon19:c.G4674T:p.L1558L,ENSG00000172534:ENST00000354233:exon20:c.G4335T:p.L1445L	HCFC1:NM_005334:exon19:c.G4542T:p.L1514L	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.4065	0.1192	0.383841	MU27601772	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon19:c.G4542T:p.L1514L	.	AFR:LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611,AMR:0.1675,EAS:0.4943,FIN:0.2663,NFE:0.7549,OTH:0.1337,ASJ:0.0704	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.1494
X	153219665	153219665	C	T	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs2071133	ENSG00000172534:ENST00000310441:exon17:c.G4185A:p.A1395A,ENSG00000172534:ENST00000369984:exon17:c.G4185A:p.A1395A,ENSG00000172534:ENST00000354233:exon18:c.G3978A:p.A1326A	HCFC1:NM_005334:exon17:c.G4185A:p.A1395A	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3173	0.1513	0.403179	COCA-CN|5|321|0.0155763	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon17:c.G4185A:p.A1395A	.	AFR:0.2003,AMR:0.1108,EAS:0.2762,FIN:0.7653,NFE:0.1721,OTH:0.1801,ASJ:0.5083	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.2348
X	153220360	153220360	A	G	HCFC1	exonic	nonsynonymous SNV	ENSG00000172534	rs1051152	ENSG00000172534:ENST00000310441:exon17:c.T3490C:p.S1164P,ENSG00000172534:ENST00000369984:exon17:c.T3490C:p.S1164P,ENSG00000172534:ENST00000354233:exon18:c.T3283C:p.S1095P	HCFC1:NM_005334:exon17:c.T3490C:p.S1164P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 1, 0, 0, 0, -1, 2, -1, 0, 0] 	0.5008	0.3424	0.58596	1(large_intestine)	-0.925	0.023	1.0	-0.339	0.731	.	.	Immunoglobulin-like fold	HCFC1:uc004fjp.3:exon17:c.T3490C:p.S1164P	-1.026	AFR:1(pancreas),AMR:MU1777482,EAS:0.3640,FIN:0.6809,NFE:0.5435,OTH:0.2841,ASJ:LUSC-KR|1|170|0.00588235,COCA-CN|4|321|0.0124611	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	0.0	4.25	0.000	-2.125	X	1(lung)	0.7737
X	153221657	153221657	T	C	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs730106	ENSG00000172534:ENST00000310441:exon16:c.A2841G:p.P947P,ENSG00000172534:ENST00000369984:exon16:c.A2841G:p.P947P,ENSG00000172534:ENST00000354233:exon17:c.A2634G:p.P878P	HCFC1:NM_005334:exon16:c.A2841G:p.P947P	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3737	0.3636	0.585166	0.3632	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon16:c.A2841G:p.P947P	.	AFR:0.6821,AMR:0.5468,EAS:0.7704,FIN:0.1785,NFE:0.1877,OTH:0.2744,ASJ:0.3011	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	MU21067151	hom
X	153222835	153222835	G	C	HCFC1	exonic	synonymous SNV	ENSG00000172534	rs2071134	ENSG00000172534:ENST00000310441:exon13:c.C2283G:p.T761T,ENSG00000172534:ENST00000369984:exon13:c.C2283G:p.T761T,ENSG00000172534:ENST00000354233:exon14:c.C2076G:p.T692T	HCFC1:NM_005334:exon13:c.C2283G:p.T761T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.2882	0.1158	0.384106	LUSC-KR|3|170|0.0176471,COCA-CN|4|321|0.0124611	.	.	.	.	.	.	.	.	HCFC1:uc004fjp.3:exon13:c.C2283G:p.T761T	.	AFR:0.1662,AMR:0.0685,EAS:0.2637,FIN:0.7525,NFE:0.1326,OTH:0.1498,ASJ:0.4894	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	1(stomach)	0.2090
X	153227770	153227770	G	A	HCFC1	intronic	.	ENSG00000172534	rs59607260	.	.	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.3419	0.1494	0.404503	0.2011	.	.	.	.	.	.	.	.	.	.	AFR:0.1162,AMR:0.5,EAS:0.7677,FIN:0.1725,NFE:0.1815,OTH:0.2293,ASJ:0.2826	300019	309541;	369962;	369962|Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX<br>Methylmalonic aciduria with homocystinuria, type cblX|<1 / 1 000 000|X-linked recessive|Infancy<br>Neonatal|309541 ~	.	.	.	.	.	.	.	.	X	MU27601829	hom
X	153994596	153994596	G	T	DKC1	exonic	synonymous SNV	ENSG00000130826	rs2728532	ENSG00000130826:ENST00000452771:exon4:c.G327T:p.T109T,ENSG00000130826:ENST00000369550:exon5:c.G369T:p.T123T,ENSG00000130826:ENST00000413910:exon5:c.G369T:p.T123T	DKC1:NM_001142463:exon5:c.G369T:p.T123T,DKC1:NM_001288747:exon5:c.G369T:p.T123T,DKC1:NM_001363:exon5:c.G369T:p.T123T	clinvar: Benign 	 CancerVar: 1#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, -1, 2, 0, 0, 0] 	0.9974	0.9919	0.992583	0.9937	.	.	.	.	.	.	.	.	DKC1:uc004fmm.3:exon5:c.G369T:p.T123T,DKC1:uc010nvf.3:exon5:c.G369T:p.T123T	.	AFR:0.9777,AMR:0.9935,EAS:1,FIN:1,NFE:1,OTH:0.9986,ASJ:1	300126	305000;	1775;3322;	1775|DC<br>DKC<br>Zinsser-Engman-Cole syndrome|1-9 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Neonatal<br>Infancy<br>Childhood<br>Adolescent<br>Adult|127550 224230 305000 613987 613988 613989 613990 615190 616353 ~3322|Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome|<1 / 1 000 000|Autosomal dominant<br>or&nbsp;Autosomal recessive<br>or&nbsp;X-linked recessive|Infancy<br>Neonatal|305000 613989 613990 615190 616353 616553 ~	.	.	.	.	.	.	.	.	X	MU82060809	hom
X	154020114	154020114	C	A	MPP1	exonic	synonymous SNV	ENSG00000130830	rs1126762	ENSG00000130830:ENST00000369531:exon3:c.G204T:p.T68T,ENSG00000130830:ENST00000369534:exon3:c.G255T:p.T85T,ENSG00000130830:ENST00000393529:exon3:c.G117T:p.T39T,ENSG00000130830:ENST00000393531:exon3:c.G255T:p.T85T,ENSG00000130830:ENST00000413259:exon4:c.G165T:p.T55T	MPP1:NM_001166460:exon3:c.G204T:p.T68T,MPP1:NM_001166461:exon3:c.G255T:p.T85T,MPP1:NM_002436:exon3:c.G255T:p.T85T,MPP1:NM_001166462:exon4:c.G165T:p.T55T	clinvar: UNK 	 CancerVar: 2#Tier_IV_benign EVS=[0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0] 	0.6400	0.5528	0.544106	0.5864	.	.	.	.	.	.	.	.	MPP1:uc004fmp.2:exon3:c.G255T:p.T85T,MPP1:uc010nvg.2:exon3:c.G255T:p.T85T,MPP1:uc011mzw.2:exon3:c.G204T:p.T68T,MPP1:uc011mzv.2:exon4:c.G165T:p.T55T	.	AFR:0.2496,AMR:0.5728,EAS:0.7547,FIN:0.7600,NFE:0.7057,OTH:0.7155,ASJ:0.6441	305360	.	.	.	.	.	.	.	.	.	.	.	X	MU13868845	hom
